<SEC-DOCUMENT>0001493152-25-004524.txt : 20250203
<SEC-HEADER>0001493152-25-004524.hdr.sgml : 20250203
<ACCEPTANCE-DATETIME>20250203061619
ACCESSION NUMBER:		0001493152-25-004524
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		104
FILED AS OF DATE:		20250203
DATE AS OF CHANGE:		20250203

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OneMedNet Corp
		CENTRAL INDEX KEY:			0001849380
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				862076743
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276130
		FILM NUMBER:		25580470

	BUSINESS ADDRESS:	
		STREET 1:		TRIDENT COURT, 1 OAKCROFT ROAD
		STREET 2:		CHESSINGTON
		CITY:			SURREY
		STATE:			X0
		ZIP:			KT9 1BD
		BUSINESS PHONE:		011-44-208-090-2009

	MAIL ADDRESS:	
		STREET 1:		TRIDENT COURT, 1 OAKCROFT ROAD
		STREET 2:		CHESSINGTON
		CITY:			SURREY
		STATE:			X0
		ZIP:			KT9 1BD

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Data Knights Acquisition Corp.
		DATE OF NAME CHANGE:	20210304
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ONMD="http://onemednet.com/20240930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_ONMD_onemednet.com_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20240101_20240930 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_058_edei%2D%2DEntityCentralIndexKey_0001849380 -->
<!-- Field: Set; Name: xdx; ID: xdx_07A_XDX_Z%2D%2D\2025 OPERATIONS\EDGAR\01 JANUARY\ONEMEDNET CORPORATION\01%2D08%2D2025\Form S%2D1A\Draft\Production\form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_064_Integer_5_Integer -->
<!-- Field: Set; Name: xdx; ID: xdx_06E_CAD_0_iso4217%2D%2DCAD -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000004" name="dei:EntityCentralIndexKey">0001849380</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0013" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:CryptoAssetFairValue" contextRef="AsOf2023-12-31_custom_RestatedMember" id="xdx2ixbrl0047" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:YorkvilleNotesPayableCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="xdx2ixbrl0092" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-09-30" id="xdx2ixbrl0118" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31_custom_RestatedMember" id="xdx2ixbrl0119" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-09-30" id="xdx2ixbrl0130" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31_custom_RestatedMember" id="xdx2ixbrl0131" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TreasuryStockCommonValue" contextRef="AsOf2023-12-31_custom_RestatedMember" id="xdx2ixbrl0172" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0253" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0255" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0263" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:GainLossOnFairValueOfYorkvilleNote" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:GainLossOnFairValueOfYorkvilleNote" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0274" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0275" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0278" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0280" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0284" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl0287" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl0356" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0365" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0390" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_custom_TemporaryEquityMember" id="xdx2ixbrl0400" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0407" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0408" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_custom_TemporaryEquityMember" id="xdx2ixbrl0409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0426" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2024-04-012024-06-30" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0437" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_custom_TemporaryEquityMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0444" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_custom_TemporaryEquityMember" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0476" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0487" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0488" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_custom_TemporaryEquityMember" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0496" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0497" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0498" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_custom_TemporaryEquityMember" id="xdx2ixbrl0504" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0518" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0530" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember" id="xdx2ixbrl0531" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0532" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0534" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0538" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember" id="xdx2ixbrl0539" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0540" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0542" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0546" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember" id="xdx2ixbrl0547" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0548" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0556" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0568" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember" id="xdx2ixbrl0569" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0570" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0572" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-04-012023-06-30" id="xdx2ixbrl0573" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0578" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember" id="xdx2ixbrl0579" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0580" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0582" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0586" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember" id="xdx2ixbrl0587" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0588" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0590" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0593" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0594" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember" id="xdx2ixbrl0595" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0596" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0597" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0604" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0618" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0629" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0630" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember" id="xdx2ixbrl0631" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0632" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0633" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0634" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-07-012023-09-30" id="xdx2ixbrl0635" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0639" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0640" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember" id="xdx2ixbrl0641" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0642" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0644" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0648" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0650" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0651" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0652" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0657" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0658" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember" id="xdx2ixbrl0659" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0660" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0662" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl0665" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl0666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember" id="xdx2ixbrl0667" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0668" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0669" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0676" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0690" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0720" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0726" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ChangeInFairValueOfYorkvilleNote" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0729" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0732" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CryptoAssetRealizedLossNonoperating" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0735" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0738" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:NoncashInterest" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0741" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0743" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentForAcquisitionCryptoAsset" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0771" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromDisposalCryptoAsset" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0774" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0783" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0792" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0795" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0798" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0801" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RepaymentForCommonStockRepurchase" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0804" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RepaymentOfDeferredUnderwriterFees" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0807" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RepaymentsOfBankDebt" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0810" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0812" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0815" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0821" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0849" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" contextRef="From2023-01-012023-09-30" id="xdx2ixbrl0852" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CryptoAssetFairValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl0900" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1120" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1123" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30_us-gaap_CostOfSalesMember" id="xdx2ixbrl1137" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30_us-gaap_SellingAndMarketingExpenseMember" id="xdx2ixbrl1143" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30_us-gaap_CostOfSalesMember" id="xdx2ixbrl1152" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30_us-gaap_SellingAndMarketingExpenseMember" id="xdx2ixbrl1158" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl1201" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember" id="xdx2ixbrl1237" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember" id="xdx2ixbrl1238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1242" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1243" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl1246" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl1247" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="xdx2ixbrl1251" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="xdx2ixbrl1252" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="xdx2ixbrl1256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="xdx2ixbrl1257" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember" id="xdx2ixbrl1261" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember" id="xdx2ixbrl1262" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember" id="xdx2ixbrl1266" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember" id="xdx2ixbrl1267" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember" id="xdx2ixbrl1268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_custom_StandbyEquityPurchaseAgreementMember" id="xdx2ixbrl1269" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1271" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl1276" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl1277" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="xdx2ixbrl1281" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="xdx2ixbrl1282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="xdx2ixbrl1286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="xdx2ixbrl1287" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl1292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl1330" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl1331" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl1333" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl1334" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_YorkvilleNoteMember" id="xdx2ixbrl1341" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2024-01-012024-09-30_custom_PIPENotesMember" id="xdx2ixbrl1343" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember" id="xdx2ixbrl1352" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember" id="xdx2ixbrl1358" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl1473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl1479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl1482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl1485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2022-12-31" id="xdx2ixbrl1494" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl1502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31" id="xdx2ixbrl1503" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1508" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1527" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31" id="xdx2ixbrl1546" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl1552" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl1553" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl1572" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1642" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1648" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1651" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1693" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1704" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1705" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1710" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1718" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1719" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1720" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1721" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1722" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1723" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1724" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1728" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1729" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1730" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1731" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1733" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1738" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1739" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1741" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1743" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1746" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1747" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1748" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1751" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1754" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1755" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1756" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1757" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1759" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1762" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1763" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1764" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1765" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1766" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1773" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1787" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1798" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1799" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1800" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1801" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1802" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1803" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1804" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1809" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1811" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1812" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1813" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1818" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1819" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1820" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1821" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1823" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1826" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1827" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1828" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1829" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1830" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1831" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1832" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1836" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1837" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1838" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1839" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1840" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1841" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1842" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1846" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1847" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1848" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1851" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1861" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1862" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1870" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1871" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1872" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1873" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1875" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1880" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1881" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1882" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1883" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1885" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1888" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1889" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1890" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl1891" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1892" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1896" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1897" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1898" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1904" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1906" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1910" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1911" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember" id="xdx2ixbrl1912" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl1918" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl1920" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1943" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1945" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1949" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:NoncashInterest" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1955" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1988" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1991" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1997" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl1999" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2021" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonSharesRelatedToConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2024" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonSharesIssuedToDataKnightsShareholders" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2027" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2060" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2061" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2064" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2065" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2066" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2067" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2070" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2071" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2079" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2080" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2084" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2085" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2088" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2089" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2090" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2091" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2094" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2095" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2099" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2100" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2115" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember" id="xdx2ixbrl2119" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl2121" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ExciseTaxCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember" id="xdx2ixbrl2124" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ExciseTaxCurrent" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl2126" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2129" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2130" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2134" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2135" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2136" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:LoanExtensionsCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2139" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:LoanExtensionsCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2140" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2144" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2023-12-31" id="xdx2ixbrl2146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CanadaEmergencyBusinessLoanAct" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2149" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CanadaEmergencyBusinessLoanAct" contextRef="AsOf2023-12-31" id="xdx2ixbrl2151" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2154" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2156" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2159" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2160" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2165" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2168" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2169" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2173" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2174" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2176" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2183" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2184" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2186" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2188" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2189" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2190" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2191" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2199" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2200" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2204" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2205" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2206" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2208" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2209" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2210" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2023-12-31" id="xdx2ixbrl2211" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2214" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2216" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2218" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2225" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2228" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2229" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2230" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-12-31" id="xdx2ixbrl2231" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl2238" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl2239" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl2240" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl2241" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl2259" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl2260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl2261" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl2262" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2280" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2281" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2023-12-31" id="xdx2ixbrl2283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2290" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2291" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2292" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl2293" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2313" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2334" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2339" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2344" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2348" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2349" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2370" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl2376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2380" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2399" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2403" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2404" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2409" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember" id="xdx2ixbrl2429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" id="xdx2ixbrl2430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2439" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2444" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl2445" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2449" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl2450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2458" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2463" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl2465" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:AccruedInterestRelatedParty" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:AccruedInterestRelatedParty" contextRef="AsOf2022-12-31" id="xdx2ixbrl2470" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2474" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl2475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2022-12-31" id="xdx2ixbrl2480" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2484" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2022-12-31" id="xdx2ixbrl2485" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2022-12-31" id="xdx2ixbrl2490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2493" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2504" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31" id="xdx2ixbrl2505" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl2512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember" id="xdx2ixbrl2514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl2533" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember" id="xdx2ixbrl2535" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2554" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2556" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2566" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl2567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2587" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2592" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2597" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2602" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember" id="xdx2ixbrl2620" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember" id="xdx2ixbrl2621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember" id="xdx2ixbrl2625" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember" id="xdx2ixbrl2626" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2630" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2631" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2635" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2640" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2641" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2651" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2655" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl2657" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2660" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2661" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2684" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2686" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl2687" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl2692" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2696" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2701" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2711" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2716" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2720" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2724" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2725" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2726" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl2727" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2739" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2746" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2762" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2764" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2778" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2780" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember" id="xdx2ixbrl2800" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember" id="xdx2ixbrl2801" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember" id="xdx2ixbrl2805" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember" id="xdx2ixbrl2806" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2811" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2815" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2816" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2821" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2831" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2835" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2837" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2840" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2841" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2846" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2866" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2867" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2871" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2872" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2874" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2876" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2881" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2882" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2884" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2886" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2890" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2896" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2897" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2909" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2910" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2928" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2930" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2940" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="xdx2ixbrl2942" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2969" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:BusinessCombinationCost" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl2974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CashHeldInTrustAccount" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl2978" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2980" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockWarrantExpenses" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2984" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2988" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl2989" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl2990" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ChangeInFairValueOfWarrantLiabilities" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2992" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ChangeInFairValueOfPipeNotes" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl2996" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3000" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:NoncashInterest" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3004" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3013" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3025" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3028" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3029" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3030" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncreaseDecreaseInExerciseTaxLiability" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3034" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncreaseDecreaseInExtensionLoan" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3038" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncreaseDecreaseFranchiseTaxPayable" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3042" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3046" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncreaseDecreaseInWorkingCapitalLoan" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3050" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3061" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3065" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3072" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3073" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3074" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromCommonStockSubjectToRedemption" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3086" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromDeferredUnderwritingFee" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3090" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromWarrantLiability" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3094" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromContributedCapital" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3098" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProccedsFromRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3102" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3108" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3109" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl3110" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3112" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3116" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3133" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonSharesIssuedToPreferredShareholders" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3140" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonSharesRelatedToConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3144" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonSharesIssuedToDataKnightsShareholders" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3148" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CashHeldInTrustAccount" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3184" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockWarrantExpenses" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3186" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3190" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3203" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3215" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3220" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncreaseDecreaseInExtensionLoan" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3224" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncreaseDecreaseFranchiseTaxPayable" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3228" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:IncreaseDecreaseInWorkingCapitalLoan" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3236" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3247" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3251" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3260" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromCommonStockSubjectToRedemption" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3264" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProceedsFromWarrantLiability" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3268" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromContributedCapital" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3272" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:ProccedsFromRetainedEarningsAdjustment" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl3276" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3282" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3286" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3322" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3326" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3328" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3344" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3345" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3347" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3348" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3350" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3364" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3367" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3370" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3372" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3375" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3378" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3379" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3381" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3386" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3389" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3395" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3415" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3426" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3429" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3435" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3437" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3440" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3448" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3451" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3454" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3457" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3473" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3484" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3486" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3488" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3490" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3514" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3517" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3518" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3522" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3523" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3524" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3525" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3534" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3535" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3537" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3540" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3541" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3543" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3548" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3549" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3551" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3556" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3557" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3559" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3564" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3567" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3582" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3583" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3585" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3590" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3591" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3593" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3596" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3597" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3599" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3604" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3606" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3607" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3610" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3611" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3613" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3616" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3617" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3618" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3622" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3623" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3624" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3629" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3634" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3638" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3640" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3642" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3644" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3646" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3647" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3664" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3665" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3666" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3667" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3668" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3684" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3687" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3690" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3692" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3693" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3694" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3698" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3700" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3701" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3702" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3718" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3732" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3733" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3734" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3735" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3736" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3738" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3739" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3741" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3742" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3744" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3745" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3747" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3752" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3753" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3754" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3755" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3756" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3758" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3759" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3761" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3764" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3765" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3766" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3767" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="xdx2ixbrl3768" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3770" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3771" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3772" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_RestatedMember_custom_CommitmentMember" id="xdx2ixbrl3777" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="xdx2ixbrl3782" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="xdx2ixbrl3784" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember" id="xdx2ixbrl3786" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember" id="xdx2ixbrl3788" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_RestatedMember" id="xdx2ixbrl3790" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3808" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3812" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3814" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3818" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3819" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3826" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3827" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3829" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3834" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3835" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3837" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3842" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3843" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3844" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3845" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3846" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3848" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3849" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3850" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3851" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3852" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3854" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3855" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3857" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3860" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="xdx2ixbrl3861" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3862" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3874" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3878" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember" id="xdx2ixbrl3880" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3890" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="xdx2ixbrl3894" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3902" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3903" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3914" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3915" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3917" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3922" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3923" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3925" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3930" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3931" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3933" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3936" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3937" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3939" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3942" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3943" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3945" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl3948" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl3949" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3950" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3972" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_AsRestatedMember_custom_CommitmentMember" id="xdx2ixbrl3973" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl3990" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember" id="xdx2ixbrl3991" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl3992" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl3993" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember" id="xdx2ixbrl3994" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl4002" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember" id="xdx2ixbrl4003" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl4004" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl4005" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember" id="xdx2ixbrl4006" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl4010" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember" id="xdx2ixbrl4011" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl4013" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="xdx2ixbrl4018" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="xdx2ixbrl4019" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl4021" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl4027" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl4030" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember" id="xdx2ixbrl4031" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="xdx2ixbrl4033" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl4036" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember" id="xdx2ixbrl4037" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl4038" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="xdx2ixbrl4042" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_AsRestatedMember_custom_CommitmentMember" id="xdx2ixbrl4043" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember" id="xdx2ixbrl4156" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl4159" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember81071859" id="xdx2ixbrl4165" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember81071875" id="xdx2ixbrl4168" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember" id="xdx2ixbrl4171" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4296" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl4297" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4299" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl4300" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4308" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl4309" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4311" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl4312" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4314" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl4315" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredOtherTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="xdx2ixbrl4317" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredOtherTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="xdx2ixbrl4318" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ONMD:DeferredTaxAssetsCapitalizedResearchCosts" contextRef="AsOf2022-12-31" id="xdx2ixbrl4361" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2023-12-31" id="xdx2ixbrl4387" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2022-12-31" id="xdx2ixbrl4388" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MinimumMember" id="xdx2ixbrl4502" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P1Y</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2021-12-31" id="xdx2ixbrl4512" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-31" id="xdx2ixbrl4540" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-12-31" id="xdx2ixbrl4542" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-12-31" id="xdx2ixbrl4544" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2023-12-31" id="xdx2ixbrl4546" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-12-31" id="xdx2ixbrl4548" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-12-31" id="xdx2ixbrl4550" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2023-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="xdx2ixbrl4558" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2023-12-31_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl4564" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl4566" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2023-01-012023-12-31_us-gaap_MeasurementInputExpectedTermMember" id="xdx2ixbrl4568" name="ONMD:EquitySecuritiesFvNiMeasurementTerm" xs:nil="true"></ix:nonNumeric>
  <ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2023-12-31_us-gaap_MeasurementInputPriceVolatilityMember" id="xdx2ixbrl4574" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="xdx2ixbrl4588" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="xdx2ixbrl4590" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="xdx2ixbrl4612" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="xdx2ixbrl4614" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember" id="xdx2ixbrl4636" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember" id="xdx2ixbrl4639" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember" id="xdx2ixbrl4642" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember" id="xdx2ixbrl4644" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember" id="xdx2ixbrl4647" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember" id="xdx2ixbrl4651" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl4703" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl4704" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl4708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl4709" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="xdx2ixbrl4713" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="xdx2ixbrl4714" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="xdx2ixbrl4718" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="xdx2ixbrl4719" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl4723" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl4724" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember" id="xdx2ixbrl4728" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember" id="xdx2ixbrl4729" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl4733" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="xdx2ixbrl4734" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_custom_PrivateWarrantsMember" id="xdx2ixbrl4740" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_custom_PIPENotesAndWarrantsMember" id="xdx2ixbrl4741" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-12-31_custom_PrivateWarrantsMember" id="xdx2ixbrl4744" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-12-31_custom_PIPENotesAndWarrantsMember" id="xdx2ixbrl4745" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2022-01-012022-12-31_custom_PrivateWarrantsMember" id="xdx2ixbrl4748" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2022-01-012022-12-31_custom_PIPENotesAndWarrantsMember" id="xdx2ixbrl4749" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_PrivateWarrantsMember" id="xdx2ixbrl4752" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_PIPENotesAndWarrantsMember" id="xdx2ixbrl4753" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_PrivateWarrantsMember" id="xdx2ixbrl4756" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_PIPENotesAndWarrantsMember" id="xdx2ixbrl4757" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" contextRef="From2023-01-012023-12-31_custom_PrivateWarrantsMember" id="xdx2ixbrl4768" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" contextRef="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember" id="xdx2ixbrl4769" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_ConvertiblePromissoryNotesMember" id="xdx2ixbrl4774" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_ConvertiblePromissoryNotesMember" id="xdx2ixbrl4778" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl4806" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl4807" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl4808" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember" id="xdx2ixbrl4809" unitRef="Pure" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="onmd-20240930.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-012024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_TemporaryEquityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:TwoCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:TwoCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BitcoinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ConvertibleNotesWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertibleNotesWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-282023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-28</xbrli:startDate>
        <xbrli:endDate>2023-06-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-06-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-282024-03-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-28</xbrli:startDate>
        <xbrli:endDate>2024-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-282024-03-28_custom_HelenaTerminationAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:HelenaTerminationAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-28</xbrli:startDate>
        <xbrli:endDate>2024-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-182024-06-18_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-18</xbrli:startDate>
        <xbrli:endDate>2024-06-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-17_custom_BeneficialOwnershipMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">ONMD:BeneficialOwnershipMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyTwoNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-11_custom_TwentyTwentyTwoNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-102022-11-11_custom_TwentyTwentyTwoNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-10</xbrli:startDate>
        <xbrli:endDate>2022-11-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-11-102022-11-11_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-11-10</xbrli:startDate>
        <xbrli:endDate>2022-11-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-062023-11-07_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-06</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-062023-11-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-06</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-31_custom_BOCBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ONMD:BOCBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-03-31_custom_BOCBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ONMD:BOCBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-012020-12-31_custom_CEBALoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CEBALoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_CEBALoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-07</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-28_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-072023-11-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-07</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-012024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-07-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-012025-01-01_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-01</xbrli:startDate>
        <xbrli:endDate>2025-01-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_ConvertibleNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17_srt_MaximumMember_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-152024-10-15_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-15</xbrli:startDate>
        <xbrli:endDate>2024-10-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-232024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-25_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-23_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-252024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-25</xbrli:startDate>
        <xbrli:endDate>2024-07-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-242024-09-24_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SeptemberTwoThousandTwentyFourFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-24</xbrli:startDate>
        <xbrli:endDate>2024-09-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-24_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-24_us-gaap_WarrantMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_OptionsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_OptionsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:UnvestedRestrictedStockUnitsAndAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:UnvestedRestrictedStockUnitsAndAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember81071859">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember81071859">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember81071875">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember81071875">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_SellingAndMarketingExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:EmployeesDirectorsAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:NewEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:EmployeesDirectorsAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:NewEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:EmployeesDirectorsAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:NewEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember81072609">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember81072609">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:LegacyONMDWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:LegacyONMDWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-07-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-07-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-062023-11-07_custom_ConvertiblePromissoryNotesWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-06</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_BusinessCombinationWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-09-30_custom_BusinessCombinationWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentyOneServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:TwentyTwentyOneServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TwentyTwentyTwoServiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:TwentyTwentyTwoServiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_WarrantMember81073500">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_WarrantMember81073500">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PublicWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BitcoinMember81074171">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_StandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember81074390">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_BusinessCombinationWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember81074640">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_PIPEWarrantsMember81074640">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_PIPENotesMember81075421">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_PIPEWarrantsMember81075437">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember81075453">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_ConvertiblePromissoryNotesAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:ConvertiblePromissoryNotesAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-30_custom_DataKnightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DataKnightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPEWarrantsMember81075625">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember81075656">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:ConvertiblePromissoryNotesAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_ShareholderLoansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ShareholderLoansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-08_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MsCoonseMcCrawMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:MsCoonseMcCrawMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MrClarkeMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:MrClarkeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_EFHuttonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ONMD:EFHuttonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ONMD:KingwoodCapitalPartnersLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember81076734">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:KingwoodCapitalPartnersLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-282024-03-28_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-28</xbrli:startDate>
        <xbrli:endDate>2024-03-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-14_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-232024-07-23_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-23</xbrli:startDate>
        <xbrli:endDate>2024-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-252024-07-25_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-25</xbrli:startDate>
        <xbrli:endDate>2024-07-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-23_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-25_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-242024-09-24_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-24</xbrli:startDate>
        <xbrli:endDate>2024-09-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-24_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-24_srt_ScenarioForecastMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-17_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-172024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-17</xbrli:startDate>
        <xbrli:endDate>2024-06-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-222024-03-22_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-22</xbrli:startDate>
        <xbrli:endDate>2024-03-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-22_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-302024-08-30_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-30</xbrli:startDate>
        <xbrli:endDate>2024-08-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-01_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestatedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestatedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestatedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestatedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_RestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AsRestatedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AsRestatedMember_custom_CommitmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFiveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-072023-11-07_custom_BusinessCombinationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:BusinessCombinationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-07</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-11-072023-11-07_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-11-07</xbrli:startDate>
        <xbrli:endDate>2023-11-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_SeriesATwoPreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_SeriesAOnePreferredStockMember_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_DataKnightsAcquisitionCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_FurnitureAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ONMD:FurnitureAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_FurnitureAndEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ONMD:FurnitureAndEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CEBALoanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_MeasurementInputExpectedTermMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_PIPENotesAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_PIPENotesAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_custom_PIPENotesAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PrivateWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_PIPENotesAndWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-31_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PrivatePlacementWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-07_custom_PIPENotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001849380</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>ONMD:Integer</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="CAD">
      <xbrli:measure>iso4217:CAD</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001674" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact001676" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact001678" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact001680" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2061" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2066" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2071" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2080" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2085" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2090" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2095" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2100" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2115" toRefs="Footnote002351 Footnote002352"/>
  <ix:relationship fromRefs="Fact002120" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002125" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2130" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2135" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2140" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002145" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002150" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002155" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2160" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2165" toRefs="Footnote002351 Footnote002353"/>
  <ix:relationship fromRefs="Fact002170" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2175" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002180" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2190" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2200" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2205" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2210" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002215" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002220" toRefs="Footnote002351 Footnote002354"/>
  <ix:relationship fromRefs="xdx2ixbrl2225" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2230" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2240" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2261" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2282" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2292" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2313" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2334" toRefs="Footnote002351 Footnote002355"/>
  <ix:relationship fromRefs="xdx2ixbrl2339" toRefs="Footnote002351 Footnote002356"/>
  <ix:relationship fromRefs="xdx2ixbrl2344" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="xdx2ixbrl2349" toRefs="Footnote002351"/>
  <ix:relationship fromRefs="Fact002113" toRefs="Footnote002352"/>
  <ix:relationship fromRefs="Fact002114" toRefs="Footnote002352"/>
  <ix:relationship fromRefs="Fact002116" toRefs="Footnote002352"/>
  <ix:relationship fromRefs="Fact002163" toRefs="Footnote002353"/>
  <ix:relationship fromRefs="Fact002164" toRefs="Footnote002353"/>
  <ix:relationship fromRefs="Fact002166" toRefs="Footnote002353"/>
  <ix:relationship fromRefs="xdx2ixbrl2218" toRefs="Footnote002354"/>
  <ix:relationship fromRefs="Fact002219" toRefs="Footnote002354"/>
  <ix:relationship fromRefs="Fact002221" toRefs="Footnote002354"/>
  <ix:relationship fromRefs="Fact002332" toRefs="Footnote002355"/>
  <ix:relationship fromRefs="Fact002333" toRefs="Footnote002355"/>
  <ix:relationship fromRefs="Fact002335" toRefs="Footnote002355"/>
  <ix:relationship fromRefs="Fact002337" toRefs="Footnote002356"/>
  <ix:relationship fromRefs="Fact002338" toRefs="Footnote002356"/>
  <ix:relationship fromRefs="Fact002340" toRefs="Footnote002356"/>
  <ix:relationship fromRefs="xdx2ixbrl2370" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2375" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2380" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2389" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2394" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2399" toRefs="Footnote002604 Footnote002606"/>
  <ix:relationship fromRefs="xdx2ixbrl2404" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2409" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2424" toRefs="Footnote002604 Footnote002607"/>
  <ix:relationship fromRefs="xdx2ixbrl2429" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2434" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2439" toRefs="Footnote002604 Footnote002608"/>
  <ix:relationship fromRefs="xdx2ixbrl2444" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2449" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2454" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="Fact002464" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2469" toRefs="Footnote002604 Footnote002608"/>
  <ix:relationship fromRefs="xdx2ixbrl2474" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2479" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2484" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2489" toRefs="Footnote002604 Footnote002605"/>
  <ix:relationship fromRefs="Fact002494" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2499" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2504" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2514" toRefs="Footnote002604 Footnote002609"/>
  <ix:relationship fromRefs="xdx2ixbrl2535" toRefs="Footnote002604 Footnote002609"/>
  <ix:relationship fromRefs="xdx2ixbrl2556" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2566" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2587" toRefs="Footnote002604 Footnote002610"/>
  <ix:relationship fromRefs="xdx2ixbrl2592" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2597" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="xdx2ixbrl2602" toRefs="Footnote002604"/>
  <ix:relationship fromRefs="Fact002368" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002369" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002371" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002373" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002374" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2376" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002427" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002428" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2430" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002442" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002443" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2445" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002447" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002448" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2450" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002472" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002473" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2475" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002477" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002478" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2480" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002482" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002483" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2485" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002487" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002488" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="xdx2ixbrl2490" toRefs="Footnote002605"/>
  <ix:relationship fromRefs="Fact002397" toRefs="Footnote002606"/>
  <ix:relationship fromRefs="Fact002398" toRefs="Footnote002606"/>
  <ix:relationship fromRefs="Fact002400" toRefs="Footnote002606"/>
  <ix:relationship fromRefs="Fact002422" toRefs="Footnote002607"/>
  <ix:relationship fromRefs="Fact002423" toRefs="Footnote002607"/>
  <ix:relationship fromRefs="Fact002425" toRefs="Footnote002607"/>
  <ix:relationship fromRefs="Fact002437" toRefs="Footnote002608"/>
  <ix:relationship fromRefs="Fact002438" toRefs="Footnote002608"/>
  <ix:relationship fromRefs="Fact002440" toRefs="Footnote002608"/>
  <ix:relationship fromRefs="Fact002467" toRefs="Footnote002608"/>
  <ix:relationship fromRefs="Fact002468" toRefs="Footnote002608"/>
  <ix:relationship fromRefs="xdx2ixbrl2470" toRefs="Footnote002608"/>
  <ix:relationship fromRefs="xdx2ixbrl2512" toRefs="Footnote002609"/>
  <ix:relationship fromRefs="Fact002513" toRefs="Footnote002609"/>
  <ix:relationship fromRefs="Fact002515" toRefs="Footnote002609"/>
  <ix:relationship fromRefs="xdx2ixbrl2533" toRefs="Footnote002609"/>
  <ix:relationship fromRefs="Fact002534" toRefs="Footnote002609"/>
  <ix:relationship fromRefs="Fact002536" toRefs="Footnote002609"/>
  <ix:relationship fromRefs="Fact002585" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002586" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="Fact002588" toRefs="Footnote002610"/>
  <ix:relationship fromRefs="xdx2ixbrl2621" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2626" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2631" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2636" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2641" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2651" toRefs="Footnote002785 Footnote002786"/>
  <ix:relationship fromRefs="Fact002656" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2661" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2666" toRefs="Footnote002785 Footnote002786"/>
  <ix:relationship fromRefs="Fact002671" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2686" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2691" toRefs="Footnote002785 Footnote002787"/>
  <ix:relationship fromRefs="xdx2ixbrl2696" toRefs="Footnote002785 Footnote002788"/>
  <ix:relationship fromRefs="xdx2ixbrl2701" toRefs="Footnote002785 Footnote002789"/>
  <ix:relationship fromRefs="xdx2ixbrl2706" toRefs="Footnote002785 Footnote002790"/>
  <ix:relationship fromRefs="xdx2ixbrl2711" toRefs="Footnote002785 Footnote002791"/>
  <ix:relationship fromRefs="xdx2ixbrl2716" toRefs="Footnote002785 Footnote002788"/>
  <ix:relationship fromRefs="Fact002721" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2726" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="Fact002731" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="Fact002736" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="Fact002741" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="xdx2ixbrl2746" toRefs="Footnote002785"/>
  <ix:relationship fromRefs="Fact002649" toRefs="Footnote002786"/>
  <ix:relationship fromRefs="Fact002650" toRefs="Footnote002786"/>
  <ix:relationship fromRefs="Fact002652" toRefs="Footnote002786"/>
  <ix:relationship fromRefs="Fact002664" toRefs="Footnote002786"/>
  <ix:relationship fromRefs="Fact002665" toRefs="Footnote002786"/>
  <ix:relationship fromRefs="Fact002667" toRefs="Footnote002786"/>
  <ix:relationship fromRefs="Fact002689" toRefs="Footnote002787"/>
  <ix:relationship fromRefs="Fact002690" toRefs="Footnote002787"/>
  <ix:relationship fromRefs="xdx2ixbrl2692" toRefs="Footnote002787"/>
  <ix:relationship fromRefs="Fact002694" toRefs="Footnote002788"/>
  <ix:relationship fromRefs="Fact002695" toRefs="Footnote002788"/>
  <ix:relationship fromRefs="Fact002697" toRefs="Footnote002788"/>
  <ix:relationship fromRefs="Fact002715" toRefs="Footnote002788"/>
  <ix:relationship fromRefs="Fact002717" toRefs="Footnote002788"/>
  <ix:relationship fromRefs="Fact002699" toRefs="Footnote002789"/>
  <ix:relationship fromRefs="Fact002700" toRefs="Footnote002789"/>
  <ix:relationship fromRefs="Fact002702" toRefs="Footnote002789"/>
  <ix:relationship fromRefs="Fact002704" toRefs="Footnote002790"/>
  <ix:relationship fromRefs="Fact002705" toRefs="Footnote002790"/>
  <ix:relationship fromRefs="Fact002707" toRefs="Footnote002790"/>
  <ix:relationship fromRefs="xdx2ixbrl2709" toRefs="Footnote002791"/>
  <ix:relationship fromRefs="Fact002710" toRefs="Footnote002791"/>
  <ix:relationship fromRefs="Fact002712" toRefs="Footnote002791"/>
  <ix:relationship fromRefs="Fact002754" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002756" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002758" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002760" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="xdx2ixbrl2762" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="xdx2ixbrl2764" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002766" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002768" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002770" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002772" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002774" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="Fact002776" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="xdx2ixbrl2778" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="xdx2ixbrl2780" toRefs="Footnote002792"/>
  <ix:relationship fromRefs="xdx2ixbrl2801" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2806" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2811" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2816" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2821" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2831" toRefs="Footnote002947 Footnote002948"/>
  <ix:relationship fromRefs="Fact002836" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2841" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2846" toRefs="Footnote002947 Footnote002948"/>
  <ix:relationship fromRefs="Fact002851" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="Fact002856" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2866" toRefs="Footnote002947 Footnote002949"/>
  <ix:relationship fromRefs="xdx2ixbrl2871" toRefs="Footnote002947 Footnote002950"/>
  <ix:relationship fromRefs="xdx2ixbrl2876" toRefs="Footnote002947 Footnote002951"/>
  <ix:relationship fromRefs="xdx2ixbrl2881" toRefs="Footnote002947 Footnote002949"/>
  <ix:relationship fromRefs="xdx2ixbrl2886" toRefs="Footnote002947 Footnote002950"/>
  <ix:relationship fromRefs="Fact002891" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="xdx2ixbrl2896" toRefs="Footnote002947 Footnote002949"/>
  <ix:relationship fromRefs="Fact002901" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="Fact002906" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="Fact002911" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="Fact002916" toRefs="Footnote002947"/>
  <ix:relationship fromRefs="Fact002829" toRefs="Footnote002948"/>
  <ix:relationship fromRefs="Fact002830" toRefs="Footnote002948"/>
  <ix:relationship fromRefs="Fact002832" toRefs="Footnote002948"/>
  <ix:relationship fromRefs="Fact002844" toRefs="Footnote002948"/>
  <ix:relationship fromRefs="Fact002845" toRefs="Footnote002948"/>
  <ix:relationship fromRefs="Fact002847" toRefs="Footnote002948"/>
  <ix:relationship fromRefs="Fact002864" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="Fact002865" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="xdx2ixbrl2867" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="Fact002879" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="Fact002880" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="xdx2ixbrl2882" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="Fact002894" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="Fact002895" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="xdx2ixbrl2897" toRefs="Footnote002949"/>
  <ix:relationship fromRefs="Fact002869" toRefs="Footnote002950"/>
  <ix:relationship fromRefs="Fact002870" toRefs="Footnote002950"/>
  <ix:relationship fromRefs="xdx2ixbrl2872" toRefs="Footnote002950"/>
  <ix:relationship fromRefs="xdx2ixbrl2884" toRefs="Footnote002950"/>
  <ix:relationship fromRefs="Fact002885" toRefs="Footnote002950"/>
  <ix:relationship fromRefs="Fact002887" toRefs="Footnote002950"/>
  <ix:relationship fromRefs="xdx2ixbrl2874" toRefs="Footnote002951"/>
  <ix:relationship fromRefs="Fact002875" toRefs="Footnote002951"/>
  <ix:relationship fromRefs="Fact002877" toRefs="Footnote002951"/>
  <ix:relationship fromRefs="Fact002924" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002926" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="xdx2ixbrl2928" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="xdx2ixbrl2930" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002932" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002934" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002936" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002938" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="xdx2ixbrl2940" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="xdx2ixbrl2942" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002944" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002946" toRefs="Footnote002952"/>
  <ix:relationship fromRefs="Fact002960" toRefs="Footnote003151"/>
  <ix:relationship fromRefs="Fact002961" toRefs="Footnote003151"/>
  <ix:relationship fromRefs="Fact002962" toRefs="Footnote003151"/>
  <ix:relationship fromRefs="Fact002972" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact002973" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl2974" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003016" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003017" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003018" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003020" toRefs="Footnote003152 Footnote003153 Footnote003159"/>
  <ix:relationship fromRefs="Fact003021" toRefs="Footnote003152 Footnote003153 Footnote003159"/>
  <ix:relationship fromRefs="Fact003022" toRefs="Footnote003152 Footnote003153 Footnote003159"/>
  <ix:relationship fromRefs="Fact003032" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003033" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="xdx2ixbrl3034" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003036" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003037" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="xdx2ixbrl3038" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003040" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003041" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="xdx2ixbrl3042" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003044" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003045" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="xdx2ixbrl3046" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003048" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003049" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="xdx2ixbrl3050" toRefs="Footnote003152 Footnote003153"/>
  <ix:relationship fromRefs="Fact003084" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003085" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3086" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003088" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003089" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3090" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003092" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003093" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3094" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003096" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003097" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3098" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003100" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003101" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3102" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3112" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003113" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003114" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3116" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003117" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003118" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3140" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003141" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003142" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3144" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003145" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003146" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="xdx2ixbrl3148" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003149" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact003150" toRefs="Footnote003152"/>
  <ix:relationship fromRefs="Fact002976" toRefs="Footnote003153"/>
  <ix:relationship fromRefs="Fact002977" toRefs="Footnote003153"/>
  <ix:relationship fromRefs="xdx2ixbrl2978" toRefs="Footnote003153"/>
  <ix:relationship fromRefs="xdx2ixbrl2980" toRefs="Footnote003154"/>
  <ix:relationship fromRefs="Fact002981" toRefs="Footnote003154"/>
  <ix:relationship fromRefs="Fact002982" toRefs="Footnote003154"/>
  <ix:relationship fromRefs="xdx2ixbrl2984" toRefs="Footnote003155"/>
  <ix:relationship fromRefs="Fact002985" toRefs="Footnote003155"/>
  <ix:relationship fromRefs="Fact002986" toRefs="Footnote003155"/>
  <ix:relationship fromRefs="xdx2ixbrl2992" toRefs="Footnote003156"/>
  <ix:relationship fromRefs="Fact002993" toRefs="Footnote003156"/>
  <ix:relationship fromRefs="Fact002994" toRefs="Footnote003156"/>
  <ix:relationship fromRefs="xdx2ixbrl2996" toRefs="Footnote003157"/>
  <ix:relationship fromRefs="Fact002997" toRefs="Footnote003157"/>
  <ix:relationship fromRefs="Fact002998" toRefs="Footnote003157"/>
  <ix:relationship fromRefs="Fact003080" toRefs="Footnote003157"/>
  <ix:relationship fromRefs="Fact003081" toRefs="Footnote003157"/>
  <ix:relationship fromRefs="Fact003082" toRefs="Footnote003157"/>
  <ix:relationship fromRefs="xdx2ixbrl3000" toRefs="Footnote003158"/>
  <ix:relationship fromRefs="Fact003001" toRefs="Footnote003158"/>
  <ix:relationship fromRefs="Fact003002" toRefs="Footnote003158"/>
  <ix:relationship fromRefs="Fact003104" toRefs="Footnote003158"/>
  <ix:relationship fromRefs="Fact003105" toRefs="Footnote003158"/>
  <ix:relationship fromRefs="Fact003106" toRefs="Footnote003158"/>
  <ix:relationship fromRefs="xdx2ixbrl3004" toRefs="Footnote003160"/>
  <ix:relationship fromRefs="Fact003005" toRefs="Footnote003160"/>
  <ix:relationship fromRefs="Fact003006" toRefs="Footnote003160"/>
  <ix:relationship fromRefs="Fact003076" toRefs="Footnote003160"/>
  <ix:relationship fromRefs="Fact003077" toRefs="Footnote003160"/>
  <ix:relationship fromRefs="Fact003078" toRefs="Footnote003160"/>
  <ix:relationship fromRefs="Fact003166" toRefs="Footnote003305"/>
  <ix:relationship fromRefs="Fact003167" toRefs="Footnote003305"/>
  <ix:relationship fromRefs="Fact003168" toRefs="Footnote003305"/>
  <ix:relationship fromRefs="Fact003182" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003183" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3184" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003206" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003207" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003208" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003210" toRefs="Footnote003306 Footnote003310"/>
  <ix:relationship fromRefs="Fact003211" toRefs="Footnote003306 Footnote003310"/>
  <ix:relationship fromRefs="Fact003212" toRefs="Footnote003306 Footnote003310"/>
  <ix:relationship fromRefs="Fact003218" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003219" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3220" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003222" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003223" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3224" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003226" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003227" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3228" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003230" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003231" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3232" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003234" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003235" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3236" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003262" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003263" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3264" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003266" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003267" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3268" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003270" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003271" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3272" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003274" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003275" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3276" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="xdx2ixbrl3286" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003287" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003288" toRefs="Footnote003306"/>
  <ix:relationship fromRefs="Fact003178" toRefs="Footnote003307"/>
  <ix:relationship fromRefs="Fact003179" toRefs="Footnote003307"/>
  <ix:relationship fromRefs="Fact003180" toRefs="Footnote003307"/>
  <ix:relationship fromRefs="xdx2ixbrl3186" toRefs="Footnote003308"/>
  <ix:relationship fromRefs="Fact003187" toRefs="Footnote003308"/>
  <ix:relationship fromRefs="Fact003188" toRefs="Footnote003308"/>
  <ix:relationship fromRefs="xdx2ixbrl3190" toRefs="Footnote003308"/>
  <ix:relationship fromRefs="Fact003191" toRefs="Footnote003308"/>
  <ix:relationship fromRefs="Fact003192" toRefs="Footnote003308"/>
  <ix:relationship fromRefs="xdx2ixbrl3194" toRefs="Footnote003309"/>
  <ix:relationship fromRefs="Fact003195" toRefs="Footnote003309"/>
  <ix:relationship fromRefs="Fact003196" toRefs="Footnote003309"/>
  <ix:relationship fromRefs="Fact003278" toRefs="Footnote003309"/>
  <ix:relationship fromRefs="Fact003279" toRefs="Footnote003309"/>
  <ix:relationship fromRefs="Fact003280" toRefs="Footnote003309"/>
  <ix:relationship fromRefs="Fact003496" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003497" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003498" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003499" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003500" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003502" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003504" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003506" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003508" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003510" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003512" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3596" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3597" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003598" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3599" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003600" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003602" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3604" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003605" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3606" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3607" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003608" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3616" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3617" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3618" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003619" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="Fact003620" toRefs="Footnote003793"/>
  <ix:relationship fromRefs="xdx2ixbrl3350" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3514" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3515" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3516" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3517" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3518" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="Fact003520" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3522" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3523" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3524" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3525" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="Fact003526" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="Fact003528" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="Fact003530" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="Fact003532" toRefs="Footnote003794"/>
  <ix:relationship fromRefs="xdx2ixbrl3534" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="xdx2ixbrl3535" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="Fact003536" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="xdx2ixbrl3537" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="Fact003538" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="xdx2ixbrl3590" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="xdx2ixbrl3591" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="Fact003592" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="xdx2ixbrl3593" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="Fact003594" toRefs="Footnote003795"/>
  <ix:relationship fromRefs="xdx2ixbrl3540" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3541" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003542" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3543" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003544" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003546" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3548" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3549" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003550" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3551" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003552" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003554" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3556" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3557" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003558" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3559" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003560" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003562" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3564" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3565" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003566" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3567" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003568" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003570" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003572" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003574" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003576" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003578" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003580" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3582" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3583" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003584" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3585" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003586" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="Fact003588" toRefs="Footnote003796"/>
  <ix:relationship fromRefs="xdx2ixbrl3610" toRefs="Footnote003797"/>
  <ix:relationship fromRefs="xdx2ixbrl3611" toRefs="Footnote003797"/>
  <ix:relationship fromRefs="Fact003612" toRefs="Footnote003797"/>
  <ix:relationship fromRefs="xdx2ixbrl3613" toRefs="Footnote003797"/>
  <ix:relationship fromRefs="Fact003614" toRefs="Footnote003797"/>
  <ix:relationship fromRefs="xdx2ixbrl3622" toRefs="Footnote003798"/>
  <ix:relationship fromRefs="xdx2ixbrl3623" toRefs="Footnote003798"/>
  <ix:relationship fromRefs="xdx2ixbrl3624" toRefs="Footnote003798"/>
  <ix:relationship fromRefs="Fact003625" toRefs="Footnote003798"/>
  <ix:relationship fromRefs="Fact003626" toRefs="Footnote003798"/>
  <ix:relationship fromRefs="Fact003884" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003885" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003886" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003887" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003888" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="xdx2ixbrl3890" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003892" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="xdx2ixbrl3894" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003896" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003898" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="Fact003900" toRefs="Footnote004059"/>
  <ix:relationship fromRefs="xdx2ixbrl3902" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3903" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003904" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003905" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003906" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003908" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003910" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003912" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3914" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3915" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003916" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3917" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003918" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003920" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3922" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3923" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003924" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3925" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003926" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="Fact003928" toRefs="Footnote004060"/>
  <ix:relationship fromRefs="xdx2ixbrl3930" toRefs="Footnote004061"/>
  <ix:relationship fromRefs="xdx2ixbrl3931" toRefs="Footnote004061"/>
  <ix:relationship fromRefs="Fact003932" toRefs="Footnote004061"/>
  <ix:relationship fromRefs="xdx2ixbrl3933" toRefs="Footnote004061"/>
  <ix:relationship fromRefs="Fact003934" toRefs="Footnote004061"/>
  <ix:relationship fromRefs="xdx2ixbrl3936" toRefs="Footnote004062"/>
  <ix:relationship fromRefs="xdx2ixbrl3937" toRefs="Footnote004062"/>
  <ix:relationship fromRefs="Fact003938" toRefs="Footnote004062"/>
  <ix:relationship fromRefs="xdx2ixbrl3939" toRefs="Footnote004062"/>
  <ix:relationship fromRefs="Fact003940" toRefs="Footnote004062"/>
  <ix:relationship fromRefs="xdx2ixbrl3942" toRefs="Footnote004063"/>
  <ix:relationship fromRefs="xdx2ixbrl3943" toRefs="Footnote004063"/>
  <ix:relationship fromRefs="Fact003944" toRefs="Footnote004063"/>
  <ix:relationship fromRefs="xdx2ixbrl3945" toRefs="Footnote004063"/>
  <ix:relationship fromRefs="Fact003946" toRefs="Footnote004063"/>
  <ix:relationship fromRefs="xdx2ixbrl3948" toRefs="Footnote004064"/>
  <ix:relationship fromRefs="xdx2ixbrl3949" toRefs="Footnote004064"/>
  <ix:relationship fromRefs="xdx2ixbrl3950" toRefs="Footnote004064"/>
  <ix:relationship fromRefs="Fact003951" toRefs="Footnote004064"/>
  <ix:relationship fromRefs="Fact003952" toRefs="Footnote004064"/>
  <ix:relationship fromRefs="Fact004157" toRefs="Footnote004176"/>
  <ix:relationship fromRefs="Fact004160" toRefs="Footnote004176"/>
  <ix:relationship fromRefs="Fact004163" toRefs="Footnote004176"/>
  <ix:relationship fromRefs="Fact004166" toRefs="Footnote004176"/>
  <ix:relationship fromRefs="Fact004169" toRefs="Footnote004176"/>
  <ix:relationship fromRefs="Fact004172" toRefs="Footnote004176"/>
  <ix:relationship fromRefs="Fact004175" toRefs="Footnote004176"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on January 31, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-276130</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span id="xdx_90A_edei--AmendmentDescription_c20240101__20240930_z5G9AVumolr6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000012" name="dei:AmendmentDescription">Amendment
No. 3</ix:nonNumeric></b></span><b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90B_edei--DocumentType_dxL_c20240101__20240930_z0NKBPByWQo" title="::XDX::S-1%2FA"><span style="-sec-ix-hidden: xdx2ixbrl0013">S-1</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT<br/>
UNDER THE SECURITIES ACT OF 1933</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_900_edei--EntityRegistrantName_c20240101__20240930_zPqXmEK6U9s8"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000014" name="dei:EntityRegistrantName">ONEMEDNET
CORPORATION</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20240101__20240930_zXA3wmwGYc1i"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:stateprovnameen" id="Fact000015" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3721</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityTaxIdentificationNumber_c20240101__20240930_z5Izny13pck5"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000016" name="dei:EntityTaxIdentificationNumber">86-2049355</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation or organization)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Primary
                                            Standard Industrial</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
    Code Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OneMedNet
Corporation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20240101__20240930_zWSlbdEEKgQg"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000017" name="dei:EntityAddressAddressLine1">6385
Old Shady Oak Road</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressAddressLine2_c20240101__20240930_zOruefSTe60c"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000018" name="dei:EntityAddressAddressLine2">Suite 250</ix:nonNumeric></span><br/>
<span id="xdx_90E_edei--EntityAddressCityOrTown_c20240101__20240930_z9UWv225twph"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000019" name="dei:EntityAddressCityOrTown">Eden Prairie</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20240101__20240930_zKYmH1FwJl61"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000020" name="dei:EntityAddressStateOrProvince">MN</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20240101__20240930_zagSzWcmqNn4"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000021" name="dei:EntityAddressPostalZipCode">55344</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone:
<span id="xdx_908_edei--CityAreaCode_c20240101__20240930_z3iD3nVYNRmg"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000022" name="dei:CityAreaCode">800</ix:nonNumeric></span>-<span id="xdx_90A_edei--LocalPhoneNumber_c20240101__20240930_z4bZIRqb9Nh1"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact000023" name="dei:LocalPhoneNumber">918-7189</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aaron
Green</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><b>Chief Executive
Officer</b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
OneMedNet Corporation<br/>
6385 Old Shady Oak Road, Suite 250<br/>
Eden Prairie, MN 55344</span></b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><br/></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone:
800-918-7189</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name,
                                            address, including zip code, and telephone number, including area code, of agent for service)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Copies
to:</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_902_edei--ContactPersonnelName_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zHHcI4io8bqi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000024" name="dei:ContactPersonnelName">Eitan
Hoenig</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ned
Prusse</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><b>Perkins
Coie LLP</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zAVtWXzT2434" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000025" name="dei:EntityAddressAddressLine1">41
Madison Avenue</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_904_edei--EntityAddressAddressLine2_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zV3ig10Vm7Te"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000026" name="dei:EntityAddressAddressLine2">Suite 3310</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><b><span id="xdx_90B_edei--EntityAddressAddressLine3_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zDz9Mtmgj2F7"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000027" name="dei:EntityAddressAddressLine3">New York</ix:nonNumeric></span>,
<span id="xdx_902_edei--EntityAddressStateOrProvince_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zCLtpav9O98i"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000028" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zoW1Bf8oGxne"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000029" name="dei:EntityAddressPostalZipCode">10036</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Telephone:
<span id="xdx_908_edei--CityAreaCode_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zdF2aQnTYohe"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000030" name="dei:CityAreaCode">(332)</ix:nonNumeric></span>
<span id="xdx_907_edei--LocalPhoneNumber_c20240101__20240930__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zhKtKjMnuiAe"><ix:nonNumeric contextRef="From2024-01-012024-09-30_dei_BusinessContactMember" id="Fact000031" name="dei:LocalPhoneNumber">238-2820</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
date of commencement of proposed sale to the public: <b>As soon as practicable after the effective date of this registration statement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933 check the following box. <b>&#9746;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. <b>&#9744;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. <b>&#9744;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. <b>&#9744;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large-accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large-accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large-accelerated
    filer <b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer <b>&#9744;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityFilerCategory_c20240101__20240930_zIW0XCkaLC12" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:entityfilercategoryen" id="Fact000032" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <b><span id="xdx_904_edei--EntitySmallBusiness_c20240101__20240930_zwedJ5ig7Ila"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleantrue" id="Fact000033" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <b><span id="xdx_906_edei--EntityEmergingGrowthCompany_c20240101__20240930_zl8nKRHFoBo5"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleantrue" id="Fact000034" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check market if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <b><span id="xdx_909_edei--EntityExTransitionPeriod_c20240101__20240930_zxAEt4dt1XEl"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:booleanfalse" id="Fact000035" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the Commission acting pursuant to said section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities
and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><b>PRELIMINARY
    PROSPECTUS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><b>SUBJECT
    TO COMPLETION</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"><b>DATED
    JANUARY 31, 2025</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_001.jpg" alt="A logo with blue and black letters&#10;&#10;Description automatically generated" style="height: 95px; width: 234px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Primary
Offering of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 12,085,275 Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Upon the Exercise of Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Secondary
Offering of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 19,123,352 Shares of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Up
to 585,275 Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the primary issuance by us of up to an aggregate of 12,085,275 shares of common stock, par value $0.0001 per share
(the &#8220;<span style="text-decoration: underline">Common Stock</span>&#8221;), of OneMedNet Corporation, a Delaware corporation (&#8220;<span style="text-decoration: underline">we</span>,&#8221; &#8220;<span style="text-decoration: underline">us</span>,&#8221;
the &#8220;<span style="text-decoration: underline">Company</span>&#8221; and &#8220;<span style="text-decoration: underline">OneMedNet</span>&#8221;), which consists of (i) up to 11,500,000 shares of Common Stock issuable
upon the exercise of 11,500,000 warrants (the &#8220;<span style="text-decoration: underline">Public Warrants</span>&#8221;) originally issued and registered in the initial public
offering of Data Knights Acquisition Corp, a special purpose acquisition company (&#8220;<span style="text-decoration: underline">Data Knights</span>&#8221;) at a price
of $10.00 per unit with each unit consisting of one share of Class A common stock and one warrant (each Public Warrant entitles the holder
thereof to purchase one share of Common Stock at a price of $11.50 per share), and (ii) up to an aggregate of 585,275 shares of
Common Stock issuable upon the exercise of 585,275 warrants (the &#8220;<span style="text-decoration: underline">Private</span><span style="text-decoration: underline"> Placement Warrants</span>,&#8221; together
with the Public Warrants, the &#8220;<span style="text-decoration: underline">Warrants</span>&#8221;) that made up a part of the private units originally issued in a private
placement in connection with Data Knights&#8217;s initial public offering at a price of $10.00 per unit, for an aggregate purchase
price of $5,852,750, with each unit consisting of one share of Class A common stock and one warrant (each Private Placement Warrant
entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share). We will receive the proceeds from
any exercise of the Warrants for cash.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus also relates to the offer and resale from time to time by: (a) the selling shareholders named in this prospectus
(including their permitted transferees, donees, pledgees and other successors-in-interest) (collectively, the &#8220;<span style="text-decoration: underline">Selling Shareholders</span>&#8221;) of
up to an aggregate of 19,123,352 shares of Common Stock, consisting of (i) up to 1,504,292 shares of Common Stock issuable
upon conversion of up to $1,714,893.64 of OneMedNet Senior Secured Convertible Notes (the &#8220;<span style="text-decoration: underline">Pre-Closing PIPE
Notes</span>&#8221;) issued at the closing of the Business Combination (as defined below) that are convertible into shares of Common
Stock at the election of the Pre-Closing PIPE Notes holders at a conversion price equal to the lower of (A) $10.00 per
share, and (B) 92.5% of the lowest volume weighted average trading price (&#8220;<span style="text-decoration: underline">VWAP</span>&#8221;) for the ten (10)
trading days immediately preceding the Conversion Date (as defined in the Pre-Closing PIPE Notes), subject to a floor price
of $1.14 per share of Common Stock pursuant to the terms of the Securities Purchase Agreement (the
&#8220;<span style="text-decoration: underline">Pre-Closing PIPE SPA</span>&#8221;), dated June 28, 2023, by and among Data Knights (as defined below) and the investors
named therein (the &#8220;<span style="text-decoration: underline">Pre-Closing PIPE Investors</span>&#8221; and such transaction, the &#8220;<span style="text-decoration: underline">Pre-Closing
PIPE</span>&#8221;), (ii) 95,744 shares of Common Stock underlying 95,744 warrants (the
&#8220;<span style="text-decoration: underline">Pre-Closing PIPE Warrants</span>&#8221;) issued to the Pre-Closing PIPE Investors as additional
consideration for the Pre-Closing PIPE Investors&#8217; investment in the Pre-Closing PIPE Notes, which warrant
agreements were executed at the closing of the Business Combination, (iii) 277,778 shares of Common Stock issued pursuant
to the terms of the Satisfaction and Discharge Agreement (the &#8220;<span style="text-decoration: underline">Satisfaction and Discharge Agreement</span>&#8221;) dated as
of June 28, 2023, by and among Data Knights, Legacy ONMD (as defined below), and EF Hutton LLC (&#8220;<span style="text-decoration: underline">EF Hutton</span>&#8221;) at $0.87
per share of Common Stock (lowest VWAP for 5 trading days before the 6-month anniversary), of which 128,472 shares were
transferred to Joseph T. Rallo and 128,472 shares were transferred to D. Boral Capital LLC (Boral Capital) on January 23, 2025, (iv)
2,123,424 shares of Common Stock issuable at a conversion rate of $0.7535 per share of Common Stock (95% of VWAP 10-day
average $0.7932) for an aggregate $1,600,000 investment in the Company by Dr. Thomas Kosasa, (v) [&#9679;] shares
of Common Stock held by [Data Knights, LLC (the &#8220;<span style="text-decoration: underline">Sponsor</span>&#8221;) and its affiliates], including [&#9679;] shares
of Common Stock originally issued as shares of Class B common stock, par value $0.0001 per share of the Company
(&#8220;<span style="text-decoration: underline">Class B Common Stock</span>&#8221;) in connection with the initial public offering of Data Knights for aggregate
consideration of $25,000, or approximately $0.009 per share, and [&#9679;] shares of Common Stock originally issued to the
Sponsor as part of the placement units issued to the Sponsor in connection with Data Knights&#8217; initial public
offering at $10.00 per unit, (vi) 50,000 shares of Common Stock underlying a warrant (the &#8220;<span style="text-decoration: underline">Helena Warrant</span>&#8221;)
issued to Helena Global Investment Opportunities 1 Ltd. (&#8220;<span style="text-decoration: underline">Helena</span>&#8221;) as consideration for entry into the
Termination Agreement, effective as of June 14, 2024, between the Company and Helena (the &#8220;<span style="text-decoration: underline">Helena Termination
Agreement</span>&#8221;), (vii) 4,767,616 shares of Common Stock issuable pursuant to advances under the Standby Equity Purchase
Agreement (the &#8220;<span style="text-decoration: underline">SEPA</span>&#8221;), dated June 17, 2024, by and between the Company and YA II PN, LTD, a Cayman
Islands exempt limited partnership managed by Yorkville Advisors Global, LP (&#8220;<span style="text-decoration: underline">Yorkville</span>&#8221;), (viii) 346,404 shares
of Common Stock issued to Yorkville as part of a commitment fee paid in connection with the SEPA (the &#8220;<span style="text-decoration: underline">Commitment Fee Shares</span>&#8221;), (ix) up to 1,785,714 shares of
Common Stock issuable upon conversion of a $1,500,000 convertible promissory note, of which $500,000 remains outstanding, (the
&#8220;<span style="text-decoration: underline">Yorkville Note</span>&#8221;), dated June 18, 2024, issued to Yorkville in connection with the SEPA that is convertible into
shares of Common Stock at a conversion price equal to the lower of (A) $1.3408 per share, and (B)&#160;90% of the lowest daily VWAP
of the Common Stock on Nasdaq during the seven trading days immediately prior to each conversion, subject to a floor price of
$0.28 per share pursuant to the terms of the Yorkville Note, (x) 455,000 shares of Common Stock issued to Yorkville, which have
registration rights, (xi) 1,297,059 shares of Common Stock issued pursuant to the terms of the Securities Purchase Agreement (the
&#8220;<span style="text-decoration: underline">OTC PIPE SPA</span>&#8221;), dated July 23, 2024, by and between the Company and Off the Chain, LP, an affiliate of Off the
Chain Capital (&#8220;<span style="text-decoration: underline">OTC</span>&#8221;), (xii) 1,323,530 shares of Common Stock underlying 1,323,530 pre-funded warrants issued to
OTC pursuant to the OTC PIPE SPA (together with the OTC PIPE SPA, the &#8220;<span style="text-decoration: underline">OTC PIPE</span>&#8221;), (xiii) 2,301,791 shares of
Common Stock issued pursuant to the terms of the Securities Purchase Agreement (the &#8220;<span style="text-decoration: underline">Discovery PIPE SPA</span>&#8221;), dated
July 25, 2024, by and between the Company and Discovery Global Opportunity Master Fund, Ltd., an affiliate of Discovery Capital
Management, LLC (&#8220;<span style="text-decoration: underline">Discovery</span>&#8221;), (xiv) 1,473,696 shares of Common Stock issued pursuant to the terms of the
Securities Purchase Agreement (as amended, the &#8220;<span style="text-decoration: underline">OTC Follow-On PIPE SPA</span>&#8221;), dated September 24, 2024, by and
between the Company and OTC (such transaction, the &#8220;<span style="text-decoration: underline">OTC Follow-On PIPE</span>&#8221;), (xv) 1,188,209 shares of Common Stock
underlying 1,188,209 pre-funded warrants issued to OTC pursuant to the OTC Follow-On PIPE, and (xvi) 133,095 shares of Common Stock
underlying 133,095 warrants issued to OTC pursuant to the OTC Follow-On PIPE, and (b) the selling warrant holders named in this
prospectus (including their permitted transferees, donees, pledgees and other successors-in-interest) (collectively, the
&#8220;<span style="text-decoration: underline">Selling Warrantholders</span>&#8221; and, together with the Selling Shareholders and including their permitted transferees,
the &#8220;<span style="text-decoration: underline">Selling Securityholders</span>&#8221;) of up to an aggregate of 585,275 Private Placement Warrants. Even though the
current trading price is at or significantly below Data Knights&#8217; initial public offering price, the private investors have an
incentive to sell because they will still profit on sales because of the lower price that they purchased their shares than the
public investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the offer and sale of these securities to satisfy certain registration rights we have granted. The Selling Securityholders
may offer, sell or distribute all or a portion of the securities hereby registered publicly or through private transactions at prevailing
market prices or at negotiated prices. We will not receive any of the proceeds from such sales of our shares of our Common Stock or Warrants,
except with respect to amounts received by us upon the exercise of the Warrants. We will bear all costs, expenses and fees in connection
with the registration of these securities, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws.
The Selling Securityholders will bear all commissions and discounts, if any, attributable to their sale of shares of our Common Stock
or Warrants. See section entitled <i>&#8220;Plan of Distribution&#8221; </i>beginning on page 85 of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock and Public Warrants are listed on the Nasdaq Capital Market of the Nasdaq Stock Market LLC (&#8220;<span style="text-decoration: underline">Nasdaq</span>&#8221;)
under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221; respectively. As of January 29, 2025, we had approximately
30,572,831 shares of Common Stock and 11,500,000 Public Warrants outstanding. On January 30, 2025, the last
reported closing price of our of Common Stock and Public Warrants as reported on Nasdaq was $1.02 per share of Common
Stock and $0.0315 per Public Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are an &#8220;emerging growth company&#8221; as that term is used in the Jumpstart Our Business Startups Act of 2012 and, as such, have
elected to comply with certain reduced public company reporting requirements. We may amend or supplement this prospectus from time to
time by filing amendments or supplements as required. You should read this entire prospectus and any amendments or supplements carefully
before you make your investment decision.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our securities involves a high degree of risk. See &#8220;<i>Risk Factors</i>&#8221; beginning on page 16 of this prospectus
for a discussion of information that should be considered in connection with an investment in our securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
date of this prospectus is &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2025.</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; text-align: left; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Page</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_001">ABOUT THIS PROSPECTUS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_002">MARKET AND INDUSTRY DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_003">TRADEMARKS AND COPYRIGHTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">3</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_004">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_005">PROSPECTUS SUMMARY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">6</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_007">RISK FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">16</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_008">USE OF PROCEEDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">31</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_009">DETERMINATION OF OFFERING PRICE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">32</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_010">MARKET INFORMATION FOR COMMON STOCK AND DIVIDENDS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">33</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_011">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">34</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_012">BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_013">MANAGEMENT</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">62</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_014">EXECUTIVE AND DIRECTOR COMPENSATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">66</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_015">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">67</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_016">PRINCIPAL SECURITYHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">69</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_017">SELLING SECURITYHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">70</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_018">DESCRIPTION OF SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">72</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#abdje_001">CERTAIN U.S. FEDERAL INCOME TAX CONSEQUENCES</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">79</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Va_001">PLAN OF DISTRIBUTION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">85</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Va_002">LEGAL MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">87</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Va_003">EXPERTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">87</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Va_004">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">87</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Va_005">INDEX TO FINANCIAL INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">PART II-INFORMATION NOT REQUIRED IN PROSPECTUS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">II-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Va_006">EXHIBIT INDEX</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">II-4</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Va_007">SIGNATURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">II-7</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>You
should rely only on the information contained in this prospectus or any supplement. Neither we nor the Selling Securityholders have authorized
anyone else to provide you with different information. The securities offered by this prospectus are being offered only in jurisdictions
where the offer is permitted. You should not assume that the information in this prospectus or any supplement is accurate as of any date
other than the date on the front of each document. Our business, financial condition, results of operations and prospects may have changed
since that date.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Except
as otherwise set forth in this prospectus, neither we nor the Selling Securityholders have taken any action to permit a public offering
of these securities outside the United States or to permit the possession or distribution of this prospectus outside the United States.
Persons outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions
relating to the offering of these securities and the distribution of this prospectus outside the United States.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_001"></span>ABOUT
THIS PROSPECTUS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement that we filed with the SEC using a &#8220;shelf&#8221; registration process. By using
a shelf registration statement, the Selling Securityholders may, from time to time, sell any combination of the securities
described in this prospectus in one or more offerings. We will not receive any proceeds from the sale of Common Stock or Warrants
by the Selling Securityholders. This prospectus provides you with a general description of the securities that the Selling Securityholders
may offer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part
that may contain material information relating to this offering. The prospectus supplement or post-effective amendment, as the
case may be, may add, update or change information contained in this prospectus with respect to such offering. If there is any inconsistency
between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the
prospectus supplement or post-effective amendment, as applicable. Before purchasing any of the Common Stock or Warrants, you should carefully
read this prospectus and any prospectus supplement and/or post-effective amendment, as applicable, together with the additional information
described under &#8220;<i>Where You Can Find More Information.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the Selling Securityholders have authorized anyone to provide you with any information or to make any representations other than
those contained in this prospectus and any prospectus supplement and/or post-effective amendment, as applicable, prepared by or on behalf
of us or to which we have referred you. We and the Selling Securityholders take no responsibility for, and can provide no assurance as
to the reliability of, any other information that others may give you. The Selling Securityholders will not make an offer to sell
the Common Stock or Warrants in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing
in this prospectus and any prospectus supplement and/or post-effective amendment, as applicable, is accurate only as of the date on the
respective cover. Our business, prospects, financial condition or results of operations may have changed since those dates. This prospectus
contains, and any prospectus supplement or post-effective amendment may contain, market data and industry statistics and forecasts that
are based on independent industry publications and other publicly available information. Although we believe these sources are reliable,
we do not guarantee the accuracy or completeness of this information and we have not independently verified this information. In addition,
the market and industry data and forecasts that may be included in this prospectus and any prospectus supplement and/or post-effective
amendment, as applicable, may involve estimates, assumptions and other risks and uncertainties and are subject to change based on various
factors, including those discussed under &#8220;<i>Risk Factors</i>&#8221; in this prospectus and any prospectus supplement and/or post-effective
amendment, as applicable. Accordingly, investors should not place undue reliance on this information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_002"></span>MARKET
AND INDUSTRY DATA</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, information contained in this prospectus concerning our industry and the regions in which we operate, including
our general expectations and market position, market opportunity, market share and other management estimates, is based on information
obtained from various independent publicly available sources and other industry publications, surveys and forecasts. While we believe
that the market data, industry forecasts and similar information included in this prospectus are generally reliable, such information
is inherently imprecise. In addition, assumptions and estimates of our future performance and growth objectives and the future performance
of our industry and the markets in which we operate are necessarily subject to a high degree of uncertainty and risk due to a variety
of factors, including those discussed under the headings &#8220;<i>Risk Factors</i>,&#8221; &#8220;<i>Cautionary Note Regarding Forward-Looking
Statements</i>&#8221; and &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</i>&#8221;
in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
contained in this prospectus concerning our industry, market and competitive position data are derived from our own internal estimates
and research as well as from publicly available information, industry and general publications and research, surveys and studies conducted
by third parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry
publications and forecasts generally state that the information they contain has been obtained from sources believed to be reliable,
but such information is inherently imprecise. Forecasts and other forward-looking information obtained from these sources are subject
to the same qualifications and uncertainties as the other forward-looking statements in this prospectus. These forecasts and forward-looking
information are subject to uncertainty and risk due to a variety of factors, including those described under &#8220;<i>Risk Factors</i>&#8221;.
These and other factors could cause results to differ materially from those expressed in any forecasts or estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_003"></span>TRADEMARKS
AND COPYRIGHTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own or have rights to trademarks or trade names that we use in connection with the operation of our business, including our corporate
names, logos and website names. In addition, we own or have the rights to copyrights, trade secrets and other proprietary rights that
protect the content of our products and the formulations for such products. This prospectus may also contain trademarks, service marks
and trade names of other companies, which are the property of their respective owners. Our use or display of third parties&#8217; trademarks,
service marks, trade names or products in this prospectus is not intended to, and should not be read to, imply a relationship with or
endorsement or sponsorship of us. Solely for convenience, some of the copyrights, trade names and trademarks referred to in this prospectus
are listed without their &#169;, &#174; and <sup>TM</sup> symbols, but we will assert, to the fullest extent under applicable law, our
rights to our copyrights, trade names and trademarks. All other trademarks are the property of their respective owners.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_004"></span>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements that we make from time to time, including statements contained in this prospectus, constitute &#8220;forward-looking statements&#8221;
within the meaning of the Private Securities Litigation Reform Act of 1995,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
and of Section 27A of the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities Act</span>&#8221;), and Section 21E of the Securities
Exchange Act of 1934, as amended (the &#8220;<span style="text-decoration: underline">Exchange Act</span>&#8221;). All statements other than statements of historical fact
contained in this prospectus are forward-looking statements. The forward-looking statements in this prospectus are only predictions.
We have based these forward-looking statements largely on our current expectations and projections about future events and financial
trends that we believe may affect our business, financial condition, and results of operations. In some cases, you can identify these
forward-looking statements by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221;
&#8220;depends,&#8221; &#8220;estimate,&#8221; &#8220;expects,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;ongoing,&#8221;
&#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221;
&#8220;would&#8221; or the negative of those terms or other similar expressions, although not all forward-looking statements contain
those words. We have based these forward-looking statements on our current expectations and projections about future events and trends
that we believe may affect our financial condition, results of operations, strategy, short- and long-term business operations and objectives,
and financial needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could
materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based
these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may
affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives,
and financial needs. Forward-looking statements in this prospectus include, without limitation, statements reflecting management&#8217;s
expectations for future financial performance and operating expenditures (including our ability to continue as a going concern, to raise
additional capital and to succeed in our future operations), expected growth, profitability and business outlook, and operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our
actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements.
These factors include, among other things, the unknown risks and uncertainties that we believe could cause actual results to differ from
these forward looking statements as set forth under the heading, &#8220;Risk Factors&#8221; and elsewhere in this prospectus and other
documents we file with the Securities and Exchange Commission. New risks and uncertainties emerge from time to time, and it is not possible
for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation,
risks and uncertainties relating to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            projected financial position and estimated cash burn rate;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            estimates regarding expenses, future revenues and capital requirements;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to continue as a going concern;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to raise substantial additional capital in sufficient amounts or on acceptable
                                            terms to fund our operations and our business plan;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to reverse the recent decline in our revenue and resume growing our revenue;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain and maintain intellectual property protection for our current products
                                            and services;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to protect our intellectual property rights and the potential for us to incur substantial
                                            costs from lawsuits to enforce or protect our intellectual property rights;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            possibility that a third party may claim we have infringed, misappropriated or otherwise
                                            violated their intellectual property rights and that we may incur substantial costs and be
                                            required to devote substantial time defending against these claims;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            reliance on third-party suppliers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            success of competing products or services that are or become available;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to expand our organization to accommodate potential growth and our ability to retain
                                            and attract key personnel; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            potential for us to incur substantial costs resulting from lawsuits against us and the potential
                                            for these lawsuits to cause us to limit our commercialization of our products and services.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in &#8220;<i>Risk
Factors</i>.&#8221; Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time.
It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent
to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking
statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed
in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected
in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events
and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, except as required by law, neither
we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation
to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual
results or to changes in our expectations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus with the understanding that our actual future results, levels of activity, performance and events and circumstances
may be materially different from what we expect. As a result of a number of known and unknown risks and uncertainties, our actual results
or performance may be materially different from those expressed or implied by these forward-looking statements including those described
in the &#8220;<i>Risk Factors</i>&#8221; section beginning on page 16 and elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_005"></span>PROSPECTUS
SUMMARY</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary of the prospectus highlights material information concerning our business and this offering. This summary does not contain all
of the information that you should consider before making your investment decision. You should carefully read the entire prospectus,
including the information presented under the section entitled &#8220;Risk Factors&#8221; and the financial data and related notes, before
making an investment decision. It does not contain all the information that may be important to you and your investment decision. You
should carefully read this entire prospectus, including the matters set forth under &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s
Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and our financial statements and related notes included
elsewhere in this prospectus. This summary contains forward-looking statements that involve risks and uncertainties. Our actual results
may differ significantly from future results contemplated in the forward-looking statements as a result of factors such as those set
forth in &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements.&#8221;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this prospectus, unless the context indicates otherwise, &#8220;OneMedNet,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221;
&#8220;ours&#8221; or &#8220;us&#8221; refer to OneMedNet Corporation (f/k/a Data Knights Acquisition Corp.), a Delaware corporation,
and consolidated subsidiaries following the effective time of the Business Combination.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not authorized anyone to provide you with different information and you must not rely on any unauthorized information or representation.
We are not making an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. This document may only
be used where it is legal to sell these securities. You should assume that the information appearing in this prospectus is accurate only
as of the date on the front of this prospectus, regardless of the time of delivery of this prospectus, or any sale of our Common Stock.
Our business, financial condition and results of operations may have changed since the date on the front of this prospectus. We urge
you to carefully read this prospectus before deciding whether to invest in any of the Common Stock being offered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. The Company
was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions that simplify digital medical
image management, exchange, and sharing. The Company has one wholly-owned subsidiary, OneMedNet Technologies (Canada) Inc. (&#8220;<span style="text-decoration: underline">ONMD
Canada</span>&#8221;), incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia. ONMD
Canada&#8217;s functional currency is the Canadian dollar. The Company&#8217;s headquarters location is 6385 Old Shady Oak Road, Suite
250, Eden Prairie, Minnesota 55344 and its telephone number is 800-918-7189.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, Merger Sub merged with and into Legacy ONMD, with Legacy ONMD surviving as a wholly owned subsidiary of Data Knights.
Following the consummation of the Business Combination, Data Knights was renamed to &#8220;OneMedNet Corporation&#8221; and the business
of Data Knights became the business of Legacy ONMD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Background</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial
Public Offering</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 11, 2021, Data Knights consummated an initial public offering (the &#8220;<span style="text-decoration: underline">Initial Public Offering</span>&#8221;). The registration
statement for Data Knights&#8217; Initial Public Offering was declared effective on May 6, 2021. Data Knights&#8217; Initial Public Offering
of 10,000,000 units (the &#8220;<span style="text-decoration: underline">Units</span>&#8221; and, with respect to the common stock, par value $0.0001 per share, the &#8220;<span style="text-decoration: underline">Common
Stock</span>&#8221; included in the Units, and the Public Warrants, at $10.00 per Unit, generated gross proceeds of $100,000,000. Data Knights
granted the underwriter a 45-day option to purchase up to an additional 1,500,000 Units at the Initial Public Offering price to cover
over-allotments, which the underwriters exercised the over-allotment option in full, and the closing of the issuance and sale of the
additional Units occurred (the &#8220;<span style="text-decoration: underline">Over-allotment Option Units</span>&#8221;). The total aggregate issuance by Data Knights of 1,500,000
units at a price of $10.00 per unit resulted in total gross proceeds of $15,000,000. Simultaneously with the consummation of the closing
of the Initial Public Offering, Data Knights consummated the private placement of an aggregate of 585,275 units (the &#8220;<span style="text-decoration: underline">Placement
Units</span>&#8221;) to the Sponsor at a price of $10.00 per Placement Unit, generating total gross proceeds of $5,852,750 (the &#8220;<span style="text-decoration: underline">Private
Placement</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Placement Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve
a public offering. A total of $117,300,000, comprised of the proceeds from the Initial Public Offering and the proceeds of private placements
that closed on May 11, 2021, net of the underwriting commissions, discounts, and offering expenses, was deposited in the Trust Account
(as defined below) established for the benefit of Data Knights&#8217; public stockholders. On June 22, 2021, the Common Stock and Public
Warrants included in the Units began separate trading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
payments for our expenses were made in the Initial Public Offering directly or indirectly to (i) any of our directors, officers or their
associates, (ii) any person(s) owning 10% or more of any class of our equity securities or (iii) any of our affiliates, except in connection
with the repayment of outstanding loans and pursuant to the administrative support agreement disclosed herein which we entered into with
the Sponsor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
Combination</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 25, 2022, Data Knights, OneMedNet Solutions Corporation (f/k/a OneMedNet Corporation) (&#8220;<span style="text-decoration: underline">Legacy ONMD</span>&#8221;), Data
Knights Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Data Knights (&#8220;<span style="text-decoration: underline">Merger Sub</span>&#8221;), the
Sponsor, and Paul Casey, in his capacity as the Seller Representative, entered into a definitive Agreement and Plan of Merger (the &#8220;<span style="text-decoration: underline">Merger
Agreement</span>&#8221;). Pursuant to the Merger Agreement, upon the closing (the &#8220;<span style="text-decoration: underline">Closing</span>&#8221;) of the transactions contemplated
in the Merger Agreement (collectively, the &#8220;<span style="text-decoration: underline">Business Combination</span>&#8221;), the Parties would consummate the merger of Merger
Sub with and into Legacy ONMD, with Legacy ONMD continuing as the surviving entity (the &#8220;<span style="text-decoration: underline">Merger</span>&#8221;), which would result
in all of the issued and outstanding capital stock of Legacy ONMD being exchanged for shares of Data Knight&#8217;s Common Stock upon
the terms set forth in the Merger Agreement. The Merger and Merger Agreement and the related transactions were approved unanimously by
the boards of directors of each of Data Knights and Legacy ONMD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, on June 28, 2023, Data Knights, Legacy ONMD, and EF Hutton entered into the Satisfaction
and Discharge Agreement, whereby EF Hutton agreed to waive the related merger underwriting fees that were payable at closing ($4.0
million) in exchange for allocated payments as follows: (i) a one-time cash payment of $500,000 paid at the time of the Closing;
(ii) a $500,000 promissory note executed by Data Knights on June 30, 2023 in which Data Knights was obligated to make six monthly
payments to EF Hutton in the cash amount of $83,333.33 commencing after the Closing and maturing on March 1, 2024; and (iii) a
transfer of 277,778 shares of Common Stock at $10.89 per share, for an aggregate value of $3,025,000. If, five trading days prior to the six-month anniversary, the aggregate
VWAP value of the 277,778 shares of Common Stock was lower than the original share value of $3,025,000, the Company was obligated to compensate
EF Hutton at a new share price equal to the difference in amount on such date. Due to the decrease in share value on the six-month anniversary,
the Company was required to either pay to EF Hutton an additional $2,782,738 or issue to EF Hutton an additional 3,175,000 shares of Common
Stock. In January 2024, the Company issued the original 277,778 shares of Common Stock as consideration for $242,262 owed by the Company.
The Company remains obligated to pay to EF Hutton the true-up of either $2,782,738 or 3,175,000 shares of Common Stock valued at $0.88
per share to settle the aggregate value of $3,025,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 17, 2023, Data Knights held a special meeting of its stockholders (the &#8220;<span style="text-decoration: underline">Stockholders</span>&#8221;) in lieu of its 2023
annual meeting of Stockholders (the &#8220;<span style="text-decoration: underline">Special Meeting</span>&#8221;) in connection with the transactions contemplated by the Merger
Agreement. At the Special Meeting, the stockholders of Data Knights were asked to consider and vote on the proposals identified in the
Definitive Proxy; 4,690,565 shares of Common Stock were represented in person or by proxy at the Special Meeting, and, therefore, a quorum
was present and all proposals were approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, we held the Closing of the Business Combination transaction whereby Merger Sub merged with and into Legacy ONMD with
Legacy ONMD continuing as the surviving entity, which resulted in all of the issued and outstanding capital stock of Legacy ONMD being
exchanged for shares of the Company&#8217;s Common Stock upon the terms set forth in the Merger Agreement. The Merger and other transactions
that closed on November 7, 2023, pursuant to the Merger Agreement, led to Data Knights changing its name to &#8220;OneMedNet Corporation&#8221;
and the business of the Company became the business of Legacy ONMD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Merger Agreement, the total consideration for the Business Combination and related transactions (the &#8220;<span style="text-decoration: underline">Merger
Consideration</span>&#8221;) was approximately $200 million. In connection with the Special Meeting, certain public holders (the &#8220;<span style="text-decoration: underline">Redeeming
Stockholders</span>&#8221;) holding 1,600,741 shares of Common Stock exercised their right to redeem such shares for a pro rata portion
of the funds held by Continental Stock Transfer &amp; Trust Company, as trustee (&#8220;<span style="text-decoration: underline">Continental</span>&#8221;) in the trust account
established in connection with Data Knights&#8217; initial public offering (the &#8220;<span style="text-decoration: underline">Trust Account</span>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
November 7, 2023, Data Knights&#8217; Units ceased trading, and effective November 8, 2023, the Common Stock began trading on the Nasdaq
Global Market under the symbol &#8220;ONMD&#8221; and the Public Warrants began trading on the Nasdaq Global Market under the symbol
&#8220;ONMDW.&#8221; As described in further detail herein, at the opening of business on August 19, 2024, the shares of Common Stock
and Public Warrants were transferred from the Nasdaq Global Market to the Nasdaq Capital Market and continue to trade under the symbols
&#8220;ONMD&#8221; and &#8220;ONMDW,&#8221; respectively</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Merger and the Business Combination, holders of Data Knights common stock automatically received common stock of OneMedNet,
and holders of Data Knights warrants automatically received warrants of OneMedNet with substantively identical terms. At the Closing
of the Business Combination, all shares of Data Knights owned by the Sponsor (consisting of shares of Data Knights Class A Common Stock
and shares of Data Knights Class B Common Stock (such shares of Common Stock owned by the Sponsor, the &#8220;<span style="text-decoration: underline">Founder Shares</span>&#8221;),
automatically converted into an equal number of shares of OneMedNet&#8217;s Common Stock, and the Private Placement Warrants held by
the Sponsor automatically converted into warrants to purchase one share of OneMedNet Common Stock with substantively identical terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of the Closing on November 7, 2023, among other holders, public stockholders of Data Knights owned 98,178 shares of OneMedNet Common
Stock, representing approximately 0.35% of the outstanding shares of OneMedNet Common Stock&#894; the Sponsor and its affiliates owned
approximately 15.1% of the outstanding shares of OneMedNet Common Stock (inclusive of shares received upon conversion of the Sponsor&#8217;s
loan)&#894; security holders of Legacy ONMD owned approximately 61.992% of the outstanding shares of OneMedNet Common Stock from the
conversion of their shares&#894; Pre-Closing PIPE Investors owned 0.46% of the outstanding shares of OneMedNet Common Stock, and convertible
note holders of Legacy ONMD owned approximately 16.24% of the outstanding shares of OneMedNet Common Stock resulting from the issuance
of 5,238,800 shares of Common Stock upon conversion of their convertible notes.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, following the approval of the Merger Agreement and the transactions contemplated thereby at the Special Meeting of
the shareholders of Data Knights held on October 17, 2023, Merger Sub merged with and into Legacy ONMD pursuant to the Merger Agreement,
with Legacy ONMD surviving the Merger as a wholly-owned subsidiary of Data Knights. Following Closing, Data Knights changed its name
to &#8220;OneMedNet Corporation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, Data Knights
was treated as the acquired company and Legacy ONMD was treated as the acquirer for financial statement reporting purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Material Agreements and Recent Developments</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Registration Rights Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Closing of the Business Combination and funding of the Pre-Closing PIPE pursuant to the Pre-Closing PIPE SPA, the Pre-Closing PIPE
Investors each executed a Pre-Closing PIPE Note and a Pre-Closing PIPE Warrant in the amount corresponding to each Pre-Closing PIPE Investor&#8217;s
investment amount and in accordance with the terms set forth in the Pre-Closing PIPE SPA as well as a registration rights agreement (the
&#8220;<span style="text-decoration: underline">Pre-Closing PIPE Registration Rights Agreement</span>&#8221;). We are required to register the offer and sale of these securities
to satisfy the registration rights we have granted in the Pre-Closing PIPE Registration Rights Agreement. At the Closing of the Business
Combination, Legacy OneMedNet, Data Knights and the Sponsor entered into a registration rights agreement (the &#8220;<span style="text-decoration: underline">Registration
Rights Agreement</span>&#8221;), pursuant to which, among other things, the Company is obligated to file a registration statement to register
the resale of certain securities of the Company held by the Holders (as defined in the Registration Rights Agreement) and the Sponsor.
The Registration Rights Agreement also provides the Holders and the Sponsor with &#8220;piggy-back&#8221; registration rights, subject
to certain requirements and customary conditions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
Agreement and Sponsor Support Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with entry into the Merger Agreement, Data Knights entered into voting agreements (the &#8220;<span style="text-decoration: underline">Voting Agreements</span>&#8221;)
with certain stockholders of Legacy ONMD representing approximately 55% of the outstanding voting power of Legacy ONMD&#8217;s equity
securities (the &#8220;<span style="text-decoration: underline">Legacy ONMD Stockholders</span>&#8221;) pursuant to which the Legacy ONMD Stockholders agreed to (i) vote their
Legacy ONMD equity securities in favor of the approval of the Merger Agreement and the Business Combination, (ii) be bound by certain
covenants and agreements related to the Business Combination and (iii) take other customary actions to cause the Business Combination
to occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with entry into the Merger Agreement, Data Knights, the Sponsor and Legacy ONMD entered into a sponsor support agreement (the
&#8220;<span style="text-decoration: underline">Sponsor Support Agreement</span>&#8221;) pursuant to which the Sponsor agreed to vote its Data Knights securities in favor of
the approval of the Merger Agreement and the Business Combination and to take other customary actions to cause the Business Combination
to occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
Employment Agreements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Closing of the Business Combination, the Company entered into employment agreements (the &#8220;<span style="text-decoration: underline">Employment Agreements</span>&#8221;)
with executive officers: Aaron Green (President and Chief Executive Officer), Lisa Embree (former Chief Financial Officer), and Paul
Casey (former Chief Executive Officer). The Employment Agreements provide for at-will employment that may be terminated by the Company
with or without cause, by the executive with or without good reason, or mutually by the parties. See the section titled, &#8220;Executive
Compensation&#8212;Executive Employment Arrangements&#8221; for additional information on current employment agreements of our executive
officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pre-Closing
PIPE Stock Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2023, Data Knights entered into the Pre-Closing PIPE SPA with the Pre-Closing PIPE Investors for a PIPE financing in the aggregate
original principal amount of $1,595,744.70 and the purchase price of $1.5 million. Pursuant to the Pre-Closing PIPE SPA, Data Knights
issued and sold to each of the Pre-Closing PIPE Investors the Pre-Closing PIPE Notes, which are convertible into shares of Common Stock
at the Pre-Closing PIPE Investor&#8217;s election at a conversion price equal to the lower of (i) $10.00 per share, and (ii) 92.5% of
the lowest VWAP for the ten (10) Trading Days (defined as a day on which the Common Stock is traded on a trading market) immediately
preceding the Conversion Date (defined as any date), subject to the floor price of $1.14 (representing 20% of the closing price of the
Common Stock on the last trading day before the closing of the Business Combination), or the alternative conversion ratio of the greater
of the floor price and the lesser of 80% of the VWAP of the Common Stock as of the trading day and 80% of the price computed as the quotient
of the sum of the VWAP of the Common Stock for each of the three trading days with the lowest VWAP of the Common Stock during the fifteen
consecutive trading day period ending and including the trading day immediately preceding the delivery or deemed delivery of the applicable
conversion notice, divided by three. All such determinations are to be appropriately adjusted for any stock dividend, stock split, stock
combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock. The PIPE Investors&#8217;
$1.5 million investment in the PIPE Notes closed and funded contemporaneous to the Closing of the Business Combination. Effective immediately
prior to the Closing, Data Knights issued the Pre-Closing PIPE Notes to the Pre-Closing PIPE Investors pursuant to the private offering
rules under the Securities Act. In conjunction with the issuance of the Pre-Closing PIPE Notes, Data Knights also issued and sold to
each of the Pre-Closing PIPE Investors 95,744 Pre-Closing PIPE Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Helena
SPA and Helena Termination Agreement</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company entered into a definitive securities purchase agreement (the &#8220;<span style="text-decoration: underline">Helena SPA</span>&#8221;) with Helena,
an affiliate of Helena Partners Inc., a Cayman-Islands based advisor and investor providing for up to $4.5 million in funding through
a private placement for the issuance of senior secured convertible notes. On June 14, 2024, the Company and Helena entered into the Helena
Termination Agreement to terminate the Helena SPA and related documents. Pursuant to the Helena Termination Agreement, the Company issued
to Helena a warrant to purchase 50,000 shares of Common Stock at an exercise price of $1.20 per share and agreed to reimburse Helena
for certain reasonable and documented out-of-pocket legal fees and expenses incurred in connection with entry into the Helena SPA and
Helena Termination Agreement and related documents. The Company incurred legal fees and expenses of $42 thousand in connection with the
Helena Termination Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 23, 2024 and July 25, 2024, the Company entered into the OTC PIPE SPA and the Discovery PIPE SPA, respectively in connection with
the private placement of its Common Stock and pre-funded warrants with aggregate gross proceeds of approximately $4.6 million, before
deducting fees and expenses payable by the Company. The Company used $2.8 million of the net proceeds to purchase Bitcoin. There is no
guarantee on the holding period for the purchased Bitcoin. The Company intends to use the remaining net proceeds for working capital
and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the OTC PIPE SPA, the Company agreed to issue and sell to OTC 1,297,059 shares of its Common Stock at a price of $1.0278 per share
and pre-funded warrants exercisable for 1,323,530 shares of its Common Stock at an exercise price of $1.0278 per share. Pursuant to the
Discovery PIPE SPA, the Company agreed to issue and sell to Discovery 2,301,791 shares of its Common Stock at a price of $0.85 per share.
The investors were required to prepay the exercise price for the pre-funded warrants, other than $0.0001 per share. The pre-funded warrants
will be exercisable at any time after the date of issuance and will not expire. The price per share of all Common Stock and pre-funded
warrants sold in the private placement meets the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued
to institutional accredited investors in a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 24, 2024, the Company entered into the OTC Follow-On PIPE SPA in connection with the private placement of its Common Stock,
warrants and pre-funded warrants with aggregate gross proceeds of approximately $1.7 million, before deducting fees and expenses payable
by the Company. The Company used $0.4 million of the net proceeds to purchase Bitcoin. There is no guarantee on the holding period for
the purchased Bitcoin. The Company intends to use the remaining net proceeds for working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the OTC Follow-On PIPE SPA, the Company agreed to issue and sell to the investor 1,473,696 shares of its Common Stock at a price
of $0.65 per share, warrants exercisable for 133,095 shares of its Common Stock at an exercise price of $0.325 per share and
pre-funded warrants exercisable for 1,188,209 shares of its Common Stock at an exercise price of $0.65 per share. OTC was required
to prepay the exercise price for the pre-funded warrants, other than $0.0001 per share. The warrants and pre-funded warrants will be
exercisable at any time after the date of issuance and will not expire. The price per share of all Common Stock and pre-funded
warrants sold in the private placement meets the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were
issued to an institutional accredited investor in a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under
the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Standby
Equity Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company entered into the SEPA with Yorkville. Pursuant to the SEPA, subject to certain conditions, the Company has
the option to sell to Yorkville an aggregate amount of up to $25.0 million of shares of Common Stock at the Company&#8217;s request from
time to time following both the repayment of the Yorkville Promissory Note described below and the effectiveness of a resale registration
statement covering the shares of Common Stock issued under the SEPA. The SEPA terminates on its 24-month anniversary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
advance may not exceed the greater of 500,000 shares and 100% of the average daily volume traded of the Common Stock during the five
trading days immediately prior to requested advance. The shares would be purchased at a price equal to 97% of the Market Price as defined
in the SEPA. The Company may establish a minimum acceptable price in each advance below which the Company will not be obligated to make
any sales to Yorkville.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
purchase under an advance would be subject to certain limitations, including that Yorkville will not purchase or acquire any shares that
would result in it and its affiliates beneficially owning more than 4.99% of the then outstanding voting power or number of shares of
Common Stock or any shares that when aggregated with shares issued under all other earlier advances, would exceed 4,767,616 shares of
Common Stock (representing 19.99% of the aggregate number of then outstanding shares of Common Stock) (the &#8220;<span style="text-decoration: underline">Exchange Cap</span>&#8221;)
unless shareholders approved issuances in excess of the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the execution of the SEPA, the Company paid a $25,000 structuring fee to Yorkville. The Company agreed to pay a commitment
fee of $0.5 million to Yorkville, which was payable in shares. In September 2024, the Company issued 526,312 shares of Common Stock to
Yorkville to settle the commitment fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
Yorkville agreed to advance to the Company, in exchange for the Yorkville Note, a principal amount of $1.5 million, which was funded
on June 18, 2024. The Yorkville Promissory Note is due on June 18, 2025, and interest accrues at an annual rate equal to 0%, subject
to an increase to 18% upon an event of default as described in the Yorkville Promissory Note. The Yorkville Promissory Note will be convertible
by Yorkville into shares of Common Stock at an aggregate purchase price based on a price per share equal to the lower of (a) $1.3408
per share (subject to downward reset upon the filing of the resale registration statement described below) or (b) 90% of the lowest daily
VWAP of the Common Stock on Nasdaq during the seven trading days immediately prior to each conversion (the &#8220;<span style="text-decoration: underline">Variable Price</span>&#8221;),
but which Variable Price may not be lower than the Floor Price then in effect. The &#8220;<span style="text-decoration: underline">Floor Price</span>&#8221; is $0.28 per share,
subject to the Company&#8217;s option to reduce the Floor Price to any amount set forth in a written notice to Yorkville. While the Yorkville
Promissory Note is outstanding, Yorkville may initiate an investor advance under the SEPA at the Yorkville Promissory Note conversion
price, the proceeds of which would be used to repay the Yorkville Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Yorkville Promissory Note may be accelerated by Yorkville upon specified events of default, and may become amortizable for cash if (i)
the daily VWAP is less than the Floor Price for five trading days during a period of seven consecutive trading days, (ii) the Company
has issued in excess of 95% of the shares of Common Stock available under the Exchange Cap or (iii) the Company is in material breach
of its obligations under a registration rights agreement it entered into with Yorkville in connection with the SEPA or Yorkville becomes
limited in its ability to freely resell shares subject to an advance as further described in the Yorkville Promissory Note, subject to
de-amortization after certain cures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Yorkville
Letter</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, Yorkville sent the Company a letter notifying the Company that it had breached a registration rights agreement with
Yorkville by failing to file a Registration Statement on Form S-1 on the timeline set forth in the registration rights agreement (the
&#8220;<span style="text-decoration: underline">Yorkville Letter</span>&#8221;). The Yorkville Letter asserted that this breach was an event of default and an amortization event
under the prepaid advance in connection with the SEPA. The Yorkville Letter also asserted that the Company&#8217;s failure to timely
file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 was an event of default under the Yorkville Promissory
Note. The Company subsequently engaged in discussions with Yorkville regarding the Yorkville Letter, which discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Promissory Note, upon the occurrence of an amortization event, the Company is required to pay all principal and accrued
interest on the Yorkville Promissory Note, plus a 10% payment premium on the principal amount, in equal installments over 3 calendar
months or until the amortization event is cured, whichever is earlier. In addition, upon the occurrence of an event of default, the interest
rate on the Yorkville Promissory Note increases to 18% retroactive to the date of the event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Executive
Turnover</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on Form 8-K, on August 26, 2024, Lisa Embree, Chief Financial Officer, Executive Vice President, Treasurer and Secretary,
notified the Company of her intention to resign from her position effective August 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
August 30, 2024, the Board of Directors of the Company (the &#8220;<span style="text-decoration: underline">Board</span>&#8221;) appointed Mr. Robert Golden to serve as the Chief
Financial Officer (&#8220;<span style="text-decoration: underline">CFO</span>&#8221;) on an interim basis to fill the vacancy created by the resignation of Lisa Embree. Effective
on his appointment as interim CFO, Mr. Golden stepped down as a member and the chair of the Audit Committee of the Board. In connection
with his appointment as interim CFO, the Company entered into a consulting agreement with Mr. Golden, pursuant to which Mr. Golden will
receive a $12,000 monthly salary and a grant of 100,000 restricted stock units, which will vest on the first anniversary of the consulting
agreement, subject to the terms and conditions set forth in the consulting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on October 8, 2024, on October 1, 2024, Paul J. Casey and Erkan
Akyuz resigned from the Board, effective immediately. Also on October 1, 2024, the Board appointed Jair Clarke and Sherry Coonse McCraw
to the Board to fill the vacancies created by Mr. Casey and Mr. Akyuz, respectively. In connection with Ms. Coonse McCraw and Mr. Clarke&#8217;s
service on the Board, the Board approved an RSU grant providing for the grant of 45,000 RSUs to each director for one full year of service
(pro-rated for 2024). The RSUs will vest at the end of December 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Associated with our Common Stock</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in our Common Stock involves risk. These risks are described more fully in the section entitled &#8220;Risk Factors,&#8221; immediately
following this prospectus summary. These risks include the following, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            Common Stock may be subject to extreme volatility.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to maintain listing of our securities on the Nasdaq Capital Market or any stock
                                            exchange, our stock price could be adversely affected and the liquidity of our stock and
                                            our ability to obtain financing could be impaired and it may be more difficult for our stockholders
                                            to sell their securities.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            principal stockholders will continue to have significant influence over the election of our
                                            Board and approval of any significant corporate actions, including any sale of the Company.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            could be subject to securities class action litigation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            securities or industry analysts do not publish research or publish inaccurate or unfavorable
                                            research about our business, the market price for the shares of Common Stock and trading
                                            volume could decline.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            do not expect to pay dividends in the foreseeable future, and you must rely on price appreciation
                                            of your shares of Common Stock for return on your investment.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
                                            sales of substantial amounts of our Common Stock or securities convertible into or exchangeable
                                            or exercisable for shares of Common Stock, either by us or by our existing stockholders,
                                            or the possibility that such sales could occur, could adversely affect the market price of
                                            our Common Stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
                                            of the Private Placement Warrants purchased in this offering will have no rights as holders
                                            of Common Stock until such holders exercise such Private Placement Warrants and acquire our
                                            Common Stock.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            securities being offered in this prospectus represent a substantial percentage of our outstanding
                                            Common Stock, and the sales of such securities, or the perception that these sales could
                                            occur, could cause the market price of our Common Stock to decline significantly.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are an &#8220;emerging growth company,&#8221; and the reduced reporting requirements applicable
                                            to emerging growth companies may make our Common Stock less attractive to investors.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Associated with our Business</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to implement our business strategy is subject to numerous risks that you should be aware of before making an investment decision.
These risks are described more fully in the section entitled &#8220;Risk Factors,&#8221; immediately following this prospectus summary.
These risks include the following, among others:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have a history of operating losses and may never achieve profitability in the future.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            report of our independent registered public accounting firm for the fiscal years ended December
                                            31, 2023 and 2022 contains an explanatory paragraph regarding substantial doubt about our
                                            ability to continue as a going concern.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
                                            significant customer represented 51% and 29% of our revenues for 2023 and 2022 respectively
                                            and is expected to continue to represent a significant portion of our forecasted revenue
                                            for 2024.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may encounter difficulties in managing our attempted growth of our business, which could
                                            negatively impact our operations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be unable to execute our business objectives and growth strategies successfully or sustain
                                            our growth and, as a result, this could have a material adverse effect on our operating results.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Real World Data and Real World Evidence business market continues to evolve and is highly
                                            competitive, and we may not be successful in competing in this industry or establishing and
                                            maintaining confidence in our long-term business prospects among current and future partners
                                            and customers.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to attract and retain key employees and qualified personnel, our ability to
                                            compete could be harmed.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            inability to expand our development, use and adoption of artificial intelligence, or issues
                                            presented in our development, use and adoption of artificial intelligence, could harm our
                                            reputation, expose us to liability and cause us to lose customers.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                            material breach in security relating to the Company&#8217;s information systems and regulation
                                            related to such breaches, cyber-attacks, or other disruptions could adversely affect the
                                            Company, expose us to liability and affect our business and reputation.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to adequately protect or expand our intellectual property related to our current
                                            or future products, our business prospects could be harmed.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we fail to comply with the extensive legal and regulatory requirements affecting the health
                                            care industry, we could face increased costs, penalties and a loss of business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            collection, use, and disclosure of personal information is subject to U.S. state and federal
                                            privacy and security regulations, and our failure to comply with those regulations or to
                                            adequately secure the information we hold could result in significant liability or reputational
                                            harm.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            ability to utilize our net operating loss and tax credit carryforwards to offset future taxable
                                            income may be subject to certain limitations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
                                            we do not currently hedge our investment in Bitcoin and do not intend to for the foreseeable
                                            future, we are directly exposed to Bitcoin&#8217;s price volatility and surrounding risks.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            management has limited experience in operating a public company.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have incurred and will continue to incur significant increased expenses and administrative
                                            burdens as a public company, which could have an adverse effect on our business, financial
                                            condition and results of operations.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have identified material weaknesses in our internal control over financial reporting, and
                                            if our remediation of these material weaknesses is not effective, or if we fail to maintain
                                            an effective system of internal controls over financial reporting in the future, we may not
                                            be able to accurately or timely report our financial condition or operating results, which
                                            may adversely affect our business.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            business model is capital-intensive, and we may not be able to raise additional capital on
                                            attractive terms, if at all, and any additional capital we do raise through issuances of
                                            equity securities could be dilutive to stockholders. If we cannot raise additional capital
                                            when needed, our operations and prospects could be materially and adversely affected.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
Knights was originally incorporated in Delaware on February 8, 2021 under the name &#8220;Data Knights Acquisition Corp.&#8221; as a
special purpose acquisition company, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase,
reorganization or similar business combination with one or more businesses. On November 7, 2023, we held the Closing of the Business
Combination whereby Merger Sub merged with and into Legacy ONMD, with Legacy ONMD continuing as the surviving entity, which resulted
in all of the issued and outstanding capital stock of Legacy ONMD being exchanged for shares of the Company&#8217;s Common Stock, upon
the terms set forth in the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination that closed on November 7, 2023, pursuant to the Merger Agreement, led to Data Knights changing its name to &#8220;OneMedNet
Corporation&#8221; and the business of Data Knights became the business of Legacy ONMD. We are located at 6385 Old Shady Oak Road, Suite
250, Eden Prairie, MN 55344 and reachable by telephone on 800-918-7189.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
ONMD was incorporated in the State of Delaware on November 20, 2015. Its wholly-owned subsidiary, ONMD Canada, was incorporated on October
16, 2015 under the provisions of the Business Corporations Act of British Columbia. ONMD Canada&#8217;s functional currency is the Canadian
dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Implications
of Being an Emerging Growth Company and a Smaller Reporting Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
qualify as an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;<span style="text-decoration: underline">JOBS
Act</span>&#8221;). For so long as we remain an emerging growth company, we are permitted, and currently intend, to rely on the following
provisions of the JOBS Act that contain exceptions from disclosure and other requirements that otherwise are applicable to public companies
and file periodic reports with the SEC. These provisions include, but are not limited to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
                                            permitted to present only two years of audited financial statements and selected financial
                                            data and only two years of related <i>&#8220;Management&#8217;s Discussion and Analysis of
                                            Financial Condition and Results of Operations&#8221; </i>in our periodic reports and registration
                                            statements, including this prospectus, subject to certain exceptions;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            being required to comply with the auditor attestation requirements of Section 404 of the
                                            Sarbanes-Oxley Act of 2002, as amended (&#8220;<span style="text-decoration: underline">SOX</span>&#8221;);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
                                            disclosure obligations regarding executive compensation in our periodic reports, proxy statements,
                                            and registration statements, including in this prospectus;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            being required to comply with any requirement that may be adopted by the Public Company Accounting
                                            Oversight Board (the &#8220;<span style="text-decoration: underline">PCAOB</span>&#8221;) regarding mandatory audit firm rotation
                                            or a supplement to the auditor&#8217;s report providing additional information about the
                                            audit and the financial statements; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">exemptions
                                            from the requirements of holding a nonbinding advisory vote on executive compensation and
                                            stockholder approval of any golden parachute payments not previously approved.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company until the earliest to occur of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
                                            31, 2026 (the last day of the fiscal year that follows the fifth anniversary of the
                                            completion of our initial public offering);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            last day of the fiscal year in which we have total annual gross revenue of at least $1.235
                                            billion;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            date on which we are deemed to be a &#8220;large-accelerated filer,&#8221; as defined in
                                            the Exchange Act; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            date on which we have issued more than $1 billion in non-convertible debt over a three-year
                                            period.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to take advantage of certain of the reduced disclosure obligations in this prospectus and may elect to take advantage of
other reduced reporting requirements in our future filings with the SEC. As a result, the information that we provide to holders of our
Common Stock may be different than what you might receive from other public reporting companies in which you hold equity interests. We
have elected to avail ourselves of the provision of the JOBS Act that permits emerging growth companies to take advantage of an extended
transition period to comply with new or revised accounting standards applicable to public companies. As a result, we will not be subject
to new or revised accounting standards at the same time as other public companies that are not emerging growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company
even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosure requirements
available to smaller reporting companies until the fiscal year following the determination that our voting and non-voting common stock
held by non-affiliates is $250 million or more measured on the last business day of our second fiscal quarter, or our annual revenues
are less than $100 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates
is $700 million or more measured on the last business day of our second fiscal quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_006"></span>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuer</b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
    Corporation (f/k/a Data Knights Acquisition Corp)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Issuance
    of Common Stock</i></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock Offered by Us</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,085,275
    shares of Common Stock, including (a) 11,500,000 shares of Common Stock issuable upon exercise of the Public Warrants and (b) 585,275
    shares of Common Stock issuable upon exercise of the Private Placement Warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    of Common Stock Outstanding Prior to Exercise of All Public Warrants and Private Placement Warrants</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,572,831
    shares (as of January 29, 2025)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
    of Common Stock Outstanding Assuming Exercise of All Public Warrants and Private Placement Warrants</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,658,106
    shares (based on total shares outstanding as of January 29, 2025)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    Price of Public Warrants</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.50
    per share</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
    Price of Private Placement Warrants</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11.50
    per share</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of Proceeds</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will receive up to an aggregate of approximately $139.0 million from the exercise of the Public Warrants, assuming the exercise in
    full of all of the Public Warrants for cash. We will receive up to an aggregate of approximately $6.7 million from the exercise of
    the Private Placement Warrants, assuming the exercise in full of all of the Private Placement Warrants for cash. We expect to use
    the net proceeds from the exercise of the Warrants for working capital and general corporate purposes. We believe the likelihood
    that Public Warrant holders and the Private Placement Warrant holders will exercise their Public Warrants and Private Placement
    Warrants, as applicable, and therefore the amount of cash proceeds that we would receive, is dependent upon the market price of our
    Common Stock. If the market price of our Common Stock is less than $11.50 per share, we believe the Public Warrant holders and
    Private Placement Warrant holders will be less likely to exercise their Public Warrants and Private Placement Warrants,
    respectively. As of January 30, 2025, the closing price of our Common Stock was $1.02 per share. See &#8220;<i>Use of
    Proceeds.&#8221;</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Resale
    of Common Stock</i></b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Stock Offered by the Selling Securityholders:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 19,123,352 shares of Common Stock.</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
    Placement Warrants to Purchase Common Stock Offered by the Selling Securityholders </b></span></td>
    <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 585,275 Private Placement Warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offering
    prices for resales:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Selling Securityholders may resell or otherwise dispose of all, some or none of the shares of Common Stock and Private Placement
    Warrants included in this prospectus, at any time or from time to time in a number of different ways in its discretion and at varying
    prices. See the section titled &#8220;<i>Plan of Distribution</i>&#8221; for more information about how the Selling Securityholders
    may sell or otherwise dispose of the shares of Common Stock and Private Placement Warrants being offered in this prospectus.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of Proceeds:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any proceeds from the resale of Common Stock or Private Placement Warrants to be offered by the Selling Securityholders.
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
    for Common Stock and Public Warrants:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Common Stock and our Public Warrants are listed on the Nasdaq Capital Market under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221;
    respectively.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
    Factors:</b></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    investment in the securities offered hereby is speculative and involves a high degree of risk. You should carefully consider the
    information set forth under &#8220;<i>Risk Factors</i>&#8221; and elsewhere in this prospectus.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this prospectus, unless otherwise indicated, the number of shares of Common Stock that will be outstanding after this offering is based
on 30,572,831 shares of our Common Stock outstanding as of January 29, 2025 and excludes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,357,223 shares of Common Stock reserved for issuance under our 2022 Equity Incentive Plan&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">1,650,403
                                            shares issuable upon vesting of outstanding restricted stock units;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">147,000
                                            shares issuable upon exercise of outstanding stock options with an exercise price of $1.00
                                            per share; or</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
exercise of Warrants to purchase up to 12,085,275 shares of Common Stock.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_007"></span>RISK
FACTORS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>An
investment in our securities involves a high degree of risk. This prospectus contains a discussion of the risks applicable to an investment
in our securities. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not
presently known to us or that we currently deem immaterial may also affect our business, financial condition, and results of operations.
The occurrence of any of these known or unknown risks might cause you to lose all or part of your investment in the offered securities.
We may not be successful in preventing the material adverse effects that any of the following risks and uncertainties may cause. You
could lose all or a significant portion of your investment due to any of these risks and uncertainties.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should carefully consider the following risks, as well as the other information contained in this prospectus, including our historical
financial statements and related notes included elsewhere in this prospectus before you decide to purchase our securities. Any one of
these risks and uncertainties has the potential to cause material adverse effects on our business, prospects, financial condition and
operating results which could cause actual results to differ materially from any forward-looking statements expressed by us and a significant
decrease in the value of our Common Stock and Warrants. Refer to &#8220;Cautionary Statement Regarding Forward-Looking Statements.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to this Offering and Our Common Stock</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock may be subject to extreme volatility.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our Common Stock may be subject to extreme volatility. We cannot predict the magnitude of future fluctuations in the
trading price of our Common Stock. The trading price of our Common Stock may be affected by a number of factors, including events described
in this section entitled, &#8220;Risk Factors&#8221; and in our other periodic reports filed with the SEC from time to time, as well
as our operating results, financial condition and other events or factors. Any of the factors listed below could have a material adverse
effect on your investment in our securities. Factors affecting the trading price of our securities may include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            by us or our competitors regarding technical developments and levels of performance achieved
                                            by our or their Real World Data and Real World Evidence offering;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
                                            by us regarding developments in our relationship with existing and future key customers;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to bring our products and technologies to market on a timely basis, or at all;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            operating results or development efforts failing to meet the expectation of securities analysts
                                            or investors in a particular period;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
                                            or anticipated fluctuations in our quarterly financial results or the quarterly financial
                                            results of companies perceived to be similar to us;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in the market&#8217;s expectations about our operating results or the Real World Data and
                                            Real World Evidence industry;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">success
                                            of competitors&#8217; actual or perceived development efforts;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in financial estimates and recommendations by securities analysts concerning the Company
                                            or the Real World Data and Real World Evidence industry in general;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
                                            and share price performance of other companies that investors deem comparable to the Company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disputes
                                            or other developments related to proprietary rights, including patents, litigation matters
                                            and our ability to obtain intellectual property protection for our technologies;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in laws and regulations affecting our business;</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to meet compliance requirements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencement
                                            of, or involvement in, litigation involving the Company;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
                                            in our capital structure, such as future issuances of securities or the incurrence of additional
                                            debt;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            volume of shares of Common Stock available for public sale;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            level of demand for our Common Stock, including the amount of short interest in our Common
                                            Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            major change in our Board or management;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
                                            of substantial amounts of shares of our Common Stock by our directors, executive officers
                                            or significant stockholders or the perception that such sales could occur;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            expiration of contractual lock-up agreements with our executive officers, directors and certain
                                            stockholders, which we have entered into and may enter into in the future from time to time;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
                                            economic and political conditions such as recessions, interest rates, fuel prices, international
                                            currency fluctuations and acts of war or terrorism.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Broad
market and industry factors may materially harm the market price of our securities irrespective of our operating performance. The stock
market in general, and the Nasdaq in particular, have experienced price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of our securities,
may not be predictable. A loss of investor confidence in the market for retail stocks or the stocks of other companies which investors
perceive to be similar to the Company could depress our share price regardless of our business, prospects, financial conditions or results
of operations. A decline in the market price of our securities also could adversely affect our ability to issue additional securities
and our ability to obtain additional financing in the future.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Following
certain periods of volatility in the market price of our securities, we may become subject to securities litigation. We have experienced,
and may in the future experience, additional litigation following periods of volatility. This type of litigation may result in substantial
costs and a diversion of management&#8217;s attention and resources.</span></p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently listed on the Nasdaq Capital Market. If we are unable to maintain listing of our securities on Nasdaq or any stock exchange,
our stock price could be adversely affected and the liquidity of our stock and our ability to obtain financing could be impaired and
it may be more difficult for our stockholders to sell their securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
our Common Stock is currently listed on The Nasdaq Capital Market, we may not be able to continue to meet the exchange&#8217;s minimum
listing requirements or those of any other national exchange. If we are unable to maintain listing on Nasdaq or if a liquid market for
our Common Stock does not develop or is sustained, our Common Stock may remain thinly traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2024, the Company received written notice (the &#8220;<span style="text-decoration: underline">MVLS Nasdaq Notice</span>&#8221;) from Nasdaq indicating that for the
preceding 30 consecutive business days, the market value of the Company&#8217;s listed securities (&#8220;<span style="text-decoration: underline">MVLS</span>&#8221;) did not
maintain a minimum market value of $50,000,000 (the &#8220;<span style="text-decoration: underline">Minimum MVLS Requirement</span>&#8221;) as required by Nasdaq Listing Rule
5450(b)(2)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company had a compliance period of 180 calendar days, or until
August 5, 2024, to regain compliance with the Minimum MVLS Requirement. Compliance could have been achieved if the Company&#8217;s MVLS
closed at $50,000,000 or more for a minimum of ten consecutive business days at any time during the 180-day compliance period, in which
case Nasdaq would notify the Company of its compliance and the matter would be closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company did not regain compliance with the Minimum MVLS Requirement by August 5, 2024, Nasdaq would have provided written notification
to the Company that its Common Stock was subject to delisting. At that time, the Company could have appealed the relevant delisting determination
to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. The Company sought to apply for a transfer
to The Nasdaq Capital Market, and on August 15, 2024, the Company received approval from Nasdaq to list the Common Stock and Public Warrants
on The Nasdaq Capital Market. The Common Stock and Public Warrants were transferred from The Nasdaq Global Market to The Nasdaq Capital
Market at the opening of business on August 19, 2024, and continue to trade under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221;
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2024, the Company received written notice (the &#8220;<span style="text-decoration: underline">Bid Price Nasdaq Notice</span>&#8221;) from Nasdaq notifying the Company
that, for the 30 consecutive business days prior to the date of the Bid Price Nasdaq Notice, the Common Stock did not meet the minimum
bid price of $1.00 per share requirement (the &#8220;<span style="text-decoration: underline">Minimum Bid Price Requirement</span>&#8221;) as required by Nasdaq Listing Rule
5450(a)(1). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a compliance period of 180 calendar days, or until
September 23, 2024, to regain compliance with the Minimum Bid Price Requirement. Compliance could have been achieved if the closing bid
price of the Company&#8217;s Common Stock was at least $1 for a minimum of ten consecutive business days. On June 10, 2024, the Nasdaq
staff determined that for the prior 11 consecutive business days, from May 23, 2024, to June 7, 2024, the closing bid price of the Company&#8217;s
Common Stock had been at $1.00 per share or greater. Accordingly, the Company regained compliance with Listing Rule 5450(a)(1), and this
matter was closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;<span style="text-decoration: underline">Q1 2024 Form 10-Q Nasdaq Notice</span>&#8221;),
which indicated that, as a result of the Company&#8217;s delay in filing its Quarterly Report on Form 10 Q for the fiscal quarter ended
March 31, 2024 (the &#8220;<span style="text-decoration: underline">Q1 2024 Form 10-Q</span>&#8221;) by the applicable due date, the Company was not in compliance with Nasdaq
Listing Rule 5250(c)(1) (the &#8220;<span style="text-decoration: underline">Periodic Report Rule</span>&#8221;), which requires Nasdaq-listed companies to timely file all required
periodic financial reports with the SEC. The Q1 2024 Form 10-Q Nasdaq Notice stated that the Company had 60 calendar days to submit to
Nasdaq a plan to regain compliance with the Periodic Report Rule. If Nasdaq accepted the Company&#8217;s plan to regain compliance, then
Nasdaq could have granted the Company up to 180 calendar days from the prescribed due date of the Form 10-Q to regain compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 9, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;<span style="text-decoration: underline">Q2 2024 Form 10 Q Nasdaq Notice</span>&#8221;),
which indicated that, as a result of the Company&#8217;s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended
June 30, 2024 (the &#8220;<span style="text-decoration: underline">Q2 2024 Form 10-Q</span>&#8221;) by the applicable due date, the Company was not in compliance with the Periodic
Report Rule, which requires Nasdaq listed companies to timely file all required periodic financial reports with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 10, 2024, the Company received a notification letter from Nasdaq (the &#8220;<span style="text-decoration: underline">Nasdaq Compliance Plan Notice</span>&#8221;),
which responded to the Company&#8217;s plan to regain compliance regarding its delinquent Q1 2024 Form 10 Q and Q2 2024 Form 10-Q, granting
the Company an exception until October 31, 2024 to file the delinquent Q1 2024 Form 10 Q and Q2 2024 Form 10-Q with the SEC and regain
compliance with the Periodic Report Rule. In the event the Company did not regain compliance with the Periodic Report Rule by October
31, 2024, Nasdaq would provide written notification that the Company&#8217;s securities will be delisted. At that time, the Company may
appeal Nasdaq&#8217;s determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;<span style="text-decoration: underline">Second MVLS Nasdaq Notice</span>&#8221;)
indicating that for the preceding 30 consecutive business days, the Company&#8217;s MVLS was below the minimum of $35 million required
for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2). The staff at Nasdaq also noted in the
Second MVLS Nasdaq Notice that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies
to maintain a minimum stockholders&#8217; equity of $2.5 million, and Nasdaq Listing Rule 5550(b)(3), which requires listed companies
to maintain a minimum of $500,000 of net income from continuing operations. In accordance with Nasdaq listing rule 5810(c)(3)(C), the
Company has 180 calendar days, or until April 7, 2025, to regain compliance with the Minimum MVLS Requirement. Compliance may be achieved
if the Company&#8217;s MVLS closes at $35 million or more for a minimum of ten consecutive business days at any time during the 180-day
compliance period, in which case Nasdaq will notify the Company of its compliance and the matter will be closed, If the Company does
not regain compliance by the end of the 180-day compliance period, Nasdaq staff will provide written notice to the Company that its securities
are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 16, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;<span style="text-decoration: underline">Second Bid Price Nasdaq Notice</span>&#8221;)
notifying the Company that, for the 30 consecutive business days prior to the date of the Second Bid Price Nasdaq Notice, the Common
Stock did not meet the Minimum Bid Price Requirement as required by Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing
Rule 5810(c)(3)(A), the Company has 180 calendar days, or until April 14, 2025, to regain compliance. The Second Bid Price Nasdaq Notice
notes that to regain compliance, the Common Stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business
days at any time during the 180-day compliance period. In the event the Company does not regain compliance by the end of the 180-day
compliance period, the Company may be eligible for additional time to regain compliance. To qualify for additional time, the Company
must (i) meet the continued listing requirement for the market value of its publicly held shares and all other initial listing standards
for the Nasdaq Capital Market, with the exception of the bid price requirement and (ii) provide written notice of its intention to cure
the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If the Company meets these requirements,
the Company may be granted an additional 180 calendar days to regain compliance. However, if it appears to Nasdaq that the Company will
be unable to cure the deficiency, or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide written
notice to the Company that its securities are subject to delisting. At that time, the Company may appeal any such delisting determination
to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 21, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;<span style="text-decoration: underline">Q3 2024 Form 10 Q Nasdaq Notice</span>&#8221;
and together with the MVLS Nasdaq Notice, the Bid Price Nasdaq Notice, the Q1 2024 Form 10-Q Nasdaq Notice, the Q2 2024 Form 10 Q Nasdaq
Notice, the Nasdaq Compliance Plan Notice, the Second MVLS Nasdaq Notice, and the Second Bid Price Nasdaq Notice, the &#8220;<span style="text-decoration: underline">Nasdaq
Notices</span>&#8221;), which indicated that, as a result of the Company&#8217;s delay in filing its Quarterly Report on Form 10-Q for the
fiscal quarter ended September 30, 2024 (the &#8220;<span style="text-decoration: underline">Q3 2024 Form 10-Q</span>&#8221;) by the applicable due date, the Company was not
in compliance with the Periodic Report Rule, which requires Nasdaq listed companies to timely file all required periodic financial reports
with the SEC. Previously, Nasdaq granted the Company an exception until December 11, 2024 to file its delinquent Q1 2024 Form 10-Q and
Q2 2024 Form 10-Q (collectively with the Q3 2024 Form 10-Q, the &#8220;<span style="text-decoration: underline">Delinquent Filings</span>&#8221;). As a result, any additional
Nasdaq exception to allow the Company to regain compliance with all Delinquent Filings were required to be filed by December 11, 2024.
The Company filed with the SEC its Q1 2024 Form 10-Q on December 5, 2025, its Q2 2024 Form 10-Q on December 11, 2024, and its Q3 2024
Form 10-Q on December 17, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 23, 2024, the Company received a notification letter from Nasdaq informing the Company that it has regained compliance with
the Periodic Report Rule and the matter is now closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">On January 7,
2025, the Nasdaq staff notified the Company that it had determined that for the prior 10 consecutive business days, from December 20,
2024, to January 6, 2025, the closing bid price of the Company&#8217;s Common Stock had been at $1.00 per share or greater. Accordingly,
the Company regained compliance with Listing Rule 5550(a)(2), and the Minimum Bid Price Requirement matter was closed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 10, 2025, the Nasdaq staff notified the Company that it had determined that for the prior 10 consecutive
business days, from December 20, 2024, to January 8, 2025, the Company&#8217;s market value of listed securities had been $35,000,000
or greater. Accordingly, the Company regained compliance with Listing Rule 5550(b)(2), and the Minimum MVLS Requirement matter was closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 10, 2025, the Company had regained compliance with all Nasdaq listing requirements. However, there can be no assurance that the Company will be successful in maintaining the listing of its Common Stock on the Nasdaq Capital
Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
listing rules of Nasdaq require listing issuers to comply with certain standards in order to remain listed on its exchange. If, for any
reason, we should fail to maintain compliance with these listing standards and Nasdaq should delist our securities from trading on its
exchange and we are unable to obtain listing on another national securities exchange, a reduction in some or all of the following may
occur, each of which could have a material adverse effect on our stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            liquidity of our Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            market price of our Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain financing for the continuation of our operations;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of institutional and general investors that will consider investing in our Common
                                            Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of investors in general that will consider investing in our Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of market makers in our Common Stock;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            availability of information concerning the trading prices and volume of our Common Stock;
                                            and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of broker-dealers willing to execute trades in shares of our Common Stock.</span></td></tr></table>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal stockholders will continue to have significant influence over the election of our Board and approval of any significant corporate
actions, including any sale of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
founders, executive officers, directors, and other principal stockholders, in the aggregate, beneficially own a majority of our outstanding
stock. These stockholders currently have, and likely will continue to have, significant influence with respect to the election of our
Board and approval or disapproval of all significant corporate actions. The concentrated voting power of these stockholders could have
the effect of delaying or preventing an acquisition of the Company or another significant corporate transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
could be subject to securities class action litigation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, securities class action litigation has often been brought against companies following a decline in the market price of their
securities. In 2020, 22% of securities class action litigation filings were against defendants in the health technology and services
sector, which accounted for 22% of new filings. If we face such litigation, it could result in substantial costs and a diversion of management&#8217;s
attention and resources, which could harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the market
price for the shares of Common Stock and trading volume could decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading market for our Common Stock will depend in part on the research and reports that securities or industry analysts publish about
us or our business. If research analysts do not establish and maintain adequate research coverage or if one or more of the analysts who
covers us downgrades our Common Stock or publishes inaccurate or unfavorable research about our business, the market price for our Common
Stock would likely decline. If one or more of these analysts cease coverage of our Company or fail to publish reports on us regularly,
we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for our Common Stock
to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not expect to pay dividends in the foreseeable future, and you must rely on price appreciation of your shares of Common Stock for
return on your investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have paid no cash dividends on any class of our stock to date, and we do not anticipate paying cash dividends in the near term. For the
foreseeable future, we intend to retain any earnings to finance the development and expansion of our business, and we do not anticipate
paying any cash dividends on our stock. Accordingly, investors must be prepared to rely on sales of their shares after price appreciation
to earn an investment return, which may never occur. Investors seeking cash dividends should not purchase our shares. Any determination
to pay dividends in the future will be made at the discretion of our Board of Directors and will depend on our results of operations,
financial condition, contractual restrictions, restrictions imposed by applicable law and other factors our Board of Directors deems
relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
sales of substantial amounts of our Common Stock or securities convertible into or exchangeable or exercisable for shares of Common Stock,
either by us or by our existing stockholders, or the possibility that such sales could occur, could adversely affect the market price
of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
sales in the public market of shares of our Common Stock or securities convertible into or exchangeable or exercisable for shares of
Common Stock, shares held by our existing stockholders or shares issued upon exercise of our outstanding stock options or warrants, or
the perception by the market that these sales could occur, could lower the market price of our Common Stock or make it difficult for
us to raise additional capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holders
of the Private Placement Warrants purchased in this offering will have no rights as holders of Common Stock until such holders exercise
such Private Placement Warrants and acquire our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
holders of the Private Placement Warrants acquire shares of our Common Stock upon exercise of such Private Placement Warrants, holders
of the Private Placement Warrants will have no rights with respect to the shares of our Common Stock underlying such Private Placement
Warrants. Upon exercise of the Private Placement Warrants, the holders will be entitled to exercise the rights of a holder of Common
Stock only as to matters for which the record date occurs after the exercise date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities being offered in this prospectus represent a substantial percentage of our outstanding Common Stock, and the sales of such
securities, or the perception that these sales could occur, could cause the market price of our Common Stock to decline significantly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the primary issuance by us of up to an aggregate of 12,085,275 shares of Common Stock, consisting of (i) up to
11,500,000 shares of Common Stock issuable upon the exercise of 11,500,000 Public Warrants and (ii) up to an aggregate of 585,275 shares
of Common Stock issuable upon the exercise of 585,275 Private Placement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus also relates to the offer and resale from time to time by: (a) the Selling Shareholders of up to an aggregate of
19,123,352 shares of Common Stock, consisting of (i) up to 1,504,292 shares of Common Stock issuable upon conversion of up to
$1,714,893.64 of the Pre-Closing PIPE Notes issued at the closing of the Business Combination that are convertible into shares of
Common Stock at the election of the Pre-Closing PIPE Notes holders at a conversion price equal to the lower of (A) $10.00 per share,
and (B) 92.5% of the lowest VWAP for the ten (10) trading days immediately preceding the Conversion Date (as defined in the
Pre-Closing PIPE Notes), subject to a floor price of $1.14 per share of Common Stock pursuant to the terms of the PIPE SPA, (ii)
95,744 shares of Common Stock underlying 95,744 PIPE Warrants issued to the Pre-Closing PIPE Investors as additional consideration
for the Pre-Closing PIPE Investors&#8217; investment in the Pre-Closing PIPE Notes, which warrant agreements were executed at the
closing of the Business Combination, (iii) 277,778 shares of Common Stock issued at $0.87 per share (lowest VWAP for 5 trading days
before the 6-month anniversary), pursuant to the terms of the Satisfaction and Discharge Agreement, (iv) 2,123,424 shares of Common
Stock issuable at a conversion rate of $0.7535 per share of Common Stock (95% of VWAP 10-day average $0.7932) for an aggregate
$1,600,000 investment in the Company by Dr. Thomas Kosasa, (v) [&#9679;] shares of Common Stock issued to the Sponsor and its
affiliates, including [&#9679;] shares of Common Stock originally issued as shares of Class B Common Stock in connection with the
initial public offering of Data Knights for aggregate consideration of $25,000, or approximately $0.009 per share, and [&#9679;]
shares of Common Stock originally issued to the Sponsor as part of the Placement Units issued to the Sponsor in connection with Data
Knights&#8217; initial public offering at $10.00 per unit, (vi) 50,000 shares of Common Stock underlying the Helena Warrant issued
to Helena as consideration for entry into the Helena Termination Agreement, (vii) 4,767,616 shares of Common Stock issuable pursuant
to advances under the SEPA, (viii) 346,404 shares of Common Stock issued to Yorkville as part of a commitment fee paid in connection
with the SEPA, (ix) up to 1,785,714 shares of Common Stock issuable upon conversion of the remaining balance under the Yorkville
Note, (x) 455,000 shares of Common Stock issued to Yorkville, which have registration rights, (xi) 1,297,059 shares of Common Stock
issued pursuant to the OTC PIPE SPA, (xii) 1,323,530 shares of Common Stock underlying 1,323,530 pre-funded warrants issued to OTC
pursuant to the OTC PIPE SPA, (xiii) 2,301,791 shares of Common Stock issued pursuant to the terms of the Discovery PIPE SPA, (xiv)
1,473,696 shares of Common Stock issued pursuant to the OTC Follow-On PIPE SPA, (xv) 1,188,209 shares of Common Stock underlying
1,188,209 pre-funded warrants issued to OTC pursuant to the OTC Follow-On PIPE, and (xvi) 133,095 shares of Common Stock underlying
133,095 warrants issued to OTC pursuant to the OTC Follow-On PIPE, and (b) the Selling Warrantholders of up to an aggregate of
585,275 Private Placement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup></sup></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, the price at which our Common Stock trades is lower than the initial trading price of the shares
sold pursuant to the initial public offering of Data Knights. Despite the differences in the trading price of our securities and the
initial trading price of the securities of Data Knights, certain of the Selling Securityholders may be incentivized to sell their
shares because they may experience a positive rate of return on the securities they purchased due to the differences in the purchase
prices described in the preceding paragraph and the public trading price of our securities. Based on the closing price of our Common
Stock of $1.02 as of January 30, 2025, upon the sale of our Common Stock, (a) the PIPE investors in the Pre-Closing PIPE Notes may
experience a potential loss of up to $0.12 per share, (b) Joseph T. Rallo may experience a potential profit of up to $0.15 per
share, (c) Boral Capital may experience a potential profit of up to $0.15 per share, (d) the Sponsor may experience a potential
profit of $[&#9679;] per share on the Founder Shares and may experience a potential loss of up to $[&#9679;] per share on the
private placement shares that, together with the Private Placement Warrants, made up the private units originally issued in a
private placement in connection with Data Knights&#8217; initial public offering at a price of $10.00 per unit, (e) Dr. Thomas
Kosasa may experience a potential loss of up to $0.2665 per share for the shares issuable pursuant to his investments in the Company, (f) Helena may experience a potential loss of up to $0.18
per share, (g) Yorkville may experience a potential profit of up to $0.07 per share for the Commitment Fee Shares and may experience
a potential profit of up to $0.74 per share for shares issued and issuable pursuant to the Yorkville Note (plus an additional amount pursuant
to Advances (as defined in the SEPA) under the SEPA), (h) OTC may experience a potential loss of
up to $0.0078 per share for the shares issued to OTC in connection with the OTC PIPE and a potential profit of up to $0.37 per share for
the shares issued to OTC in connection with the OTC Follow-On PIPE, and (i) Discovery may experience a potential profit of up to $0.17 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even though the current trading price is at or significantly below Data Knights&#8217; initial public offering price, the private investors
have an incentive to sell because they will still profit on sales because of the lower price that they purchased their shares than the
public investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the Sponsor, private placement investors, Pre-Closing PIPE Investors and other Selling Securityholders may experience a positive rate
of return based on the current trading price of the Company&#8217;s Common Stock, the public securityholders may not experience a similar
rate of return on the securities they purchased due to differences in the purchase prices and the current trading price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock and Private Placement Warrants being offered for resale in this prospectus represent a substantial percentage of the total
outstanding shares of our Common Stock as of the date of this prospectus. The outstanding Common Stock being offered in this prospectus
represent approximately 62.6% of our outstanding shares of Common Stock. Additionally, if all the Private Placement Warrants are
exercised, the Selling Securityholders would own an additional 585,275 shares of Common Stock, representing an additional 1.9%
of the total outstanding Common Stock. The sale of all the securities being offered in this prospectus, or the perception that these
sales could occur, could result in a significant decline in the public trading price of our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Closing PIPE Investors are entitled to require us to register shares underlying the Pre-Closing PIPE Notes and the PIPE Warrants
owned by them for public sale in the United States, and certain investors and shareholders under various agreements are entitled to require
us to register shares underlying securities related thereto, thus we are filing this prospectus to register those shares of Common Stock.
Subject to the satisfaction of applicable exercise periods, the shares issued upon exercise of the Pre-Closing PIPE Notes and the PIPE
Warrants will be available for immediate resale in the United States in the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company,&#8221; and the reduced reporting requirements applicable to emerging growth companies may make
our Common Stock less attractive to investors.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. For as long as we continue to be an emerging growth company,
we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies, including, among other things, exemption from compliance with the auditor attestation requirements of Section 404 of
the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary
of the closing of our initial public offering, (b) in which we have total annual gross revenue of at least $1.235 billion or (c) in which
we are deemed to be a large accelerated filer, which means the market value of our common stock held by non-affiliates exceeds $700 million
as of the end of our prior second fiscal quarter, and (2) the date on which we have issued more than $1 billion in non-convertible debt
during the prior three-year period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards until such time as those
standards apply to private companies. We may elect not to avail ourselves of this exemption from new or revised accounting standards
and, therefore, may be subject to the same new or revised accounting standards as other public companies that are not emerging growth
companies. We cannot predict if investors will find our Common Stock less attractive because we may rely on these exemptions. If some
investors find our Common Stock less attractive as a result, there may be a less active trading market for our common stock and our share
price may be more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anti-takeover
provisions contained in our certificate of incorporation and bylaws as well as provisions of Delaware law, could impair a takeover attempt.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Third Amended and Restated Certificate of Incorporation (&#8220;<span style="text-decoration: underline">Certificate of Incorporation</span>&#8221;), Amended and Restated Bylaws
(&#8220;<span style="text-decoration: underline">Bylaws</span>&#8221;) and Delaware law contain provisions which could have the effect of rendering more difficult, delaying or
preventing an acquisition deemed undesirable by our Board of Directors. Our corporate governance documents include provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">authorizing
                                            &#8220;blank check&#8221; preferred stock, which could be issued by our Board of Directors
                                            without stockholder approval and may contain voting, liquidation, dividend, and other rights
                                            superior to our Common Stock&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
                                            the liability of, and providing indemnification to, our directors and officers&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
                                            the ability of our stockholders to call and bring business before special meetings&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
                                            advance notice of stockholder proposals for business to be conducted at meetings of our stockholders
                                            and for nominations of candidates for election to our Board&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlling
                                            the procedures for the conduct and scheduling of Board and stockholder meetings&#894; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing
                                            our Board of Directors with the express power to postpone previously scheduled annual meetings
                                            and to cancel previously scheduled special meetings.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
provision of our Certificate of Incorporation, Bylaws or Delaware law that has the effect of delaying or deterring a change in control
could limit the opportunity for our stockholders to receive a premium for their shares of our Common Stock and could also affect the
price that some investors are willing to pay for our Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Our Business</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a history of operating losses and may never achieve profitability in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have experienced net losses in each annual period since inception. We generated net losses of $33.8 million and $30.5 million for the
years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, we had accumulated losses of approximately $91.4 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to continue to incur significant losses in the development, marketing, sale and delivery of our services. If we do not grow our
revenues or if we lose existing customers, we expect to continue to incur losses from operations for the foreseeable future. Because
of the numerous risks and uncertainties associated with the development, marketing, sale and delivery of our iRWD<sup>TM</sup> services,
we may experience larger than expected future losses and may never become profitable. Moreover, there is a substantial risk that we may
not be able to successfully commercialize our iRWD<sup>TM</sup> services, which would make it unlikely that we would ever achieve profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
believes it has demonstrated its quality and responsiveness in clinical imaging and curation of RWD based upon success in compiling one
of the largest networks of imaging centers (comprised of hospitals, imaging centers and clinics) throughout the United States covering
more than 15 million patients to date. On the global front, OneMedNet works with hospitals and life science companies around the world
including in Ireland, United Kingdom, Ghana, Denmark and South Korea and growing. We base these claims on our understanding of our competition
in the United States and globally. However, if we were to lose these relationships with our network of imaging centers or lose our customers
or if our competitors&#8217; technology surpasses ours, our competitors could claim a greater market share domestically or abroad, which
could reduce our growth and our profits, which could harm our business, financial position, results of operations and prospects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
report of our independent registered public accounting firm for the fiscal years ended December 31, 2023 and 2022 contains an explanatory
paragraph regarding substantial doubt about our ability to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
stated above, we have experienced net losses in each annual period since inception. We generated net losses of $33.8 million and $30.5
million for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, we had an accumulated deficit of approximately
$91.4 million. In their audit report for the fiscal year ended December 31, 2023 included in this report, our auditors have expressed
their concern as to our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability
to generate cashflows from operations and obtain financing. We intend to continue funding our operations through equity and debt financing
arrangements, which may be insufficient to fund our capital expenditures, working capital and other cash requirements in the long term.
There can be no assurance that the steps management is taking will be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
significant customer represented 51% and 29% of our revenues for 2023 and 2022 respectively and is expected to continue to represent
a significant portion of our forecasted revenue for 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
Healthcare represented 51% and 29% of our revenues in 2023 and 2022, respectively. Change Healthcare is expected to continue to represent
a significant portion of our forecasted revenue for 2024. If we fail to maintain and grow our relationship with Change Healthcare, we
could lose a significant portion of our revenue for 2023, which would materially adversely affect our results of operations and our business.
If OneMedNet were to lose this significant customer, its revenue may significantly decline. In addition, revenue from this significant
customer may vary from period to period depending on the timing of renewing existing agreements or entering into new agreements for additional
OneMedNet products as well as other unforeseen risks and variables discussed in this prospectus. The loss of this significant customer
could adversely affect our business, results of operations and financial condition. You should not rely on our historical relationship
with this compan<i>y</i> as an indication of our future performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may encounter difficulties in managing our attempted growth of our business, which could negatively impact our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we expand, market, sell and deliver our service offerings, we anticipate that we will need to increase our service development, sales
and marketing and administrative headcount. Such an evolution may impact our strategic focus and our deployment and allocation of resources.
Our ability to manage our operations and growth effectively depends upon the continual improvement of our procedures, reporting systems
and operational, financial and management controls. We may not be able to implement administrative and operational improvements in an
efficient or timely manner and may discover deficiencies in existing systems and controls. If we do not meet these challenges, we may
be unable to execute our business strategies and may be forced to expend more resources than anticipated addressing these issues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may acquire additional technology and complementary businesses in the future. Acquisitions involve many risks, any of which could materially
harm our business, including the diversion of management&#8217;s attention from core business concerns, failure to effectively exploit
acquired technologies, failure to successfully integrate the acquired business or realize expected synergies or the loss of key employees
from either our business or the acquired businesses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to execute our business objectives and growth strategies successfully or sustain our growth and, as a result, this could
have a material adverse effect on our operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
highly complex nature of our industry requires that we effectively execute and manage our business objectives and growth strategies,
such as expanding our marketing and commercialization of our services in the U.S. and internationally, adding new customers, and increasing
our service delivery capacity. However, we may not be able to execute on these strategies as effectively as anticipated. Our ability
to execute on these strategies depends on a number of factors, including, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to obtain adequate capital resources to execute our growth plans&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to hire, train and retain skilled managers and personnel, including quality and production
                                            personnel, and marketing and commercial specialists&#894;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to protect our existing and new services by registering and defending our intellectual
                                            property rights&#894; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to successfully add new customers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent we are unable to execute our growth strategies in accordance with our expectations, this could have a material adverse effect
on our business, financial condition, and future results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Real World Data and Real World Evidence business market continues to evolve and is highly competitive, and we may not be successful in
competing in this industry or establishing and maintaining confidence in our long-term business prospects among current and future partners
and customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Real World Data and Real World Evidence business market in which we compete continues to evolve and is highly competitive. To date, we
have focused our efforts on our expertise in clinical imaging innovation solutions that connect healthcare providers and patients and
satisfy a crucial need for the life sciences. We offer direct access to clinical images and associated contextual patient records. OneMedNet
proved the commercial and regulatory viability of iRWD&#8482;, a promising emerging market, that exactly matches OneMedNet&#8217;s life
science partners&#8217; case selection protocol. OneMedNet has the immediate ability to quickly search and extensively curate multi-layer
data from a federated group of healthcare facilities and to provide fast access to curated medical images that has proved the commercial
and regulatory viability of imaging Real World Data and covers the complete value chain in imaging Real World Data, validated by an increasing
federated network of providers. However, Real World Data and Real World Evidence has been increasingly adopted, and our current competitors
have, and future competitors may have, greater resources than we do and may also be able to devote greater resources to the development
of their current and future technologies. These competitors also may have greater access to customers and may be able to establish cooperative
or strategic relationships amongst themselves or with third parties that may further enhance their resources and competitive positioning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developments
in improvements in Real World Data and Real World Evidence curation by competitors may materially adversely affect the sales, pricing
and gross margins of our business. If a competing technology or process is developed that has superior operational or price performance,
our business will be harmed. Similarly, if we fail to accurately predict and ensure that our Real World Data and Real World Evidence
offering can address customers&#8217; changing needs or emerging technological trends, or if our customers fail to achieve the benefits
expected from our Real World Data and Real World Evidence offering, our business will be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must continue to commit resources to develop our Real World Data and Real World Evidence technology in order to establish a competitive
position, and these commitments will be made without knowing whether such investments will result in products potential customers will
accept. There is no assurance we will successfully identify new customer requirements, develop and bring our Real World Data and Real
World Evidence to market on a timely basis, or that products and technologies developed by others will not render our Real World Data
and Real World Evidence obsolete or noncompetitive, any of which would adversely affect our business and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to attract and retain key employees and qualified personnel, our ability to compete could be harmed.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on the talents and continued efforts of our senior management and key employees. The loss of members of our management or key
employees may disrupt our business and harm our results of operations. Further, our ability to manage further expansion will require
us to continue to attract, motivate and retain additional qualified personnel. Competition for this type of personnel is intense, and
we may not be successful in attracting, integrating and retaining the personnel required to grow and operate our business effectively.
There can be no assurance that our current management team or any new members of our management team will be able to successfully execute
our business and operating strategies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
inability to expand our development, use and adoption of artificial intelligence, or issues presented in our development, use and adoption
of artificial intelligence, could harm our reputation, expose us to liability and cause us to lose customers.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently incorporate certain AI capabilities into our solutions, and we endeavor to continue researching and developing AI capabilities
within our solutions. As with many innovative and disruptive technologies, AI presents risks, challenges, and unintended consequences,
many of which cannot be fully appreciated currently. These risks, challenges and unintended consequences could negatively affect further
adoption of AI in our solutions, impacting our ability to compete effectively within the regulatory-grade imaging RWD industry. AI algorithms
and the training methodologies for such algorithms may contain flaws, which could result in ineffective, inadequate, or inaccurate AI
capabilities, or could impair customer or partner acceptance of our solutions leveraging such AI capabilities. Should we develop and
incorporate flawed AI capabilities within our solutions, such flaws would negatively impact our brand and reputation, increase costs
to develop and implement new AI capabilities, or lead to a decline in sales revenue. Such impacts would harm our business, financial
condition, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
AI is an emerging technology with a developing legal and regulatory landscape both in the United States and globally, incorporating AI
into our solutions and internal business processes could result in an increased risk of litigation and regulatory non-compliance due
to changes in laws or regulations,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> including, but
not limited to, intellectual property, privacy, or data protection. Our obligations to comply with current and future legal and regulatory
obligations in the United States and worldwide could require us to incur significant costs to achieve compliance, which could negatively
impact our business, financial condition and results of operations, or may hinder our ability to incorporate AI capabilities into our
solutions or distribute our solutions in certain markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we continue to develop ways to leverage AI capabilities within our internal business operations to create economic efficiencies for our
business, the use of AI capabilities in our internal business operations could present risks and challenges. While we strive to use AI
in an ethical and compliant manner, we may be unsuccessful in identifying and/or resolving ethical or legal issues before they arise,
which could increase our legal and regulatory risks, including, but not limited to, data privacy and security, leading to the improper
transmission of proprietary or sensitive information, whether or not intentional. We could fail to implement and maintain the AI tools
we develop, may incur significant research and development costs without achieving the anticipated economic efficiencies we desire, and/or
may fail to establish adequate AI governance processes safeguards, which could negatively impact our business, financial condition, and
results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>A
material breach in security relating to the Company&#8217;s information systems and regulation related to such breaches, cyber-attacks,
or other disruptions could adversely affect the Company, expose us to liability and affect our business and reputation.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
security risks have generally increased in recent years, in part because of the proliferation of new technologies and the use of the
Internet, and the increased sophistication and activity of organized crime, hackers, terrorists, activists, cybercriminals and other
external parties, some of which may be linked to terrorist organizations or hostile foreign governments. Cybersecurity attacks are becoming
more sophisticated and include malicious software, ransomware, attempts to gain unauthorized access to data and other electronic security
breaches that could lead to disruptions in critical systems, unauthorized release of confidential or otherwise protected information
and corruption of data, substantially damaging the Company&#8217;s reputation. Any person who circumvents the security measures could
steal proprietary or confidential information or cause interruptions in the Company&#8217;s operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are increasingly dependent on our information technology systems and infrastructure for our business. We, our collaborators and our service
providers collect, store, and transmit sensitive information including intellectual property, proprietary business information, and personal
information in connection with our business operations. The secure maintenance of this information is critical to our operations and
business strategy. Some of this information could be an attractive target of criminal attack by third parties with a wide range of motives
and expertise, including organized criminal groups, &#8220;hacktivists,&#8221; disgruntled current or former employees, nation-state
and nation-state supported actors, and others. Cyber-attacks are of ever-increasing levels of sophistication, and despite our security
measures, our information technology and infrastructure may be vulnerable to such attacks or may be breached, including due to employee
error or malfeasance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have implemented information security measures to protect our systems, proprietary information, and sensitive data against the risk of
inappropriate and unauthorized external use and disclosure and other types of compromise. However, despite these measures, and due to
the ever-changing information cyber-threat landscape, we cannot guarantee that these measures will be adequate to detect, prevent or
mitigate security breaches and other incidents and we may be subject to data breaches through cyber-attacks, malicious code (such as
viruses and worms), phishing attacks, social engineering schemes, and insider theft or misuse. Any such breach could compromise our networks,
and the information stored there could be accessed, modified, destroyed, publicly disclosed, lost or stolen. If our systems become compromised,
we may not promptly discover the intrusion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
security breach or other incident, whether real or perceived, could cause us to suffer reputational damage. Such incidents could result
in costs to respond to, investigate and remedy such incidents, notification obligations to affected individuals, government agencies,
credit reporting agencies and other third parties, legal claims or proceedings, and liability under our contracts with other parties
and federal and state laws that protect the privacy and security of personal information. The Company&#8217;s failure to prevent security
breaches, or well-publicized security breaches affecting the Internet in general, could significantly harm the Company&#8217;s reputation
and business and financial results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to adequately protect or expand our intellectual property related to our current or future products, our business prospects
could be harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success, competitive position and future revenues will depend in part on our ability to obtain and maintain intellectual property protection
for our products, methods, processes and other technologies, to preserve our trade secrets, to prevent third parties from infringing
on our proprietary rights and to operate without infringing the proprietary rights of third parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will be able to protect our proprietary intellectual property rights from unauthorized use by third parties only to the extent that our
proprietary rights are effectively maintained as trade secrets. Our industry involves complex legal and factual questions, and, therefore,
we cannot predict with certainty whether we will be able to ultimately enforce our proprietary intellectual property rights. Therefore,
any intellectual property rights that may be challenged, invalidated or circumvented, and may not provide us with the protection against
competitors that we anticipate. The degree of future protection for our proprietary intellectual property rights is uncertain because
legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to comply with the extensive legal and regulatory requirements affecting the health care industry, we could face increased costs,
penalties and a loss of business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
activities, and the activities of our collaborators, partners and third-party providers, are subject to extensive government regulation
and oversight both in the United States and in foreign jurisdictions. The FDA and comparable agencies in other jurisdictions directly
regulate many of our most critical business activities, including product manufacturing, advertising and promotion, product distribution,
adverse event reporting and product risk management. States increasingly have been placing greater restrictions on the marketing practices
of healthcare companies and have instituted pricing disclosure and other requirements for companies in the health sciences industry.
In addition, health sciences companies have been the target of lawsuits and investigations alleging violations of government regulations,
including claims asserting submission of incorrect pricing information, improper promotion of products, payments intended to influence
the referral of federal or state healthcare business, submission of false claims for government reimbursement, antitrust violations,
violations of the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar anti-bribery or anti-corruption laws, or violations
related to environmental matters. There is also enhanced scrutiny of company-sponsored patient assistance programs, including insurance
premium and co-pay assistance programs and donations to third-party charities that provide such assistance. Violations of governmental
regulation by us, our customers, and our partners may be punishable by criminal and civil sanctions, including damages, fines and penalties
and exclusion from participation in government programs. Actions taken by federal or local governments, legislative bodies and enforcement
agencies with respect to these legal and regulatory compliance matters could also result in reduced demand for our products. We cannot
ensure that our compliance controls, policies, and procedures will in every instance protect us from acts committed by our employees,
collaborators, partners or third-party providers that would violate the laws or regulations of the jurisdictions in which we operate.
Whether or not we have complied with the law, an investigation into alleged unlawful conduct could increase our expenses, damage our
reputation, divert management time and attention and adversely affect our business, and any settlement of these proceedings could result
in significant payments by us. Risks relating to compliance with laws and regulations may be heightened as we continue to expand our
global operations, which may result in additional regulatory burdens and obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
collection, use, and disclosure of personal information is subject to U.S. state and federal privacy and security regulations, and our
failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational
harm.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
privacy and security of personal information stored, maintained, received, or transmitted, including electronically, is a major issue
in the U.S. and abroad. Numerous federal and state laws and regulations, including state privacy, data security and breach notification
laws, federal and state consumer protection and employment laws, the Health Insurance Portability and Accountability Act of 1996 (&#8220;<span style="text-decoration: underline">HIPAA</span>&#8221;),
as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and the Genetic Information Nondiscrimination
Act of 2008, govern the collection, dissemination, use, and confidentiality of personal information, including genetic, biometric, and
health information. These laws and regulations are increasing in complexity and number, may change frequently, and sometimes conflict.
Penalties for violations of these laws vary but can be severe.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we strive to comply with all applicable privacy and security laws and regulations, including our own posted privacy policies, these laws
and regulations continue to evolve, and any failure or perceived failure to comply may result in proceedings or actions against us by
government entities or others or could cause us to lose customers, which could have a material adverse effect on our business. Recently,
there has been an increase in public awareness of privacy issues in the wake of revelations about the data collection activities of various
government agencies and in the number of private privacy-related lawsuits filed against companies. Concerns about our practices with
regard to the collection, use, retention, disclosure, or security of personal information or other privacy-related matters, even if unfounded
and even if we are in compliance with applicable laws, could damage our reputation and harm our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
operations could be damaged or adversely affected as a result of natural disasters and other catastrophic events.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations could be adversely affected by events outside of our control, such as natural disasters, wars, health epidemics such as the
COVID-19 pandemic, and other calamities. We cannot assure you that any backup systems will be adequate to protect us from the effects
of fire, floods, typhoons, earthquakes, power loss, telecommunications failures, break-ins, war, riots, terrorist attacks or similar
events. Any of the foregoing events may give rise to interruptions, breakdowns, system failures, technology platform failures or internet
failures, which could cause the loss or corruption of data or malfunctions of software or hardware as well as adversely affect our ability
to provide services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
ability to utilize our net operating loss and tax credit carryforwards to offset future taxable income may be subject to certain limitations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under Section 382 of the Internal Revenue Code, a corporation that undergoes an &#8220;ownership change&#8221; is subject to
limitations on its ability to use its pre-change net operating loss carryforwards (&#8220;<span style="text-decoration: underline">NOLs</span>&#8221;) to offset future taxable
income. An &#8220;ownership change&#8221; is generally defined as a greater than 50 percentage point change (by value) in its equity
ownership by certain stockholders over a three-year period. If we have experienced an ownership change at any time since our incorporation,
we may already be subject to limitations on our ability to utilize our existing NOLs and other tax attributes to offset taxable income
or tax liability. In addition, the Business Combination and future changes in our stock ownership, which may be outside of our control,
may trigger an ownership change. Similar provisions of state tax law may also apply to limit our use of accumulated state tax attributes.
As a result, even if we earn net taxable income in the future, our ability to use these or our pre-change NOLs and other tax attributes
to offset such taxable income or tax liability may be subject to limitations, which could potentially result in increased future income
tax liability to us. The Company has not yet conducted a formal study of whether, or to what extent, past changes in control of the Company
impacts its ability to utilize NOLs because such NOLs cannot be utilized until the Company achieves profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is also a risk that changes in law or regulatory changes made in response to the need for some jurisdictions to raise additional revenue
to help counter the fiscal impact from unforeseen reasons, including suspensions on the use of net operating losses or tax credits, possibly
with retroactive effect, may result in our existing net operating losses or tax credits expiring or otherwise being unavailable to offset
future income tax liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are subject to many hazards and operational risks that can disrupt our business, some of which may not be insured or fully covered by
insurance.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to many hazards and operational risks inherent to our business, including: (a) general business risks; (b) warranty
liability; and (c) damage to third parties (e.g., our vendors), our infrastructure or properties caused by fires, floods and other natural
disasters, power losses, telecommunications failures, terrorist attacks, riots, cyberattacks, public health crises such as the COVID-19
pandemic (and other future pandemics or epidemics), human errors and similar events. As a result of the COVID-19 outbreak, or similar
pandemics, we have and may in the future experience disruptions that could severely impact our business and the business of our customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
insurance coverage may be inadequate to cover our liabilities related to such hazards or operational risks. For example, we do not currently
maintain cybersecurity insurance and our insurance providers may take the position that our coverage, under present circumstances, does
not extend to business interruptions. In addition, we may not be able to maintain adequate insurance in the future at rates we consider
reasonable and commercially justifiable, and insurance may not continue to be available on terms as favorable as our current arrangements.
The occurrence of a significant uninsured claim or a claim in excess of the insurance coverage limits maintained by us could have a material
adverse effect on our business, financial condition and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
value of Bitcoin has historically been subject to wide swings. Because we do not currently hedge our investment in Bitcoin and do not
intend to for the foreseeable future, we are directly exposed to Bitcoin&#8217;s price volatility and surrounding risks.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
Bitcoin prices are determined primarily using data from various exchanges, over-the-counter markets and derivative platforms, they have
historically been volatile and are impacted by a variety of factors. Such factors include, but are not limited to, the worldwide growth
in the adoption and use of Bitcoins, the maintenance and development of the software protocol of the Bitcoin network, changes in consumer
demographics and public tastes, fraudulent or illegitimate actors, real or perceived scarcity, and political, economic, regulatory or
other conditions. Furthermore, pricing may be the result of, and may continue to result in, speculation regarding future appreciation
in the value of Bitcoin, or our share price, making prices more volatile.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we do not use a formula or specific methodology to determine whether or when we will sell Bitcoin that we hold, or the number of Bitcoins
we will sell. Rather, decisions to hold or sell Bitcoins are currently determined by management by analyzing forecasts and monitoring
the market in real time. Such decisions, however well-informed, may result in untimely sales and even losses, adversely affecting an
investment in us. At this time, we do not anticipate engaging in any hedging activities related to our holding of Bitcoin; this would
expose us to substantial decreases in the price of Bitcoin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Being a Public Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
management has limited experience in operating a public company.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
executive officers have limited experience in the management of a publicly traded company. Our management team may not successfully or
effectively manage the significant regulatory oversight and reporting obligations under federal securities laws to which we are now subject
now that we are a public company. Their limited experience in dealing with the increasingly complex laws pertaining to public companies
could be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which
will result in less time being devoted to the management and growth of our Company. We may not have adequate personnel with the appropriate
level of knowledge, experience, and training in the accounting policies, practices or internal controls over financial reporting required
of public companies in the United States. The development and implementation of the standards and controls necessary for us to achieve
the level of accounting standards required of a public company in the United States may require costs greater than expected. It is possible
that we will be required to expand our employee base and hire additional employees to support our operations as a public company, which
will increase our operating costs in future periods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have incurred and will continue to incur significant increased expenses and administrative burdens as a public company, which could have
an adverse effect on our business, financial condition and results of operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently face and will continue to face increased legal, accounting, administrative and other costs and expenses as a public company
that Legacy ONMD did not incur as a private company. The Sarbanes-Oxley Act, including the requirements of Section 404, as well as rules
and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules
and regulations promulgated and to be promulgated thereunder, the Public Company Accounting Oversight Board and the securities exchanges,
impose additional reporting and other obligations on public companies. Compliance with public company requirements has increased and
will continue to increase costs and make certain activities more time-consuming. A number of those requirements will require us to carry
out activities we have not done previously. For example, we have created new Board of Directors committees and adopted new internal controls
and disclosure controls and procedures. In addition, expenses associated with SEC reporting requirements have been and will continue
to be incurred. Furthermore, if any issues in complying with those requirements are identified (for example, the auditors identified
a material weakness and significant deficiency in our internal control over financial reporting), we could incur additional costs rectifying
those issues, and the existence of those issues could adversely affect our reputation or investor perceptions of it. It may also be more
expensive to obtain director and officer liability insurance. Risks associated with our status as a public company may make it more difficult
to attract and retain qualified persons to serve on our Board of Directors or as executive officers. The additional reporting and other
obligations imposed by these rules and regulations has increased and will continue to increase legal and financial compliance costs and
the costs of related legal, accounting and administrative activities. These increased costs have required and will continue to require
us to divert a significant amount of money that could otherwise be used to expand the business and achieve strategic objectives. Advocacy
efforts by stockholders and third parties may also prompt additional changes in governance and reporting requirements, which could further
increase costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have identified material weaknesses in our internal control over financial reporting, and if our remediation of these material weaknesses
is not effective, or if we fail to maintain an effective system of internal controls over financial reporting in the future, we may not
be able to accurately or timely report our financial condition or operating results, which may adversely affect our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2024, we identified material weaknesses in our internal controls over financial reporting related to user access/segregation
of duties, lack of a formalized control environment and oversight of controls over financial reporting, error in accounting for non-routine
transactions, and lack of record keeping. Upon re-evaluation of the effectiveness of our internal control over financial reporting as
of December 31, 2023, management has determined that, as of December 31, 2023 and 2022, we did not maintain effective internal control
over financial reporting. We cannot assure you that we will adequately remediate the material weaknesses or that additional material
weaknesses in our internal controls will not be identified in the future. Any failure to maintain or implement required new or improved
controls, or any difficulties we encounter in their implementation, could result in additional material weaknesses, or could result in
material misstatements in our financial statements. Such misstatements have resulted in the restatement of the financial statements included
in this Amended Form 10-K, and misstatements could result in future restatements of our financial statements, cause us to fail to meet
our reporting obligations in addition to stock exchange listing requirements, cause investors to lose confidence in our reported financial
information, result in a decline in our stock price, and cause us to be subject to litigation or regulatory enforcement actions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are in the process of remediating the identified material weaknesses in our internal controls, but we are unable at this time to estimate
when the remediation efforts will be completed. If we fail to remediate these material weaknesses, there will continue to be an increased
risk that our future financial statements could contain errors that will be undetected. We cannot assure you that the measures we have
taken to date, or any measures we may take in the future, will be sufficient to avoid potential future material weaknesses. The potential
consequences of any material weakness could have a material adverse effect on our business, results of operations and financial condition.
Further and continued determinations that there are material weaknesses in the effectiveness of our internal controls could impact the
operations of our business, including our ability to obtain financing, impact the cost of any financing we obtain or require additional
expenditures of resources to comply with applicable requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
business model is capital-intensive, and we may not be able to raise additional capital on attractive terms, if at all, and any additional
capital we do raise through issuances of equity securities could be dilutive to stockholders. If we cannot raise additional capital when
needed, our operations and prospects could be materially and adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
can be expected to continue to sustain substantial operating expenses without generating sufficient revenues to cover expenditures. Over
time, we expect that we will need to raise additional funds, including through the issuance of equity, equity-related or debt securities
or through obtaining credit from financial institutions to fund, together with our principal sources of liquidity, ongoing costs, any
significant unplanned or accelerated expenses, and new strategic investments. We cannot be certain that additional capital will be available
on attractive terms, if at all, when needed, which could be dilutive to stockholders, and our financial condition, results of operations,
business and prospects could be materially and adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Risks
Related to Our Public Warrants</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may redeem the unexpired Public Warrants prior to their exercise at a time that is disadvantageous to Public Warrant holders.</span></p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Public Warrants are currently exercisable for one share of Common Stock at a price of $11.50 per share. We have the ability to redeem
outstanding Public Warrants at any time prior to their expiration, at a price of $0.01 per Public Warrant, provided that the last reported
sales price of Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third
trading day prior to the date we send the notice of redemption to Public Warrant holders and provided certain other conditions are met.
If and when the Public Warrants become redeemable by us, we may exercise our redemption rights even if we are unable to register or qualify
the underlying securities for sale under all applicable state securities laws. As a result, we may redeem the Public Warrants, as set
forth above even if the holders are otherwise unable to exercise the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redemption
of the outstanding Public Warrants could force Public Warrant holders (i) to exercise their Public Warrants and pay the exercise price
therefor at a time when it may be disadvantageous for them to do so, (ii) to sell their Public Warrants at the then-current market price
when they might otherwise wish to hold their Public Warrants or (iii) to accept the nominal redemption price which, at the time the outstanding
Public Warrants are called for redemption, we expect would be substantially less than the market value of their Public Warrants. None
of the private placement warrants will be redeemable by us so long as they are held by the Sponsor or its permitted transferees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_008"></span>USE
OF PROCEEDS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the shares of Common Stock offered by the Selling Securityholders pursuant to this prospectus will be sold by the Selling Securityholders
for their respective accounts. The Company will not receive any of the proceeds from these sales.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will receive an aggregate of approximately $139.0 million from the exercise of the Public Warrants and an aggregate of
approximately $6.7 million from the exercise of the Private Placement Warrants, assuming the exercise in full of all of the Public
Warrants and Private Placement Warrants, respectively, for cash. The Company expects to use the net proceeds from the exercise of
the Warrants for working capital and general corporate purposes. There is no assurance that the holders of the Warrants will elect
to exercise any or all of such Warrants. To the extent that Warrants are exercised on a &#8220;cashless basis,&#8221; the amount of
cash we would receive from the exercise of such Warrants will decrease. We believe the likelihood that Warrant holders will exercise
their Warrants, and therefore the amount of cash proceeds that we would receive, is dependent upon the market price of our Common
Stock. If the market price for our Common Stock is less than $11.50 per share, we believe the Warrant holders will be less likely to
exercise their Warrants. As of January 30, 2025, the closing price of our Common Stock was $1.02 per share. See
&#8220;<i>Description of Securities</i>&#8221; for additional information regarding the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders will pay any underwriting fees, discounts and selling commissions incurred by such Selling Securityholders in
disposing of their Common Stock or Private Placement Warrants. The Company will bear all other costs, fees and expenses incurred in effecting
the registration of the Common Stock and Warrants covered by this prospectus, including, without limitation, all registration and filing
fees, Nasdaq listing fees and fees and expenses of counsel and independent registered public accountants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_009"></span>DETERMINATION
OF OFFERING PRICE</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering price of the shares of Common Stock underlying the Public Warrants offered hereby is determined by reference to the exercise
price of the Public Warrants of $11.50 per share. The Public Warrants are listed on Nasdaq under the symbol &#8220;ONMDW.&#8221; The
offering price of the shares of Common Stock underlying the Private Placement Warrants offered hereby is determined by reference to the
exercise price of the Private Placement Warrants of $11.50 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot currently determine the price or prices at which shares of our Common Stock or Private Placement Warrants may be sold by the Selling
Securityholders under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_010"></span>MARKET
INFORMATION FOR COMMON STOCK AND DIVIDENDS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Common Stock and Public Warrants are currently listed on Nasdaq under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221; respectively.
As of January 29, 2025, there were 41 holders of record of our Common Stock, and there was one holder of record of our Public
Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend
Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not paid any cash dividends on the Common Stock to date. The Company may retain future earnings, if any, for future operations,
expansion and debt repayment and has no current plans to pay cash dividends for the foreseeable future. Any decision to declare and pay
dividends in the future will be made at the discretion of the Board and will depend on, among other things, the Company&#8217;s results
of operations, financial condition, cash requirements, contractual restrictions and other factors that the Board may deem relevant. In
addition, the Company&#8217;s ability to pay dividends may be limited by covenants of any existing and future outstanding indebtedness
the Company or its subsidiaries incur. The Company does not anticipate declaring any cash dividends to holders of the Common Stock in
the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Authorized for Issuance under Equity Compensation Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below summarizes information relating to our equity compensation plans at December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif">Plan category</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of securities to be issued upon exercise of outstanding options, warrants and rights</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted-average
    exercise price of outstanding options, warrants and rights</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number
    of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in the first
    column)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity compensation plans approved
    by security holders</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,357,223</span></td><td style="width: 3%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(1)(2)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Equity compensation plans not approved by
    security holders</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8211;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right">4<span style="font-family: Times New Roman, Times, Serif">,357,223</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    the Special Meeting held on October 17, 2023, our stockholders considered and approved the OneMedNet Corporation 2022 Equity Incentive
    Plan (the &#8220;<span style="text-decoration: underline">2022 Plan</span>&#8221;) and reserved for issuance thereunder an amount of shares of Common Stock equal to 10% of
    the number of shares of Common Stock of the Company following the Business Combination. The Business Combination closed on November
    7, 2023. All prior equity plans were cancelled in connection with the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    2022 Plan allows for the issuance of options, stock appreciation rights, restricted stock, restricted stock units, performance awards
    and other equity awards.</span></td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_011"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion and analysis should be read in conjunction with our consolidated financial statements and notes thereto that appear
elsewhere in this prospectus. See &#8220;Risk Factors&#8221; elsewhere in this prospectus for a discussion of certain risks associated
with our business. The following discussion contains forward-looking statements. Forward-looking statements give our current expectations
or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current
facts. The use of words such as &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221;
&#8220;plan,&#8221; &#8220;believe,&#8221; and other words and terms of similar meaning in connection with any discussion of future operating
or financial performance. From time to time, we also may provide forward-looking statements in other materials we release to the public.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
Corporation is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. The Company
was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions that simplify digital medical
image management, exchange, and sharing. The Company has one</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
wholly-owned subsidiary, OneMedNet Technologies (Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business
Corporations Act of British Columbia whose functional currency is the Canadian dollar. The Company&#8217;s headquarters location is
Eden Prairie, Minnesota.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, we held the closing of the Business Combination whereby Merger Sub merged with and into Legacy ONMD,
with Legacy ONMD continuing as the surviving entity, which resulted in all of the issued and outstanding capital stock of Legacy
ONMD being exchanged for shares of Common Stock upon the terms set forth in the Merger Agreement, by and among Data Knights, Merger
Sub, Legacy ONMD, the Sponsor, and Paul Casey, in his capacity as representative of the stockholders of Legacy ONMD. The Business Combination
and other transactions that closed on November 7, 2023, pursuant to the Merger Agreement, led to Data Knights changing its name to
&#8220;OneMedNet Corporation&#8221; and the business of the Company became the business of Legacy ONMD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Merger Agreement, the Merger Consideration was approximately $200 million. In connection with the special meeting
of stockholders of Data Knights, certain public holders holding 1,600,741 shares of Data Knights common stock exercised their right to
redeem such shares for a pro rata portion of the funds held by Continental Stock Transfer &amp; Trust Company, as trustee in the trust
account established in connection with Data Knights&#8217; initial public offering.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Effective November 7, 2023, Data Knights&#8217; units ceased trading, and effective November 8, 2023, the Common Stock began trading
on the Nasdaq Global Market under the symbol &#8220;ONMD&#8221; and the Public Warrants began trading on the Nasdaq Global
Market under the symbol &#8220;ONMDW.&#8221; The Common Stock and Public Warrants were transferred from The Nasdaq Global Market
to The Nasdaq Capital Market at the opening of business on August 19, 2024, and continue to trade under the symbols &#8220;ONMD&#8221;
and &#8220;ONMDW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Business Combination, holders of Data Knights common stock automatically received Common Stock of OneMedNet, and holders
of Data Knights warrants automatically received warrants of OneMedNet with substantively identical terms.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
At the closing of the Business Combination, all shares of Data Knights owned by the Sponsor (consisting of shares of Data Knights
common stock and shares of Data Knights Class B common stock), automatically converted into an equal number of shares of OneMedNet&#8217;s
Common Stock, and the private placement warrants held by the Sponsor automatically converted into warrants to purchase one share
of OneMedNet Common Stock with substantively identical terms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
Components of Consolidated Statements of Operations</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company generates revenue from two streams: (1) iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical,
device manufacturing, contract research organizations, and AI markets and (2) BEAM, which is a medical imaging exchange platform between
hospital/healthcare systems, imaging centers, physicians and patients. iRWD is sold on a fixed fee basis based on the number of data
units and the cost per data unit committed to in the customer contract. Revenue is recognized when the data is delivered to the customer.
BEAM revenue is subscription-based revenue that is recognized ratably over the subscription period committed to by the customer. The
Company invoices its BEAM customers quarterly or annually in advance with the customer contracts automatically renewing unless the customer
issues a cancellation notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority and imposed on and concurrent
with a specific revenue-producing transaction. The transaction price for the products is the invoiced amount. Advanced billings from
contracts are deferred and recognized as revenue when earned. Deferred revenue consists of payments received in advance of performance
under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives payments from
customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes unconditional.
Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost
of Revenue</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
cost of revenue is composed of our distinct performance obligations of hosting, labor, and data cost.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
and Administrative</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">General
and administrative functions include finance, legal, human resources, operations, and information technology support. These functions
include costs for items such as salaries and benefits and other personnel-related costs, maintenance and supplies, professional fees
for external legal, accounting, and other consulting services, and depreciation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Research
and Development</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Costs
incurred in the research and development of our products are expensed as incurred. Research and development costs include personnel,
contracted services, materials, and indirect costs involved in the design and development of new products and services, as well as hosting
expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sales
and Marketing</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
sales and marketing costs consist of labor and tradeshow costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest
Expense</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Interest
expense consists of interest incurred on shareholder loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
(Income) Expenses, Net</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Other
(income) expenses, net, primarily includes the changes in fair value of convertible debt and change in fair value of PIPE Notes for which
we have elected the fair value option of accounting. Convertible notes payable, which include convertible promissory notes, PIPE Notes
issued to related parties and the Yorkville Note, including accrued interest and contingently issuable warrants, contain embedded derivatives,
including settlement of the contingent conversion features, which require bifurcation and separate accounting. Accordingly, we have elected
to measure the entire contingently convertible debt instruments, including accrued interest, at fair value. These debt instruments were
initially recorded at fair value as liabilities and are subsequently re-measured at fair value on our condensed consolidated balance
sheet at the end of each reporting period and at settlement, as applicable. Other income or expenses, net, also includes changes in fair
value of loan extensions, deferred underwriting fees, Bitcoin and warrants which are treated as liability instruments measured at fair
value for accounting purposes, initially recorded at fair value and subsequently re-measured to fair value on our condensed consolidated
balance sheets at the end of each reporting period. The changes in the fair value of these debt and liability instruments are recorded
in changes in fair value, included as a component of other (income) expenses, net, in the condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">At
the closing of the Business Combination, convertible promissory notes were converted into Common Stock immediately prior to the Closing
and were no longer outstanding as of the closing date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Other
(income) expenses, net, also includes foreign exchange and tax expenses related to the Company&#8217;s operations and revenue outside
of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of Operations</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nine
Months Ended September 30, 2024 Compared to Nine Months Ended September 30, 2023</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth our condensed consolidated statements of operations data for the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine
                                            Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Subscription
    revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">443</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">595</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(152</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-26</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Web
    imaging revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">174</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">88</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">617</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">681</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(64</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-9</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">872</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">812</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">60</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Gross
    margin</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(255</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(131</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(124</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">95</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,934</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,475</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,459</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">99</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">623</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">813</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(190</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-23</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Research
    and development</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,127</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,566</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(439</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-28</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    operating expenses</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,684</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,854</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,830</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,939</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,985</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,954</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">39</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other expense (income),
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">120</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">120</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of PIPE Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of Yorkville Note</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">561</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">561</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of Bitcoin</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">124</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">124</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of convertible promissory notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,872</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,872</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock warrant expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,385</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(8,352</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other
    expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-60</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other expense, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">816</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,299</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(25,483</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-97</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,755</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(31,284</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">23,529</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-75</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine
                                            Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Subscription revenue (Beam)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">443</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">595</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(152</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-26</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Web imaging revenue
    (Real-World Data)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">174</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">88</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">102</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">617</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">681</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(64</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-9</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue is comprised of sales made from our subscription revenue (BEAM) and from our web imaging (iRWD). For the nine months ended September
30, 2024, overall revenue decreased by 9%. The primary driver for the decrease in subscription revenue was because of the planned discontinuation
of this platform in 2025. As we move away from the BEAM platform to focus on iRWD sales, we have stopped renewals for most of our customers
leading to an immaterial increase for the nine months ended September 30, 2024. The primary driver for the web imaging revenue increase
was due to our enhanced focus on iRWD sales leading to increased customer deliveries during the nine months ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine
    Months Ended September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">872</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">812</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">% of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">141</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">119</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024, our cost of revenue as a percentage of revenue increased by 22%. The increase is primarily
driven by the decrease in BEAM revenue due to our planned discontinuation of the platform in 2025. In addition, due to our enhanced focus
on the iRWD product, we have incurred increased iRWD data and consulting costs during the nine months ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expense increased $2.5 million, or 99%, to $4.9 million for the nine months ended September 30, 2024 from
$2.5 million for the nine months ended September 30, 2023. The increase is primarily due to an increase in professional fees of $2.3
million from being a public company (e.g. higher legal, audit and consulting fees), a commitment fee of $0.5 million from the SEPA, salaries
and benefits of $0.2 million, and bad debt expense of $0.1 million, which are partially offset by a decrease in stock compensation expense
of $0.6 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
and Marketing</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales &amp; marketing expense decreased $0.2 million, or 23%, to $0.6 million for the nine months ended September 30, 2024 from $0.8
million for the nine months ended September 30, 2023. The decrease is primarily due to a decrease in salaries and benefits of $0.3 million,
which is partially offset by an increase in trade shows of $0.1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expense decreased $0.4 million, or 28%, to $1.1 million for the nine months ended September 30, 2024 from $1.5
million for the nine months ended September 30, 2023. The decrease is primarily due to a decrease in stock compensation expense $0.4
million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the nine months ended September 30, 2024, interest expense was primarily comprised of interest expense on loans made from related parties
(Management and Directors) and interest expense on the remaining $0.4 million of deferred underwriter fees payable that is payable in
cash. During the nine months ended September 30, 2023, we did not incur any interest expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of Warrants during the nine months ended September 30, 2024 was due to the closing of the Business Combination and
the resulting fluctuations in the market price of shares of Common Stock<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of PIPE Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of PIPE Notes during the nine months ended September 30, 2024 was due to the closing of the Business Combination
and the resulting fluctuations in the market price of shares of Common Stock<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Yorkville Note</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of Yorkville Note during the nine months ended September 30, 2024 was due to the Yorkville Note issued in June 2024
and the resulting fluctuations of the market price of shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Bitcoin</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of Bitcoin during the nine months ended September 30, 2024 relates to the mark-to-market adjustment of Bitcoin,
which we began strategically investing in using excess cash from our private placement transactions. During the nine months ended September
30, 2023, we did not have any Bitcoin holdings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Convertible Promissory Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of convertible promissory notes was due to the closing of the Business Combination and the resulting fluctuations
of the market price of shares of Common Stock<i>. </i>The Legacy ONMD Convertible Promissory Notes were converted at the closing of the
Business Combination and were no longer outstanding during the nine months ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Warrant Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
warrant expense during the nine months ended September 30, 2024 was due to the Helena Termination Warrants, which was considered a cost
to terminate the Helena SPA<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
warrant expense during the nine months ended September 30, 2023 was due to the Convertible Promissory Notes Warrants, which was most
accurately portrayed as an issuance cost related to the Convertible Promissory Notes<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
Ended December 31, 2023 Compared to Year Ended December 31, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth our consolidated statements of operations data for the years ended December 31, 2023 and 2022:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the year ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Subscription
    revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">878</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">678</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Web
    imaging revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">143</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">475</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(332</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-70</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Total
    revenue</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,021</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,153</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(132</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-11</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,150</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,513</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(363</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-24</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Gross
    margin</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(129</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(360</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">231</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-64</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">General and administrative</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,544</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,806</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,262</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-26</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Sales and marketing</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,115</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">958</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">157</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">16</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Research
    and development</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,065</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,591</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">474</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    operating expenses</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,724</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,355</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(631</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-9</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loss from operations</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(6,853</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(7,715</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">862</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-11</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other (income) expense,
    net</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock warrant expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,207</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,073</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,134</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(129</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(129</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of PIPE notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">269</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">269</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of convertible promissory notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">17,517</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">14,616</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,901</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Other
    expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">34</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">30</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Total
    other (income) expenses, net</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26,909</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">22,719</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,190</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Loss
    before income taxes</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,762</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30,434</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,328</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Income tax expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">17</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Net
    loss</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,780</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(30,451</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,329</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the year ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Change
    2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Subscription revenue (Beam)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">878</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">678</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">200</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Web imaging revenue
    (Real-World Data)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">143</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">475</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(332</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-70</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,021</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,153</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(132</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue is comprised of sales made from our subscription revenue (BEAM) and from our web imaging (RWD). For the year ended December 31,
2023, overall revenue was down by 11%. The primary driver for the subscription revenue increase was delivery of revenue to a significant
customer. The primary driver for the decrease in web imaging revenue was revenue deliveries pushed to the first quarter of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cost
of Revenue</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For
    the year ended December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span style="font-family: Times New Roman, Times, Serif">Cost of revenue</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,150</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,513</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">% of revenue</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">113</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">131</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2023 we were able to reduce our cost of revenue as a percentage of revenue by 18%. In the year ended 2023 our software cost, iRWD consultants
and iRWD Data cost each decreased by $0.2 million ($0.6 million total). The decrease in cost of revenue was partially offset by a $0.2
million increase in payroll expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
and Administrative</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expense decreased $1.3 million, or 26%, to $3.5 million for 2023 from $4.8 million for 2022. The decrease
is primarily due to a decrease in stock compensation expense of $0.2 million, board of director warrant expense of $1.2 million, recruiting
fees of $0.2 million and bad debt expense of $0.2 million. The decrease in general and administrative expenses was partially offset by
$0.3 million in additional employees&#8217; salaries.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
and Marketing</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales &amp; marketing expense increased $0.2 million, or 16%, to $1.1 million for 2023 from $1.0 million for 2022. The increase is due
to the addition of an employee and consultant in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Research
and development</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expense increased $0.5 million, or 30%, to $2.1 million for 2023 from $1.6 million for 2022. The increase is
primarily due to the additional cost in salaries for curators, consultants and increased hosting costs, which increased by $0.4 million,
$0.2 million and $0.1 million, respectively. The increase is partially offset by a $0.2 million decrease in stock compensation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Income
tax provision</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended 2023, the Company recorded a tax provision of $18 thousand due to the earnings of its Canadian subsidiary. As a result
of its U.S. taxable loss, no U.S. federal or state tax provision was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Interest
Expense</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Company incurred interest expense on loans made from related parties (Management and Directors). Interest expense for the year ended
2023 was immaterial.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of Warrants was due to the Closing of the Business Combination and the resulting fluctuations in the market price
of shares of Common Stock<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of PIPE Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of PIPE Notes was due to the resulting fluctuations in the market price of shares of Common Stock<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Change
in Fair Value of Convertible Debt</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
change in fair value of convertible debt was due to the Closing of the Business Combination and the resulting fluctuations of the market
price of shares of Common Stock<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-GAAP
Financial Measure</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">In
addition to providing financial measurements based on U.S. generally accepted accounting principles (&#8220;<span style="text-decoration: underline">GAAP</span>&#8221;), we provide
an additional financial metric that is not prepared in accordance with GAAP (a &#8220;<span style="text-decoration: underline">non-GAAP financial measure</span>&#8221;). We use
this non-GAAP financial measure, in addition to GAAP financial measures, to understand and compare operating results across accounting
periods, for financial and operational decision making, for planning and forecasting purposes, to measure executive compensation, and
to evaluate our financial performance. This non-GAAP financial measure is Adjusted EBITDA, as discussed below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">We
believe that this non-GAAP financial measure reflects our ongoing business in a manner that allows for meaningful comparisons and analysis
of trends in the business, as it facilitates comparing financial results across accounting periods and to those of peer companies. We
also believe that this non-GAAP financial measure enables investors to evaluate our operating results and future prospects in the same
manner as we do. This non-GAAP financial measure may exclude expenses and gains that may be unusual in nature, infrequent, or not reflective
of our ongoing operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">This
non-GAAP financial measure should not be viewed as a substitute for a GAAP financial measure and may be different from a similarly titled
non-GAAP financial measure used by other companies. Furthermore, there are limitations inherent in the non-GAAP financial measure because
it excludes charges and credits that are required to be included in a GAAP presentation. Accordingly, the non-GAAP financial measure
does not replace the presentation of our GAAP financial measures and should only be used as a supplement to, not as a substitute for,
our financial results presented in accordance with GAAP. GAAP net loss is the closest comparable GAAP measure used.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">We
consider Adjusted EBITDA to be an important indicator of the operational strength and performance of our business and a good measure
of our historical operating trends. Adjusted EBITDA eliminates items that we do not consider to be part of our core operations. We define
Adjusted EBITDA as GAAP net loss excluding the following items: interest expense; income tax expense; depreciation and amortization of
tangible assets; stock-based compensation; Business Combination transaction expenses; and other non-recurring items that may arise from
time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
non-GAAP adjustments, and our basis for excluding them from our non-GAAP financial measure, are outlined below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Adjusted
                                            EBITDA does not reflect interest expense or the cash requirements necessary to service payments
                                            on our shareholder loans, which is not a core form of financing for our business;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Adjusted
                                            EBITDA does not reflect income tax expense, which relates to our foreign subsidiary, because
                                            we have suffered recurring consolidated operating losses since inception and expect that
                                            to continue in the future;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Although
                                            depreciation and amortization are non-cash charges, the assets that we currently depreciate
                                            and amortize will likely have to be replaced in the future, and Adjusted EBITDA does not
                                            reflect the cash required to fund such replacements;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Adjusted
                                            EBITDA excludes stock-based compensation expense which has been, and will continue to be
                                            for the foreseeable future, a significant recurring non-cash expense for our business and
                                            an important part of our compensation strategy;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Adjusted
                                            EBITDA does not reflect the effect of earnings or charges resulting from matters that our
                                            management does not consider to be indicative of our ongoing operations. However, some of
                                            these charges and gains (such as mark-to-market adjustments, stock warrant expense, etc.)
                                            have recurred and may recur; and</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Other
                                            companies, including companies in our industry, may calculate Adjusted EBITDA differently,
                                            which reduces its usefulness as a comparative measure.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles GAAP net loss to Adjusted EBITDA during the three months ended June 30, 2024 and 2023 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three
    Months Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,589</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(9,601</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">41</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation and amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">11</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">103</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">280</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of PIPE Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">52</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of Yorkville Note</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of convertible promissory notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,836</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Stock
    warrant expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,165</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Adjusted
    EBITDA</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,360</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,314</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reconciles GAAP net loss to Adjusted EBITDA during the six months ended June 30, 2024 and 2023 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Six
    Months Ended June 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net loss</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,698</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(17,444</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Interest expense</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">83</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation and amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">21</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">13</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Stock-based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">240</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">648</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of warrants</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of PIPE Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of Yorkville Note</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">823</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of derivative liability</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">160</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Change in fair value
    of convertible promissory notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Stock
    warrant expense</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">33</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4,100</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Adjusted
    EBITDA</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(4,306</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,433</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
and Capital Resources</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, our principal sources of liquidity were proceeds from related party investors and private placement transactions
and cash received from customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows net cash and cash equivalents used in operating activities, net cash and cash equivalents used in investing activities,
and net cash and cash equivalents provided by financing activities during the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine
    Months Ended September 30,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2024</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Net cash provided by
    (used in)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Operating
    activities</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(5,007</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(3,066</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Investing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,296</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Financing activities</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,190</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,435</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Operating
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net cash and cash equivalents used in operating activities consists of net loss adjusted for certain non-cash items, including depreciation
and amortization, stock-based compensation expense, changes in fair value of financial instruments, and as well as changes in operating
assets and liabilities. The primary changes in working capital items, such as the changes in accounts receivable and deferred revenue,
result from the difference in timing of payments from our customers related to contract performance obligations. This may result in an
operating cash flow source or use for the period, depending on the timing of payments received as compared to the fulfillment of the
performance obligation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities was $5.0 million during the nine months ended September 30, 2024. Net cash used in operating activities
was due to our net loss of $7.8 million, which is offset by non-cash items of $1.2 million, primarily consisting of stock-based compensation
of $0.4 million, change in fair value of Yorkville Note of $0.6 million, change in fair value of Bitcoin of $0.1 million, non-cash interest
expense of $0.1 million, and cash from operating assets and liabilities of $1.5 million due to the timing of cash payments to vendors
and cash receipts from customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">By
comparison, the Company&#8217;s net cash used in operating activities was $3.1 million during the nine months ended September 30, 2023.
Net cash used in operating activities for the nine months ended September 30, 2023 was due to our net loss of $31.3 million, which is
offset by non-cash items of $27.7 million, primarily consisting of the change in fair value of convertible debt of $17.9 million, stock
warrant expense of $8.4 million and stock-based compensation expense of $1.4 million, and cash from operating assets and liabilities
of $0.5 million due to the timing of cash payments to vendors and cash receipts from customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Investing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
investing activities have consisted primarily of property and equipment purchases and Bitcoin holdings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash and cash equivalents used in investing activities during the nine months ended September 30, 2024 consisted of a $2.8 million investment
in Bitcoin and $28 thousand of purchased property and equipment, which are partially offset by a $0.5 million sale of Bitcoin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash and cash equivalents used in investing activities during the nine months ended September 30, 2023 consisted of $28 thousand of purchased
property and equipment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing
Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by financing activities was $9.2 million for the nine months ended September 30, 2024, which primarily consisted of $6.3
million of net proceeds received from three private placement transactions, $2.0 million of proceeds received from related party loans
(net of $0.2 million of repayments) and $1.4 million of proceeds received from the issuance of the Yorkville Note. These increases are
partially offset by repayments of $0.1 million to settle a portion of our deferred underwriter fees payable and repurchases of Common
Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
comparison, the Company&#8217;s net cash provided by financing activities was $3.4 million for the nine months ended September 30, 2023,
which primarily consisted of $3.9 million of proceeds from the issuance of convertible promissory notes, and $0.7 million of proceeds
received from related party loans, offset by $1.2 million of Business Combination costs paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Contractual
Obligations and Commitments and Going Concern Outlook</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
management does not believe that our cash and cash equivalents is sufficient to meet our foreseeable cash needs for at least the next
12 months. Our foreseeable cash needs, in addition to our recurring operating expenses, include our expected capital expenditures to
support the expansion of our infrastructure and workforce, interest expense and minimum contractual obligations. Management intends to
raise cash for operations through debt and equity offerings. As a result of the Company&#8217;s recurring loss from operations and the
need for additional financing to fund its operating and capital requirements there is uncertainty regarding the Company&#8217;s ability
to maintain liquidity sufficient to operate its business effectively, which raises substantial doubt as to the Company&#8217;s ability
to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future capital requirements will depend on many factors, including our growth rate, the timing and extent of spending to support research
and development efforts, the expansion of sales and marketing activities, the introduction of new and enhanced product and service offerings,
and the cost of any future acquisitions of technology or businesses. In the event that additional financing is required from outside
sources, we may be unable to raise the funds on acceptable terms, if at all.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our current and long-term material cash requirements as of September 30, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Payments
    due in:</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Less
    than 1 year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1-3
    years</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Accounts payable &amp; accrued
    expenses</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,161</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">6,161</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loan extensions</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,992</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Deferred underwriter fee payable</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,237</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,237</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Loan, related party</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">PIPE Notes</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,593</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,593</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">Yorkville Note</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,911</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,911</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,200</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical
Accounting Policies and Estimates</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
management&#8217;s discussion and analysis of financial condition and results of operations is based on our condensed consolidated financial
statements which have been prepared in accordance with GAAP. In preparing our financial statements, we make estimates, assumptions, and
judgments that can have a significant impact on our reported revenue, results of operations, and net income or loss, as well as on the
value of certain assets and liabilities on our balance sheet during and as of the reporting periods. These estimates, assumptions, and
judgments are necessary because future events and their effects on our results of operations and the value of our assets cannot be determined
with certainty and are made based on our historical experience and on other assumptions that we believe to be reasonable under the circumstances.
These estimates may change as new events occur or additional information is obtained, and we may periodically be faced with uncertainties,
the outcomes of which are not within our control and may not be known for a prolonged period of time. Because the use of estimates is
inherent in the financial reporting process, actual results could differ from those estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">For
a discussion of our critical accounting estimates, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations&#8221; in the Form 10-K/A and subsequent quarterly reports on Form 10-Q, the notes to our audited financial statements
appearing in the Form 10-K/A and subsequent quarterly reports on Form 10-Q, and the notes to the financial statements appearing elsewhere
in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_012"></span>BUSINESS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (&#8220;<span style="text-decoration: underline">iRWD</span><sup>TM</sup>&#8221;)
OneMedNet&#8217;s innovative solutions connect healthcare providers and patients satisfying a crucial need within the life sciences
field offering direct access to clinical images and the associated contextual patient record. OneMedNet&#8217;s innovative technology
proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides
regulatory-grade image-centric iRWD<sup>TM</sup> that exactly matches OneMedNet&#8217;s life science partners case selection
protocols and paves the way for Real World Evidence (as defined below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
was founded to solve a deficiency in how clinical images were shared between healthcare providers. This resulted in OneMedNet&#8217;s
initial product BEAM<sup>TM</sup> image exchange that enabled the successful sharing of images for more than a decade with OneMedNet&#8217;s
largest customer being the Republic of Ireland.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
continued to innovate by responding to the demand for and utilization of Real World Data (as defined below) (&#8220;<span style="text-decoration: underline">RWD</span>&#8221;)
and Real World Evidence (&#8220;<span style="text-decoration: underline">RWE</span>&#8221;), specifically data that focused on clinical images with its associated
contextual clinical record. We were able to leverage internal technological competencies along with OneMedNet&#8217;s formidable healthcare
provider installed base from its first product with BEAM<sup>TM</sup> to become the first RWD solution for life science companies
with its launch of iRWD<sup>TM</sup> in 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
provides innovative solutions that unlock the significant value contained within clinical image archives. With a growing federated
network of 95+ healthcare facilities, OneMedNet has the immediate ability to quickly search and extensively curate multi-layer data
from a federated group of healthcare facilities. The term &#8220;healthcare facilities&#8221; refers specifically to the hospitals, integrated
delivery networks (&#8220;<span style="text-decoration: underline">IDNs</span>&#8221;) and imaging centers that provide imaging to OneMedNet, which represent the core source
of our data. At present, OneMedNet works with more than 95 facilities who provide regulatory grade imaging to us. OneMedNet has access
to these more than 95 facilities because these contracted facilities have more than 200 locations among them including offices and clinics,
which in total generates regulatory grade imaging from more than 200 customers. Among these customers, all are data providers, and some
are data purchasers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initially,
it was all about solving the diverse access needs of patient care providers. This focus systematically evolved to addressing the rapidly
growing needs of image analysis and researchers, clinicians, regulators, scientists and more. The federated network allows OneMedNet
to access the following data to provide to research as RWD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Data is any data that is collected in the context of the routine delivery of care, in contrast to data collected within
a clinical trial where study design controls variability in ways that are not representative of Real World care and outcomes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
key component driving its mission is that OneMedNet believes we have a unique opportunity to affect a material positive impact on the
lives of tens of millions of people while improving our customers&#8217; business productivity. First and foremost, OneMedNet&#8217;s
iRWD<sup>TM</sup> offering plays a significant role in enabling life science companies to bring safer and more effective patient
care to market sooner. Using our highly curated de-identified clinical data in our iRWD<sup>TM</sup> offering in life science
product development, validation, and regulatory approval processes, life science companies contribute to patient care advancements
in more meaningful ways. Moreover, life sciences improve life science companies&#8217; product development and validation
processes, which benefits all parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
documentation exists that shows that Real World Data can provide expanded insights across broader and more representative patient populations.
For this reason, the Food and Drug Administration (&#8220;<span style="text-decoration: underline">FDA</span>&#8221;) has instituted Real World Data guidelines for regulatory
approvals. Utilization of highly reliable and quality Real World Data that strictly adheres to all of the very specific data stratification
requirements can supplement or supplant clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
covers the complete value chain in imaging Real World Data; it begins with our 10+ year federated network of providers and is supported
by a multi-faceted data curation process managed by an expert in-house clinical team. Additionally, we work hand-in-hand with our life
science partners regarding the case selection protocol and, when required, producing case report forms for regulatory
clearance. We are focused on delivering value by supporting life science advancements with OneMedNet&#8217;s iRWD<sup>TM</sup>
which holds the key to unlocking boundless patient care advances. We believe we unleash the power of research-grade image-centric
iRWD<sup>TM </sup>that is curated to meet every cohort requirement and stand up to the rigors of prospective clinical trials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Today,
life science companies, including pharmaceutical companies, artificial intelligence (&#8220;<span style="text-decoration: underline">AI</span>&#8221;) developers, medical
device businesses, and clinical research organizations, share the same widespread challenge in obtaining insight-rich, high-quality patient
data that explicitly matches their precise cohort specifications. A substantial portion of patient diagnosis involves clinical imaging,
and approximately 90% of healthcare data, by size, is associated with imaging. Historically, much of imaging value has been derived from
its initial review, and further gains from the image archives have been very limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
help providers to &#8220;Unlock the Value in Imaging Archives.&#8221;<sup>TM</sup> By utilizing OneMedNet&#8217;s iRWD<sup>TM</sup> offering,
providers can greatly improve their research efforts with streamlined data access. Health care providers such as hospitals, clinics,
and imaging centers can also accelerate life science patient care innovations by sharing de-identified data in a well-defined and de-identified
and secure manner. In return for doing so, income is generated and applied to critical and possibly unfunded provider projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
OneMedNet Difference</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> OneMedNet has been a leader in the business
of extracting, securing, and transferring medical data for 10+ years. Doing so requires specialized expertise in:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compliance
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(HIPAA
                                            (as defined below), GDPR, 21 CFR Part11)</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
                                            privacy &amp; security measures</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clinical
                                            patient condition(s) and hospital processes</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Radiology
                                            interpretation</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI/ML
                                            (Artificial Intelligence and Machine Learning) technology</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attaining
in-house expertise in all essential elements is a challenge and we believe deters many organizations from attempting such a venture.
We take pride in this ambitious achievement - while continually working to maintain state-of-the-art expertise. OneMedNet strictly adheres
to the highest level of professional and ethical standards and applicable regulations throughout all interactions and activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe OneMedNet is a leader in the field of regulatory-grade imaging RWD curators. Doing so requires specialized expertise
in AI/ML technology, data privacy/security, as well as expertise in clinical patient condition(s) and healthcare record keeping. Having,
or achieving, expertise in all essential disciplines is a challenging achievement. OneMedNet had a significant head start with our clinical
image exchange solution which served to launch the Company over a decade ago. All data remains &#8220;native&#8221; within the
federated OneMedNet iRWD<sup>TM </sup>provider network - meaning all the data remains locally onsite until specific de-identified data
is licensed for a particular life science research opportunity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OneMedNet&#8217;s
Competitive Advantages</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that OneMedNet iRWD<sup>TM</sup> offers the best of advanced technology, clinical expert curation, and service. Medical imaging
and associated clinical data are indexed at each network site using state-of-the-art AI/ML technology. This typically includes
electronic health records (&#8220;<span style="text-decoration: underline">EHR</span>&#8221;), radiology, cardiology, lab, pathology and more. Our in-house clinical team
performs intensive curation of the data so that results meet the specifications and requirements of life science
Data Collection Protocol (&#8220;<span style="text-decoration: underline">DCP</span>&#8221;) - regardless of the complexity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that OneMedNet unlocks the value in imaging and EHR data in the following three principal ways:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory
                                            Grade - Our imaging results serve as proof of effectiveness for regulatory agencies, meeting
                                            requirements for quality &amp; diversity.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            Demand - Our powerful indexing platform accesses and harmonizes complete patient profiles
                                            across fragmented data silos, delivering images and records on-demand.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expertly
                                            Curated - We curate to the most stringent multi-level stratified requirements, providing
                                            unmatched data accuracy and completeness.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_012.jpg" alt="" style="width: 650px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet&#8217;s
data is fully de-identified using a multi-step quality control process and goes beyond protected health information (&#8220;<span style="text-decoration: underline">PHI</span>&#8221;)
to include personally identifiable information (&#8220;<span style="text-decoration: underline">PII</span>&#8221;), site identifiable information, and more. Importantly,
life science users receive the data in the exact format that they require. No data sifting or manipulation is needed. The data
is simply ready for use. Moreover, OneMedNet has the unique combination of knowledge, tools, and experience to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
                                            and harmonize complete patient profiles across fragmented data silos;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide
                                            unmatched data accuracy and completeness;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ensure
                                            the security and privacy of patients&#8217; PHI;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Imaging
                                            RWD is our singular passion and focus and no one does it better.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finally,
OneMedNet has a team of highly experienced and clinically trained data curators. This team appreciates the complexity and criticality
of clinical data and can effectively communicate with both providers and life science specialists.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_013.jpg" alt="" style="width: 650px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Industry
Background</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
2016 analysis published in the Journal of Health Economics and authored by the Tufts Center for the Study of Drug Development
placed the cost of bringing a drug to market, including post-approval research and development, at a staggering $2.87 billion. Meanwhile,
a 2018 study from the Tufts Center for the Study of Drug Development noted that the timeline for new drug development ranged from 12.8
years for the average drug to 17.2 years for ultra-orphan drugs that only affect several hundred patients. This places the onus on life
science organizations to find ways to deliver treatments to patients faster&#8201;-&#8201;especially those who cannot wait 17 years
for a potentially life-saving treatment. Knowing how a medicinal product is actually used by patients can help stakeholders across the
healthcare ecosystem make important and potentially life-saving real-time decisions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Data is observational data typically gathered when an approved medical product is on the market and used by &#8220;real&#8221;
patients in real life, as opposed to clinical trials or real world images for real patients. The FDA cites several potential sources
of Real World Data, including EHR, claims, and disease and product registries. There are multiple types of data
including structured and unstructured data, clinical and billing data, transactional and claims data, patient-generated data, and data
gathered from additional sources that can shed light on a patient&#8217;s health status and more. As reliance on healthcare data grows
exponentially, OneMedNet has observed that the reliance on information has increased coming from multiple additional sources including
EHR, claims, registries, clinical trials, patient and provider surveys, wearable devices and more. These additional sources include
the internet of things (&#8220;<span style="text-decoration: underline">IoT</span>&#8221;), social media forums and blogs. Real World Data has the potential to break down inefficiencies
and fill gaps in information silos among stakeholders throughout the healthcare ecosystem of providers, payers, manufacturers, government
entities and patients. This information sharing, in turn, enables all parties to derive new insights, support value-based care and deliver
better health outcomes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercializing
a drug requires its developer to harness various sources of Real World Data to identify patient populations and refine sales and marketing
strategies for those populations among many other undertakings. Historically, this practice involved purchasing large amounts of data
from data aggregators or data platforms, if not directly from the source itself, sometimes without much knowledge about the quality of
the data. Preparing this data for analysis is both expensive and time-consuming; thus, many organizations would outsource the process
to consultants or third-party vendors. Moreover, the process of preparing this data for analysis by untrained consultants can
yield a static analysis that is difficult to modify or rerun in response to follow-up questions or potential discrepancies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Definitions
of Real World Data and Real World Evidence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Data has become a powerful tool in the life sciences industry. After decades of relying on clinical data as the gold standard for
decision making, industry leaders now recognize how data collected in the real world adds valuable context and insight to their efforts.
From identifying unmet medical needs and defining the patient journey, to supporting regulatory submissions, proving value to payers,
and shaping market strategies, Real World Data adds value at every stage of the drug development lifecycle. Real World Data also sets
the foundation for Real World Evidence, and while the terms are often used interchangeably, they are distinct, and they are changing
health care. Here&#8217;s how it happens:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
                                            Real World Data are data relating to patient health status and/or the delivery of health
                                            care routinely collected from a variety of sources. Real World Data is aggregated and transformed
                                            such as through OneMedNet&#8217;s robust analytics. Real World Data are the data relating
                                            to patient health status and/or the delivery of health care routinely collected from a variety
                                            of sources. There are many different types, sources and uses of Real World Data, for example:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clinical
                                            Data</i> - For example, clinical data from EHR and case report forms (&#8220;<span style="text-decoration: underline">eCRF</span>&#8221;)
                                            including biopsies and other pathology tests, diagnostic imaging, social determinants of
                                            health, cancer organoids, which provide patient demographics, family history, comorbidities,
                                            procedure and treatment history, and outcomes.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patient
                                            Generated Data</i> - For example, patient-generated data from patient-reported outcome surveys,
                                            which data provide insights directly from the patient and help researchers understand what
                                            happens outside of clinic visits, procedures, and hospital stays.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
                                            and Utilization Data (Qualitative Studies)&#8201;-&#8201;For example, cost and utilization
                                            data from claims and public datasets, which data provides information regarding healthcare
                                            services utilization, population coverage, and prescribing patterns.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
                                            Health Data</i> - For example, public health data from various government data sources,
                                            which add critical information to enable stakeholders to best serve the needs of the
                                            populations they serve.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
availability of medical imaging in Real World Data such as that provided by OneMedNet is facilitated by the development of digital image
analysis to increase the accuracy of diagnostics and conduct passive screening on large databases of medical images using AI algorithms
such as those applied by OneMedNet. Algorithms can also help identify additional diagnostic tests of value from medical images with pathology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis
of Real World Data, as defined by the FDA. Real World Evidence can be generated by different study designs or analyses, including
but not limited to randomized trials, including large simple trials, pragmatic trials, and observational studies (prospective and/or
retrospective). The difference in Real World Evidence and Real World Data focuses on the end use case. Real World Data can take the form
of claims, EHR, labs, data etc. Often this insight is used to better understand a patient&#8217;s journey or a natural history
of a disorder (how does a disease progress if left untreated.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_014.jpg" alt="" style="width: 650px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Evidence in contrast builds upon many of these data sets and prepares them for submission, as part of regulatory review such as
to the FDA or the European Medicines Agency (&#8220;<span style="text-decoration: underline">EMA</span>&#8221;), for example, in support of a customer&#8217;s clinical
trial application. When data and, in particular, imaging data is submitted to the FDA, the agency requires the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guard
                                            against bias&#8201;-&#8201;evidence must align with the patient population being
                                            studied&#8201;-&#8201;expectations focus on the similar patient demographics,
                                            comorbidities, disease severity, etc.;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Traceability&#8201;-&#8201;confirm
                                            the chain of custody, the source of the data is known and can be validated if required; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Go-forward
                                            basis&#8201;-&#8201;regulatory agencies seek evidence that aligns with the trial&#8217;s
                                            timeframe and, when possible, collect evidence that mirrors the clinical trial&#8217;s
                                            timeline.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
area where Real World Evidence has been relied on heavily relates to oncology approvals. The FDA&#8217;s Oncology Center
of Excellence presented an analysis of this at the American Society of Clinical Oncology in 2021, looking at oncology applications
containing Real World Data and Real World Evidence. That analysis looked at 94 applications that were submitted from 2011&#8211;2020
and showed that inclusion of Real World Data to support regulatory decision-making has increased dramatically over that period. In 2020
alone, there were 28 submissions for oncology products that contained Real World Data. Outside of the oncology context, probably the
most notable recent example of an approval relying on Real World Evidence is the FDA&#8217;s July 2021 approval of a new indication
for Astella Pharma Inc.&#8217;s&#8217; drug program (or tacrolimus) for the prevention of organ rejection in lung transplant
patients. The approval there was based on a non-interventional study providing Real World Evidence of effectiveness. FDA&#8217;s
press release announcing the approval noted that the approval was &#8220;significant because it reflects how a well-designed, non-interventional
study relying on fit-for-purpose Real World data, when compared to a suitable control, can be considered adequate and well-controlled
under FDA regulations.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
additional recent approval of note was the FDA&#8217;s December 2021 approval of the supplemental BLA (Biological License Application)
for Orencia&#174; to prevent graft versus host disease. The application included data from a randomized clinical trial, with
additional evidence of effectiveness provided by a registry-based clinical study that was conducted using Real World data from
the Center for International Blood and Marrow Transplant Research. That registry study analyzed outcomes of 54 patients treated
with Orencia&#174; for the prevention of graft versus host disease, in combination with standard immunosuppressive drugs, versus
162 patients treated with the standard immunosuppressive drugs alone, and showed efficacy in that indication.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
is employed in Real World Data to enhance data anomaly detection, standardization, and quality checking at the pre-processing stage.
AI is expected to offer pharma and biotech companies the ability to increase meaningful Real World Evidence output, decrease time to
insights, and make the most of the available vast data sources. A Real World Evidence technology platform that delivers smart data processing,
analysis, and outcomes offers an unparalleled opportunity to capitalize on these computing advancements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
used as part of an overall comprehensive Real World Evidence strategy, AI innovations can enhance drug development, improve patient treatment
and access, and drive valuable new business opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
post-marketing studies, adverse events reporting is an area where AI is used, creating greater automation and efficiency in historical
data sets. Techniques like natural language processing (&#8220;<span style="text-decoration: underline">NLP</span>&#8221;) enable AI to scan tens of thousands of records and
quickly find adverse event details. AI-integrated analytics and automation provide access to crucial insights from historical clinical
trial Real World Data and Real World Evidence, expanding end-to-end clinical trial capabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
                                            ingestion&#8201;-&#8201;publicly/historically available Real World Data</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Text
                                            extraction&#8201;-&#8201;NLP used to extract key entities from clinical trial documents</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
                                            transformation &amp; standardization&#8201;-&#8201;data standardization using pre-built
                                            models</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
                                            model deployment&#8201;-&#8201;predicting trial design impacts on costs, feasibility, cycle
                                            times, and quality risk</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
is driving ground-breaking leaps in protein structure identification, and advances in regulations are providing healthcare research organizations
with access to Real World data to accelerate clinical trial processes. We believe that AI-enabled technologies have unparalleled
potential to offer innovative trial design and collection, organizing, and analyzing the increasing amount of data generated by clinical
trials. AI has many applications in clinical trials, both short and long-term. AI technologies make possible innovations crucial for
transforming clinical trials, such as seamlessly combining Phases I and II, developing novel patient-centered endpoints, and collecting
and analyzing Real World Data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
believes that AI tools also have wider benefits for hospitals and health systems. Professor Alexander Wong, University of Waterloo Canada
Research Chair in AI and Medical Imaging, points out that AI benefits include the potential to ease the burden on radiology departments
in terms of assessing scans and predicting upcoming demand for general hospital and intensive care beds, and demand for equipment such
as respirators and ventilators, medicines, masks, and ventilator mouthpieces, as well as aiding workforce planning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Across
a diverse set of imaging modalities, digital images typically include metadata and/or annotations that may include protected health information
(e.g., patient name, date of birth). Although diagnostic images generally do not warrant the same level of privacy concerns as genomic
data, researchers must also remove facial characteristics or other features that could identify a patient.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Digital
image analysis can be used to support research and development by analyzing large volumes of tissue specimens or other medical images
to run molecular screens that model biomarkers and treatment responses by transplanting a portion of a patient&#8217;s tumor into humanized
mice or 3D tissue cultures derived from stem cells that resemble miniature organs. These models allow researchers to conduct controlled
laboratory experiments that can inform treatment approaches and link predicted treatment response to actual clinical outcomes by linking
this data to EHR, claims, and other sources of Real World Data. Similarly, preclinical studies can be informed by safety assessments
conducted in animal models or studies of animal molecular biomarkers or anatomic abnormalities to minimize the burden on human study
participants. Findings can also inform clinical trial optimization by stratifying participants according to predicted response and determining
appropriate eligibility criteria.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
                                            Real World Evidence is the clinical evidence about the usage and potential benefits or risks
                                            of a medical product derived from analysis of Real World Data. Real World Evidence provides
                                            clinically-rich insights into what actually happens in everyday practice and why. The U.S.
                                            Federal Food, Drug, and Cosmetic Act of 1938 (&#8220;<span style="text-decoration: underline">FD&amp;C Act</span>&#8221;) defines
                                            Real World Evidence as &#8220;<i>data regarding the usage, or the potential benefits or risks,
                                            of a drug derived from sources other than traditional clinical trials</i>.&#8221; In developing
                                            its Real World Evidence program, the FDA believes it is helpful to distinguish between
                                            the sources of Real World Data and the evidence derived from that data.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluating
Real World Evidence in the context of regulatory decision-making depends not only on the evaluation of the methodologies used to generate
the evidence but also on the reliability and relevance of the underlying Real World Data; these constructs may raise different types
of considerations. Real World Evidence refers to evidence about the risks and benefits of a product derived from analysis of the Real
World Data. For example, the FDA has used Real World Data and Real World Evidence, derived from its Sentinel System, the largest multisite
distributed database in the world dedicated to medical product safety, for monitoring the safety of regulated products, in place
of post-marketing studies. It has carried this out for nine potential safety issues involving five products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis
of Real World Data. Real World Evidence can be generated by different study designs or analysis, including but not limited to, randomized
trials, including large simple trials, pragmatic trials, and observational studies (prospective and/or retrospective).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
traditional clinical trials, where necessary data elements can be curated and collection mandated, the creation of Real World Evidence
requires assessing, validating and aggregating various, often disparate, sources of data available through routine clinical practice.
Real World Evidence is used by different stakeholders in many different ways.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            gives life sciences companies insight into how their drugs are being used.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            helps providers improve the delivery of care.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            enables regulatory authorities to monitor post-market safety and adverse events.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
                                            helps payers assess outcomes from treatments.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>From
Real World Data to Real World Evidence</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
creation of Real World Evidence requires a combination of high-powered analytics, a validated approach and a robust knowledge of available
Real World Data sources (e.g., what data is captured within existing quality registries, what data can be captured through EHR
and case report forms or claims, and which patient organizations capture data on relevant patient cohorts). This process includes
several steps, which are summarized here:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defining
                                            a study protocol answering relevant clinical questions.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defining
                                            which data elements can be collected from which Real World Data sources.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishing
                                            data capture arrangements and protocols with existing Real World Data sources.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blending
                                            disparate data sources through probabilistic record matching algorithms.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Validating
                                            and supplementing blended data through editable eCRFs.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defining
                                            and calculating clinically relevant outcomes and measures.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
<tr style="vertical-align: top">
    <td style="width: 0.75in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
  <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appropriately assessing and
  controlling for variability in data quality, availability and confounding patient factors affecting measured outcomes.</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
                                            World Evidence can provide a holistic view of patients that in many cases cannot be studied
                                            through traditional clinical trials.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Evidence has been proven to fill a gap between research (what we learn) and everyday practice (what we do) in healthcare, and it
creates a difference between what is expected to happen and what really happens. Driving measurable improvements in healthcare requires
us all to be rooted in the reality of what actually happens before, during, and after clinical procedures, interventions, and office
visits. Real World Evidence fills those gaps and documents the truth by establishing definitively what really happens when doctors
treat a wide range of patients that do not look like the homogeneous patient groups in a clinical trial. Because of this, Real World
Evidence serves many uses and provides many benefits across the healthcare ecosystem.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
more countries battle to contain healthcare costs, and as the population ages and the number of patients with chronic diseases increases,
the need to remove inefficiencies and upgrade the delivery of coordinated care that improves outcomes is more pressing. At the same time,
life sciences companies are facing tumultuous times. Industry globalization, the end of the blockbuster era, and an increasingly complex
regulatory environment all add to the difficulty of bringing products to market. And across the board, companies are moving toward a
patient-centric and outcome-focused model. In this environment, Real World Evidence can be transformative for the industry when Real
World Data is combined with the right technology framework and the regulatory intelligence to make sense of it. As data is consumed across
life sciences in different ways and by different stakeholders, it can provide valuable insights and &#8220;evidence&#8221; across the
product life cycle. In addition, stakeholders across the healthcare ecosystem use this new knowledge to support decision-making and improve
safety and effectiveness, and ultimately, patient outcomes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Uses
of Real World Evidence in Life Sciences, Among Regulators, Clinicians, Researchers and Healthcare Systems</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to repeated studies by Deloitte, the importance of Real World Evidence continues to rise as it promises to accelerate regulatory decision-making
and support the approval of new indications for drugs already on the market. Life sciences, pharmaceutical and medical device
companies are significant consumers of Real World Evidence because it can provide value across the entire product lifecycle from pre-trial
design to clinical studies and trials to post-market surveillance. Medical product developers are using Real World Evidence to support
clinical trial designs (<i>e.g.</i>, large simple trials, pragmatic clinical trials) and observational studies to generate innovative,
new treatment approaches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Evidence can be used to make clinical trials more effective and efficient, for example in patient recruitment or label extension,
Real World Evidence gathered from other studies or from currently marketed products in a similar category, for example, can have a positive
effect on the product portfolio by exposing positive side effects as new potential indications. The most famous example is Viagra, which
was initially studied as a drug to lower blood pressure, but an unexpected side effect led to the drug ultimately being approved for
erectile dysfunction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
benefits of Real World Evidence derived from Real World Data are increasingly being recognized by regulatory authorities. The FDA released
a framework for using Real World Evidence to support the process of drug regulation and submission. This is a major step toward recognizing
that clinical trials, while still relevant, are not the only way to assess the efficacy and safety of a product. Indeed, the FDA is soon
expected to conduct its first full post-market safety approval using only Real World Evidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Evidence is now accepted as a reliable source of information for regulatory decision making in certain circumstances. A primary
rationale for the FDA to use Real World Evidence is to help support the approval of a new or extended use for a drug approved under the
FD&amp;C Act and to help support or satisfy post-approval study requirements always with the condition that the data quality is up to
the standard required. In a recent statement, the FDA even noted how new tools for capturing data in the post-market period, including
more sophisticated use of Real World Data and Real World Evidence are providing new approaches to address important questions about the
safety and benefits of new drugs in real world settings and that these approaches have the potential to do to so more rapidly and with
greater efficiency than traditional methods.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Why
Do We Need Real World Evidence?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> a gap between research (what we learn) and everyday
practice (what we do) in healthcare, and it creates a difference between what is expected to happen and what really happens. But it
is what really happens that matters. Driving measurable improvements in healthcare requires us all to be rooted in the reality of
what actually happens before, during, and after clinical procedures, interventions, and office visits. Real World Evidence is here to
fill those gaps and root us in truth. It tells us what really happens when doctors treat a wide range of patients that don&#8217;t look
like the homogeneous patient groups in a clinical trial. Because of this, Real World Evidence serves many uses and provides many benefits
across the healthcare ecosystem.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Uses
of Real World Evidence in Pharmaceutical and Device Companies</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmaceutical
and medical device companies are major consumers of Real World Evidence, as it can provide value across the entire product lifecycle.
Real World Evidence plays an important role for research across the product lifecycle for both pharmaceutical and device companies. It
can inform pre-trial study design by helping researchers identify potential patients and create proper inclusion criteria for clinical
trials. Much of medical innovation is driven by traditional clinical trials, where new pharmaceuticals and devices are rigorously studied
and tracked before they can be sold and widely distributed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
clinical trials are incredibly important to determine the safety and efficacy of new technologies, when compared to Real World Evidence,
they do have some limitations. For example, a traditional clinical trial can have strict inclusion criteria that makes
it challenging for providers to accurately extrapolate the results of a clinical trial to a broader population. Clinical trial participation
is often limited by who the study administrators are able to recruit, and various demographics are often not able to participate. This
again challenges the generalizability of clinical trial results across patient populations. Real World Evidence can help overcome
the limitations of clinical trials by providing information about a broader cross-section of society. This can help clinicians, researchers,
and industry partners better understand their products and how they work.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
a product is approved and marketed, Real World Evidence assists pharmaceutical or medical device companies understand their products&#8217;
relative safety, effectiveness, value, off-label use and more. This post-market surveillance, or post-marketing surveillance, is valuable
to stakeholders across the healthcare industry.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_015.jpg" alt="" style="width: 650px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
AI-enabled patient enrichment and recruitment process can improve suitable cohorts and increase clinical trial effectiveness, data management,
analysis, and interpretation of multiple Real World Data sources, including EHR and medical imaging data. This presents a unique
opportunity for NLP to perform the sophisticated analysis necessary to combine genomic data with electronic medical records (&#8220;<span style="text-decoration: underline">EMR</span>&#8221;)
and other patient data, present in various locations, owners, and formats&#8201;-&#8201;from handwritten paper copies to digital
medical images&#8201;-&#8201;to surface biomarkers that lead to endpoints that can be more efficiently measured, and thereby identify
and characterize appropriate patient subpopulations. AI-enabled systems can help to improve patient cohort composition and aid with patient
recruitment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
technologies can help biopharma companies identify target locations, qualified investigators, and priority candidates and collect and
collate evidence to satisfy regulators that the trial process complies with good clinical practice requirements. One of the most important
elements of a clinical trial is a selection of high-functioning investigator sites. Site qualities such as resource availability, administrative
procedures, and experienced clinicians with in-depth knowledge and understanding of the disease can shape study timelines and data quality,
accuracy, completeness, and consistency.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
integrated clinical trial programs can help monitor and manage patients by automating Real World Data capture, sharing data across
systems, and digitalizing standard clinical assessments. AI technologies and wearable technologies can help enable continuous patient
monitoring and generate real-time insights into the safety and effectiveness of treatment while predicting the possible risk of dropouts,
thereby enhancing patient engagement and retention. To comply with trial adherence criteria, patients must keep detailed records of their
medication intake and other data points related to their bodily functions, response to medication, and daily protocols. This can be an
overwhelming and tedious task, leading to 40% of patients becoming non-adherent after 150 days into a clinical trial. Wearable devices/sensors
and video monitoring are used to collect patient data automatically and continuously, thereby relieving the patient of this task. In
combination with wearable technology, AI techniques offer new approaches to developing real-time, power-efficient, mobile, and personalized
patient monitoring systems.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
regulators, clinicians, academic researchers and healthcare systems, the reliance on curated Real World Evidence has grown significantly
because of the value it can provide, which is unique relative to each parties&#8217; objectives and mandates. It also helps that the
FDA has also sharpened its focus on Real World Data and Real World Evidence. For example, in late 2022, the FDA published
proposed guidance related to data standards for product submissions with Real World Data and also weighed in on the use of Real World
Data and Real World Evidence to support regulatory decision-making for drugs and biological products with specific advice for data from
EHR and medical claims. In addition, the FDA uses Real World Data and Real World Evidence to monitor post-market safety and adverse
events and to make regulatory decisions. The health care community is using these data to support coverage decisions and to develop guidelines
and decision support tools for use in clinical practice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
with deep-learning capability is also helpful in organizing and translating a vast amount of structured and unstructured data to Real
World Evidence. The human mind can possibly manage 4-5 variables; therefore, AI-enabled data mapping and integration and their normalization
into a common data model according to disease pathway and workflow will likely be useful for both quality management in clinical trials
and generating meaningful insight for human disease by providing a broader perspective based on Real World data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market
Size</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
global Real World Evidence solutions market size was estimated at USD $2.6 billion in 2023 and is expected to grow at a compound annual
growth rate (CAGR) of 8.4% from 2024 to 2030. The market growth is driven by rising demand for enhanced Real World Evidence capabilities
within the life science industry, reflecting an increasing market shift from volume to value-based care. Advancements in data analytics
and Real World Evidence contribute to supporting regulatory compliance, research, and solution development efforts in medical device
and life sciences organizations. For instance, the increased demand for Real World Evidence solutions is prompting players to introduce
new products, fostering market growth. In October 2023, Maxis Clinical Sciences launched Real World Evidence Solutions, providing diverse
Real World Data capture and analysis to improve clinical research and care.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
initiatives supporting Real World Evidence programs, evolving regulations, and actionable Real World Data enable organizations to conduct
outcomes-based analyses, contributing to the overall market expansion. For instance, in December 2022, the FDA launched the Real World
Evidence Program. This program aims to raise awareness that Real World Evidence can support regulatory decisions, identify approaches
for generating Real World Evidence to meet post-approval study requirements or effectiveness labeling and develop agency processes that
foster consistent decision-making and shared learning regarding Real World Evidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_016.jpg" alt="" style="width: 650px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic further accelerated the adoption of Real World Evidence solutions, with governments collaborating with market players
to implement these solutions. For instance, in June 2021, ConcertAI and the FDA initiated a five-year collaborative research program,
<i>Evaluation of Real World Outcomes and Safety in the Treatment of Cancer</i>. The partnership leverages ConcertAI&#8217;s oncology
Real World Data and advanced AI technology solutions to generate Real World Evidence for various clinical and regulatory use cases.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real
World Evidence</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> solutions services allow pharmaceutical
companies and healthcare providers as well as payers by providing efficient management of operations and accelerating the
process of drug development and its approval, which fuels market growth. Support from regulatory bodies for using Real World Evidence
solutions and an increase in research and development spending are anticipated to boost the market growth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Real World Evidence solution providers are increasingly forming strategic partnerships with AI solution providers to offer integrated
solutions. For instance, in April 2023, ConcertAI, a player in AI SaaS technology and Real World Evidence solutions for healthcare and
life sciences, partnered with PathAI, an AI-powered pathology provider, to introduce a first-in-class quantitative histopathology and
curated clinical Real World Data solution. This collaboration integrates ConcertAI&#8217;s Patient360 and RWD360 products with PathAI&#8217;s
PathExplore tumor microenvironment panel.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Based
on end user, the global Real World Evidence solutions market is segmented into pharmaceutical, biotechnology, and medical device companies;
healthcare payers; healthcare providers; and other end-users (academic research institutions, patient advocacy groups, regulators, and
health technology assessment agencies). The large share of this segment is primarily attributed to the increasing importance of Real
World Evidence studies in drug development and approvals and the growing need to avoid costly drug recalls and assess drug performance
in Real World settings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the growing need for evidence generated from Real World Data, the increasing importance of epidemiological data in decision making, and
a shift from volume to value-based care, there has been an increased focus on patient registries, a rise in the adoption of EMR in hospitals,
and exponential growth in mobile health data and social media, which have resulted in the generation of huge amounts of medical data.
In 2021, the Real World datasets segment is estimated to account for the larger share of 51.2% of the global Real World
evidence solutions market. According to Coherent Market Insights, the global Real World Data market is estimated to be valued
at $1.59 billion in 2023 and is expected to exhibit a CAGR of 14.4% during the forecast period (2023-2030).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Long-Term Growth Strategies</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
long-term growth strategy is anchored on the following key pillars:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Increase
                                            Global Reach to Meet Demand</i></b><i>: </i>Our strategy is to continue growing our global
                                            footprint into areas where we expect high demand growth in the global Real World Evidence
                                            solutions market, which is projected to grow from $2.62 billion in 2024
                                            to $4.55 billion by 2030, at a CAGR of 8.2%. There is a rise in emphasis on
                                            evidence-based medicine that relies on Real World Evidence, which comes from Real World Data.
                                            Market players in healthcare industries, including regulators, healthcare providers, and
                                            payers are becoming more aware of the importance of using Real World Data for making informed
                                            decisions regarding comparative effectiveness, treatment effectiveness, cost-effectiveness,
                                            and safety. As a result, the demand for Real World Data solutions is increasing rapidly,
                                            which is further driving the growth of the market. Regulatory agencies such as EMA
                                            and the FDA are making use of Real World Evidence in regulatory decision making processes.
                                            These regulatory authorities have frameworks and guidelines for using Real World Evidence
                                            and Real World Data in regulatory submissions, post-market surveillance, and drug approvals.
                                            As a result, the demand for Real World Data is rising, which in turn is expected to
                                            support growth of the market in the coming future.17 The use of Real World Evidence derived
                                            from Real World Data demonstrates value and cost-effectiveness of medical devices and drugs
                                            for healthcare technology assessment agencies and payers. With this Real World Evidence,
                                            market access becomes easier, and it also enables reimbursement negotiations. This further
                                            facilitates the inclusion of new therapies in the coverage of healthcare, which in
                                            turn creates major opportunities in the global market.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Innovate
                                            Our Commercial Approach to Drive Incremental Market Share</i></b><i>: </i>We intend to expand
                                            our sales network across the globe, while simultaneously building out our sales infrastructure.
                                            We intend to focus on our target markets, which include (i) Imaging AI; (ii) medical device
                                            companies; and (iii) pharmaceutical companies, as summarized here:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><img src="forms-1_017.jpg" alt="" style="width: 650px"/></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Enhance
                                            and Refine Our Service Offering: </i></b>Building on our customer-centric mindset throughout
                                            our development, curation and commercial processes, we plan to continue expanding and improving
                                            our service offering. As we continue to expand into additional geographies globally, we plan
                                            to build upon these three pillars:</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1_018.jpg" alt="" style="width: 650px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Expand
                                            Our Product Offering: </i></b>We plan to continually evaluate the benefits of expanding our
                                            portfolio into other high-growth, high-demand Real World Data and Real World Evidence solutions
                                            in the future<i>.</i></span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
Proceedings</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be subject from time to time to various claims, lawsuits and other legal and administrative proceedings arising in the ordinary course
of business. Some of these claims, lawsuits and other proceedings may involve highly complex issues that are subject to substantial uncertainties,
and could result in damages, fines, penalties, non-monetary sanctions or relief. We are not presently party to any legal proceedings
that, in the opinion of management, if determined adversely to us, would individually or taken together have a material adverse effect
on our business, operating results, financial condition, or cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to recognize provisions for claims or pending litigation when we determine that an unfavorable outcome is probable, and the amount
of loss can be reasonably estimated. Due to the inherent uncertain nature of litigation, the ultimate outcome or actual cost of settlement
may materially vary from estimates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Corporate
Information</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
Knights was</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> originally incorporated in Delaware
on February 8, 2021 under the name &#8220;Data Knights Acquisition Corp.&#8221; as a special purpose acquisition company, formed for
the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses. On November 7, 2023, we held the Closing of the Business Combination whereby Merger Sub merged with
and into Legacy ONMD, with Legacy ONMD continuing as the surviving entity, which resulted in all of the issued and outstanding
capital stock of Legacy ONMD being exchanged for shares of the Company&#8217;s Common Stock, upon the terms set forth in the Merger
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination that closed on November 7, 2023, pursuant to the Merger Agreement, led to Data Knights changing its name
to &#8220;OneMedNet Corporation&#8221; and the business of Data Knights became the business of Legacy ONMD. We are located
at 6385 Old Shady Oak Road, Suite 250, Eden Prairie, MN 55344 and reachable by telephone on 800-918-7189.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legacy
ONMD was</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> incorporated in the State of Delaware on
November 20, 2015. Its wholly-owned subsidiary, ONMD Canada, was incorporated on October 16, 2015 under the provisions
of the Business Corporations Act of British Columbia. ONMD Canada&#8217;s functional currency is the Canadian dollar.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government
Regulation</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
aspects of our businesses are regulated by federal and state laws, rules and regulations. Accordingly, we maintain a robust compliance
program aimed at ensuring we operate our business in compliance with all existing legal requirements material to the operation of our
businesses. There are, however, occasionally uncertainties involving the application of various legal requirements, the violation of
which could result in, among other things, fines or other sanctions. See &#8220;Risk Factors&#8221; for additional detail.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regulation
of Patient Information</i></b>. Our information management services relate to the processing of information regarding patient diagnosis
and treatment of disease and are, therefore, subject to substantial governmental regulation. In addition, the confidentiality of patient-specific
information and the circumstances under which such patient-specific records may be released for inclusion in our databases or used in
other aspects of our business is heavily regulated. Federal, state and foreign governments are contemplating or have proposed or adopted
additional legislation governing the possession, use and dissemination of personal data, such as personal health information and personal
financial data, as well as security breach notification rules for loss or theft of such data. Additional legislation or regulation of
this type might, among other things, require us to implement additional security measures and processes or bring within the legislation
or regulation deidentified health or other data, each of which may require substantial expenditures or limit our ability to offer some
of our services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
particular, personal health information is recognized as a special, sensitive category of personal information, subject to additional
mandatory protections. Violations of data protection regulations are subject to administrative penalties, civil money penalties and criminal
prosecution, including corporate fines and personal liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
Privacy</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of our operations are subject to regulation under the administrative simplification provisions of the Health Insurance Portability and
Accountability Act of 1996, as amended (&#8220;<span style="text-decoration: underline">HIPAA</span>&#8221;). Federal regulations related to HIPAA contain minimum standards for
electronic transactions and code sets and for the privacy and security of protected health information.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Patient health information is among the most sensitive of personal information, and it is critically important that information about
an individual&#8217;s healthcare is properly protected from inappropriate access, use and disclosure. Real World Evidence&#8201;-&#8201;information
that allows us to examine actual practices and outcomes&#8201;-&#8201;is essential to increase access to care, improve outcomes,
and lower costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information
on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed
for better outcomes. We employ a wide variety of methods to manage privacy requirements, including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">governance,
                                            frameworks, models and training to promote good decision making and accountability;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            layered approach to privacy and security management to avoid a single point of failure;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ongoing
                                            evaluation of privacy and security practices to promote continuous improvement;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">use
                                            of technical, administrative, physical and organizational safeguards and controls;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaboration
                                            with data suppliers and trusted third parties for our syndicated market research and analytics
                                            offerings to remove identifiable information or employ effective encryption or other techniques
                                            to render information non-identified before data is delivered to us; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">work
                                            with leading researchers, policy makers, thought leaders and others in a variety of fields
                                            relevant to the application of effective privacy and security practices, including statistical,
                                            epidemiological and cryptographic sciences, legal, information security and compliance, and
                                            privacy.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have relied on expertise in the industry with de-identifying data. Our capabilities allow us to render data non-identified while still
maintaining data utility, thus protecting privacy while still advancing innovation. Not only do we make use of de-identification techniques
with respect to the data we hold, but we also share our expertise in this area with policymakers, regulators and others to help them
understand de-identification methodologies and practical considerations to avoid re-identification risk. We operate in more than 100
countries around the world, many of which have data protection and privacy laws and regulations based on similar core principles (e.g.,
openness, accountability, security safeguards, etc.). We apply those principles globally and augment our practices to address local laws,
contractual obligations and other data privacy requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compliance team, led by our Chief Compliance Officer, is comprised of privacy professionals and privacy law experts who drive our strategy
and develop and manage our policies and standards. The Compliance team provides subject matter expertise related to the proper management
of all data types.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> In addition, our Compliance team
liaises with our Legal, Information Technology, Information Security and other teams so that privacy requirements are addressed
in technology, contracting, offerings and other business activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
OneMedNet Privacy Policy is our foundational privacy policy. It explains how, when applicable, we collect, hold, use and disclose
personal information, including that of our personnel, consumers, healthcare professionals, patients, medical research subjects, clinical
investigators, customers, suppliers, vendors, business partners and investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulatory
Quality Compliance (FDA 21 CFR Part 11)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
provides high-quality, de-identified, regulatory-grade imaging and clinical data; as such OneMedNet adheres to all applicable local and
Federal regulatory quality requirements, including but not limited to FDA 21 CFR Part 11. OneMedNet maintains a rigorous and ongoing
internal quality management system to enable the organization to produce high quality regulatory compliant clinical data for our
clients and consumers. This program includes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ongoing
                                            internal audits, policy reviews, and procedure testing to ensure validation, audit trails,
                                            legacy systems, and record handling and retention adhere to the latest regulatory guidelines
                                            and best practices; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regular
                                            third-party or client-initiated external audits to assess the compliance of OneMedNet to
                                            ensure operations are in accordance with the applicable regulations, standards, policies,
                                            and standard operating procedures.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Human
Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
workforce is comprised of approximately 20 employees (as of December 31, 2023), including approximately 0 part-time employees (references
herein to &#8220;employees&#8221; include to the employees of our subsidiaries). Our Board of Directors and its committees oversee human
capital matters through regular reporting from management and advisors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Diversity,
Equity and Inclusion</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are committed to fostering a culture of inclusion that embraces and supports our patients, colleagues, partners, physicians and communities.
Our policies prohibit discrimination on the basis of age, gender, disability, race, color, ancestry, citizenship, religion, pregnancy,
sexual orientation, gender identity or expression, national origin, medical condition, marital status, veteran status, payment source
or ability, or any other basis prohibited by federal, state or local law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
and Benefits</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
provide competitive compensation and benefits programs to help meet the needs of our employees. In addition to salaries, these programs
(which vary by location of the employee) include a 2022 Stock Option Plan, health care and insurance benefits, health savings and flexible
spending accounts, paid time off, family leave, family care resources, and employee assistance programs, among many others.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Closing of the Business Combination, the Company&#8217;s executive offices were located at Unit G6, Frome Business Park,
Manor Road, Frome, United Kingdom, BA11 4FN and its telephone number was +44 203 833 4000. The Company agreed to pay ARC Group Ltd.,
an affiliate of the Sponsor, up to an amount of $10,000 per month for office space, secretarial and administrative support. For the
years ended December 31, 2023 and 2022, we had incurred $90,000 and $120,000 in fees under this agreement, respectively.
Upon completion of our Business Combination, the Company ceased paying these monthly fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
the Closing of the Business Combination, our headquarters is located at 6385 Old Shady Oak Road, Suite 250, Eden Prairie, MN 55344
and our telephone number is (800) 918-7189, where we lease and occupy our office space with an aggregate floor area of approximately
67 square feet from unrelated third parties under operating lease agreements. We believe our current office space is adequate
for our current operations and our anticipated future needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cybersecurity</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
manages cybersecurity and data protection through a continuously evolving framework, as described in further detail below. The framework
allows us to identify, assess and mitigate the risks we face, and assists us in establishing policies and safeguards to protect our systems
and the information of those we serve. Our cybersecurity program is managed by James Wang, our Chief Technology Officer. James holds
a degree in computer science from the University of Hawaii at Manoa and has 19 years of development experience focused on architecture
and security. In his career, he has led initiatives for companies to attain SOC2 compliance and PCI compliance for their product solutions.
The Audit Committee of the Board of Directors has oversight of our cybersecurity program and is responsible for reviewing and assessing
the Company&#8217;s cybersecurity and data protection policies, procedures and resource commitment, including key risk areas and mitigation
strategies. As part of this process, the Audit Committee receives regular updates from the Chief Technology Officer on critical issues
related to our information security risks, cybersecurity strategy, supplier risk and business continuity capabilities. The Company&#8217;s
framework includes an incident management and response program that continuously monitors the Company&#8217;s information systems for
vulnerabilities, threats and incidents; manages and takes action to contain incidents that occur; remediates vulnerabilities; and communicates
the details of threats and incidents to management, including the Director Product Management, Head of Data, as deemed necessary or appropriate.
Pursuant to the Company&#8217;s incident response plan, any incidents are to be reported by the Chief Technology Officer to the Audit
Committee, appropriate government agencies and other authorities, as deemed necessary or appropriate, considering the actual or potential
impact, significance and scope. The Company is not aware of any previous cybersecurity incidents or threats that are reasonably likely
to materially affect its business strategy, results of operations, or financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
employ an array of data security technologies, processes, and methods across our infrastructure to protect systems and sensitive information
from unauthorized access. OneMedNet maintains comprehensive identity and access management practices (e.g., roles and access privileges
for each user; multi-factor authentication, privileged user accounts, single sign-on, user lifecycle management) and employs a variety
of security information and event management tools. We developed, maintained and utilized a global integrated information security framework
to guide our practices, based on relevant industry frameworks and laws, including, but not limited to NIST, GxP, HITRUST, the ISO 27000
family, COBIT, GDPR, and HIPAA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
framework consists of policies, standards, procedures, work instructions and documentation. Information is classified into four categories
to help individuals apply the right level of controls and safeguards to information, applications and systems. Our cybersecurity program
focuses on all areas of our business, including cloud-based environments, data centers, devices used by employees and contractors, facilities,
networks, applications, vendors, disaster recovery / business continuity and controls and safeguards enabled through business processes
and tools. We continuously monitor for threats and unauthorized access.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
draw on the knowledge and insight of external cybersecurity experts and vendors, and our Chief Technology Officer&#8217;s experience
in building solutions that are secure and compliant with our information security framework. OneMedNet leverages an array of security
services and tools to secure OneMedNet information infrastructure and protect systems and information from unauthorized access. OneMedNet&#8217;s
products and solutions, including 3rd party software and services such as hosted cloud based platforms are monitored by a healthcare
cloud, security and compliance organization that provides a real-time dashboard to monitor for potential threats and vulnerabilities.
Non-technical safeguards also play an important role in our cybersecurity program. We provide various training programs and tools to
employees so they can avoid risky practices and help us promptly identify potential or actual issues. We also have global incident response
procedures, global service tools to log incidents and issues for investigation, and an ethics line to report concerns and follow up on
matters already reported. The Compliance team, led by our Chief Technology Officer, develops and implements our strategy, as well as
monitors systems and devices for risks and threats.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_013"></span>MANAGEMENT</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
concerning our executive officers and members of our Board of Directors as of the date hereof is set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 24%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 4%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 68%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title/Position</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Green</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer, President and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Golden</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Financial Officer, Corporate Secretary and Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Jeffrey Yu</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founder,
    Chief Medical Officer, Vice President, Chairman of the Board of Directors</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    Casaburi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jair
    Clarke</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sherry
    Coonse McCraw</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Thomas Kosasa</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">79</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Zeinfeld</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aaron
Green, Chief Executive Officer, President and Director</b>&#8201;&#8212;&#8201;Mr. Green is a healthcare IT business transformation
leader with more than 20 years of leadership experience in healthcare management, sales, strategic planning, M&amp;A, product development,
customer support and services operations. Mr. Green has served as OneMedNet&#8217;s Chief Executive Officer and a Director since March
2024 and President since May 2023. Prior to joining OneMedNet, Mr. Green served in a variety of healthcare technology roles including
most recently at Optum, a United Health Group company (NYSE: UHG), a leading healthcare technology company, as Vice President Cloud Solutions.
At Optum, Mr. Green was responsible for developing and attaining the P&amp;L, Bookings, Revenue and EBIDTA targets of its Cloud Solution
lines. Before Optum, Mr. Green worked nearly six years, from March 2017 to May 2023, with Change Health Care, most recently as Vice President
Cloud Solutions from March 2021 to May 2023. Previously, Mr. Green worked for more than 15 years with McKesson growing to Division Vice
President, Sales where he led an organization of 50+ executives, salespersons and staff, across the US, Canada, and the US government
territories. He holds a Bachelor of Science in Biochemistry from the University of Victoria, British Columbia, a Systems Analyst Diploma
from Royal Roads University, British Columbia, and an Executive MBA from the Wharton School. We believe Mr. Green is well-qualified to
serve as a member of our Board of Directors due to his experience as a public company executive and healthcare IT leader.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Robert
Golden, Chief Financial Officer, Corporate Secretary, and Director</b> &#8212; Mr. Robert (Bob) Golden is an accomplished Certified
Public Accountant (&#8220;<span style="text-decoration: underline">CPA</span>&#8221;) with more than 30 years of experience. Mr. Golden has served as OneMedNet&#8217;s Interim
Chief Financial Officer since August 2024 and Corporate Secretary since September 2024 and a member of the Board of Directors since November
2023. Mr. Golden also serves as the Managing Partner of Cohen, Bender &amp; Golden LLP, where he provides consulting, accounting and
tax services to middle market businesses and owners since September 2015. Prior to that, from January 2013 to August 2015, Mr. Golden
worked at Fenton &amp; Ross Accountancy Corporation and, from September 2004 to December 2012, at Saffer &amp; Flint Accountancy Corporation.
From December 1989 to June 2004, Mr. Golden was at Good Swartz Brown &amp; Berns LLP (now CohnReznick) (&#8220;<span style="text-decoration: underline">GSBB</span>&#8221;), where
he served as a partner from 1994 onwards. There, Mr. Golden performed administrative duties, including overseeing the company&#8217;s
merger negotiations in 2000 and performed financial statement audits, reviews and income tax planning for middle market businesses and
owners. While at GSBB and continuing today, Mr. Golden consults with his business clients to assist their entrepreneurial owners to better
understand the financial performance of their businesses and to help them improve operational efficiencies and profitability by acting
as their outside CFO. Bob also assists with structuring and negotiating financing, compensation planning, investment opportunity review,
as well as merger and acquisition activities and works with wealthy families acting in a CFO-type role for their family office activities.
After leaving GSBB in 2004, in addition to continuing to provide consulting services to middle-market companies, Bob was the owner and
CEO of several companies in the construction and engineering field, coffee and baked goods industries and also syndicated commercial
real estate acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
September 1984 to December 1989, Mr. Golden was a CPA at Ernst &amp; Young in Los Angeles. Apart from his experience as a CPA, Mr. Golden
is currently the Chief Financial Officer of Promo Shop, Inc. &amp; Subsidiaries, a specialty advertising promotional products multi-office
distributor based in Los Angeles. Mr. Golden establishes the company&#8217;s annual budget among other duties and has been in this role
since January 2008. Mr. Golden is also currently the Chief Financial Officer at iKahan Media, Inc., an out of home media company specializing
in digital and traditional billboards and advertisement, where he has served since September 2014. Mr. Golden is a member of the Board
of Directors of Talon International, Inc. (OTCMKTS: TALN), the world&#8217;s oldest and largest zipper manufacturer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
1984, Mr. Golden received his Bachelor of Science degree in Business Administration from the University of Southern California. Mr. Golden
also holds a Certified Public Accountant certification from the California Board of Accountancy, is an Investment Advisor Representative
with the SEC and is a Licensed Engineering Contractor with the California Contractors State License Board. We believe Mr. Golden is well-qualified
to serve as a member of our Board of Directors due to his extensive experience as a Certified Public Accountant at numerous firms as
well as his experience as an executive officer at multiple companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Jeffrey Yu, Founder, Chief Medical Officer, Vice President, Chairman of the Board</b>&#8201;&#8212;&#8201;Dr. Yu serves as the Chief
Medical Officer, Vice President and Chairman of the Board of Directors of OneMedNet, roles he has held since 2023. The concept of what
would become Legacy OneMedNet was founded in 2015 by Dr. Yu, who applies his 28 years of sophisticated healthcare IT experience to the
Company every day. Dr. Yu is a board-certified Radiologist and is also fellowship-trained and board-certified in Nuclear Medicine. In
2006, he was part of a small group that recognized there was a need to develop electronic sharing technology to help imaging specialists
move patient imaging studies quickly, securely, and cost-effectively. Dr. Yu&#8217;s early research and development led to the BEAM solution
which helped improve care and outcomes for stroke and trauma patients. In 2015, he started the concept of what would become Legacy ONMD
to commercialize the BEAM product. Since that time, Dr. Yu has remained an integral part of the strategic decision-making within OneMedNet.
Dr. Yu received his B.S. at U.C. Berkeley and his M.D. at Wake Forest University, conducted MRI research at Stanford University, and
completed his Radiology residency and Nuclear Medicine fellowship at the Mallinckrodt Institute at Washington University. We believe
Dr. Yu is well-qualified to serve as a member of our Board of Directors due to his extensive healthcare IT experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
background information of Aaron Green, Robert Golden, and Dr. Jeffrey Yu is set forth under &#8220;Executive Officers&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eric
Casaburi, Director</b>&#8201;&#8212;&#8201;Eric Casaburi is an experienced entrepreneur and chief executive officer with a successfully
demonstrated history of explosive growth in the franchising, health and wellness, food services, and real estate industries including
founding and leading RetroFitness from a start-up single-gym business to a $150 million per year in sales operation while expanding its
national footprint. Mr. Casaburi has founded and held positions as chief executive officer for multiple franchise brands, each having
successful exits with impressive returns for investors and private equity partners. Since 2021, Mr. Casaburi has served as founder and
Chief Executive Officer of Serotonin Enterprises LLC, a cutting edge Anti-Aging Health Optimization Franchise that offers a vast service
menu covering all aspects of optimal health, appearance and performance. Serotonin Centers have been featured in the Franchise Times
as the first franchise of its kind in the United States. Since 2019, Mr. Casaburi has served as the Chair of TIGER 21 Orlando, a group
of men and women who have achieved both success and significance in their lives that helps members build the skill set to successfully
transition from focused entrepreneurs to disciplined managers of wealth.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2020, Mr. Casaburi has founded and operated Longevity Brands and since 2016, Mr. Casaburi founded and owns CEVD Holdings, a commercial
real estate investment and management company. Mr. Casaburi developed all sales, operations, and marketing systems for both the RetroFitness
fitness centers and the franchise and designed and implemented a diversified reoccurring revenue model to improve business health and
value. Mr. Casaburi also founded and served as the Chief Executive Officer of Lets YO! Yogurt from 2012-2015, a self-serve yogurt and
treats restaurant popularized through social media savvy, in which he franchised the business model and opened 24 restaurants in the
first year and led to a successful exit to an industry private equity firm. We believe Mr. Casaburi is well-qualified to serve as a member
of our Board of Directors due to his experience successfully founding and growing companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jair
Clarke, Director</b>&#8201;&#8212;&#8201;Jair Clarke is the Chairman&#8217;s Executive Advisor and board advisor of World Wide Technology
($20B company) and the CEO/Chief AI Officer of Laigic, an A.I. and tech advisory firm of C-level Fortune 15 consultants and physicians,
where he has served since November 2023. From August 2020 until July 2023, Mr. Clarke served as the Global Chief Technology Officer of
Commercial Systems at Microsoft Corporation, where he was responsible for commercial systems, artificial intelligence, and products across
all industries for Customers and Partner Solutions. Within this organization, Mr. Clarke was responsible for all technology and processes
at scale to empower customers, partners, sellers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
2014 through 2020, Mr. Clarke was responsible for Disney&#8217;s big data, digital analytics, and strategy technologies supporting the
Chief Commercial Officer to influence traditional/non-traditional monetization, products, and experiences such as mobile apps, wearable
devices, and e-commerce. Mr. Clarke was a leader for IBM&#8217;s Watson, held a U.S. Top Secret SCI Full Scope Polygraph security clearance,
oversaw all technical capabilities for the United States counter-narcotics command partnering with various government agencies (e.g.
CIA, FBI), increased business revenue by 800% within 2 years, and consistently doubled annual revenue. He&#8217;s had global P&amp;L
responsibility and held roles as the executive champion of diversity and inclusion. From 2007 to 2014, Mr. Clarke was an IT &amp; Business
Development Executive at IBM. From 2005 to 2007, Mr. Clarke consistently expanded his technology responsibilities at Lockheed Martin.
Jair has served as a member of the board of directors of the publicly traded company Xponential Fitness (NYSE: XPOF) since July 2022.
Mr. Clarke holds a B.B.A. degree in computer information systems from the University of Miami. We believe Mr. Clarke is well-qualified
to serve as a member of our Board of Directors due to his experience in technology, business and operations roles concentrated in product
management, digital transformation, digital marketing, cybersecurity, data science, emerging technology, business architecture, customer
experiences and worldwide innovation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sherry
Coonse McCraw, Director</b>&#8201;&#8212;&#8201;Sherry McCraw has 30 years of leadership experience in engineering, finance, project
management, and manufacturing at BMW Manufacturing Co., LLC (&#8220;<span style="text-decoration: underline">BMW</span>&#8221;). Ms. McCraw has served as a Senior Manager responsible
as Chief Financial Officer, Vice President of Assembly Manufacturing, and currently holds the role of Vice President of Human Resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
McCraw began her career with BMW in 1993 with responsibilities for the facility&#8217;s Testing and Finish operation. Over the next eight
years, she played a key role in various aspects of assembly production, planning, engineering, and technology steering. In 2001, Ms.
McCraw served as the project manager in Munich, Germany to manage the structural planning for the second-generation BMW X5. In 2004,
she returned to Spartanburg, South Carolina as the Planning Manager of Assembly and Technology Steering. In 2007, Ms. McCraw managed
the plant&#8217;s 1.2 million square foot expansion of its second assembly hall in preparation to produce the BMW X3. In 2011, she was
selected to lead BMW&#8217;s largest single investment of $900 million to expand the plant for the fifth time in BMW&#8217;s history.
In 2013, Ms. McCraw was named Chief Financial Officer and Vice President Finance of BMW. From March 2018 to April 2022, she was appointed
to lead both production halls in her role as Vice President of Assembly Manufacturing. Since April 2022, Ms. McCraw has served as the
Vice President of Human Resources at BMW. Ms. McCraw currently serves on the Board of Directors for the North Carolina Textile Foundation.
She has a Bachelor of Science in Textile Engineering from North Carolina State University. We believe Ms. McCraw is well-qualified to
serve as a member of our Board of Directors due to her senior leadership experience in financial roles at a large company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr.
Thomas Kosasa, Director</b>&#8201;&#8212;&#8201;Dr. Thomas Kosasa is a renowned Ob/Gyn/Fertility specialist at the Pacific In Vitro
Fertilization Institute and serves on the Board of Trustees of Pan Pacific Surgical and as a professor of reproductive endocrinology
at the University of Hawaii, John A. Burns School of Medicine. Dr. Kosasa is a consultant for Maternal and Reproductive Health for the
Food and Drug Administration and a past member for the Hawaii State Board of Medical Examiners and the Food and Drug Administration.
Dr. Kosasa is a retired Major in the United States Army and was the Chief of Gyn-Surgical Service and the Director of the Infertility
Division at Martin Army Hospital in Fort Benning, Georgia. Dr. Kosasa graduated from Dartmouth College and earned his medical degree
at the McGill University School of Medicine. He completed his residency in obstetrics and gynecology and fellowship in reproductive endocrinology
at Harvard Medical School in the Boston Hospital for Women and completed a Reproductive Endocrinology Fellowship at the Peter Bent Brigham
Hospital, Harvard Medical School. Dr. Kosasa&#8217;s professional societies include American College of Obstetricians and Gynecologists,
American Fertility Society, Board of Trustees, Pan Pacific Surgical Association, Hawaii Medical Association and Pacific Coast Obstetrical
and Gynecological Society. We believe Dr. Kosasa is well-qualified to serve as a member of our Board of Directors due to his extensive
experience in the medical field.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Andrew
Zeinfeld, Director</b>&#8201;&#8212;&#8201;Andy Zeinfeld has over 30 years of public and private sector senior management experience
across a variety of industries, including retail, online, telecom, distribution and real estate. In addition to managing these various
businesses, Mr. Zeinfeld also developed strategies to drive profitable growth both organically and through mergers and acquisitions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
June 2019, Mr. Zeinfeld has been the managing partner of several LLCs that manage his real estate developments and investment portfolio.
From November 2019 through March 2023, Mr. Zeinfeld served as the Chief Executive Officer of Sunstrike International Ltd., a leading
distributor of second life refurbished mobile devices and trade-in solutions within the circular economy. From 2013 through 2018, Mr.
Zeinfeld also worked at Brightstar Corp. (n/k/a Likewize), an end-to-end mobile device management solutions company, where he served
in various roles of increasing responsibility. We believe Mr. Zeinfeld is well-qualified to serve as a member of our Board of Directors
due to his senior management experience in both the public and private sector.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delinquent
Section 16(a) Reports</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our executive officers, directors, and people who own more than 10% of a registered class of our equity
securities to file an initial report of ownership (on a Form 3) and reports on subsequent changes in ownership (on Forms 4 or 5) with
the SEC by specified due dates. Our executive officers, directors, and greater-than-10% stockholders are also required by SEC rules to
furnish us with copies of all Section 16(a) forms they file. As a matter of practice, our staff assists our executive officers and directors
in preparing initial ownership reports and reporting ownership changes, and typically files those reports on their behalf. We are required
to disclose in this proxy statement any failure to file any of these reports on a timely basis. Based solely on our review of the copies
of the forms filed electronically with the SEC, and on written representations from certain reporting persons, we believe that all of
these requirements were satisfied during the year ended December 31, 2023, except for the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Reports of Ownership on Form 3 for the following individuals:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erkan
    Akyuz, upon his appointment as a director of the Company on November 7, 2023 in connection with the closing of the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    Casaburi, upon his appointment as a director of the Company on November 7, 2023 in connection with the closing of the Business Combination;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa
    Embree, upon her appointment as an executive officer of the Company on November 7, 2023 in connection with the closing of the Business
    Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Golden, upon his appointment as a director of the Company on November 7, 2023 in connection with the closing of the Business Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Green, upon his appointment as an executive officer of the Company on November 7, 2023 in connection with the closing of the Business
    Combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R.
    Scott Holbrook, upon his appointment as a director of the Company on November 7, 2023 in connection with the closing of the Business
    Combination; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Jeffrey Yu, upon his appointment as an executive officer and director of the Company on November 7, 2023 in connection with the closing
    of the Business Combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics and Business Conduct Policy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a written code of ethics and business conduct policy (&#8220;<span style="text-decoration: underline">code of ethics</span>&#8221;) in place that applies to all the Company&#8217;s
directors, officers and employees, including the Company&#8217;s principal executive officer, principal financial officer, principal
accounting officer or controller, or persons performing similar functions. A copy of our code of ethics is available on our website at
https://www.onemednet.com/investor-relations/. We intend to use the Investor Relations section of our website as a method of disclosing
any change to, or waiver from, our code of ethics as permitted by applicable SEC and Nasdaq rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Committee</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors has a separately-designated standing Audit Committee. The Audit Committee operates under a written charter adopted
by the Board of Directors. A copy of the Audit Committee Charter is available under Corporate Governance on the Investor Relations page
of the Company&#8217;s website at https://www.onemednet.com/investor-relations/.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Audit Committee are Sherry Coonse McCraw, Jair Clarke, and Dr. Thomas Kosasa. Ms. Coonse McCraw serves as the Chair of
the Audit Committee. Our Board of Directors has determined that each of the directors serving on our Audit Committee is independent within
the meaning of the rules of the Nasdaq Stock Market LLC (the &#8220;<span style="text-decoration: underline">Nasdaq Rules</span>&#8221;) and Rule 10A-3 under the Exchange Act
and meet the requirements for financial literacy under the Nasdaq Rules. In addition, our Board of Directors has determined that Ms.
Coonse McCraw qualifies as an &#8220;audit committee financial expert&#8221; within the meaning of SEC regulations and applicable Nasdaq
Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_014"></span>EXECUTIVE
AND DIRECTOR COMPENSATION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023
Summary Compensation Table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the total compensation earned for services rendered during the years shown by our named executive officers
as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Name
    and principal position</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Year</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
                                            awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
                                            awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            other compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
                                            Casey</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
                                            Chief Executive Officer<sup>(1)</sup></span></p></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">144,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">180,250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">324,250</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">84,545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">240,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">60,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">384,545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
                                 Green</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
                                            and Chief Executive Officer<sup>(2)</sup></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">213,512</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">213,512</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa
                                 Embree</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
                                            Chief Financial Officer<sup>(3)</sup></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">225,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">275,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">106,250</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">132,300</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">27,231</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">265,781</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debra
                                 Reinhart</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former
                                            Clinical Application/ Product Analyst<sup>(4)</sup></span></p></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">220,074</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">220,074</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">163,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">54,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">&#8212;</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">246,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Casey served as a consultant to the Company from January 2022 through May 31, 2022, and then as Chief Executive Officer through his
    retirement in March 2024. Amounts for stock awards represents excess compensation expense for previously granted awards, which were
    cancelled in connection with the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Green has served as President since May 2023 and as Chief Executive Officer since March 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Embree served as a consultant from January 2022 through April 15, 2022, and then as Chief Financial Officer until her resignation
    in August 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Reinhart separated from the Company in October 2023.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Employment Arrangements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination, the Company entered into employment agreements with certain executive officers:
Aaron Green, Lisa Embree, and Paul Casey. The employment agreements provide for at-will employment that may be terminated by the Company
with or without cause, by the executive with or without good reason, or mutually terminated by the parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
employment agreement for Mr. Green provides for a $350,000 annual base salary, eligibility to receive an annual cash performance bonus
of up to $175,000 upon achievement of certain performance goals, and eligibility to receive additional shares under the Company&#8217;s
equity plan, subject to approval by the Board of Directors. In the event that his employment is terminated by the Company without Cause
(as defined in the employment agreement), or is terminated by Mr. Green for Good Reason (as defined in the employment agreement), after
six months of employment, and he signs and does not revoke a standard release of claims with the Company in a form reasonably satisfactory
to the Company&#8217;s Board of Directors (a &#8220;<span style="text-decoration: underline">Release</span>&#8221;), which Release becomes irrevocable no later than sixty (60)
days (the &#8220;<span style="text-decoration: underline">Release Deadline</span>&#8221;), after the date of his termination of employment (the &#8220;<span style="text-decoration: underline">Termination Date</span>&#8221;)
he will be entitled to the following severance payment, as follows: (a) if the Termination Date is after six (6) months&#8217; of employment,
but before he has completed 12 months&#8217; of employment, he will receive three months&#8217; salary; and (b) if the Termination Date
is after 12 months&#8217; employment he will receive six months&#8217; salary. If the Release does not become effective and irrevocable
by the Release Deadline, he will forfeit any right to severance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
employment agreement for Ms. Embree provided for a $225,000 annual base salary, eligibility to receive an annual cash performance bonus
of twenty-five percent (25%) of her annual salary upon her achievement of certain performance goals, and eligibility to receive additional
shares under the Company&#8217;s equity plan, subject to approval by the Board of Directors. In connection with her separation from the
Company, Ms. Embree received one month&#8217;s salary, the continuation of all her benefits for one month, and the ability to vest one-third
of her prior equity awards (such portion equal to 86,667 shares) on the one-year anniversary of the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
employment agreement for Mr. Casey provided for $144,000 annual salary, eligibility to receive 147,000 shares of stock upon the successful
fundraising of an amount equal to or greater than $5,000,000 and further equity subject to the approval of the Board of Directors. On
March 22, 2024, Mr. Casey notified the Company of his intention to retire as Chief Executive Officer of the Company effective March 29,
2024. Effective October 1, 2024, Mr. Casey resigned from the Board of Directors and the Compensation Committee of the Board of Directors.
In connection with Mr. Casey&#8217;s retirement, Mr. Casey and the Company entered into a Resignation Agreement and Release, dated March
22, 2024, pursuant to which Mr. Casey was paid $12,000 as a severance payment, and the Board of Directors approved a stock option grant
providing for the grant of 147,000 five-year options exercisable at $1.00 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023
Outstanding Equity Awards at Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the named executive officers had outstanding equity award as of December 31, 2023. All outstanding equity awards during 2023 were
converted or terminated in connection with the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
compensation was paid to our Board of Directors for services through December 31, 2023 following the closing of the Business Combination.
Any outstanding equity awards at the time of the Business Combination were converted or terminated in connection with the Business Combination.
The Company reimburses all of its directors for all reasonable out-of-pocket expenses incurred in connection with attendance at meetings
of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2024, the Board adopted a revised director compensation policy (the &#8220;<span style="text-decoration: underline">Director Compensation Policy</span>&#8221;). The Director
Compensation Policy provides for the annual automatic grant of 45,000 shares of common stock to each director for each full year of service.
Such grants will occur annually at year end of the one-year anniversary thereafter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_015"></span>CERTAIN
RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of certain transactions, arrangements and relationships in which we were a participant since January 1, 2022
and the amount involved exceeded or will exceed $120,000, and in which any of our executive officers, directors or holders of more than
5% of any class of our voting securities, or an affiliate or immediate family member thereof, had or will have a direct or indirect material
interest. Certain equity, compensation, and other arrangements are described under &#8220;Executive Compensation&#8221; and are not considered
related person transactions for these purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PIPE
Notes and Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in Note 3 and Note 6 to the Consolidated Financial Statements as of and for the years ended December 2023, 2022, and 2021
included herein, <span style="background-color: white">Data Knights issued and sold PIPE Notes in connection with the Business
Combination, which are convertible into shares of Common Stock. Total proceeds raised from the PIPE Notes were $1.5 million, of
which $1.0 million were with related party investors, including our Mr. Green (our Chief Executive Officer), Dr. Yu (our Chairman of
the Board) and Dr. Kosasa (a director). </span>In connection with the issuance of the PIPE Notes, the Company also issued a total of
95,744 shares of PIPE Warrants, of which 63,829 shares were issued to the same related party investors. Refer to Note 10 to the
Consolidated Financial Statements as of and for the years ended December 2023 and 2022 included herein for additional details on the
terms of the PIPE Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Promissory Notes and Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
2019 to 2023, the Company issued various Convertible Promissory Notes to related party investors. Total gross proceeds raised from
Convertible Promissory Notes with related parties was $12.3 million (out of $14.2 million total). In connection with the issuance of
the Convertible Promissory Notes, the Company also issued 2,976,000 shares of Convertible Promissory Note Warrants to the same
related parties (out of 3,726,000 total). Refer to Note 6 and Note 10 to the Consolidated Financial Statements as of and for the
years ended December 2023 and 2022 included herein for additional details on the terms of the Convertible Promissory Notes and
Convertible Promissory Note Warrants, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Closing of the Business Combination triggered the conversion of all Convertible Promissory Notes into shares of Common Stock, as disclosed
in Note 3 to the Consolidated Financial Statements as of and for the years ended December 2023 and 2022 included herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
Loans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
April 2023 to December 2023, the Company entered into shareholder loans with two related party investors, including <span style="background-color: white">Dr.
Yu (our Chairman of the Board) and Dr. Kosasa (a director)</span> (the &#8220;<span style="text-decoration: underline">Shareholder Loans</span>&#8221;) for aggregate gross proceeds
of $954 thousand. The Shareholder Loans bear an interest rate of 8.0% and mature one year from issuance. There are no financial or non-financial
covenants associated with the Shareholder Loans. The Shareholder Loans are not convertible into equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, in connection with the Business Combination, one of the Shareholder Loans for $0.5 million was converted into a PIPE
Note equal to the amount of principal and interest outstanding at the time of Closing. The Company accounted for the exchange as an extinguishment
whereby the Shareholder Loan was written off and a separate PIPE Note was recorded at fair value, as disclosed in Note 6 to the Consolidated
Financial Statements as of and for the years ended December 2023 and 2022 included herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, a total of $454 thousand of Shareholder Loans remains outstanding which is classified as loan &#8211; related party
on the consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024,  the Company received gross proceeds of $2.0 million in connection with shareholder loans with
related party investors, including <span style="background-color: white">Dr. Yu (our Chairman of the Board) and Dr. Kosasa (a director)</span>.
Of the $2.0 million, $1.6 million is convertible into shares of Common Stock at a conversion price of $0.7535 per share. The remaining
$0.4 million is not convertible into equity and bears an interest rate of 8.0% with a maturity date one year from issuance. The Company
subsequently repaid $0.2 million of the non-convertible shareholder loans through December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Extensions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in Note 3 to the Consolidated Financial Statements as of and for the years ended December 2023 and 2022 included herein, in
connection with the Business Combination, the Company assumed Data Knights&#8217; liabilities, which included existing loan extensions
to related parties. The loan extensions were to be exchanged for a fixed amount of the Company&#8217;s Common Stock upon the closing
of a business combination or a similar event. As of December 31, 2023, a balance of $3.0 million remains outstanding and is recorded
as loan extensions on the Company&#8217;s consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Approving Transactions with Related Persons</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee reviews and oversees all related person transactions in accordance with our Related Party Transactions Policy, either
in advance or when we become aware of a related person transaction that was not reviewed and approved in advance. Other than as described
above, there were no related person transactions in the years ended December 31, 2022 or 2023. The transactions described above were
approved by the Board of Directors at the time they were entered into.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rules of Nasdaq require that a majority of the Company&#8217;s board of directors be independent. An &#8220;independent director&#8221;
is generally defined under applicable Nasdaq rules as a person other than an officer or employee of the Company or its subsidiaries or
any other individual having a relationship which, in the opinion of the Board, would interfere with the director&#8217;s exercise of
independent judgment in carrying out the responsibilities of a director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is comprised of a majority of independent directors. Our Board has determined that each of Eric Casaburi, Jair Clarke, Sherry Coonse
McCraw, Dr. Thomas Kosasa, and Andrew Zeinfeld is an independent director under the rules of the SEC and Nasdaq and do not have any material
relationship with us other than their positions as directors and stockholders. The following individuals also served as a director during
the year ended December 31, 2023 and were determined by our Board to be independent under the rules of the SEC and Nasdaq: Erkan Akyuz,
R. Scott Holbrook, and Dr. Julianne Huh. In making these determinations, our Board considered past employment, remuneration, and all
other relationships each of these directors have with OneMedNet, as well as the specific independence tests set forth in Nasdaq&#8217;s
director independence rules. As our President and Chief Executive Officer, our Interim Chief Financial Officer and Corporate Secretary,
and our Chief Medical Officer and Vice President, respectively, none of Mr. Green, Mr. Golden, or Dr. Yu is considered an independent
director under SEC and Nasdaq rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors also has determined that Mr. Casaburi, Mr. Clarke, Ms. Coonse McCraw, Mr. Kosasa and Mr. Zeinfeld are &#8220;independent
directors&#8221; under SEC rules applicable to Audit Committee members and Compensation Committee members, and that each of Mr. Akyuz,
Mr. Golden, and Ms. Huh was an &#8220;independent director&#8221; under Nasdaq listing standards and SEC rules applicable to Audit Committee
members and Compensation Committee members for the periods in 2023 and 2024 that they each served on such committees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_016"></span><br/>
PRINCIPAL SECURITYHOLDERS</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth certain information regarding the beneficial ownership of our Common Stock by beneficial owners of more than 5%
of our outstanding Common Stock, each current director, each named executive officer included in the Summary Compensation Table, and
all current directors and executive officers as a group, as of January 29, 2025 (unless otherwise noted below). Percentage ownership
is based on 30,572,831 shares of Common Stock outstanding as of January 29, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have determined beneficial ownership in accordance with the rules of the SEC. Under these rules, beneficial ownership includes any shares
as to which the individual or entity has sole or shared voting power or investment power. In computing the number of shares beneficially
owned by an individual or entity and the percentage ownership of that person, shares subject to options, or other rights, held by such
person that are currently exercisable or convertible, or will become exercisable or convertible or will vest within 60 days of January
29, 2025, are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage
ownership of any other person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, the address of all listed stockholders is c/o OneMedNet Corporation, 6385 Old Shady Oak Road, Suite 250, Eden Prairie,
Minnesota 55344. Except as indicated by the footnotes below, we believe that the persons and entities named in the table below have sole
voting and investment power with respect to all securities that they beneficially own, subject to applicable community property laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of Shares of Common Stock Beneficially Owned</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent
                                            of Class</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(%)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5%
    Owners</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Data Knights LLC</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,415,275</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discovery
    Capital Management, LLC<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,301,791</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Off
    the Chain, LP<sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,770,755</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors
    and Named Executive Officers</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Casey(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Green(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466,671</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    Golden</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lisa
    Embree(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debra
    Reinhart(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Jeffrey Yu(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,889,213</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    Casaburi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jair
    Clarke</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sherry
    Coonse McCraw</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Thomas Kosasa(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,860,594</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew
    Zeinfeld</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
    Current Directors and Executive Officers as a Group (8 people)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14,214,126</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>41.8</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>%</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    beneficial ownership of less than 1%.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    solely on a Schedule 13G filed by Discovery Capital Management, LLC (&#8220;<span style="text-decoration: underline">Discovery</span>&#8221;) with the SEC on August 5, 2024.
    Discovery&#8217;s address is listed on the Schedule 13G as 20 Marshall Street, Suite 310, South Norwalk, Connecticut 06854.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    solely on a Schedule 13G filed by OTC with the SEC on October 1, 2024. OTC&#8217;s address is listed on the Schedule 13G as 10337
    Los Feliz Dr., Orlando, Florida 32836.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Casey retired from the Company in March 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    250,715 shares issuable upon conversion of the Pre-Closing PIPE Notes and 15,956 shares underlying warrants related to the Pre-Closing
    PIPE and the Warrant Agreements executed at the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Embree resigned from the Company in August 2024. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Reinhart separated from the Company in October 2023. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    501,430 shares issuable upon conversion of the Pre-Closing PIPE Notes and 31,916 shares underlying warrants related to the Pre-Closing
    PIPE and the Warrant Agreements executed at the closing of the Business Combination. Excludes an aggregate of 1,145,484 shares
    held by the Jeffrey N.C. Yu Spousal Trust and the Wendy Sanderson Yu Spousal Trust, for which Mr. Yu is not the trustee of either
    trust and has no investment control over the share held in trust.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 501,430 shares issuable upon conversion of the Pre-Closing PIPE Notes, (ii) 2,123,424 shares issuable upon conversion of
    shareholder loans, and (iii) 31,916 shares underlying warrants related to the Pre-Closing PIPE and the Warrant Agreements executed
    at the closing of the Business Combination.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_017"></span>SELLING
SECURITYHOLDERS<b><sup></sup></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders may offer and sell, from time to time, any or all of the Common Stock or Private Placement Warrants being offered
for resale by this prospectus, which consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
                                            to 1,504,292</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            shares of Common Stock upon conversion of up to $1,714,893.64 of the Pre-Closing PIPE
                                            Notes issued at the closing of the Business Combination subject to a floor price of $1.14
                                            per share pursuant to the terms of the Pre-Closing PIPE,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,744
                                            shares underlying 95,744 PIPE Warrants related</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                            to the Pre-Closing PIPE and the related Warrant Agreements executed at the closing
                                            of the Business Combination,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">277,778
                                            shares of Common Stock issued at $0.87 per share pursuant to the terms of the Satisfaction
                                            and Discharge Agreement</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,123,424
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of Common Stock issuable at a conversion rate of $0.7535 (95% of VWAP 10-day
                                            average $0.7932) for an aggregate $1,600,000 investment by Dr. Thomas Kosasa,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of Common Stock issued to the Sponsor and its affiliates in connection with the initial
                                            public offering of Data Knights,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000
                                            shares of Common Stock issuable upon exercise of warrants issued to Helena as consideration
                                            for entry into the Helena Termination Agreement,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,767,616
                                            shares of Common Stock issuable pursuant to advances under the SEPA,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">346,404
                                            shares of Common Stock issued to Yorkville as part of a commitment fee paid in connection
                                            with the SEPA,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">up to 1,785,714
                                            shares of Common Stock issuable to Yorkville upon conversion of the Yorkville Note,</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                                                                                                    <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">455,000
                                            shares of Common Stock issued to Yorkville, which have registration rights,</td></tr>
                                                                                                                                                    </table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,297,059
                                            shares of Common Stock issued to OTC pursuant to the terms of the OTC PIPE SPA,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,323,530
                                            shares of Common Stock underlying 1,323,530 pre-funded warrants issued to OTC pursuant to
                                            the OTC PIPE SPA,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,301,791
                                            shares of Common Stock issued to Discovery pursuant to the Discovery PIPE SPA,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,473,696
                                            shares of Common Stock issued to OTC pursuant to the terms of the OTC Follow-On PIPE SPA,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,188,209
                                            shares of Common Stock underlying 1,188,209 pre-funded warrants issued to OTC pursuant to
                                            the OTC Follow-On PIPE SPA,</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,095
                                            shares of Common Stock underlying 133,095 warrants issued to OTC pursuant to the OTC Follow-On
                                            PIPE SPA, and</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
                                            to an aggregate of 585,275 Private Placement Warrants.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders may from time to time offer and sell any or all of the Common Stock and Private Placement Warrants set forth
in the table below pursuant to this prospectus. When we refer to the &#8220;Selling Securityholders&#8221; in this prospectus, we refer
to the persons listed in the table below, and the pledgees, donees, transferees, assignees, successors and other permitted transferees
that hold any of the Selling Securityholders&#8217; interest in the shares of Common Stock or warrants after the date of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides, as of the date of this prospectus, information regarding the beneficial ownership of our Common Stock and Private
Placement Warrants of each Selling Securityholder, the number of shares of Common Stock or Private Placement Warrants that may be sold
by each Selling Securityholder under this prospectus and that each Selling Securityholder will beneficially own after this offering.
The following table also sets forth the percentage of shares of Common Stock or Private Placement Warrants beneficially owned by a Selling
Securityholder after giving effect to the sale by the Selling Securityholder of all securities being offered hereby, based on 30,572,831
shares of Common Stock outstanding as of January 29, 2025. The Common Stock issuable upon exercise of the Private Placement Warrants
are not included in the table below as the table assumes the Private Placement Warrants are sold in the offering prior to their exercise
by the applicable Selling Securityholder. The following table does not include Public Warrants or the primary issuance of Common Stock
underlying the Public Warrants, but includes the 3,375,853 warrants outstanding as of the date hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
cannot advise you as to whether the Selling Securityholders will in fact sell any or all of such Common Stock or Private Placement Warrants.
In particular, the Selling Securityholders identified below may have sold, transferred or otherwise disposed of all or a portion of their
securities after the date on which they provided us with information regarding their securities in transactions exempt from registration
under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information provided by or on behalf of the Selling Securityholders concerning the Common Stock and
Private Placement Warrants that may be offered from time to time by each Selling Securityholder with this prospectus. For the purposes
of this following table, we have assumed that the Selling Securityholders will have sold all of the securities covered by this prospectus
upon the completion of the offering. Please see the section entitled &#8220;<i>Plan of Distribution</i>&#8221; for further information
regarding the Selling Securityholders&#8217; method of distributing the Common Stock and Private Placement Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated below, the address of each beneficial owner listed in the tables below is c/o OneMedNet Corporation, 6385 Old Shady
Oak Road, Suite 250, Eden Prairie, MN 55344.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            of Selling</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securityholder</b></span></p></td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of Shares of Common Stock Owned Prior</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
the Offering</b></span></p>

</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of Warrants Owned</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior
to</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>the
Offering<sup>(11)</sup></b></span></p>

</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maximum
                                            Number</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
Shares</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
Be</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sold
Pursuant</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
this</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus</b></span></p>

</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Maximum
                                            Number</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
Be</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sold</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
this</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prospectus</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(11)</b></span></p>

</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Shares of Common Stock Owned After the Offering</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%(1)</td>
    <td>&#160;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
    of Warrants Owned After the Offering</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D. Boral Capital
    LLC<sup>(2)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">128,472</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#8212;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">128,472</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#8212;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#8212;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#8212;</td>
    <td style="width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 5%">&#8212;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Rallo<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">128,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">128,472</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas Kosasa<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,860,594</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,656,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,203,824</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30.1</td>
    <td>%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,916</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Yu<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,889,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,916</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">533,346</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,355,867</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.4</td>
    <td>%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,916</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Helena Global Investment
    Opportunities 1 Ltd.<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron Green<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">466,671</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,671</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.6</td>
    <td>%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steven Kester<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,956</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">266,671</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">125</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">nm
                                            </span></td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,956</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">YA II PN, Ltd. <sup>(9)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,394,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,394,643</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Off the Chain, LP<sup>(10)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,415,589</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,644,834</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,415,589</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,644,834</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Discovery Global Opportunity Master Fund, Ltd.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,301,791</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,301,791</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">nm = not meaningful</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The percentage of beneficial ownership after this offering is calculated based on 30,572,831 shares of Common Stock outstanding as of
January 29, 2025. Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment
power with respect to all shares beneficially owned by them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
D. Boral Capital LLC is a successor to EF Hutton, the underwriter in Data Knights&#8217; initial public offering. Consists of
128,472 shares of Common Stock issued pursuant to the terms of the Satisfaction and Discharge Agreement at $0.87 per share. Boral Capital&#8217;s address is 590 Madison Ave, 39th Floor, New York, NY, 10022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Joseph Rallo is a successor to EF Hutton, the underwriter in Data Knights&#8217; initial public offering. Consists of 128,472 shares
of Common Stock issued pursuant to the terms of the Satisfaction and Discharge Agreement at $0.87 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Consists of 8,333,824 existing shares of Common Stock plus 2,123,424 shares of Common Stock issuable upon conversion of convertible
loans issued in an aggregate amount of $1,600,000, 501,430 shares of Common Stock issuable upon conversion of the Pre-Closing
PIPE Notes and 31,916 shares underlying 31,916 warrants related to the Pre-Closing PIPE and the Warrant Agreements executed at the
closing of the Business Combination to Thomas Kosasa, a member of our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Includes 501,430 shares issuable upon conversion of the Pre-Closing PIPE Notes and 31,916 shares underlying warrants related to the
Pre-Closing PIPE and the Warrant Agreements executed at the closing of the Business Combination. Excludes an aggregate of 1,145,484
shares held by the Jeffrey N.C. Yu Spousal Trust and the Wendy Sanderson Yu Spousal Trust, for which Mr. Yu is not the trustee of either
trust and has no investment control over the share held in trust.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Consists of 50,000 shares of Common Stock issuable to Helena upon exercise of the warrants issued to Helena pursuant to the Helena Termination
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)
Consists of up to 250,715 shares of Common Stock issuable to Aaron Green, our chief executive officer, president and a member of the
Board of Directors, upon conversion of the Pre-Closing PIPE Notes and 15,956 shares underlying 15,956 warrants related to the
Pre-Closing PIPE and the Warrant Agreements executed at the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)
Consists of 125 existing shares of Common Stock and up to 250,715 shares of Common Stock issuable to Iron Family Holdings
LLC owned by Steve Kester upon conversion of the Pre-Closing PIPE Notes and 15,956 shares underlying 15,956 warrants related to the
Pre-Closing PIPE and the Warrant Agreements executed at the closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">(9) Consists of
up to 4,767,616 shares of Common Stock issuable pursuant to advances under the SEPA, 346,404 shares of Common Stock issued as part of
the commitment fee paid under the SEPA, and up to 1,785,714 shares of Common Stock issuable upon conversion of the Yorkville Note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">(10) Consists of
2,770,755 shares of Common Stock and up to 2,644,843 shares underlying pre-funded warrants and warrants issued in the OTC PIPE and OTC
Follow-On PIPE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)
Excludes 11,500,000 public warrants sold in Data Knights&#8217; initial public offering which converted to OneMedNet warrants at the
closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="bs_018"></span>DESCRIPTION
OF SECURITIES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>The
following summary of certain material provisions of the Company&#8217;s securities does not purport to be complete and is subject to
the provisions of the Certificate of Incorporation, the Bylaws and applicable law. The applicable provisions of the Certificate of Incorporation
and the Bylaws that are filed with the registration statement of which this prospectus forms a part should be read carefully and in their
entirety.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized
and Outstanding Stock</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Certificate of Incorporation authorizes the issuance of 101,000,000 shares, consisting of (a) 100,000,000 shares of Common Stock and
(b) 1,000,000 shares of preferred stock. As of January 29, 2025, there were 30,572,831 shares of Common Stock outstanding and no
shares of preferred stock outstanding. All shares of Common Stock are fully paid and non-assessable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Stock</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting
rights</i></b>. Each holder of Common Stock is entitled to one vote for each share of Common Stock held of record by such holder on all
matters submitted to a vote of the stockholders. Holders of Common Stock will vote together as a single class on all matters. Except
as expressly required by law, holders of Common Stock, will not be entitled to vote on any amendment to the Certificate of Incorporation
(including any certificate of designation) that relates solely to the rights, powers, preferences (or the qualifications, limitations
or restrictions thereof).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividend
rights</i></b>. The holders of Common Stock will be entitled to the payment of dividends and other distributions of cash, stock or property
on the Common Stock when, as and if declared by the Board in accordance with law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
upon liquidation</i></b>. In the event of any liquidation, dissolution or winding up, whether voluntary or involuntary, our funds and
assets that may be legally distributed to our stockholders will be distributed among the holders of the then-outstanding shares of Common
Stock pro rata in accordance with the number of shares held by each such holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
rights</i></b>. The holders of Common Stock have no preemptive or conversion rights or other subscription rights. There are no redemption
or sinking fund provisions applicable to the Common Stock. The rights, preferences and privileges of holders of the Common Stock will
be subject to those of the holders of any shares of the preferred stock we may issue in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Authorized
but Unissued Shares</i></b>. The authorized but unissued shares of Common Stock are available for future issuance without stockholder
approval, subject to any limitations imposed by the listing standards of Nasdaq. These additional shares may be used for a variety of
corporate finance transactions, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved Common
Stock and preferred stock could make more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender
offer, merger or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combinations</i></b>. OneMedNet is governed by Section 203 of the Delaware General Corporation Law (&#8220;<span style="text-decoration: underline">DGCL</span>&#8221;). In general,
Section 203 prohibits a publicly held Delaware corporation from engaging in a business combination, such as a merger, with an &#8220;interested
stockholder&#8221; (which includes a person or group owning 15% or more of the corporation&#8217;s voting stock) for a period of three
years following the date the person became an interested stockholder, unless (with certain exceptions) the business combination or the
transaction in which the person became an interested stockholder is approved in a prescribed manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">The
Board has the authority to issue shares of preferred stock from time to time on terms it may determine, to divide shares of preferred
stock into one or more series and to fix the designations, preferences, privileges, and restrictions of preferred stock, including dividend
rights, conversion rights, voting rights, terms of redemption, liquidation preference, sinking fund terms, and the number of shares constituting
any series or the designation of any series to the fullest extent permitted by the DGCL. The issuance of preferred stock could have the
effect of decreasing the trading price of Common Stock, restricting dividends on the capital stock of the Company, diluting the voting
power of the Common Stock, impairing the liquidation rights of the capital stock of the Company, or delaying or preventing a change in
control of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Public
Warrants and Private Placement Warrants</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
&#8211;</i></b> The following is a brief summary of certain terms and conditions of the Warrants. The following description is
subject in all respects to the provisions contained in the applicable Warrant, the forms of which are filed as exhibits
to the registration statement of which this prospectus forms a part<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Duration
and Exercise Price &#8211;</i></b> The Warrants offered hereby have an exercise price of $11.50 per share. The warrants
will be immediately exercisable and may be exercised at any time on or after the initial exercise date. The Warrants will expire at
5:00 p.m., New York City time, on November 7, 2028, or earlier upon redemption or liquidation. The exercise prices
and numbers of shares of Common Stock issuable upon exercise are subject to appropriate adjustment in the event of stock dividends, stock
splits, reorganizations or similar events affecting our Common Stock. Warrants will be issued in registered form only<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercisability
&#8211;</i></b> The Warrants may be exercised upon surrender of the Warrant certificate on or prior to the expiration date at the offices
of the Warrant agent, with the exercise form on the reverse side of the Warrant certificate completed and executed as indicated, accompanied
by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to the Company,
for the number of Warrants being exercised. A holder of a Warrant may notify us in writing in the event it elects to be subject to a
requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise,
such person (together with such person&#8217;s affiliates), to the Warrant agent&#8217;s actual knowledge, would beneficially own in
excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the shares of Common Stock outstanding immediately after giving
effect to such exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
will not be obligated to deliver any shares of Common Stock pursuant to the exercise of a Warrant and will have no obligation to settle
such Warrant exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying
the Warrants is then effective and a current prospectus relating thereto is current, subject to OneMedNet satisfying its obligations
described below with respect to registration. No Warrant will be exercisable, and OneMedNet will not be obligated to issue shares of
Common Stock upon exercise of a Warrant unless shares of Common Stock issuable upon such Warrant exercise has been registered, qualified
or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that
the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant will
not be entitled to exercise such Warrant, and such Warrant may have no value and expire worthless. In no event will the Company be required
to net cash settle any Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
the Warrants become exercisable, we may call the Warrants for redemption:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            whole and not in part;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            a price of $0.01 per Warrant;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
                                            not less than 30 days&#8217; prior written notice of redemption given after the Warrants
                                            become exercisable to each warrant holder; and</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if,
                                            and only if, the reported last sale price of the shares of Common Stock equals or exceeds
                                            $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
                                            and the like) for any 20 trading days within a 30-trading day period commencing once the
                                            Warrants become exercisable and ending three business days before we send the notice of redemption
                                            to the Warrant holders.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
and when the Warrants become redeemable by us, we may not exercise our redemption right if the issuance of shares of Common Stock upon
exercise of the Warrants is not exempt from registration or qualification under applicable state blue sky laws or we are unable to effect
such registration or qualification. We have established the last of the redemption criterion discussed above to prevent a redemption
call unless there is at the time of the call a significant premium to the Warrant exercise price. If the foregoing conditions are satisfied
and we issue a notice of redemption of the Warrants, each Warrant holder will be entitled to exercise its Warrant prior to the scheduled
redemption date. However, the price of the shares of Common Stock may fall below the $18.00 redemption trigger price (as adjusted for
stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $11.50 warrant exercise price after the
redemption notice is issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cashless
Exercise &#8211; </i></b>If we call the Warrants for redemption as described above, our management will have the option to require any
holder that wishes to exercise its Warrant to do so on a &#8220;cashless basis.&#8221; If our management takes advantage of this option,
all holders of Warrants would pay the exercise price by surrendering their Warrants for that number of shares of Common Stock equal to
the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the
difference between the exercise price of the Warrants and the &#8220;fair market value&#8221; (defined below) by (y) the fair market
value. The &#8220;fair market value&#8221; for this purpose shall mean the average reported last sale price of the shares of Common Stock
for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of
warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transferability
&#8211;</i></b> A Warrant may be transferred at the option of the holder upon surrender of the Warrant to us together with the appropriate
instruments of transfer<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fractional
Shares &#8211;</i></b> No fractional shares will be issued upon exercise of the Warrants. If, upon exercise of the warrants, a holder
would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number of shares
of Common Stock to be issued to the Warrant holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Trading
Market &#8211;</i></b> The Company&#8217;s Public Warrants are listed on Nasdaq under the symbol &#8220;ONMDW.&#8221; There is no established
trading market for any of the Company&#8217;s warrants other than the Public Warrants, and we do not expect a market to develop. We do
not intend to apply for a listing for any of the warrants other than the Public Warrants on any securities exchange or other nationally
recognized trading system. Without an active trading market, the liquidity of the warrants other than the Public Warrants will be limited<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights
as a Shareholder &#8211;</i></b> Except as otherwise provided in the Warrants or by virtue of the holders&#8217; ownership of shares
of our Common Stock, the holders of Warrants do not have the rights or privileges of holders of our Common Stock, including any voting
rights, until such Warrant holders exercise their warrants<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reorganization&#8211;
</i></b>In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than those described above
or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation us with or into another
corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification
or reorganization of our outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity
of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the holders
of the Warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in
the Warrants and in lieu of the shares of Common Stock immediately theretofore purchasable and receivable upon the exercise of the rights
represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification,
reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would
have received if such holder had exercised their Warrants immediately prior to such event.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
if less than 70% of the consideration receivable by the holders of shares of Common Stock in such a transaction is payable in the form
of shares of Common Stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established
over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of
the Warrant properly exercises the Warrant within thirty days following public disclosure of such transaction, the Warrant exercise price
will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the Warrant.
The purpose of such exercise price reduction is to provide additional value to holders of the Warrants when an extraordinary transaction
occurs during the exercise period of the Warrants pursuant to which the holders of the Warrants otherwise do not receive the full potential
value of the Warrants in order to determine and realize the option value component of the Warrant. This formula is to compensate the
Warrant holder for the loss of the option value portion of the Warrant due to the requirement that the Warrant holder exercise the Warrant
within 30 days of the event. The Black-Scholes model is an accepted pricing model for estimating fair market value where no quoted market
price for an instrument is available.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Waivers
and Amendments &#8211;</i></b> No term of the warrants may be amended or waived without the written consent of the holder of such warrant<i>.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Helena
Warrant</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration
and Exercise Price <span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">The Helena Warrant entitles
Helena to purchase up to 50,000 shares of Common Stock at an exercise price of $1.20 per share. The Helena Warrant is immediately exercisable
and may be exercised at any time on or after the initial exercise date. The Helena Warrant will expire at 5:00 p.m., New York City time,
on December 4, 2029, or earlier upon redemption or liquidation. The exercise price and numbers of shares of Common Stock issuable upon
exercise are subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting
our Common Stock.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability
<span style="font-weight: normal">- </span></i><span style="font-weight: normal">The Helena Warrant is exercisable,</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: normal">
at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full
for the number of shares of our Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below).</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise <span style="font-weight: normal">- </span></i><span style="font-weight: normal">If, at the time the holder exercises the Helena
Warrant, a registration statement registering the issuance of the shares of Common Stock underlying the warrants under the Securities
Act, is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated
to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise
(either in whole or in part) the net number of shares of Common Stock determined according to a formula set forth in the warrant<i>.</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability
<span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">The Helena Warrant may not be transferred unless
(i) there is an effective registration statement under such Securities Act and applicable state securities laws covering any such transaction
involving said securities, (ii) the Company receives an opinion of legal counsel for the holder of the securities satisfactory to the
Company stating that such transaction is exempt from registration, or (iii) the Company otherwise satisfies itself that such transaction
is exempt from registration.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fractional
Shares</i> <span style="font-weight: normal">- No fractional shares of Common Stock will be issued upon the exercise of the Helena Warrant.
Rather, the number of shares of Common Stock to be issued will, at our election, either be rounded up to the nearest whole number or
we will pay a cash adjustment in respect of such final fraction.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trading
Market</i> <span style="font-weight: normal">- There is no established trading market for the Helena Warrant, and we do not expect a market
to develop. We do not intend to apply for a listing for the Helena Warrant on any securities exchange or other nationally recognized
trading system. Without an active trading market, the liquidity of the Helena Warrant will be limited.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Shareholder <span style="font-weight: normal">- </span></i><span style="font-weight: normal">Except as otherwise provided in the
Helena Warrant or by virtue of the holder&#8217;s ownership of our Common Stock, the holder of the Helena Warrant does not have the rights
or privileges of holders of our Common Stock, including any voting rights, until such Helena Warrant holder exercise their warrants.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transaction <span style="font-weight: normal">- </span></i><span style="font-weight: normal">In the event of a Fundamental Transaction
(as defined in the Helena Warrant), the holder of the Helena Warrant will be entitled to receive upon exercise of the Helena Warrant
the kind and amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately
prior to such Fundamental Transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Waivers
and Amendments <span style="font-weight: normal">- </span></i><span style="font-weight: normal">No term of the Helena Warrant may be
amended or waived without the written consent of the holder of the Helena Warrant.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>OTC
Warrant</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration
and Exercise Price <span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">The warrant issued to OTC in
connection with the OTC Follow-On PIPE (the &#8220;<span style="text-decoration: underline">OTC Warrant</span>&#8221;) entitles OTC to purchase up to 133,095 shares of Common
Stock at an exercise price of $0.325 per share. The OTC Warrant is immediately exercisable and may be exercised at any time on or after
the initial exercise date. The OTC Warrant will expire when it is exercised in full. The exercise price and numbers of shares of Common
Stock issuable upon exercise are subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or
similar events affecting our Common Stock.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability
<span style="font-weight: normal">- </span></i><span style="font-weight: normal">The OTC Warrant is exercisable, at the option of the
holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares
of our Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below).</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: normal">
The holder (together with its affiliates) may not exercise any portion of such holder&#8217;s warrants to the extent that the holder
would own more than 4.99% (or 9.99%, at the holder&#8217;s election) of our outstanding Common Stock immediately after exercise, except
that upon notice from the holder to us, the holder may decrease or increase the limitation of ownership of outstanding stock after exercising
the holder&#8217;s warrants up to 9.99% of the number of shares of our Common Stock outstanding immediately after giving effect to the
exercise, as such percentage ownership is determined in accordance with the terms of the warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise <span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">At the option of the holder
of the OTC Warrant, in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of
the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number
of shares of Common Stock determined according to a formula set forth in the warrant<i>.</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability
<span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">The OTC Warrant may be transferred at the
option of the holder upon surrender of the warrant to us together with the appropriate instruments of transfer.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fractional
Shares</i> <span style="font-weight: normal">- No fractional shares of Common Stock will be issued upon the exercise of the OTC Warrant.
Rather, the number of shares of Common Stock to be issued will, at our election, either be rounded up to the nearest whole number or
we will pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trading
Market</i> <span style="font-weight: normal">- There is no established trading market for the OTC Warrant, and we do not expect a market
to develop. We do not intend to apply for a listing for the OTC Warrant on any securities exchange or other nationally recognized trading
system. Without an active trading market, the liquidity of the OTC Warrant will be limited.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Shareholder <span style="font-weight: normal">- </span></i><span style="font-weight: normal">Except as otherwise provided in the
OTC Warrant or by virtue of the holder&#8217;s ownership of our Common Stock, the holder of the OTC Warrant does not have the rights
or privileges of holders of our Common Stock, including any voting rights, until such OTC Warrant holder exercise their warrants.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transaction <span style="font-weight: normal">- </span></i><span style="font-weight: normal">In the event of a Fundamental Transaction
(as defined in the OTC Warrant), the holder of the OTC Warrant will be entitled to receive upon exercise of the OTC Warrant the kind
and amount of securities, cash or other property that the holders would have received had they exercised the warrants immediately prior
to such Fundamental Transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Waivers
and Amendments <span style="font-weight: normal">- </span></i><span style="font-weight: normal">No term of the OTC Warrant may be amended
or waived without the written consent of the holder of the OTC Warrant.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>OTC
Pre-Funded Warrants</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
<span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">The term &#8220;pre-funded&#8221; refers to the
fact that the purchase price of the pre-funded warrants issued to OTC in connection with the OTC PIPE and Follow-On PIPE (the &#8220;<span style="text-decoration: underline">OTC
Pre-Funded Warrants</span>&#8221;) includes almost the entire exercise price that will be paid under the OTC Pre-Funded Warrants, except
for a nominal remaining exercise price of $0.0001. The purpose of the OTC Pre-Funded Warrants is to enable the holder that may have restrictions
on their ability to beneficially own more than 4.99% (or, at the election of the holder, 9.99%) of our outstanding Common Stock to invest
capital into the Company without triggering their ownership restrictions, by receiving OTC Pre-Funded Warrants in lieu of shares of our
Common Stock which would result in such ownership of more than 4.99% (or, at the election of the holder, 9.99%), and receiving the ability
to exercise their option to purchase the shares underlying the OTC Pre-Funded Warrants at a nominal price at a later date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration
and Exercise Price <span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">The OTC Pre-Funded Warrants
entitle OTC to purchase up to 2,066,844 shares of Common Stock at exercise price of $0.0001 per share. The OTC Pre-Funded Warrants are
immediately exercisable and may be exercised at any time on or after the initial exercise date. Each OTC Pre-Funded Warrants will expire
when it is exercised in full. The exercise price and numbers of shares of Common Stock issuable upon exercise are subject to appropriate
adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our Common Stock.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability
<span style="font-weight: normal">- </span></i><span style="font-weight: normal">The OTC Pre-Funded Warrants are exercisable, at the
option of the holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the
number of shares of our Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). The
holder (together with its affiliates) may not exercise any portion of such holder&#8217;s warrants to the extent that the holder would
own more than 4.99% (or 9.99%, at the holder&#8217;s election) of our outstanding Common Stock immediately after exercise, except that
upon notice from the holder to us, the holder may decrease or increase the limitation of ownership of outstanding stock after exercising
the holder&#8217;s warrants up to 9.99% of the number of shares of our Common Stock outstanding immediately after giving effect to the
exercise, as such percentage ownership is determined in accordance with the terms of the warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise <span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">At the option of the holder of an OTC
Pre-Funded Warrant, in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate
exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of Common
Stock determined according to a formula set forth in the warrant<i>.</i></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability
<span style="font-weight: normal">&#8211; </span></i><span style="font-weight: normal">The OTC Pre-Funded Warrants may be transferred
at the</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-weight: normal">
option of a holder upon surrender of the warrant to us together with the appropriate instruments of transfer.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fractional
Shares</i> <span style="font-weight: normal">- No fractional shares of Common Stock will be issued upon the exercise of the OTC Pre-Funded
Warrants. Rather, the number of shares of Common Stock to be issued will, at our election, either be rounded up to the nearest whole
number or we will pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise
price.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trading
Market</i> <span style="font-weight: normal">- There is no established trading market for the OTC Pre-Funded Warrants, and we do
not expect a market to develop. We do not intend to apply for a listing for the OTC Pre-Funded Warrants on any securities exchange
or other nationally recognized trading system. Without an active trading market, the liquidity of the OTC Warrant will be limited.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Shareholder <span style="font-weight: normal">- </span></i><span style="font-weight: normal">Except as otherwise provided in the
OTC Pre-Funded Warrants or by virtue of the holder&#8217;s ownership of our Common Stock, a holder of an OTC Pre-Funded
Warrants does not have the rights or privileges of holders of our Common Stock, including any voting rights, until such OTC Pre-Funded
Warrant holder exercise their warrants.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transaction <span style="font-weight: normal">- </span></i><span style="font-weight: normal">In the event of a Fundamental Transaction
(as defined in the OTC Pre-Funded Warrants), the holder of an OTC Pre-Funded Warrants will be entitled to receive upon exercise of an
OTC Pre-Funded Warrant the kind and amount of securities, cash or other property that the holders would have received had they exercised
the warrants immediately prior to such Fundamental Transaction.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Waivers
and Amendments <span style="font-weight: normal">- </span></i><span style="font-weight: normal">No term of the OTC Pre-Funded Warrants
may be amended or waived without the written consent of the applicable holder of the OTC Pre-Funded Warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Limitations
on Liability and Indemnification of Officers and Directors</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Our
Certificate of Incorporation and Bylaws provide indemnification and advancement of expenses for the directors and officers to the fullest
extent permitted by the DGCL, subject to certain limited exceptions. We have entered into indemnification agreements with each of our
directors and officers. In some cases, the provisions of those indemnification agreements may be broader than the specific indemnification
provisions contained under Delaware law. In addition, as permitted by Delaware law, the Certificate of Incorporation and Bylaws include
provisions that eliminate the personal liability of directors for monetary damages resulting from breaches of certain fiduciary duties
as a director. The effect of this provision is to restrict our rights and the rights of our stockholders in derivative suits to recover
monetary damages against a director for breach of fiduciary duties as a director. These provisions may be held not to be enforceable
for violations of the federal securities laws of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dissenters&#8217;
Rights of Appraisal and Payment</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Under
the DGCL, with certain exceptions, OneMedNet&#8217;s stockholders will have appraisal rights in connection with a merger or consolidation
of OneMedNet. Pursuant to Section 262 of the DGCL, stockholders who properly demand and perfect appraisal rights in connection with such
merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court
of Chancery.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders&#8217;
Derivative Actions</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">Under
the DGCL, any of our stockholders may bring an action in the Company&#8217;s name to procure a judgment in its favor, also known as a
derivative action, provided that the stockholder bringing the action is a holder of our shares at the time of the transaction to which
the action relates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forum
Selection</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Certificate of Incorporation provides that unless we consent in writing to the selection of an alternative forum, to the fullest extent
permitted by applicable law, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any internal or
intra-corporate claim or any action asserting a claim governed by the internal affairs doctrine as defined by the laws of the State of
Delaware, including, but not limited to, (i) any derivative action or proceeding brought on behalf of OneMedNet; (ii) any action asserting
a claim of breach of a fiduciary duty owed by any director, officer or other employee or stockholder of OneMedNet to OneMedNet or its
stockholders; or (iii) any action asserting a claim arising pursuant to any provision of the DGCL or the Certificate of Incorporation
or the Bylaws, or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware, will be a state court
located within the State of Delaware (or, if no court located within the State of Delaware has jurisdiction, the federal district court
for the District of Delaware). Further, unless we consent in writing to the selection of an alternative forum, to the fullest extent
permitted by applicable law, the sole and exclusive forum for any action asserting a cause of action arising under the Securities Act
and the rules and regulations promulgated thereunder will be the federal district court for the District of Delaware (or if such court
does not have jurisdiction over such action, any other federal district court) of the United States; provided that, if such forum is
illegal, invalid or unenforceable, the sole and exclusive forum for any action asserting a cause of action arising under the Securities
Act will be the Court of Chancery of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing
of Common Stock and Public Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Common Stock and Public Warrants
are listed on Nasdaq under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221; respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="abdje_001"></span>CERTAIN
U.S. FEDERAL INCOME TAX CONSEQUENCES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain U.S. federal income tax consequences of the purchase, ownership and disposition of (i) shares of
our Common Stock, (ii) warrants to purchase our Common Stock (&#8220;warrants&#8221;), and (iii) shares of Common Stock received on the
exercise of warrants (&#8220;warrant shares&#8221;), each as of the date hereof. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Scope
of this Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is based upon provisions of the Internal Revenue Code of 1986, as amended (the &#8220;<span style="text-decoration: underline">Code</span>&#8221;), and
regulations, rulings and judicial decisions as of the date hereof. Those authorities may be changed, perhaps retroactively, or be
subject to differing interpretations, so as to result in U.S. federal income and estate tax consequences different from those summarized
below. This summary is for general information purposes only and does not address all aspects of U.S. federal income taxes and
does not address any other federal, foreign, state, local or other tax considerations that may be relevant to holders in light
of their particular circumstances. In addition, this summary does not take into account the individual facts and
circumstances of any particular holder that may affect the U.S. federal income tax consequences to such holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><b>Accordingly,
this summary is not intended to be, and should not be construed as, legal or tax advice with respect to any particular holder. Each holder
should consult its own tax advisors regarding the U.S. federal, state and local, and non-U.S. tax consequences arising from and relating
to the acquisition, ownership and disposition of shares of Common Stock, warrants and warrant shares.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">No legal opinion
from U.S. legal counsel or ruling from the Internal Revenue Service (the &#8220;<span style="text-decoration: underline">IRS</span>&#8221;) has been requested, or will be obtained,
regarding the U.S. federal income tax consequences related to the acquisition, ownership and disposition of shares of Common Stock, warrants
and warrant shares. This summary is not binding on the IRS, and the IRS is not precluded from taking a position that is different from,
or contrary to, the positions taken in this summary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>U.S. Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
used in this summary, the term &#8220;U.S. Holder&#8221; means a beneficial owner of shares of Common Stock, warrants or warrant shares
acquired pursuant to this prospectus that is, for U.S. federal income tax purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
  <td style="text-align: justify; width: 0.25in">&#9679;</td>
  <td style="text-align: justify">an individual who is a citizen or resident of the U.S.;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify">&#9679;</td>
  <td style="text-align: justify">a corporation (or other entity taxable as a corporation) organized under the laws of the U.S., any
  state thereof or the District of Columbia;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify">&#9679;</td>
  <td style="text-align: justify">an estate whose income is subject to U.S. federal income taxation regardless of its source; or</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
  <td style="text-align: justify">&#9679;</td>
  <td style="text-align: justify">a trust that (1) is subject to the primary supervision of a court within the U.S. and the control
  of one or more U.S. persons for all substantial decisions or (2) has a valid election in effect under applicable Treasury Regulations
  to be treated as a U.S. person.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>Non-U.S. Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, a &#8220;Non-U.S. holder&#8221; means a beneficial owner of shares of Common Stock, warrants, or warrant shares
acquired pursuant to this prospectus that is neither a U.S. Holder nor</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
a partnership (or an entity or arrangement treated as a partnership for U.S. federal income tax purposes). A Non-U.S.
Holder should review the discussion under the heading &#8220;Non-U.S. Holders&#8221; below for more information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>Holders Subject to Special
U.S. Federal Income Tax Rules</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">This summary
deals only with persons or entities who hold shares of Common Stock, warrants, warrants or warrant shares as a capital asset within the
meaning of Section 1221 of the Code (generally, property held for investment purposes). This summary does not address all aspects of
U.S. federal income taxation that may be applicable to holders in light of their particular circumstances or to holders subject to special
treatment under U.S. federal income tax law, such as: banks, insurance companies, and other financial institutions; dealers or traders
in securities, commodities or foreign currencies; regulated investment companies, real estate investment trusts, government organizations
or tax-exempt organizations; U.S. expatriates or former long-term residents of the U.S.; persons required for U.S. federal income tax
purposes to conform the timing of income accruals to their financial statements under Section 451(b) of the Code; persons holding shares
of Common Stock, warrants or warrant shares as part of a straddle, appreciated financial position, synthetic security, hedge, conversion
transaction or other integrated investment; persons holding shares of Common Stock, warrants or warrant shares as a result of a constructive
sale; real estate investment trusts; U.S. Holders that have a &#8220;functional currency&#8221; other than the U.S. dollar; holders that
acquired shares of Common Stock, warrants, or warrant shares in connection with the exercise of employee stock options or otherwise as
consideration for services; or holders that are &#8220;controlled foreign corporations&#8221; or &#8220;passive foreign investment companies.&#8221;
Holders that are subject to special provisions under the Code, including holders described immediately above, should consult their own
tax advisors regarding the U.S. federal, state and local, and non-U.S. tax consequences arising from and relating to the acquisition,
ownership and disposition of shares of Common Stock, warrants and warrant shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an entity classified as a partnership for U.S. federal income tax purposes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
holds shares of Common Stock, warrants or warrant shares, the tax treatment of a partner generally will depend on
the status of the partner and the activities of the partnership. This summary does not address the tax consequences to any such owner
or entity. Partners of entities or arrangements that are classified as partnerships for U.S. federal income tax purposes should consult
their own tax advisors regarding the U.S. federal income tax consequences arising from and relating to the acquisition, ownership and
disposition of shares of Common Stock, warrants and warrant shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>Tax Consequences Not Addressed</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">This summary does not address
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the U.S. state and local, U.S. federal estate
and gift, U.S. federal alternative minimum tax, or non-U.S. tax consequences to holders of the acquisition, ownership
and disposition of shares of Common Stock, warrants and warrant shares. Each holder should consult its own tax advisors regarding
the U.S. state and local, U.S. federal estate and gift, U.S. federal alternative minimum tax, and non-U.S. tax consequences of
the acquisition, ownership and disposition of shares of Common Stock, warrants and warrant shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>U.S. Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><i>Exercise of Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder generally will not recognize gain or loss on</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
the exercise of a warrant and related receipt of a warrant share (unless cash is received in lieu of the issuance of a fractional
warrant share). A U.S. Holder&#8217;s initial tax basis in the warrant share received on the exercise of a warrant should be equal to
the sum of (i) the U.S. Holder&#8217;s tax basis in the warrant plus (ii) the exercise price paid by the U.S. Holder on the exercise
of the warrant. A U.S. Holder&#8217;s holding period for the warrant share received on the exercise of a warrant generally will begin
on the day the warrant is exercised by the U.S. Holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The U.S. federal
income tax treatment of a cashless exercise of warrants into warrant shares is unclear, and the tax consequences of a cashless exercise
could differ from the consequences upon the exercise of a warrant described in the preceding paragraph. U.S. Holders should consult their
own tax advisors regarding the U.S. federal income tax consequences of a cashless exercise of warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Disposition of Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A U.S. Holder will recognize
gain or loss on the sale or other taxable disposition of a warrant in an amount equal to the difference, if any, between (i) the amount
of cash plus the fair market value of any property received upon such taxable disposition and (ii) the U.S. Holder&#8217;s tax basis
in the warrant sold or otherwise disposed of. Any such gain or loss generally will be a capital gain or loss, which will be long-term
capital gain or loss if the U.S. Holder&#8217;s holding period in the warrant is more than one year at the time of the taxable disposition.
Long-term capital gains recognized by certain non-corporate U.S. Holders (including individuals) may be eligible for preferential rates
of taxation. Deductions for capital losses are subject to limitations under the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Expiration of Warrants
without Exercise</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Upon the lapse
or expiration of a warrant, a U.S. Holder will recognize a loss in an amount equal to such U.S. Holder&#8217;s tax basis in the warrant.
Any such loss generally will be a capital loss and will be long-term capital loss if the U.S. Holder&#8217;s holding period in the warrant
is more than one year at the time of the lapse or expiration. Deductions for capital losses are subject to limitations under the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Certain Adjustments to
the Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 305 of the Code, an adjustment to the number of warrant shares that will be issued on the exercise of the warrants, or an adjustment
to the exercise price of the warrants, may be treated as a constructive</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
distribution to a U.S. Holder of the warrants if, and to the extent that, such adjustment has the effect of increasing such U.S. Holder&#8217;s
proportionate interest in our &#8220;earnings and profits&#8221; or assets, depending on the circumstances of such adjustment (for example,
if such adjustment is to compensate for a distribution of cash or other property to our stockholders). Adjustments to the exercise price
of a warrant made pursuant to a bona fide reasonable adjustment formula that has the effect of preventing dilution of the interest of
the holders of the warrants generally should not result in a constructive distribution (see the more detailed discussion of the rules
applicable to distributions made by us at &#8220;Distributions on Shares of Common Stock and Warrant Shares&#8221; below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Distributions on Shares
of Common Stock and Warrant Shares</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have paid no cash dividends on any class of our stock to date, and we do not anticipate paying cash dividends in the near term. If we
were to pay cash dividends in the future, such distributions made on shares of Common Stock and warrant shares generally would be included
in a U.S. Holder&#8217;s income as ordinary</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> dividend
income to the extent of our current or accumulated earnings and profits (determined under U.S. federal income tax principles)
as of the end of our taxable year in which the distribution occurred. Dividends received by certain non-corporate U.S. Holders may be
eligible for taxation at preferential rates provided certain holding period and other requirements are satisfied. Distributions in excess
of our current and accumulated earnings and profits would be treated as a return of capital to the extent of a U.S.
Holder&#8217;s adjusted tax basis </span>in the shares and thereafter as capital gain from the sale or exchange of such shares,
which would be taxable according to rules discussed under the heading &#8220;Sale or Other Taxable Disposition of Shares of Common Stock
and Warrant Shares,&#8221; below. Dividends received by a corporate holder may be eligible for a dividends received deduction, subject
to applicable limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Sale or Other Taxable Disposition
of Shares of Common Stock or Warrant Shares</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Upon the sale
or other taxable disposition of shares of Common Stock or warrant shares, a U.S. Holder generally will recognize capital gain or loss
equal to the difference, if any, between (i) the amount of cash and the fair market value of any property received upon such taxable
disposition and (ii) the U.S. Holder&#8217;s adjusted tax basis in the shares of Common Stock or warrant shares sold or otherwise disposed
of. Such capital gain or loss will be long-term capital gain or loss if a U.S. Holder&#8217;s holding period in the shares of Common
Stock or warrant shares is more than one year at the time of the taxable disposition. Long-term capital gains recognized by certain non-corporate
U.S. Holders (including individuals) may be eligible for taxation at preferential rates. Deductions for capital losses are subject to
limitations under the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Additional Tax on Passive
Income</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Individuals,
estates and certain trusts whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surtax on &#8220;net investment
income&#8221; including, among other things, dividends and net gain from disposition of property (other than property held in certain
trades or businesses). U.S. Holders should consult their own tax advisors regarding the effect, if any, of this tax on their ownership
and disposition of shares of Common Stock, warrants and warrant shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Information Reporting and
Backup Withholding</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Information reporting
requirements generally will apply to payments of dividends on shares of Common Stock, warrants and warrant shares and to the proceeds
of a sale of shares of Common Stock, warrants or warrant shares paid to a U.S. Holder unless the U.S. Holder is an exempt recipient (such
as a corporation). Backup withholding will apply to those payments if the U.S. Holder fails to provide its correct taxpayer identification
number, or certification of exempt status, or if the U.S. Holder is notified by the IRS that it has failed to report in full payments
of interest and dividend income. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules
generally will be allowed as a refund or a credit against a U.S. Holder&#8217;s U.S. federal income tax liability, if any, provided the
required information is furnished in a timely manner to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b>Non-U.S. Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Exercise of Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">A Non-U.S. Holder
generally will not recognize gain or loss for U.S. tax purposes on the exercise of a warrant and related receipt of a warrant share (unless
cash is received in lieu of the issuance of a fractional warrant share and certain other conditions are present, as discussed below under
&#8220;Sale or Other Taxable Disposition of Shares of Common Stock, Warrants and Warrant Shares&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">The U.S. federal
income tax treatment of a cashless exercise of warrants into warrant shares is unclear, and the tax consequences of a cashless exercise
could differ from the consequences upon the exercise of a warrant described in the preceding paragraph. Non-U.S. Holders should consult
their own tax advisors regarding the U.S. federal income tax consequences of a cashless exercise of warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Expiration of Warrants
without Exercise</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Upon the lapse
or expiration of a warrant, a Non-U.S. Holder will not recognize a capital loss unless such Non-U.S. Holder is otherwise subject to U.S.
federal income tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Certain Adjustments to
the Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Under Section
305 of the Code, an adjustment to the number of warrant shares that will be issued on the exercise of the warrants, or an adjustment
to the exercise price of the warrants, may be treated as a constructive distribution to a Non-U.S. Holder of the warrants if, and to
the extent that, such adjustment has the effect of increasing such Non-U.S. Holder&#8217;s proportionate interest in our &#8220;earnings
and profits&#8221; or assets, depending on the circumstances of such adjustment (for example, if such adjustment is to compensate for
a distribution of cash or other property to our stockholders). Adjustments to the exercise price of a warrant made pursuant to a bona
fide reasonable adjustment formula that has the effect of preventing dilution of the interest of the holders of the warrants generally
should not result in a constructive distribution. See the more detailed discussion of the rules applicable to distributions made by us
under the heading &#8220;Distributions on Shares of Common Stock and Warrant Shares&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><i>Distributions on Shares
of Common Stock, Warrants and Warrant Shares</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">We have paid
no cash dividends on any class of our stock to date, and we do not anticipate paying cash dividends in the near term. If we were to pay
cash dividends in the future on our Common Stock or warrant shares, they would be subject to U.S. federal income tax in the manner
described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Cash distributions
on shares of Common Stock and warrant shares generally will constitute dividends for U.S. federal income tax purposes to the extent paid
out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles as of the end of our taxable
year in which the distribution occurred. Distributions in excess of current and accumulated earnings and profits will be applied against
and reduce a Non-U.S. Holder&#8217;s tax basis in shares of Common Stock or warrant shares, to the extent thereof, and any excess will
be treated as capital gain realized on the sale or other disposition of the shares and subject to tax in the manner described under the
heading &#8220;Sale or Other Taxable Disposition of Shares of Common Stock, Warrants and Warrant Shares,&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion of backup withholding and FATCA withholding below, any dividends paid to a Non-U.S. Holder with respect to shares of
Common Stock or warrant shares that constitute dividends under the rules described above</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an applicable
income tax treaty. However, dividends that are effectively connected with the conduct of a trade or business by a Non-U.S. Holder
within the U.S. and, where an income tax treaty applies, are attributable to a U.S. permanent establishment
of the Non-U.S. Holder, are not subject to this withholding tax, but instead are subject to U.S. federal income
tax on a net income basis at applicable individual or corporate rates. A Non-U.S. Holder generally must deliver an IRS Form W-8ECI
certifying under penalties of perjury that such dividends are effectively connected with a U.S. trade or business of the holder
in order for effectively connected dividends to be exempt from this withholding tax. Any such effectively connected dividends received
by a foreign corporation may be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate or such lower rate as may be
specified by an applicable income tax treaty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Non-U.S. Holder of shares of Common Stock or warrant shares who is entitled to and wishes to claim the benefits
of an applicable treaty rate (and avoid backup withholding as discussed below) with respect to dividends received generally
will be required to (i) complete an IRS Form W-8BEN, W-8BEN-E or other appropriate IRS Form W-8 (or an acceptable
substitute form) and make certain certifications, under penalty of perjury, to establish its status as a non-U.S. person
and its entitlement to treaty benefits or (ii) if the shares of Common Stock or warrants shares are held through
certain foreign intermediaries, satisfy the relevant certification requirements of applicable U.S. Treasury regulations. Special
certification and other requirements apply to certain Non-U.S. Holders that are entities rather than individuals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
certification requirements described above must be satisfied prior to the payment of dividends and may be required to be updated periodically.
A Non-U.S. Holder</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> eligible for a reduced rate of
U.S. federal withholding tax pursuant to an income tax treaty may obtain a refund of any excess amounts withheld by timely filing an
appropriate claim for refund with the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale
or Other Taxable</i></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> Disposition of Shares
of Common Stock, Warrants or Warrant Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a Non-U.S. Holder of shares of Common Stock, warrants or warrant shares</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
will not be subject to U.S. federal income tax with respect to gain recognized on a sale or other disposition of such shares of Common
Stock, warrants or warrant shares, unless: (i) the gain is effectively connected with a trade or business of the Non-U.S.
Holder in the U.S. and, where a tax treaty applies, is attributable to a U.S. permanent establishment
of the Non-U.S. Holder (in which case, the special rules described below apply), (ii) in the case of a Non-U.S. Holder who
is an individual, such holder is present in the U.S. for 183 or more days in the taxable year of the sale
or other disposition and certain other conditions are met, in which case the gain would be subject to a flat 30% tax, or such
reduced rate as may be specified by an applicable income tax treaty, which may be offset by U.S. source capital losses, even though the
individual is not considered a resident of the U.S.; or (iii) subject to certain exceptions, we are or have been a &#8220;U.S.
real property holding corporation,&#8221; as such term is defined in Section 897(c) of the Code, during the shorter of the five-year
period ending on the date of disposition or the holder&#8217;s holding period of our shares of Common Stock, warrants or warrant shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">We believe we
currently are not, and do not anticipate becoming, a &#8220;U.S. real property holding corporation&#8221; for U.S. federal income tax
purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Any gain described
in (i) above will be subject to U.S. federal income tax at the regular graduated rates. If the Non-U.S. Holder is a corporation, under
certain circumstances, that portion of its earnings and profits that is effectively connected with its U.S. trade or business, subject
to certain adjustments, generally would be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate or such lower
rate as may be specified by an applicable income tax treaty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Withholding</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
must report annually to the IRS and to each Non-U.S. Holder the amount of dividends paid to such holder on the shares of</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Common Stock, warrants and warrant shares and the tax withheld (if any) with respect to such dividends, regardless of
whether withholding was required. Copies of the information returns reporting such dividends and any withholding may also
be made available to the tax authorities in the country in which the Non-U.S. Holder resides under the provisions of an applicable
income tax treaty or information sharing agreement. In addition, dividends paid to a Non-U.S. Holder may be subject to backup
withholding unless applicable certification requirements are met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Payment of the
proceeds of a sale of shares of Common Stock, warrants or warrant shares within the U.S. or conducted through certain U.S. related financial
intermediaries is subject to information reporting and, depending upon the circumstances, backup withholding unless the
Non-U.S. Holder certifies under penalties of perjury that it is not a U.S. person (and the payor does not have actual
knowledge or reason to know that the holder is a U.S. person) or the holder otherwise establishes an exemption.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in">Any amounts withheld
under the backup withholding rules may be allowed as a refund or a credit against such holder&#8217;s U.S. federal income tax liability
provided the required information is timely furnished to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b>Foreign Account Tax Compliance
Act (&#8220;FATCA&#8221;)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legislation
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commonly referred to as the Foreign Account Tax
Compliance Act and associated guidance, or FATCA, generally will impose a 30% U.S. federal withholding tax on any &#8220;withholdable
payment&#8221; (as defined below) paid to (i) a &#8220;foreign financial institution&#8221; (as specifically defined in the legislation),
whether such foreign financial institution is the beneficial owner or an intermediary, unless such foreign financial institution
agrees to verify, report and disclose its U.S. &#8220;account&#8221; holders (as specifically defined in the legislation) and
meets certain other specified requirements, or (ii) a non-financial foreign entity, whether such non-financial foreign entity
is the beneficial owner or an intermediary, unless such entity provides a certification that the beneficial owner of the payment does
not have any substantial U.S. owners or provides the name, address and taxpayer identification number of each such substantial U.S. owner
and certain other specified requirements are met. In certain cases, the relevant foreign financial institution or non-financial foreign
entity may qualify for an exemption from, or be deemed to be in compliance with, these rules. Under final regulations and other current
guidance, &#8220;withholdable payments&#8221; generally include dividends on shares of Common Stock, warrants and warrant shares, and
(subject to the proposed Treasury regulations discussed below) the gross proceeds of a disposition of shares of Common Stock,
warrants, and warrant shares. Proposed Treasury regulations eliminate withholding under FATCA on payments of gross proceeds. Taxpayers
may rely on these proposed Treasury regulations until final Treasury regulations are issued, but such Treasury regulations are subject
to change. Investors are urged to consult their own tax advisors regarding the possible application of these rules to their
investment in our shares of Common Stock, warrants, and warrant shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="Va_001"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLAN
OF DISTRIBUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Securityholder of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell
any or all of their securities covered hereby on the principal trading market for such securities or any other stock exchange, market
or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Securityholder may use any one or more of the following methods when selling securities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits subscribers;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules&#160;of the applicable exchange;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the Selling Securityholders to sell a specified number of such securities at
    a stipulated price per security;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders may also sell securities under Rule&#160;144 or any other exemption from registration under the Securities Act,
if available, rather than under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Securityholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Securityholders (or, if any broker-dealer acts as agent for the subscriber of securities, from the
subscriber) in amounts to be negotiated, but except as set forth in a supplement to this prospectus, in the case of an
agency transaction not in excess of a customary brokerage commission in compliance with Financial Industry Regulatory Authority (&#8220;<span style="text-decoration: underline">FINRA</span>&#8221;)
Rule&#160;2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Securityholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the
positions they assume. The Selling Securityholders may also sell securities short and deliver these securities to close out their short
positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Securityholders may
also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities
which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities
such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such
transaction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Securityholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Securityholder has informed the Company that it does not have any written or oral agreement
or understanding, directly or indirectly, with any person to distribute the securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred incident to the registration of the securities. The Company has agreed
to indemnify the Selling Securityholders against certain losses, claims, damages and liabilities, including liabilities under the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to keep this prospectus effective until the earlier of (i)&#160;all of the securities have been sold pursuant to this
prospectus or Rule&#160;144 under the Securities Act or any other rule&#160;of similar effect, (ii) all of the securities may
be sold pursuant to Rule&#160;144 without volume or manner-of-sale restrictions, (iii)&#160;it has been two years from the Closing
of the Business Combination, or (iv) as required by other agreements. The resale securities will be sold only through registered
or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities
covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the
registration or qualification requirement is available and is complied with.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules&#160;and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not
simultaneously engage in market making activities with respect to the shares of Common Stock for the applicable restricted period, as
defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Securityholders will be subject to applicable
provisions of the Exchange Act and the rules&#160;and regulations thereunder, including Regulation M, which may limit the timing of purchases
and sales of the shares of Common Stock by the Selling Securityholders or any other person. We will make copies of this prospectus available
to the Selling Securityholders and have informed them of the need to deliver a copy of this prospectus to each Subscriber at or prior
to the time of the sale (including by compliance with Rule&#160;172 under the Securities Act).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Va_002"></span>LEGAL
<span style="letter-spacing: -0.1pt"><span id="a_014"></span>MATTERS</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 33.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities offered by this prospectus will be passed upon for us by </span>Perkins Coie LLP, New York,
New York.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 33.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="Va_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPERTS<sup></sup></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial statements as of and for
the years ended December 31, 2023 and 2022, included in this Registration Statement have been audited by WithumSmith+Brown, PC,
independent registered public accounting firm, as stated in their report appearing herein (which report includes an explanatory paragraph
about the existence of substantial doubt concerning our ability to continue as a going concern). Such consolidated financial statements
have been so included in reliance upon the authority of said firm as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="Va_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_019"></span>WHERE
YOU CAN FIND MORE <span style="letter-spacing: -0.1pt">INFORMATION</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement we filed with the SEC. This prospectus does not contain all of the information set forth
in the registration statement and the exhibits to the registration statement. For further information with respect to us and our
securities, we refer you to the registration statement and the exhibits and schedules filed as
a part of the registration statement. You should rely only on the information contained in this prospectus or incorporated by reference
into this prospectus. We have not authorized anyone else to provide you with different information. We are not making an offer of these
securities in any jurisdiction where the offer is not permitted. You should assume that the information contained in this prospectus,
or any document incorporated by reference in this prospectus, is accurate only as of the date of those respective documents, regardless
of the time of delivery of this prospectus or any sale of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the
public via the Internet at the SEC&#8217;s website at http://www.sec.gov. We maintain a website at www.onemednet.com. You
may access our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those
reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act with the SEC free of charge at our website as soon
as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. The information contained in, or
that can be accessed through, our website is not incorporated by reference into, and is not part of, this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></p>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="Va_005"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> FINANCIAL INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Condensed
Consolidated</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> Financial Statements as of
and for the three and nine months ended September 30, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 92%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#D_004">Unaudited  Condensed Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: -10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#D_005">Unaudited
    Condensed Consolidated Statements of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#D_006">Unaudited
    Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders&#8217; Deficit</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#D_008">Unaudited
    Condensed Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#D_007">Notes
    to the Unaudited Condensed Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audited Condensed Consolidated Financial
Statements as of and for the years ended December 31, 2023 and 2022</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_002">Report of Independent Registered Public Accounting Firm</a> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-17</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_003">Consolidated Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_004">Consolidated Statements of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>19</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_005">Consolidated Statements of Changes in Temporary Equity and Stockholders&#8217; Deficit</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>20</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_006">Consolidated Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-</span>21</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sk_007">Notes to the Consolidated Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-22</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 91; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="D_004"></span>CONDENSED
CONSOLIDATED BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_pn3n3_zg8p3Cyv1wya" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240930_z83eS9MyQGVg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20231231__srt--RestatementAxis__custom--RestatedMember_z8l4wKY9Ixw4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_z6UKfmyYV4qh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_zxDCof5mTV9i" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maACziwX_zhf8JdRSrpug" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-left: 20pt">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-09-30" id="Fact000043" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,934</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000044" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CryptoAssetFairValue_i02I_maACziwX_zpYQSRKGAbM7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Bitcoin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetFairValue" contextRef="AsOf2024-09-30" id="Fact000046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0047">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsReceivableNetCurrent_i02I_maACziwX_zrRZAgO9YBA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-09-30" id="Fact000049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maACziwX_zaYgdpDPNwo2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-09-30" id="Fact000052" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000053" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_mtACziwX_maAzezs_z1PxPEplNYD1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 30pt">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-09-30" id="Fact000055" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,304</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000056" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">365</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredCostsNonCurrent_i01I_maAzezs_zWhxme3ESAk4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Deferred transaction costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maAzezs_z12NA9vacL7b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-09-30" id="Fact000061" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">84</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_i01TI_mtAzezs_zXDeH4Z3Eno" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-09-30" id="Fact000064" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,388</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000065" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zkGoJZ7oB4a6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Liabilities and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrentAbstract_i01B_zaoJu5ETUkuh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzhFV_z1dINeR5NkU7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000073" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,161</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,965</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DeferredRevenueCurrent_i02I_maLCzhFV_zY1oEeXmPvT" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-09-30" id="Fact000076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">428</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000077" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LoansPayableCurrent_i02I_maLCzhFV_zTtjrczuBhmh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2024-09-30" id="Fact000079" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,992</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000080" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,992</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzhFV_zA9NDi1txbf9" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt"><p>Convertible promissory notes</p>
</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LoansPayable_i02I_maLCzhFV_z0u8qVyukqY" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Loan Payable </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NotesPayableCurrent_i02I_maLCzhFV_zjN7en5iYrVj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-09-30" id="Fact000088" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,593</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--YorkvilleNotesPayableCurrent_i02I_maLCzhFV_z9pdV2X6OKb8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Yorkville Note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:YorkvilleNotesPayableCurrent" contextRef="AsOf2024-09-30" id="Fact000091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,911</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0092">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_maLCzhFV_z0y3QEIW3flb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2024-09-30" id="Fact000094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,237</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000095" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,525</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ShortTermBorrowings_i02I_maLCzhFV_zayl1MjPRcu7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Loan &#8211; related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2024-09-30" id="Fact000097" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,306</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShortTermBorrowings" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_i02I_maLCzhFV_zzG9VPQvuw8b" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Other current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesCurrent_i02TI_maLzbd1_mtLCzhFV_zQW81VHjMR5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-left: 30pt">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-09-30" id="Fact000103" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,628</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000104" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,838</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzbd1_zUZ5EXejsTe4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_maLzbd1_zvEhhdmePe5h" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Loan, related party</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzbd1_zuMzTEFrESX7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2024-09-30" id="Fact000112" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Liabilities_i01TI_mtLzbd1_maLASEz9Ja_z3E2Y0fvesV6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 10pt">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-09-30" id="Fact000115" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,656</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,906</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CommitmentsAndContingencies_i01I_maLASEz9Ja_zRnE8bxNMKL8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0118">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0119">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--TemporaryEquityAbstract_i01B" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEz9Ja_zq9PNfZ4DKwh" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total temporary equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_z3vtaHaA5qt7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; deficit:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--PreferredStockValue_i02I_maSEzog2_zjQFXHHV3pf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt">Preferred Stock, par value $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240930_zZwemknVNx81" title="Preferred stock, par value"><span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zNk6VFkoShYe" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact000133" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000135" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240930_zJIuWJ4gRni1" title="Preferred stock, shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zldvrM4yMmOi" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-09-30" id="Fact000137" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000139" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2024 and December 31, 2023; <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20240930_zD7rX8eHrpo8" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240930_zRHSrD9Q4gfi" title="Preferred stock, shares outstanding"><span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20231231_zDUohJBmaTSd" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_z4rUOue4OT96" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-09-30" id="Fact000141" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact000143" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000145" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000147" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding at September 30, 2024 and December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0130">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0131">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CommonStockValue_i02I_maSEzi45_maSEzavK_maSEzog2_z5LIwuTgVhe3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt">Common Stock, par value $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zZj28PgmnGYb" title="Common stock, par value"><span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_z4EcFylKYlxk" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact000154" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>; <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240930_zeKWFD388bL5" title="Common stock, shares authorized"><span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z9JXKO29hzrj" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-09-30" id="Fact000156" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact000158" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20240930_zUMQZrxLlCJ3" title="Common stock, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-09-30" id="Fact000160" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,175,172</ix:nonFraction></span> shares issued and <span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240930_zH1Ii5H8Gvi" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact000162" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,987,427</ix:nonFraction></span> shares outstanding at September 30, 2024, and <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zwzMSKlJniL4" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zdUBOjwMpOS2" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact000164" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact000166" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-09-30" id="Fact000149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000150" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdditionalPaidInCapital_i02I_maSEzog2_z5e13GMudpng" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-09-30" id="Fact000168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85,455</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,996</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--TreasuryStockCommonValue_i02NI_di_msSEzog2_z0ZHGAdMxwXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Treasury stock, at cost, <span id="xdx_904_eus-gaap--TreasuryStockCommonShares_iI_pid_c20240930_zFKF3uesGb2i" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2024-09-30" id="Fact000174" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">187,745</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--TreasuryStockCommonShares_iI_pid_c20231231_ziiWAWNF1p5l" title="Treasury stock, shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2023-12-31" id="Fact000176" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span> shares at September 30, 2024 and December 31, 2023, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:TreasuryStockCommonValue" contextRef="AsOf2024-09-30" id="Fact000171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">529</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0172">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzog2_zDQZZmjFx816" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-09-30" id="Fact000178" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">99,196</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000179" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,440</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockholdersEquity_i02TI_mtSEzog2_maLASEz9Ja_zFlgmBo72f09" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 30pt">Total stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000181" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,268</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000182" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,442</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEz9Ja_z0fhFi9xWPM5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000184" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,388</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact000185" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="D_005"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30F_113_pn3n3_zW9GCX76GHTk" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240701__20240930_z0xDWNfC7Pob" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230701__20230930_zlhKazlND7Xe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240101__20240930_z84rp2BOKuP9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20230101__20230930_zW4uJrvWiN8h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended <br/>September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nine Months Ended <br/>September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenuesAbstract_iB_zhuZdI4TRHAa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zijh8kSK3zyh" style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left; padding-left: 10pt">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-07-012024-09-30_custom_SubscriptionRevenueMember" id="Fact000192" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012023-09-30_custom_SubscriptionRevenueMember" id="Fact000193" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">256</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-01-012024-09-30_custom_SubscriptionRevenueMember" id="Fact000194" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">443</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-09-30_custom_SubscriptionRevenueMember" id="Fact000195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">595</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zwGzAwJE9d07" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-07-012024-09-30_custom_WebImagingRevenueMember" id="Fact000197" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012023-09-30_custom_WebImagingRevenueMember" id="Fact000198" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-01-012024-09-30_custom_WebImagingRevenueMember" id="Fact000199" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-09-30_custom_WebImagingRevenueMember" id="Fact000200" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">86</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPz2AZ_zqwneNiVIIei" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-07-012024-09-30" id="Fact000202" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">142</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-07-012023-09-30" id="Fact000203" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">326</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-01-01to2024-09-30" id="Fact000204" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">617</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-09-30" id="Fact000205" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">681</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CostOfRevenue_msGPz2AZ_zU7dcl2P89k8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2024-07-012024-09-30" id="Fact000207" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">226</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-07-012023-09-30" id="Fact000208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">293</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2024-01-01to2024-09-30" id="Fact000209" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">872</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-09-30" id="Fact000210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">812</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPz2AZ_zsv1WAH5CYx4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-07-012024-09-30" id="Fact000212" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">84</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-07-012023-09-30" id="Fact000213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-01-01to2024-09-30" id="Fact000214" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">255</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-09-30" id="Fact000215" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">131</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zBB8pYH42Qzd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zxA1psBjRDjg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-07-012024-09-30" id="Fact000222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-07-012023-09-30" id="Fact000223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,312</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,934</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-09-30" id="Fact000225" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,475</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zIN0TEpp9mef" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-07-012024-09-30" id="Fact000227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-07-012023-09-30" id="Fact000228" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">243</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000229" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">623</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-09-30" id="Fact000230" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">813</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zkntK18SqzUj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-07-012024-09-30" id="Fact000232" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">298</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-07-012023-09-30" id="Fact000233" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">405</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,127</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-09-30" id="Fact000235" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,566</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_z1aLBlIJ3N55" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-07-012024-09-30" id="Fact000237" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,303</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-07-012023-09-30" id="Fact000238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,960</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-01-01to2024-09-30" id="Fact000239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,684</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-09-30" id="Fact000240" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,854</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maILFCOzVat_z2bx3CQFocDb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Loss from operations</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000242" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,387</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact000243" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,927</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000244" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,939</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact000245" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,985</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zMI96DnFc2r1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestExpenseNonoperating_i01_msNIEz6U0_zSYPRrb8miO1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-07-012024-09-30" id="Fact000252" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0253">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2024-01-01to2024-09-30" id="Fact000254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0255">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEz6U0_zcCs0DNvhCr" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-07-012024-09-30" id="Fact000257" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-01to2024-09-30" id="Fact000259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0260">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEz6U0_zc7KkmR6cT95" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2024-07-012024-09-30" id="Fact000262" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">77</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0263">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2024-01-01to2024-09-30" id="Fact000264" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--GainLossOnFairValueOfYorkvilleNote_i01_msNIEz6U0_z7KyqH1xo1B9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of Yorkville Note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:GainLossOnFairValueOfYorkvilleNote" contextRef="From2024-07-012024-09-30" id="Fact000267" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">262</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0268">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:GainLossOnFairValueOfYorkvilleNote" contextRef="From2024-01-01to2024-09-30" id="Fact000269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0270">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GainLossOnDerivativeInstrumentsNetPretax_i01N_di_maNIEz6U0_zGSF7v4WwQd2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of derivative liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" contextRef="From2024-07-012024-09-30" id="Fact000272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0274">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0275">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CryptoAssetRealizedAndUnrealizedGainLossNonoperating_i01N_di_maNIEz6U0_z0y3TI2C4Oj2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of Bitcoin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating" contextRef="From2024-07-012024-09-30" id="Fact000277" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0278">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating" contextRef="From2024-01-01to2024-09-30" id="Fact000279" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0280">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_maNIEz6U0_zcUMYaSIxmL3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2023-07-012023-09-30" id="Fact000283" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,621</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0284">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-09-30" id="Fact000285" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,872</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockOptionPlanExpense_i01_msNIEz6U0_zfwTcrqWFMud" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0287">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                                          <p style="margin-top: 0; margin-bottom: 0"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-07-012023-09-30" id="Fact000288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,285</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-01-012023-09-30" id="Fact000290" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEz6U0_zxWF9soJLnve" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-07-012024-09-30" id="Fact000292" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-07-012023-09-30" id="Fact000293" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000294" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-09-30" id="Fact000295" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">42</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NonoperatingIncomeExpense_iNT_di_maILFCOzVat_mtNIEz6U0_zlkRWZyGX0Sh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"><p style="margin-top: 0; margin-bottom: 0">Total other expense
(income), net</p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-07-012024-09-30" id="Fact000297" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">329</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-07-012023-09-30" id="Fact000298" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,913</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000299" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">816</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-09-30" id="Fact000300" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,299</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzF5z_mtILFCOzVat_zfj2XT4Q1C4j" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Loss before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_msNILzF5z_z0SLmxcy7WN7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Income tax expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzF5z_z4J8FAthHPf9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000312" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,058</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact000313" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,840</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000314" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,755</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact000315" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,284</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_z7M5mlNwQJlb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--EarningsPerShareBasic_i01_pid_c20240701__20240930_zF72UXJtkE55" title="Basic net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20240701__20240930_zQ7g3SNrKwpk" title="Diluted net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-09-30" id="Fact000322" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30" id="Fact000324" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.07</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_i01_pid_c20230701__20230930_zrgmJOwoS4X1" title="Basic net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230701__20230930_zfvR47LumM28" title="Diluted net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-07-012023-09-30" id="Fact000326" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-07-012023-09-30" id="Fact000328" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">3.23</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_i01_pid_c20240101__20240930_zRUL3Tsgfwnd" title="Basic net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_i01_pid_c20240101__20240930_zKT1XVnBAeji" title="Diluted net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-01to2024-09-30" id="Fact000330" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-01to2024-09-30" id="Fact000332" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.31</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20230930_zVNNQJhI8jZh" title="Basic net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20230930_zq5NNYCOTiek" title="Diluted net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-09-30" id="Fact000334" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-09-30" id="Fact000336" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">7.56</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20240701__20240930_zKgNInSYtvC2" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20240701__20240930_zY6sbhHiLjf1" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-09-30" id="Fact000338" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30" id="Fact000340" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">27,878,399</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230701__20230930_zfZZ9xzW0eLi" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230701__20230930_zbRoIY35gcIi" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-07-012023-09-30" id="Fact000342" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-07-012023-09-30" id="Fact000344" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,280,777</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20240101__20240930_z7iFQfEjsKAl" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20240101__20240930_z6QkpX7l0sRb" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-01to2024-09-30" id="Fact000346" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-01to2024-09-30" id="Fact000348" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">25,051,293</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20230930_zDHWS2sNlKcg" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20230930_zlgCigHbhIue" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-09-30" id="Fact000350" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-09-30" id="Fact000352" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,139,730</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="D_006"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>STOCKHOLDERS&#8217; DEFICIT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
and Nine Months Ended September 30, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_302_114_pn3n3_zCHYO5pqHmVc" summary="xdx: Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_us-gaap--StatementClassOfStockAxis_custom--SeriesATwoPreferredStockMember_z5yoeghY7Xw6">&#160;</td>
    <td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_us-gaap--StatementClassOfStockAxis_custom--SeriesAOnePreferredStockMember_zRG7YVDkmGue">&#160;</td>
    <td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_zshVzLTbUX59">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zBQjKBUITp47" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockCommonMember_zbmTfGiiBHsb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z19rPAVIAeV2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B4_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zXYh0yfasoad" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_zcMZEqkLh7ej" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Treasury Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_435_c20240101__20240331_eus-gaap--StockholdersEquity_iS_pn3n3_zIXbfDdvMWrd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 34%; font-weight: bold">Balances as of December 31, 2023</td>
    <td style="width: 1%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0354">-</span></span></td>
    <td style="width: 1%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></span></td>
    <td style="width: 1%"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0356">-</span></span></td>
    <td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVA8udmI28q6" title="Balance, shares" style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000363" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zou1kEwKTjDj" title="Balance, shares" style="width: 5%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0365">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0358">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000359" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,996</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000360" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,440</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 5%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000361" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,442</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_zV9ulyu9CHsg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common stock to settle deferred underwriter fee payable</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHzkkCucvVfk" title="Issuance of common stock to settle deferred underwriter fee payable, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000376" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">277,778</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0370">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000372" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31" id="Fact000374" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">242</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zKk7sEdx9nnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0381">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-01-012024-03-31" id="Fact000385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">137</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_zGB4F0qVQ67e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Repurchase of common stock</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOI4SKI8BIbc" title="Repurchase of common stock, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000396" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">187,745</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember" id="Fact000391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">529</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2024-01-012024-03-31" id="Fact000394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">529</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--NetIncomeLoss_pn3n3_zelreks1mu0h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0398">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0400">-</span></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0402">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact000404" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,109</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31" id="Fact000405" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,109</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20240401__20240630_eus-gaap--StockholdersEquity_iS_pn3n3_zGalPggtOqs3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balances as of March 31, 2024</td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0407">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0408">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></span></td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zC4pDww0Iap3" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000416" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,850,010</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_z3aTBDaQW8ec" title="Balance, shares" style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-03-31_us-gaap_TreasuryStockCommonMember" id="Fact000418" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">187,745</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_TreasuryStockCommonMember" id="Fact000411" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">529</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000412" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78,375</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember" id="Fact000413" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">93,549</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31" id="Fact000414" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15,701</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_zQKeKBxLVoLk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vesting of restricted stock units</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z7ia8P5MTde3" title="Vesting of restricted stock units, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="Fact000429" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0427">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zX4rmhSmiZpc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation expense</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0435">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-04-012024-06-30" id="Fact000438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_zFy3sS2mSBya" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0441">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0442">-</span></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0444">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0445">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000446" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,589</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30" id="Fact000447" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,589</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_438_c20240701__20240930_eus-gaap--StockholdersEquity_iS_pn3n3_zHk8vMGR8007" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balances as of June 30, 2024</td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0449">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0450">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></span></td>
    <td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1EGb6u8qnil" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000458" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,050,010</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zpwZerhjJVo3" title="Balance, shares" style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000460" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">187,745</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember" id="Fact000453" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">529</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">78,478</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000455" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">97,138</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000456" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">19,187</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_pn3n3_zUELKenw3rX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgFMKDBHoLjk" title="Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000471" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,598,850</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0466">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,270</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0468">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" contextRef="From2024-07-012024-09-30" id="Fact000469" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,270</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee_pn3n3_z3SiPfiQgifg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common stock to settle Yorkville commitment fee</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zusAX0tEgFO6" title="Issuance of common stock to settle Yorkville commitment fee, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="Fact000482" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">526,312</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0476">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" contextRef="From2024-07-012024-09-30" id="Fact000480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zU1E5efqDjx4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0487">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Balance, shares" style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0488">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000489" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2024-07-012024-09-30" id="Fact000491" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_pn3n3_z4reMe9hIba8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0496">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td title="Balance, shares" style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0498">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000499" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,058</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000500" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,058</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20240701__20240930_eus-gaap--StockholdersEquity_iE_pn3n3_zm6mQBu2hrSb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balances as of September 30, 2024</td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0502">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td>
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0504">-</span></span></td>
    <td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRSfTATSM0Hd" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000511" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,175,172</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000505" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zzpAiX3IlYw4" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember" id="Fact000513" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">187,745</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember" id="Fact000506" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">529</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000507" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">85,455</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact000508" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">99,196</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000509" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,268</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three
and Nine Months Ended September 30, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_us-gaap--StatementClassOfStockAxis_custom--SeriesATwoPreferredStockMember_zTdwHd8ycozc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_us-gaap--StatementClassOfStockAxis_custom--SeriesAOnePreferredStockMember_z3dqiuR1RTdg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_z6O4BEEsG4Sg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zCodk6cpfMD6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zP9h0ZfA1Z23" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zSyO2ZeK1I81" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zbaDZOAIPWK5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_435_c20230101__20230331_eus-gaap--StockholdersEquity_iS_pn3n3_zUDGfpO1DI0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold">Balances as of December 31, 2022</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zkjdpmeahXdh" title="Balance, shares" style="width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000523" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zP5Q6jXRuJ07" title="Balance, shares" style="width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000525" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember" id="Fact000517" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1VAJC81hmZ2" title="Balance, shares" style="width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact000527" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0518">-</span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000519" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,657</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 3%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact000520" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,660</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 3%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact000521" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,359</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_z52tfnfcXuZb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0529">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0530">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0531">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0532">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000533" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0534">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-03-31" id="Fact000535" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,935</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zIveHLHEBhx7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0538">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0539">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000541" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">368</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0542">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-03-31" id="Fact000543" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">368</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_pn3n3_zT9ysJRCqkai" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0546">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0547">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0548">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0549">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" id="Fact000550" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,843</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31" id="Fact000551" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,843</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43C_c20230401__20230630_eus-gaap--StockholdersEquity_iS_pn3n3_zL01sZh4Ii3c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balances as of March 31, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zJ8W0AWqZXw2" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000561" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000553" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Rj1nCok5Yh" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000563" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000554" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_custom_TemporaryEquityMember" id="Fact000555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYlPGYWydvV1" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="Fact000565" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0556">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,960</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" id="Fact000558" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">65,503</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" id="Fact000559" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,899</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_zTTO6rCYogJ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common stock in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0568">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230401__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwSEcb3WkU32" title="Issuance of common stock in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember" id="Fact000575" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">177,275</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0571">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0572">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0573">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_zaclMwJPqch6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0578">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0579">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000581" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,165</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-04-012023-06-30" id="Fact000583" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,165</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zSCUn903E7b2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0586">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0587">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000589" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">280</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0590">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-04-012023-06-30" id="Fact000591" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">280</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NetIncomeLoss_pn3n3_zEUM0z7j0qx" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0593">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0595">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0597">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember" id="Fact000598" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,601</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-04-012023-06-30" id="Fact000599" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,601</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20230701__20230930_eus-gaap--StockholdersEquity_iS_pn3n3_zt9TPJezbBwb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balances as of June 30, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zdCCXEy5HYx9" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000609" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000601" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUP9OWrctuId" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000611" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000602" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember" id="Fact000603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWLAmBnZsp08" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000613" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,210,445</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,405</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000606" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">75,104</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000607" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,055</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_43F_c20230701__20230930_eus-gaap--StockholdersEquity_iS_pn3n3_zGpgurIPEib3" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Balance</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zIBq4ooPkk8b" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000623" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zVJ4k8Edslhl" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000625" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000616" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_custom_TemporaryEquityMember" id="Fact000617" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhnUoCymmnsf" title="Balance, shares" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-06-30_us-gaap_CommonStockMember" id="Fact000627" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,210,445</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0618">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000619" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,405</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember" id="Fact000620" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">75,104</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-06-30" id="Fact000621" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39,055</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_zLKW016q7j46" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common stock in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0629">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0630">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxnWGOBB7t01" title="Issuance of common stock in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember" id="Fact000637" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">88,638</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0633">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0634">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0635">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_zPrO3abyfav8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0639">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0640">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0641">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0642">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000643" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,285</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0644">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-07-012023-09-30" id="Fact000645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,285</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock_pn3n3_zUtoFs82EL95" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of Legacy ONMD Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z3vxfplx9WF9" title="Issuance of Legacy ONMD Series A-2 Preferred Stock, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000655" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">5,673</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000647" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0648">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember" id="Fact000649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0650">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0651">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0652">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" contextRef="From2023-07-012023-09-30" id="Fact000653" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_zYvg7uqMNAi5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0658">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0659">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000661" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">798</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0662">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-07-012023-09-30" id="Fact000663" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">798</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_pn3n3_zvVjdud1hZe1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0666">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0667">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0668">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0669">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember" id="Fact000670" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,840</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-07-012023-09-30" id="Fact000671" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,840</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20230701__20230930_eus-gaap--StockholdersEquity_iE_pn3n3_zYDI7iEIeyRg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balances as of September 30, 2023</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zXHyZ9HBVLxi" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000681" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,421,596</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000673" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,650</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zXHMNVz65ZEc" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000683" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000674" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember" id="Fact000675" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCgKmHWGxK4c" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000685" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,299,083</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0676">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000677" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,488</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact000678" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88,944</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" id="Fact000679" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">47,796</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20230701__20230930_eus-gaap--StockholdersEquity_iE_pn3n3_z0W6a20agqdj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zH9XwjcZuVFl" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000695" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,421,596</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact000687" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,650</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYOG57jLTbW2" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000697" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact000688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_custom_TemporaryEquityMember" id="Fact000689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDAZB7eUrASl" title="Balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-09-30_us-gaap_CommonStockMember" id="Fact000699" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,299,083</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0690">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember" id="Fact000691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,488</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember" id="Fact000692" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88,944</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-09-30" id="Fact000693" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">47,796</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="D_008"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_112_pn3n3_z3j3XZD5w4b2" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20240930_zL4AwVof4m4l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230101__20230930_zbG6tKo3z2hf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nine Months Ended September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zr6scm5BXVJ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_i01_maNCPBUz2mk_zuaZG4dLKWdd" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000704" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,755</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-09-30" id="Fact000705" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,284</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zYmfoIsidfD" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUz2mk_zImXh49tvMW6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-01-01to2024-09-30" id="Fact000710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-09-30" id="Fact000711" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUz2mk_zWciGJp1OJj2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-01-01to2024-09-30" id="Fact000713" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">447</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-09-30" id="Fact000714" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,446</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockWarrantExpense_i02_maNCPBUz2mk_z4OcvdXVfom" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000716" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-09-30" id="Fact000717" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,385</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FairValueAdjustmentOfWarrants_i02_maNCPBUz2mk_zrnIFhbSksjj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2024-01-01to2024-09-30" id="Fact000719" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--WarrantExpense_i02N_di_msNCPBUz2mk_zM9IgBrA5Ykh" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i02_maNCPBUz2mk_zfTTn8EwOQt6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2024-01-01to2024-09-30" id="Fact000725" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--ChangeInFairValueOfYorkvilleNote_i02N_di_msNCPBUz2mk_zRbRqs8aoMOl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of Yorkville Note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfYorkvilleNote" contextRef="From2024-01-01to2024-09-30" id="Fact000728" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">561</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0729">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CryptoAssetRealizedAndUnrealizedGainLossNonoperating_i02N_di_msNCPBUz2mk_zxThl18v0rd5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of Bitcoin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating" contextRef="From2024-01-01to2024-09-30" id="Fact000731" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0732">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CryptoAssetRealizedLossNonoperating_i02_maNCPBUz2mk_z2v9HMILQcEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Realized loss on sale of Bitcoin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="us-gaap:CryptoAssetRealizedLossNonoperating" contextRef="From2024-01-01to2024-09-30" id="Fact000734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0735">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_di_msNCPBUz2mk_zDRMnEBvHIQ6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Gain on forgiveness of CEBA loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-01-01to2024-09-30" id="Fact000737" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0738">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--NoncashInterest_i02_maNCPBUz2mk_zCQkuPsze1L1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-cash interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:NoncashInterest" contextRef="From2024-01-01to2024-09-30" id="Fact000740" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0741">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz2mk_zLuZx8CA0WGj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0743">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-09-30" id="Fact000744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,872</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_z2NvtVPYseO1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz2mk_z79Cmd8yeDg9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-01-01to2024-09-30" id="Fact000749" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">89</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-012023-09-30" id="Fact000750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">86</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz2mk_zC32MtElqq07" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2024-01-01to2024-09-30" id="Fact000752" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15</ix:nonFraction></td><td style="text-align: left"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-01-012023-09-30" id="Fact000753" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz2mk_zqiOxMjtqVIi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-01-01to2024-09-30" id="Fact000755" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,232</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-09-30" id="Fact000756" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">340</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz2mk_zHataGdXxKd7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Deferred revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2024-01-01to2024-09-30" id="Fact000758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-01-012023-09-30" id="Fact000759" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">228</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz2mk_zO4M39L0wMU" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact000761" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,956</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-09-30" id="Fact000762" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,066</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zt4bpTEyDSYa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzo3b_zXSnJd68f8xk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchases of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-01-01to2024-09-30" id="Fact000767" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-09-30" id="Fact000768" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentForAcquisitionCryptoAsset_i01N_di_msNCPBUzo3b_zV6lJy1iaBL7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Purchases of Bitcoin</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentForAcquisitionCryptoAsset" contextRef="From2024-01-01to2024-09-30" id="Fact000770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,800</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0771">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromDisposalCryptoAsset_i01_maNCPBUzo3b_zgTP3BuMJn13" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Sales of Bitcoin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromDisposalCryptoAsset" contextRef="From2024-01-01to2024-09-30" id="Fact000773" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">469</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0774">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_maCCERCzG9C_mtNCPBUzo3b_zf4NaHbXgvBe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact000776" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,347</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-09-30" id="Fact000777" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zeZSVrZJPbja" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_maNCPBUzhCa_zsM0jzpgP99j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from private placements, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-01-01to2024-09-30" id="Fact000782" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,270</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0783">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzhCa_zaaIedj9nEF" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of shareholder loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2024-01-01to2024-09-30" id="Fact000785" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2023-01-012023-09-30" id="Fact000786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">704</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzhCa_zos5PNLzJRtl" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of pipe notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUzhCa_zARHQ3flzaB7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of Yorkville Note, net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-01-01to2024-09-30" id="Fact000791" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,350</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0792">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromLinesOfCredit_i01_maNCPBUzhCa_zJQI8I9zGz6g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from line of credit borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2024-01-01to2024-09-30" id="Fact000794" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0795">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RepaymentsOfLongTermDebt_i01N_di_msNCPBUzhCa_zxkegf2GjQZ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Repayment of shareholder loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLongTermDebt" contextRef="From2024-01-01to2024-09-30" id="Fact000797" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0798">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RepaymentsOfLinesOfCredit_i01N_di_msNCPBUzhCa_z2mkqS8mLOD4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Repayment of line of credit borrowings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2024-01-01to2024-09-30" id="Fact000800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0801">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--RepaymentForCommonStockRepurchase_i01N_di_msNCPBUzhCa_zbgF4Ah9sZmf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Repayment for common stock repurchase</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:RepaymentForCommonStockRepurchase" contextRef="From2024-01-01to2024-09-30" id="Fact000803" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--RepaymentOfDeferredUnderwriterFees_i01N_di_msNCPBUzhCa_zR4bDIhGgTI9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Repayment of deferred underwriter fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:RepaymentOfDeferredUnderwriterFees" contextRef="From2024-01-01to2024-09-30" id="Fact000806" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0807">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RepaymentsOfBankDebt_i01N_di_msNCPBUzhCa_ziZTdZvKw9Ag" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Repayment of CEBA loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfBankDebt" contextRef="From2024-01-01to2024-09-30" id="Fact000809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzhCa_z52bQP8aaX8l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-09-30" id="Fact000813" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,875</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_i01_maNCPBUzhCa_z0Frw33uzz39" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0815">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2023-01-012023-09-30" id="Fact000816" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzhCa_zM9NVw1C2mUl" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Proceeds from exercise of stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzhCa_zM8YIIylL7U5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2023-01-012023-09-30" id="Fact000822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,160</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_maCCERCzG9C_mtNCPBUzhCa_z9bdMZA8EdUe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-01to2024-09-30" id="Fact000824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,190</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-09-30" id="Fact000825" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,435</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zsIUEmDjQJ82" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-01-01to2024-09-30" id="Fact000827" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,887</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-09-30" id="Fact000828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">341</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_z1diWfOj3Ac8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of period</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000830" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact000831" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zYOQSECl6IX9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-09-30" id="Fact000833" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,934</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-09-30" id="Fact000834" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">612</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zha69WJtpMT3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssued1_i01_zh3ZXsoEFqR5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to preferred shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_znQhvT3tDdqf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Common shares related to convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zE8N6VfZ9Llj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to Data Knights shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable_i01_zGHt7yTYKOaj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Issuance of common stock to settle deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ONMD:IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" contextRef="From2024-01-01to2024-09-30" id="Fact000848" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">242</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0849">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses_i01_zDVX4zbS1Uq2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Consideration for repurchase of common stock included in accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" contextRef="From2024-01-01to2024-09-30" id="Fact000851" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">429</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_047_20240101_20240930_EabwgBZ4qqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="D_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000854" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_807_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_znib4Gc2T9Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span id="xdx_827_zqInMuCwveq5">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organization
and description of business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
Corporation (the &#8220;Company&#8221;) is a healthcare software company with solutions focused on digital medical image management,
exchange, and sharing. The Company was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions
that simplify digital medical image management, exchange, and sharing. The Company has one wholly owned subsidiary, OneMedNet Technologies
(Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional
currency is the Canadian dollar. The Company&#8217;s headquarters location is Eden Prairie, Minnesota.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, Data Knights Merger Sub, Inc. (&#8220;Merger Sub&#8221;)<span style="background-color: white">,</span> a Delaware corporation
and a wholly owned subsidiary of Data Knights Acquisition Corp. (&#8220;Data Knights&#8221;), a Delaware corporation, merged with and
into OneMedNet Solutions Corporation (formerly named OneMedNet Corporation) (&#8220;Legacy ONMD&#8221;), with Legacy ONMD surviving as
a wholly owned subsidiary of Data Knights (the &#8220;Business Combination&#8221;). Following the consummation of the Business Combination,
Data Knights was renamed to &#8220;OneMedNet Corporation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of presentation and consolidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange Commission
(&#8220;SEC&#8221;) for interim reporting. As permitted under those rules and regulations, certain notes or other financial information
normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The interim unaudited
condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and,
in the opinion of management, reflect all adjustments, which include only normal, recurring adjustments that are necessary to present
fairly the Company&#8217;s results for the interim periods presented. The results from operations for the three and nine months ended
September 30, 2024, are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or for any future
annual or interim period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the annual consolidated
financial statements and the related notes for the year ended December 31, 2023 in the Company&#8217;s Annual Report on Form 10-K, as
amended, filed with the SEC on November 5, 2024 (the &#8220;Form 10-K/A&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
interim unaudited condensed consolidated financial statements include the consolidated accounts of the Company&#8217;s wholly owned subsidiary,
OneMedNet Technologies (Canada) Inc. All significant intercompany transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
and going concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred recurring net losses since its inception, including $<span id="xdx_908_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240701__20240930_z6MPxtVWWQwl" title="Net loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000856" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">2.1</ix:nonFraction></span>
million and $<span id="xdx_901_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20240930_zrBdsC7RWwe6" title="Net loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-09-30" id="Fact000858" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">7.8</ix:nonFraction></span>
million for the three and nine months ended September 30, 2024, respectively. In addition, the Company had an accumulated deficit of
$<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20240930_zV2Iyaf3OJH5" title="Accumulated defecit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-09-30" id="Fact000860" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">99.2</ix:nonFraction></span>
million as of September 30, 2024. The Company&#8217;s cash and Bitcoin  balance of $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20240930_zLEFKpQiCbTb" title="Cash"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-09-30" id="Fact000862" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.9</ix:nonFraction></span>
million and $<span id="xdx_90E_ecustom--CryptoCash_iI_pn5n6_c20240930_zdbeBGvW3d3j" title="Crypto assets"><ix:nonFraction name="ONMD:CryptoCash" contextRef="AsOf2024-09-30" id="Fact000864" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.2</ix:nonFraction></span> million, respectively, is not adequate to fund its operations through at least twelve months from the date these
condensed consolidated financial statements were available for issuance. Therefore, these conditions raise substantial doubt about
the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital
through an equity or debt offering and ultimately hopes to attain profitable operations to fulfill its operating and capital requirements
for at least 12 months from the date of the issuance of the condensed consolidated financial statements. However, the Company may not
be able to secure such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity securities
to raise additional funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences
and privileges senior to those of the Company&#8217;s existing stockholders. The condensed consolidated financial statements do not include
any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company
be unable to continue as a going concern. The Company&#8217;s continuation as a going concern is dependent upon its ability to continue
receiving working capital cash payments and generating cash flow from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to risks common to companies in the markets it serves, including, but not limited to, global economic and financial
market conditions, fluctuations in customer demand, acceptance of new products, development by its competitors of new technological innovations,
dependence on key personnel, and protection of proprietary technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has invested in Bitcoin, which is a crypto asset. Crypto assets are loosely regulated and there is no central marketplace
for currency exchange. Supply is determined by a computer code, not by a central bank, and prices have been extremely volatile. Certain
crypto asset exchanges have been closed due to fraud, failure or security breaches. Any of the Company&#8217;s crypto assets that reside
on an exchange that shuts down may be lost. Several factors may affect the price of crypto assets, including, but not limited to: supply
and demand, investors&#8217; expectations with respect to the rate of inflation, interest rates, currency exchange rates or future regulatory
measures (if any) that restrict the trading of crypto assets, and the use of crypto assets as a form of payment. There is no assurance
that crypto assets will maintain their long-term value in terms of purchasing power in the future, or that acceptance of crypto asset
payments by mainstream retail merchants and commercial businesses will continue to grow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
crypto assets have grown in popularity and market size, various countries and jurisdictions have begun to develop regulations governing
the crypto asset industry. To the extent future regulatory actions or policies limit the ability to exchange crypto assets or utilize
them for payments, the demand for crypto assets could be reduced. Furthermore, regulatory actions may limit the ability of end-users
to convert crypto assets into fiat currency (e.g., U.S. dollars) or use crypto assets to pay for goods and services. Such regulatory
actions or policies could result in a reduction of demand, and in turn, a decline in the underlying crypto asset unit prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect of any future regulatory change on crypto assets in general is impossible to predict, but such change could be substantial and
adverse to the Company and the value of the Company&#8217;s investments in crypto assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crypto
assets are not insured or protected under the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) or the Securities Investor Protection
Company (&#8220;SIPC&#8221;). Accordingly, with respect to its Bitcoin investment, the Company does not enjoy the protections of other
assets covered by the FDIC or SIPC.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Segment
information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in one operating segment and, accordingly, no segment disclosures have been presented herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000866" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zH1VqNaltdWe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_828_zrIhmBlVwG25">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described below, the accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained
in the Form 10-K/A, and the accounting policies followed by the Company for interim financial reporting are consistent with the accounting
policies therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000868" name="us-gaap:StockholdersEquityPolicyTextBlock"><p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zykcr4STYTP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_ztClUiPVzDv5">Treasury
stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records the repurchase of its common stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zV5aGhhoxuBl" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-09-30" id="Fact000870" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (&#8220;Common Stock&#8221;) at cost on the trade date
of the transaction. These shares are considered treasury stock, which is a reduction to stockholders&#8217; equity (deficit). Treasury
stock is included in authorized and issued shares but excluded from outstanding shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000872" name="us-gaap:DerivativesPolicyTextBlock"><p id="xdx_846_eus-gaap--DerivativesPolicyTextBlock_zZ2V9HQlBKzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zWX2Asy1zIL7">Derivative
financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 480, <i>Distinguishing
Liabilities from Equity </i>and ASC 815, <i>Derivatives and Hedging</i>. The result of this accounting treatment is that the fair value
of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability.
The change in fair value is recorded in the condensed consolidated statement of operations as a component of other expense (income),
net. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that
fair value is reclassified to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
reassessed at the end of each reporting period. Derivative instrument liabilities will be classified in the condensed consolidated
balance sheets as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12
months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000874" name="srt:PlatformOperatorCryptoAssetPolicyTextBlock"><p id="xdx_845_esrt--PlatformOperatorCryptoAssetPolicyTextBlock_zibQBfSiylnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zd4ljSuuHwQ9">Crypto
assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-08, <i>Intangibles
- Goodwill and Other - Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets </i>(&#8220;ASU
2023-08&#8221;), which provides an update to existing crypto asset guidance and requires an entity to measure certain crypto assets
at fair value. In addition, this guidance requires disclosures related to crypto assets once it is adopted. As of January 1, 2024,
the Company has adopted ASU 2023-08.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reflects crypto assets held at fair value on the condensed consolidated balance sheets and condensed consolidated statements
of cash flows, the activity from remeasurement of crypto assets at fair value on the condensed consolidated statements of
operations, and the required expanded disclosures in Note 3, <i>Crypto Assets Held</i>. The adoption of ASU 2023-08 resulted in no
cumulative-effect adjustment to the opening balance of retained earnings as of January 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crypto
assets are generally valued using prices as reported on reputable and liquid exchanges and may involve using an average of bid and ask
quotes using closing prices provided by such exchanges as of the date and time of determination. The time used is 4:00 pm EST.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000876" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zgtB9aGPE3O9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zJw7ipdRavCd">Net
loss per share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required
for participating securities. Certain warrants participate in distributions of the Company. The pre-funded warrants associated with the
July and September 2024 private placements (see Note 7) are considered outstanding shares in the basic earnings per share calculation
given their nominal exercise price. The net loss attributable to common stockholders is not allocated to the warrant holders as the warrant
holders do not have a contractual obligation to share in losses. Basic net loss per share is calculated by dividing the net loss by the
weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss
by the weighted-average number of shares of Common Stock and common stock equivalents outstanding for the period. Common stock equivalents
are only included when their effect is dilutive. The Company&#8217;s potentially dilutive securities, including outstanding warrants
to purchase Common Stock and outstanding stock options under the Company&#8217;s equity incentive plan, have been excluded from the computation
of diluted net loss per share as their inclusion would be anti-dilutive. For all periods presented, there is no difference in the number
of shares used to calculate basic and diluted shares outstanding to the Company&#8217;s net loss position.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000878" name="ONMD:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_844_ecustom--EmergingGrowthCompanyPolicyTextBlock_zcRl5YIt2WRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_z0NQmbkWgKc4">Emerging
growth company status</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company&#8221;, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;).
Under the JOBS Act, emerging growth companies can take advantage of an extended transition period for complying with new or revised accounting
standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company has elected to
use this extended transition period for complying with certain new or revised accounting standards that have different effective dates
for public and private companies until the earlier of the date that it (1) is no longer an emerging growth company or (2) affirmatively
and irrevocably opts out of the extended transition period provided in the JOBS Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000880" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUkuk6y4J0ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zBbPJIwc5OK3">Accounting
pronouncements not yet adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No.
2023-09, <i>Improvements to Income Tax Disclosures (Topic 740)</i> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires disaggregated information
about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. ASU 2023-09
is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual
financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of
adopting ASU 2023-09 on the presentation of its condensed consolidated financial statements and footnotes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment
Disclosures</i>, which is intended to provide enhancements to segment disclosures, even for entities with only one reportable
segment. In particular, the standard will require disclosures of information related to significant segment expenses regularly
provided to the chief operating decision maker and included within each reported measure of segment profit and loss. The standard
will also require disclosure of all other segment items by reportable segment and a description of its composition. Finally, the
standard will require disclosure of the title and position of the chief operating decision maker and an explanation of how the chief
operating decision maker uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to
allocate resources. The standard is effective for annual periods beginning after December 15, 2023, and interim periods within
annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the
standard on the presentation of its condensed consolidated financial statements and footnotes.</span></p>

</ix:nonNumeric><p id="xdx_852_zNGSKxUsp7Mc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000882" name="us-gaap:CryptoAssetTextBlock"><p id="xdx_805_eus-gaap--CryptoAssetTextBlock_zKLCg55gnXuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
<span id="xdx_827_zoO8pgRsi5F8">Crypto Assets Held</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000884" name="us-gaap:CryptoAssetHoldingTableTextBlock"><p id="xdx_897_eus-gaap--CryptoAssetHoldingTableTextBlock_zTB0AIener44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s crypto assets are comprised solely of Bitcoin. In accordance with ASC Topic 820, <i>Fair Value Measurement</i>, the Company measures the fair value of its Bitcoin based on the quoted
end-of-day price on the measurement date for a single Bitcoin on an active trading platform, River.com. Management has determined that
River.com, an active exchange market, represents a principal market for Bitcoin and the end-of-day quoted price is both readily available
and representative of fair value (Level 1 inputs). The following table sets forth the units held,
cost basis, and fair value of Bitcoin held, as shown on the condensed consolidated balance sheet as of September 30, 2024 (in
thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B4_zY3UlrZWZ5ne" style="display: none">Schedule of
Crypto Assets Held</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Units</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost Basis</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Crypto assets held:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; padding-bottom: 1pt">Bitcoin</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zLOn4p19mJN7" title="Crypto assets, Units" style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetNumberOfUnits" contextRef="AsOf2024-09-30_custom_BitcoinMember" id="Fact000886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Integer">34</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zp3DECi0H9Qi" title="Crypto assets, Cost Basis" style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetCost" contextRef="AsOf2024-09-30_custom_BitcoinMember" id="Fact000888" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,280</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zroUcn7ulLG3" title="Crypto assets, Fair Value" style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetFairValue" contextRef="AsOf2024-09-30_custom_BitcoinMember" id="Fact000890" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930_zxCzDZA5h31d" title="Crypto assets, Units" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetNumberOfUnits" contextRef="AsOf2024-09-30" id="Fact000892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Integer">34</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930_znPTUFykpP3e" title="Crypto assets, Cost Basis" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetCost" contextRef="AsOf2024-09-30" id="Fact000894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,280</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930_zkrQPxzIqVEi" title="Crypto assets, Fair Value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetFairValue" contextRef="AsOf2024-09-30" id="Fact000896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_z4zmSbHVicB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000898" name="us-gaap:CryptoAssetActivityTableTextBlock"><p id="xdx_893_eus-gaap--CryptoAssetActivityTableTextBlock_z1bD7UqESyQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents a reconciliation of the fair values of the Company&#8217;s Bitcoin for the nine months ended September 30, 2024
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify; text-indent: 0.5in"><span id="xdx_8BA_zCLq1qYiSvyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Crypto Assets Reconciliation of Fair Values</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20240930_ztdl1EyPS13j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bitcoin</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CryptoAssetFairValue_iS_pn3n3_zQZHqSEdjwW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0900">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CryptoAssetAddition_pn3n3_zMGUwIBFwPFg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Additions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetAddition" contextRef="From2024-01-01to2024-09-30" id="Fact000902" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,800</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CryptoAssetDisposition_iN_pn3n3_di_zMvzW35TKVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Dispositions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CryptoAssetDisposition" contextRef="From2024-01-01to2024-09-30" id="Fact000904" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">520</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--CryptoAssetRealizedAndUnrealizedGainLossNonoperating_pn3n3_zm0rtpou1iD4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized loss, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating" contextRef="From2024-01-01to2024-09-30" id="Fact000906" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">124</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--CryptoAssetFairValue_iE_pn3n3_zoOCyIpKptze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CryptoAssetFairValue" contextRef="AsOf2024-09-30" id="Fact000908" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zV7be24ybcl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions
are the result of the Company acquiring Bitcoin with liquid assets from private placements, while dispositions are the
result of sales of Bitcoin. During the three and nine months ended September 30, 2024, the Company had Bitcoin dispositions of $<span id="xdx_90E_eus-gaap--CryptoAssetDisposition_pn5n6_c20240701__20240930_z8aIxi1EOSC6" title="Bitcoin dispositions"><span id="xdx_90B_eus-gaap--CryptoAssetDisposition_pn5n6_c20240101__20240930_zcLh8GIt5kVi" title="Bitcoin dispositions"><ix:nonFraction name="us-gaap:CryptoAssetDisposition" contextRef="From2024-07-012024-09-30" id="Fact000910" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD"><ix:nonFraction name="us-gaap:CryptoAssetDisposition" contextRef="From2024-01-01to2024-09-30" id="Fact000912" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></ix:nonFraction></span></span> million,
inclusive of realized losses of $<span id="xdx_909_eus-gaap--CryptoAssetRealizedAndUnrealizedLossNonoperating_pn3n3_c20240701__20240930_zgdIrfF1UOv1" title="Bitcoin realized losses"><span id="xdx_903_eus-gaap--CryptoAssetRealizedAndUnrealizedLossNonoperating_pn3n3_c20240101__20240930_zBKqUhCaUN02" title="Bitcoin realized losses"><ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating" contextRef="From2024-07-012024-09-30" id="Fact000914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating" contextRef="From2024-01-01to2024-09-30" id="Fact000916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">51</ix:nonFraction></ix:nonFraction></span></span> thousand. The Company uses a first-in, first-out methodology to assign costs to Bitcoin for purposes
of the Bitcoin held and realized gains and losses disclosure above. Bitcoin is included in current assets in the condensed consolidated
balance sheet due to the Company&#8217;s ability to sell them in a highly liquid marketplace and its intent to liquidate its Bitcoin
to support operations when needed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000918" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zgE3dIWpWlTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_823_zK5JMJPEWQKa">Convertible Debt</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
Promissory Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
2019 to 2023, the Company issued various convertible promissory notes to related and unrelated party investors, which were convertible
into equity securities of Legacy ONMD upon a next equity financing transaction (the &#8220;Convertible Promissory Notes&#8221;). The
Convertible Promissory Notes bore interest at a rate of either <span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zqFlkQW35Io2" title="Debt conversion converted instrument rate"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentRate" contextRef="From2024-01-012024-09-30_srt_MinimumMember" id="Fact000920" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4</ix:nonFraction></span>% or <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zI4ZzeUpZyhi" title="Debt conversion converted instrument rate"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentRate" contextRef="From2024-01-012024-09-30_srt_MaximumMember" id="Fact000922" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>% annually from the date of issuance until the outstanding principal
was paid or converted. In connection with the issuance of Convertible Promissory Notes in 2022 and 2023, the Company also issued warrants
at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240930__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesWarrantsMember_zj1mzTFDZnO9" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30_custom_ConvertibleNotesWarrantsMember" id="Fact000924" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per share (the &#8220;Convertible Promissory Notes Warrants&#8221;). See additional information on the
accounting for the warrants in Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Promissory Notes were issued for general working capital purposes. The Company elected the fair value option (&#8220;FVO&#8221;)
of accounting under ASC 825, <i>Financial Instruments</i>, for its Convertible Promissory Notes. Under the FVO election, the financial
instrument is initially measured at its issue-date estimated fair value and subsequently remeasured at estimated fair value on a recurring
basis at each reporting period date. The estimated fair value adjustment is presented as a single line item within other expense (income),
net in the accompanying condensed consolidated statements of operations under the caption change in fair value of convertible promissory
notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, all Convertible Promissory Notes were converted pursuant to their provision in connection with the Business Combination
between Data Knights and Legacy ONMD and were no longer outstanding as of December 31, 2023. See the Form 10-K/A for all other details
relating to the Convertible Promissory Notes issued prior to December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2023, <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20230628__20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zn2SjncbvHzc" title="Debt description"><ix:nonNumeric contextRef="From2023-06-282023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember" id="Fact000926" name="us-gaap:DebtInstrumentDescription">Data
Knights and certain investors (the &#8220;Purchasers&#8221;) entered into a Securities Purchase Agreement pursuant to which Data
Knights issued and sold to the Purchasers a new series of senior secured convertible notes (the
&#8220;PIPE Notes&#8221;), which are convertible into shares of Common Stock at the Purchasers&#8217; election at a conversion price equal
to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) Trading
Days immediately preceding the conversion date.</ix:nonNumeric></span> The PIPE Notes matured on the first anniversary of the issuance date, or
November 7, 2024. The majority of the PIPE Notes holders have elected to convert their PIPE Notes into shares of Common Stock, which
will occur upon the Company&#8217;s filing of a Registration Statement on Form S-1.</span> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected the FVO of accounting for its PIPE Notes. The estimated fair value adjustment is presented as a single line item
within other expense (income), net in the accompanying condensed consolidated statements of operations under the caption change in
fair value of PIPE Notes. As of September 30, 2024 and December 31, 2023, the fair value of the PIPE Notes was $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20240930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zF04u7lLsVK5" title="PIPE Notes"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2024-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember" id="Fact000928" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span>
million and $<span id="xdx_90A_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7xn7Wmwz6Oh" title="PIPE Notes"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-12-31_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember" id="Fact000930" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span> million, respectively, which is included in current liabilities on the condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholder
Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January to June 2024, the Company received gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1KAO1HJLP76" title="Loans payable"><ix:nonFraction name="us-gaap:ProceedsFromLoans" contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember" id="Fact000932" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span> million in connection with shareholder loans with a related party investor
which are convertible into <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240101__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlfrraQ7AUe9" title="Stock issued during period shares conversion of convertible securities"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember" id="Fact000934" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,123,312</ix:nonFraction></span> shares of Common Stock at a conversion price of $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH7crsHhNtOi" title="Debt conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember" id="Fact000936" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.7535</ix:nonFraction></span> per share. These loans do not bear interest
and mature one year from issuance. The balance of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZwwcM2VIfsh" title="Principal amount of notes payable"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember" id="Fact000938" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span> million is included in loan &#8211; related party on the condensed consolidated
balance sheet as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Helena
Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company entered into a definitive securities purchase agreement (the &#8220;Helena SPA&#8221;) with Helena Global
Investment Opportunities 1 Ltd. (&#8220;Helena&#8221;), an affiliate of Helena Partners Inc., a Cayman Islands-based advisor and investor
providing for up to $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240328__20240328_ztXQ0WdfGwha" title="Proceeds from issuance of convertible notes"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-03-282024-03-28" id="Fact000940" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.5</ix:nonFraction></span> million in funding through a private placement for the issuance of senior secured convertible notes and warrants
across multiple tranches. The Helena SPA was subsequently terminated in June 2024 prior to the closing of any tranches (the &#8220;Helena
Termination Agreement&#8221;). As such, except as described below, the Helena SPA had no impact on the Company&#8217;s condensed consolidated
financial statements as of and for the <span style="background-color: white">nine months </span>ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Helena Termination Agreement, the Company agreed to issue to Helena a warrant to purchase <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240328_zCFfsfDipzhl" title="Warrant outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-03-28" id="Fact000942" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> shares of Common Stock at an
exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240328_ziHpzXLON6Dg" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-03-28" id="Fact000944" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.20</ix:nonFraction></span> per share (the &#8220;Helena Termination Warrants&#8221;) and agreed to reimburse Helena for certain reasonable
and documented out-of-pocket legal fees and expenses incurred in connection with entry into the Helena SPA and Helena Termination Agreement
and related documents. The Company incurred legal fees and expenses of $<span id="xdx_901_eus-gaap--LegalFees_pn3n3_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--HelenaTerminationAgreementMember_zzR87PxCnC26" title="Legal fees"><ix:nonFraction name="us-gaap:LegalFees" contextRef="From2024-03-282024-03-28_custom_HelenaTerminationAgreementMember" id="Fact000946" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></span> thousand in connection with the Helena Termination Agreement.
As of September 30, 2024, the Helena Termination Warrants were not yet issued or outstanding. However, in accordance with the loss contingency
guidance of ASC Topic 450, <i>Contingencies</i>, the Company determined that it was probable that a liability had been incurred (its
obligation to issue warrants) and the amount of the loss could be reasonably estimated (the fair value of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930_zZrhrCT2XWac" title="Number of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-30" id="Fact000948" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> warrants at an exercise
price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240930_zc0rvQmwEsK" title="Exercise price of warrant"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-30" id="Fact000950" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.20</ix:nonFraction></span> per share). Therefore, the Company recorded stock warrant expense of $<span id="xdx_90B_ecustom--StockWarrantExpense_pn3n3_c20240101__20240930_zRGCkZplq2Kd" title="Stock warrant expense"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2024-01-01to2024-09-30" id="Fact000952" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33</ix:nonFraction></span> thousand in its condensed consolidated statement
of operations, with an offsetting liability to accounts payable and accrued expenses on its condensed consolidated balance sheet. The
Company will reclassify the contingent liability to equity or warrant liabilities under applicable guidance when the Helena Termination
Warrants are issued, which occurred in December 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Yorkville
Note</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company entered into a Standby Equity Purchase Agreement (&#8220;SEPA&#8221;) with YA II PN, LTD, a Cayman Islands
exempt limited partnership managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;) (see Note 7). Upon entry into the SEPA,
the Company issued Yorkville a $<span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_pn5n6_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zulY9UuqiMc8" title="Convertible promissory note"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember" id="Fact000954" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million convertible promissory note for $<span id="xdx_906_eus-gaap--Cash_iI_pn4n6_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zdRaAM9caZl7" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember" id="Fact000956" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">1.35</ix:nonFraction></span> million in cash (after a <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zvPgkJeJYYmk" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember" id="Fact000958" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% original issue discount)
(the &#8220;Yorkville Note&#8221;). The Yorkville Note does not bear interest and matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_pid_dd_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zzxsn56vjOY9" title="Maturity date"><ix:nonNumeric contextRef="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember" format="ixt:datemonthdayyearen" id="Fact000960" name="us-gaap:DebtInstrumentMaturityDate">June 17, 2025</ix:nonNumeric></span>. <span id="xdx_909_eus-gaap--DebtInstrumentDescription_pid_dd_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zT4Bij1QnXaj" title="Debt description"><ix:nonNumeric contextRef="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember" id="Fact000962" name="us-gaap:DebtInstrumentDescription">The Yorkville Note is convertible
by Yorkville into shares of Common Stock at an aggregate purchase price based on a price per share equal to the lower of (a) $1.3408
per share (subject to downward reset upon the filing of the resale registration statement described below) or (b) 90% of the lowest daily
volume-weighted average price (&#8220;VWAP&#8221;) of the Common Stock on Nasdaq during the seven trading days immediately prior to each
conversion (the &#8220;Variable Price&#8221;), but which Variable Price may not be lower than the Floor Price then in effect.</ix:nonNumeric></span> The &#8220;Floor
Price&#8221; is $<span id="xdx_90F_ecustom--FloorPricePerShare_iI_c20240617__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zb6WTBadgGxb" title="Floor price per share"><ix:nonFraction name="ONMD:FloorPricePerShare" contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember" id="Fact000964" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.28</ix:nonFraction></span> per share, subject to the Company&#8217;s option to reduce the Floor Price to any amounts set forth in a written
notice to Yorkville. Upon the occurrence and during the continuation of an event of default (as defined in the Yorkville Note), the Yorkville
Note will become immediately due and payable. The issuance of the Common Stock upon conversion of the note and otherwise under the SEPA
is capped at <span id="xdx_902_ecustom--PrecentageOfOutstandingCommonStock_dp_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zpCKLojZ4v" title="Precentage of outstanding common stock"><ix:nonFraction name="ONMD:PrecentageOfOutstandingCommonStock" contextRef="From2024-06-182024-06-18_custom_StandbyEquityPurchaseAgreementMember" id="Fact000966" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.9</ix:nonFraction></span>% of the outstanding Common Stock as of June 18, 2024. Further, the note and SEPA include a beneficial ownership blocker
for Yorkville such that Yorkville may not be deemed the beneficial owner of more than <span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_c20240617__srt--OwnershipAxis__custom--BeneficialOwnershipMember__srt--RangeAxis__srt--MinimumMember_zwaRDlaPWXqi" title="Beneficial ownership percentage"><ix:nonFraction name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" contextRef="AsOf2024-06-17_custom_BeneficialOwnershipMember_srt_MinimumMember" id="Fact000968" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of the Company&#8217;s Common Stock. As a
result of the Company&#8217;s failure to file its Form 10-Q for the fiscal quarter ended June 30, 2024 by August 14, 2024 (i.e., a deemed
Event of Default under the Yorkville Note), the Company began accruing interest at the default rate of <span id="xdx_904_ecustom--DebtInstrumentInterestRateDefaultPercentage_iI_pid_dp_c20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh45U7CPLqtl" title="Debt default interest rate"><ix:nonFraction name="ONMD:DebtInstrumentInterestRateDefaultPercentage" contextRef="AsOf2024-10-01_us-gaap_SubsequentEventMember" id="Fact000970" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18.0</ix:nonFraction></span>% as of August 14, 2024. A
further event of default occurred as a result of the Company&#8217;s failure to file a registration statement with the SEC for the resale
by Yorkville of the shares of Common Stock issuable under the SEPA by August 30, 2024 (see Note 7). As such, the full unpaid principal
amount of the Yorkville Note may become immediately due and payable at Yorkville&#8217;s election. The Company subsequently engaged in
discussions with Yorkville regarding these events of default, which discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected the FVO of accounting for the Yorkville Note. The estimated fair value adjustment is presented as a single line item
within other expense (income), net in the accompanying condensed consolidated statements of operations under the caption change in fair
value of Yorkville Note. As of September 30, 2024, the fair value of the Yorkville Note was $<span id="xdx_90C_ecustom--YorkvilleNotesPayableCurrent_iI_pn5n6_c20240930_zTt1BiL2G7s9" title="Fair value of Yorkville Note"><ix:nonFraction name="ONMD:YorkvilleNotesPayableCurrent" contextRef="AsOf2024-09-30" id="Fact000972" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.9</ix:nonFraction></span> million, which is included in current
liabilities on the condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000974" name="us-gaap:ShortTermDebtTextBlock"><p id="xdx_80C_eus-gaap--ShortTermDebtTextBlock_z4jlZwJEgNVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
<span id="xdx_821_z9XD6EJMgSTb">Line of Credit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, the Company obtained a line of credit of $<span id="xdx_904_eus-gaap--LineOfCredit_iI_pn5n6_c20240331__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_z2ljrRYshtkj"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2024-03-31_custom_BOCBankMember" id="Fact000975" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.0</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million with BOC Bank to support short-term working
capital needs. The line of credit bears an interest rate of <span id="xdx_900_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20240301__20240331__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_zkT76zUVUPZ"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" contextRef="From2024-03-012024-03-31_custom_BOCBankMember" id="Fact000976" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.0</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and matures in 120 days. In July 2024, the maturity date was extended an additional 120 days to November 2, 2024. The line of credit
was terminated at maturity in November 2024. As of September 30, 2024, there was <span id="xdx_90B_eus-gaap--LineOfCredit_iI_pn6n6_do_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_zMfBfm3SyjYl">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">balance outstanding on the line of credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000979" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80D_eus-gaap--DebtDisclosureTextBlock_z1hJ0b91gQV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
<span id="xdx_82E_zjLpuYW4gLRd">Canadian Emergency Business Account (&#8220;CEBA&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, the Company applied for and received a $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zW2YBo3xqU05" title="Proceeds from loans"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfUnsecuredDebt" contextRef="From2020-12-012020-12-31_custom_CEBALoanMember" id="Fact000981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="CAD">60</ix:nonFraction></span> thousand CAD ($<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zsSziDGlhTH1" title="Proceeds from loans"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfUnsecuredDebt" contextRef="From2020-12-012020-12-31_custom_CEBALoanMember" id="Fact000983" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></span> thousand USD) equivalent CEBA loan. The loan was provided
by the government of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and
better position them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through
December 31, 2023. If the loan was paid back by January 18, 2024, $<span id="xdx_90F_eus-gaap--DebtInstrumentDecreaseForgiveness_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zCvOcNhwQZp8" title="Forgiven of loan"><ix:nonFraction name="us-gaap:DebtInstrumentDecreaseForgiveness" contextRef="From2020-12-012020-12-31_custom_CEBALoanMember" id="Fact000985" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span> thousand of the loan would have been forgiven. If the loan was
not paid back by January 18, 2024, the full $<span id="xdx_900_eus-gaap--DebtConversionOriginalDebtAmount1_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zDdu5sArUMTe" title="Conversion of loan"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2020-12-012020-12-31_custom_CEBALoanMember" id="Fact000987" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></span> thousand loan would have been converted to a loan repayable over <span id="xdx_905_eus-gaap--DebtInstrumentTerm_dc_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJ1ETCo2z78l" title="Loan payment term"><ix:nonNumeric contextRef="From2020-12-012020-12-31_custom_CEBALoanMember" format="ixt-sec:durwordsen" id="Fact000989" name="us-gaap:DebtInstrumentTerm">three years</ix:nonNumeric></span> with a <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJW1VlW8jUH4" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-31_custom_CEBALoanMember" id="Fact000991" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>%
interest rate. The loan was paid back prior to January 18, 2024, and the Company recognized a gain on extinguishment of $<span id="xdx_905_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zhhHczOlBPTj" title="Gain loss on extinguishment of debt"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-01-012024-09-30_custom_CEBALoanMember" id="Fact000993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span> thousand,
which is presented in other expense (income), net in the condensed consolidated statement of operations for the nine months
ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact000995" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zbu0Xd6kkx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_824_z8w5WKUjnEca">Stockholders&#8217; Deficit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, Data Knights entered into an agreement with their underwriters (&#8220;EF Hutton&#8221;) whereby
EF Hutton agreed to waive the related merger underwriting fees that were payable at closing ($<span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z6urNFkClzm" title="Business combination, underwriter fees payable"><ix:nonFraction name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact000997" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.0</ix:nonFraction></span> million) in exchange for allocated
payments as follows: (i) $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zvUH5CDkDTia" title="Business combination, closing cash balance"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact000999" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million in cash at closing; (ii) a $<span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2LBqOIJPwt9" title="Promissory note"><ix:nonFraction name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact001001" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million promissory note that matured on <span id="xdx_90D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_dd_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zwqfRnR2ompe" title="Debt maturity date"><ix:nonNumeric contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember" format="ixt:datemonthdayyearen" id="Fact001003" name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable">March 1, 2024</ix:nonNumeric></span>; and (iii)
a transfer of <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesTransferred_pid_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_ziDLyoHhrEb4" title="Number of shares transferred"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesTransferred" contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact001005" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">277,778</ix:nonFraction></span> shares of Common Stock, which were valued at the closing stock price of $<span id="xdx_900_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20230628__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zX32Y339OjGi" title="Closing stock price"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2023-06-28_custom_DataKnightsAcquisitionCorpMember" id="Fact001007" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.89</ix:nonFraction></span> per share on June 28, 2023. If,
five trading days prior to the six-month anniversary, the aggregate VWAP value of the <span id="xdx_901_ecustom--VolumeWeightedAveragePrice_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zTCVDJ7AbY69" title="Volume weighted average price"><ix:nonFraction name="ONMD:VolumeWeightedAveragePrice" contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact001009" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">277,778</ix:nonFraction></span> shares of Common Stock was lower than the
original share value of $<span id="xdx_90A_ecustom--VolumeWeightedAveragePriceValue_pn5n6_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_ziS1IXEzQMT8" title="Volume weighted average price, value"><ix:nonFraction name="ONMD:VolumeWeightedAveragePriceValue" contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact001011" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.0</ix:nonFraction></span> million, <span id="xdx_902_eus-gaap--BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_c20231107__20231107_zFiw5oWDxzq8" title="Description of contingent consideration"><ix:nonNumeric contextRef="From2023-11-072023-11-07" id="Fact001013" name="us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod">the Company was obligated to compensate EF Hutton at a new share price equal to the difference
in amount on such date. Due to the decrease in share value on the six-month anniversary, the Company was required to either pay to EF
Hutton an additional $2.8 million or issue to EF Hutton an additional 3,175,000 shares of Common Stock.</ix:nonNumeric></span> In January 2024, the Company
issued the original <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240131_z5qYSXwZjKpb" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-01-31" id="Fact001015" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">277,778</ix:nonFraction></span> shares of Common Stock as consideration for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20240101__20240131_z2KmEz1Wayy6" title="Number of shares issued, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-01-31" id="Fact001017" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.2</ix:nonFraction></span> million owed by the Company. As of September 30, 2024, <span id="xdx_909_eus-gaap--BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_c20240101__20240930_zpEl2i5CdVH1" title="Description of contingent consideration"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" id="Fact001019" name="us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod">the
Company was obligated to pay to EF Hutton the true-up of either $2.8 million or 3,175,000 shares of Common Stock valued at $0.88 per
share, plus the $0.5 million promissory note. Upon the occurrence of an event of default, the promissory note bears interest at a rate
of 12.5% until such event of default is cured.</ix:nonNumeric></span> The promissory note remained unpaid upon maturity on <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930_zeyArWQOPkud" title="Debt instrument maturity date"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt:datemonthdayyearen" id="Fact001021" name="us-gaap:DebtInstrumentMaturityDate">March 1, 2024</ix:nonNumeric></span>, and the Company recorded
interest expense of $<span id="xdx_900_eus-gaap--InterestExpense_pn3n3_c20240701__20240930_zcn8rAIeESu9" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-07-012024-09-30" id="Fact001023" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span> thousand and $<span id="xdx_905_eus-gaap--InterestExpense_pn3n3_c20240101__20240930_zOKu6Tg4Igm5" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001025" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span> thousand during the three and nine months ended September 30, 2024, respectively, because of
the event of default. In August 2024, the Company made a promissory note payment of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn5n6_c20240801__20240831_z4eFN6762kA2" title="Promissory note payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2024-08-012024-08-31" id="Fact001027" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2024, the Company entered into a stock repurchase agreement with a former holder of Convertible Promissory Notes pursuant to
which the Company repurchased <span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_z5nR21WZrNw7" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember" id="Fact001029" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">187,745</ix:nonFraction></span> shares of Common Stock in exchange for cash of $<span id="xdx_90F_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_z4lZwsyqSJsi" title="Number of shares repurchased, value exchange for cash"><ix:nonFraction name="ONMD:StockRepurchasedDuringPeriodValueExchangeForCash" contextRef="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember" id="Fact001031" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million that is payable in installments. The
Company made payments of $<span id="xdx_906_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20240701__20240731__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zxuisEtQbsH9" title="Number of shares repurchased, value exchange for cash"><span id="xdx_906_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20241001__20241031__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zWOI9TrnsEx" title="Number of shares repurchased, value exchange for cash"><ix:nonFraction name="ONMD:StockRepurchasedDuringPeriodValueExchangeForCash" contextRef="From2024-07-012024-07-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember" id="Fact001033" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD"><ix:nonFraction name="ONMD:StockRepurchasedDuringPeriodValueExchangeForCash" contextRef="From2024-10-012024-10-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember" id="Fact001035" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></ix:nonFraction></span></span> million in July and October 2024 and the remaining $<span id="xdx_904_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20250101__20250101__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zNwEvUsCi5U6" title="Number of shares repurchased, value exchange for cash"><ix:nonFraction name="ONMD:StockRepurchasedDuringPeriodValueExchangeForCash" contextRef="From2025-01-012025-01-01_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember_srt_ScenarioForecastMember" id="Fact001037" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.3</ix:nonFraction></span> million is expected to be repaid in early 2025.
The $<span id="xdx_905_ecustom--PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_pn5n6_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zcjM0GEMUd2k" title="Principal and accrued interest outstanding"><ix:nonFraction name="ONMD:PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" contextRef="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember" id="Fact001039" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million represents the principal and accrued interest outstanding on the holder&#8217;s Convertible Promissory Note immediately
prior to the Business Combination. The $<span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pn5n6_c20240930__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zT2xs2JQhRe6" title="Accounts payable and accrued expenses"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-09-30_us-gaap_ConvertibleNotesPayableMember" id="Fact001041" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.4</ix:nonFraction></span> million outstanding at September 30, 2024 is classified in accounts payable and accrued expenses
on the condensed consolidated balance sheet. The <span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodShares_pid_di_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zgGJ0fXdvaJ" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-01-012024-09-30_us-gaap_TreasuryStockCommonMember" id="Fact001043" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">187,745</ix:nonFraction></span> repurchased shares were reclassified to treasury stock as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Standby
Equity Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company and Yorkville entered into the SEPA. Under the SEPA, the Company has the right to sell to Yorkville up to
$<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20240617__20240617__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zy3RW0tarPAk"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-06-172024-06-17_srt_MaximumMember_custom_StandbyEquityPurchaseAgreementMember" id="Fact001044" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">25.0</ix:nonFraction></span> million of its Common Stock, subject to certain limitations and conditions set forth in the SEPA, from time to time, over a 24-month
period. Sales of the Common Stock to Yorkville under the SEPA, and the timing of any such sales, are at the Company&#8217;s option, and
the Company is under no obligation to sell any shares of Common Stock to Yorkville under the SEPA except in connection with notices that
may be submitted by Yorkville, in certain circumstances as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the satisfaction of the conditions precedent in the SEPA, which include having a resale shelf for shares of Common Stock issued to Yorkville
declared effective, the Company has the right to direct Yorkville to purchase a specified number of shares of Common Stock by delivering
written notice (each an &#8220;Advance&#8221;). <span id="xdx_902_ecustom--StockholdersDeficitDescription_c20240617__20240617_zvU7MkX7Ut32" title="Stockholders deficit description"><ix:nonNumeric contextRef="From2024-06-172024-06-17" id="Fact001046" name="ONMD:StockholdersDeficitDescription">An Advance may not exceed the greater of (i) 100% of the average of the daily trading
volume of the Common Stock on Nasdaq, during the five consecutive trading days immediately preceding the date of the Advance, and (ii)
five hundred thousand (500,000) shares of Common Stock.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
will generally purchase shares pursuant to an Advance at a price per share equal to 97% of the VWAP, on Nasdaq during the three consecutive
trading days commencing on the date of the delivery of the Advance (unless the Company specifies a minimum acceptable price or there
is no VWAP on the subject trading day).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEPA will automatically terminate on the earliest to occur of (i) the first day of the month next following the 24-month anniversary
of the date of the SEPA or (ii) the date on which Yorkville shall have made payment for shares of Common Stock equal to $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20240617__20240617__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zIH8y2gxPS1d" title="Sale of stock, value"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="From2024-06-172024-06-17_srt_MaximumMember_custom_StandbyEquityPurchaseAgreementMember" id="Fact001048" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">25.0</ix:nonFraction></span> million.
The Company has the right to terminate the SEPA at no cost or penalty upon five trading days&#8217; prior written notice to Yorkville,
provided that there are no outstanding advances for which shares of Common Stock need to be issued and the Yorkville Note has been paid
in full. The Company and Yorkville may also agree to terminate the SEPA by mutual written consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for Yorkville&#8217;s commitment to purchase the shares of Common Stock pursuant to the SEPA, the Company paid Yorkville
a $<span id="xdx_907_ecustom--CashStructuringFee_pn3n3_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_znZy7cQ2SMKk" title="Cash structuring fee"><ix:nonFraction name="ONMD:CashStructuringFee" contextRef="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember" id="Fact001050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span> thousand cash structuring fee. In addition, the Company must pay a commitment fee in shares equal to $<span id="xdx_900_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20240617__20240617_z4UVITkTX5O6" title="Commitment fees"><ix:nonFraction name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" contextRef="From2024-06-172024-06-17" id="Fact001052" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million. In September
2024, the Company paid an equivalent of the commitment fee by issuing to Yorkville <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240901__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zf1dBTjppzlc" title="Number of shares, issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-09-012024-09-30_us-gaap_CommonStockMember" id="Fact001054" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">526,312</ix:nonFraction></span> shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the entry into the SEPA, on June 17, 2024, the Company entered into a registration rights agreement with Yorkville, pursuant
to which the Company agreed to file with the SEC no later than August 30, 2024, a registration statement for the resale by Yorkville
of the shares of Common Stock issued under the SEPA (including the commitment fee shares). The Company agreed to use commercially reasonable
efforts to have such registration statement declared effective within 30 days of such filing and to maintain the effectiveness of such
registration statement during the 24-month commitment period. The Company will not have the ability to request any Advances under the
SEPA (nor may Yorkville convert the Yorkville Note into Common Stock) until such resale registration statement is declared effective
by the SEC. The Company has not yet filed a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock
issued under the SEPA, which is deemed an event of default under the SEPA and as a result, a payment of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_pn5n6_c20241015__20241015__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zojNJMkB7h58" title="Payments of common stock issuance"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="From2024-10-152024-10-15_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember" id="Fact001056" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.6</ix:nonFraction></span> million became due on October
15, 2024. The $<span id="xdx_909_eus-gaap--ConversionOfStockAmountConverted1_pn5n6_c20240617__20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zQ9Hi1T67mEi" title="Conversion of stock amount"><ix:nonFraction name="us-gaap:ConversionOfStockAmountConverted1" contextRef="From2024-06-172024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember" id="Fact001058" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.6</ix:nonFraction></span> million due includes the outstanding principal of $<span id="xdx_90C_eus-gaap--ConversionOfStockAmountIssued1_pn5n6_c20240617__20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_z3M4E1zg82Q8" title="Conversion of stock amount issued"><ix:nonFraction name="us-gaap:ConversionOfStockAmountIssued1" contextRef="From2024-06-172024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember" id="Fact001060" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million, accrued and unpaid interest, and a payment premium
of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zsyvkv30hVMc" title="Interest rate percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember" id="Fact001062" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span>. As described in Note 4, the Company subsequently engaged in discussions with Yorkville regarding the events of default, which
discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEPA was accounted for as a liability under ASC 815 as it includes an embedded put option and an embedded forward option. The put option
is recognized at inception and the forward option is recognized upon issuance of notice for the sale of the Company&#8217;s Common Stock.
The fair value of the derivative liability related to the embedded put option was estimated at $<span id="xdx_902_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet_iI_pn5n6_c20240930_zHDJEwQljAKf" title="Fair value of embedded derivative"><ix:nonFraction name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" contextRef="AsOf2024-09-30" id="Fact001064" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.2</ix:nonFraction></span> million at the inception of the agreement.
As of September 30, 2024, the embedded put option was determined to have no value because of alternative financing options now available
to the Company making future draws on the SEPA improbable. Further, as described in Note 4, the Company is currently in default on the
SEPA due to its failure to file a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock issuable
under the SEPA by August 30, 2024. As such, no shares can currently be issued under the SEPA. The embedded forward option was also deemed
to have <span id="xdx_908_eus-gaap--ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_pn6n6_do_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zIzYL1tscM74" title="Emdedded derivative liabilities"><ix:nonFraction name="us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" contextRef="From2024-01-012024-09-30_custom_StandbyEquityPurchaseAgreementMember" id="Fact001066" format="ixt-sec:numwordsen" decimals="-6" scale="6" unitRef="USD">no</ix:nonFraction></span> value as there were no notices for the sale of the Company&#8217;s Common Stock as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
2024 Financings</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 23, 2024, the Company entered into a securities purchase agreement with a certain institutional investor, pursuant to which the
<span style="background-color: white">Company agreed to issue and sell <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240723__20240723__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_ziycdSX0h8t6"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-07-232024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember" id="Fact001067" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,297,059</ix:nonFraction>
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of its
Common Stock at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240723__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zYyR5fsvYxAb"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember" id="Fact001068" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.0278</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">per share and pre-funded
warrants exercisable for <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240725__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zrx2aZ0PW1Eg"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-07-25_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember" id="Fact001069" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,323,530</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of its Common
Stock at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240723__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zVNzJxMls8yl"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-07-23_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember" id="Fact001070" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.0278</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">per share (the &#8220;July
2024 Pre-Funded Warrants&#8221;). The investor was required to prepay the exercise price for the pre-funded warrants, other than $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20240723__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zcHEiulFOAuf"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-07-23_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember" id="Fact001071" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">per share. The warrants
and pre-funded warrants will be exercisable at any time after the date of issuance and will not expire. </span>Holders of pre-funded
warrants are entitled to receive dividends, if declared, on an as-if-converted-to-common-stock basis, and in the same form as dividends
actually paid on shares of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 25, 2024, the Company entered into a securities purchase agreement with a certain institutional investor, pursuant to which the
<span style="background-color: white">Company agreed to issue and sell <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240725__20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_ztn0egyHIIee" title="Shares issued"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-07-252024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember" id="Fact001073" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,301,791</ix:nonFraction></span> shares of its Common Stock at a price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zM3p4ROkUGz8" title="Share price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember" id="Fact001075" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.85</ix:nonFraction></span> per share.
</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received net proceeds of approximately $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240725__20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zvUjTQ7mgbki" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-07-252024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember" id="Fact001077" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.5</ix:nonFraction></span> million from the July 2024 private placements, after deducting offering expenses
of $<span id="xdx_90C_eus-gaap--DeferredOfferingCosts_iI_pn5n6_c20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zbThqG9oN5jl" title="Offering expenses"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember" id="Fact001079" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>September
2024 Financing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 24, 2024, <span style="background-color: white">the Company entered into a securities purchase agreement with a certain
institutional investor, pursuant to which the Company agreed to issue and sell to the investor <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240924__20240924__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember_zqaXbNHvWJYf" title="Number of shares issue and sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-09-242024-09-24_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SeptemberTwoThousandTwentyFourFinancingMember" id="Fact001081" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,918,591</ix:nonFraction></span>
shares of its Common Stock at a price of $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240924__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z1h5FIrPdXg7" title="Common stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-09-24_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001083" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.65</ix:nonFraction></span>
per share, warrants exercisable for <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240924__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z4GbEX3nT4g5" title="Number of warrants exercisable"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-24_us-gaap_WarrantMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001085" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,095</ix:nonFraction></span>
shares of its Common Stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zFqKpOrDFCu" title="Exercise price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-24_us-gaap_WarrantMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001087" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.325</ix:nonFraction></span>
per share (the &#8220;September 2024 Warrants&#8221;) and pre-funded warrants exercisable for <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zId4hUKgOcrj" title="Warrants exercisable for common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001089" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">743,314</ix:nonFraction></span>
shares of its Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zNXG4Yp6C95i" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001091" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.65</ix:nonFraction></span>
per share (the &#8220;September 2024 Pre-Funded Warrants&#8221;). The investor was required to prepay the exercise price for the
pre-funded warrants, other than $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zEF4yi1GhB6a" title="Share issued price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001093" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
per share. The warrants and pre-funded warrants will be exercisable at any time after the date of issuance and will not
expire.</span> Holders of pre-funded warrants are entitled to receive dividends, if declared, on an as-if-converted-to-common-stock
basis, and in the same form as dividends actually paid on shares of the Common Stock. The Company received net proceeds of
approximately $<span id="xdx_900_eus-gaap--DeferredOfferingCosts_iI_pn5n6_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zHbqIeVuXAze" title="Offering expenses"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember" id="Fact001095" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.7</ix:nonFraction></span>
million, after deducting an immaterial amount of offering expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company had not yet issued the <span id="xdx_90F_eus-gaap--CommonStockSharesSubscriptions_iI_c20240930__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhFakj1H2JH7" title="Common stock shares not yet issued"><ix:nonFraction name="us-gaap:CommonStockSharesSubscriptions" contextRef="AsOf2024-09-30_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,918,591</ix:nonFraction></span>
shares of Common Stock in order to keep the investor&#8217;s ownership percentage below a defined threshold. The net proceeds of
$1.7 million was recorded akin to an equity forward sale contract and was included in additional paid-in-capital in
stockholders&#8217; deficit in the condensed consolidated balance sheets as it met the criteria for equity accounting under ASC
815.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024 and December 31, 2023, <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20240930_zB4kRjVHpEWl" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240930_zA8vYPBvdAR8" title="Preferred stock, shares outstanding"><span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20231231_zx1qR4kbKCEk" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zkO4bCSJRIc8" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-09-30" id="Fact001099" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-09-30" id="Fact001101" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001103" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001105" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares of Preferred Stock were issued or outstanding. All shares of Legacy ONMD Series
A-2 Preferred Stock and Series A-1 Preferred Stock were converted into Common Stock in connection with the Business Combination. See
the Form 10-K/A for all other details relating to the Series A-2 Preferred Stock and Series A-1 Preferred Stock issued prior to December
31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001107" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_802_eus-gaap--EarningsPerShareTextBlock_zo4sKw1lCajl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
<span id="xdx_82D_znfi6OmWrAm4">Net Loss per Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the weighted-average number of shares of Common Stock outstanding used to calculate
both basic and diluted net loss per share is the same. In computing diluted net loss per share for the nine months ended September 30,
2024 and 2023, the Company excluded the following potentially dilutive securities, as the effect would be anti-dilutive and reduce the
net loss per share calculated for each period:</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001109" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zqtHkWkniuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zY8WtyweXEh" style="display: none">Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20240930_z6rh7ChKA2Wg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20230930_zKvl5Q7cKBM9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zaJ6qRuqQiMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Options to purchase Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_custom_OptionsToPurchaseCommonStockMember" id="Fact001111" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">147,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_custom_OptionsToPurchaseCommonStockMember" id="Fact001112" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">913,856</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockUnitsAndAwardsMember_z5KFPMnET3Gk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unvested restricted stock units and awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember" id="Fact001114" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">1,371,950</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember" id="Fact001115" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">177,275</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9UCKP9FSwd5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember" id="Fact001117" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">12,314,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember" id="Fact001118" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">3,112,165</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zbjJYN3YAy93" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_custom_SeriesAOnePreferredStockMember" id="Fact001121" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zvZe6nAtBTo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_custom_SeriesATwoPreferredStockMember" id="Fact001124" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_ztASWlHwy9G3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember" id="Fact001126" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">1,118,735</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30_custom_ConvertiblePromissoryNoteMember" id="Fact001127" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">4,643,325</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_zjyHAg7uOSp" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-01-01to2024-09-30" id="Fact001129" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">14,951,799</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-09-30" id="Fact001130" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">15,102,501</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zIvCM8d23g3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001132" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_808_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zmmJnBI3xJC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span id="xdx_822_zD5XNNHaN0Qf">Stock-Based Compensation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001134" name="us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zmQ9ejPefDJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded stock-based compensation expense in the following categories on the accompanying condensed consolidated statements of
operations for the periods presented (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_zi0VxjIuHy3i" style="display: none">Schedule
of Stock-based Compensation Expense</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240701__20240930_zKe5IeXI8tO2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20230930_zPik3Muw8Nki" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_z5CcHjp4W8cg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30_us-gaap_CostOfSalesMember" id="Fact001136" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1137">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlNN63lq1rKd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001139" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">195</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001140" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">782</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z0UM3n2cDlXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30_us-gaap_SellingAndMarketingExpenseMember" id="Fact001142" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zD4NQnRNXEl1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001146" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_zrPprdz5h9x1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30" id="Fact001148" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30" id="Fact001149" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">798</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20240101__20240930_zCXyAW0gQ6m9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20230930_zUxBQ3iUyj55" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nine Months Ended September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zTvqXJwV9Q39" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_CostOfSalesMember" id="Fact001151" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zbpaTM3KueYe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001154" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">416</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact001155" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,014</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zuV9qFZzQJR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_SellingAndMarketingExpenseMember" id="Fact001157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zA0HIOZurbKf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact001161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">432</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_zaOnxrxwLm6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-01to2024-09-30" id="Fact001163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30" id="Fact001164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,446</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zERfolW97EGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
incentive plan &#8211; summary</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, the Company adopted the OneMedNet Corporation 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) and reserved an amount of
shares of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20230101__20231231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zbcMaXdNixLa" title="Share-based payment award, description"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_EquityIncentivePlanMember" id="Fact001166" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">Common Stock equal to 10% of the number of shares of Common Stock of the Company following the Business Combination for issuance
thereunder.</ix:nonNumeric></span> The 2022 Plan became effective immediately upon the closing of the Business Combination and replaced the Legacy ONMD equity
incentive plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
incentive plan &#8211; stock options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zUK9zKMM1Pfb" title="Allocated share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember" id="Fact001168" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zIwcSslyOIAe" title="Allocated share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember" id="Fact001170" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></span> million, respectively,
on its outstanding stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zlO3F3xU2w4h" title="Allocated share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember" id="Fact001172" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34</ix:nonFraction></span> thousand and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zsjV1UxaDgl7" title="Allocated share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember" id="Fact001174" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.3</ix:nonFraction></span> million,
respectively, on its outstanding stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
incentive plan &#8211; restricted stock units (&#8220;RSU&#8221;)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zhQRdT52C3og" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-07-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember" id="Fact001176" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.2</ix:nonFraction></span> million and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zS2prSD6oS3f" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-07-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember" id="Fact001178" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.7</ix:nonFraction></span> million,
respectively, on its outstanding restricted stock units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_z6OLIQ8Pc1ja" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-01-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember" id="Fact001180" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.1</ix:nonFraction></span> million and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zEffsyIvwjea" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember" id="Fact001182" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.4</ix:nonFraction></span> million,
respectively, on its outstanding restricted stock units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001184" name="ONMD:StockWarrantsDisclosureTextBlock"><p id="xdx_80F_ecustom--StockWarrantsDisclosureTextBlock_ztOIwOA4uPL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
<span id="xdx_823_zFq1DEMSVs97">Stock Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001186" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCMbuaAL3aN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following warrants outstanding for the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BF_zucWbKPNhz7h" style="display: none">Schedule
of Warrants Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240930_zWJZDgwOrKM5" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230930_zeJvgEiBBr9g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Liability Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zl9OioKXlJk2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember" id="Fact001188" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">585,275</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember" id="Fact001189" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">585,275</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zfjJaZLYqMRb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember" id="Fact001191" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">95,744</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember" id="Fact001192" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">95,744</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_z4O1VnLEy1kk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember" id="Fact001194" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">681,019</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember" id="Fact001195" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">681,019</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Equity Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zNapLquh5uid" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember" id="Fact001197" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">11,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember" id="Fact001198" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">11,500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zldFgxmFL3gl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Private Placement Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember" id="Fact001200" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">2,199,939</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zpBzg3MT2qkk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember" id="Fact001203" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">13,699,939</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember" id="Fact001204" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">11,500,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_zZvdffyDsfn9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt">Grand Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30" id="Fact001206" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">14,380,958</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30" id="Fact001207" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">12,181,019</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_z81XCOvU8O52" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt">Warrants outstanding </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30" id="Fact001209" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">14,380,958</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-09-30" id="Fact001210" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="Shares">12,181,019</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zKtXBqQzJVdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 7, the Company issued the July 2024 Pre-Funded Warrants, the September 2024 Pre-Funded Warrants and the September 2024
Warrants in connection with the July and September 2024 private placements (together, the &#8220;Private Placement Warrants&#8221;).
The Private Placement Warrants are classified as equity in accordance with ASC Subtopic 815-40, <i>Derivatives and Hedging - Contracts
in Entity&#8217;s Own Equity </i>(&#8220;ASC 815-40&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
Promissory Notes Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 4, the Company issued Convertible Promissory Notes Warrants in 2022 and 2023. The Convertible Promissory Notes
Warrants are classified as equity in accordance with ASC 815-40. The Company determined that the fair value of the combined
instrument (inclusive of the Convertible Promissory Notes) significantly exceeded the proceeds received; therefore, the Company
concluded that the Convertible Promissory Notes Warrants are most accurately portrayed as an issuance cost related to the
Convertible Promissory Notes. This resulted in an expense of $<span id="xdx_907_ecustom--StockWarrantExpense_pn5n6_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zolgecQDBM7h"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-07-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember" id="Fact001211" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.3</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million
and $<span id="xdx_904_ecustom--StockWarrantExpense_pn5n6_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zmYnBdlopzO8"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember" id="Fact001212" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">8.4</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million
being allocated to the Convertible Promissory Notes Warrants during the three and nine months ended September 30, 2023,
respectively, which is classified as stock warrant expense in the condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, all Convertible Promissory Notes Warrants were cashless
exercised into shares of Legacy ONMD common stock and exchanged based on the appropriate conversion ratio for the Common Stock less an
exercise price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionRatio1_c20231106__20231107__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_z6oys9OoGAe2" title="Conversion ratio"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionRatio1" contextRef="From2023-11-062023-11-07_custom_ConvertiblePromissoryNotesWarrantsMember" id="Fact001214" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.00</ix:nonFraction></span>. See the Form 10-K/A for all other details relating to the Convertible Promissory Notes Warrants issued prior
to December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the issuance of the PIPE Notes described in Note 4, Data Knights also issued and sold to each of the Purchasers <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zN9Dj3BSne9g" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-06-30_custom_PIPEWarrantsMember" id="Fact001216" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,745</ix:nonFraction></span>
warrants to purchase Common Stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zU4rqCJm5dYg" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-30_custom_PIPEWarrantsMember" id="Fact001218" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share (the &#8220;PIPE Warrants&#8221;). The PIPE Warrants are classified
as liabilities because they did not meet the criteria for equity treatment under ASC 815-40. During the three and nine months ended September
30, 2024, the Company recognized a change in fair value of PIPE Warrants of $<span id="xdx_90B_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_z8wxBZL1Kkbj" title="Fair value adjustment of warrants"><ix:nonFraction name="ONMD:ChangeInFairValueOfWarrants" contextRef="From2024-07-012024-09-30_custom_PIPEWarrantsMember" id="Fact001220" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and a gain of $<span id="xdx_909_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zLG20waQ0Uq" title="Change in fair value of warrants"><ix:nonFraction name="ONMD:ChangeInFairValueOfWarrants" contextRef="From2024-01-012024-09-30_custom_PIPEWarrantsMember" id="Fact001222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></span> thousand, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zIngphbYmskb" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-11-07_custom_BusinessCombinationWarrantsMember" id="Fact001224" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">585,275</ix:nonFraction></span> private warrants to purchase
Common Stock at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zWNONsMV3EY8" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-11-07_custom_BusinessCombinationWarrantsMember" id="Fact001226" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share (the &#8220;Business Combination Warrants&#8221;). The Business Combination Warrants
are classified as liabilities because they did not meet the criteria for equity treatment under ASC 815-40. During the three and nine
months ended September 30, 2024, the Company recognized a change in fair value of Business Combination Warrants of $<span id="xdx_908_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zBOohwu0h8V8" title="Change in fair value of warrants"><ix:nonFraction name="ONMD:ChangeInFairValueOfWarrants" contextRef="From2024-07-012024-09-30_custom_BusinessCombinationWarrantsMember" id="Fact001228" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></span> thousand and $<span id="xdx_900_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zakQydafQdN7" title="Change in fair value of warrants"><ix:nonFraction name="ONMD:ChangeInFairValueOfWarrants" contextRef="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember" id="Fact001230" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></span>
thousand, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001232" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zvVW2LA9B6ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_820_zQIUTrXaomp3">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001234" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zRomgSLwyzAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_z6OnWbN41Jea" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zs7pR7XVeyMj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk3pYUiIki1g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zXOdtOYYgdYc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240930_zdkwazVils0b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_hus-gaap--FinancialInstrumentAxis__custom--BitcoinMember_zdVOpdadhZDk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 10pt">Bitcoin</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember" id="Fact001236" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_custom_BitcoinMember81074171" id="Fact001239" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--AssetsFairValueDisclosure_iI_zoiZUdhtjPae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets, at fair value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact001241" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1242">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact001244" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,156</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zvinzheDArVi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="Fact001248" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_custom_PrivateWarrantsMember" id="Fact001249" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6mlQXo9f3pk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">PIPE Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="Fact001253" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember" id="Fact001254" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zWZUo7FwPkMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1257">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="Fact001258" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,593</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_custom_PIPENotesMember" id="Fact001259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,593</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--YorkvilleNoteMember_zpy6dS3QhFX7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Yorkville Note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember" id="Fact001263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,911</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_custom_YorkvilleNoteMember" id="Fact001264" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,911</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--StandbyEquityPurchaseAgreementMember_z1Xn1KGKY8Cc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">SEPA derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1267">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1269">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zPmbDddjA7Aa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact001273" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,532</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2024-09-30" id="Fact001274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,532</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zN3iPl8icnZc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxhyQBVx04zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zh3kUdO6GkT9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20231231_zE8iY7eZmuX" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zGWT8OSMZHFe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1277">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="Fact001278" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember" id="Fact001279" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_ziPfBuKEeew8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="Fact001283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390" id="Fact001284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z3bFjG8RlQfl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="Fact001288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_custom_PIPENotesMember" id="Fact001289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zKKLbNt0V9Rg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1291">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1292">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact001293" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact001294" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zuJLVb9AbE4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Warrants and PIPE Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" continuedAt="ConU001302-01" escape="true" id="Fact001302" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"><p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-TLSO_zps6BRM4jDQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the Business Combination Warrants and PIPE Warrants measured at fair value during the nine months
ended September 30, 2024 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B2_zusMWR8dIK1d" style="display: none">Schedule
of Warrants and Notes Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--FinancialInstrumentAxis_custom--BusinessCombinationWarrantsMember_zg0zZVWpBMNg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Business Combination Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PIPEWarrantsMember_zRZ4VYo3g01h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zhOUxxDJFxxb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Balance, December 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_BusinessCombinationWarrantsMember" id="Fact001304" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390" id="Fact001305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_z9qk9ZWF20Cj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Additions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_z6iSqRCmiCo3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember81074640" id="Fact001310" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2024-01-012024-09-30_custom_PIPEWarrantsMember81074640" id="Fact001311" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z2MZKufSZT7h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember" id="Fact001313" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember" id="Fact001314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_z1XGBbNMWzcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company remeasured the fair value of the Business Combination Warrants and PIPE Warrants at September 30, 2024 using the Black-Scholes
option-pricing model with the following assumptions:</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001316" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z0EbGI9XuKg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_zbo4lpUx1OU6" style="display: none">Schedule
of Fair Value Assumptions and Valuation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6yoFZjdrjI3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember_zdnqqfp3XZQ8" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Business Combination</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z8ofOzO0ac9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember" id="Fact001318" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.61</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputSharePriceMember" id="Fact001319" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.61</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zesH5Uq4iOC1" style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember" id="Fact001321" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">10.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExercisePriceMember" id="Fact001322" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zaCri8ck8v0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact001324" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">72.1</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact001325" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">72.1</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zr6WHQ05YrM9" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact001327" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.6</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact001328" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.6</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zXlftvXvisyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1331">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zSVXH8G4Gmsl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants measurement input</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1334">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zUh0Fyou3Ww5" title="Expected term (in years)"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" format="ixt-sec:duryear" id="Fact001336" name="us-gaap:WarrantsAndRightsOutstandingTerm">4.1</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zU8xg8Aetap4" title="Expected term (in years)"><ix:nonNumeric contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" format="ixt-sec:duryear" id="Fact001338" name="us-gaap:WarrantsAndRightsOutstandingTerm">4.2</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zyYLtmo7pxr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Notes and Yorkville Note</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C09_gL3FVLMORBUIR-TLSO_zJFslKp8psI3"><ix:continuation continuedAt="ConU001302-02" id="ConU001302-01">The
following table presents the changes in the PIPE Notes and Yorkville Note measured at fair value during the nine months ended September
30, 2024 (in thousands):</ix:continuation></span></span></p>

<div id="xdx_C0F_gL3FVLMORBUIR-TLSO_zrNp9ZRq9Rk8"><ix:continuation continuedAt="ConU001302-03" id="ConU001302-02"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_134_zREtuuhIhXSl" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--FinancialInstrumentAxis_custom--PIPENotesMember_ze2r3E2jMVR2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Notes</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--YorkvilleNoteMember_zYzz8DZAcSY5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Yorkville Note</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlOJacrmtqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Balance, December 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_PIPENotesMember" id="Fact001340" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1341">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zMhjgFKRCOX2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1343">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2024-01-012024-09-30_custom_YorkvilleNoteMember" id="Fact001344" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,350</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zGJO8EE1uXi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2024-01-012024-09-30_custom_PIPENotesMember" id="Fact001346" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2024-01-012024-09-30_custom_YorkvilleNoteMember" id="Fact001347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">561</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zeIf64bpYuG4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2024-09-30_custom_PIPENotesMember" id="Fact001349" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,593</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2024-09-30_custom_YorkvilleNoteMember" id="Fact001350" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,911</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C06_gL3FVLMORBUIR-TLSO_zSEPh11Sejia"><ix:continuation continuedAt="ConU001302-04" id="ConU001302-03">&#160;</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair values of the PIPE Notes and Yorkville Note are determined based on the aggregated, probability-weighted average of the
outcomes of certain possible scenarios. The combined value of the probability-weighted average of those outcomes is then discounted back
to each reporting period in which the convertible notes are outstanding, in each case, based on a risk-adjusted discount rate estimated
based on the implied discount rate. The discount rate was held constant over the valuation periods given the fact pattern associated
with the Company and the stage of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SEPA
Derivative Liability</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C06_gL3FVLMORBUIR-TLSO_zz4orYY35kX2"><ix:continuation continuedAt="ConU001302-05" id="ConU001302-04">The
following table presents the changes in the SEPA derivative liability measured at fair value during the nine months ended September 30,
2024 (in thousands):</ix:continuation></span></span></p>

<div id="xdx_C00_gL3FVLMORBUIR-TLSO_zOsMKlhlCRO"><ix:continuation continuedAt="ConU001302-06" id="ConU001302-05"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_134_zvn2i2KWbCdj" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--YorkvilleStandbyEquityPurchaseAgreementMember_zeuekKn7dFk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Yorkville SEPA</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_438_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zBVYNCg9VPa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1352">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zTX2QegBErif" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Additions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2024-01-012024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember" id="Fact001354" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zNqLPzGMpOE4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2024-01-012024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember" id="Fact001356" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">160</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zhdfOaCxSyfa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C02_gL3FVLMORBUIR-TLSO_z93qpH9mH618"><ix:continuation id="ConU001302-06">&#160;</ix:continuation></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair value of the SEPA derivative liability was determined using a scenario-based valuation model based on the aggregated amount
of draws expected to be made over the 24-month commitment period. The derivative value of such draws was then discounted back to each
reporting period in which the put option was outstanding, in each case, based on a risk-adjusted discount rate based on the implied discount
rate. As of September 30, 2024, the derivative liability was determined to have no value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001360" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z72lCXGJ7Bkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_823_zcaO490Ct6w6">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Notes and Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
Knights issued and sold PIPE Notes in connection with the Business Combination, which are convertible into shares of Common Stock. Total
proceeds raised from the PIPE Notes were $<span id="xdx_90A_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zxvBfqWuzhld" title="Related party proceeds"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-01-012024-09-30_custom_PIPENotesMember81075421" id="Fact001362" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million, of which $<span id="xdx_907_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zKD4shLrCAAh" title="Related party proceeds"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_PIPENotesMember" id="Fact001364" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.0</ix:nonFraction></span> million was with related party investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the issuance of the PIPE Notes, the Company also issued a total of <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zVhs2mYBQuKb" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember81075437" id="Fact001366" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,744</ix:nonFraction></span> shares of PIPE Warrants, of which <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zEhojPn2C22l" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember" id="Fact001368" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,829</ix:nonFraction></span> shares
were issued to the same related party investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
Promissory Notes and Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 4, the Company issued various Convertible Promissory Notes to related party investors. Total gross proceeds raised
from Convertible Promissory Notes with related parties were $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z92zLciIy6D7" title="Gross proceeds from convertible promissory notes"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember" id="Fact001370" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">12.3</ix:nonFraction></span> million (out of $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zzWdKRh7BLf9" title="Gross proceeds from convertible promissory notes"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember81075453" id="Fact001372" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">14.2</ix:nonFraction></span> million total). In connection with the issuance
of the Convertible Promissory Notes, the Company also issued Convertible Promissory Notes Warrants to purchase <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteWarrantsMember_z6VrAV2L82g9" title="Number of shares issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember" id="Fact001374" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,976,000</ix:nonFraction></span> shares of Legacy
ONMD common stock to the same related parties (out of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConvertiblePromissoryNotesAndWarrantsMember_zdoCtpSCKObe" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-30_custom_ConvertiblePromissoryNotesAndWarrantsMember" id="Fact001376" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,726,000</ix:nonFraction></span> total). The closing of the Business Combination triggered the conversion
of all Convertible Promissory Notes and Convertible Promissory Notes Warrants into shares of Common Stock. See the Form 10-K/A for all
other details relating to the Convertible Promissory Notes and Convertible Promissory Notes Warrants issued prior to December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholder
Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the convertible shareholder loans described in Note 4, the Company also received gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20240930_zYokDN1xcVMe" title="Gross proceeds from loans"><ix:nonFraction name="us-gaap:ProceedsFromLoans" contextRef="From2024-01-01to2024-09-30" id="Fact001378" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.4</ix:nonFraction></span> million in connection
with non-convertible shareholder loans with related party investors during the nine months ended September 30, 2024. In June 2024 and
July 2024, the Company repaid $<span id="xdx_905_eus-gaap--OtherLongTermDebt_iI_pn5n6_c20240731_zzqhohe1eolk" title="Non convertible shareholder loan"><span id="xdx_900_eus-gaap--OtherLongTermDebt_iI_pn5n6_c20240630_zSJP3IguPoQ7" title="Non convertible shareholder loan"><ix:nonFraction name="us-gaap:OtherLongTermDebt" contextRef="AsOf2024-07-31" id="Fact001380" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD"><ix:nonFraction name="us-gaap:OtherLongTermDebt" contextRef="AsOf2024-06-30" id="Fact001382" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></ix:nonFraction></span></span> million of the outstanding non-convertible shareholder loan balance. These loans bear an interest
rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930_zTCd9R4V9eu8" title="Loan interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-30" id="Fact001384" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.0</ix:nonFraction></span>% with a maturity date <span id="xdx_900_eus-gaap--DebtInstrumentTerm_dc_c20240101__20240930_zTLaZv1Whwh8" title="Loan term"><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" format="ixt-sec:durwordsen" id="Fact001386" name="us-gaap:DebtInstrumentTerm">one year</ix:nonNumeric></span> from issuance. The following table summarizes shareholder loans outstanding for the periods
presented (in thousands):</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001388" name="us-gaap:ScheduleOfDebtTableTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zesL6qwSYE91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_z0ak4ixSjEGh" style="display: none">Schedule
of Shareholder Loans Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240930_zNCE49yHztcl" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231_zvDVQSrNcA7i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_maCNPzu2j_zdGkeCM8yN3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Shareholder loans &#8211; nonconvertible</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="AsOf2024-09-30" id="Fact001390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">654</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="AsOf2023-12-31" id="Fact001391" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">454</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_maCNPzu2j_zkQ0zSIF2Cyc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shareholder loans &#8211; convertible</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2024-09-30" id="Fact001393" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestPayableCurrent_iI_pn3n3_maCNPzu2j_z6xU62AlZM37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2024-09-30" id="Fact001396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001397" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LongTermDebt_iTI_pn3n3_mtCNPzu2j_zmPrw76GaPF6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total loan &#8211; related party</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2024-09-30" id="Fact001399" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,306</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LongTermDebt" contextRef="AsOf2023-12-31" id="Fact001400" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zTKrshboB99h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loan
Extensions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assumed Data Knights&#8217; liabilities, which included existing loan extensions to related parties. The loan extensions were
to be either repaid in cash or, at the option of the lender, exchanged for a fixed amount of Common Stock at a price of $<span id="xdx_900_eus-gaap--SharePrice_iI_c20240930_zLI7R5vnH7g4"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-09-30" id="Fact001401" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share
upon the closing of a business combination or a similar event. At the closing of the Business Combination, all lenders provided notice
to have their loans converted into shares upon the filing of a registration statement on Form S-1 with the SEC. As of September 30, 2024
and December 31, 2023, a registration statement has not yet been declared effective by the SEC, and a balance of $<span id="xdx_905_eus-gaap--LoansPayableCurrent_iI_pn5n6_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsMember_zl1jqYoxGAx6" title="Loans remains outstanding"><span id="xdx_90D_eus-gaap--LoansPayableCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsMember_zafvvM4LTVj5" title="Loans remains outstanding"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2024-09-30_custom_DataKnightsMember" id="Fact001403" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2023-12-31_custom_DataKnightsMember" id="Fact001405" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.0</ix:nonFraction></ix:nonFraction></span></span> million remains
outstanding on the Company&#8217;s condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001407" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zhU0Ncx89oif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_823_z7gQBnBFOdKk">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a month-to-month lease for a suite at a cost of $<span id="xdx_902_eus-gaap--LeaseCost_pp0p0_c20240101__20240930_zCSTbaDzmzE" title="Lease cost"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2024-01-01to2024-09-30" id="Fact001409" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">530</ix:nonFraction></span> per month. The Company incurred $<span id="xdx_906_eus-gaap--PaymentsForRent_pn3n3_c20240701__20240930_zXMEQALoya99" title="Rent expenses"><span id="xdx_906_eus-gaap--PaymentsForRent_pn3n3_c20230701__20230930_znug2H9sqLH2" title="Rent expenses"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2024-07-012024-09-30" id="Fact001411" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-07-012023-09-30" id="Fact001413" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></ix:nonFraction></span></span> thousand of rent expense, including
common tenant costs and cancellation costs, during the three months ended September 30, 2024 and 2023, respectively, and $<span id="xdx_907_eus-gaap--PaymentsForRent_pn3n3_c20240101__20240930_zZKWpc76Lks3" title="Rent expense"><span id="xdx_90C_eus-gaap--PaymentsForRent_pn3n3_c20230101__20230930_zmnRJuF7JT71" title="Rent expense"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2024-01-01to2024-09-30" id="Fact001415" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-01-012023-09-30" id="Fact001417" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></ix:nonFraction></span></span> thousand
for the nine months ended September 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Liabilities for loss contingencies
arising from claims, assessments, litigation, fines, penalties, and other sources are recognized, if and when it is probable that a liability
has been incurred and the amount can be reasonably estimated. The Company was not subject to any material legal proceedings during the
nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-01-01to2024-09-30" escape="true" id="Fact001419" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zgUvaltT6Vi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_82F_zfVEdnL5mIQl">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events occurring through December 17, 2024, the date the condensed consolidated financial statements
were issued, for events requiring recording or disclosure in the Company&#8217;s condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Letter</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, Yorkville sent the Company a letter notifying the Company that it had breached a registration rights agreement with
Yorkville by failing to file a Registration Statement on Form S-1 on the timeline set forth in the registration rights agreement (the
&#8220;Yorkville Letter&#8221;). The Yorkville Letter asserted that this breach was an event of default and an amortization event under
the prepaid advance in connection with the SEPA. The Yorkville Letter also asserted that the Company&#8217;s failure to timely file its
Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 was an event of default under the Yorkville Promissory Note.
The Company subsequently engaged in discussions with Yorkville regarding the Yorkville Letter, which discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Promissory Note, upon the occurrence of an amortization event, the Company is required to pay all principal and accrued
interest on the Yorkville Promissory Note, plus a <span id="xdx_909_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_c20241008__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zegkBJys0W3l" title="Payment premium percentage on principal amount"><ix:nonFraction name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" contextRef="AsOf2024-10-08_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember" id="Fact001421" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% payment premium on the principal amount, in equal installments over 3 calendar
months or until the amortization event is cured, whichever is earlier. In addition, upon the occurrence of an event of default, the interest
rate on the Yorkville Promissory Note increases to <span id="xdx_909_ecustom--DebtInstrumentInterestRateDefaultPercentage_iI_pid_dp_c20241008__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zFdKUfq7UWFh" title="Debt default interest rate"><ix:nonFraction name="ONMD:DebtInstrumentInterestRateDefaultPercentage" contextRef="AsOf2024-10-08_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember" id="Fact001423" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>% retroactive to the date of the event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
Turnover</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on October 8, 2024, on October 1, 2024, Paul J. Casey and
Erkan Akyuz resigned from the Board of Directors of the Company (the &#8220;Board&#8221;), effective immediately. Also on October 1, 2024, the Board appointed Jair Clarke and Sherry
Coonse McCraw to the Board to fill the vacancies created by Mr. Casey and Mr. Akyuz, respectively. In connection with Ms. Coonse
McCraw and Mr. Clarke&#8217;s service on the Board, the Board approved an RSU grant providing for the grant of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241001__20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MsCoonseMcCrawMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkmul9Br5Qwc" title="Number of restricted stock units granted"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241001__20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MrClarkeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPrE32kpU4z3" title="Number of restricted stock units granted"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MsCoonseMcCrawMember_us-gaap_RestrictedStockUnitsRSUMember" id="Fact001425" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MrClarkeMember_us-gaap_RestrictedStockUnitsRSUMember" id="Fact001427" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction></ix:nonFraction></span></span>
RSUs to each director for one full year of service (prorated for 2024). The RSUs will vest at the end of December 2024.</span></p>

</ix:nonNumeric><p id="xdx_810_zXy24qbrj4Yl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_002"></span>Report
of Independent Registered Public Accounting Firm</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and Stockholders of</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
Corporation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of OneMedNet Corporation (the &#8220;Company&#8221;) as of December 31, 2023
and 2022, and the related consolidated statements of operations, changes in temporary equity and stockholders&#8217; deficit, and cash
flows for each of the two years in the period ended December 31, 2023, and the related notes (collectively referred to as the &#8220;consolidated
financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial
position of the Company as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the two
years in the period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restatement
to Correct Previously Issued Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 2 to the consolidated financial statements, the 2023 and 2022 consolidated financial statements have been restated
to correct misstatements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 1 to the consolidated financial statements, the Company has suffered recurring operating losses and negative cash flows from
operating activities since inception and expects to continue incurring operating losses and negative cash flows in the future. These
matters raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters
are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome
of this uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion
on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting
Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with
the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing
an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
WithumSmith+Brown, PC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">East
Brunswick, New Jersey</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
4, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
ID Number 100</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p id="xdx_046_c20230101__20231231_zF2Z0vJWGEh7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_003"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_111_pn3n3_zACVx54ns1n3" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20231231_zrcfas880n" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_494_20221231_zdYulh1R3te7" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(As
    Restated)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(As
    Restated)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z8Uj6HYWlEx5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zpt1iDVFPPG1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    assets:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_z4M3jFEerQC8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact001435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact001436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--AccountsReceivableNetCurrent_i02I_zoBc9ZI5ZuQh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable, net of allowance for credit losses of $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_z8ysl00VlKsd" title="Accounts receivable, allowance"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-12-31" id="Fact001441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zhrkBNQiucO7" title="Accounts receivable, allowance"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2022-12-31" id="Fact001443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125,233</ix:nonFraction></span> at December 31, 2023 and December 31, 2022, respectively</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31" id="Fact001438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" id="Fact001439" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zfKaK3l4sX54" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    expenses and other current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact001445" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" id="Fact001446" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--AssetsCurrent_i02TI_zj1bz55eChBe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact001448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">365</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" id="Fact001449" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">391</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--DeferredCostsNonCurrent_i01I_zYTM4qCGM179" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred transaction costs</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1451">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2022-12-31" id="Fact001452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">815</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentNet_i01I_zjS1NcKJo7Cf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    and equipment, net</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact001454" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" id="Fact001455" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--Assets_i01TI_z30bC01rB4j6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact001457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" id="Fact001458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,289</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zlN5qMhb7DF9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities,
    temporary equity and stockholders&#8217; deficit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_ztONmWzUQM47" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    liabilities:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_z4qOfuRei7Ki" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable &amp; accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001466" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,682</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact001467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,177</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_zIuZY0NWJXle" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    revenues</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-12-31" id="Fact001469" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-12-31" id="Fact001470" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LoansPayableCurrent_i02I_zvRsYaq1QT6b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan extensions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LoansPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,992</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--ConvertibleDebtCurrent_i02I_zkScBDF9rqxe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    promissory notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1475">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-12-31" id="Fact001476" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,743</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--NotesPayableCurrent_i02I_znXAlUoq1Px7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIPE Notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31" id="Fact001478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1479">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_z0W2wWG9Pj9h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
    underwriter fee payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2023-12-31" id="Fact001481" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,525</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilitiesCurrent_i02I_zFa8oI8FbwDe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">283</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1485">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_z0oxWxiFoExi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact001487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,373</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact001488" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,104</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ConvertibleDebtNoncurrent_i01I_zS6ZXPW47cjd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible promissory notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-12-31" id="Fact001491" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LongTermLoansPayable_i01I_zKYnbqj0EOze" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan, related party</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2023-12-31" id="Fact001493" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilitiesNoncurrent_i01I_z0jU3d7zdu56" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    long-term liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact001496" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" id="Fact001497" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--Liabilities_i01TI_zgvNdxIUBB68" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact001499" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,906</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" id="Fact001500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,648</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--CommitmentsAndContingencies_i01I_zmssWmUuyvFi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments
    and contingencies (Note 13)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span>&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--TemporaryEquityAbstract_i01B_zVEexpTQDzMi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Temporary
    equity:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zwtco6fAb685" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Series A-2, par value $<span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zotVZC506U87" title="Temporary equity, par value per share"><span id="xdx_908_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zw7ez6IRU9Rj" title="Temporary equity, par value per share"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001511" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001513" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zryViHmGOTsh" title="Temporary equity, shares authorized"><span id="xdx_909_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxqq1pMgwtu" title="Temporary equity, shares authorized"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001515" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001517" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,200,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, and <span id="xdx_902_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zjOHz6kowSvc" title="Temporary equity, shares issued"><span id="xdx_90C_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zdmzAuSWfaa" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001519" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001521" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_909_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z14XINRrVXu3" title="Temporary equity, shares issued"><span id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zc89Esf7SxR9" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001523" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001525" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31,
    2023 and December 31, 2022, respectively</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1508">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact001509" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zkFKYFTGTqll" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Shares A-1, par value $<span id="xdx_90A_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zlzLanvFIDO7" title="Temporary equity, par value per share"><span id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zLT7FEXliD7f" title="Temporary equity, par value per share"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001530" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001532" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z4EvnaPdyiRg" title="Temporary equity, shares authorized"><span id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_ztm0BEeqj1yi" title="Temporary equity, shares authorized"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001534" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001536" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,400,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, and <span id="xdx_901_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zlVLEWsEs9Gk" title="Temporary equity, shares issued"><span id="xdx_90F_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z6iL473I8p02" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001538" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001540" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_900_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z3etrZnxK89f" title="Temporary equity, shares issued"><span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMiW9wclCoK2" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001542" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001544" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31,
    2023 and December 31, 2022, respectively</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1527">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact001528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr id="xdx_404_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_zHp4y2NuxDCe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    temporary equity</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1546">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" id="Fact001547" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B_zjNBTeyCRSy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders&#8217;
    (deficit) equity:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--PreferredStockValue_i02I_z4JQmYTIofXd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Stock, par value $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_z6nmoqElkZp2" title="Preferred stock, par value"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_z3VZLpQLa7t2" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001555" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact001557" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zuMp14K48Jgk" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001559" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> and <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zeZmdSQP0Znc" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact001561" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span> shares authorized at December 31, 2023 and 2022, respectively; <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20231231_zq8nS4McDShd" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zY5lh1gl1YR3" title="Preferred stock, shares outstanding"><span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20221231_zcdxWqOgGDz4" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20221231_zBijIs4530Mc" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001563" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001565" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact001567" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact001569" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding
    at December 31, 2023 and 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1552">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1553">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--CommonStockValue_i02I_z63LDLg1fm3c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, par value $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZ6wVAFtOwii" title="Common stock, par value"><span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_zuvEsJjnKDy6" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact001574" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact001576" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z6m6GjJwLWr8" title="Common stock, shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_z9XbD6vGyOG1" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact001578" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact001580" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized and <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zbEdhWsPbQod" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zmuTYAk9W2qk" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact001582" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact001584" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_z14XnpqN0Mlb" title="Common stock, shares issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zTg8IgFjDfM" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact001586" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact001588" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December
    31, 2023 and December 31, 2022, respectively</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact001571" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1572">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--AdditionalPaidInCapital_i02I_z9dKfb2DLKW7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid-in-capital</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="Fact001590" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,996</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" id="Fact001591" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,657</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_zTvgYyKuXNkb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    deficit</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact001593" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,440</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" id="Fact001594" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,660</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_zMEakzgLIuhj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 30pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    stockholders&#8217; deficit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001596" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,442</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact001597" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,359</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_zTWwDdsKjdBb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities, temporary equity, and stockholders&#8217; deficit</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001599" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" id="Fact001600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,289</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_004"></span>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share and per share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_113_pn3n3_zNUATev5a1Ji" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_491_20230101__20231231_zvUvohUP89Fc" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" id="xdx_49E_20220101__20221231_zQNpNN4cTuKd" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the year ended December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(As
    Restated)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(As
    Restated)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--RevenuesAbstract_iB_z6YxeWeVfUjk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zxdYEoL09B7g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
    revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_SubscriptionRevenueMember" id="Fact001605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">878</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_SubscriptionRevenueMember" id="Fact001606" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">678</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zADr4Gbotndh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Web
    imaging revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_WebImagingRevenueMember" id="Fact001608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_WebImagingRevenueMember" id="Fact001609" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">475</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_zLc9NQ8tJ2d5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    revenue</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31" id="Fact001611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,021</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31" id="Fact001612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,153</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--CostOfRevenue_zomKbjq0f3of" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenue</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31" id="Fact001614" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,150</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31" id="Fact001615" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,513</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--GrossProfit_iT_zVcIWUP3aX86" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    margin</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-12-31" id="Fact001617" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">129</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31" id="Fact001618" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">360</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zcMo6hH8N02f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--GeneralAndAdministrativeExpense_i01_zGpK4AkGLVeb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31" id="Fact001623" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,544</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31" id="Fact001624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,806</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--SellingAndMarketingExpense_i01_zpNGhCMuLzol" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales and marketing</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31" id="Fact001626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,115</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31" id="Fact001627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">958</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_zKwvdnnhSAE7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
    and development</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31" id="Fact001629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,065</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31" id="Fact001630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,591</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingExpenses_i01T_zzDrTuaE4S49" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    operating expenses</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31" id="Fact001632" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,724</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31" id="Fact001633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,355</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iT_z5l45CLiZCd8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss from
    operations</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact001635" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,853</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact001636" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,715</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z6NxRzyCygF" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expense
    (income), net</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--InterestExpenseNonoperating_i01_zwStcbnrTG58" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-01-012023-12-31" id="Fact001641" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1642">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--StockOptionPlanExpense_i01_zjVWQgAWWZu2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock warrant expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2023-01-012023-12-31" id="Fact001644" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockOptionPlanExpense" contextRef="From2022-01-012022-12-31" id="Fact001645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--FairValueAdjustmentOfWarrants_i01_zPlKyFCvtsQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31" id="Fact001647" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">129</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_zowejbJ8TiZh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of PIPE
    Notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-12-31" id="Fact001650" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_zO2QD9ORWS14" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in fair value of convertible
    promissory notes</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31" id="Fact001653" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,517</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31" id="Fact001654" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,616</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_zQ3tZ12GZpCi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31" id="Fact001656" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">34</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" id="Fact001657" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_i01NT_di_z6MxmCyPDrXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other expense, net</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31" id="Fact001659" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,909</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" id="Fact001660" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,719</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_zf6YDKkuy4i2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before
    income taxes</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31" id="Fact001662" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,762</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" id="Fact001663" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,434</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_zSgBuWlvCFwa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
    tax expense</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact001665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact001666" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_iT_zfvm1vQoGEsf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact001668" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact001669" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zOODUGlx4PSi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings per share:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted net loss per common share outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fKDEp_zrAQo7Jdpr4c" title="Basic net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90D_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fKDEp_z5KGQUeQRvxf" title="Diluted net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31" id="Fact001674" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31" id="Fact001676" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">4.77</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fKDEp_zK5DJuSof0v4" title="Basic net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fKDEp_zZJP7vLUHFPh" title="Diluted net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31" id="Fact001678" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31" id="Fact001680" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">7.66</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and diluted weighted average number of common shares outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zhVvUBRFx4M1" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90F_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zoNvfO1FF6Ta" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31" id="Fact001682" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31" id="Fact001684" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,084,068</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_zDvedm35C1qi" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_zzW7MiS7d4Ll" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31" id="Fact001686" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-12-31" id="Fact001688" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,973,897</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_005"></span>CONSOLIDATED
STATEMENTS OF CHANGES IN TEMPORARY EQUITY AND STOCKHOLDERS&#8217; DEFICIT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands, except share data)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_308_114_pn3n3_zoKB3Mzsewn1" summary="xdx: Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BD_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_us-gaap--StatementClassOfStockAxis_custom--SeriesATwoPreferredStockMember_zAtYKqvEceGc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_us-gaap--StatementClassOfStockAxis_custom--SeriesAOnePreferredStockMember_zNrL0fwWP5Ka" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--TemporaryEquityMember_zjskvKjjL8i2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z0w7bc8YRu0i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zHYlOn6ZdfJ1" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Capital</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z3ECLk3ZroWl" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Deficit</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_z8qeVrRRHHG3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Total</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">Series A-1</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Temporary</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Additional</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Preferred Stock</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Equity</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Paid-in</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">Accumulated</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Capital</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Deficit</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_433_c20220101__20221231_eus-gaap--StockholdersEquity_iS_zXlReM15sHH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmTdhSm4TQ7f" title="Balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001698" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,853,797</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001690" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z257w5okW5j6" title="Balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001700" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,204,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001691" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember" id="Fact001692" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4t9335HN749" title="Balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="Fact001702" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,342,666</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1693">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001694" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,513</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" id="Fact001695" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">27,209</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" id="Fact001696" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,052</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_z2KPAOVrLHR8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to the Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zZS2JHj9EWXk" title="Retroactive application of recapitalization due to the Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001712" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">437,874</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zDdnRUE41Bm7" title="Retroactive application of recapitalization due to the Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001714" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">364,043</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1705">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zr8MGnYdmfy" title="Retroactive application of recapitalization due to the Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact001716" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">493,420</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1707">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1710">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zdM4YPFhkLNl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1718">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1719">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1720">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsPGY7Djoo0g" title="Issuance of common shares in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact001726" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">177,276</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1721">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1722">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1723">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1724">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zQF5hPF5mcL9" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1728">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1729">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1730">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpojfSiGr4Y9" title="Exercise of stock options, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember" id="Fact001736" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,648</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001732" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1733">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31" id="Fact001734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_zIVP2VhX25Ie" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1738">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1739">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1741">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001742" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1743">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31" id="Fact001744" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_zxIYjyHJDMj6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1746">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1747">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1748">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1751">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31" id="Fact001752" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zObcQ1KQ8ef4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1755">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1756">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1757">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1759">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31" id="Fact001760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_z9jU6zAZcy1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1762">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1763">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1764">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1765">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1766">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember" id="Fact001767" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact001768" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_435_c20230101__20231231_eus-gaap--StockholdersEquity_iS_zY6z57ypeBZj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (Restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zUuILEPuHhg8" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001778" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001770" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z3liwgkylc4d" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001780" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001771" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember" id="Fact001772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8FscDemrnXk" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact001782" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1773">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001774" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,657</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact001775" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,660</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact001776" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,359</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_439_c20230101__20231231_eus-gaap--StockholdersEquity_iS_zUo6ZfsbZyi6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balance</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zTCnsZZVyIdi" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001792" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001784" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zEYZlGa8H8E1" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001794" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001785" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember" id="Fact001786" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmzzxTu7t7q4" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact001796" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1787">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001788" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,657</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" id="Fact001789" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,660</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact001790" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,359</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
<tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zos0dl4jbnNi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1798">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1799">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1800">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE4qc8zfqgj2" title="Issuance of common shares in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001806" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">265,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1802">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1803">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1804">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zNosOCshye7l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zFo6L0nw8Ide" title="Issuance of Series A-2 Preferred Stock. shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001816" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,673</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001808" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1809">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="Fact001810" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1813">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31" id="Fact001814" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_zST9HJkLiqk9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001822" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31" id="Fact001824" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_z4ehCNZ5esw2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1826">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1827">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zAR1lH60Br82" title="Exercise of OMN stock options upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001834" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">543,056</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1829">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1830">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1832">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_zplp6MDAZ8Zg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1838">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsT8mSgr9JRe" title="Exercise of OMN warrants upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001844" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,420,945</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1839">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1842">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_zgjFlSVNioZ7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1846">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1847">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFH69U3rszth" title="Conversion of OMN convertible promissory notes upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001854" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,475,362</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001849" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001850" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1851">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31" id="Fact001852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,936</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_zwxljtEQy0g2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zrTDlmvmc7pg" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001864" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">3,421,596</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember" id="Fact001856" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,650</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zVi143TLQzj1" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001866" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember" id="Fact001857" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,010</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember" id="Fact001858" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,660</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znwR8uAnUSp9" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001868" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,261,553</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001859" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001860" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1861">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1862">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_zDEjTYwNZrXb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1870">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1871">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1872">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zo2Iazbl5dHa" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember" id="Fact001878" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,572,232</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1873">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001874" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,937</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1875">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31" id="Fact001876" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,937</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zsUjcypgdHGk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1880">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1882">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1883">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1885">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31" id="Fact001886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetIncomeLoss_zu6zbFWjMdZj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1889">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1890">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1891">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember" id="Fact001893" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact001894" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43E_c20230101__20231231_eus-gaap--StockholdersEquity_iE_pn3n3_zchm9iZzocJj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (Restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zTLQ8rcwc4J9" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1904">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1896">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z2nVry0b84Y" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1906">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1897">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1898">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkCifJolY8n7" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001908" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001899" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001900" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,996</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact001901" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,440</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001902" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,442</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20230101__20231231_eus-gaap--StockholdersEquity_iE_zn9YAE4NUE4e" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balance</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zLbtKYEiuZqh" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1918">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1910">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYlpUa0TYfW" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1920">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1911">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1912">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRaP7TI88d5d" title="Balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001922" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact001913" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001914" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,996</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact001915" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,440</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact001916" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,442</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_006"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In
thousands)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_112_pn3n3_zLAHfTrwlU06" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20230101__20231231_zFxnhMUZs0R9" style="text-align: center; font-weight: bold">2023</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_495_20220101__20221231_zTGLf9r6B7ne" style="font-weight: bold; text-align: center">2022</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold">2023</td><td style="text-align: center; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2022</td><td style="text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">(As Restated)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(As Restated)</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zWRNfya1tZLb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetIncomeLoss_i01_zJaFEdBRpODf" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact001927" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact001928" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zapofXVqtmZa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DepreciationDepletionAndAmortization_i02_z5ktOpD9aOQh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-12-31" id="Fact001933" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-12-31" id="Fact001934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ShareBasedCompensation_i02_zaqYGd3YniM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31" id="Fact001936" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31" id="Fact001937" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockWarrantExpense_i02_zgIc78tTt2rd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-12-31" id="Fact001939" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2022-01-012022-12-31" id="Fact001940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FairValueAdjustmentOfWarrants_i02_zUyqkBCwED62" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31" id="Fact001942" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1943">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--WarrantExpense_i02N_di_zDNAgBzouJL9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1945">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2022-01-012022-12-31" id="Fact001946" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i02_zKIhfGTdIse" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-12-31" id="Fact001948" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1949">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_z6Kdq9XHGoT5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31" id="Fact001951" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,517</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31" id="Fact001952" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,616</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--NoncashInterest_i02_zUwF7HNbNMta" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Non-cash interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:NoncashInterest" contextRef="From2023-01-012023-12-31" id="Fact001954" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1955">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zqL3czmcGvg5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_zPFWc4FJY5Rj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-012023-12-31" id="Fact001960" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-12-31" id="Fact001961" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">73</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_zcFWvEUAnXAe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-01-012023-12-31" id="Fact001963" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-01-012022-12-31" id="Fact001964" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_z6AcB6m52nv8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-12-31" id="Fact001966" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">717</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-012022-12-31" id="Fact001967" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">415</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_z3wH2AEtkXOa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Deferred revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-01-012023-12-31" id="Fact001969" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-012022-12-31" id="Fact001970" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">458</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_zfSCgTQRBoQ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact001972" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,791</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31" id="Fact001973" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,703</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zfv9U8FojdKi" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_zMFLt8kpmUTj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31" id="Fact001978" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31" id="Fact001979" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_zvtW91AS2f0f" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact001981" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact001982" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_z5BoDZn68D5b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_zxZNic0VlKie" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of shareholder loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2023-01-012023-12-31" id="Fact001987" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">454</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1988">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_zFs1l5JGGrZb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of pipe notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-012023-12-31" id="Fact001990" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1991">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromConvertibleDebt_i01_zrZAqKuOqdp6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-12-31" id="Fact001993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-012022-12-31" id="Fact001994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,140</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_i01_zB7FqO0pSDaf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2023-01-012023-12-31" id="Fact001996" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1997">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromStockOptionsExercised_i01_zQX9ZxAk12Gh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1999">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-012022-12-31" id="Fact002000" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--BusinessCombinationCosts_i01N_di_zWSDS3Wf0gKi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2023-01-012023-12-31" id="Fact002002" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2022-01-012022-12-31" id="Fact002003" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">815</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_zxUBIZnPzGNd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact002005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,611</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact002006" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,333</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_z7Gq3aJMPqm5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
decrease in cash and cash equivalents</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-12-31" id="Fact002008" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">224</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-12-31" id="Fact002009" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">428</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDVKbxGDEfu1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact002011" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" id="Fact002012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">699</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zW0adxuonHQk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents at end of year </span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact002014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact002015" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zTdCqG4mqril" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssued1_i01_z3xOZ13QURl8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Common shares issued to preferred shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssued1" contextRef="From2023-01-012023-12-31" id="Fact002020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2021">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zF0D6P31LGzj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Common shares related to convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ONMD:CommonSharesRelatedToConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31" id="Fact002023" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2024">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zCopBisiNuYf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Common shares issued to Data Knights shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CommonSharesIssuedToDataKnightsShareholders" contextRef="From2023-01-012023-12-31" id="Fact002026" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,937</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2027">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
CORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_04D_c20230101__20231231_zFwQNFDlpA6a" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sk_007"></span>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact002029" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_809_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zmJ0QR35bxR9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span>Organization and Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_826_zjtp8qAyKhgl" style="display: none">Description of Business</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
Corporation (the &#8220;Company&#8221;) is a healthcare software company with solutions focused on digital medical image management,
exchange, and sharing. The Company was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions
that simplify digital medical image management, exchange, and sharing. The Company has one wholly-owned subsidiary, OneMedNet Technologies
(Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional
currency is the Canadian dollar. The Company&#8217;s headquarters location is Eden Prairie, Minnesota.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 7, 2023, we consummated a merger (the &#8220;Merger&#8221;) </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">following
the approval at the special meeting of the shareholders of Data Knights Acquisition Corp. (&#8220;Data Knights&#8221;), a Delaware corporation,
held on October 17, 2023 (the &#8220;Special Meeting&#8221;), of the agreement and plan of merger, dated as of April 25, 2022 (the &#8220;Merger
Agreement&#8221;), by and among Data Knights, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;) and a
wholly-owned subsidiary of Data Knights, OneMedNet Solutions Corporation (formerly named OneMedNet Corporation) (&#8220;Legacy ONMD&#8221;),
Data Knights, LLC, a Delaware limited liability company (&#8220;Sponsor&#8221;), and Paul Casey, in his capacity as representative of
the stockholders of Legacy ONMD. Pursuant to the Merger Agreement, Merger Sub merged with and into Legacy ONMD, with Legacy ONMD surviving
the Merger as a wholly-owned subsidiary of Data Knights (such transactions contemplated by the Merger Agreement, the &#8220;Business
Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to risks common to companies in the markets it serves, including, but not limited to, global economic and financial
market conditions, fluctuations in customer demand, acceptance of new products, development by its competitors of new technological innovations,
dependence on key personnel, and protection of proprietary technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going
Concern and Management&#8217;s Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets
and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects
on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of this
uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred recurring net losses since its inception, including $<span id="xdx_90B_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231231_zsU0xSLZvHcl" title="Net loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact002031" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">33.8</ix:nonFraction></span> million and $<span id="xdx_909_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20220101__20221231_z3LJ3ACCrSm3" title="Net loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact002033" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">30.5</ix:nonFraction> </span>million for the years ended December
31, 2023 and 2022, respectively. In addition, the Company had an accumulated deficit of $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20231231_zMzKn9enX4Ei" title="Accumulated defecit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact002035" format="ixt:numdotdecimal" decimals="-5" scale="6" sign="-" unitRef="USD">91.4</ix:nonFraction></span> million as of December 31, 2023. The Company&#8217;s
cash balance of $<span id="xdx_900_eus-gaap--Cash_iI_pn3n3_c20231221_z8kT95TFPK4i" title="Cash balance"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-12-21" id="Fact002037" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></span> thousand is not adequate to fund its operations through at least twelve months from the date these consolidated financial
statements were available for issuance. Therefore, these conditions raise substantial doubt about the Company&#8217;s ability to continue
as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital
through an equity or debt offering and ultimately attain profitable operations to fulfill its operating and capital requirements for
at least 12 months from the date of the issuance of the consolidated financial statements. However, the Company may not be able to secure
such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity securities to raise additional
funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences and privileges senior
to those of the Company&#8217;s existing stockholders. The consolidated financial statements do not include any adjustments relating
to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as
a going concern. The Company&#8217;s continuation as a going concern is dependent upon its ability to continue receiving working capital
cash payments and generating cash flow from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nasdaq
Notices</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2024, the Company received written notice (the &#8220;MVLS Nasdaq Notice&#8221;) from the Nasdaq Stock Market (&#8220;Nasdaq&#8221;)
indicating that for the preceding 30 consecutive business days, the market value of the Company&#8217;s listed securities (&#8220;MVLS&#8221;)
did not maintain a minimum market value of $50,000,000 (the &#8220;Minimum MVLS Requirement&#8221;) as required by Nasdaq Listing Rule
5450(b)(2)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company had a compliance period of 180 calendar days, or until
August 5, 2024, to regain compliance with the Minimum MVLS Requirement. Compliance could have been achieved if the Company&#8217;s MVLS
closed at $50,000,000 or more for a minimum of ten consecutive business days at any time during the 180-day compliance period, in which
case Nasdaq would notify the Company of its compliance, and the matter would be closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company did not regain compliance with the Minimum MVLS Requirement by August 5, 2024, Nasdaq would have provided written notification
to the Company that its Common Stock was subject to delisting. At that time, the Company could have appealed the relevant delisting determination
to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. The Company sought to apply for a transfer
to The Nasdaq Capital Market, and on August 15, 2024, the Company received approval from Nasdaq to list the Common Stock and Public Warrants
on The Nasdaq Capital Market. The Common Stock and Public Warrants were transferred from The Nasdaq Global Market to The Nasdaq Capital
Market at the opening of business on August 19, 2024, and continue to trade under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221;
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2024, the Company received written notice (the &#8220;Bid Price Nasdaq Notice&#8221;) from Nasdaq notifying the Company that,
for the 30 consecutive business days prior to the date of the Bid Price Nasdaq Notice, the Common Stock did not meet the minimum bid
price of $1.00 per share requirement (the &#8220;Minimum Bid Price Requirement&#8221;) as required by Nasdaq Listing Rule 5450(a)(1).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a compliance period of 180 calendar days, or until September 23,
2024, to regain compliance with the Minimum Bid Price Requirement. Compliance could have been achieved if the closing bid price of the
Company&#8217;s Common Stock was at least $1 for a minimum of ten consecutive business days. On June 10, 2024, the Nasdaq staff determined
that for the prior 11 consecutive business days, from May 23, 2024, to June 7, 2024, the closing bid price of the Company&#8217;s Common
Stock had been at $1.00 per share or greater. Accordingly, the Company regained compliance with Listing Rule 5450(a)(1), and this matter
was closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Q1 2024 Form 10-Q Nasdaq Notice&#8221;),
which indicated that, as a result of the Company&#8217;s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended
March 31, 2024 (the &#8220;Q1 2024 Form 10-Q&#8221;) by the applicable due date, the Company was not in compliance with Nasdaq Listing
Rule 5250(c)(1) (the &#8220;Periodic Report Rule&#8221;), which requires Nasdaq-listed companies to timely file all required periodic
financial reports with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The Q1 2024 Form 10-Q Nasdaq Notice stated that
the Company had 60 calendar days to submit to Nasdaq a plan to regain compliance with the Periodic Report Rule. If Nasdaq accepted the
Company&#8217;s plan to regain compliance, then Nasdaq could have granted the Company up to 180 calendar days from the prescribed due
date of the Form 10-Q to regain compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 9, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Q2 2024 Form 10-Q Nasdaq Notice&#8221;),
which indicated that, as a result of the Company&#8217;s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended
June 30, 2024 (together with the Q1 2024 Form 10-Q, the &#8220;Delinquent Filings&#8221;) by the applicable due date, the Company was
not in compliance with the Periodic Report Rule, which requires Nasdaq-listed companies to timely file all required periodic financial
reports with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 10, 2024, the Company received a notification letter from Nasdaq the &#8220;Nasdaq Compliance Plan Notice&#8221;), which responded
to the Company&#8217;s plan to regain compliance regarding its delinquent Q1 2024 Form 10-Q, granting the Company an exception until
October 31, 2024 to file the Delinquent Filings with the SEC and regain compliance with the Periodic Report Rule. In the event the Company
does not regain compliance with the Periodic Report Rule by October 31, 2024, Nasdaq will provide written notification that the Company&#8217;s
securities will be delisted. At that time, the Company may appeal Nasdaq&#8217;s determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Second MVLS Nasdaq Notice&#8221;) indicating
that for the preceding 30 consecutive business days, the Company&#8217;s MVLS was below the minimum of $35 million required for continued
listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2). The staff at Nasdaq also noted in the Second MVLS Nasdaq
Notice that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum
stockholders&#8217; equity of $2.5 million, and Nasdaq Listing Rule 5550(b)(3), which requires listed companies to maintain a minimum
of $500,000 of net income from continuing operations. In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar
days, or until April 7, 2025, to regain compliance with the Minimum MVLS Requirement. Compliance may be achieved if the Company&#8217;s
MVLS closes at $35 million or more for a minimum of ten consecutive business days at any time during the 180-day compliance period, in
which case Nasdaq will notify the Company of its compliance and the matter will be closed, If the Company does not regain compliance
by the end of the 180-day compliance period, Nasdaq staff will provide written notice to the Company that its securities are subject
to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 16, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Second Bid Price Nasdaq Notice,&#8221;
and together with the MVLS Nasdaq Notice, the Bid Price Nasdaq Notice, the Q1 2024 Form 10-Q Nasdaq Notice, the Q2 2024 Form 10 Q Nasdaq
Notice, the Nasdaq Compliance Plan Notice, and the Second MVLS Nasdaq Notice, the &#8220;Nasdaq Notices&#8221;) notifying the Company
that, for the 30 consecutive business days prior to the date of the Second Bid Price Nasdaq Notice, the Common Stock did not meet the
Minimum Bid Price Requirement as required by Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the
Company has 180 calendar days, or until April 14, 2025, to regain compliance. The Second Bid Price Nasdaq Notice notes that to regain
compliance, the Common Stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days at any time
during the 180-day compliance period. In the event the Company does not regain compliance by the end of the 180-day compliance period,
the Company may be eligible for additional time to regain compliance. To qualify for additional time, the Company must (i) meet the continued
listing requirement for the market value of its publicly held shares and all other initial listing standards for the Nasdaq Capital Market,
with the exception of the bid price requirement and (ii) provide written notice of its intention to cure the deficiency during the second
compliance period by effecting a reverse stock split, if necessary. If the Company meets these requirements, the Company may be granted
an additional 180 calendar days to regain compliance. However, if it appears to Nasdaq that the Company will be unable to cure the deficiency,
or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide written notice to the Company that its
securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nasdaq Notices received have no immediate effect on the Company&#8217;s continued listing on the Nasdaq Capital Market or the trading
of the Company&#8217;s Common Stock, subject to the Company&#8217;s compliance with the other continued listing requirements. The Company
is presently evaluating potential actions to regain compliance with all applicable requirements for continued listing on the Nasdaq Capital
Market. There can be no assurance that the Company will be successful in maintaining the listing of its Common Stock on the Nasdaq Capital
Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact002039" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zfl75WnLdHg5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_829_zf1Bh0qhZm65">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact002041" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zV1XxAmYpNw2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z66TBxyppqMl">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#8220;GAAP&#8221;). The accompanying consolidated financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of OneMedNet Corporation, formerly Data Knights, and its wholly-owned
subsidiary, OneMedNet Technologies Canada Ltd. All intercompany transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact002043" name="ONMD:RestatementToFinancialStatementsPolicyTextBlock"><p id="xdx_84E_ecustom--RestatementToFinancialStatementsPolicyTextBlock_zlfs5i9HvsA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zF84H1NjBDH9">Restatement
to Previously Issued Consolidated Financial Statements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s consolidated financial statements for the years ended December 31, 2023 and 2022, as previously filed with the SEC on
April 9, 2024, have been restated. The previously filed consolidated financial statements did not reflect the proper accounting for the
business combination transaction, convertible notes, warrants, preferred stock, stock-based compensation expense, and accounts payable
and accrued expenses. The Company has also restated related amounts within the accompanying footnotes to the consolidated financial statements
to conform to the restated amounts in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following consolidated financial statements provide a reconciliation from the originally &#8220;as reported&#8221; financial information
to the now &#8220;as restated&#8221; consolidated financial information as of and for the years ended December 31, 2023 and 2022 (in
thousands, except share and per share data).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact002045" name="us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zQobtUlY9Fg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zmqNIyggURV3">Schedule
of Restatement of Financial Statements</span><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--StatementOfFinancialPositionAbstract_pn3n3_zHB7otDeIImb" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheet (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zruyu53jUhca" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zcfTKFbd2jqd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zCrqV71XHMwj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zseXWl5ARgmk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (<span id="xdx_F56_zoHeAO3yRzkb">1</span>)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z3fZH6OQ10X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zXmzyt8ADHpc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACznbB_zwfJYNAqd4h2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002059" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-12-31" id="Fact002062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%; text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsHeldInTrustCurrent_i02I_zQhwodfyf5vd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2064">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2065">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2066">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2067">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACznbB_zhZl1KSXxike" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance for credit losses of $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zPo9iq8qLwpk" title="Accounts receivable, allowance" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-12-31" id="Fact002074" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zMIhH9k6HRqe" title="Accounts receivable, allowance" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2022-12-31" id="Fact002076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125,233</ix:nonFraction></span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002069" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2070">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-12-31" id="Fact002072" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACznbB_zUCqDZwvR8h1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2079">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2080">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-12-31" id="Fact002081" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">166</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACznbB_maAzRE3_zWVgddrEhU8f" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002083" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">365</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2084">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2085">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-12-31" id="Fact002086" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">365</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeferredCostsNonCurrent_i01I_pn3n3_maAzRE3_zadfKDc4WIPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2088">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2089">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2090">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2091">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzRE3_zG9krXgkbKe1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2095">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact002096" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Assets_i01TI_pn3n3_mtAzRE3_zRG9OArPib89" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002098" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2099">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-12-31" id="Fact002101" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zq1I6hLyExog" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbZJCma4btqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zssMDVKCKb27" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002113" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002114" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">498</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2115">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact002116" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zNPcfhGy81Dl" style="text-align: center">2</td></tr>
  <tr id="xdx_408_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z5EoFfgXn103" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember" id="Fact002118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember" id="Fact002120" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2121">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ExciseTaxCurrent_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_zoHwN3FbTAHf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Excise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ExciseTaxCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember" id="Fact002123" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ExciseTaxCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember" id="Fact002125" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">113</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2126">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredRevenueCurrent_i02I_pn3n3_maLCzjPj_zgTzWhgM5q78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2129">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2130">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-12-31" id="Fact002131" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">254</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zqzqEDRPdHVe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2133">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2134">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2135">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LoanExtensionsCurrent_i02I_pn3n3_maLCzjPj_zxQs4dQZsJhi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:LoanExtensionsCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002138" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,992</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2139">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:LoanExtensionsCurrent" contextRef="AsOf2023-12-31" id="Fact002141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,992</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LoansPayable_i02I_pn3n3_maLCzjPj_z4rAes4v5eLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002143" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002145" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--CanadaEmergencyBusinessLoanAct_i02I_pn3n3_maLCzjPj_zh8sEs0vfagg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:CanadaEmergencyBusinessLoanAct" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002148" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2149">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CanadaEmergencyBusinessLoanAct" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002150" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">45</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2151">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccruedIncomeTaxesCurrent_i02I_pn3n3_maLCzjPj_zMZx9uIWYCb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002153" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2154">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002155" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">120</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2156">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_pn3n3_maLCzjPj_zBTLDRUX27Ba" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002158" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,525</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2023-12-31" id="Fact002161" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,525</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_pn3n3_maLCzjPj_zjmSYJKQeNEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002164" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-12-31" id="Fact002166" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z70r7UPIkBw8" style="text-align: center">3</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zxhw1hbC8X8d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Other current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2168">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002170" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">283</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact002171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">283</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_z7XLQgC9gMPe" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2173">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2174">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzjPj_maLzhoA_zUAVIkx4mgr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002178" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,833</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">585</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002180" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">45</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-12-31" id="Fact002181" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,373</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ConvertibleDebtNoncurrent_i01I_pn3n3_maLzhoA_zXYxZv4wnbE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2183">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_z0sV3xK1qwE8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2188">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2189">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2191">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_z3W70HCcYUcf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_pn3n3_maLzhoA_zWCkZbDgLii7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loan, related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002198" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2199">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2200">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2023-12-31" id="Fact002201" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_z3TrqGM1swRk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2206">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WorkingCapitalLoan_i01I_maLzhoA_znG3RD0bmoD8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2210">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--WarrantLiabilityNonCurrent_i01I_pn3n3_maLzhoA_zvrWCZOR9MLe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002213" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2214">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002215" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2216">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLzhoA_zzAZ5vz1nGW5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2218">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002219" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002220" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2023-12-31" id="Fact002221" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">68</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4E_zdVxtDBJ0vy4" style="padding-bottom: 1pt; text-align: center">4</td></tr>
  <tr id="xdx_401_eus-gaap--Liabilities_i01TI_pn3n3_mtLzhoA_maLASEzB9f_zWurd1Dcwf66" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002223" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,323</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">583</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2225">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-12-31" id="Fact002226" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,906</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_maLASEzB9f_zriAse0CJx5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2228">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2229">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2230">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2231">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--TemporaryEquityAbstract_i01B_zCjF4hRjdSM9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxCEJ7wpVb28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span id="xdx_90B_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zcQDvHCATRy3" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmw2jLMPLdv3" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002243" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002245" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zk2kv65ICmXe" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8QQZwnKdLZf" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002247" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002249" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,200,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, and <span id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zbwzb6ONsLgi" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBohDzYt6cuc" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002251" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002253" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zPYyjWP6t8nl" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zDpri74qdrj4" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002255" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002257" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2238">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2240">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2241">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zvgShIKHTHql" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUdnjUXJ4Nc1" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUBfnzNHxmQ7" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002264" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002266" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zD2AuNLE5jti" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_908_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYuIuwhSTul" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002268" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002270" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,400,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, and <span id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zFfkQRyVN4Y8" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgXlLITRaRd" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002272" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002274" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z75ktmKy0962" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z5lkoDhcdVvc" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002276" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002278" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></ix:nonFraction> </span></span>shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2260">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2261">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2262">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEzB9f_zFJ3TKul93Da" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2280">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2283">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zWgvLMcwUEad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_pn3n3_maSEzYAb_zDP929DLJBcj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zTouxWv5xMNj" title="Preferred stock, par value" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zoAhJQ97gzT" title="Preferred stock, par value" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact002295" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact002297" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zY9mbTXbyWjg" title="Preferred stock, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact002299" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zaAG4dvCdMGb" title="Preferred stock, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact002301" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span> shares authorized at December 31, 2023 and 2022, respectively; <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zeXWFKcteVZa" title="Preferred stock, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zFLSOBzdiIYi" title="Preferred stock, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2RDRUICTuA3" title="Preferred stock, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zF0OtUHrvAid" title="Preferred stock, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact002303" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact002305" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact002307" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact002309" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding at December 31, 2023 and 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2290">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzYAb_zKclxpQQ1fc5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zO8f1W2CvHd1" title="Common stock, par value" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z0fgb54GPpF7" title="Common stock, par value" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact002316" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact002318" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z87XB46c1rqk" title="Common stock, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zlJ0WFifrcwj" title="Common stock, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact002320" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact002322" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized and <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z37TR95QhdKj" title="Common stock, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zhQfhe7EP9Z4" title="Common stock, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact002324" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact002326" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zD5XPgF0KCAh" title="Common stock, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zOrvrjW3oymd" title="Common stock, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact002328" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact002330" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002311" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002312" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2313">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-12-31" id="Fact002314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pn3n3_maSEzYAb_zr99liLi1UOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002332" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,221</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002333" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,775</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2334">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-12-31" id="Fact002335" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,996</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zsHwSQ1sDr3" style="text-align: center">5</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pn3n3_maSEzYAb_zaNz42WzTBF6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002337" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,083</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002338" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">36,357</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-12-31" id="Fact002340" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,440</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F49_zKvHtgqXejJk" style="padding-bottom: 1pt; text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzYAb_maLASEzB9f_zPwz0JsddSC7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total stockholders&#8217; deficit </b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002342" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,859</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002343" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">583</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact002345" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,442</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzB9f_zgvnToSh7PEc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-12-31" id="Fact002350" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">464</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0A_zxpPh2kj3NLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zv3t0HiTxmkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002351" xml:lang="en-US">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zHmIIEvFd8Ne" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zQ2Kprb6wXq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002352" xml:lang="en-US">Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_z45MNyUdVjC3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z1BUgtO53Nk2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002353" xml:lang="en-US">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zI0DPexFF7Xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_z8uJZPF6GN1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002354" xml:lang="en-US">Impact
    of errors related to the valuation of liability-classified warrants.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zzIQLbw8bWJj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zWvic4rLmBCb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002355" xml:lang="en-US">Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zfMaYzeUq0yi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_z9pixMR8yD4a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002356" xml:lang="en-US">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ivgJzJjlvk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBNy3rflnLOh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zDVc23ZbTal1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F5B_z2orGC7gqCVd">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zyrQoTWDbpmg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zoHhxMUlwOn3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zylrCrVigph8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zklWvSmRU3hg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002368" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">302</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(<ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002369" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2370">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2022-12-31" id="Fact002371" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F44_zWiYZ0g0Crw7" style="width: 6%; text-align: center">2</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsHeldInTrustCurrent_i02I_z5i7O4J0zNh9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,029</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002374" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29,029</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2376">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zlMEbFIQFeXl" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_z91VCg6KuhUk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance of $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zXowDYdGPzGi" title="Accounts receivable, allowance" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-12-31" id="Fact002383" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zIJD7O8FvRM6" title="Accounts receivable, allowance" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2022-12-31" id="Fact002385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125,233</ix:nonFraction></span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002378" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2380">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" id="Fact002381" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zQeyB686mQ62" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002387" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2388">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2389">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" id="Fact002390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtACznbB_maAzRE3_zeC41by6Wz69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002392" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,451</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002393" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29,060</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2394">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" id="Fact002395" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">391</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredCostsNonCurrent_i02I_maAzRE3_zjz3cdl7FRTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002397" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">900</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002398" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">85</ix:nonFraction></td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ONMD:DeferredCostsNonCurrent" contextRef="AsOf2022-12-31" id="Fact002400" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">815</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zugrWwR5FxFg" style="text-align: center">3</td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAzRE3_zbYTPH2Futm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2404">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" id="Fact002405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_iTI_mtAzRE3_zuFdBSWVj8ce" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002407" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,434</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002408" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29,145</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2409">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" id="Fact002410" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,289</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3idIMSAttVf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfMGnFVZHtZj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzjPj_zlbUKNPQwEya" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002422" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,814</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002423" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,637</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact002425" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,177</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z1PDq4D8k1bg" style="text-align: center">4</td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilities_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z387LtueELU9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember" id="Fact002427" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember" id="Fact002428" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2430">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zSY0KCHBsjBj" style="text-align: center">2</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_maLCzjPj_z9JdmARHcJg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002432" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2433">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-12-31" id="Fact002435" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zIdFD76ACDwf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,490</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,253</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2022-12-31" id="Fact002440" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,743</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zHBwRYiaiQg5" style="text-align: center">5</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzjPj_zd0KrYwUO0fh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">215</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AccruedIncomeTaxesCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002443" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">215</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2444">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2445">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zPc4odgOaoCa" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_zvh30x1dLpB5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002448" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">70</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4F_zT5OAzrQZl5f" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzALC_maLzDXj_zJod9ww4Wxj7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002452" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,785</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,319</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" id="Fact002455" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,104</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzhoA_zIHuzIhaWiC5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002457" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2458">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtNoncurrent" contextRef="AsOf2022-12-31" id="Fact002460" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_zfKNTjGJYna2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002462" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2463">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:UnsecuredDebtCurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002464" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_zGr6iAAo4DVb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:AccruedInterestRelatedParty" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002467" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:AccruedInterestRelatedParty" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002468" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">691</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2469">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zWbk5Oymcxfk" style="text-align: center">5</td></tr>
  <tr id="xdx_409_ecustom--WarrantLiabilityNonCurrent_i01I_maLzhoA_zGpl8dgESeb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002472" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">363</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:WarrantLiabilityNonCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002473" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">363</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2474">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zoFnY3Hr2jo6" style="text-align: center">2</td></tr>
  <tr id="xdx_40C_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_zmTEozCqcKo5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002477" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,025</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableNonCurrent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002478" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,025</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2480">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy1llbxdPwRd" style="text-align: center">2</td></tr>
  <tr id="xdx_408_ecustom--WorkingCapitalLoan_i01I_maLzhoA_zCJ6wwyiyxX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002482" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:WorkingCapitalLoan" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002483" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">207</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2484">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy8mdZVEYor6" style="text-align: center">2</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermLoansPayable_i01I_maLzhoA_zLbIae4ITDb1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Extension loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002487" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,546</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:LongTermLoansPayable" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002488" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,546</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2489">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2490">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zj7IDgjpWd1b" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzhoA_zTmH1HjVwx28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2492">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002494" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="AsOf2022-12-31" id="Fact002495" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtLzhoA_maLASEzB9f_zJPu33kIRNI8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002497" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,161</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002498" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,488</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" id="Fact002500" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27,648</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzB9f_z4bET9jAmas6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002502" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002503" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--TemporaryEquityAbstract_i01B_zChswc4s12K1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zCNQhtB5sb38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span id="xdx_900_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMglAdrlMTt5" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8CjB97Kyrk8" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002517" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002519" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_907_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zuhtwF938LQ" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zvZjuO1dS995" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002521" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002523" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,200,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, and <span title="Preferred stock, shares authorized"><span id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zYta6rHV0Uib" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zacGgWoOstM" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002525" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002527" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span></span> and <span id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_ziGtk3V4nsb6" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zOLOUQaIz6v7" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002529" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002531" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2512">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember" id="Fact002513" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact002515" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_z50ydQvD68Td" style="text-align: center">6</td></tr>
  <tr id="xdx_401_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgG0PJuk8Sdf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUXcga9S2JVd" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYCHWXEzs9ai" title="Temporary equity, par value per share" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002538" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002540" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zcQRvID0AXgg" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zQOdJGerQ3jb" title="Temporary equity, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002542" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesAuthorized" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002544" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,400,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, and <span id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zg3c3qDYeBj" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Aai5K2fUv4" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002546" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002548" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90F_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrtw0CUjcqna" title="Temporary equity, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMctTmHlLhfa" title="Temporary equity, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002550" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002552" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2533">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember" id="Fact002534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2535">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact002536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4B_z0vVaUYkTlw9" style="text-align: center; padding-bottom: 1pt">6</td></tr>
<tr id="xdx_40C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_zQNtilKUcrb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2554">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002555" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2022-12-31" id="Fact002557" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zlBYW8gmYu2d" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockValue_i02I_maSEzYAb_zc9TdGIsqNa6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z5EF10mnZfIg" title="Common stock, par value" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZset6MUT9Se" title="Common stock, par value" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" id="Fact002569" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-12-31" id="Fact002571" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span>, <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zQcjfsQlc3r3" title="Common stock, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zDDZaWxqSTr5" title="Common stock, shares authorized" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-12-31" id="Fact002573" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" id="Fact002575" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized and <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zzH2BT9iwqQ4" title="Common stock, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z24UGTu0EBAg" title="Common stock, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact002577" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact002579" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zr2XpGWsvCs3" title="Common stock, shares issued" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zFaCWuPdJL7b" title="Common stock, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" id="Fact002581" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" id="Fact002583" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002564" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002565" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2566">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzYAb_z6yOhGiOFPc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002585" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002586" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,375</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2587">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" id="Fact002588" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,657</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zejDbpADROE9" style="text-align: center">7</td></tr>
  <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzYAb_ze7UyEDUJZR1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002590" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,510</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002591" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,150</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" id="Fact002593" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,660</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzYAb_maLASEzB9f_zq9LusNyoTo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002595" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,273</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002596" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,632</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" id="Fact002598" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,359</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzB9f_zQ7TyynSymYi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30,434</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002601" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29,145</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" id="Fact002603" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,289</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zQQ25kVU5LG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td id="xdx_F1D_zcom1f3JbKv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002604" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F08_zxRpE7ddi9se" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F10_zqdJW85EC7P9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002605" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zaUqYTsXpy75" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F17_z12r7OJ9cdv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002606" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0D_zkzbOYh5KVrc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1E_z0YDHGimDoYl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002607" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zhrofTMKWeul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F1C_zGaauYyovNfl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002608" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F07_zg7mY89UOBh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F15_zu9Mge4cdMl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002609" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for historical preferred stock as temporary equity.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zjbye4RasFl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F17_zTscRma7hil8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002610" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zwkFbooRqn5b" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Operations (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaXGkJXpTCe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z028oDaLxcnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z40LEykJTRCe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F50_zZzgLezQkhG9">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zi0ZRYIKnBM3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zfQPdTtBiee3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zHeJfx3Vozbg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember" id="Fact002619" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">878</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2620">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2621">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_SubscriptionRevenueMember" id="Fact002622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">878</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zPcMCXCGZPc9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember" id="Fact002624" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2625">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2626">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_custom_WebImagingRevenueMember" id="Fact002627" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">143</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHDo_z9waVkSQPWO7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,021</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2631">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-012023-12-31" id="Fact002632" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,021</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHDo_z6GMLbvVfSac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,150</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2635">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-01-012023-12-31" id="Fact002637" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,150</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHDo_znNyLw8scYyi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002639" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">129</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2640">-</span></td><td style="padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2641">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-012023-12-31" id="Fact002642" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">129</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zCYcQRN6Sc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zq3x0GU7zIea" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002649" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002650" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,730</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2651">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-012023-12-31" id="Fact002652" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,544</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zE9FiJGZnz6l" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zDBuLJ2WlWs8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">226</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002656" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">226</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zryX8YnXH7Yc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002659" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2661">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-012023-12-31" id="Fact002662" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,115</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zaz5jo1m1yvc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002664" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,632</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002665" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">433</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2666">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-12-31" id="Fact002667" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,065</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F45_z9ClZTf3FKq8" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zJHTG9nQ0lGe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,247</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002670" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,297</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002671" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">226</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-012023-12-31" id="Fact002672" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,724</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zbQSvWT10ge1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002674" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,376</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002675" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,523</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact002677" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,853</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8jXu5rEIzza" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zIkUcqgVzEBc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2686">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetImpairmentCharges_i01_msNIEzJuG_zSWikkgtMta9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002689" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,504</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AssetImpairmentCharges" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002690" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,504</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zMsz0tSF3PPe" style="text-align: center">3</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zy58V1qNXhb3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002694" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">749</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002695" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">738</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2696">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2023-01-012023-12-31" id="Fact002697" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUF6AddaOctl" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zj7QMQhvOLi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002699" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,572</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002700" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,635</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-12-31" id="Fact002702" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zPun54PZDMy8" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zpKYnI4UO24l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002704" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">47</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002705" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">82</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2023-01-012023-12-31" id="Fact002707" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F49_zXwujTSGCHxc" style="text-align: center">6</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEzbEL_zb5UH1P07sL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2711">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity" contextRef="From2023-01-012023-12-31" id="Fact002712" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zQGlpsX4Pmdi" style="text-align: center">7</td></tr>
  <tr id="xdx_401_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zJEambHaPBre" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002715" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,517</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2716">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31" id="Fact002717" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,517</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zzPTykfoVGAl" style="text-align: center">4</td></tr>
  <tr id="xdx_404_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zPo3ZpZ7XnEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002719" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">52</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2720">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002721" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31" id="Fact002722" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">34</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zL4eFL1DWeh6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2725">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_ziS6Q11zdOnd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002729" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,830</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002730" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,097</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-01-012023-12-31" id="Fact002732" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,909</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zPKUMtZQ1iU6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002734" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">23,206</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002735" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,574</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31" id="Fact002737" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,762</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zgynma3E0s1d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2739">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2740">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember" id="Fact002741" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact002742" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzord_zgVpHaAbAfT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002744" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">23,206</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002745" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,574</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2746">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact002747" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zgtaMKf18hbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zfMorvUR0clk" title="Basic net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zpRU0cyDmo7b" title="Diluted net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002754" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002756" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.98</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zmNg5vQC4Bo8" title="Basic net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_906_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zFkAcqHuTXUi" title="Diluted net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002758" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002760" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">3.78</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zJ0ZQpMQvn22" title="us-gaap:EarningsPerShareBasic" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zVerDL4ZXGak" title="Diluted net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span style="-sec-ix-hidden: xdx2ixbrl2762"><span style="-sec-ix-hidden: xdx2ixbrl2764">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fOA_____zaBkgZhbjVei" title="Basic net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fOA_____zmwUHhQcSOc5" title="Diluted net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-12-31" id="Fact002766" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-12-31" id="Fact002768" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">4.77</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____z36ArBhqPUy6" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zErTzsc1irw3" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002770" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002772" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zoMuYwYXrcGa" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zyyYt7a033s" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__">(<ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002774" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002776" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">16,488,164</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zsBYKMj5kk97" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zDQ3reWdjQE7" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span style="-sec-ix-hidden: xdx2ixbrl2778"><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zt2ybXAaUhe8" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zDgEREjS19nb" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-12-31" id="Fact002782" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-12-31" id="Fact002784" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,084,068</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z39dTMQ7aKS1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zBDhOn7yGByb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002785" xml:lang="en-US">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0B_zkIyW9V6GaL5" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z6pc3v68oqb6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002786" xml:lang="en-US">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zbAjVkGiaN6h" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F1A_zmaqyPMOauU5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002787" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zUiPPdP75J9g" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z4AQVNJgwwje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002788" xml:lang="en-US">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zfMpc6kW3D1j" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z30zalgt25Q7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002789" xml:lang="en-US">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_znmNTrFvBWK8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zqbSoM383NGc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002790" xml:lang="en-US">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zTL2gO4Z7NK1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z7OzvY6Ptmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002791" xml:lang="en-US">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zgGQG6V9gICj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F10_z2vSr1u7Bt34" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002792" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></ix:footnote></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAqyObC2l9kb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTj9bNOVZAOd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z7veP8m81sFd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F55_zM3RLW9AQV3j">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220101__20221231_z7s5h9N5psD8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zhSG1L632XDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zmHR78PheYDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember" id="Fact002799" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">678</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2800">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_SubscriptionRevenueMember" id="Fact002802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">678</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zfuzVjy0bBO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember" id="Fact002804" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">475</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2805">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2806">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_custom_WebImagingRevenueMember" id="Fact002807" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">475</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHNd_z3M7b4W4iwk4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002809" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,153</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002810" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,153</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2811">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-12-31" id="Fact002812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,153</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHNd_zp2gco9roem6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002814" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,513</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2816">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-01-012022-12-31" id="Fact002817" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,513</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHNd_zq3yDkZbOD2e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002819" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">360</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,153</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"/><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-12-31" id="Fact002822" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">360</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zMh80MASqE16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zkvLEULoFTgd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002829" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,756</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002830" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,950</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-12-31" id="Fact002832" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zzjd3qehnLZi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zBXkCMPrzTD7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002834" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">399</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherGeneralExpense" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002836" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">399</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zKEs7uT3IEsi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002839" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">958</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-12-31" id="Fact002842" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">958</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zoahsy8GI69d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002844" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">953</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002845" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">638</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2846">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-12-31" id="Fact002847" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,591</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F42_z2kghhNL2bcg" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zScGRpGXcBLh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002849" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,066</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002850" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,312</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002851" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">399</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-12-31" id="Fact002852" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,355</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zwUEJLMn9Lq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002854" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,426</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002855" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">399</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact002857" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,715</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8Q9WxvWWZJc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zgoKVFgTyK7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002864" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">215</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:IncomeTaxProvision" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002865" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">215</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2866">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2867">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_z6C8HsKy7cj1" style="text-align: center">3</td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zXSimJByCVFj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002869" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">403</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestExpenseNonoperating" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002870" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">403</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2871">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zv3crlecuyh8" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zBEXfcaZ2Tnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002875" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2022-01-012022-12-31" id="Fact002877" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_zrwCVEVSOSW7" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zJsTq68EZYH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002879" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,489</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002880" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,489</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2882">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z7PyhTCf4XM2" style="text-align: center">3</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zUXxZiut0JIl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2884">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002885" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31" id="Fact002887" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zazMZoxkpDv6" style="text-align: center">4</td></tr>
  <tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zplVkutO87u5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><p style="margin-top: 0; margin-bottom: 0">Other</p>
                                                     <p style="margin-top: 0; margin-bottom: 0">expense</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002889" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">47</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2890">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002891" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" id="Fact002892" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zKLZPn97d85g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002894" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,372</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ONMD:UnrealizedGainLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002895" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,372</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F46_zxXsAtefuDHc" style="text-align: center; padding-bottom: 1pt">3</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_zck2r7mIQ1ua" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002899" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,196</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002900" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">27,932</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002901" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-01-012022-12-31" id="Fact002902" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22,719</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zQQsZ98kFFhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002904" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,230</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002905" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,221</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">416</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" id="Fact002907" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,434</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zlXyhHrqYtG6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2910">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002911" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact002912" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzord_zxSEeHKVrTTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002914" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,230</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002915" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,221</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember" id="Fact002916" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">399</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact002917" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zLpq4rZCb2K3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span title="Basic net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span title="Diluted net loss per common share outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zLdkHTcYaNcb" title="Basic net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zWqk08J9R21j" title="Diluted net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002924" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002926" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">7.66</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zALngv2ajKAa" title="Basic net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zmVC2juKldy3" title="Diluted net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span style="-sec-ix-hidden: xdx2ixbrl2928"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fNg_____zr4Fpw3Z764f" title="Basic net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fNg_____z5J1Eds5vKJb" title="Diluted net loss per common share outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-12-31" id="Fact002932" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-12-31" id="Fact002934" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">7.66</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span title="Basic weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zGauFJJaMMa2" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____z2m8eKFmBKdi" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002936" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002938" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,973,897</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zupxhmAMKlB" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zAANc7O5PDva" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span style="-sec-ix-hidden: xdx2ixbrl2940"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_fNg_____zI6r7ZgLzbhg" title="Basic weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_fNg_____zO0Kt17dPiZ3" title="Diluted weighted average number of common shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-12-31" id="Fact002944" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-12-31" id="Fact002946" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,973,897</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F02_zMW0yTCrPjCc" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zOXZ2WhRJaBb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002947" xml:lang="en-US">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zElkDXBk5h94" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zodThWHzZ69i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002948" xml:lang="en-US">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0D_zTdonRR7Nadi" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F13_znclEY6Lw4te" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002949" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_z8AAMabERG51" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_z8S0HYfft0v8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002950" xml:lang="en-US">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zwrpnNPz4BW2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_ztJ1mOOHa1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote002951" xml:lang="en-US">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_z08xFT13J7Uf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F12_zpWOpJCTLxQ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote002952" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></ix:footnote></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Cash Flows for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_zRnKaIw7jdjk" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYZd2yEkwFr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zr7cwzqut9Ii" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zBcdhZk85qA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGvm_z64DQItPSa96" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002960" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">23,206</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002961" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,574</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact002962" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F43_zw3VLV9eU38g" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzSqX_z1Siz3WmGyPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2969">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-12-31" id="Fact002970" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationCost_i02_maNCPBUzSqX_zKu7p8ybV0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Business combination cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:BusinessCombinationCost" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002972" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCost" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002973" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">900</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zhSRmmNKghZj" style="text-align: center">2</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zIioh3o057C2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:CashHeldInTrustAccount" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact002976" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,029</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CashHeldInTrustAccount" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002977" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29,029</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zvkI2gMnv3K4" style="text-align: center">3</td></tr>
  <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzSqX_ztlKU4wKp3L" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2980">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002981" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-01-012023-12-31" id="Fact002982" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F40_zuT4zzgsB7S7" style="text-align: center">4</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_z1LfWwh2ycDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2984">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpenses" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002985" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpenses" contextRef="From2023-01-012023-12-31" id="Fact002986" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zWhhCrOvLBH1" style="text-align: center">5</td></tr>
  <tr id="xdx_402_ecustom--WarrantExpense_i02_msNCPBUz449_zroQluWiV8M5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2989">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ChangeInFairValueOfWarrantLiabilities_i02N_di_zly6v0jfmvIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ChangeInFairValueOfWarrantLiabilities" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002993" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ChangeInFairValueOfWarrantLiabilities" contextRef="From2023-01-012023-12-31" id="Fact002994" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">129</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4C_zLzzviNlbyti" style="text-align: center">6</td></tr>
  <tr id="xdx_405_ecustom--ChangeInFairValueOfPipeNotes_i02_maNCPBUz449_ztCqzYltXv2j" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2996">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfPipeNotes" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact002997" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfPipeNotes" contextRef="From2023-01-012023-12-31" id="Fact002998" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zBYtlwHGJs4a" style="text-align: center">7</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_z6Wa9gfFadpl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003001" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,517</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31" id="Fact003002" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,517</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zUuACnxP3RHe" style="text-align: center">8</td></tr>
  <tr id="xdx_40C_ecustom--NoncashInterest_i02_maNCPBUz449_zRk5FKwAcIlj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-cash interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:NoncashInterest" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003005" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:NoncashInterest" contextRef="From2023-01-012023-12-31" id="Fact003006" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zX8QjC4r71w1" style="text-align: center">10</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zmyVVkwjHxCk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_zkjFOQ06zN9g" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-012023-12-31" id="Fact003014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">133</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zsMiljgIih9h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003016" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003017" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">22</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2023-01-012023-12-31" id="Fact003018" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4E_z8iICOZIL45l" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_zxkdC3Z1VQSe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,372</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003021" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">655</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-01-012023-12-31" id="Fact003022" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">717</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zgbHqM25Rwih" style="text-align: center">2, 3, 9</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zS794PTHhJgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003024" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3025">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-01-012023-12-31" id="Fact003026" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_zKQni9fVV3Pf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3028">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3029">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInExerciseTaxLiability_i03_maNCPBUzSqX_zZPZkw6z6kg7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Excise tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:IncreaseDecreaseInExerciseTaxLiability" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003032" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">113</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:IncreaseDecreaseInExerciseTaxLiability" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003033" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">113</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zTpyxRxtxAA2" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInExtensionLoan_i03_pp3d_maNCPBUzSqX_zSXrTBuq4qfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:IncreaseDecreaseInExtensionLoan" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003036" format="ixt:numdotdecimal" decimals="3" unitRef="USD">446</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:IncreaseDecreaseInExtensionLoan" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003037" format="ixt:numdotdecimal" decimals="3" sign="-" unitRef="USD">446</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUlA1KyjgDe1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zDM2jYf7zMT6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:IncreaseDecreaseFranchiseTaxPayable" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003040" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">70</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:IncreaseDecreaseFranchiseTaxPayable" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003041" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zqJtwPbubevg" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zhTXU4CWz6xj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003044" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">95</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003045" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">95</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3046">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zYqLLsaf7Lh1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_406_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zirFCYKadrqb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:IncreaseDecreaseInWorkingCapitalLoan" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003048" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">168</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ONMD:IncreaseDecreaseInWorkingCapitalLoan" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003049" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3050">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4D_zH1aXYrl5jG7" style="text-align: center; padding-bottom: 1pt">2, 3</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zE1wO1c9Wxi5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003052" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,221</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003053" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,012</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-012023-12-31" id="Fact003054" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,791</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zKOBqaEyKXva" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zYXgFU3g6oD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003060" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3061">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-01-012023-12-31" id="Fact003062" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zqHSZoyjrJ1l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003064" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3065">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-012023-12-31" id="Fact003066" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkxDU18xN9nb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01_maNCPBUzy34_zJEOsi6pVYlc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3072">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3073">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3074">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzGlA_zOdW1gnmqlp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of shareholder loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003076" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003077" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2023-01-012023-12-31" id="Fact003078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">454</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zaFdLfoupmci" style="text-align: center">10</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzGlA_zg5nyHeTYEI" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003080" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003081" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">50</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-01-012023-12-31" id="Fact003082" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_z7M2VCjCnc7k" style="text-align: center">7</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_z07juzthWC5b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProceedsFromCommonStockSubjectToRedemption" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003084" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromCommonStockSubjectToRedemption" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003085" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3086">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_z3atOgujEQs4" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--ProceedsFromDeferredUnderwritingFee_i01_maNCPBUzy34_z9DVkGtZLhz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriting fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProceedsFromDeferredUnderwritingFee" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003088" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">500</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromDeferredUnderwritingFee" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3090">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zGwrp2TfzbYk" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_zZ0dyaR3S7wd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProceedsFromWarrantLiability" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">338</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromWarrantLiability" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003093" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">338</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zf9QU9Misnz9" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_zAYoX8b1m1Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromContributedCapital" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003096" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,189</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromContributedCapital" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003097" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">18,189</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zYzwxZ33MZH7" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zWwMIO92Lofd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProccedsFromRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003100" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,633</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProccedsFromRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003101" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,633</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3102">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zx7FQKfwoy5h" style="text-align: center">2</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzy34_zR6lDSHfT83b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds (repayment) from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003104" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,681</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003105" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,856</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-12-31" id="Fact003106" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,175</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zxaWnkX1BqN2" style="text-align: center">8</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zsP3rV8DUkjg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3108">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3109">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3110">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ProceedsFromIssuanceOfSeriesA2PreferredStock_i01N_di_msNCPBUzy34_zDu7i4VAkpD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3112">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003113" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock" contextRef="From2023-01-012023-12-31" id="Fact003114" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zISOUvH1P1t6" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z8WjtJFHZn59" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3116">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003117" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2023-01-012023-12-31" id="Fact003118" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,534</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F40_zyrejfqwdML3" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zfXYzRVj6q5a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003120" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,432</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003121" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,043</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-012023-12-31" id="Fact003122" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,611</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_z8gBwTb88MTj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003124" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">255</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003125" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-012023-12-31" id="Fact003126" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">224</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zW01Oi5i7WK7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003128" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">302</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003129" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact003130" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zXFeWXa49hi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003132" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3133">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact003134" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoOYkLkcKEY8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_ecustom--CommonSharesIssuedToPreferredShareholders_i01_zL5AXy97jdhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to preferred shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ONMD:CommonSharesIssuedToPreferredShareholders" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003141" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ONMD:CommonSharesIssuedToPreferredShareholders" contextRef="From2023-01-012023-12-31" id="Fact003142" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zsN1AMyCjzzd" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zoPsrtyw1oY" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Common shares related to convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ONMD:CommonSharesRelatedToConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003145" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="ONMD:CommonSharesRelatedToConvertiblePromissoryNotes" contextRef="From2023-01-012023-12-31" id="Fact003146" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zZAuoRZhbqq6" style="text-align: center">2</td></tr>
  <tr id="xdx_40D_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zK8SHJvpIxr8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to Data Knights shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3148">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CommonSharesIssuedToDataKnightsShareholders" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003149" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,937</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CommonSharesIssuedToDataKnightsShareholders" contextRef="From2023-01-012023-12-31" id="Fact003150" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,937</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F45_zurSmY3KUYv1" style="text-align: center">2</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F01_zhL240hE6k3b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z9dm4Vp0An6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003151" xml:lang="en-US">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zGGQ55l6kmh1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zUeE55Ju80t3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003152" xml:lang="en-US">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0A_z4MZv7ZYiCC8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zI2WxXsdey6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003153" xml:lang="en-US">Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zG13g7DRpeth" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1C_zYTXI3E04L3i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003154" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zHRA8LZW1Ws9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F11_zg5hJyL5Obpi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003155" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F01_zyqW1Xm1i1Kh" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F10_zrt2utkjYT66" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003156" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0F_zIYCaCTFZ5G9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F1B_zgD8LP6mENc7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003157" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0F_z7fNBeaoaagc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F1E_zTJJUc68HjP" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003158" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_zrYUaf70UVgf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td id="xdx_F15_z2QRlzGBbmY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003159" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zjJ3QhCQi3U6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td id="xdx_F12_zWah1vcZocA8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003160" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</span></ix:footnote></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b><i>Reconciliation of the
Original and Restated Statement of Cash Flows for the Year Ended December 31, 2022</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd1GVUj81Op9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBhCw3tfNvi7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_ztK2LT4qQfpe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_pn3n3_zFzKoT6TF5kc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUz449_zhjXV3tvln2c" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003166" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,230</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003167" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,221</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact003168" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F4D_zjxT1FD9l7P" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_pn3n3_z0076fqc8VT5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DepreciationDepletionAndAmortization_i02_pn3n3_maNCPBUz449_zm9JPLeVIQE8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-12-31" id="Fact003176" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maNCPBUz449_z6Q7ZgrwjTL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003178" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">265</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-01-012022-12-31" id="Fact003180" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zIJNrmfhBsRc" style="text-align: center">3</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zS5SB85M13E2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:CashHeldInTrustAccount" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003182" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">88,292</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CashHeldInTrustAccount" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003183" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88,292</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1NfzNBC5JKe" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_zC68WqLkgJX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpenses" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003187" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockWarrantExpenses" contextRef="From2022-01-012022-12-31" id="Fact003188" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_z6tBAOitcY1h" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--WarrantExpense_i02N_di_msNCPBUz449_zEuTdXmz78d8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003191" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:WarrantExpense" contextRef="From2022-01-012022-12-31" id="Fact003192" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zkBk4aNHnwei" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_zCUJBEmM2g0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3194">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003195" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ChangeInFairValueOfConvertiblePromissoryNotes" contextRef="From2022-01-012022-12-31" id="Fact003196" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,616</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zpczmZJibJ92" style="text-align: center">6</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zAzE1OfS3Mo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_ztG0vsbqUXte" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003202" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">73</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-12-31" id="Fact003204" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">73</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zluTWoieg0s6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003206" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">876</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003207" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">817</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="From2022-01-012022-12-31" id="Fact003208" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4B_zNedHdvlJBW" style="text-align: center">2</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_z0I3mGes2Dxf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003210" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,929</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003211" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,514</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-01-012022-12-31" id="Fact003212" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">415</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z37tNNq9Qes9" style="text-align: center">2, 7</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zeDSeDuJMSm6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003214" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">458</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3215">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-01-012022-12-31" id="Fact003216" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">458</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_z2GxU8Wb6ygk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003218" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003219" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3220">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zSE3xgLclZB5" style="text-align: center">2</td></tr>
  <tr id="xdx_409_ecustom--IncreaseDecreaseInExtensionLoan_i03_maNCPBUzSqX_zgskN7980aF2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:IncreaseDecreaseInExtensionLoan" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,546</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:IncreaseDecreaseInExtensionLoan" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003223" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,546</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zmZ2D62zyLMe" style="text-align: center">2</td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zyV7jFslgyRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:IncreaseDecreaseFranchiseTaxPayable" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003226" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:IncreaseDecreaseFranchiseTaxPayable" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003227" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3228">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zQybhbNoVMKf" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zL2rQVS8QfE" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003230" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">215</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003231" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">215</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zdRnntdJgKm" style="text-align: center">2</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zzuEL6o9ruce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ONMD:IncreaseDecreaseInWorkingCapitalLoan" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003234" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:IncreaseDecreaseInWorkingCapitalLoan" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003235" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">207</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3236">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F47_zNJP4fjQSaP9" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zJJhW4QBOtek" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003238" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87,241</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003239" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,944</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-12-31" id="Fact003240" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,703</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zilVvTyW6epe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zNGRgLG7f9O3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003246" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3247">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-01-012022-12-31" id="Fact003248" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zjhR5EClnx7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003250" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3251">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-12-31" id="Fact003252" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">58</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zyvRblK7SBoe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01I_maNCPBUzy34_z2KX3jMiyK3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003258" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003259" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3260">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_zrfUrQmF8m43" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProceedsFromCommonStockSubjectToRedemption" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003262" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88,550</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromCommonStockSubjectToRedemption" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">88,550</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3264">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zA55vPOU2Hib" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_z9RjVyh6e9h6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProceedsFromWarrantLiability" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,489</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProceedsFromWarrantLiability" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003267" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,489</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3268">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1Q1QdwsjcB" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_z6L0fxtNkTd5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromContributedCapital" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003270" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,826</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromContributedCapital" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003271" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,826</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3272">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zVJ0w3BVrU96" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zYdeays3yNz7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:ProccedsFromRetainedEarningsAdjustment" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003274" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,360</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:ProccedsFromRetainedEarningsAdjustment" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,360</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3276">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zvYGPpCF8ALi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzGlA_zxuSCkdEwgk1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003278" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,543</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003279" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">403</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-012022-12-31" id="Fact003280" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,140</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zQ8Xe760x2r2" style="text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zYGmsnBOP9B5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003283" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2022-01-012022-12-31" id="Fact003284" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z3TyDWcTRTM6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination Costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3286">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003287" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">815</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationCosts" contextRef="From2022-01-012022-12-31" id="Fact003288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">815</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F43_zKeSKcvznUJk" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zwmIc6mhnd5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003290" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">88,033</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003291" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92,366</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-12-31" id="Fact003292" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,333</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zp4EyvM8G2Tg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003294" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">850</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003295" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">422</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-12-31" id="Fact003296" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">428</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDY2bKGDYzo7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003298" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,152</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003299" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">453</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" id="Fact003300" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">699</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zKczG8qKbiOc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">302</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003303" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" id="Fact003304" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">271</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zYSJMmCsa0ka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zLKRQx9dshs8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003305" xml:lang="en-US">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_z87rmpJn3ZB8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F15_zDRZS1dv1eOl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003306" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zxbQFNbtYzE9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F10_z42bK2J0pX1f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003307" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_zAgkZCBqrDZc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1A_zFDMqwcniOib" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003308" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zCFiNFZCBLKj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F13_zrElvg95e3hb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><ix:footnote id="Footnote003309" xml:lang="en-US"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></ix:footnote></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zMeCuTCN8Un6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z00H9AjztdPb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003310" xml:lang="en-US">Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improper
    presentation of Business Combination costs as well as errors identified related to capitalization of such costs. Refer to balance
    sheet restatement reconciliation for more information.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zbzwUQkL3AE" summary="xdx: Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zd8vvcZGRvQ" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zK5CmsM1ZRH1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zqwRhzUrgNN" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zWLv2SAVVLB" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zJ1EbxPqWHa2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zkuypag4rQ83" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSbLFbtZqFHd" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003320" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,853,797</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlv5Cf5sOUO3" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3322">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1NbSqGrvhck" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003324" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,204,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8AgftvLtU5f" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3326">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUidXthwSV4a" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3328">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXBFGFyRKYs2" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003330" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,388,958</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003314" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="Fact003315" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,750</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003316" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,032</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003317" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,510</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003318" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,273</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXjcEC2yKbDd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zww2RJZCA4ii" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTybYcahs77" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fMg_____z83jL5Bb2Imd" title="Issuance of common shares in exchange for services, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3350">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3344">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3345">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3347">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3348">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM6gBXLBUoac" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKviQDmZq1Bf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrI4xcsaTqM3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdXG50votS8i" title="Issuance of Series A-2 Preferred Stock, shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3370">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3364">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3365">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3368">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoFXc0EowaZ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3372">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3373">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3376">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqMk9V97gCEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcyI1ubllCfe" title="Exercise of OMN stock options upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003384" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">612,670</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3378">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003380" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">613</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3381">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003382" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">613</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3isqa2ILvij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0wDNGMku6F5" title="Exercise of OMN warrants upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003392" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,859,464</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3386">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3387">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003388" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,859</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,859</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB1ofR7bGO37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible loans upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCuKJG4XINv" title="Conversion of OMN convertible loans upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003400" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,177,229</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003394" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3395">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003396" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,177</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3397">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003398" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,178</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjRLnI869rq7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Conversion of OMN convertible loans upon Business Combination, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWPCyxfSZ185" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td title="Conversion of OMN convertible loans upon Business Combination, shares" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4v1VSB6GRm4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOvsvOeYyLy8" title="Conversion of OMN convertible promissory notes upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003420" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">3,853,797</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBDYBabeNKUb" title="Conversion of OMN convertible promissory notes upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003422" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">3,204,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zp8TtqKLkxy6" title="Conversion of OMN convertible promissory notes upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003424" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,057,797</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003414" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3415">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003416" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,057</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3417">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003418" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,058</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4R3JHuzW4d4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZtIFRsSvo14" title="Private OneMedNet to ONMD Public Shares, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003432" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">2,257,326</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3427">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003428" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,257</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003430" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,257</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zImjAQyx1dl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3435">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003436" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003438" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgVEMYmeVYy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHK8uetxWRNh" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003446" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,266,560</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3440">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3441">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">746</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3443">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003444" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">746</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf5V5sZPtbyj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3448">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="Fact003449" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003452" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwO9nIUVQfV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3455">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003456" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,893</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3457">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003458" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,893</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqIeAYcOEJbg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3461">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003463" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,633</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003464" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,633</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5nNrvH7L1L9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Issuance of OMN warrants to board of directors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcqEVw4aErc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3472">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3473">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003475" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">23,206</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003476" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">23,206</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z4K0kNmW97ad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjvqdYJmE8N2" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3484">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0iPc6CFVON" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3486">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zy620ElYt97c" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3488">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zz3W42bVrfFi" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3490">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdbBjALrE3Gc" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3492">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd0cvaM8AvNe" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003494" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003478" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3479">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003480" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42,221</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003481" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">55,083</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003482" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,859</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Restatement Adjustments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zLnYlZvsp0f9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F40_zDAvoewh2ue2" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zpxqTeO4I9oj" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003502" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">437,874</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z3b6qXBzzlG9" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003504" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zNnUY7L7xiFg" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003506" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">364,043</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zHGmzmExCnHh" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zvzFm0ziawq9" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z8CWxY9bZ134" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003512" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">5,355,788</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003496" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="Fact003497" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28,750</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003498" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,375</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003499" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,150</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003500" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,632</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zygwwWmssSs5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zHj5CkaxLx3i" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z7bwirrTghH1" title="Issuance of common shares in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003520" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">265,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3515">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3516">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3517">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3518">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhw8GZcbOHQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zCtEitmMNUb6" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zq0XsuIEjQvb" title="Issuance of Series A-2 Preferred Stock, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003528" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,673</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zQsW2gSboNpd" title="Issuance of Series A-2 Preferred Stock" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z1nHfpTejBah" title="Issuance of Series A-2 Preferred Stock" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3522">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3523">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3524">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3525">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zsl433z8PvWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zTC0qdQyxOY2" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3534">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zRyPxcD6Gycd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zhV9klln87bd" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zAVkHqJQ1fb2" title="Exercise of OMN stock options upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003546" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">69,614</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3541">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003542" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">613</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3543">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003544" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">613</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjBvsJuZkRNl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_zcH3UUXvIdIc" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zpIkisGK5jO4" title="Exercise of OMN warrants upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003554" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">438,519</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3548">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3549">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003550" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,859</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3551">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueWarrantsExercised" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003552" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,859</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zplLOy1ht2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_ziLCg9j2iOU2" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zRbYZNCGx08i" title="Conversion of OMN convertible promissory notes upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003562" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">701,867</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3557">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003558" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,758</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3559">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003560" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,758</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zaAxdbDBbKxl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4A_z0OGPFi514ba" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zMlytimJOcF6" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003570" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">432,201</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zFcFkIPEa4kh" title="Conversion of preferred stock to common stock upon Business Combination" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003572" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,650</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____z9frGH3YO8Og" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003574" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">364,043</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zT27h15QDmob" title="Conversion of preferred stock to common stock upon Business Combination" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003576" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,010</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zbrxmPwclQl8" title="Conversion of preferred stock to common stock upon Business Combination" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003578" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,660</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zITjZmoEl281" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003580" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">796,244</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3564">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3565">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003566" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,602</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003568" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,058</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGSxBeU5qafe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F43_zDEM3QbSe4Z8" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zD5Fu6pKoZ99" title="Private OneMedNet to ONMD Public Shares, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003588" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,257,326</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3583">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003584" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,257</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3585">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003586" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,257</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuatop1tYVa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_zH7SDweyyBr1" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3590">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3591">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003592" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">101</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3593">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003594" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">101</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zu7klaV3kl0e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F41_zXvkqXSkdojg" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zQZ4FUPjak9f" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003602" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,838,792</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3596">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003598" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,683</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3599">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003600" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,683</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZcv5xa7e8kd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F45_zbh8HYc2n1da" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3604">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="Fact003605" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3606">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3607">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:CommonStockSubjectToPossibleRedemptionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zqFv5qjxO3F8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zPksoWAMCJv6" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3610">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3611">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003612" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">418</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3613">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003614" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">418</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z1PrgZqUBDwg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zEpLKUsQUK54" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3616">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3617">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3618">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003619" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,633</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003620" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,633</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgO3DzksH894" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4E_zebKylsMKZnd" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3622">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3623">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3624">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003625" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,574</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003626" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,574</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zEzrIG974kB6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (restatement adjustments)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3xQtxPEgetg" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3634">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z0LbHAIAdUp" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3636">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zWsGyytsoFY1" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3638">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3dqYsKfeCd7" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3640">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_ziLn7iNhwNub" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3642">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGiZyyb9ObIh" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3644">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003628" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3629">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003630" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,775</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003631" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">36,357</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003632" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">583</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">As Restated</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zCERd0BC8Edb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zi65lAIuLzI5" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="Fact003652" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z6uXJ7vZHdjg" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="Fact003654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zcrTCJ23Lc8h" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember" id="Fact003656" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zSIzwmTqxAae" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember" id="Fact003658" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zQlhYEki4WHj" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_RestatedMember" id="Fact003660" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zEa3Euv8yG7b" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003662" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3646">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3647">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,657</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="Fact003649" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,660</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_RestatedMember" id="Fact003650" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,359</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zRh9MNfOQbN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zKhabU7B1IXj" title="Issuance of common shares in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003670" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">265,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3664">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3665">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3666">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3667">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3668">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zhvp3TSV5JVc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zkKNCOHCGNYi" title="Issuance of Series A-2 Preferred Stock, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="Fact003678" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,673</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zBl8PdJEW3Fg" title="Issuance of Series A-2 Preferred Stock" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="Fact003680" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_ztPun9js0gHl" title="Issuance of Series A-2 Preferred Stock" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_RestatedMember" id="Fact003682" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="Fact003676" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zAmG6EO8ecvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003686" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="Fact003688" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,207</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zV9qXvnTf4X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zof3JCdzGJy6" title="Exercise of OMN stock options upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003696" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">543,056</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3690">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3693">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3694">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zcMHotUSQHRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zeypJR6uOcGa" title="Exercise of OMN warrants upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesWarrantsExercised" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003704" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,420,945</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3698">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3700">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3702">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zfItEKG9a5D5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z8Q793oFY6nc" title="Conversion of OMN convertible promissory notes upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003712" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,475,362</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003708" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="Fact003710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47,936</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zg0xUHJQhupl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_ztPA7LA28WGd" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="Fact003720" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">3,421,596</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zM2ygMU7QyFk" title="Conversion of preferred stock to common stock upon Business Combination" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember" id="Fact003722" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,650</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zFWUKYVBc9i5" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember" id="Fact003724" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z91jAoZWsSK4" title="Conversion of preferred stock to common stock upon Business Combination" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember" id="Fact003726" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,010</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zVxd72lcoUS8" title="Conversion of preferred stock to common stock upon Business Combination" style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_RestatedMember" id="Fact003728" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,660</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z842Un0CdEeg" title="Conversion of preferred stock to common stock upon Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003730" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,261,553</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003714" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003716" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,659</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3718">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z8QjpVGyUPod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3732">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3733">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3734">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3735">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3736">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zVfX9LzWmXC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3738">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3739">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3740">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3741">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3742">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z4FQbGPN3q37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zGyfI7Nay6Tf" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares" style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003750" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,572,232</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3744">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003746" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,937</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3747">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="Fact003748" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,937</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zn28LbtLErUe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3755">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3756">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zPS9BXk3A5Q6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3759">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3761">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="Fact003762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zoyWjR9ZfmX4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3765">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3766">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3768">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zpMrABjxHPM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3770">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3771">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3772">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="Fact003773" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31_custom_RestatedMember" id="Fact003774" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,780</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zfRwOC5WxoLl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zA8QIoRKWpBf" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3782">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zrinSGD4zYy" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3784">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zTYsCn8TomIb" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3786">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zVYGhC0pQrw8" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3788">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zRQ4EtchBpk7" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3790">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zboRJOiguk2e" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003792" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_CommonStockMember" id="Fact003776" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3777">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003778" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">77,996</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember" id="Fact003779" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">91,440</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_custom_RestatedMember" id="Fact003780" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">13,442</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F06_zUiD7Qvo1dF5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zbiLSN0c8sW" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003793" xml:lang="en-US">Cumulative
    impact of corrections of errors to the prior year.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zuwvJHWa9Qsc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zoyXhvCVdcj2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003794" xml:lang="en-US">Impact
    of errors related to the accounting and presentation of the recapitalization.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F00_zXFfXM0FUxdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_z8741aGRMBg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003795" xml:lang="en-US">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zR4FwFBByqVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zyRwSInVDUs2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003796" xml:lang="en-US">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zlaXOkrERoi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zG6TTXuWq7t7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003797" xml:lang="en-US">Impact
    of errors related to improper valuation of stock compensation expense.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F02_zXs8hJHKY1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zUXZ0owxwFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote003798" xml:lang="en-US">Current
    year impact of corrections of errors to the consolidated statements of operations.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zW5uco0SMtSh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zrIdmjFOdate" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_ztCUO5HaRbVk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zhuYeBR4mRoh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zkCvhsJ1MJPl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrNm0ijsZPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAcgwhinqMD4" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003806" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,853,797</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1T2qWsARIe4" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3808">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuS7rvgTthDk" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003810" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,204,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAPwynqPG39e" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3812">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmIeWOsviLx8" title="Beginning balance" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3814">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGS035o8Ql7d" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003816" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,802,941</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003800" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="Fact003801" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,750</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,607</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003803" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,920</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003804" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,438</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuKXvvBVg7qa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcpL8pWl3lf2" title="Retroactive application of recapitalization due to Business Combination, shares" style="text-align: right"><ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003824" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,378,517</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3818">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3819">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003820" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,826</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003821" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,360</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003822" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">534</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIWlWMbHJUOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9ML9jv2UZS3" title="Issuance of common shares in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003832" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">200,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3826">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3827">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003828" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3829">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003830" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBYL9zVXKgk" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNn9md3kQVj9" title="Exercise of stock options, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003840" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3834">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003836" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003838" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvh2OxydzaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3842">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3843">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3844">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3845">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3846">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaiX9poMuPoh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3849">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3850">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3851">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3852">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5thZ2Xh2Hsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3854">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003856" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,392</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3857">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003858" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,392</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0tYj64RAV6g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3860">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3861">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3862">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003863" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,230</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003864" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,230</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zobHW8vZbi64" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyvTNxCFGuE5" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003872" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,853,797</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8vxe5cfXKMl" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3874">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuu4od7drGh4" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember" id="Fact003876" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,204,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoiV8vo2EkS5" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3878">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNG5tnOqwZd3" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3880">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfDbaFYqc7d1" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003882" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,388,958</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember" id="Fact003866" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember" id="Fact003867" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28,750</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003868" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,032</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember" id="Fact003869" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">43,510</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember" id="Fact003870" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,273</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Restatement Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zhDxKNCYKEJj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4F_zNoljWR8FXOg" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zOiSKm9Y18M5" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3890">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z4SX7bmLswU1" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003892" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zp50a3vBuuyc" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3894">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zbwued2BiB6" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003896" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zLCW3sTmfox5" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003898" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z5j9fZFJU6s1" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003900" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">3,460,275</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003884" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="Fact003885" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28,750</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003886" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,094</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003887" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,711</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003888" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">21,490</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zmjfh2oZy4n5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_z4BL9SKw3H43" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zBqgxqtz2p6c" title="Retroactive application of recapitalization due to Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003908" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">437,874</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zsXNpsNJNxp5" title="Retroactive application of recapitalization due to Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003910" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">364,043</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zkFrQeWMPwqe" title="Retroactive application of recapitalization due to Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003912" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">1,871,937</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3902">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3903">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003904" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,826</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003905" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,360</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003906" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">534</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zUwl79ZHOcIi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zLyF1icLyyY7" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zvEl2Uhodt9a" title="Issuance of common shares in exchange for services, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003920" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">22,724</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3914">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3915">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003916" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003918" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">200</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhK8jGiUmqO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4D_z3pfjJmavaVd" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zlNdzOClaP1i" title="Exercise of stock options, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003928" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">852</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3922">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3923">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003924" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3925">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003926" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_za9Aev5bcs01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zGaE6XDWo0We" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3930">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3931">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003932" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3933">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003934" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z8hLbwNTPbb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F49_zCojnMZDTpW6" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3936">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3937">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003938" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3939">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003940" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zEVLrZSKq5Bl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zae9qLTfo1K5" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3942">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3943">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003944" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">473</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3945">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003946" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">473</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zclWPo1aIwbe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F47_zBbAJaZMwUgg" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3948">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3949">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3950">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003951" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,221</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003952" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">24,221</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43F_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zyYjTX0xhooj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (restatement adjustments)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgWvh1mNxHC1" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003960" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">437,874</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zefDHoLOM7El" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003962" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuXimcaSYwmi" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003964" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">364,043</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVF3mcJLaYTc" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003966" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVW6xo9eel76" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zO8CGAdbB5Se" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003970" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">5,355,788</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember" id="Fact003954" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember" id="Fact003955" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">28,750</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003956" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,375</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember" id="Fact003957" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">14,150</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact003958" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,632</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">As Restated</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrXFWLTIonP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_znrSJXtswFu1" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember" id="Fact003978" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,853,797</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zDWmfRBTLSv8" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember" id="Fact003980" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9eknUZYUPk" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember" id="Fact003982" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,204,000</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zLWYelQ5MJg9" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember" id="Fact003984" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_zAD8l9lcw6Zd" title="Beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember" id="Fact003986" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zEbjcWBfmguh" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="Fact003988" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,342,666</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3973">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact003974" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,513</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="Fact003975" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">27,209</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_custom_AsRestatedMember" id="Fact003976" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">7,052</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zGTdqTNBZigd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zMytJlaMvyi5" title="Retroactive application of recapitalization due to Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember" id="Fact003996" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">437,874</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zjkVEXnj5cM" title="Retroactive application of recapitalization due to Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember" id="Fact003998" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">364,043</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zS3jYyKzBF04" title="Retroactive application of recapitalization due to Business Combination, shares" style="text-align: right">(<ix:nonFraction name="ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="Fact004000" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">493,420</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3991">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3993">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3994">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zcFGLAmG0cU9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_z0wnuWNESsub" title="Issuance of common shares in exchange for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="Fact004008" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">177,276</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4002">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4003">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4005">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4006">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zHMgzJLqZJb6" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zajonvshXIY2" title="Exercise of stock options, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="Fact004016" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,648</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4010">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4011">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact004012" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember" id="Fact004014" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTnAIjQZ5aT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4018">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4019">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact004020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4021">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" id="Fact004022" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,073</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_z8tAwixWGQHh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact004026" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4027">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember" id="Fact004028" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zaJ6OskwPPY7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4031">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact004032" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4033">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember" id="Fact004034" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zmUgeFgH4gy" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4036">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4037">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4038">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="Fact004039" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31_custom_AsRestatedMember" id="Fact004040" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,451</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z6eucAVAQpA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zW5wCE0trGKd" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember" id="Fact004048" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zIKJ6AxaTxh8" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember" id="Fact004050" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,634</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_z3lPg63tnHJ3" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember" id="Fact004052" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zcL2aOMXs0D5" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember" id="Fact004054" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,010</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_ztospgNmuhO5" title="Ending balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember" id="Fact004056" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,644</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9vePJiASM6" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember" id="Fact004058" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4042">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4043">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember" id="Fact004044" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,657</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember" id="Fact004045" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">57,660</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_custom_AsRestatedMember" id="Fact004046" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">26,359</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 0.25in; text-align: left"><span id="xdx_F0F_zGF24QwsV3Ke" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1A_zGlRskPx0Ma4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004059" xml:lang="en-US">Cumulative
    impact of corrections of errors to the prior year.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zGSobA1i1T6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F11_zodBNv0iJGqk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004060" xml:lang="en-US">Impact
    of errors related to the accounting and presentation of the recapitalization.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F0D_zsNEl2u7LGlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F11_zbg3ir20cxef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004061" xml:lang="en-US">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zrPYGRKo8Joa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F10_zerEnUYVHRTd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004062" xml:lang="en-US">Impact
    of error related to identificatoin and recognition of board of director warrante expense.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zDtv9dtOoYMi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F19_zFz7iviKaa8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004063" xml:lang="en-US">Impact
    of errors related to improper valuation of stock compensation expense.</ix:footnote></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F05_zMr7Ef6oH2v7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1E_zuS5qUnBBoP6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004064" xml:lang="en-US">Current
    year impact of corrections of errors to the consolidated statements of operations.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004066" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zpvQ5rh7nhV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zYjKwepWsD0e">Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company, including its subsidiaries. All intercompany accounts and transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004068" name="us-gaap:UseOfEstimates"><p id="xdx_842_eus-gaap--UseOfEstimates_zr2hwzXh7qd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z3i8w8qiCyLh">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in these notes to the consolidated
financial statements. Actual results and outcomes may differ materially from management&#8217;s estimates, judgments, and assumptions.
Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to
revenue such as determining the nature and timing of the satisfaction of performance obligations, allowances for accounts receivable,
useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and stock-based compensation.
Estimates are periodically reviewed in light of changes in circumstances, facts, and experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004070" name="ONMD:OperatingSegmentsPolicyTextBlock"><p id="xdx_844_ecustom--OperatingSegmentsPolicyTextBlock_zgianBikxImj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zRjKMzLPlLFc">Operating
Segments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial
information is regularly evaluated by the chief operating decision maker (&#8220;CODM&#8221;), which is the Company&#8217;s Chief Executive
Officer, in deciding how to allocate resources and assess performance. The Company&#8217;s CODM evaluates the Company&#8217;s financial
information and resources and assesses the performance of these resources on a consolidated basis. The Company is not organized by market
and is managed and operated as one business. A single management team that reports to the chief executive officer comprehensively manages
the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and
does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial
segment information can be found in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004072" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgvoIrAOYflg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrYd84kCcMGb">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents
consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC insured
limits. The Company believes that, as of December 31, 2023 and 2022, its risk relating to deposits exceeding federally insured limits
was not significant. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s
financial condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004074" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zdRDjIpsIbS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zvZhFGQmgyM1">Accounts
Receivable and Allowance for Credit Losses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable is unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable is considered past due if not
paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections
have been exhausted. The Company determines the need for an allowance for credit losses based upon factors surrounding the credit risk
of specific customers, historical trends and other information. As of December 31, 2023 and 2022, the Company established allowances
for credit losses of $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zStClmmHs8Z4" title="Accounts receivable"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-12-31" id="Fact004076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_z8w2bWI5XRIf" title="Accounts receivable"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2022-12-31" id="Fact004078" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></span> million, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not
require collateral from its customers and generally requires payment from 0 to 90 days from the invoice date. For the year ended December
31, 2023, there was 1 customer that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zrvQn5txl485" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" id="Fact004080" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% or more of total revenue, and there were 2 customers that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z3ByJ3wUEWOf" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember" id="Fact004082" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% or
more of total revenue for the year ended December 31, 2022. The following table represents these customers&#8217; aggregate percent of
total revenue:</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004084" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"><p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_ztBzoaioJk74" style="display: none">Schedule
of Aggregate Percentage Revenue and Accounts Receivable</span> </span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact004086" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact004087" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Customer 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember" id="Fact004089" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember" id="Fact004090" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Aggregate percent of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember" id="Fact004092" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember" id="Fact004093" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, three customers accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember" id="Fact004095" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% of the Company&#8217;s accounts receivable balance, and four customers
accounted for over <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember" id="Fact004097" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% of the Company&#8217;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#8217; aggregate percent of total accounts receivable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact004099" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">36</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember" id="Fact004100" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White">
    <td>Customer 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember" id="Fact004102" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember" id="Fact004103" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember" id="Fact004105" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">27</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember" id="Fact004106" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White">
    <td>Customer 4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember" id="Fact004108" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember" id="Fact004109" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">39</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember" id="Fact004111" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember" id="Fact004112" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">32</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White">
    <td>Customer 6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember" id="Fact004114" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember" id="Fact004115" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">16</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Customer 7</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember" id="Fact004117" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember" id="Fact004118" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate percent of total accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember" id="Fact004120" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">96</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember" id="Fact004121" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate Percent of Revenue and Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember" id="Fact004123" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">96</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember" id="Fact004124" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
</table>

</ix:nonNumeric></ix:nonNumeric><p id="xdx_8A4_zqJD9t4ymDAb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004126" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zbneL7aFcAJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zpfxMSc0ozV2">Property
and Equipment</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The straight-line method is used for computing depreciation
and amortization. Assets are depreciated and amortized over their estimated useful lives ranging from three to five years. Cost of maintenance
and repairs are charged to expense when incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004128" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZXcFP3hWAY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zVpXbo6CoYFj">Impairment
of Long-Lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances
indicate that the carrying amount of an asset may not be fully recoverable. An impairment loss would be recognized when the estimated
future undiscounted net cash flows from the use of the asset are less than the carrying amount of that asset. There were <span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20230101__20231231_zAMAdUgdylq7" title="Impairment of long-lived assets"><span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zxpllUrCgDsc" title="Impairment of long-lived assets"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2023-01-012023-12-31" id="Fact004130" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" contextRef="From2022-01-012022-12-31" id="Fact004132" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> such losses
during the years ended December 31, 2023 or December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004134" name="ONMD:FairValueOptionOfAccountingPolicyTextBlock"><p id="xdx_845_ecustom--FairValueOptionOfAccountingPolicyTextBlock_zPgodBycYS55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zOFCpgo5lkt9">Fair
value option of accounting</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
financial instruments contain various embedded derivatives which may require bifurcation and separate accounting of those derivatives
apart from the entire host instrument, if eligible, ASC 825, <i>Financial Instruments</i>, allows issuers to elect the fair value option
(&#8220;FVO&#8221;) of accounting for those instruments. The FVO may be elected on an instrument-by-instrument basis and is irrevocable
unless a new election date occurs. The FVO allows the issuer to account for the entire financial instrument at fair value with subsequent
remeasurements of that fair value recorded through the statements of operations at each reporting date. A financial instrument is generally
eligible for the FVO if, amongst other factors, no part of the convertible, or contingently convertible, instrument is classified in
stockholders&#8217; equity and the instrument does not contain a beneficial conversion feature at issuance. In addition, because a contingent
beneficial conversion feature, if any, is not separately recognized within stockholders&#8217; equity at the issuance date, a convertible
debt instrument with a contingent beneficial conversion feature is therefore eligible for the FVO if all other criteria are met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the eligibility assessment discussed above, the Company concluded that its convertible notes payable is eligible for the FVO and accordingly
elected the FVO for those debt instruments. This election was made because of operational efficiencies in valuing and reporting for these
debt instruments in their entirety at each reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
promissory notes and the PIPE Notes contain embedded derivatives, which require bifurcation and separate accounting under GAAP, for which
the Company elected the FVO. In addition, certain term PIPE Notes were issued with separately exercisable and freestanding warrants to
purchase common stock, were issued with substantial discounts at issuance and contained certain embedded derivatives to be bifurcated
and accounted for separately for those term notes, unless the FVO is eligible and elected. Accordingly, the Company qualified for and
elected the FVO for the entire PIPE Notes instruments. The convertible debt and accrued interest at their stated interest rates were
initially recorded at fair value as liabilities on the consolidated balance sheets and were subsequently re-measured at fair value at
the end of each reporting period presented within the consolidated financial statements. The changes in the fair value of the convertible
promissory notes and PIPE Notes are recorded in changes in fair value of convertible debt and change in fair value of PIPE Notes, included
as a component of other (income) expenses, net, in the consolidated statements of operations. The change in fair value related to the
accrued interest components is also included within the respective single line of change in fair value of convertible debt and change
in fair value of PIPE Notes on the consolidated statements of operations. See additional information on valuation methodologies and significant
assumptions used in Note 6 and Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004136" name="ONMD:WarrantPolicyTextBlock"><p id="xdx_849_ecustom--WarrantPolicyTextBlock_zFCbjB1MuvZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zlRvn7HvG6e5">Warrants</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in ASC 480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, <i>Derivatives
and Hedging</i>. Warrants that meet the definition of a derivative financial instrument and the equity scope exception in ASC 815-10-15-74(a)
are classified as equity and are not subject to remeasurement provided that the Company continues to meet the criteria for equity classification.
Warrants that are classified as liabilities are accounted for at fair value and remeasured at each reporting date until exercise, expiration,
or modification that results in equity classification. Any change in the fair value of the warrants is recognized as change in fair value
of warrant liabilities included as a component of other (income) expenses, net in the consolidated statements of operations. The classification
of warrants, including whether warrants should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The fair value of liability-classified warrants is determined using the Black-Scholes options pricing model (&#8220;Black-Scholes model&#8221;)
which includes Level 3 inputs, as shown in Note 11 to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004138" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z7mrkflN4v37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zgP8byl9dztb">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes
the inputs to valuation methodologies used to measure fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
1</b> - Valuations based on quoted prices for identical assets and liabilities in active markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
2</b> - Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets
and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other
inputs that are observable or can be corroborated by observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
3</b> - Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made
by other market participants. These valuations require significant judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
quoted market prices are available in active markets, the fair value of assets and liabilities is estimated within Level 1 of the valuation
hierarchy. If quoted prices are not available, then fair values are estimated by using pricing models, quoted prices of assets and liabilities
with similar characteristics, or discounted cash flows, within Level 2 of the valuation hierarchy. In cases where Level 1 or Level 2
inputs are not available, the fair values are estimated by using inputs within Level 3 of the hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies&#894; however,
considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative
of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using
different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based
on carrying values and future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, convertible notes
payable, liability classified financial instruments and certain privately issued warrants. The carrying amounts of cash and cash equivalents
and accounts payable financial instruments approximate their fair value due to their short-term nature. The carrying amount of accounts
receivable is net of an allowance that reflects management&#8217;s best estimate of expected credit losses. See Note 11 for fair value
measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004140" name="us-gaap:StockholdersEquityPolicyTextBlock"><p id="xdx_84C_eus-gaap--StockholdersEquityPolicyTextBlock_zJjjHU9EiIXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Classification
of Series A-1, and Series A-2 preferred stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_zuHE7wZUI1Lf" style="display: none">Treasury
stock</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company originally classified its Series A-1 and Series A-2 preferred stock (collectively &#8220;Preferred Stock&#8221;) outside of permanent
equity because the Preferred Stock contained certain redemption features that result in those shares being redeemable upon the occurrence
of certain events that are not solely within the Company&#8217;s control, including liquidation, sale or transfer of control. Accordingly,
the Preferred Stock was recorded outside of permanent equity and was subject to the classification guidance provided under ASC 480-10-S99.
Because dividends were not contractually required to be accrued on the Preferred Stock as there was no stated or required dividend rate
per annum, the Company was not required to accrete dividends into the carrying amount of the Preferred Stock in anticipation of a future
contingent event or redemption value. Accordingly, the Company did not adjust the carrying values of the Preferred Stock to the respective
liquidation preferences of such shares because of the uncertainty of whether or when such events would occur. As of December 31, 2023,
all shares of Preferred Stock were converted into Common Stock pursuant to their provisions in connection with the Business Combination,
which closed on November 7, 2023 (see Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004142" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zixMabdmKOj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zghowmw5w7cc">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic 606, <i>Revenue from Contracts with Customers</i>, which aligns revenue recognition
with the transference of promised goods or services to customers in an amount that reflects the consideration to which the Company expects
to be entitled in exchange for those goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
core principle is achieved to the application of a five-step model: (1) identify the contract with a customer, (2) identify the performance
obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to performance obligations in the
contract, and (5) recognize revenue as performance obligations are satisfied. Payment terms between customers related to product and
services sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable
or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to
a customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit
of account under Topic 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation in proportion to
the standalone selling price for each and recognized as revenue when, or as, the performance obligation is satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
promised goods and services in a contract are considered a performance obligation and accounted for separately if the good or service
is distinct. A good or service is considered distinct if the customer can benefit from the good or service on its own or with other resources
that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price for the products is the invoiced amount. Advanced billings from contracts are deferred and recognized as revenue when
earned. Revenue is recognized only to the extent that it is probable that a significant reversal of revenue will not occur and when collection
is considered probable. The Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority
and imposed on and concurrent with a specific revenue-producing transaction. Deferred revenue consists of payments received in advance
of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives
payments from customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes
unconditional. Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subscription
Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenues are generated from the Company&#8217;s data exchange (BEAM) product, which is a medical imaging exchange platform between hospital/healthcare
systems, imaging centers, physicians and patients. Subscriptions to the BEAM platform offering are recognized over time as the customer
consumes the benefits of the services as the Company stands ready to provide access to the programs throughout the subscription period.
Subscription customers are invoiced either quarterly or annually in advance with the customer contracts automatically renewing unless
the customer issues a cancellation notice. The timing of revenue recognition is based on a time-based measure of progress as the Company
provides access to the programs evenly over the course of the subscription period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Web
Imaging Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Web
imaging revenues are generated from the Company&#8217;s data broker (iRWD) product, which provides regulatory grade imaging and clinical
data in the pharmaceutical, device manufacturing, clinical research organizations, and artificial intelligence markets. Web imaging customers
are invoiced in installments as the related data is delivered. Revenue from the sale of web imaging products is recognized over time
using an output measure of progress, which is based on the number of data units delivered relative to the total data units committed
by the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004144" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zbR50DAB7kV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zKJcBN4npTdf">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes income taxes under the asset and liability method. Deferred income taxes are recognized for differences between the
financial reporting and tax bases of assets and liabilities, at enacted statutory tax rates in effect for the years in which the differences
are expected to reverse. The Company establishes a valuation allowance if it believes it is more likely than not that the deferred tax
assets will not be recovered based on an evaluation of all available evidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely
than not that a position will be sustained, none of the benefit attributable to the position is recognized. The tax benefit to be recognized
for any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than
50% likely to be realized upon resolution of the contingency. The Company accounts for interest and penalties related to uncertain tax
positions as part of its provision for income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004146" name="ONMD:PatentsAndTrademarksPolicyTextBlock"><p id="xdx_848_ecustom--PatentsAndTrademarksPolicyTextBlock_zzT15pKsuKh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z477QSUwNVti">Patents
and Trademarks</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
associated with the submission of a patent application are expensed as incurred given the uncertainty of the patents resulting in probable
future economic benefits to the Company and are included in research and development expenses on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004148" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4Hi9QUf8Quf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zOHYXgR61V4k">Research
and Development</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its research and development (&#8220;R&amp;D&#8221;) costs in accordance with ASC 730, <i>Research and Development
</i>(&#8220;ASC 730&#8221;). ASC 730 requires that R&amp;D costs are generally recognized as an expense as incurred. However, some costs
associated with R&amp;D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.
For the years ended December 31, 2023 and December 31, 2022 research and development expenditures were charged to operating expense as
incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004150" name="us-gaap:CompensationRelatedCostsPolicyTextBlock"><p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_znU3DnHp0JGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zgmkIrGoakvg">Stock-based
Compensation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense related to employee option grants and restricted stock grants, if any, in accordance with ASC
718, <i>Compensation - Stock Compensation</i> (&#8220;ASC 718&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures all stock options and other stock-based awards granted based on the fair value of the award on the date of the grant
and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the
respective award. The Company has elected to recognize forfeitures as they occur. The reversal of compensation cost previously recognized
for an award that is forfeited because of a failure to satisfy a service condition is recognized in the period of the forfeiture. Generally,
and unless otherwise specified, the Company grants stock options with service-based only vesting conditions and records the expense for
these awards using the straight-line method over the requisite service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award
recipient&#8217;s payroll costs are classified or in which the award recipients&#8217; service payments are classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Business Combination, the Company was required to periodically estimate the fair value of its Common Stock with the assistance
of an independent third-party valuation firm when issuing stock options and computing estimated stock-based compensation expense. The
assumptions underlying these valuations represented the Company&#8217;s best estimates, which involved inherent uncertainties and the
application of significant levels of judgment. In order to determine the fair value of its Common Stock, the Company considered, among
other items, previous transactions involving the sale of Company securities, the business, financial condition and results of operations,
economic and industry trends, the market performance of comparable publicly traded companies, and the lack of marketability of the Company&#8217;s
Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. These estimates and assumptions include
a number of objective and subjective factors, including external market conditions, guideline public company information, the prices
at which the Company sold convertible preferred stock and common stock to third parties in arms&#8217; length transactions, the rights
and preferences of securities senior to the Company&#8217;s common stock at the time, and the likelihood of achieving a liquidity event
such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in materially
different fair values of stock options at each valuation date, as applicable. Following the Business Combination (see Note 3), the Company
used the public price of its Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each stock option grant is estimated using the Black-Scholes option-pricing model. The Company estimates its expected stock
volatility based on the historical volatility of a publicly traded set of peer companies within the biotechnology industry with characteristics
similar to the Company. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221;
method, which reflects the weighted-average of time-to-vesting. The risk-free interest rate is determined by reference to the U.S. Treasury
yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected
dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends
in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004152" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zpI0qE49LlHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Net
loss per common share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86B_zl2x1xmQ1a1e" style="display: none">Net
loss per share</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
per share attributable to common stockholders is calculated using the two-class method, which is an earnings allocation formula that
determines earnings per share for the holders of the Company&#8217;s Common Stock and participating securities. Although the Company&#8217;s
historical Preferred Stock contained participating rights in any dividend declared and paid by the Company and were therefore participating
securities, the Preferred Stock had no stated dividends and OneMedNet has never paid any cash dividends and does not plan to pay any
dividends in the foreseeable future. Net loss attributable to common stockholders and participating securities is allocated to each share
on an if-converted basis as if all of the earnings for the period had been distributed. However, the participating securities do not
include a contractual obligation to share in the losses of the Company and are not included in the calculation of net loss per share
in the periods that have a net loss. In addition, common stock equivalent shares (whether or not participating) are excluded from the
computation of diluted earnings per share in periods in which they have an anti-dilutive effect on net loss per common share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
net loss per share is computed using the more dilutive of (a) the two-class method or (b) the if-converted method and treasury stock
method, as applicable. Contingently convertible notes payable and PIPE Notes were not included for purposes of calculating the number
of diluted shares outstanding as the number of dilutive shares is based on a conversion contingency associated with the completion of
a future financing event that had not occurred, and the contingency was not resolved, in the reporting periods presented herein. In periods
in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders
is the same as basic net loss per share attributable to common stockholders since dilutive common shares are not assumed to have been
issued if their effect is anti-dilutive. Diluted net loss per share is equivalent to basic net loss per share for the periods presented
herein because common stock equivalent shares from the Preferred Stock, convertible notes, stock option awards and outstanding warrants
to purchase common stock were antidilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Company reporting net loss attributable to common stockholders for all periods presented herein, the following common
stock equivalents were excluded from the computation of diluted net loss per common share for the years ended December 31, 2023 and 2022
because including them would have been antidilutive (in thousands):</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004154" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none">Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022
    <span id="xdx_F53_zMknzVxwFW2d">(1)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022 (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Employee stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4156">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember" id="Fact004157" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">913,856</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember" id="Fact004160" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">177,276</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember" id="Fact004162" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">12,181,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember" id="Fact004163" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">2,367,607</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember81071859" id="Fact004166" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">2,839,957</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4168">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember81071875" id="Fact004169" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,415,923</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4171">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNoteMember" id="Fact004172" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">3,786,610</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total common stock equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-12-31" id="Fact004174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">12,181,019</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-12-31" id="Fact004175" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">13,501,229</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote004176" xml:lang="en-US">Retroactively restated
for the reverse recapitalization in Note 3.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AD_zdniDLLHaxk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004178" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock"><p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zAtmvX74dVB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zHJ6xeHhZUah">General
and Administrative</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses include all costs that are not directly related to satisfaction of customer contracts. General and administrative
expenses include items for the Company&#8217;s selling and administrative functions, such as sales, finance, legal, human resources,
and information technology support. These functions include costs for items such as salaries and benefits and other personnel-related
costs, maintenance and supplies, professional fees for external legal, accounting, and other consulting services, and depreciation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004180" name="ONMD:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zYqQNQ3xCV7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86C_zEsoVgjxUZrh" style="display: none">Emerging
growth company status</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an emerging growth company, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#8220;JOBS Act&#8221;). Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to
comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has not elected to opt out of such extended transition
period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004182" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK1ZhnNCN3aa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zW7YQkl7K4D5">Accounting
Pronouncements Not Yet Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No. 2023-09, <i>Improvements to Income Tax Disclosures (Topic 740)</i> (&#8220;ASU 2023-09&#8221;).
ASU 2023-09 requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional
information on income taxes paid. ASU 2023-09 is effective on a prospective basis for annual periods beginning after December 15, 2024.
Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. The Company
is currently evaluating the impact of adopting ASU 2023-09.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): <i>Improvements to Reportable Segment Disclosures</i>, which
is intended to provide enhancements to segment disclosures, even for entities with only one reportable segment. In particular, the standard
will require disclosures of significant segment expenses regularly provided to the chief operating decision maker and included within
each reported measure of segment profit and loss. The standard will also require disclosure of all other segment items by reportable
segment and a description of its composition. Finally, the standard will require disclosure of the title and position of the chief operating
decision maker and an explanation of how the chief operating decision maker uses the reported measure(s) of segment profit or loss in
assessing segment performance and deciding how to allocate resources. The standard is effective for annual periods beginning after December
15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently
evaluating the impact of the standard on the presentation of its consolidated financial statements and footnotes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004184" name="ONMD:RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_zZpd1abxoVL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zkTd0xEMhp11">Recently
adopted accounting pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU No. 2016-13, <i>Financial Instruments - Credit Losses</i>, &#8220;Topic 326&#8221;, an amendment on measurement
of credit losses on financial assets held by at each reporting date. The guidance requires the use of a new current expected credit loss
(&#8220;CECL&#8221;) model in estimating allowances for doubtful accounts with respect to accounts receivable. The CECL model requires
that the Company estimate its lifetime expected credit loss with respect to these receivables and record allowances that, when deducted
from the balance of the receivables, represent the estimated net amounts expected to be collected. Effective January 1, 2023, the Company
adopted ASU No. 2016-13 and the adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU No. 2022-03, <i>Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </i>(&#8220;ASU
2022-03&#8221;), which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit
of account of the equity security and, therefore, is not considered in measuring fair value. ASU 2022-03 is effective for public business
entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. The Company adopted
ASU No. 2022-03 and the adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial statements.</span></p>
</ix:nonNumeric><p id="xdx_854_z0kpDrFoQhHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004186" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z3R99EqtFyhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
<span id="xdx_827_zlyxvGrPX9Ph">Business Combination</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, the Company closed the previously announced Business Combination pursuant to the Merger Agreement, dated April 25,
2022, by and among Data Knights, Merger Sub, and Legacy ONMD, as described in Note 1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement: (i) Merger Sub merged with and into Legacy ONMD, with Legacy ONMD surviving the Merger, as a wholly-owned subsidiary
of Data Knights, and (ii) Data Knights, which had been formed as a Delaware corporation solely for the purpose of facilitating the Business
Combination, changed its name to OneMedNet Corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Data
Knights was treated as the acquired company for financial reporting purposes. This determination is primarily based on the fact that
subsequent to the Business Combination, Legacy ONMD&#8217;s stockholders have the majority of the voting power of the combined entity,
Legacy ONMD comprised all of the ongoing operations of the combined entity, Legacy ONMD comprised a majority of the governing body of
the combined entity, and Legacy ONMD&#8217;s senior management comprised all of the senior management of the combined entity. Accordingly,
for accounting purposes, the Business Combination was treated as the equivalent of Legacy ONMD issuing shares for the net assets of Data
Knights, accompanied by a recapitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
this is considered a recapitalization for accounting purposes, the net assets of Data Knights were not remeasured at fair value but were
stated at historical cost and there was no goodwill or intangibles recognized. Operations prior to the Business Combination are those
of Legacy ONMD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate consideration to the stockholders of Legacy ONMD at the closing of the Business Combination was approximately $<span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zZrIMnXzNyMk" title="Business combination transfered"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-11-072023-11-07_custom_BusinessCombinationMember" id="Fact004188" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">20.0</ix:nonFraction></span> million,
which consisted of the Company&#8217;s shares of common stock, par value $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231107_zl8Bo6GlONw5" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-11-07" id="Fact004190" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share (&#8220;Common Stock&#8221;), valued at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231107_zf0hmCOPqbMd" title="Share issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-11-07" id="Fact004192" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span>
per share, resulting in the issuance of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231107__20231107_ztzPtfHo23Gj" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-11-072023-11-07" id="Fact004194" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000,000</ix:nonFraction></span> shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing, each of Legacy ONMD&#8217;s outstanding convertible notes, with a fair value of $<span id="xdx_904_eus-gaap--FairValueOfAssetsAcquired_pn5n6_c20231107__20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOBrwTAadHA2" title="Fair value of common stock"><ix:nonFraction name="us-gaap:FairValueOfAssetsAcquired" contextRef="From2023-11-072023-11-07_us-gaap_CommonStockMember" id="Fact004196" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">47.9</ix:nonFraction></span> million, converted into <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231107__20231107_zg9E7qZgwyWk" title="Conversion of convertible securities"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-11-072023-11-07" id="Fact004198" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,475,362</ix:nonFraction></span>
shares of the Company&#8217;s Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
upon the closing, <span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zdX6qskCQdia" title="Temporary equity shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-11-07_custom_SeriesATwoPreferredStockMember_us-gaap_PreferredStockMember" id="Fact004200" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,853,797</ix:nonFraction></span> shares of Series A-2 Preferred Stock and <span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrsFeo5Bwm47" title="Temporary equity shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2023-11-07_custom_SeriesAOnePreferredStockMember_us-gaap_PreferredStockMember" id="Fact004202" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,204,000</ix:nonFraction></span> shares of Series A-1 Preferred Stock converted into <span id="xdx_90A_eus-gaap--SharesOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9fFhcQvSdZi" title="Shares outstanding"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-11-07_us-gaap_CommonStockMember" id="Fact004204" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,261,553</ix:nonFraction></span>
shares of Common Stock. Legacy ONMD&#8217;s <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231107_zLRlOIAINj81" title="Stock options outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-11-07" id="Fact004206" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">612,670</ix:nonFraction></span> outstanding stock options and <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107_zYHJp0Z4Ty7f" title="Warrant outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-11-07" id="Fact004208" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,859,464</ix:nonFraction></span> outstanding warrants converted into <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znblmrgQpkRi" title="Warrant outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-11-07_us-gaap_WarrantMember" id="Fact004210" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">543,057</ix:nonFraction></span>
and <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFWXoqZmsHb" title="Warrant outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-11-07_us-gaap_CommonStockMember" id="Fact004212" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,420,945</ix:nonFraction></span> shares, respectively, of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the above, the share figures in the consolidated statement of temporary equity and stockholders&#8217; deficit for the year
ended December 31, 2022 have been adjusted for the application of the recapitalization ratio of <span id="xdx_90D_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_c20221231_zS7cyIYfXSO7" title="Temporaray equity liquidation preference per share"><ix:nonFraction name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" contextRef="AsOf2022-12-31" id="Fact004214" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.88637847</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_DataKnightsAcquisitionCorpMember" escape="true" id="Fact004216" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zRy8eAdFV65e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received net cash consideration of approximately $<span id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107_zbbqF5bZQ9o3" title="Business combination net cash" class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2023-11-07" id="Fact004218" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></span> million and net liabilities of Data Knights of approximately $<span id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn5n6_c20231107_zTn2aNDCmvh9" title="Business combination net liabilities" class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2023-11-07" id="Fact004220" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">11.0</ix:nonFraction></span> million.
The net liabilities of Data Knights were as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zHJ1yIjtART1" style="display: none">Schedule
of Business Combination Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7elQfgFA4Kk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3_maBCRIAzlc7_zgyL2s3cJb8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid expenses and other current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004222" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_iNI_pn3n3_di_msBCRIAzlc7_zWeMZxmWTzX7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004224" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,501</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_iNI_pn3n3_di_msBCRIAzlc7_zcTLjIZHttxe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004226" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,992</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_iNI_pn3n3_di_msBCRIAzlc7_zrbKiKasH2c1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004228" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,525</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_iNI_pn3n3_di_msBCRIAzlc7_zFHOfonhcp2g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004230" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pn3n3_mtBCRIAzlc7_zMtAJwotwOA2" style="vertical-align: bottom; background-color: White">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Liabilities</span></td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004232" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11,016</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_z1Epc1DulgYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred transaction costs of $<span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn5n6_c20231107_z4ovNNGng9f6" title="Business combination transaction cost"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2023-11-07" id="Fact004234" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.9</ix:nonFraction></span> million in connection with the Business Combination. Following consummation of the Business
Combination, the Company owned all of the issued and outstanding equity interests in Legacy ONMD and its subsidiary, and the Legacy ONMD
securityholders held approximately <span id="xdx_909_ecustom--BusinessAcquisitionCostPercentage_iI_dp_uPure_c20231107_zfOehGTNqnB7" title="Business combination percentage"><ix:nonFraction name="ONMD:BusinessAcquisitionCostPercentage" contextRef="AsOf2023-11-07" id="Fact004236" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">78.2</ix:nonFraction></span>% of the Company. Following consummation of the Business Combination, the Company&#8217;s Common
Stock and the Company&#8217;s Public Warrants began trading on the Nasdaq Global Market under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW&#8221;,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Investment in Public Equity (&#8220;PIPE&#8221;) Financing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 28, 2023, the Company and Data Knights entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with certain investors
(collectively referred to as the &#8220;Purchasers&#8221;) for PIPE financing in the aggregate original principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20230628__20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z0HPlQ9zlf6h" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentIssuedPrincipal" contextRef="From2023-06-282023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember" id="Fact004238" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million.
Pursuant to the Securities Purchase Agreement, Data Knights issued and sold to each of the Purchasers, a new series of senior secured
convertible notes (the &#8220;PIPE Notes&#8221;), which are convertible into shares of Common Stock at the Purchasers election at a conversion
price equal to the lower of (i) $10.00 per share, pr (ii) 92.5% of the lowest volume weighted average trading price for the ten (10)
Trading Days immediately preceding the Conversion Date. The Purchasers&#8217; $<span id="xdx_902_eus-gaap--Investments_iI_pn5n6_c20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2PfLnEjXCT6" title="Investment"><ix:nonFraction name="us-gaap:Investments" contextRef="AsOf2023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember" id="Fact004240" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million investment in the PIPE Notes closed and funded
contemporaneous to the Closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
immediately prior to the Closing, Data Knights issued the PIPE Notes to the Purchasers under the private offering exemptions under Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<ix:exclude><!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Deferred
Underwriter Fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, Data Knights entered into an agreement with their underwriters (&#8220;EF Hutton&#8221;) whereby
EF Hutton agreed to waive the related merger underwriting fees that were payable at closing ($<span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2ObVj4jthDi" title="Business combination underwriter fees"><ix:nonFraction name="ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" contextRef="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember" id="Fact004242" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.0</ix:nonFraction></span> million) in exchange for allocated
payments as follows: (i) $<span id="xdx_90D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zooYjfpGnop5" title="Business combination cash"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004244" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million in cash at closing; (ii) a $<span id="xdx_900_eus-gaap--NotesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zIk6LAMsMJN" title="Promissory note"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004246" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million promissory note that matures on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zJhNp7Imv2e8" title="Debt maturity date"><ix:nonNumeric contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember" format="ixt:datemonthdayyearen" id="Fact004248" name="us-gaap:DebtInstrumentMaturityDate">March 1, 2024</ix:nonNumeric></span>; and (iii)
a transfer of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zeWpOliOfmCh" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004250" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">277,778</ix:nonFraction></span> shares of Common Stock. The Company paid the $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zPjj32GbaKe4" title="Business combination cash"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember" id="Fact004252" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million of cash due at closing and the remaining $<span id="xdx_901_ecustom--DeferredUnderwriterFeePayableCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zz69NWPh80n8" title="Business combination cash"><ix:nonFraction name="ONMD:DeferredUnderwriterFeePayableCurrent" contextRef="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember" id="Fact004254" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.5</ix:nonFraction></span> million
is recorded as deferred underwriter fee payable on its consolidated balance sheet as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Extensions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, the Company assumed Data Knights&#8217; liabilities, which included existing loan extensions
to related parties. The loan extensions were to be exchanged for a fixed amount of Common Stock upon the closing of a business combination
or a similar event. As of December 31, 2023, a balance of $<span id="xdx_908_ecustom--LoanExtensionsCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2c0KhMGSMo9" title="Loan extensions"><ix:nonFraction name="ONMD:LoanExtensionsCurrent" contextRef="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember" id="Fact004256" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.0</ix:nonFraction></span> million remained outstanding and is recorded as loan extensions on the
Company&#8217;s consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004258" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zI3WrqxnE3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_820_zryoLV1ClL83">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are summarized as of December 31 (in thousands):</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004260" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zctF042YaQBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zsdgk10zk6S2" style="display: none">Schedule
of Property and Equipment </span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20231231_zScowbnVX4r8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zSU3yWvcNnRg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zmMLhg6gxMr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Computers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_us-gaap_ComputerEquipmentMember" id="Fact004262" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">303</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_ComputerEquipmentMember" id="Fact004263" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">259</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndEquipmentMember_zKjXoUbbvTVf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Furniture and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31_custom_FurnitureAndEquipmentMember" id="Fact004265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_FurnitureAndEquipmentMember" id="Fact004266" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzSdJ_zBDrk6m2BQQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-12-31" id="Fact004268" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">307</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" id="Fact004269" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzSdJ_z65ajHtdtx35" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-12-31" id="Fact004271" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">208</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" id="Fact004272" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzSdJ_z8519SR6uWia" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-12-31" id="Fact004274" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">99</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" id="Fact004275" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_8A8_zwUdgbVD3zwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense was $<span id="xdx_90E_eus-gaap--DepreciationAndAmortization_pn4n6_c20230101__20231231_za7kmkupZMad" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-01-012023-12-31" id="Fact004277" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">0.03</ix:nonFraction></span> million and $<span id="xdx_903_eus-gaap--DepreciationAndAmortization_pn4n6_c20220101__20221231_zKa7PPYBZwXk" title="Depreciation and amortization expense"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-01-012022-12-31" id="Fact004279" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">0.02</ix:nonFraction></span> million for the years ended December 31, 2023 and 2022, respectively, which is recorded
within general and administrative expenses in the consolidated statements of operations.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004281" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zWzbpj6gh1Ha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
<span id="xdx_828_zx0hAoTsBH57">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004283" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zz2CDF9Xeoi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has operations in the United States and Canada. The components of income (loss) before the provision for income taxes are as
follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zQTOOeov4NVh" style="display: none">Schedule
of Components of Income (Loss) Before Provision for Income Tax</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_zFL9j071bVj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zsYuUmfCvrs9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pn3n3_maILFCOzkfc_z8EUKV3XXp13" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">United States</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2023-01-012023-12-31" id="Fact004285" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,827</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" contextRef="From2022-01-012022-12-31" id="Fact004286" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,456</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pn3n3_maILFCOzkfc_zvC4tlK0ELh9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2023-01-012023-12-31" id="Fact004288" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" contextRef="From2022-01-012022-12-31" id="Fact004289" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pn3n3_mtILFCOzkfc_z10nWaDT2DZd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total loss before income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-12-31" id="Fact004291" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,762</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-12-31" id="Fact004292" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">30,434</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zWxVPdswhZGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004294" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYDZ9Jadipe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the income tax provision for the years ended December 31, 2023 and 2022 were as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zO05iQweijl6" style="display: none">Schedule
of Income Tax Provision</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230101__20231231_zqBXVBFcUOLk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_zgYoS1eO7HAc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCITEBz04w_zGN0u9zFCaza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4297">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCITEBz04w_zh67G1FT8SPh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current state</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4299">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4300">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentForeignTaxExpenseBenefit_pn3n3_maCITEBz04w_ziHBSRkZEypi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1pt">Current foreign</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact004302" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact004303" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pn3n3_mtCITEBz04w_maITEBzoUt_zV2WZZOV3jHc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total current tax provision (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact004305" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact004306" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_z5t8b0vJCsI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4308">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4309">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zz1dXMgyjO5h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred state</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4312">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zfo1x4Qtobcf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Deferred foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4314">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4315">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredOtherTaxExpenseBenefit_iT_pn3n3_mtDOTEBz8fT_maITEBzoUt_zipeTfX0cS11" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total deferred tax provision (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4317">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4318">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtITEBzoUt_zFVUU1sujEae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total income tax provision (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-12-31" id="Fact004320" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-12-31" id="Fact004321" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zlok7NUULzo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004323" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuhQpduCjgzk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zKcFvDGMybEj" style="display: none">Schedule
of Reconciliation of Income Tax Benefit</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zgp3TP5wiPX9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_z6ojoo4FoUtb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maA91O_zNocUp5KIQej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Tax provision at statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2023-01-012023-12-31" id="Fact004325" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-01-012022-12-31" id="Fact004326" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maA91O_zTekL1evozOc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">State taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2023-01-012023-12-31" id="Fact004328" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2022-01-012022-12-31" id="Fact004329" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.2</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_pid_dp_uPure_maA91O_z9DpQZJhwmlf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2023-01-012023-12-31" id="Fact004331" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.9</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2022-01-012022-12-31" id="Fact004332" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.4</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_pid_dp_uPure_maA91O_zK7kcATDWhu" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Permanent differences - other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" contextRef="From2023-01-012023-12-31" id="Fact004334" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.2</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" contextRef="From2022-01-012022-12-31" id="Fact004335" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_pid_dp_uPure_maA91O_zJXgkx4VyDic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" contextRef="From2023-01-012023-12-31" id="Fact004337" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">11.0</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" contextRef="From2022-01-012022-12-31" id="Fact004338" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">10.5</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_405_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_pid_dp_uPure_maA91O_zAwT4x19t7M4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" contextRef="From2023-01-012023-12-31" id="Fact004340" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">5.7</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" contextRef="From2022-01-012022-12-31" id="Fact004341" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">5.8</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maA91O_zbxozSWzftM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-01-012023-12-31" id="Fact004343" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">3.4</ix:nonFraction></td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-01-012022-12-31" id="Fact004344" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.0</ix:nonFraction></td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_pid_dp_uPure_maA91O_zGZOfZDfpHi9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" contextRef="From2023-01-012023-12-31" id="Fact004346" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" contextRef="From2022-01-012022-12-31" id="Fact004347" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.2</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtA91O_z2AjT5u3dcB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective income tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2023-01-012023-12-31" id="Fact004349" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.1</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2022-01-012022-12-31" id="Fact004350" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.1</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zIDiT5N71Ckg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004352" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSK7CbxAzVsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are as follows
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zErVYRkVefe4" style="display: none">Schedule
of Components of Deferred Tax Assets and Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_zuw1iEzGQ6T" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20221231_zus8BdIoMwTl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zJCjM3nGYhn8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzqvH_zaLcZourTz2h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-12-31" id="Fact004357" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,393</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2022-12-31" id="Fact004358" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,551</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalizedResearchCosts_iI_pn3n3_maDTAGzqvH_zIDBvLOxQ3r" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Capitalized research costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredTaxAssetsCapitalizedResearchCosts" contextRef="AsOf2023-12-31" id="Fact004360" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">337</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4361">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsFixedAssets_iI_pn3n3_maDTAGzqvH_zuVmYqAMaLt6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredTaxAssetsFixedAssets" contextRef="AsOf2023-12-31" id="Fact004363" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="ONMD:DeferredTaxAssetsFixedAssets" contextRef="AsOf2022-12-31" id="Fact004364" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzqvH_zwenP6nEqmKh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2023-12-31" id="Fact004366" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" contextRef="AsOf2022-12-31" id="Fact004367" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzqvH_maDTANzhf6_zTdbmAIfpww6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total gross deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2023-12-31" id="Fact004369" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,759</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2022-12-31" id="Fact004370" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,601</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzhf6_zwXYLUTJSVRa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-12-31" id="Fact004372" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,753</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2022-12-31" id="Fact004373" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,597</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzhf6_maDTALNzTQu_zL2kMVGTT5uj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-12-31" id="Fact004375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-12-31" id="Fact004376" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zMvwfAqU62Hj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iI_pn3n3_zDmqy1gEjvyc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2023-12-31" id="Fact004381" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2022-12-31" id="Fact004382" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pn3n3_di_msDTALNzTQu_zZmIn0dnsln1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2023-12-31" id="Fact004384" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2022-12-31" id="Fact004385" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzTQu_zWflyjbJOhU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4387">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4388">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</ix:nonNumeric><p id="xdx_8AE_ztSceRVsz8k7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has generated both federal and state net operating losses (NOL) of approximately $<span id="xdx_90D_eus-gaap--FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pn5n6_c20230101__20231231_zVehpsR5P5ah" title="Federal and state net operating losses"><ix:nonFraction name="us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2023-01-012023-12-31" id="Fact004390" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">31.3</ix:nonFraction></span> million and $<span id="xdx_909_eus-gaap--FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pn5n6_c20220101__20221231_zHX0bWmkbQuk" title="Federal and state net operating losses"><ix:nonFraction name="us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" contextRef="From2022-01-012022-12-31" id="Fact004392" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">15.9</ix:nonFraction></span> million, respectively.
The federal NOLs include $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231_zOZ9Jq2eHiI3" title="Operating loss carry forward"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-12-31" id="Fact004394" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">12.2</ix:nonFraction></span> million which expire at various dates beginning in 2030 and $<span id="xdx_90B_ecustom--OperatingLossCarryForwardIndefinitely_iI_pn5n6_c20231231_zG37F84hkPse" title="Operating loss carry forward indefinitely"><ix:nonFraction name="ONMD:OperatingLossCarryForwardIndefinitely" contextRef="AsOf2023-12-31" id="Fact004396" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">19.1</ix:nonFraction></span> million which carry forward indefinitely.
The state NOLs expire at various dates beginning in 2030.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
changes, as defined in the Internal Revenue Code Section 382, could limit the amount of NOLs that can be utilized annually to offset
future taxable income. Generally, an ownership change occurs when the ownership percentage of 5% or greater stockholders increases by
more than <span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe_dp_uPure_c20230101__20231231_z4v0DuH9cosg" title="Effective federal income tax percentage"><ix:nonFraction name="ONMD:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" contextRef="From2023-01-012023-12-31" id="Fact004398" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% over a three-year period. The Company&#8217;s ability to utilize its federal and state tax attributes may be limited by
ownership changes that have occurred in the past or may occur in the future. The Company has not yet conducted a formal study of whether,
or to what extent, past changes in control of the Company impacts its ability to utilize NOL carryforwards because such NOL carryforwards
cannot be utilized until the Company achieves profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has evaluated the positive and negative evidence bearing upon the realizability of the Company&#8217;s net deferred tax assets, which
are comprised primarily of net operating loss carryforwards and research costs capitalized for tax purposes. Management has considered
the Company&#8217;s history of cumulative operating losses and estimated future tax losses and has determined that it is more likely
than not that the Company will not recognize the benefits of the net deferred tax assets. As a result, the Company has recorded a full
valuation allowance at December 31, 2023 and 2022. The valuation allowance increased by $<span id="xdx_900_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn5n6_c20230101__20231231_zR3Kx372k8Y2" title="Deferred tax assets valuation allowance"><ix:nonFraction name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" contextRef="From2023-01-012023-12-31" id="Fact004400" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.2</ix:nonFraction></span> million in 2023 due to the increase in deferred
tax assets, primarily due to net operating loss carryforwards and capitalized research costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, the Company had no uncertain tax positions. The Company recognizes both interest and penalties associated
with unrecognized tax benefits as a component of income tax expense. The Company has not recorded any interest or penalties for unrecognized
tax benefits since its inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files federal, various state, and Canada tax returns. In the U.S., all tax years since inception remain open to examination by
major tax jurisdictions to which the Company is subject, as carryforward attributes generated in years past may still be adjusted upon
examination by the respective tax authorities if they have or will be used in a future period. In Canada, the Company is generally no
longer subject to income tax examinations for the years before 2020. The Company is currently not under examination by any tax authority.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004402" name="us-gaap:LongTermDebtTextBlock"><p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zC9TDOK2uHLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
<span id="xdx_82E_zDVmmJ93akyj">Convertible Debt</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
Promissory Notes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2019
Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
November 2019, the Company entered into a convertible promissory note (the &#8220;2019 Note&#8221;) agreement with a related party investor.
The total amount of the 2019 Note is $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20191130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesMember_z7BHlTR6w47a" title="Convertible promissory note"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2019-11-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNotesMember" id="Fact004404" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million. The 2019 Note is unsecured and bears interest at a rate of four percent annually from
the date of issuance until the outstanding principal is paid or converted. The 2019 Note matures on January 1, 2025. The 2019 Note shall
automatically convert into the next offering of preferred stock upon closing of such next equity financing. The number of shares of preferred
stock to be issued upon conversion shall be equal to the number obtained by dividing the outstanding principal and unpaid accrued interest
owed on the date of conversion, by the conversion price. The conversion price is 100 percent of the lowest price per share paid for the
next equity preferred stock by other investors in the next equity financing. In the event that prior to the conversion or repayment of
amounts owed, the Company completes a financing transaction in which the Company sells equity securities but such transaction does not
qualify as next equity financing (i.e., an &#8220;alternative financing&#8221;), then the principal and unpaid accrued interest may (upon
written election of the purchaser holding the 2019 Note) convert into the securities issued by the Company in the alternative financing.
The number of alternative financing equity securities to be issued upon such conversion shall be equal to the number obtained by dividing
the outstanding principal and unpaid accrued interest owed by an amount equal to 100 percent multiplied by the lowest price per share
at which the alternative financing equity securities are sold and issued for cash in the alternative financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022
Notes and 2023 Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2022, the Company entered into convertible promissory notes with related party investors totaling $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zaEIMSCzD1wk"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesMember" id="Fact004405" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.7</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and unrelated party investors totaling
$<span id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z84gLen9mjC5"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyTwoNotesMember" id="Fact004406" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.4</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (each investor, a &#8220;Purchaser&#8221;)
(the &#8220;2022 Notes&#8221;). During 2023, the Company entered into various convertible promissory notes with related party investors
totaling $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zScIJdljMyq1"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyThreeNotesMember" id="Fact004407" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.3</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and unrelated party investors totaling
$<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zPiEqF6dGaxa"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyThreeNotesMember" id="Fact004408" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.9</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;2023 Notes&#8221;, and together
with the 2019 Notes and 2022 Notes, the &#8220;Convertible Promissory Notes&#8221;). The 2022 Notes and 2023 Notes issued are unsecured
and bear an interest rate of six percent annually from the date of issuance until the outstanding principal is paid or converted. On
November 11, 2022, the 2022 Notes were amended and restated in order to (i) provide for the sale and issuance to Purchasers of additional
convertible promissory notes and warrants to purchase shares of the Company&#8217;s capital stock, (ii) provide for the sale and issuance
of warrants to purchase shares of the Company&#8217;s common stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221111__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zMg9smYsOPXi"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-11-11_custom_TwentyTwentyTwoNotesMember" id="Fact004409" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share to Purchasers who purchased 2022 Notes
between January 1, 2022 and November 11, 2022; and (iii) <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20221110__20221111__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zM9SsSGgiV91"><ix:nonNumeric contextRef="From2022-11-102022-11-11_custom_TwentyTwentyTwoNotesMember" id="Fact004410" name="us-gaap:DebtInstrumentMaturityDateDescription">extend
the maturity date of all outstanding 2022 Notes from December 31, 2022 to March 31, 2023.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal and unpaid accrued interest on each of the 2022 Notes and 2023 Notes will convert: (i) automatically, upon the Company&#8217;s
issuance of equity securities (the &#8220;Next Equity Financing&#8221;) in a single transaction, or series of related transactions, with
aggregate gross proceeds to the Company of at least $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20221110__20221111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zb9buOx6XVB7" title="Proceeds from equity financing"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="From2022-11-102022-11-11_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" id="Fact004412" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,000</ix:nonFraction></span>, into shares of the Company&#8217;s capital stock issued to investors
in the Next Equity Financing, at a conversion price equal to the lesser of (A) <span id="xdx_902_ecustom--EquityFinancingDescription_c20221110__20221111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zFfxmD1ydLoc" title="Equity financing, description"><ix:nonNumeric contextRef="From2022-11-102022-11-11_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" id="Fact004414" name="ONMD:EquityFinancingDescription">a 20% discount to the lowest price per share of shares
sold in the Next Equity Financing, or (B) $2.50 per share; (ii) at the noteholder&#8217;s option, in the event of a defined Corporate
Transaction (as defined in the next paragraph) while the 2022 Notes and 2023 Notes remain outstanding, into shares of the Company&#8217;s
Series A-2 Preferred Stock at a conversion price equal to $2.50 per share; and (iii) at the noteholder&#8217;s option, on or after the
maturity date while the 2022 Notes and 2023 Notes remains outstanding, into shares of the Company&#8217;s Series A-2 Preferred Stock
at a conversion price equal to $2.50 per share</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a Corporate Transaction occurs before the repayment or conversion of the 2022 Notes and 2023 Notes, the Company will pay at the closing
of the Corporate Transaction to each noteholder that elects not to convert its 2022 Notes and 2023 Notes in connection with such Corporate
Transaction an amount equal to the outstanding principal amount of such noteholder&#8217;s Note plus a 20% premium. &#8220;Corporate
Transaction&#8221; means (a) a sale by the Company of all or substantially all of its assets, (b) a merger of the Company with or into
another entity (if after such merger the holders of a majority of the Company&#8217;s voting securities immediately prior to the transaction
do not hold a majority of the voting securities of the successor entity) or (c) the transfer of more than 50% of the Company&#8217;s
voting securities to a person or group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the issuance of the 2022 Notes and 2023 Notes, the Company also issued <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zm5Ff5qL1Vgf" title="Warrant issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" id="Fact004416" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,056,000</ix:nonFraction></span> and <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zFmpnIUAy6Ta" title="Warrant issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" id="Fact004418" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,670,000</ix:nonFraction></span> warrants (the &#8220;Convertible Notes Warrants&#8221;) in 2022 and 2023, respectively, with an exercise
price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zP4hBCP8Ullf" title="Warrant exercise price"><span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zBfU8sqpchoa" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" id="Fact004420" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" id="Fact004422" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></ix:nonFraction></span></span> per share. The expiration date of the Convertible Notes Warrant is the earliest to occur the expiration of the
five-year period following the date of issuance, the closing of a firm commitment underwritten public offering of the
Company&#8217;s Common Stock; or the closing of an Corporation Transaction. The Convertible Notes Warrants when exercised entitles
the holder to one share of the Company&#8217;s Common Stock. The Convertible Notes Warrants include anti-dilutive measure to address
stock dividends, stock splits, and additional shares of Common Stock due to reorganization of the Company. In the case of
reclassification or reorganization, each holder shall be entitled to receive, in lieu of stock or other securities and property
receivable, the stock or other securities or property to which such holder would have been entitled if the holder had exercised the
Convertible Notes Warrants immediately prior. The Convertible Notes Warrants will terminate at the earliest of (1) the expiration of
five-year period following the date of issuance, (2) the closing of a firm commitment underwritten public offering of the
Company&#8217;s Common Stock; (3) the closing of a sale of the Company. The holders of the Convertible Notes Warrants are not
permitted to sell, pledge, distribute, offer for sale, transfer, or otherwise dispose of the Convertible Notes Warrants in the
absence of (i) an effective registration statement under the Securities Act, or (ii) an opinion of counsel, satisfactory to the
Company and to be provided at the sole cost of the holder, that such registration and qualification are not required. Furthermore,
neither the Convertible Notes Warrants nor any rights may be assigned, conveyed, or transferred, in whole or in part, without the
Company&#8217;s prior written consent. See additional information on the accounting for the warrants in Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Promissory Notes were issued for general working capital purposes. The Company elected the FVO of accounting for its Convertible
Promissory Notes. Under the FVO election, the financial instrument is initially measured at its issue-date estimated fair value and subsequently
remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value adjustment is presented
as a single line item within other (income) expenses, net in the accompanying consolidated statements of operations under the caption
change in fair value of convertible debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 the fair value of the 2019 Notes and 2022 Notes was $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zBi7Qikvai4j"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" id="Fact004423" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">26.2</ix:nonFraction></span> million which was included in both short-term and long-term
liabilities on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the Convertible Promissory Notes were converted pursuant to their provision in connection with the Business Combination
between Data Knights and the Company and were no longer outstanding as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PIPE
Notes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2023, the Company entered into the PIPE SPA in which the Company was required to sell senior secured convertible notes and warrants
to directors of the Company. The PIPE SPA stipulates a collateral security agreement between the Company and the directors for punctual
payment and performance by the Company on its obligations to the Directors. The intellectual property of the Company serves as the collateral
for the PIPE Notes. The PIPE Notes and related warrants were issued through a PIPE financing transaction, which is a form of debt and
equity offering under an exemption in the securities laws for qualifying private placements by issuers of publicly traded securities.
On November 7, 2023, the Company received a total of $<span id="xdx_900_eus-gaap--ProceedsFromNotesPayable_pn5n6_c20231106__20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_z8k0D0yOkjKc" title="Proceeds from PIPE notes payable"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-11-062023-11-07_srt_DirectorMember" id="Fact004425" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million from the directors in exchange for PIPE Notes in the aggregate principal
amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zlkShAiGVR8h" title="Principal amount of notes payable"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-11-07_srt_DirectorMember" id="Fact004427" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span> million (plus accrued interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn5n6_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zvbTkj1vYl62" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-11-07_srt_DirectorMember" id="Fact004429" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.1</ix:nonFraction></span> million) and <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zyED3tIWHpzj" title="Warrants to acquire common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-11-07_srt_DirectorMember" id="Fact004431" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,745</ix:nonFraction></span> warrants to acquire Common Stock. <span id="xdx_90F_eus-gaap--DebtConversionDescription_c20231106__20231107_zLTTrexhiRe2"><ix:nonNumeric contextRef="From2023-11-062023-11-07" id="Fact004432" name="us-gaap:DebtConversionDescription">The PIPE Notes are convertible
into shares of Common Stock at the PIPE Investor&#8217;s election at a conversion price equal to the lower of (i) $10.00 per share, and
(ii) 92.5% of the lowest VWAP for the ten (10) trading days immediately preceding the conversion date, subject to the floor price of
$1.14 (representing 20% of the closing price of the Common Stock on the last trading day before the closing of the Business Combination),
or the alternative conversion ratio of the greater of the floor price and the lesser of 80% of the VWAP of the common stock as of the
trading day and 80% of the price computed as the quotient of the sum of the VWAP of the Common Stock for each of the three trading days
with the lowest VWAP of the Common Stock during the fifteen consecutive trading day period ending and including the trading day immediately
preceding the delivery or deemed delivery of the applicable conversion notice, divided by three</ix:nonNumeric></span>. All such determinations are to be appropriately
adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases
or increases the Common Stock. The PIPE Notes mature on the first anniversary of the issuance date, or November 7, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected the FVO of accounting for its PIPE Notes. Under the FVO election, the financial instrument is initially measured at its
issue-date estimated fair value and subsequently remeasured at estimated fair value on a recurring basis at each reporting period date.
The estimated fair value adjustment is presented as a single line item within other (income) expenses, net in the accompanying consolidated
statements of operations under the caption change in fair value of pipe notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 the fair value of the PIPE Notes was $<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231_zgoCh02dX8d6" title="PIPE notes payable"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-12-31" id="Fact004434" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span> million which was included in current liabilities on the consolidated
balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004436" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zbByYFCJ25A1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_82A_zufdttgdxKAf">Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, the Company applied for and received a $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_z51TPmXNcXJk" title="Proceeds from loans"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfUnsecuredDebt" contextRef="From2020-12-012020-12-31_custom_CEBALoanMember" id="Fact004438" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="CAD">0.06</ix:nonFraction></span> CAD ($<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zxvovi9W7qR6" title="Proceeds from loans"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfUnsecuredDebt" contextRef="From2020-12-012020-12-31_custom_CEBALoanMember" id="Fact004440" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">0.04</ix:nonFraction></span> USD) equivalent CEBA loan. The loan was provided by the Government
of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and better position
them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through December 31,
2023. If the loan was paid back by January 18, 2024, $<span id="xdx_900_eus-gaap--DebtInstrumentDecreaseForgiveness_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zcINTLeES6l7" title="Forgiven of loan"><ix:nonFraction name="us-gaap:DebtInstrumentDecreaseForgiveness" contextRef="From2020-01-012020-12-31_custom_CEBALoanMember" id="Fact004442" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">0.01</ix:nonFraction></span> million of the loan would have been forgiven. If the loan was not paid back
by January 18, 2024, the full $<span id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zilxXcAVSdJd" title="Loan repayable"><ix:nonFraction name="us-gaap:DebtConversionOriginalDebtAmount1" contextRef="From2020-01-012020-12-31_custom_CEBALoanMember" id="Fact004444" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">0.04</ix:nonFraction></span> million loan would have been converted to loan repayable over <span id="xdx_902_eus-gaap--DebtInstrumentTerm_dc_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zSLYP65LwAj" title="Loan payment term"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_CEBALoanMember" format="ixt-sec:durwordsen" id="Fact004446" name="us-gaap:DebtInstrumentTerm">three years</ix:nonNumeric></span> with a <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zFaaRuPr70p6" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2020-12-31_custom_CEBALoanMember" id="Fact004448" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% interest rate.
The loan was paid back prior to January 18, 2024. At December 31, 2023 the loan was classified as Canada Emergency Business Loan Act
under other long-term liabilities on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the loan as debt in accordance with FASB ASC 470, <i>Debt</i>, and accrued interest in accordance with the interest
method under FASB ASC 835-30.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004450" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zi7ZxxHRJrQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
<span id="xdx_82A_zVYHd5BfLrad">Stockholders&#8217; Deficit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziD1ppxE4qj9" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKN7exbp24Mg" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact004452" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="Fact004454" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,033,170</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_znKxiQssX0m8" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGvP0XY6gBJ8" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" id="Fact004456" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" id="Fact004458" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,255,880</ix:nonFraction></ix:nonFraction></span></span> shares of Common Stock and Preferred Stock were issued and outstanding, respectively (after
giving effect to the exchange ratio in Note 3). Subsequent to the Business Combination, the Company was authorized to issue up to <span id="xdx_905_eus-gaap--CapitalUnitsAuthorized_iI_pid_c20231107_zU4mp57hBj43" title="Capital stock authorized"><ix:nonFraction name="us-gaap:CapitalUnitsAuthorized" contextRef="AsOf2023-11-07" id="Fact004460" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">101,000,000</ix:nonFraction></span>
shares of capital stock, par value $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231107_zKKAc21qZoca" title="Capital stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-11-07" id="Fact004462" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share, consisting of (a) <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231107_z4HVtrbs4vie" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-11-07" id="Fact004464" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000,000</ix:nonFraction></span> shares of Common Stock and (b) <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231107_zMDtvyv8Amy2" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-11-07" id="Fact004466" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction> </span>shares of
preferred stock (the &#8220;Preferred Stock&#8221;). As of December 31, 2023, <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zixxKZSE5Ar1" title="Common stock, shares issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_znhu3H33Aaqe" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-12-31" id="Fact004468" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact004470" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">23,572,232</ix:nonFraction></ix:nonFraction></span></span> shares of Common Stock were issued and outstanding.
The Company had <span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zK95ULydJLX2" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-12-31" id="Fact004472" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span> Preferred Stock outstanding at December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
A-2 Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s previously issued and outstanding Series A-2 preferred stock included a $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBKJPxLe8OA6" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact004474" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.15</ix:nonFraction></span> per share annual noncumulative dividend
when and if declared by the Board of Directors. <span id="xdx_906_eus-gaap--DividendsPreferredStock_do_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zdsKi8CzXLs5" title="Dividends"><span id="xdx_90A_eus-gaap--DividendsPreferredStock_do_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zflOYliUMIxk" title="Dividends"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact004476" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact004478" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">No</ix:nonFraction></ix:nonFraction></span></span> dividends were declared in the years ended December 31, 2023 or December 31, 2022.
The Series A-2 preferred stock also included a liquidation preference of 1.25 times the original issue price plus any declared but unpaid
dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and had a preference upon
liquidation over Series A-1 preferred stock and Common Stock. Each share of Series A-2 preferred stock could have been converted into
equal shares of Common Stock at the option of the holder at any time. In addition, the Series A-2 preferred stock shares were automatically
convertible into common shares upon the sale of shares of common stock to the public at the then applicable conversion price in a firm
commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, resulting in at least
$<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn5n6_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zlRRO4uYC9e1" title="Proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact004480" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">20</ix:nonFraction></span> million in proceeds, net of underwriting discounts and commissions. Each share of Series A-2 preferred stock had voting rights equal
to the number of shares of Common Stock then issuable upon conversion of such share of Series A-2 preferred stock. The Company was obligated
to redeem shares of Series A-2 Preferred Stock upon liquidation, dissolution, or winding-up of the Company, or a merger, consolidation,
lease or transfer of the Company (a &#8220;Deemed Liquidation Event&#8221;), unless a majority of the holders of Series A-2 Preferred
Stock and a majority of the holders of Series A-1 Preferred Stock consent otherwise. As of December 31, 2022, the liquidation preference
of the Series A-2 Preferred Stock was $<span id="xdx_909_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn5n6_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMyVwPLyQKs4" title="Liquidation preference amount"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember" id="Fact004482" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">10.7</ix:nonFraction></span> million (after giving effect to the Business Combination exchange ratio described Note 3).
In connection with the Business Combination, the shares of <span id="xdx_902_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8MXT69UcHY1" title="Convertible preferred stock terms of conversion"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember" id="Fact004484" name="us-gaap:ConvertiblePreferredStockTermsOfConversion">Series A-2 preferred stock were converted into Common Stock using an exchange
ratio of 1:1.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
A-1 Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s previously issued and outstanding Series A-1 preferred stock included a $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9DcjHvxUBuj" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact004486" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.15</ix:nonFraction></span> per share annual noncumulative dividend
when and if declared by the Board of Directors. <span id="xdx_90B_eus-gaap--DividendsPreferredStock_do_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zTGP1H9Th8S3" title="Dividends"><span id="xdx_90F_eus-gaap--DividendsPreferredStock_do_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zCjKSq33MIH3" title="Dividends"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact004488" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact004490" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">No</ix:nonFraction></ix:nonFraction></span></span> dividends were declared in the years ended December 31, 2023 or December 31 2022.
The Series A-1 preferred stock also included a liquidation preference of 1.25 times the original issue price plus any declared but unpaid
dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and had a preference upon
liquidation over Common Stock. Each share of Series A-1 preferred stock could have been converted into equal shares of Common Stock at
the option of the holder at any time. In addition, the Series A-1 preferred stock shares were automatically convertible into common shares
upon the sale of shares of common stock to the public at the then applicable conversion price in a firm commitment underwritten public
offering pursuant to an effective registration statement under the Securities Act, resulting in at least $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn5n6_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrhmugFeTule" title="Proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact004492" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">20</ix:nonFraction></span> million in proceeds, net
of underwriting discounts and commissions. Each share of Series A-1 preferred stock had voting rights equal to the number of shares of
Common Stock then issuable upon conversion of such share of Series A-1 preferred stock. The Company was obligated to redeem shares of
Series A-1 Preferred Stock upon a Deemed Liquidation Event, unless a majority of the holders of Series A-1 Preferred Stock consent otherwise.
As of December 31, 2022, the Series A-1 preferred stock has a liquidation preference of $<span id="xdx_90B_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn5n6_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zaPzycsYQTBi" title="Liquidation preference amount"><ix:nonFraction name="us-gaap:PreferredStockLiquidationPreferenceValue" contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember" id="Fact004494" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">8.9</ix:nonFraction></span> million (after giving effect to the Business
Combination exchange ratio described in Note 3). In connection with the Business Combination, the shares of <span id="xdx_908_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zuwR6ZzPZde3" title="Convertible preferred stock terms of conversion"><ix:nonNumeric contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember" id="Fact004496" name="us-gaap:ConvertiblePreferredStockTermsOfConversion">Series A-1 preferred stock
were converted into Common Stock using an exchange ratio of 1:1.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004498" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_805_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zn1CW1MJFz76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span>Stock Based Compensation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_822_zs7tydbu9lU2" style="display: none">Stock-Based Compensation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2020, the Company adopted an equity incentive plan (the &#8220;2020 Plan&#8221;), which provided for the granting of incentive and nonqualified
stock options to employees, directors, and consultants of Legacy ONMD. As of December 31, 2020, the Company had reserved <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember_zDOj9LDparpd" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember" id="Fact004500" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,000,000</ix:nonFraction></span> shares
of common stock under the 2020 Plan. Under the 2020 Plan, option awards were generally granted with an exercise price equal to the fair
market value of the Company&#8217;s stock at the date of grant; those option awards generally vested with a range of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zlZpHg7eG1f4" title="Vesting period::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl4502">one</span></span> to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zy90sXbISqYk" title="Vesting period"><ix:nonNumeric contextRef="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MaximumMember" format="ixt-sec:durwordsen" id="Fact004504" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">four years</ix:nonNumeric></span>
of continuous service and had ten-year contractual terms. Certain option awards provided for accelerated vesting if there was a change
in control, as defined in the 2020 Plan. The 2020 Plan also permitted the granting of restricted stock and other stock-based awards.
Unexercised options were cancelled upon termination of employment and became available for reissuance under the 2020 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">At
the Special Meeting </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held on October 17, 2023<span style="background-color: white">,
Data Knights shareholders considered and approved the OneMedNet Corporation 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;)
and reserved an amount of shares of Common Stock equal to 10% of the number of shares of Common Stock of OneMedNet following the Business
Combination for issuance thereunder. The 2022 Plan was approved by the Legacy ONMD Board of Directors on October 17, 2023. The 2022 Plan
became effective immediately upon the Closing of the Business Combination and replaced the 2020 Plan.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004506" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z2t4WLtze2Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to options outstanding is summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zI0hPK0P8F83" style="display: none">Schedule of Options Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 1pt">Outstanding as of December 31, 2021</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_z0U5wRYmtbh1" title="Options outstanding, beginning balance" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2021-12-31" id="Fact004508" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">728,603</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zypioOXRPhOh" title="Weighted average exercise price, beginning balance" style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2021-12-31" id="Fact004510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20221231_z2shuwnGqzv7" title="Aggregate Intrinsic value, begining balance" style="padding-bottom: 1pt; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4512">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zkHMNrDUKqhe" title="Options, Granted - under the Plan" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2022-01-012022-12-31" id="Fact004514" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">511,440</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zk4YloymnWac" title="Weighted average exercise price, granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31" id="Fact004516" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zSOuwTZiIgnh" title="Options, Exercised - under the Plan" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2022-01-012022-12-31" id="Fact004518" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,648</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_zMm45h2raGe8" title="Weighted average exercise price, exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31" id="Fact004520" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231_z4SWf21Q8baj" title="Options, cancelled" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2022-01-012022-12-31" id="Fact004522" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">319,539</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zCs3JyTynD6g" title="Weighted average exercise price, cancelled" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2022-01-012022-12-31" id="Fact004524" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Outstanding as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zG6cgN86wjbc" title="Options outstanding, beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31" id="Fact004526" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">913,856</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_ziK5f5y9plyi" title="Weighted average exercise price, beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31" id="Fact004528" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20220101__20221231_zacYP68Ics54" title="Aggregate Intrinsic value, ending balance" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-12-31" id="Fact004530" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,199</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zPkyqh888cac" title="Options, Exercised - under the Plan" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-01-012023-12-31" id="Fact004532" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">613,510</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zQAZULygsM78" title="Weighted average exercise price, exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31" id="Fact004534" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231_z2d2eoaUXYkb" title="Options, cancelled" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-01-012023-12-31" id="Fact004536" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">300,346</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zqse2nLXHYZ5" title="Weighted average exercise price, cancelled" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-12-31" id="Fact004538" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USDPShares">1.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding as of December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zU6jFtbBUQul" title="Options outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4540">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zWf8X159Qfye" title="Weighted average exercise price, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4542">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zdxFOEhSQHri" title="Aggregate Intrinsic value, ending balance" style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4544">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Vested and exercisable as of December 31, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20230101__20231231_zN0GsflAab1" title="Options vested and exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4546">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zGLHNwZ28Ntc" title="Weighted average exercise price, vested and exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4548">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20230101__20231231_zbWHYtXkhaD8" title="Aggregate Intrinsic value, exercisable" style="padding-bottom: 1pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4550">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zYbHAJ80DLd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022, the Company recorded stock-based compensation expense of $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zmHPvBDFJHJ8" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember81072609" id="Fact004552" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.4</ix:nonFraction></span> million and $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8y6TFp8Ri1i" title="Stock-based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember81072609" id="Fact004554" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.3</ix:nonFraction></span> million, respectively,
on its outstanding stock options. The Company has determined its share-based payments to be a Level 3 fair value measurement. For the
year ended December 31, 2023 and 2022, the Company has used the Black-Scholes option pricing model and estimated no expected dividends
and the following weighted average assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004556" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z7nEjYXPSKbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zvdqLwiSHLH8" style="display: none">Schedule
of Fair Value of  Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zb4EqjAVvHcj" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4558">-</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zv7TKOPtaZah" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember" id="Fact004560" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.73</ix:nonFraction></span>% - <span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zI0UX2ZfVXvg" title="Risk-free interest rate"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" id="Fact004562" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">2.96</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left">% </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlxm0i4Fc2ii" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4564">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zhjGUBcEXN8j" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4566">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--EquitySecuritiesFvNiMeasurementTerm_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zwbvwcufSdP4" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4568">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zn4w2yHn1Mt7" title="Expected life in years"><ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact004570" name="ONMD:EquitySecuritiesFvNiMeasurementTerm">1.36</ix:nonNumeric></span> - <span id="xdx_904_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zh6oP8V6f0u8" title="Expected life in years"><ix:nonNumeric contextRef="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact004572" name="ONMD:EquitySecuritiesFvNiMeasurementTerm">1.85</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z2C4T4M15t91" title="Equity securities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl4574">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zMW0leDnbjz9" title="Equity securities, measurement input"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember" id="Fact004576" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">50.0</ix:nonFraction></span>% - <span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zlG8ca1XMgD" title="Equity securities, measurement input"><ix:nonFraction name="us-gaap:EquitySecuritiesFvNiMeasurementInput" contextRef="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember" id="Fact004578" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">86.3</ix:nonFraction></span></span></td><td style="text-align: left">% </td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zZbNHcszloYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, as part of the Business Combination, the 2020 Plan was cancelled and all vested shares were exercised and converted
at the appropriate conversion ratio to Common Stock of the Company. The Company issued shares of Common Stock of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231106__20231107_zg54JLj28jij" title="Options vested"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-11-062023-11-07" id="Fact004580" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">543,057</ix:nonFraction></span> which represents
<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231107_zuvA5M6IYxvc" title="Options vested"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2023-11-07" id="Fact004582" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">613,510</ix:nonFraction></span> vested options less an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_pid_c20231107_z5yVFnwzTKTf" title="Options vested exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-11-07" id="Fact004584" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted
Stock Awards</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
employees, directors and consultants have been awarded restricted stock. The restricted stock vesting consists of milestone and time-based
vesting as well as compensation for services performed by the Board of Directors. The following table summarizes restricted stock award
activity for the years ended December 31, 2023 and 2022:</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004586" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"><p id="xdx_898_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zaIIOAu2S4uh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zXSVQhE5UcOj" style="display: none">Schedule of Restricted Stock Award Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Grant</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Nonvested as of December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zvfPYjAAeNEl" title="Number of Awards, Outstanding, Beginning" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4588">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAoAz1WPFED5" title="Weighted Average Grant Date Fair Value, Beginning" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4590">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfX5vHFqtBEi" title="Number of Awards, Granted" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004592" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">354,551</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCyDlDn6Jvda" title="Weighted Average Grant Date Fair Value,Granted" style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004594" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.80</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pn3n3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQPozxL4uH2b" title="Number of Awards, Vested" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004596" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">177,276</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKPiHSYAxXyj" title="Weighted Average Grant Date Fair Value,Vested" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004598" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.80</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Nonvested as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr8UrStWR5N4" title="Number of RSU's, Outstanding, Beginning" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004600" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">177,275</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKSsMEgmMLqf" title="Weighted Average Grant Date Fair Value, Beginning" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004602" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.48</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxumWCm4Z35" title="Number of Awards, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004604" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">88,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQdIs7KuM5v5" title="Weighted Average Grant Date Fair Value,Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004606" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.21</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkdkl5JVM3i2" title="Number of Awards,Vested" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004608" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">265,914</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoUC71Ddonyb" title="Weighted Average Grant Date Fair Value,Vested" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember" id="Fact004610" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.60</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Nonvested as of December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmZOtsbnNOZb" title="Number of Awards Outstanding, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4612">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zEDtpDjm3f49" title="Weighted Average Grant Date Fair Value, Ending" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4614">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zmWF9J4G2aae" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total fair value of the Company&#8217;s previous stock awards vested during the years ended December 31, 2023 and 2022 was $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20230101__20231231_zIWmzStO4wa5" title="Fair value of stock awards vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2023-01-012023-12-31" id="Fact004616" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.1</ix:nonFraction></span> million
and $<span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20220101__20221231_zgQFIjeMNuP4" title="Fair value of stock awards vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2022-01-012022-12-31" id="Fact004618" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million, respectively. On November 7, 2023, as part of the Business Combination, all vested shares were exercised and converted
at the appropriate conversion ratio to Common Stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004620" name="us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z9r9Rg9z2JJ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations
for the periods presented (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span id="xdx_8BA_zJ8hjkB5chs7" style="display: none">Schedule
of Stock-based Compensation Expense</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230101__20231231_zIv3aKKO2Fp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20221231_ztsCIA6dA2wd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zXzlU3y29go5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact004622" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">434</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember" id="Fact004623" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">638</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zMeHDmxXicLh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact004625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,041</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember" id="Fact004626" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,227</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zjOIa7QUTmS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-01-012023-12-31" id="Fact004628" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,475</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2022-01-012022-12-31" id="Fact004629" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,865</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_z6wRGiAx7q99" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004631" name="ONMD:StockWarrantsDisclosureTextBlock"><p id="xdx_800_ecustom--StockWarrantsDisclosureTextBlock_zt5W4FWxH85b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.<span id="xdx_821_zzYLEnC1X84k">
Stock Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004633" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zu5JqleAdXq" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following warrants outstanding for the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zG2q7k4Ebt4i" style="display: none">Schedule
of Warrants Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zIUs3EeLK35f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_zLCOAaHt6oZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Liability Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zIopUMHIq1k3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Private Placement Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember" id="Fact004635" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">585,275</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4636">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PIPEWarrantsMember_ztSA693FySo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember" id="Fact004638" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">95,744</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4639">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_zjz9wl3Tamn8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember" id="Fact004641" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">681,019</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4642">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Equity Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--LegacyONMDWarrantsMember_zLhixHsn0I2a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Legacy ONMD Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4644">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember" id="Fact004645" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">545,213</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConvertiblePromissoryNoteWarrantsMember_zvPE6d1ivh4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Convertible Promissory Note Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4647">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember" id="Fact004648" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">1,822,394</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_z5D6JH42Oaxg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Public Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember" id="Fact004650" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">11,500,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4651">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zAfgYG3UDX34" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember" id="Fact004653" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">11,500,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember" id="Fact004654" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">2,367,607</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_z5RAfkTgNBjd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1pt">Grant Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31" id="Fact004656" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">12,181,019</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2022-12-31" id="Fact004657" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">2,367,607</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_z3X1Y2OPQ7w3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legacy
ONMD Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021, there were <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211231_z2BDWtycSAq9" title="Warrants issued for service"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2021-12-31" id="Fact004659" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">174,102</ix:nonFraction></span> Legacy ONMD outstanding common stock warrants (&#8220;Legacy ONMD Warrants&#8221;) issued to directors for service
at a weighted average exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211231_zhq3DYfnctOe" title="Weighted average exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2021-12-31" id="Fact004661" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.10</ix:nonFraction></span>. In 2022 for the exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231_zCy9vH7cPvHi" title="Weighted average exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2022-12-31" id="Fact004663" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span>, Legacy ONMD issued <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--TwentyTwentyOneServiceMember_zK4ziu1weG7b" title="Warrants issued for service"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-12-31_custom_TwentyTwentyOneServiceMember" id="Fact004665" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">145,746</ix:nonFraction></span> warrants to directors
for 2021 service and <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--TwentyTwentyTwoServiceMember_zYy8YPzFgIV7" title="Warrants issued for service"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoServiceMember" id="Fact004667" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">294,000</ix:nonFraction></span> warrants for 2022 service. The Legacy ONMD Warrants are equity-classified and accounted for in accordance
with ASC 718. ASC 718 requires the use of the &#8220;fair-value-based method&#8221; for measuring the value of stock-based compensation.
In applying &#8220;fair-value-based method&#8221; (absent identical or similar instruments) companies are required to use an option-pricing
model, adjusted to accommodate the unique characteristics of the employee stock options. ASC 718&#8217;s measurement objective is to
determine the fair value of stock-based compensation at the grant date assuming that employees/directors fulfill the award&#8217;s vesting
conditions (if applicable) and will retain the award. The fair value of an award is the cost to the Company for granting the award and
should reflect the estimated value of the instruments that the company would be obligated to provide to an employee/director when the
employee has satisfied the service conditions. This resulted in an expense of $<span id="xdx_90E_eus-gaap--OtherNoncashExpense_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuP7WJQHfSvi" title="Other expense"><ix:nonFraction name="us-gaap:OtherNoncashExpense" contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember81073500" id="Fact004669" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--OtherNoncashExpense_pn5n6_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUEwn5C3kcr1" title="Other expense"><ix:nonFraction name="us-gaap:OtherNoncashExpense" contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember81073500" id="Fact004671" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.2</ix:nonFraction></span> million for the years ended December 31, 2023
and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, all Legacy ONMD Warrants issued for services were cashless
exercised into shares of Legacy ONMD common stock and exchanged for Common Stock based on the appropriate conversion ratio less the applicable
exercise price per Legacy ONMD Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
Promissory Notes Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 6, the Company issued Convertible Promissory Notes Warrants in 2022 and 2023. The Convertible Promissory Note Warrants
are classified as equity in accordance with ASC 815. The Company has elected to measure the Notes using the fair value option under ASC
825 discussed in Note 6. The Company determined that the fair value of the combined instrument significantly exceeds the proceeds received,
therefore, the Company concluded that the warrants are most accurately portrayed as an issuance cost related to the convertible promissory
notes. This resulted in an expense of $<span id="xdx_906_ecustom--StockWarrantExpense_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zsBmSiQHdVV" title="Stock warrant expense"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesWarrantsMember" id="Fact004673" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">9.2</ix:nonFraction></span> million and $<span id="xdx_904_ecustom--StockWarrantExpense_pn5n6_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zjVA8qACXRmd" title="Stock warrant expense"><ix:nonFraction name="ONMD:StockWarrantExpense" contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesWarrantsMember" id="Fact004675" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">8.0</ix:nonFraction></span> million being allocated to the Convertible Promissory Notes Warrants during
the year ended December 31, 2023 and 2022, respectively, which is classified as stock warrant expense in the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, all Convertible Promissory Notes Warrants were cashless
exercised into shares of Legacy ONMD common stock and exchanged based on the appropriate conversion ratio for the Common Stock less an
exercise price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionRatio1_c20231106__20231107_zPNVO3ziksY3" title="Conversion ratio"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionRatio1" contextRef="From2023-11-062023-11-07" id="Fact004677" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">1.00</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PIPE
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the PIPE Notes described in Note 6, the Company also issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfxwolB9zID7" title="Warrants to acquire common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember81073500" id="Fact004679" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,745</ix:nonFraction></span> warrants to purchase Common Stock (&#8220;PIPE Warrants&#8221;).
The Company accounts for the PIPE Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because
the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting treatment of derivative financial instruments in accordance with ASC 815, <i>Derivatives and Hedging, </i>requires that the
Company record a derivative liability upon issuance of the warrants. Accordingly, the Company classifies each warrant as a liability
at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This
liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted
to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the
classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be
reclassified as of the date of the event that causes the reclassification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, all <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PIPEWarrantsMember_zGE7usDUmBsh" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember" id="Fact004681" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,745</ix:nonFraction></span> PIPE Warrants remain outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Public
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuoSGRnh76rl" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-11-07_custom_PublicWarrantsMember" id="Fact004683" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> public warrants (the &#8220;Public
Warrants&#8221;) to purchase Common Stock with an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zFxRKrAR8V5a" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-11-07_custom_PublicWarrantsMember" id="Fact004685" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share. The Public Warrants became exercisable 30 days
after the Closing of the Business Combination. Each Public Warrant is exercisable for one share of Common Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may redeem the outstanding Public Warrants for $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zqy9MXo8nB03" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-12-31_custom_PublicWarrantsMember" id="Fact004687" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></span> per Public Warrant upon at least 30 days&#8217; prior written notice of
redemption given after the Public Warrants become exercisable, if the reported last sale price of the Common Stock equals or exceeds
$<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zO1KCmMrQN9a" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2023-12-31_custom_PublicWarrantsMember" id="Fact004689" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">18.00</ix:nonFraction></span> per share (as adjusted for stock dividends, sub-divisions, reorganizations, recapitalizations and the like) for any 20 trading
days within a 30-trading day period commencing after the Public Warrants become exercisable and ending on the third trading day before
the Company sends the notice of redemption to the holders of the Public Warrants. Upon issuance of a redemption notice by the Company,
the holders of the Public Warrants may, at any time after the redemption notice, exercise the Public Warrants on a cashless basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Public Warrants are classified as equity, with the fair value of the Public Warrants as of the date of the Business Combination closed
to additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, all <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zH2x0pfemkbe" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-12-31_custom_PublicWarrantsMember" id="Fact004691" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,500,000</ix:nonFraction></span> Public Warrants remain outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
Placement Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zCZnvCbnGZgj" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-11-07_us-gaap_PrivatePlacementMember" id="Fact004693" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">585,275</ix:nonFraction></span> private warrants to purchase
Common Stock with an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zTJdO2deMUz7" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-11-07_us-gaap_PrivatePlacementMember" id="Fact004695" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span> per share (the &#8220;Private Placement Warrants&#8221;). The Private Placement Warrants
(and shares of Common Stock issued or issuable upon exercise of the Private Placement Warrants) in general were not transferable, assignable
or salable until 30 days after the Closing (excluding permitted transferees) and they will not be redeemable under certain redemption
scenarios by the Company so long as they are held by the Sponsor or their respective permitted transferees. Otherwise, the Private Placement
Warrants have terms and provisions that are identical to those of the Public Warrants, including as to exercise price, exercisability
and exercise period. If the Private Placement Warrants are held by holders other than the Sponsor, Metric or their respective permitted
transferees, the Private Placement Warrants will be redeemable by the Company under all redemption scenarios and exercisable by the holders
on the same basis as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that
because the Private Placement Warrants do not meet the criteria for equity treatment thereunder, each Private Placement Warrant must
be recorded as a liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting treatment of derivative financial instruments in accordance with ASC 815, <i>Derivatives and Hedging, </i>required that the
Company record a derivative liability upon the closing of the Business Combination. Accordingly, the Company classifies each Private
Placement Warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each
such re-measurement, the Private Placement Warrant liability will be adjusted to fair value, with the change in fair value recognized
in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification
changes as a result of events during the period, the Private Placement Warrants will be reclassified as of the date of the event that
causes the reclassification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, all <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zLtA21qzdP2d" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember" id="Fact004697" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">585,275</ix:nonFraction></span> Private Placement Warrants remained outstanding.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004699" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_zytubuymQfMg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_826_zcyW7FFQ9JZi">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004701" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zx4VUb6mkiqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_znx9PfAgWcDd" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWRkkLWyDgri" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgBvYaGFcJta" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdg0MYNCkvU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zepYc0t5lBkb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zjzKmD4Pi2S8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Private warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4703">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4704">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="Fact004705" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember" id="Fact004706" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z9y2aSkYHAta" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Business Combination Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4708">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="Fact004710" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember" id="Fact004711" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zeFOUJUazrzj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4713">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4714">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember" id="Fact004715" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390" id="Fact004716" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_za6JYscss8Ef" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4718">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4719">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember" id="Fact004720" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_custom_PIPENotesMember" id="Fact004721" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zauQYLn1Y5zh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4723">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4724">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact004725" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2023-12-31" id="Fact004726" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,660</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzMl7Ns3zPMk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8ezS87zniPi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z40QOrbBk7mb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zFch3jrLMbgh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--ConvertiblePromissoryNotesMember_zicdAbkJfVnj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4728">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4729">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember" id="Fact004730" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,243</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004731" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,243</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z5WLuEaC5E1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4733">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4734">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember" id="Fact004735" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,243</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2022-12-31_custom_PrivateWarrantsMember" id="Fact004736" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,243</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_z4D4SxvaTPTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004738" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"><p id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zfPVMYOIcIFk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the Private Warrants, PIPE Notes and PIPE Warrants, and the convertible promissory notes measured
at fair value for the years ended December 31, 2023 and 2022 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zrEje0gHNQzk" style="display: none">&#160;Schedule
of Warrants and Promissory Notes Measured at Fair Value</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">Level 3 Rollforward:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PrivateWarrantsMember_zWco2KKGbyyb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Private</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--PIPENotesAndWarrantsMember_zEJ3Ft6aQVr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Notes &amp;<br/>
 Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--ConvertiblePromissoryNotesMember_zGKgmWZJDTJ9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Convertible</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Promissory</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Notes</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_z2fMhsCUjYpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">Balance, December 31, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4740">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4741">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2021-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004742" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,487</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zBviuiQPjWkl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4744">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004746" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,140</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zsijmKJu6ZB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4748">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4749">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004750" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,616</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zwRtIU9PSg3j" style="vertical-align: bottom; background-color: White">
    <td>Balance, December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004754" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,243</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlT96CCKvkPg" style="display: none; vertical-align: bottom; background-color: White">
    <td>Beginning balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4756">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4757">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004758" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,243</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_431_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zh4h2E26WEMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-12-31_custom_PrivateWarrantsMember" id="Fact004760" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember" id="Fact004761" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004762" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,175</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zVP5orAuH799" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2023-01-012023-12-31_custom_PrivateWarrantsMember" id="Fact004764" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember" id="Fact004765" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004766" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,517</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_zoNaKcB1iatd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Reclassified to additional paid-in-capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4768">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4769">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember" id="Fact004770" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">47,935</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z5E6isg1SAxe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember" id="Fact004772" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_PIPENotesAndWarrantsMember" id="Fact004773" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4774">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zVxglYhpJHcd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember" id="Fact004776" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="AsOf2023-12-31_custom_PIPENotesAndWarrantsMember" id="Fact004777" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,651</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4778">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A9_zgtlbXuVek8k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement Warrants and PIPE Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate fair value of the Private Placement Warrants and PIPE Warrants was $<span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20231107__us-gaap--FinancialInstrumentAxis__custom--PrivatePlacementWarrantsMember_zu5p8dMflpwg" title="Aggregate fair value of private placement warrants"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2023-11-07_custom_PrivatePlacementWarrantsMember" id="Fact004780" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,602</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zzfuy6Pm8d58" title="Aggregate fair value of PIPE warrants"><ix:nonFraction name="us-gaap:DerivativeLiabilities" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390" id="Fact004782" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,393</ix:nonFraction></span> as of November 7, 2023 and December
31, 2023, respectively. The Company remeasured the fair value of the Private Placement Warrants and PIPE Warrants at November 7, 2023
and December 31, 2023 using the Black-Scholes option-pricing model with the following assumptions:</span></p>

<ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004784" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"><p id="xdx_896_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zG7JtzNR8yvg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_8BA_zSAFMhLzu8hj" style="display: none">Schedule
of Fair Value Assumptions and Valuation</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zOyVpPVa8Vb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6Vs42s56Jnc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20231107__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zgw83huQwyL6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231107__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6IiyATv7Zh3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of November 7,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Private</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Private</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zEO2MB9nrjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember" id="Fact004786" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.81</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember" id="Fact004787" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">0.81</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember" id="Fact004788" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember" id="Fact004789" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">7.76</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zf1afDFSdnJa" style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember" id="Fact004791" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">10.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember" id="Fact004792" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember" id="Fact004793" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">10.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember" id="Fact004794" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">11.50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zjnp3s5He9p4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact004796" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">80.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact004797" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">51.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact004798" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">45.0</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember" id="Fact004799" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.2</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ztzmHVQD3t67" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact004801" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.8</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact004802" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.9</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact004803" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.5</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember" id="Fact004804" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.6</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zyS14PyGAws9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4806">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4807">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4808">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4809">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z1JB6b2FrNW7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004811" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.9</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004812" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004813" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004814" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zaQnSbTaqZDa" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
     measurement input</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004816" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.9</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004817" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">4.8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004818" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember" id="Fact004819" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">5.0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A0_zJarw7z46Wk1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Promissory Notes and PIPE Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair values of the convertible promissory notes and PIPE Notes are each determined based on the aggregated, probability-weighted
average of the outcomes of certain possible scenarios. The combined value of the probability-weighted average of those outcomes is then
discounted back to each reporting period in which the convertible notes are outstanding, in each case, based on a risk-adjusted discount
rate estimated based on the implied discount rate. The discount rate was held constant over the valuation periods given the fact pattern
associated with the company and the stage of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, in connection with the Closing of the Business Combination described in Note 3, all convertible promissory notes
were converted to Common Stock in accordance with the conversion provisions in the original agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the PIPE Notes was $<span id="xdx_907_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pn5n6_c20231107__us-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zjWLkGM5LzLl" title="Aggregate fair value"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="AsOf2023-11-07_custom_PIPENotesMember" id="Fact004821" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.8</ix:nonFraction></span> million and $<span id="xdx_909_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pn5n6_c20231231__us-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z1pfvwSQk0Vj" title="Aggregate fair value"><ix:nonFraction name="us-gaap:ConvertibleDebtFairValueDisclosures" contextRef="AsOf2023-12-31_custom_PIPENotesMember" id="Fact004823" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span> million as of November 7, 2023 and December 31, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004825" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zsXhXjToTkUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_824_z8bVfPCGmR92">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PIPE
Notes and Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in Note 3 and Note 6, <span style="background-color: white">Data Knights issued and sold PIPE Notes in connection with the
Business Combination, which are convertible into shares of the Company&#8217;s Common Stock. Total proceeds raised from the PIPE Notes
were $<span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zqyuQVvSZ6xh" title="Related party proceeds"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-01-012023-12-31_custom_PIPENotesMember" id="Fact004827" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million, of which $<span id="xdx_901_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_znyIsT87tOd8" title="Related party proceeds"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_PIPENotesMember" id="Fact004829" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.0</ix:nonFraction></span> million were with related party investors. Refer to Note 3 and Note 6 for additional details on the
terms of the PIPE Notes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the issuance of the PIPE Notes, the Company also issued a total of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zd4nIU6zM2xj" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81075625" id="Fact004831" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">95,744</ix:nonFraction></span> shares of PIPE Warrants, of which <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zsSFb7AMlCYd" title="Warrants issued"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember" id="Fact004833" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,829</ix:nonFraction></span> shares
were issued to the same related party investors. Refer to Note 10 for additional details on the terms of the PIPE Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Promissory Notes and Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
2019 to 2023, the Company issued various Convertible Promissory Notes to related party investors. Total gross proceeds raised from Convertible
Promissory Notes with related parties was $<span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zMYiNMEsFLok" title="Gross proceeds from convertible promissory notes"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember" id="Fact004835" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">12.3</ix:nonFraction></span> million (out of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z9GTc5SDlPb2" title="Gross proceeds from convertible promissory notes"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember81075656" id="Fact004837" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">14.2</ix:nonFraction></span> million total). In connection with the issuance of the Convertible
Promissory Notes, the Company also issued <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteWarrantsMember_z3m9Ls9o7ft3" title="Number of shares issued"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember" id="Fact004839" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,976,000</ix:nonFraction></span> shares of Convertible Promissory Note Warrants to the same related parties (out of
<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConvertiblePromissoryNotesAndWarrantsMember_zNrDfrawjOL1" title="Number of warrants issued"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesAndWarrantsMember" id="Fact004841" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,726,000</ix:nonFraction></span> total). Refer to Note 6 and Note 10 for additional details on the terms of the Convertible Promissory Notes and Convertible
Promissory Note Warrants, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Closing of the Business Combination triggered the conversion of all Convertible Promissory Notes into shares of Common Stock of the Company,
as disclosed in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
Loans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
April 2023 to December 2023, the Company entered into shareholder loans with two related party investors (the &#8220;Shareholder Loans&#8221;)
for aggregate gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromLoans_pn3n3_c20230401__20231231_zB5USk2fmhKl" title="Loans payable"><ix:nonFraction name="us-gaap:ProceedsFromLoans" contextRef="From2023-04-012023-12-31" id="Fact004843" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">954</ix:nonFraction></span> thousand. The Shareholder Loans bear an interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20231231_zGLH05NCNbUe" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-12-31" id="Fact004845" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.0</ix:nonFraction></span>% and mature <span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dc_c20230401__20231231_zlG3K0VQUHhk" title="Debt term"><ix:nonNumeric contextRef="From2023-04-012023-12-31" format="ixt-sec:durwordsen" id="Fact004847" name="us-gaap:DebtInstrumentTerm">one year</ix:nonNumeric></span> after the commencement
date of each agreement. There are no financial or non-financial covenants associated with the Shareholder Loans. The Shareholder Loans
are not convertible into equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, in connection with the Business Combination, one of the Shareholder Loans for $<span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn5n6_c20231107__us-gaap--DebtInstrumentAxis__custom--ShareholderLoansMember_z8nK6Rw9ZgE9" title="Shareholder loan"><ix:nonFraction name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" contextRef="AsOf2023-11-07_custom_ShareholderLoansMember" id="Fact004849" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million was converted into a PIPE
Note equal to the amount of principal and interest outstanding at the time of Closing. The Company accounted for the exchange as an extinguishment
whereby the Shareholder Loan was written off and a separate PIPE Note was recorded at fair value, as disclosed in Note 6. The extinguishment
had no impact on the Company&#8217;s consolidated statement of operations for the year ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, a total of $<span id="xdx_903_ecustom--ProceedsFromIssuanceOfShareholderLoans_pn3n3_c20230101__20231231_zlPH2RzABGx7" title="Shareholder loans outstanding"><ix:nonFraction name="ONMD:ProceedsFromIssuanceOfShareholderLoans" contextRef="From2023-01-012023-12-31" id="Fact004851" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">454</ix:nonFraction></span> thousand of Shareholder Loans remains outstanding which is classified as loan &#8211; related party
on the consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Extensions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in Note 3, in connection with the Business Combination, the Company assumed Data Knights&#8217; liabilities, which included
existing loan extensions to related parties. The loan extensions were to be exchanged for a fixed amount of the Company&#8217;s Common
Stock upon the closing of a business combination or a similar event. As of December 31, 2023, a balance of $<span id="xdx_903_ecustom--LoanExtension_iI_pn5n6_c20231231_zYYxp7LkBjZ5" title="Loan extensions"><ix:nonFraction name="ONMD:LoanExtension" contextRef="AsOf2023-12-31" id="Fact004853" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.0</ix:nonFraction></span> million remains outstanding
and is recorded as loan extensions on the Company&#8217;s consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004855" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_807_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXYkCDbsfPyg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_826_zkxTMBMkPgV">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a month-to-month lease for a suite at a cost of $<span id="xdx_90D_eus-gaap--LeaseCost_c20230101__20231231_zpIm00S5UX23" title="Lease cost"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-01-012023-12-31" id="Fact004857" format="ixt:numdotdecimal" decimals="0" unitRef="USD">530</ix:nonFraction></span> per month. The Company incurred $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20230101__20231231_zB0D3imQifNd" title="Rent expenses"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-01-012023-12-31" id="Fact004859" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,695</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--PaymentsForRent_c20220101__20221231_zct23zrZB2va" title="Rent expenses"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2022-01-012022-12-31" id="Fact004861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,694</ix:nonFraction></span> of rent expense, including
common tenant costs and cancellation costs, during the years ended December 31, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Liabilities for loss
contingencies arising from claims, assessments, litigation, fines, penalties, and other sources are recognized, if and when it is
probable that a liability has been incurred and the amount can be reasonably estimated. The Company was not subject to any material
legal proceedings during the years ended December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-012023-12-31" escape="true" id="Fact004863" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zPBy6qAhhAna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_824_zTqWkPMINjKc">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events occurring through November 4, 2024, the date the consolidated financial statements were issued,
for events requiring recording or disclosure in the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Settlement
of Deferred Underwriting Fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024, through the date of this report, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__dei--LegalEntityAxis__custom--EFHuttonMember_zBftqySKYD17" title="Stock issued during period, shares, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_EFHuttonMember" id="Fact004865" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">256,944</ix:nonFraction></span> and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__dei--LegalEntityAxis__custom--KingwoodCapitalPartnersLLCMember_zAfDykodpXHe" title="Stock issued during period, shares, new issues"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember" id="Fact004867" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,834</ix:nonFraction></span> shares of Common Stock to EF Hutton LLC and Kingwood Capital
Partners, LLC, respectively, as consideration for $<span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--BusinessAcquisitionAxis__custom--KingwoodCapitalPartnersLLCMember_zo7ZtAxpXrZ4" title="Business combination, consideration underwriting commission"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember81076734" id="Fact004869" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">3.0</ix:nonFraction></span> million owed by the Company for underwriting commission due at the Closing of
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Repurchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024, through the date of this report, the Company bought back <span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodShares_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbxxIiqKyiQ2" title="Bought back shares of Common Stock"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember" id="Fact004871" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">187,745</ix:nonFraction></span> shares of Common Stock from a convertible note holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i>Shareholder Loans</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in">During
2024, through the date of this report, the Company received gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIVB1s45zjO7" title="Gross proceeds from related party loans"><ix:nonFraction name="us-gaap:ProceedsFromLoans" contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember" id="Fact004873" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million in connection with shareholder loans with
related party investors. Of the $<span id="xdx_90D_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zs9XWGdV7ft2" title="Gross proceeds from related party loans"><ix:nonFraction name="us-gaap:ProceedsFromLoans" contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember" id="Fact004875" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million, $<span id="xdx_908_eus-gaap--ConvertibleDebt_iI_pn5n6_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKkdBCFLQ73i" title="Loans converted into common stock"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember" id="Fact004877" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.6</ix:nonFraction></span> million is convertible into shares of Common Stock at a conversion price of
$<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdrlsXYPnNuj" title="Debt conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember" id="Fact004879" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.7535</ix:nonFraction></span> per share. The remaining $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGNe1qVqMNDf" title="Non convertible loans"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember" id="Fact004881" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.4</ix:nonFraction></span> million is not convertible into equity and bears an interest rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKwzmjr2xkbf" title="Business combination, consideration underwriting commission"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember" id="Fact004883" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.0</ix:nonFraction></span>% with a maturity date
one year from issuance. The Company subsequently repaid $<span id="xdx_908_eus-gaap--DebtInstrumentRepaidPrincipal_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zYDuQglPKcik" title="Non convertible loans repaid"><ix:nonFraction name="us-gaap:DebtInstrumentRepaidPrincipal" contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember" id="Fact004885" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.2</ix:nonFraction></span> million of the non-convertible shareholder loans through the date of
this report.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on April 2, 2024, on March 28, 2024, the Company <span style="background-color: white">entered
into a definitive securities purchase agreement (the &#8220;Helena SPA&#8221;) with Helena Global Investment Opportunities 1 Ltd. (&#8220;Helena&#8221;),
an affiliate of Helena Partners Inc., a Cayman-Islands based advisor and investor providing for up to $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxokvY670cSd" title="Proceeds form convertible notes"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember" id="Fact004887" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.5</ix:nonFraction></span></span> million <span style="background-color: white">in
funding through a private placement for the issuance of senior secured convertible notes (the &#8220;Helena Notes&#8221;). On June 14,
2024, the Company and Helena entered into a termination agreement (the &#8220;Helena Termination Agreement&#8221;) to terminate the Helena
SPA and related documents. Pursuant to the Helena Termination Agreement, the Company issued to Helena a warrant to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240614__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zCr5M7stk2Ne" title="Warrants outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-06-14_srt_ScenarioForecastMember" id="Fact004889" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000</ix:nonFraction></span> shares
of Common Stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240614__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvUkTrj6JmB" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-06-14_srt_ScenarioForecastMember" id="Fact004891" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.20</ix:nonFraction></span> per share and agreed to reimburse Helena for certain reasonable and documented out-of-pocket
legal fees and expenses incurred in connection with entry into the Helena SPA and Helena Termination Agreement and related documents.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 23, 2024 and July 25, 2024, the Company entered into securities purchase agreements (the &#8220;Securities Purchase Agreements&#8221;)
with certain institutional investors in connection with the private placement of its Common Stock and pre-funded warrants with aggregate
gross proceeds of approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240723__20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zX7izELbJGS7" title="Proceeds form private placement"><span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240725__20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zp6qxt2VR9Eb" title="Proceeds form private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-07-232024-07-23_srt_ScenarioForecastMember" id="Fact004893" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-07-252024-07-25_srt_ScenarioForecastMember" id="Fact004895" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">4.6</ix:nonFraction></ix:nonFraction></span></span> million, before deducting fees and expenses payable by the Company. The Company intends to use the
net proceeds for working capital and general corporate purposes. Pending use of the funds, the Company used a portion of the net proceeds
to purchase Bitcoin ($BTC). There is no guarantee on the holding period for the purchased Bitcoin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Securities Purchase Agreements, the Company agreed to issue and sell to the investors <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240723__20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z8wqyx1MpH5g" title="Shares issued"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240725__20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zAdDFfpgPsnk" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-232024-07-23_srt_ScenarioForecastMember" id="Fact004897" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-07-252024-07-25_srt_ScenarioForecastMember" id="Fact004899" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,297,059</ix:nonFraction></ix:nonFraction></span></span> shares of its Common Stock at
a price of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zAVN7FBPZ893" title="Share price"><span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zsYZ31Cls7d4" title="Share price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-07-23_srt_ScenarioForecastMember" id="Fact004901" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-07-25_srt_ScenarioForecastMember" id="Fact004903" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.0278</ix:nonFraction></ix:nonFraction></span></span> per share, pre-funded warrants exercisable for <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvawEyY9i0li" title="Warrants outstanding"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z1wKcfgBP8wg" title="Warrants outstanding"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-07-23_srt_ScenarioForecastMember" id="Fact004905" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:WarrantsAndRightsOutstanding" contextRef="AsOf2024-07-25_srt_ScenarioForecastMember" id="Fact004907" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,323,530</ix:nonFraction></ix:nonFraction></span></span> shares of its Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zNZCzUTb3Mzg" title="Warrant exercise price"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zQKuNYG6xlMl" title="Warrant exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-07-23_srt_ScenarioForecastMember" id="Fact004909" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-07-25_srt_ScenarioForecastMember" id="Fact004911" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.0278</ix:nonFraction></ix:nonFraction></span></span>
per share, and <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zN3OKGGh6yz3" title="Shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zijLi9OYJpd6" title="Shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-07-23_srt_ScenarioForecastMember" id="Fact004913" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-07-25_srt_ScenarioForecastMember" id="Fact004915" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,301,791</ix:nonFraction></ix:nonFraction></span></span> shares of its Common Stock at a price of $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zgzy8ikCO8Zd" title="Share price"><span id="xdx_90C_eus-gaap--SharePrice_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zWYLOicPMrF1" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-07-23_srt_ScenarioForecastMember" id="Fact004917" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-07-25_srt_ScenarioForecastMember" id="Fact004919" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.85</ix:nonFraction></ix:nonFraction></span></span> per share. The investors were required to prepay the exercise
price for the pre-funded warrants, other than $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zf3RXXknyvib" title="Share price"><span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYMgyXWVTMna" title="Share price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-07-23_srt_ScenarioForecastMember" id="Fact004921" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-07-25_srt_ScenarioForecastMember" id="Fact004923" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> per share. The pre-funded warrants will be exercisable at any time after the date
of issuance and will not expire. The price per share of all Common Stock and pre-funded warrants sold in the private placement meets
the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued to institutional accredited investors in
a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
September 24, 2024, the Company entered into securities purchase agreements (the &#8220;Follow-on SPA&#8221;) with an institutional investor
in connection with the private placement of its Common Stock, warrants and pre-funded warrants with aggregate gross proceeds of approximately
$<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240924__20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zSTxumnw4BQi" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-09-242024-09-24_srt_ScenarioForecastMember" id="Fact004925" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.7</ix:nonFraction></span> million, before deducting fees and expenses payable by the Company. The Company intends to use the net proceeds from the Private
Placement for working capital and general corporate purposes. Pending use of the funds, the Company plans to use a portion of the net
proceeds to purchase Bitcoin ($BTC).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Follow-on SPA, the Company agreed to issue and sell to the investor <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240924__20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGc3RjPunQWk" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-09-242024-09-24_srt_ScenarioForecastMember" id="Fact004927" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,918,591</ix:nonFraction></span> shares of its Common Stock at a price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z1gcZAEZr328" title="Sale of share price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-09-24_srt_ScenarioForecastMember" id="Fact004929" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.65</ix:nonFraction></span> per
share, warrants exercisable for <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdNWhpB7bqAd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_us-gaap_WarrantMember" id="Fact004931" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,095</ix:nonFraction></span> shares of its Common Stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zU08lBCI29Gk" title="Share price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_us-gaap_WarrantMember" id="Fact004933" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.325</ix:nonFraction></span> per share and pre-funded warrants exercisable
for <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zsCkIckSPkAd" title="Warrants exercisable"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember" id="Fact004935" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">743,314</ix:nonFraction></span> shares of its Common Stock at an exercise price of <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGLNeMTAVWU9" title="Warrant exercise price">$<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember" id="Fact004937" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.65</ix:nonFraction></span> per share. The investor was required to prepay the exercise price
for the pre-funded warrants, other than $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zUeqEEafWzPj" title="Share issued price"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember" id="Fact004939" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share. The warrants and pre-funded warrants will be exercisable at any time after
the date of issuance and will not expire. The price per share of all Common Stock and pre-funded warrants sold in the private placement
meets the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued to institutional accredited investors
in a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Standby
Equity Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company entered into a standby equity purchase agreement (the &#8220;SEPA&#8221;) with YA II PN, LTD, a Cayman Islands
exempt limited partnership managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;). Pursuant to the SEPA, subject to certain
conditions, the Company has the option to sell to Yorkville an aggregate amount of up to up to $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_za5ulDzBSSyb" title="Proceeds from issuance of common stock"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember" id="Fact004941" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">25.0</ix:nonFraction></span> million of the Company&#8217;s shares
of Common Stock at the Company&#8217;s request from time to time following both the repayment of the Promissory Note described below
and the effectiveness of a resale registration statement covering the shares of Common Stock issued under the SEPA. The SEPA terminates
on its 24-month anniversary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--EquityPurchaseAgreementDescription_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYAq5pWfzSrh" title="Equity purchase agreement description"><ix:nonNumeric contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember" id="Fact004943" name="ONMD:EquityPurchaseAgreementDescription">Each
advance may not exceed the greater of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zHQhy3JzpGG" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember" id="Fact004945" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> shares and 100% of the average daily volume traded of the Common Stock during the five
trading days immediately prior to requested advance. The shares would be purchased at a price equal to 97% of the Market Price as defined
in the SEPA. The Company may establish a minimum acceptable price in each advance below which the Company will not be obligated to make
any sales to Yorkville</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
purchase under an advance would be subject to certain limitations, including that Yorkville will not purchase or acquire any shares that
would result in it and its affiliates beneficially owning more than <span id="xdx_906_ecustom--ShareOutstandingVotingPercentage_dp_uPure_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zBBpmClKZkqd" title="Shares outstanding voting percentage"><ix:nonFraction name="ONMD:ShareOutstandingVotingPercentage" contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember" id="Fact004947" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.99</ix:nonFraction></span>% of the then outstanding voting power or number of shares of
Common Stock or any shares that when aggregated with shares issued under all other earlier advances, would exceed <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zSIkTYfZ2dKl" title="Shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-06-17_srt_ScenarioForecastMember" id="Fact004949" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,767,616</ix:nonFraction></span> shares of
Common Stock (representing <span id="xdx_90A_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_dp_uPure_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zZxGWmk9dCx6" title="Sale of stock percentage"><ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember" id="Fact004951" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.99</ix:nonFraction></span>% of the aggregate number of then outstanding shares of Common Stock) (the &#8220;Exchange Cap&#8221;)
unless shareholders approved issuances in excess of the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the execution of the SEPA, the Company paid a $<span id="xdx_90B_eus-gaap--LoanProcessingFee_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqS8XQiua3Q6" title="Structuring fees"><ix:nonFraction name="us-gaap:LoanProcessingFee" contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember" id="Fact004953" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> structuring fee to Yorkville. The Company agreed to pay a commitment
fee of $<span id="xdx_905_eus-gaap--PaymentForManagementFee_pn5n6_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zn0k3FaPCwv1" title="Commitment fees"><ix:nonFraction name="us-gaap:PaymentForManagementFee" contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember" id="Fact004955" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">0.5</ix:nonFraction></span> million to Yorkville, which will be paid in shares in two tranches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
Yorkville agreed to advance to the Company, in exchange for a convertible promissory note (the &#8220;Yorkville Promissory Note&#8221;),
a principal amount of $<span id="xdx_907_eus-gaap--LoansPayable_iI_pn5n6_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z0SPG43PmNoc" title="Principal amount"><ix:nonFraction name="us-gaap:LoansPayable" contextRef="AsOf2024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember" id="Fact004957" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million, which was funded on June 18, 2024. <span id="xdx_904_eus-gaap--DebtInstrumentDescription_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z2KdxXcCgXl8" title="Debt instrument description"><ix:nonNumeric contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember" id="Fact004959" name="us-gaap:DebtInstrumentDescription">The Yorkville Promissory Note is due on June 18, 2025, and interest shall accrue at an annual rate equal to 0%, subject to an increase to 18% upon an event of default as described in the Yorkville Promissory Note.</ix:nonNumeric> </span>The Yorkville Promissory Note will be convertible by Yorkville into shares of Common Stock at an aggregate purchase price based
on a price per share equal to the lower of <span id="xdx_90A_eus-gaap--DerivativeDescriptionOfTerms_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zsT4HGZdcNOe" title="Description of promissory note"><ix:nonNumeric contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember" id="Fact004961" name="us-gaap:DerivativeDescriptionOfTerms">(a) $1.3408 per share (subject to downward reset upon the filing of the resale registration
statement described below) or (b) 90% of the lowest daily VWAP of the Common Stock on Nasdaq during the seven trading days immediately
prior to each conversion (the &#8220;Variable Price&#8221;), but which Variable Price may not be lower than the Floor Price then in effect</ix:nonNumeric></span>.
The &#8220;Floor Price&#8221; is $<span id="xdx_90E_eus-gaap--DerivativeFloorPrice_iI_pid_uUSDPShares_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zRdng1nVbrFk" title="Floor price"><ix:nonFraction name="us-gaap:DerivativeFloorPrice" contextRef="AsOf2024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember" id="Fact004963" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.28</ix:nonFraction></span> per share, subject to the Company&#8217;s option to reduce the Floor Price to any amounts set
forth in a written notice to Yorkville. While the Promissory Note is outstanding, Yorkville may initiate an investor advance under the
SEPA at the Promissory Note conversion price, the proceeds of which would be used to repay the Yorkville Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Yorkville Promissory Note may be accelerated by Yorkville upon specified events of default, and may become amortizable for cash if (i)
the daily VWAP is less than the Floor Price for five trading days during a period of seven consecutive trading days, (ii) the Company
has issued in excess of 95% of the shares of Common Stock available under the Exchange Cap or (iii) the Company is in material breach
of its obligations under a Registration Rights Agreement it entered into with Yorkville in connection with the SEPA or Yorkville becomes
limited in its ability to freely resell shares subject to an advance as further described in the Yorkville Promissory Note, subject to
de-amortization after certain cures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 145; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Letter</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
October 8, 2024, Yorkville sent the Company a letter notifying the Company that it had breached a registration rights agreement with
Yorkville by failing to file a Registration Statement on Form S-1 on the timeline set forth in the registration rights agreement (the
&#8220;Yorkville Letter&#8221;). The Yorkville Letter asserted that this breach was an event of default and an amortization event under
the prepaid advance in connection with SEPA. The Yorkville Letter also asserted that the Company&#8217;s failure to timely file its Quarterly
Report on Form 10-Q for the fiscal quarter ended June 30, 2024 was an event of default under the Yorkville Promissory Note. The Company
subsequently engaged in discussions with Yorkville regarding the Yorkville Letter, which discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Yorkville Promissory Note, upon the occurrence of an amortization event, the Company is required to pay all principal and accrued
interest on the Yorkville Promissory Note, plus a 10% payment premium on the principal amount, in equal installments over 3 calendar
months or until the amortization event is cured, whichever is earlier. In addition, upon the occurrence of an event of default, the interest
rate on the Yorkville Promissory Note increases to 18% retroactive to the date of the event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Executive
Turnover</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on April 2, 2024, on March 22, 2024, Paul J. Casey notified the
Company of his intention to retire as Chief Executive Officer of the Company effective March 29, 2024. Mr. Casey continued to serve as
a member of the Board of Directors until October 1, 2024. In connection with Mr. Casey&#8217;s retirement from the Company, Mr. Casey
and the Company entered into a Resignation Agreement and Release, dated March 22, 2024, pursuant to which Mr. Casey was paid $<span id="xdx_904_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240322__20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zGcIbdExzlSg" title="Monthly shares"><ix:nonFraction name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" contextRef="From2024-03-222024-03-22_us-gaap_SubsequentEventMember" id="Fact004965" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></span>
as a severance payment, and the Board of Directors approved a stock option grant providing for the grant of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240322__20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUBl9VGx7qbe" title="Shares exerciseable"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-222024-03-22_us-gaap_SubsequentEventMember" id="Fact004967" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">147,000</ix:nonFraction></span> five-year options
exercisable at $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrAvHy9n9e61" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-03-22_us-gaap_SubsequentEventMember" id="Fact004969" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1.00</ix:nonFraction></span> per share to Mr. Casey. On March 27, 2024, Scott Holbrook, a member of the Board of Directors and a member of the
Company&#8217;s Audit Committee, notified the Company of his intention to retire from the Company&#8217;s Board of Directors effective
March 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 29, 2024, the Board of Directors (i) appointed Aaron Green to serve as Chief Executive Officer of the Company to fill the vacancy
created by the retirement of Paul Casey; (ii) appointed Mr. Green, to serve as a member of the Board of Directors to fill the vacancy
created by the retirement of Scott Holbrook; and (iii) appointed Dr. Thomas Kosasa, a member of the Board of Directors, to serve on the
Company&#8217;s Audit Committee, also to fill the vacancy created by the retirement of Scott Holbrook.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on Form 8-K, on August 26, 2024, Lisa Embree, Chief Financial Officer (&#8220;CFO&#8221;), Executive Vice President,
Treasurer and Secretary, notified the Company of her intention to resign from her position effective August 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
August 30, 2024, the Board appointed Mr. Robert Golden to serve as the Chief Financial Officer on an interim basis to fill the vacancy
created by the resignation of Lisa Embree. Effective on his appointment as interim CFO, Mr. Golden stepped down as a member and the chair
of the Audit Committee of the Board. In connection with his appointment as interim CFO, the Company entered into a consulting agreement
with Mr. Golden, pursuant to which Mr. Golden will receive a $<span id="xdx_908_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240830__20240830__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqix75530DOa" title="Monthly shares"><ix:nonFraction name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" contextRef="From2024-08-302024-08-30_srt_ScenarioForecastMember" id="Fact004971" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></span> monthly salary and a grant of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20240830__20240830__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvOQfNAEF0Fb" title="Restricted stock units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2024-08-302024-08-30_srt_ScenarioForecastMember" id="Fact004973" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span> restricted stock units, which
will vest on the first anniversary of the consulting agreement, subject to the terms and conditions set forth in the consulting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on October 8, 2024, on October 1, 2024, Paul J. Casey and Erkan
Akyuz resigned from the Board, effective immediately. Also on October 1, 2024, the Board of Directors appointed Jair Clarke and Sherry
Coonse McCraw to the Board to fill the vacancies created by Mr. Casey and Mr. Akyuz, respectively. In connection with Ms. Coonse McCraw
and Mr. Clarke&#8217;s service on the Advisory Board of the Company, the Board of Directors approved a restricted stock unit (&#8220;RSU&#8221;)
grant providing for the grant of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20241001__srt--StatementScenarioAxis__srt--ScenarioForecastMember_ztmeWu91wV0c" title="Restricted stock units issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" contextRef="AsOf2024-10-01_srt_ScenarioForecastMember" id="Fact004975" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,000</ix:nonFraction></span> RSUs to each director for one full year of service (pro-rated for 2024). The RSUs will vest at
the end of December 2024.</span></p>

</ix:nonNumeric><p id="xdx_81A_zUDm587Eyfwd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p id="xdx_04D_z1jMZGhqelLa" style="font: 10pt Times New Roman, Times, Serif; display: none; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 146; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_021"></span>PART
II&#8212;INFORMATION NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
13. Other Expenses of Issuance and Distribution</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth all expenses, other than underwriting discounts and commissions, payable by the registrant in connection with
the offering of the securities being registered. All the amounts shown are estimates except the SEC registration fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    to be paid</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC
    registration fee</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,560</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal
    fees and expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printing
    and engraving expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="margin: 0">Miscellaneous</p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">175,560</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
14. Indemnification of Directors and Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
102 of the General Corporation Law of the State of Delaware (the &#8220;<span style="text-decoration: underline">DGCL</span>&#8221;) permits a corporation to eliminate the personal
liability of directors and officers of a corporation to the corporation or its stockholders for monetary damages for a breach
of fiduciary duty as a director or officer, except where the director or officer breached his or her duty of loyalty,
failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved
a stock repurchase in violation of the DGCL or obtained an improper personal benefit or, in the case of an officer, in an action
by or in the right of the corporation. Our Certificate of Incorporation provides that no director of the Company shall be personally
liable to it or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of
law imposing such liability, except to the extent that the DGCL prohibits the elimination or limitation of liability of directors for
breaches of fiduciary duty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL provides that a corporation has the power to indemnify a director, officer, employee, or agent of the corporation, or
a person serving at the request of the corporation for another corporation, partnership, joint venture, trust or other enterprise in
related capacities against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably
incurred by the person in connection with an action, suit or proceeding to which such person was or is a party or is threatened
to be made a party to any threatened, pending or completed action, suit or proceeding by reason of such position, if such person
acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the corporation,
and, in any criminal action or proceeding, had no reasonable cause to believe such person&#8217;s conduct was unlawful, except
that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim,
issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the
Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances
of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court
shall deem proper.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 147; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation and Bylaws provide that we will indemnify each person who was or is a party or threatened to be made
a party to any threatened, pending or completed action, suit or proceeding (other than an action by or in the right of us to procure
a judgment in our favor) by reason of the fact that such person is or was, or has agreed to become, a director or officer,
or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar
capacity with, another corporation, partnership, joint venture, trust or other enterprise (all such persons being referred to as an &#8220;<span style="text-decoration: underline">Indemnitee</span>&#8221;),
or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees),
judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding and
any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to,
our best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct
was unlawful, except that no indemnification shall be made with respect to any claim, issue or matter as to which such Indemnitee
shall have been adjudged to be liable to us, unless a court determines that, despite such adjudication but in view of all of the
circumstances, such Indemnitee is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that
any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by us against all expenses (including attorneys&#8217;
fees) actually and reasonably incurred in connection therewith. Expenses must be advanced to an Indemnitee under certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into separate indemnification agreements with each of our directors and executive officers. Each indemnification agreement
provides, among other things, for indemnification to the fullest extent permitted by law and our Certificate of Incorporation
and Bylaws against any and all expenses, judgments, fines, penalties and amounts paid in settlement of any claim. The indemnification
agreements provide for the advancement or payment of all expenses to the indemnitee and for the reimbursement to us if it is found that
such indemnitee is not entitled to such indemnification under applicable law and our Certificate of Incorporation and Bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also have a general liability insurance policy that covers certain liabilities of directors and officers of our corporation arising out
of claims based on acts or omissions in their capacities as directors or officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
15. Recent Sales of Unregistered Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pre-Closing
PIPE</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2023, Data Knights entered into the Pre-Closing PIPE SPA with the Pre-Closing PIPE Investors in connection with a
PIPE financing in the aggregate original principal amount of $1,595,744.70 and a purchase price of $1.5 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
immediately prior to the closing of the Pre-Closing PIPE on September 7, 2023, as provided under the Pre-Closing PIPE SPA,
the Company issued and sold to each of the Pre-Closing PIPE Investors the Pre-Closing PIPE Notes, a new series of senior secured
convertible notes, which are convertible into shares of Common Stock at the Pre-Closing PIPE Investors election at a conversion
price equal to the lower of (i) $10.00 per share, and (ii) 92.5% of the lowest volume weighted average trading price for the ten (10)
Trading Days (defined as a day on which the Common Stock is traded on a trading market) immediately preceding the Conversion Date
(defined as any date). We deemed the offer, sale and issuance of such securities to be exempt from registration under the Securities
Act in reliance on Section 4(a)(2) of the Securities Act, including Regulation D and Rule 506 promulgated thereunder, relative
to transactions by an issuer not involving a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i>Helena Termination Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described elsewhere in this prospectus, on March 28, 2024, the Company entered into the Helena SPA with Helena, which provided for up
to $4.54 million in funding through a private placement for the issuance of senior secured convertible notes. On June 14, 2024, the Company
and Helena entered into the Helena Termination Agreement to terminate the Helena SPA and related documents. Pursuant to the Helena Termination
Agreement, the Company issued to Helena a warrant to purchase 50,000 shares of Common Stock at an exercise price of $1.20 per share and
agreed to reimburse Helena for certain reasonable and documented out-of-pocket legal fees and expenses incurred in connection with entry
into the Helena SPA and Helena Termination Agreement and related documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 148; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i>OTC and Discovery PIPEs</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 23, 2024 and July 25, 2024, the Company entered into the OTC PIPE SPA and the Discovery PIPE SPA, respectively in connection with
the private placement of its Common Stock and pre-funded warrants with aggregate gross proceeds of approximately $4.6 million, before
deducting fees and expenses payable by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the OTC PIPE SPA, the Company agreed to issue and sell to OTC 1,297,059 shares of its Common Stock at a price of $1.0278 per share
and pre-funded warrants exercisable for 1,323,530 shares of its Common Stock at an exercise price of $1.0278 per share. Pursuant to the
Discovery PIPE SPA, the Company agreed to issue and sell to Discovery 2,301,791 shares of its Common Stock at a price of $0.85 per share.
The investors were required to prepay the exercise price for the pre-funded warrants, other than $0.0001 per share. The pre-funded warrants
will be exercisable at any time after the date of issuance and will not expire. The price per share of all Common Stock and pre-funded
warrants sold in the private placement meets the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued
to institutional accredited investors in a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 24, 2024, the Company entered into the OTC Follow-On PIPE SPA in connection with the private placement of its Common Stock,
warrants and pre-funded warrants with aggregate gross proceeds of approximately $1.7 million, before deducting fees and expenses payable
by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the OTC Follow-On PIPE SPA, the Company agreed to issue and sell to the investor 1,473,696 shares of its Common Stock at a price of
$0.65 per share, warrants exercisable for 133,095 shares of its Common Stock at an exercise price of $0.325 per share and pre-funded
warrants exercisable for 1,188,209 shares of its Common Stock at an exercise price of $0.65 per share. OTC was required to prepay the exercise
price for the pre-funded warrants, other than $0.0001 per share. The warrants and pre-funded warrants will be exercisable at any time
after the date of issuance and will not expire. The price per share of all Common Stock and pre-funded warrants sold in the private placement
meets the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued to an institutional accredited investor
in a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 149; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
16. Exhibits and Financial Statement Schedules</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The following exhibits are filed as part of
this registration statement:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="Va_006"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of Document</b></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000110465922049684/tm2213454d1_ex2-1.htm" style="-sec-extract: exhibit">Agreement
    and Plan of Merger, dated April 25, 2022, by and among Data Knights, Merger Sub, Sponsor, OneMedNet, and Paul Casey (incorporated
    by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K filed with the SEC on April 25, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">3.1</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315223040642/ex3-1.htm" style="-sec-extract: exhibit">Third Amended and Restated Certificate of Incorporation of OneMedNet Corporation (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Form 8-K, filed with the SEC on November 13, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">3.2</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315223040642/ex3-2.htm" style="-sec-extract: exhibit">Amended and Restated Bylaws of OneMedNet Corporation (incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on November 13, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">4.1</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex4-1.htm" style="-sec-extract: exhibit">Warrant Agreement, dated May 6, 2021, by and between the Company and Continental Stock Transfer &amp; Trust Company (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021).</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">4.2</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921047461/tm218584d2_ex4-3.htm" style="-sec-extract: exhibit">Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Company&#8217;s Form S-1/A, filed with the SEC on April 7, 2021).</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">4.3</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224029420/ex4-1.htm" style="-sec-extract: exhibit">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on July 29, 2024).</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">4.4</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224038855/ex4-1.htm" style="-sec-extract: exhibit">Form of Warrant (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on October 1, 2024).</a></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">4.5</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224038855/ex4-2.htm" style="-sec-extract: exhibit">Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on October 1, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">4.6*</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex4-6.htm">Form of Amendment to Pre-Funded Warrant<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1&#167;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of Perkins Coie LLP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">10.1</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315223040642/ex10-11.htm" style="-sec-extract: exhibit">Securities Purchase Agreement dated June 28, 2023 with OneMedNet Corporation (incorporated by reference to Exhibit 10.11 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on November 13, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000110465921064666/tm218584d10_ex10-1.htm" style="-sec-extract: exhibit">Letter Agreement, dated May 6, 2021, by and between Data Knights, the initial security holders and the officers and directors of the Data Knights (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 8-K, filed with the SEC on May 11, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000110465923102862/tm2220656-34_s4a.htm#tANND" style="-sec-extract: exhibit">Form of OneMedNet Corporation 2022 Equity Incentive Plan (incorporated by reference to Annex D to the proxy statement/prospectus which is part of the Registration Statement on Form S-4 declared effective by the SEC on September 22, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000110465923102862/tm2220656-34_s4a.htm#tANNB" style="-sec-extract: exhibit">Form of Registration Rights Agreement by certain OneMedNet equity holders (incorporated by reference to Exhibit G to Annex B to the proxy statement/prospectus which is part of the Registration Statement on Form S-4 declared effective by the SEC on September 22, 2023).</a></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 150; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000110465923102862/tm2220656-34_s4a.htm#tANNB" style="-sec-extract: exhibit">Lockup Agreement by certain OneMedNet equity holders (incorporated by reference to Exhibit C to Annex B to the proxy statement/prospectus which is part of the Registration Statement on Form S-4 declared effective by the SEC on September 22, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315223040642/ex10-8.htm" style="-sec-extract: exhibit">Employment Agreement between OneMedNet Corporation and Aaron Green, President (incorporated by reference to Exhibit 10.8 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on November 13, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315223040642/ex10-9.htm" style="-sec-extract: exhibit">Employment Agreement between OneMedNet Corporation and Lisa Embree, Chief Financial Officer (incorporated by reference to Exhibit 10.09 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on November 13, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315223040642/ex10-10.htm" style="-sec-extract: exhibit">Employment Agreement between OneMedNet Corporation and Paul Casey, Chief Executive Officer (incorporated by reference to Exhibit 10.10 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on November 13, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224012826/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement entered into as of March 28, 2024, by and between OneMedNet Corporation and each investor identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on April 2, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224012826/ex10-2.htm" style="-sec-extract: exhibit">Registration Rights Agreement dated as of March 28, 2024, by and among OneMedNet Corporation and each of the investors to the Securities Purchase Agreement (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on April 2, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224012826/ex10-3.htm" style="-sec-extract: exhibit">Subscription Escrow Agreement effective March 28, 2024, by and among OneMedNet Corporation, each investor identified on the signature pages thereto, and Rimon, P.C., as the Escrow Agent (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on April 2, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224022951/ex10-1.htm" style="-sec-extract: exhibit">Amendment to the Securities Purchase Agreement, effective as of June 4, 2024, between OneMedNet Corporation and each investor identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on June 6, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224024802/ex10-4.htm" style="-sec-extract: exhibit">Termination Agreement, dated as of June 14, 2024, between OneMedNet Corporation and Helena Global Investment Opportunities 1 Ltd. (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on June 21, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224024802/ex10-1.htm" style="-sec-extract: exhibit">Standby Equity Purchase Agreement, dated as of June 17, 2024, by and between OneMedNet Corporation and YA II PN, LTD. (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on June 21, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224024802/ex10-2.htm" style="-sec-extract: exhibit">Promissory Note, dated as of June 18, 2024, issued by OneMedNet Corporation to YA II PN, LTD. (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on June 21, 2024).</a></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224024802/ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated as of June 17, 2024, by and between OneMedNet Corporation and YA II PN, LTD. (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on June 21, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224029420/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on July 29, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224029420/ex10-2.htm" style="-sec-extract: exhibit">Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on July 29, 2024).</a></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224029420/ex10-3.htm" style="-sec-extract: exhibit">Form of Voting Agreement (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on July 29, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224034629/ex10-1.htm" style="-sec-extract: exhibit">Consulting Agreement, dated August 30, 2024, between OneMedNet Corporation and Robert Golden (incorporated by reference to Exhibit 10.1 the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on August 30, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.21</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="margin: 0"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224038855/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on October 1, 2024).</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">10.22</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="margin: 0"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224038855/ex10-2.htm" style="-sec-extract: exhibit">Form of Amendment to Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on October 1, 2024).</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.23</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="margin: 0"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224038855/ex10-3.htm" style="-sec-extract: exhibit">Form of Amendment to Voting Agreement (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on October 1, 2024).</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.24*</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex10-24.htm">Form of Amendment to Securities Purchase Agreement.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.25*</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex10-25.htm">Form of Registration Rights Agreement.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">21.1</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="margin: 0"><a href="https://www.sec.gov/Archives/edgar/data/1849380/000149315224014092/ex21.htm" style="-sec-extract: exhibit">Subsidiaries of the Registrant (incorporated by reference to Exhibit 21 to the Registrant&#8217;s Annual Report on Form 10-K filed with the SEC on April 9, 2024).</a></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><a href="ex23-1.htm">Consent of Withum Smith+Brown, PC.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><p style="margin: 0">23.2&#167;</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><p style="margin: 0">Consent of
                                            Perkins Coie LLP (included in Exhibit 5.1).</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">24.1*</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="#Ka_001">Power of Attorney (included on signature page hereto).</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">107*</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex107.htm">Filing Fee Table</a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Filed herewith.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#167;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">To be filed by amendment.</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
    a management or compensatory plan.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
    to this exhibit have been omitted pursuant to Item 601(b)(2) of Registration S-K. The Registrant hereby agrees to furnish a copy
    of any omitted schedules to the SEC upon request.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 151; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
17. Undertakings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    include any prospectus required by section 10(a)(3) of the Securities Act of 1933;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
    post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
    forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
    the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
    of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
    if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set
    forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                            include any material information with respect to the plan of distribution not previously
                                            disclosed in the registration statement or any material change to such information in the
                                            registration statement;</span></p>
                                                         <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
                                                         <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided, however, that paragraphs (i), (ii) and (iii) do not apply if the registration statement is on Form S-1 and the information required
to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by
the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the
registration statement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
    to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
    be deemed to be the initial <i>bona fide</i> offering thereof.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
    termination of the offering.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That,
    for the purpose of determining liability under the Securities Act of 1933 to any purchaser: each prospectus filed pursuant to Rule
    424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other
    than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of
    the date it is first used after effectiveness. <i>Provided, however</i>, that no statement made in a registration statement or prospectus
    that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
    statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
    to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the
    registration statement or made in any such document immediately prior to such date of first use; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:</span></p>
                                                                              <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                                              <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
    424;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
    the undersigned registrant;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
    or its securities provided by or on behalf of the undersigned registrant; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
    other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
    as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
    persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
    of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933
    and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment
    by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense
    of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities
    being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent,
    submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed
    in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>


<!-- Field: Page; Sequence: 152; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="Va_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement on Form S-1
to be signed on its behalf by the undersigned, thereunto duly authorized on January 31, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ONEMEDNET
    CORPORATION</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Aaron Green</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Green</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief
    Executive Officer, President and Director</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="Ka_001"></span><b>POWER OF ATTORNEY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Aaron Green and Robert Golden,
his or her true and lawful attorney-in-fact and agent with full power of substitution and re-substitution, for him or her and in his
or her name, place and stead, in any and all capacities to sign any or all amendments (including, without limitation, post-effective
amendments) to this Registration Statement, any related Registration Statement filed pursuant to Rule 462(b) under the Securities Act
of 1933, as amended, and any or all pre- or post-effective amendments thereto, and to file the same, with all exhibits thereto, and all
other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent,
full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises,
as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that said attorney-in-fact
and agent, or any substitute or substitutes for him, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements
of the Securities Act of 1933, as amended, the following persons in the capacities and on the dates indicated have signed this Registration
Statement below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-1 has been signed by the following
persons in the capacities and on the dates indicated below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 35%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 19%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Aaron Green</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer, President and Director</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Green</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Robert Golden</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">Robert Golden</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer and Principal Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    <span style="letter-spacing: 0.2pt">Dr. Jeffrey Yu</span></i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">Chairman
    of the Board of Directors, Founder, Chief Medical Officer, Vice President</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt"><i>Dr.
    Jeffrey Yu</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    <span style="letter-spacing: 0.2pt">Eric Casaburi</span></i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">Eric
    Casaburi</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    <span style="letter-spacing: 0.2pt">Jair Clarke</span></i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><p style="margin: 0">January
                                            31, 2025</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">Jair
    Clarke</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    <span style="letter-spacing: 0.2pt">Sherry Coonse McCraw</span></i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">Sherry
    Coonse McCraw</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    <span style="letter-spacing: 0.2pt">Dr. Thomas Kosasa</span></i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">Dr.
    Thomas Kosasa</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt"><i>/s/
    Andrew Zeinfeld</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: 0.2pt">Andrew
    Zeinfeld</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Page; Sequence: 153; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.6
<SEQUENCE>2
<FILENAME>ex4-6.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.6</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
TO PRE-FUNDED WARRANT<BR>
TO PURCHASE SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Amendment to Pre-Funded Warrant to Purchase Shares of Common Stock (this &ldquo;<B><I>Amendment</I></B>&rdquo;) is made as of January
__, 2025 and effective as of September 24, 2024, by and between OneMedNet Corporation (the &ldquo;<B><I>Company</I></B>&rdquo;) and Off
the Chain, LP (the &ldquo;<B><I>Investor</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RECITALS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company issued to the Investor a Pre-Funded Warrant to Purchase Shares of Common Stock with an original issuance date of September
24, 2024 (the &ldquo;<B><I>Pre-Funded Warrant</I></B>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company and the Investor desire to amend the Pre-Funded Warrant as set forth in this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing recitals and the mutual promises set forth in this Amendment, and for other good and valuable
consideration (the receipt and sufficiency of which are hereby acknowledged), the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Capitalized Terms</U>. Capitalized terms not defined in this Amendment shall have the respective meanings given in the Pre-Funded
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Amendments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.
The Warrant Shares line appearing on the cover page of the Pre-Funded Warrant shall be amended and restated as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares: _________ </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.
The recitals paragraph of the Pre-Funded Warrant shall be amended by replacing the reference to &ldquo;up to 743,314 shares of common
stock&rdquo; with &ldquo;up to 1,188,209 shares of common stock.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.
Section 1 of the Pre-Funded Warrant shall be amended and restated as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement, dated September 24, 2024, by and between the Company and Off the Chain, LP, as amended by Amendment to Securities
Purchase Agreement, dated as of January 21, 2025 and effective as of September 24, 2024 (as so amended, the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Full Force and Effect</U>. Except as expressly amended hereby, all other terms of the Pre-Funded Warrant shall continue in full force
and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Governing Law</U>. This Amendment shall be governed by the internal law of the State of Delaware, without regard to conflict of law
principles that would result in the application of any law other than the law of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Counterparts</U>. This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including
pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page Follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Amendment to Pre-Funded Warrant as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>COMPANY</B>:</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ONEMEDNET CORPORATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron Green</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><B>INVESTOR</B>:</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 5%">&nbsp;</TD>
  <TD STYLE="width: 45%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD COLSPAN="2"><B>OFF THE CHAIN, LP</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Name:</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>Title:</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page to Amendment to Pre-Funded Warrant - OTC]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>3
<FILENAME>ex10-24.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.24</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
TO SECURITIES PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Amendment to Securities Purchase Agreement (this &ldquo;<B><I>Amendment</I></B>&rdquo;) is made as of January __, 2025 and effective
as of September 24, 2024, by and between OneMedNet Corporation (the &ldquo;<B><I>Company</I></B>&rdquo;) and Off the Chain, LP (the &ldquo;<B><I>Investor</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RECITALS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company and the Investor entered into a Securities Purchase Agreement dated September 24, 2024 (the &ldquo;<B><I>Agreement</I></B>&rdquo;);
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
the Company and the Investor desire to amend the Agreement as set forth in this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AGREEMENT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing recitals and the mutual promises set forth in this Amendment, and for other good and valuable
consideration (the receipt and sufficiency of which are hereby acknowledged), the parties hereto agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Capitalized
Terms</U>. Capitalized terms not defined in this Amendment shall have the respective meanings given in the Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Amendments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1. The
Shares of Common Stock line item appearing on the signature page to the Agreement shall be amended and restated as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock: _________ </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2. The
Shares of Common Stock underlying the Pre-Funded Warrants line item appearing on the signature page to the Agreement shall be amended
and restated as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock underlying the Pre-Funded Warrants: _________ </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Representation
of Investor</U>. The Investor (together with such Investor Group) does not beneficially own (as defined in Rule 13d-3 under the 1934
Act) any shares of Common Stock other than the shares of Common Stock acquired pursuant to (i) the Agreement, as amended by this Amendment,
and (ii) the Securities Purchase Agreement, dated as of July 23, 2024, by and between the Company and the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>Full
Force and Effect</U>. Except as expressly amended hereby, all other terms of the Agreement shall continue in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Governing
Law</U>. This Amendment shall be governed by the internal law of the State of Delaware, without regard to conflict of law principles
that would result in the application of any law other than the law of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Counterparts</U>.
This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic
signature complying with the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com) or other transmission method and any counterpart
so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature
Page Follows]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Amendment to Securities Purchase Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ONEMEDNET CORPORATION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Green</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OFF
    THE CHAIN, LP</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page to Amendment to Securities Purchase Agreement - OTC</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>4
<FILENAME>ex10-25.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
10.25</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REGISTRATION
RIGHTS AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>REGISTRATION RIGHTS AGREEMENT</B> (this &ldquo;<B>Agreement</B>&rdquo;), dated as of January __, 2025, is by and between OneMedNet
Corp, a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and Dr. Thomas Kosasa, an individual (the &ldquo;<B>Investor</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RECITALS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and the Investor have entered into (i) a Loan Agreement, dated January 2, 2024 (the &ldquo;<B>January 2024 Loan Agreement</B>&rdquo;),
pursuant to which the Investor loaned to the Company an aggregate principal amount of $1,000,000 in cash, which is convertible into 1,327,140
shares of the Company&rsquo;s Common Stock, par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;); (ii) a Loan Agreement,
dated April 24, 2024 (the &ldquo;<B>April 2024 Loan Agreement</B>&rdquo;), pursuant to which the Investor loaned to the Company an aggregate
principal amount of $200,000 in cash, which is convertible into 265,428 shares of Common Stock; (iii) a Loan Agreement, dated May 28,
2024 (the &ldquo;<B>May 28, 2024 Loan Agreement</B>&rdquo;), pursuant to which the Investor loaned to the Company an aggregate principal
amount of $200,000 in cash, which is convertible into 265,428 shares of Common Stock; (iv) a Loan Agreement, dated May 31, 2024 (the
&ldquo;<B>May 31, 2024 Loan Agreement</B>&rdquo;), pursuant to which the Investor loaned to the Company an aggregate principal amount
of $100,000 in cash, which is convertible into 132,714 shares of Common Stock; and (v) a Loan Agreement, dated June 10, 2024 (collectively
with the January 2024 Loan Agreement, the April 2024 Loan Agreement, the May 28, 2024 Loan Agreement, and the May 31, 2024 Loan Agreement,
the &ldquo;<B>Kosasa Loan Agreements</B>&rdquo;), pursuant to which the Investor loaned to the Company an aggregate principal amount
of $100,000 in cash, which is convertible into 132,714 shares of Common Stock (all such shares of Common Stock issuable upon conversion
of the loans made pursuant to the Kosasa Loan Agreements, the &ldquo;<B>Shares</B>&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
pursuant to the terms of, and in consideration for the Investor entering into, the Kosasa Loan Agreements, and to induce the Investor
to execute and deliver the Kosasa Loan Agreements, the Company has agreed to provide the Investor with certain registration rights under
the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the
&ldquo;<B>Securities Act</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AGREEMENT</U></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE,</B> in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Loan Agreements. As used in this
Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not
be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential
employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental
authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York
generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>Effective Date</B>&rdquo; means the date that the applicable Registration Statement has been declared effective by the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Effectiveness Deadline</B>&rdquo; means (i) with respect to the initial Registration Statement required to be filed pursuant
to Section 2(a), the earlier of the (A) 60th calendar day (or, if a full review by the SEC the 100th calendar day) after the date of
this Agreement and (B) 2nd Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC
that such Registration Statement will not be reviewed or will not be subject to further review and (ii) with respect to any additional
Registration Statements that may be required to be filed by the Company pursuant to the Loan Agreements, the earlier of the (A) 60th
calendar day (or, if a full review by the SEC the 100th calendar day) following the date on which the Company was required to file such
additional Registration Statement and (B) 2nd Business Day after the date the Company is notified (orally or in writing, whichever is
earlier) by the SEC that such Registration Statement will not be reviewed or will not be subject to further review.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Exchange Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Filing Deadline</B>&rdquo; means, (i) with respect to the initial Registration Statement required to be filed pursuant to Section
2(a), the 20th calendar day after the date of this Agreement and (ii) with respect to any additional Registration Statements that may
be required to be filed by the Company pursuant to this Agreement, the date on which the Company was required to file such additional
Registration Statement pursuant to the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization or a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>register</B>,&rdquo; &ldquo;<B>registered</B>,&rdquo; and &ldquo;<B>registration</B>&rdquo; refer to a registration effected
by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant to Rule 415 and the declaration
of effectiveness of such Registration Statement(s) by the SEC s.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Registrable Securities</B>&rdquo; means all of (i) the Shares, and (ii) any capital stock of the Company issued or issuable
with respect to the Shares, including, without limitation, (1) as a result of any stock split, stock dividend, recapitalization, exchange
or similar event or otherwise, and (2) shares of capital stock of the Company into which the shares of Common Stock are converted or
exchanged and shares of capital stock of a successor entity into which the shares of Common Stock are converted or exchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Registration Statement</B>&rdquo; means a registration statement or registration statements of the Company filed under the
Securities Act covering Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Rule 144</B>&rdquo; means Rule 144 promulgated by the SEC under the Securities Act, as such rule may be amended from time to
time, or any other similar or successor rule or regulation of the SEC that may at any time permit the Investor to sell securities of
the Company to the public without registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<B>Rule 415</B>&rdquo; means Rule 415 promulgated by the SEC under the Securities Act, as such rule may be amended from time to
time, or any other similar or successor rule or regulation of the SEC providing for offering securities on a continuous or delayed basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>SEC</B>&rdquo; means the Securities and Exchange Commission or any other federal agency administering the Securities Act and
the Exchange Act at the time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<B>Securities Act</B>&rdquo; shall have the meaning set forth in the Recitals above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mandatory Registration</U>. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline,
file with the SEC an initial Registration Statement on Form S-1 covering the resale of all of the Registrable Securities. Such initial
Registration Statement, and each other Registration Statement required to be filed pursuant to the terms of this Agreement, shall contain
&ldquo;Selling Stockholders&rdquo; and &ldquo;Plan of Distribution&rdquo; sections. The Company shall use its reasonable best efforts
to have such initial Registration Statement, and each other Registration Statement required to be filed pursuant to the terms of this
Agreement, declared effective by the SEC as soon as practicable, but in no event later than the applicable Effectiveness Deadline for
such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
[Reserved].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Sufficient Number of Shares Registered</U>. In the event the number of shares available under any Registration Statement is insufficient
to cover all of the Registrable Securities required to be covered by such Registration Statement, the Company shall amend such Registration
Statement (if permissible), or file with the SEC a new Registration Statement (on the short form available therefor, if applicable),
or both, so as to cover all of the Registrable Securities not covered by such initial Registration Statement, as soon as practicable,
but in any event not later than fifteen (15) days after the necessity therefor arises (but taking account of any Staff (as defined herein)
position with respect to the date on which the Staff will permit such amendment to the Registration Statement and/or such new Registration
Statement (as the case may be) to be filed with the SEC). Notwithstanding anything to the contrary contained herein, in the event that
the SEC requires the Company to reduce the number of Registrable Securities to be included in a Registration Statement in order to allow
the Company to rely on Rule 415 with respect to a Registration Statement, then the Company shall reduce the number of Registrable Securities
to be included in such Registration Statement (after consultation with the Investor as to the specific Registrable Securities to be removed
therefrom) to the maximum number of securities as is permitted by the SEC to be registered in such Registration Statement. The Company
shall use its reasonable best efforts to cause such amendment to such Registration Statement and/or such new Registration Statement (as
the case may be) to become effective as soon as practicable following the filing thereof with the SEC, but in no event later than the
applicable Effectiveness Deadline for such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Effect of Failure to File and Obtain and Maintain Effectiveness of any Registration Statement</U>. If (i) a Registration Statement
covering the resale of all of the Registrable Securities required to be covered thereby (disregarding any reduction pursuant to Section
2(f)) and required to be filed by the Company pursuant to this Agreement is (A) not filed with the SEC on or before the Filing Deadline
for such Registration Statement (a &ldquo;<B>Filing Failure</B>&rdquo;) (it being understood that if the Company files a Registration
Statement without affording the Investor the opportunity to review and comment on the same as required by Section 3(c) hereof, the Company
shall be deemed to not have satisfied this clause (i)(A) and such event shall be deemed to be a Filing Failure) or (B) not declared effective
by the SEC on or before the Effectiveness Deadline for such Registration Statement (an &ldquo;<B>Effectiveness Failure</B>&rdquo;) (it
being understood that if on the Business Day immediately following the Effective Date for such Registration Statement the Company shall
not have filed a &ldquo;final&rdquo; prospectus for such Registration Statement with the SEC under Rule 424(b) in accordance with Section
3(b) (whether or not such a prospectus is technically required by such rule), the Company shall be deemed to not have satisfied this
clause (i)(B) and such event shall be deemed to be an Effectiveness Failure), (ii) other than during an Allowable Grace Period (as defined
below), on any day after the Effective Date of a Registration Statement sales of all of the Registrable Securities required to be included
on such Registration Statement (disregarding any reduction pursuant to Section 2(f)) cannot be made pursuant to such Registration Statement
(including, without limitation, because of a failure to keep such Registration Statement effective, a failure to disclose such information
as is necessary for sales to be made pursuant to such Registration Statement, a suspension or delisting of (or a failure to timely list)
the shares of Common Stock on the Principal Market (as defined in the Securities Purchase Agreement) or any other limitations imposed
by the Nasdaq Capital Market or any other exchange on which the shares of Common Stock are then-listed (the &ldquo;<B>Principal Market</B>&rdquo;),
or a failure to register a sufficient number of shares of Common Stock or by reason of a stop order) or the prospectus contained therein
is not available for use for any reason (a &ldquo;<B>Maintenance Failure</B>&rdquo;), or (iii) if a Registration Statement is not effective
for any reason or the prospectus contained therein is not available for use for any reason, and either (x) the Company fails for any
reason to satisfy the requirements of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information
requirement under Rule 144(c) or (y) the Company has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in
the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<B>Current Public Information Failure</B>&rdquo;)
as a result of which the Investor is unable to sell Registrable Securities without restriction under Rule 144 (including, without limitation,
volume restrictions), then, as partial relief for the damages to any holder by reason of any such delay in, or reduction of, its ability
to sell the underlying shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity,
including, without limitation, specific performance), the Company shall pay to each holder of Registrable Securities relating to such
Registration Statement an amount in cash equal to 0.5% of the Investor&rsquo;s original principal amount stated in the Loan Agreements
(1) on the date of such Filing Failure, Effectiveness Failure, Maintenance Failure or Current Public Information Failure, as applicable,
and (2) on every thirty (30) day anniversary of (I) a Filing Failure until such Filing Failure is cured; (II) an Effectiveness Failure
until such Effectiveness Failure is cured; (III) a Maintenance Failure until such Maintenance Failure is cured; and (IV) a Current Public
Information Failure until the earlier of (i) the date such Current Public Information Failure is cured and (ii) such time that such public
information is no longer required pursuant to Rule 144 (in each case, prorated for periods totaling less than thirty (30) days). The
payments to which a holder of Registrable Securities shall be entitled pursuant to this Section 2(e) are referred to herein as &ldquo;<B>Registration
Delay Payments</B>.&rdquo; Following the initial Registration Delay Payment for any particular event or failure (which shall be paid
on the date of such event or failure, as set forth above), without limiting the foregoing, if an event or failure giving rise to the
Registration Delay Payments is cured prior to any thirty (30) day anniversary of such event or failure, then such Registration Delay
Payment shall be made on the third (3rd) Business Day after such cure. In the event the Company fails to make Registration Delay Payments
in a timely manner in accordance with the foregoing, such Registration Delay Payments shall bear interest at the rate of 0.5% per month
(prorated for partial months) until paid in full. Notwithstanding the foregoing, no Registration Delay Payments shall be owed to the
Investor (other than with respect to a Maintenance Failure resulting from a suspension or delisting of (or a failure to timely list)
the shares of Common Stock on the Principal Market) with respect to any period during which all of the Investor&rsquo;s Registrable Securities
may be sold by the Investor without restriction under Rule 144 (including, without limitation, volume restrictions) and without the need
for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Offering</U>. Notwithstanding anything to the contrary contained in this Agreement, but subject to the payment of the Registration
Delay Payments pursuant to Section 2(e), in the event the staff of the SEC (the &ldquo;<B>Staff</B>&rdquo;) or the SEC seeks to characterize
any offering pursuant to a Registration Statement filed pursuant to this Agreement as constituting an offering of securities by, or on
behalf of, the Company, or in any other manner, such that the Staff or the SEC do not permit such Registration Statement to become effective
and used for resales in a manner that does not constitute such an offering and that permits the continuous resale at the market by the
Investor participating therein (or as otherwise may be acceptable to the Investor) without being named therein as an &ldquo;underwriter,&rdquo;
then the Company shall reduce the number of shares to be included in such Registration Statement by the Investor until such time as the
Staff and the SEC shall so permit such Registration Statement to become effective as aforesaid. In making such reduction, the Company
shall reduce the number of shares to be included by the Investor on a pro rata basis (based upon the number of Registrable Securities
otherwise required to be included for the Investor) unless the inclusion of such shares is resulting in the Staff or the SEC&rsquo;s
&ldquo;by or on behalf of the Company&rdquo; offering position, in which event the shares held by such Investor shall be the only shares
subject to reduction. In addition, in the event that the Staff or the SEC requires the Investor seeking to sell securities under a Registration
Statement filed pursuant to this Agreement to be specifically identified as an &ldquo;underwriter&rdquo; in order to permit such Registration
Statement to become effective, and the Investor does not consent to being so named as an underwriter in such Registration Statement,
then the Company shall reduce the total number of Registrable Securities to be registered on behalf of the Investor, until such time
as the Staff or the SEC does not require such identification or until the Investor accepts such identification and the manner thereof.
In the event of any reduction in Registrable Securities pursuant to this paragraph, the Investor shall have the right to require, upon
delivery of a written request to the Company signed by the Investor, the Company to file a registration statement within twenty (20)
days of such request (subject to any restrictions imposed by Rule 415 or required by the Staff or the SEC) for resale by the Investor
in a manner acceptable to such Investor, and the Company shall following such request cause to be and keep effective such registration
statement in the same manner as otherwise contemplated in this Agreement for registration statements hereunder, in each case until such
time as: (i) all Registrable Securities held by the Investor have been registered and sold pursuant to an effective Registration Statement
in a manner acceptable to the Investor or (ii) all Registrable Securities may be resold by the Investor without restriction (including,
without limitation, volume limitations) pursuant to Rule 144 (taking account of any Staff position with respect to &ldquo;affiliate&rdquo;
status) and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or (iii) the
Investor agrees to be named as an underwriter in any such Registration Statement in a manner acceptable to the Investor as to all Registrable
Securities held by the Investor and that have not theretofore been included in a Registration Statement under this Agreement (it being
understood that the special demand right under this sentence may be exercised by the Investor multiple times and with respect to limited
amounts of Registrable Securities in order to permit the resale thereof by the Investor as contemplated above).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Piggy-Back Registrations</U>. Without limiting any obligation of the Company hereunder or under the Loan Agreements, if there is not
an effective Registration Statement covering all of the Registrable Securities or the prospectus contained therein is not available for
use and the Company shall determine to prepare and file with the SEC a registration statement or offering statement relating to an offering
for its own account or the account of others under the Securities Act of any of its equity securities (other than on Form S-4 or Form
S-8 (each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection
with any acquisition of any entity or business or equity securities issuable in connection with the Company&rsquo;s stock option or other
employee benefit plans), then the Company shall deliver to the Investor a written notice of such determination and, if within fifteen
(15) days after the date of the delivery of such notice, the Investor shall so request in writing, the Company shall include in such
registration statement or offering statement all or any part of such Registrable Securities the Investor requests to be registered; provided,
however, the Company shall not be required to register any Registrable Securities pursuant to this Section 2(g) that are eligible for
resale pursuant to Rule 144 without restriction (including, without limitation, volume restrictions) and without the need for current
public information required by Rule 144(c)(1) (or Rule 144(i)(2), if applicable) or that are the subject of a then-effective Registration
Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Related Obligations</U>. The Company shall use its reasonable best efforts to effect the registration of the Registrable Securities
in accordance with the intended method of disposition thereof, and, pursuant thereto, the Company shall have the following obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall promptly prepare and file with the SEC a Registration Statement with respect to all the Registrable Securities (but
in no event later than the applicable Filing Deadline) and use its reasonable best efforts to cause such Registration Statement to become
effective as soon as practicable after such filing (but in no event later than the Effectiveness Deadline). Subject to Allowable Grace
Periods, the Company shall keep each Registration Statement effective (and the prospectus contained therein available for use) pursuant
to Rule 415 for resales by the Investor on a delayed or continuous basis at then-prevailing market prices (and not fixed prices) at all
times until the earlier of (i) the date as of which the Investor may sell all of the Registrable Securities required to be covered by
such Registration Statement (disregarding any reduction pursuant to Section 2(f)) without restriction pursuant to Rule 144 (including,
without limitation, volume restrictions) and without the need for current public information required by Rule 144(c)(1) (or Rule 144(i)(2),
if applicable) or (ii) the date on which the Investor shall have sold all of the Registrable Securities covered by such Registration
Statement (the &ldquo;<B>Registration Period</B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement, the Company
shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all amendments
and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto) used in connection
with such Registration Statement (1) shall not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in
which they were made) not misleading and (2) will disclose (whether directly or through incorporation by reference to other SEC filings
to the extent permitted) all material information regarding the Company and its securities. The Company shall submit to the SEC, within
two Business Days after the later of the date that (i) the Company learns that no review of a particular Registration Statement will
be made by the Staff or that the Staff has no further comments on a particular Registration Statement (as the case may be) and (ii) the
consent of legal counsel to the Investor is obtained pursuant to Section 3(c) (which consent shall be immediately sought), a request
for acceleration of effectiveness of such Registration Statement to a time and date not later than twenty-four (24) hours after the submission
of such request. The Company shall respond in writing to comments made by the SEC in respect of a Registration Statement as soon as practicable,
but in no event later than fifteen (15) days after the receipt of comments by or notice from the SEC that an amendment is required in
order for a Registration Statement to be declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to Section 3(r) of this Agreement, the Company shall prepare and file with the SEC such amendments (including, without limitation,
post-effective amendments) and supplements to each Registration Statement and the prospectus used in connection with each such Registration
Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep each
such Registration Statement effective at all times during the Registration Period for such Registration Statement, and, during such period,
comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required
to be covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the seller or sellers thereof as set forth in such Registration Statement; provided, however,
by 8:30 a.m. (New York time) on the Business Day immediately following each Effective Date, the Company shall file with the SEC in accordance
with Rule 424(b) under the Securities Act the final prospectus to be used in connection with sales pursuant to the applicable Registration
Statement (whether or not such a prospectus is technically required by such rule). In the case of amendments and supplements to any Registration
Statement which are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section 3(b)) by
reason of the Company filing a report on Form 8-K, Form 10-Q or Form 10-K or any analogous report under the Exchange Act, the Company
shall, if permitted under the applicable rules and regulations of the SEC, have incorporated such report by reference into such Registration
Statement, if applicable, or shall file such amendments or supplements with the SEC on the same day on which the Exchange Act report
is filed which created the requirement for the Company to amend or supplement such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company shall (A) permit legal counsel for the Investor to review and comment upon (i) each Registration Statement at least five
(5) Business Days prior to its filing with the SEC and (ii) all amendments and supplements to each Registration Statement (including,
without limitation, the prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and any similar or successor reports) within a reasonable number of days prior to their filing with the SEC, and
(B) not file any Registration Statement or amendment or supplement thereto in a form to which legal counsel for the Investor reasonably
objects. The Company shall not submit a request for acceleration of the effectiveness of a Registration Statement or any amendment or
supplement thereto or to any prospectus contained therein without the prior consent of legal counsel of the Investor, which consent shall
not be unreasonably withheld. The Company shall promptly furnish to legal counsel for the Investor, without charge, (i) copies of any
correspondence from the SEC or the Staff to the Company or its representatives relating to each Registration Statement, provided that
such correspondence shall not contain any material, non-public information regarding the Company or any of its subsidiaries, (ii) after
the same is prepared and filed with the SEC, one (1) copy of each Registration Statement and any amendment(s) and supplement(s) thereto,
including, without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested by the
Investor, and all exhibits and (iii) upon the effectiveness of each Registration Statement, one (1) copy of the prospectus included in
such Registration Statement and all amendments and supplements thereto. The Company shall reasonably cooperate with legal counsel for
the Investor in performing the Company&rsquo;s obligations pursuant to this Section 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company shall promptly furnish electronically to the Investor, without charge, (i) after the same is prepared and filed with the
SEC, at least one (1) copy of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation,
financial statements and schedules, all documents incorporated therein by reference, if requested by the Investor, all exhibits and each
preliminary prospectus, (ii) upon the effectiveness of each Registration Statement, an electronic copy of the prospectus included in
such Registration Statement and all amendments and supplements thereto and (iii) such other documents, including, without limitation,
copies of any preliminary or final prospectus, as the Investor may reasonably request from time to time in order to facilitate the disposition
of the Registrable Securities owned by such Investor</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The Company shall use its reasonable best efforts to (i) register and qualify, unless an exemption from registration and qualification
applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other securities or
&ldquo;blue sky&rdquo; laws of New York, in the United States, (ii) prepare and file in such jurisdiction, such amendments (including,
without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period, (iii) take such other actions as may be necessary to maintain such registrations
and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary or advisable
to qualify the Registrable Securities for sale in such jurisdictions; provided, however, the Company shall not be required in connection
therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify
but for this Section 3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service
of process in any such jurisdiction. The Company shall promptly notify legal counsel for the Investor and the Investor of the receipt
by the Company of any notification with respect to the suspension of the registration or qualification of any of the Registrable Securities
for sale under the securities or &ldquo;blue sky&rdquo; laws of any jurisdiction in the United States or its receipt of actual notice
of the initiation or threatening of any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Company shall notify legal counsel for the Investor and the Investor in writing of the happening of any event, as promptly as practicable
after becoming aware of such event, as a result of which the prospectus included in a Registration Statement, as then in effect, may
include an untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall
such notice contain any material, non-public information regarding the Company or any of its subsidiaries), and, subject to Section 3(r),
promptly prepare a supplement or amendment to such Registration Statement and such prospectus contained therein to correct such untrue
statement or omission and deliver an electronic copy of such supplement or amendment to legal counsel for the Investor and the Investor
(or such other number of copies as legal counsel for the Investor or the Investor may reasonably request). The Company shall also promptly
notify legal counsel for the Investor and the Investor in writing (i) when a prospectus or any prospectus supplement or post-effective
amendment has been filed, when a Registration Statement or any post-effective amendment has become effective (notification of such effectiveness
shall be delivered to legal counsel for the Investor and the Investor by facsimile or e-mail on the same day of such effectiveness and
by overnight mail), and when the Company receives written notice from the SEC that a Registration Statement or any post-effective amendment
will be reviewed by the SEC, (ii) of any request by the SEC for amendments or supplements to a Registration Statement or related prospectus
or related information, (iii) of the Company&rsquo;s reasonable determination that a post-effective amendment to a Registration Statement
would be appropriate; and (iv) of the receipt of any request by the SEC or any other federal or state governmental authority for any
additional information relating to the Registration Statement or any amendment or supplement thereto or any related prospectus. The Company
shall respond as promptly as practicable to any comments received from the SEC with respect to each Registration Statement or any amendment
thereto (it being understood and agreed that the Company&rsquo;s response to any such comments shall be delivered to the SEC no later
than fifteen (15) Business Days after the receipt thereof).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
The Company shall (i) use its reasonable best efforts to prevent the issuance of any stop order or other suspension of effectiveness
of each Registration Statement or the use of any prospectus contained therein, or the suspension of the qualification, or the loss of
an exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension
is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and (ii) notify legal counsel for the
Investor and the Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation
or threat of any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
If the Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and the
Investor consents to so being named an underwriter, at the request of the Investor, the Company shall furnish to the Investor, on the
date of the effectiveness of such Registration Statement and thereafter from time to time on such dates as the Investor may reasonably
request (i) a letter, dated such date, from the Company&rsquo;s independent certified public accountants in form and substance as is
customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the Investor,
and (ii) an opinion, dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form,
scope and substance as is customarily given in an underwritten public offering, addressed to the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If the Investor may be required under applicable securities law to be described in any Registration Statement as an underwriter and the
Investor consents to so being named an underwriter, upon the written request of the Investor, the Company shall make available for inspection
by (i) the Investor, (ii) legal counsel for the Investor and (iii) one (1) firm of accountants or other agents retained by the Investor
(collectively, the &ldquo;<B>Inspectors</B>&rdquo;), all pertinent financial and other records, and pertinent corporate documents and
properties of the Company (collectively, the &ldquo;<B>Records</B>&rdquo;), as shall be reasonably deemed necessary by each Inspector,
and cause the Company&rsquo;s officers, directors and employees to supply all information which any Inspector may reasonably request;
provided, however, each Inspector shall agree in writing to hold in strict confidence and not to make any disclosure (except to the Investor)
or use of any Record or other information which the Company&rsquo;s board of directors determines in good faith to be confidential, and
of which determination the Inspectors are so notified, unless (1) the disclosure of such Records is necessary to avoid or correct a misstatement
or omission in any Registration Statement or is otherwise required under the Securities Act, (2) the release of such Records is ordered
pursuant to a final, non-appealable subpoena or order from a court or government body of competent jurisdiction, or (3) the information
in such Records has been made generally available to the public other than by disclosure in violation of this Agreement or the Loan Agreements.
The Investor agrees that it shall, upon learning that disclosure of such Records is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt notice to the Company and allow the Company, at its expense, to undertake appropriate
action to prevent disclosure of, or to obtain a protective order for, the Records deemed confidential. Nothing herein (or in any other
confidentiality agreement between the Company and the Investor, if any) shall be deemed to limit the Investor&rsquo;s ability to sell
Registrable Securities in a manner which is otherwise consistent with applicable laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in
such Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena or
other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made
generally available to the public other than by disclosure in violation of this Agreement or the Loan Agreements. The Company agrees
that it shall, upon learning that disclosure of such information concerning an Investor is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor&rsquo;s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Without limiting any obligation of the Company under the Loan Agreements, the Company shall use its reasonable best efforts either to
(i) cause all of the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which
securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is
then permitted under the rules of such exchange, or (ii) if, despite the Company&rsquo;s best efforts to satisfy the preceding clause
(i) the Company is unsuccessful in satisfying the preceding clause (i), without limiting the generality of the foregoing, to use its
reasonable best efforts to arrange for at least two market makers to register with the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;)
as such with respect to such Registrable Securities. In addition, the Company shall cooperate with the Investor and any broker or dealer
through which the Investor proposes to sell its Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule 5110 as
requested by the Investor. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section
3(k).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Company shall cooperate with the Investor and, to the extent applicable, facilitate the timely preparation and delivery of certificates
(not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a Registration Statement and enable
such certificates to be in such denominations or amounts (as the case may be) as the Investor may reasonably request from time to time
and registered in such names as the Investor may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
If requested by the Investor, the Company shall as soon as practicable after receipt of notice from the Investor and subject to Section
3(r) hereof, (i) incorporate in a prospectus supplement or post-effective amendment such information as the Investor reasonably requests
to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with
respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of
the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement
or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment;
and (iii) supplement or make amendments to any Registration Statement or prospectus contained therein if reasonably requested by the
Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
The Company shall use its reasonable best efforts to cause the Registrable Securities covered by a Registration Statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
If requested by the Investor, the Company shall make generally available to its security holders as soon as practical, but not later
than ninety (90) days after the close of the period covered thereby, an earnings statement (in form complying with, and in the manner
provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period beginning not later than the first day
of the Company&rsquo;s fiscal quarter next following the applicable Effective Date of each Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
The Company shall otherwise use its reasonable best efforts to comply with all applicable rules and regulations of the SEC in connection
with any registration hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
Within one (1) Business Day after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the
Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the SEC in the form required
by the transfer agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
Notwithstanding anything to the contrary herein (but subject to the last sentence of this Section 3(r)), at any time after the Effective
Date of a particular Registration Statement, the Company may delay the disclosure of material, non-public information concerning the
Company or any of its subsidiaries the disclosure of which at the time is not, in the good faith opinion of the board of directors of
the Company, in the best interest of the Company and, in the opinion of counsel to the Company, otherwise required (a &ldquo;<B>Grace
Period</B>&rdquo;), provided that the Company shall promptly notify the Investor in writing of the (i) existence of material, non-public
information giving rise to a Grace Period (provided that in each such notice the Company shall not disclose the content of such material,
non-public information to the Investor) and the date on which such Grace Period will begin and (ii) date on which such Grace Period ends,
provided further that (I) no Grace Period shall exceed ten (10) consecutive days and during any three hundred sixty five (365) day period
all such Grace Periods shall not exceed an aggregate of thirty (30) days, (II) the first day of any Grace Period must be at least five
(5) Business Days after the last day of any prior Grace Period and (III) no Grace Period may exist during the sixty (60) Business Day
period immediately following the Effective Date of such Registration Statement (provided that such sixty (60) Business Day period shall
be extended by the number of Business Days during such period and any extension thereof contemplated by this proviso during which such
Registration Statement is not effective or the prospectus contained therein is not available for use) (each, an &ldquo;<B>Allowable Grace
Period</B>&rdquo;). For purposes of determining the length of a Grace Period above, such Grace Period shall begin on and include the
date the Investors receive the notice referred to in clause (i) above and shall end on and include the later of the date the Investor
receives the notice referred to in clause (ii) above and the date referred to in such notice. The provisions of Section 3(g) hereof shall
not be applicable during the period of any Allowable Grace Period. Upon expiration of each Grace Period, the Company shall again be bound
by the first sentence of Section 3(f) with respect to the information giving rise thereto unless such material, non-public information
is no longer applicable. Notwithstanding anything to the contrary contained in this Section 3(r), the Company shall cause its transfer
agent to deliver unlegended shares of Common Stock to a transferee of the Investor in connection with any sale of Registrable Securities
with respect to which the Investor has entered into a contract for sale, and delivered a copy of the prospectus included as part of the
particular Registration Statement to the extent applicable, prior to the Investor&rsquo;s receipt of the notice of a Grace Period and
for which the Investor has not yet settled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
The Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable Securities
pursuant to a Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
Neither the Company nor any subsidiary or affiliate thereof shall identify the Investor as an underwriter in any public disclosure or
filing with the SEC or the Principal Market and the Investor being deemed an underwriter by the SEC shall not relieve the Company of
any obligations it has under this Agreement or the Loan Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
Neither the Company nor any of its subsidiaries has entered, as of the date hereof, nor shall the Company or any of its subsidiaries,
on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing
the rights granted to the Investor in this Agreement or otherwise conflicts with the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Obligations of the Investor</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
At least five (5) Business Days prior to the first anticipated filing date of each Registration Statement, the Company shall notify the
Investor in writing of the information the Company requires from the Investor with respect to such Registration Statement. It shall be
a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the Registrable
Securities of the Investor that the Investor shall furnish to the Company such information regarding itself, the Registrable Securities
held by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect
and maintain the effectiveness of the registration of such Registrable Securities and shall execute such documents in connection with
such registration as the Company may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Investor, by such Investor&rsquo;s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested
by the Company in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has notified
the Company in writing of the Investor&rsquo;s election to exclude all of the Investor&rsquo;s Registrable Securities from such Registration
Statement. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section
3(g) or the first sentence of 3(f), the Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration
Statement(s) covering such Registrable Securities until the Investor&rsquo;s receipt of the copies of the supplemented or amended prospectus
contemplated by Section 3(g) or the first sentence of Section 3(f) or receipt of notice that no supplement or amendment is required.
Notwithstanding anything to the contrary in this Section 4(c), the Company shall cause its transfer agent to deliver unlegended shares
of Common Stock to a transferee of the Investor in accordance with the terms of the Securities Purchase Agreement in connection with
any sale of Registrable Securities with respect to which the Investor has entered into a contract for sale prior to the Investor&rsquo;s
receipt of a notice from the Company of the happening of any event of the kind described in Section 3(g) or the first sentence of Section
3(f) and for which the Investor has not yet settled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Expenses of Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
reasonable expenses, other than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications
pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting
fees, FINRA filing fees (if any) and fees and disbursements of counsel for the Company shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor and each
of its directors, officers, stockholders, members, partners, employees, agents, advisors, representatives and each Person, if any, who
controls the Investor within the meaning of the Securities Act or the Exchange Act and each of the directors, officers, stockholders,
members, partners, employees, agents, advisors, representatives of such controlling Persons (each, an &ldquo;<B>Indemnified Person</B>&rdquo;),
against any losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges, costs (including,
without limitation, court costs, reasonable attorneys&rsquo; fees and costs of defense and investigation), amounts paid in settlement
or expenses, joint or several, (collectively, &ldquo;<B>Claims</B>&rdquo;) incurred in investigating, preparing or defending any action,
claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative
or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an Indemnified Person is or may be a party
thereto (&ldquo;<B>Indemnified Damages</B>&rdquo;), to which any of them may become subject insofar as such Claims (or actions or proceedings,
whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement
of a material fact in a Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification
of the offering under the securities or other &ldquo;blue sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered
(&ldquo;Blue Sky Filing&rdquo;), or the omission or alleged omission to state a material fact required to be stated therein or necessary
to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained in
any preliminary prospectus if used prior to the effective date of such Registration Statement, or contained in the final prospectus (as
amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission
to state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements
therein were made, not misleading or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act,
any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating to the offer or
sale of the Registrable Securities pursuant to a Registration Statement or (iv) any violation of this Agreement (the matters in the foregoing
clauses (i) through (iv) being, collectively, &ldquo;<B>Violations</B>&rdquo;). Subject to Section 6(c), the Company shall reimburse
the Indemnified Persons, promptly as such expenses are incurred and are due and payable, for any legal fees or other reasonable expenses
incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein,
the indemnification agreement contained in this Section 6(a): (i) shall not apply to a Claim by an Indemnified Person arising out of
or based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by such
Indemnified Person for such Indemnified Person expressly for use in connection with the preparation of such Registration Statement or
any such amendment thereof or supplement thereto, if such prospectus was timely made available by the Company pursuant to Section 3(d);
and (ii) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent
of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of any of the Registrable Securities
by the Investor pursuant to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In connection with any Registration Statement in which the Investor is participating, the Investor agrees to indemnify, hold harmless
and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its
officers who signs the Registration Statement and each Person, if any, who controls the Company within the meaning of the Securities
Act or the Exchange Act (each, an &ldquo;<B>Indemnified Party</B>&rdquo;), against any Claim or Indemnified Damages to which any of them
may become subject, under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified Damages arise out of
or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs in reliance upon and
in conformity with written information furnished to the Company by the Investor expressly for use in connection with such Registration
Statement; and, subject to Section 6(c) and the below provisos in this Section 6(b), the Investor will reimburse an Indemnified Party
for any legal or other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such
Claim; provided, however, the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained
in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent
of the Investor, which consent shall not be unreasonably withheld or delayed, provided further that the Investor shall be liable under
this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to the Investor as a result
of the applicable sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in full force and
effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of any of the Registrable
Securities by any of the Investors pursuant to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Promptly after receipt by an Indemnified Person or Indemnified Party (as the case may be) under this Section 6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Indemnified
Person or Indemnified Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under
this Section 6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have
the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly
noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person
or the Indemnified Party (as the case may be); provided, however, an Indemnified Person or Indemnified Party (as the case may be) shall
have the right to retain its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the
indemnifying party has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume
the defense of such Claim and to employ counsel reasonably satisfactory to such Indemnified Person or Indemnified Party (as the case
may be) in any such Claim; or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties) include
both such Indemnified Person or Indemnified Party (as the case may be) and the indemnifying party, and such Indemnified Person or such
Indemnified Party (as the case may be) shall have been advised by counsel that a conflict of interest is likely to exist if the same
counsel were to represent such Indemnified Person or such Indemnified Party and the indemnifying party (in which case, if such Indemnified
Person or such Indemnified Party (as the case may be) notifies the indemnifying party in writing that it elects to employ separate counsel
at the expense of the indemnifying party, then the indemnifying party shall not have the right to assume the defense thereof and such
counsel shall be at the expense of the indemnifying party, provided further that in the case of clause (iii) above the indemnifying party
shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for such Indemnified Person
or Indemnified Party (as the case may be). The Indemnified Party or Indemnified Person (as the case may be) shall reasonably cooperate
with the indemnifying party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall
furnish to the indemnifying party all information reasonably available to the Indemnified Party or Indemnified Person (as the case may
be) which relates to such action or Claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person (as the case
may be) reasonably apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying
party shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent; provided, however,
the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior
written consent of the Indemnified Party or Indemnified Person (as the case may be), consent to entry of any judgment or enter into any
settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
Indemnified Party or Indemnified Person (as the case may be) of a release from all liability in respect to such Claim or litigation,
and such settlement shall not include any admission as to fault on the part of the Indemnified Party or Indemnified Person (as the case
may be). Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified
Party or Indemnified Person (as the case may be) with respect to all third parties, firms or corporations relating to the matter for
which indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable time of the
commencement of any such action shall not relieve such indemnifying party of any liability to the Indemnified Person or Indemnified Party
(as the case may be) under this Section 6, except to the extent that the indemnifying party is materially and adversely prejudiced in
its ability to defend such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The indemnification required by this <U>Section 6</U> shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or Indemnified Damages are incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified
Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject
to pursuant to the law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The parties hereto agree that the mechanics and procedures concerning indemnification obligations set forth in this Section 6 shall be
the mechanics and procedures concerning the indemnification obligations in this Section 6.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Contribution</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however: (i) no contribution shall be made under circumstances where the maker would not have been liable for indemnification
under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable Securities which
Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) in connection with such
sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent
misrepresentation; and (iii) contribution by any seller of Registrable Securities shall be limited in amount to the amount of net proceeds
received by such seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement. Notwithstanding
the provisions of this Section 7, the Investor shall not be required to contribute, in the aggregate, any amount in excess of the amount
by which the net proceeds actually received by the Investor from the applicable sale of the Registrable Securities subject to the Claim
exceeds the amount of any damages that the Investor has otherwise been required to pay, or would otherwise be required to pay under Section
6(b), by reason of such untrue or alleged untrue statement or omission or alleged omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Reports Under the Exchange Act</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a view to making available to the Investor the benefits of Rule 144, the Company agrees to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
make and keep public information available, as those terms are understood and defined in Rule 144;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act so long as the Company remains subject to such requirements (it being understood and agreed that nothing herein shall limit any obligations
of the Company under the Loan Agreements) and the filing of such reports and other documents is required for the applicable provisions
of Rule 144; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
furnish electronically to the Investor so long as such Investor owns Registrable Securities, promptly upon request, (i) a written statement
by the Company, if true, that it has complied with the reporting, submission and posting requirements of Rule 144, the Securities Act
and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so
filed by the Company with the SEC if such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably
requested to permit the Investors to sell such securities pursuant to Rule 144 without registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<U>Assignment of Registration Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
or any portion of the rights under this Agreement shall be automatically assignable by the Investor to any transferee or assignee (as
the case may be) of all or any portion of the Investor&rsquo;s Registrable Securities if: (i) the Investor agrees in writing with such
transferee or assignee (as the case may be) to assign all or any portion of such rights, and a copy of such agreement is furnished to
the Company within a reasonable time after such transfer or assignment (as the case may be); (ii) the Company is, within a reasonable
time after such transfer or assignment (as the case may be), furnished with written notice of (a) the name and address of such transferee
or assignee (as the case may be), and (b) the securities with respect to which such registration rights are being transferred or assigned
(as the case may be); (iii) immediately following such transfer or assignment (as the case may be) the further disposition of such securities
by such transferee or assignee (as the case may be) is restricted under the Securities Act or applicable state securities laws if so
required; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this sentence such transferee
or assignee (as the case may be) agrees in writing with the Company to be bound by all of the provisions contained herein; and (v) notwithstanding
anything else contained in this Section 9 or elsewhere herein to the contrary, such transfer or assignment (as the case may be) shall
have been made in accordance with all applicable federal and state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>Amendment of Registration Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provisions
of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively
or prospectively), only with the written consent of the Company and the Investor. Any amendment or waiver effected in accordance with
this Section 10 shall be binding upon the Investor and the Company, provided that no such amendment shall be effective to the extent
that it (1) applies to less than all of the holders of Registrable Securities or (2) imposes any obligation or liability on the Investor
without the Investor&rsquo;s prior written consent (which may be granted or withheld in the Investor&rsquo;s sole discretion). No waiver
shall be effective unless it is in writing and signed by an authorized representative of the waiving party. No consideration shall be
offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration
(other than the reimbursement of legal fees) also is offered to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns, or is deemed
to own, of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic
mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party
does not receive an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered to
such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each
case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6385
Old Shady Oak Road, Suite 250</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eden
Prairie, MN 55344</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Aaron Green</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
800-918-7189</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
aaron.green@onemednet.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Investor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">___________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically
generated by the sender&rsquo;s e-mail containing the time, date and recipient&rsquo;s e-mail or (C) provided by a courier or overnight
courier service shall be rebuttable evidence of personal service, receipt by e- mail or receipt from a nationally recognized overnight
delivery service in accordance with clause (i), (ii) or (iii) above, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right
or remedy, shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that each party hereto shall be entitled to an injunction or injunctions to prevent or cure breaches
of the provisions of this Agreement by any other party hereto and to enforce specifically the terms and provisions hereof (without the
necessity of showing economic loss and without any bond or other security being required), this being in addition to any other remedy
to which any party may be entitled by law or equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State
of Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of Wilmington,
Delaware, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue
of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process
being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under
this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES
ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH
OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent
jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest
extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity
of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without material change,
the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the
provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical
realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations
to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible
to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
This Agreement, the Loan Agreements, the schedules and exhibits attached hereto and thereto, if any, and the instruments referenced herein
and therein constitute the entire agreement among the parties hereto and thereto solely with respect to the subject matter hereof and
thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein.
This Agreement, the Loan Agreements, the schedules and exhibits attached hereto and thereto, if any, and the instruments referenced herein
and therein supersede all prior agreements and understandings among the parties hereto solely with respect to the subject matter hereof
and thereof; provided, however, nothing contained in this Agreement or the Loan Agreements shall (or shall be deemed to) (i) have any
effect on any agreements the Investor has entered into with the Company or any of its subsidiaries prior to the date hereof with respect
to any prior investment made by the Investor in the Company, except with regard to the investments made in the Loan Agreements, (ii)
waive, alter, modify or amend in any respect any obligations of the Company or any of its subsidiaries or any rights of or benefits to
any Investor or any other Person in any agreement entered into prior to the date hereof between or among the Company and/or any of its
subsidiaries and the Investor and all such agreements shall continue in full force and effect or (iii) limit any obligations of the Company
the Loan Agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Subject to compliance with Section 9 (if applicable), this Agreement shall inure to the benefit of and be binding upon the permitted
successors and assigns of each of the parties hereto. This Agreement is not for the benefit of, nor may any provision hereof be enforced
by, any Person, other than the parties hereto, their respective permitted successors and assigns and the Persons referred to in Sections
6 and 7 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall
be construed broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo;
&ldquo;hereof&rdquo; and words of like import refer to this entire Agreement instead of just the provision in which they are found.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
This Agreement may be executed in two or more identical counterparts, each of which shall be deemed an original, but all of which shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party. In the event that any signature is delivered by facsimile transmission or by an email which contains a portable document
format (.pdf) file of an executed signature page, such signature page shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party. Notwithstanding anything to the contrary set forth in Section 10, terms used
in this Agreement but defined in the Loan Agreements shall have the meanings ascribed to such terms in the Loan Agreements unless otherwise
consented to in writing by the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Investor and the Company have caused their signature page to this Registration Rights Agreement to be duly executed
as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ONEMEDNET
    CORPORATION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aaron
    Green</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Dr. thomas kosasa</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page to Kosasa Registration Rights Agreement</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-transform: uppercase; text-align: left; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the use in the Prospectus constituting a part of this Registration Statement Amendment No. 3 on Form S-1 of our report
dated November 4, 2024 (which includes an explanatory paragraph relating to OneMedNet Corporation&rsquo;s ability to continue
as a going concern), relating to the consolidated financial statements of OneMedNet Corporation. as of and for the years ended
December 31, 2023 and 2022, which is contained in that Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the reference to our firm under the caption &ldquo;Experts&rdquo; in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
                                            WithumSmith+Brown, PC</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">East
    Brunswick, New Jersey</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>ex107.htm
<DESCRIPTION>CALCULATION OF FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation of Filing Fee Table</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Table 1: Newly Registered Securities*</U></B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="vertical-align: bottom; border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
    Type</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
    Class Title</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
    Calculation or Carry Forward Rule</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    Registered(1)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed
    Maximum Offering Price Per Unit</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Aggregate Offering Price</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
    Rate</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    of Registration Fee</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry
    Forward Form Type</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry
    Forward File Number</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carry
    Forward Initial effective date</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
    Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="13" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Newly
    Registered Securities</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD ROWSPAN="4" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
    Previously Paid</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock, par value $0.0001 per share (&ldquo;Common Stock&rdquo;) (2)</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
    457(o)</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0001476</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$885.60(3)</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock (4)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
    457(g)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,085,275</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$
    11.50(5)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$138,980,662.50</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0001476</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$20,513.55</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock (6)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
    457(c)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,683,367</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$13,087,634.61</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.0001476</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,931.73</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Private
    Placement Warrants to Purchase Shares of Common Stock (7)</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
    457(i)</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">585,275</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;(8)</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
Offering Amounts</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 2pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$21,559.68</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Fees Previously Paid</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$21,559.68(9)</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Fee Offsets</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Fee Due</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$&mdash;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized terms used herein and not otherwise defined herein have the meanings assigned to them in OneMedNet Corporation<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rsquo;</FONT>s Registration Statement on Form S-1 to which this exhibit relates.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Securities Act<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT>), there are also being registered such indeterminable additional shares of Common Stock as may be issued to prevent dilution as a result of stock splits, stock dividends or similar transactions, and the resale of such shares of Common Stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 18, 2023, the Registrant filed a Registration Statement on Form S-1 (the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Original Registration Statement<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT>) to register a primary offering of Common Stock for a proposed maximum aggregate offering price of $6,000,000. In connection therewith, the Registrant paid a filing fee of $885.60 based on the then-current filing fee rate of $0.0001476. No such shares of Common Stock have been sold on the Original Registration Statement on Form S-1 to date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 17, 2024, the Registrant filed Amendment No. 1 to the Original Registration Statement on Form S-1 (the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>First Amendment<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT> and, the Original Registration Statement as so amended by the First Amendment and as may be further amended from time to time, the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Registration Statement<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT>) to register, among other things, 12,085,275 shares of Common Stock consisting of (i) up to 11,500,000 shares of Common Stock issuable upon exercise of 11,500,000 warrants (the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Public Warrants<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT>) originally issued in the initial public offering of Data Knights Acquisition Corp, a Delaware corporation (<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Data Knights<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT>), and (ii) up to 585,275 shares of Common Stock issuable upon the exercise of 585,275 warrants (the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Private Placement Warrants<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT>) that made up a part of the private units originally issued in a private placement in connection with Data Knights<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rsquo;</FONT> initial public offering. In connection with the registration of the shares of Common Stock issuable upon exercise of the Public Warrants and the Private Placement Warrants, the Registrant paid a filing fee of $20,513.55 based on the then-current filing fee rate of $0.0001476. No such shares of Common Stock issuable upon exercise of the Public Warrants and the Private Placement Warrants have been sold on this Registration Statement on Form S-1 to date.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects the shares of Common Stock that may be issued upon exercise of the Public Warrants and the Private Placement Warrants at an exercise price of $11.50 per share of Common Stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the First Amendment, the Registrant registered for resale 19,683,367 shares of Common Stock to be sold by certain selling shareholders named in the First Amendment (the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Resale Shares<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT>), and the Registrant paid a filing fee of $1,931.73 in connection with the Resale Shares. Although the filing fee table included with the First Amendment showed the Registrant paid a filing fee of $1,714.11 in connection with the registration of the Resale Shares, the Registrant actually paid a filing fee of $1,931.73 in connection with the registration of such Resale Shares. No such shares of Common Stock registered for resale have been sold on this Registration Statement on Form S-1 to date. The First Amendment also incorrectly failed to note that the $885.60 filing fee paid in connection with the Original Registration Statement was being subtracted from the total filing fee due under the First Amendment of $22,445.28, for an aggregate net fee due under the First Amendment of $21,559.68. Because the Registrant is registering fewer Resale Shares on this Registration Statement than that which was registered on the First Amendment, the Registrant is not paying an additional filing fee herewith.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents the resale by the Selling Warrantholders named in this Registration Statement (including their permitted transferees, donees, pledgees and other successors-in-interest) of up to an aggregate of 585,275 Private Placement Warrants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with Rule 457(i), the entire registration fee for the Private Placement Warrants is allocated to the shares of Common Stock underlying such Private Placement Warrants, and no separate fee is payable for the Private Placement Warrants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As described above the <FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&ldquo;</FONT>Total Fees Previously Paid<FONT STYLE="font-size: 10pt; font-family: Times New Roman, Times, Serif">&rdquo;</FONT> amount listed here is the sum of the fees due in connection with the filing of the First Amendment ($22,445.28) minus the fees paid in connection with the filing of the Original Registration Statement ($885.60).</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-right: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>forms-1_001.jpg
<TEXT>
begin 644 forms-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !? .H# 2(  A$! Q$!_\0
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M/K2U!&C12$'E3SG/3L!BIZQ:.A.X4444AA1110 4444 %%%% !1110 4444
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MI5N"#@CI7)_ G_D#ZS_U^_\ LM<EX8U+PMIWC#Q*?%<<+H]RPA\V R<[VSC
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MIZ>12I1O=ZA1116)J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>forms-1_012.jpg
<TEXT>
begin 644 forms-1_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )1!@@# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#VBBBBNLX
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHJ6@N%%%%0YI%J+88HH+4PMBLI58HT5)CB
M!33)MJ,N2:3K7!5Q%CLI46*[>8<^E-Q2].E&:X)5%)W.V*:T$Q3EXI W-!-*
M,PE&Y*'Q3Q)NJKFEW^E==.LD<\Z)9/'2@$FH5EQ]ZI%F5FP*[:55,XZM)H=G
MUHVXYHD'<4@SBN^)R-6%HHHJA!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%%( HHHH **** "BBB@ HHHI,+7"BBBE=AR!1112N5RA1115<Q
M+04444[A8**** "BBB@ HHHI@%%%% !1110 4444 %%%% !1110""BBBBQ3D
M%%%%2T2F%%%%/F2*M<*0YI:-P7K6$ZJBKC5)R=A *4X IC/Z5&6)KCJ8BYUT
MZ#0\O32U,I*X9U+GH0A8 FXYIV0O%!?%)L_B-83:Y2Y:BL68[5./>B-E+8<;
M\>E5;J[@@7<[@>V:QI_$H2006L9+-QDUC&K8'3NCIVN$3F1P(NFVGAD*[HN1
M7(WEE>^0D\\I 8YVYKI].799KDYXKV<+5NSSL33T)T8OUI:,]\45ZB=SA:L@
MHHHJD2%%%% !1110 4444 %%%% !1112 **** "BBB@ HHHI@%%%% !1110]
M06@4445DY*)IR\P8HI"V*:7K)U4M2U2;'XS1BHUDYIX?-5&NI: Z+B.I*7K2
M5I>QDXW"BBBJ3%RA11157%8****0!1110 4444P"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ H'6B@TF-"'/:E^M-,H3K3#('Z&N*K7Y3IA0
MYB0L!4;2]A3#S28%<,J]SKC1L.WM29S116,JALH("5 ]34$DZ1J2[!1[TMP'
M:)A$<-7(W]KJ?FLTA8Q^U<-6HSJIQ1KW?B""$,(G#M[5)IFI2WENTC]>U<B?
M)!("$'OFNBT3!LV"UR*;;.EQ5C>CF!4%NM3 ANE9ZG 53UIYG*# KH4K(P:U
MT+AP.IJK)<")^#D54EGD?.#4.,1ELY-3*;Z#Y;;EB2]=SA1Q5G36:23YZI+%
M(T6_;Q5S2SF4YKIPM23D<M>*L:N<MCM1GG%)_P M#1_%7TM*]CQ:BLQ:***W
M,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 %%%%
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MS;2(YN&*G@MGC-2OX?OK>)9!([J_0YK0M_$%FMM]GN8?-!.>:UT\26DPALU
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M<C9X]K HVX=Q3SED102,T[.:#R0?2J2U"XC*V=H(R*.9B$( ([TO<GN:*FS
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MY6JKCYN.:LK/(Z".--HKGA3E<N4TT2&VMUM [M\_I7#?$"PO-5TI8[6$R8/
M4<UW<6FO+S(3BM&*W2W7  )]Q7MX6$D[GGU:J2L?.$'AOQ+:V36[6LHBE_A
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MZ]T!POPT\&'0XWO;I2LLG.#7H>6E)D/0<4,2P XP.F*0<<=JY97;N M%%%,
MHHHH ****70:$)Q4%Q$74%>M6,9H''2LYQNK%QE9E(W$\,7ELO!I8?(D0A\
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M&0B%=I.TU8L]8O;:>6*.P=8FY VGK1[<"E_PC%R68F0 )3+3PW]I#MYX)4]
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M XKF[BW\6VUK'?6VH+=NV#Y0;M79:1=75UI,9NXO(N#]\4PN/BT^SL8H_LT
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MHHHHN 4444T 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,#L)'<4^RTS3H/#;ZI>)YS@XI]I#X?U(+;Q*(9I1QFL[0[#YI]R!/'6K;-^
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MZ*,;>E><_#ELW,OTKT51E:\.KK(].CL%%%%9G6%%%% !1113 **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBBF(K:C:M>V+VZG!<8KB_\ A6J
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MANA S*01ZUVMKJ5C>J'@G )Z FK6QGY:0'Z52Q#?4QEA;' +\-P&R9B12_\
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M10 4444@7F%%%%!6@444468)@>E(H&.I-+118=Q,;3DBE+]T)!HHI.*'S6V
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M'HT.5;EE/'>+=%BC,LA'89JF\WB37)?W:F&(^O%:&A>%7TV<NZAN>XKKL *
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M%B]\-2BN7@G;JR]31;^!["SU1=364S76<EFKI@"#G(H52 1G@T[L0I;+ACT
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M&T4[BCBD&HVBG<4<4!J-HIW%'%.X]1M%.XHXHN&HVBG<4AQV/-)C0E I> *
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M*/JLA?6#U[=]*-WTKR'_ (2[6?\ GJ*/^$NUG_GJ*/JK#ZR>O;OI1^5>0_\
M"7:S_P ]12?\)=K/_/84?59,/K!Z_P#E1^5>0?\ "7:S_P ]A1_PEVM?\]A3
M^IR#ZP>O_E1^5>0?\)=K/_/84?\ "7:S_P ]A2^J2#ZP>O\ /M1S[5Y#_P )
M?K'_ #U%'_"7ZQ_SU%'U1L?UA'KWY4?E7D/_  E^L_\ /44?\)?K/_/44?4Y
M![='KV3[4;C[5Y ?%VLG_EJ*/^$NUG_GJ*/JC)>(/7]Q]J,GVKR#_A+M9_Y[
M"C_A+M9_Y["CZHP^L'K^3[4FX^U>0_\ "7:S_P ]A2_\)=K/_/44?5)!]8/7
M=Q]J-Q]J\B_X2_6?^>HH_P"$OUG_ )ZBCZK(/K!Z[N^E ;Z5Y%_PEVL_\]11
M_P )?K/_ #U%/ZK(%B#U[=]*-WTKR'_A+]9_YZBC_A+M9_Y["CZK(OZPCU[=
M]*-WTKR'_A+]9_Y["C_A+]9_YZBCZK(7UA'KV[V%&[V%>0_\)?K/_/44?\)?
MK/\ SU%+ZK(/K!Z]N]A1N]A7D/\ PE^L_P#/44?\)?K/_/44_JL@^L'KV[V%
M&[V%>0_\)?K/_/44?\)?K/\ SU%'U60OK*/7MWL*-WL*\A_X2_6?^>HH_P"$
MOUG_ )ZBE]5D/ZR>O;O84;O85Y#_ ,)?K/\ SU%'_"7ZS_SU%#PTD'M[GKV3
MZ"@$]@*\A_X2_6?^>HJQ8^-=2M[M9+IM\/<"H=&2Z%QJH]69]N RTK8"96J.
MC:Y9:U;J48!_2MD0H!@URR?+N=D/>V*8Z45>\A,XQ1Y,><8J.8VY2C1BKZP(
M1TQ2_9T]*.8?(9]%:'V=#VH^S)Z4<X<AGT5H?9D]*/LR>E'.'(9]%:'V9/2C
M[,GI1SAR&?16A]F3TIK6ZJN=N:.8.0HT5>,,:IO;"CWIJQQ.#Y>&QZ&CF#D*
M=%7!'&S8 ^I]* D1)SP!WHY@Y"GQ1Q5Q8X6[TA2)3@C&>GO1S!R%3BCBKWD1
M].-WIFFK$C<$8;THYA\A3XHXJX8X@<9'OSTI?)3=MQ1S!R%+BBKPMXS36CC!
MP!GU-'.'(4Z*N^7!M+;AM'>E:&,#U.,T<X<A1HJ['%'*NX"E\E,9Q1SAR%&B
MKOE1D@ 9S^E*($SC%',+D*-%7?*BY]J/*3&=O'K1S!R%*BKPBB*[@05]::8H
MQVXHYQ\A3HJ\88PNX]/6F^7$6  R#WHYPY"G15_R(^_%,*PAMN1N["CG#D*=
M%7'B1=N$SG]*"D6_:,'U([4<XN0IT5=,<>1M&0>] B3=@K^-','(4J*O"&/N
M,4"!".E','(4:*OBW0]J4VZ#M1SAR&?Q1Q6A]F3TH^S)Z4<X<AG\4<5H?9D]
M*/LR>E'.'(9]%:'V9/2C[,GI1SCY#/HK0^S)Z4?9D]*.<.0SZ JDYSS6A]F3
MTIOV>-6SCK4RJ60U3*<43._M4TKQ6R9D(%17]_%80LV0#7 ZAKES?3,%8A :
M\C$XU1TN=U#"N3V.BU/Q9';YC@Y:N7NM6O;TDLQ"FJ;*K'<>6]Z7>X';%?/5
ML9*3T/:I8.,5J,^7/SY/UJ3*E<( *3.X= 32*H)^8%1ZUQ2G)G6H10;3WZT8
MI2P' .1ZTF=QP 334)2!RC$4#-+M%*MM<R']W"S#UQ5R+1+V7'RE:TCAILSE
M7BNI1(('RGFFY;^)JW8O"EW)@F4 5<B\'/\ QR9KIA@IOH82Q45U.6WKW:C?
M'ZUVJ>#K7'SY)JP/"5D!]VMO[/FS+Z[%'![T]:-Z^A-=\/"EC_<J5/#%BHQY
M=:++I$/&H\\WK_=-&\=E->B_\(U8_P#/.E7PW9*<^75_V<R?KJ/.=_\ LG\J
M-_\ L&O2/^$>LO\ GF*#X>LB/]6*G^SF-8Y'F^\>AH\X#L:]$_X1>P_YYTG_
M  BUA_SSJ?[-8_KZ/._,4\\TN]/6N_?PO8YXCJ)O"EF>B&D\"T5]=3.$+)_>
MH!!Z-7:OX0MCT%02>#Q_ V*S>"GV-8XR'<Y3\:3 KI)/!UP 2LHJA)X:O8^^
M:REA9KH4L3"74RL"BK,VEWL/_+%FJL5D3[\9!K&5&:Z&JJQ?4,49V]LT*P/M
M2MV(-8VDC5.+&[@?X,4N".5D*GZTX/@?/@"D^1QE03[T*HTQN":+MIK%[8,#
MYA9!VKJ=-\5P7 "R#:WO7#XH9=WM]*[Z.,E'J>?6PT9=#U9!'<+N5@<U#)$R
M-7$:-KT]C(J3L73H*[N&ZBN[=91SGM7T6%Q7/U/&KX=QZ$)I.*O"!" <4HMT
M]*]/F1Q*)0I*T?L\8'(JLUQ8))Y;3(']":.8.0K\#KTH!7=N1B:OB&)ES_#Z
MUR?CS6IO#VC+/9*&;/:FF'(;N&0EI$.#[41@1MO8'8>@-<5:W7C&^T>"_CD0
MHZ[@F.:O^'O&::AJ+Z1JL!M[U.A;@-57$XG2QB1=X( 5CD"G'&ZL&]FO?^$K
M@MDN5$6/]7W-;=[JNE:<<7=PD;XY4GFBXN4?Q1Q4=AJ^DZH2MI<+(X_A%.O]
M4TK2\"]N8X6/16/)I<P<HN:,U#IFLZ7J\CQVLJLR]J;=:_HEDYCGNXUE'5,\
MT[CY2SQ1Q266I:9J*[K2=)<#+;3TIUI?Z9?RO%:7"3.APP4]*.8.43BCBG75
M[I]E,D5Q,J._W03UIE]J>EZ=&KW4Z1ANF3UHYA<HO%'%0V>MZ1?N([>Y1Y#T
M7O5F:]TVV?9<7"1MZ,:.9ARC.**AAUS2+F^%G!<(\Q["M;[,GI2YAJ!GT5H?
M9DH^S)Z4<X^0SZ*T/LR>E'V9/2CG#D,^BM#[,GI1]F3THYPY#/HK0^S)Z4?9
MD]*.<.0SZ*T/LR>E'V9/2CG#D,^BM#[,GI1]F3THYPY#/HK0^S)Z4?9D]*.<
M?(9]%:'V9/2C[,GI1SAR&?16A]F3TH^S)1SAR&?16A]F2C[,E'.+D,^BM#[,
ME'V9*.<.0SZ*T/LR4?9DHYPY#/HK0^S)1]F2CG#D,^BM#[,E'V9/2CG#D,^B
MM#[,GI1]E3THYPY#/HK0^RI11SH.0^=:*6BOJ>4^5YA**6BCD#F$HI:,4<@<
MPE%+1BGR"YA**7%'4X'6ERV'S"44H&>G.*3(S19!S!11D9VYY]*7':E96#F$
MHHXI64I]\8H20KW$HI<<9I,CUJVDRDV@HI<4=ZS=D%Q**7::3C&:>C"X44+A
MAE>12D8ZBGH%V)12K\WW>:,9;;W]*'8+L2BEQSCO1BFDK"YA**7;SCO1C.<=
MJ5D/F$HI1STH(QUHL@N)11Q0,$9':CE0<P44<%=W;UI1S19!S"44N.<=Z,<9
M[461+=Q**!@].:7%/D&F)12T4<@W(2@D <]*6@%0?F&10Z::(525R6QN[S3)
MQ<6<AV@Y(S7J'AKQK;:G&L-RP68<<UY4@96)4X4]C2)F*7S(24?KD5Y];"J1
MWT<2T?122+L!SG/3%.SQD"O+/"_CA[=UM;_+#H&->DVEY'=1B2&170CM7CU:
M+@>S3K1F7%X'6ES3$*G@'-..!U-<J;OJ=7H.!YI::O6G58(****!A1110 5!
M=SI:P//(V$0$FIZK7UJE[9RV\GW)%(.* /--)GUGQ]K-W<_:FL]-MF,:JA^]
M[U-XAT/6?#.G_P!JZ;J<L_V<[I(F/WA5#PG>3>!-0O\ 2KZUE>.>4O%*/N@>
M]:OBWQ4U[H4FF:=;O<75V-N4'"_6@"TGQ%T^W\,6^K78*-)A751WI?\ A8=G
M%/;I)"PMI\;788ZUQ>O^'[O1?#&DVDD'VF2253)&!G'-=1\1;2,>%+18+(&1
M57&Q>5X% '2ZSXITW2(8F+J9)A\B@]:S=,\:6$M['87K[)93^Z)KSW6M%U#^
MU?#^J3J[V20A9!V!]ZNW>FV^H>(].2UB>1T8$NG\- %7Q]JNO6'C6WDLKR00
M(PW(O0BO5HM;B_X17^URP)2')/OBN)EL&N?B&EE)$7@,)!<CC.*Q[%M3?Q$W
M@^2&1;5)2[.>C+Z4 5_AWK.LZCX]NYM0NI#93$M'$W3%>@WWCFS^UR6]B1-)
M"3NQS7(V-A<6WCZ6QMX3'"D3*C8]JR/#6F-H=[J,5\C1W#2LWF2=&% 'I^E^
M,-/U6SGNHY LEM_K4)K&N?B#%>:9?R6<#^5&A'F =ZY+3O#USJ6GZK/IJ/$^
M[<?1Q[5KZ7XAT^S\$WEM+I_EW:H5:-EY<^M &7::[J5]\-=3O3<.L@?$3=\U
MH?#GQC?6GDZ+XE+"YD :&=OXAV%9>D_:F^&M_)]C9&>7*QD>]==>>&#XA\&:
M?(JK#J-L@=' P<CM0!4EOM2'Q/BMTN62QZM&.A%;VJ>.[.UU!K"S_?3Q\N!V
MKSCPG=:Q?^.6M]2MW6>!603$<'TIVB:=<:+X@U(ZHI6:25F69QP1Z4 >C0^+
M[*XTF[N;9]UTB'=%_=-8/PQ\7:AK[WUO?QG"R':Y_E5#P?I<=SK.J7$5O(JE
M6R6^Z_TJ[\*IEC&JZ?/!Y4PN6921R10!W6M:K:Z'I4VH71Q%#R:Y"/XE6UW:
M+>P0R&U)^8[>U:OQ'02^!=05@"% W#UKC?#GB72E^'SV8TX><82BIMY8D<&@
M#M=0\;:1IV@)J@;=:OZ>M0Z9XVMIK(WETICMV&Z-B.HKSF;2;VT^'D$5[;LR
MRR96(CD#-=AXFT>:[^&]C#8V^)8T5MBCG [4 3O\1H S3/;O]A!PS[>U:<_C
MC2K:*WE#$VD^ K^A-<O!XGTO_A"VL9M-_P!+V>68=GS$^M1:+X0N[WP+<6UX
MGEOO^T0;ARH'.* .[UCQ#::+;6[7!)-S_JO?-8=KK-K/XG3-TPVQ[F0]JY3P
MM<:MXVUZ&WU2V,4.DM\A8</CBI)[.[O_ !Y?0P0F/]TP5P..G2@#J6^(MG/>
MS16<4DEO#D/*%K*^''B*2_?7;V\N";-)3L+]A57PAKEIH.@W&G:KIV+J)W+9
M3F05@Z#8W.N^%O$?V"VDLYI)BT49&,B@#O&^(-H9G>!/]!B/SR"M>Y\9:/%H
M0U59PT!Z8ZYKR_28(]/\)/;7T>+H'#1$<M5V#2(;#P1,]Q83RQ3OD1X^Z* .
MRL?'D-S/$LL#>3,<(ZC-;]SKMI:ZI;Z=+O\ M%P,QX'&*\FDNK_2SIXT5$N8
M6(W0XRR5Z<NIVHN;&"X@4WTJ9!(Y2@#?!/>E/(I%/'O2CD4 +1110 4444 %
M%%% !1110 5#/((D9SV%351U(_Z'*.G%8UG:)45=GGNOZE)>7C1QL=H-98 5
M /XN]$C&&\E+=2>* GR>83U[5\;BYMS/H\-!*-PH)X-+BCCO7&SLO="1AW.(
MT)-:MMX?O+Q<N"%K2T>6Q6(;PH?WKJ+21'7Y"N/:O3P]&$V>97KSB<[:>#T7
M!D<GVK9@\/V<./W0)K8&T#KS1D>HKVJ>&A%'F3KSD5H[&&(8CC5?PJ40 ?PB
MI 0W>G9XZUT1IP,7.1&L8!^[Q4FU1VI0:4ULHQ6Q#;$XI>/2DHJHV$+D>E'%
M%(:K0!>*.!3:6C0 S1FC\*/PIV0"T4E%%D(7 -)@445/*B@P/2C'M112Y4 A
M6HS&#V%2G.*:"/2H<$QIM$36X;^$52FTJVDR6A4D^U:@--)&>M93IQ9<9R1S
MEQX8M9@=B[36/<^#9%RT4I)]*[DFF_*.<UQ3P\&;QKS1Y;=6-W9,5F@+KZXJ
ML#Z97_9KTB]F@Y$NS'O7&:O'9F0M"1N]J\?$T(1V/4P]6<MS*HI:*\S9Z'H\
ME]Q)5/D[E^]73>%-2;S1;RGZ9KFFRH4>]7M#!;78RGW1UQ7K8*LT['G8NFK'
MJ"\BGU#"3M-2YKZRD^:-SY^2LPD&Z,@=37AOB7PCXMN/'"75K/(+3>#@'C&:
M]Q=OEXJ*60PQF23&U>]:K<@991/%IL$4IS(J -]:X?XK@#PZJHP0Y%=F-4T_
M&3=1AO3-9GB/0[+Q7IP@:3<IZ,IJEHP%\*310^%M.,EQ'@1#)+"O/-:=-:^*
M=J-/^80-F21.AKH[?X>RPHEJ;V3[,HQ@-VK?T3PKIGALF2!"\C]7;DU5];DG
M$:I<'_A;=F!*0JJ 13_%GA+49/$YUBV*WD0&6@9N *ZZ7P=:W/B--88_,HZ5
M!J^@:D;J2[L[X01$88.> *+CL8_A7Q!HMQJ,EK'9+:7Z*?E7UK!T"WA\1?$3
M4(=:D\Q8,F..0XKL/#O@[3[&\.K"19;QNL@Z&C6_ =O?ZG_:MA(;:];[S X!
MJ0L7]1TW3M)TFYN=-ACBF5"1L/-</\-["P\0->7^KHLMP7*A93@BNOTO1'TH
MO<:M>!HR,'>?E-4KCP9%+<O?:-<>6)>@0X%--@<R\/\ 87Q)MK71I UI<<31
M@Y"YJ>Y4^!_'XNHUV:;><.Q/ )KJM!\#VVE71OKV4S7C'.[-:/B7PU:^)]+-
MG<@@?P$=0:+A8X6%Y/&'CTSKEM.L?XP>#61KEW=WOQ#.GM")84'[M'. :]0\
M*^&+;PMI_P!DAR[-]]CWJKXB\%VVM7 O828;U>CKQ1<+'%:CH&O-K%E>6%C#
M:"$C>$;[PJ+XC1R2ZUI%L)"DDC*)#G%=E8^%M3CNX)KB]=O)ZC=PU6M9\&6^
MNZG;WURQ#PD%<4.06+6E>&=+TMDECA#7&T'S#70#D"JZQL%5#T  %6 , "H&
MD+BBBB@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ^;LT9HQ1BOLKGQ89HS1BC%%P#-&:,48H
MN-(,T9HQ1BG<=@S0Y 4,.#[48K0\/VR7^NP6SH<$]^AKGKSY8W+A&[&6NC7]
MU#YD"$;O[W%3/X?U:&(,]LK*.K*<UN>+M7DLKL:7: )M'5>*PM*\17NFW8+N
MTD!_U@<YKD]L[&GLS+W,DC%HCN''(J_9Z3J-^GFV\65/4MQBM>&2S\1>(XTM
MD"H>67'6IO%>JR:?/_9]@/+B0?O O!-'MM;![,RV\.ZFJ^7Y*G'.5.:R&5HK
MMXYV9I>@5JT+37-0TZ\AN8Y2\)(#(YS70^+K.TN+"TU6*+9,Y&<"HE7:*C3N
M<[)HNI6MM]KD@+1,,CCH*H%]C1.J9!/(]*]:%];VFCV27P7R)HPI)[&N#\1^
M'GTC44NH'#6DQ!7TK-8IENB47T;48BK^4"DW*D]JLMX6U1]OE(I9O0UN^*V>
M'1[%P^T[!C%8GAO4KUM;MHWF=D8^M:.JW&YFX:C#X2U<#;(%0CWJO#HU[)=&
MUCC#L.N*V/&%]>6VNXAG8#TS4W@62676Y7D8N2.:2K.Q2IG.C3;M[TZ=#$!-
MFF7EC=Z9<BVO8]N?XS74V41?XE,0<>U;^NV^G^([A](F98[N/E6[FL_K#3+5
M&YYO9V4]]>?9+5>>N1WJ2/3+EK][0 _:%X(K:\*V=QIOC,:?."-@.">]:-L=
MOQ%F&W/M3^LNXW1.-G@>SD:&08E%+8V=S?3"&!=TG<5J^*MG_"038&&!Z5/X
M%W2>)6&0"!T-="K^[<Q]GJ8=U$UC=F*?(E' %6;3P]J5RIF5-J'D9XS6]]B@
MU/QY-%<KG8<@5!XIUZX2[.GVG[J*+@XX)J%B&-TS-F\/:O%$95@5D'7:<UF$
M"2=86++.3C:16CI>OW]C>1DR,8'(!5SFN@\7Z9 +S3-2A0(TC*3M'6E]88*F
M<Q=Z=<Z=Y?G1XWU7B222<0QIR_%=C\0@WD613 .T9KF-(9X]6M69ARP%5]8T
M)]F17>G7&G?).N >0/6K%KHNI:E$&C@$:#HQXK;\>L5U:R=\")<$UNW(&N:-
M##I%Y'"P7#8.*EXAE>R.,N?#6JV\?F)$) /O8YK++,F4D7#^E=A;P>)O#S,'
M/VN ]<<URVH2M/J#3-'M<G[E:4ZS9$H6*ZL I"C#>E )QSUI2/F\PC#>E')Y
M/6NZ,KHS:$S1FC%&*INY.P9HS1BC%3J/0,TN:3%&*.6Y/-87RS+]TX-;.A^*
M;S1+A8I&+15C+DC(.#2Y4CYQDUS5**FC>G5E!GN.BZ[::M:B6!@'/49K8!W#
M#=:^?;#5+W2)A<6K$J#R@KU/PQXOM]7A5+AQ'/Z&O&KX;E=SV:&*YMSL5/SX
MJ2H8R"V<YXJ:N*UCTD[JX=Z*3O2T#"BBB@ IDN?+.WK3ZBG;8 S,%0<L30!!
M/9V][&!<P*_U%0VNE:?83&2"!48]\50LO%^AW>I/807\33J<;<]ZV]H9"6Y&
M,C% $%Q'9R2J9S'Y@Y!8BG.MM=1$,$D7H<<UX_I,.M>+?%&IV]Q?>7;P2%8U
M!YQ5[6X/$7@5(+V&X-QIZO\ O5)R<4 >GW%G;368MY(QY/9<5'9Z9864AFM8
M%1B,$UDR>+H8M$M+_P AIOM"AE1>HJI%X\T][V&WN[66UDE.%#\9H Z=;6U:
M<SI&OG?WN]--I;^:UR\2BX(QO YKS76?&]_9_$NRT]86^R2#&!WKLM0\50:?
M="U-G+*Q&[ % &K:V=L)S-L#S#^,CFDNM*L=1;==VZL>U8^D>,]/U74?L(B:
MWN1TC?JU=%<%O*=D^\HRH]Z (+>&"R!1%CMXEX"\#=4,FC:5>.9S;1R,>I%>
M7V^J7OB37;^'6K[^S1:OMA5CMWBN@T*QU^TUD36VJ0WFF=T4Y(H [8Z=:K9B
M'RU$7]W%3!4BB"Q+A5'2L'7/%UCI#B$HUS,W2&/[P-+H?BRTU><VSK]FN5&3
M$_7% &J+6V,HN884$G<XIM]IMAJ$B_:X1(<=,5S]_P".],M=0ELH;66X>+[Y
MCZ"IX?'6ERZ3_:!& &V&,_>!H Z""TBM%5+:-5CQSBHX]-M+>=YX8565NKBJ
ML^O6\&@G5^5AQG!K,O\ QWIEAH\.HR@E)3A0.YH N^)=&.O>&[G35G\HS8^<
MG%1:'X3TW2M*MH#$DLL2@&0]S6-J7BFWU'3UE99+2,$'+<9K#\5^.+O1M4TJ
MUM(W>&8+R/XJ /3YK:VN]JRQJRQ] 13XR5&TH%0# 'M6!I_BZQOK\:>T;17)
M4$JU6+CQ!9V^NIHQR\S+NXH LMHNDO="\:S039^]BK[+QC ,9XQ2*WF#.S /
M8T_C&TG!H @@M+>S<R0QJI?K@4+;6R3F:*)?-/4XJ?#8VMT]:% 4?+U]: *-
MSI6G7LXEN;9&F'?%6+6UM;8D00*A[X%3!1G+#GUI_P H% &;-H6F3W7VB:V5
MI<YSBKQBB:+RFC4Q8QMQ4O&*9M&<F@"A;:)IUI.;BVMUCD/4XJ>33[6:Z6Z:
M(&=>C58YQST]J%'S J>* '#@4=Z.]*3B@!:*** "BBB@ HHHH **** $JK<1
M^:'1NF.*M&F, QQ6=2/,K#B[,\OUJQ-IJ#/(OR9XJBP.=X^X>E>D:KI<-]$1
M(!G'%>>WUE-8W3)("(L_+7S.+PUG<]G#U[JQ7S1GUI<4 9//2O%J+H>K3>@
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MZ/J&D6EI(\D,P7,H'WQ6-J4VK7WP_M7U.$EMXVAQSC-7?$HBC?PW/-;#RU"
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M:C"FN7<7V\^:BEA'7,>/[>*VU/PVUI:A)O-7>ZCM3]-03?$?4 Z\^5QGH>*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<:X=<U>;=,C'RD(Z"MB?QSI=O=&%(Y)50X:1.@^M:3:[IYTXZG]I7[.@Y.:
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M>20>M(%&[YC1FC- !BC%"Y?E?NBDSN;"_C4II;D.+>PY2N[!I))0IP*)#&N
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MFLZ%IL/PSAD$.)!;!@XZYQ7;#1M/:SBL6ME-O%]V/'RU;FL;>XM/LLL:F(#
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MWQ;\EY)(T"<NM+>Z8_@WQA%=Z@SW>GS,/*W\[*T;)N>F7FO6VF:)#>WK[2R
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MO5V%<ZJ36O":VBV+2AK8CA<9I]OX+\/7:+=P1.8WY&&K1B\*Z-! +?[&C8&
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M97B@+F:NE6D=@ME&H2Q4;3'ZTR+0M+M]/?3X[8?8WY9:U2@8$$4ACY)'IC%
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M )]:V<CUHR/6CGEW#V<3%_X171O^?:C_ (171O\ GWK9RM&5HYY=P]G$QO\
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ML?TJ/(HR*.4.<D^V/Z4?;']*CR*,BCE#G)/MC^E%1Y%%'('.)1115F04444
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MBBBBX!1110 4444T 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP**  !D&BJ0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFB-NH'H;>&=$\T(MK%CZ"E/AC1 <?9XOR%>7^%].\4>)-+:=-0=6!(SFME/
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M_P (2?\ GI1_PA)[25U'VAZ/M#U'U&/8OZW/N<R/!3.ZF208%;>GZ!:V#!E
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MB#0-L(X+>7TK>,$QH]8T77[76M*?4;5A(0A;:*\UNOC#>1:E-8VUD\LB.1M
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M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 <[XQ\3?\(SI9FB3,[_=S7#I#XO\
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MM2#)[TM%%T&H8Q1113N1J%%%%%PU"BBB@ HHHH **** "BBBF 4444 %%%%
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MA[P_I.F0CS+FX&/I0GCJZT34K>'48MT-PP7>.<9IW%8]% D8 (,CO22!V.P
M(!ZUP>M^.;O^VQ8641CB !\W'6MOPSK&IZA#.;N%&$8.P@\M2N*QT6YB O!
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MNF(^M;%IX5TJR ^7S#[UL\G[QS1A1T&*I4T9NJ,BM;>)0(8$7'3BI6:4<;U
M]!3/FSRW'I2\>E:I6,)5 4 @YY-*2^W X%&?04A)/>G[.[N1[23T!0%!!ZT4
M45I:PG'J%%%%2MR0HHHYW=/E]:I[@.B_UI^E>3W7_)6H_I7J\;+YQ"G)Q7E5
MRA/Q9C]<41Z@>KM]]?I5/4O^03>_]<S5QP0%?VJGJ0/]D79'.8S4Q8'"?"DM
M_I^!_&W2F^(=0TM-2>._T:9AGF95Z4[X4,/,U!=V&#G(%6O$6I:Y:ZD<:6+G
M3_XFVYK2_O <;K]CX=?2&N+&^F$I^[$S=#3]"L_#;:,DFI7TJS <HK=:/$>H
MZ-=Z/*\>DM;3J.3MQBG>&;_18M$22;2&NI,?>VUJY.P&_P"&=0TF+4U@TG29
M6CS_ *]U_K1\5BP^PL?F!=>/2K7AO4M6NM046VD"UL,\?+BJGQ9W"6PVG!+K
MD5@V[@=_I@!T>T(Y_=+QZ<5;CZGZ55TLJ=(M0/EQ$N?RJU'\Q)7D8J6!Y3;?
M\E;E^E>KR??KRFW7'Q?E4_W<UZM)]^FP&T444( HHHJ@"BBB@ HHHH ****
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M@"A/WB;U!VT7 ** ,C/:BF 4444 %%%% !1110 4444 %%%% !1110 4444
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MF7 4;FJ_5(EA1115$A1110,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH  HZ]Z:56;Y7'%*.:4D8XZT  40KY2#Y33$BCCA:)E^\<T\G"Y
M]*4XDD4^U9N)2FT5VL+<KM"BG+:0Q;2 .*E&"X(I1A@WM2Y2W48PPQM)OQ2&
MWC*%"HY.:>"!&,=329;J?I1RDJH1/9VTCES&.1CI3HT$8"J, =*D''![<T'U
MJD@<KCL\4VC-%:6("BBBD 4444 &:,T;:0[!UEC'U84@%S1FD_=_\]H_^^A1
M^[_Y[1_]]"@!<T4F8Q_RVC_[Z%+\I^ZZM]#F@ HHHI, HHHH0!1115 %%%%
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M#;58=:ZYIE4*!M&>, <8IS_(P&\(QZ "@+GCSV3YO5O+>X@O2Q\LPC -=?\
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MX@ &>.M'<>U%%%A7&[?FSD_2G'GM112L.XH.*3'.:**+!< ,$^]';%%%.PA
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M %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY21%R8PQ[]J6BBG8 HHHI@%%%% @HHHH&%%%% !1110 4444P"BBB@ HHHI
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M446&%+FDHHL N:2BBBP!11118 YHHHHL 4444#"BBB@ HHHIB"BBB@ HHHH
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MW9%+SWHSS16AS=0HHHH ****!A1113 **** "BBB@ HHHH ****E@%%%%+4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBBL3=!1113*"BBB@ I#110B9 *6BBM3 **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBBD 4444 %%%%, HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBH ****L HHHH
M **** "BBBI0!1115 %%%%2 44450!1114 %%%%4@"BBBF 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>forms-1_013.jpg
<TEXT>
begin 644 forms-1_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'Z!BD# 2(  A$! Q$!_\0
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MI8H(3([X5>2:JZ9K5EJYF^QR;Q$<,: - 87I1DD].*:LJ,<*<FGEB!DT !!
M^6@9 YI#TW%L"D7GD'(H :PW9R<"@G +#GBLZ[U_3[34XM/FE FEZ#-7_O8V
M'"]: '(<HN1UIS$KT%-\P %OX1T-&\[-ZG=0 HQ*?F'(IS-MP *:.1ECMS1N
M96  R/6@!VU>M("2Q). *5@"P^;!]*RYM>TU-2&G-.OVAOX<\T :**JAN^:<
MAXZ4U>?N]J4-AR,T "@(Q!_BI<J7V>G-0W4\5I$;F9@JH.<U6TS6++54,UM(
M&P<<&@#1R<T@ )I><^U()$+$ \T ,(;D!N/2D^4,& R15;4-1M=)@:XO'VIZ
MTMC?07L"S6IW)(,@T 6R !N ZT<;>!42$HY!;+'^&I 2HR>E "CD=*?T%-ZC
M(-)]X]: '<TPC:=V.:<6"G%!X^;/% " ;OF(H+]B.*3D_,QP*4,#R.1ZT *<
M@86ACQD]:#A3ECC- &/<&@!BD,<8QBD<?O P/2G%6#@J1S68WB#2H]5&FF<?
M:C_!0!ID;4R.]*,D FFL<1LS_*J\UFZ=KUEJEU+!!,I:+J : -7KUZ4$G=C'
M%)D*,D\&G=\]J $)P#CK3 X*G/!/%/+#!"G)JG>7UM86C7-X1&B<Y- %D !0
M!VIR*HR1U-4M,U.UU.S%W:OOB;@$5<4'!/!^E #LY!W4C' &V@D!,N,"A2I3
M*\B@!KMC! SFE+8XSBA$;;R>]9FHZ[IVG7D-K<R@2RG % &F.OS,,]J K$G>
M<BLR;7+&.\2UW?O6^Z*TMV!UR"* %7.<8^7M2YP",4P;PI(.0>E/WA2%8X)H
M 1AA0!Q2;BK $9&.M#84,7;Y:$8;"V<KB@ +J,$<YIXPHSBLJTUJPO;Y[.%_
MWT?45J=#\QY-  0&Y(I0<GI2=.6/%*#DY[4 *P!/6AON\4PLCG ;FEZ<=0:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :
MR[L9KPCQCJ]]XU^(<'A*SF:&!3^]P<<"O=)V:-"Z\[>WK7D?BWP#J<'B./Q=
MX=D*7@Y>(=30!L:M\-= L?"5PLGRO#"6$QZA@.M<I\+_ !-?:;X0UNYN9'F@
MLRP@D8YS5J[L_&WC2./3[I7L;<\3,?XA6KXE\$W6G^!T\.^'X\B4CSG'?UH
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M(PCD0'TXKMO '@^ZL-0U>ZU<9ENG8+G^Z:Y.'X5:C:?$Y;T9_LU)=X/8CTH
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ML>#_ !Y<"QC_ .)+,WITH QM8=="^+%A/?3E88H,L6/4@5S/C:;5/'5U<:Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@".6(R%2&(QV]: I ) YJ2B@!@W 8/-1J)O,9< )V-3T4 1
M*'QA@#S2/$Y<,&QCM4U% $3B0X(/U6FN'4!5'RMUJ>H;J=+6UDG?[L:EC0!7
M2X4W'V831^P!YJSR/E/ ]:^;]/UO7+SQ_JFIZ2D\T$3'"@D@5ZAX"\?'Q-:W
MT=^OEW%J27'IB@#O/M-ND@B-Q'YG]TL,T2Q/-*"&*J/UKQWP_K^FZOXJU?5[
MQY5M;')C;=\K$4K?$[Q#JSSW>D:?)]A@.=V.& H ]CD<QJHZMG I29 0,9)Z
MG'2N*\/>/K/6_"5YK(0QRVJGS%;U%<?IGQ/\1:]:7-W8:?(+>'.'QU H ]E+
MCS=C#/O34N8))FA6>-W'5 1D5Q/@[QM'XD\+W]W(I2:V5MX/7(%>3^$O$6M'
M7M;UBWBGDA0MLR20,&@#Z.28'?@$;3CD4".1W+LQ]E[5PW@#Q\_BS2;RX>#]
M]:YW*.Y%<QJ?Q2U.WFN)Q$8X(&(,9ZF@#V*)6&[<>3V]* "BDJG-<1=?$!(O
MAQ_PD_EE'V\(>I-8?A;QMXD\0V[:BT'DV07=EAVH ]3&X+OQ@G[U. #=><\U
MY!;_ !1U+5;Z^M+&U:1+?.Z51P,5'I?Q0U/6M,O!96<C7-H3ND X % 'L66"
ME]OX&DP[!7''M7!^!_'<WB;2;NXFA)-L#N _B(KE=3^*FJ6OVBZ2$QV\+[1$
M>N* /9B=O!YS2%"Q'SY']VL7PSKZ^)M"@OHAM+ %@?6J_BK7G\-Z;)<QP-)*
M1\N* .C\MA\O;K3AG.2*\5B^+6HV6I6D-XOF+<L  /X<UTGCKXBGPQ<V,4*%
MY;H A![T >B*ARV?N]L]J<HX*L!CL*\<NOBGJ^BZS8V^J6;B*[(V#'K6[XR^
M(AT>ZM+#2X6FO;E0VQ>2H- 'H+2M$KM.ZI&.C,<40NLBYB97C/\ $#7@'CCQ
MQKSV2:+>0RQ3W)'E..*]E\%V$UEX2L([B1FF\L%R30!N -M* 97UIIE2T0M/
M*%C_ +SG&*\\\7_$J33M7_L71;5KJ^4_/MYQ7 >.?&FOZI%:Z#<PR6\]RZG"
M\$"@#Z%$J3*"CAU/0J<BG-'N3:>*\FO/&\/A*QT_P]9,TM]Y0+NQS@U=\(_$
MX:MJUQI%[C[6JDH1WH ],RRD XVCO36<%R.AQ]ZN!\)^/!K5UJUMJ0\E;)R-
MS<<"J^@>.;G6]8U*=(B-'LP=DO9B* /0TNK=I/*,\;/Z9YJ4H6Y< XZ"O%O"
MWB'3Y[S6O$EX\J6]NYVAFX;Z4Y?B;XBU$/JMAIDLVEHW"J.2* /9E!0DD\GH
M*22,MRWS#KBN'U3XDV.F>$(=:OK=HWF&%@/WE-<?!\6;RPGM[J\(>PN6 1.Z
MYH ]J1P5!' Z4-AF!5<D=#5.UNH[^SCN5/[F50R@>]<'XV^(<_A76[32;:W:
M>6Y^XJ]10!Z.SNI'')K'\1^&X/$5LL-Q,T:C^[WKS5_BOJNF:_'I%_8N9Y@"
M@ Y&:L6'Q,U*/QO;Z%J<!"7!^3CF@#T'PWX6L/"]HT%BGW^6;'6MG;M&,=>U
M>?\ C#QEJ.EWWV6R01[1]YN]0^ /B(WB;4;O3[B(B>W4EI.U 'HY!W!5.!2*
MY+E&Z_2O(8OBCJ>I>)+[1K"V9S;L?WH''%:O@3XCR>)-<O-(O8O+>U!+2'IQ
M0!Z0NXN>< =#ZTTEI\H,J!U/K7"^'?&L_B'Q;?Z?#&?L=GG]Z.AQ6=HWQ!O]
M<\2:E8VT?[JT)&1WQ0!Z1<3VT*!);F.$>C,!3XY$=!Y1$D9_B7G-?-$TOB#Q
M_P#$5[5Y)TMX7^=8V(X!KT'5?&=YH$T6C:;&T/V=/F,O);% 'K&2J8/X"N*O
MOAMI][J4^I0RM#<R_>QTJGX*^)5MK>FWDMXA26T!+L>AQ7.R_$_7-;EN)M T
M^1H(&QP/O 4 >@^&O"&F>&RS6\0>\?EYB.:Z%V!^7>#].M>=7_CJ_N/A]-JM
MO;M!>1#;(K#D&N9^'?B;7SI.I>)-6+-9J"8\]* /:R^S"MR>QHD5G8;CA1TK
MS[PQXY>_\+:EKUVNR*/)BW=Z7PQXWN-7\(:EKUW\D=ODQ@]\4 >AG=CCCZ"E
MP6&?:O(?"_Q(UWQ4'>VLFBACY+L."*34?BPUY>R6VFD1O; B3/=A0!ZYDQ *
M!G/2A82)/,+$D]J\]\(?$B/7](OI;@".ZLU).>^*P]&^(^M>)+F>'2K5RL4F
M&DQQB@#V EMQ %,8$2C+'FO)->^*EU#K:Z#;+Y-XJ_.[#@FNE\&>*]1U8S6F
MHVS+)']V;L: .W5B^<#IZU%)>06[B.:YB1CT#-@U1UZ]NK'1;BYM5S+"A?ZX
MKY^\-3:IXX\67.O:K=RQ6-JQ+*&P.* /<O$W@ZU\6+'Y]S(D:\[4Z-6GI.CV
M>A:>ME9PK&H&.!UKRYOB/K&HSRP^'K-Y+2UX,@&<@5T_@GX@0>([2ZBN(S%=
MVH)D4]>* .Y"$LIQTIS<C&=HKQV#XH:IKFM76F:#:.WE/M:7&0O->I::;J:S
MC%[]\K\Q'K0!?.!@)U/<4DF_ V?>KR7Q%\3[O3_&3>'-*MVEESC=UQ5K6/B-
M<^'+$6FIX_M2;_5 =J /3OG4;.^.6I8PQ&&;..AKR?0/BG,NKV^FZPRM+<'$
M9%7/$GQ-FM]?&B:)9O/<_P ;+SB@#TQ/, .\?-G@TX%B6SU%>._\+3U.WUVS
MT&]LG%Y*XSQVK?U;Q]<1^-[+0;.(EFQYWM0!Z)R$XYSUJ!YH(=H:9(LG@,<9
MKA==\>267CVS\/6,9E:4#S".U<I\0;N\U7XC:5I%K.Z&-@TJ(<<4 >O:OI%I
MK^GO:7:"2)JXU?A/I2+L:=WMP?\ 4GI5;Q3XVO-)NHM(L(6A=%YF?H:7P?\
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MA@Y]*\Z\3_$7^R=*T[6+%=]G>$;O]G-7/%OQ CT'0[![<";4+X#RXUY(SWH
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M",AL'H*EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 8X)5@.I%,3*(JGEJE(YI F"3ZT -4MOQVJ2FHNW/.:=0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1110 4444 %-<''%.IC,0P':@ 4Y'6E&<<UE:QJHTV,;1ECVK"7Q'J+_ #K
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MX-.JK>W*6D#2,PR!TH FPSCGBGC@8KB9/%5[/*R6\1(!Z@4H\1ZL.!;L<>U
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M4'(S2&+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:IZ"Q:*2B@8M%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E*:BRS
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MH **** $)YJ-@6/'2G2 M\H./>J]S<K;1/,[82,9^M &9XBU8:=8M'$?WS\
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MW%I%+(.C,N35Q80J[1TH,9*C!Y'>@"FFG:?:2"2&TCC<]T7%(VD:;-.;A["
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MQN$.$?JM;] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2TE%
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MVS>;^/'RCUKF=$T^6[N6U";F20Y /:@AR-C0].6WMU.,,1\WUK<4;13(U"*
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M\K;3]:[]&\R)98SPPS0 \%MO7FFNQ5&?=\JC)I5.%W?G4-U@6%R3T\IC^AH
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MN+9^[2)XBTN5!&EWR>-_;\Z ,#_A (H-"-A#+EO.\W)[&H+[P5<7%U;:C%<
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MG"J,T 9^OZM'I6FR2G[Y& *\:ED:_O)+J<DY/&:W/%VO-J&HM'&V8AQ7/]$
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M#("8QG%9NE^([:[MY&F;8X- &-;^"[[3K6;3[)XOL<K$G</FJQ>^ XKJVT]
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M**LBX48-%'EOC<KX'I28K=@HI%9G;9#&7?VK0BT+4Y5W_9VYI7*Y64**U?\
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MRWUNJ6\RJN\=2:P;G1M6O/!ATE(F+I*"<CWKI/%.C7=_X8TBTB1O,@*E\>P
MH FOO&CMJ/V/2(HI)@,N7-2:)XP6\U-M*O4\N[//R]*Y*X\'7&E:Q'J,WF20
MS 92,\BMKP_HDC^)QJ(MVBC48&\<T >AHH'-/J))=TC)M(QWJ6@ HHHH ***
M* "BBD)P,T +03@9-,!8CZ]*PO$VN#2+ C<!*PP* .4\=Z^&D%G;OGL0*XI
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MF_YE[]*]4SGL,4A'H!57(Y3RL^,O&C(5/AW)[<4D?B_QNP(;0=H ]*]4/3
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MY^Z">M3W>K6=FP6650Q[9H NT5!!=P7*!H958>QJ?K0 4444 %%%% !1110
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M,]"V9%Y'_P!]4UO&6A#:GVU/F_VJY%"2-G,Z('BEKGO^$QT->/ML?'^U2_\
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MSJFP&JI\&ZG;6US96-Z(K><G(KMN%<!5Y/>G$L#N(XH X>#14\*^&;BSNO\
M2Q,",#U-4_AMX4FTNQN[B\RJW+G:C=0I[5WTL238,D8=/>G*08PL:Y4'IZ4
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MGP(;E->O09VDAW_+&>PKU!#E<XQ6=9Z1:Z<@^S0J)/XG[FM%#E>>M #J***
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MYHI:!AGVHS110 F:7-%% !GVHS1Q1Q0(,T9]J.*.* #@CD4N >U%% !1110
M4444 %%%% !2'I2T'I0 P"D(IU!HO84E<X3QGHN?],B7D=<5Q@X <?>/!%>R
M75LMS;O%(,AA7E>K:>VF7TH8?)SMK:+N>=6A8SRQWE3VHH!W1AS]X]:*U.-A
M1110(****3$PHHHI6 .M '-% .#FBP"Y7=M-+'--9SB2%B/I33AVSTI2K>O%
M)HJ,FC<3QA>^5Y.WC'6L2YF:ZN#))R32&3:H&*&7Y=U)#E-L0D=!12*01Q2U
M:(04444QA1D@%NR\T4Z&*2ZN$@C&<GFHGL5%79K^&-+;5+T3LORH>E>HQ1+'
M&JJ  !C K+T'3(],LE  #,.:UD!&:Q9ZM*%D/I,49HS4FZ'4444#"BBB@ Q1
M110 8I  .@I:* $P#U I<444 &!Z48HHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1C@4M(>E "'&,UDZ]I:ZI
M8NN 3MXK5Q\AS2+\B\]* /![NVEM+I[252 I.#35&X<]J[_QYH?F1K=VR?-_
M%BO/B>B#J.M "GK12D ' I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *;''+/<I;("0YIU=GX&T,S2FYN$X'*DT =;X9T=-(TQ,J-[#.>];J
M\C.*8$R<?PKTIZG\J %Q0!BES1F@ HHHH *,444 %)@>E+10 4$ C!%%% "8
M&,8I:** "C ]*** #%&*** #%&*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 3%&*6B@"-TW8]J;(JNA0J"&&"#3R6WX
M[48&?>F@/FOXM^#ET/6#J-M&?L\IRV!T-><)C[LGWS]VOK[Q1H5OXET.XM)T
M&X*2I([U\F:MILVBZS/9W:E71CLSZ5Z&'JNUF<U6*N5-I (/4=:*3=N;<3]:
M0GTKTEJCDDA:0C)HHJA(,"EI**5BM Q[T8HHHL%T&:,TE%.Q(O6BDHI6"XZB
MFTM%@%I"1O"BBA<+G/7M0[V*2%8>6VU^IZ4JK(\J6L:[IY3A13=VTB:;MTKT
MOX2^"VUS6AJ]VG[F(Y3(KCK3M$WA%7/3OA;X.C\.Z$EQ(G^E2C+$CD5Z$R\#
M'%,"[&5% $:C J0'=T/2O)G*YTI6 /A<FC<3R.E( %SNZ&F,X"%F.$ S41-"
M0,><D>U*&."37,IXUT"75QIRW:^>#@KFNC5@1E3E#TH:$+YA"[B.*<7^3/3Z
MTW)V<57N(WD@>(2[7D4A?:A("O)X@TR"40SW\$<N>C-5S[9 T!F65!$!GS,_
M+7CGBCPOH^A:?=RZO=/=ZK<9^SHC\J>U9&H76OZ1X!LK&\E=8[A@",\X)K11
MN2W8]QL]<TV_E,5M>PRNO!"MFEEUFPCG-LUY#'<]D9N:\;UG1H/"=MHNJZ3,
M\4LVWS%9L[C7*>+X[V^\8#5(IY!)&JLRJU/D%S'THU_#% 99Y%C1?O.QXIEG
MJ5OJ'SVEQ'+'T^4YKQ?Q9XAG\1>%[71M/N"LQBS+M// K7^", AL)D\QY"AV
MDL<\T.&@<QZYN8O@#CO3B3C(%><?$CQCJ7AJ\L[>Q7+7!P*YRY\=^(M*U2UM
M+M"#= ;?QJ%$+GLY=@,]A2"8./E'/I7E%EXVU:S\5Q:9J,1"2\ACVI]]XOU?
MQ%K\]IX<0K]DX>3L33<0YCU/S\'D'Z4NYURQ&5[8KS#3/B-<1VFH6&HVY34[
M5"Q)_BJCX5\5^)M>=KXJ8K&+);/<"ER#YCU\.2 0IP:;YVV3:P^E>'ZC\5-2
MN[V<Z?+Y<-NQ##'WL5Z+X*\4OXHT@2R6YCD'!)HY0YCJD:0LROC/\/TI^\AB
M&&!ZUY_XY\:7.CW,&D:;&7OYNC^E0Z+JWB:SNR-;A+V6W<9/2CE'S'HI=MI(
M&[TQ0\A4 D'GM7DQ\8:[XDU6Z@\.?+;6A^9O6K&G?$F>73;^TOH_)U"V0X)_
MBQ3Y1.1Z@6<,.,@]*4%^XYKQ-/''BB3PS_;6PI;Q.>3W%6+KQ_X@72+375A(
MM6(5AZT^47,>MSZA#;S".215)Z*3R:L)(9$W!2/K7D&M^(UN=6T6<AC).P)P
M>!4^I>.-;;QF-%LX2RD<,.U#B/F/5I97BVDKD$XI^7!Y'%>5:+XZU73?$MSI
MGB('Y5+H3Z5';>+/$'B36KEM*4K:PYROK2Y0YCUS/;O0">]>:_#[QA>Z_JM[
M:W>1);OLQ7I=*UAW 9S10#FBD,,TM)2T %%%% !1110 F*3%+10!$<G/M7.>
M)]'74+(R@?O4Y&*Z9L YJ)@#P1E333L85(7/%V#K(T;C#+U%(=RGGI72>+M(
M:TO/M$*_*_7%<W&QD!!ZBMHL\^I"S%..,44T J2*=6AS,****D84444Q7"BB
MB@!&&[VI><8S110(0C*XI<_+M[4446 !P,4444NH!2@KW_"DI%7<WTICB[@"
M%R).I^[77^#M'9O]-F3YB>,^E<WI5@^L:FB*#L0\UZU:VZ6MLD2+@*,5E)G?
M2IJ]R4KEE':I"".E)VS2D;EZXK([XB$_G0-WM2\=!S5.]U.SL%'VB4+GUH*+
MF['TI=Q(X%5[6Y@N8=\#AP>:G#$KTP:!"%G!YQ37F"+O8A(Q]YFZ"FMG()/X
M5QGQ&\0)I6EI8.3NOOD&WJM SKK35+._+BUN8Y2AP=IS5K<QR1R*\2T6>'P7
MXDT]+:9Y[2Y4>=DYPQKMK[Q#>ZAXD_L72OD*IYC24 =KYC*NYA]!2&;#;2""
M>A-</<>(=7T"VN9-3A,B*=J2]N:()O$7E0W[_P"DP2D,L:]@: N=RSL%SC!I
M4EWC[I'UKA_#_B>YU'Q;>:;=C;Y2_*G]VJ&H>,[VRU"[@?\ U<9(4^] 'HY=
MMOH?>CS""%*G)[BN T'5=8N-%N-;OGWQKGRXZR-0\;:I86*Z@)PXD< 0X^Z*
M /4VNH4E\MY41ST4GFI%8G->-ZM-J&M>)]+GM[HC<%9@#Q]*W;SQA<7GB"31
MK:?[,UJH\US_ !4 >AS74=NNZ9@B_P!X]*5+A)8P\3"13W7I7E6J>*7U+1[G
M2[ERL@;Y)1W%+H&N7^A6NGP2.9+6>3:9#SBD*YZN6;9D<FFM+@;B0%'4FN.?
MQ/->>+(K#3!YELG^N8=*U?%#W$.ERM$V!MIDRD:G]I6S$A95./>G/?0QLNZ5
M0&]Z\^T^!HO#IOGD8L3SS5C6)U-EI\B;OF89YIF7M&=Y]KBW[/-7=VYJ8$[0
M37"W4@C\26L0W;649YKNEPJ@#I2-8RN+DT FDS1F@T'44E+0(3-&:**!"T44
M4#"BBB@ HHHH **** "BBB@!"H(Q2% 1BG44 5I8%N(Y()0"C#%>.>(=(?1M
M5D(!\ESU->TE3@X-<]XKT1=7TMM@'F(,T >2'"\]C2;@>E*5:&1H)1AE.*0J
M%Y% "\T4@SG)I: "BBB@ HHHH **** "BBB@ HHHH **** "@$'GM2'...M*
M#M^4#.[@?6@"[I&F2:QJ26\0)C4_O".U>T6-E%96<<$0P%7&:YOP/HG]FZ?]
MHD7][-US76]Z $V#;C-&,  4ZFG&<YH 3D=: V32'DT9^8 "@5R2BBB@8S?\
MVWO2>9\VW'S5GZQJL6CZ=-?W PL7ZUS=IX[GU&U^TV>E2/%_ST% ';%\#D4U
M9"<Y&*R-&URWUE62&8"X3_61]Q5]KF%7VM,H]3F@"R7]*:TI'&.:R-4\1:?H
MLD"3RC=.VU:T'FB"I(T@V,,@4 3^8<CTI3)MQN(YZ5 DT5Q'O@D#*.N*IZOJ
MUEHME]KO' C'2@#1,K)RXSZ8IWFY7(%4+/5+:^LH[U)56%QD9-6%FA8-*)5V
M+U.: )C(43<PX]J19C(N4'YTQ)8Y1N2560^])+=6]L@DDE55Z=: )C+M SUI
M!(2V*8LL3IYJ.I0]\TU;F"63RT<;QVS0!*)"&^;@'I2[R,[OPJ":>W1E\Z51
MZ#-2(N07+@J>10 \NPQG&?2@NW855BN8'E*F9?-';/:IY)HHAEY54'U- $FX
M\8Q3LU@OXITF#6$T[[0IF<=,UO9R 1WH ,TM)2B@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** &MN[4W:<@_G4E% $3H"OISFO'?C#X'_M&T.MV
M<8\R(9D ':O96&156YMX;^V>"5<Q.,$5<)69$HW/BD%63/3^\#VIV1CBNK^(
M_A.3PSXDF9$(M)FRO' KDQ@CBO:HU$T<DXBXXS2 TF2#CM3C@=*WN9-!D49%
M)FC-.Y(N11D4F:,T7 6BDS1FBX6%HI,^U&:+A86C(I,TH-%PL&13@HQS]X]*
M:::TA2/;C+L<+45)I(UBB]HVEW&OZQ#81H3E@#@5]:>%=#BT+1(;*-0LBJ-Q
M%>=?!OP3]@TW^UKZ+]_+]P$=!7K\/RC8>H[UXM:I=V.N$1P4D8-*J;.E.I:Y
MMS6Q$%9B=_3M4<\!N+=X6^4,,9%6**%H,\CA^#$</C :T+QBK/N*YKU:&$V\
M2Q+RH&,FILT9H;$,((7WJO=K)]CD:%0UQM.S/K4TR[MO7B@OA@".,=:$P9X>
M? /B]]?DUF[47<I<[(G/"BNOU'PMJ?B;0C;ZI&L-S'@Q!>G%=E-KVEV\ICGU
M*"-NFTMS5K[3$UN+E9E, &=^>*T3:):N>5V/@C7]7U:U37L)8V8 CP>N*T+/
MP'/'XVO;Z50^GRIM0&NWC\1:+=S>2FH1&3.-NZK=Y>VME )+JX2"(_Q,<"GS
M,7*CS/P[\-)M*U_4]1N&!24,L"9[&MGX?>%+OPR+QKGA99"X4>AKJK75-*U&
M8&VODF9>@5J=<:YI<,ICFU&&-EZHQY%#DPY3C_'/A"]\1ZSIE[:M^ZMV!8'Z
MU5\5^"M0UOQ#I5["1Y5J%W?A7>66I:?J+DVEVDI7KL/%5]>URU\/Z=-J%RQ5
M%!QGH34IA8Y+7?!5YJ?BNPU-&_<Q !Q69<^#-;\+:Y<WOAEC*MX<R(>QK63X
MF:?/X5EUB YE0_ZL5LZ%XSTK4M+M[J>]B@FE'^K<\U7,(Y2P^'5TUGJ%_?R[
M]6NT*E?3-;_@SPQ<Z-X<ETR]/^M!!QVS71W%_86@^T27B1AA]YCQ1;:O8WT+
MR6U['(J?>8'@4KCL>3_\*\U;2;NZBTZQBN;6=B2[]17HGA'0O[!TA4DXE/++
M5^/Q%HTDOE1ZG"TO3:&[U/+>VD$D8N[J-'D/[M2?O4KL+''>-? \VMW]OK>G
M3%+^WQMB[-4&GZ1XKU"_SK4GEV6W:8U[UW=S?V5E(ANKA(V;A03UJ*]U?3M/
M9'N[M(_,^Z&-&H6/-XO!_B#PQJEY-X=4/;79^8'M4MG\-9UTF]N+U_,U*Y!P
M#VS7?2:]IYBD%M?122!2P537->&_B%8:TMRUS.MLUO(4+.>*J[%9%2+PAJ7_
M  K27P_(!Y['Y14=UX&U"7X<6_A]&Q<(P8FN_M+ZUOT66TN4G7NR'BENKVVL
M07N;E(D/\3&I<A\J/,[OP)J32:.1&,6K#>?I5^Q\$W]MX_76FDS;<<5V4?B+
M1WF6)=5@9VZ+NY-6[J_M+-0]U<I&AZ%CQ1=BL<#J_@RZU#Q]+K4H$ECY6W![
M5P%KXAN_#'BB_M[.&5;=LC.VO>;?4]/N('N(KV.2(=6!X%9]Q8Z%=P->NMN\
M1ZR@#%4F%CS?X/65X^LZEJ,L3+'-(6RPQFO9,GS".W:LJ"ZTJRL1<020QV8X
M++P":OP3PW4 EMI0Z'H14O<M$Z,"<#M3ZB1BSC QCK4M2,*6DI:!A1110(*0
M]*6@]* &BEHI:!(C*ECSTI C8(/2I**!O4S=5L5O;-H]H+X^6O*;RV>POWAE
M&&SQ7LLA"KDUQOC#1!/;FZB7YQS5Q9R58'"]&.:,4Q0<!6^\#S4F*V3/.FM1
M*7%&*3F@EH7%&*3FCFF387%&*3FCF@+"XHQ2<T<T#L+BC%)S1S0%@/%%'3DT
M??Z5/4?0",4$%MJ1\NQQ2#Y<[C70>%=(-Y>>=*OR \4-ETJ;;.I\+:,NGV:S
M2*!(PS71@'=D=*156.,(.@Z5(O2L&SUH0LA .3FAE+<#I3J44C2Q'AEZ<US^
MO^%DUL M*4(YXKI**!F3HVD#2+01*Y=@,<UI*69?F&#3Z,4 1]&!85PDWA"X
MU'QFVHZ@?.LD.8T;H*[J8^60W4DXQ3)KB*$%I7"@=!GK0%SF?$G@^TO])>.R
MB6.<L&5AU%8>E^%]<T6]74X2);EQL=6]*[^WO+:X;]U*"_\ =S22WELC[9IU
M0CWIDW..O?#6K^)HIXM8F,$6<QHG0TZ*R\50V,6F1 )!&0HE[[:[$7*B,R^8
M'B'>F_VE:'!^TH!]:+!<XF'PMJN@Z\VIV*BZDF&)6?K67'X(UF[N;Z6^ _TA
MBRCTKTMM0M@0%N$Y]Z;+>1+@-<HI/(YHL)LY*#PG>KX(FT3[4R7)R585AW/A
M#6;KPM%H[6D8FC(_?]S7I$-_:W$Q2&56D [&LVSUUKC59;$(=RG&32L+F.5_
MX1'5;&&P>T0-/'@2'VITG@R\TS7YM6M(5NWNUQ,K_P -=U)?06WRR3KO/'6G
M&ZCBC!DE&UN^:+!S'!'P7<W5C=/<0JDSD^6!VJMJ^DC2OAZ=.OMPOE):WV#)
MSVKTC[7#'M#S*2WW1GK4<UC#=S++*BR%>0K#-!:2.1^&>BW.F>'?M-['B\FY
M)/6NHUBSDO=/>).688Q5B:[L[=U26=(O]G.*>)TD3S(9 T8ZL#3%)'.MHUQ_
MPC?V!4 E!YJ.\\/7,UC9QH!NB(+5T*7]I+,!%<H7/\.:)]2M(0^Z90ZCIFF9
M<B,2XT>=M8M[DK\B@#-=,65< UC:-J_]I>86XC0\$U?6^M"Y59T+GWH*5D6^
M*,J!DU4>]A@?]_,HSTYH>]M-N3.H!Z<TBN8M[AC.>*-PX-5H[B"==L4JGZ&K
M"=,&D4G<>*#24M Q1THHHH **** "BBB@ HHHH **** "@]*** &*&V\]:39
MC('(;K4E% 'E_C;0?L=TUXB_NF]/6N.B.1N/W:]RU?3XM2L9(9!DXXKQ?4+)
M].OY('!"YXH KMG=Q]VBE VI@]:;B@!:*3%&* %HI,4H% !12XI"* "BDQ1B
M@!:*3%&* %S2X.,]J: 1("?NTKGY@1]V@!-X"EJZ+P?H;:I?*\R_Z.IW ^]8
MEM;G4+J.WA7.X\XKV#0-,CTG3D7&'(YH U441H$0<*,8I]-'!SZTZ@ IK]*=
MB@KD4"90U&\^P633$9 ':L/1?%L6H7HM@K9)QDBNDN($N8C%(N5-4[/1+*RE
M\R.)0_J!02:E%%%!9R?Q#3/@V['7)'6F> ?(7PI!&KQA<?,,UNZQIL&LV$EE
M,?D;KBN9M? YLH3;VETZQYZ9H XV*06'C?6)K21D@C^^R]*-0FOYM)GO+.[W
M1@[]Q:O1;;PGIEM87%M(F]KD8F;N:RX/A_9BUELY9'%BW10>: .$G4>(['P_
M<7DVUS.%)SQ70:K?JWB--*M;LGRP%Y/%="? FGC2K>R7<([=]\6.N:2;P+8M
M/'<*6%P>K=Z .8\(ZE?6GQ#N-%N90T)3< #Q70_%"RAN/"C^8Q"*1TJUIO@>
MSTO6WU@NTDY7')K9U32X-:TYK292%?L: /+M>$EIH6A6EG<LD<H7.TUM^(_+
MTI=,M8[YQ+(!E<_?K;_X0NWG$ E8D6Q&P?2K>N>$K/6F@G?/FVP'ED>U 'GU
MQ?ZKI7C.V22?%O)&2(@:L^&+.ZU[5M3DN[]VB4'9$3]VNK_X0:QNKZ/4+AW-
MY&, $\5H:7X8T_1KB:>$,9YN']* .$L9=7N[/4+'3[C=+ V!N-6;&]71+B'^
MU;I_M;+T4YYKKD\(V=L\[VKLCSG+$&JX\$P-<B><^8R#C=S0!R_A^UDUKQ5J
MC76HLL&S,:%NE8]QXCU/1/M^GVUQ)=1++M\T\[16WI7@NZN/%5]<N\D4)&!@
MXKK[;P=I<%I):21%_-Y9SUS0!RUYIT</A:/58]3)GVAS\W)/I6"FJ:CX@UC1
MK.>X:"*0X)!^]7<_\();,5A:5_LP;(7-7!X0T[^T[6YB0J;7[M '#ZOX>M5^
M)MA 9MF$#;B>M>O* J*H.<#%<WJGA6TU?5XM3)9+B$@ UT:#"*OH,4 .I:**
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#112 8_W:C7;SC[
MM3,,BFE1C %"T XWXA^%(_%/AZ6)$'VA1E#WKY5NK633[F6WD5@T3;3D5]MR
M%$0EL 8KQGQ1H.BZGK32QPA?F^; ZFNRA4:.><3P99 P^Z?RHWCT/Y5[*?"&
MCK*#Y7'TI!X,TC))C//M7H*KH8N)XWO'H?RHWCT/Y5[+_P (;H__ #S_ $H_
MX0W1_P#GG^E/V@N0\:WCT/Y4;QZ'\J]E_P"$-T?_ )Y_I1_PANC_ ///]*/:
MAR'C>\>E&\>A_*NYUGP]:Z'K,<QC+6SG!R.!73V?A/1KV$3J%,;#.15>T#D/
M']X]#^5&\>A_*O96\&Z,, )D>H%)_P (;H__ #S_ $J?:AR'C>\>A_*@./0_
ME7LG_"&Z-_SS_2C_ (0[1_\ GF?RI.I<.0\;+CT/Y5V7PZ\*-XJ\0PRNA^S0
M$%\CC-=D?!NC'_EF?RKT#P';:?IL#VT$:1D]QU-<U6>AK"!V=O"EM;QP1J%6
M-=H J="#TZT@^7CK[T]5 )->9)W9U+0*6EQ13&)12T4F@$HQ1WI:+"(Y4+(0
M#CWJE?;CIL\>_9\A_>#M5V0L!\HJ$*NQ]XW(W4&FA,^;+_3DMYKV^:[DOBKD
MX)(VUT>L>(=1F^'=G_9QDCB.!(0#TKTF^\"Z+<SFX*%1(>40<&MA=!TV'2EL
M?LL8M@,8(K1-$L\5UN'1++POI]YI4[OJQ*E@#SFF:]J&L7\FCP:YYD=@Y'F-
MSTKU:V^'VB6UZ+E4##.54C@5LZCH-CJMH+:[MT* 84XZ4[H6IXWK;VFD^(=/
M3PI*[Y4!@.>*-#T=/$'Q-FAOV<H(MS)DXSBO4M(\&:1H]P9+>,/+V+#I5ZTT
M"QM-7DU**("Y<88@4-JP['DGAR*31?BU<:?:S.MH&QY?.*[_ .)MBEYX0NS*
MI9$4D*/6MN/PWIRZLVII&OVEN2<<UH7%NEY#)#<('C<8(-1H'*?/NG0Z/'\*
M99(G(OMQ!3O6F_AVUC^%T.K-$S7HY0@\BO2X_A]HL/F!4&USG9CBM<Z)8S::
MNGM&!"HQMQQ570K'@VK7MSJ/AO1X;J611+*$8\]*ZCQKI4OA/P9#_8N\12[?
M.D7)//6O1)/!^CR1Q020 B,Y3CH:U)-/@NK,V,T*O; 8(84706/#M5MO#]CX
M.L[K3KEVU=P&+ G):H]9U'45G\+7FKI)'&L@W-SR/>O5[7X>Z);WWVD1!B#E
M8R.!6KJ_AW3==M4MKJ!=D7W>.E--#L>2?$GQ!:7WB'2UL9WE&5(5>E(K)JOC
MI(O$,S)91P@QJ3CG%>CVO@+08W67R=SQ'Y685R7C3P!JVJ^(4O=/*B$#"CO3
M31+1R5L+>#XAS)83,]OL;:N>U7/ 7ANRUO\ MR6ZW%%D;]WTYKH_"?PUO[+7
M?[2U9D^484+7>V.@6>F"<6\2HLI+-M'4T-H5F>;_  BGE_X2'5]/1W%M;D[4
M:I_C2\WV6SAB=PCRJ&VUZ#I>@VFEW$UU:Q*DD_\ K,#DT_5=$L-91#=Q[O+.
M0".]0,\B\8>&[+P_H>CZK9[_ +0X7)!/I6)XDO\ 6-2U+2[>YED%K(O/7%>\
M:GH>GZI90VMT@,<6-@]*AOO"VF7]A%:/" J#Y7 ^84:"/(O!^D7=QK%[I=O=
M/]B:(_+DX)K,FUC4(S<^!XFD25V(0\U[EHWARPT'/V09<\%CUIC>%-+EUM=6
M-NOVI3G?BJ30'A$.HZE;V\7@FY\SS3(,OS7T%H&G+I.CVUJ,LP09-5I?"NFW
M.KC4F@3SP?O8YK;X4!5&<<9J&S1;#E&&X%.I.I%.J2A*6BB@ HHHH *#THHH
M 3-&:6B@ HHHH :X!P#5>>)98FB<9!%6&QTIK =.]-$35T>3^(]+;3;\L =C
M'L*RM_L:]3UR&"YC$;HK$=S7/?V-:_W16JD>=.GJ<;O]C1O]C79?V-:_W12_
MV-9]UIIF?LSC=_L:-_L:[+^QK/\ NT'1K3LM/F%R'&[_ &-&\5V1T:TS]T53
MO]%MQ$S*,8':CF#D.9W^U&_V-;^E6UG=#R'7##O6C_8]GOV%>G>G<?(<?O\
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M6TBW4".J_-WJ:XLUNHG1SVX-86F3R:??-;S$A"< FG<7*;Q&#C;2<_W*FP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%(R.U,\MF*D';CJ/6E=A8K&WM%MP#:QLG9-O2IA;P(@9(8T..,#I4N#YAPN
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 U^*:QVH33SSQ5:=\_)0!G3_O7-1>2*NB#!S2^35Q>A+*/DBE\
MJKODTGE55Q6*?E4GE5=\JCRJ+@D4_*H\JKGE&CRC1<93\JD\JKOE&CRC1<"E
MY5'E5>\FCR:=PL41&2P4#!_O5Y]\1/#CHT6NZ4FV6 [I-O\ $!7IS1L5\M1R
M>],GM8KFU>V90=XVL#3N38YGPGKD?B/1HIT($J##KW&*W?)C92?XA7E96Y^'
MWC10<BPNWY'89->NQF"ZM4NH""CC(Q0V!5B4[&+KG%'EYYQ5]EV[5V]:0PX.
M,5-QE'RJ:8,D''2M#R:41#!H;*0MG+P%J_TQ6?%'L?-7E.X5DQCZ***0!111
M0 4444 %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J\TF.*F8[14!3><T
M 0;<\T;:G*]J-M!+1!MHVU/MHVT"L0;:-IJ?;1MH!(@VFC::GVT;:!D&TT;3
M4^VC;0!!M-&TU/MHVU0C.O[!+ZV:-AD@5SFBW4NGZB]E<$B'.!FNT91MXZUS
M7BC36:);N 89.2102T;P''R_=/2C;5'0-234+%8P<N@P:U=M(:(-M&TU/MHV
MT#(-IJ6([>*=MHVXYH&3KS2FFH>*6D-"T444#%HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** &2-M6J+_ #-5J7FHQ'QF@"'91L%3;,T>6: (
M=@HV"IO+-'EF@"'8*-@J;RS1Y9H AV"C8*F\LT>6: (=@I"F!Q4_EFC8: ()
M$.P'O0(A/$5?N,5.%)ZTI0'[M '!W$3^&]8\P@^3(U=A Z/;K,3N,@^7VIFK
M:4NK6#I(/G4?*?>N<\+ZB]K>2:=?'YU.(\T =5Y6!SU-+L%3%"3S1Y9H @*#
M%(8^*LA*;CF@"%!M-78SD"HBG%21\4 2D4"DSFG"@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@!"*88P3G%244 1>71Y=2'@4FZBX
M#/+H\H4_=1NHN(9Y0H$5/W4N:+C(_+H\NI,T9HN!'Y='EU)FC-%P(_+I-GM4
MN:,T7"Q&$P.*1(QNW8^;UJ3-!%/F%8YKQAX:C\0:)/"4!GQF-^XKD?AEXA>-
MYO#>I,1<PG:F[N*]2R>_2O*OB1X=FTR^A\4:2I6>-AYBKW%.Y+/4$0(-K<GL
M:=LSUK%\-:[#X@T2"Z1AYH #K[UO Y&:+@B/R_:E$8]*DS0*5RAGECTI=IQQ
M3Z#TJ1D0+,>O H#9!V')H "D\\&H+HM#:2-;C+XXIH"<%F7&1N%$;D@YZBO"
M(_%_CE?'9M#:2_8_,QG;QBO=(&=[6*1QB0J"PIM 2%LH<\5%,ZI;,[/MC4;B
MU2ORN".M5[V 7&FW$!XWQE1^52!Q"^+M2\0ZK+9:)#NMX3AICW(I[^)]6T#4
MX8-9B"VTYP)/2LWX?71\-M>:7J<?V<-*S)*PQN%.\>W:>)9+;2-.C:9BP+2K
MSMI@=?<>+M)@O4L?.+3LF]5'<5:TOQ#8ZN[+;R89>"K<&O.-*L4C^*%C:SQ%
MG@M<%B.#@5?L8_(^*=]MC9(F& !P* .F\7^)9/"VFF[:,NI;'3I4%MXXL?[%
MBOKABGF 9!Z_A3/B3&9?"$@*!CYB\$=JX3Q#'#<6WAR.%"0)%#*@_G0!ZC%X
MFT[^S_M9=Q%VW#DT6'BG3]1F$$4@60_=#'%<AXXNEM=:TFQM[?"N &=1\B_6
MN/UV"YL_%D0M7,S.N \/0&@#UN]\6:;9WIM))&-PG4)R*Q]9\:O!J]G;Z>!(
MDN-^>U8GA2:TM+F[36XL7!7[T@ZUA>*8&U+4H[?PZC02OUE?I^% 'K'_  D5
MDMXEH'WW#*"0G(%1^)/$,7AW1I=0F4L0.% KA/!,A\.ZG_9FJ RWCC)F?G\J
M[#QJB#PO=N4$H;H",T 9'@WQ;-K&G3ZK?MY5J#\N>*W[+Q9INI3F"-V3L&<8
MS7E;6E[_ ,(K921QLEF)P7C7KC/>ND\6S6-RFEP:4R_:"!CRN,<=Z .MF\8Z
M5:WXL3(SR9P<<\UN+.'4.3M3&037D7A"RG'C0K>P&3'WF8<9KTS7(97T2\2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0S# /2O'='\07.CZ7;_:4\R1V ?=VKH5\87VJ:U)I>E-'E8]S%STH ]#,@!
M]:&D"C)KS6+X@WT-K=V[VK2W=L=ORC.:L:3XEU.^\JY0QHKMATD/(H ]"WY
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MR =Q0!U_<#J1UI]9FC:E%J=DD\9&]A\P]*U,8% !2TAY% Z4 +1110 4444
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MX>9H% :/N:]$HI#/,&\&ZIXA\03:AJ3[(7CVJOI4[Z;K^F:)-H5HI<#B*7'
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M_'OC<?6NYHH RS93#0_L43;9/*V[O?%>>6GA34+"UNK:2%YIYB=DO9:]7HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4E+10 E0ELD@C&.]3XIA7(.>: .,^(?A7_A(]$,\ Q>V
MHWPD=215/X:>*WU32VT[4SMU&V.V0-UXKO "RD#@UY?XI\,7^F>)[;5-&0@S
M-FYV_P 5.XK'J7W ".AIPXY/>J5A+)<V$;2#8P'-6@VX@ =*0R6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH 0T4N*3%%A!12XHI6 2DIU&!19 -
MI:7%&*+ )Q1Q2XHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-2#H*#TH'2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>forms-1_014.jpg
<TEXT>
begin 644 forms-1_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )"!LL# 2(  A$! Q$!_\0
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M0,W4]* ),XHS41)DY4\4JL,;0>: '[J4'(J(Y0]:>O- "[LT;L"@M36P#UH
M=DXS0&S3>5'7B@#=\QZ4 /)P/6DW<=*;NYXIB2$D[NE $NZC</6F $]#3=RY
MV]30!*6P: V:9T89%.4#F@!W-'-'\J* #FEYH%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.EJJR(1NQ0!0U'Q6;+4E@49#FNDCUB!+17E<!F'2O,]=*MKT2*IZ\&I=8OI
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M36ZV/VE7'EXZT:5X@MM10MN! H L7^DV>I+NF0;AT-9Q\+1%<$_N_2MPO#=
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M %7+73+6SCVJH.: /-?#QE75&34064'O5/QP]K-<Q+:1<@]A7IUSH5L[>8J
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M4\4 +M%& :6B@!-HI>*** $XHXI:* $VBEQ110 4444 %%%% !1110 4444
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MKW,<,19W Q5?4+I+.W,KL!Q7D?BKQG.9FCMF.#QQ4-FT:?-L=MK/CBVM7,4
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MTJ#/-%AJ3.D\'ZG=6VN0B-R5W=*^F_\ A'K?7]%BDF0+(5Z@5\L>%,C7H?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH :>M)2GK24 %%%% !1110 HI:04M
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M'B?3BYV\X6N9="&&VNR\%>,$\/7 69 T9/.: -Q?B'K.G*8-3MRP''SBN_\
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M7'0'FF[V(/K0!-14._ Y.32F7"YQ0!+15;SVSTXIZMN&: )J*8&[YH+;>30
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MQ&:WM7M;FST!+D2'<!GK0!Z&KI)AHR"*DKA_ NLRW\.R0G(]:[G%  *6BB@
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MDXZUW_@SPU)/*MY=J6;KDUENSI4;([3PMI0T[38R!RP%=&%VKN[U#"@C0(.
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M6@ HHHH **** %'2B@=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DHHH 0]*;WIU+B@"-
MS@<4Q>#FIL"EVB@" Y;V-($^7!&:E;BF]:EH%H9.H:!:7RDM&NX]\5P6N?#L
M7(8*.#7JN*:R@]:5C93/G:^^%4R(3&F3]*DTCP;-8DB2W_2OH$Q(>"H-,^R0
M$\Q+^5.Q7,?/&K^ +K49<Q08_"GZ=\(KEV4R@@?2OH<6L"](U'X4\(J]%%%B
M7(\RT?X9VULJAU&1[5W&G:+:Z7&%C09K7_"D #'D46(;*MSI]G<IF>%7'N*H
M_P#"-Z9N!2U3!]JV\ \4HPO%4B#,CT73X #';(&]A5[A5 5< 5*<&CC&* (9
M,NF%)!J)5D/#+D>M6L"C- %26VBD!5E!K%O/#5G=9W1 _A72X!I-HJ6C12L>
M<:CX#C=28/D;MBN=ET76](<M#([**]E95)J.6UBD0[D!J313/*++QGJE@0ES
M&QQW(KJ=.\>6LP N&VFM2\\.V=VIW1*#]*Y+5_!B(I:'@CTI79=DT>@6NL6E
MX@,<J\^]7@Z$<,#7@TKZCI$GR.^!6UH_C:[WJDI/'K3YC-TT>P;J3.:P--UZ
M"[5=TBY/O6R'0C*-FFI&3C8FSS3@:C0]S3AN//:JN2/!XI:K/(RMBI VY<TQ
M$A-**C')I_2@+CJ,TVB@=QV:*;FEH 6DH%%( HH%+BF,::8V:DIIH$1@-ZTH
MR*<*=@4 ,VC/6C!!QGBG[128H :PXXJ/86ZC%3XIIH*4F1;$Q@U7N;6.6,KB
MKH4&D914M#4M3S7Q+X52Y)DC7##TKE+._O/#ET$?<4S7MUQ;I(G05Q?B70HK
MF)B(QGUQ4-6.RG4N:>@:Y!?P*2X#'MFNDZJ"#Q7@0EN]"O\ >KL$!Z5ZEX6\
M1#4[=59QN^M(BJE>Z.M!P.E+NIH(QCN:<N!P>M6CDDQ&XY I1\PR::[$=N*5
M.>:JQ-KCP*=@8I**+6#84#%+0**-0M<*,T48ICL%(>E%&: 8TTTU(132*&$6
M1G.#Z5S7B&_%O;28/:NAG?RXV.:\T\7ZA^[=5-<\FSJIG*:>&U+7B2,C=7L=
ME81-9)')$" /2O,O UH7NS*P[U[!  L0'M3BKFDYNQA7OA;3[OI$H/TKEK_X
M>1NY>&, CIBO2PH'-)WK6QS\QY&- U[3I,0L_ECH!5F?4=?6'RC"S >U>IE5
M8<J#49M86ZQ+^5*P^8\@::]N(C%=6Y"GKQ7&Z_X.^U!FL[<[S[5]%MIMJ_6%
M?RH73+1?^6"?E2L/F1\PZ+X$N8YLW<!Q]*] TJVN=$ ^PP'/TKV Z=9G_E@O
MY4#3[8'B%?RHL',CR^4Z_J3<JR ]Z1/!>I7SC[5,^VO5EMHT'RQK3PH':@7,
M<+I_@&", 3N6^M;]GX5T^V((A4X]JW"/04X XI6)<R%+6*)-L:A?I3UCP.3F
MI0*"*N*,VV1#(/(IW/8<4N,TX#BJL96&XH*\\TM(1G%-&ER.0[5(KR#XD61=
MFDV\5[#(0",UR'C33EN;!B$SQ4-&])GRSK,7[PGL*R(V GCP.XKT.3P\EYJC
M6\G )KI[/X2P-LFP2.O2DM#6H[H[?X?ZY:Z7X32:X(7:O>JFL^*-!\61212?
M,R\#%<YXOMET;PZUI$^WC%1?![0H+PR2W #\]ZI,Y#G;_P )V4\[>5$P';BL
MNY\*V5H,SY13ZU]0'0=.C('V=,?2O+/C!I$-II1F@0+CTIV X?3/AU-J%OY^
MFS$CM@UD:QI'B?PS*9))9 B]*],^"5[)<6_ENV0/6M[XOM;KH[*57<>](1Y+
MX7^*^I6%RD5Q(Q4'')KZ'\,>)(O$FGI*K#=CFOC*Z14F+*><]J^B?@D7;3<L
M30![(O[M3SG%?,_QIO)CJA3)VYKZ4#Y8J>]>=>-OA]!K\QE(^:@#YEL;R&%,
MN@)]Z+J\2;("  UUOB_P/'H'(R*XCRP& SQ0!'L'6NW^&+;?$43= #6CX+\
M1^(TW-G%>@:?\.(O#3M<*>@R* .TU?Q[I>DQI;W+ Y&,5Y[XAL=%\0DW-NF&
M;G.*XCQ-.]]XIBA8EEW@8KV:+2['3_""3&-0^SK4LZJ1XS<Z5%8RC9ZXKUWX
M:::WV832#'I7G94:MJ@C0<!J]S\)V LM,1<8.VI2-:CLC>4L6P?NBG;?GRM*
MOW3BG(.*T1P/<5CQ4><?*>E2[>*-H- $0SQCI2D*QSCD5)P.*,"@0Q<O]\4X
MJ&7%.R*6@!@4!<4IY&,4[%&*8$6S:VX4XKO&6IY H]J (CMZ 4C(".#BI=@S
MFEVB@9#M*KA>:7YE&0.:EP!2T 1$;U!8<TPA@>G%3\4'% %=@?X>]/ P!D5*
M !1@&@"!E+/Z"E(7TR:FXHP* (MXQTYIH!Y&.M3;5I<"@"%8]H.*4(2.34N*
M,4 1%.0:'^9AQP*FQ2;10 S:&[4['RXI< 4M $+1C'6F[=J?*/FJQBDP!0!"
M0-@)'STJ@XR>M2D T<4 1MDKP.:11A?FJ44$"@"/@\"D5#G+5)M IU $8]AB
MAQD8Q3\#-+B@"-0%7IS2BGXHQ0 E%+BC% "4N*** $I:** "BBB@ HHHH **
M** "BBB@!IZTE*>M)0 4444 %%%% "BEI!2T %%%% !112&@!PZ44@Z4M !1
M110 4444 %%%% !11FB@ HHS1F@ HHHH **** "BBB@ HHHH **** "BBC-
M!11FC- !11FC- !11FC- !11FDS0 4444 %%&*7% "49HHH 0\TW;3\<T8H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 -/6DI324 %%%% !1110 C9
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M@!PHI!2T %%%% !1110 4F*6B@!,48I:* $Q2&G4TT -Q2TM+B@!*0C-.HH
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MBGS$\C)R<T@SGD5$9 . >>]*NYFSGBBXFF2]Z6DR ?>CO0 H-+2"EH ****
M"BBB@ HHHH **** "BBB@ I,4M% "44M% "44M% !24M% "8I#Q2T'F@5B//
M-/R .*:!3@ : (SR:&!QQ3RHI:+#O8@Q[4A4$8*BI\4F,G%+E&IF;<Z5!< [
MD!S[5SM_X,M+@DK& ?6NUX%,8CTJ>4M3/+KSP#)&I:!B#]:QI;'6M*.8Y';%
M>T@ CD<56EL()"28P?PJ&F6I7W/+K'QOJ-DNRZC;CU%=3I_CFSFAW3,%/O5S
M4?"]I<Y;RP*\[UWPI>1R-]F1@OM4ZFMHM'HMMXNL)Y=HE7\ZWX9XIU#1D$&O
MGV/1-3A<%=^X&O0O#FJW=I J7&<CUIHRDD>BR2"$98\5CWVN1IE8QDUDW^K3
M7F%BSBHH+0N 6Y:MT8LAN9[J]?[Y ]*L6NG&0 ,"3ZUIVFEEF!(XK9CMXH4[
M9% C)M='*G)/%:4=O!;KSC-,FO1'D"J$EPSG(--C+\EZJC:%XJL;STJON+<&
MFD"D2R5[AFJ++$\GBDZ4\<\4KBL(&R<4;ES36)!P%H 63C.#2*46*2,TWC/6
ME4 '!.:<J(6R305RL0 T9-.W#=C/%,)RW%"%84$TIR1Q2%2!F@'/&<4T0TQJ
M\\&@+AJ>#@T.A W9H:*BF@!);':E*^M,5CUI2Q-)&C;&,@)Z4SR><BI\\4E6
M9%9UD4Y#5/%>L@V,O%.(!J-T&WWI#+BO#,N#@9J%[-HSNA-4PKI\P-6[2_VG
M:] B:*_EM4Q*I/O7)^*/$=RT316H))]*[9EAO$VG'-8UUX>C23>J[JAHV@['
MC<L.KSRF1]_)Z<UO:-X?N]3 $X8#WKTR#3+-P%>)0?I6O;:=!;J#&@%1RF_M
M4E8Y'3/ T$&"_P"M=%::#:6W(C4GZ5KX [4H JE$PE4N5X[2-3PHQ]*F$2KT
M%/ YI>M78B[&A:4JOIS3L8HQ18ER&AN,8HZ]J=MHQ3$  '2@"E[T4QA1112
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M7S%3/-=+<:=<0: ES&S&7;7H7]G6!4'RTQ0;6V<>4%4IZ4 >40W>L262^8'
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M:VAEP74'%5'2UW[-@H \NU/PQJ-[8Q2*#A!6C:QS1Z1]C:,[\8SBO2/*7 4
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M>_-P/O&I+KPU:W,_GN?GH P-9UYD<")OF([5S<?C.[@U-8I"Q4FNRG\(13W
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M><&C1=3.@V[P2KG (IB"#QE>PZF+*9#Z4^;Q0\>K*@&2>U<RD]QJGB-I(H<
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M9=)>VGD5%P6/:@#NK;7K=8VDDE&1VS4;^+$(W(A*^HKDD\-79MR^YO7%307
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M5%@]HCR'[#KPZ.]-,/B!/XGKUW[-#_<%(;2$_P  _*BP<Z/(]_B$?WZ<+OQ
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MD)(IB,JST"QM7#K& WTK4\M<C@8IV"11MXH 8T$4AR44T&WAZ[!Q4@&!2@4
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M'E,?PKMM$\ WTDB?NV /M7T!;^$=,@(98%X]JU8M/MH0 D0&/:@'-' ^'O
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M5'GBER:=PM<?S24W)HYHN+E'44W)HR:!\HII-U!I#TIB>@M(*;FESBD*X[%
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M2L.:MXI,#TIV*O8RY-*MIA\T8/X5G77A6RN%(\M0?I72G / I*7*4JAYU>^
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ME_&M\EKIKQY^8BN6\!VTD]RTI7C/6J'B'59-?U<6\!RH;!Q7HOA?1QI^G)D
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M19*7#?G1<5CT)+ZWE/RR+^=60ZD<$'\:\LD\/:];@F*9SBJPO_$FFO\ O [
M4[BL>N<GVHSZ<UYA;_$*\@<)<P,!W.*ZC3O&6G7BJ#-M<]C3N*QU(Y]J.<XJ
MO%<Q2QAUD!!]#4C2<#%,EQ)<D=J6HU)(I03F@BXXTGXTA%)@TRDQ]-+"EZ<&
MDVB@3&EC1@'J*?P.U!P:DHKO$N[(%.QG (J8 48% 7(FC '04PP1GDJ/RJP"
M.])@$T#YBO\ 9(6Y\L?E2K;QY_U8_*K)X&!1T%%@YB$Q)CA /PH$:CHH_*IA
MTYH'/:BPN8K]&Z"G$\]*D*\]*7 '6BP-W(\TH6G8% %,08-**":4<T +BC%+
M10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8I:** $(IH!I])0 FVBG44 -Q1
MBG48H 9BG"EQ10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 T]:2E/6DH **** "BBB@!#1BEHQQ0 'E:\?\ '3>7K4>3D%J]A[5Q&O>$
MVU/4UGZC/2@"+3;]8M-BVV^[CTJAK5A=:U%MMHMC9[5VUCI<=O9I"T2\"K<,
M$4(("@&@#A5>?P[HJI*Y\S&*J0WE]-8/=B5B ,XKI_$7ATZI"2K$MZ5E6>A7
M\6GO:%/E(QF@#$\->)KF^U"2R8D]JR;^RG;QFH65@-W3-=3X?\$R:9JKWA)Y
MJUJ'A:9]6^VQ=: ,75-2DL=3@@+D]*-7\6SQS0VBDC=@9K1N/!]Q>:E'<39X
MJ[J'@N.5HY ,NO>@#.O+BZL].6X$S$D9QFJS>)KMM':8%@0*UWT*[E;RG&8P
M,8JS/X8232S;1H Q% '/>&;S4-9CDD,K#&:2+Q#=:=K@M)')#'%=/X9\.MI$
M;(QQFLS4?![W&O)=#H#F@#DM<MI;GQ3 _FE48@]:]8TR Q6D2AMP ZUS&K>$
MY)KN*>,\KBNFTV*>VM%63G H BUO46L+*1T&<"N*T#4[[6KJ4ARJ@]*[O4;.
M.ZM&63N*X&VMY=&NY1 K!6/84 5O$&H:EI>J(B2DH3SS3]1\;2000P+G<W!-
M9^JV>IZOJL1C1BN>>*ZV7P/%+8Q2.@,P7- % W4RZ<+I9V)(SBBS\2WDFFSA
M@> <&KBZ/??9OLPB&WI5V+PM_P 2R2-OE=A0%CEO#-U?ZM<R*TC8#&K-[JUU
MI6M)&SL5STKH?"OAUM&=VD[FJ^N^&Y+_ %1+@+\H-,#'\0>,Y]\4,>5#8R:E
M^T7']F?:5D).,XK4U+P9!=6Z,H'F**KQZ%?) ;<+\G2@+E#3_%%Y]AF#@_*#
M5?P]>7^LWDI,S!5/ S710^%,6#HW#,*?X8\,G29)68GYJ ,O5]:GTZ1;;S#O
M/'6JNI7^HPZ7]I#GIGK6IXA\)37^H+=1G.WFHYM U"\TQK8C '%(#G?#?B^X
MO[MK1G);&*S'LIF\7[O.(^;.,UT7A[P#+IVI_:6ZUI:GX1G_ +52\MSSGF@#
M*UKQ5-;W,6G#/3&ZK-Q=7,.F+.DA)QG%:-]X+%VR7+C]\!48T._:/R&3Y.E
M%*W\93KI;&1#N'>K6A_:]<B>X,Y4#MFM.'PA ^G,D@ <BJ5MH5_I2-%;$[3Z
M4 </=V\\?C!0TQ(W>M>SV(VV4?.3@5Y^G@R]FU5;N0G.<UZ':VQ@M40G) H
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M#.$O49DSC)%=QI/B:SU55(D"R'MFN+TSQAI/B&$6]^BI,1CGUJIJN@W6F/\
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MBLN[URQMP?,E7CWK!NO'^F6V0LG3WJ&RU [%2V[)J.1V.<XKSE_BA;W<AAM
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M'% P 8>]&T]Q3A3J (]N>*<!CMFG44 )[4@7&:=FB@! *6BB@ HHHH ****
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M* "EIOS9I2#VH 6EI.U&* %HHI#0 M%)10 M%)FD[YH =13<$4Z@ HHI,^E
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M4'0 5JQ_$;5K<XN+:3WXKUD00.=CQ*1[BJUQH6FS9WP1\^U#8T</I_Q-M9I
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M/UH ]"/P0LF'!!J_IWP;T^TF5Y,<'/-6_ACKVJ:K%G4=P/O4?Q.\1:MI*?Z
MK?A0!WVGZ?9Z;;+;0LJX&.*NQA8@09 <].:^6QX\\5LV=LF?QJW9>.O%LM]&
MDBR;,^] 'TX"0,YS4.H-_H$I([&LSPS<W%WI,4MQG>1SFM/4?^/"3TVF@#Y&
M^)#>9KTH4?Q5R$@544#K76?$0[?$4V.?FKD,^8,XZ4,J.YZ]\+;1+JSD# $@
M5U>A2O9>)&BS@;JYOX.G]Q,6/8UT$.9/%A*=-U<KW/0CK$]DLI-\0:K+-N;
MJG8KLM4!]*N*N&S71$X:NX]:?40ZU)3,PI:::6F M%)2T %%%!Z4 %%)10 &
MDH/2@4"N02\FN3\9Z$NIZ<^%R0*Z]ADU%,HDC*,O!I,UA*QX9X1U,:%K9LY%
MVC=C)KTGQ-X@>PT8W-NV<KGBL'QGX/ !O;)/WHYXKAM4\0W2:.UC<@E@,<U#
M.CXD==X'\;7FM:@893E0:]69NF.IKYO\!ZM%I%]YTO )S7KH^(FF-MRP!IIF
M4HV.S9BGS'@5B2>+=+ANVMYIT# XY-8TOQ#TR3Y"XVGBO//%HTV]9KNRG/FG
MG -68M'N=M<0W<8DMY0P/H:R/$'B2WT"$O.1FO"-)\?ZIHH\IBQ4>M5]<\67
M?BNYC@&[D\TR;'I\/Q8MW+!("X]J<?B4LJ,C6;%#V(J3P5X)LHM*22ZARY&>
M175+X9TLDXMU ^E(=CS^#Q+I:W1N4L"LF<\+6J/B4%^46KX'M761^%-)!),
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MJJ,<T)$2D(.1BC&.*=CTHQQ5$ *6D IU,!N:44;:4<4 +1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%"FCFD)P?:E[XH .:6FYYQ2@T +1110 4444 %)BEHH 3%+129H #28S2T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M** "BBB@ I#110 M+110 &DHHH !1110 4444 %%%% !1110 4444 )2T44
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %)110 M12T44 2Q?=H:BB@!@ZU(>E%% %:4_.*LI]P444 -;[U*_W:**
M (&Z5)!T-%%,!9?NTL?^KHHH$0_Q&K"_=HHH 7^*H[C_ %9HHH&,MON5)V:B
MB@EB1?<-0 _,U%%,I%F/_5BF_P 5%%2!(.E1RT44 1_Q"K Z"BB@!C?>IS?<
M-%% #8ON5%_RUHHH 6;J*<O2BB@!PH[T44 +2=Z** %HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
>**** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>forms-1_015.jpg
<TEXT>
begin 644 forms-1_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *7!-@# 2(  A$! Q$!_\0
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MX!EQ@>M5]6\8:/HK1B^NMJL_E[TY&[T->7:=XUN+?X=W]S=67D:U8*;,S*,
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MOXJUOC@S1^ X[>V0;Y9U1$3G(K \6:=<6/P0LK>[B;[6P"HG<9H WOAX)H/
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M(3<P[T%"1M)Y_E0!R5O\/-)MR$(+6BMO\O/!/O6K>^&[*\EBN(LPSQIL1E.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*,CUI"P'4B@ S1Q4:7$4N?+=7QUVGI4@(- "T444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 1$;"3ZURWCSQ-#X<\.S3LP%RRE4'>NIFD6.)I'(
M 49R:^6_BMXOFU_Q(]I&&^SPG''0T =-\)_B%.^L7-MJ<ORS/\NXU[^C*P5U
M/RL,BOB2*YDLKJWNH=VZ(Y8+7U5\.O%47B3PY Q_UL:X(/6@#M<T4P&G4 +1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)D>M+0 449'K10 44
M49H **,BDR/6@!:*3(]:6@ HHHH **** "BC-&: "BDR/6ER* "BC(HH ***
M* "BC(]:,B@ HHR,44 %%&<44 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !0>E%% %>:%;F,Q2#,;#!KAO$7@#0(M'OKQ;<>:$+ X[UWW0@#IBLGQ&F
M[PU>CI^[- 'BOPD\,:7K<U^+R /M<CD5[3HGAK3M \S[#$$#>E>7_ W_ (^-
M6QVD./SKV9<A1GO0 ZG"C%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!5-$_AK3IHXD*[60?*U $3WM]'<LL<.;0K\IKE[+38+BQU>:?/FY)4^E>@K
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M44 %%%% !1110 4444 -/WA67XE_Y%V^_P"N3?RK4/WA67XE_P"1=OO^N34
M>6? W_CXU7_KH?YU[0*\7^!O_'QJO_70_P Z]H% "T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "449Y
MHZC(H 7-)3=P]:4D+U.* %HHI,CF@!V:,TW(]: <G /- #LT4S</6ER >30
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M "T49I 0>E "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6+.QLX9+V[1)2H. >M>=?$5+>SM-%33G41[EY%<KXNO+Y_$EE;."8S&.3TH
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MN6+$]JMPPBUC6*(#:HP*Y&/QFFI:7>36T>V: D9-6=(\86LEHAN6Q(1R3ZT
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M\-M(L[X7,$DH<-N\O/%7-8\"Z7K,HN&WQ3J/O+738=<$+G/4U'=!H;2=T/\
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M)X?*N09.#[5'8:+O^UV=Y.(PC87/>O3UTRUCNS>"!3,W\6.E176BV=S*9)$
M)Y)'<T ,T.T%AI,<*S*ZA>#7$Z3-IBZSJRW.UI<G:6KT:&"."$(BC:%Q7+6'
MA=/[1N;B\A4B1R5(':@#FK;4KFR@:U4#R9I,9(XQ4FBH8O$EROWX6A[=,UWT
MFC64L'V:2%2B\@@<TMIH]E9$M'%SCJ: .#TR.UC\/ZQ%Y>R8N<<4G]FPQ^#[
M=_*)N&;KBNZ_L6Q5W<Q@K+U JP;"!;9;?RP4!^7VH \FE^TQ7D>DJKA+E<,:
ML6JRVFMQ>'UR\2?/D]*]/.E61F29X5\U?NG%*=/M1<_:?(C$W]_% 'FVL:A+
MJ*746Q4-J,#(ZXH"R:?H-IK:AO-S@UW]SH%A=3^<T:KN^\ /O5CZ[IMQ>^7I
MEM!MM%.<XXH R=.T>WUK1)+RZE:*2<YS5OPUJ$EMJ9TV6%2%&%=1VKJ(=(A7
M2XK)@,*,9%%GHMKI\K20H6E/\34 7QQQC)[9J:H461?OD$GN*FH **** "BB
MB@ HHHH **** "BBB@ HI,CUH# YP>E "'K63XD_Y%J]_P"N1K5W \@\5E>)
M#_Q3EZ._E&@#R[X&_P#'QJO_ %T/\Z]H%>+_  -_X^-5_P"NA_G7M H 6BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCEDSM#CF@#HM._Y!=OD_P"KFY=O)X]:Y6Q\9:1'I\"&7)"#(Q5D>--')PTN
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MOAZ[O3=>>0CO\V*Z/2=1&J6$=P@Q(1\WL:OF$,^]B<XQQ3 X9M*U2]M(=.F
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MQ1FF 8HQ1S1S0 8HQ1S1S0 8HQ1S1S0 8HQ1S1S0 8HVBCFEH 3:*,4M)S0
M8HQ1S1S0 8HQ1S1S0 8I:3FEH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ H/0T4'H<4 9]\LK:=<& XD*'BOGT:K%I7B&:2[$S7>6'>OH+4-\
M=C+*GWU4FO*]-\3>%WOYTURU47@<\[* .I^';75SI\MY<[@C'Y5:NB\1D_\
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MCCL34]K?6U[&9+:42*#C(H M9I*H76L:?9R>7<7*(WH31'JMI=1%K:8/CTH
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M=E9D"XG5"?4T 6Z*@MKRVO!FWE60>QIESJ5G9G%S.L?U- %JCBJUKJ-I>_\
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MHO$8!\.7J]6$1_E0!YA\#?\ CXU7_KH?YU[0*\7^!O\ Q\:K_P!=#_.O:!0
MM%%% !1110 4444 %%%% !1110 4444 %%%% %34/^0=<_[AKXWUO_D8KW_K
MJU?9%_SI]P!R2A KY.UGPMKDFNWCI8R%6D)!"GI4B.:R"C+TS7:^$/$-MH_A
MW4+4N5EE3"X/-81\):X#D6$I_P" FD;PEKN04L)5/^Z:!6*UIJ,IUBVNKB9C
M'%+D[CFO7=7\0>!]2FM=2N@)+N&,;1ZFO*SX2UPDJ]A*P/?:::/!VM[0/L$H
MY_NF@#L[;QQ97_BQ;N\3;;P?ZH&EE^*FH'Q6TP4?8E.!]*XW_A$=<(PUA*<=
M/E-+_P (CKC$*;&7'^Z: .VU>ST3Q?JTVI"58=L>3SU->:3;4N&C@Y6.3[WJ
M,UKQ^'/$5O \:6DX![@&HO\ A%]9@C\PV4BI_$6!%%@L>H1>(_"&K>&[.SU6
M1HYHDQP>]<MH>K:7H6L:E]G?-O(I",37+#PMJ\J!XK.21">H'2I%\':Y\P:S
ME(/?::+!8[NT\>Z>G@V\MIL&\W'RV[XK.U#Q+87_ (1T^PF;YED#/7*?\(CK
M;C+:=*".VT\TJ^$]=5R?[/EYX^Z>* .U\2?$N:SL[.QT.1/L\*KGBJ_BKQ=8
M>*/"=N+D@WZ#' KD%\'ZY&Q_T"5@?]DT?\(EK^,+I\H&?[IH&9!&V,J$)&.M
M>I?#3P=:^*=$N(9)&1L<<UPK^%=?Y(M)<8_N&O9_@GI=_IMG/'>PM$S'Y<B@
M9R^A_"K4-)\:#*L;4-G=7OT-M%#:"V0GA<$U8*%AGC=]*CNUV6,Q'783FF!R
M=UX"T>^F\YI7WYR=K5U-C9Q6-G';0Y**,9)KEO E[<WWVTS-E4<@9^M=D5)&
M.],#E-1\"Z7J%[)<S/('8YX-;^G:?'IEA';09**,<FKA5\\$8H*$]Z .6U7P
M1I>IWAN9WD#GT-:^CZ3#H]KY-MDJ3WK1"'')IDTJQC(.&Q22$<WK?A+2M4NC
M/</(']C3]-TF#2H"D#$KGO6@\DC]2/RII'S YJP,G5O#MCKJ[;IF3Z4NE>'[
M+1/EM"YQW)K6))&,4F&(Y?CTQ3 RM5\/6.O+MNG9/H:32?#5EHK?Z(S$CN36
MMR>*"&*X+9'I0!1U72H-;B\J[)11W%4M,\*:;I$N^WD<MZDUN8XY.:3GH0,>
ME %+4])M-:@\FZ9D4=P:S+#P7I>G3;[>1\CG)/6M\ACWXI1G&"<CTH K7UG#
MJ=L+:<,J 8R*R+/P9I=A<K/ [EP<\FNA()_BQ^%!)VXR* (;RS6_@,,S;(\8
MR*Y^V\#:/!,)%:3>&SG-=*X#H >M.)88 8;?I0!"\(>U-J#^[QBN?3P)HXNQ
M=&60RYSC-=+@9)ZTH^[P0#0!%Y"I;BW7F/&,US\_@;2)[S[2\D@DSGK72<]V
MI,$GYB/RH C@MTM+3[,C9CQC-8%QX(T>\NC</)(),YZUT8Z\BE!YZ "@"*VM
MQ9P);QG,8&*Q-2\%Z3J%TTTS2;F]#TK?QDG/'I2KO '[P#U&* *>G6$&C6ZP
M6A+KTYK.U'P?INJ7#7%P[AV[ ]*W0>6^7'O0 P7AN3UH S])TJVT5#';!G![
MFJNJ^&M/U>0-=,X/;!Z5LX=>C_I2C@'&,GK0!G:3H5EH:$6K,^?4U7U?PS8:
MZRO>NRE/NA36SR.AI,'.<T 9.E>'+'2#^X9C]34VJZ-9ZT@CN]P4="*T3GUH
M#. 0",4 8VD^&-.T)R]H[N3V)JYJFE0:O$([HE5/I5T9'2D(8@_-0!@Z?X1T
MO19Q):EW8\Y)K3U+38-3MC#<L<'H!5P%QCYACZ48PY(XSWH Y_3_  7I6FW2
MW$+R;QSR:Z&?RKZ![:=CL/ Q30'P=S@^@Q2C:<'9AA0!CV/@72;2\^U1R2%\
MYQFNEN;..ZLC;29"$8S5=)Y W+#'TJ[%*LH^]R*3 Y2+X?Z1%>?:%>3?G.-U
M=2+=%M?L^/W>W;FI\'/:C:>QJ1G'CP!HYO6N0\GF,<]:ZF*T2.T%L#\@7;4^
MT[NV*0K\W"YH Y&3X>Z7+=-<,[[B<XS72V-G#8VH@BSL4=#5@HY;(? ]*0QD
MMD]?6@#D]0\"Z7JMX;N5I$D)S@&NBT^P33K5;2%28@,;B:M>4_'S#\J?M;UH
M Y74? ^FZC>&>61]Q]#6OHVC6^AVK0VNYD)SR:T]GIUHV-CEN: .:UKP;8:W
M.)[EG5L] :T='T:WT6V\BV),?7D\UJ[3MQG)IFPAMQ.?:@#!UKPM9:XVZ:1U
M/L:=H7ARU\/J_P!F=GR.YK;W'/(P#TI3PW;ZT6 PM:\-VGB$(]R73:>QIVB>
M&K/1"3:LQ![L:V<$*5+C)Z4NTLH^8<=13 SM9T2'6K0PW#D+[5FZ+X-TS1IC
M+ TC/[M718.[ P* K#J^<>U*P%+6-*AU>R-M<9">U8>E^!M+TR]2X@>0NI[F
MNL&W/4$TSEL\@4QE74["/4K-[>8$(1C@U@Z?X%TRQN!/#(^X<X)KJ@, '/UI
MIW<8/'>DQ'#?%:!W\&2",?='6OEI,8 SE@W-?8_BBP&H>'+R%OG^0X%?']Q"
MUK>W$#1[620\&I8BYH:,_BFR.0 ''/XU[QXI\:CPYK&E0RQQO'(H4.PSBOGF
M.22&9+F%L.AS5W4]:O-=V?;F+B+_ %?/2D!VGQ5T:^AU*WU]G,]K*0ZA3PM>
MF>&88/$'A"RU*X=-]M&2,GD8%>#3^)M6O-(739YBT"<*K<\4ZP\4ZOIMDUG;
M3,(&&-N:8'J7@[6?[>\5ZEI4T@,3MMY/'%9OQ<NA9)9Z%;N-J."P!KS.QU*\
MTJ]>^M)2L[')P:=J6I7>L7)NKR4M-V)HN![W-)KR_#S2VT$*\P3! ->.>,?^
M$A-Q%)K<85SU%,L?'?B#3+=+6VN2(4'%4-7\0ZEKK+]NEWO0!F*F^>WC7HSB
MOL#P9#Y/A>Q7_8%?*WA6P.K>)K2V52=KC(K[ L+9;.P@MT& B 4T"+ ')IPI
M*6F,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ H/(HH[4 9VIB4:5<B'AU0D&O#
M[KQ3K^L6LNC6;R)<1,26 ["O8O%&JG2M$GN,%L*> .M>6Z#X]T>VL;BZ;2G^
MW-D [.M '=?#FXNIM),=\S-.G!)KH/$C$>'[[ Y\IOY5S_P[NIKW3KBYF@,;
M2-E01CBM[Q(Q_P"$<O2>#Y9H \O^!O\ Q\:K_P!=#_.O:!7B_P #?^/C5?\
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MM-=PJDF@".:01I[UFO(9&R:=/*9'(SQ40R#5(0M%%%4 4444@"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHQF@ HI<&DQB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *<DACY%-H]NU)@:-O<K(N">:L9K&!*'*FKD%R",,
M>:D9>HIBG(S3\T %%%% !1110 4444 %-;KFG4TYR?3% #';:A..@S7 ?VAK
M.KZC<+82;8XV*XKOY,B-LCC!KB_!L>-7U CIYAJD4,6Q\4[P3-2_8?%2\B;Y
M<UVNXD9]#3&FC0@22JI/0$T <:;'Q.&WM<A5'J:00>))%*K>(<^AK4\771&B
ML\,X'.,J:Y>*PU"S:RO?MC&%L,V3VJTM!V-/['XE2/\ UQ+"G26/BE_+*SX!
MZBM&7QGI<)V!RQQR0*TM,URQU92;:4%UZ@G%1U"QS-CJFJV?B2/3[QMP:N[Q
MS[5PVJG_ (KJSXPQKN,'&":&)C64/OC<91ABOFOXO^$GT?5FU"VC/D2GG KZ
M6(8IC'-8OB;0+;Q#ICVER@.!\A]ZADGQZI20KL/;D4F?2M[Q9X5N_"VK2>;"
MRPD_*0*P$8,*D0N:7-)D XI<T %(2:7(II)SP*0"Y--9OE+,<%?N^]!;!QW]
M!7;> / 5SXKU%6N(V2T4YW$=:: [7X*^$W;=K%W%@'E"1UKW522!GBL_3=+B
MTO38M/M@%CB &1WK14' S5 AQHHHIC"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *#THH/2@#-U06PTV=[Y!+"@)(KQ]-?DENYO[+\.I+:J2 =M>PWEOYUC<P@;
MO,4@ UX]!:^+M%O;FUT\P%78D*2*0'IGA.\NKG3%%S9"T/IC%7=?4GP]?B0[
MAY9P?PJIX4?5)-+ U?:91UVU;\287PY?!2!^[/\ *@#R_P"!O_'QJO\ UT/\
MZ]H%>+_ W_CXU7_KH?YU[0*8"T444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !69K6H#2=*FO6&1'S6ET-9?B#3CJNCW%GVD&*
M (M U8:W8I=!?E-:R[1(0!S6)X6T:71-'2T=OG!K<4'>30 ^BBB@ HHHH **
M** "H+[_ (\+C_KFW\JGJ"^_X\+C_KFW\J .+^''^KU#_KJ?YUW/4BN&^''^
MKU#_ *ZG^==PQQC% "_6J5U-C@=*GN9?+CZ\UF,S.>:8"CDYI32=N*!TYJA!
M1110 4444""BBB@ HHHH **** "BBB@ HHHZ4 %%!XI"0!EB%'O3N,6BJ-QK
M6FVN?.NXEQ_M52/B_0@V/MT>?]ZI; VZ*S8?$.DW! BO(R3_ +5:"2)*NZ-@
MP]C23 =SZT4BDOTX^M .21Z55P%HHZT4 %%%% !1110(**** "BBB@ HHHH
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M;O6QSY1_E7EW@7Q5<:3&=/.FS NW!*\ 5Z;KSF?PM<RME2T)./PH \R^!O\
MQ\:K_P!=#_.O:!7B_P #?^/C5?\ KH?YU[0* %HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *#THHH *K7<T4"&6<@1KUSTJS7/\
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M?+WPZ@:X\7VY R 17U W1?85<6(2BBBK8!1112$%%%% !1110 4444 %%%%
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M444 %07G_'E/_P!<V_E4]07G_'E/_P!<V_E0!Y[X!_UFH_\ 70_SKK^YKD/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%(WW3]* ,[4UEETZZCM_\ 6LAP:\3MKO1+"WU&TUS3I9=18GRWQGGM
M7N$LJPP>8[;%&2<UFV^G:%K9-VEO'*X/)([T 87PQBO%T,M/N"%OE#=<5TGB
M7YO#M[Z>6:T$@2WC"Q((Q_=7I6?XE^7P[>D?\\S_ "H \O\ @;_Q\:K_ -=#
M_.O:!7B_P-_X^-5_ZZ'^=>T"@!:*** "BBB@ HHHH **** "BBB@ HHS1F@
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M P%H!9N6&#0O)._H/NXI<DCGK6@!1110 4444""BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH&%%%%
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M@/\ #>D?V+IJ6GI6P 0QK+T/54UFRCNXP0K#.#6H"<\T .HHS1F@ HHS1F@
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MX-!P!G/%/0=@HI <]*=BE="$HHI2/?-(8E%%% !1112$%%%% !1110 4444
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MQ?X&_P#'QJO_ %T/\Z]H% "T444 %%%% !1110 4444 (>E8_BB+SO#5ZO\
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M='TI,!:***D84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4_Y^G_.D_P"$BU0_\O3_ )UF9]A1GZ4N4+FG_P )!JG_ #]O^='_  D&J?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(#C+6UALH]D:@FIP20=U' [4TY)YK2Q(M%%%, HHHIW$%%+BC%%P$HI<48I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/BAIC1[A&1S7 >*=8M]<U/[1'D5B  1E-HY.>E+G   'Y4<H7"BBB@04444
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M "+=[_UR-:QZBLGQ+_R+=]_UR- 'EOP-_P"/C5?^NA_G7M KQ;X(%8YM3+,
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M2CD4@"BEQ[TAH **** "EI**!BI_K5K87[HK(3_7+6NOW14L$+1112&%%%%
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MWI<T )1110 4444 %%+BC% "44N*,4 )1110 44N*,4 )12XHQB@ HHS1F@
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M* .*_P"%7>'/^?5?RH_X5=X<_P"?5?RKML>]&/>@5CB?^%7>'/\ GU7\J/\
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M  '3%*$QGF@!H.T98Y)[5(.133&#CUI] !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH **** "BBB@ HHHH *#110 E%+10 E%+10 E%+BC%
M"44N*,4 )12XHQ0 E**,44 %%%% !1112L 448HQ3 *0TN** $HI:*-0$I:*
M* "BBB@ HHHH **** "BBB@ HHHH **** "DI:* $HI<48H 2EHQ10 4444
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M5IK<EBIVDBL^&TO!X=0&(LJ7&YE/]W->F):PQ[]J ;NO%)]F@6(Q^6-AZC%
M'%:U/#J'A=XM,!CE7[P45E:%I-K,+423R-.O+*1BO18--L[?=Y4"J&ZBB/3;
M-)=Z0J']10!*J%$50<J!4J^W2D" $\\>E. VT +12;N* V?K0 M%%% !1110
M 4449H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"A]HD/2DF\4Z?;@1,Y9U^][4 ;^:">*K6=[#?VXFMVW(:IZCKMGI?RW#'?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-K&-MGE=17.:?I,]W/=I=S%"\G&3S7JT=C;1%2J %1BH)-&LII?,:(!LYXH
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M^-899'.WUK4T>Q2'PC<E8LS%3ECU-=*^BV#RF5H%))R:M+;1+%Y2*%C/\(H
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M@4\9H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH 2BEQ2$9%("&1XX$:61L*.M9W]O:8P/^E*,>]1^*P5\/
MS[200.M>"^9,&?\ ?/\ >]::N.Y[^-:TUAE;I/SJS;7UM>Y$,BMCK@U\[F2?
M82)W'XUZ/\+#(YF,DC/CCFJU!L]*&TG[O%*05(V 8[UF:]>R6.D37"'#J/EK
MDH];UBVLK>^DD0I(W*Y[5#$>AYI">#BL2;Q-:6\,+RG!?&3V%5M9\8V6E-;[
M2)5F. 5YQ3 Z,8QR1F@$CM7.'5C+?0HD@ D&0":M3^)]/M[I;1Y 9<X)'04
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBBD!'D#FFM*I('-%%4 \+W!II=-P&WFBB
M@"2BBBD M%%% "4444 %%%% !1110 M%%% "4444 %%%% !0>E%% #0,FC:<
M]>*** ' 4M%% !1110 E%%% !1110 4444 %%%% !1110 M%%% !0:** $HH
MHH *!110 M%%% !0:** $HHHH *!110 M!HHH 2D9=V/:BB@!&!Z TX#%%%
M"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>forms-1_016.jpg
<TEXT>
begin 644 forms-1_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *5!HD# 2(  A$! Q$!_\0
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MJ-LW^U1[(/;G?_VA:_\ /5:7^T;7_GJ*\_VS_P"U1MN/]JG[$/;GH']HVO\
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M0^L'H']HVO\ SU%']HVO_/45Y_MN/]JC;<?[5'L0^L'H']HVO_/5:/[1M?\
MGJM>?;)O]NC9-_MT>Q%]8/0?[1M?^>JT?VC:_P#/5:\^V3?[=&R;_;H]B'U@
M] _M&U_YZK1_:%K_ ,]5_.N VS?[5&V;_:I^Q#VYW_\ :%K_ ,]5_.C^T+7_
M )ZK^=<!MF_VJ-LW^U1[$/;G?_VC:_\ /5:7^T;7_GJ*\_VS_P"U1MN/]JCV
M(>W/0/[1M?\ GJ*/[1M?^>HKS_;<?[5&VX_VJ7L1_6#T#^T;7_GJ*/[1M?\
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MCV(>S/L'_A(=*_Y_HO\ OJC_ (2#2?\ G^B_[ZKX^^WZ@?\ E\D_.D^W7_\
MS^2?G1[$/9GV%_PD&D_\_P!%_P!]4?\ "0:3_P _T7_?5?'OVZ__ .?R3\Z/
MMU__ ,_DGYT>Q#V9]A?\)!I/_/\ 1?\ ?5'_  D&D_\ /]%_WU7Q[]NO_P#G
M\D_.C[=?_P#/Y)^='L0]F?8>IY\I<]SS0EA;>2I\L9(YHU7_ %:?6K,)_<)]
M*P3.*HN8K_V?!_SS%+]@M_\ GF*MT8JN=F$:,;ZE3^SK<_\ +,4?V9;_ //,
M5; (HR::G(MT8]BI_9MN/^68H_L^W_YYBK?-%/FD+V,2I_9]O_SS%)_9]O\
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M_9]O_P \Q1_9]O\ \\Q5RBCG8>RB4_[/M_\ GF*/[/M_^>8JY11SL/91*?\
M9]O_ ,\Q1_9]O_SS%7**.=A[*)4_L^W_ .>8H_L^W_YYBK=%+G8_8Q*G]GV_
M_/,4?V?;_P#/,5;Q1BCG8>QB4_[/M_\ GF*/[/M_^>8JY13YV+V42G_9]O\
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MD;V.Z$;"$<T4IZFDJSH"C%%%4@N&*,444PN@Q1110%PHHHH"X4444#N%%%%
M704444!=!BC%%% KABC%%% 7#%)BEHH"X8HQ110%PQ1110%PHHHH"X48HHH'
M<,48HHIW"Z#%&***5PN%%%% KA1110%PHHHH'=!1110%T%%%%(5PHHHH ***
M* /LO5>(D^M6(3F!![5!JW^J3ZU-!_J4^E>2>>/(YZT8]Z<>M)3)#G/'2D5L
MD@]J#D,#GY>]*<'E.:38(:) V1T-.(.,URFM_$'1="NOLUZP5J=H/CW2-?N6
M@M'R13BF:)'4 @G&:=QNQFHI98[6V>=S\B\FN)?XI^'H;QK9I!Y@;;UH:8K'
M<G(/ H#!CQ^-0VMW'>VJ74',;#(J88/S*..]*Y(-N_A&1WI1@C(--?Y5W!P%
M'6L'4O&.A:0Q2>Z3<.HS32;':YT ![T8.>,5PI^+7ADOL%PN?K6SIGC+1-5^
M2WNT#GU-/E8^5G0.P0\T@<-]VDC(V;@0ZGN*<H[@<4B1:***87$+87(/-*0P
M /K3)'2"%I)3PO-<9>_%30+*Z:VFD 93CK2LRK';9&[&:"0#7!?\+=\,@8\X
M 4L/Q:\.SR!$F'/>J46-09WAQC@TF2#R.*R=.\2Z3JHQ;7"ECVS6M@*!N.0>
MAJ6G<AIIAN'4=*7.>E(>#A5RM+D^E,+!AJ7\:3D]Z0KZ'-1=AJ*2*0M@@4JM
MCJN:3>2WW:H5F .3BC)YQBEXY)XKE=>\;:1X<N!'?28D/3FA)E139U(+>66(
MP1VH4EDW=ZY30_B%HVOW8M;60%C75>6R/\I^4T/0)*PO.S/?TI<$ ;C@FH;F
M:.UA:64\*,UQEW\5?#EO.\$TF'0XQFBPE<[C.0<=12!B4)/#>E9>C:Y9ZW9K
M<V#!E/6J'B3QII7AN2/[>X!/44<K+L=*/NY;K30^21T]*Y?0?'NBZ_?_ &>R
ME#-C.,UNW]]!8V[W%T=D:<YHLQ<I;RX W 9I6(&,<FN,MOBAH%Y??8X7W2 X
MKKXI$G198AP10Q-,D+*.N: P/2@9!^=<T[(_NXHN3<3!HX]>:4GBFA1UHN%Q
M1[\4BG+[:"0W2J>IZI;:19O<W+ *HHW&M2V-Q<@\ =Z7YJX+_A;?APOY;3#.
M<=:[>PNXK^QBNH&S%(,K3<6BI)DV1WI/,3>%YYIV,'I61XB\0VGAZR%Q=8"Y
MZTK,E)FJ-V\J< 4@;)(-<1;?%/PW?7$<23CS&.,9KM+>5+F)9$.8R,@TW%V$
MTR1=S-@C ]:4<L1Z4K$X&VLS6]=M=!M3<71 0#+5*N4DS4V^N*0#UK@!\7/#
M1Y\X?G3Q\7?#9X\]?SJN5E\IW@P0:09[C%</#\6O#LUPL$<P+-Q786MU'?PK
M/"<HW-'*R;%H %<TW.3B@'' '%.R.PYHL2(0P(QC!ZFD&3GVIK\C]X<+7):M
M\1]"T*[-I</\XHL.QU_S8Y&*7'&:YKP_XYTGQ-<&*S;+KTKI2Q#8Q2:8-,!D
MTAW#&,&DD;:C.?NJ,FN(N?BCX>L+Z2VEEPR'!YHBF%F=R1Z'FE ..16)H'BC
M3O$,1DLW#5M;6/>BUF)IBG I,YI=I7MFC[W.,8IW%9B<#K2!E)P#S3MXZ8HV
M*>=N*+A9B8]Z7'O300QQBE("G'K2'</I0!ZT[(7M322W04!<-R],T?2@CCI2
M 'Z4["%PWI1TZT9/8TA)],TK%)"Y!Z&BD!]L4M*PFA#G''6C/8?>H)(''6CY
M4&?XC0)"\#[QP:7'&2:@FEBMD,MRX51SR:YN_P#B%H%@Q$ERIQ[U7+<OE.J_
M&FG?_" 17%P?%7PW</L%POYUTNGZ[I>I(&M;I&+=LT<HN4OEU'?FE^;TXI,*
MK?,,^]*"3UZ=JFP6'8XZTASGBDV#UI#G&%ZT["LQ<_O M*>#BJ6HZE;:3:M<
MW)P *X\_%KPX9O+,H\S.!S32'RG>;N.>OI1\V!QS52SO(=2LXKN$Y5QFK1!W
M9["DR;,7/..]*<CK2?*>1UH(]>E(+,0MTQSFG'"D FF/)'#&\C<*HSFN?E\:
M:+%)LDN4WYQC--)LI)G1=3QTH4[B1W%16MW'=VZSPG,9&<US6M?$+1- NC%=
MN U#3N*S.KP01TH/'2N1T+Q_HGB._P#LUG+F4]!778*=>:&AM!D#K1]*4G(^
M[31E>U%@L*/>E^E(3N[4;=HS0(,-Z44;L]J,'K1<5PYH;@<=:7?CM2''7%*X
M7 <CGBD)YI=H-'RBG8 HHHH :6^8 4[!W8JGJ.J6VDVK7%P0%6N-?XN>'%9E
M>8 @XZTU%LJ,6SOCP<=Z/J:YG0_'.D:ZP2RE5B3BM76-8M-%@\^[;"]:3B[C
MY7<T2,+G-)SY>ZN"?XN>&E8HTHX]ZU=#\?Z-KTWD6K@FFXL;B=2,LN11TZTW
M)7D?=HX>HU(L.SZ48;TI-JK2Y-4%A,@=:7/3%(3[9H^9ATP*&@28O\6*0L%?
M#=/6J&K:I:Z1:&XN#@"N1_X6WX>+>4K@N3BFHL?*SO>O2E/# 55M+J'4+**Y
M@;Y7&:L!NP'(HL*S'%@.M)D'I2Y'\0I<C^$4!9C=P]Z4<TF\_P!REW?A2"S$
M9B%)')%&[Y03U-)\JHS'H.37/3^-=$MYVMY9U$BG&,T68TF=&,]Q2\55L+V#
M4+<36[AD/<5:(JK !P*3-!QBDH$+FC-)10 N:,TE% "YHS244 +FC-)10 N:
M*2B@!<4F*6BD)ACI22?ZMOI2]A22?ZMOI31<6?+GQ1/_ !53#WKC3_#78_%'
M_D:V^M<<>@KMB]#KB@/6B@]:*U- HHHH6Y+"@#Y]K$"I;6W-W=Q6P.TR'&?2
MO4['X*S7EM',;H<C-*<DB6SR92"6Y'%+U[C\Z]B'P*D^8"Z'-(/@1+C_ (^A
M6?M4A<QX]^(_.C\1^=>Q?\*(E_Y^A1_PHB7_ )^A1[9!S(\=_$?G1^(KV+_A
M1$O_ #]"D_X41-VNA1[9!S(\>_$4?B*]A_X41/\ \_0_.C_A1,X_Y>A3]L@Y
MD>._B*/Q%>Q_\**G_P"?H4A^!4^/^/H4>V0<R/'AP,M@"D# ]*]"\4_#*;PY
MIAG=]V*\[#[1@+5PES#;[#_;O29Q]X@5UNA^#EUNW5XY0)".1FM,_#&99-KR
M5:5V<LZ_)N>?Y'<BC<OK7H'_  K&;N]+_P *QD_OUI[-F#QD>YY_E?6DW+ZU
MZ#_PK*7^_1_PK&7^_3]FQ?78=SS[</6E_$5Z!_PK&7^_1_PK*;^_2Y&'UV+V
M9Y_GW%!RO7&*] _X5C-_STI!\,7<'=< 8[4<C*6,CW. XQP:0DA<K@FN_3X9
M/G G!JEK'@==(L_M#W )],TI*R-8XF,G9''L%5%.?F/:@@ X!%-8#>?8UWGA
M#X;2^*H&G6;8 *QF[(ZU-6.#_$4OXBO8O^%%3_\ /T*3_A1<^<?:A6<:JZBY
MSQ[\11^(KV+_ (43-_S]"C_A1,W_ #]#\Z?MD',CQW\11^(KV'_A14W_ #]"
MC_A14W_/T*/;(.8\>S[BDS[BO8O^%$S_ //T*/\ A1,__/T*7MD+F/'<^XHS
M[BO8A\"9_P#GZ%+_ ,*(F_Y^A1[9!S'CFX9'(I6!# #D5ZOJ7P5FT^R>Y\\-
MM&<5Y==6S65Y)"3G:<4U.^Q2=R#<-VVEINWG=BG5LBPHHHI"/LS5O]4GUJ:#
M_4I]*AU;_5)]:F@_U*?2O*.%DIZTE*>M)02!&Y=M-C.R3:O2E/KZ4Y&#/TI#
M1\S?&6&-O%N2?PJU\&(U&NR8 P*I_&,C_A+#WJY\'BJ:PQV]:ZHK0W2T/?=;
M&[1)\'HIXKY(UB*-O$\KD;2)AT^M?6VL'9HD_P O537R9J^!XG<$?>F'\ZA+
M1DV/JSPDH/A:T'8QBM8AT8(GW>]9/A([O#-I@=$%:^6+G*]NM<[CJ38X;XF:
M[/H.AF6 MAQC(KYN>>?6=0W7MP^)#USVKZK\4Z%;^(=*>REE5'QQN->!ZW\+
MM7TR=_LS">+MM-==-*QI!&II_P +]$O=*$\>HQ>>1G;OYJAI_P -?$":LHTZ
MZ 16_O=17,_V)XBTHF98KA0/<XJ:R\;>(-*NA*9V^4\J>U5)(MV/I[PU9W]A
MIR6^H-N=1UK83')S7%_#_P 8GQ+I(:X.9@*[),[0K#!/0URR1A)$F?FV]Z0$
M$D#M2[2AW$YIO3)]:2,TBKJ:9TV?)_A-?(_BJ(?\)+<DC.&-?7.I'_B6S_[I
MKY*\4D?\))<YZ;C7131T1.L\"?#K3/%-E]IN9O+"_>YI/&_PZL/#4'GV-R&7
MV/-<[HQ\51V3-I1<6WJN:SM2UC5[B0P7EPS$<$$UHK&RL2>&]:O-,UF#R9W*
MLPR,U]5Z3J<;:%#<WTJI\H/S'%>&?#3P);ZQ,E[/("4^;;4_Q4\3RP7JZ+9L
MR+&,':<5C*-V92CJ>F:C\5_#VF2-$TV\J<?*:KVOQD\-7,HC+NA/=J\#\.OI
MRWGGZE"]PJGE>M;/B6[T*_14L-,D@8#A@N*?)H+E/I/3=<T[5X]UI.KY'0&K
M-U>6VGV[3W$JHB]=QKY7\%:_K&@Z["NV9K=G P0:]S\6V']O:"D\]W]E1U&1
MNQ4<@N4EU'XK^';$D&;>1_=-4[;XR^')YA'N=2>YKRA-%\.:5?J;F\^TC/(S
MFJ'BZXT*>+=IEJT1'&[&*ODT'RGTCI/B;2]?A9K.X4GTS7AOQI56U5!C)]:P
M?AI?W,7B2WMDE;:[<C-=#\9R#JD('8<TXP*BC'^$$0_X2U%'K7T^X8/DGY0*
M^9/@_P#\C@E?3SG# 'O653<B>Y#+"MQ;21R+E64@5\K?$70ET_Q-*YCPI8FO
MJPL0_'05XY\:=",ELE["G/<BB(HE?X*ZP$MI[65MN.5KCOBMJ*:EKYB+;DC/
M.36#X:UZ;0KG*G (YJ>WM7\6>*6Y)#<UT)(U2#P%?KHWB&.520KD <U[-\4-
M<,'@Y C R2KGK7A%_92Z#X@6-L@(_%:GB7Q1-J\4-H6)"C&*)10-&G\*-$_M
M3Q&;EXL@')-?1-]K.G:' !<3I&J#D9YKSGX7Z<-&\*2ZJZX(4G]*\B\7^);[
M7M<G;SG$"N1@&L^6Y-CW:\^,?AFRD(\YG[<5>TSXH^'M5D6..?:S=-QKSKP-
M\,]-UW2#=76<L,C-<9X\\,KX=U3;8S%-G3!I<B)Y$SZD^V0&U:YC=715W'![
M5PLGQA\/1ZB;)B_F!MIKB/A;XOGN[&ZTZZ<N1&0"37EVLKY?B&[DS@^8<?G3
M]F'LT?2VH?%#0--C1YI.&Y&#5'Q=J]MK_@::_M 3"R\9KR/PYX"O_&"I.TI,
M:^]>J:WI!\.?#N2R;G"XI)),%%)GS>L:_;%8(#E^]?7G@]D3PC8,6"JL>3[5
M\D*F+]&!XW]*^BM2U;^R/A=#+"2)&CQ^E7-%R1MZS\2]!T9V2>;++P=IKSWX
MB^.-'\4>&2EG(=^>A->1 RZIJL9N)2PEDY!->C^,/ -EHO@Z"_BD.6 )%*$4
M"1YYX=@C_MRU"K\P<9-?76B'.CP*!CY!7R3H'.MVA'3<*^N-#_Y!-OC^X**E
MK$21?)(C&.U>;_%X?\2!V[8Z5Z0?NFO.?BYC_A'CGIBLH*[")\V6EK%=WD<+
MKM#M@8KU:S^"]O=64<S7B*7&<;J\LA\WS$6$?O"WRUVB:5\06B1K<S>41\N"
M:Z&D:M'66/P36'4(YX;I'V') :NUN?'>E>"H8["\#AE&,URGPZL/&,&M!]3$
MGDCKN)K:^+GA==3TIKN*/YT&20*R9#.CT'XCZ+XAG\BS<[_0UK^(/$NG^&;+
M[5?,0A]*^6?"&H/X?U^.=G(0-@BNL^)7BT^(OL]G;OD/@8%)Q,VCV/0?'^F^
M)6=+)791W(KS[QW%X/\ [<)U$N)CU KK?A=X831?#ZS3(/,D7.<5X_\ %0%_
M%<I!X%.**2/2/A@/#?\ :$K:06+CUKN=>\;:/H,ACNYQO] :\1^$5RUB+ZYZ
M[%-<9XBU.XUO7+F:69L"0@#/O52B78^@K;XM>';Y9X4E(.TCYN]?/?BIX;WQ
M#=7,:@0LQQBO3?!_PUL-4T$WTCE7VYXKR_Q'9C3M9N+4'(4X%.$0L>Q?!"-8
M[!SDG)XKU+5O$6GZ)%NO)U4^F:\F^$UV-.\-W%SU9 37FWC'Q'>:WK%P99F$
M>[A<T.-V*Q[I/\9?#MO-Y1=V]QTK6TGXC:#K)Q#< -G&":\'T6]T&UT9A>Z<
M\\Q'#!<US4QGAU'[5IEO- F<A,&E[-!RGUMJNNVFD:6VHS'= HR2M<6GQJ\.
M2S! S@$XYKF++Q!=:G\-[J"]C;<J8!8>U>*0VPDGVDX!?BCV8N4^IKSXH>'[
M.W65Y@=PR,&H-,^+/AW4Y5BCD(9C@9KB8/AQ83^#5U"64EPF0":\;G3^SKU_
M*8J$?@BIY$'LT?:$-U#- )U=3'C.<US.L?$70='=DGN 67J :\]?Q9<Z9\-5
ME5F+NN U>16$,_B+68Q<3L3,_0FCD0>S1]#6OQE\-W$FT2GKCFNRTW7M/UF$
M26LZG(Z9YKQ[4/@I$NDI+928F9<]>]2>!O WB/0-1$L]PS0 ]-U38CE/9IKJ
M"TMVFF?:HZYKD-3^*?AW2V(>8N1V0YK@OBWXOOH+H:? YC5EP<5YKX6>SAU%
MWU6-KG/..M4HEJ)]!:=\6_#=_.(O-*$]-U=G9:C::C%YMK,LB^QKY3\32:;<
M '2K*2WE)ZA373?"WQ!JNDZQ#97 D>.0@?-FB4+$R1]'@^G6D1=SDMU%'4AB
M, C-"MG)6L3)+4\4^+WBR]LI#:0,R=J\HT33H]=OU2_NF0,>2QKZ$\?^!+;Q
M/;F59D28<]:\1U+X>>(+"0F!#(%Z%#7332L=$4=)?_"BR6S$NF7Z-(1G :M'
MP1X"\3Z=>BY^T!H5/3-><,?$FE-^\>:''][-=)X6^)NL:7J$4-Y,7@9@"?6G
M)#:/I*"8QV0:Y(#*.2:YW5OB)H6DOY<UPK,.N#7(?$GQM+::!!)8D_OU&2/>
MO&O#FGOXE\0K#<S.?,;+9-8N)-CWI/C-X;DD*B1N*ZG1O%FE:X@-I<+N/8GF
MO-=?^$>EV.A&XMC^\5<DUX_8ZM>^'M;#VT[!4?!&:+!9'TQ\0U#^&)^,D*>:
M^43&IO3)C_EI@5]):EJTFM?#DW)Y)3YC^%?.FU1>C_KI5Q121]/:%KMIX=\!
M6EW>9V!.<5G6OQH\.SW(C!?YSM%9'B+YOA;;@\#R_P"E>%:9$/[4@Y_Y:?UH
MY">4^L-8\:Z=H6F17]R&$,@RI%8-C\8O#^H7L=I'O\QS@5S7Q+7=X"L01C"#
M%>/>&/D\1V3?[8I<@<I]#^-?B%I6F:=+9NS+-*GRXKYQNKJ:YO\ [0+APN_=
MU[9KWSQ_X2T^ZT"/4I%S,(QS7SZY5;Q8R?W>[%5%(I(^AO /Q$TJZL[;159F
MN<;2:R/B'%X376 -4+;^^*V? '@33+;3[?5X4Q,PR37G/QB9#KJ@=<U-E<5E
M<Z[X<#PHNM,=,!\T?=S7KUY?VUA"9KF0*ON:^<_@T%7Q0QZ[><5I?%WQ9=OJ
MCZ?;.R #'!HDM0DCTG4OBQX=TZ0HTVX^QHTSXJ^'=2F\J.<JW^T:\7^&O@^#
MQ3<3#4)2S ]S3?B1X1B\)WD?V"4J2>QHY16/IB#4+:[M6N() Z*,G!KAK_XQ
M^'["\DM92^Z,X:N!^%?B^X\^33[AR^8R.37GWBP*/%-\63AF-"A<2C<^CH/B
MCH$NG_;5E'E^A/-44^,GAQYO++OG.*\X^'7@>S\1:>WG2D <[<UQWC31HM"\
M02VMN^%0T_9H?LT?5>DZW9:S;":UD!4BJ&M>,=)T,'[3.NX?P@UY-\&;^]N(
M;N$LS[5.*X/QR-4;Q+-]H$BQ!NO.*7LQ>S/:Y/C1X=23;^\/N*W=%^(N@:V0
ML%PJL> '-> :3K7ARVLO*N[+S9<8W$5I^'QX8N=4CF\XVQ#Y SBAQ!Q/I965
MT#(P8'TI3P,FL[1VMWT]6M)A*,#G.:OJK,F7K)F;1R'Q'P_AF;C^$\U\MK9I
M//(H7<Y8XKZH^(H!\(7##T-?.G@JS&H>)Q;N,@L:WIV-X6L6O %V=*\5PJ[E
M(]P!4'O7J'Q?UQ'TN"VC8%Y5XQ7D_B:SDT3Q6S)E0K9%+<:O<^(M5LX')8*0
M*IQ5QZ7.;>T\OB9,.QKT/X0QJNO=. :RO'VG1:9<6T8&&*@UL?"0A=>Q_$3Q
M3<58)(^AK_5;/2[?SKJ9$0#H37(7GQ=\-6;%3*6/M53Q[H2:M"?M-_Y 4=-V
M*\LL+'POIER8[]_M)![<UAR&=CUFW^,/ARYF6,.RD]VKK],U[3]9C+64ZL0,
MD9KY=\82:3+<QC3+=H$['&*Z+X.WUV/$36QG9DQT)I\@6/6];^*.B>'[XV=X
M7$H..*E'Q)T+^RQ?M.0C=LUXC\64#^*G!XP:RO#&@WGBMCI\$S>6O;-/E*2/
M8_$GC#3/$_A:<V)+8!Y-?.Y@7[>&)P?-&,?6O<;CP2?"G@Z=)&RVTUXDN%N#
M)G.U\X_&M8I6*LCZM\-W<&E^$+2:=PJB,'DUCR_%[0H]1^Q('DE)P-G->+ZS
M\0+N[T.'3HV9 H"Y%=A\(/#FDWN^[O)%DNP<@-S64D0XGMFGZE'?VPN""B$9
MRW%8NL^/]#T,L)KA68=E-87Q-\0-H.@B&V39N& 1Q7SK'<R7.KK->,\L;')7
M.<U*C<.4^B8OC3X;ED"$N/>NJTGQ5I.M@&UN48GMGFOG[4+_ ,.-I/D0:2Z3
ME<!MO>N6T*^U70]5$MNLVTGA>:KD"Q]&>*OB3HWA^22PN2WG,I VU\X:U?27
MVN2WJ3L(BV0,UZYXLT"TO_!2:[<K_I3+EL]<UXM9)'->1QR ['?%:12*21[]
M\*_&>GRZ>FE;W:Y/<]*]7#;CM[UYYX'\ V&G6L&HQ8#E0:]#.01MK&6YA+<3
MC.!UHI2J@Y'WJ2I)"BBB@ HHHH **** "BBB@ HHHH 6BBBD)AV%))_JV^E+
MV%))_JV^E-%1/EOXH_\ (UM]:XX]!78_%'_D:V^M<<>@KL@=L0/6B@]:*V+"
MBBBA"+FC_P#(<M/]\5]=:*O_ !)K;;_=%?(NC_\ (;M/]\5]>:'_ ,@:V_W!
M7+79A-FAMQ]:>!QTI,\TZN2[9BV)CVI"0.U.IA^1MY/'I3%<=P:08(X%8=QX
MGT^WNVA$NZ0=5%(/%-KC.UORH"YO8]J,>U87_"56O]UORH_X2JU_NM^5 7-W
M'M01Q6%_PE5I_=;\J/\ A*K7^ZWY4!<YCXM+M\,GYN3ZU\S,23CC(-?0WQ4U
MF*[\-@",C-?/2[0Y;83790.BGJ:>CZ[>:1<B2&0[.XKU?P_XLM-7C57E(F]Z
M\7&,YQU[5)#/<6=PLT#D '/%=L7J<F*H<RT/HD,Q_BR.Q%)O.<9K@?"_C:.9
M%@NF^8<9-=YYL-Q&)+=@V?2NR+1\Y6HRBV.W$'&ZC<?[QIHS_%UI:O0X6VF.
MW-_>-)O.<;L&DY[=:0J.K]:5D--]!Y9@<;C3>^ ,Y[TKNBQY8A?K7%^)O&\&
MFPO;6A#2GC(K*32.JA2G)FSX@\466AVQ4LK3$< &O)-;\0WFM7&9'*Q9X45F
MW5S/=W#3W4I8L<@$U%@AN:PE),^FP^%2U$P!N':OHCX+#_B2N#Z5\[GO]:^B
M?@O_ ,@9_I7#7>AV3ARH]3 &*;CYNE+VH'6O/4F<UQ?PH_"G8HQ5A<;@>E&!
MZ4M% 7$XHQ5#5-4@TN$RW!*IZ@5C6OCK1KEBL5P"P['BG89TYP#R0*,5@-XE
MLV<8!?W%//B:U4<AA^%%@)_$9VZ'<8_NFOD?5AG6+G<>=QKZ=UWQ);3:/.JJ
M2=I[5\P:F\=QJMPR\?,:ZJ.QM IY8+CK2T#Y01176CHZ!1112(/LS5O]4GUJ
M:#_4I]*AU;_5)]:F@_U*?2O*.(E/6DI3UI*"1#SQ3MP5PH'7O244 CPCXO\
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MG!-4=8U^TT>!C-*K.!\O->2>(?%=WJ\Q5"?+IRJ#HX374VO%/CJ2]D:VLCM
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MAR,4I;)()P.U<1?>/GLHC)<6CJJGN*T_#/BV#Q-"\D<9CC3[S,,4$G1_.O\
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M^^/SJGJ3M'I-TX&'5"017AVB>)]9T_Q')-=SR26I? 5N@H$CWP$ G'-.!/7
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M&[=EL%:87 (S#[W%+\J\ Y-! I H!S3"X$9^;HU!< ?-R:7))YZ4  'I0%Q
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M28<C.F&>II<YK-T[4#=C'>M*LW&S(<;!11118FP44446"P4444F#0'H*)/\
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MHHHL%@HHHHL%@HHHHL%@HHHHL%@HHHHL%@HHHHL%@H-%!HL%A****8PHHHH
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M "-3?6N./:NQ^*/_ "-;?6N./:NV!VQ$/6B@]:*W+"BBBDA!1113L 44446
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[,U;_5)]:F@_U*?2H=6_U2
M?6IH/]2GTKR3@)3UI*4]:2@AA1115(I!1113&%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 444P$#(4DD_I2 ?132S)A0 2
M:=L).[=SZ4""BD(<'.!]*#@X).">U%P%HIK;RP50"/6G'Y1P0<=:+C"BF,9
M=R@$&G,"%W@C/I1<!:*:S-P !SU-+]P<G.:!"T4T%L[0./6G-E>F": "BFYD
M;JH%.)VKZF@ HI%W%> ,T@60ODX"T7 =131)ND( &*=0 4444QA1112$%%%%
M( HHHH ****8PHHHH ****!7044447%<***3-%QBT4F:7% 7"BC!I*8DQ:*2
MBD,6BDHP3TH 6BJUW=K;1\]:RQKR@D5:@VKFD8W-VBL/^WQ_=I/[?']VA0;'
M[-F[16'_ ,) O]VC_A(%_NT<C%[-FY16&=?7&<4]-?C8A<<FAP:$X-&S14<,
MHFC#"I*@D**** "J&H_\>QR*OU1U,_Z,:J.Y4-SDL?.V#1SW-'\34#I7IP5D
M=L5H%%+2&J<;CL%')Z&B@4DN@7 G(P:Z#0R53I7/8KH=")*GFN6M&QC4-NBB
MBN,Y0HHHH BN/]2U<==?\?3?6NQN/]2WTKCKK_CZ;ZUU4'J;TB(_>HH/WJ*[
M6=+"EI*6FP84=J*0TN@+8T=(_P"/@5U7I7*Z1_Q\"NJ/:O-J[G)4"BDHK(Q%
MI#THI#TH0T<MK/\ Q\UG'K6CK7_'S6<.M>C1V.VF]!:***V3U*3U%[44E%$F
M-L6I;7_CZ3ZU#WJ6V_X^D^M9U/A%-Z':1?ZA:=3(3^Y7Z4^O->YPO<****!!
M61K?_'K6O63K?-N15PW+AN<Q_P LQ3J:"0O3-*#D9QBO3CL=RE="THI**I"3
M%I&Z49HW8YQF@:&O]T5UFC?\>@^E<H3N XKK-(&+,5Q8@PJNYH4445R'(%%%
M% $-TF^$C-<\^G*TA-=%/_JS66WWS6M/1F,ZCB4#IR$]:/[-3UJ]CFEKI;,/
MK#90_LU*/[-%7Z2ART#V\BC_ &:M(=,7/6K]-[9I18_;LFTNU$#GFM:J-ESU
MJ]7+/XCHA)L****@T"BBB@84445+$P/042?ZIOI0>@I)/]4WTIHJ)\N?%'_D
M:V^M<<>U=C\4?^1K;ZUQQ[5VP.R(AZT4'K16Y84444(04444P"BBB@ HHHH
M****0!1111< HHHH ****$ 4444 %%%%*X!1110F 44450!1112 **** "BB
MB@5PHHHH"X4444#"BBB@ HHHI@%%%% !1110 4444 %%%% 'V9JW^J3ZU-!_
MJ4^E0ZM_JD^M30?ZE/I7D' 2GK24IZTE!#"BBBF 4444!<**** N%%%% 7"B
MBB@+A1110%PHHHH"X4444!<**** N%%%% 7"BBB@+A1110%PHHHH"X4WD-A1
M@=S3JQO$L]Z-&F?3P3(H(- T2ZEKVGZ/'YEQ.I)]ZGTR_M-1A%Q:SJX;G&:\
M5U!X;O09Q?32K= \ANE==X T:)+.&YMM1W C!C+4%6.YU'6K'2QNGF!?^[67
M;^,]*N)L9*D\9-<+XN232_$\=Q=2>;;$Y*9IGB'Q)H6I:?';Z?;?9Y^F_&.:
M /3[O6K33[3[5OWQMZ5CKXZT9&!7<6;M2>#M,0>'%2]Q<;^QYJGXNCT30K#;
M':1_:I.$&* -6R\::1J5S]FAD_>YQBKVHZWIVD1[[B<$G^'-<QX*\*V\<9U.
M6(">09&>QJPO@;[;KCWU_.7B!XC)XH O6WCC29I!$#MW=S7002QN@>%Q(I]*
MX3QMIFCV6FM]F\N.[ ^0+5_X<BZ.BLUV6W]L],4 =A))'&A:5@B>IKGKSQCI
M-E-Y8;S#ZBE\864]YH,BVLQ4H,D@UYOX9\1Z/I ECU6U,[@X+$9H"QZEI_B+
M3M1<".8*?0U#J7B[2]*O%MYY "W%>;0ZC9^(?%D#:2#:PH?F!X!JKX[TI[[Q
M%%;A\E!G*]Z L>TP3Q7D2W5O)F,CM5+5M<L=#M_-NYP >Q-<S\/M87[%/I]P
M</!P,]Q7$?$.677KN6*-R+:(]10.Q[!I>J6>M6@N+-^*T:XOX7PK%X7"@#*G
M -=KBE>Q+$HI.:6G<D**3-&:=QBT4F:447"P44N5_&DHN 4444!<**** N%%
M Z\]*S;W5?LS84 U*BVQJ#9I49%<\?$+_P 2?E2?\)$?[E:JDS14F=%D49%<
M[_PD)_N4?\)$?[E'LF5[)G19%+FN<_X2(_W*</$#X^Z*/92)=)G0YIIZUBP:
MX99@C  &MD$,H(Z&I<6B'#E%HHHI""E'6DI1UH P]<) Q7/J@ZUOZZ<BL#TK
MNI6:.VG'0=@48'I116T8JYIRB8%&!2T53C$%81MH7FDV ,K"AOFPM.!P57M4
MR2L3*QUNF-NM5J[5/3!BU7Z5<KS9[G%/<****DBX51U/_CV:KU4=3_X]FJX;
MEPW.1_B-.'2F_P 1IPZ5ZD=CO6P4&B@U2&A*44E**2W%U&]JZ'0?NFN>[5T.
M@_=-<V(,:IMT445P'(%%%% $5Q_J6^E<==?\?;?6NQN/]2WTKCKK_C[;ZUTT
M-SHI$1^]10?O45WG0PI:2EH8PI#2TAJ>@+8T=(_X^!]:ZH]OI7*Z1_Q\#ZUU
M1[?2O.J[G)4$HHHK(Q"D/2EI#T--#6YRVM?\?59PZUHZQCS\FL_@#/<UZ-+8
M[81T"BBBM5N-1U"BBBE(;B'I4MO_ ,?2?6H@,]:FMU/VI/K43^$4HZ'90_ZE
M?I3ZC@SY2Y]*DKS);G#/1A1112(N%9&MAC!\HK7JK>*&3!&:N#U'S\IQJB0+
MRIIV&/\ ":WMB8V[!0(D ^Z*[U+0?UBQ@[7_ +IHVO\ W36]Y:?W11Y:?W13
MYR?K)@[6_NFE"L/X36[Y:?W108T_NBESC^M& XDP,*:ZO1]WV,;A50HFS[@K
M4M#B  #%<U9W#VW,3T445S!<****!7(Y_P#5FLIOOFM6?_5FLIOOFMZ9RUA.
M]+2=Z6N@Y4%)2TE)[#"F]J=3>U.(^I>L:O51L:O5R5-SNI[!11169I<****!
MA1110P8'H*)/]4WTH/042?ZEOI3143Y;^*'_ "-3?6N./:NQ^*'_ "-3?6N.
M/:NV!VQ$/6B@]:*W+"BBBD(****8!1110 4444 %%%'\)/I2$PHH()0%>M!(
M &3R:$""B@^U!!'2JNBPHHP?448]Q1= [!10<;3@Y(HY\O(ZT-W(844<%1Z]
MZ*AC044 9IKDJ>* '449&,]Z0GC@8/O0V%Q:*5AA5P<D]:0@@'-%AW"BEC7<
MI)XH )Y_AI[ )11D'(%!!# 'G/3%-6$%%!X;:0=U("<X;BDV M%*%)[BF@_-
MB@!:*** "BBB@ HHHI@%%%% !1110 4444 ?9FK?ZI/K4T'^I3Z5#JW^J3ZU
M-!_J4^E>2<!*>M)2GK24$,****JQ2044446"P44446"P44446"P44446"P44
M446"P44446"P44446"P44446"P4444 %%%% !11118+!11118 K,UB\ELK%Y
MHHMZC[PQUK3IKJ'785!0_>!HL-'D7BG6-#O] E>6U,,W? Q6=X7BN#<P'1P[
M*8\YSQFO3]:\':9J]L\1A5=WH*NZ+H-EHEC';P1@%1]X#FD,\QC#_P#"3$^)
M(7,8/4CBMG7U\(W&ER&RB!N%&4VKWKT"\T^TOU*7$",#_$1S5*#PSI-KRELK
M<YY% '.?#M-3^S%KL,L./E#5SVM-/K/CZ.VN48P1M\OI7JZ0@1E54(@^Z%JK
M'I5D)_M!B!F_O8H$3"%8+>..,A8D'(%<#XJ^),6GW)L+.%VDS@D"O0C$&8YS
M@CI65)X6TF:=IY+5&D;N10%SS[3IM(G<7VN7#NWW@GI7:R^)=.L=$6[M$(M1
MUP.U6O\ A$M'P0UN&!]15O\ L6P^Q_8_LZ^1_=Q2N,XSQ+K,VL:!#-H;,(F/
M[P8JMH?_  C4%DO]IQ!IB/G)7O7?VVEVME;F"WA18CU7%59/"VDS9W0C)Z\4
MP/,O$D%C)=QMX<C*.2,%119QW \4V45TC-*P 8D5ZE;:'I]D0T$"[UZ$BI&T
MNTDNENY(E^T+T(% 'E'C."^\.^(_M&GQMY,ORMM]ZT9=*^S^"IKB:,F>4;NG
M->DW.GVEZ!]IB#D<\BG36=O<VHMY8P8P, 8H Y/X8JP\-MO!4[NAKM22QX'%
M5K6RM["#R;5 JFI9)#'&?4"BUP6I+CCK3<XXKF+K5K@3,$.,5#_:US_>K54F
MS3V;.LW4NZN2_M:Y]:/[6N?[U7[&0>S9UNZC=BN2_M:Z_O4G]JW7]ZCV,A^S
M9UN.<YH+'.!TKDFU:Z/1JTM+U*6=PCU+IM"<;&Y111FLC&P449HS0%AK$[2*
MY75O]<376'[AKD]5)\\UM25V;4]R@I)' I?F]!0,$<<48'J:]%)6.SH'S>@H
M^;T%&!ZFDP/4T60"_-CH*: N*7 ]328XI2CH)D]F%^U+78Q?ZI?I7'6G%RM=
MC#_J5^E<-4YJKT'T445SG.% ZT4#K0-&'KE8 [5OZ[P*P.PKT*"T.VF]!U%&
M:,UJEJ:7"BBBFT*PT_>I?XUH(^:@_?6HG'0B2.OTW_CU7Z5<JEII_P!%7Z5=
MS7G2W..2U"BC-&:DFP51U/\ X]FJ]FJ&I_\ 'L:N&Y<%J<E_$:<.E)_$U Z5
MZ<=CN6PM!HS25:'L%**2E%);BL-[5T.@_=-<]VKH-!Z&N7$&51&Y1117"<@4
M444 17'^I;Z5QUU_Q]M]:[&X_P!2U<==\71/O730W-J;(C]ZB@GYLT9KO.D*
M6DSS2YH8VPI#2YI!\PI=!71HZ1_Q\#ZUU1[?2N6T@?Z0.>]=2>U>;5W.2H)1
M1161D%'8T4OKF@-CD]9'[\UGY4*,]:Z*_M$DDR:JFPA8#CFNVE*R-%B.5:F1
MQ1Q6O]@C]*/L$5:*>I/U@R,BC(K7^P14?8(O2AR']9,?OD5+:L3=J/>M06,0
M/3BGQ648F#**F<M!_6+K0W85Q I]J?38_P#5@"G5PLSO?5A1112"P56N_NU9
MJM=_=JH[F=1*QF]Z6D[TM=?0X9VN%%&**1 4'I1126Y#O<0_<K3M/]2*S3]V
MM*T_U(J*AV4;%BBBBN>QV!11118".;_5FLIOOFM6?_5FLIOOFMJ9QUQ.]+2=
MZ7-=!RH*2BBD]AA3>U.I,<4X[#ZEVQJ]5&QJ]7)/<[Z>P4445%C6P44446"P
M4444F# ]!1)_JF^E!Z"B3_4M]*:*B?+?Q0_Y&IOK7''M78_%'_D:V^M<<>U=
ML#LB(>M%!ZT5N6%%%%"$%%%%, HHHI %%%% !1UX]:*0G#*: #YD0UL>'/"]
MUXFN!!;Y#GH:R'R 3D<UWWPV\06?A^[$UVPVCO42OT$RS_PI36\??-'_  I3
M72/OFO44^+GA\@_.>/>G#XO>']N?,_6N24IHR;DCRS_A2.N?WS1_PI+6_P"^
M:]@TWXDZ7JUR(+16D)[CI76-< 1AV.%QDGTJ5.1*DSY/\3^";WP@BR7>2&[U
MS@RZ!UZ&O6?C)XEM-79;&%@3">3ZUY*21"HCX ZUU4VWN;1U 4M'' '4T8.>
MAK7J58,$CBA% !+&D^8\ <U+!;O=3I:QJ6D<XP*):"N/L+*?4[M(+9"SN<#
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M$R'\ZUA#F-H0N=E]HB_YZ"CSXO\ GJ*XSS9?[YH\V7^^?SK7V!K[$[3SX_\
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MQ_K$,,MP\D98;@#VKUO7=4T[X=>%QIMJ ;N1,$KUS6=B3#^)OC1=(L5T6Q5
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MJ_$<-3XA3VI*#VHK,S#O3)_]6WTI_>F3_P"K;Z4UN5'<XZX_X^7^M0U-<?\
M'R_UJ&O0I['<M@HHHK;H/H%%%%(8#O6CHG_'P/K6<.]:.B?\? ^M85-C"9U)
MZT4&BN Y HHHH 7^$UR>K?Z\UU?\)KE-6_UYK>AN;TMR@M+2+2UZ)U!24M)0
MAA0.E% Z4Y"9-:?\?*UV,/\ J5^E<=:_\?*UV,/^I7Z5YU8Y*@^BBBN<Q"CO
M11WH P]>^[6!V%;^O?=K ["O0H;'93V%HHHK=;FJ%HHHHD,0]:#]]?K1W%!^
M^OUJ9_"1(Z[3?^/5:N53TW_CU6KE>9/<XY[A1114D!5+4\M <5=J&X"M$<T)
MV8<W*<6Z.)#@&E"OC[IK<\B/<>*<(DQPHKT(RT)^L6,':_\ <I=K?W*W?*3^
M[1Y2?W13YBEBC"VM_<-)M?LM;_E1_P!T4ABCQ]T5*EJ+ZU<P=CD?=KH-$)5<
M$4P0H>PK1L$5 <"LZTKHI5;ERBBBN404444 -?[M94W^M-:K_=-94W^M-:TU
MJ<U6XSO11WHK9G%JV%+24M)E/0*:*=33TIK8F.Y9M?OUI=JS+3[]:=<TUJ>A
M3B%%%%18VL%**2CUHL2UH9MU]ZJ]6+K[U5ZZX;'GU=PHHHH6Y'06BBBJ$A#3
MXOO"F&GQ?>J)%0W-2/[@I],C^X*?7,]ST8[!1112+L%5[K[M6*KW7W:J.YE4
MV,T]:6D/6EKJZ'GO<*#10:$)B4444NHF!^[6E:?ZH5FG[M:5I_J145#JHEBB
MBBN>QV)!11118+$4_P#JZRV^^:U)_P#5FLMOOFM8''6$-%!HKH.9!1110'4*
M!THH[4+8KJ7+&KQJC8U>-<L]SNI[!11146-K!11118+!11128F@/042?ZEOI
M0>@HD_U3?2FBXH^6_BA_R-3?6N./:NQ^*/\ R-;?6N./:NV!V1$/6B@]:*W+
M"BBBA""BBBBP!1110 4444 %%%% !2KUI*53@T^@S3\.Z>VH:W! B[AO&17U
MAI5H+/2+:")%#*HS7S/\-;RST[Q)]HOY0L8.>:^@D\>^&"-_]H( .,5PU=S"
M9@?%[5#8^'E52,M7S@IR6F?C=7L/Q8\2:-K.GI'8W0<CTKQR(EEV,,J!54HA
M!#MXC4.!N ]:ZCPOX%U#Q9;R36I"5RDB_)MC[U['\'?$.G:/;2Q7]TL9([UK
M-V6AI+1&._P3UN& R/,"BKN*YKSR^@EAO9;9E ,1P:^IKSQYX=^Q7"IJ*,Q0
M@"OF'7'6?6[J:*3*.Q-9PDY/4A:GI?P_^(^F>&=)^RWBGGG(KL1\:_#G7#U\
MZF,'''XT"):J5+J/EN?1?_"[O#>X9WUV/AWQ38>*;8RVA.P>M?(1MU;@<GTK
MW'X5^*-&TC1GM[R=87]ZRG2TT(E ]BO;B.RMGN7/RH,UY1XC^+.BW-K<V,88
MR#*FNGUOQWX<FT>YMXK]79E(KYCU 1MJT\D?W68D'UJ:4'<((+B9);R::)3A
MB3265I/=W:0QQ[FD. *A8_PB3;7J7PT3PYIO^GZS=)YP^XI]:Z)QT+D=GX<T
MFT^'OA=M1O BW4B97UKQ77]>N?$?B/S9W)C,G&3VS6_\2?&<FOZH;6VF)M5.
M$ Z8KAEPI"D_O$YS67*(^L=#$<?@>/[. 2+?MZXKYJ)?_A88+LV\S?=_&NZ\
M _$X:=!_9^H',6,<^E=2'^'IU(:U)*GVE?F"^]9N+$=GK@BD\%,9@!^XXSZX
MKY1NR!?RHHRNXUZGX_\ B?'J$'V#2S^YZ<>E>4LQ8DCEV.:Z*42HA11170]"
MV%%%% PHHHH **** "BBBBP!11118#[,U;_5)]:F@_U*?2H=6_U2?6IH/]2G
MTKR3@)3UI*4]:2@AA1113N-,****=QW =:3;AB0:7K2?=4BEU!;G-ZQ>RI-M
M1B/I6:+FX(SYC?G5K56Q='(JD<GFN^G&Z.RFE8D^TW'_ #T;\Z3[3/WD;\ZC
MPWK1SW-:."-&D2?:9_\ GHWYTAN+@CB1OSIG/K2C/K2Y Y21;FX"_P"L;\ZL
M6-U,UPH9V(S53!V]:DL@1<*<]ZSE'0SDCLQS$M.["HXCF%:D;@"N)G)(****
M2($-86M_=K=-86M_<K:GN;0,%>1S3J:G2G5Z<=CNB(:*4]*2DP>X4H^]24H^
M]28,!]^NNT[_ (]%^E<BOWZZ[3O^/1?I7)6V.>J6Q]R@=*!]R@=*XV<K8M(>
MU+2&F"90U3_CW-<H/OM75ZI_J#7*?QM791V.JD%%%%=9T-!1113!(!WH[4H[
MTG:LI"9T.A_ZMJV#]X5CZ'_JVK8/WJX*GQ''4W''K10>M%9&*"HY_P#5M]*D
MJ.?_ %;?2J6YJCCKC_CY?ZU%4MQ_Q\O]:BKT8;'7"04AI:0UKT+84AI:0T[$
MW%]:TM$_X^!]:S?6M+1/^/@?6N>HM&1+8ZBBBBO/.(****  _<-<KJW^N-=4
M?N&N4U;_ %QK>CN:PT* Z4M(.E+7=<ZU)6"DI324VQ<R"E%)2BAL')$EI_Q]
MK]:[.+_4K]*XRU_X^U^M=G%_JE^E<59G+4'T445S&5PHHHQF@+V,7687D'%8
M:6DOI74WH'?FJ6X#C%=E*6ADZ[3,;['+Z4?8Y/2MK/M1GVK3F*^M:&+]CE]*
M/L<OI6SGVHS1S">*,7['+GI0+.42 XK:[9Q2Y!(XJ92!8DO:>K+  P[5;J*W
M.8Q4M<<M6:<_-J%%%%2%PJ&Y_P!6:FJ&Y_U9IK<SJ/0S/6@4>M%=G0XGN%!H
MH-(R>XE%%%-#8+5^RZ506K]GTK*H=%$MT445SG;<**** N-?[IK*E_UIK5?[
MIK*E_P!::UIG'7&=Z6CO16S.:(4E+250=0H[44=J3(>Y/:_?%:8Z5F6OWZTQ
MTKFD>E2V"BBBH-KA11103)Z&;<_?-5ZL7/WS5>NJ&QY]7<****9 M%%%,2$-
M/B^^*:>M.B^^*B15/<U8_N"G4V/[@IU<[/2B] HHHI%7"JUW]VK-5KO[M5'<
MB>J,[O11WHKKZ'G6U"BBBFMA2"BBBIZC>PG\-:=I_J169_#6I:?ZD5E4.B@3
MT445A<ZT%%%%%QLCG_U9K*/WS6K/_JS64WWS6U,Y*RT$[T4'K16QR*P4444V
MQ)*X4G:EI.QH1;L7+&K]4;&KU<LWJ=]+8****BYK<****+A<****3$V!Z"B3
M_5-]*#T%$G^J;Z4T7%GRW\4?^1K;ZUQQ[5V/Q0_Y&IOK7''M7; [(B'K10>M
M%;EA1110A!1111< I#\HY-+Z5U&FZ#H=Q"K3Z@58C)'I28'+IC:3GFFAR:[C
M_A&O#:GC4S33X;\.DY&I&I%<XK<?:C<.]=I_PC7A[_H)'\Z/^$9\._\ 02/Y
MTT!Q>Y: ZYKM?^$9\._]!(T#PSX=)_Y"1IW XHD'[IP?:FE&/_+1L?6NX_X1
MCP\.FI_K2?\ ",^'_P#H)'\ZAH#B,9ZMFG @=Z[;_A&/#?\ T$S2'PSX;_Z"
M9H6@CB\C'!%)AOX9"OTKMO\ A&/#A'&IG\Z3_A&/#O\ T$S3>H'$ .O_ "U/
M/O2_C7;KX8\.D<ZF?SH_X1?PY_T$S^=1L,XG< .31O6NU_X1GPZ.FID_C1_P
MC7A[_H(G\Z=V,XK>.QQ2<]I#7;?\(UX=_P"@D?SI?^$8\.?]!,_G33 XCG_G
MH:7<O>NV_P"$8\.?]!,_G2?\(UX>_P"@B:=Q'$Y3TH+;N-QQZ5VW_"-^'O\
MH(FE'AGPZ?\ F)&B]P.(PF<DY/K3@4SD]?6NU_X1CP[_ -!(TG_",^'3_P Q
M(_G2 XEBF<C@^M-[_?-=S_PC'AW_ *"1_.C_ (1GPY_T$OUHL!P_RCGC-+N
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MH**#UHKB,0HHHH 7&5-8%_9>;*:W@.#S69< ^:>:UI;F<I-&2NFXZFE_LVM
MY]:3YO6NER,'790_LWWI/[-'K6ASZTG/K3Y@]NRA_9H]:7^S>:O<T?-GK0Y
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MNP44446"P4444,&!Z"B3_4M]*#T%$G^J;Z4T5$^6_BA_R-3?6N./:NQ^*/\
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M3BO)$MYY 6CB8_-\IQ70^(O%USXC3['&?LULG1!P*EM_&5K;>'ETX6*F5/\
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M25H5XD_B/IJ'PH****@[>@5FZO\ \>C?2M*LW5_^/-OI6E/XCBQ'PG$?Q/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_GLWYT>;<?\ /9OSKI50YO[.1[U_PD.F?\]U_.C_ (2'3/\ GNOYUX+YL_\
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M^M<<?X:[8'9$0]:*#UHK8L****8@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ^S-6_U2?6IH/]2GTJ'5O]4GUJ:#_4I]*\DX
M"4]:2E/6DH(84444[C3"BBBG<+@.M,<#YLMQ3Z8PWQ2 C'!H3U%+70\^\0ZU
MI]K>E)9@#GUK(_X2/2/^?I?SKSGXG^:OB!U21@-WK7$_O.\K9^M>K1G9''/
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M_P!T5\D^%_\ D8;;_>%?6VF_\@NW_P!T5QU3"9:%)2TE8F#84J_>%)2K]X4
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M;:YZUK&-5Z'3#GD=Z 2<Y[4,=NT"E-<YSA1R>!12$L"-M)A<XWXF?\B_(O\
MLFOEQP?M$OS @$\5]1?$W!T!^"3M/2OEPD+=2Y5LY/:NBC*QT4V&?8TN?:C<
MW]UORHW-_=;\JZO:(V<@_"C\*-S?W6_*C<W]UORHYB+H1B01Q2E"R$B@-N."
MC9^E1AY,L C8SZ4KA='O_P %,BPE!KUM^,XKR7X)C-A,<'/O7K3'.17'4?O'
M/-Z@.@HI/2EK.Y%PK/UL_P#$HGR#]TUH50UO/]CS[NNTT)ZE19\E^(Q_Q/;C
M_>-9E:7B('^WK@LK8W&LS=Z(V/I7H4YJVIU1D+1^%)N_V&_*E#'LK?E5.:'S
M!^!I<$@\4;F_NM2,SXX5ORJ>8?,(&!XP:]%^$0)\01D?WJ\Z!*H1M;/TKT3X
M/AO[?0MD?-4R:LR6]#Z5;[U-IS_>IM<)QW"BBB@+B$G8_P!*^9/BCG_A('/J
M:^FV!$;G/:OF/XJ[QKK$*2,]JNG*S-:;U.'^7H*.*0L-HPC9^E)N/]QORKN4
MU8ZKJP[BD_ TFX]D;\J7<W]UORJ>:Y/,'X4NT!<,<FDRW]UORI!PQ)5ORIW0
M<Z-CPL"?$%OZ[A7UKIF?[*M\]=HKY)\*ECXCMVV,%W#M7UOIQSID!']T5S5;
M&522L6ATI#UI1TH/6L#GN)0,Y&** "6&#B@$SQGXTN/* (YKPV/_ %?->Y?&
MD_NQM!)'I7A8=F4#RV&/:NFE*QU0D244F[_8;\J-W^PWY5T.:-7(7\*/P-&Y
MO[K?E2;F_NM^5/F0<R%[Y/:G1,#<(<?Q4S<><JWY4L+.\T86-OO#M6<F0V?5
MGP[(/A6  =JZJN5^'?\ R*T /7%=57'/XCFF]0-%*:2I(N%<=\1\GP[(<<8K
ML:X[XC$IX;E'4XJHO4J+U/EMR/M,O'>DI&9A=2YC;KZ4!L#[C?E7=":L=L9*
MPM'X4F[_ &&_*C<>RM^5#FA<RN+^%&,]!BC+?W6_*@LP_A;\JM-%<R&Y.W)'
M->\_!+/V>0X[5X,[-Y>%C8GZ5[S\$MPM'W@CCO7+5=S";1Z_1117,<]PHHHH
M%<I:OC^RYP?[IKY*\1<^(;@$<;C7UIK(_P")3.<_PGBODOQ,677;@[&^\>U:
MTY69M3EJ99X8CM1^!I%)(W;6_*ERW]UORKLYU8ZN96#\*/P-&YO[K?E1EO[K
M?E4^TN0IA^!I>B FDW-C[K?E2;CY8^1LY]*J4U8IR5CT'X4'_BHT('>OI;.0
M/I7S/\)M_P#PD:$J0,]Q7TR<<8]*X)N[..;$HHHJ;D7"@_<;C/%%'\#<XXHN
M%SYE^*Y/]OG*G&:X,L,C KN_BP91KY 4D9[5P?.1E6_*NFE,ZZ<A:*3=_L-^
M5&[_ &&_*MW-&DI"_A1GVHRW]UORHRW]UORI1FA1D@'+<]*U?#GS:_; #HPK
M+#8'*MGZ5I^%][>(+?",!N':IJ35A3GH?6^E$G2;?/\ <%6ZIZ4N-*@R>=HX
MJY7%<XV]0HHHHN*X=Z\P^,BDZ+CM7IXZUY?\9=ZZ-\N6X[4T]2XO4^>(R,8[
MTX@5'$3C+(V?I3BW/W&_*NZ$U8[8R5AW%'%-W'^XWY4;O]AORH<T3*0[BBF[
MC_<;\J-V1C8WY52FAJ2&29\GVS7T]\(R?^$.C)Z5\PR,?(V*C$D^E?3WPCY\
M&1HQPP[&N6K*YA4E<[RBBBL#GN%%%% 7,#QD<>'+GC^$U\EW9"WT_'5C7UIX
MS/\ Q35SCKM/%?)%VSB^GW1M]X]JWILZ*<K!WQVH_ TW<=V0K=/2G;F_NM^5
M==U8Z.9!^!H_"C<W]UORHRW]UORK/GL2Y:A^%!(\HEOO=J,M_=;\JC)8Q%MC
M9'M3E-6&Y:'LOP'XN+@L.2>*]UY!.?6O"O@.7DFG+J5P>]>['J:XI/4XYO42
MBBBIN1<****+A<****3&'84DG^K;Z4O84DG^K;Z4T%SY?^*'_(SN?0UQK?=4
MUVOQ.'_%2R?6N-8?(GUKNAL=47H--)3R*,5NBKC**?BC%,+C**?BC% 7&44_
M%&* N,HI^*,4!<913\48H"XRBGXHQ0%QE%/Q1B@+C**?BC% 7&44_%&* N,H
MI^*,4!<913\48H"XRBGXHQ0%QE%/Q1B@+C**?BC% 7&44_%&* N,HI^*,4!<
M913\48H"XRBGXHQ0%QE%/Q1B@+C**?BC% 7&44_%&* N,HI^*,4!<913\48H
M"Y]C:M_JD^M30?ZE/I4.K?ZI/K4T'^I3Z5XYQDIZTE*>M)00PHHHIV ****+
M#L&<<TTD!<L.#VI22 2!DBLW6+R:PTV2YMT,L^.$I6"QGZEX(T?5;@33P*Q/
M7-4#\-?#98XM00.I%95I9>)M?C>\>9[7'(3.*D\/^+;BUU232[P;UC'SO5*3
M1:=C2_X5GX;"[C;*![T[_A6/AS&?LHQ62]_J?B;7)(K"4I;+T(-,M];U7PWK
MBV.IN7A<X5C0Y,?,; ^&7AP]+88]:!\,?#AY^S*1576M7UJ]NQ:Z?"5B?^,"
MJ&IKKGA:S%[-=&3/5">E'M)!S,V6^&GAT-@6@.:EMOAUH%I*)H85653E3Z47
M'BX6_AB&]<8EE3CZUA6\&OZI9OJ$4S*J?,%SUI<[8.1Z!&PC1,#Y5^6IV(W@
MKS7%>#_$4EU</87G,JGO7: CS#M%!G8=1110%A"<D '&*RM7\-6&MC_2HPP]
MZTII3%!)($RRC(]Z\^:3Q'XFU*2$%[.%#PPXS0M!HU&^&OAT*2MJK$=0*!\-
M?#K<"U&>]8;ZUJWA;5X;.Z?S4<X#9ZUH:]XEFO;V&RTQBLS@;\=JKF9HI%P?
M#;PXS86V4XZXQ2?\*V\.9(^RC(]JQ=0;7?"3Q7KRM-%(?G&>E;.I^)[JXT-)
M]+B+S2 ;L#I2YVA\P\?#7P[U-JH/IQ33\-?#J,2UN!GVK)32/$D%D=5DNVSL
MW&-CTK:\&^))=<M98KI/WL?>CVC#F&CX:^'B49;88!]*Z:RL8M.L_L]O@1KP
M .U</XM\6ZI;0SVUG;E=@^_BM[P/?SZCH*2W)S+CYC0Y-D2=SHLXVJ>3ZT[&
M.](!D@TO4FD18*,D9Q10>F?2@$BK?Z;::K;&&X 8'UKF1\,O#I9F:V4L?I57
MQ!J6M7.IK9VD31J3C>!6;K7]M^&(([V6[,BC!*DTTVC2]C:'PT\.-G%J,CM2
MCX9>'"/^/5<^G%0:EXS4:';20@K<SJ*SI-.\1'3O[2%VX'WMN>U/F8^8V#\,
M_#BGFU&*/^%9^'#]VV4C\*;I'C)[_19#Y>;J(;=OJ:R[&P\2ZX9;EYGM54_*
MN<9I<["YKCX9>'/X;8<4U?AOX;(95MEWU1\->(KW^WI-&O6R\/\ %ZU)KMYK
ME]K0L;.%HHLX\P"CVC"YT^B^';+08]ED@0'[W-:1YRP_*O-M7?6_"K0SW%T9
M(F(R,UWNDWRZKIT-W&,9 S2O?4S>K+P.0.*6F1$DOZ T^BPK!TYIDL4=Q"R2
M\AN,4\#/!Z5R_BG6=3TY1%86QE#<;@*0T1R_#C0+B9Y9H%9GYJ(_#7PVC!?L
MPS]*RYM.\0?V:=3:[:-L9V$U/HGC%CHMS-<C=/#\N3ZU:FRU(O'X:>'!UME
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MB@ HHHH ",]&P::-O0DDTZB@!A#%N5Y[&@9B/+EF-/HH 8 =V&.&-.8%NK8
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M#,<>PI7!R IQ33@8P">:CN[VUL?WEU,(Q[T 3[B#MQ^-!#=NE9?_  DFC_\
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M5SUN-.&D"VN+F1)2N#'@TMUIL5KX3E6T@92Q!W8ZT ;4GBR;2/#$$MO&OF,
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MNGN(&/<&HK#2SIWB"XDOR\(SU&:=AV.VT7Q4XU%['59$:X'9#Q6?J'B[5?\
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M19+U[!)+_:"%SS7#>,K.X2#2;\HQ$97< ,\5I:SXSLKC1X[6R<_:V 4+C&*
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M'JNHGR%P0I%>I:-/9OIL<-E*)$10.*!EW("!N3]*>"",@4*,+C./:ESGDB@
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M8)4$*VXYZ$4^0[(A\H5CZ"H8KRWN8'DM)4?:,DBN?MO$Q^T7'VETV19H Z7
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M,!09"<M0'&P@]?2O/M;\:WL&L'3;"'<X. ?6@9Z$-V,&)1[XIO5AC!4=>*X
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MKGO$%U;V<UF]C 8<L 7]:Z[5?A\Q\EK&0 IVJKJ/@35-22V2YN$,<1!"J.:
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M/>"Y-):Z^U7"R+<$_+Z9K.F\&:KIT\ITJY\N*0Y*B@#)T.^ETOQ+>:7'*TD
MS@]:KZ!HT>M^+=0>XF9HXP3MS79>'_"BZ<);B[</=2 C)I/#OAB31]7OKMY
M?/SA: .>\)74L&M:EIT1S& <<]*K:#"+R[U>"8;]N[O74:1X2;3=3O+XR\W!
M/X9IVA^$FTJ^O)GEW"ZS^M ',_#O1K,:G=R^6'9&.!Z4UW?7O&[Z?=S-]G4X
M$9X%;MAX4U/1-8DFL[@""1B3FK&K>$+B:X%[92".[/5Q0!S6JQ'PMXHMX;%S
MLEXV@]*HV6EMJWC!EFF)5FR5S78:9X+N3>B[U>Y$T@'R^U/TCP@]GXEDU!I#
MMSD"@#G?%%DUAXETRWMI"B*1QGK5?QC:C4O%=C9B=EX&[FNPU[PO)K&O6NH(
M^WR#R*BU3PA-?:_#?B4*8P* .9\6:1;Z!+926<C+-E06SUJKJUZ9=9MH=2F8
MVNT$XKN/$WAE];MH(PXWQD'/KBO._$]A>0ZW%&R%8E 4DB@"W?V]I?:Y:1Z/
M"[P*1NZUZW96ZP6L:!=F%'R^E>01ZW=Z1*BV,:R$]PM>IZ'=SWNE0SW *RL/
MF% C1W'<0*09R<TY5YS0<9XH)$HQFBC.*12 $@US^NS.K@=C70=#S5'4+!;M
M?K5QW+6YR0QGUH1L/QQ5^719XF_= M4MKHTTLG[T;:Z)31LY(V-+D:2V"O5\
M#8>*BCMQ%"$3^'BI0<8!ZUS2U,)6/+/&I!\760?&S>.M>C71MCHS+<[!%Y7'
MY5ROC#P==Z[=1W=K,(S&<BJ,GA?Q'<1QPSWV8<8(S2$8?A1Y8KG5/LLCF#YL
M>@J3P-X<&JZA>7=W.SA9#@9KOM,\-V^D:-+91;3<2K\S57\*>&YM DF\R4$2
M-NQ0!R^F#R/B(81(RQ)P%/>E9Y!\3)%@?.1G&:V]>\)W5]K!U#39UBF_O5F6
MG@[4=(U5]:N;C[1*%YVT 8MW<02>*KN/5F9E'W1GO6IX)T]7UZ:80-Y0/RD^
ME<O,LUWK]Q=S-Y>3T85T'ASQ%J46J1V=O:DPDX9]M 'J;["2R]0,&O*4P/B4
MJ@C[W&:]3R$CSW;K7!:UX$OI=9_M2QN@C@Y H Z?Q4]D=!NEO=F=AV^M>26^
MM7^D>'W%L[E'8A1[5V+>$-=U"0+J-Z&B/&*Z&Y\(V,FBI8+&#+&N V.] '!Z
M?Y<NB&=K O=,,[_>J,=EK&I:=+<3[D$#97GM781>%_$-O;F"*ZA6+L".U=#I
M?A]K2P>"[D$C2+@XH X.3Q(VKZ%;Z7$W[Y3AL'FLJ^O;JWU&VTDLSQ  N/6N
MKTCX=_V;XD;4#)FW+9VUJZ]X.2_ODO; A)QW/2@9Q-\9;>^MWTRW:$9&XGO6
MCXM>:YOM+DD0!P1GWK;A\,ZS=SA;^XC*1$8*#&:MZ[X4?5IK.2.;RFA(QGO0
M!R+7$VM^*8=-NG*VX'3-6_%FD1>&TCFL&(<D=ZW=7\%S3-%=6$HBNX_O-ZU6
M/A+6M4G0:G>(\2XX%,#E]9>34]1TXSSL'91E<]:U?&&A0:18V>HV,_D2KC<
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M #CI1DT44  &WIQ28 .0.:6B@ Z4N3244 &><T$!B">2.E%% "Y--VCTI:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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-X-3_ &=?>BBI8S__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>forms-1_017.jpg
<TEXT>
begin 644 forms-1_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *>!I4# 2(  A$! Q$!_\0
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M*** "DI:3O0 44'BCM0 AIA-2&HVIV,IG,^,?^06YXZ5Y=:JQ1VP*].\9?\
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M&%%%% !1110 444F: %HI,TM !1110 444F: %HI*6@ HHHH **** "BBB@
MHHHH *CD[5)44O2FMS.H_=/+/&;?\3LJ1G-<Z%16V[:Z'QFNW6=_<5A,V<28
MYKZ#"*T3Y/&M\PV-'N9!#&!70VWA&XGA''6L33MR:G&Z<Y;D5Z]9KMMX]O\
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M:7GTJ;"^E&!0!#SZ4<U-@48% $5+3]M*1Q0 P$4N:8>#29H DS3#UI,TH.:
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ML4>6* (LT9J7RQ1Y8H BS14OEBB@!:3BBEJ4+J)QF@CB@#F@]*I;BD96M?\
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MO^/Z+_>KV.S_ ./>/_=%>'CMT?3Y:6A2]Z04O>O+/H4+1110,**** "BBB@
MHHHH *9+]PT_M4<OW#0!2!Y-+FH\\FES0 _-*A^>H\TL9^:@#0'W*%Z4B_<I
M5Z4 .HHHH **** "DI:2@ H/2B@]*!(04QJ>*8U4C.H<OXQ_Y!4GTKS)/]4M
M>F^,?^05)]*\RC_U*U[&$^$^9QM^9C\X%=+I_A..]M4G:0@MVKFL9%=38>)D
ML[*.$CE1756<[>Z>=2C&^I;_ .$'@QQ(:%\"P%N93BE'C-,?=H_X32//(K@M
M69Z2]DC3LO"EI9L&SOQZUJ3VJO;F&+Y!C'%<RWC>(#"C)I@\: 'YEXK)T:CW
M-E5I]!9/!*/,\LDY<MV-5KCPE%;6LL@;D"K3>,H^-O.:JW7BP7$,D07J*UI1
MJ1>AS5Y0:.3*!"5W'@T#IUS2S.Q?=M')H//7BO9I*5KL\6>XE%+BC%;61B)1
M2XHQ3L5J)12XHQ2%82E%&*,4:%)!12XHQ2T*2&T4N*,4^9(30E%+BBG=,GE$
MHI<48I2:(MJ)12XHQ1=6+044M)BH<@8&DI:,4[DV$I11BC%.Q23"BC%%/E&)
M12XHQ19#$I: *7% -"44N*,4&30E%+28J)FT/B-CPK_R&XZ]87M7D_A7_D-Q
MUZPO:OG<7\9];EWPD@ZT^F#K3ZX6>V%%%%( HHHH **** "BBB@!#5>Y. *L
M&JMYT% $0-*#40-.S0 [=UJ:V/)JMGK5BU/- %KO2TG>EH **** "BBB@ HH
MHH 2EI*6@ J*3I4M1/TIK<SJ?">7>-/^0J:YP_ZFNC\:_P#(5-<[UBKW<-K
M^1Q3Y:AZ!X+D TX+WKKE8 5Y5HVO2Z:/+5<K6V/'!QC8,UR5J$G+0[\-B8QB
M=R\@$9;L.37GFL:A=ZWK/]GV^?)Z$U-<>-G-LZ!.6&*B\)2J\LS,!YS9(K!4
M''XCHGBU+8OP>&],LHA#/(I=NN33ET'1E;RU9"3V!KE]<:^35W25G /0BJNC
M/=QZLF]I&!;N*)0LC"-3F9Z GA*P"9"CFL[4_"$30DP<$>E=? V+=-W<5'(#
MOSGY:5.<HO0VK48RB>0W%K)93&*7.145;OBW9_:PV'ZXK"Q7OT97@F?,U86D
MT%%+BC%=".=B4=J7%)B@!**7%&*H@2BEQ1B@!**7%&*3=BDKB44N*,55]!-!
M12XHQ4<UPL(:2E(HQ5:#U$HI<48I:!J)12XHQ3N@L)12XHQ4W'%"444N*:W9
M+6HE+1BBA6L5;0**6DHLA.XE%+BC% E$2BEQ13!K42AON&EI&^X:QGL=5/='
MH7@K_CRKL5Z"N.\%?\>-=BO05\U7^-GU^!^ EHHHKF/3"BBB@ HHHH ****
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MKA!D'-=$BA$"CH!BO/K5><]?"4.0<#S2CK35ZTX'YJY+'IWZ#J***8PHHHH
M**** "BBB@!#3)O]6:>:9-_JC0!F _,:>#48^\:>#Q0 $TY/]8*831&?WHH
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M8&>>M35@>A'8****"@HHHH **** "DI:2@!#56]Z+5HU4O>BT 5A2BF@TH-
M!ZU9L^M52>M6;/K0!=[TM)WI: "BBB@ HHHH **** "BBB@ -12DJ!@5*:BF
MQLY.*"9;'EWC;#ZGDG%<Y'M0GG/%>GZKX2@U67S6D(K/7P#;)_RT)KU,/B(P
M6I\]B\'.H[H\_$@;)/!H_=YKT#_A [4]7I?^$"M?^>AK66*BV<T,%42L<!F,
MC%6M.U-].N QX]Z[7_A K4?\M#3&\"6\G#N:3Q%.2U*^J5(L2WU[2;M ]TB%
M_4U;36_#T1RJH&'?%51\/K7M,12_\*[LLY,S5R3E!['H4J,DMC07Q9IC#"R#
MBL[4/%ML(F2-N33A\/;.,Y69J:_P^MBP;S31!TT.I3FSB+NZ-S.9&).34.\5
MZ ? EM@8>D_X0.V_YZ5WQQ4$K'F3P4V[V. WBEWKZUWW_""6W_/2C_A K;_G
MH:KZY#N9O 3[' [U]:-RGO7>_P#"!6W_ #T-'_"!6W_/0T?7($_V?/L<%N7U
MHW+ZUWO_  @=K_SU-'_"!VO_ #U-'UZ(_P"SY=C@MR^M&Y?6N]_X0.U_YZFC
M_A [7_GJ:/KT0_L^78X+*^M&]/6N]_X0.U_YZFE_X0.T_OFCZ[%[C6 GV.!W
MIZT%U]:[[_A!+3^^:/\ A!+3^^:/KD!?4)=C@-X]:-Z^M=__ ,(':_\ /0T?
M\(':_P#/0T?7(!_9\^QP'F**/,2N_P#^$#M?[YH_X0.U_OFD\:N@?V?/L<!Y
MBT>8GK7?_P#"!VO]\T?\(':_WS2^NH/J$^QP'F)ZT>8A[UW_ /P@=K_?-'_"
M!VO]\T?74'U"?8X'<GK1N3UKOO\ A [;_GH:/^$#M?\ GH:/KD0^H3[' [E]
M:-R^M=]_P@=M_P ]#1_P@=M_ST-"QD0^H3[' [E]:7<OK7>_\(';?\]#1_P@
M=M_ST-/Z[$/J$^QP.Y/6C<OK7??\(';?\]#1_P (':_\]#1]=0_[/GV.!W)Z
MT;D]:[[_ (0.V_YZ&C_A [7_ )Z&CZZ@^H3[' [D]:-R>M=\? =K_P ]#2?\
M(':_\]#1]=0OJ$[['!;D]:CE?Y"%KT'_ (0*V_YZ&E/@*VV_ZPU$\6FC6.!D
MGL.\$G.GCUKL$##%96D:+'I< 16K463YMM>75GS,]["4G!:EBEI*6L3N"BBB
M@ HHHH **** &**4THH-,3&GI2"G=J2H8T(R ]* E.%#=:KF)<%<3;[4;?:B
MBCF#E0FP4>6*7%+1<7*A-F*,4O2DW4[A9!BC;[4;O:E!I7"R$V^U&WVI<T9H
MY@Y4)M'I1M'I3LT9IW"R&[1Z4;13J*+A9#=HHV^E.I*5PLA-M&VEYHYH'9";
M:-M+10%D)M]J-HI:3-.XK(-HHVBC-+FBX60FT4;12T47"R$VTFVEHHU%9";:
M-M+1FC4+(3;1MI<TN: LANWVHV^U.S1FES#LANWVI=@]*6C\:.8+(38/2C8*
M7\:*+ARH38*-M+13N'*ANWVHV^U._&BBX<J&[>:0H*<:*FS$TAFSTIY'%**#
M2:+BD(H(ZTH'S4M ZTTQM"T444P"BBB@ HHHH ***#0 AIDW^J-/-1S_ .J-
M &7GYC3@>*C_ (C4@Z4 (:(O]:*#1'_K10!K#[@I::/N"G4 %%%% "BB@44
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M_P!4:D-1S_ZHT 9/\1J0=*C_ (C4@Z4 (:(_]:*#1'_K10!JC[@IU-'W!3J
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MF*,!SS24BI4&9'C'<FD-L'-4?"!+Z#.2N#M-=9<6D>H0-'(.*9::9!:6K0Q
M '@T^<S5 X/PO(W_  D4RL"%W5WFL,(].D(]#3+31+:UG,ZH-QY-7Y84NHFC
M9>*SE4U.BG2T/.O!SG[?=*01N)JOJ%I<Z'XC%\(R8B<DXKOK'1;:QE:1$ )-
M6KVP@OK<K*H85HYF;PR;N<IJ'C&U6R4VY)F/\-6]-OKJ_P!'EENHC'P=OO5I
M/"VEI(K&,;A6T+:(6_DA1L P*')&BIV5CS;PVY_MZ4$$#=Z5J>.6,5LA&3[5
MTEMHMM;7+3(@R35B^TN#45"RJ"!3YS!4'<R/!S*^EHV,'%=!.ZPQ&4] *BLM
M/AT^/RXQ@58E1)H3$>XK)RU.J,-+'E6IF3Q'XB%OR$#=?2NB/@B 1K'YQSZU
MO66@VME<M+M&]CP:U&AW8.>15J9RRH7/+-?T-=!>.6,ECGK73F[^T^$&<99]
MG-;]]ID&H*$F4-BECTFWBLS;*!M/:J<P5#0Y'X>AB9MRX.37>*,,5JEINDQ:
M;N,8 S6CC<,CK63E<ZX4[(\S\<EUU.# )&:Z:'GPUN YV=*T[[1+>_D5YE!(
MJR+*);;[.!\F,57.8.AK<\]\%,?[:N<J1DFIO'!9IX@JYP:[.RT.VLIFDC4!
MFI+S1X;YOW@!Q3YQ>Q,)K3[;X1"[<L%Z5A^&=7.DAX+M2B G;Q7H5O9QVUN(
M?X?2JEWH-C=X+1#(HY[D.@^AQ&OZHOB&2.TM@>#R<5MW&BR+X6^S@;G5<UM6
M>@6-E+YJ1#<:TRI.5V_+0JEBO8)K4\U\.:S'I8:WN<JP/W<51\2:B;V^BDAW
M;,^E>@W7AW3YI3*T*[SUH;0+'R@! N16G.MSFJ4)7,*^TYM4\,1&,'<BYQ65
MHE[IL"&#4(!N4]2*]"M+=8+<0A!M]*SY_#-A/.9&B&34JH=$:"LC&L[_ $6Z
MU 1P0#<#PV*SO'C^4;;RP6.1Q78V>@Z?9N98H5W>M)?:3;:BRM(HRM2IZFCH
MI1&^''+Z3%E<<"MA2=U06T*6T(CC' %6%88S7/-WD=5*-HD@HI%.12TS8***
M* "BBB@ HHHH **** "BBB@ H-%!H 0U'/\ ZHU(:CG_ -4: ,G^(U(.E1_Q
M&I!TH 0T1_ZT4&B/_6B@#5'W!3J:/N"G4 %%%% "BB@44 %%%% !1110 444
M4 !HI#10 &@@&@T4"$-)UI:*"A,4N[%+32*-!6%!!H-(!BBG8&-*#TI-R@[1
MUJ2JLDPBD)=0%'>A(SEIN2L?4=*SKO7=.LY5CGF"N> *JR>(]/BNFCDGKB_%
M<UI?:A;M <C=R:T43EE629Z7'.)HQ)'RK=*<SJ%VL?F-9VFR+#I<6&^55&2:
MKS^)--A<B20;A2Y65&LC9QE0,]*<90%!!JC8ZA;W\>^)P?:JK:Y:0ZBUF[ -
M0XFGM4S7!&_?NX-/9L\"J[2((#)GY0,U0M==LK^9K>"3,R\$4N4?M$:^2HYJ
M,;S*2?NU0N=8L]/&+J8!O2J]OXFL+IPJ2]>!3Y2?:HU;F58;<NQP%YJC8:Q;
M:C(8XFRRU%K3XTN9MV05KD/ L@-_.V>YHY68RK*YZ,QQ2D@+SR:HW.HV]G'Y
MEQ(%7/%9P\4Z:;C89>.U'*S3VRL;Y(QUI5P!Q6?'<Q7*^=')F,<G%5F\2:8D
MIC,XR."*.5E1JHVCC.<TF.,9K"?Q3IRL%$E:$>H6]W"9(9,@#)J>34IU(LG=
MC'QUJ5!\N3UK$B\1Z>2R22C<IQ3/^$FL3=!#+A:MP9FIQ1O<%>#BFLQ.-HK)
MG\2:;;)N:4$&IK+6K._&+>0$FH]FR_:IFF0'4;J;@A\@Y'I5.6ZBL8VEN),+
M6;#XNTN>8QI+SFGRA[5'0*6;@C%(00_'(JJEW'+^]20%,=JIOXBL!,83-M<4
M>S;'[5&J>3TI>%&,\UA3^*K"W8(\G7O5I=3MI8?M,<F5Q35,AUD6;B^M[?B1
MP#Z5)%-&$#ALANE>9:EKBR:\&,A,2GI7>Z-J-OJ-L-B]!3E3L3"I=FL#QN]:
M>O(YJ)6R<8X%2J01Q65CI0NT>E& *6BBQ>@G'I1QZ48HQ19#T 8IU- IU @H
MHHH **** "BBB@ I*6DH 0U2O^BU=-4K_HM %5:<::M.- "'[IJQ8]:KG[IJ
MQ8]: -"BBB@ HHHH **** "BBB@ HHHH *9(2!P*?37Z4":NCC?&.DS:I:JB
M+R#6EX7L9;'2%AD'S"MS;DY84CY7[HXJN9V,537,,VG&2*QO$MB^H:8T:#FM
MPEB*"N8\5,9,)P1R?A'2)]-MV63.TGI6AXET][W3&C3GVK:5#MVCBE;CY6&1
M5>TU(5#0YCPEITMEITD$@(![5E:KX8N[2X:]T_)D)R5%=XBKG"C%!0J_!XJO
M::B]AH><MI&KZNJP7)9%[BNIM-(.E:0UK N2RXK?" -G IO!4Y/-4ZFI*P^A
MPWAS0+K3]:DGF4@,<UU]_"TMI*@'52*N;?DSU--PY&*AU-314%8X7PQH-S8Z
MM+,X(1FJ7Q9X=N-0NTN8%RR]#7:E2JX5>32HNT88YS3]H0\.CD-.M-0_LA[>
MYC+G;@9JOH&C7EBERQ!RV<"NXW!3C'%(8P>5.*KVHOJZ/*Y?#^K'4WN3 7^;
M(K4*:]M0+$R@'M7H!4J,#FA 3U%/VFA"PRN<W=Z7)J^CA+B/$X'!KG+>PUW3
M,PIN9.@]J]&=<R##8I6'J,U*J%2PZ.3T+3M52Z\^[D8K_=-=2Q8, !Q4AY7D
MXIN2!FI=17-8TK+0YGQ@^S2W#?=/:N0\.65V;:2ZLB>/X17=>*-,EU/3BD?6
MJO@S2IM-LY(I15JHK'//#N3.?B\.:CJ.IQW-]G8#G::W_$6E3W.E"VMUR .!
M73A-V:,A2%I>U''#6.1\-:?<Z;IDJW$>P@' KD[:S>_\1RNDFQP>,5ZG=HTM
MNZ+]XCBN*T7P[=VNOO<R9VDYJU4,:N'U*5UI6K7TC6DKL8B>M==I6CI8Z6MH
M5&,8/O6MC]\,K@>M3;>3GI4RJ,WCAO=//+_P]J-A>-/IV0I.2!2V]EKUU=1N
M[,B*>:[\A]W R*?M_"E[5A]61S/B'3;B]T;R4!\S'6H/#&CW.F::T<HRS ]:
MZ[:".>:8P)P!TI*H-X='!:7X>N[?Q!)=,#L8YJQXIT2YU*ZA:-3A<5VV,*>.
M:%0 9;FJ]KJ)89&596DL.DI;D?,%Q7*:9X?O[;Q%)</'B(GK7H!4E@1TIS*6
M'7%1[0MX=,X_Q+X=>]D2>U.R4=2*R9K7Q D20(6V]"U>@C;&V&YI_<<<&JYV
M2\,D8^@6=S!:[;J0R'WK8";,J!@4USY9^6G(Q8=*CF.E4[1.8\2^'3J6V6'Y
M95YS7/FS\0+^X*MY73->C.#VIN&"Y(JXSMH<LJ-V>>2>#+B2$S*Y\XUU/ANQ
MNK2S6.Y8EAZULI\X(!VFI57:N,Y/K1.=RJ=&PK G&#3L8/6D48!H7):L4SL1
M)1113&%%%% !1110 4444 %%%% !1110 4AI:* &\T8-.HH CPP%+MSSCFGT
M4 0'=DY'%)Y>_FIG^[48;%-LGENQDN44!1DTI.$!QS3\9YIC ,,9Q0@EL)&,
M'IUHV[&P.0:CED6VB,KMP*HV&O6]_.T,9!(--F*L:V0!BD&%H("@L:C&)#N)
MX%1)=2T[:"G.[GI3B3&.!D&E#@C/4"FOEV7' IK7<KELKH:/F.=G-.<D)TIR
MC9GFDW G![T-"0BK@ FESN!VTA8YP!P*-X4[0.335QZ(=C(&1R*:G5CCI69J
M>O6^FW,<4K %JOI,)(UF0Y5J.4FX]?WS9(P13W.VFJR\D<$TH3()S1U*2N&]
M .G-&!][-&U3QBHBH5SEJ3>@2T)LY^E&X 8'6F Y[<"G9&-P[TDPOH.W9[4O
MX5&K$'I1M9FR3QZ5=Q7'9YSBD.,9!YHDD\L=.*9_K5!' I7&D2;<KDFDP']L
M4?=&,YI=P;IUHN#$(H4$=Z5<D<TTJ#QNIW)ZC71MX.*<X&!0&[9IAD"*6D/R
MCO2)EJ/4$]#3]O-48-0@NIMD+YQUQ6@*=P2&%2IX'%-,7<=:GHI+0TY;HB13
MSD4!3SD5-0>E2]7<N*LK#5&!3J0=*6F 4444 %%%% !1110 4444 %%%% !0
M:*#0 AJ.?_5&I#4<_P#JC0!D_P 1J0=*C_B-2#I0 AHC_P!:*#1'_K10!JC[
M@IU-'W!3J "BBB@!110** "C-%-I .S1FFT4"N+FDS1BC%,K0*6C&**! :2E
MHH$)12T4#0A-(2:4TE(3 '-%&**$&E@SCK7)^-;]["QWJY^;M75MS7'>.H6?
M3PP3?BM8G-5D[&/H&AKJUJ+NX'7H:S=8L/L6K1*@R@-=/X5U.!=(2*5@A7M7
M.>)KF.[UR Q2X"MT'>NB+/.DKF]K=^]OH*>6=A*UDZ3::=<6/FWLO[QCW-7O
M%%N]QH$4B @!1G%4M$TRRU+2%5[@)(O7FKM$RO).Q!IUZ^D^(0D,A>V<X JY
MXLL&@O8M30X4X)J[8:%8)=#;<"1U/3-:WB'3OMFDL@/"K4-JYK[UBK)K"OX:
M:0-P4P#63X.LA;Q7&I-S(<FN92\D98]*!.-^*])L[ V>B&W1,NR4FD$>9G#>
M?%K7B"07DI$8/2K&MVUE:1(UE+@KSP:J65M!'K$EO<_)(S'!KH)-!TV  7%T
M#GD#-4K$7E>Q<L[M[_PK(S99@F.:R?!1599SMP036_+#!9^')A:'*[>M<YX(
M#2/<AAR2:E6%.]R'4GEUSQ#]@$A$2FM^\\+6L>G,8US*B=:Y^-H=+\6-+<.5
M#&NSOM5M(M->82 Y7CFALTL['+^$-4D^TSZ?)DXR,5DZE:;O$GEQK\I;D5H>
M$H6EU>>^5?E.>:JWM\(?%GF.,1[N:I(SYI;'077AR$V!EC7YPN:H>$KXF6YM
MF/(!&*Z2ZU.S?3',4P!*=*Y7PE 1?74PR<YYJ.IHKF4ML;CQ*\"9P7YK2\4:
M.NG6*3Q?>[TW1FC/BR4G[VZMCQF3'IXW\KFM;HR;;*FA:1#J.D&:?YB%Z&J'
MAUFM_$S6_P!U >*Z7PLP;0B8QD8KF+-$/C3#2;3GI473+2DD:7C+4I4O([51
ME&/-1FQT:/31*C!9BN2?>J_C2.1=7@8 ^7W:M"#1]-DM4F-R-I7YAFG9$7E<
MJ^$M0D-S+"9#(O8&J&M0_:/$J1QC82><5UFCZ78PRM+:D' ZBN7N) _C)<GD
M&BZ1:YC8U;PY"VDB=N'1<U#X+N!=6LUM(N0O S71ZUA=#?><#;7,^!VC\R<+
MZU*+=T9&JV\,'B$0^6"K-7I.D6<-E9(T: 9%>?:V$3Q5&TS87=UKT>PG@N;1
M%A?< *SF=%!:W+RE<9]:5>^*8@YVFI%&,USV9Z"LQ>:.:6BC4H;DT9IV*,"C
M48@/-.IN*6A +1244Q"T4E% "T4E H 6DI:2@!#5*_Z+5TU2O^BT 55IQIJT
MXT (?NFK%CUJN?NFK%CUH T**** "BBB@ HHI.] !N&:,BF9!<CO03QB@5R3
M(QFD+ #.:B#9&,XJ/@L5+<4[,7.BR&!&>U,=MP^4U&IV<=J7<.W2BQ+FMD!8
M$XSTI< CKQ49D13D#K3V?;@8X-%@O;48X([\4J\GK3OO-@]*C#YDV@4)"=]Q
MXR).O%*S<<]:#D9 IJGY?FZTN4.;2P[(QFFXXR6YI509Y-(2 >>E%AN22 ;B
MG6G[=H%,.2PP<"AVPH(-5:X<Z2)!S1DBF!LX.:<K#O4M.X*:8_)ZTTG<N1UI
MI?+8[4'[ORTVK(.;4" P]Z7</N#K0#CMS3=XZ@<THJXW)(4 CJ:5B0.#2;_6
MFNN[!W8%4T*,T. QR:<>>E1@>800>!0[G=M' I),<I18XGCUI" 1@G%-4&,$
MYS3E(89/6AQ(4PW;2%ZB@$*V1P*7 '.:3(SCM0DP<D.8DL-G0T >HYHQZ&H+
MV:2*W9HEW-BCJ4WI<F<87<.M1J^X9 YKG-,U#4IK\K<1%8\UTC';R@JK&-TQ
M3^\3CB@9&%)IRGY3Q@TTD+\SGI4V9KSJQ( 5Z4TDDY-)Y@?!!XJMJ-R]I9R3
M(NYE'2J2,I31: SSFGC%<7H?B6?4;YTE3;@]*M:EJVJ+?+%;6Y,>>31RDJLC
MJ&93D#J*.",&JUN6>!&<8DQR*E5R^0PQBERFRFFB4\#VIA&#G=2AL #J#32
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MB#,,BN%\4:6FCWD-_:?N^?NBKVNW,MWX:BN3RQ'2CV:$Z[L= _B^P6V63?\
M,>HJ6V\1V$\?F>> ?2N;\+:+;7&F":Y3<6[&L)[!1XI\B-ML6[[N:;IHGZQ(
M[P^+=/\ /$#OUXS6REQ'+$IC?Y/6N$\5Z1:6]@'B3;(!]ZKN@WCCPE(X8M(B
MG!J?9HI8B1LWWB*TT]RK/N-/TWQ'9ZB^R-PK>E<#H+V][>33ZD_&3P:?KTVG
MV4\%QIDI4@\@=Z?LT+ZQ*YZ3>:E%:1[G; %9R^)K!H6=9,D5DZI.U]X3-R%^
M8I6/X'TJ.YA:6Y&[D\&CD1?MG<ZBP\46E[/Y .#GO4/B?6#:VK1)T8=:Y?7;
M1+#7(WMQY:$]JZ'68(KCPYYK#+!.M/D0O;/4Q?"NL)9W8\PEC*<"O3%.0#ZC
M->;>"+.WN&)EC#E3P?2O25& /:LZB2V.FA-RW).U%)F@5B=JV%%*>E(*4]*0
M"#I2T@Z4M, HHHH **** "BBB@ HHHH **** "@T4&@!#4<_^J-2&HY_]4:
M,G^(U(.E1_Q&I!TH 0T1_P"M%!HC_P!:* -4?<%.IH^X*=0 4444 ***!10
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MKKT&%4>@Q6<VF=%&#CN/HHS2UD=B 4IZ4@I3TI (.E+2#I2TP"BBB@ HHHH
M**** "BBB@ HHHH *#10: $-1S_ZHU(:CG_U1H R?XC4@Z5'_$:D'2@!#1'_
M *T4&B/_ %HH U1]P4ZFC[@IU !1110 HHH%% !3.]/IN.:3$Q:8[!5))IS=
M*HZ@Q%C*0<''6J2,YRLAKZE9QG#3*#]:/[5M'7Y9US]:\JM+6[U?6)XQ<L #
MZUH7?AO4+2)I8[ECMYZUNH' \39GIL4H9 =V[-/Y# YKAO!FLRR%[>Z<EEX&
M:[-Y51=[L H]:SE#4Z(5KJY89E?@'I0I(&.M4(]5L96*K,NZK:G*Y#9%3RFW
MM28FFYXZU5FO(H/OR ?C42:G:RG:DHW'H,T<A#JELG<=N>:8MS&',6\%A52_
MNTL[1Y&;YL5Q6EZX7U=GFD^4GBKC S=;4]%'W>M-E<0Q%R>!3+>194#J<J1Q
M536R4TF<@\A:AQU-.?2XJ:M;2X42#=]:NB0%.#UKQ6WO[J+4%9G.S?7JMI=K
M_9:SD]%S6SI:'']9]YHMR:E;0L8WD 8>]6894GCW(V17CNN7MY/J4TT+G8/2
MO0?",SR:'&\C<GUH=.R"GBKRL='P.K4;P> :J37]I;C]Y*,_6BWO(+CF)P?Q
MK*VIUNIU+:Y#9S2R-C!!JO-<Q0)NE<*#WJ$:E9JBYF')]:?+J.-4FN[R*W"^
M8X&:DAD610ZME37!>-KEG:(P3$ GM71^'I3'I"--)QCJ35<NAA[;WC>+*ZX4
M\TJ'8N&-4(-2M)IBD3@M[58GGAA7=*X J.4W]H3XW#@T#"]\U2CU&UN/DAE!
M/UHN[R.RMF9VYQ0H@ZB+/VB(OMW#/I4N5(XKS?3?$#OXE82-^Y)XKT.*:.2,
M,IX-#B.G5N2#@55DN8HV)>4+[9J+4KPVML\@Z 9KSD-?>(-3=HIRD8.,9JHQ
MN8UJMF>DQW]M(V%F!/UJT&W %>17EUQH&KZ>WFQ3,PZ]:[+PU<7<EIBYSD>M
M.4+"IUM3H"?G&*>>!5+^T;5)?+:0;_2GR7"0#S)'PA]:RL='M%8LJ0%R:!CK
MBJL=[;W"9CD! ]*C_M*W6389 /QJK"=1%QFYIV>.M9\NIV<9^:45/!=17*YB
M<,*+"4RR,]<TAPW>JUU>QVJC<P%%O<)<1[E-%@<RS\IZ'FFDOG Z53FU.SMV
MVO*H/UJS'<)*@:-@P-2X#59#)[VTMB!-(%)]:&ECVB?S!Y77-86NZ7%>RKOG
M\OG/6H=;C:#P]Y4,IP%QNS6D:=R)5K'2PW5O=J3$X8+UQ3$U&VDF\E7!85Q_
M@1I%L;C?(7/-8UM/<?\ "8F-)#M+=,TW3)^L'J?F8^E'!YJHTR1(/-<#ZFH1
MJUD9 @F&?K4.!<:QHCW-' [U")!(-RMQ4+:A;AO+:0 _6IY"_:EP,-W#4-DG
M@U1_M"SCD"&5=Q]ZMK(KCY&!^E/EL"J#^@^8T*58_*:AEN(H1F5P![FH8M1L
MI6(CE7/UHL/VA=/7I2L1MJ$MN&5;(J&:_M;=?WTJK^-%@]H6T/%.W<U6M[R*
M<9C8%3T-6.^:1:D.[T4T]13J10AJE?\ 1:NFJ5_T6@=BJM.--6G&@!#]TU8L
M>M5S]TU8L>M &A1110 444&@ I#UHHH R-:MGGL9U4]5Z5YYH-_+H5Y,K0$Y
M)[5ZH8_WA+'(/:JCZ59-(6:!2?I6BE9').E=W/,M?OKC5[J)UA( ;TKJYHW?
MPJ<)R$Z5T']F67\,"\>U3&"-H?*V#9Z5K[38Q=$X3P*TK321O$5 /7%,\;JZ
MW<"B,L"W7%=Y#9VUI_J8PK'THGLK>Z(,\08CID5'/J#HJQSLFFO>^'%C0X.S
MI7.:1JT^@;[>:(LH/I7I"6R1_=X3TJ";2;*5MTD*MGVH<B70ET."36=4U76(
MWMT9;;=R*U_%VC275I#/&N9%P374P:?:VHVPQ*J^PJ9E#KAERM3S%^QT."LO
M$\FF6:P2PDLHQTJG96LOB+Q +V2,JHY&17>R:1I\IWRPK5B"S@M!B"(*/:GS
M$J@^I5N+)9M.DMW&?D(%>41V5S'JILO+;R_,S7M(4$$U5_LVU:3S?)7S/7%'
M,.6'*]G:K%8)&HP"N*X*_L7T?Q&;MHR\9YQBO3#$&3"G %13V%M=J/-0-BJ4
MQ/#:'$1^+(FF$0M.#_LUNW9^T:#(\<>,KTQ6D-#TX,&%NH(JT841/*6/*$=*
M3F.&'."\#F47DJ-$5^;KBO1  *KV]C;6Q+11A6/6K/!-1*5SHA#E&2+B-S[5
MY<\%PWC -L.S=UKU,_,,=JIC3;83^=L&^G"6@5*?,97B2)CH#*BY;%8'@S>+
M::"1"-V1TKO)85FC*2+\M01:?;VP+0H ?:K4[&$J%SSLV<OA[7GF,):)SD\5
MI)XIAFNA&EKG)_NUV<UG#=K^_C!J"/1M.A<%+==WKBFZA"PXVV_TFS.(_+##
MI7F&O6%Q%J9BASL9^<5ZXJ[#C&$JN^FVDTGF/&"?6A3L%3#\R.6O+%?^$45
M/W@6N<\*VD\VL1F8$A.F:]1-I"Z>64&STID&FVMK)NCB 8T>UN9QPMG<M+'P
M . *JZH&%C($&3@U='2FN RD,.#67-J=_)[IYKX5CGCUV<2H<%N#2>,%EBUR
M!DC+#([5Z#%I]O#(9$0;CWI9]/M9Y!)/&&8=,UHYG/[&YF;&;05<CG9TKC?"
M[R_V_*IA*@D\XKTTPH8P@7Y/2H$T^U@8O%"H?U I>T*^KGGWBC3KBQUV*]@4
ME2<G%6;GQ++<V36_DG<1C.*[F6&&X $Z X]:K+I%@I+>2O-'.9RH'#>"H)5O
MYGD!&<U7UM9%\2HRJ2-W6O1H["VM"6BB SZ4V32[2:03/$-U/VA#PNAS'B'2
M3JFDQRJ,M&!Q6;I?BF33K46<D)W+P.*] 6%0"FSY/2J3Z#I\TV\PC<*7,-4)
M):'(Z)>:M?ZRTC!E@S67K4#V/B?[5+&7CS7I,5NL.Z.*,(/7%-DTZVN!MN(@
MY[$BA2'["36IP7B#5WO[ +;6_P H'.!6QX0_>Z7L*[&QS70Q:1:1[U\D!/I5
MFWLK>W0^0@%/G%'#,\NO$ETWQ.TN"5W=<5T/B2;^T-%1HP=Q%=5+I%G<'=-$
M"Y[T_P#LRU$0B,8VBCG%'#.QR_A>!I="DM7^\1@5@V_V[PWJCDH6C8^E>E0V
M4-IS$H%$UE;7F#+&&^M+F+5#0\_U7Q#<:M']EMH6#-QG%;FE:5)IOAV4RKF9
MER:WX])L8)-\<"AQ[588;P5D7Y3QBGSC5'N><^%$E_MB4F,J"Q[5L^-XB^FJ
M-F[':NI@TZUMY#)'&%)J2:UANODE0,/>CG*]A?8Y#0$9O#+?9E*2@<+6/8Z[
M/;7,D&K6Q*YX)%>BQ6L-M\D$84>@J"YTFSO&_?P GUQ350SEA[GF=U =:U:,
M6,)CC5LY KT_3H&MK&-'^\ *+;3+2U(\B *1WQ5PD%L&LY3N=%*ARBCD9-/4
MY%-.,8%.3@5F=*5AU%%%!04444 %%%% !1110 4444 %%%% !C--V+Z4ZB@!
M, TA0'M3J* &&-3U%+L [4ZBBXN5#=H]*38H[4^B@+(:% [4;!G.*=10.PTQ
MJW44;0!C%.HH%9#<"@JI.2*=10%D)M![4FQ?2G44!9#2H]*B*[FPPXJ8\"DZ
MCI0%C+U32DU"'RF/R'M4>BZ&FDJRI]T]!6L%]Z5#R:=R>1 $ Z"C:/2GT4AV
M&[%/44N!2T4#L(% Z4;0:6B@+";1GI2;!G..:=10%D)M&<XHVC.<4M% 6&[
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MJ&&"*38H&,4ZB@+";0.U&T9SBEHH"PF!05![4M% Q-H]*0HIZBG44"L &*3
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M[T +11FC- !FBFGK3J "BD-+0 4444 %%%% !1110 4444 %!HH- "&HY_\
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MT +13<'UIV: "BC-&: "BC-&: "BDS[T9]Z %HI,^]+F@ HHS1F@ HHS1F@
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MZ-KU(&XR:3S!G'>@!FUZ-KT\N1VI/,YP!F@!NUZ-KT]G(' R::9U0?.<'TH
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M?- '49Y^7@4V0J6"D9-<IX?\<IJTDT5[:FS:,9PU4KCXBB&_,%M9&XC!QO%
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MTS[=]G20$"L-?B#]H\7Q6$*ED)Q0!Z2.@I:13E0?6EH **** "BBB@ HHHH
M**** "DI:2@!#5*_Z+5TU2O^BT 55IQIJTXT (?NFK%CUJN?NFK%CUH T***
M* "BBB@ HHHH 0TW=2GK1P.M( W4H--+J/2@&@=A]-..]+2'!(!H$59;JU\W
MRGF ?TJ4(&P4/%>=7[2CX@R!G/D1C=C-7)_B(JW3PV]L6CB'S,*8'>-P,CDB
MHPRLN]UPU<$GQ*%VJM!:'R]V&D[5O7WBJ.VTN.ZBB\]F_A'K0!T)&Z/D9]*B
M3]VI#MN;L*Y'1_'IO-4^QWUJ;7(X+4FM>/(M+OV@M+8W9"[BR]J .LFO8;:+
MS[G]V.F34T%Q%=1;X6WIZUPL7C&RU[1O.N8\?/C9[U/<>,K/0[9(;>#>S#B,
M4 =A+$\B9C.Q@:-VQ55OG/K7,:%XXBU2]:VN8O(<+NP:SK_XBFTO95M[(S6T
M9(:0#@4 =RP8R ;\#TJ3"H>.M8GAG78?$U@UY$,8./I5/7_&,/A^X^S&'SI2
M,@"@#IP"BDMSFD8[$WJ,M7-:!XP&K6\L]U;FWC09Y[UE-\1&:\8Q61:U1MI>
M@#M_WJ)YG7/:E5LQ\<,:Y;5O'EMIMK%-LW&3HM,L/'2S:A#:7=J86F&5)% '
M8/P@ .&J"4J)%1DW$]ZQ;WQ!#;Z_':.< KN'O6+)\2"+R2.+3V>*-]ID]* .
MXVDK@CZ4XOM7/IVKG=5\965AIB7,;"25QGRQUJKX?\:R:U>+;2V+0[^C&@#J
M=X\HECL]Z%D;(XX]:BU"=+6T:21=RKVKC)/B%-:AFDT]A;JV ] '=[ P(8Y%
M(=H7 .T"N7U7QM:6FF0SVV)9I1D1BI/#_BI]<Q%/9-"Q]: .BZNHW\>GK35<
M2,RM$0!5+7=3@T'36O91D)TKGM/^(#W]Y#"FGMLD&0] '7F)U0@/UZ4[Y0@1
MCEC6+9>*;6]OY;11^\CZBJ7_  F=FINW=/FMC@T =/&@8%9!TI=J8R!G;T%<
M3'X_+V4NHFU/V:/J<5/HWC^/4]/FOGM##;Q]&/\ %0!UI5Q^\)X_NT]=H^8<
M9[5P-M\2))KS]Y8LEEG'G$<5JZ]XWM=)BMY+2/[4TPRJK0!TY/S?<I2A'\6,
MUQFC_$.+4KDP36Y@E'\!HU'Q]-9RR?\ $N9HHSR] ':X  #GGUJ$HX+-ORO8
M5Y]XS\7SIH-KJ&F99WQE!5^W\;M:>&K2YGMBUU*.(^YH [9#E,XP:%*L" >>
MYKF- \:#5Y_L]U:FUD/0-WK?O;B+3H7N)>(U&6- %A!@')X]:12"<'D=C7#-
M\1)7O0L>G,UAG!G[5IZQXWL=+@MWC D\[[BCO0!TDIVD )DMWI[,((\NV!7&
M:1\0/M^J&SN;0P9Z$U#XC^("V;7%K;637)1>67M0!V:W5M<-LB<.W<#M4Q 5
M?+4X->;?#"ZFU*^N[V60X?.(S_#73>+O%L7A5(7>'S'E. * .C!\M=OWB:<"
M#QC%<7I_Q CNKF.*YMC;B3H6INM?$ :?>FTLK4W;*,LR]J .LNYX[7!EEVBG
MK*LT*NC94_K7,2>([#5-&65EWW'>/N*J7?CBTTG2XDAB\V=C@1CJ* .W7$>6
MQ@4>:A'F!ABN)M/'BZC8W<$L!ANDC)"FL?X?^*]2U+49[*\M6\L,0&- 'IP!
M=BX?Y33&^4?(=W/-<1\3-<O_  ]IUM-IZD[VP5%+:^-#:>&H;V>$_:7 Q'W)
MH [?> <E<587&WCI7$Z#X[BUF\-I?VQLW_A#?Q5VD9!3@<=J 'T444 1DA>O
M2N=UV'46O(VLY"L>>0*Z&12R8IH_U>&&32 6U5EMH]_+8YJ6F19V\U)0 E>>
M>/F_TV$$[0"#FO1*SM1TNQOR&NXPP'2@#RNSTFSU[Q?;M=0GRECQGUIMYI\7
M@'QQ#=I"TEG*1R><9KU&RTJR23S4@"E> :=J.D6>KQB.ZB#*IR#3 \Y^)-X]
MI%::_;H2KJ%&*L6ED6^',MS*F9)E\P>M=S?:+8ZEIZ:=/"##']T$5933[<Z<
M+$1@0JNW'M0!YE\,6DUBWO+Z9"#;J44&IO >OZ79WVJI>W*PS><<!OK7H6FZ
M)::/!)!9QA%D.6Q6/<> O#\L[SM:DRN<L1ZT <EK=TGB+QE:_83YT2$985Z0
MFE6TCP7$D?[^)<!O2JNF>'--T4>;:0@-ZFME,D9/&: ,ZYT"PO"3/"'+<G-%
MOH%A:S++#"%=.AK4HH XCXDV[3Z"6VDHK#=BH-/\1:#%X;M;>,QS7 CQY8'(
M-=C>6\5[$T-RH,!&&![U@VG@;1;6]^UV]OR#D<T <=X8OK+3=?GFU>+R?,SY
M9<=*S-2:&XN[^YTO)MR_SXZ-7J&J^&-+U9E^UQC(Z8XI(O#.F6=I]CMH J/]
MXT </?V=I_PK]IO(S(<8XJQ=PVZ^&-*=8L2[!SCD5V\^DVILTL1&#'W%2MI%
ME]F1'C#)$.!0!YA9WVEZ?X@MAJ,B[W'#-VJMJ CFU&^FT_\ X]R?F<=#6K>^
M$DU7Q5&T]FWV<'AO2N\C\.:9;6;V<4 6-NI]: /'=1M+H0V]P)3%&O?L:O1P
M27NKZ<R78GP.0O:O59- TR2Q6VN( \2=*JZ=X4TS3K@W-O%MQ]T'M0!PMA(D
M5QK5K-@3L#Y8QR:YK38I([:\CNK\0N2<1MU->SGPUI\E_P#;VB_>_P ZK77@
MS0]1NOM$EM^\[XH \U$4MHVFLS&1&/!]*T/&,C^$Q!>6QYNL9Q[UZ,VAZ<D"
MQM ,1_<%<9XF@FUW5K*QDL6%O$P^;% &WX,TU$TY=34XEN!EZR/B&D;:]HV]
M-REQG\Z[FQM$L;-;:-<*HX%5[W2[74&CFN$#/"<J* /.?B;:W+ZAI3VF8;>/
M!9ATJA-:R:MJ]F]OJ E\G&47BO6KVQM=2M%CN;?<H& ,=*RK/PKI.CF6ZLX<
M3D$@&@#BO#NK:-:^(]574%6*15P=PZUENF^]FO($*VCD[#VK=T+P6FH>)[Z\
MU:W;9)G';-=T-!TY;5;00 01]!0!YL?$26Z6]JZ>02<"<CBN?M$DGU[5/)N?
MM,C)PRU[%>^%-(U2"..6W&Q.@%%AX5T;2;@M9V>QC]YNN: .2\+ZSH>E^'S#
M?,@OAG,;#EJY7Q +J^O[>_V-9VZOE >AKT^]\$:%J%\MX8,3H<Y!K1U'0K'5
M;!+:>(%8Q\N.U 'E%C$VI:RTSW0957YP.,BC68+/3@][8ZBJ;1DP=S7I>G>&
M-*M&94M\-W;UJ&;P3H-S=&>6T)/UXH ?X%U-M3\-0W#Q^6<XY[UR,L]O8_$J
MYN=679:X^1VZ5Z-96EM90"&U4+$O11535= TW7HME]!GW'6@#B/$^N66HD?V
M=;^9'T,RCBN?1044Y+G/45ZC9>%M.LK4VD" 0]P:='X<TR/,<< P.<T <3X=
MAMMVH-)%E_*/)%8!XT-%12$\\\?C7K<>BV=N)"D6#(,&H1X;L!;+"81C=NZ4
M ><Z%<6^E^*_MFJ#R[8IA9'Z9K;UWQII-H[3V5H+H,,>8@X%=;J7AG2=5M%M
M;F %%Z =:@M?"VCV]L;.*TVQXQDB@#R+7-4EU"QM+@3@)YH/E <BMNPEDE\5
MVDBQD#8 37>)X)T6,@26X(!R*T8=!LXKE9T0#:.* - 1B2-,],5(I[#H*,X7
M [4D6<'- $E%%% !1110 4444 %!HH- "&HY_P#5&I#4<_\ JC0!D_Q&I!TJ
M/^(U(.E "&B/_6B@T1_ZT4 :H^X*=31]P4Z@ HHHH 444"B@ IBDY.:?32*3
M :"2QK%UMKU(B;9R#6WC S3"BRC##-2,J:4TS6"&<YDQR:O$_)[TP$)A%' J
M0XP::$1LY  /(-<QX[5H_#DQ5OE/:NH;[F.]4=7TU-3TYK>3H:H#RS4(K:\'
MAN%\^62-XJ37-&TRW\:VEM:PE(7QO]Z[C_A%+1OL6!DV_2K-WX<AGU2*\9<E
M.E '"6QLO#^O:@MMGR2/G7UK*\0:IIMWH]PT-B5_Z:>E>EOX7L;N>Y=HL/(.
M36&WP]9ED@,H-NW5?6@#AK67[18:-%<LQM-PW'/45T?B33/#\>KZ6VF.JS!\
ME5/6M'7M)LM$T>"R%OO7^%@/N5QVG:3->^);22W5W6%LEJ +]U*BWFM9)W^7
MS[5>MM"TMOATFH>7_I(R0V>IKM&\*6<TUQ,\>#<+AZG?P[;G0UTN,[8UZ4 >
M7:-,NIFSAUEBD ?"AN]:4FG:#8>-8CIL@60D9 -:/B:SM=,M;>RGM22I^68#
MI7/^%M#:;Q8;ED:55.1)0!ZEXF=O^$9O$"Y!AQ7END>#[S5O"$KV=X8G4DA0
M:]BNX%N[%[9N Z[:IZ/HT.CVIA49!.30!P'PX^QQQ76D70_XF)RK.>IK&U"_
M.E^+X=%.3&9.GXUZ)#X1@M_$KZO"=N\]!27/@VRO?$']IRJ#(O(H XWQVO\
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MTS##Y62M;7@G3M/N7O9IX26C)+-70Z1X2DTZ[>6YD$^Y=N:T=.\/PZ7]H"N
ML^<K]: /.]0O]#U".\6WML>5D>9Z&J5@(;_P&6N090MQ@$]AFNO/PY03S202
M[()B2R>M:B>"K>W\-/I=L0 S;B?0T >=^)OEO=/MH@6M @)44^U_TGQ%$;+-
MJ@3:P_K7>1>"XGT?[,\H>X'W9?2I-&\&QZ;<&2[83,1@-0!P.HZ9!I=XTC/]
MLA+;G8'H:])\%ZO;:MI>ZVA,:Q_+BLB]\ 237S&"XV6KMED)ZUUFDZ3;:/;"
M"V3:/XO<T >?:_;Z;)\2[>&_(V,N3DU2U*.VL?&:6^B<6K0DR;3QG%2^*=$F
MU7XCP!<@%?O#M78Z%X0@TH3&?$LS@@.>: .&\-:;:/H^KWD49%XLAY]JM:/8
M>'-0T*Y>\<+=*222>]=SH^@VNFI<Q,!F9B2*YV^^&\-Q=M);3&.)FW,H- '%
MPW<Y?[)>EO[,#X4GH16GKEAX?MM4L6T]@)63A?6O0+GPMIUSHRV#H RK@-[U
MS^F_#F&WU 7E[*7,?^KR>@H S_"D]M:ZM/%=S[)74E5)KF[R>0PZI]AD8KYV
M&(/09KT#5O!%MJ-\EY:R;)U&-P-6]%\%V>FP3PR8D\[E\]S0!D:;9^%K?0K>
M[EV-<^6"W/)-8&F6^GOXXM[J%-B9KH(?APD6M&ZEN";0'/E9K3NO"$#ZQ;7=
MD0D<751WH ZX$$9'2EI$&U /04M !1110 4444 %%%% !1110 4E+24 (:I7
M_1:NFJ5_T6@"JM.--6G&@!#]TU8L>M5S]TU8L>M &A1110 4444 %%%% #2>
M:859G//%/;J*;(VW!%(#FXXM1.OL#(?(':NE':FX56\S')IXI#N+2'&1FG5'
M(VT XS3$>::E< >.;Z)AG,1P:K>%[2W-EJRSIE]C$$BO06T2QGO'O7B'G,,&
MEAT6QMHY%2(9DX:F!Y_X9L89? ]V@APWFG#8JC<>(HM T:&RDA,DKR8$F,[:
M]/MM(M+"S>V50L+G./>J<_AG2+N/RY[</SD''2@#R"ZGDG\4JCW8E,D>5V]O
M:NHT"YT_2?M4>JJ$G9#C>.HKL8?!VB6<HF6V#7*\J?2N(\2.TFK2QSZ4\K,I
M5& Z4 9D+6TMG)-:I^Y\[.1]:OV<<-UXEM79-X&!BM;P+X1FAT]Q>H5A9MP0
MUV4/AZPANA<01@%: /._%$ 'C7R;!")3#R%JUX:OM*L_#5_::GL2Z);*,.37
M<W>F6:W#W\<0-\J\'UKR[7-][<2!M(D%R[%=X'ZT =A\+C ='NC;#]WYIQ4'
MC73+*]O_ -[<BUFQQ(:U? FBMX>T3R)!CS#O.>U:.K^'K#7DS=+EAT(H \KM
M]4N8[:;0;<&[8@_OE':LVQ$\6E2V3705O,Y!ZU[+I?AS3-)7%O"%D(P6/I4%
MQX0TF2Y\Q;;#,=S'U- 'FTEFIOK))R95&#75>/+*.UT:WU9%VR0* "!TKK?^
M$=TW<C"( ITJQ?:?:ZA9FVN8_,@Q@K0!Y9HQG\0Z))J95GN(U(5JY[33)%;7
M<=Q>B)F<_(>N:]QTK2;#3;1K>RB"0GJM9%QX*T6>[,T]MR3G/O0!Q%MHMI_P
MCS_;;KRYWYCD8U!X=U631_$EO8^:+[=T=1TKTN]\.:3>VJVTL/R*,+BH]+\)
MZ3H\PF@M\RCHQYQ0 OB/4AIVA27LD!D4#F.O(/$6M-JOA>22VF$>7'[K'(KW
M&>"._@>*X3,9XP:PHO NAP!V>W#*QSB@#B$M;"\\,6 ,GV:[$?\ K6J3P7KD
MUKKRZ9(/M:DX\\#@5W4WAG2;BW^SO'E1]T#M4^EZ#INF#_1+7:X[D4 ,\806
M=QH$R7KA(SW/:O+[*Z/AK5[4V]T+^&1<*B\[:];O+"WU2!X;T;XCU2LC3O!>
MD:==?:4BX'W0W.* .+T2[M=,\4W%]?R>29P2$-8T#Q74>NSQR;U:3Y:]8U#P
MKH^JR^?<V^7'0BDMO"6CV4#PPVV!)RQ]: .7OH((?A4%BCY=1NXYJ"XMHX_A
M?";5=VU070#FNY?3K26P.G-'B+L*+?2K2&T^S",+;KPP/>@#A)=3T>7X>):(
M4^ULF!%CYLU@>&@^BW]F=;C*PO\ ZMG_ (17HI\#:,=02_C3"KSC/%9'CB)I
MY85%@9X$'R[10!A7NHZ/+XJ:ZL0)!'][;WK,UOQ&=5T_45C80!>B8Y-:7A/P
M[]LUDS?8FMXE/S!N]=U<>"=$N+@R>0 #]X#O0!YUIVS_ (0^WGE_AZYJIKWV
MB].ES6\WE0J1ENPKU[_A&]+:R-HL($/]WTJ*7PQIKV(LC!F/L?2@#S*Q@GOO
M%-G);W@F6,C>5KT?QS%+/X3NXH@2S)VI=(\,:=H<C-:0Y;N36VR+/$R2*&1A
M@K0!X/I37!\,MIKWX1LD;#UK1ETX12Z%%-F0HX->D2^"=%DN1,MOM?.>*N3:
M!IY>!F #0_=H X7QFBP:[9):18EE 'RCI3=&O]-TF\U)-9Q&VSJX^]7H<^E6
M=Q=)<R1AIE^ZWI5'5/"6C:M+YE]!YCGKCO0!RGPVGMKG5;Z>S7;;DG:>U3?$
MS[-'>:7<7A'D*XSGZUV&EZ%IVA1%+&$11'J*Y/XB:2^LSZ=&$,EL'&[% &+X
MPDL/$,5C%H#AID(SLI_A&\L-)U2[MM9 AF*8W2?Q5VVC>%M)TDI-9V^QMHR3
MZT:UX0TO79!-<Q_O!_$.* /-_E&N74EJ#':MG:_8T6\4)U>R+1%SYGW^U>GQ
M>&]/CL4M#""B]ZF70-/A1&CA&8SD4 >=:LD1\63K%%L9H\9 K6\#W<,.H363
M@>=ZXKL&T>QFG^UR0#S.AJ*#0+"UOWOHH\2&@# ^(A$>G6HD7> ^2<=*Y:^O
MK>UFL+F=/,M,CYL<+7J5Y8V^K6K0W<>1T&:SW\*Z9-IBV,D0:)3G% '"^);W
M2]3UK3VT=A-,"-VSM7J]OD6T6[KL&?RK!TSPIH>F3F:RM=DOJ>:WX\A>3F@!
M]%%% #03G.*".>E.HH :"=V,<4ZBB@ KGO$7B:QT%H_M;CYS@*:Z&O+/BKHL
M>ISVC-)L(<=Z ._35[%K.*0W"H)!N'-4EO)+C6X_(F#6^.0*\ZGTNYNO%NEZ
M7'<'[,(@3@ULR&72/'45FDN+;R^<F@#NKG5],M;D1SW:)(> I-<_XP\13:-%
M"UL-Z2L,,*XSQ#;6[2W%UYIN'5\J5/2H(-2GU31ECN^B, A/:@#U>'6K2'3K
M66]N$B>5 <,:NV\B2*)(G#QMR"*\:UI-0AO;,7MO)-:;/E<=!7>>!I5:QD$=
MX)AGA,_=H 3QYXJC\/6*HCXGD. *T=!U)HM AOM4N%02 $%C7+_$72(KZY@>
M1=S*00?2LW[!/K-U::7)=_Z,%QL!Q0!ZM!=07, FAE5XSSN!XJ%=4L7G\A;E
M#)_=!YKS.47WA"^.GK=&6!U^5<YQ5GP#HSW6H7>H7,K,P?Y1GI0!Z,R_(X?Y
MAUKS'4_'MW;^,8=,MU(M0V)'["NZU[5#IVCW%X1L\L$<]Z\<_M5KG0-0G&G,
M;N63<DF.U 'KOB;5ETSPZ=11=Y &"*L>'[Z35M$ANF789!FN-;4EU?X5@,?W
MT2A7![&NM\'H1X8LQNR-M &M'&R-SR:KW>I6.G.!=W"QE^@)JZYVQ.V,%5->
M('5G\0^(+^&[5G^SL0F#0!ZEXAU@Z;H,E];%9%_A(K+LM0O+^*QO'FVHXRR9
MZUQMIJ]W)X?U#3IHV(!Q&3VJ2XN;FV.C1QR[5"_,/6@#U)]4L(Y DERBD_PD
MTK:IIR.L1N4!;[HS7D,>GW6KKJ]S]I;?$?D.>E/M=%OK_P ,F\^U-Y]O_'F@
M#TK5Y+J/4K00S;86///6M&?4]/M/EEND1OK7G-WJ-VQT17GZ#YSGK5+1=)N?
M$NM:TEU,WEQ?ZHYZ4 >KBXA, G\P/&>C"H(M1TVYFV)<QM+V'<5YYX5FN%M-
M2TR_O=D460CL:P=48:5=VTMG,2V[F7/#4 >G:CXLL['5H+*650S'!IUC--<Z
MM<3"8?9H^>M>>ZAHXU;7-*NY7(+$%N>M6;J[OK276;:UD(C5,+STH ],&LZ=
M)*JK=H&/&W-3W,UK;IY\\JH@YW$\5Y%#X;N4\*P:N]TPFSDG=4RWUYXF:PL/
M./DJ<2<_>% 'JEOJFGW8!M[B.3/0K5ECG.[A1R37DBZ1<^'/&<20SDVKD8BS
MTKO?&&I2:=X<FDB!#LF ?2@"/Q%XDM+'3Y3!=*LJ#@9J?P]J_P!K\.)?WL@5
M3U8UYJ?!USK'A/\ M62[._!8C/6J5UKUQ'HNGZ8,K"'VR8[B@#V>TOK*[0RV
M<JRKW*FFRZE8VS[IKI4SV)KR?3]1N='U0+8*WV60?=]*FL- O-?UN^>XNSY:
MKE$W=#0!ZX)X9(!-&X,9_B%5(M4L9;@P1W:/)_<!KR6X\37^A64FENY<#(!]
M*J6DUS!]DOH$?SF?+-GK0![7->65B-\TJQ^N32VM]:WHWVTJR)W(->4"VO\
MQ5XH,$UR8X=O*9I;.ZN_"NN:EIL3-)$D9*\YP: /1-6\0:=86UTOVE1,J$@9
M[U6\):N;W0FO;EPJ[C\Q]*X.S\*S:_X9NM6N+@^<VXKS6.VN7>E^$[;3%RS>
M;AL=Q0![;#J=E>-BVN$D(/132W.J6-JX2XN$C;T)KQ^&^GT6>&ZM4<+(!E<]
MZLV6EW7B76KNYNKH[!&2J9Z&@#U>.XAN5,L#AT ^^#52/5[.Z9K<72B9>V:\
MVTS6[W1=.FL'<E68JKGM6AI?@FYFA746O]DLC9R6[4 >BPSPNFSS ["GI<P,
MWE)("_\ =KS2'4;CP[XEN8;Z4_9O*.QR>":UO!44]\\^IR3$AG(3)[4 =Q+/
M%;+NE8(OJ:BM-3LKUREM.DA'4*:X#QC?W=_J46@Q2F)BW,G3(K.U'2KSP5<1
M7D%R6CD7#+G.30!Z?-JUA;MMENHT/3!-3Q7$,\0EBD5T/<&O&['1KOQ%>W$L
MMRP4H6 ST-=+\.)+B&"XT^[F,I1R%R: /1**13QC&,4M !1110 4&B@T (:C
MG_U1J0U'/_JC0!D_Q&I!TJ/^(U(.E "&B/\ UHH-$?\ K10!JC[@IU-'W!3J
M "BBB@!110** "D-+10!'DDXQ3@NWFG44K , YSBDR>>*DHHL!'@E<TA^X2U
M+*2!D=NU<KXQUV;1]/\ +B4M+-PN.U,"SKWB6'0C$P3?NZ@5L6FH)<Z='>8V
MJXS@UXMK>A>(!)IU_/<F2&4@LF>E:5]XBN=0DM]*L[C[,(AAJ /75<&,.,?/
M3@-JYSTZFO);'Q!J(M[VQ6Z\Z>(?NR#6XWB*X'AB&U$N[4GX8=Z .SN[2UO8
M]LX!0]2:IR6MCH.FS75I HV#.:\YU+Q%?>7:Z;/<_9I2?F<FFV>NWUBEY97E
MW]J@=<(<YH ] \.^(/\ A(+=W VA.M;4)CER%8$#MGI7DUEJTFF62VMH,2W1
MPI^M6I(?$7A6ZL[F:Z,T5PWSKGI0!Z1=Z=;WRLEZBO&.F>U%EIUIIJ?Z)& I
M]*\T%[K_ (F\1W-E:71MX@O!S4EGXBU70XM2T>[<S7,2G9)Z&@#U%MDS !@'
M';-*!\Q#,.!R,UXO(_B1-"AU1=0/F2/R,]!6C"WB&Q:QU"XOC+%.P#+F@#U8
MLB1[R0$%*CHT9E7D5Y/K/B"Z\0>(O['L[X62P@%R3C-2Z3XEO;*;4=-,OVE8
MHSME'K0!ZC^[E ;(&/>JNIZS::2L9NI GF'"Y/6O++2'Q'>Z*^JKJ.V*-B<9
M[50\4?VAKFEZ3=/,S 2A>#0![9$XGA653P1D&E=TBP[=3Q6?I<<UI80)*V[]
MV./3BN*\21:A/>W!35UMHHU+*I:@#T9D,B@J<&E5@'*%QG'2O)+#Q5JHT&6$
M3&249 F%5MWB.RT^UU2;4"X>7YAGM0![(!MR"<>]<W<>+;:'Q#_8S1;G[/7-
M:EJVJ^)+^WT[3)C ZJ"S9Q61I&D7FG?$0IJ=QYS;>&S0!ZZB.7#,WRD<"@Q(
M)?E.']<UD>)-6_L71FGSEVX4UQ6EZ7XJU!DU>/43Y1;/E9[4 =3/XF>#7Y-+
M";W5<UKZ5=3WEN\T\9CP<;37G$K2KXRFN/. F6+E?>JU_K>N'P\#!=;96FVY
M'IF@#UH/& PB<%@,[<UDV.J27^H/'):LH4XW5PLQUCP^;>\GNBWFJ"1FK \5
M7%K*TC,%#K\OUH ]+WQ[]K.%/]W-(ZB-20P5?<UYOI6C^)-44ZF]X<%\JF>U
M6]?M]3N"!_:HMMB?=+=30!UFH7J:9I[W03,8YQ47AO6AKUF\^W:JG KSC2-<
MO+F&XTR]N/.10<-78_#\B+2YXT^91)UH Z\_(<L<#UI!M7+[QL]:\S\:^);H
M^((]%AN/LRO_ !FJFGZIJ-G>-I!OOMA9=P93G% 'J L;<S_:M@:7LU4;G5I1
MJ\=G% 7C/60=JXN/Q/?0^'+@^9_I:R[%7OBH(]>U+3-8MXIC\DL6\@^M 'I=
MPT5LC3R$%D7('K6/X?U]?$3W!C3RTA;:1ZUP\=OX@\8)>7UO>&&.(E0F>M9>
MAZM<^%/#>H)<3_Z4\A ;TH ]G5HI\JI!*]>:>VQTP>0.M>,V^IZCI3P:FNJ"
MXCFP6B!K1U&^UO7->M;;3;LV\4J;G&: /4HUB7F+&.Y!ITFQ.C ,>^:\MLO$
M-]X2NY[74KC[0#D YSS2Z?I'B?7II;]-1,=NS;HTSVH ]0*J$W2MD>N:;M5T
M/D'\:\JU_P 2W;ZO;:"EWY+@8=\]ZM^&-?O;'Q(NCR7'VI'/WQSB@#U% 0@#
M')IU%% !1110 4444 %%%% !1110 4E+24 (:I7_ $6KIJE?]%H JK3C35IQ
MH 0_=-6+'K5<_=-6+'K0!H4444 %%%% !1110 W'S4%=W6G44 ,VYX]*>***
M "FD4ZD)Q0!GW%]:6;F6ZN%B [$U)!J%M=0_:;>19(^Y%<1XFM;:\U29Y+K>
MBC/D@UR_AW5[N.[U"VAW)9A"%4GH: /5I=6TQYQ&UVA;/W,U?4#C:.".*\:@
M\.W$OAF35OM3"Y64D-N[5Z/X/OI[GP_')<-YCKQF@#5FNK:T!>YE$1/\1I;9
MK*[0S(\<V.=V.E>>:M!<^)?&S:;]JV0(N2H-9]Q)?>%]>GTR*8F%HL]?:@#U
M>.YAE)>*53$O!QT%8VN^+-/T*%':53O;;7+: \__  @EY-'/NEWDYS7,ZEI7
M]K>&H+NYD.]9P,9]Z /7_M]D]A%J$DRQQ, V\GBI8)[#4D^T6[12A?X@*\TE
MLKC5]4M- 2<K:"$$KGVJ?6K.?P1I2Q6EW_K3MVYH [_^UM.EF^S_ &E X.-N
M:GGO+.S4>=($&,C)KRR]\,W-MH<.LB[/VAV#GYJBO[J\\0W=G;K*4P &YZT
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M7J%K699<=2#7E>J/K.I>$;"\BW3*/];&IY(J70M0&GZ/>7D$_DR(O^H)Y!H
M]+FU/3XIOLUQ=(LC<;":F<VHA_>%1&O(8UXA:W,VLV5QJTS,;D9V\]*NCQ'J
M&N6-AI"LT4A;;))_>% '9^)?%D4%_86FG3+()'VN%[5VHCW0ICT!KQW7O"+Z
M#K6E3QW&[=(-P)KU36+Q[#09KJ,?-''N_2@!\FK6$$H@GND27^Z35AKJ"-=S
M2*L?9B>#7E5CX>G\1:5<^(9;H^80Q09Z8JE<:SJ$NAVNG2.Q??M,N>HH ];C
MU73YI2D=TCO_ '0:LJN5W8Q[5X]JNCW/AB33K];AB9V&>:]=LV:6QBD+9)0$
MT 2JK,VX]/2G;0,\<FB-]QQBI* *WS1<[<YJ=%VK3J* "BBB@ HHHH ****
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M.:[LX"JS/&LC?=XY-3H!Y>9,,O;- 'G/@K0UCU*>_N+1HQ(.%85F+X6U5OB
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MG#-9Z1-ILRD/(QPIZT >S:+JL&MV"74/W3UKG/%7BJZM;Y=.TE#)..6VU?\
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MG&FK3C0 A^Z:L6/6JY^Z:L6/6@#0HHHH **** "BBB@ HHHH **** "HY3@
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M649^4$5WD)W(<^M(P16WA1GUH Y/QKH4FI65O!$,Q(0"/:M;2/#]AI4,#PQ
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MS],T2YUFWNKU[AB8U)4@]*Z.3PIJM[$&N9=Q5=OX5H:+X=N+#3KFV#8612*
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MD8SGBC(]:A#$80C(]:>0HX'6@"3-%0<LWIBI-V.O6@!]&13,D<TT$&@"6@D
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MCI3E1MAQ][UH^? "]>] $4A7Y6;YI!Z5,#YJ\]3UIOE84E?OFG(I1>?O&@!
M$A./6FLC!LH>M/<9(+"@87GK0 <@;&YS00(B,9XIP!/S=Z7:3]Z@"-N/F7AC
M0S[$&X%C[4\H2<'I2D= .E $)3)!#$9ISYQ\O4=ZD9%8@GM32N3A>G>@",X3
M#'+,>](7< N&W =J>%R^%Z#K41A;S]T9X[B@":)MZ^9C&>U 0EFSWJ3&0.U!
MH CB#*2IIS?,0*49!)IB*PD)/2@!=H7(]:8S[ (\$AJE9<@\U&04B('+GI0
MQ3L<Q@'%.QAN&P#VHB5DC)?[Y[TNQ2 6.30 -"KD%CPO(Q3@Q<' Y'2D'((
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M44 %)2TE "&J5_T6KIJE?]%H JK3C35IQH 0_=-6+'K5<_=-6+'K0!H4444
M%%%% !1110 4TYI<_-BHS)EBH'(H DXI:YX:_OU7["(FW _>KH >!0 M,D)"
M8!P3TI^:9( PY- 'G?C ^*-/\RXL+C:F,U4\,7/BF\TB6]N[C<%YKK_%KYT*
M<$A<*>363X(=I/!5R6((^;!_"@"/PUXMAN+F2+4+I(RIP-QK=UV[;[)%/8W:
M(&;!?/!%>9:+X7M-6DU.XN';]V&9=I[U#!<W$GAJ.UED;RX[C"MGMF@#UY+R
MUL;6-[R\C4,,EF/!J6*Y6Z82VEPDL'^R<UY-K=A=O<17%V99]-$8Q&AY%=7\
M/;JP:!K>VD*D'_5L>10!V=Q<16:>=,P6/N37$>*?&1L9[=-*N$D,C@,JFF?$
M._G#V]@&*12. 37/>(O"D&BRZ?>0RDR/M)5C0!Z6VN6%K;VWVV=%FD0$@FDU
M'7[&QTQK])T:,#/!KAM;&ER%);C=-,(<A4/0XKF-'=-5T>[MI6=8]Q 1CSB@
M#UC0/%%EK5@]^LR+"AP35Z/6=*NI<+=QENPS7 :+IFFZ9X*DB,IB1GY!/6N6
MURYM;'4;/[!',@9AER>#0![PQ) 92-GK5*;6=,ADV27L0D_N[N:6W<GP^CLW
M/D9S^%>3Z'X>36VU2_GG=I8F;9AJ /57UC24(8WD6X]!NJR]U;E%)E52W09Z
MUX[HOAQ;S0[N]N+AS<0R_)\U7+N_N93:?O2I0A<YH ]3EO;594@>55<CC-5[
MG6M/MIEMYKI 6Z<UP_B23_B?:>GG[6:,<9[USFJ6<MEJ'F7R2SQELJZG@4 >
ME>(/%]AH,,9:9&#G .:U[&[34;"&[MV!#KGBO(O$]CI^K:)!)&[,%8=^E>I^
M'K:.Q\,6J1' $(/- %N74+.S3_2[J.-O]HXIXO;.: 3QW*&,?Q@\5XQJVJ)J
M7B>6*[BEDB0D;5-:O@]I+J2[TN021VK9*[CR* /5&O;00AS<H%/\6:KS:MIU
ML@%Q=1Q!NA8XS7BVF:A/=>.WT":X8VB-A>:Z#5M!75?&=M8W5RWV.,8"JU '
M?:EJL$.C376GRK,R]"IS7.:-K.HZNA:2Y5&!^Z3S6&T3^'M4GTZ"0O;.> QS
MBJ44I@U!O*RO?/:@#U>;4;6QMHC=W21MCHQZU1U2Z^V0I/87J;1R<&N$T73O
M^$TU&3^T+AMEN<*H/6I_$%C#H6(K&Z+)G##=TH Z*/QO9PZI;Z5-*OG..OO4
M?AOQ#-<:UJ,5Y.H@A;"9-<=%H5C<^)M-N6+-(RYR#4\.F2W,^MQVS'<C<8ZT
M >IM=QQ)YYE7RFZ&E1U*^="X9#UQ7F+ZTU]:6.BV[$SI@28/->A0P?V7X?*,
M29 G.?6@"676M-AE"&[C#]USTIL^N:=%)&CWD8#].:\BTS2#>V^NZC<S.9(R
M3'STJQIV@?:_"$NIWD[M)']P@]* /79=1LK:(/+.BH>C$]:9:ZIIMP2T%U'(
M>X!K@I6L9_#>GM=S%^.$!Y-<U8W<$'BZ"ULUE@CE.&#GK0!Z)HOC*SUCQ#=Z
M:'7? < 5N3:QI<$_E37T0D'\!;FO*=/TZUTS5O$%_;$BZC&5-;'ASP?9ZYIR
M:W?7#_:')+'=P* +NO>+;RR\06D$<HCM)6 W'IBNT@O[2Z4BUN8YI0.=IS7E
M'B?3X]1\1Z98_:5>W5@,J:LV5JWAOQP(+*9C#)C<&- 'I]Q>QV:QB=@"W7-/
MEO+:",2M(-K=#61XPL7N]#FD@)$RKE<5P0UEK^PTW2DE+WP?$B@\B@#TVYU:
MSMH!//=I$IZ;CUHM]1M;^V,T<Z%1WS7D.IW,<WB0Z5J22S)",@(:=87\\)U2
M&%)([54.Q3VH ]:CUK2R-GV^+S!U^:K)NH(8A.90R-T8&O+O#OA*WO\ PG<:
MD9)&NFR5^:HUUV231K;0E8K>!]I)/- 'K*2I*@E0Y5JE^7BLW1;*:STJ&WN'
MW2 9)K2 !:@!]%%% !1110 4444 %%%% !1112 **** "H)?-5]P^YW%3UC>
M(M>M] T\W,Y![!?6@#1 !/F@'-)MD\SS#]WTK@;;XBR1RJT]A)';N1AV'%=/
M-KQWPO%$7BD /%,#=P2<T@!W$TT2J85?ID=*<[C8"#0 H7KS0<*/>F'.P%3F
MG%@L1<\X&: (Y&((P.M2#) .:YBT\96TUW-!)@!#C)KH+.]MKZ,O;R!E'7!H
M LY!& >: ".II@:(GY7&?K2L0JY=L"@ & 232]3[4BE9!D=*;]HC$GE]Z )"
M>..M"CCFFN1&I<]!2JZRIN4\4 ( 2W%*V >>M(ORGGO2%\/@C(]:  $D'-(%
MP010K1MN*L#MZBN?T7Q,FJZM=60X,)Q0!THH+ 4 8'K2$*>M  #FC IK2*OR
M^M*N#QWH 7BD(P1B@[<XS379 N"<&@!P7#$@]: I!)S4?F+"H+-UI22<.#\M
M $F3CWH))'O2!@><]:1B$!;M0 )D=:?42R"7E3TJ3=@9-  0.YII _A/-()$
MD.W/-*NP-A3SWH 3EAAJ1MJXP,TH(,A':J>J:BFF6,MPRY"#- %T$X+$8%(6
M^7..#6#I_BJSGL(KF:15$K;5!-3#5I3JGD+$3$>C4 :^.!L/'>D;);/84/M3
M W8)[5A>(]?_ +!%LK#)F;% &^6+*,<4JJJG.>:BAD4VZ2N0H8 \U*I5SE>G
MK0 _&:-M(,"@,&X%  W I QQTH9E3YG8!?>F\L04(VT .4Y-/J,.C':K#<.U
M24 %%%% !1110 4444 %%%% !0:*#0 AJ.?_ %1J0U'/_JC0!D_Q&I!TJ/\
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MOBK@I&&<4X4#"HYD+@8/2I::X)'% C(US3#K&FM;@X)&*K:%H3:5X?ET_/+
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M>34M>U75[2&VN BY^<9K.D;7K^+3]/@A9! <2$CK6]I.CWEKK\4TB,%'4]J
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M 0#..].HH ;Y:YSCFE*@G-+10 P1JIR*4QJ>U.HH :47CBE"@=*6B@ HHHH
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M72;:22ZG!BV9^8]ZS+OPQ=>'X8]1LT+L/FV@<U*MUXB\2V\K,K16RIC8>IH
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M?VK6O&EY;1-;M L+?,7'6MGPGH]QH_B>]>1#L9>OK0!R_AC1-5A^(]XTER7
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MUCJ-\]K# ZB,_?/2H+OXD6L%ZT,5K)((_P#62 <4 =@L2.-H14=?[HQ4^PJ
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M@.P:TDM92Z@MN!0XYKL!10!R6D^ M-T^\^UG=)*.A;FNK4;5QZ4ZB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "DI:2@!#5*_Z+5TU2O^BT 55IQIJTXT (?NFK%CUJN?NFK%CUH
MT**** "BBB@ HHHH 0T4M% "44M% K"4U@?X:?2'IQUH&<Q!X9CA\63:W( [
M2+MP1G%;[HL/**,$\J!Q7,:WX^L=$NVM&A>>X7DHG)J6+QK93:-_:;1-$O='
MZT =)LC*#"[1UXH"P'D1(3Z[17$VOQ.L+B]2!K61(I#M$A'&:U-;\86.@*BA
M#<-(,A$Y- '1;0>JAAZ4@AC#YC15;N *P-$\7V6K1NNTVTJC<4DX-9-Y\2+2
MUO1#'9R3-NVET'% '8O):F3R7://]RHI+G3X) //ABD] 0*Y.ZUK39+]IU#_
M &DQ[@M<%9Z@-5\3RR7RSK&IXYXH ]N5H+A=VV.4]FQFI578FW:%KE8_$FE:
M'H)N$)?G 3/.:30_&\6K2O#/;O&P&Y<CJ* .I==XVA%8_P"T,T1K&O#1H#Z@
M5QEU\2+>WG:(6,H16VER.*SO&/C9[/2;>[T]&9'89Q0!Z \D'V@1,ZJQ_A]:
ML,J1Q\(-OM7"Z9K%IJ-U:75V'CG\L'!J34_B/;6-^((;5YX@<,ZC(% '8O#;
M;0YB3/J!S3FWJHVXQ7.W/C73;?1!J;#=#T*CL:SK/XC6-UJ$-O);O&LOW7/2
M@#LC#$1S&KD\_,,U(H4C:0 OIVKDM=\<V>CWT=HD33,XW?)S6EH'B*'Q' [P
MP20E#@[Q0!L; @(BC56/<"D93Y68U7S.YQ06:,Y<\>E8>O\ BJ'P^P1K:2=F
M&<(,T ;L:!4^XN3UP*>(HE^81(I]0.:Y7P_XZLO$#21QPO;2(,E9.":S[OXG
M6223QP6LDOD-M<@4 =K*I8!BJNH[,,TIEMK8+O:.(MVZ5@+XNLSHG]JYQ$!\
MT?>O.=<\<IK^LVT4<$T R-N>,T >JZYH\.KZ1+:HJ;I.0V*/#^CG2M+6SEPX
M'8\U/IP*:3 \KX*IG)KF+CXD64>HM:PPM+Y;;79>0* .S$2KP(XU Z8%!5"/
MWJ*_H2,UYAXX\<W=AJ.GI91/Y4V-QKH;GQB+32H&-K))*ZY( H ZY8UZE1M[
M#'%12!.1(HV'ICM7-Z)XWL]:MI2J-"T'WT?K63>_$RS^U>5#:R/"AQ(P'2@#
MN8HXXC@J'4]"1G%.;[/"Q21D3?T7UK"N?%=C;:7%>)S&XR%[UP>M>,3K/BK3
M+>WAEA!(Y/ - 'K(CAC4_ND*^PI%#J0VQ=G;BJ[W26-H9902$7+5G67BJTO;
M6XN\8A@ZB@#>"?-N0]>M-\N$N6:)"PZ$CFN9G\<V%O8&^V,8SV]:HZ;\3-.U
M&[CMS:R0&0X5G&!0!VA19N60,OH1366*&,N L<8^]V%5-2NY+;3I+B AMJY)
M'>O+]/\ &5_X@LM:B(9$@!YH ];4P30[H K1GKCO2E2$58P G]TUY9X6^(,=
MAI<,$MO)(H;#2=J['4O&-CI=C%?,#,DWW$3DT =#Y04$B-$/;:,4-N2'&T"1
MNAQ7+Z)X\LM<N#;FWDMI?X1)QFN@N[G[!8RWET=R1#=Q0!+Y:% UTJ@ISNJ2
M">.=BT3AT]17%Q>/;/6=/N<0.( ""PJU8^(=+T;P^MS&Q*$\*3R: .N5][E2
M, 5(, <5P-M\2K.ZNXH6MGB$AP-PQ5G6_B+8:)/Y/V>2X;&2(^<4 =KN&<9&
M:6N5M?&>F3Z2VI_=P,F,]152P\?6=U;RWDB%+=?ND]Z .USQFDW+ZBN%T_XB
M0:E=^3':2>43@/C@UUQDC\@2OE4 SSVH NU&\B1J6=@H'4FN)U#XC6EG?&UB
MMGG"?>=.16/XY\8"Y\-1S::'+2G:ZCJ!0!Z7!<V]P"8)DD _NG-3BN)\ VJQ
M^'(YXRXD?E@YKLXR"G% #Z*** "BBB@ HHHH *\P\?Q20^(;6[N,FR& P[5Z
M?6?J^DVFLVAM;M,H>] '(77B'0+>WC>TA1YQ'G*#FN2O?$<^L:7<"V$$:@G(
M8#=7H.F^!=(TV5FC!<$8^;G%5G^'.AO<O."RACDJO2@#@]'M+2^\*S0S.5N-
MW#$\9JUIFI7&BZHMC=^7<.\1$;0]A7H?_"':2---FJE8F[CK4>F>"]*T:Y%S
M"K22] 9#F@#R[0&U*PN]31I(D\]B5,W45<TC2!_9=XVK29#/E67[M>B:KX*T
MG5Y]\V]'//R<5;_X1G3SHK:4<^3Z]Z /,[#5;G1M?M8D$,UN<!=@YQ7K%U;1
M:II#)(N%D3=@UBZ9X$T?3;Q+J+<[ITW\UT89\D$?)T % 'A #:]JUUX;=6%O
M&Q8'Z5I^%ICX@UM]-96$6FJ8USWQ7IT'A?3+?4'O8HOWTGWB!3M/\-Z=H]W-
M<VR!'G)+G% 'E[1F+0=9@E0,ZS?)D=LU:U*6WDAT*,*DN%7>JC.*]#_X1JPE
MCN%D&5E.6J&R\&Z582B6-6<CH&YQ0!R?BJ*VC\4Z(T<*Q\#A1BNWU]A_PCDK
M8_AI]YH-EJ-W#=3KF6'[GM5R:W2ZMGMY!\A&* /,_"MO#'H&I3K&ID).,BL+
MRKAI%NG!^S(?G4=*]9LO#]G:6\L,:X5^M*OAJQ%G);;!Y<G7B@#F;OQ!H4=A
M;);0QM<LF%V#D5D^%+>UFM=8DFMU=VR3D<BNLTWP#I.G71N$#.W8-VK6M-"L
M[+S_ "4QYWWJ .)^'DJ69OS*^V,,=H/:O0K>19XEF0Y4BL"_\+0"PFCLLI-)
MW%:NBVTEGI<-M*<NHP30!YXL-M<?$ ^9$&()QD<5E7Z%]8U>"S0H>X3BO5%T
M"S2_-Z%_?=C3;?PY96]]+>(@,LOW\CK0!XQ8/?KH]S:M+$B=]_WJU#'-9IH[
M7*H]L#]YA7?WWP^T>^NFN)!(K$Y(4X%:-YX6T^\T^&SD4^7%]T]Z /*_%+7I
M\26EQ9E1;G&-WW:3;<W5W=,C)G'S&/I7J-UX1TZ\LXK:4';'T(ZTS3?!NF:6
MDRPJQ$PPVZ@#B_#]D%\.:FWE@R!3M8#FG^&[O28/!U^+ORA<X.5?[QKT"RT:
MTL(7A@7Y6Z@UB7?P\T>\O/M!WJQ.2JG@T >66*W$-[8W4D3_ &%I.,CY0,UU
M7CFYT>YU#2_LAB^TY&/+%=!XKABLM)2SAM@;>,?-M'-<+IOAR/5=8L[NQAF1
M('R1)0!!9/J-GXGOS(54.G_+7I3K:SG^RW\CRY5@<[3P:]2U/PAIVLE9;@%'
M*@,5XJ6W\(Z9;V!LT5C&>I/6@#@I[6 >!;#; BLK_> YK!U%=16YLI5;$088
M+]*]A?PW9OIRV17]TGW:9>^%K#4--2SG3"IT*]: /*+BVU"[OYY(Y%,FS_EE
MWK<T.?1;3PU=1WJH+_:<J_6NTTCP?8Z-*982SMVW56O_  !I6HZC]OFW+,>H
M7I0!YCOG^QV<SH1;+-D>@&:Z/QIX@L+Z'2+>#$K!UR5YQTKOY?#6G3:9]@:(
M>5C' YK,L_A_H]FR,JLVTY&[F@#C]=L($NFN=.FCBN/*&[SNAK9^'VMK-;/;
M7:A'0_ZSHIK;UGP-I>MNK7!D7;Q\AQ1=>%K>WT5;"Q&P#^+O0!O12B=]\3AD
MSVKRCQ3I]K?^/A!(&#'J17I.@:<^FZ>L,C%G!ZFEG\/V<^IB_=1YP[XH HZ9
MX4L=&1KFW+F0IU8UR/A_4+)/'=R+F18Y!G!8XKTLQNV4S^[QBN8OOA[I-]>M
M>,72<]UH YKQS?VGB&_M=.LP9'@D#NR],5E7]KJ7B'Q7!!I<VR*", ACW%>D
M:3X0T[29'DC4O(XP6:K%EX<LK"\:Z@4B5CDF@#RX6VJ^$O%J:EJ3AQ*-BD=*
MZ.YT_P 9W.K1W=M<I]A?#;<]C78ZOH%IK:QK=KD(<C%7X(/L\21(?D08&: *
MUK%*;1$O&!E YQ4[#8H4=*=Y"[MV3FG[21\U "H %IU(J[1BEH **** "@T4
M&@!#4<_^J-2&HY_]4: ,G^(U(.E1_P 1J0=* $-$?^M%!HC_ -:* -4?<%.I
MH^X*=0 4444 ***!10 444G>@ I*3>,XIW% @HHI,T .HIA<+UI&F52!US0,
MDHIH<-G':E# C- "T4PRJ,4X-F@ HJ-9@TC)@C'>A9E9BO3'>@"444Q9 6('
MYT+(&<J.U #Z*8LH9RN.E.+ #F@!:*895 SVH$JE-P/% #Z*:'!&>E(9 #@\
M4 /HJ,S*&V_K3MPS@4 .HIN\;MM!<#O0 ZBHVF5<>I[4>:H?:: 'TTC!H9]O
MO2*^XXQB@!X-+3-ZJ>32[QNVXH =12;N<4@=3QGGTH =130X.>U"N&Z4 .HI
MC2!3@T*X89QB@!]%-+@'DT!U/>@!U%,,@!Z&EWCB@!U%-+@'!I#* N: 'T4U
M7##TIIF57VGK0!)12%@.]&X4 +12%@!GK2;QC- #J*0,,9[4@D5NAH =129Y
MI-Z^M #J*:&!IV: "BC-% !1110 4444 %)2TE "&J5_T6KIJE?]%H JK3C3
M5IQH 0_=-6+'K5<_=-6+'K0!H4444 %%%% !1110 4444 %%%% !3)6V(7QG
M'-/IKG Z9H \J\2V49UB?5].FBCO%4[TF[UCG6!K&AJEU#Y;(WSNHPIKT?6?
M!6DZS>_:[EI%<]0AP*R/%GAZ*W\-16&G0_NRWS$#G% &%K5UHMSX0M+?3?*\
M]6'W?O9KG((-7M_$,4\[!2%&TR]*] \._#_2(+6&X?>9E^8J3T-=#JWAS3];
MME2Z79MX!7@T >6BWOKWQ!<SR2*T@B/^IZ5T'@K5='M-$FCODC$XE.1(/F-=
MCHWA73M#W- "[,,$OS5.\\ Z->WOVIE96SG"GB@#B_.BN?&$MQ;1_N]G [5;
MMXHWM[AGA57!)Z<UW%OX<TVUDWQIA@,4Z/1;.4.63!- 'E5NL0N5N;[/V028
MP>E=I>:]X?M]OV>%7E6+(,8K:NO">FWVG&T9?DSG(J*P\%Z3IRDQ*6)&"7YH
M \VOO$IUK1;EH(X8@C$8(^:G6I"> HY[I0^)AU^M=XWP]T)G:0*RACD@=,UH
M_P#"*:;+I7]GE#]F!SB@#@]8#W6HV4MHRA/L_(7Z58\&:AI=MINH6=^L:RL6
MP91R:[&W\*6-M=HZDD*, &JVI>!='U.X$S[HY <_+Q0!Y;+%/'I=Q&X)LFN,
MKZ8S74>*8+6/0],:"$(=J_,!S7<?\(UICZ4MA)&/*4YSWJ>[T.QO+>&VE3,<
M0 2@#SC6K':UEJ%G+&DR1<B7O6OX"\1&>.=+B-8P&^:0# -;VI>"[#5=@NF=
M1'PNTXXI;GPK;6N@-8:>NS<?O=Z -_=#,HE1PX'I7G_BOQ/%9Z_%901IYS#[
MT@X%=?H=A+IFGK;N2S8ZFJ>K>#=*UN8272D2C^): /,]+DN9?&)DNF0(5/\
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MM]O+,UUN&X@_+7JOA.ZEO_#EM-+]YEH VBP*_+3U^Z*:%"#FDC))- $E%%%
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M'8+C@9IT89U+,>#T->4ZSJ6O:KXO&DV1*VX[UH:5XBU>QOI=%U$_Z1TB;VH
M]#C=2Q195+>F:J7NMVFGS+!<N%D;H#WKS+7+K6=&@EO4O%-SY@VC=VJEXDCU
M+Q%>:1<I*4GV@N >M 'I\NHSOJ$4$0)BDYW#I6N%BC8 N X[9KSS^W[G1[^V
MM9E^0)\S'UK GU[6+ZXN[V&Y&R)_D /:@#V8MQR<5"KHY8]=OI7F%_XOU&]T
M6*.T;;=< FEM-0\2Z9J%G!>2*4N$R: /1;;6[":Z-JDJ^:.-N>:TZ\7\,Z5?
MR?$.:[FF/EJ_"YXKV@T %**2E% !1110 4444 %)2TE "&J5_P!%JZ:I7_1:
M *JTXTU:<: $/W35BQZU7/W35BQZT :%%%% !1110 4444 %%%% !1110 5%
M-OP-A YYJ6HIMORAL\GM0! ;BTB?=+,B-W#'%/WP3IYBO')&.X.0*\MUBSOM
M?^(<VE"9X[=4)&TXJ/[1J'AZ]N]%6X+*(R02>: /48Y[0R'9/&7'4*:66\L<
MB-[F-6[ M7EF@6US:^';G4I+AS.[$*6/ J1/#-YJ.A'5)+M_M,3;R0W&* /4
M6FCA3?<2JL>.&)XI(KNVE0_9YT<>H.:\?U'5=4U724;,CV<1VOLZUJ>'[NWA
ML;AK69U3RC^[D/S9H ]'-[9,VU[N(29Z;JL,Z)#OD=8QZMTKR'2/"]Y?Z'<Z
MM+=2?:8Y"R?-QBJ^J>,+RZT1;:]9@RML)0\D4 >P6UU:L_EV]PDI/7:<U)<7
M=K$PCGG2(GIN.,UXO8ZJ="ECN=/$Y5ERWF>M:]G:7?CJ_,EU.T:*,@*<<T =
M_K&OZ?I-O&\TRE6. 0:I2W]]>7<$EC.BVQ )R>U<'XR\.S6NAP0SW?F8F"C!
MYQ5^Z@FLKNPL[>5E#P#O[4 >FQ/%< .D@9E'S$&F32P)^_,@*C@D'@5YW8ZZ
MWAVTGL[AS]IF)"[CZUC:GJ^I:/9FUE=FCN6W9SS@T >O)<VMR-J7$;MZ*:EC
M;Y"&'3I7B=OJ+:-K-I+;&9A)C=N/%>MW^HM;Z)]MQR8\X]\4 6;B_M(,"XNH
MUSP%)YKGM3\13V&N16F0T$BY7%<GH/A^X\52SZI>W+J(Y,H >*GU."4>+;=7
MF5UCCPO- ';:7=W;"66]E3RL_+ST%::7]C,WEI<QECVW<UY--J=XNB7[)*V\
M2[5YZ4DWAV^TK2;?7/M;^8V#C=QS0!Z1+<WD6L);(X\MNU:+7%I!)M>Y17[@
MFO,[O7KF"^L[MB3(8^*71M"O?$S75]=73J0V5P>!0!Z=-/!'&)&GCC7^\3Q4
M#W\!M))+>X29@,_(<UQ6H62M"MKJ5]O@08Q&W-<KI%^NG>)38Z8\IM'!W>8:
M /1O#&O2ZU+=1MUB;%2Z_P")K309X;>9@&E]ZQOAT@6[U4]S)_6LCXE:1_:7
MB/3QO(Z<"@#T&"]M9;:.47*(CC.&-9BWE_)K"1+(K6A/4'M7"7.E37GB33[
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M [IVHQGG%&,#B@9H 80Q/'6D3S%!W]*><CD4 EAS0 SG'R]:<I('-+@ U'N
M;8.IH >&4TV0XHVB(;C3U(/.* &DX0'O29!/M2JRL2M1C:P*'@T /$@Z8XI/
M+"G<.]*K*5VXZ4\,.A% #% 4$9Y-*?DX'6EV#.:4LM $81D!]#UI^#LP.M.S
MQ2%OEXH CW*K -]ZE"XSSUI&10PD/)I?EE'I0 %2<'/ I_;--Y3 ZTI^;I0
M-\RXI%(V8'6G<JM(%"_,.IH 2,D YH7&^@')Z4KX SWH DS1FHC\\?H: /D
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MX% 'IN'2,L.]. X4D@9ZBN!D\?\ V2_#7,3K;$\9%9?BGQA?KXETQ;$-]DG
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M_P"(U(.E "&B/_6B@T1_ZT4 :H^X*=31]P4Z@ HHHH 444"B@ HHHH ****
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MM<_X:=I;W5(I8RH*GMP:]7U?P?IFJ70NI<QR=RO>GP^%+".)HXD 5A@MCDT
M<'=63S^ Q'I\.V5&).T=:YO8]UI,$%S&JR*W\(YKVZUTZWL[3[#"@*=R166G
M@O2EOOM )+YSM[4 3^&$\CP_$B[N .M;5OAAN!J,;+= GRHN, 4^ A6*?Q4
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M4 '&:6F]6IU !1110 4444 %%%% !24M)0 AJE?]%JZ:I7_1: *JTXTU:<:
M$/W35BQZU7/W35BQZT :%%%% !1110 4444 1RJ3C%!4%"!][%.)Q3<$G=2
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M;*(O*'0<5H01QP?$58[>$+$1U KJSI%K)>K=OM,T8P"*EAT^W^UFZV#S1WH
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MDE>]0QS#3=4T6]FC)M@@YQTKH?&/@B"YTJ1[2,>;OS@"MG3= CU#PU:V=_&
MT:8SCF@#C]4UN#6/'%L]O%OB5<;L5G3QJUAJX:/.9>!BO2]/\(Z9IT@D1 7
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MW'VJU\[E2WK4FT@9R3ZUY9-XIU^_-M::=&JEO2M7P_XQOHFO;;64VO;#KZT
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MP!?'K0!<CDW#:>M.V#.1P:A@.XC/!'6K% ";1NW=Z,<]:6B@!NWWXIIA1CR
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M*"2-V[D=/>@#DM+\*2K936U_(9A)V?FLU?A_))=;&D*P Y ':N\FN(HT,C.
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M1S_ZHT 9/\1J0=*C_B-2#I0 AHC_ -:*#1'_ *T4 :H^X*=31]P4Z@ HHHH
M444"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H%B99F<MP>
MU3U%*C,5P>E !SPI-,P&EQZ5,0=O'6F1(1DMUH EHHHH **** "HGRS$$<"I
M::^>,4 (IRO--7/FG-*RMQMIP'.: '4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH,N0?PJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D;I2T4
M-'3%-"X.33L<TN*   #I2T@&#2T %%%% !1110 4444 %%%% !1110 4444
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M$6.<+0!Y[;PR6EO*)MV'.5 Z59E*>3&0#G%>D#PQ:K:);8#[1C<>M-/A*S(
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MHH 3:,YI"@)S3J* &[,MG-(4!.:?10 TKD=:-GO3J* &E:4+BEHH 3 I:**
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>forms-1_018.jpg
<TEXT>
begin 644 forms-1_018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )L!3L# 2(  A$! Q$!_\0
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M<?YTG3DBHXJ!L\D]:",FJEK?17B P2*P]JNUD[HZH24E<0<4^F8I]!84444
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M%OGL4=D??K]:&0(,@9'UJ0*Q'$+-[@4U\@X=2OL:T]PSYIAY*!=S'&>V:84
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MBD)V\@5K%HSE%@'4YXYH';-( =A;%3?9I5A$CC"GI2<U>PU%V(VX/%(<CI2
M9/6G<55T1RL3FEQQ1D4F[M1=#U$!IW%&!2<4-I"LVP/M1@]Z,XZT;@>E":94
MDT@HI**H@6BDHH 44M(** %HI**8 :5AP*2E/05G/8TI[G8^ O\ 72_2O00
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M9IF#1@T .R?2C)J/#T8>@"0L:-QIF&H(:FM@8[/%4M4_Y!MQ_N&K6#574_\
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M'K62NYPT;,2JC-1QS#:0N5]Z:PK(>)[&_H6JQQ7%S9W&=CDX8=JGC\/P+?\
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M&T>E:?7)F7]GPL>6_P#"&ZK_ 'DH_P"$-U7^\E>H^6#VI?+I?6Y"67Q/+?\
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M#&*/KLBO[-1Y!_8.J_\ /!ORH_L'5?\ G@WY5Z]Y0]*/+'I3^NR)_LU'D/\
M8.J_\\&_*C^P=5_YX-^5>O>6/2CRAZ4?79!_9J/(/[ U0]8&_*C_ (1_4_\
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MZDSQ,D=EXHUA].TW='(JW!Z#UI_AW54O;!-\P:<C+C/2L+Q+#'<>&(+F7F8
M?/19E-,\)&]AA E9>6'4U7(FC+V\KZG6RZM812>7)=QAQVS5V":*YB\R)@5]
M17EVEG2Y[=I;]G:YDS@^E;/@;4)7O;JQ)<Q*25+5,Z=D=%&M=G=3,1 2.N*\
MP:/5=4UZZMX+LH WK7I<Q_=,N>U>6"ZNK;Q)<M9QEY%;E?6G22L3B)-O0M:A
M9:YX?5;V2[,L:GD9K7UK5)[KPA'>6SE)#R361>?V[XB=8)(###GYACK6OXAL
M_L7A5+< #:,&J:1S1;1L>&KM_P"P89KN7)(R235UO$&F"81FZ3=Z9K!T^!+S
MPI#%-)Y";<;P:Q=0AT6STQX(BTMR.1-WJ>2YLL1*)W5_J<5M8/=*XP!UKEO#
MGB'SIIVNK@*C-E<GM3/#[MJ/A&<7/S8! S57P;IUO=I<">%75'*C--1MN3*N
MY;$>I:G<:CK+6XO!%;AOD;/6NXT_99Z<NZXW #[Y-<*--L9/&:VC#Y!R%J[X
MEN'-];Z7;L8HR<''>G**9,:LH[G81ZWIS.(_M<;/Z U9EO(K=/,D8!#WKB]2
M\+VUOI336Y*W$:;B^:@@U"34_!TGFDEH?E+>M9^S1T?6&=D=<TY<'[7'EO>G
M'6+(.%^TIS[UQ?A#0[2YM'GG'FY/&3TJA/:)/XT%FF5A';-/V:#V\CT.+5[*
MXD:..Y0LO7!IIUK3Q,(?M"%_3->?>(K%-)U:&*T+(92 2#5CQ'I<6EZ-#=Q$
MF?();-'(@59]3TE7! *G(/>I :Q_#LS7&AVTK$DE:UA6,CMIRN/IU,I]0;!1
M113 **** "D[TM)WH BNO]0:REK5NO\ 4&LI>E #J=#_ *T?6F&G0_ZX4 :W
MI0O4T>E"]30 ZBBB@ HHHH 9WIIZU)36 I7LQ=#(UTXTR<XS\M<3X4LM-FAG
MDN$3)8\FNSU_Y=)N&'I7 ^'M#DU>&5DG:)-W:NJ&QX];FYA-<M;2RURS_LYQ
M\SC(2NGUOQ&='N+6+:6+*.*=I7@RWL;D32RF<KR-W8UD>- &URP3 ZBFVF*T
MHZFM9ZY>ZA'*\UJ%MU&3N'6G>'=8M]0GG6"W6!8^"P&*U[F-4TEE50 (^GX5
MQ7AMG%CJ17CJ!BDDF.<G'4W+_P 6F.[:VTZ(SLOWBO-/T?Q.U]=FTO(S%*>@
M/%9G@6.-8[EB 9R_)/6H/$95/$UF8?EEW#<11RH:JR-C5O%;:?J M#&<MPII
M+/7+VYM+JXO+;$4:G:I'WJP];C:?Q9:JX!4 =:[#445=&F'  CHLD+VDF8=G
MKIN/#MS=V=H(Y 2I0#M6+X4O;N'4)A''O68Y<^E:GA$8T._;=O!)Q4'@96-S
MJ'3&XXJDE9F;E)M,TX-;MG\1-9-:JD@'RR8ZFFW7B'58;J5/LA\M#UQU%9-J
MI?QM(&.[;R/:K_BO6F0"PM&S/(=I(%)1U-'4=B71O%TFI:PMEY>%QR:GU7Q:
MMG=-:V4+33*?FV\TWP_HG]FZ<\\R?Z0RD[NXKF](-ZNJWGV6,27&XXWTU%-A
M[221UVD>*%O;C[+<PM%-C.#71;0PYY%<"NEZ]=:Y!>7%O'$JGYRO<5WJG'':
ML963.JG)R6IY]XNGGU#6(=-1RD6><5N6_A73UM1"T0)*\MBN>\0E;7Q3%).2
M$+?>KN89XY+=761?+V]<U:9C42N<'!')X9\2I;1L1#*W>NCUGQ2-(U"*W9-R
MR+P1ZUSNL3)J'B^U,;;T1@#BI_%RH/$>G@J"..*JRZF7.X[%V7QE<VK*US;%
M(F/#$5/XGGCO/#?G?PN,YIGC%%_L)24!QC'M5"XD:3P.HZY&![52BB'4DQ-(
MU^>PT:-;2V:4*.2!71Z)XEBU<-'M,<R]0:I^#S#_ &*BHHR!AA6%IQ!\77ZP
M@J$!X%3**;*A6:6YO:IXJ-K=?9+2,S2^@YHTWQ8\UX+.\B,4C=,UD>#3#)K%
MZTPW3*QVENHIWC/8E]:/$"+@OU'7%'*GH:*L][G0:WX@;2W2&*,N[]*S!XON
M[>YCBN[=D#G@D57U+6?LLUK!';K/=.HP7[&L?7CJB3VTFH*@#,,8[4*"9$L3
M)'7Z[XC_ +(MH)40LLG6J]AXGO;Z[15M6^SL.6Q63XQPNBV2YX.W!KI[1!;^
M'XO*4 ^2#D?2DTBXU9M7,O4O&'DWWV6QMVF=?O;1G%<YJEW_ &IKMF9HVBF!
M'!K0\&%'U6]++F3>>33/$Z))XCM&0896&<522,YS;1L:YJT-C-9PS0K*7P 2
M.E3:UX@&CVT#[?E?L*PO%<9-[ITH.1D9!IWC!OW%@2 02*'$4*C+=SXPFCCB
MG%I*(3U;'%=!:ZO!<Z=]N!Q'C)K+U=5/A *%&"@K)L21X(G$3%F'2DH*US7V
MCBRY_P )A=7-TPM;9GA4XW 58TGQ6U[J)M73:0<4SP6$&A[65=V?FK'TS8?'
M<D8 ">U)Q#VK<CTE<$"IJKH3DC' [U8KG>YZL/A"BBBD4%)2TE !1110!5OO
M]76>G2K]]]RJ*?=H <>E+;?\?(I#TI;;_CY% &L.E!Z4#I0: $%*:**5@0W
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M<[37:X#8/2C:O)]:/:%?58[G'Z_X;GO;^*[LSL=1UK/O/"^JZEY;75P6,9!
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M!24M)0 4444 5+[[E44^[5Z^^Y5%/NT ./2EMO\ CY%(>E+;?\?(H UATH-
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MB.;=\JBM'Q:#)?:=E<L2 :GO/#&K7>I6]_<S!I$.<#I5_7-"O-0U&SE1@!&
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MX8TNTCI0*R8S:!3@!1M-)M-*P<J0 4Z@ @48-,(H**44$4% *6D%+0 4444
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M)O7U% #J*;O7U%&]?44 .HI-R^HHW+ZB@!:*3<OJ*-R^HH 6BDWKZBC>OJ*
M%HI-R^HHW+ZB@!:*3<OJ*-R^HH 6BDWKZBC>OJ* %HIN]?44;U]10 ZBD# G
M@TM !1110 4444 %%%% !24M)0 4444 5+[[E44^[5Z^^Y5%/NT ./2EMO\
MCY%(>E+;?\?(H UATH/:@=*#VH 6BBB@ HHHH **** "BBB@ HHHH **0D#J
M:3>OJ* '44W>OJ*7<OJ* %HI-R^HHW+ZB@!:*3<OJ*3>OJ* '8HIN]?44N]?
M44 +12;E]11N7U% "T4FY?44F]?44 .HIN]?44;U]10 ZBF[U]11O7U% #J*
M3<OJ*-R^HH 6BDW+ZBC<OJ* %HI-Z^HHWKZB@!:*3<OJ*-R^HH 6BDW+ZBC<
MOJ* %HI-Z^HHWKZB@!:*3>OJ*-Z^HH 6BDW*3C(I: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!K*IZBDV)Z4^DH ;Y:'M1Y2TZB@!OE+1Y2TZB@!OE
M+2>2M/I: (_)6CRUJ2DP* &>6M+Y2T[ HH ;Y2TGE+3Z!0 SR5H\M!VJ2B@!
MFQ/2CRT/:G44 -\I:/*6G44 -\I:/*6G44 -V)Z4;$]*=10 SRUH\M:?@48%
M #?*6CREIU% #/*6CR5IXI: (_+0=J78GI3Z2@!%50>!3J** "BBB@ HHHH
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M=Z (KK_4&LI>E:MU_J#64O2@!33H?]<*::=#_KA0!K>E"]31Z4+U- #J***
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M;7^H6 33+D@*^>1FJNO>)-<UF"^&B6>^R@!61Q_%2+I^OZM';Z/J<7DVMNX
MFQPX%$FF>(_#K7EEI<7F6]R<B3'"\4 0:?XJDTSPMINGV,(>\G)W!C]PU?\
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MO([13%>VT_E[U[UI^)=%UF6;3'M_-D@CC"/$C8Q[U1T3PEJMM8:G$IYED\U
M>OTH G'B_5+#3-/TLHK:G*FYF)JY'\07GT@000 ZNS;$A[$UD7_A6_:WL]3N
M8'DN8P5,2GFFGPZUAI4.J3C[+?Q/OC5N_M0!JVOBK6OM,^CZSIBI)Y'FD@]1
MZ4R/Q5<,D.G:'8@W$BEO+STK&@OM1\0>*I%F0B1K;8 *U(_"^K:')!JEE\]Q
M&A4P]VH [#P]=ZI=V;1ZS:""=/0]:X&ZU#5;#QQJ+Z;!YPCCRW/:NX\-C6GB
MDNM7(W2?=B[K69;>';Z/Q#JMZ&^2YBVJ* *-SXI2>"WNI[,&0#E<]#1:^--3
M$-U?75DL=A"=H(/4]JJ2>$=3-JT+9W%L@UH0^%;F[\+W>E7#&)W.58]Z *MA
MXZOEU"!=0ME^RW>=CJ<_2DM?&NJW>L;8+8"#S?+ ?CCUJAHWA:^34[.VDLY$
MMK<G=(YR&^E.U30=6N]5*I:O&ZR?)*G VT =SXFFNAX5O)+9=MP(B5V]N*XS
M0/$VM67A:PM9(3<ZK=D^4K=Q7=36=R?#+V:R9N?(*DGUQ7$P:'K\.E6E]''_
M *7IY(2/'+B@#;\-^)+^XU*;2M:M!!=1C<I'>L7XA6]]>Z_IL449DM0X+\XQ
M6EX<TC5KK6YM;U,>2\BX$1ZK6EKNE7=YJME-;G]TC@R>XH I:9XFN'TG4RMM
ML%@=D8]:S;KQQ<FRL5LH5:\N<[R3C;BJ=_H_B*POM3M[--UM>/N5O0>E17?@
MJ\CL;"Z2)Y)8<^9"IP>: &ZUK\NO:3:PW2>3=1RX9$/6N[N=3CT7PM#=-]]8
MP$![GTKB[;P=J'V.*Z6,Q2^9DQOR<5UOB#3$OO"ODW+^2\295CV:@#FQXS\0
MP7=H][IHCM+CG>.PJ0>,M2?4KR;[*/[+M1EI#_$:YR;6=5GN=+TNX ,07 EQ
MG?7767A>ZN],U"TN?W:S*"AH JKXMU^ K?76F!=.N#B,>WK2ZC\0VL]!^VQV
MP=Q<"(1^Q[U4BTSQ+JCVFD7'R6EHX)FQPZCM4L_@B=O%4I SIAA)$?K)ZT 2
M>)?$U[>:0$TN, E09'!^Z:YLSZ\%T:YN$+W9D^3GK71>&O">HVNB:K%=,3+,
MQ,>>WI2:;H.L7-[IDMT2$M)"2#Z4 ;7A;Q)>ZO<SV6HVPM[N)N@[BH];UZ+2
M?$R1+:AY/)+AJET/1[RV\5WU]<C]W)G8:J^)/#MU>ZZEU;\CR2M &5!XYUO;
M!?RV 6QF?:3Z<UVFL:H=-\/2:I%&7(C#[%&2<US%WX8U"7P?9V"-B:*3<1Z\
MUU5Q#<IX=$, 7STB  89&<4 <OX8\5:GJLS>?;(L;)O0$\_0BH-2\7ZSI<ZW
M5]91_93($"AN3[UEZ=X:U>ZUB6Y6.2QE"'<Y/RM]!5&Z\*Z[?Q/!+'+(XF#)
M,3\N : -F#7H-(UW6-7)+*\:E4)[FK.F>-]0MKU5U6W58K@;H=ASUJO-X+N]
M5^W17'[K=$H4^I%0Z+X7O9;R**>UD@-OPDTAR&Q0!;LO&>L7VNN(;1?)239M
M<XX]:[R\NGM[)YH8PTFW[I/&:\UU+PUJVHZU'"L#P21RA_M2'"L!7;^(K&^N
MO#3VUG+BYV@9'5N* .:C\7ZS::Q:6^H01HERQ"*K9J.Y\9>(+FXO'L-.5[:S
M)W-GTK#M_"NL3WVF7$UM-'):N2S.V=U=5I.A7UOHVL1AL2W)8A3[T ,G\:WN
MHP6=KI-H);V>+>Z_W:K?#F?4)]7UJ345*3 X,?I5?_A%M7TC[#J.F<W4<11U
MK9\$:9J5O?:C?:H-LMP<D4 =EG ! IW7G%&00,=*3'^U0!)1112 **** &,A
M)]N])L8' P5QQGUJ2BF!&49P-V,BF^6Q^]@YZU-10!''$8QM#$K[TH5LDYQ3
MZ* *M_80:E:-;7*!HV_2LO2/"UEI$K.@\YC]UY.67Z5O44 1[7\S.[Y<4C1,
MW&['N*EHH A6-P"I;CL>]+Y.2N6/R_K4M% $+1,TA9CD=@>U/VMP=W3M3Z*
M(RA)P#@>U* V?FP13Z* (C$6!R>>QIIMEDB\N0!E[@]ZGHH A2(QJ%0!0.@%
M.,()R.#[5)10!"\;R'#-\GM3@K@GG@=*DHH C,9QM0[1WQ3#'*S[2W[O'7OF
MIZ* (RC$8SD#UIOE,R_,>V,5-10!GV.DP:;N6U4*CMN;W-6O*;G.#SQ[5-10
M PJ^W ;)]Z:8?F#!CD5+10!&T9(XX--\CD$.<C]:FHH 9LX(P,&D\LE0&Y J
M2B@")HB_!/%"(Z J",=JEHH 8%8<\9/6D\H"3?GGTJ2B@!GE_/O)^;I6+JOA
M6QU:=9IBZN.ZGK6[10!2MM.BL[>."W41QQ]%7H?K5K:3P<8/6GT4 1[&#8XV
MXQ3D7:H%.HH *3O2TG>@"*Z_U!K*7I6K=?Z@UE+TH 4TZ'_7"FFG0_ZX4 :W
MI0O4T>E"]30 ZBBB@ HHHH ****5@"BBBBP$3!1,&R=V.E,EA\P'(QWR.M4_
M$-V^GZ%>W<0S+%$67ZUYM8ZOXEL[73]>NI]]O/\ >@)X S3 ]756:/:<8]JB
M,D,4HC,RJ[=$)ZUY5J?C2\N]0NI;21T2UVE47^*JVH-JOB+Q'87EC/)&Y0!H
MSP ?6@#V,X#!< '%,6$8)D^9CT![5Y=JWB_4['3Q;0D37<-R%F.>0G<U<OO&
M=Z4:>QP\/RKO;L30!Z0 RJ,L<^_:JVH7T.G6<ES<,%B4<FN!.HZ[X:NX+B_E
M$\=[PJD_=XK*N[C5-2T#4-5U"0_98G(6$'J* /5+*ZANK**ZC(,,@RK#O4_$
MN3T(Z8ZUYM\.]4NO$8@G3]Q86Z[/LYX)]\5O^+-7OM.DM=-TQ US>' 8]J .
MFN"L,!>1@8UY8MVJCI.O6^KM(+6-A#&=I8]":X.^O-:T^SOM%O9 XECR)<\@
MGTKH_AUI4NF>&/)EE\PNVX,>M '176HVEK&T[RJ1'PP!Z4^&\AO+2.\B;Y/X
M3ZUY(UEJKMXDD,VZ))L!2>E2Z)>:OX?CTV6:3SK.Y)W1L>$H ]>"[AOV@L1P
M:1@,?, 6'/->13>,+VXN+O4HKB18H"0D2=#7H6G:J^J>%OMVQHV: L<]0: -
M2::."![J;;M49Q4.F:M!J]B;NW)$62O->.>$;?5]>D\07U]JLWDVH?RX,\'&
M:AM?$VH6_@.QMK=O*DOKIHMPZH,]: /<I)$M[5I7VK$HW$BL_1]8LM;CF>RE
MWI&V&(/>O)O+UC0?%Z:3<ZM-=V4]MO='/<BN?LK*]TW2]8U6RU2:W$-X-L,9
M^5ESWH ]_NK^RLKF*&ZN8TEF_P!6C'K]*@U?0X-9-OYN<0-N'O7CGB>SG\0:
MYX2N7O9(Q=X)*GE,>E>M:]?G0?#;XE9I88P$<_Q&@"Y>:C::+'!#-PDC!5'O
M6DR;U )^4CIWKR#4+/5TNM&U#49C):SRJX!/W2:U/$^I:KI][)>?;>%<>7'$
M<\>] 'HWVF&*5;<R#<W"KWK(7PI:#6SJ;RR.XY 8\"N#1M1U3QAI>H+</'&P
M^9 >":FU_6=5TNYEU!KW>\;X%NARI'O0!ZBR!V#D;L=/2E\H_?/W^Y%94.IS
M3^$_[4*!)6MC)L'0'%<#;>(]<TWPK/K]Y)OCDDV(N>F30!ZGMWMC&,?Q=ZR;
MWPY:7VIQ:A+N\Z/[OH:X&Q\67NGWL'VN624W2[@O9<]*2"\\3RV\FL33E;:.
M<CRP?X: /5')= !G(/.VF20[SY>T 'N.U><'7-=\4W).D$0PPIEB#]XU%=>*
M];DT@6T<9,D7$TB<D4 >BWM\+%$62-I%/&5J6VNH9L1I*I?&=F>0*\\M=:N_
M^$;,K3B20\;&/S#\*R=!?4--U^[U$SO+BW+JC=,^E 'L$J%\#C'>H)]EM&92
M1Y:C[O\ A7FZ:AXBTZ&#Q-/+OLYC^\@!X7)I+35=7U;4M1ND?-G H94S0!Z/
MI]TFH0^<(RH!P-W6K(4#([DYP:\EE\9WM]'%ID1^S2E_F=>PJ[!XNU2ZT6YM
M((9'N;=MADQ\Q7UH ]. )^\O'I4E>>^ M1O;F>037C2H3RLQPX_"O0J "BBB
M@ I*6DH **** *E]]RJ*?=J]??<JBGW: ''I2VW_ !\BD/2EMO\ CY% &L.E
M![4#I0>U "T444 %%%% !1110!&^&R,X-5+F<VEN\XC9U4<@=35N3/.T?,>]
M9FMR21Z+>/&VV1(B: +5G>+=:>ER08T8<!^HJ=GPJ@GK7CMK-J6OW>FV#ZE)
M!%)$S'8>I'2NJ\ 7MS*;ZRO9VN);5B S>E '<(I3(S\I_B-($PV0P ]:\\OT
MO_%/B^>P34Y+&V@CW*(SRQK(O-9U:XTU]*-YY8AN1$;A3R10!ZTY=^(B&]2:
MJWFF6VHVDEG<?."/O'JOTKS6\O\ 4/ UT88KZ2^2Y3*[S]SBJ&EZ_?6E]:7:
M7<\TEQ(1)&_W0* /3M&\-V6B.?L_[QR/OORPK6! GVA@3CGUKS/1$U+4[W4;
M^\U.2!8F)5%/ %8^J:M_9=W;75GJMU/)/*%8'[HYH ]0N-<MEDN8E)EFMOO1
M)]XU>M;@3VJW&QHAC)5^HKR>*R-MJOB#48[^1;A51N3ZU?LIM1\4:FNG/J+V
MR11!V=3]^@#TX.>'/*GH1V%)D-\\9#KW]J\CO=:U6"R_LA+PD?:Q$)E/.WTK
M32/5= UUM/M[YIVFBWA9#P#B@#TAIE9]N[<.^WM]:D7+J,'H:\C\.7KKXDMU
MU/4+B&\DD(: _P"K<5Z^G3H,=L4 -\K#$@\FEVMDC.!3Z* (Q&0A&XDGN:01
M$*5W'!J6B@"$)(H"J<@>M!B8/E6QN^]4U% #2&P,&H+FT2[@>"8;HW'(-6:*
M .=T_P &Z;I][]I7?*P^ZLG(7Z5O",@;=W%244 1-&Q7:#A::L!08#$CWJ>B
M@!NT_E3=A*X.!GKBI** &A3MP333&3R#@BI** &D$@?SJ-HFS\IZ]<U-10!$
M\190,].F::R3;1M8 ^E3T4 1"-@=Q.6/6C8X_BR/>I:* &;6S]ZF^6P;<#S4
MM% $3QNR[0W!ZFFK"RX.>1^M3T4 1>65)96Y/K08V8_,>.]2T4 ,*= .@IAB
M8DX-344 %%)12 0R*'"'J:4L <&J9F!G: 3)YQ&5'<5*@8(HDY8=:; GW#UI
MIEC499U7ZG%,)QDKSCM7GOCZ-[G5+&U226,2N VQL4 >BK+&_P!R16_W3FG%
M@!G->9ZK87'@F^LKVPO':V8A)XI&R3GO6QJ7C^UM+M;>WL9+L  R/&>$SZT
M=GYBY(STH#J5R#Q7)ZEXRL]+@M_(C-W+/C$2=15:Z\?6]C8K<36$J,[^6(CU
MW4 =KO7'6@.IZ&N+N_'2VB1QK8/-=.,^2.JBKT?BNVET7[7:VKRS#[UN#\P-
M '3;U]: ZG.#TKC;3QW;3SW$-[9R6<L,7F%7[BETCQO%J5\L)L7B@*[A*>F*
M .Q+J"!GDTI8#J:X>X\?V]KJ$JBS>6U5@K7(/RK737%W!)HYN0V^%UW!E]Z
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M_ENOHWK7<T4 >=VO@K624TZYU$MI<9R$]:U-.\'2:9-J)AN/DNEVA?2NPHH
M\WN_AS*MNDT$^ZZ#9S6C8>$=3L-)D6&_5;USN\S;V_NUV]% ' ^'_!=[:ZZ-
M:O)SYR\>4. ?>N^'2BB@ HHHH *2EI* "BBB@"I??<JBGW:O7WW*HI]V@!QZ
M4MM_Q\BD/2EMO^/D4 :PZ4'M0.E![4 +1110 4444 %%%% $;HQ.0V*J:C8?
M;[*:U/ E0J6J_10!R&F>!X-.N[:99,^2A4?C5_1_#8T:XN)H9-S2L2WO7044
M <;KO@F34M0-_87S6%PXVN5[BN?\4^%/)TRSTS3]PG,JR33]V;UKU!USCFHF
MC20[GC!(Z&@#EM*\$1(LTFJ7)OGF4 %OX?I5:R\ -;WZ227N^WC8E8]M=LN,
M#M[4^@#GK7PK#:VU_;B0F.[!!]LUS</PR>'R8FU'S+:)]RQE>GXUZ+10!QT_
M@837EU-]I(2X #+]*;>>!-T<9L+PVTZC#2#N*[.B@#C(_A]:)80P^<3,DPF:
M4]6-:-[X62^UA-0DF.Y$V@#^==%10!PT'@&1]6BO+^^\]8&W1 #!%=PHPH&,
M8XI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9'K1D>M0E=K$@_,>@-(S8C)E(15&2: )\@]Z P)P#5>":*X0/;N'4<9!H6>
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M9;>VL=+\@OO#'<:I/I6M^)KIM2OHQ$84*Q)C%1W&CZWI*:=?VBAGC#+*,>M
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M@+7I[66SDN$D02!@[<GK0 LVL_V+XGO]:DR[2VBL!_<R*=IGC/4;6>":ZO\
M[>MUS' %QMS6M)X'FN[JX-],I\RV$2@=,BJ>D^"M3CNXUF\D16_$9QS0!7B\
M6:S=>))83.;:-7 %NPZCZUW.OWTVE>'9+NV.9%4$#U-<CJ_A+7=3O@K2PQ0A
MPQD488@>]=?J6D/>^'3IL$G)0+O- '$+XHU?3/#XU+4I<S7I\N'_ *9^]&F^
M-+JQNGL+VX-W.\!D6XQ@ ^E;&I>#9=1\,6VE^<OVBV;<"W>LRW\+W]O:WMYJ
MGDD10,J;1R>* *J:[XHBL8-:O6Q9;\$>Q->F6LQN+.*XS\KH&'XUY=X?TCQ%
MXB\,PV5W,B:>),H".< UZG!&L5K%#&1MC0+^0H L(!M!'>G4U&#+P<TZ@!#1
M0:* &R$*A8G '-5(-0M[N0QI(I8=@:MR*'C*'H1@UY1XBTG4?"6OIK>G22RV
MC-F9,Y %!+/4I9%@1I'<*BC)).*\MU[Q+?\ BS6UT;P]N,*MB:4=!5?5?%-W
MX\NH])TA9([9L":1>WK7?^&/#=MX<L!%$B^<1AGQR?K0(NZ38/I]A%9RS&4H
M.7/K6K46 #D?>-2T%(*6DI:!A1110 4444 %%%% !1110!"3B9@.I]>E5[G4
M;73D_P!*G2+/=C5F5@"!_%VKA/&NIZ<FI6]G<V_GSOTC8X7\Z .N_M6R,/VA
M;F%[<G!=6[U)-<6L"(9)E7*ED!/6O$+!Y'M-6M0C0(ER#Y:G(4?6NLUG4;/4
M=5\/V,4Y<>60[*?:@#JM"\8:?KEO=2[U3[*Y60D\8%:=IJ^GZDI:VN8I549P
M#R/>O)H8+2UTYH(LQ![MA<X[IGO5_4H+'3M5SX?)4-:$.J-D8]: /2AKFF"4
M0_VA 6/7YAQ3[?4K*ZE9+>\BD$?+8;.*\BGT&R'@N*\"N+EY@#(&.2,\UL"V
ML]%U;_1D>*V,*F0@Y+'% 'H,.MZ9<7+0"\A,HXVAN:S=+\6V6HZY<Z>CC?;D
M@DUY=JM];R7VEW%A9"#==[3*K<O]15Z[BATY-4ELE8:C+)D[>N* /5X-5T^[
MN7MX+N.2;^ZK9(K.U[Q%9:+I]R1=Q&[B&0C-S7E^G)>1W=C/I\"P7!4EV#Y+
MGW%6I;;1+SPSJ<VMLW]I@G+$\CF@#U+0K^74](AOIU"22+D$=*&U>P6Z%N;R
M 7'0?-69X:?S/!$";V51#A7QSCUKSORH])OI;B> 72O*"DN_Y@<^E 'K=UJM
MA:2Q1WMW%',WW06I;S4;'3T$]Q<I'')]W)X^M>-S27&HZMJ<EU:"8JHV>8VW
MR_3%:3:E;QZ9:6&K1M=WA;Y8W.%"]N: /5H]1LGM?M(NX6A YD#=*A_MK3WM
M'N%O(A&O\9;@UXW8S.=#O[8H41KG"Q!L@#ZUNWNGV-KJ.A6MP&CTR2+-PN?E
M+>YH ZOQ!XM33M/@NK"2.9)&P[*<A:V=,U>RU&"-K6ZCDEV!G1#FO.O$ZZ/]
MB_LW205MV(WXY!Y[&K-EI]GHOB_3UTT-$LD"AUSP: .O\0>*K'PVD'G']Y<2
M!0/K5Z75].M&1KJ]B5I0"H9NE<E\1[>SN+C3$N(0<W"_O.PK,MK32;KQ-K$>
ML >5#&/LV]L#IVH ]'GU*TM8$N'N(U@;H^>#69JWB"&RT::_TZ5+LKSA3FO,
M-()N[FTM-3ED_LI9V$6[@,/3-:=W]FT[4KV'0\FPV'>N<KNH [RU\163Z/:7
M]]/'$9UR4)Z&M1[^RM[83RW,21$960MP:\>NM/)@M+SBZ 7+P.VT*/:DU;4I
M-3N='B@M6;34R&B<X!_&@#TS5_%6FZ5HYU5I4DC)VAE-:6DWT>IZ9%?6S;EE
M7< :\=DMGDL]2$L'_$M5?W<0.0IKU7PQ]GA\,Z>]N,)Y0! ]: -I2^SD#=3C
MRF&QFGKR <4FQ<YQS0 P##$#TIJ9W%B<8J? I-HQC% %&ZLK74(S%<6ZS*>H
M>H['2+#22SVELD)/7:*T@ !Q00",$<4 1J6'4  TH7#9)I^T<<=*"H/:@!H7
M#9I]&** "BBB@ HHHH **** "D[TM)WH BNO]0:REZ5JW7^H-92]* %-.A_U
MPIIIT/\ KA0!K>E"]31Z4+U- #J*** "BBB@",\DXHP#_6GX%&T#M2 1%"K@
M=*=0!BB@"O>7$5I:RW$[!8HUW,37,3^,;$7MD(I$:TG&2X/ K3\76XNO"VHQ
M,=J^2QS7E%OH5O+8^'K*&XP)AEQN]Z8'M$%Q'<H&M9$DB/4@TD=];7$CQP7$
M;LGWE4]*\IN[V[\+S:W:V<[LL:+Y:#G;ZU4TZYO;2]TN\LB,W+CSQNZYH ]D
M$R$%V?8 ,<U%:SP2NPM[E)B#\P!R17+_ !!E>+0(42<PRRS*-R]AZ5SSV4OA
M/7+"2VNFD^UP%G!/4XH ]--[;K<F$W">8>D>>:9A) T9E7>IW%0>GUKQ.+4;
M^[MKC402NHQS$*2W49J_XSU*^TBXTJ[M;IR^H1K'=*G/E@]6H ]0D\1:;!J4
M.G2W$0ED&5&>#5G4]2ATNREO)CE%'3U^E>9W?A^S_P"$QT-5N!,/)WB4M]ZN
MB^)CW47@YWMEW-N51CM[T /TCQI<W>I);WEA)#!,<1-MZ_6NON)#$H9610#R
M6]*\RM_MFA7^AR2:B-26]VJ8L#]UP*Z#XC-)]@L+>*=H6FN0A(]* .F-[9["
MXNT*9Y8'A:F-S%Y1E\Q#$!P^>*\I;0)+?Q4^D#47-M)"9&3/?%1VUU<S6UEH
MLUTT5J92KS$]!F@#UN.YANH=\<L<B=R#3%O+5I?)2XC9O[@/->7Z@TWAR[O[
M33[PSP&V!X;.P^M0R:1+I>BZ5K,6H.;NYD57.>H)H [G4/&&G16EYY$@:2T<
M*ZCK6II>K1:E:1R13Q%V&2@/->6/I<*IXCE#A90ZX^;KFI(-*ET230IH+QA)
M>,1(<T >KM>6RS^7).BS'@)GFIG,B8V@>]>/7;76F:VLNKSC8+C,<Z-DD>F*
M]=L9Q=VL<P^XZ@KGN* )<$MD8/H:1D8\^8?I4JHJ]!2[1Z4 0E\ 87)%",V6
M)(YZ>U3;1GI2>6HSQUH @;<7RI((H!PX=.2W! [58(![4BQJGW1B@"-^4(Z\
M\T1D<9&,]/:I=H]*"H)SB@"%PP.$/)ZGTIFYO-P.@'YFK.T>E&U?2@"'.!N/
M4]0*807(&/D7L>]6 B@YQ3L4 5B['#+]P\-[4_=^]Q@;<=:DV+M*XX-&Q<8Q
MQ0!&22<EL>F*0@^7M!.3WJ7RUR#CITIU $ !0*J_,?6GE,MG@CN*>% .0*
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M@/DR=0QR35NQTZ/3K5;:S4QPIT5N:T%B4#'7W-+M&: %7[HI: ,"B@ HHHH
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MZ5JW7^H-92]* %-.A_UPIIIT/^N% &MZ4+U-'I0O4T .HHHH **** "BBB@
MHHHH ***,TK@%%!I,TP%HI"32;J '44FZDS2N*XZC--+447&.S1249I@+13=
MWM2@YH 6BDS03[4 +12;O:@&@!:*** "BC-&: "BBB@ HHHH **** "BBC-
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M$.M22WTKM&56,XVGO5\:M%Y;MC#KU6H9=)F;SI$VB5FRM1)H=PTIEE9=S?>
MZ4] U)7U^.,9\DNX&2!V%6K35H[R0($*$KD9J&32'>:>1-H+Q[14EOI;PSP2
M$C")AO<U#L/4HZEJ<\-TL2S+M[BK*ZNJPQ%HR97X8?W:9<Z&US=/(Y 4G*XI
MCZ9>B1RNS=(-I]A35@U+<NJ0V[*CD!6_BJIJ&L^5L%LN1G!<56E\/W4SB*1P
M8AW[YIYT:]CM_L\90IG()ZU6@:EI]?AA0>8FYN]2Q:M#<1NRJ4:,;L5"-%)@
M*L%+Y!S3;K2ILR30[5R@7%+0-20:];F$2A29"=H6K]A?+>*P(VNO4>E<O/I-
MQ9PP2X!FWY [5T.E6,\ FFN"OF2G.!VJ96'&YIC &:4=*8%;8 :?G J2Q:*0
M'-('!S0 ZBDW>U (/0T +1110 4444 %%(3CM2B@ HII;':E#9&>E "T4=:*
M $[TO:D-+2 80=PQ5>Z++:R,#SCBK!ZTCH&4JP^4TT)G/PZA'I]@;NXRV6Q@
M55;QYIJOL9'_ "JY=64EO.7:-9;8_P !I\&G:5>#/V!0WJ5JM"+.Y67Q?8.N
MX*V/I5@>)+<P^;Y;;!WJ_'I-BB;?LL7Y4Y=-M0"ODKM],4[HEIW,)?'-A(YC
MC1F8=L5N:;J(OX]WEE:B/A_3/,$@MD5O85H1P1Q+B-0H]JEV-5L/)['FG#I3
M=N.G6G4AA1110 4G>EI.] $5U_J#64O2M6Z_U!K*7I0 IIT/^N%--.A_UPH
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M>,;&6.W5[:,$;P/N4 07WCY[:\,-K:/*(AFX('"^M7M0\;VT%A;26$1N+NX
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MYPEW<I$Q_O5>8G!(%>2_%($ZK!GIBD]#&I)H]%_X2C1O^@A%^='_  E&C_\
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M9B_OUB[O<T;O<TQFWNB_OC\Z-T7]\?G6'G_:-&?]HT6 W=T7_/3]:-T7]_\
M6L3G^\:.?[QH'<VLP_WQ^=)^Y_OC\ZQ<_P"T:,^YH"YM?N?[X_.C]S_?'YUB
M[O<T;O<T6 V\Q?WQ^=&8O[X_.L3=_M&DW'^\:+ ;FZ+^_P#K2[H_[_ZUAAB?
MXC2Y/]ZBP7-LM$?X_P!:3,7]_P#6L7)_O4;O]HT!<VLQ?W_UI%"[N&K&W''W
MC5FRW[_F-(9J\#K3J;QZ4Z@ HHHH *3O2TG>@"*Z_P!0:REZ5JW7^H-92]*
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MG:PJFHHIIM!GTI,TN,4F*2U,]@SS2X %&,\=Z/*8<G(^M/5!=,0%B<=J4D=
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M:/L(_P">M4M[^IHWOZFG85R[]B'_ #U%'V)?^>HJEO;U-&YO4TK#N7?L2_\
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MDX':NQM6(29B.TCRLS_>)Y%,W'=P,&K,\+,3*G.[FH_*D*\K@UFFC2S$::0
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MX^12'I2VW_'R* -8=*#VH'2@]J %HHHH **** "BBB@ HHHH **** "BBB@
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M>:Y?3[&>U3$[LWX5J>7(T8VH<4 I&D-6@)QS2'4XMW S[UD&"7/^KH\AV21
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M%/NU>OON513[M #CTI;;_CY%(>E+;?\ 'R* -8=*#VH'2@]J %HHHH ****
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M_P#A.K?_ )X-1_PG5O\ \\&K@]RTN]:/JM(EXVL=Y_PG%O\ \^[4?\)Q;_\
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MDO#Q.,_X5_IGJ:=_P@.F =Z[' HP*?M9=Q?5HG'?\(%IGO2CP'I@[&NPP*3
MH]K+N2\-$Y#_ (073/0TH\"Z;_=-=;@4H H]K+N'U6!R7_"#:;_=-!\#:;_=
M-==@4F!1[:7<?U6!R/\ P@^F^AI?^$(T[^Z:ZW HP*?MI=R?JL#DO^$)T[^[
M2_\ "%:?_=KK,"C:*/;2[B^J0.4_X0RQ]#1_PAECZ&NKP*,"CVTNX?4X'*_\
M(=9>E+_PA]EZ5U6T4;1Z4>WEW#ZE3['*_P#"'V?I2?\ "'V?I758%)@4_;S[
MD_4J?8Y;_A$++T-+_P (C9>AKJ,"C I>VEW%]2I]CF!X3LUZ"E_X1:T]*Z;
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,0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>onmd-20240930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaqDabP9z5Z86ekhvWB0bQmK7yIjsXtHMi7W8RYGAaMC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ONMD="http://onemednet.com/20240930" elementFormDefault="qualified" targetNamespace="http://onemednet.com/20240930">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://onemednet.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" id="StatementsOfChangesInTemporaryEquityAndStockholdersDeficit">
          <link:definition>00000005 - Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
          <link:definition>999007 - Disclosure - Description of Business</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>999008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CryptoAssetsHeld" id="CryptoAssetsHeld">
          <link:definition>999009 - Disclosure - Crypto Assets Held</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ConvertibleDebt" id="ConvertibleDebt">
          <link:definition>999010 - Disclosure - Convertible Debt</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/LineOfCredit" id="LineOfCredit">
          <link:definition>999011 - Disclosure - Line of Credit</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba" id="CanadianEmergencyBusinessAccountCeba">
          <link:definition>999012 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StockholdersDeficit" id="StockholdersDeficit">
          <link:definition>999013 - Disclosure - Stockholders&#8217; Deficit</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/NetLossPerShare" id="NetLossPerShare">
          <link:definition>999014 - Disclosure - Net Loss per Share</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/Stock-basedCompensation" id="Stock-basedCompensation">
          <link:definition>999015 - Disclosure - Stock-Based Compensation</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StockWarrants" id="StockWarrants">
          <link:definition>999016 - Disclosure - Stock Warrants</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/FairValueMeasurements" id="FairValueMeasurements">
          <link:definition>999017 - Disclosure - Fair Value Measurements</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>999018 - Disclosure - Related Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>999019 - Disclosure - Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>999020 - Disclosure - Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/BusinessCombination" id="BusinessCombination">
          <link:definition>999021 - Disclosure - Business Combination</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>999022 - Disclosure - Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>999023 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba" id="CanadianEmergencyBusinessLoanActCeba">
          <link:definition>999024 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>999025 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CryptoAssetsHeldTables" id="CryptoAssetsHeldTables">
          <link:definition>999026 - Disclosure - Crypto Assets Held (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/NetLossPerShareTables" id="NetLossPerShareTables">
          <link:definition>999027 - Disclosure - Net Loss per Share (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/Stock-basedCompensationTables" id="Stock-basedCompensationTables">
          <link:definition>999028 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StockWarrantsTables" id="StockWarrantsTables">
          <link:definition>999029 - Disclosure - Stock Warrants (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
          <link:definition>999030 - Disclosure - Fair Value Measurements (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
          <link:definition>999031 - Disclosure - Related Party Transactions (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/SubsequentEventsTables" id="SubsequentEventsTables">
          <link:definition>999032 - Disclosure - Subsequent Events (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/BusinessCombinationTables" id="BusinessCombinationTables">
          <link:definition>999033 - Disclosure - Business Combination (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>999034 - Disclosure - Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>999035 - Disclosure - Income Taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative" id="DescriptionOfBusinessDetailsNarrative">
          <link:definition>999036 - Disclosure - Description of Business (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>999037 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails" id="ScheduleOfCryptoAssetsHeldDetails">
          <link:definition>999038 - Disclosure - Schedule of Crypto Assets Held (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" id="ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails">
          <link:definition>999039 - Disclosure - Schedule of Crypto Assets Reconciliation of Fair Values (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative" id="CryptoAssetsHeldDetailsNarrative">
          <link:definition>999040 - Disclosure - Crypto Assets Held (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ConvertibleDebtDetailsNarrative" id="ConvertibleDebtDetailsNarrative">
          <link:definition>999041 - Disclosure - Convertible Debt (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/LineOfCreditDetailsNarrative" id="LineOfCreditDetailsNarrative">
          <link:definition>999042 - Disclosure - Line of Credit (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative" id="CanadianEmergencyBusinessAccountCebaDetailsNarrative">
          <link:definition>999043 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;) (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StockholdersDeficitDetailsNarrative" id="StockholdersDeficitDetailsNarrative">
          <link:definition>999044 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" id="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails">
          <link:definition>999045 - Disclosure - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails" id="ScheduleOfStock-basedCompensationExpenseDetails">
          <link:definition>999046 - Disclosure - Schedule of Stock-based Compensation Expense (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/Stock-basedCompensationDetailsNarrative" id="Stock-basedCompensationDetailsNarrative">
          <link:definition>999047 - Disclosure - Stock-Based Compensation (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails" id="ScheduleOfWarrantsOutstandingDetails">
          <link:definition>999048 - Disclosure - Schedule of Warrants Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/StockWarrantsDetailsNarrative" id="StockWarrantsDetailsNarrative">
          <link:definition>999049 - Disclosure - Stock Warrants (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" id="ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails">
          <link:definition>999050 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" id="ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails">
          <link:definition>999051 - Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails" id="ScheduleOfFairValueAssumptionsAndValuationDetails">
          <link:definition>999052 - Disclosure - Schedule of Fair Value Assumptions and Valuation (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails" id="ScheduleOfShareholderLoansOutstandingDetails">
          <link:definition>999053 - Disclosure - Schedule of Shareholder Loans Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>999054 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
          <link:definition>999055 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails" id="ScheduleOfRestatementOfBalanceSheetDetails">
          <link:definition>999056 - Disclosure - Schedule of Restatement of Balance Sheet (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" id="ScheduleOfRestatementOfBalanceSheetDetailsParenthetical">
          <link:definition>999057 - Disclosure - Schedule of Restatement of Balance Sheet (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" id="ScheduleOfOriginalAndRestatedStatementOfOperationsDetails">
          <link:definition>999058 - Disclosure - Schedule of the Original and Restated Statement of Operations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" id="ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails">
          <link:definition>999059 - Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" id="ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails">
          <link:definition>999060 - Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" id="ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails">
          <link:definition>999061 - Disclosure - Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>999062 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails" id="ScheduleOfBusinessCombinationLiabilitiesDetails">
          <link:definition>999063 - Disclosure - Schedule of Business Combination Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/BusinessCombinationDetailsNarrative" id="BusinessCombinationDetailsNarrative">
          <link:definition>999064 - Disclosure - Business Combination (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>999065 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>999066 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" id="ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails">
          <link:definition>999067 - Disclosure - Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails" id="ScheduleOfIncomeTaxProvisionDetails">
          <link:definition>999068 - Disclosure - Schedule of Income Tax Provision (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails" id="ScheduleOfReconciliationOfIncomeTaxBenefitDetails">
          <link:definition>999069 - Disclosure - Schedule of Reconciliation of Income Tax Benefit (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" id="ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
          <link:definition>999070 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>999071 - Disclosure - Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails" id="ScheduleOfOptionsOutstandingDetails">
          <link:definition>999072 - Disclosure - Schedule of Options Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails" id="ScheduleOfFairValueOfStockOptionsDetails">
          <link:definition>999073 - Disclosure - Schedule of Fair Value of Stock Options (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails" id="ScheduleOfRestrictedStockAwardActivityDetails">
          <link:definition>999074 - Disclosure - Schedule of Restricted Stock Award Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" id="ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails">
          <link:definition>999075 - Disclosure -  Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative" id="CanadianEmergencyBusinessLoanActCebaDetailsNarrative">
          <link:definition>999076 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;) (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="onmd-20240930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="onmd-20240930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="onmd-20240930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="onmd-20240930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="ONMD_RestatedMember" name="RestatedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_SeriesATwoPreferredStockMember" name="SeriesATwoPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_SeriesAOnePreferredStockMember" name="SeriesAOnePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_SubscriptionRevenueMember" name="SubscriptionRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_WebImagingRevenueMember" name="WebImagingRevenueMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_TemporaryEquityMember" name="TemporaryEquityMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_OneCustomerMember" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_TwoCustomersMember" name="TwoCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ThreeCustomersMember" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BitcoinMember" name="BitcoinMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConvertibleNotesWarrantsMember" name="ConvertibleNotesWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DataKnightsAcquisitionCorpMember" name="DataKnightsAcquisitionCorpMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_HelenaTerminationAgreementMember" name="HelenaTerminationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StandbyEquityPurchaseAgreementMember" name="StandbyEquityPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_YorkvilleNoteMember" name="YorkvilleNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BeneficialOwnershipMember" name="BeneficialOwnershipMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConvertiblePromissoryNotesMember" name="ConvertiblePromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_TwentyTwentyTwoNotesMember" name="TwentyTwentyTwoNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_TwentyTwentyThreeNotesMember" name="TwentyTwentyThreeNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" name="TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BOCBankMember" name="BOCBankMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CEBALoanMember" name="CEBALoanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockRepurchaseAgreementMember" name="StockRepurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_JulyTwoThousandTwentyFourFinancingMember" name="JulyTwoThousandTwentyFourFinancingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PrefundedWarrantsMember" name="PrefundedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_SeptemberTwoThousandTwentyFourFinancingMember" name="SeptemberTwoThousandTwentyFourFinancingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_OptionsToPurchaseCommonStockMember" name="OptionsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_UnvestedRestrictedStockUnitsAndAwardsMember" name="UnvestedRestrictedStockUnitsAndAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConvertiblePromissoryNoteMember" name="ConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EquityIncentivePlanMember" name="EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EmployeesDirectorsAndConsultantsMember" name="EmployeesDirectorsAndConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_NewEquityIncentivePlanMember" name="NewEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_LiabilityClassifiedWarrantsMember" name="LiabilityClassifiedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationWarrantsMember" name="BusinessCombinationWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PIPEWarrantsMember" name="PIPEWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EquityClassifiedWarrantsMember" name="EquityClassifiedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PublicWarrantsMember" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PrivatePlacementWarrantsMember" name="PrivatePlacementWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_LegacyONMDWarrantsMember" name="LegacyONMDWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConvertiblePromissoryNoteWarrantsMember" name="ConvertiblePromissoryNoteWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConvertiblePromissoryNotesWarrantsMember" name="ConvertiblePromissoryNotesWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_TwentyTwentyOneServiceMember" name="TwentyTwentyOneServiceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_TwentyTwentyTwoServiceMember" name="TwentyTwentyTwoServiceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PrivateWarrantsMember" name="PrivateWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PIPENotesMember" name="PIPENotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_YorkvilleStandbyEquityPurchaseAgreementMember" name="YorkvilleStandbyEquityPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConvertiblePromissoryNotesAndWarrantsMember" name="ConvertiblePromissoryNotesAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DataKnightsMember" name="DataKnightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ShareholderLoansMember" name="ShareholderLoansMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_MsCoonseMcCrawMember" name="MsCoonseMcCrawMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_MrClarkeMember" name="MrClarkeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EFHuttonMember" name="EFHuttonMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_KingwoodCapitalPartnersLLCMember" name="KingwoodCapitalPartnersLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ReclassificationAdjustmentMember" name="ReclassificationAdjustmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CommitmentMember" name="CommitmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_AsRestatedMember" name="AsRestatedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomersMember" name="CustomersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomerThreeMember" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomerFourMember" name="CustomerFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomerFiveMember" name="CustomerFiveMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomerSixMember" name="CustomerSixMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CustomerSevenMember" name="CustomerSevenMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationMember" name="BusinessCombinationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_FurnitureAndEquipmentMember" name="FurnitureAndEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PIPENotesAndWarrantsMember" name="PIPENotesAndWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DeferredCostsNonCurrent" name="DeferredCostsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_YorkvilleNotesPayableCurrent" name="YorkvilleNotesPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DeferredUnderwriterFeePayableCurrent" name="DeferredUnderwriterFeePayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" name="FairValueAdjustmentOfPrivateInvestmentInPublicEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_GainLossOnFairValueOfYorkvilleNote" name="GainLossOnFairValueOfYorkvilleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" name="FairValueAdjustmentOfConvertiblePromissoryNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" name="StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" name="StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" name="StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" name="StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" name="StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" name="RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" name="RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" name="StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueWarrantsExercised" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" name="StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" name="StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" name="StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" name="StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" name="StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" name="StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockWarrantExpense" name="StockWarrantExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_WarrantExpense" name="WarrantExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ChangeInFairValueOfYorkvilleNote" name="ChangeInFairValueOfYorkvilleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_NoncashInterest" name="NoncashInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" name="ChangeInFairValueOfConvertiblePromissoryNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromIssuanceOfShareholderLoans" name="ProceedsFromIssuanceOfShareholderLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_RepaymentForCommonStockRepurchase" name="RepaymentForCommonStockRepurchase" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_RepaymentOfDeferredUnderwriterFees" name="RepaymentOfDeferredUnderwriterFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationCosts" name="BusinessCombinationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" name="CommonSharesRelatedToConvertiblePromissoryNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CommonSharesIssuedToDataKnightsShareholders" name="CommonSharesIssuedToDataKnightsShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" name="IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" name="ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DisclosureStockWarrantsAbstract" name="DisclosureStockWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockWarrantsDisclosureTextBlock" name="StockWarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_RestatementToFinancialStatementsPolicyTextBlock" name="RestatementToFinancialStatementsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_OperatingSegmentsPolicyTextBlock" name="OperatingSegmentsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_FairValueOptionOfAccountingPolicyTextBlock" name="FairValueOptionOfAccountingPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_WarrantPolicyTextBlock" name="WarrantPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PatentsAndTrademarksPolicyTextBlock" name="PatentsAndTrademarksPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" name="RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CryptoCash" name="CryptoCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_FloorPricePerShare" name="FloorPricePerShare" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PrecentageOfOutstandingCommonStock" name="PrecentageOfOutstandingCommonStock" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DebtInstrumentInterestRateDefaultPercentage" name="DebtInstrumentInterestRateDefaultPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EquityFinancingDescription" name="EquityFinancingDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" name="BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesTransferred" name="StockIssuedDuringPeriodSharesTransferred" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_VolumeWeightedAveragePrice" name="VolumeWeightedAveragePrice" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_VolumeWeightedAveragePriceValue" name="VolumeWeightedAveragePriceValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash" name="StockRepurchasedDuringPeriodValueExchangeForCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" name="PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockholdersDeficitDescription" name="StockholdersDeficitDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CashStructuringFee" name="CashStructuringFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ChangeInFairValueOfWarrants" name="ChangeInFairValueOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_LoanExtension" name="LoanExtension" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ExciseTaxCurrent" name="ExciseTaxCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_LoanExtensionsCurrent" name="LoanExtensionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CanadaEmergencyBusinessLoanAct" name="CanadaEmergencyBusinessLoanAct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_AccruedInterestRelatedParty" name="AccruedInterestRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DeferredUnderwriterFeePayableNonCurrent" name="DeferredUnderwriterFeePayableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_WorkingCapitalLoan" name="WorkingCapitalLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_WarrantLiabilityNonCurrent" name="WarrantLiabilityNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_IncomeTaxProvision" name="IncomeTaxProvision" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_UnrealizedGainLoss" name="UnrealizedGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationCost" name="BusinessCombinationCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CashHeldInTrustAccount" name="CashHeldInTrustAccount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockWarrantExpenses" name="StockWarrantExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ChangeInFairValueOfWarrantLiabilities" name="ChangeInFairValueOfWarrantLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ChangeInFairValueOfPipeNotes" name="ChangeInFairValueOfPipeNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_IncreaseDecreaseInExerciseTaxLiability" name="IncreaseDecreaseInExerciseTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_IncreaseDecreaseInExtensionLoan" name="IncreaseDecreaseInExtensionLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_IncreaseDecreaseFranchiseTaxPayable" name="IncreaseDecreaseFranchiseTaxPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_IncreaseDecreaseInWorkingCapitalLoan" name="IncreaseDecreaseInWorkingCapitalLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct" name="ProceedsFromCanadaEmergencyBusinessLoanAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromCommonStockSubjectToRedemption" name="ProceedsFromCommonStockSubjectToRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromDeferredUnderwritingFee" name="ProceedsFromDeferredUnderwritingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromWarrantLiability" name="ProceedsFromWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProccedsFromRetainedEarningsAdjustment" name="ProccedsFromRetainedEarningsAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" name="ProceedsFromIssuanceOfSeriesA2PreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CommonSharesIssuedToPreferredShareholders" name="CommonSharesIssuedToPreferredShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" name="StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" name="StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" name="StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" name="StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CommonStockSubjectToPossibleRedemptionValue" name="CommonStockSubjectToPossibleRedemptionValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" name="StockIssuedDuringPeriodValueRetainedEarningsAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EquityPurchaseAgreementDescription" name="EquityPurchaseAgreementDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ShareOutstandingVotingPercentage" name="ShareOutstandingVotingPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessAcquisitionCostPercentage" name="BusinessAcquisitionCostPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" nillable="true" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" name="EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" name="EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DeferredTaxAssetsCapitalizedResearchCosts" name="DeferredTaxAssetsCapitalizedResearchCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_DeferredTaxAssetsFixedAssets" name="DeferredTaxAssetsFixedAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_OperatingLossCarryForwardIndefinitely" name="OperatingLossCarryForwardIndefinitely" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" name="EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_EquitySecuritiesFvNiMeasurementTerm" name="EquitySecuritiesFvNiMeasurementTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_AccountingPronouncementsNotYetAdoptedPolicyTextBlock" name="AccountingPronouncementsNotYetAdoptedPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromIssuanceOfCommonStockOne" name="ProceedsFromIssuanceOfCommonStockOne" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromIssuanceOfCommonStockTwo" name="ProceedsFromIssuanceOfCommonStockTwo" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_CommonClassAOneMember" name="CommonClassAOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ProceedsFromBusinessLoan" name="ProceedsFromBusinessLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ClassBCommonStock" name="ClassBCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueIssuanceOfPipeWarrants" name="StockIssuedDuringPeriodValueIssuanceOfPipeWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueStockOptionsToCommonStock" name="StockIssuedDuringPeriodValueStockOptionsToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueConvertingOfWarrantsToCommonStock" name="StockIssuedDuringPeriodValueConvertingOfWarrantsToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueConvertingDataKnightsCommonShares" name="StockIssuedDuringPeriodValueConvertingDataKnightsCommonShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesStockOptionsToCommonStock" name="StockIssuedDuringPeriodSharesStockOptionsToCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesConvertingOfWarrantsToCommonStock" name="StockIssuedDuringPeriodSharesConvertingOfWarrantsToCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesConvertingDataKnightsCommonShares" name="StockIssuedDuringPeriodSharesConvertingDataKnightsCommonShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_BoardOfDirectorsMember" name="BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ConvertiableNotesMember" name="ConvertiableNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ExtensionLoan" name="ExtensionLoan" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_WarrantOneMember" name="WarrantOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_PubliclyTradedWarrantsMember" name="PubliclyTradedWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_SeniorConvertibleNotesMember" name="SeniorConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_ManagementAndDirectorsMember" name="ManagementAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesConvertibleNotesToCommonStock" name="StockIssuedDuringPeriodSharesConvertibleNotesToCommonStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodSharesIssuanceOfPipeWarrants" name="StockIssuedDuringPeriodSharesIssuanceOfPipeWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_InvestmentsHeldInTrustMember" name="InvestmentsHeldInTrustMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueCommonStockRedemption" name="StockIssuedDuringPeriodValueCommonStockRedemption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockIssuedDuringPeriodValueConvertibleNotesToCommonStock" name="StockIssuedDuringPeriodValueConvertibleNotesToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_RetainedEarningsAdjustment" name="RetainedEarningsAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="ONMD_StockWarrantExpenseNonOperating" name="StockWarrantExpenseNonOperating" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>onmd-20240930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://onemednet.com/role/Cover" xlink:href="onmd-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BalanceSheets" xlink:href="onmd-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BalanceSheetsParenthetical" xlink:href="onmd-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfOperations" xlink:href="onmd-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:href="onmd-20240930.xsd#StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfCashFlows" xlink:href="onmd-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/DescriptionOfBusiness" xlink:href="onmd-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeld" xlink:href="onmd-20240930.xsd#CryptoAssetsHeld" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ConvertibleDebt" xlink:href="onmd-20240930.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/LineOfCredit" xlink:href="onmd-20240930.xsd#LineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessAccountCeba" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockholdersDeficit" xlink:href="onmd-20240930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/NetLossPerShare" xlink:href="onmd-20240930.xsd#NetLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensation" xlink:href="onmd-20240930.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrants" xlink:href="onmd-20240930.xsd#StockWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/FairValueMeasurements" xlink:href="onmd-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactions" xlink:href="onmd-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CommitmentsAndContingencies" xlink:href="onmd-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEvents" xlink:href="onmd-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombination" xlink:href="onmd-20240930.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipment" xlink:href="onmd-20240930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxes" xlink:href="onmd-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessLoanActCeba" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeldTables" xlink:href="onmd-20240930.xsd#CryptoAssetsHeldTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/NetLossPerShareTables" xlink:href="onmd-20240930.xsd#NetLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensationTables" xlink:href="onmd-20240930.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrantsTables" xlink:href="onmd-20240930.xsd#StockWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/FairValueMeasurementsTables" xlink:href="onmd-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactionsTables" xlink:href="onmd-20240930.xsd#RelatedPartyTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEventsTables" xlink:href="onmd-20240930.xsd#SubsequentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombinationTables" xlink:href="onmd-20240930.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipmentTables" xlink:href="onmd-20240930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxesTables" xlink:href="onmd-20240930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="onmd-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails" xlink:href="onmd-20240930.xsd#ScheduleOfCryptoAssetsHeldDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative" xlink:href="onmd-20240930.xsd#CryptoAssetsHeldDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ConvertibleDebtDetailsNarrative" xlink:href="onmd-20240930.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/LineOfCreditDetailsNarrative" xlink:href="onmd-20240930.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockholdersDeficitDetailsNarrative" xlink:href="onmd-20240930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails" xlink:href="onmd-20240930.xsd#ScheduleOfStock-basedCompensationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="onmd-20240930.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrantsDetailsNarrative" xlink:href="onmd-20240930.xsd#StockWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:href="onmd-20240930.xsd#ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfShareholderLoansOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="onmd-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="onmd-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails" xlink:href="onmd-20240930.xsd#ScheduleOfRestatementOfBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:href="onmd-20240930.xsd#ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEventsDetailsNarrative" xlink:href="onmd-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombinationDetailsNarrative" xlink:href="onmd-20240930.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="onmd-20240930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="onmd-20240930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:href="onmd-20240930.xsd#ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="onmd-20240930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:href="onmd-20240930.xsd#ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxesDetailsNarrative" xlink:href="onmd-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails" xlink:href="onmd-20240930.xsd#ScheduleOfRestrictedStockAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="loc_us-gaapCryptoAssetFairValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCryptoAssetFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredCostsNonCurrent" xlink:label="loc_ONMDDeferredCostsNonCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_ONMDDeferredCostsNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNotesPayableCurrent" xlink:label="loc_ONMDYorkvilleNotesPayableCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ONMDYorkvilleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaapTreasuryStockCommonValue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockCommonValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_GainLossOnFairValueOfYorkvilleNote" xlink:label="loc_ONMDGainLossOnFairValueOfYorkvilleNote" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ONMDGainLossOnFairValueOfYorkvilleNote" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDStockWarrantExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantExpense" xlink:label="loc_ONMDWarrantExpense" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDWarrantExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfYorkvilleNote" xlink:label="loc_ONMDChangeInFairValueOfYorkvilleNote" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDChangeInFairValueOfYorkvilleNote" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedLossNonoperating" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCryptoAssetRealizedLossNonoperating" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NoncashInterest" xlink:label="loc_ONMDNoncashInterest" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDNoncashInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" xlink:label="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="loc_us-gaapPaymentForAcquisitionCryptoAsset" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentForAcquisitionCryptoAsset" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDisposalCryptoAsset" xlink:label="loc_us-gaapProceedsFromDisposalCryptoAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromDisposalCryptoAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="loc_ONMDProceedsFromIssuanceOfShareholderLoans" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ONMDProceedsFromIssuanceOfShareholderLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RepaymentForCommonStockRepurchase" xlink:label="loc_ONMDRepaymentForCommonStockRepurchase" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ONMDRepaymentForCommonStockRepurchase" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RepaymentOfDeferredUnderwriterFees" xlink:label="loc_ONMDRepaymentOfDeferredUnderwriterFees" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ONMDRepaymentOfDeferredUnderwriterFees" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="loc_us-gaapRepaymentsOfBankDebt" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfBankDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCosts" xlink:label="loc_ONMDBusinessCombinationCosts" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ONMDBusinessCombinationCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/DescriptionOfBusiness" xlink:title="999007 - Disclosure - Description of Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeld" xlink:title="999009 - Disclosure - Crypto Assets Held" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ConvertibleDebt" xlink:title="999010 - Disclosure - Convertible Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/LineOfCredit" xlink:title="999011 - Disclosure - Line of Credit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba" xlink:title="999012 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockholdersDeficit" xlink:title="999013 - Disclosure - Stockholders&#8217; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/NetLossPerShare" xlink:title="999014 - Disclosure - Net Loss per Share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensation" xlink:title="999015 - Disclosure - Stock-Based Compensation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrants" xlink:title="999016 - Disclosure - Stock Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/FairValueMeasurements" xlink:title="999017 - Disclosure - Fair Value Measurements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactions" xlink:title="999018 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CommitmentsAndContingencies" xlink:title="999019 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEvents" xlink:title="999020 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombination" xlink:title="999021 - Disclosure - Business Combination" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba" xlink:title="999024 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999025 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeldTables" xlink:title="999026 - Disclosure - Crypto Assets Held (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/NetLossPerShareTables" xlink:title="999027 - Disclosure - Net Loss per Share (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensationTables" xlink:title="999028 - Disclosure - Stock-Based Compensation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrantsTables" xlink:title="999029 - Disclosure - Stock Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/FairValueMeasurementsTables" xlink:title="999030 - Disclosure - Fair Value Measurements (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactionsTables" xlink:title="999031 - Disclosure - Related Party Transactions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEventsTables" xlink:title="999032 - Disclosure - Subsequent Events (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombinationTables" xlink:title="999033 - Disclosure - Business Combination (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipmentTables" xlink:title="999034 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxesTables" xlink:title="999035 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="999036 - Disclosure - Description of Business (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999037 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails" xlink:title="999038 - Disclosure - Schedule of Crypto Assets Held (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:title="999039 - Disclosure - Schedule of Crypto Assets Reconciliation of Fair Values (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative" xlink:title="999040 - Disclosure - Crypto Assets Held (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ConvertibleDebtDetailsNarrative" xlink:title="999041 - Disclosure - Convertible Debt (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/LineOfCreditDetailsNarrative" xlink:title="999042 - Disclosure - Line of Credit (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:title="999043 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockholdersDeficitDetailsNarrative" xlink:title="999044 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:title="999045 - Disclosure - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails" xlink:title="999046 - Disclosure - Schedule of Stock-based Compensation Expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="999047 - Disclosure - Stock-Based Compensation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="999048 - Disclosure - Schedule of Warrants Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrantsDetailsNarrative" xlink:title="999049 - Disclosure - Stock Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:title="999050 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:title="999051 - Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:title="999052 - Disclosure - Schedule of Fair Value Assumptions and Valuation (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails" xlink:title="999053 - Disclosure - Schedule of Shareholder Loans Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999054 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999055 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails" xlink:title="999056 - Disclosure - Schedule of Restatement of Balance Sheet (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredCostsNonCurrent" xlink:label="loc_ONMDDeferredCostsNonCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_ONMDDeferredCostsNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ExciseTaxCurrent" xlink:label="loc_ONMDExciseTaxCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ONMDExciseTaxCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtensionsCurrent" xlink:label="loc_ONMDLoanExtensionsCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ONMDLoanExtensionsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CanadaEmergencyBusinessLoanAct" xlink:label="loc_ONMDCanadaEmergencyBusinessLoanAct" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ONMDCanadaEmergencyBusinessLoanAct" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtCurrent" xlink:label="loc_us-gaapUnsecuredDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapUnsecuredDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AccruedInterestRelatedParty" xlink:label="loc_ONMDAccruedInterestRelatedParty" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ONMDAccruedInterestRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableNonCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableNonCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ONMDDeferredUnderwriterFeePayableNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WorkingCapitalLoan" xlink:label="loc_ONMDWorkingCapitalLoan" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ONMDWorkingCapitalLoan" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantLiabilityNonCurrent" xlink:label="loc_ONMDWarrantLiabilityNonCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_ONMDWarrantLiabilityNonCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" weight="1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:title="999057 - Disclosure - Schedule of Restatement of Balance Sheet (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:title="999058 - Disclosure - Schedule of the Original and Restated Statement of Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncomeTaxProvision" xlink:label="loc_ONMDIncomeTaxProvision" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ONMDIncomeTaxProvision" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_UnrealizedGainLoss" xlink:label="loc_ONMDUnrealizedGainLoss" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_ONMDUnrealizedGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:title="999059 - Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpenses" xlink:label="loc_ONMDStockWarrantExpenses" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDStockWarrantExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantExpense" xlink:label="loc_ONMDWarrantExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDWarrantExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfPipeNotes" xlink:label="loc_ONMDChangeInFairValueOfPipeNotes" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDChangeInFairValueOfPipeNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" xlink:label="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NoncashInterest" xlink:label="loc_ONMDNoncashInterest" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_ONMDNoncashInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="loc_ONMDProceedsFromIssuanceOfShareholderLoans" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ONMDProceedsFromIssuanceOfShareholderLoans" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCosts" xlink:label="loc_ONMDBusinessCombinationCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_ONMDBusinessCombinationCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:title="999060 - Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:title="999061 - Disclosure - Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEventsDetailsNarrative" xlink:title="999062 - Disclosure - Subsequent Events (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:title="999063 - Disclosure - Schedule of Business Combination Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombinationDetailsNarrative" xlink:title="999064 - Disclosure - Business Combination (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999065 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999066 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:title="999067 - Disclosure - Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="999068 - Disclosure - Schedule of Income Tax Provision (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredOtherTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredOtherTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredOtherTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredOtherTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredOtherTaxExpenseBenefit" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:title="999069 - Disclosure - Schedule of Reconciliation of Income Tax Benefit (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" xlink:label="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:label="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsOther" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="999070 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredTaxAssetsCapitalizedResearchCosts" xlink:label="loc_ONMDDeferredTaxAssetsCapitalizedResearchCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_ONMDDeferredTaxAssetsCapitalizedResearchCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredTaxAssetsFixedAssets" xlink:label="loc_ONMDDeferredTaxAssetsFixedAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_ONMDDeferredTaxAssetsFixedAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxesDetailsNarrative" xlink:title="999071 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails" xlink:title="999072 - Disclosure - Schedule of Options Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails" xlink:title="999073 - Disclosure - Schedule of Fair Value of Stock Options (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails" xlink:title="999074 - Disclosure - Schedule of Restricted Stock Award Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:title="999075 - Disclosure -  Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:title="999076 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;) (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>onmd-20240930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://onemednet.com/role/Cover" xlink:href="onmd-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BalanceSheets" xlink:href="onmd-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BalanceSheetsParenthetical" xlink:href="onmd-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfOperations" xlink:href="onmd-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:href="onmd-20240930.xsd#StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfCashFlows" xlink:href="onmd-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/DescriptionOfBusiness" xlink:href="onmd-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeld" xlink:href="onmd-20240930.xsd#CryptoAssetsHeld" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ConvertibleDebt" xlink:href="onmd-20240930.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/LineOfCredit" xlink:href="onmd-20240930.xsd#LineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessAccountCeba" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockholdersDeficit" xlink:href="onmd-20240930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/NetLossPerShare" xlink:href="onmd-20240930.xsd#NetLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensation" xlink:href="onmd-20240930.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrants" xlink:href="onmd-20240930.xsd#StockWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/FairValueMeasurements" xlink:href="onmd-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactions" xlink:href="onmd-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CommitmentsAndContingencies" xlink:href="onmd-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEvents" xlink:href="onmd-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombination" xlink:href="onmd-20240930.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipment" xlink:href="onmd-20240930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxes" xlink:href="onmd-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessLoanActCeba" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeldTables" xlink:href="onmd-20240930.xsd#CryptoAssetsHeldTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/NetLossPerShareTables" xlink:href="onmd-20240930.xsd#NetLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensationTables" xlink:href="onmd-20240930.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrantsTables" xlink:href="onmd-20240930.xsd#StockWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/FairValueMeasurementsTables" xlink:href="onmd-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactionsTables" xlink:href="onmd-20240930.xsd#RelatedPartyTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEventsTables" xlink:href="onmd-20240930.xsd#SubsequentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombinationTables" xlink:href="onmd-20240930.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipmentTables" xlink:href="onmd-20240930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxesTables" xlink:href="onmd-20240930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="onmd-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails" xlink:href="onmd-20240930.xsd#ScheduleOfCryptoAssetsHeldDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative" xlink:href="onmd-20240930.xsd#CryptoAssetsHeldDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ConvertibleDebtDetailsNarrative" xlink:href="onmd-20240930.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/LineOfCreditDetailsNarrative" xlink:href="onmd-20240930.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockholdersDeficitDetailsNarrative" xlink:href="onmd-20240930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails" xlink:href="onmd-20240930.xsd#ScheduleOfStock-basedCompensationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="onmd-20240930.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrantsDetailsNarrative" xlink:href="onmd-20240930.xsd#StockWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:href="onmd-20240930.xsd#ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfShareholderLoansOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="onmd-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="onmd-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails" xlink:href="onmd-20240930.xsd#ScheduleOfRestatementOfBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:href="onmd-20240930.xsd#ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEventsDetailsNarrative" xlink:href="onmd-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombinationDetailsNarrative" xlink:href="onmd-20240930.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="onmd-20240930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="onmd-20240930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:href="onmd-20240930.xsd#ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="onmd-20240930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:href="onmd-20240930.xsd#ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxesDetailsNarrative" xlink:href="onmd-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails" xlink:href="onmd-20240930.xsd#ScheduleOfRestrictedStockAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RestatedMember" xlink:label="loc_ONMDRestatedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDRestatedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsCurrentAbstract_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="loc_us-gaapCryptoAssetFairValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapCryptoAssetFairValue_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_90" xlink:to="loc_us-gaapAssetsCurrent_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredCostsNonCurrent" xlink:label="loc_ONMDDeferredCostsNonCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_ONMDDeferredCostsNonCurrent_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssets_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapDeferredRevenueCurrent_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapLoansPayableCurrent_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapConvertibleDebtCurrent_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapLoansPayable_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapNotesPayableCurrent_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNotesPayableCurrent" xlink:label="loc_ONMDYorkvilleNotesPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_ONMDYorkvilleNotesPayableCurrent_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapShortTermBorrowings_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrent_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapConvertibleDebtNoncurrent_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLongTermLoansPayable_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilities_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommitmentsAndContingencies_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapTemporaryEquityAbstract_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityAbstract_90" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquityAbstract_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapPreferredStockValue_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommonStockValue_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAdditionalPaidInCapital_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaapTreasuryStockCommonValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapTreasuryStockCommonValue_90" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_90" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_90" xlink:type="arc" order="37" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_80" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SubscriptionRevenueMember" xlink:label="loc_ONMDSubscriptionRevenueMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDSubscriptionRevenueMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WebImagingRevenueMember" xlink:label="loc_ONMDWebImagingRevenueMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDWebImagingRevenueMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_190" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_190" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_190" xlink:to="loc_us-gaapSellingAndMarketingExpense_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_190" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_190" xlink:to="loc_us-gaapOperatingExpenses_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_us-gaapInterestExpenseNonoperating_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity_190" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_GainLossOnFairValueOfYorkvilleNote" xlink:label="loc_ONMDGainLossOnFairValueOfYorkvilleNote_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_ONMDGainLossOnFairValueOfYorkvilleNote_190" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax_190" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating_190" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes_190" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_us-gaapStockOptionPlanExpense_190" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_190" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_190" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpense_190" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_190" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_190" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_190" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract_190" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_190" xlink:to="loc_us-gaapEarningsPerShareBasic_190" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_190" xlink:to="loc_us-gaapEarningsPerShareDiluted_190" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_190" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_190" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_190" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_190" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TemporaryEquityMember" xlink:label="loc_ONMDTemporaryEquityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDTemporaryEquityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_90" xlink:type="arc" order="32" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/DescriptionOfBusiness" xlink:title="999007 - Disclosure - Description of Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeld" xlink:title="999009 - Disclosure - Crypto Assets Held" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ConvertibleDebt" xlink:title="999010 - Disclosure - Convertible Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/LineOfCredit" xlink:title="999011 - Disclosure - Line of Credit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba" xlink:title="999012 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockholdersDeficit" xlink:title="999013 - Disclosure - Stockholders&#8217; Deficit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/NetLossPerShare" xlink:title="999014 - Disclosure - Net Loss per Share" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensation" xlink:title="999015 - Disclosure - Stock-Based Compensation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrants" xlink:title="999016 - Disclosure - Stock Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/FairValueMeasurements" xlink:title="999017 - Disclosure - Fair Value Measurements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactions" xlink:title="999018 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CommitmentsAndContingencies" xlink:title="999019 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEvents" xlink:title="999020 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombination" xlink:title="999021 - Disclosure - Business Combination" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba" xlink:title="999024 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999025 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeldTables" xlink:title="999026 - Disclosure - Crypto Assets Held (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/NetLossPerShareTables" xlink:title="999027 - Disclosure - Net Loss per Share (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensationTables" xlink:title="999028 - Disclosure - Stock-Based Compensation (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrantsTables" xlink:title="999029 - Disclosure - Stock Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/FairValueMeasurementsTables" xlink:title="999030 - Disclosure - Fair Value Measurements (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactionsTables" xlink:title="999031 - Disclosure - Related Party Transactions (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEventsTables" xlink:title="999032 - Disclosure - Subsequent Events (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombinationTables" xlink:title="999033 - Disclosure - Business Combination (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipmentTables" xlink:title="999034 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxesTables" xlink:title="999035 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="999036 - Disclosure - Description of Business (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999037 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OneCustomerMember" xlink:label="loc_ONMDOneCustomerMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDOneCustomerMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwoCustomersMember" xlink:label="loc_ONMDTwoCustomersMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDTwoCustomersMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ThreeCustomersMember" xlink:label="loc_ONMDThreeCustomersMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDThreeCustomersMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf_100" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails" xlink:title="999038 - Disclosure - Schedule of Crypto Assets Held (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingLineItems" xlink:label="loc_us-gaapCryptoAssetHoldingLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTable" xlink:label="loc_us-gaapCryptoAssetHoldingTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCryptoAssetHoldingLineItems" xlink:to="loc_us-gaapCryptoAssetHoldingTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetAxis" xlink:label="loc_srtCryptoAssetAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapCryptoAssetHoldingTable" xlink:to="loc_srtCryptoAssetAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetDomain" xlink:label="loc_srtCryptoAssetDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCryptoAssetAxis" xlink:to="loc_srtCryptoAssetDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetDomain" xlink:label="loc_srtCryptoAssetDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCryptoAssetAxis" xlink:to="loc_srtCryptoAssetDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BitcoinMember" xlink:label="loc_ONMDBitcoinMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtCryptoAssetDomain" xlink:to="loc_ONMDBitcoinMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="loc_us-gaapCryptoAssetNumberOfUnits_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCryptoAssetHoldingLineItems" xlink:to="loc_us-gaapCryptoAssetNumberOfUnits_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetCost" xlink:label="loc_us-gaapCryptoAssetCost_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCryptoAssetHoldingLineItems" xlink:to="loc_us-gaapCryptoAssetCost_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="loc_us-gaapCryptoAssetFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCryptoAssetHoldingLineItems" xlink:to="loc_us-gaapCryptoAssetFairValue_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:title="999039 - Disclosure - Schedule of Crypto Assets Reconciliation of Fair Values (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative" xlink:title="999040 - Disclosure - Crypto Assets Held (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ConvertibleDebtDetailsNarrative" xlink:title="999041 - Disclosure - Convertible Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertibleNotesWarrantsMember" xlink:label="loc_ONMDConvertibleNotesWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertibleNotesWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDYorkvilleNoteMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesMember" xlink:label="loc_ONMDConvertiblePromissoryNotesMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoNotesMember" xlink:label="loc_ONMDTwentyTwentyTwoNotesMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDTwentyTwentyTwoNotesMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyThreeNotesMember" xlink:label="loc_ONMDTwentyTwentyThreeNotesMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDTwentyTwentyThreeNotesMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" xlink:label="loc_ONMDTwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDTwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_ONMDSecuritiesPurchaseAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDSecuritiesPurchaseAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_HelenaTerminationAgreementMember" xlink:label="loc_ONMDHelenaTerminationAgreementMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDHelenaTerminationAgreementMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDStandbyEquityPurchaseAgreementMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDStandbyEquityPurchaseAgreementMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BeneficialOwnershipMember" xlink:label="loc_ONMDBeneficialOwnershipMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_ONMDBeneficialOwnershipMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentRate_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentRate_340" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_340" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_340" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_340" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLoans_340" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_340" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_340" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_340" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_340" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_340" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLegalFees_340" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_340" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDStockWarrantExpense_340" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleDebt_340" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapCash_340" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_340" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_340" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FloorPricePerShare" xlink:label="loc_ONMDFloorPricePerShare_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDFloorPricePerShare_340" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrecentageOfOutstandingCommonStock" xlink:label="loc_ONMDPrecentageOfOutstandingCommonStock_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDPrecentageOfOutstandingCommonStock_340" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners_340" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DebtInstrumentInterestRateDefaultPercentage" xlink:label="loc_ONMDDebtInstrumentInterestRateDefaultPercentage_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDDebtInstrumentInterestRateDefaultPercentage_340" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNotesPayableCurrent" xlink:label="loc_ONMDYorkvilleNotesPayableCurrent_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDYorkvilleNotesPayableCurrent_340" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription_340" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity_340" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityFinancingDescription" xlink:label="loc_ONMDEquityFinancingDescription_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDEquityFinancingDescription_340" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_340" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_340" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionDescription_340" xlink:type="arc" order="27" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/LineOfCreditDetailsNarrative" xlink:title="999042 - Disclosure - Line of Credit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BOCBankMember" xlink:label="loc_ONMDBOCBankMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_ONMDBOCBankMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCredit_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:title="999043 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CEBALoanMember" xlink:label="loc_ONMDCEBALoanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDCEBALoanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockholdersDeficitDetailsNarrative" xlink:title="999044 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockRepurchaseAgreementMember" xlink:label="loc_ONMDStockRepurchaseAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDStockRepurchaseAgreementMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDStandbyEquityPurchaseAgreementMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDStandbyEquityPurchaseAgreementMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_ONMDSecuritiesPurchaseAgreementMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDSecuritiesPurchaseAgreementMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrefundedWarrantsMember" xlink:label="loc_ONMDPrefundedWarrantsMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPrefundedWarrantsMember_250" xlink:type="arc" order="253" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ONMDYorkvilleNoteMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_JulyTwoThousandTwentyFourFinancingMember" xlink:label="loc_ONMDJulyTwoThousandTwentyFourFinancingMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDJulyTwoThousandTwentyFourFinancingMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeptemberTwoThousandTwentyFourFinancingMember" xlink:label="loc_ONMDSeptemberTwoThousandTwentyFourFinancingMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDSeptemberTwoThousandTwentyFourFinancingMember_290" xlink:type="arc" order="293" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable_470" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_470" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_470" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_470" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesTransferred" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesTransferred_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesTransferred_470" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice_470" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_VolumeWeightedAveragePrice" xlink:label="loc_ONMDVolumeWeightedAveragePrice_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDVolumeWeightedAveragePrice_470" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_VolumeWeightedAveragePriceValue" xlink:label="loc_ONMDVolumeWeightedAveragePriceValue_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDVolumeWeightedAveragePriceValue_470" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:label="loc_us-gaapBusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_470" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_470" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_470" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_470" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapInterestExpense_470" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_470" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_470" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockRepurchasedDuringPeriodValueExchangeForCash" xlink:label="loc_ONMDStockRepurchasedDuringPeriodValueExchangeForCash_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDStockRepurchasedDuringPeriodValueExchangeForCash_470" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" xlink:label="loc_ONMDPrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDPrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_470" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_470" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction_470" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockholdersDeficitDescription" xlink:label="loc_ONMDStockholdersDeficitDescription_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDStockholdersDeficitDescription_470" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CashStructuringFee" xlink:label="loc_ONMDCashStructuringFee_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDCashStructuringFee_470" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts_470" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts_470" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1_470" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1_470" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_470" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeNet_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeNet_470" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaapChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_470" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_470" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_470" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_470" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_470" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_470" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_470" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts_470" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscriptions_470" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_470" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_470" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_470" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_470" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalUnitsAuthorized" xlink:label="loc_us-gaapCapitalUnitsAuthorized_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCapitalUnitsAuthorized_470" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_470" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_470" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_470" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDividendsPreferredStock_470" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock_470" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaapPreferredStockLiquidationPreferenceValue_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreferenceValue_470" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:label="loc_us-gaapConvertiblePreferredStockTermsOfConversion_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockTermsOfConversion_470" xlink:type="arc" order="47" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:title="999045 - Disclosure - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OptionsToPurchaseCommonStockMember" xlink:label="loc_ONMDOptionsToPurchaseCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDOptionsToPurchaseCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_UnvestedRestrictedStockUnitsAndAwardsMember" xlink:label="loc_ONMDUnvestedRestrictedStockUnitsAndAwardsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDUnvestedRestrictedStockUnitsAndAwardsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteMember" xlink:label="loc_ONMDConvertiblePromissoryNoteMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_290" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails" xlink:title="999046 - Disclosure - Schedule of Stock-based Compensation Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_270" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="999047 - Disclosure - Stock-Based Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityIncentivePlanMember" xlink:label="loc_ONMDEquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ONMDEquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NewEquityIncentivePlanMember" xlink:label="loc_ONMDNewEquityIncentivePlanMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ONMDNewEquityIncentivePlanMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EmployeesDirectorsAndConsultantsMember" xlink:label="loc_ONMDEmployeesDirectorsAndConsultantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ONMDEmployeesDirectorsAndConsultantsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_190" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="999048 - Disclosure - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LiabilityClassifiedWarrantsMember" xlink:label="loc_ONMDLiabilityClassifiedWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDLiabilityClassifiedWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityClassifiedWarrantsMember" xlink:label="loc_ONMDEquityClassifiedWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDEquityClassifiedWarrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPIPEWarrantsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PublicWarrantsMember" xlink:label="loc_ONMDPublicWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPublicWarrantsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivatePlacementWarrantsMember" xlink:label="loc_ONMDPrivatePlacementWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPrivatePlacementWarrantsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivatePlacementWarrantsMember" xlink:label="loc_ONMDPrivatePlacementWarrantsMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDPrivatePlacementWarrantsMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDPIPEWarrantsMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LegacyONMDWarrantsMember" xlink:label="loc_ONMDLegacyONMDWarrantsMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDLegacyONMDWarrantsMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNoteWarrantsMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteWarrantsMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PublicWarrantsMember" xlink:label="loc_ONMDPublicWarrantsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDPublicWarrantsMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_310" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrantsDetailsNarrative" xlink:title="999049 - Disclosure - Stock Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNotesWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPIPEWarrantsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyOneServiceMember" xlink:label="loc_ONMDTwentyTwentyOneServiceMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDTwentyTwentyOneServiceMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoServiceMember" xlink:label="loc_ONMDTwentyTwentyTwoServiceMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDTwentyTwentyTwoServiceMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNotesWarrantsMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesWarrantsMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDPIPEWarrantsMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PublicWarrantsMember" xlink:label="loc_ONMDPublicWarrantsMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDPublicWarrantsMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapPrivatePlacementMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockWarrantExpense_240" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionRatio1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionRatio1_240" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_240" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_240" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfWarrants" xlink:label="loc_ONMDChangeInFairValueOfWarrants_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDChangeInFairValueOfWarrants_240" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNoncashExpense_240" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_240" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_240" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_240" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_240" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:title="999050 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BitcoinMember" xlink:label="loc_ONMDBitcoinMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDBitcoinMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivateWarrantsMember" xlink:label="loc_ONMDPrivateWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivateWarrantsMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDYorkvilleNoteMember_200" xlink:type="arc" order="203" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDStandbyEquityPurchaseAgreementMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDStandbyEquityPurchaseAgreementMember_240" xlink:type="arc" order="243" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesMember" xlink:label="loc_ONMDConvertiblePromissoryNotesMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesMember_440" xlink:type="arc" order="443" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_530" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_530" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure_530" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure_530" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:title="999051 - Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDYorkvilleNoteMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleStandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDYorkvilleStandbyEquityPurchaseAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDYorkvilleStandbyEquityPurchaseAgreementMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_160" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:title="999052 - Disclosure - Schedule of Fair Value Assumptions and Valuation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivateWarrantsMember" xlink:label="loc_ONMDPrivateWarrantsMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivateWarrantsMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput_370" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_370" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails" xlink:title="999053 - Disclosure - Schedule of Shareholder Loans Outstanding (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999054 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDPIPENotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteMember" xlink:label="loc_ONMDConvertiblePromissoryNoteMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNoteWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteWarrantsMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ShareholderLoansMember" xlink:label="loc_ONMDShareholderLoansMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDShareholderLoansMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesAndWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNotesAndWarrantsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesAndWarrantsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPIPEWarrantsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsMember" xlink:label="loc_ONMDDataKnightsMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_270" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_270" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_270" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromLoans_270" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaapOtherLongTermDebt_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLongTermDebt_270" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_270" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_270" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharePrice_270" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLoansPayableCurrent_270" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_270" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_270" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="loc_ONMDProceedsFromIssuanceOfShareholderLoans_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ONMDProceedsFromIssuanceOfShareholderLoans_270" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtension" xlink:label="loc_ONMDLoanExtension_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ONMDLoanExtension_270" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999055 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails" xlink:title="999056 - Disclosure - Schedule of Restatement of Balance Sheet (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ReclassificationAdjustmentMember" xlink:label="loc_ONMDReclassificationAdjustmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDReclassificationAdjustmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract_330" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_330" xlink:to="loc_us-gaapAssetsCurrentAbstract_330" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_330" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_330" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustCurrent" xlink:label="loc_us-gaapAssetsHeldInTrustCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_330" xlink:to="loc_us-gaapAssetsHeldInTrustCurrent_330" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_330" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_330" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_330" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_330" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_330" xlink:to="loc_us-gaapAssetsCurrent_330" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredCostsNonCurrent" xlink:label="loc_ONMDDeferredCostsNonCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_330" xlink:to="loc_ONMDDeferredCostsNonCurrent_330" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_330" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_330" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_330" xlink:to="loc_us-gaapAssets_330" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_330" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapOtherLiabilities_330" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ExciseTaxCurrent" xlink:label="loc_ONMDExciseTaxCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_ONMDExciseTaxCurrent_330" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapDeferredRevenueCurrent_330" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapConvertibleDebtCurrent_330" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtensionsCurrent" xlink:label="loc_ONMDLoanExtensionsCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_ONMDLoanExtensionsCurrent_330" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapLoansPayable_330" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CanadaEmergencyBusinessLoanAct" xlink:label="loc_ONMDCanadaEmergencyBusinessLoanAct_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_ONMDCanadaEmergencyBusinessLoanAct_330" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent_330" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent_330" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapNotesPayableCurrent_330" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_330" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent_330" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_330" xlink:to="loc_us-gaapLiabilitiesCurrent_330" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapConvertibleDebtNoncurrent_330" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtCurrent" xlink:label="loc_us-gaapUnsecuredDebtCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapUnsecuredDebtCurrent_330" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AccruedInterestRelatedParty" xlink:label="loc_ONMDAccruedInterestRelatedParty_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_ONMDAccruedInterestRelatedParty_330" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapLongTermLoansPayable_330" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableNonCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableNonCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_ONMDDeferredUnderwriterFeePayableNonCurrent_330" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WorkingCapitalLoan" xlink:label="loc_ONMDWorkingCapitalLoan_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_ONMDWorkingCapitalLoan_330" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantLiabilityNonCurrent" xlink:label="loc_ONMDWarrantLiabilityNonCurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_ONMDWarrantLiabilityNonCurrent_330" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent_330" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapLiabilities_330" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapCommitmentsAndContingencies_330" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapTemporaryEquityAbstract_330" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTemporaryEquityAbstract_330" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent_330" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapStockholdersEquityAbstract_330" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_330" xlink:to="loc_us-gaapPreferredStockValue_330" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_330" xlink:to="loc_us-gaapCommonStockValue_330" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_330" xlink:to="loc_us-gaapAdditionalPaidInCapital_330" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_330" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_330" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_330" xlink:to="loc_us-gaapStockholdersEquity_330" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_330" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_330" xlink:type="arc" order="44" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:title="999057 - Disclosure - Schedule of Restatement of Balance Sheet (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:title="999058 - Disclosure - Schedule of the Original and Restated Statement of Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ReclassificationAdjustmentMember" xlink:label="loc_ONMDReclassificationAdjustmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDReclassificationAdjustmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SubscriptionRevenueMember" xlink:label="loc_ONMDSubscriptionRevenueMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDSubscriptionRevenueMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WebImagingRevenueMember" xlink:label="loc_ONMDWebImagingRevenueMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDWebImagingRevenueMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_250" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_250" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_250" xlink:to="loc_us-gaapOtherGeneralExpense_250" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_250" xlink:to="loc_us-gaapSellingAndMarketingExpense_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_250" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_250" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOperatingExpensesAbstract_250" xlink:to="loc_us-gaapOperatingExpenses_250" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_250" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncomeTaxProvision" xlink:label="loc_ONMDIncomeTaxProvision_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_ONMDIncomeTaxProvision_250" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_us-gaapAssetImpairmentCharges_250" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_us-gaapInterestExpenseNonoperating_250" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_ONMDStockWarrantExpense_250" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_250" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity_250" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes_250" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract_250" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_250" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_UnrealizedGainLoss" xlink:label="loc_ONMDUnrealizedGainLoss_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDUnrealizedGainLoss_250" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpense_250" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_250" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_250" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_250" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract_250" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_250" xlink:to="loc_us-gaapEarningsPerShareBasic_250" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_250" xlink:to="loc_us-gaapEarningsPerShareDiluted_250" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_250" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_250" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareAbstract_250" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_250" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:title="999059 - Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_us-gaapNetIncomeLoss_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCost" xlink:label="loc_ONMDBusinessCombinationCost_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDBusinessCombinationCost_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CashHeldInTrustAccount" xlink:label="loc_ONMDCashHeldInTrustAccount_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDCashHeldInTrustAccount_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_us-gaapShareBasedCompensation_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpenses" xlink:label="loc_ONMDStockWarrantExpenses_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDStockWarrantExpenses_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantExpense" xlink:label="loc_ONMDWarrantExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDWarrantExpense_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfWarrantLiabilities" xlink:label="loc_ONMDChangeInFairValueOfWarrantLiabilities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDChangeInFairValueOfWarrantLiabilities_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfPipeNotes" xlink:label="loc_ONMDChangeInFairValueOfPipeNotes_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDChangeInFairValueOfPipeNotes_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" xlink:label="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NoncashInterest" xlink:label="loc_ONMDNoncashInterest_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_ONMDNoncashInterest_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable_160" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther_160" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_160" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue_160" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties_160" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInExerciseTaxLiability" xlink:label="loc_ONMDIncreaseDecreaseInExerciseTaxLiability_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_ONMDIncreaseDecreaseInExerciseTaxLiability_160" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInExtensionLoan" xlink:label="loc_ONMDIncreaseDecreaseInExtensionLoan_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_ONMDIncreaseDecreaseInExtensionLoan_160" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseFranchiseTaxPayable" xlink:label="loc_ONMDIncreaseDecreaseFranchiseTaxPayable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_ONMDIncreaseDecreaseFranchiseTaxPayable_160" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable_160" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInWorkingCapitalLoan" xlink:label="loc_ONMDIncreaseDecreaseInWorkingCapitalLoan_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_160" xlink:to="loc_ONMDIncreaseDecreaseInWorkingCapitalLoan_160" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_160" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_160" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_160" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_160" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_160" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_160" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_160" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct" xlink:label="loc_ONMDProceedsFromCanadaEmergencyBusinessLoanAct_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDProceedsFromCanadaEmergencyBusinessLoanAct_160" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="loc_ONMDProceedsFromIssuanceOfShareholderLoans_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDProceedsFromIssuanceOfShareholderLoans_160" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_us-gaapProceedsFromNotesPayable_160" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromCommonStockSubjectToRedemption" xlink:label="loc_ONMDProceedsFromCommonStockSubjectToRedemption_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDProceedsFromCommonStockSubjectToRedemption_160" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromDeferredUnderwritingFee" xlink:label="loc_ONMDProceedsFromDeferredUnderwritingFee_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDProceedsFromDeferredUnderwritingFee_160" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromWarrantLiability" xlink:label="loc_ONMDProceedsFromWarrantLiability_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDProceedsFromWarrantLiability_160" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="loc_us-gaapProceedsFromContributedCapital_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_us-gaapProceedsFromContributedCapital_160" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProccedsFromRetainedEarningsAdjustment" xlink:label="loc_ONMDProccedsFromRetainedEarningsAdjustment_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDProccedsFromRetainedEarningsAdjustment_160" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_160" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_160" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" xlink:label="loc_ONMDProceedsFromIssuanceOfSeriesA2PreferredStock_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDProceedsFromIssuanceOfSeriesA2PreferredStock_160" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCosts" xlink:label="loc_ONMDBusinessCombinationCosts_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_ONMDBusinessCombinationCosts_160" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_160" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_160" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_160" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_160" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract_160" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesIssuedToPreferredShareholders" xlink:label="loc_ONMDCommonSharesIssuedToPreferredShareholders_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_160" xlink:to="loc_ONMDCommonSharesIssuedToPreferredShareholders_160" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" xlink:label="loc_ONMDCommonSharesRelatedToConvertiblePromissoryNotes_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_160" xlink:to="loc_ONMDCommonSharesRelatedToConvertiblePromissoryNotes_160" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesIssuedToDataKnightsShareholders" xlink:label="loc_ONMDCommonSharesIssuedToDataKnightsShareholders_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_160" xlink:to="loc_ONMDCommonSharesIssuedToDataKnightsShareholders_160" xlink:type="arc" order="48" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:title="999060 - Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RestatedMember" xlink:label="loc_ONMDRestatedMember_470" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDRestatedMember_470" xlink:type="arc" order="471" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AsRestatedMember" xlink:label="loc_ONMDAsRestatedMember_990" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDAsRestatedMember_990" xlink:type="arc" order="991" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommitmentMember" xlink:label="loc_ONMDCommitmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDCommitmentMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TemporaryEquityMember" xlink:label="loc_ONMDTemporaryEquityMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDTemporaryEquityMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_1230" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_1230" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination_1230" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_1230" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_1230" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1230" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_1230" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_1230" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1230" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1230" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_1230" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_1230" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_1230" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised_1230" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised_1230" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_1230" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_1230" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_1230" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_1230" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_1230" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_1230" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_1230" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_1230" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_1230" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_1230" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_1230" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonStockSubjectToPossibleRedemptionValue" xlink:label="loc_ONMDCommonStockSubjectToPossibleRedemptionValue_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDCommonStockSubjectToPossibleRedemptionValue_1230" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1230" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" xlink:label="loc_ONMDStockIssuedDuringPeriodValueRetainedEarningsAdjustment_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueRetainedEarningsAdjustment_1230" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_1230" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_1230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_1230" xlink:type="arc" order="30" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:title="999061 - Disclosure - Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerOneMember" xlink:label="loc_ONMDCustomerOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerOneMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerTwoMember" xlink:label="loc_ONMDCustomerTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerTwoMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomersMember" xlink:label="loc_ONMDCustomersMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomersMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerThreeMember" xlink:label="loc_ONMDCustomerThreeMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerThreeMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerFourMember" xlink:label="loc_ONMDCustomerFourMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerFourMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerFiveMember" xlink:label="loc_ONMDCustomerFiveMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerFiveMember_140" xlink:type="arc" order="143" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerSixMember" xlink:label="loc_ONMDCustomerSixMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerSixMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerSevenMember" xlink:label="loc_ONMDCustomerSevenMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerSevenMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_230" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEventsDetailsNarrative" xlink:title="999062 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDYorkvilleNoteMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteMember" xlink:label="loc_ONMDConvertiblePromissoryNoteMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_MsCoonseMcCrawMember" xlink:label="loc_ONMDMsCoonseMcCrawMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ONMDMsCoonseMcCrawMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_MrClarkeMember" xlink:label="loc_ONMDMrClarkeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ONMDMrClarkeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EFHuttonMember" xlink:label="loc_ONMDEFHuttonMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ONMDEFHuttonMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_KingwoodCapitalPartnersLLCMember" xlink:label="loc_ONMDKingwoodCapitalPartnersLLCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_ONMDKingwoodCapitalPartnersLLCMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_KingwoodCapitalPartnersLLCMember" xlink:label="loc_ONMDKingwoodCapitalPartnersLLCMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDKingwoodCapitalPartnersLLCMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrefundedWarrantsMember" xlink:label="loc_ONMDPrefundedWarrantsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPrefundedWarrantsMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="loc_us-gaapLongTermDebtPercentageBearingFixedInterestRate_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLongTermDebtPercentageBearingFixedInterestRate_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DebtInstrumentInterestRateDefaultPercentage" xlink:label="loc_ONMDDebtInstrumentInterestRateDefaultPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ONMDDebtInstrumentInterestRateDefaultPercentage_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromLoans_280" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConvertibleDebt_280" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_280" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_280" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_280" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="loc_us-gaapDebtInstrumentRepaidPrincipal_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentRepaidPrincipal_280" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_280" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_280" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_280" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_280" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_280" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding_280" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_280" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice_280" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_280" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_280" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_280" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityPurchaseAgreementDescription" xlink:label="loc_ONMDEquityPurchaseAgreementDescription_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ONMDEquityPurchaseAgreementDescription_280" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ShareOutstandingVotingPercentage" xlink:label="loc_ONMDShareOutstandingVotingPercentage_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ONMDShareOutstandingVotingPercentage_280" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_280" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_280" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoanProcessingFee" xlink:label="loc_us-gaapLoanProcessingFee_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLoanProcessingFee_280" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForManagementFee" xlink:label="loc_us-gaapPaymentForManagementFee_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentForManagementFee_280" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLoansPayable_280" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_280" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeDescriptionOfTerms" xlink:label="loc_us-gaapDerivativeDescriptionOfTerms_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDerivativeDescriptionOfTerms_280" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFloorPrice" xlink:label="loc_us-gaapDerivativeFloorPrice_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDerivativeFloorPrice_280" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation_280" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_280" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_280" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_280" xlink:type="arc" order="36" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:title="999063 - Disclosure - Schedule of Business Combination Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_20" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombinationDetailsNarrative" xlink:title="999064 - Disclosure - Business Combination (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationMember" xlink:label="loc_ONMDBusinessCombinationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDBusinessCombinationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_ONMDSecuritiesPurchaseAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDSecuritiesPurchaseAgreementMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaapFairValueOfAssetsAcquired_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFairValueOfAssetsAcquired_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharesOutstanding_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessAcquisitionCostPercentage" xlink:label="loc_ONMDBusinessAcquisitionCostPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessAcquisitionCostPercentage_150" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal_150" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapInvestments_150" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_150" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapNotesPayable_150" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_150" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent_150" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtensionsCurrent" xlink:label="loc_ONMDLoanExtensionsCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDLoanExtensionsCurrent_150" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999065 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FurnitureAndEquipmentMember" xlink:label="loc_ONMDFurnitureAndEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ONMDFurnitureAndEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999066 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:title="999067 - Disclosure - Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="999068 - Disclosure - Schedule of Income Tax Provision (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:title="999069 - Disclosure - Schedule of Reconciliation of Income Tax Benefit (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="999070 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxesDetailsNarrative" xlink:title="999071 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails" xlink:title="999072 - Disclosure - Schedule of Options Outstanding (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails" xlink:title="999073 - Disclosure - Schedule of Fair Value of Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:label="loc_us-gaapEquitySecuritiesFvNiMeasurementInput_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiMeasurementInput_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquitySecuritiesFvNiMeasurementTerm" xlink:label="loc_ONMDEquitySecuritiesFvNiMeasurementTerm_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDEquitySecuritiesFvNiMeasurementTerm_120" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails" xlink:title="999074 - Disclosure - Schedule of Restricted Stock Award Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:title="999075 - Disclosure -  Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivateWarrantsMember" xlink:label="loc_ONMDPrivateWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivateWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesAndWarrantsMember" xlink:label="loc_ONMDPIPENotesAndWarrantsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesAndWarrantsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesMember" xlink:label="loc_ONMDConvertiblePromissoryNotesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_160" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:title="999076 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CEBALoanMember" xlink:label="loc_ONMDCEBALoanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDCEBALoanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivatePlacementWarrantsMember" xlink:label="loc_ONMDPrivatePlacementWarrantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivatePlacementWarrantsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaapConvertibleDebtFairValueDisclosures_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtFairValueDisclosures_80" xlink:type="arc" order="6" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>onmd-20240930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="srt_RestatementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RestatementAxis" xlink:to="srt_RestatementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RestatementAxis_lbl" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RestatedMember" xlink:label="ONMD_RestatedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RestatedMember" xlink:to="ONMD_RestatedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_RestatedMember_lbl" xml:lang="en-US">Restated [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="ONMD_SeriesATwoPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SeriesATwoPreferredStockMember" xlink:to="ONMD_SeriesATwoPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_SeriesATwoPreferredStockMember_lbl" xml:lang="en-US">Series A-2 Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="ONMD_SeriesAOnePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SeriesAOnePreferredStockMember" xlink:to="ONMD_SeriesAOnePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_SeriesAOnePreferredStockMember_lbl" xml:lang="en-US">Series A-1 Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SubscriptionRevenueMember" xlink:label="ONMD_SubscriptionRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SubscriptionRevenueMember" xlink:to="ONMD_SubscriptionRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_SubscriptionRevenueMember_lbl" xml:lang="en-US">Subscription Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WebImagingRevenueMember" xlink:label="ONMD_WebImagingRevenueMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WebImagingRevenueMember" xlink:to="ONMD_WebImagingRevenueMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_WebImagingRevenueMember_lbl" xml:lang="en-US">Web Imaging Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TemporaryEquityMember" xlink:label="ONMD_TemporaryEquityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TemporaryEquityMember" xlink:to="ONMD_TemporaryEquityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_TemporaryEquityMember_lbl" xml:lang="en-US">Temporary Equity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="us-gaap_RevenueFromContractWithCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerMember" xlink:to="us-gaap_RevenueFromContractWithCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerMember_lbl" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OneCustomerMember" xlink:label="ONMD_OneCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_OneCustomerMember" xlink:to="ONMD_OneCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_OneCustomerMember_lbl" xml:lang="en-US">One Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwoCustomersMember" xlink:label="ONMD_TwoCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwoCustomersMember" xlink:to="ONMD_TwoCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_TwoCustomersMember_lbl" xml:lang="en-US">Two Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ThreeCustomersMember" xlink:label="ONMD_ThreeCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ThreeCustomersMember" xlink:to="ONMD_ThreeCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ThreeCustomersMember_lbl" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetAxis" xlink:label="srt_CryptoAssetAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CryptoAssetAxis" xlink:to="srt_CryptoAssetAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CryptoAssetAxis_lbl" xml:lang="en-US">Crypto Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BitcoinMember" xlink:label="ONMD_BitcoinMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BitcoinMember" xlink:to="ONMD_BitcoinMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BitcoinMember_lbl" xml:lang="en-US">Bitcoin [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertibleNotesWarrantsMember" xlink:label="ONMD_ConvertibleNotesWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertibleNotesWarrantsMember" xlink:to="ONMD_ConvertibleNotesWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ConvertibleNotesWarrantsMember_lbl" xml:lang="en-US">Convertible Notes Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SecuritiesPurchaseAgreementMember" xlink:label="ONMD_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SecuritiesPurchaseAgreementMember" xlink:to="ONMD_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="ONMD_DataKnightsAcquisitionCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DataKnightsAcquisitionCorpMember" xlink:to="ONMD_DataKnightsAcquisitionCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DataKnightsAcquisitionCorpMember_lbl" xml:lang="en-US">Data Knights Acquisition Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_HelenaTerminationAgreementMember" xlink:label="ONMD_HelenaTerminationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_HelenaTerminationAgreementMember" xlink:to="ONMD_HelenaTerminationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_HelenaTerminationAgreementMember_lbl" xml:lang="en-US">Helena Termination Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StandbyEquityPurchaseAgreementMember" xlink:label="ONMD_StandbyEquityPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StandbyEquityPurchaseAgreementMember" xlink:to="ONMD_StandbyEquityPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StandbyEquityPurchaseAgreementMember_lbl" xml:lang="en-US">Standby Equity Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="ONMD_YorkvilleNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_YorkvilleNoteMember" xlink:to="ONMD_YorkvilleNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_YorkvilleNoteMember_lbl" xml:lang="en-US">Yorkville Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BeneficialOwnershipMember" xlink:label="ONMD_BeneficialOwnershipMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BeneficialOwnershipMember" xlink:to="ONMD_BeneficialOwnershipMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BeneficialOwnershipMember_lbl" xml:lang="en-US">Beneficial Ownership [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesMember" xlink:label="ONMD_ConvertiblePromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertiblePromissoryNotesMember" xlink:to="ONMD_ConvertiblePromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ConvertiblePromissoryNotesMember_lbl" xml:lang="en-US">Convertible Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoNotesMember" xlink:label="ONMD_TwentyTwentyTwoNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwentyTwentyTwoNotesMember" xlink:to="ONMD_TwentyTwentyTwoNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_TwentyTwentyTwoNotesMember_lbl" xml:lang="en-US">Twenty Twenty Two Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xml:lang="en-US">Nonrelated Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyThreeNotesMember" xlink:label="ONMD_TwentyTwentyThreeNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwentyTwentyThreeNotesMember" xlink:to="ONMD_TwentyTwentyThreeNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_TwentyTwentyThreeNotesMember_lbl" xml:lang="en-US">Twenty Twenty Three Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" xlink:label="ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" xlink:to="ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_lbl" xml:lang="en-US">Twenty Twenty Two Notes And Twenty Twenty Three Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BOCBankMember" xlink:label="ONMD_BOCBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BOCBankMember" xlink:to="ONMD_BOCBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BOCBankMember_lbl" xml:lang="en-US">B O C Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CEBALoanMember" xlink:label="ONMD_CEBALoanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CEBALoanMember" xlink:to="ONMD_CEBALoanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CEBALoanMember_lbl" xml:lang="en-US">CEBA Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockRepurchaseAgreementMember" xlink:label="ONMD_StockRepurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockRepurchaseAgreementMember" xlink:to="ONMD_StockRepurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockRepurchaseAgreementMember_lbl" xml:lang="en-US">Stock Repurchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_JulyTwoThousandTwentyFourFinancingMember" xlink:label="ONMD_JulyTwoThousandTwentyFourFinancingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_JulyTwoThousandTwentyFourFinancingMember" xlink:to="ONMD_JulyTwoThousandTwentyFourFinancingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_JulyTwoThousandTwentyFourFinancingMember_lbl" xml:lang="en-US">July Two Thousand Twenty Four Financing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrefundedWarrantsMember" xlink:label="ONMD_PrefundedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrefundedWarrantsMember" xlink:to="ONMD_PrefundedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PrefundedWarrantsMember_lbl" xml:lang="en-US">Prefunded Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeptemberTwoThousandTwentyFourFinancingMember" xlink:label="ONMD_SeptemberTwoThousandTwentyFourFinancingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SeptemberTwoThousandTwentyFourFinancingMember" xlink:to="ONMD_SeptemberTwoThousandTwentyFourFinancingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_SeptemberTwoThousandTwentyFourFinancingMember_lbl" xml:lang="en-US">September Two Thousand Twenty Four Financing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OptionsToPurchaseCommonStockMember" xlink:label="ONMD_OptionsToPurchaseCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_OptionsToPurchaseCommonStockMember" xlink:to="ONMD_OptionsToPurchaseCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_OptionsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Options To Purchase Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_UnvestedRestrictedStockUnitsAndAwardsMember" xlink:label="ONMD_UnvestedRestrictedStockUnitsAndAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_UnvestedRestrictedStockUnitsAndAwardsMember" xlink:to="ONMD_UnvestedRestrictedStockUnitsAndAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_UnvestedRestrictedStockUnitsAndAwardsMember_lbl" xml:lang="en-US">Unvested Restricted Stock Units And Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteMember" xlink:label="ONMD_ConvertiblePromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertiblePromissoryNoteMember" xlink:to="ONMD_ConvertiblePromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Convertible Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="us-gaap_SellingAndMarketingExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpenseMember" xlink:to="us-gaap_SellingAndMarketingExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpenseMember_lbl" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and Development Expense [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityIncentivePlanMember" xlink:label="ONMD_EquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquityIncentivePlanMember" xlink:to="ONMD_EquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EquityIncentivePlanMember_lbl" xml:lang="en-US">Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EmployeesDirectorsAndConsultantsMember" xlink:label="ONMD_EmployeesDirectorsAndConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EmployeesDirectorsAndConsultantsMember" xlink:to="ONMD_EmployeesDirectorsAndConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EmployeesDirectorsAndConsultantsMember_lbl" xml:lang="en-US">Employees Directors and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NewEquityIncentivePlanMember" xlink:label="ONMD_NewEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_NewEquityIncentivePlanMember" xlink:to="ONMD_NewEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_NewEquityIncentivePlanMember_lbl" xml:lang="en-US">New Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LiabilityClassifiedWarrantsMember" xlink:label="ONMD_LiabilityClassifiedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LiabilityClassifiedWarrantsMember" xlink:to="ONMD_LiabilityClassifiedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_LiabilityClassifiedWarrantsMember_lbl" xml:lang="en-US">Liability Classified Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="ONMD_BusinessCombinationWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationWarrantsMember" xlink:to="ONMD_BusinessCombinationWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationWarrantsMember_lbl" xml:lang="en-US">Business Combination Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="ONMD_PIPEWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PIPEWarrantsMember" xlink:to="ONMD_PIPEWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PIPEWarrantsMember_lbl" xml:lang="en-US">P I P E Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityClassifiedWarrantsMember" xlink:label="ONMD_EquityClassifiedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquityClassifiedWarrantsMember" xlink:to="ONMD_EquityClassifiedWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EquityClassifiedWarrantsMember_lbl" xml:lang="en-US">Equity Classified Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PublicWarrantsMember" xlink:label="ONMD_PublicWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PublicWarrantsMember" xlink:to="ONMD_PublicWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PublicWarrantsMember_lbl" xml:lang="en-US">Public Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivatePlacementWarrantsMember" xlink:label="ONMD_PrivatePlacementWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrivatePlacementWarrantsMember" xlink:to="ONMD_PrivatePlacementWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PrivatePlacementWarrantsMember_lbl" xml:lang="en-US">Private Placement Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LegacyONMDWarrantsMember" xlink:label="ONMD_LegacyONMDWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LegacyONMDWarrantsMember" xlink:to="ONMD_LegacyONMDWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_LegacyONMDWarrantsMember_lbl" xml:lang="en-US">Legacy O N M D Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteWarrantsMember" xlink:label="ONMD_ConvertiblePromissoryNoteWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertiblePromissoryNoteWarrantsMember" xlink:to="ONMD_ConvertiblePromissoryNoteWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ConvertiblePromissoryNoteWarrantsMember_lbl" xml:lang="en-US">Convertible Promissory Note Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesWarrantsMember" xlink:label="ONMD_ConvertiblePromissoryNotesWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertiblePromissoryNotesWarrantsMember" xlink:to="ONMD_ConvertiblePromissoryNotesWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ConvertiblePromissoryNotesWarrantsMember_lbl" xml:lang="en-US">Convertible Promissory Notes Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyOneServiceMember" xlink:label="ONMD_TwentyTwentyOneServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwentyTwentyOneServiceMember" xlink:to="ONMD_TwentyTwentyOneServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_TwentyTwentyOneServiceMember_lbl" xml:lang="en-US">2021 Service [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoServiceMember" xlink:label="ONMD_TwentyTwentyTwoServiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwentyTwentyTwoServiceMember" xlink:to="ONMD_TwentyTwentyTwoServiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_TwentyTwentyTwoServiceMember_lbl" xml:lang="en-US">2022 Service [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrivatePlacementMember_lbl" xml:lang="en-US">Private Placement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivateWarrantsMember" xlink:label="ONMD_PrivateWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrivateWarrantsMember" xlink:to="ONMD_PrivateWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PrivateWarrantsMember_lbl" xml:lang="en-US">Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="ONMD_PIPENotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PIPENotesMember" xlink:to="ONMD_PIPENotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PIPENotesMember_lbl" xml:lang="en-US">P I P E Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleStandbyEquityPurchaseAgreementMember" xlink:label="ONMD_YorkvilleStandbyEquityPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_YorkvilleStandbyEquityPurchaseAgreementMember" xlink:to="ONMD_YorkvilleStandbyEquityPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_YorkvilleStandbyEquityPurchaseAgreementMember_lbl" xml:lang="en-US">Yorkville Standby Equity Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="us-gaap_MeasurementInputExercisePriceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExercisePriceMember" xlink:to="us-gaap_MeasurementInputExercisePriceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExercisePriceMember_lbl" xml:lang="en-US">Measurement Input, Exercise Price [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesAndWarrantsMember" xlink:label="ONMD_ConvertiblePromissoryNotesAndWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertiblePromissoryNotesAndWarrantsMember" xlink:to="ONMD_ConvertiblePromissoryNotesAndWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ConvertiblePromissoryNotesAndWarrantsMember_lbl" xml:lang="en-US">Convertible Promissory Notes And Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsMember" xlink:label="ONMD_DataKnightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DataKnightsMember" xlink:to="ONMD_DataKnightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DataKnightsMember_lbl" xml:lang="en-US">Data Knights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ShareholderLoansMember" xlink:label="ONMD_ShareholderLoansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ShareholderLoansMember" xlink:to="ONMD_ShareholderLoansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ShareholderLoansMember_lbl" xml:lang="en-US">Shareholder Loans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_MsCoonseMcCrawMember" xlink:label="ONMD_MsCoonseMcCrawMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_MsCoonseMcCrawMember" xlink:to="ONMD_MsCoonseMcCrawMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_MsCoonseMcCrawMember_lbl" xml:lang="en-US">Ms Coonse Mc Craw [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_MrClarkeMember" xlink:label="ONMD_MrClarkeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_MrClarkeMember" xlink:to="ONMD_MrClarkeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_MrClarkeMember_lbl" xml:lang="en-US">Mr Clarke [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EFHuttonMember" xlink:label="ONMD_EFHuttonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EFHuttonMember" xlink:to="ONMD_EFHuttonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EFHuttonMember_lbl" xml:lang="en-US">EF Hutton [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_KingwoodCapitalPartnersLLCMember" xlink:label="ONMD_KingwoodCapitalPartnersLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_KingwoodCapitalPartnersLLCMember" xlink:to="ONMD_KingwoodCapitalPartnersLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_KingwoodCapitalPartnersLLCMember_lbl" xml:lang="en-US">Kingwood Capital Partners LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="srt_ScenarioPreviouslyReportedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioPreviouslyReportedMember" xlink:to="srt_ScenarioPreviouslyReportedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioPreviouslyReportedMember_lbl" xml:lang="en-US">Previously Reported [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:to="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_lbl" xml:lang="en-US">Revision of Prior Period, Reclassification, Adjustment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ReclassificationAdjustmentMember" xlink:label="ONMD_ReclassificationAdjustmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ReclassificationAdjustmentMember" xlink:to="ONMD_ReclassificationAdjustmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ReclassificationAdjustmentMember_lbl" xml:lang="en-US">Reclassification Adjustment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommitmentMember" xlink:label="ONMD_CommitmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommitmentMember" xlink:to="ONMD_CommitmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CommitmentMember_lbl" xml:lang="en-US">Commitment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AsRestatedMember" xlink:label="ONMD_AsRestatedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_AsRestatedMember" xlink:to="ONMD_AsRestatedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_AsRestatedMember_lbl" xml:lang="en-US">As Restated [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerOneMember" xlink:label="ONMD_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerOneMember" xlink:to="ONMD_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerTwoMember" xlink:label="ONMD_CustomerTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerTwoMember" xlink:to="ONMD_CustomerTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomersMember" xlink:label="ONMD_CustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomersMember" xlink:to="ONMD_CustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomersMember_lbl" xml:lang="en-US">Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerThreeMember" xlink:label="ONMD_CustomerThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerThreeMember" xlink:to="ONMD_CustomerThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomerThreeMember_lbl" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerFourMember" xlink:label="ONMD_CustomerFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerFourMember" xlink:to="ONMD_CustomerFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomerFourMember_lbl" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerFiveMember" xlink:label="ONMD_CustomerFiveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerFiveMember" xlink:to="ONMD_CustomerFiveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomerFiveMember_lbl" xml:lang="en-US">Customer Five [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerSixMember" xlink:label="ONMD_CustomerSixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerSixMember" xlink:to="ONMD_CustomerSixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomerSixMember_lbl" xml:lang="en-US">Customer Six [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerSevenMember" xlink:label="ONMD_CustomerSevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerSevenMember" xlink:to="ONMD_CustomerSevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CustomerSevenMember_lbl" xml:lang="en-US">Customer Seven [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationMember" xlink:label="ONMD_BusinessCombinationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationMember" xlink:to="ONMD_BusinessCombinationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationMember_lbl" xml:lang="en-US">Business Combination [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FurnitureAndEquipmentMember" xlink:label="ONMD_FurnitureAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FurnitureAndEquipmentMember" xlink:to="ONMD_FurnitureAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_FurnitureAndEquipmentMember_lbl" xml:lang="en-US">Furniture And Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesAndWarrantsMember" xlink:label="ONMD_PIPENotesAndWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PIPENotesAndWarrantsMember" xlink:to="ONMD_PIPENotesAndWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PIPENotesAndWarrantsMember_lbl" xml:lang="en-US">P I P E Notes And Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="us-gaap_CryptoAssetFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetFairValue" xlink:to="us-gaap_CryptoAssetFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetFairValue_lbl" xml:lang="en-US">Bitcoin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredCostsNonCurrent" xlink:label="ONMD_DeferredCostsNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredCostsNonCurrent" xlink:to="ONMD_DeferredCostsNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DeferredCostsNonCurrent_lbl" xml:lang="en-US">Deferred transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities, temporary equity and stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable &amp; accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="us-gaap_LoansPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableCurrent_lbl" xml:lang="en-US">Loan extensions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayable_lbl" xml:lang="en-US">Loan Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">PIPE Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNotesPayableCurrent" xlink:label="ONMD_YorkvilleNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_YorkvilleNotesPayableCurrent" xlink:to="ONMD_YorkvilleNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_YorkvilleNotesPayableCurrent_lbl" xml:lang="en-US">Yorkville Note</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="ONMD_DeferredUnderwriterFeePayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredUnderwriterFeePayableCurrent" xlink:to="ONMD_DeferredUnderwriterFeePayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DeferredUnderwriterFeePayableCurrent_lbl" xml:lang="en-US">Deferred underwriter fee payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Loan &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xml:lang="en-US">Convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="us-gaap_LongTermLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLoansPayable_lbl" xml:lang="en-US">Loan, related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Note 13)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="us-gaap_TemporaryEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAbstract" xlink:to="us-gaap_TemporaryEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAbstract_lbl" xml:lang="en-US">Temporary equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xml:lang="en-US">Total temporary equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; (deficit) equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in-capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="us-gaap_TreasuryStockCommonValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonValue" xlink:to="us-gaap_TreasuryStockCommonValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockCommonValue_lbl" xml:lang="en-US">Treasury stock, at cost, 187,745 and 0 shares at September 30, 2024 and December 31, 2023, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities, temporary equity, and stockholders&#8217; deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Accounts receivable, allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Temporary equity, par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Temporary equity, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Temporary equity, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Temporary equity, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Web imaging revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross margin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other expense (income), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:to="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity_lbl" xml:lang="en-US">Change in fair value of PIPE Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_GainLossOnFairValueOfYorkvilleNote" xlink:label="ONMD_GainLossOnFairValueOfYorkvilleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_GainLossOnFairValueOfYorkvilleNote" xlink:to="ONMD_GainLossOnFairValueOfYorkvilleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_GainLossOnFairValueOfYorkvilleNote_lbl" xml:lang="en-US">Change in fair value of Yorkville Note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xml:lang="en-US">Change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:label="us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:to="us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating_lbl" xml:lang="en-US">Change in fair value of Bitcoin</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:to="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes_lbl" xml:lang="en-US">Change in fair value of convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Stock warrant expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other expense, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings per share:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic net loss per common share outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net loss per common share outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic weighted average number of common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted weighted average number of common shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Series A-2 Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Series A-2 Preferred Stock. shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Repurchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Repurchase of common stock, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Vesting of restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Vesting of restricted stock units, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:to="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_lbl" xml:lang="en-US">Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:to="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts_lbl" xml:lang="en-US">Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" xlink:to="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee_lbl" xml:lang="en-US">Issuance of common stock to settle Yorkville commitment fee</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" xlink:to="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee_lbl" xml:lang="en-US">Issuance of common stock to settle Yorkville commitment fee, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Issuance of OMN warrants in conjunction with convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of common shares in exchange for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of common shares in exchange for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" xlink:to="ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock_lbl" xml:lang="en-US">Issuance of Legacy ONMD Series A-2 Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" xlink:to="ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock_lbl" xml:lang="en-US">Issuance of Legacy ONMD Series A-2 Preferred Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:label="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:to="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_lbl" xml:lang="en-US">Retroactive application of recapitalization due to the Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:label="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:to="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_lbl" xml:lang="en-US">Retroactive application of recapitalization due to the Business Combination, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of OMN stock options upon Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of OMN stock options upon Business Combination, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:to="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_lbl" xml:lang="en-US">Issuance of OMN warrants to board of directors</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="ONMD_StockIssuedDuringPeriodValueWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="ONMD_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xml:lang="en-US">Exercise of OMN warrants upon Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="ONMD_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xml:lang="en-US">Exercise of OMN warrants upon Business Combination, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_lbl" xml:lang="en-US">Conversion of OMN convertible promissory notes upon Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_lbl" xml:lang="en-US">Conversion of OMN convertible promissory notes upon Business Combination, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_lbl" xml:lang="en-US">Conversion of preferred stock to common stock upon Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_lbl" xml:lang="en-US">Conversion of preferred stock to common stock upon Business Combination, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:to="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_lbl" xml:lang="en-US">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:to="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_lbl" xml:lang="en-US">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="ONMD_StockWarrantExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantExpense" xlink:to="ONMD_StockWarrantExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_StockWarrantExpense_lbl" xml:lang="en-US">Stock warrant expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_2_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantExpense" xlink:label="ONMD_WarrantExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantExpense" xlink:to="ONMD_WarrantExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_WarrantExpense_lbl" xml:lang="en-US">Board of director warrant expense</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfYorkvilleNote" xlink:label="ONMD_ChangeInFairValueOfYorkvilleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfYorkvilleNote" xlink:to="ONMD_ChangeInFairValueOfYorkvilleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_ChangeInFairValueOfYorkvilleNote_lbl" xml:lang="en-US">Change in fair value of Yorkville Note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedLossNonoperating" xlink:label="us-gaap_CryptoAssetRealizedLossNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetRealizedLossNonoperating" xlink:to="us-gaap_CryptoAssetRealizedLossNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetRealizedLossNonoperating_lbl" xml:lang="en-US">Realized loss on sale of Bitcoin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on forgiveness of CEBA loan</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NoncashInterest" xlink:label="ONMD_NoncashInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_NoncashInterest" xlink:to="ONMD_NoncashInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_NoncashInterest_lbl" xml:lang="en-US">Non-cash interest</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" xlink:label="ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" xlink:to="ONMD_ChangeInFairValueOfConvertiblePromissoryNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ChangeInFairValueOfConvertiblePromissoryNotes_lbl" xml:lang="en-US">Change in fair value of convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable &amp; accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForAcquisitionCryptoAsset" xlink:to="us-gaap_PaymentForAcquisitionCryptoAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_lbl" xml:lang="en-US">Purchases of Bitcoin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDisposalCryptoAsset" xlink:label="us-gaap_ProceedsFromDisposalCryptoAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDisposalCryptoAsset" xlink:to="us-gaap_ProceedsFromDisposalCryptoAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDisposalCryptoAsset_lbl" xml:lang="en-US">Sales of Bitcoin</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from private placements, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="ONMD_ProceedsFromIssuanceOfShareholderLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:to="ONMD_ProceedsFromIssuanceOfShareholderLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ProceedsFromIssuanceOfShareholderLoans_lbl" xml:lang="en-US">Proceeds from issuance of shareholder loans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from issuance of pipe notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from issuance of Yorkville Note, net of issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from line of credit borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_RepaymentsOfLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLongTermDebt_lbl" xml:lang="en-US">Repayment of shareholder loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Repayment of line of credit borrowings</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RepaymentForCommonStockRepurchase" xlink:label="ONMD_RepaymentForCommonStockRepurchase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RepaymentForCommonStockRepurchase" xlink:to="ONMD_RepaymentForCommonStockRepurchase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_RepaymentForCommonStockRepurchase_lbl" xml:lang="en-US">Repayment for common stock repurchase</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RepaymentOfDeferredUnderwriterFees" xlink:label="ONMD_RepaymentOfDeferredUnderwriterFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RepaymentOfDeferredUnderwriterFees" xlink:to="ONMD_RepaymentOfDeferredUnderwriterFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_RepaymentOfDeferredUnderwriterFees_lbl" xml:lang="en-US">Repayment of deferred underwriter fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="us-gaap_RepaymentsOfBankDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfBankDebt" xlink:to="us-gaap_RepaymentsOfBankDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfBankDebt_lbl" xml:lang="en-US">Repayment of CEBA loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from issuance of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Proceeds from issuance of Series A-2 preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCosts" xlink:label="ONMD_BusinessCombinationCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationCosts" xlink:to="ONMD_BusinessCombinationCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_BusinessCombinationCosts_lbl" xml:lang="en-US">Business Combination costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net decrease in cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and cash equivalents at beginning year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssued1_lbl" xml:lang="en-US">Common shares issued to preferred shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" xlink:label="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" xlink:to="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes_lbl" xml:lang="en-US">Common shares related to convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesIssuedToDataKnightsShareholders" xlink:label="ONMD_CommonSharesIssuedToDataKnightsShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonSharesIssuedToDataKnightsShareholders" xlink:to="ONMD_CommonSharesIssuedToDataKnightsShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CommonSharesIssuedToDataKnightsShareholders_lbl" xml:lang="en-US">Common shares issued to Data Knights shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" xlink:label="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" xlink:to="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable_lbl" xml:lang="en-US">Issuance of common stock to settle deferred underwriter fee payable</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" xlink:label="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" xlink:to="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses_lbl" xml:lang="en-US">Consideration for repurchase of common stock included in accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetTextBlock" xlink:label="us-gaap_CryptoAssetTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetTextBlock" xlink:to="us-gaap_CryptoAssetTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetTextBlock_lbl" xml:lang="en-US">Crypto Assets Held</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Convertible Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">Line of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Canadian Emergency Business Account (&#8220;CEBA&#8221;)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_2_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Net Loss per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DisclosureStockWarrantsAbstract" xlink:label="ONMD_DisclosureStockWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DisclosureStockWarrantsAbstract" xlink:to="ONMD_DisclosureStockWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DisclosureStockWarrantsAbstract_lbl" xml:lang="en-US">Stock Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantsDisclosureTextBlock" xlink:label="ONMD_StockWarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantsDisclosureTextBlock" xlink:to="ONMD_StockWarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_StockWarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Stock Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_2_lbl" xml:lang="en-US">Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xml:lang="en-US">Treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative financial instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetPolicyTextBlock" xlink:label="srt_PlatformOperatorCryptoAssetPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_PlatformOperatorCryptoAssetPolicyTextBlock" xlink:to="srt_PlatformOperatorCryptoAssetPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_PlatformOperatorCryptoAssetPolicyTextBlock_lbl" xml:lang="en-US">Crypto assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EmergingGrowthCompanyPolicyTextBlock" xlink:label="ONMD_EmergingGrowthCompanyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EmergingGrowthCompanyPolicyTextBlock" xlink:to="ONMD_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EmergingGrowthCompanyPolicyTextBlock_lbl" xml:lang="en-US">Emerging growth company status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Accounting Pronouncements Not Yet Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RestatementToFinancialStatementsPolicyTextBlock" xlink:label="ONMD_RestatementToFinancialStatementsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RestatementToFinancialStatementsPolicyTextBlock" xlink:to="ONMD_RestatementToFinancialStatementsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_RestatementToFinancialStatementsPolicyTextBlock_lbl" xml:lang="en-US">Restatement to Previously Issued Consolidated Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OperatingSegmentsPolicyTextBlock" xlink:label="ONMD_OperatingSegmentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_OperatingSegmentsPolicyTextBlock" xlink:to="ONMD_OperatingSegmentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_OperatingSegmentsPolicyTextBlock_lbl" xml:lang="en-US">Operating Segments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueOptionOfAccountingPolicyTextBlock" xlink:label="ONMD_FairValueOptionOfAccountingPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FairValueOptionOfAccountingPolicyTextBlock" xlink:to="ONMD_FairValueOptionOfAccountingPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_FairValueOptionOfAccountingPolicyTextBlock_lbl" xml:lang="en-US">Fair value option of accounting</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantPolicyTextBlock" xlink:label="ONMD_WarrantPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantPolicyTextBlock" xlink:to="ONMD_WarrantPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_WarrantPolicyTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PatentsAndTrademarksPolicyTextBlock" xlink:label="ONMD_PatentsAndTrademarksPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PatentsAndTrademarksPolicyTextBlock" xlink:to="ONMD_PatentsAndTrademarksPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PatentsAndTrademarksPolicyTextBlock_lbl" xml:lang="en-US">Patents and Trademarks</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xml:lang="en-US">General and Administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently adopted accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTableTextBlock" xlink:label="us-gaap_CryptoAssetHoldingTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetHoldingTableTextBlock" xlink:to="us-gaap_CryptoAssetHoldingTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetHoldingTableTextBlock_lbl" xml:lang="en-US">Schedule of Crypto Assets Held</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetActivityTableTextBlock" xlink:label="us-gaap_CryptoAssetActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetActivityTableTextBlock" xlink:to="us-gaap_CryptoAssetActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Crypto Assets Reconciliation of Fair Values</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Schedule of Stock-based Compensation Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Options Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Award Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrants Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value Assumptions and Valuation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Fair Value Assumptions and Valuation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US">Schedule of Warrants and Promissory Notes Measured at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Shareholder Loans Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:to="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_lbl" xml:lang="en-US">Schedule of Aggregate Percentage Revenue and Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Schedule of Aggregate Percentage Revenue and Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Schedule of Aggregate Percentage Revenue and Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementOfCashFlowsAbstract_2_lbl" xml:lang="en-US">Schedule of Aggregate Percentage Revenue and Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Schedule of Aggregate Percentage Revenue and Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_lbl" xml:lang="en-US">Schedule of Aggregate Percentage Revenue and Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US">Schedule of Business Combination Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Income (Loss) Before Provision for Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Income Tax Provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Income Tax Benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Deferred Tax Assets and Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated defecit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CryptoCash" xlink:label="ONMD_CryptoCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CryptoCash" xlink:to="ONMD_CryptoCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_CryptoCash_lbl" xml:lang="en-US">Crypto assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Nature of Operation, Product Information, Concentration of Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Percentage of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTable" xlink:label="us-gaap_CryptoAssetHoldingTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetHoldingTable" xlink:to="us-gaap_CryptoAssetHoldingTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetHoldingTable_lbl" xml:lang="en-US">Crypto Asset, Holding [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingLineItems" xlink:label="us-gaap_CryptoAssetHoldingLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetHoldingLineItems" xlink:to="us-gaap_CryptoAssetHoldingLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetHoldingLineItems_lbl" xml:lang="en-US">Crypto Asset, Holding [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="us-gaap_CryptoAssetNumberOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetNumberOfUnits" xlink:to="us-gaap_CryptoAssetNumberOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetNumberOfUnits_lbl" xml:lang="en-US">Crypto assets, Units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetCost" xlink:label="us-gaap_CryptoAssetCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetCost" xlink:to="us-gaap_CryptoAssetCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetCost_lbl" xml:lang="en-US">Crypto assets, Cost Basis</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetFairValue" xlink:to="us-gaap_CryptoAssetFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CryptoAssetFairValue_2_lbl" xml:lang="en-US">Crypto assets, Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetFairValue" xlink:to="us-gaap_CryptoAssetFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CryptoAssetFairValue_3_lbl" xml:lang="en-US">Balance, December 31, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetAddition" xlink:label="us-gaap_CryptoAssetAddition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetAddition" xlink:to="us-gaap_CryptoAssetAddition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetAddition_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetDisposition" xlink:label="us-gaap_CryptoAssetDisposition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetDisposition" xlink:to="us-gaap_CryptoAssetDisposition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CryptoAssetDisposition_lbl" xml:lang="en-US">Dispositions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:to="us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating_2_lbl" xml:lang="en-US">Unrealized loss, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetFairValue" xlink:to="us-gaap_CryptoAssetFairValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CryptoAssetFairValue_4_lbl" xml:lang="en-US">Balance, September 30, 2024</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetDisposition" xlink:to="us-gaap_CryptoAssetDisposition_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetDisposition_2_lbl" xml:lang="en-US">Bitcoin dispositions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating" xlink:label="us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating" xlink:to="us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating_lbl" xml:lang="en-US">Bitcoin realized losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xml:lang="en-US">Debt conversion converted instrument rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Debt description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">PIPE notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoans" xlink:label="us-gaap_ProceedsFromLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLoans" xlink:to="us-gaap_ProceedsFromLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLoans_lbl" xml:lang="en-US">Loans payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Stock issued during period shares conversion of convertible securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Debt conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrant outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to acquire common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Convertible promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Original issue discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FloorPricePerShare" xlink:label="ONMD_FloorPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FloorPricePerShare" xlink:to="ONMD_FloorPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_FloorPricePerShare_lbl" xml:lang="en-US">Floor price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrecentageOfOutstandingCommonStock" xlink:label="ONMD_PrecentageOfOutstandingCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrecentageOfOutstandingCommonStock" xlink:to="ONMD_PrecentageOfOutstandingCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PrecentageOfOutstandingCommonStock_lbl" xml:lang="en-US">Precentage of outstanding common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_lbl" xml:lang="en-US">Beneficial ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DebtInstrumentInterestRateDefaultPercentage" xlink:label="ONMD_DebtInstrumentInterestRateDefaultPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DebtInstrumentInterestRateDefaultPercentage" xlink:to="ONMD_DebtInstrumentInterestRateDefaultPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DebtInstrumentInterestRateDefaultPercentage_lbl" xml:lang="en-US">Debt default interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_YorkvilleNotesPayableCurrent" xlink:to="ONMD_YorkvilleNotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_YorkvilleNotesPayableCurrent_2_lbl" xml:lang="en-US">Fair value of Yorkville Note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xml:lang="en-US">Debt Instrument, Maturity Date, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xml:lang="en-US">Proceeds from equity financing</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityFinancingDescription" xlink:label="ONMD_EquityFinancingDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquityFinancingDescription" xlink:to="ONMD_EquityFinancingDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EquityFinancingDescription_lbl" xml:lang="en-US">Equity financing, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_2_lbl" xml:lang="en-US">Proceeds from PIPE notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionDescription" xlink:label="us-gaap_DebtConversionDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionDescription" xlink:to="us-gaap_DebtConversionDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionDescription_lbl" xml:lang="en-US">Debt Conversion, Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Long-Term Line of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfUnsecuredDebt_lbl" xml:lang="en-US">Proceeds from loans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDecreaseForgiveness_lbl" xml:lang="en-US">Forgiven of loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xml:lang="en-US">Conversion of loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Loan payment term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Gain loss on extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable_lbl" xml:lang="en-US">Business combination, underwriter fees payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Business combination, closing cash balance</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_lbl" xml:lang="en-US">Promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_lbl" xml:lang="en-US">Debt maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesTransferred" xlink:label="ONMD_StockIssuedDuringPeriodSharesTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesTransferred" xlink:to="ONMD_StockIssuedDuringPeriodSharesTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesTransferred_lbl" xml:lang="en-US">Number of shares transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Closing stock price</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_VolumeWeightedAveragePrice" xlink:label="ONMD_VolumeWeightedAveragePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_VolumeWeightedAveragePrice" xlink:to="ONMD_VolumeWeightedAveragePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_VolumeWeightedAveragePrice_lbl" xml:lang="en-US">Volume weighted average price</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_VolumeWeightedAveragePriceValue" xlink:label="ONMD_VolumeWeightedAveragePriceValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_VolumeWeightedAveragePriceValue" xlink:to="ONMD_VolumeWeightedAveragePriceValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_VolumeWeightedAveragePriceValue_lbl" xml:lang="en-US">Volume weighted average price, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:label="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:to="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_lbl" xml:lang="en-US">Description of contingent consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of shares, issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Number of shares issued, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Debt instrument maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Promissory note payment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockRepurchasedDuringPeriodValueExchangeForCash" xlink:label="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash" xlink:to="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash_lbl" xml:lang="en-US">Number of shares repurchased, value exchange for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" xlink:label="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" xlink:to="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_lbl" xml:lang="en-US">Principal and accrued interest outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Sale of stock, value</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockholdersDeficitDescription" xlink:label="ONMD_StockholdersDeficitDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockholdersDeficitDescription" xlink:to="ONMD_StockholdersDeficitDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockholdersDeficitDescription_lbl" xml:lang="en-US">Stockholders deficit description</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CashStructuringFee" xlink:label="ONMD_CashStructuringFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CashStructuringFee" xlink:to="ONMD_CashStructuringFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CashStructuringFee_lbl" xml:lang="en-US">Cash structuring fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl" xml:lang="en-US">Commitment fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Payments of common stock issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Conversion of stock amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="us-gaap_ConversionOfStockAmountIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversion of stock amount issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_2_lbl" xml:lang="en-US">Interest rate percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" xlink:to="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet_lbl" xml:lang="en-US">Fair value of embedded derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:to="us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_lbl" xml:lang="en-US">Emdedded derivative liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of shares issue and sold</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Common stock price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrants exercisable for common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2_lbl" xml:lang="en-US">Proceeds from issuance of private placement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Offering expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="us-gaap_CommonStockSharesSubscriptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscriptions" xlink:to="us-gaap_CommonStockSharesSubscriptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesSubscriptions_lbl" xml:lang="en-US">Common stock shares not yet issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalUnitsAuthorized" xlink:label="us-gaap_CapitalUnitsAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalUnitsAuthorized" xlink:to="us-gaap_CapitalUnitsAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalUnitsAuthorized_lbl" xml:lang="en-US">Capital stock authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Capital stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="us-gaap_DividendsPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStock_lbl" xml:lang="en-US">Dividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2_lbl" xml:lang="en-US">Proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockLiquidationPreferenceValue" xlink:to="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockLiquidationPreferenceValue_lbl" xml:lang="en-US">Liquidation preference amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:to="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockTermsOfConversion_lbl" xml:lang="en-US">Convertible preferred stock terms of conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total common stock equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Total stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Share-based payment award, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Options vested exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Fair value of stock awards vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Grant Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xml:lang="en-US">Conversion ratio</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xml:lang="en-US">Warrants to purchase common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Warrants exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfWarrants" xlink:label="ONMD_ChangeInFairValueOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfWarrants" xlink:to="ONMD_ChangeInFairValueOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_ChangeInFairValueOfWarrants_lbl" xml:lang="en-US">Change in fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashExpense" xlink:label="us-gaap_OtherNoncashExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl" xml:lang="en-US">Other expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Warrants to acquire common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total assets, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Total liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_lbl" xml:lang="en-US">Fair Value, off-Balance-Sheet Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_lbl" xml:lang="en-US">Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance, December 31, 2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_lbl" xml:lang="en-US">Changes in fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2_lbl" xml:lang="en-US">Balance, September 30, 2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingMeasurementInput_lbl" xml:lang="en-US">Warrants measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Expected term (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xml:lang="en-US">Shareholder loans &#8211; nonconvertible</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Shareholder loans &#8211; convertible</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Total loan &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_2_lbl" xml:lang="en-US">Related party proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xml:lang="en-US">Gross proceeds from convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermDebt" xlink:label="us-gaap_OtherLongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermDebt" xlink:to="us-gaap_OtherLongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLongTermDebt_lbl" xml:lang="en-US">Non convertible shareholder loan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentTerm_2_lbl" xml:lang="en-US">Debt term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LoansPayableCurrent_2_lbl" xml:lang="en-US">Loans remains outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Number of warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Shareholder loan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:to="ONMD_ProceedsFromIssuanceOfShareholderLoans_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_ProceedsFromIssuanceOfShareholderLoans_2_lbl" xml:lang="en-US">Shareholder loans outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtension" xlink:label="ONMD_LoanExtension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LoanExtension" xlink:to="ONMD_LoanExtension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_LoanExtension_lbl" xml:lang="en-US">Loan extensions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Rent expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustCurrent" xlink:label="us-gaap_AssetsHeldInTrustCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustCurrent" xlink:to="us-gaap_AssetsHeldInTrustCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsHeldInTrustCurrent_lbl" xml:lang="en-US">Investments held in trust</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_2_lbl" xml:lang="en-US">Accounts receivable, net of allowance of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Loan amount due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ExciseTaxCurrent" xlink:label="ONMD_ExciseTaxCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ExciseTaxCurrent" xlink:to="ONMD_ExciseTaxCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ExciseTaxCurrent_lbl" xml:lang="en-US">Excise tax</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtensionsCurrent" xlink:label="ONMD_LoanExtensionsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LoanExtensionsCurrent" xlink:to="ONMD_LoanExtensionsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_LoanExtensionsCurrent_lbl" xml:lang="en-US">Loan extensions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LoansPayable_2_lbl" xml:lang="en-US">Loan payable</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CanadaEmergencyBusinessLoanAct" xlink:label="ONMD_CanadaEmergencyBusinessLoanAct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CanadaEmergencyBusinessLoanAct" xlink:to="ONMD_CanadaEmergencyBusinessLoanAct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CanadaEmergencyBusinessLoanAct_lbl" xml:lang="en-US">Canada Emergency Business Loan Act</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="us-gaap_AccruedIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedIncomeTaxesCurrent_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayableCurrent_2_lbl" xml:lang="en-US">PIPE notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_lbl" xml:lang="en-US">Franchise tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtCurrent" xlink:label="us-gaap_UnsecuredDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtCurrent" xlink:to="us-gaap_UnsecuredDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnsecuredDebtCurrent_lbl" xml:lang="en-US">Canada Emergency Business Loan Act</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AccruedInterestRelatedParty" xlink:label="ONMD_AccruedInterestRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_AccruedInterestRelatedParty" xlink:to="ONMD_AccruedInterestRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_AccruedInterestRelatedParty_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LongTermLoansPayable_2_lbl" xml:lang="en-US">Extension loans</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableNonCurrent" xlink:label="ONMD_DeferredUnderwriterFeePayableNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredUnderwriterFeePayableNonCurrent" xlink:to="ONMD_DeferredUnderwriterFeePayableNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_DeferredUnderwriterFeePayableNonCurrent_lbl" xml:lang="en-US">Deferred underwriter fee payable</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WorkingCapitalLoan" xlink:label="ONMD_WorkingCapitalLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WorkingCapitalLoan" xlink:to="ONMD_WorkingCapitalLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_WorkingCapitalLoan_lbl" xml:lang="en-US">Working capital loan</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantLiabilityNonCurrent" xlink:label="ONMD_WarrantLiabilityNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantLiabilityNonCurrent" xlink:to="ONMD_WarrantLiabilityNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_WarrantLiabilityNonCurrent_lbl" xml:lang="en-US">Warrant liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockValue_2_lbl" xml:lang="en-US">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="us-gaap_OtherGeneralExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherGeneralExpense" xlink:to="us-gaap_OtherGeneralExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherGeneralExpense_lbl" xml:lang="en-US">Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncomeTaxProvision" xlink:label="ONMD_IncomeTaxProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncomeTaxProvision" xlink:to="ONMD_IncomeTaxProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_IncomeTaxProvision_lbl" xml:lang="en-US">Income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges" xlink:label="us-gaap_AssetImpairmentCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentCharges" xlink:to="us-gaap_AssetImpairmentCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentCharges_lbl" xml:lang="en-US">Impairment</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_UnrealizedGainLoss" xlink:label="ONMD_UnrealizedGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_UnrealizedGainLoss" xlink:to="ONMD_UnrealizedGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_UnrealizedGainLoss_lbl" xml:lang="en-US">Unrealized gain or loss</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCost" xlink:label="ONMD_BusinessCombinationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationCost" xlink:to="ONMD_BusinessCombinationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationCost_lbl" xml:lang="en-US">Business combination cost</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CashHeldInTrustAccount" xlink:label="ONMD_CashHeldInTrustAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CashHeldInTrustAccount" xlink:to="ONMD_CashHeldInTrustAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CashHeldInTrustAccount_lbl" xml:lang="en-US">Cash held in trust account</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpenses" xlink:label="ONMD_StockWarrantExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantExpenses" xlink:to="ONMD_StockWarrantExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_StockWarrantExpenses_lbl" xml:lang="en-US">Stock warrant expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantExpense" xlink:to="ONMD_WarrantExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_WarrantExpense_2_lbl" xml:lang="en-US">Board of director warrant expense</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfWarrantLiabilities" xlink:label="ONMD_ChangeInFairValueOfWarrantLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfWarrantLiabilities" xlink:to="ONMD_ChangeInFairValueOfWarrantLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_ChangeInFairValueOfWarrantLiabilities_lbl" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfPipeNotes" xlink:label="ONMD_ChangeInFairValueOfPipeNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfPipeNotes" xlink:to="ONMD_ChangeInFairValueOfPipeNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_ChangeInFairValueOfPipeNotes_lbl" xml:lang="en-US">Change in fair value of PIPE Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xml:lang="en-US">Amount due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInExerciseTaxLiability" xlink:label="ONMD_IncreaseDecreaseInExerciseTaxLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseInExerciseTaxLiability" xlink:to="ONMD_IncreaseDecreaseInExerciseTaxLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_IncreaseDecreaseInExerciseTaxLiability_lbl" xml:lang="en-US">Excise tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInExtensionLoan" xlink:label="ONMD_IncreaseDecreaseInExtensionLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseInExtensionLoan" xlink:to="ONMD_IncreaseDecreaseInExtensionLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_IncreaseDecreaseInExtensionLoan_lbl" xml:lang="en-US">Extension loan</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseFranchiseTaxPayable" xlink:label="ONMD_IncreaseDecreaseFranchiseTaxPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseFranchiseTaxPayable" xlink:to="ONMD_IncreaseDecreaseFranchiseTaxPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_IncreaseDecreaseFranchiseTaxPayable_lbl" xml:lang="en-US">Franchise tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Income tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInWorkingCapitalLoan" xlink:label="ONMD_IncreaseDecreaseInWorkingCapitalLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseInWorkingCapitalLoan" xlink:to="ONMD_IncreaseDecreaseInWorkingCapitalLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_IncreaseDecreaseInWorkingCapitalLoan_lbl" xml:lang="en-US">Working capital loan</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct" xlink:label="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct" xlink:to="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct_lbl" xml:lang="en-US">Payments of Canada Emergency Business Loan Act</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_3_lbl" xml:lang="en-US">Proceeds from issuance of PIPE notes</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromCommonStockSubjectToRedemption" xlink:label="ONMD_ProceedsFromCommonStockSubjectToRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromCommonStockSubjectToRedemption" xlink:to="ONMD_ProceedsFromCommonStockSubjectToRedemption_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ProceedsFromCommonStockSubjectToRedemption_lbl" xml:lang="en-US">Common stock subject to redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromDeferredUnderwritingFee" xlink:label="ONMD_ProceedsFromDeferredUnderwritingFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromDeferredUnderwritingFee" xlink:to="ONMD_ProceedsFromDeferredUnderwritingFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ProceedsFromDeferredUnderwritingFee_lbl" xml:lang="en-US">Deferred underwriting fee</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromWarrantLiability" xlink:label="ONMD_ProceedsFromWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromWarrantLiability" xlink:to="ONMD_ProceedsFromWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_ProceedsFromWarrantLiability_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="us-gaap_ProceedsFromContributedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromContributedCapital" xlink:to="us-gaap_ProceedsFromContributedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromContributedCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProccedsFromRetainedEarningsAdjustment" xlink:label="ONMD_ProccedsFromRetainedEarningsAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProccedsFromRetainedEarningsAdjustment" xlink:to="ONMD_ProccedsFromRetainedEarningsAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ProccedsFromRetainedEarningsAdjustment_lbl" xml:lang="en-US">Retained earnings adjustment</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" xlink:label="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" xlink:to="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock_lbl" xml:lang="en-US">Proceeds from issuance of Series A-2 preferred stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationCosts" xlink:to="ONMD_BusinessCombinationCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ONMD_BusinessCombinationCosts_2_lbl" xml:lang="en-US">Business Combination Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesIssuedToPreferredShareholders" xlink:label="ONMD_CommonSharesIssuedToPreferredShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonSharesIssuedToPreferredShareholders" xlink:to="ONMD_CommonSharesIssuedToPreferredShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_CommonSharesIssuedToPreferredShareholders_lbl" xml:lang="en-US">Common shares issued to preferred shareholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:to="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_2_lbl" xml:lang="en-US">Retroactive application of recapitalization due to Business Combination</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:to="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_2_lbl" xml:lang="en-US">Retroactive application of recapitalization due to Business Combination, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_lbl" xml:lang="en-US">Exercise of OMN stock options upon Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_lbl" xml:lang="en-US">Exercise of OMN stock options upon Business Combination, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_lbl" xml:lang="en-US">Conversion of OMN convertible loans upon Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_lbl" xml:lang="en-US">Conversion of OMN convertible loans upon Business Combination, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Private OneMedNet to ONMD Public Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Private OneMedNet to ONMD Public Shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Issuance of PIPE warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonStockSubjectToPossibleRedemptionValue" xlink:label="ONMD_CommonStockSubjectToPossibleRedemptionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonStockSubjectToPossibleRedemptionValue" xlink:to="ONMD_CommonStockSubjectToPossibleRedemptionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CommonStockSubjectToPossibleRedemptionValue_lbl" xml:lang="en-US">Common stock redemption</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" xlink:label="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" xlink:to="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment_lbl" xml:lang="en-US">Retained earnings adjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_2_lbl" xml:lang="en-US">Aggregate Percent of Revenue and Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xml:lang="en-US">Payment premium percentage on principal amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xml:lang="en-US">Number of restricted stock units granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Business combination, consideration underwriting commission</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_3_lbl" xml:lang="en-US">Bought back shares of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLoans" xlink:to="us-gaap_ProceedsFromLoans_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromLoans_2_lbl" xml:lang="en-US">Gross proceeds from related party loans</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleDebt_2_lbl" xml:lang="en-US">Loans converted into common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Non convertible loans</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Business combination, consideration underwriting commission</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRepaidPrincipal" xlink:to="us-gaap_DebtInstrumentRepaidPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRepaidPrincipal_lbl" xml:lang="en-US">Non convertible loans repaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xml:lang="en-US">Proceeds form convertible notes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_3_lbl" xml:lang="en-US">Sale of share price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="us-gaap_WarrantsAndRightsOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Warrants outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Share issued price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Warrants exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityPurchaseAgreementDescription" xlink:label="ONMD_EquityPurchaseAgreementDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquityPurchaseAgreementDescription" xlink:to="ONMD_EquityPurchaseAgreementDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EquityPurchaseAgreementDescription_lbl" xml:lang="en-US">Equity purchase agreement description</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ShareOutstandingVotingPercentage" xlink:label="ONMD_ShareOutstandingVotingPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ShareOutstandingVotingPercentage" xlink:to="ONMD_ShareOutstandingVotingPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ShareOutstandingVotingPercentage_lbl" xml:lang="en-US">Shares outstanding voting percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xml:lang="en-US">Sale of stock percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoanProcessingFee" xlink:label="us-gaap_LoanProcessingFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanProcessingFee" xlink:to="us-gaap_LoanProcessingFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanProcessingFee_lbl" xml:lang="en-US">Structuring fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForManagementFee" xlink:label="us-gaap_PaymentForManagementFee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForManagementFee" xlink:to="us-gaap_PaymentForManagementFee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentForManagementFee_lbl" xml:lang="en-US">Commitment fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansPayable_3_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentDescription_2_lbl" xml:lang="en-US">Debt instrument description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeDescriptionOfTerms" xlink:label="us-gaap_DerivativeDescriptionOfTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeDescriptionOfTerms" xlink:to="us-gaap_DerivativeDescriptionOfTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeDescriptionOfTerms_lbl" xml:lang="en-US">Description of promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFloorPrice" xlink:label="us-gaap_DerivativeFloorPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFloorPrice" xlink:to="us-gaap_DerivativeFloorPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFloorPrice_lbl" xml:lang="en-US">Floor price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeBenefitsAndShareBasedCompensation_lbl" xml:lang="en-US">Monthly shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Shares exerciseable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Restricted stock units</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Restricted stock units issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_lbl" xml:lang="en-US">Accounts payable &amp; accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_lbl" xml:lang="en-US">Loan extensions</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_lbl" xml:lang="en-US">Deferred underwriter fee payable</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_lbl" xml:lang="en-US">Warrant liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Net Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Business combination transfered</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_3_lbl" xml:lang="en-US">Share issued price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="us-gaap_FairValueOfAssetsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfAssetsAcquired" xlink:to="us-gaap_FairValueOfAssetsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfAssetsAcquired_lbl" xml:lang="en-US">Fair value of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Conversion of convertible securities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_2_lbl" xml:lang="en-US">Temporary equity shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Stock options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:to="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityLiquidationPreferencePerShare_lbl" xml:lang="en-US">Temporaray equity liquidation preference per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xml:lang="en-US">Business combination cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business combination net liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xml:lang="en-US">Business combination transaction cost</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessAcquisitionCostPercentage" xlink:label="ONMD_BusinessAcquisitionCostPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessAcquisitionCostPercentage" xlink:to="ONMD_BusinessAcquisitionCostPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessAcquisitionCostPercentage_lbl" xml:lang="en-US">Business combination percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIssuedPrincipal" xlink:to="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIssuedPrincipal_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_lbl" xml:lang="en-US">Business combination underwriter fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_3_lbl" xml:lang="en-US">Debt maturity date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredUnderwriterFeePayableCurrent" xlink:to="ONMD_DeferredUnderwriterFeePayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_DeferredUnderwriterFeePayableCurrent_2_lbl" xml:lang="en-US">Business combination cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Total property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US">United States</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Foreign</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Total loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Current federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">Current state</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Current foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total current tax provision (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred federal</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred state</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOtherTaxExpenseBenefit" xlink:to="us-gaap_DeferredOtherTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit_lbl" xml:lang="en-US">Total deferred tax provision (benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total income tax provision (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Tax provision at statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes, net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xml:lang="en-US">Permanent differences - other</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" xlink:to="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_lbl" xml:lang="en-US">Change in fair value of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:to="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_lbl" xml:lang="en-US">Change in fair value of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_lbl" xml:lang="en-US">Other, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredTaxAssetsCapitalizedResearchCosts" xlink:label="ONMD_DeferredTaxAssetsCapitalizedResearchCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredTaxAssetsCapitalizedResearchCosts" xlink:to="ONMD_DeferredTaxAssetsCapitalizedResearchCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DeferredTaxAssetsCapitalizedResearchCosts_lbl" xml:lang="en-US">Capitalized research costs</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredTaxAssetsFixedAssets" xlink:label="ONMD_DeferredTaxAssetsFixedAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredTaxAssetsFixedAssets" xlink:to="ONMD_DeferredTaxAssetsFixedAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DeferredTaxAssetsFixedAssets_lbl" xml:lang="en-US">Fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total gross deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesNetAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US">Federal and state net operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carry forward</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OperatingLossCarryForwardIndefinitely" xlink:label="ONMD_OperatingLossCarryForwardIndefinitely" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_OperatingLossCarryForwardIndefinitely" xlink:to="ONMD_OperatingLossCarryForwardIndefinitely_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_OperatingLossCarryForwardIndefinitely_lbl" xml:lang="en-US">Operating loss carry forward indefinitely</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" xlink:to="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe_lbl" xml:lang="en-US">Effective federal income tax percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Deferred tax assets valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Options outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic value, begining balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options, Granted - under the Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4_lbl" xml:lang="en-US">Options, Exercised - under the Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Options, cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic value, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Options outstanding, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average exercise price, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Options vested and exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price, vested and exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic value, exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:label="us-gaap_EquitySecuritiesFvNiMeasurementInput" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:to="us-gaap_EquitySecuritiesFvNiMeasurementInput_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesFvNiMeasurementInput_lbl" xml:lang="en-US">Equity securities, measurement input</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquitySecuritiesFvNiMeasurementTerm" xlink:label="ONMD_EquitySecuritiesFvNiMeasurementTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquitySecuritiesFvNiMeasurementTerm" xlink:to="ONMD_EquitySecuritiesFvNiMeasurementTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EquitySecuritiesFvNiMeasurementTerm_lbl" xml:lang="en-US">Expected life in years</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of RSU's, Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of Awards, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value,Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Number of Awards,Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value,Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number of Awards Outstanding, Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems_lbl" xml:lang="en-US">Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_lbl" xml:lang="en-US">Reclassified to additional paid-in-capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_2_lbl" xml:lang="en-US">Loan repayable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Aggregate fair value of PIPE warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xml:lang="en-US">Aggregate fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SecuritiesPurchaseAgreementMember" xlink:to="ONMD_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DataKnightsAcquisitionCorpMember" xlink:to="ONMD_DataKnightsAcquisitionCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_DataKnightsAcquisitionCorpMember_doc" xml:lang="en-US">Data Knights Acquisition Corp [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_OperatingSegmentsPolicyTextBlock" xlink:to="ONMD_OperatingSegmentsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_OperatingSegmentsPolicyTextBlock_doc" xml:lang="en-US">Operating Segments [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerOneMember" xlink:to="ONMD_CustomerOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerTwoMember" xlink:to="ONMD_CustomerTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerThreeMember" xlink:to="ONMD_CustomerThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CustomerThreeMember_doc" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerFourMember" xlink:to="ONMD_CustomerFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CustomerFourMember_doc" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomerFiveMember" xlink:to="ONMD_CustomerFiveMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CustomerFiveMember_doc" xml:lang="en-US">Customer Five [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredUnderwriterFeePayableNonCurrent" xlink:to="ONMD_DeferredUnderwriterFeePayableNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_DeferredUnderwriterFeePayableNonCurrent_doc" xml:lang="en-US">Deferred underwriter fee payable noncurrent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredUnderwriterFeePayableCurrent" xlink:to="ONMD_DeferredUnderwriterFeePayableCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_DeferredUnderwriterFeePayableCurrent_doc" xml:lang="en-US">Deferred underwriter fee payable current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WorkingCapitalLoan" xlink:to="ONMD_WorkingCapitalLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_WorkingCapitalLoan_doc" xml:lang="en-US">Working capital loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LoanExtensionsCurrent" xlink:to="ONMD_LoanExtensionsCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_LoanExtensionsCurrent_doc" xml:lang="en-US">Loan extensions current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PatentsAndTrademarksPolicyTextBlock" xlink:to="ONMD_PatentsAndTrademarksPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_PatentsAndTrademarksPolicyTextBlock_doc" xml:lang="en-US">Patents And Trademarks [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EmergingGrowthCompanyPolicyTextBlock" xlink:to="ONMD_EmergingGrowthCompanyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EmergingGrowthCompanyPolicyTextBlock_doc" xml:lang="en-US">Emerging Growth Company [Policy Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="ONMD_AccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_AccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="ONMD_AccountingPronouncementsNotYetAdoptedPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_AccountingPronouncementsNotYetAdoptedPolicyTextBlock_doc" xml:lang="en-US">Accounting Pronouncements Not Yet Adopted [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SeriesATwoPreferredStockMember" xlink:to="ONMD_SeriesATwoPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_SeriesATwoPreferredStockMember_doc" xml:lang="en-US">Series A Two Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SeriesAOnePreferredStockMember" xlink:to="ONMD_SeriesAOnePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_SeriesAOnePreferredStockMember_doc" xml:lang="en-US">Series A One Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseFranchiseTaxPayable" xlink:to="ONMD_IncreaseDecreaseFranchiseTaxPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_IncreaseDecreaseFranchiseTaxPayable_doc" xml:lang="en-US">Increase decrease franchise tax payable.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfCommonStockOne" xlink:label="ONMD_ProceedsFromIssuanceOfCommonStockOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromIssuanceOfCommonStockOne" xlink:to="ONMD_ProceedsFromIssuanceOfCommonStockOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromIssuanceOfCommonStockOne_doc" xml:lang="en-US">Proceeds from issuance of common stock one.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfCommonStockTwo" xlink:label="ONMD_ProceedsFromIssuanceOfCommonStockTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromIssuanceOfCommonStockTwo" xlink:to="ONMD_ProceedsFromIssuanceOfCommonStockTwo_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromIssuanceOfCommonStockTwo_doc" xml:lang="en-US">Proceeds from issuance of common stock two.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonClassAOneMember" xlink:label="ONMD_CommonClassAOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonClassAOneMember" xlink:to="ONMD_CommonClassAOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CommonClassAOneMember_doc" xml:lang="en-US">Common Class A One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProccedsFromRetainedEarningsAdjustment" xlink:to="ONMD_ProccedsFromRetainedEarningsAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProccedsFromRetainedEarningsAdjustment_doc" xml:lang="en-US">Procceds from retained earnings adjustment.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromBusinessLoan" xlink:label="ONMD_ProceedsFromBusinessLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromBusinessLoan" xlink:to="ONMD_ProceedsFromBusinessLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromBusinessLoan_doc" xml:lang="en-US">Proceeds from business loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromDeferredUnderwritingFee" xlink:to="ONMD_ProceedsFromDeferredUnderwritingFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromDeferredUnderwritingFee_doc" xml:lang="en-US">Proceeds from deferred under writing fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromCommonStockSubjectToRedemption" xlink:to="ONMD_ProceedsFromCommonStockSubjectToRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromCommonStockSubjectToRedemption_doc" xml:lang="en-US">Proceeds from common stock subject to redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationCost" xlink:to="ONMD_BusinessCombinationCost_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationCost_doc" xml:lang="en-US">Business combination cost.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CashHeldInTrustAccount" xlink:to="ONMD_CashHeldInTrustAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CashHeldInTrustAccount_doc" xml:lang="en-US">Cash held in trust account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_UnrealizedGainLoss" xlink:to="ONMD_UnrealizedGainLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_UnrealizedGainLoss_doc" xml:lang="en-US">Unrealized gain loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseInExtensionLoan" xlink:to="ONMD_IncreaseDecreaseInExtensionLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_IncreaseDecreaseInExtensionLoan_doc" xml:lang="en-US">Increase decrease in extension loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseInWorkingCapitalLoan" xlink:to="ONMD_IncreaseDecreaseInWorkingCapitalLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_IncreaseDecreaseInWorkingCapitalLoan_doc" xml:lang="en-US">Increase decrease in working capital loan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseInExerciseTaxLiability" xlink:to="ONMD_IncreaseDecreaseInExerciseTaxLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_IncreaseDecreaseInExerciseTaxLiability_doc" xml:lang="en-US">Increase decrease in exercise tax liability.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ClassBCommonStock" xlink:label="ONMD_ClassBCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ClassBCommonStock" xlink:to="ONMD_ClassBCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ClassBCommonStock_doc" xml:lang="en-US">Class B common stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfPipeWarrants" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfPipeWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueIssuanceOfPipeWarrants" xlink:to="ONMD_StockIssuedDuringPeriodValueIssuanceOfPipeWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfPipeWarrants_doc" xml:lang="en-US">Stock issued during period value issuance of pipe warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CustomersMember" xlink:to="ONMD_CustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CustomersMember_doc" xml:lang="en-US">Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsToCommonStock" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueStockOptionsToCommonStock" xlink:to="ONMD_StockIssuedDuringPeriodValueStockOptionsToCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsToCommonStock_doc" xml:lang="en-US">Stock issued during period value stock options to common stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConvertingOfWarrantsToCommonStock" xlink:label="ONMD_StockIssuedDuringPeriodValueConvertingOfWarrantsToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConvertingOfWarrantsToCommonStock" xlink:to="ONMD_StockIssuedDuringPeriodValueConvertingOfWarrantsToCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueConvertingOfWarrantsToCommonStock_doc" xml:lang="en-US">Stock issued during period value converting of warrants to common stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConvertingDataKnightsCommonShares" xlink:label="ONMD_StockIssuedDuringPeriodValueConvertingDataKnightsCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConvertingDataKnightsCommonShares" xlink:to="ONMD_StockIssuedDuringPeriodValueConvertingDataKnightsCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueConvertingDataKnightsCommonShares_doc" xml:lang="en-US">Stock issued during period value converting data knights common shares.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsToCommonStock" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesStockOptionsToCommonStock" xlink:to="ONMD_StockIssuedDuringPeriodSharesStockOptionsToCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsToCommonStock_doc" xml:lang="en-US">Stock issued during period shares stock options to common stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConvertingOfWarrantsToCommonStock" xlink:label="ONMD_StockIssuedDuringPeriodSharesConvertingOfWarrantsToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConvertingOfWarrantsToCommonStock" xlink:to="ONMD_StockIssuedDuringPeriodSharesConvertingOfWarrantsToCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesConvertingOfWarrantsToCommonStock_doc" xml:lang="en-US">Stock issued during period shares converting of warrants to common stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConvertingDataKnightsCommonShares" xlink:label="ONMD_StockIssuedDuringPeriodSharesConvertingDataKnightsCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConvertingDataKnightsCommonShares" xlink:to="ONMD_StockIssuedDuringPeriodSharesConvertingDataKnightsCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesConvertingDataKnightsCommonShares_doc" xml:lang="en-US">Stock Issued During Period shares converting data knights common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquityFinancingDescription" xlink:to="ONMD_EquityFinancingDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EquityFinancingDescription_doc" xml:lang="en-US">Equity financing description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CEBALoanMember" xlink:to="ONMD_CEBALoanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CEBALoanMember_doc" xml:lang="en-US">CEBA Loan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BoardOfDirectorsMember" xlink:label="ONMD_BoardOfDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BoardOfDirectorsMember" xlink:to="ONMD_BoardOfDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BoardOfDirectorsMember_doc" xml:lang="en-US">Board Of Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EmployeesDirectorsAndConsultantsMember" xlink:to="ONMD_EmployeesDirectorsAndConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EmployeesDirectorsAndConsultantsMember_doc" xml:lang="en-US">Employees Directors and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_NewEquityIncentivePlanMember" xlink:to="ONMD_NewEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_NewEquityIncentivePlanMember_doc" xml:lang="en-US">New Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquitySecuritiesFvNiMeasurementTerm" xlink:to="ONMD_EquitySecuritiesFvNiMeasurementTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EquitySecuritiesFvNiMeasurementTerm_doc" xml:lang="en-US">Equity securities FvNi measurement term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantsDisclosureTextBlock" xlink:to="ONMD_StockWarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockWarrantsDisclosureTextBlock_doc" xml:lang="en-US">Stock warrants disclosure text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwentyTwentyOneServiceMember" xlink:to="ONMD_TwentyTwentyOneServiceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_TwentyTwentyOneServiceMember_doc" xml:lang="en-US">Twenty Twenty One Service [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwentyTwentyTwoServiceMember" xlink:to="ONMD_TwentyTwentyTwoServiceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_TwentyTwentyTwoServiceMember_doc" xml:lang="en-US">Twenty Twenty Two Service [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiableNotesMember" xlink:label="ONMD_ConvertiableNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertiableNotesMember" xlink:to="ONMD_ConvertiableNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ConvertiableNotesMember_doc" xml:lang="en-US">Convertiable Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ExtensionLoan" xlink:label="ONMD_ExtensionLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ExtensionLoan" xlink:to="ONMD_ExtensionLoan_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ExtensionLoan_doc" xml:lang="en-US">Extension loan.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantOneMember" xlink:label="ONMD_WarrantOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantOneMember" xlink:to="ONMD_WarrantOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_WarrantOneMember_doc" xml:lang="en-US">Warrant One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PubliclyTradedWarrantsMember" xlink:label="ONMD_PubliclyTradedWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PubliclyTradedWarrantsMember" xlink:to="ONMD_PubliclyTradedWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_PubliclyTradedWarrantsMember_doc" xml:lang="en-US">Publicly Traded Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrivateWarrantsMember" xlink:to="ONMD_PrivateWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_PrivateWarrantsMember_doc" xml:lang="en-US">Private Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeniorConvertibleNotesMember" xlink:label="ONMD_SeniorConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_SeniorConvertibleNotesMember" xlink:to="ONMD_SeniorConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_SeniorConvertibleNotesMember_doc" xml:lang="en-US">Senior Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ManagementAndDirectorsMember" xlink:label="ONMD_ManagementAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ManagementAndDirectorsMember" xlink:to="ONMD_ManagementAndDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ManagementAndDirectorsMember_doc" xml:lang="en-US">Management and Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EFHuttonMember" xlink:to="ONMD_EFHuttonMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EFHuttonMember_doc" xml:lang="en-US">EF Hutton [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_KingwoodCapitalPartnersLLCMember" xlink:to="ONMD_KingwoodCapitalPartnersLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_KingwoodCapitalPartnersLLCMember_doc" xml:lang="en-US">Kingwood Capital Partners LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConvertiblePromissoryNotesMember" xlink:to="ONMD_ConvertiblePromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ConvertiblePromissoryNotesMember_doc" xml:lang="en-US">Convertible Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantLiabilityNonCurrent" xlink:to="ONMD_WarrantLiabilityNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_WarrantLiabilityNonCurrent_doc" xml:lang="en-US">Warrant liability non current.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConvertibleNotesToCommonStock" xlink:label="ONMD_StockIssuedDuringPeriodSharesConvertibleNotesToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConvertibleNotesToCommonStock" xlink:to="ONMD_StockIssuedDuringPeriodSharesConvertibleNotesToCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesConvertibleNotesToCommonStock_doc" xml:lang="en-US">Stock issued during period shares convertible notes to common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_OneCustomerMember" xlink:to="ONMD_OneCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_OneCustomerMember_doc" xml:lang="en-US">One Customer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_TwoCustomersMember" xlink:to="ONMD_TwoCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_TwoCustomersMember_doc" xml:lang="en-US">Two Customers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ThreeCustomersMember" xlink:to="ONMD_ThreeCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ThreeCustomersMember_doc" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfPipeWarrants" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfPipeWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesIssuanceOfPipeWarrants" xlink:to="ONMD_StockIssuedDuringPeriodSharesIssuanceOfPipeWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesIssuanceOfPipeWarrants_doc" xml:lang="en-US">Stock issued during period shares issuance of pipe warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromWarrantLiability" xlink:to="ONMD_ProceedsFromWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromWarrantLiability_doc" xml:lang="en-US">Proceeds from warrant liability.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_InvestmentsHeldInTrustMember" xlink:label="ONMD_InvestmentsHeldInTrustMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_InvestmentsHeldInTrustMember" xlink:to="ONMD_InvestmentsHeldInTrustMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_InvestmentsHeldInTrustMember_doc" xml:lang="en-US">Investments Held In Trust [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_AccruedInterestRelatedParty" xlink:to="ONMD_AccruedInterestRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_AccruedInterestRelatedParty_doc" xml:lang="en-US">Accrued interest related party.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueCommonStockRedemption" xlink:label="ONMD_StockIssuedDuringPeriodValueCommonStockRedemption" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueCommonStockRedemption" xlink:to="ONMD_StockIssuedDuringPeriodValueCommonStockRedemption_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueCommonStockRedemption_doc" xml:lang="en-US">Stock issued during period value common stock redemption.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonStockSubjectToPossibleRedemptionValue" xlink:to="ONMD_CommonStockSubjectToPossibleRedemptionValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CommonStockSubjectToPossibleRedemptionValue_doc" xml:lang="en-US">Common stock subject to possible redemption value.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConvertibleNotesToCommonStock" xlink:label="ONMD_StockIssuedDuringPeriodValueConvertibleNotesToCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConvertibleNotesToCommonStock" xlink:to="ONMD_StockIssuedDuringPeriodValueConvertibleNotesToCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueConvertibleNotesToCommonStock_doc" xml:lang="en-US">Stock issued during period value convertible notes to common stock.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetainedEarningsAdjustment" xlink:label="ONMD_RetainedEarningsAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RetainedEarningsAdjustment" xlink:to="ONMD_RetainedEarningsAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_RetainedEarningsAdjustment_doc" xml:lang="en-US">Retained earnings adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommitmentMember" xlink:to="ONMD_CommitmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CommitmentMember_doc" xml:lang="en-US">Commitment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:to="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity_doc" xml:lang="en-US">Fair value adjustment of private investment in public equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_GainLossOnFairValueOfYorkvilleNote" xlink:to="ONMD_GainLossOnFairValueOfYorkvilleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_GainLossOnFairValueOfYorkvilleNote_doc" xml:lang="en-US">Gain loss on fair value of Yorkville note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:to="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes_doc" xml:lang="en-US">Fair value adjustment of convertible promissory notes.</link:label>
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpenseNonOperating" xlink:label="ONMD_StockWarrantExpenseNonOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantExpenseNonOperating" xlink:to="ONMD_StockWarrantExpenseNonOperating_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockWarrantExpenseNonOperating_doc" xml:lang="en-US">Stock warrant expense non operating.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" xlink:to="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee_doc" xml:lang="en-US">Stock issued during period value issuance of common stock to settle commitment fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_YorkvilleNotesPayableCurrent" xlink:to="ONMD_YorkvilleNotesPayableCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_YorkvilleNotesPayableCurrent_doc" xml:lang="en-US">Yorkville notes payable current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RepaymentForCommonStockRepurchase" xlink:to="ONMD_RepaymentForCommonStockRepurchase_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_RepaymentForCommonStockRepurchase_doc" xml:lang="en-US">Repayment for common stock repurchase.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationCosts" xlink:to="ONMD_BusinessCombinationCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationCosts_doc" xml:lang="en-US">Business combination costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" xlink:to="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable_doc" xml:lang="en-US">Issuance of common stock to settle deferred underwriter fee payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" xlink:to="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses_doc" xml:lang="en-US">Consideration for repurchase of common stock included in accounts payable and accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CryptoCash" xlink:to="ONMD_CryptoCash_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CryptoCash_doc" xml:lang="en-US">Crypto cash.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RepaymentOfDeferredUnderwriterFees" xlink:to="ONMD_RepaymentOfDeferredUnderwriterFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_RepaymentOfDeferredUnderwriterFees_doc" xml:lang="en-US">Repayment of deferred underwriter fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FloorPricePerShare" xlink:to="ONMD_FloorPricePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_FloorPricePerShare_doc" xml:lang="en-US">Floor price per share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrecentageOfOutstandingCommonStock" xlink:to="ONMD_PrecentageOfOutstandingCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_PrecentageOfOutstandingCommonStock_doc" xml:lang="en-US">Precentage of outstanding common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DebtInstrumentInterestRateDefaultPercentage" xlink:to="ONMD_DebtInstrumentInterestRateDefaultPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_DebtInstrumentInterestRateDefaultPercentage_doc" xml:lang="en-US">Debt instrument interest rate default percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed notes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesTransferred" xlink:to="ONMD_StockIssuedDuringPeriodSharesTransferred_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesTransferred_doc" xml:lang="en-US">Stock issued during period shares transferred.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_VolumeWeightedAveragePrice" xlink:to="ONMD_VolumeWeightedAveragePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_VolumeWeightedAveragePrice_doc" xml:lang="en-US">Volume weighted average price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_VolumeWeightedAveragePriceValue" xlink:to="ONMD_VolumeWeightedAveragePriceValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_VolumeWeightedAveragePriceValue_doc" xml:lang="en-US">Volume weighted average price value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash" xlink:to="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockRepurchasedDuringPeriodValueExchangeForCash_doc" xml:lang="en-US">Stock repurchased during period value exchange for cash.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" xlink:to="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_doc" xml:lang="en-US">Principal and accrued interest outstanding on convertible promissory note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockholdersDeficitDescription" xlink:to="ONMD_StockholdersDeficitDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockholdersDeficitDescription_doc" xml:lang="en-US">Stockholders deficit description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CashStructuringFee" xlink:to="ONMD_CashStructuringFee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CashStructuringFee_doc" xml:lang="en-US">Cash structuring fee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfWarrants" xlink:to="ONMD_ChangeInFairValueOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ChangeInFairValueOfWarrants_doc" xml:lang="en-US">Change in fair value of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:to="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_doc" xml:lang="en-US">Retroactive application of recapitalization due to business combination shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_doc" xml:lang="en-US">Business combination recognized identifiable assets maturity date assumed notes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:to="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_doc" xml:lang="en-US">Stock issued during period value issuance of warrants to board of directors.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_doc" xml:lang="en-US">Stock issued during period value conversion of convertible promissory notes upon business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_doc" xml:lang="en-US">Stock issued during period shares conversion of preferred stock to common stock upon business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:to="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_doc" xml:lang="en-US">Stock issued during period value stock options upon business combination with net of liabilities assumed and transaction costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:to="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_doc" xml:lang="en-US">Stock issued during period shares stock options upon business combination with net of liabilities assumed and transaction costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantExpenses" xlink:to="ONMD_StockWarrantExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockWarrantExpenses_doc" xml:lang="en-US">Stock warrant expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfWarrantLiabilities" xlink:to="ONMD_ChangeInFairValueOfWarrantLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ChangeInFairValueOfWarrantLiabilities_doc" xml:lang="en-US">Change in fair value of warrant liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantExpense" xlink:to="ONMD_WarrantExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_WarrantExpense_doc" xml:lang="en-US">Warrant expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfPipeNotes" xlink:to="ONMD_ChangeInFairValueOfPipeNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ChangeInFairValueOfPipeNotes_doc" xml:lang="en-US">Change in fair value of pipe notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" xlink:to="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CommonSharesRelatedToConvertiblePromissoryNotes_doc" xml:lang="en-US">Common shares related to convertible promissory notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonSharesIssuedToDataKnightsShareholders" xlink:to="ONMD_CommonSharesIssuedToDataKnightsShareholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CommonSharesIssuedToDataKnightsShareholders_doc" xml:lang="en-US">Common shares issued to data knights shareholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RestatementToFinancialStatementsPolicyTextBlock" xlink:to="ONMD_RestatementToFinancialStatementsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_RestatementToFinancialStatementsPolicyTextBlock_doc" xml:lang="en-US">Restatement to financial statements [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ExciseTaxCurrent" xlink:to="ONMD_ExciseTaxCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ExciseTaxCurrent_doc" xml:lang="en-US">Excise tax current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CanadaEmergencyBusinessLoanAct" xlink:to="ONMD_CanadaEmergencyBusinessLoanAct_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CanadaEmergencyBusinessLoanAct_doc" xml:lang="en-US">Canada emergency business loan act.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncomeTaxProvision" xlink:to="ONMD_IncomeTaxProvision_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_IncomeTaxProvision_doc" xml:lang="en-US">Income tax provision.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct" xlink:to="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct_doc" xml:lang="en-US">Proceeds from canada emergency business loan act.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" xlink:to="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock_doc" xml:lang="en-US">Proceeds from issuance of series A2 preferred stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonSharesIssuedToPreferredShareholders" xlink:to="ONMD_CommonSharesIssuedToPreferredShareholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_CommonSharesIssuedToPreferredShareholders_doc" xml:lang="en-US">Common shares issued to preferred shareholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_doc" xml:lang="en-US">Stock issued during period value stock options exercised upon business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_doc" xml:lang="en-US">Stock issued during period shares stock options exercised upon business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_doc" xml:lang="en-US">Stock issued during period value conversion of convertible loans upon business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_doc" xml:lang="en-US">Stock issued during period shares conversion of convertible loans upon business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" xlink:to="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment_doc" xml:lang="en-US">Stock issued during period value retained earnings adjustment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FairValueOptionOfAccountingPolicyTextBlock" xlink:to="ONMD_FairValueOptionOfAccountingPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_FairValueOptionOfAccountingPolicyTextBlock_doc" xml:lang="en-US">Fair value option of accounting [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_WarrantPolicyTextBlock" xlink:to="ONMD_WarrantPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_WarrantPolicyTextBlock_doc" xml:lang="en-US">Warrant [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed accounts payable and accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessAcquisitionCostPercentage" xlink:to="ONMD_BusinessAcquisitionCostPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessAcquisitionCostPercentage_doc" xml:lang="en-US">Business acquisition cost percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed underwriter fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" xlink:to="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_doc" xml:lang="en-US">Effective Income Tax Rate Reconciliation Change In Fair Value Of Convertible Notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:to="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_doc" xml:lang="en-US">Effective income tax rate reconciliation change in fair value of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredTaxAssetsCapitalizedResearchCosts" xlink:to="ONMD_DeferredTaxAssetsCapitalizedResearchCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_DeferredTaxAssetsCapitalizedResearchCosts_doc" xml:lang="en-US">Deferred tax assets capitalized research costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredTaxAssetsFixedAssets" xlink:to="ONMD_DeferredTaxAssetsFixedAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_DeferredTaxAssetsFixedAssets_doc" xml:lang="en-US">Deferred tax assets fixed assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_OperatingLossCarryForwardIndefinitely" xlink:to="ONMD_OperatingLossCarryForwardIndefinitely_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_OperatingLossCarryForwardIndefinitely_doc" xml:lang="en-US">Operating loss carryforward indefinitely.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" xlink:to="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe_doc" xml:lang="en-US">Effective income tax rate reconciliation state and local income taxe.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LoanExtension" xlink:to="ONMD_LoanExtension_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_LoanExtension_doc" xml:lang="en-US">Loan extension.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EquityPurchaseAgreementDescription" xlink:to="ONMD_EquityPurchaseAgreementDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_EquityPurchaseAgreementDescription_doc" xml:lang="en-US">Equity purchase agreement description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ShareOutstandingVotingPercentage" xlink:to="ONMD_ShareOutstandingVotingPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ShareOutstandingVotingPercentage_doc" xml:lang="en-US">Share outstanding voting percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_doc" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Loan Extension.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed deferred underwriter fee payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed warrant liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ReclassificationAdjustmentMember" xlink:to="ONMD_ReclassificationAdjustmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_ReclassificationAdjustmentMember_doc" xml:lang="en-US">Reclassification Adjustment [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_doc" xml:lang="en-US">Recently Adopted Accounting Pronouncements Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtNoncurrent_2_lbl" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonValue" xlink:to="us-gaap_TreasuryStockCommonValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonValue_2_lbl" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2_lbl" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:to="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes_3_lbl" xml:lang="en-US">FairValueAdjustmentOfConvertiblePromissoryNotes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantExpense" xlink:to="ONMD_StockWarrantExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockWarrantExpense_2_lbl" xml:lang="en-US">StockWarrantExpense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfYorkvilleNote" xlink:to="ONMD_ChangeInFairValueOfYorkvilleNote_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ChangeInFairValueOfYorkvilleNote_2_lbl" xml:lang="en-US">ChangeInFairValueOfYorkvilleNote</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForAcquisitionCryptoAsset" xlink:to="us-gaap_PaymentForAcquisitionCryptoAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForAcquisitionCryptoAsset_2_lbl" xml:lang="en-US">Payment for Acquisition, Crypto Asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermDebt" xlink:to="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLongTermDebt_2_lbl" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xml:lang="en-US">Repayments of Lines of Credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RepaymentForCommonStockRepurchase" xlink:to="ONMD_RepaymentForCommonStockRepurchase_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_RepaymentForCommonStockRepurchase_3_lbl" xml:lang="en-US">RepaymentForCommonStockRepurchase</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_RepaymentOfDeferredUnderwriterFees" xlink:to="ONMD_RepaymentOfDeferredUnderwriterFees_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_RepaymentOfDeferredUnderwriterFees_3_lbl" xml:lang="en-US">RepaymentOfDeferredUnderwriterFees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfBankDebt" xlink:to="us-gaap_RepaymentsOfBankDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfBankDebt_2_lbl" xml:lang="en-US">Repayments of Bank Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationCosts" xlink:to="ONMD_BusinessCombinationCosts_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationCosts_4_lbl" xml:lang="en-US">BusinessCombinationCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantsDisclosureTextBlock" xlink:to="ONMD_StockWarrantsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockWarrantsDisclosureTextBlock_3_lbl" xml:lang="en-US">StockWarrantsDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_2_lbl" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CryptoCash" xlink:to="ONMD_CryptoCash_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CryptoCash_3_lbl" xml:lang="en-US">CryptoCash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense, Operating and Nonoperating</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfWarrants" xlink:to="ONMD_ChangeInFairValueOfWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ChangeInFairValueOfWarrants_3_lbl" xml:lang="en-US">ChangeInFairValueOfWarrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_3_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_lbl" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_2_lbl" xml:lang="en-US">Interest Payable, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Long-Term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LoanExtension" xlink:to="ONMD_LoanExtension_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_LoanExtension_3_lbl" xml:lang="en-US">LoanExtension</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_LoanExtensionsCurrent" xlink:to="ONMD_LoanExtensionsCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_LoanExtensionsCurrent_3_lbl" xml:lang="en-US">LoanExtensionsCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebtCurrent" xlink:to="us-gaap_UnsecuredDebtCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnsecuredDebtCurrent_2_lbl" xml:lang="en-US">Unsecured Debt, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_AccruedInterestRelatedParty" xlink:to="ONMD_AccruedInterestRelatedParty_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_AccruedInterestRelatedParty_3_lbl" xml:lang="en-US">AccruedInterestRelatedParty</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_DeferredUnderwriterFeePayableNonCurrent" xlink:to="ONMD_DeferredUnderwriterFeePayableNonCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_DeferredUnderwriterFeePayableNonCurrent_3_lbl" xml:lang="en-US">DeferredUnderwriterFeePayableNonCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_UnrealizedGainLoss" xlink:to="ONMD_UnrealizedGainLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_UnrealizedGainLoss_3_lbl" xml:lang="en-US">UnrealizedGainLoss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockWarrantExpenses" xlink:to="ONMD_StockWarrantExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockWarrantExpenses_3_lbl" xml:lang="en-US">StockWarrantExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfWarrantLiabilities" xlink:to="ONMD_ChangeInFairValueOfWarrantLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ChangeInFairValueOfWarrantLiabilities_3_lbl" xml:lang="en-US">ChangeInFairValueOfWarrantLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ChangeInFairValueOfPipeNotes" xlink:to="ONMD_ChangeInFairValueOfPipeNotes_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ChangeInFairValueOfPipeNotes_3_lbl" xml:lang="en-US">ChangeInFairValueOfPipeNotes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseFranchiseTaxPayable" xlink:to="ONMD_IncreaseDecreaseFranchiseTaxPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_IncreaseDecreaseFranchiseTaxPayable_3_lbl" xml:lang="en-US">IncreaseDecreaseFranchiseTaxPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_IncreaseDecreaseInWorkingCapitalLoan" xlink:to="ONMD_IncreaseDecreaseInWorkingCapitalLoan_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_IncreaseDecreaseInWorkingCapitalLoan_3_lbl" xml:lang="en-US">IncreaseDecreaseInWorkingCapitalLoan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromWarrantLiability" xlink:to="ONMD_ProceedsFromWarrantLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ProceedsFromWarrantLiability_3_lbl" xml:lang="en-US">ProceedsFromWarrantLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" xlink:to="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock_3_lbl" xml:lang="en-US">ProceedsFromIssuanceOfSeriesA2PreferredStock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_CommonSharesIssuedToPreferredShareholders" xlink:to="ONMD_CommonSharesIssuedToPreferredShareholders_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_CommonSharesIssuedToPreferredShareholders_3_lbl" xml:lang="en-US">CommonSharesIssuedToPreferredShareholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" xlink:to="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" xlink:to="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodValueRetainedEarningsAdjustment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_2_lbl" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForManagementFee" xlink:to="us-gaap_PaymentForManagementFee_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentForManagementFee_2_lbl" xml:lang="en-US">Payment for Management Fee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:to="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOtherTaxExpenseBenefit" xlink:to="us-gaap_DeferredOtherTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Other Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:to="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_3_lbl" xml:lang="en-US">EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>onmd-20240930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://onemednet.com/role/Cover" xlink:href="onmd-20240930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BalanceSheets" xlink:href="onmd-20240930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BalanceSheetsParenthetical" xlink:href="onmd-20240930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfOperations" xlink:href="onmd-20240930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:href="onmd-20240930.xsd#StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StatementsOfCashFlows" xlink:href="onmd-20240930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/DescriptionOfBusiness" xlink:href="onmd-20240930.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeld" xlink:href="onmd-20240930.xsd#CryptoAssetsHeld" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ConvertibleDebt" xlink:href="onmd-20240930.xsd#ConvertibleDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/LineOfCredit" xlink:href="onmd-20240930.xsd#LineOfCredit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessAccountCeba" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockholdersDeficit" xlink:href="onmd-20240930.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/NetLossPerShare" xlink:href="onmd-20240930.xsd#NetLossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensation" xlink:href="onmd-20240930.xsd#Stock-basedCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrants" xlink:href="onmd-20240930.xsd#StockWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/FairValueMeasurements" xlink:href="onmd-20240930.xsd#FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactions" xlink:href="onmd-20240930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CommitmentsAndContingencies" xlink:href="onmd-20240930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEvents" xlink:href="onmd-20240930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombination" xlink:href="onmd-20240930.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipment" xlink:href="onmd-20240930.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxes" xlink:href="onmd-20240930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessLoanActCeba" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeldTables" xlink:href="onmd-20240930.xsd#CryptoAssetsHeldTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/NetLossPerShareTables" xlink:href="onmd-20240930.xsd#NetLossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensationTables" xlink:href="onmd-20240930.xsd#Stock-basedCompensationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrantsTables" xlink:href="onmd-20240930.xsd#StockWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/FairValueMeasurementsTables" xlink:href="onmd-20240930.xsd#FairValueMeasurementsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactionsTables" xlink:href="onmd-20240930.xsd#RelatedPartyTransactionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEventsTables" xlink:href="onmd-20240930.xsd#SubsequentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombinationTables" xlink:href="onmd-20240930.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipmentTables" xlink:href="onmd-20240930.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxesTables" xlink:href="onmd-20240930.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative" xlink:href="onmd-20240930.xsd#DescriptionOfBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="onmd-20240930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails" xlink:href="onmd-20240930.xsd#ScheduleOfCryptoAssetsHeldDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative" xlink:href="onmd-20240930.xsd#CryptoAssetsHeldDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ConvertibleDebtDetailsNarrative" xlink:href="onmd-20240930.xsd#ConvertibleDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/LineOfCreditDetailsNarrative" xlink:href="onmd-20240930.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockholdersDeficitDetailsNarrative" xlink:href="onmd-20240930.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails" xlink:href="onmd-20240930.xsd#ScheduleOfStock-basedCompensationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="onmd-20240930.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/StockWarrantsDetailsNarrative" xlink:href="onmd-20240930.xsd#StockWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:href="onmd-20240930.xsd#ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfShareholderLoansOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="onmd-20240930.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="onmd-20240930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails" xlink:href="onmd-20240930.xsd#ScheduleOfRestatementOfBalanceSheetDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:href="onmd-20240930.xsd#ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:href="onmd-20240930.xsd#ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/SubsequentEventsDetailsNarrative" xlink:href="onmd-20240930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/BusinessCombinationDetailsNarrative" xlink:href="onmd-20240930.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="onmd-20240930.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="onmd-20240930.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:href="onmd-20240930.xsd#ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:href="onmd-20240930.xsd#ScheduleOfIncomeTaxProvisionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:href="onmd-20240930.xsd#ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="onmd-20240930.xsd#ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/IncomeTaxesDetailsNarrative" xlink:href="onmd-20240930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails" xlink:href="onmd-20240930.xsd#ScheduleOfOptionsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails" xlink:href="onmd-20240930.xsd#ScheduleOfFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails" xlink:href="onmd-20240930.xsd#ScheduleOfRestrictedStockAwardActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:href="onmd-20240930.xsd#ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:href="onmd-20240930.xsd#CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RestatedMember" xlink:label="loc_ONMDRestatedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDRestatedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="loc_us-gaapCryptoAssetFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCryptoAssetFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredCostsNonCurrent" xlink:label="loc_ONMDDeferredCostsNonCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_ONMDDeferredCostsNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNotesPayableCurrent" xlink:label="loc_ONMDYorkvilleNotesPayableCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ONMDYorkvilleNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue" xlink:label="loc_us-gaapTreasuryStockCommonValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockCommonValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SubscriptionRevenueMember" xlink:label="loc_ONMDSubscriptionRevenueMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDSubscriptionRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WebImagingRevenueMember" xlink:label="loc_ONMDWebImagingRevenueMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDWebImagingRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_GainLossOnFairValueOfYorkvilleNote" xlink:label="loc_ONMDGainLossOnFairValueOfYorkvilleNote" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ONMDGainLossOnFairValueOfYorkvilleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TemporaryEquityMember" xlink:label="loc_ONMDTemporaryEquityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_ONMDTemporaryEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="80" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDStockWarrantExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantExpense" xlink:label="loc_ONMDWarrantExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDWarrantExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfYorkvilleNote" xlink:label="loc_ONMDChangeInFairValueOfYorkvilleNote" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDChangeInFairValueOfYorkvilleNote" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedLossNonoperating" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCryptoAssetRealizedLossNonoperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NoncashInterest" xlink:label="loc_ONMDNoncashInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDNoncashInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" xlink:label="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForAcquisitionCryptoAsset" xlink:label="loc_us-gaapPaymentForAcquisitionCryptoAsset" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentForAcquisitionCryptoAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDisposalCryptoAsset" xlink:label="loc_us-gaapProceedsFromDisposalCryptoAsset" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromDisposalCryptoAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="loc_ONMDProceedsFromIssuanceOfShareholderLoans" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_ONMDProceedsFromIssuanceOfShareholderLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RepaymentForCommonStockRepurchase" xlink:label="loc_ONMDRepaymentForCommonStockRepurchase" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_ONMDRepaymentForCommonStockRepurchase" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RepaymentOfDeferredUnderwriterFees" xlink:label="loc_ONMDRepaymentOfDeferredUnderwriterFees" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_ONMDRepaymentOfDeferredUnderwriterFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfBankDebt" xlink:label="loc_us-gaapRepaymentsOfBankDebt" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapRepaymentsOfBankDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCosts" xlink:label="loc_ONMDBusinessCombinationCosts" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_ONMDBusinessCombinationCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="loc_us-gaapStockIssued1" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapStockIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" xlink:label="loc_ONMDCommonSharesRelatedToConvertiblePromissoryNotes" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDCommonSharesRelatedToConvertiblePromissoryNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesIssuedToDataKnightsShareholders" xlink:label="loc_ONMDCommonSharesIssuedToDataKnightsShareholders" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDCommonSharesIssuedToDataKnightsShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" xlink:label="loc_ONMDIssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDIssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" xlink:label="loc_ONMDConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/DescriptionOfBusiness" xlink:title="999007 - Disclosure - Description of Business">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999008 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeld" xlink:title="999009 - Disclosure - Crypto Assets Held">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetTextBlock" xlink:label="loc_us-gaapCryptoAssetTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ConvertibleDebt" xlink:title="999010 - Disclosure - Convertible Debt">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/LineOfCredit" xlink:title="999011 - Disclosure - Line of Credit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba" xlink:title="999012 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockholdersDeficit" xlink:title="999013 - Disclosure - Stockholders&#8217; Deficit">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/NetLossPerShare" xlink:title="999014 - Disclosure - Net Loss per Share">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensation" xlink:title="999015 - Disclosure - Stock-Based Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrants" xlink:title="999016 - Disclosure - Stock Warrants">
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DisclosureStockWarrantsAbstract" xlink:label="loc_ONMDDisclosureStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantsDisclosureTextBlock" xlink:label="loc_ONMDStockWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ONMDDisclosureStockWarrantsAbstract" xlink:to="loc_ONMDStockWarrantsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/FairValueMeasurements" xlink:title="999017 - Disclosure - Fair Value Measurements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaapFairValueDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactions" xlink:title="999018 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CommitmentsAndContingencies" xlink:title="999019 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEvents" xlink:title="999020 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombination" xlink:title="999021 - Disclosure - Business Combination">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxes" xlink:title="999023 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba" xlink:title="999024 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999025 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="loc_us-gaapStockholdersEquityPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStockholdersEquityPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_PlatformOperatorCryptoAssetPolicyTextBlock" xlink:label="loc_srtPlatformOperatorCryptoAssetPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_srtPlatformOperatorCryptoAssetPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_ONMDEmergingGrowthCompanyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ONMDEmergingGrowthCompanyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RestatementToFinancialStatementsPolicyTextBlock" xlink:label="loc_ONMDRestatementToFinancialStatementsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ONMDRestatementToFinancialStatementsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OperatingSegmentsPolicyTextBlock" xlink:label="loc_ONMDOperatingSegmentsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ONMDOperatingSegmentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueOptionOfAccountingPolicyTextBlock" xlink:label="loc_ONMDFairValueOptionOfAccountingPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ONMDFairValueOptionOfAccountingPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantPolicyTextBlock" xlink:label="loc_ONMDWarrantPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ONMDWarrantPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PatentsAndTrademarksPolicyTextBlock" xlink:label="loc_ONMDPatentsAndTrademarksPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ONMDPatentsAndTrademarksPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCompensationRelatedCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_ONMDRecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_ONMDRecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeldTables" xlink:title="999026 - Disclosure - Crypto Assets Held (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTableTextBlock" xlink:label="loc_us-gaapCryptoAssetHoldingTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetHoldingTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetActivityTableTextBlock" xlink:label="loc_us-gaapCryptoAssetActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/NetLossPerShareTables" xlink:title="999027 - Disclosure - Net Loss per Share (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensationTables" xlink:title="999028 - Disclosure - Stock-Based Compensation (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrantsTables" xlink:title="999029 - Disclosure - Stock Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DisclosureStockWarrantsAbstract" xlink:label="loc_ONMDDisclosureStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ONMDDisclosureStockWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/FairValueMeasurementsTables" xlink:title="999030 - Disclosure - Fair Value Measurements (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactionsTables" xlink:title="999031 - Disclosure - Related Party Transactions (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEventsTables" xlink:title="999032 - Disclosure - Subsequent Events (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:label="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapIncomeStatementAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementOfCashFlowsAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:label="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombinationTables" xlink:title="999033 - Disclosure - Business Combination (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipmentTables" xlink:title="999034 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxesTables" xlink:title="999035 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative" xlink:title="999036 - Disclosure - Description of Business (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CryptoCash" xlink:label="loc_ONMDCryptoCash" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_ONMDCryptoCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999037 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OneCustomerMember" xlink:label="loc_ONMDOneCustomerMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDOneCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwoCustomersMember" xlink:label="loc_ONMDTwoCustomersMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDTwoCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ThreeCustomersMember" xlink:label="loc_ONMDThreeCustomersMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDThreeCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails" xlink:title="999038 - Disclosure - Schedule of Crypto Assets Held (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingTable" xlink:label="loc_us-gaapCryptoAssetHoldingTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetHoldingTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetHoldingLineItems" xlink:label="loc_us-gaapCryptoAssetHoldingLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCryptoAssetHoldingTable" xlink:to="loc_us-gaapCryptoAssetHoldingLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetAxis" xlink:label="loc_srtCryptoAssetAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCryptoAssetHoldingTable" xlink:to="loc_srtCryptoAssetAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CryptoAssetDomain" xlink:label="loc_srtCryptoAssetDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCryptoAssetAxis" xlink:to="loc_srtCryptoAssetDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BitcoinMember" xlink:label="loc_ONMDBitcoinMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCryptoAssetDomain" xlink:to="loc_ONMDBitcoinMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetNumberOfUnits" xlink:label="loc_us-gaapCryptoAssetNumberOfUnits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCryptoAssetHoldingLineItems" xlink:to="loc_us-gaapCryptoAssetNumberOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetCost" xlink:label="loc_us-gaapCryptoAssetCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCryptoAssetHoldingLineItems" xlink:to="loc_us-gaapCryptoAssetCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="loc_us-gaapCryptoAssetFairValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCryptoAssetHoldingLineItems" xlink:to="loc_us-gaapCryptoAssetFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails" xlink:title="999039 - Disclosure - Schedule of Crypto Assets Reconciliation of Fair Values (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="loc_us-gaapCryptoAssetFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetAddition" xlink:label="loc_us-gaapCryptoAssetAddition" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetAddition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetDisposition" xlink:label="loc_us-gaapCryptoAssetDisposition" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetDisposition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetRealizedAndUnrealizedGainLossNonoperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetFairValue" xlink:label="loc_us-gaapCryptoAssetFairValue_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative" xlink:title="999040 - Disclosure - Crypto Assets Held (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetDisposition" xlink:label="loc_us-gaapCryptoAssetDisposition" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetDisposition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating" xlink:label="loc_us-gaapCryptoAssetRealizedAndUnrealizedLossNonoperating" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapCryptoAssetRealizedAndUnrealizedLossNonoperating" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ConvertibleDebtDetailsNarrative" xlink:title="999041 - Disclosure - Convertible Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertibleNotesWarrantsMember" xlink:label="loc_ONMDConvertibleNotesWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertibleNotesWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDYorkvilleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesMember" xlink:label="loc_ONMDConvertiblePromissoryNotesMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoNotesMember" xlink:label="loc_ONMDTwentyTwentyTwoNotesMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDTwentyTwentyTwoNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyThreeNotesMember" xlink:label="loc_ONMDTwentyTwentyThreeNotesMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDTwentyTwentyThreeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" xlink:label="loc_ONMDTwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDTwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_ONMDSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_HelenaTerminationAgreementMember" xlink:label="loc_ONMDHelenaTerminationAgreementMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDHelenaTerminationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDStandbyEquityPurchaseAgreementMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDStandbyEquityPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtOwnershipAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BeneficialOwnershipMember" xlink:label="loc_ONMDBeneficialOwnershipMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_ONMDBeneficialOwnershipMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtTitleOfIndividualAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDStockWarrantExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FloorPricePerShare" xlink:label="loc_ONMDFloorPricePerShare" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDFloorPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrecentageOfOutstandingCommonStock" xlink:label="loc_ONMDPrecentageOfOutstandingCommonStock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDPrecentageOfOutstandingCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DebtInstrumentInterestRateDefaultPercentage" xlink:label="loc_ONMDDebtInstrumentInterestRateDefaultPercentage" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDDebtInstrumentInterestRateDefaultPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNotesPayableCurrent" xlink:label="loc_ONMDYorkvilleNotesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDYorkvilleNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityFinancingDescription" xlink:label="loc_ONMDEquityFinancingDescription" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDEquityFinancingDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionDescription" xlink:label="loc_us-gaapDebtConversionDescription" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/LineOfCreditDetailsNarrative" xlink:title="999042 - Disclosure - Line of Credit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BOCBankMember" xlink:label="loc_ONMDBOCBankMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_ONMDBOCBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative" xlink:title="999043 - Disclosure - Canadian Emergency Business Account (&#8220;CEBA&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CEBALoanMember" xlink:label="loc_ONMDCEBALoanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDCEBALoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockholdersDeficitDetailsNarrative" xlink:title="999044 - Disclosure - Stockholders&#8217; Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockRepurchaseAgreementMember" xlink:label="loc_ONMDStockRepurchaseAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDStockRepurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDStandbyEquityPurchaseAgreementMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDStandbyEquityPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_ONMDSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtStatementScenarioAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrefundedWarrantsMember" xlink:label="loc_ONMDPrefundedWarrantsMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPrefundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ONMDYorkvilleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAwardTypeAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_JulyTwoThousandTwentyFourFinancingMember" xlink:label="loc_ONMDJulyTwoThousandTwentyFourFinancingMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDJulyTwoThousandTwentyFourFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeptemberTwoThousandTwentyFourFinancingMember" xlink:label="loc_ONMDSeptemberTwoThousandTwentyFourFinancingMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDSeptemberTwoThousandTwentyFourFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesTransferred" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesTransferred" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_VolumeWeightedAveragePrice" xlink:label="loc_ONMDVolumeWeightedAveragePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDVolumeWeightedAveragePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_VolumeWeightedAveragePriceValue" xlink:label="loc_ONMDVolumeWeightedAveragePriceValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDVolumeWeightedAveragePriceValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:label="loc_us-gaapBusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockRepurchasedDuringPeriodValueExchangeForCash" xlink:label="loc_ONMDStockRepurchasedDuringPeriodValueExchangeForCash" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDStockRepurchasedDuringPeriodValueExchangeForCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" xlink:label="loc_ONMDPrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDPrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockholdersDeficitDescription" xlink:label="loc_ONMDStockholdersDeficitDescription" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDStockholdersDeficitDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CashStructuringFee" xlink:label="loc_ONMDCashStructuringFee" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_ONMDCashStructuringFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfStockIssuanceCosts" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPaymentsOfStockIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockAmountIssued1" xlink:label="loc_us-gaapConversionOfStockAmountIssued1" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapConversionOfStockAmountIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" xlink:label="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmbeddedDerivativeFairValueOfEmbeddedDerivativeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:label="loc_us-gaapChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapChangeInUnrealizedGainLossOnFairValueHedgingInstruments1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOfferingCosts" xlink:label="loc_us-gaapDeferredOfferingCosts" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDeferredOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesSubscriptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalUnitsAuthorized" xlink:label="loc_us-gaapCapitalUnitsAuthorized" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCapitalUnitsAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDividendsPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockLiquidationPreferenceValue" xlink:label="loc_us-gaapPreferredStockLiquidationPreferenceValue" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockLiquidationPreferenceValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockTermsOfConversion" xlink:label="loc_us-gaapConvertiblePreferredStockTermsOfConversion" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapConvertiblePreferredStockTermsOfConversion" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails" xlink:title="999045 - Disclosure - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OptionsToPurchaseCommonStockMember" xlink:label="loc_ONMDOptionsToPurchaseCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDOptionsToPurchaseCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_UnvestedRestrictedStockUnitsAndAwardsMember" xlink:label="loc_ONMDUnvestedRestrictedStockUnitsAndAwardsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDUnvestedRestrictedStockUnitsAndAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteMember" xlink:label="loc_ONMDConvertiblePromissoryNoteMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails" xlink:title="999046 - Disclosure - Schedule of Stock-based Compensation Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaapSellingAndMarketingExpenseMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingAndMarketingExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="999047 - Disclosure - Stock-Based Compensation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityIncentivePlanMember" xlink:label="loc_ONMDEquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ONMDEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NewEquityIncentivePlanMember" xlink:label="loc_ONMDNewEquityIncentivePlanMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_ONMDNewEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EmployeesDirectorsAndConsultantsMember" xlink:label="loc_ONMDEmployeesDirectorsAndConsultantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ONMDEmployeesDirectorsAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails" xlink:title="999048 - Disclosure - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DisclosureStockWarrantsAbstract" xlink:label="loc_ONMDDisclosureStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaapClassOfWarrantOrRightTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ONMDDisclosureStockWarrantsAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaapClassOfWarrantOrRightLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LiabilityClassifiedWarrantsMember" xlink:label="loc_ONMDLiabilityClassifiedWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDLiabilityClassifiedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityClassifiedWarrantsMember" xlink:label="loc_ONMDEquityClassifiedWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDEquityClassifiedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPIPEWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PublicWarrantsMember" xlink:label="loc_ONMDPublicWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivatePlacementWarrantsMember" xlink:label="loc_ONMDPrivatePlacementWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivatePlacementWarrantsMember" xlink:label="loc_ONMDPrivatePlacementWarrantsMember_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDPrivatePlacementWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDPIPEWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LegacyONMDWarrantsMember" xlink:label="loc_ONMDLegacyONMDWarrantsMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDLegacyONMDWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNoteWarrantsMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PublicWarrantsMember" xlink:label="loc_ONMDPublicWarrantsMember_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_ONMDPublicWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/StockWarrantsDetailsNarrative" xlink:title="999049 - Disclosure - Stock Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DisclosureStockWarrantsAbstract" xlink:label="loc_ONMDDisclosureStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ONMDDisclosureStockWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNotesWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPIPEWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyOneServiceMember" xlink:label="loc_ONMDTwentyTwentyOneServiceMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDTwentyTwentyOneServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TwentyTwentyTwoServiceMember" xlink:label="loc_ONMDTwentyTwentyTwoServiceMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_ONMDTwentyTwentyTwoServiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNotesWarrantsMember_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaapClassOfWarrantOrRightAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapClassOfWarrantOrRightAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaapClassOfWarrantOrRightDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightAxis" xlink:to="loc_us-gaapClassOfWarrantOrRightDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDPIPEWarrantsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PublicWarrantsMember" xlink:label="loc_ONMDPublicWarrantsMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_ONMDPublicWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaapPrivatePlacementMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfWarrantOrRightDomain" xlink:to="loc_us-gaapPrivatePlacementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockWarrantExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionRatio1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionRatio1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfWarrants" xlink:label="loc_ONMDChangeInFairValueOfWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDChangeInFairValueOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" xlink:title="999050 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BitcoinMember" xlink:label="loc_ONMDBitcoinMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDBitcoinMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivateWarrantsMember" xlink:label="loc_ONMDPrivateWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDYorkvilleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDStandbyEquityPurchaseAgreementMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDStandbyEquityPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesMember" xlink:label="loc_ONMDConvertiblePromissoryNotesMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails" xlink:title="999051 - Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDYorkvilleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleStandbyEquityPurchaseAgreementMember" xlink:label="loc_ONMDYorkvilleStandbyEquityPurchaseAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDYorkvilleStandbyEquityPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails" xlink:title="999052 - Disclosure - Schedule of Fair Value Assumptions and Valuation (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaapFairValueDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueDisclosuresAbstract" xlink:to="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationWarrantsMember" xlink:label="loc_ONMDBusinessCombinationWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDBusinessCombinationWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivateWarrantsMember" xlink:label="loc_ONMDPrivateWarrantsMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaapMeasurementInputSharePriceMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputSharePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExercisePriceMember" xlink:label="loc_us-gaapMeasurementInputExercisePriceMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExercisePriceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails" xlink:title="999053 - Disclosure - Schedule of Shareholder Loans Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999054 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDPIPENotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteMember" xlink:label="loc_ONMDConvertiblePromissoryNoteMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNoteWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ShareholderLoansMember" xlink:label="loc_ONMDShareholderLoansMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDShareholderLoansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesAndWarrantsMember" xlink:label="loc_ONMDConvertiblePromissoryNotesAndWarrantsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesAndWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPIPEWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsMember" xlink:label="loc_ONMDDataKnightsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapProceedsFromLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermDebt" xlink:label="loc_us-gaapOtherLongTermDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="loc_ONMDProceedsFromIssuanceOfShareholderLoans" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ONMDProceedsFromIssuanceOfShareholderLoans" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtension" xlink:label="loc_ONMDLoanExtension" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_ONMDLoanExtension" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999055 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails" xlink:title="999056 - Disclosure - Schedule of Restatement of Balance Sheet (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ReclassificationAdjustmentMember" xlink:label="loc_ONMDReclassificationAdjustmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDReclassificationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsHeldInTrustCurrent" xlink:label="loc_us-gaapAssetsHeldInTrustCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsHeldInTrustCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredCostsNonCurrent" xlink:label="loc_ONMDDeferredCostsNonCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_ONMDDeferredCostsNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ExciseTaxCurrent" xlink:label="loc_ONMDExciseTaxCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ONMDExciseTaxCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtensionsCurrent" xlink:label="loc_ONMDLoanExtensionsCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ONMDLoanExtensionsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CanadaEmergencyBusinessLoanAct" xlink:label="loc_ONMDCanadaEmergencyBusinessLoanAct" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ONMDCanadaEmergencyBusinessLoanAct" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent" xlink:label="loc_us-gaapAccruedIncomeTaxesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtCurrent" xlink:label="loc_us-gaapUnsecuredDebtCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapUnsecuredDebtCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AccruedInterestRelatedParty" xlink:label="loc_ONMDAccruedInterestRelatedParty" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_ONMDAccruedInterestRelatedParty" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableNonCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableNonCurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_ONMDDeferredUnderwriterFeePayableNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WorkingCapitalLoan" xlink:label="loc_ONMDWorkingCapitalLoan" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_ONMDWorkingCapitalLoan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantLiabilityNonCurrent" xlink:label="loc_ONMDWarrantLiabilityNonCurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_ONMDWarrantLiabilityNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAbstract" xlink:label="loc_us-gaapTemporaryEquityAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTemporaryEquityAbstract" xlink:to="loc_us-gaapTemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical" xlink:title="999057 - Disclosure - Schedule of Restatement of Balance Sheet (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquityParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="loc_us-gaapTemporaryEquitySharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaapTemporaryEquitySharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails" xlink:title="999058 - Disclosure - Schedule of the Original and Restated Statement of Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ReclassificationAdjustmentMember" xlink:label="loc_ONMDReclassificationAdjustmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDReclassificationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SubscriptionRevenueMember" xlink:label="loc_ONMDSubscriptionRevenueMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDSubscriptionRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WebImagingRevenueMember" xlink:label="loc_ONMDWebImagingRevenueMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_ONMDWebImagingRevenueMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherGeneralExpense" xlink:label="loc_us-gaapOtherGeneralExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherGeneralExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncomeTaxProvision" xlink:label="loc_ONMDIncomeTaxProvision" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ONMDIncomeTaxProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpense" xlink:label="loc_ONMDStockWarrantExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ONMDStockWarrantExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:label="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ONMDFairValueAdjustmentOfPrivateInvestmentInPublicEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes" xlink:label="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_ONMDFairValueAdjustmentOfConvertiblePromissoryNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_UnrealizedGainLoss" xlink:label="loc_ONMDUnrealizedGainLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDUnrealizedGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails" xlink:title="999059 - Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCost" xlink:label="loc_ONMDBusinessCombinationCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDBusinessCombinationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CashHeldInTrustAccount" xlink:label="loc_ONMDCashHeldInTrustAccount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDCashHeldInTrustAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockWarrantExpenses" xlink:label="loc_ONMDStockWarrantExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDStockWarrantExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantExpense" xlink:label="loc_ONMDWarrantExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDWarrantExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfWarrantLiabilities" xlink:label="loc_ONMDChangeInFairValueOfWarrantLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDChangeInFairValueOfWarrantLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfPipeNotes" xlink:label="loc_ONMDChangeInFairValueOfPipeNotes" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDChangeInFairValueOfPipeNotes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ChangeInFairValueOfConvertiblePromissoryNotes" xlink:label="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDChangeInFairValueOfConvertiblePromissoryNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_NoncashInterest" xlink:label="loc_ONMDNoncashInterest" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_ONMDNoncashInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInExerciseTaxLiability" xlink:label="loc_ONMDIncreaseDecreaseInExerciseTaxLiability" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_ONMDIncreaseDecreaseInExerciseTaxLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInExtensionLoan" xlink:label="loc_ONMDIncreaseDecreaseInExtensionLoan" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_ONMDIncreaseDecreaseInExtensionLoan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseFranchiseTaxPayable" xlink:label="loc_ONMDIncreaseDecreaseFranchiseTaxPayable" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_ONMDIncreaseDecreaseFranchiseTaxPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_IncreaseDecreaseInWorkingCapitalLoan" xlink:label="loc_ONMDIncreaseDecreaseInWorkingCapitalLoan" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_ONMDIncreaseDecreaseInWorkingCapitalLoan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct" xlink:label="loc_ONMDProceedsFromCanadaEmergencyBusinessLoanAct" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDProceedsFromCanadaEmergencyBusinessLoanAct" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfShareholderLoans" xlink:label="loc_ONMDProceedsFromIssuanceOfShareholderLoans" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDProceedsFromIssuanceOfShareholderLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromCommonStockSubjectToRedemption" xlink:label="loc_ONMDProceedsFromCommonStockSubjectToRedemption" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDProceedsFromCommonStockSubjectToRedemption" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromDeferredUnderwritingFee" xlink:label="loc_ONMDProceedsFromDeferredUnderwritingFee" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDProceedsFromDeferredUnderwritingFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromWarrantLiability" xlink:label="loc_ONMDProceedsFromWarrantLiability" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDProceedsFromWarrantLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="loc_us-gaapProceedsFromContributedCapital" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromContributedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProccedsFromRetainedEarningsAdjustment" xlink:label="loc_ONMDProccedsFromRetainedEarningsAdjustment" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDProccedsFromRetainedEarningsAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock" xlink:label="loc_ONMDProceedsFromIssuanceOfSeriesA2PreferredStock" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDProceedsFromIssuanceOfSeriesA2PreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationCosts" xlink:label="loc_ONMDBusinessCombinationCosts" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_ONMDBusinessCombinationCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesIssuedToPreferredShareholders" xlink:label="loc_ONMDCommonSharesIssuedToPreferredShareholders" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDCommonSharesIssuedToPreferredShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesRelatedToConvertiblePromissoryNotes" xlink:label="loc_ONMDCommonSharesRelatedToConvertiblePromissoryNotes" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDCommonSharesRelatedToConvertiblePromissoryNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonSharesIssuedToDataKnightsShareholders" xlink:label="loc_ONMDCommonSharesIssuedToDataKnightsShareholders" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDCommonSharesIssuedToDataKnightsShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_WarrantExpense" xlink:label="loc_ONMDWarrantExpense_2" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_ONMDWarrantExpense_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails" xlink:title="999060 - Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementAxis" xlink:label="loc_srtRestatementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRestatementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RestatementDomain" xlink:label="loc_srtRestatementDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementAxis" xlink:to="loc_srtRestatementDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioPreviouslyReportedMember" xlink:label="loc_srtScenarioPreviouslyReportedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtScenarioPreviouslyReportedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:label="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_srtRevisionOfPriorPeriodReclassificationAdjustmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RestatedMember" xlink:label="loc_ONMDRestatedMember" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDRestatedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_AsRestatedMember" xlink:label="loc_ONMDAsRestatedMember" />
      <link:presentationArc order="1000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRestatementDomain" xlink:to="loc_ONMDAsRestatedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommitmentMember" xlink:label="loc_ONMDCommitmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDCommitmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_TemporaryEquityMember" xlink:label="loc_ONMDTemporaryEquityMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDTemporaryEquityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:label="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDRetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:label="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CommonStockSubjectToPossibleRedemptionValue" xlink:label="loc_ONMDCommonStockSubjectToPossibleRedemptionValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDCommonStockSubjectToPossibleRedemptionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment" xlink:label="loc_ONMDStockIssuedDuringPeriodValueRetainedEarningsAdjustment" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueRetainedEarningsAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:label="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_ONMDStockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails" xlink:title="999061 - Disclosure - Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember" xlink:label="loc_us-gaapRevenueFromContractWithCustomerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapRevenueFromContractWithCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerOneMember" xlink:label="loc_ONMDCustomerOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerTwoMember" xlink:label="loc_ONMDCustomerTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomersMember" xlink:label="loc_ONMDCustomersMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerThreeMember" xlink:label="loc_ONMDCustomerThreeMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerFourMember" xlink:label="loc_ONMDCustomerFourMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerFiveMember" xlink:label="loc_ONMDCustomerFiveMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerFiveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerSixMember" xlink:label="loc_ONMDCustomerSixMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerSixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CustomerSevenMember" xlink:label="loc_ONMDCustomerSevenMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_ONMDCustomerSevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/SubsequentEventsDetailsNarrative" xlink:title="999062 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_YorkvilleNoteMember" xlink:label="loc_ONMDYorkvilleNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDYorkvilleNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNoteMember" xlink:label="loc_ONMDConvertiblePromissoryNoteMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_MsCoonseMcCrawMember" xlink:label="loc_ONMDMsCoonseMcCrawMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ONMDMsCoonseMcCrawMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_MrClarkeMember" xlink:label="loc_ONMDMrClarkeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_ONMDMrClarkeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtStatementScenarioAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_deiLegalEntityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EFHuttonMember" xlink:label="loc_ONMDEFHuttonMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ONMDEFHuttonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_KingwoodCapitalPartnersLLCMember" xlink:label="loc_ONMDKingwoodCapitalPartnersLLCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_ONMDKingwoodCapitalPartnersLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_KingwoodCapitalPartnersLLCMember" xlink:label="loc_ONMDKingwoodCapitalPartnersLLCMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDKingwoodCapitalPartnersLLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrefundedWarrantsMember" xlink:label="loc_ONMDPrefundedWarrantsMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_ONMDPrefundedWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="loc_us-gaapLongTermDebtPercentageBearingFixedInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DebtInstrumentInterestRateDefaultPercentage" xlink:label="loc_ONMDDebtInstrumentInterestRateDefaultPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ONMDDebtInstrumentInterestRateDefaultPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLoans" xlink:label="loc_us-gaapProceedsFromLoans" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromLoans" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRepaidPrincipal" xlink:label="loc_us-gaapDebtInstrumentRepaidPrincipal" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentRepaidPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding" xlink:label="loc_us-gaapWarrantsAndRightsOutstanding" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquityPurchaseAgreementDescription" xlink:label="loc_ONMDEquityPurchaseAgreementDescription" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ONMDEquityPurchaseAgreementDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ShareOutstandingVotingPercentage" xlink:label="loc_ONMDShareOutstandingVotingPercentage" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_ONMDShareOutstandingVotingPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoanProcessingFee" xlink:label="loc_us-gaapLoanProcessingFee" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLoanProcessingFee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForManagementFee" xlink:label="loc_us-gaapPaymentForManagementFee" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentForManagementFee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeDescriptionOfTerms" xlink:label="loc_us-gaapDerivativeDescriptionOfTerms" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDerivativeDescriptionOfTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFloorPrice" xlink:label="loc_us-gaapDerivativeFloorPrice" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDerivativeFloorPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:label="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapEmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails" xlink:title="999063 - Disclosure - Schedule of Business Combination Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/BusinessCombinationDetailsNarrative" xlink:title="999064 - Disclosure - Business Combination (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationAndAssetAcquisitionAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationMember" xlink:label="loc_ONMDBusinessCombinationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDBusinessCombinationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DataKnightsAcquisitionCorpMember" xlink:label="loc_ONMDDataKnightsAcquisitionCorpMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_ONMDDataKnightsAcquisitionCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesATwoPreferredStockMember" xlink:label="loc_ONMDSeriesATwoPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesATwoPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SeriesAOnePreferredStockMember" xlink:label="loc_ONMDSeriesAOnePreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_ONMDSeriesAOnePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_SecuritiesPurchaseAgreementMember" xlink:label="loc_ONMDSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_ONMDSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfAssetsAcquired" xlink:label="loc_us-gaapFairValueOfAssetsAcquired" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapFairValueOfAssetsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaapTemporaryEquitySharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapTemporaryEquitySharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:label="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapTemporaryEquityLiquidationPreferencePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessAcquisitionCostPercentage" xlink:label="loc_ONMDBusinessAcquisitionCostPercentage" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessAcquisitionCostPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentIssuedPrincipal" xlink:label="loc_us-gaapDebtInstrumentIssuedPrincipal" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentIssuedPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Investments" xlink:label="loc_us-gaapInvestments" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" xlink:label="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredUnderwriterFeePayableCurrent" xlink:label="loc_ONMDDeferredUnderwriterFeePayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDDeferredUnderwriterFeePayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_LoanExtensionsCurrent" xlink:label="loc_ONMDLoanExtensionsCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_ONMDLoanExtensionsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999065 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_FurnitureAndEquipmentMember" xlink:label="loc_ONMDFurnitureAndEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_ONMDFurnitureAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999066 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails" xlink:title="999067 - Disclosure - Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails" xlink:title="999068 - Disclosure - Schedule of Income Tax Provision (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredOtherTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredOtherTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails" xlink:title="999069 - Disclosure - Schedule of Reconciliation of Income Tax Benefit (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" xlink:label="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:label="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ONMDEffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsOther" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxSettlementsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="999070 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaapDeferredTaxAssetsNetAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredTaxAssetsCapitalizedResearchCosts" xlink:label="loc_ONMDDeferredTaxAssetsCapitalizedResearchCosts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ONMDDeferredTaxAssetsCapitalizedResearchCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_DeferredTaxAssetsFixedAssets" xlink:label="loc_ONMDDeferredTaxAssetsFixedAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ONMDDeferredTaxAssetsFixedAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:label="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/IncomeTaxesDetailsNarrative" xlink:title="999071 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="loc_us-gaapFederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapFederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_OperatingLossCarryForwardIndefinitely" xlink:label="loc_ONMDOperatingLossCarryForwardIndefinitely" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ONMDOperatingLossCarryForwardIndefinitely" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" xlink:label="loc_ONMDEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_ONMDEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails" xlink:title="999072 - Disclosure - Schedule of Options Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails" xlink:title="999073 - Disclosure - Schedule of Fair Value of Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiMeasurementInput" xlink:label="loc_us-gaapEquitySecuritiesFvNiMeasurementInput" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapEquitySecuritiesFvNiMeasurementInput" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_EquitySecuritiesFvNiMeasurementTerm" xlink:label="loc_ONMDEquitySecuritiesFvNiMeasurementTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_ONMDEquitySecuritiesFvNiMeasurementTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails" xlink:title="999074 - Disclosure - Schedule of Restricted Stock Award Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails" xlink:title="999075 - Disclosure -  Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:label="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:label="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldToMaturityAllowanceForCreditLossTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivateWarrantsMember" xlink:label="loc_ONMDPrivateWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivateWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesAndWarrantsMember" xlink:label="loc_ONMDPIPENotesAndWarrantsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesAndWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_ConvertiblePromissoryNotesMember" xlink:label="loc_ONMDConvertiblePromissoryNotesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDConvertiblePromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems" xlink:to="loc_us-gaapFairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative" xlink:title="999076 - Disclosure - Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;) (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_CEBALoanMember" xlink:label="loc_ONMDCEBALoanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_ONMDCEBALoanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PrivatePlacementWarrantsMember" xlink:label="loc_ONMDPrivatePlacementWarrantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPrivatePlacementWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPEWarrantsMember" xlink:label="loc_ONMDPIPEWarrantsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPEWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="onmd-20240930.xsd#ONMD_PIPENotesMember" xlink:label="loc_ONMDPIPENotesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_ONMDPIPENotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfUnsecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfUnsecuredDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDecreaseForgiveness" xlink:label="loc_us-gaapDebtInstrumentDecreaseForgiveness" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentDecreaseForgiveness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="loc_us-gaapDebtConversionOriginalDebtAmount1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionOriginalDebtAmount1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaapConvertibleDebtFairValueDisclosures" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapConvertibleDebtFairValueDisclosures" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>97
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MI0$>S@/^"9OH!Y'"=-6HG*"F;75G7LN+#401ZC!L;/?PX+[U6VO8?9:/I5!
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MLS91-1)2%HDPCR_Y)@Z*/VJVJ*+&&;&!,S4+3$\I)DKS_ 3:W'. *@TH,Z-
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MN7B3L><2[X1TBZ&1-';J#N08:;^H\4/D_*U)O+65..>O>NQY[O"$:XO=A53
M1WT2&UD^^C[+4]4+.?@0[>@ZACM$8S4&Z4;9RM8(J.>S!Y%1'V:6&L $\!U8
M\U]_P2/GM]8^6*(-.VBJFQTV=[L5\$BER.-G@NJ:M])O ?WS!9(U\'];A1E1
M>PO[26C-&-1=%)O;Z LD&>-J@D7P/8_DVU$911GP,AM;HV#$[1V%0:_"B^N&
MB\T=]UQ?I_)K1NVM[KQ'N\10H7'=JK&Y5U^4=[E.FQ%[2^O<U''=U;&YK5\4
M=:68FV%[*QMU5E;/ =@\"%05!_>K.$;4WL)^$EHS!O54@<UCQ>T5QXC;.PKC
M?A6GGD*P>0RYM>(847NK.Y]77-=0<4@]KI KXTK_BF-&["N-=)YN2#W=$/-T
M<VO%,</V5H:O*K./CCKT.=,7RK=1*E ,&^7CW'NJ'//RZ*;<2)85IQ]K)B5+
MBF4(- "N#=3]#6/R?:,/5*H#M/G_4$L#!!0    ( /$Q0UJAR=E^, P  (E-
M   8    >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL[5Q;;]LZ$G[/KR"R!XM3
MH(U%4M>T#=!84FSL]IRB.1<L@CXH-AT+E26O)#OM_OHE9<6RR!'MI#P/"VP?
M&EO^YAMJ9D1RAJ3>/1;EUVK)6(V^K;*\>G^^K.OUY6A4S99LE507Q9KE_)=%
M4:Z2FG\M'T;5NF3)O!%:92-B6>YHE:3Y^=6[YMJG\NI=L:FS-&>?2E1M5JND
M_'[-LN+Q_3D^?[KP.7U8UN+"Z.K=.GE@MZS^??VIY-]&>Y9YNF)YE18Y*MGB
M_?D'?#FUB1!H$'^D[+$Z^(S$K=P7Q5?Q93I_?VZ)%K&,S6I!D? _6S9F62:8
M>#O^W9*>[W4*P<//3^QQ<_/\9NZ3BHV+[,]T7B_?G_OG:,X6R2:K/Q>/$];>
MD"/X9D56-?^CQQ9KG:/9IJJ+52O,6[!*\]W?Y%MKB ,!S@,+D%: R +V@ !M
M!>BI&NQ6P#Y5@],*.+* .R#@M@*N+$ '!+Q6P#NU27XKX)^J(6@%@B8<=OYK
MG!\F=7+UKBP>42G0G$U\:"*HD>8^3W,1[+=UR7]-N5Q]-2[R.0]=-D?\4U5D
MZ3RI^9?;FO_A,5U7J%B@7]>L3$1L5N@-^OTV1#__] K]A-(<_;8L-E62SZMW
MHYJW1G".9JWFZYUF,J"9HH]%7B\K%/$6S 'Y4"\?')./]?*8: A&W(Q[6Y(G
M6UX3+>,M6U\@:KU&Q"(VT*#QZ>(4LL>/:8]^3'NL%P_9C(OC0?')Z>)$XPJZ
M#VO:\-$!OL]LR_(-@Z)R)VC#@F)LN:S6R8R]/^>#1\7*+3N_^OO?L&N]A3QJ
MDBPT21:9)(M-DDT,D?7BPM['A:UCO_J3W:-TE3RD^0,?J@=C9$?B-"1BNK"]
MPC8/R^VAZU4,)6X?$ZH8%WM]3 1@?-S'Q$![+"*!)@ (.W0/ZMG+V=O+T=KK
MMZ).,IVE=N*NUE(J1K64BE$M!6 42P'M42T%@ 8MY>XMY6HM-2ZJ6HR5&ENY
MBEHBVV$,8 (JV4K%^)YD\PC 8 D3JQAN!DNR%0!R\("MO+VM/*VM;LJBJO@L
MIN3/(60H3]'YQK<E0ZD8*ML)H"&.(QD* &$J1Q4$(H%D*0!$70NVE+^WE*\=
MQ]J9%^^MV+>UF*>!$RW?Y)!FDBPT21:9)(M-DDT,D?5")-B'2*!_F%C.8R1#
M?!:.DCE/$=*J%C&S!?N@0'V<?5=Z)L8 B,J]1ZB"[(!*3VFD@HCM2>IB%40=
M6V*ZT1OA#G^!_ *TT;>D+G=ZA)E\T3@)6UV>96EY;I.,58V3>+_WE8EG&LR9
M+&! E?KD,0 BMMS[ 2"72* ( /E8 L50F_A((75_ "IP?+C[PP?I*=::[3-_
M7I)RMFPL-^=C:U:L15X*V@X#@Z<OVTX%V98CVTX%84SD^0B$<EQ7MA[0*DM^
MY&Z.F&$@OL$6!-+H-3W&K8]PTKF*G#!7+$X:L5JJGE&H165?J2@<N);L+!7E
MNO)\(0)0MN_8LK, +H_8<JBK*(\>S"SZ!NQR5JQ-?:[^*69%B[)8/1FQR&'C
M46!B0WU/MAX PX$<Q2$$<P,:R/8#8';@RWTYR.8[5+8@ /,\/&3"+KW#MGZ^
M5"]9^11YZ.<TGQ4K]NHURAG<8VBSQ>?.G(RRA4;9(J-LL5&VB2FV?LQT*2[6
MY[C3O&:<MWX*&S!0@!Q63MWT:N#;0*#G@?R46/+S:$A;#&G#\NBDM^ =A4<G
M0TV<'E-O:P>P+H/'1U+X99(_,%'67B1IB;9)MF$BI7],RC+):[@O5O-C)2ZT
M6I\3%ZHN.9LUI2L&=*DI[\T1@]XY<%P8:N3TF'I7&Q==M0+KRQ5#<?%I^BE"
MOQ3UP!0'J =XRABMU?R<V "TR3E49$I;#&@CKA(<>JO>>7!P_'@;^V[N2BU8
MFZ8/NOE?1?EUFV89:WP-NMH')F2N7 ;5JW^.KU5UCHME7QO2%K^$2#/6_Q6E
M$MS52K ^FQ_R\9R5Z;8IFJ L3>[3+*V_@YY6*PIOL)R1C/6->(ZG#1%%IHCB
MEQ!IHL$06W^YMJO)$'U-9B@:KM-Z5L"E:0+40N3\<*Q7^PS_GZ(M,J4M?@G1
ML&]-L?5]VQ6.B+ZJ,>3;69%O65FG][P_7_-<.ZVJHOR.\J%A7*_F=.N.B5JK
M\5QY:2HTI2X"U&%/62>*09@C+[W='#'V0 ( D=LNE@NPQ\BUTWO2U:>(OCYU
M6Q>SKT^3>5VRI^=YCLN!FA.12R8A@)*7LB( XU.E^ *@ F))OIQ 7)8WL*1'
MNNH5T5>O>J47T*QJS4?I.%6(7*X"(,I",:1)"7P5(Z]>3"#,P((>Z4I41+\%
MH2V3'EIKL#[54O77%.4L; R@, [D,GX(P'SY68P $)_)!H%L/0@66/*2* 0C
M'@X&;-B5;(@^XV\JI?=L492BAQ<U/E0GWP8Z\!=4(89K?$;90J-LD5&VF*AU
MH3>4>G):,P%QEGWP,/6=W)5CB#Y]G^X=J^U57E!,T+C7)%MHE"TRRA838&.'
M+[L6P'@#;NVJ*42?]__":I3QYQ=TYD[T< _3&V(Y\AH>!,/4E]=)0PCG><H6
M$ A&,9&7D&(01SW?DB=+1PH?/CQ9@M@MVY%7\XZQ!]K94E<-(?J=)U%2YFG^
M4*$U'Z>J95*R2]!C1O>>&&4+C;)%1MEBHVP34VS]6.FJ*D1?5;E.JG0FYC#-
M@]U$#.^Z5T6^"QQ4;.JJ3O+YP)Z'EMT_C'SKPO*LWC\L=P* %+V0=SB$,+F\
MPRN"8-Z%(R_F0S#[0B[KWARQUQVVOKR^P_":/MP2>5O!]*@*+%1HE_9I5RBA
M^D))F&8;<2S@Q2YN^9_I8D@*<#%,KK@8@@$NAF" BX]83.MBN"6*BX^J.,'%
M7;V$ZK/LW3/\V!P.XIY.MJQ,'AC*-ZM[[NNF<-*YNSKJ;V#3B^=[/I4SB3&
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MPDBQ J5WAMH[;"J<+$IA/KB7[Q[V#7D2E!V! D4H4(P")7- C/I0AUBC0!D
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MJLTG%C.XUF GGB4J7(H"95/UEO4FK .?MP[&]<9E<WFHMNZ0M A*BWUJ2ZG
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MK 7NZ0ISLF)Q)&BGW(.%H0?R6_W&% A(#?LZX02$4* )W7?TIFT/T%SL^#U
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M-'ET.#N:)O>/9Q=?))Z)[FSNZ=DDN4],&^7_7H&-L)Y8@QJZHPA-5X6&B#>
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MI)H,_L&C+8E/!A0"&5D*E7<"NP*JJOFQUA>MY5X3-WE1( FR9U"SF%4P>',
M)32TW90T+M."1H,L:X/TS=9UC=4"M6553N6?B"& ME(QH,S:Z2QMKG'VMP5-
M9JD;1KD('3:SWU< :Z >''P@S'&-)5L^4;)'CHDD'IMG]>VJK0QD%5#XOC3
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M3SP[1@GBG];(9YB<_C/;-E>@."^^')L?L]: 1AO4/2 0R U=Y&9I,5L79(=
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MW=.3&OI-[)4XR7V\)MOA0K8S[C4!87[@,($A061 X,XN!RH!8SZ)":*9L1,
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MT5.Y, G,"E]=PX<[,[%E.[:Z"GQNC+@U#C+$5S=[.C@/]U(<Z:5,=WDI+A;
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M!YXXU(_87+IB?&N( 8.FE1<P-7[AS!-64?,EJ _<)D?95N"01>0@1)[PF0
M^@C]NI%WW9 LLDO T+A("Y5[7G_-J#&@S0DDE4X 3&M@K&;L?\ZA*T5%KA0M
M-P B\<@' $<M4,B]VJ0\MEP_0N+<!(&KH""T(A>=ET9LRND$';PY0"SX#,!V
M@'B3T(K!VS@2.%;42_H,?(XC\NMZ#@@N/M/DE8'A]UW<!M!08/N$BO#*7/>@
MN(#XLO;(!R\Y\F+&30 6&=VI]&;Y'.$S$Q%/0!@4P7E@G%'.O;D1/%&ADHE/
MK(@%3&(!"+>6HVC@1[&<XH:)^(RV%MAI?0"N!D[$N!5O_ %G:3UTXF#?/=_X
MM>24(9B%5VBHJII31OM1_TJO@5UM0)&QA^$"RTXB41_@P<1.>-@O,U!&A)G$
MR)&O.P'(Z]HA 3L:I<BG>R>F4(=G12%&O;7QEF2S PO_C(\RK75[=5-96XS8
M]NU& OTSX_7NW0MZEG@OU1;JM8^3F%OTCJ.X:\\_CG#8XY&Z90ZX>9]\=,T[
MF#CDIH'#QD(=678,#D 80VN/&,@7@]4IXQ\5R^]CU_V10[X;\LZWQIF>&P)7
M]I%IM@% ^^%^U18FPER5N<+6G4J2\KM>R3U.=P-Y3L;2D<F]0_8_)4CE+&2Q
M8ZFOU40R6#8?S5O:AIH,#?;F R5_M ^P?S#.U)9!=H/L\045<[,F9DB7M$G8
ML@'IH5[NQSUC/\RY&[;_C$M7CR]"FN=DC(A0;+X]OS 8ZO^'(?VG6CK9 ^D_
MW3K*'4@_["']< O2]R.17A(%&TC? 3#*GXSFO1&T'SC"4\"[ =KW:%U#UL!_
MCB#^77@?0ZHA%+42$:8#J 4@IX?WO41D+B5;\7X2Q$0E7+=C_03(#+V8.Y,X
MNY"^ \Y/2'1YM-P@&H\L+PBV0'THXI,_ % ,8#86F$1P&WP/WA\L.8S >M\&
M?P(_^(EMJ)Z"OY&GKGLA>L!?V%N^<OO?!<_1O[1")^QNA@#=CPB@(Y;T[*T
M'3PN+W))U/#*%&U%ZY/ <A(<"#>R$@*46+WKPECLQNLAX$^;T:[K4V(,WOM
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M[KUF]93K8=\?*AF/L*O8^K\W4D)N7G!W0 .@-J;#AQC2B$/<Y;,C9A*#FY<
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M5Q?KY;\)RGOJ 5=_1]6A;!/L05GC)(%<3=F+0-26>IVNM(*J<TTL#>\PW;>
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MGO//C<(YU] $C*]*M-#- VW0?=R]_B]02P,$%     @ \3%#6I9ZGA>S P
M-@@  !D   !X;"]W;W)K<VAE971S+W-H965T,30N>&ULC5;;;MLX$'WW5PQ4
M8)\4Z^KKV@:2-(LML.T&=;M]IJ61180BM205)W^_0\I6':QC],7B9>;,F3/D
MT*N#TD^F1K3PT@AIUD%M;;N,(E/4V# S5BU*VJF4;IBEJ=Y'IM7(2N_4B"B-
MXVG4,"Z#S<JO/>K-2G56<(F/&DS7-$R_WJ%0AW60!*>%KWQ?6[<0;58MV^,6
M[??V4=,L&E!*WJ T7$G06*V#VV1YESM[;_ /QX,Y&X/+9*?4DYM\*M=![ BA
MP,(Z!$:?9[Q'(1P0T?CWB!D,(9WC^?B$_H?/G7+9,8/W2OS@I:W7P3R $BO6
M"?M5'?[$8SX3AU<H8?PO''K;- Z@Z(Q5S=&9&#1<]E_V<M3AS&'^GD-Z=$@]
M[SZ09_F16;99:74 [:P)S0U\JMZ;R''IBK*UFG8Y^=G-%ZK[7\H8:%'#MF8:
M5Y$E7+<;%4>,NQXC?0=C 9^5M+6!!UEB^=8_(CX#J?1$ZBZ]"KC%=@Q9'$(:
MI_D5O&Q(,O-XV3MX#TQ++O=]DL8EN;R490^27P9QMV-I6E;@.J#C;U _8[#Y
M[4,RC7^_0C$?*.;7T'^Q#E<Q+C.<CT?_QP8ZT2-;(Y L"$U?/735 ]+>8K,C
MRU,!@,G2#;(0G,O!'W0L;]@S:KJW(#MOKJI>6N-&]ZHA5-A:53P!]0)C"81*
M )VA&%9!P431"69QM%.V=A>+%SY0R45'Z"")M#B1]L# C2=@6(-C^"2A4$W;
M68=ZQ8GZ%OQ"IJ,+F5(2+9.O@"^%Z)R'6ZR4H$;F@K;*HK2<"?':$Z#V @:+
M3G/+T83 >KY85=2"J#MUHH0=4A#+;P8'%U)CV17HC$<7,ABD*GTRR(K:[7)5
M+F%+3;KL!#K-;PEW@-T./.#A1+_2JO%)=9;YEDA.'X_*G<Y(KX/38/3%*79^
MLR\IYBW_;AV<<75M.UW4U"7?GH DGX5Q',,BR<+Y9#KZ+I_1N+!T7*SFA1L:
M;]E);HT7A1V8+@TD839+PL4DAF0V"]/99/2#:4T:&J_&VS!IF"5YF"0Y9/2;
MALET,MJ25*3"[4T"="LJU'H(=@-I.,\6A#[[:99>,,O"/)F$"TKU7A%U;?F.
M-&])3VZ,TJ\@Z2PXKDDR#V?9!/)PFF=AEDY&WY1E@@2@($DX6RR @)(X#2=Q
M I?Z1G36RQO4>_]B&3KKG;1]6Q]6AT?QMG\+?IKW+^IGIO><RB*P(M=X/)L$
MH/M7JI]8U?J7@:X@O3-^6-/#CMH9T'ZE**WCQ 48_BIL_@-02P,$%     @
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M_H>O7&4"D>D6D9K#9U8LN+?!EW384CPA#**AWP]B"V=8)W80HJI&#=*0QI#
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MG".:$37/GPUO3M5G(QVYJSZQ:CSW6+5+@6<=0YV3Q!A1<I>T7K.9D6/1UQ2
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M!?\G)E]!3)Y$K9>'/.K7-@VI. 9-6FJA$A_7J ,4<&.+$<U(ZB<]ML$$Y+%
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MF3U=<A@-%2Z YW,)0I<7N$'U?P*N_PU02P,$%     @ \3%#6BE%=P"#!0
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MK*+TP=%JY1V$P]/CL#\YA<GZP^,3#(Q@K\FH7P\,PU%_$!Z?#H"&)P2-L.^
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M=E0!P*/!(.X/CMF'/5LBLU7^)#3ARO)PKZ-<8@.M^V#UY*2;L)E!RG4B^HR
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ME8;=\U,?=&-BS<*JLC:.N;)D0_4T)]]'[1)H?Z&4W2S< >T_R?@W4$L#!!0
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M_1"/,J'1@&BYILI4(*B3AP_$[EMCU\R#PZ54'N_-$0*4<1;0:*"A0L,FP?)
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MFBO=N^TTUZ\K"F.@SS><J\/"..C>Z_EO4$L#!!0    ( /$Q0UJNZSHKU4,
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M!&N-!M#.OC4E\+%#2:CD1BW=*!@NFEW??0X^7Y LEQD'N(\H+RVZ>DZHD8C
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M=@=/O=6]5(\I!#Q=9AA.YQR.QGWN$=4&ZRS&>3@$78^Y?"^#"/4E;Z"\U!7
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MWH\#-(\,J;+&2=^ '>3=HKQ)<FK_!0CGMHL4Q\VT-.;=#B&7I287?: YR+4
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M\)DY&VN(*-'BM(KHQ6)&*S7W05@TZFA<^[!Q_:63+S\Q0%$V'P3+Y+ZRQVB
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MINGU.WX"IIDOS<91'7KZFAQ/B+ L>22C\0HLWQ"YP\8[Z(;\[!]02P,$%
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M([P=KNF2A=H9T/^EHCS[B0NPO[;-?@!02P,$%     @ \3%#6D ZHB#P!0
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M:U':UR6P'*19@/-S(?3VPRAH;JXF?P-02P,$%     @ \3%#6H6,^:EO P
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M7^H+[MYFN?DWP1?,07X"I60*H!#&H&SCYNK=="0K].WUA$G),OTY)S@A7"V
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M93W\OAWKX0$/WDF-"@(([LU-508;B;7!CQH+ ?/Z"D MEG7"/H AN9$#9 Y
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M4L<>ER7\/Z(&)T0-CB_>/'SI*>RN._PH.ZKV[E07?SC5OZ=3G=_K5(^<V!4
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M:'QR?AJ":49(8SA=UFT[UXZ&0+U=T=1%XQWH?J&UVQH^0#O'LW]02P,$%
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M-''CJ,5FRC-AZD7G7.YB_*'4VT2;ADR[9G>,XFS#!AT3X!0F- 6X5[@;!^Q
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MKUC@>&^ F$MQ&-4=68.['1,*C(&/ \0A]AA80$JAK,=/X#/X^C0 'S]\ A\
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MC>5W+!DMD"LJ.$A<3[SIX&P^LO[.X2O%6NVMP6:R$N+6&A?9Q NL(&28:LM
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M4F9Q"H3'E" &\X%UZUZ';EL)LA)_Q[#E>]=(O<J4TM_JYFXVL!P5$200"87
M\M\&QI DBB3C^*^ 6F6=2KA__4(/LI>7+S/%',8T^2>>B>7 ZEEH!G.\3L1W
MNOT+BA?J*%Y$$Y[]1=NBK&.A:,T%30NQC""-2?X?/Q4-L2?PO#<$7B'P3A6T
M"D'K5$&[$+0/!++MZP6=0M YM89N(>B>*K@L!)>967GK9M;X6.!AG]$M8JJT
MI*F+S-],+1V)B4K%1\'DK['4B>$8$SR+,4&3%-@"2/2,1FLN"W&.;J.(KHE
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M@&? 5 'Y^YQ2\7*C*B@/B8?_ U!+ P04    " #Q,4-:SER*8<\T  ".0P0
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M#AAPP*P<,." 63E@P &S<L"  V;E@ $'S,H! PZ8E0,&'# K!PPX8%8.&'#
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M5Z9*]73,JF>SRC2+UH\J3OU%H,@\CD(_2:+XF;R+4M6P3$$;7*$T!J5Q*$U
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MBS3:%\]N?XC2--H5OVZXO^)Q/D/V]W44I2\O\@#/4?RU6)6W_P502P,$%
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M]%"]O]05WN@*MWFN8((=SWC0[GK0N!X<EKEJ=%FG7G=[6P"#9P&0H#V \R:
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MGFVMPOZ!F_=(4TQT9!N7Z\V[<XG ?@#.9H%6LZ#43/,U.47=K5:,0-D)5(U
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MDZD>LONCJN ^R[]L-]GE/U!+ P04    " #Q,4-:Z+;.%O("  "X"P  &0
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M4!D@WB\)X?N)%*C,NO\;4$L#!!0    ( /$Q0UI@'W_B1C(   6: @ 9
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M4!J%TM@0FDP#'JI:]?5(I5]KJ/W:6_?6:9\Y,B3FGC47\V/51?2-6RB-R.[
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MO;XR-&&21KOSBJ&6=(6-FMIW_A)*<Z T J4MH#072J-0&H/2/!2MKI+*Z;D
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M)6Q""!1'L3B&Q7DPG""P2G;'5.U[W[JW3NL,X+NNJ^_L5I_GIN/:_G+"YH5
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MK 7A:K,O]HO.5]GXJ:^Q,/CRD";:?1#ZX2KP-]EG[J-X>QA3[>(@BO.W7?K
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MRJUWE=(#_WPE\0MA_RJ1::WV[?4&M>8-:LT?REIU?<HF'.J[\&\DWE$FYVI
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MBLE.KZA.)X+NLG<P+U0(&F>'6X+7A*4"\OL-I>+])'VM4[PH7/P/4$L#!!0
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MH]71X-R94D0&4"]16H+2!$I+49I$:0JE92@M1VE3BG:LJSK4'=FCB>Z$=V0
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MJ!90+:>T<D2]E%GG\3)K[*\P6D5%M135Q/R\'OAF/9G-*G^<9.UQR\FTNBI
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MZIC8'QG9WTB^+D]=/'.IOHKR<@5A#$('J/<+SN7;C4Y0']R9_0=02P,$%
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M!+N/V_^-VZZ]0.8UOZ%RQ;@B,41HZ)P.$$$6#V0QT2+-'Z6ET/C$Y<,U?E2
M- =P/Q)"[R;FG:L^4_Q?4$L#!!0    ( /$Q0UH;5BV!(A$   8/ 0 9
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M>*B-3T^/T'Z=MGZ-R5!53Y]*ZW8>H=>VY4!M,7UT7X+6?1F.==TX71_>LN5
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M#0)/EE)5U.!6K4)=*Z"% U4\C*-H&%:4B2!+76RNLE0VAC,!<T5T4U54/4Z
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M4>\]%J3\W/ ;(VO7>@MIL)'=LL11"\HFX/E22K/=V NZX9W]!E!+ P04
M" #Q,4-:24D75+L"   6!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V-RYX
M;6RM55%OVC 0_BM65DVMM#8A@;3J(%*!3:VT2JBTV\.T!Y,<Q*IC9[8#[-_O
M[(2,LH#VL!?B<^[[_'W'^3+<2/6J<P!#M@47>N3EQI2WOJ_3' JJKV0) M\L
MI2JHP5"M?%TJH)D#%=P/@R#V"\J$EPS=WDPE0UD9S@3,%-%545#U:PQ<;D9>
MS]MM/+%5;NR&GPQ+NH(YF)=RIC#R6Y:,%2 TDX(H6(Z\N][M)+;Y+N$K@XW>
M6Q/K9"'EJPT>LI$76$' (366@>)C#1/@W!*AC)\-I]<>:8'[ZQW[9^<=O2RH
MAHGDWUAF\I%WXY$,EK3BYDEN[J'Q,[!\J>3:_9)-DQMX)*VTD44#1@4%$_63
M;ILZ[ %Z\1% V #"0T#_""!J )$S6BMSMJ;4T&2HY(8HFXUL=N%JX]#HA@G[
M+\Z-PK<,<2:98UMD%0<BEV0BBU(*$$;;Z$&DL@!R_D5J?4'&@!T#9*;DFKE_
M$,-=RC/=DO,I&,HX9EZ2E_F4G)]=D#/"!'G.9:6IR/30-ZC7GNJGC;9QK2T\
MHJT7DD<I3*[))Y%!]I; 1Z.MVW#G=AR>9)Q">D6BW@<2!F'4(6CR[_#PA)RH
M+7[D^*(C?'OUFS*=<JDKK/'WNX4V"OO[1U?):L9^-Z.]\[>ZI"F,/+S4&M0:
MO.3]NUX<?.RR^Y_(WICOM^;[I]B3%\$,9&1NJ('.YJCA P>WPVB=7$;137@]
M]-?['KK2@OX@;M/>J!NTZ@8GU>&,P D@NG35P'COP'APH.GO%-LO77KB5D]\
M4L^S-)03[!!-%O559'7S&+KM+E_<5;[K.#R0VI46]*/^@5Q_;\04H%9N\FJ2
MRDJ8^OZUN^UPOW,S[6!_C$._GM%_:.HOQB-5*R8TX;!$RN#J&D6I>@K7@9&E
M&V0+:7 LNF6.'RY0-@'?+Z4TN\ >T'X*D]]02P,$%     @ \3%#6EH]QQ@:
M P  = P  !D   !X;"]W;W)K<VAE971S+W-H965T-C@N>&ULK9==;]HP%(;_
MBI554RMMS0>?[2!2@4WK1254VNUBVH5)3HA5QV:V ]V_G^U (%7(0/0&8N><
MU^]CQ\[)8,W%BTP!%'K-*)-#)U5J>>NZ,DHAP_*:+X'I.PD7&5:Z*1:N7 K
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M,M6?!2!,@+Z?<*ZV#3- ^:$1_@-02P,$%     @ \3%#6H?1%+:5 P  + P
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MMJB?0J@'BB^K&_F/7"F>5X<+H"D(<X%^?\ZY>A^8 ,VS(+/_ %!+ P04
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M_PCKMU>\J:X-"W_Z)5))EH=E4LNN:3[Y;5?*E]OU[F</NY]L?/@/4$L#!!0
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M+[[K/U!+ 0(4 Q0    ( /$Q0UH'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ \3%#6K]9]L_N
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ \3%#6IE<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " #Q,4-:F[H&.NT$   2%0  &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ \3%#6N2M>(K8"P  TT<  !@              ("!, T  'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( /$Q0UKU<A%U_ ,  $P3
M   8              " @3X9  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q0
M2P$"% ,4    " #Q,4-:H<G9?C ,  ")30  &               @(%P'0
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ \3%#6G \FDI;
M%0  =_(  !@              ("!UBD  'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+ 0(4 Q0    ( /$Q0UH508EYQ T  'Q5   8              "
M@6<_  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #Q,4-:
MBBY'&B47  !M4P  &               @(%A30  >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&UL4$L! A0#%     @ \3%#6I-WJP/>(P  "YD  !@
M     ("!O&0  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (
M /$Q0UI5VFSAHP,  #D(   8              " @="(  !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6Q02P$"% ,4    " #Q,4-:S9D;.\X.   .+P  &0
M            @(&IC   >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4
M Q0    ( /$Q0UHF"J8&X (  &,&   9              " @:Z;  !X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ \3%#6KQ;=EO) @
MN0<  !D              ("!Q9X  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6Q02P$"% ,4    " #Q,4-:6?-YD;D*  #H'0  &0              @('%
MH0  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( /$Q0UJ6
M>IX7LP,  #8(   9              " @;6L  !X;"]W;W)K<VAE971S+W-H
M965T,30N>&UL4$L! A0#%     @ \3%#6G5P6XY&"   -!D  !D
M     ("!G[   'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /$Q0UJ)MN!J)0X  -8M   9              "
M@:;3  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ \3%#
M6BYL%3.?"   310  !D              ("! N(  'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6Q02P$"% ,4    " #Q,4-:W]\$JL "  !5!@  &0
M        @('8Z@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0
M   ( /$Q0UH&_@@!) @  %D4   9              " @<_M  !X;"]W;W)K
M<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ \3%#6L):"TG, @  NP<
M !D              ("!*O8  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q0
M2P$"% ,4    " #Q,4-:KNLZ*]5#  ! %P$ &0              @($M^0
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( /$Q0UI,-NF5
M5@,  / '   9              " @3D] 0!X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L! A0#%     @ \3%#6@)70:/% P  P@D  !D
M ("!QD ! 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " #Q
M,4-:0#JB(/ %  #%$@  &0              @('"1 $ >&PO=V]R:W-H965T
M<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( /$Q0UJ%C/FI;P,  *$)   9
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M970S,RYX;6Q02P$"% ,4    " #Q,4-:BZ=Y:I0"  #3!0  &0
M    @('O=@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (
M /$Q0UJP:W4:8@4  !@/   9              " @;IY 0!X;"]W;W)K<VAE
M971S+W-H965T,S4N>&UL4$L! A0#%     @ \3%#6N.\N4W0!0  X!\  !D
M             ("!4W\! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"
M% ,4    " #Q,4-:(NIC$7D$  "@'0  &0              @(%:A0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( /$Q0UHK3[V&V@(
M %<+   9              " @0J* 0!X;"]W;W)K<VAE971S+W-H965T,S@N
M>&UL4$L! A0#%     @ \3%#6K7.H I; P  F T  !D              ("!
M&XT! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #Q,4-:
M-IC^DH@"  "(!@  &0              @(&MD $ >&PO=V]R:W-H965T<R]S
M:&5E=#0P+GAM;%!+ 0(4 Q0    ( /$Q0UIE+.07GR(  '$W @ 9
M      " @6R3 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%
M  @ \3%#6G,@47%J @  7 4  !D              ("!0K8! 'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " #Q,4-:F\Z-T90$   P'@
M&0              @('CN $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+
M 0(4 Q0    ( /$Q0UK.7(IASS0  (Y#!  9              " @:Z] 0!X
M;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ \3%#6N#V4X2^
M!@  U3$  !D              ("!M/(! 'AL+W=O<FMS:&5E=',O<VAE970T
M-2YX;6Q02P$"% ,4    " #Q,4-::]300^T$  #M(@  &0
M@(&I^0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( /$Q
M0UHKV[1+E@@  +MC   9              " @<W^ 0!X;"]W;W)K<VAE971S
M+W-H965T-#<N>&UL4$L! A0#%     @ \3%#6C.R%V9'!P  )%8  !D
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M=#4R+GAM;%!+ 0(4 Q0    ( /$Q0UI $//ZJ@(  $@'   9
M  " @<DP @!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @
M\3%#6JB4T*-S#0  >K(  !D              ("!JC," 'AL+W=O<FMS:&5E
M=',O<VAE970U-"YX;6Q02P$"% ,4    " #Q,4-:Z+;.%O("  "X"P  &0
M            @(%400( >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4
M Q0    ( /$Q0UI@'W_B1C(   6: @ 9              " @7U$ @!X;"]W
M;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ \3%#6GY21S'#!
M-!P  !D              ("!^G8" 'AL+W=O<FMS:&5E=',O<VAE970U-RYX
M;6Q02P$"% ,4    " #Q,4-:H4F,!VHC  !,_ $ &0              @('T
M>P( >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( /$Q0UKC
M.3=%O2T  /1/ @ 9              " @96? @!X;"]W;W)K<VAE971S+W-H
M965T-3DN>&UL4$L! A0#%     @ \3%#6D:QHDPV@@  RP\* !D
M     ("!B<T" 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /$Q0UI_+F7C2 ,  " /   9              "
M@9N/ P!X;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ \3%#
M6KR+^!9H @  R 4  !D              ("!&I,# 'AL+W=O<FMS:&5E=',O
M<VAE970V-BYX;6Q02P$"% ,4    " #Q,4-:24D75+L"   6!P  &0
M        @(&YE0, >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0
M   ( /$Q0UI:/<<8&@,  '0,   9              " @:N8 P!X;"]W;W)K
M<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @ \3%#6H?1%+:5 P  + P
M !D              ("!_)L# 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q0
M2P$"% ,4    " #Q,4-:%1U/9E$#   G#   &0              @('(GP,
M>&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( /$Q0UHUU*-"
M!@,  "0)   9              " @5"C P!X;"]W;W)K<VAE971S+W-H965T
M-S$N>&UL4$L! A0#%     @ \3%#6I]C?0($!   HQ$  !D
M ("!C:8# 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " #Q
M,4-:\N6%E+X$   7(@  &0              @('(J@, >&PO=V]R:W-H965T
M<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( /$Q0UKG[1!"A@,  +@+   9
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M P!X;"]S='EL97,N>&UL4$L! A0#%     @ \3%#6I>*NQS     $P(   L
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64$L%!@    !4 %0  Q<  %'- P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>105
<FILENAME>0001493152-25-004524-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-004524-xbrl.zip
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MNWKZP,'*8Z6V/$S.N$IGVG8ZD>L6"QTA+::WT-#G:['9&'<6"W15E-VAA86
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ML Q)&1Z%65EAD$:LZ+:YOF#MNHXZP?#"QN C*>5S&_Y]WR^.0N(7Z_="]%$
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M';Y\RUKEV2;-\G7-3V_9YYK69Y)$F-EOOQZ='AV^Q:G%PP$>13G)='CQW_I
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MJ;M[!YV?ECG2W'TP/18H3WR\4A*>*ITI<4GF< "\TT#&2IJ?D]S&O0)$Y[5
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M2\0.;E; 1LG8M0N?K2H0GZJ*7B1N3H!VKB*+<P:.,=]#]07(R5NP-DOX#-X
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M<93,:XG-DO 7<PQCI)5U1#A[]&P<W8?_=>W4YD_=^ 4\ "PZ,/M@>C T,A'
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M].VX:BRNUY#A-58\VJ#GAX/+(ELME,>GQW=_3A%X+-W%('T)6E3-#9WY+%F
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M5#/,W8/3 KKU<5-3BIHKV*U 41,^_;&CP71LHLE/*UD>)^[ED_'(RG1*4L\
M85W(C9X0S+ LEB4"8A_;0(3O//:LD=:SI!CF:D9>,*X4W4_G) CX1NQ7M:HO
MBA)YD$SC.TV#VRJ*LJG>5M"D-P\?@A<4NBU?<T,\;6,YE+GBI=N T$E]4VHB
M<CSS!;?I3/=E4)HSD2@*A38#K9 IZ(^ 6(>\KRTV.(_*C%;2X#+DL*[00\?>
M3XGDK)NE-UU595I4)!ZW^YU ON8)$?5> -V5CK<)MV/EN1PPYC'+IZ99GVT'
M:EC*&B&DQJVU(;<H]Y5N9KL!2Q/K[[>C5EZ4RGPO*RACQ_1_?H:@^8,MXEI>
M?+45HM+D:8::7Z^2'2SAGYE[+J824VYDCV]$=3(KP5>Q=1R!!VC^?B[JAVV#
MVZ$B+K!%82Q2NO;Z["B7-;4CK.CNNS,8_75BL%VY?"B;@G%1*Q9']R4'X_9Q
MN*][0J,+T#?'/GC-DAV+SRJ,];;LP8D(8Y]/77+IM)7MP1VVN7U%-AWAEF@]
M)Z@TD[Q0 WN_C4WG-;& 6D"\=IK$ =/Y7^4S@=3BEB#Q6F7 ,A$X&'3[MC/H
MA61W9A0%[T_$<\=?8C5'S @HA)HF/+-5)#,JAC+&3=/20)E9*A*<:(I1/FH0
M()ZZL(0FC-)@E"=[Q1,.(T34/WPXF((<@BR5(%_8=5 1?F/K1\/,G>V21(O]
M")T+^96F@HRQ!P.HJ<J:/F:+I%<I8?= 3R]!)^$5P$N2V/WAA2$_F/6GP2PV
MPQ'4CX\5U:;MC?4ZP3 J<+!5:+VB]G+]J2GOO/;LSV+\L,]BW& 6XX=]%F.?
MQ=@M^R7]VNT7 U9L-E+9PI(A^AZ?W"S-R0<C*QWN:<T=8Y]"E^<6L4<)?0G:
M=)Z">4">@;W:C1L)1X&C+>+SM9JDC/! LQF5K7DBEKOJF$=<E)5+6<7(SR6>
MZISJ2@WT% >G.\]C>7?%04S[58,X=7"H%/_$>!I^JUW.WSO 4WY-8W1.J,:)
ME\^P%GKF9'-@+<B+-K,4&T8ZO(3 XW/P;<%4BH7YJ"@%^"J,XH+:6B+[ ;-M
MV_B<%&_#C,S[.B+ZCVDYFI@B?Z@ZSH\!K0;1#';^)JP2\;"AO,]3KN#0''>:
M70H'(Z1.U#];RJX:9LZ8?$HGF,"+;F6L/<O0VDV*I!3>3[UTAIN?;,]SC-+-
M$\)6"W$#C[RF3!:)B<DJ-J.ZRBY-117R52$P'5Q$033B:1%$K)ZS-2M)D*B]
M@)ON2RZ+5"@%.=F48(:NLC%A-\O4KYR$*<D L!HZD.*(#=X/I-YB#PH!YL'1
MTOV,9!=^_T>"%G/Z#Y.]"6LA,(B7A<H3VCOFZ^&6T: Y2AJA#3[#ALW6P@ZT
M5,3-U09S/1A+_,%( !%J>H,TJ1XB/A+0%QX0HQQ%X+3E79N^!A-//N'!EVF1
M.05H'L=!$>Q:<9=C=JV.-I11E42J:'HB[V(G!!M$]@H)4U4Q[)K1JH$E!(W8
M6L3AP(MO.<1ITB-3)3GH%W1/)):N8SV-BB\!L1=7[J?D<U._B \8W%*Q<?(8
M)6GS%J#J> 1.;-*;<BRE>!).H[Q?+?D2P_442V"/UT4TK'MNB=Z0V R=MI=N
M4U#B&3-?QT1'8G9THNHKU<A_-6-K3+R0K\=N>)Z&H?OE>%\WZ@BL<'I;S5T
ML42TJX^.Z5S$JL<[Q&A-((1:L\\ZE@S![AK\$SOO,G[-$QK]$0SPZ_LT<)&&
M;E$B_K$7(OQJJK1:<?20Q7;XQYJO*K#+P,(+J"#WT<V[RJ5=:F45?;M:X]P[
M;D-?GU_O2HQNX$84JU_X)C<7]#39?5KWJ&YMUKI)&^LIMVFCF;)S;4J[UH[[
M==.=&KH0 K<J)I-;H_.NT>'@L]^C'LJ$;U%*=5[_&NTX'O ZEU+R.C<L&8;A
M%=WJAFU@*5J-?KRKUBF "]\MP\'&VS>ZF<NWN9S[Z^463VCT'JZ7:W9FZVG&
MU@XY;,I"JY0U0L&W"[NYU^*][DLZL\[.4JH5+:0%J7/K*,U<I;U$4.DM#C^"
M2DVSA#N 5:K4;;]LZ,*H(&YAE,LKM1VHN]31Q[IK?0^!7UI)+^,0G1ASB!G8
MELP@-ASC*1S4F:J6:1V.%S1! !4L6B751DM,ZE)6%N8+.\&;XLXP1;2H,)+,
M5QGY]/P ;4TTGX$QI48AJOZJW!?49XT7"*/$YP7W"2NT\&B>MR"&(2E+VD&"
M(NFB9V1-%BY]-(?*RFO,90@:?C9!HN-\!L>M)*L [>("_O/0P)Q&-KCS\_')
MZ:$;VJ%^S[0539Q0SPXW6H>WCTV#8J"M^>&;D[)XS["!&=SU#/+A.R5 +8]:
MGG)6XEO0H>QV+R2-22QZ+G4,3=^S1/@3(DI\='!P+THJDXALA_:"Y5$)QZ7F
M2JCQY**JPL2)1M:HFZ%#G.#T-WVK(YH/0+_M_/W3GQ'[<9\1N\&,V(_[C-@^
M([9;%F 6##!LN(!B[8](AP279;1!]8! %E."8<OTW4ZB@@B9(LH%3 ZN2TY*
MVS-&VK> HY$I,!IFXS9 HZO=)UF !)QHN= ]J!R5<X41@VV=X<D#=3P9MJ30
M$7\N/9 FV.%>!A_)I,$I(*?%O7X]I@B[<$'<"F"')'7WCMZ"D]$]=#9MR["W
M"Y>#R6R68'CF8[MD"FVE<ASIEG=H]CM</%':*++I*ZEQ</RMT$I35-O27VF*
M=%.4)Y#@5C$!X7-)E> I3B<K[:R&5<$F7AP_90A_IXZ[;@6]+9?J4#:<M]?*
M!IW%(IL)N>2J!$>M4MS%2[ZY3%*9WMRQZR5&!JX?(YKQYZ;O<;];+-6".ME*
M<%[YY6/V#A>:F,+$-:7GC?$H@[M,.<7.;=9UF(1:D 2G'BDL:"T.V*3!;*V'
M>&VY>FQP?<2!Y/Z$YV=K?0+LY7ZPM[^Q^SP@H0':N[V:O<43&N4?2T=D01=_
M@AJH;K06E]8"1<FQUTN'W(I/OE]K!>;.5*@T=-V55&J&>&XP];=:+ (T6Z&8
MTW#@A"1V:,=W3X2+C[ 42!5VI&2<GF1K2B:BB@Z8%ED<(?>.:4XEA60Y:$F,
MB_UXK]7"B;NQ:2(\;MNBCPFIU<F:J?,X(5,YQ?(CC2OGI*$..C%>2ZIG..MM
MP4C19&W8FYU^+MR0\=$/G3B6,0^*(USUE<HNU9T%++ON& ,G"W8^EQNMV<%T
MGI:@*6;)VC#/-*.L\[2"U</:(R2#AD/ZH7::E. OG*R\WZYD _'@_J#>X@F-
MEL&[QJ:3M[EUG)0Y6?S;]P\)]I=D%]H1)3R%="[VHG2+)S3ZEZ3F,-LLL%JO
M_Q'KW.[&T\(H?HFJO3/1%.A\YU76DYGK"[-$;E@M2[2(#*4P2MCI[&)^*0X5
M#"BOYAH1W.[NU20;&Y$\"U=%$Q'*6!CMP%&>OP^>8: +O0N@KQVZEFP3+_F"
M/_Z=/TW]B8:#>_M,PPUF&@[N[5,-^U3#;MUH"-O?NK.XQN:B_^'$*PE&@3E^
M#/ZK7->;>[R@Y7A,0"BZ=C".;MV3(TO\HVWM+5H3^^X5.MYPE27K %1Q(\N5
MC[VT=VLWSU7@+5*W49L$"^$NB]J0?3EU"U+UJJW$0,F##C(:O+8\A Q3; Q9
M.O5%#N;9?-%Y1:,?LWED % Y2IRBF5_ X835:/>B;[0!"?BY37Y5+\#<)IJC
MID4?"!\][=PRK!BP>W:>7N(#RE186"(:K6Y*VJ9$LXU9-7BO-6AT*DWO<BWW
MPAA'OS2C0J:LH"2U#" -0^=Z=%WW0D_S!BQ42N=I;EDD-OU&Y;,J=MQNW>.;
M.XX?(PV%_P.>)E;OX,(0Z<R],1>Z35=D97'@ ./W*Y/J0Y8(%5V =X(24J4?
MD&2(B+,>?,?MHL4_'P[P\:UQ5L[RRKNQ0?3Y.9++Z2K]M,38Q0.)7<0P_..Q
M[];KJB)O1HM517S)&[M:N1W:_>=Q5R#OJ;0#Q\>!%40U0X+JTD[SDHR^N^>_
M%':&?Q1NBNII/A-DZ#./&T+-3'3A=^N(B?#_320I/+-1*ILX\1>JW:C7)$'H
M$95+.T('!#SCQ(2_J!$&1GT*_20KO;9VHC$Q5I2.L2]N2G\>@'_DETZ"RX-M
MP>"L4T#+ZK)#7';Z6J=6NXLMOSPB 5T\IK<K4_DY:N]Y4]TD$W#IXL 1U;4F
MY^0P2M",J2EK0U/A:@Q#>,6;Q*J*.FT(WAVC"0;#QR]VG#[JTMEZCX3*1-FV
MWHE)-2&+V^*EWEO-\QK?=A0MX\O\4* U"\YU?K/17\L)L#@G30123FYC3V7-
M[T;O$%VN/BQ3VX.,M+_[K6 :]QPQU!.\CU>Y]2A9 [FFC1W^?!SD]>Z\J(1X
M3.H,_4NEPSKAPHHBRHK\W"N!II*I[>PV>WK(.F@89D&P8Z*C8MJA!NU^+KD3
MS9")TSAGK0*_*OG0P',6=+H+\!KI9M9/4"8&[9H"33@AC0'3R)TY78FA.6L>
M %=B+('\/IHTC8.78UH;)JG81;W@M;2Q8PR&X9-2&UZ@X3=9J3V8'+<;8+ON
MS($-.(<RH'I04G%"'6N YVFM4'[K.E.SG0^(?,T3&E7!2'6C<843IM8]++Q\
M(V)U9X@TIZ8D%O@5:!WO$H]UG;5M\%E[J;K%$QK5Z.+KH@Y'NG+Q;XUCRQ[O
M'-$G8B/8FSGBTMNF+]=FTI!2/KG(7!^YQ.YC[7ZR8NR]@5M^FBZ3+'K%50)M
M]EP"LTC5;N.M3GC8>AO814M=^JX>\Q&N/9AZRJ%G!ZV^L<IMA^1C]P1^M4'@
M0P$=QUZ(A8;,&+<:@9<;/@U/HKI;E X'7%AHO4_+2^=*6<RO%D,E=VO;FZ:.
M@Q*0%EJ)[MMSD8BL2YLD'!$,,47SF:-))=)&5]$Y&&1UFZ?,&(>>]'LU[',X
MT_  <WX=LYX7:></QH:$R\$^X7*3"9>#?<)EGW#YLI?3O;N/;E:M/+P+,WCW
M]+5C@#3<XB??OGOZ117IC<_YRV_C3=L8"=@8AV[4.6H'G3T/G\-(</&F:.76
M!N5M3(+>QK;!;(58XPYI73NUXF4GG(=(RJ<*5"/T%LTV'+_HN#9!3C"LG7:$
M7'/LA$"*ML [.!1"6"F)3'K0J%;W[<-.XZ@!"W:QM*W0D\E<F4^"U,)FT9ME
M$[8U#K<XC)MO][SH"Y51A#RU?@UF\2AVME#U12'Y/P\;W(-RML_KY+%S65+8
M(F2(ONF[:4U%AQNYM?P;ZN*=V/,'S"))!U"W?70SQ"<E7'Z7V*J5SFVC_'?>
MN/R:)S2:C'T*M;C5(-J2:DV10# Q2($N,8\-#5L1JGXT>>\J6!+2:LL9B#:S
M$^.708I>WM \P2 V#6U@*/9*=3=>*C^@HUOK0WVG))^L/D@K,TO T?I^5\<$
M5.TM[0U:T:KOFQ7 '3E'7^+T3,?=!(1"F-1H&-2L)G2:S^(_P\W[]%_?IY3Y
M<.ARG:+#\[$.>[5S7YCSBIOV H8'G20W!OT*+ ->M<I=.B35"S(W:L,<>1U5
M3HU WZVT@K=G6R56!+FJ>65,X1H7"U+56J/15#/I[24S.]?-RQD6H;)0,DCR
MHK.Y7%J9*_WN-3!;S8S?0Q"U[3)^T>:$']5:7#?CAP3$Y8RTO]'!NK22H[AV
M(]_H&DUK](4,BLU)PY:M^)$YP_ZTG:32Y9!^HB.ZG:3A09XS .F+I0=WY#[X
MPL[S(PX8'&D.'D?&<:/WT8*O8$J'B&UQ,K>:4"EVZ1=-0HO" GB)KH3XG)K+
M,5<F%\VO2N&<:!JTKE<%7S65Y(U6\HW$KNB,*KI/;WNPL3"?R]7MJV+#HX:_
M]U]%-%*$=\BI[)SP9$Q"3YD)_C.35HGM3<13(\W82SI,4U'!NDQ@Y-(HTH&W
M-HM;C$],)?V^*_ 7."\;$A7W]XF*FTQ4W-\G*O:)BAV[L[YCN^,8GK_(C3K?
MFQNW/Q2'R8DS23NLLHR*F1F :-E+X4+,DBO?$T1/GD&1S H0S0HFZ6$)6,=,
M<@ZNWR*3EM3@H<Q5$ZE#=%T)(KX%%6$*6V*G-TJ%#J,0'<310B$@'>V$I*QS
M^B_3+B66_C389 VQY?A'PS:6U 1=UN]$8&1%W$'"\WIU4;#37A99U8Q<4"DO
M?H9LSTY(SF<FT,[6D>:FQ<_,"S549.,<AX,_.TD=C)?ID*W$\ZV"L'=S=F'#
M^7M>'0]B>I,TK[@L"_NUDD5J$S4QXK[3!3:R218PO KM/&Z)0.%9#O,('TH,
MTCT[%]KA.>;!8)XJ3S+Y+HC-.?^H0C8V:V$RH+=I8C*--WTY]D"/8'R4N5I7
MXG1;TY ?3,#].5K7@H/'S98)80V:L,&158A0=?)\#:&2-<S_*%)I>XV-=1"@
MW6@Q9)?Y.2V2N[2>C>X, >UICC>3L)5R?'2M#0,Z84%HV;&B(*4",@S[K&.G
M16OLSTNH:U3":-'<AAP,>R\>> +1X2<1]]@.\*2C]&') QOV6$QC^O>4EH>7
M*'!@0,Q27VKL'1XV1=]=RJ1,EUF5([!*_QD^IN(-I')O2BCSZVLJ':X$7#M-
MN\/2_8+ETR]3,V$>&W19R(/!H5*FAA&.0#%/",U(QXOWDWJ0:(@MTU+)ZN-1
MUE/AMM]3CA>Z<R5Z- DW2=_N**$R )3T@IKV(CGU),'6!1CA_8EK.HC/NRY7
M*O*:)8 WH\Z)=MK_&RG9Q-01(.2W9G*X_H;HW;WM;6]W 7.*5T:->3J2*)[+
M9RA8#$>:Y7QQR;RU9,F63C*<U_NU;"!W1I'0F,?5G^JBN*ZD9&GX)8<#+3#/
M\.EOWZ_!T,396"D1^37-*)RU-I]A&IQ0U,V%;O2BH"_9(B64<XW-)A(](@"B
M9=#;49DO4Z>0M,I4PB=<>J1>3QJB@#"XY1\<*UTB-!9),DNOYS=<F:N*PMU.
MC-.*B$8J]#98I88?7KF)XBX8[HM&2$FM@^M$,6'C[H:9W?1W39EA9=V443Y#
M3KQ<2ZZ++QYOL[^T-U5M4,\B]_XR>BC[T$;2^:AUM_04*>>Q-87.-*3E=+7@
M1K,:;&RCLO8QHNI0QN%_Z*%Q0S:$6%[$PVG286=F/VPD08,&3MPR;V*!2=/Y
M)$-Q4T2(&M2W6\C$6M\@40YG/C1-#J\5KT2329*.+V'&=5R_!PVQ%8>L[IC2
M6+)67Y,1F8-"D6BY1O@6I9MY55%T"@M4F=R=GDOP]#CJLA'^J5]9^46';UN\
MG]%W'2D:$(H%Q;XXH=R^.BG*)I77^BXSU.T)M701JX1B<"46U[&5M$S6PA0L
MN\7$,61:.09 *WZ)1=GR2):S1>B"\ R@MM5C[]R/JFF3 \>+DOK>JH.D[BZ"
M^PX<)KY[;>U 0LT929YH9,0G&#17\$ZG:=&M3O:2O=+AYV;CY;074UBPBLT#
M,*8Q3,3?S$W[J *=M+5>.XLY$FP23\%IY>B*BH N$!36&JIA\PG\#784VU=G
M:UU(NPU<8D/%,AY?L\%;*F]2_TT.TBO$!Z5$6DU*UE;]-K1;(*@=/1C-QH^=
MMN.A3>YT"K3]P4*@A^;\'>2(;T@U,WJ1EPGO4-TQ2+K)-KGI8D,)17]VA@:V
MQ"IW4"WX: )]T>G)DK6:H>X@4!KM96VU!"*\J-'Y*J.PN'0BD[( !JYQ]S"9
MG.]+T JSMX#7AX*GSFT>MRW_!@%6K<I+7;ILDLCRBEX%;I ZMC=&8!]_W'G\
MUX:8_8-]S/XF8_8/]C'[?<Q^MP*_B,$\#M?4=W%OY"%H2%H) 1-"U;GU4PB;
M5G2&AOFZ93//< M2URY="6_Y8^EC:9V:<-=<18 ;LGX\*RWV+T\=?FV$F)V/
M\8KC6"S&@:,*]J+R+J)0HXF.*'+D!9%MS'QS#'DXZ HB;PS:8O"KT;;<"=FR
M50(/#H3"@M&OX: =_HI[.DNW!NQ6!,;AP%G7>-S@%YG)?O2+AFF,Y=B0-F&[
MCD9O$\Y1%#D;;^[GEAG'FMT]!C=UH6Y:W-IF"UO>;7/;.QI;F=%]F-S'3./5
M;@=!;J&I'I@H[#,I7#M5P*69!&&:QH5L.3,<9?7=/^/Y&2?2L4A=QZ_M5.#C
M/M(5' Y(C!X;EC&GN[WCXGDMH/N<NXE=M>ZZ6CK;NF&%>1K)AW[2][?"<[#P
M^C_A.C@,;AYKF"<P!D"#*9],L99 +[NYNG/R%' ]\!F\(AR'[-<'%>4776(P
M?'\.RE]"[2U&6>(;P&U;979%'*Z@#1A0UZOHK6JZEF,U'+0\J^A:CE7'Z?E8
MQ\HK>Z*PQ3IJ"$_U%W6PON8)48G &Q/>\YH+=0:G&D>/!2O8"*O=JS'ZSD&G
M&[@\9[MLXLED+?T4F9O?[8P7^VTU D_!/.IED5UR3X#G.BGJ'Q<B<[O>9*4/
M=6IU5#M;A_J9DSH<<G+,+F/U<L<@?$U0.<8&.6^(P5H_3)I=I0,KK8<4.\6#
MK0=)%_KD4CED#]0YVECR^+LXU"NNZY$(_:^P3%32X88#WZ0&0K^"7<Z2,EL3
MFQM,B5^75-5JH;01;5 3DJK7BRYTX@SI7*SJ%37*X!ZCR922SSUK:8 HS8-
M]F;K3YT"$K0]_NP)$X8[0]-A-JA45(])W5.O<C-[$W%MMV&U.!!#[=H N@96
M)YW_)%D+A79-Z^]8#T &4C.\C.U@Z76M@4@'JXT2B;RW&=?1L/HR\L"RJJ5
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MLGA=>IYHV8./%\7,@;(SP,O8YH'&"$Z;>Z)L]08&3IW3R91#RD(UJ=6U;2D
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MZ+DA_XO%&,%.%U7C;L0'7&4SIX5/E>.+ZG9.\D*RKSC*-OFP?NR!$;5KH].
MEY7-6";I]HQ\\Z;3,!KD2ZW7JW6LRD6O&E^ZZ=6O:GV#]*]J/:-/S":IF]?7
M9@<P,>O_><M,!#*D?-S6(?Z(0L7=:3+(?8?AYB>%,^ZO\V36B(?93&W,? =>
MBBA!NI+EFQ$ =,@7*B5-1B-ICVC(2']$)8 0+JF+\5CXI*^$_9V\5[ 3>><Y
M?T;B'.A5:55GNU:.6U6DW#NIKWX@,'-,'4:HWN??U(^HG&8SW[[E2.FD=$:H
M[Q#FNLQ6_#:=U6>!8N,!DZ1TJJ?!W\%43QTP-6',)Z;/KIG380I0DX&05''
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M%V'+=?ZMB>(Q?F]+_$4N^'TO_P-02P,$%     @ ZS%#6@C*,_S$#@  V \
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M  \   !F;W)M<RTQ7S Q,BYJ<&?$NV58G,VS-S@X04,8W(.[#>XAN 5W")+
M0'!WM\$=!G>'((,&@DL(-KB[2W +"<MS]OS?]YRS9_?=W0^[?5_5']JN_E5W
M5U?U7?6\\+P!>*THJR +0$!  'Q\^0#/RP!I #HJ*AHJ"CH:&MJK5^@86$!L
M+$Q,+)(W^+A "E(J2@I2<G)J.@Y&ZK=LM.3D3 +,;%S<(!"(BE%(3)!'E(,7
MQ///( CHKUYA86(18V,3\]"0T_#\/T[/W0 \=$1U5'0DA+< 1#P$)#R$YWX
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M"P2^\7-6L@V7<&SF-I ETJ6(+\B?8;//^]2YXBR0S_>1@.?+BH!N!&/PC9^
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M/FA"99'283K>,4._L&N]3OFD'N=9S7#A'[[RI][IIN@O/CN 0^;H#Z\<7:2
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M:TY"B,[FTY[8+V3F"MH'M\SWQ(7J-);4(;E/\VP%G__C+Q,?')J81.U?D6Z
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M*W/F#4..N]Z)S+BBT7:HH8DAZ]U2)N4ZX4)'S*Y/3D+_XC,MP+N+Y]S75O"
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MZI4#$V&WD/7BT5E=W?G:%E;">,\;\"!V.YS#VGWIPP>&-^I\JW'N9UKSKCG
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MRN9UZPUE']:(\XCL&<P3=45/5?[D_;,_ !/-/P#/QN64UA4BXQ.-;Z8G'[[
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M(+)567:#E!-9+#@PF??M=T5Z ?6=/P"A<(ICV,1#^&V\OP B;3+2"DG?1*,
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M+EGGM^&E_'6@/$YJ8N'/89FRM,54;%(/W[<_RH$ 5'SHV'V>(*]I^\]S('0
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M]9*U@2U$!SC-]+PXS\LU8>HK70\AYCQG%Q1;F;/YA,=!*],KSA!;,77!@F6
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MYTX0D#??G^^M]JJ"XRNQE!%-=GX9-D(H'^(4)H]S%<0%Z@-Y3UF:(NE#$AR
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MOV+QYJ(MTT>?*V%1E?P1L,]X(3F)4.5".&J5Y ,"TR $TH_- A7WQ1,&@X4
M^?X2K_8M7+T;1O +WHEO!2CNJ^-"N&_&#ZZ0Y_#=/Z==6#D'N8GT=#,<P ='
M>K(=2<[\CTED2Q)=Y<T=R>[C5L2I'%Q!B;;XH.#M=_BO4(M3G@[[ZM-]I2UP
M .%W%\[2*=*N^D_*TKGGK299<D/<\!VD I"E\^!N$C2H^4,C<Y+PG/1N(#@+
M6:U/NQKP39(%WT%4$RD"A3PQI,U;C: =9>S*283P9B'!M8"["3'1'YI(=G2
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MYP7G)=8OII7ER3Z0 V8^:<MK<K*_DV0?0I#H[,B\!44/$ECJ9*+@KZY+7=3
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M'1<^'TXVDX8X8_,;&_'(>-!55-DU?X6@ Q.W;JPV<<9>F(7+@@;\>T6E<5;
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MVIW12YV0- @3ZRRW;UG37Y32#8Z%0:I99FES7:4IIWY#?'X(?HUI)>VM9%*
M0)@5OWL34.N WY='O505<:,BPW#;Z7#!U5+ZR85X6HPP9-^8$&UU2">X9%B_
M"Z/T>_MK":J:X%#1B!G)SRE5U3X,O:3<2'"?QRJ=B\'\Y#VY1>9\2R4XH_08
MV,A5XJ'!DZ_R'OVT^LPA(?_6WYSC)2]5JCT"8ZK>2UE6<ZL[/H@R5P5JOL\A
MJ\L1&9%S^ I8K8;[\*7XVSJ9PF08OA'M20X@,;OG#D&4C+0^">EX,^Q:G/0R
MQ(@B$YH>,NH*]>QIIHJ9$,^E$E U:W3J8=9,9&O1DFX)+Y?QM;RD<5/,7)AJ
M.V[U#YEN:MV(3\MK)B!US_YD$/ V<Y_1.8(>$8!0?DP>PM2;ID%7>*"2G1V2
M_>B'N+048>K$6J796U%Q(B@0@IO@G-L-!*@8VQ3'V?,GNV@TAQ\0Q+TEM>*+
MP0"HRIF]3]_>+W2.9+_']B@^:FM; <A;#7 I!,^'9*RC3N>V)D+9&BT$-(J?
M -@%@O7,40:XTK2[2*X^@="9=*7$@,KXQ(*,=D#+AJO S_.'>\JWQJ_*^YC0
M.SR9+-/99C:BMJ0,SJ0Z*)R4=L%J1Q_OQ.WHPK;B;J62W].NIS4])-]:NI[#
MU4RZZJ<&CSA?^.3#)$W6TDA5,@:J&Y#5U],Y]9Q.@ I.Q3M'QGYKBHK8A(=J
M?CB:TM0(.SM0D_(3(FV5_ILQU!)M*]<W&M'YG?9"$VF2,)KDD11,Z"5A/?(^
MUE>FT3M94G>)6X43#O53ZG"\]4)KM[R=L=$U4D&-[D$*/?.P6KUSI(5%]UJI
MRGKS98<87VLGC21P>7)WV6J#1*U2$B]"3WAEYW"SO"7N!/8QW][!T;X3(3?)
M8J* ;D5?*?7R@Z_=ZAT]RB16U!T?>][>AE/DMW50ODN9Q25!S%*__7/<XT@=
M[J_9".GC;%Z2:1H'8B$#2FX?J^3$S5^ 8 ,[3KNOU/4;%XR<(A2]3H7M-J8@
MU"\^"5=YTJ6(V&\L^_&,"Q311SITG^ ' M[,0<8#(ZMO,X5!CGI4M\XSGE0]
M9>1) YJ4#;[52'N?6UC'79XUU96];15YVF/E*&#_XR&.G^@#$67,R5X=,R<U
M&F9SHW1[>MVYR,DV.8[&?53$M/XL5TM1YCRW74[R"R-.,B)<@,[ QHJW@$Y7
M!N^*1MX[>HX'WP(!H [Q C-QNAF(<WN!@ XH+]>T.DN<(\.M:&8F4\2:/Y4K
MXW<OBJF<-QC)?I^;S))='P/$.R@3'154Y$<+\E\'YCCGX*P@Q8L\5>!%3@7L
M>DX$=[]XC^LD@L2;\])U+0-BH2@.X,*%$JTE/QEO)"Y$VW1(1@9PQ(M@J,2V
M==/37  ;)2>2R!21D=T,XZ\;)H+;AUG'4\>0.7Y40,3B/(#[3LG*G"+/Z8@
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M)-Q, ])_FI=)8$N3X<5;8]%Q*8F;F_X./[1_<8ORX 2^!/X7UA3W=\VP\H<
MI/OT00&L@>T/(>?;@X9D5OYP1ZAT0*7S/:DG(=JNG\6N<!R=].0G=OVPO24=
MGN-Q@7T:#V)0IC3R=Y6^GC<6X$2G*AXSC=P3Z\]K[I)$I?#_T+![V5%+6H!2
M-=GT,LOBF!&\$,IT];7'(Z?U."2TQ)3!IBV>C.^Y84U'/Q&_BH6@I"4:8<>+
MN=V.?$6!_'M:8:RF]S'#3++YB]S?*CTUBGIYZJNB=,RH><LXKQ,];/R\\A&*
MLML*9/YQ3;%ZX;EOC<9AZS2':L3#:F,$K^M0<OE"7@#0SL2YQOXL"?]G/O(/
MEQBH_$9&Z<H<A;";;]"<3U:/D:#; U[6PZ)\\-6&J]],52 1?^%.^OO#0B;D
M\F-:)5PS?Q[.7^**1>Y*GRNNW" FHR0J76M ]\OK?V06.<0TX:SK.JH[&3S=
M!%ET1+7L.*D)RE]V=]V<7\(/C,/D@*SX/M<3\$P;CG$\*::HYJ$C!UPT^VF%
MBHY]5_3&@+[PG/V*:"5.OU(+(88E\Y!7-)T7?<>_$V4Y+,;\A%[4I8TQK'8B
M''Q^*_QTKM_$ :<^[,D'(M,BKHFH3"^?IG'Y\?<?B98<,3R.('<^Q3N>0Y]G
MYJVK)/CP\<U6H\-ZJE8OX'4?Z(*B,%R_F]9^;>K$[8_M-] Y9)#"HK2+2$*P
M!Y\C"(S&GVY5<XU^FI^^+'P,17!2]=EK!G4[43"]4X 0]),$RZU3-0\PR6JN
M!J_5O+V5'(8L6VB+X"E.&4Z>?V+;^M!H1)<!/@U7B'04/.UD*7[J=K L26XY
MVZ. P\P]9J$^8; AS/ZDTDZ +J^V<RJ-]06AJ!LVD6GJB^1&E+G]P_66<L@I
M]Q->0EY\(7LD 92)IMY5K##H%-?,!.V7JNZV_K+W+B@;&'&)'Z$P_XZ3T$_"
MJ\3CRS]4//0ZBJY1N^W6;@D;G>D)9RKOF5[G?\PU)2/)/3:H6.TUH60 U5;)
M$(JXW#//TAQ?A6Y-&^GV</H_-KFF[/D%.$Y 5.DL26Z6&/%'4N(=+S^I8Y0B
M.]%):K^^GURU:O1@?^3OKX ?ES]4[S\V?<]$:O65I7I0Q5EQG4$+NHZ9927@
M-T^B6OY.@;43TI/4H??B.*0,]#.X04^,VG8>TW*Z-PIC2D@RC NC/ K=PX?)
MO9T#.L.EZSL+GLA0@AN\?*IM7@9JN.[T(,@%1<+C!ZEX245*6]MKD_&WPNVY
MQ#;O]S>9NDLNB)W]2):6>NVV^RHI8YY/]3#TF7G0=4=CLV+OQ ?ZS8&FW25[
M2$):9I]Y&;RJ^_0&N;.P5/R>P1+W=)ELT^N'R[=KE:[7>Y>$&*^BYU(,=NNR
M.OLP)96N6]VLBOOS%^8$2O.)E$2O"V$BSZ.SY14=?55TWI,D)"MTH1?.+!PP
M$Z75#3N?>6LF#GV>Y6/LTM[4R>/4]J(I@?!3/O>6K3YYOF?#Z).NOF[D CLB
M=,^>[0";IWWABA 2/Y3SL OP)BZR3&?@^SDDBU' GZ@ZY8?#%E6Q[B7(J/R.
MX45[2;XTKY8SRK0SN:_5P2,KPI,OAB_28-\T2(N\=4U:W+F*">O5>!83EV3S
M19U6_?:AM%T< 74G\TVNLYW@JT 7IO 4=.-F_PKJYO<?OM+>"1/9P;;1"Q&C
MCZS=F9G&]'4A9YV]ZI-^W@,I$)B'>&\DR3G;'4TZA>8'%?\%ILDF:J%8CUPS
MZ7F6.5]CH$RR%)HOVDFE>^YV;:*KSELI>L]9'0F^$SUTYJ/5HW#]'4ECY=8C
MP-&PUYP=-]#N*&(*9*CY95VPV3S_Y8_GO@GC;878#W&E[7_K=/Z+S:F%X^3-
M'36?5C+-T-&5DPZ?V-HO !%BURQ^L#IAFV*Z\,1E"*S;]&4ID)TQ+_($5:ER
MW,8@6HXU2V1DW@)I\=KJG0*6Q<G\6VF_-2%X"5@BZ;. :QE?W76&FP5Q\IX"
M!SWB]"*;\M/L+#:LB\3"A:X ')*"4GV"&4T9=MYOO?E#FUS!\LQ\7T!_)46+
M9$2?NQ\+39 )K/!)8X^)8V)CP_F9&H@MC"3M/EZ 3MY]K)"808X656.E#(\2
M%P&CV?6^6 UVAN:_UTB^HS*VTBZ4[OS,BX\0.22^R$$>%P<^"P:JZ-:P'LD0
MK>7P>/>BQ-'W\5[NJ=%,E[S4[3'!6C0M9@MS[G]%,$A+/FRZY2R!NV^QH3P9
M]A*)X70]D,$_SVM2#G>-A5:<YVS,03IH3ERYXCD]=.NP#JCV.ZU&^O#7+BOL
M?[%+?1*8\#QB&YB@7([^&17V**W9@CYW('2H:RO*PAPJNA1 !W_1?R0K3BA:
M8/0P'']LP>]]'^C?)=U?'O_[\G7_L4EE9J=FDDB<XPOTHS(9*L6*L$P29P;R
M&^8ARC?,V1V2&>S;7-;BBKK9'YC]^HW^"$+/%!OCD0DXF8G!EI"4>6?8RA2Q
ME;:)S=,&;'O6UH]XG^YN8\"I(U,A&7%(^VF9Z, X=H,HPJ2^C(G%9_VGIU16
MH_GY#JE5Q H)-KGN]^CJ%'6[*O:&1,_$(YWNB[30\-(DE8GQ$A#1CU&YGD9M
M-E1S3V/TS86>WOI1%;!LGD6Y31R1D?IE=IN]Z\TO0/CY8NX!=+& 5%1I/L['
MJ;LA]0DIJ62-Q&I:K\SYM%\JDS4Z)*QL:(!&-^<\^U[$PR82%AILVUH-YYF_
M4K35;F$JAE\'Y2SAGTG!U>^O\)NY,_)D66_#J&E.,L!#4W>469857,IB9%JW
M)1AT.T^F.,7=D$=MJ ;QG T4!%S*Z"#K*M<>:_3[9E\&\]Y_>ZN W*Q,'O_E
M$-?8/,UI)@:7;>AU4X#XR_Y^>>I1&D5VH TO136@^L^DC^'W1AWPOVJ1$PD^
M\_29F!IK7)PZ[NJJ ;(<J %ZLBNM^+N^./!DZISA%X8>"_JB?)*,/QP+3&S9
M+?$G2^Q5]F-7O%SRA^*J4+HN,DBNX[NQ08EY:<R&>GP:LBN_ !C]*ZWH2Y:$
M./&^NU)$VR"$XKQ6F_=4[3M!'N!V%'K0)U6IEH^J9Y?$*RWXQVFCD?#;E /=
M5^&8,GBZ%[T=-EQ=*TM#6DE9MDR-FC";D9<?)02#!8-XE55MR#&$+5X(H'0R
M%%YS]AR97%K(54?[=SE KJYIS,29_'.=(!!M6>G\LU>U&O%$&) $UKZ3*YF)
MU!_^Q]\)+&8=O=_7?N8ACW?O1VY.7]O0W+%SJHXG\\[<F\B]9:F&CF@[>P6,
M?W%2:(MC2:)'.FRI7I+=0?5'- AEK6>0]K/\K XW)8V("FS&N<>Q>+7H4[1"
M*X3P96J(0K=R&88W="G8,^P^>3TDG35\CK+=.PG'0G+?Q<E?D)HI:2- @7MM
M5J]M3?#G*I-/&:OD5M74.;0LO1(JX5,-Y$1"1PN$%ISG;-JS-QEE1WIUJLPC
M?96)>^Q^% )OQ74G&C9V_D$!Z$7%/UJGWU+C'445+(S3!BL0T 431^LQ0OF9
MV 4XNX383PC#]_TJ#\[G<'FQ6&HA1P*4JQ;GOP H@JDYW>Y[[3M.NM7JKO:
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M;?9<E:V$\%6KX@<2>KC9;S1BO^VE,Q]'#B[H+DA[$'C&IC--WU&PK8W!#BZ
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MU>W1B>@7^==VTBU-8]0L,)\X=EZYZ^(J*5=09$@S?E\UW_X3E7$G95WS%JI
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ML<3$XTY>;I'[%;1?N-4XNRWIK)+3B'V]*W,T,JDX]X_BLL>TGEID;BY0^0/
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MC N6"LB\U2C&WF1_CY!4R6T@NTX4_1RI%#6D;)UXK-JWMV)<@0>XD)=O["R
M =.E3?8G\/0@CAFPW&R%2YA#%K1"_&W\4F9GAU"O1+AU.3O3"<MKRZ%-#*_)
M2*40/M7;N"%VC3Y-8L<(X[*XG>;=;#IO:=-UJU-T8[V>+"A+-LZDF:YQW>4P
M!87IYTO"YL\_,"R'XJW.ZZ).X6CG<A/EHPO>%@<N5;$AAB$%<-\6P&@%HD6Q
M*-(.Y'EQBNVWI(#AD7^1\'>M_RB+XZ_162^Q9%<!(Q7EV:GT DGIP2*A5W\
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M:_COOP)SCIIY@HK 4X+C?"-AR R,/,#ZQ,_G=0[+O9[4^P89O+Q(;<6TX\0
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M[CRK$!&56D7]W5YFSOGD-U_/?G<#UZAK=824EAC+\1+0<EZ+/M8A1O\6Z&D
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M)^?V5OT2[*A$@+$I/).V)*R.\ "F*S;BIH1O<4I XZ29.VCET9W>S^O@88K
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MQB\I</>^*!@,YN23EI<2D[LG#A;[:Q$0R8T;Y&3D3!043&*WV6Z+_8>?JRZ
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M-2XPC]QS7WM56>J#/X=,B) U5057O'^O_'P78H7>)=WJ &-=?(YE"T?'RX_
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MY->)[;747,<:'W>3DZ>;V O/Y!.3=+-SI<D";+PYT0>.H24:Q%C5EC6U?>J
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M43_G5;A[!10$7 &+X"\/URI>QI_][P5>1PX;#S<PPP6NET3TY_^]9,8ES17
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MJ\M+OR6"J,QX%B'^Y\+L]P .=:4-G+Q,M:'1UPT5"Y+<(,A>0&.)K)7E@I^
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M,@?>]_#B:6B<4:O1.,9>NK7.V597"O:]=3PVUZ QRV+UM0&.CJ#.RZI1WA^
MCMR!\A_ 5T\ER*;C=B/46*9%GFLHA]5K[;N_Z_ET7ULRX1K\A@M-C&3>YKRZ
M5]6F:+C"*$5 (%MPQ0=S;-X/K?RNN9_HTJX8G-21GN@S7V*PE.[KU@0%1[\E
M=%Y10\M\LIJN/FL@-XCDY7[?D;LCM8+I'M-/C7,00-1@S?Q>"XONG7,PRQ0[
M.-GKAQS2N\<A'[)]=G%J+[O#JQ.\XCXTMT'4H"R!S<68"%'M<KLVNSH@KVJB
M.A0V?_=E2XQ%\=RXWJ;$B-?38!V_R=6XM,A+1&GR;,E?G"Y:@,0V);<@O3N
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M/@0-DH 8E0\/I!V0!UPH#S'+NI<&!PH2I!/3;5<"/G&/XYDR2[H.':ET(Q$
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M@-D#4X<',TG3!/_]>K-_V2A#UJC1P,(.D=/UQ'7J+!VC^HT2,R*B(2HR\3/
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M)/%;J$PQY2%0>E/R/S;._QT+V6$; I''74^IE-O'4F]=RMJ+-$0O2,I3XK&
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M OYQG-0*P+O,L6][[]<(24LNY/?45$T$;N )%#%J!C4PZ^Z[F8G='\)__P'
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M^.GPM[](4QB<K]3&HW>X)EG49F/H'-XEUEG^_L- ?DTMA<R;G^"K&O +=OR
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M61TD02WQ X8<RZM*]F](^&([RE=V3JI2$)4KPD+HGCXXLUSQN!;^>'IW/N/
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M-ZE;1R)IA>P?ZL9I/M<.@G[Q^G]_YUE9RME8P?;&Y57"T$=A]DY$^R>\?@]
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M/C\*A^JL?81N%Z,V=UC"L/:F44AX+(_69]*#9WWNJ:0^"',A.5!A'+JIT-8
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ME$X10%Y/'F&68$!95*%A-!HNJOUYN-K@:<6YDS%]_4F2SY'.E*/EAE-U6,W
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MURULR%QA KL6O "EW3E \&9P7&- 9<V7KLO39_I01J) ID8:/GXW*%_==H'
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M[P1BBOPHIN21W'T-KG4"P9*6[&GD@4;547H$%<9LDGD '!H$L.4]6P"B%&C
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M@Y.?%Q4+PVQ=^#,(^$^P0F^4S%_ YZ$3NFX2SQ05*6/)R/6[6LR#QCC['J$
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M*5NM89$]I/@4FGF1W*+URWT^:QG,S.^N2XCGAO/%I_-5E"T,0SKK;N%W47S
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M\$ A5%10K>G_7@'YSS;$U.R<E?Y 9_I0"]P'NL(D5,018'T/F$W64*%A,/Q
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M86@+BLRD$D=9#OU>EHG[<V)&+ O"9\K K]\9.N#YP>:%C](R21];4_/,W/D
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M11,JW*O9F_EI"-7!-7RPIL&\2JPO=?5/GK2T"F6;O2U?M[22'U20+G*[;*R
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MBWKWCB?6#5F#M3=AC2O79E_U,-XD,]PK5)Y&%(K#+4FQV)3*6<_.=6:D]<O
MVXF1O3;RO4FLF0PY.QS)G$Y"'4Z>3R@\^4-;0)58!C3-7)B@VEY_1I$K)Z?A
ML]'!+T)>2-<F28@4.F;X!-A[1K.',7H58_][3$'@J0*.3=3E70UX@HU\*/$U
MPL=5KZ\I#!A=VBW$#0-<2#R!4H872ZH4NT[.&*1EN?DI,,K%\\Z3'G1_)U;I
M0R_D5^?YR8K[:Q([W9Z6IJ.E [:);;>6I.MDD>8@Y)#&FVV!\'G]/;4(9Y@
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M<]_(+^JX^,PDAV)'+9 2^3K>;? O(+ZE[/Z9"%VN#)_':T"_[+@K9&@+TA)
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M-2A;E['=PN9-"OWF8?=5&#T@U>,UCE[IOYQK99*>F8;ESGR,R>A/Z)EC?_R
M=<\K<8OT:^32SY$</E.JGW(_PJ'7^RAN3<X&Z5M,5?D@UFTRWKTW;T,+8<8P
M$<WFPGAU5^YFFG ND#(+^ [B00[,"V<%GK!N$UCS O,IW8$?84>2W%+[BG 1
M=;,6BN)28GE8?C,U<'_LO5>DG+*NBE?7W9EAL8\6STNIU)]J4\Y)&W.> B8O
M9D5+G[RTNU(64&N:_8#V$9DT6$%+?]K76?X!51=,3TUY,<*I<-.3?@R,59*\
M*1<&VY9OUJ"+/7QF_A)UM)*+Z2,0[*9WB7RIOH'6?4-:4&3_HG6VU4&; YNO
MH:S,8Q-CL9PW5[UEFY;G='NUO.I$KRZW.V\MCO(O0'Z6G[R66/3,I$*'KN,S
MR4\51:_@"V(M[HH6:H2QIE+(=3?$D@HV'[QZ+]HLSGP1]F[@JQC[7AJ>+!]=
MTH?CMA&J2#\U7H&>13]ADRR@0K#*%'S.BJO+HQC "\!&SPYX@ #P &8B\V1G
M+*HM,V !&"D3[+IZ7;)?&<(!Y9(NL[K))XQC.67^7,_KG_-P@_ 1RPTO&U@G
M<=KJ/&_>-[EN]4])QF\-T-J$HA-RO,WRYY:DHVT*;DQQ;U_J%+!!>-S04LTL
M]81@!M]8H#ICA-TSC/[D2@S#.9$C#N>:3JB8X/,G)D_G\%%_ 45#\ZC.D%-T
M\= "NB_WX;H=[K\RIR\7*#6?>&.@VGOTSIZT]GUK;+S3%;RS<W+5ZPV,=L]T
M7Y$^F@M+Y8QGKSTMC=! C1E8W0U.\*EVTQ(;6AF6]^^*7A@O?L8CE46OKW74
M>4%.2H;;5<X0QD "_^C6)Y*/U.GGTB6?JJ25@8#?12?"L.Q4H-XTK(Q17;$9
M+G!(0Q ! REH:U)^CY7"8&=2)5A\[[H*ZL>.H6!T =]KP<!*3 9%#==/<C@8
M"?=C^+-KCAC%8X$6&-6;8  +*6 D$W#28?WPLXL&6K ")D#FC+&R<8:TA*GX
M67=^^=Z:VA-[/.@-$$-Q^Z40&Z]JD7@#8)J2.(2'C=OA*6,8Z6MIE?RGW<RH
M-AE0R!QMI]Y]Q8?K_-]J&-K$ 0?!"MC@!O=\#&#S_P?K;]XC4H5=Q9";3+(4
MW2!LI,B^)(5.*U]'2EJ<-Z(-=5QCY*0"L3-/L9V@L<7@T.N#-K"=Z5#V@[JL
M#;X,DM_/'+D$HX)8.<,4 M1 "26&)!>L0TBB?%=EVQ[J24Q;SJ(FY:@W^-K-
M4\A2A]'VN0))9:XWK!AL-%RKQ.$&FL6&F0+'.XT>"0J206J8[S_DFBSCZ=CO
M\4>X\KX>,_0%X81P2P)1*,$--%V8\Y=W:D!GGUGD5RZ0PF4^WN\8/EL:30"\
M;UI4]&6G?23%AWDU=?DB6Q-, *^'N)'FE(MBD(BK(BJ(&@KBA0 XF< [\;9H
MEYI8T.5)]"EE"D2^.4I 2>-"#O(T^0TW*F<QYTL*4"^+>%"P6$W/59-T(YR\
MO%9AZYUY(@B;C]L(;H3CP784Z<1X4_)TB84%J;<TABE5^.TC6#(4)KS+QSPE
MJ0:*BB$OQ5!=9%UD):'4A;W_]FNF>8P*@F% [M.?0%N.RX"6K0NW"R30:_MD
M]$!ZA(#&4?O/\W%2EB_<U>N>*O>J?^9.N=7-,_6ROGZF%Y7EA.H<;$8=.V*/
M$>TNUIWXT96,%Y/KYMG)P.3N=!5/>^>#?FIPJYG>FGLQ+[;P70$#L&K#\KCH
M)7"T3['@YTYI''F(ET(,VVVJN#\466DUZ;K;'$BZ!%#_[)@(&_W1G-9I>- I
MS$S$*G4XQ1>)T-]AB95A@YW%:4\!]<_ H3O5#XN,3=%J!*EFEGAH,/3@.;B,
M1A:)K:,O*NE0DGHGYTM%OZUR_E0LW O87,(CBJ.NTE6$'D0I/T8]72O#BM8,
M=%&$L:*Q(AX)069QGPA0#0/Z6*/< / H2506@19A)69,EJ1CI<&>4$\],D4,
M EO1*1BW2A<SR$4!B[7PFPNW# CJ"@EU:2[N$TZ$ZZ#QP]X6YL!Y%?J,K"=%
M--S%V%18N\:HB^@SI:(CA&$7.=8"C3.>:$'*/H9F9T8)L".]7DOM+<W/1B%3
M-UU5RFX^E@6) /M0U&O//*;QI]4URMEO_WB5FAL*.,Z#NG9JBS6H: Z=Y>J8
M3QHSW2E^-.-(MZBD@RVM/\7SRF5%PT&87*#T]U0((1]S.(0M&R=-^NW1DPOI
M6@S;?24.5Q7UK[ TZ!.=MCD'!Z)W1P*4E@8-$!GQ8Y< QDW#N&?TUFTT$BH1
MBH*W!VPJQ2JMC1V](6\D^_2D6Y5DO*H5>SWRON^.!U]G7U92ZI2S3N-5_> 7
M1K$-:"BY2 ARRNFU9U:KB/S.')&K:9YYD?NJ6?$OX.7O;#4^$J1 DI3$3T;U
MJ_(F#N3..RG:QBZOK&-\Y_@Z(L*.#PNFBA;%D4D729#A;>'WS%YX:*7L"1M;
M\U3X?V9[P$FU??P#O:I_"K;DEG=RIIXK'2F%\8MH9F;4D)*_>H<G@@J1)97;
M^13Q>O@[^-K,1\T9FH]FP$#PWK8(G(UBNR%[!5-Y')+X;[FS>*@/Y&*@HX4/
ML_81)$1%2#D]SH(+FR<^\YK8)P7:?*F([W7X1X)(\^%7'"N8T$F\,:OS? S-
M?1R=)<%#O?GT5SN'5)UJ]N:+#R@J=U4AJ5^H9OWT4 OF7*KXU'=V'O9_ 9SS
M%^4;;3#UWTU8Z6_N],T^BY4]@26X]$.U+R"#T&3K^$9:.5'-?I<QD>37FQ!F
M;"0G&;F&!EQI)R9&#8S#FM] 7OB894Q =4E;8!&<6X$5K>$_F6AF(;8?FC(F
MAPW,<I$D5@C^5&-A%/!U7;"FR$/J GYT-L8]R3VF""GQ&JL[""!IX1@>([!O
MGKIWL"ICJPIC\!QS\S1P0)P?Y;X)Q-ER=T+K2_-]I=Y15NLIO'?B4!W!D*3B
MCV]@)'M^5<.AS&Z"RN(>',4T#.WSB2L.,GXW0+/W(K(86R2!6B,$R\7H78!(
MI/,%"6DY8:S;/H!I1OVC@?"[=5>%9@O]9QO&PE))SAF_9GJ,I@<'FU7'8V(^
MH<PD!^P F%Y5I6<O<G,<B1[X%%1?+#"XL#VX38,T;=X1O1;;5XBUG*>3B$.J
MT81Q7U?9)] 8*VUSYG^$QB1>4L5$%46=F.7[S(N5>WWI[G^AE:K_)\[E)TL4
M7_J"="$?%-H)8);BW*Q/&7]69B&W6W.5H]E+TO!&9H/'9^XO(*+]N=E[L:Z[
M!!:^[]]MYW3DT%^%B%5"B"R"^Y0S/:5?Q4I3]A<%L:G!OKXY5, &4C98]BD$
MTH JNQ #/H688B!L8-@4'"M2C3M[6D S'#"@X;#S^(:861%C0""0UA;8\%1E
MA@!DFX\>P@L! LS_R=3$_C-.!MG^GSD24/J@-'(;/OWW(?+\C73D__(\ /C^
M,\!R+T*P[C\&%OL7F6A*$0)@69<!(/(GT0D:/ MA:-']KI(T>QRL3]1>^J H
M-:^*66  !2,4:,).4Q(3#+<7Q*8H9K2  1(I/2!O\44$"[?U$\8 TP(XGJ:M
M4",=FM;8&=^6?B'$EF?A!@T<) 3.BQ.)"H""T!!]&&]AW#)06W(-/ V4V[_^
MP84GT2#DC[]+$EEU""> "1P[O<^*EE$L2NCC@I58CGB_S-T/H=*+5V:>5AQ[
M@8;&@&!=6?VD >-X*02TZ.!B%6.5>B]\)N/2!W15XA"D-+ =$PXB 3;\1W+H
MGT0-Y'_+ !6F@\,>G\6$%40&9Z6>DGP* 89-@H+4QX"/'7>54685GXF(@7V#
MO"R"HW?OI(-[DB8U2/8E]0)8R[Y]F/ZM[K)@I*%A52YU@W#^C,,Z"'2!#)3U
MW/1)^:,OOQWL$2)]OX"6?:&]G:DND 8T0E#E6E7I*R),,]55EN=*LLHX4>7X
M(<)SJZ6N):O]0^S5!QLGM)S\']\GFN7.&'VU*=C3(3O@IH*CDKG?K+D8<666
M#3@'Q]QWM]HK*U6$6_21O4D+=G6T$&,#>"&#ACZV)VG9-+#)FWR*AKR'@#0$
M?TH:N8-CE*!%J[$7*N"(A<PQMJV/PM.>.,_H+35JU9,&[1?Q9W?RFW!S">Q5
M%C>N42L6BU[D8XX@:[HWY8S:W)= O5FE[9/+D1SMX!3!R_(3L*93R9WZGPWV
M?!8[]"*X><[]5P.=UXO47])+C/09P$'9UQ6ETLTIZF3T1+SP8QX"*0Q@D%^Q
MBRSKK&;.3(.WX[IF:");<:OVUA=%M'%,#X!?#K0H>)S-6VI6*(9&V%>/0FYK
MSI*6ND6X9O$IO0W?RILG;L"U+B[!TF'%"EET8+36%7JNBC+0K5)N-RT?P@SZ
M",)F(;5V? D3, _Q0#FK B,:,*G@.2!B)#@Q5*2B(&G+C\"6;1-N)K-ZQ9F:
M(L_Z4;#\&'PN9V-B;P>,?WJ^0%X<I(TN&"2*IN?362)C'K8K_NE85Y/1VSD[
M98"4(+VD(6%'2?C77"P)Y&7IZ'4<UU-S]O'&@BK#Y=JX'X[^]LM*..7U=)S6
MQGLZ-RP9WR8:+<<SAEDB>OPK[X+JA>[MRU"BVB[F([L175?5]UX&4Q+;B?<5
MR!]AG-::47TVY7Y3ECH!0@UY: N<3@:':23!T>D2!NO5]T\_*@F1IKR.:#1D
M'G6\]YUNXW61K2X^&W:E"F'[<#940VVL:C0M(H)FP)\KWO+VQ0XS^0GT@G@P
M06,06' 87W_6$;N&[?P,V>;O.+R)QFR4Y\/%@F$$5YI1'XSGH2:^*N<I*>>A
MEK6.G18J_CG4I_'RBWP*!$?JIX*+MO/G3^J2HBBB U;!XDTD)JX,%&T,TQ;-
MMAB1CY4$_P<-86]Y6-%YT,2@%*IS.=L7,BA6FL%A=CP@7:I&WKN&UHE,R@?M
MHE %M EPI&MV5C>E6X<%:8Y T#$C]GOVVWGK+DTT8!69X,O3^_+AT85?TPDA
MEOTO=.X/VY?&70<0@@ ?]??EV8!3AEP#G?L#[5-J2VM9EK/J[5.1:7GC!M+1
M[Z,&M[3]'-P42#DW*BISG+<MOW1")X#0D>#;.;?%[9P6<:ON!S>LJL[/55Z+
M,,!U^6PP-9XNN^NFK^"2.=%LGD"O")7K[WX<$#:#2 (G]>_I",T@'O;QO WW
MB+=]].;^;&ZW(4^?R,C]TB!C%\-P$BKFZWF=H!ZUC)"M9ILQ$9U6';Q@M>/B
MDG%?VT6 /KCH$7F5JJ10V9CX'[[EE)D[?!SL/] 2 GRRKBL$O9:=Y /]++,,
M"-9MIA&KJ1>LT"R&+Y(\,"5' ,5UA9EQ MT?*0=J&CKS_XM:SE7Q__C7 /_O
M!TR!;H7!J/_P'1#HORQOA-70Y.$FA1DNDAG4&C:HI&@,!)^W&-3H.=V$C[TX
M&\C1/(KH!$OL,&>VW=BF-*0@5" _?_;=OE(0@2&I@?';U>4=^:![^S''=N-R
MNX_>'K5OL O0BR-[%N?R,509\%<O,9,6C6XKE2*K@N#C*0/\]HG9#Z21KNM_
M1-XEC,Y4RY8/55%-D'L9]!(3R3_-+TZ:,?)[!V/HIANN^ OHG@IS5GO0[AG9
M',/ZL/.=K>BVJ:>O?HM)!N%;6LS2VUQ,QV%S7NGQ(*8OM"#Y2Q?^;=.4H%=B
MANG#=Z^?/9AOS@IWXJ3.<^Y-!.N2/H\U5BK\Z/7@)8[N5_[8ZI%5<!O_DB^K
MS&(/:G/Z;NK$%D$?GXV:R6+HB#^AD 2Q2L0IE79X2QO:MQHZQK;#V-^.#$PO
M?H9=/V\^@9"1!.\+[>2TML0)]!LX_#[B";?[$>&U2U7D#-&P/$\31H4JC\\6
M3U!4M'"D@#/'F+TV4D2GB0[4Y?\IZQ6F@ '_)2&'3LD*MH!QH<%YY0QB)^G'
MN*#%J! HGI'&M*OB? =^4(>M&(@;AH_>;)T"MO1$]#V6N?ZC8"? _'CWE'RR
MB'IKT N8XX& CT8S06$BR;Z<04Q02_&A,H<85*IP[9$;X&KPD=&$8X4JK?2]
M&2RJ)!Q/L:AG+-6V$)6N"KTHX?O3;K&3&BALU+-ME0R5VJ@W-:HUJ:O9U68Z
MT\EYX<IZO[=#H.-DB0K@&Y'?]!?"?HZAWR0N\<7H2*@HPR_V9,0\<<C$[B^
MR$ I3/I.6TC4OHS[S[+RG6;SG:HFS_&![*YL#JV0F03EN<P90:/KE+&=A$0O
MR5E'5^&FNIB=XJ'MP!A/0G]Y9YMYV$FSZ7A[+]1G:W<W\ZY<LQO^Z4> +N)C
MB_J/D8T5<2[1-7OAPP%^=;SR,=?/MP2>V]M.XS60-?#>%MP@O% EX)544]B8
M9MX&[A>_YH1MW>DNG;7+RE,OGC%L5M:9@/VAK_&OB\<7LLXK:C9H#(X5PLWP
M?7"\S(>P1 MTS">1#-3O)-@,X@2+>GYNSBYN.MM0\+FJH!K9-YZTQ?E</E!_
MR0E>Q#3\@J)O K 1B)7)IT]0T9K!(=?9WR*.='+2JOV^4;=;S'6\4&1E5JX*
M:1&SZ+9:Z&@>0%6/;N?D]F4YR'LM7B$Q%Q+-YG/! JV6"\Z].'/U\S-!">?P
M8AN+JF3ZW8_P\(+WJV5+/YZ]Z59I=#W66X-C%?8XKC9D8F7'U]F(L2X6G]I^
M7N@N0C*?.(,>##4^#(#UY!S)=]+Q9,%^*W$ ,3FC?U"'57,UUE4KT<@)&V;D
M$CL=]413U@0*V_AM'4N0F1\/Y<Y-Y:<MA*.CGC"4(S;G4B/ NQXB&D&^J.?
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M$8=;\^$]FMG\^W,@_B_#\7_&'Y!I2*H+ R0]6?D-P 38M\+$AQB+]F;MN3@
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MW91:,-S3#F3?Q5[WGU5C:_LO-6?J1'5F2(H5T:5001#1_SY*F?+O&P&DC#7
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M6^S-2.R/H6=*K"JY2U.D+[&YX6QD&4GD0W\KGR)FOB3)'=!7I]&S<#ZRS*0
MGG^@0?K]?/)NOX?+CJQJV"N4T&F+*(U[EZ5LDK^_>3CQG-<#2G])VA]D#<M:
MQ_,5;R-KH@=[)+9G%NL1X)PES[H77'BX"?57'A]CEN )=3XIV2)K<[YYLL3B
MH^7X49-L6>L".6^(^<I+"_O$=:$ZUBK_H5*Q?\\_@_[3G@<TUH8#K'4D-?Q4
MB,$8!F S8 #BI^:4AP%H+[W5)L[61G,S 6P+0'YZJT?:']:B%M-VTJ0E?<X1
M_@<JOID$&I"RHK-VA2E!J@,-"#!&*V2*X+TJAN.9 08@Q0:96S)6N:,-I^1
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MV:2NH&8J[;/K#.5"D]2!YF_B('[_+MSXKT'$;\N S7^A#_:7>515@49@YOM
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MWGO4ZB.@R4!(U1(@\\:9P^3BLG38X(4[@H"6 S\3N&&:GI_IY-E?/@P!5P
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M^^618< ']NQ,/55Q!M%M'<K61EH*4\0BL66/LCVW&QY!&ZN_';M/,7C1<[>
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M0:6\\?>9YMM#_96S15,O1S9E"ZH!RHRU]BQ72:&(Y9\^?#((JM-^9;)%VS^
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MV$]ZE]Q<)=2>I@O.ZZ3,U?HF)^XO.(NHKTF5_@9A":X-8C48(/WA=D:<3&A
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MM0[>,T0H,YJ%4BG^">,C3@K)Q;7CH=*HJX@N'XRZZEM_&+?_L'NK<@JIRB(
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M<:&F_!5XZ_R?8$C_:4F8O+JJ(,@ <+MRM?YGPXSX1I/_!35V=;L45YX@"$_
M+B R#P$\V#5BNUI'7Z@H7<;[G0AD0&#US>C]TM66L!:3!#^PH0Y1^OY4_V4E
M@H>.!L=<_3[@ZN&?(_*;?@-FKGEA,0WGJ7>=\Q!D]JK?J2 T(S.&.@66\;\L
MBGX#]""3,(YMP^&K:['CR*MER7E0Q%++Q5*+8$,(5?2^B=WAW-6IG'=XAZ>N
M?C_$'?\A>EU&_.M@_O^OY/>G_P902P,$%     @ ZS%#6F+;>\"_LP  ;]8
M  \   !F;W)M<RTQ7S Q-2YJ<&?LNG587,^6+KR;QC4$=P($#>X.P2U <'</
M$-P#A #!+8&$0.-.0X!NW-VML6#!-;@&"%Q^Y]RY,W/O?.>9N?/-/_/<ZN?=
MW;UW[;5KU:I:]:Y=ZV'N805XHBRO) ^ 0"# _/$#/"P ,@ Z*BH:*@HZ&AH:
M!@8Z)C8A#C86%C;94P(\0BIR&FHJ<DI*6@8.)EJZ%_24E,R"+"^XN/GX^&B8
MA,6%>,0X>/EX_A("0L? P,;")L7!(>5Y1OF,YS]<'MH!?'2D-.0Y,(@.0,('
M@?%!#]T #0" 4$!_*\#_+" D,#(**AHZ!B;68P7X$P )! 8C(8-14)"1'Z\&
M/5X'D/%1GC[CED8ET+1 HW,CY E-RD&G?UG50?1ZXIB!U]+]/08F,0DI&?ES
M1B9F%E8^?@%!(6$1&5DY>05%)64M;1U=/7T#0RMK&UL[>P='#T\O;Q]?/_^P
M#^$1D1^CHI-3/GU.3?OR-3TW+[^@L*BXI+2Z!@:OK:MO:.SLZN[I[>L?&)Q$
M3$W/S,[]F%]=6]_8W-K>V=T[.3T[O[B\NOY]\Y=>(  ,^J?R;^J%_Z@7$C(R
M&!GM+[U 2#Y_5<!'1GG&C?I46A/-PHV CB<4G?!E4DY5!P8][^MC(DOW"4QB
M!K[5YR=_J?8WS?Y]BKW_O]+L?RGVSWK- ]A@T*/QP/B )'!UPYP;@OD?0O'P
M<<2\C=1R>(0]DC(+&(D'G7X^]5]<[[_(HQ<: 0@UTYF!W,3J^'*TJ8FD/6:0
M?1[]3#3 G!L[#I+.X_L$:,K+NT'LLTG)E7'X"^(EV^@J;_L(O^!E(XA],VO+
MBT=V2 G4^=J5-:7ZH.RTF,PCSVBQDX%"I E%4JY^V@1'PT=1C^(*:W*#MG7&
M2GI$Z6?^]O"_FL" 6T08^KF12U)&"DN.B!3R=$&VZO!\D5?JJ:92@X(N32;3
MEV^U1R;+7[="J.3(J&$?0G@4P5/CC[++*WC*2?W#THW'07)D^2^  5H\?\"0
M!<Q"AHR_A\-=%$[C-$1>EV.. RC)R5U^X4V0$+MQ)6*FC0WK 0BU KM_UO@?
MGH_Q-5## -CKIVBO44#_U PRP$Y,VW:-"(!-Q)X/80+)T98JE)$8=(*W17PW
M4H3:SF+,"X;:NN<O0 4.5G*+IZP)K]VD\')S!757K,>(Q7VB_163L?/*\*S2
MS46BF;.1HN5M=%X, U0#^4I/I3]Y6>P5\0%[+%BL%^82A6E\@*8<X2/("/_^
M0UX!RI])&#*<#?GZ6(MYY'^>EF.\&!7$_F,/LL]^XD]NGLJSB1QM'(SKEXTV
MH53OGS#ZEYQ'*Z6_E-I[K%/X]8D=1[/7=@'SLPAI9/]HP/!O@I22]E72_[+K
MVM_ZO_#HY8),11"O%&YN^NA'GL-2\5&6W+6G';(3R?XXG2$,N>FG#,%!T^^*
M"'_"7LH'[ISLUVL@?](BML]X6DT/FHI (YSP &-'K=/ZX#(C&;+R0YB$##03
MLLT=E?]N\/\"L. I&\J,KX6(M:VA)1SQ_7%'=(D\/9PZG./\(CR'XV+H*[*R
MDV^R++KWAL<&Y\JP&2%3FTH37Y?L^ ;L%5>P CHP/;6),F*CRUQ<H=P*$8;R
M[(JQY*+#8QX $5N/.DF_-LRF(M\LU2DH$V1YI9]VLX/4YHYMV)-MKEGE1$%_
M"N[@YEKP[#37(QS9I\?NVOU^;4'MQ">F2)UUQF1"AN MQ:(&6NG"]4^9AIKZ
MYHCSYB<GS_J6^(F+UEN87AUW.9WTV\!W\GWX-U)K3WQ]5N";2VL'3=/6P^87
M0'J*$?Q^^#IH-1B'/NKY5+YN(*0W1)Q&]CK<R2.7,:^<P/;YFV[HG0S<==>4
M;>*B4DQ_Z;VYR:3+"G,EY\E%2^9AU:HZNFRT">;O KPE(LEN42P:+".'=(E/
M;39!KZ0)$=MD2"&B,0DTON_F6))W!Y7O#9%:C.8KEWSSE!&'>1$&,6ITJ)W8
MB>+[ _QY17L_\9N%5^LQ@]+4-!DF\=8DX'8]^SZKDN1]:RUB,2,\.^4$,E=5
MHT*$H(7KFC7&S-411HJY&:7YU5K9^B,3M @XV84:\?+-IJHKUV@G=ZBIQ5J)
M<[/T^@. LTM<&N5*2C! =@!QFCFTB1Y22]<*CR"-%P6%2E&KK>$1J#F?6%A^
MTTCRC.%N7.,CJU2?A#N+ZB B"AS>0LU_>LVMH[7XSGR<&5M]  A\V[18.!>^
MYD3P#IR3E@\<\;-C=;32C+M;JKWT>,:Q\)8WD1F\0--K^&R:;O+N\E8[Y,MX
MK$N/A^X#0.CL*J8FD$6(6ZO[E83 ZA!?)Z6K:FZ$,P9N- =14;%D7XE]3R>T
MGSYXC)I%M1W"_\=V\[62%QY7U5'H9(BX",U3!SU#I6GZ)AHK)ON46H>H-6=6
M-64<;B8V+Z$E\J2K2*BO,,G^L99_4X^#JU^R:!O_\I*)D> 'VA/?D/Q+W65C
M]G@EMID0T2"]'D/=,,+D/4%26?/R_5&\%B/RGMAT2T?\13PZF\&G?JX%O@]
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M#V,2GX=:6A*B)'@6VK_8\Y6YP2+N:45G7R^3'K?6E3<?_S :MD@)K+&FE"P
MO&2T80+X9F+OA0K(8JLZ+,Y+1?1BSN-,#]<F9]:]>NJ'2[LH%*!^$?"R1<<'
M@"A[TN(KRN=/ ;E1"XYE_K=3ILP(R56,B4/.W"8#+S5;5Y8"K4Z6 RFJX#@Q
MUR*Y5:/?ORJ7;-53&<$1P<J(:V?7XJZ5?0>XPW"=('AD0"S$:;A9$R>L:]45
M=5Z$[[1QS(/V*,O_"MWYW4"1 K(R=I+<9M_1HWMQ6CNBV2-I?5%WG!;10="$
M)[$1#%1 @E'Z&WF?MVR$:=$2N-6?.@W?$\@3K 5_--)ZY@(2#5S&,_U1Z44
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M@P /XI6%MFAXJQ"OPHK0P4&B:ZJ7K.PVW7<Q@R)C_;LGU75-4:TS[:Q,;NG
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M;)NT48N$3(TP=:3+IP3[N#D1SS8,?/M3?EF10%O;_FI5FD+;W"8.</=>1IJ
M;B4R2.[8W'616/Y4;JGPE5&;W4+DUTL1]X3)YX4:+>@3]!GZF'V*MP=GS(B1
M%#H9PN,+W+-::B2;[EA%'P"P_3RDN;%[(NEM&2S1+<F$XT_>-O)VZ"O:3<4[
M>W!BS;5/SN[WGUW(LEAW1U!Q<.<,-56UBN@3;7F?(*<WR2LA7 $:/MC806J
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MWT0R"NYD/Y69VK5U$[US],)B'%H8@&6R]4H U#'"^0$F72C'/B17'1!67UD
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M*FPQ--A+NS<I\D^YOWQK*+FG<3@SFH/5T::YUJL;:Z"F17GY_5JF$)4;/LT
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M?DU5383* DQ).2S$?S8S4$XE0%2-B&];DWIS0X]M;7]H^^3YYYKW5MSQZLK
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MYV58F\W.9XJ1]#[\3:6[Q/Z;*0;+LJJON,^A/!\RDH,QG5@LOEL_RL5'ZSQ
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MNW"M6Y&33)GK/%LK?6<BM"R8@35)0S6J%($\FZN .R$$'XQ3N?/)E8495#P
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MBQ(ATIA=TC/L-J])D,M8>QK$:1F7;V!'X9^29M#5Q^!#]-JG!#HN79*+%ZT
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M_5T/;7.L3Q,8YT $!_#[V9-9N.6B5HPOA<4@U,K2V56XY['#-HH-5IIMX_L
MH!EC_X4CO'HQ^=-R4^U1X C&IN\U)Q3M9?K.5F=_BSW.]R,GJ=L),DUN<)*Z
M]J?FHI>L$U.+Y723P-N:/XE8XX<[=1RYI5-LU&8\DI?K "!J(MIBE5KXH%/-
M@$%HFQ?DHD1,4-4[I^G.E&,^DS-@]:IT)YG0V]F@>V@'4LMQ+$W[Y1 1]^SW
MM+.(]%6PFG[.P+D#:8GK_E$GT!^Q-1O$]#CEJE9Q6.3,!&*/T) MRXI'FDRE
MC55_]SU[[,L]?A(7I5;&@(V+/F 4MLJZ1OAZ)>;LZ1__FSE?X)G5(*YU+HK*
M@-2B_!1@H2'%SC$GD"3:C*LJY1O@GS1BL\O1.6,JGC.86^QI6=2*E76R1NPA
M=M:]!'6G6S#U?TN(;,8H.#BR+YUR;\J<&E=%26/I+=0!01-CNSKWR"^!-0V1
MJ<<2EJGF/?H4@'H(K^;A.98(OOB$<$_:5^"<DGK?-7AVL))@"C6(:S.93WGS
M?O:'P+P"@Y'&&]C$N^?F)P>':DOD;4"$0&!]8;).S23W=3(/LHJ&JMZ>C_W/
M(F(!Y\9:21R C26D$]]Y,BMME=(Z(E[P-;5\H>I>@_[IHQRSA?9Q -*KBL=Y
M7@&[6R)OZ=OOV-<67IXH#KQ<W;BWM,'Q%SO6=L4+L40/L*0NVOCR#9"6 TE"
M^E[UXJ3;H &S"<CYKO38A(%NBUZ)*39D59&XVY6N[Y[OJ(7U&&4I_+"ZT5Y"
MEA1_L) 6([V$D6'+XKU-:<1+C"?.=XQJ0"(I%O A*MBASVO 5R Z7GZ,SY]=
M/9@A2E?W3460(-_78TJ9^Y%CPTA7>WRY#?0 M?9<)F__ >A$2>6\RKOM\&R"
MR722U/$8X(@>;Z<P/_O"/=W.$\][1#W?M\/Z>G2G_%&R)"&6,=9&&'$VF1K.
M]&V,KG*RB:^R;*NXSL8V8O4R >,:TXLV&TH;C=+;9#K#-5,"%P&(E>GR8VMU
M#3'F[V'K 6+CYV(R7O'J%4\&A9?=,ZQ_P VSF6)7?>U2;S7K2,X/4ML:*\),
M[FQQ_%3#>3M8[;,$*/WW]FG1]/FF0O?-'9M4K4X*I2E_H;#L* TJ"7_YEZ2(
MHD$?S35"=.DN_HZPZ"6I: 8:W]83X?1@/ASQU1NOJ0,&,5FA,M7Q=_8P18&J
M!LK8<+Z?<W[\\(/JU]Z*%5$^QY*X5X&!CO[07GOZ&3('5&X]0R:Z*Y<S =I&
M/J;T/-".]B86L:;,3DW6,1E:1W+1Q ?91V;QY7_L>T@#-,<EUJE=[U?*(L];
MK\G* O>*=&9([W8N 2X*^.SK!U;?9]<A!VO0B%#02RE,'\V/FY68/&<#'BWX
MQS@UT2L++\?K=2W><.'Q??![5HH4:\+Z  B"R,"3&F/4OVM)'$)03&&YV:R3
MG*6E3&94ZNN'0F4&$W=2R_X*=@8*VQA<*Q'V-+E-Q5>*^HQ%TPIME[,VV>VS
MB\/B[2Q;M[E!(B*.5+I&5Q4.1T3V3;2[P=#DU=P,/^TQ%%I3C>"S4H%[ FJG
M"+X/>=3B&HJ/%"RJKI.U(IGV$ (X@/F*$77=5,_&))K,T:B(*7GGS*FO9(<D
M1JDT[_*"CJ]<.[7AHC8V@FAUJ%D/@ ]&NN\E7LS(%=Q)!Q._Y?#Y8,@ #RM9
M:101TY:)LHZGHCGOM_:I2<ZTHTB>6>(_847OG.(0Y2SJ"UZMBGO-G$_-)@WW
MJ#]%K4H(6;+):C=KK#X^3$O#::KYAGKJ?#+7PBZB>LP9^G@9MUN,;YNZ2&(N
MZ?"/>PX\LVX947,JP*(5,7?]]/UK[[7#-!8DV#%S9WWQ_OZ^FQ#1/KQP"URV
M6D;ZUBO[N\?J>DA "!7F.FG[S?J[P.%GQH$SP,#OS\K6L/+Z4 ,;K,EC9*;[
M/C":E?@D=ZB@@:[R7M>%R9-34KGJLU_I&*U_EG>./J2X"'SO8W#_S4K4L[SZ
M3<]&;X;5\\P[MG%@.@5V$:7JS(+A+YQJU5DL<^;0=C[C3),T 7\V$=B,&3>U
M!Q'$V,73$''D*/<4HK.4DEIBH!29HLWO//<J#LP=9Y<$?W8P<#GW9B!1ELYJ
MSR!6749D#"EAW \+NDM:J?_S!,TL#<=Q9];/Q^*#Q[!Y5H2+[8K.$++I^P^7
M&;AZ6G"9Y()%RJ^+DEO#DRW1.1W9L]?\,VPJ/B/HSC]RE=BZ>7 IB>,(!O8"
M"$=ABMEB';VTTV-G"TPX;(@QW.QIYQDG<K_D[@IR_-HVB[%3]3IJA'</&BQ5
MH%R)*[><1!O57,[SD$G&V AUDX\;5V==+WA@1GAO]_IK=F;$P^+EX1-)X*7M
MB,ZH]<E:9C"Z:1UG[(XDL;L!&X[#<[;]!+5Y+4[>[Q"'6*Y;;ZK: K[Z*"&A
MG*U,I$<]5]08M>?+%_V6:ZXV3_&S'&Z8G*?4LBC;N\5X7G)"=KF:8$7&S# :
MQ&ZDVU$PAV73P880 >ZM@ELFF[A4M1WJ4YW89=*EK_:L2#$[\+ @4O;SM09U
M\+Z+)NLM#9AKFQ4EPB#)6:04&G K1<I *Q%,(D,(6X("7L+#8?P9]T=DI?ZB
M&-F?*]PL8OI3UOA&E\W3JK,/X9) !-*8 @?.J2_'$5,2$L'5GX[$1T_D& =]
MIN2'/'+:F3<93C+0EVL5%56J&"Q%S?B"G9<C:4ZVYT7C,'C38"-136!5[VU
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MIU%4C6#P%W?2[-M9(;.JKS%#N4;[Q$UZU-Y@'UB]#@=5OY@7PCK0;7@>XC9
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M_4;'D)** &*CJL(XC(J2_%Y4Q+P-&E>%IZ87(^5H?S('DB6CF6#:I,(V?8]
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M?-O8M]X^U6GO.JX*>SX%.>(:F3\ ^G^7&?MO*C'B<O]GMUV*#AO"2H:80Y.
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M$N)+0JA$X<\OGWE3@':'@IHW#WZD[4K.ANS_D,7+?(3\\T/F.VB;6[(-X8A
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M6(Z[S*!*F%$DDA(3]^*3BH0T=6UV#W+0FO?]"BF$JY/1WRL[Q,3::B8MWH4
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M36=QX90_J13_ ".RPO@+:YQ:G?XEP__$4C3[%UK_!)OT'PC4F#8-_P&[YO8
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MR0M*I\ <Z#QSC*KY4PNDK["L^$#VP<.5$^[.-LE)&9W:"J)PSB5C<=K/SO#
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M#"4I[=#_ ?7=>W_[/>?L[WSG/_X8F/M>][76NM:UUO/,.-=3UXL /#EI66D
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M+J0\T"]8R7Q;9"Y8F5M:Y&-"H$8GYFGKLZ\<FQS"CG#AZMR^0W(2>UVSE%"
M<35%1$X$".BW3$'^[(5N*4;II2B9J#TC6H$U%;H>[= .KCW&T0 S*YTFS)C1
MQ&&;2%G1QWCZ'8#_CJHF]OH4U'T)-W@47HB68C8%*#;;CJKF-0ZXD.*X)55*
MZ3>INJ<]TT'FY$7Y]4-4%U+4[R%&UX @ KZ+2TP$JP,((\G#O)UH(%V/+_Y-
M.7R7I!1N3H+@RJJ^0\-9,S1KPIZBL#A16%/X%>'+FWHPW0"((0#TOV%]W)\]
M#^/>944HX!/BOO8[XIUV^_LD1*T1=>1<3@J6H4WPOP=8T2C:-$ U&]M.71_"
MKC(G6H6J#YBZT].O6W;Q"FVKN-+,\MGDY.ZLNS!/5#Q&#(=GHE\G6B88)W,#
M+N6\62AU+E6\K2S$QO-&&[."8E.KXO-*&.[X/TBT><I=H5 T&G]VIAH3("8G
M*?-U@>Q-9*-.K"]F]9X1+_GV1Q3D@@MCNJO['?.E7E0LX [*)NM"5DFG*I&?
M.@^J9/<\F&'-+R9I(QN56&.J0D.42KQMBBG!]-< #C7> S.(/\SUCO=&R&&^
MO+0"J$B8/AVN/>S"&3;Y<.0=X]P/+='[0HW<EOXCJ-:KX<D0V^K!Y8*G_':A
MX.TSG&!3OQH*8]IF6_?U26=L:"UN**[N":3P0C5#!QXBY\EL^MK+H0[JO^6+
M5>W-Y7K.C0';J8+J\11;WK&RO 9@'<G/,2E199&D2KO\6,M'K&![B8,K(@6_
MWU&_^JFL.W3"^+XJTTRSE! 7& ;N[YZG&2T-S'4Y56+Q5).EG0/E-?*:^[[)
M8VA.GTF1T9YZZ0C4->BX!I"FW=]X6(ICAOR9?G"X^(F2I&Z%]/WGGTYK?F;?
MN2^^(U^5,:MHV<3E;4G'$]8 -E=(8X0K>(%@^2$7]+7T$4N1WL ":OB'H:L-
M2&RCBLP%?:+ 1AU4BL?I^98PQM[6RWV%Q&E;LX/VRUU+8;N]S8Z.5^XG? \3
MIPYU=R.\U"CCGL;KZGB46@NI3/)ZAMXC2;S7:2_!FUE>4<X8?%PTP*T5\"6E
MK_)>!'3"0S'O@<6KV06Y@H. 0PJ-8"^>/8;F<B[](1H&49MJL2XE@G[4S>\U
M;WO+(RCSB"*R7$R9-CW,LO8-.J9-(@D4&@MZ^JR:(-U*V+I]=.S?E5P@*'M;
M&_WNZYNOFMH+5CTFAT)MCUB/7I>-T?O[+;V#I3UZMRH:-^8\(*0!<L[>/*5$
M*N+3^##M_5G)@2630Z^[66-/O:780G";M<:LUASE#OE/,>(I7SL+9N&?OJ8R
MRC&?B2C>K3*,^[#"73JCS>9E?BJHUL#[E[ZLX>\Z,]9#F!1(.L!J9TE)0U41
M!]S@#-A6)*9;K>6'$GP*VVZ64QYJYJ.H.)@-AT$0>' )<;?B9M>=H#[QRIAQ
MLLR'W&"V"R;O:9)0\]F16P^WVQ&GX"YE",\R<F:$;R ^+EQ>6:;$6W0I8"4M
M'O,T;O$:<!&%8: DT 'PG%3CH_6,[L><U9&E"$\PI='H6\!W8AB[4&#]N)<3
M"BG"PKMP(EI.(W>B8ZC0;T_^2?L^C,'W74.KO.6.J4W=JG44O"0_-P?R,=SV
MQ9  ;\!2B8<-YCJ+_=VUO-IJ7V*WG'IZ/M[A6-X7PJ@^#7SOC1-D,5>0!CSY
MNK#MVQ97[K9^85DO<9.ZC&_ ?4_\M/?NA7I>J)?R4PCATZ!03,XP!D)L<E],
M'J4=)?RDQ' :BCB#YPO6@BXA !*";*N F%3K01^2C0[IO>R&HM*[*KYR!QPD
M\ _G^E!&.X%.S!5#\J$/*U,_K8<B?,@JHD$":;5$GB\1]YH[ZE)1 B>53K/6
M@XW8>T,*4*< 9^?DLMX!AU3AO3ZXZ^L98TZ%E">6CK3N!*+9YR9H$Z7&SDYJ
ML_:>&EB,W=2X,OE)CSC6T*:MW\-U8*>[V[956WGLSTV0%=Q=*IH-WMNN#.)^
M=#@=.WFS/7)4D[$O*3YF+ -6?! 3\-I+KVC&^@H-?#5,@,5!!J';6_>#7!@6
M",F]M/ZA7U"R@=Z1AK-286M?EQW[DE#%?&"+_+)<DT; Y_AX/> ;0?O3>YHL
MQ>ZB$P?/<CE&_)=]Y<Y8529:*D1))!_3AY(+^R0 I;X\\!CJ;$*7=I%=Z^=
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M,MZQ"_6]P+'!AH% ,[VMN"JS)F+<H'G*FGJ"GK>?H0FE!8\7=0PJOMSE1(K
M!WLM#7KE++%YS'3\7*VVIMQ(E61ST:>%)RQM]9N$RX\:W?>'FGK,_? 3%L@7
MX-+*51+H4@]9"@DVM-^PJ">\S-!=CW>349UTOI0C;:G(C")R2&2>KA)E?UI^
M-XPI,'.*J3>JJ;3G1=F8,98=<JF@H<J"I7I#\2.ANM<!F\S $($#WX#5T>6)
MQATE3]ICC=*\GNG2A'SM9PU2?D&$CN<.X!,.N-K5@\.(R+?UPA-?&@DR%(QL
MP",N..B$E^G)0TE7E'TZW4]G@Z9GP5NBW TU>1@&B@H><R$=WBA*#?+AGLXX
M K#BS2OL46?HG">@;X][0^'U_000.ERXK5$_VVE(^\S]] L%K%Z/H%7PJ;_K
M21*_G^C$>$!,-*?6EP45AGQ6>R1*:_2N,\=-,.K*XT\/,51U5@S->2;5/CS5
M0GL5)46_3;_MI9/__&WI+FW\8@8-BG[6GK&LSN>T&AZ3Y6;6\1^BY'!7Y7KW
M7;;7E123@Z%+6]2XG8;E0:^HY5HL# 26#$BK$BJA=WKK5 <=]+TS='PMK,ND
MT^L>(W5Y6Q>[&2M H5>/\%B]K?D4X:Y+E^P.(CF%10&I\0*S7JM%V#C\%TP\
M*\M?06E]S0[[:0'5E+BO8][XIS[R[O*#%.'+Y2/9HY,6_FRP23DCK/?7I%:6
ME6M?$Q9KHR8HJ1*AGYKOJ<XDU1>$DBR+X<G"2G2K(W#:FE ]CZ$=8MCSLHW3
M^70E.F,7^$N7S &29DDA7LI#XP(@#KCY8E(XY=,ME09)LBFW-_KR,+*)XZVZ
MLS=#AY *KX^-P8'/[[SD]&.-3EIR#<E+E5VK4:5+GO 47^,4Q8Z=1B,\U&FY
MKW2AJEKDZ#)Y$IFA]?V)^U-E5*H)8Y4QF^H7]_A8,&.4O6TI>KH=6BY>^C%F
M'4&R(%4N4)\'VCUW5XV&H&'CU)@7?!0E K4J/>"MMSL/*\JC)OE[8K,P69)W
M^>B6:X*].;2P' AH@@Y[M_1#8&E4;1"X'*6@D&L?.Y9QV(FW4FL#,80CQ>%M
M3G/"/5_<1A$*-'RK#*5J3!<<3VIV./"GQW&#.0T_I/3H_@-IOX#N$=V=V@Y<
MG)FY4)B_9 !XJV0I:I3A'6\[A]PG^8^)K+'4#3(>A[[AV;[M@E<=X"-@RE*0
M^>89T8=:%!FGC(3@NSQ2!Z$OX+!IN(0#X=8UX/$,/T2]&KXX^:%<)]S0A8FL
MRT,3KK&4SGDBE8,8X!I+D-,CI;XJ8'U1S/I)"\5J?5W4'%LKUU,,Y":/66Q@
M1Z?\.X:7DSQB6(V\=_I9M//?]);F3L\]-L1[EO:9*,[DJ5?6<B19E9Z/4YOF
MP0M>NZ7=0"_9DG:3+YI3%. S#JT]VT@8&IOKVQR0:IA/R.(E74?+_BIF0='Z
M:-M7*YWVF@^RMFC(CUC7.,(<F?=UTREPK#>EU1GIO:K[-]-PC["-5O,^UZKL
MS,<FA'QU&VI_(0JEW"D\CJ;PA-+!4G"V9*!YV%C%.E_FHE@WYK#:P$HAIH>/
MLY ^JY6H=FBK5V3KZ[":3T.F43XMZ]^#IUCF?E<RW/M$P8Z&ZI[XWO8:4,6;
M%%ZK2FH<3=Z<5 FW7NIGY* L?&=9ZXOM)>3#)_\V.TS.!0<8 )= MM*GK*NQ
M2_B(QSW?^*.[F6"<Q\;(5<?5K=\$CQ^2RV-P;\HBYFW%^T>"1B4&EI/@6-+2
M=/5C>N6A_'A0FA?#<@JNY-A+\MPDBHKER'[PT.?]@8FK= W$L./D?B,N=W(.
M"M8G!RMQEA""6_+<6,7'2!]X/I\70"<\[5OGE\^W>PBW$^E:;;3_G.OB'S#:
MB#9MPC=2$5?WI9?WQ#8KIZUPVCMV[>&J,6GI&U$BN*G9/382>Z%*^62!7ALM
ML25]IIZ+BJN$PT=Y#BTJ#<_04)(]H=_HY&O(7:?NB$M$&-6[^Q##K62I9&KT
M=@8M@>')L+>-0HSO1<F?E;'#"E*R2MSI+=V7!AQ,P?//\6K)B(Z;X[*G+29I
M)X>Q4Q/DE?>"086FI24Q4^?*@Q3K$9O4Y+GUHRKS?8^T$AR.BYH!^WSASDG[
M)]D.2"(*'H346!=\=YH-:W37^;N<)K6]HU)(PR917XF@LK\!4@GLF[?5NII8
MV6<)^SD2:B3#5=7".\"9_47??N@>D%EOD1G+1O<\?A-_%K9N=X&2;L6N[VE"
M?Z[&\H'\T[(H'1R4J_\BYKO'<Z$>%97:9BK90FO!=[-SEOUW5=MFPHY8E8+G
MR:NB92D+33PU%&RL;8SQHJ:)$)YQ<CI7'?7RK!(''89?G=XU5L3"J:HW_D)8
M\ID,N8)F'S?T:3-+68,ESZDI)Y7BV'2=#36,N#93/BG] .!^'VB@+']/X[UQ
MZA.)Q14-(?>]\PYHZ<L/!5^.2@C[UX0Y.JGO9^Y3%@1.I3MR)FBO-PHM>>[X
MJH4J-!;=-02&G3VE#O8AK_'^8I66X.1"+IV2FZYC@>\P%B;0\?&0^H$;#NQ'
M^Q.V?(9%B8.?$)IA"'LC6PG#Q$!6@61 C(&N#2.M%"JN5?=X(T/FICOW= ;C
M=)3]FG"/'KS)W#G]@1N!TR@[9MA!"FO'-.B]L[-:3?1C2%T-Z_>I*Q(W*[Y#
MJ<+=+3WBM"S+::<W-B4C=W^$Z;8!WT\<!2S]"!G5K$3V:MDPX.FAT:G Z'=O
M8MVAE%<(4*M]HD?#"5[U75)W,_[*A65ZB"N0F_/FD&*WTI1MH=T3B,?>+AJP
MH8^.0BEX12U IBGVC'7[Q=&,M0TOS_=E-!K.L+9&N,W2S):_<,U6(T4J\[G$
M82HO;(%4O@3N,_]5AS^*M_O"05<I:$4)+EM"U^WC8* \"^>62E0BEK?Z#(Q*
MD,8-UD9-F%7ML,U4$\A*%NBG8JX '[;E\@?[ EM_C#9K-KZ3Q_K ]Z2!JUG\
MS0\#\VRK-_@\QA:D7<!IB%\5F[X2%VP.0W0\/NBK^T(')!37G:$FBI:6EW20
M-0'>OG\-L-MM/8;8C@EC97RO"-UABQ<\5[%JOCOB)2$VS<$V7MO$>HQCW-F,
M]0(",YHUK2MI":?":(H]4U"9YEHY#"+:!(N]X[%!7E$P?EO$:,2:D<JTB]<C
M+.&_%:/02P%*O*)V*_&B\UB[>O3,8T4%?M@5T 5=_-8Z%/61Z ??-0!76"2_
M5]]:[;%W <\U  #W?%DW1U2Q7B,EBBAJY5+BN])A^<+9[A$;R9]![D/A>8Q=
M?'[+2.4&>I)W9 EF'HL_E^8GZI_SXMP[OAP;XFWX1+H"UEW,=C1 6P&=,\^0
M\D.XX.DCM6%Y+B+P+F_&++AMAWA$AR7>W0X*=;.<O?-GXQ#1,6?;4IU2RT-0
M\D':.S[%6I(26[XW@AXCL!^$SZ<[VGQSGKRRU['Q)/9?O&3MB&L$>V%1;9;G
MNP'E)K"P/K\VMP6&"70->IT=P-D]5;:3'M'ELD:E]LX9W!FCB0Y^RXS<_,$N
M*)4L5F''HKY$3ZAMFNIC1V^5N(QD&,4NCBN7#^E&+=@N)(&]__3C]XEI[-;[
M/72C"6I&I  ?PG0@>"!Z4 @F%+17O#5&DZPQU()CAK7,-'1NHC'>$)5F722^
MI]=3+ZB.EK2W)3X&P9ZHPJ0?!*J1.<;G&/==<5DB3^\*5>E3.BH 6S"KJL<O
ME-&.^U!B'0RDMD2IQZJGU+&F4((6S8J^7^&.5F'<J2'>S&MFJ>_YZJ;1'13%
M<?^Q<28[*F,[!G[U?MR0L?Y"J1N=S#XJ=-J.!A5T9]12'W7$B3FPQAXP/WZ9
M?CI$"B]AKP&OA'_RZ9-1V]"]!OBS'WGJ[)P5NO<(LQX:*&QZ$*<5=1-O$KWY
M+F68U\&!W>.P'J[6NY;(7^KFVZGPK/O*[1I0N=V)CP2U93$(..CV4G&IE9AL
MFC]L;4"]H&6LTL6U"I?=(P[/7/#.[/[V^F>7:@%"(G2PSX]]6!P5%[U9S1?#
MF297#X:(MLGS_)STM+=G]<6+>R9SAAL?9,$]S,'=>+%\.?()'1\'X5$S7@+V
MNOM5T'[.!.NY],OU;C'R<Y9KP,O:B9W4Z5.^A]O6GY2"KLCNAZ)6_%!-C8\O
MYJ7K/\8-P:\-4'WMSR=;ZP#0P%_RO2^_%.E(8N;\H*S/>HN49\:BZD=9)BXC
MHO%(J+&\!)RY91D:/F$,6CC6 3_ILU4J4;J)"CSNJ\K@<]!'_@"=IQX?-]"Y
M'R-&$Y797#52):] 3%TY0X,Q6KBICS]2+4"V6Y+PJ:F@8$I@B.(S/&GIP_ H
M$\_'JTD2LF_SY57>KIJ3SDRC8[(@2V%.151/\@NVO5;O]@G@46F XMY)2E8Z
M<1E33[6H Y"B)^RH*"DM!((B+3I2^;A0"#H@Q#B6AP;CBB1806;=AA%+L=(;
M6^[H3N;L_12?,#O,J]7K28VO[_@(\Z&\D!),:LMK?$DD3K:CWXC!2+<+JY_C
M:!-\&D/S89)(UP/SNZ0M#5-[6/#NUU38"I7GB%RK>0G#0U1"E6%D97DI  -A
MU:N__GB2&<;,I>GRZTM$'&]NOU.D*O7\% @#743:')?RG)3VW_S)=ES*?PW
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M"J6TM%%EBTP9TD;S%T[J4+N&S)Y\/:'2>V\;J<?),3(C7S:G;"O151BDR/H
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M,9W5Y_ML!X7#ASD']Y@^6NB'.2<0TT^[H!3+K#/Z\I65!Y!)31+*6;WO;>S
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MA&.<34Q*RP!9+(;R5MEP$X2@==+6@>E1,9KZB&8OB%SJ6;_!(6Q9D#&PRI%
MYUH5QF1>Z<""29 CQL#%MAO"V\>\K4LJ+P":@^V&.R[J=2Z]XZ.)6')PY<='
M>>O:%2*HRJYR O48D9QR@LPND2&^B^4*T\ZV9-D@XY320JG?>83HEJ'BAI&M
M8;?22S"((C("/-*GO): 9QH]I+#59;$@&[*/0ISWL42SYB5>UB,318UJ?A#4
M"]/)C6REUVT88=[+6+^FB_",WO=GOAV"&#ZYI.W]DE>)_O5^-%,]2!G6,I%S
M6"AC>E5")+OU&?7;>XAW7V3.3-;DW"A:B+QS]T8PEM^78[#IZY8WEB:_;-1!
MG6\\SAN&N^6)OQM0:K/WA*KME0WWSB2A@& $QU4@8PQ8T4ZNKD7*J71#:@#1
M)>566HA9(UX_HZ/$6/*EDA&L <,5;?A'AS+ZKMW@IT-Q-B2\2Z3$GGE C?$F
MN?RM(NN2R#':.FT;V+Z3NG,]UJ-HZPW]:0_?_LPSYOW*,W+O92&"OT^UDO^@
M35PS<-PP#&]E^D$[]K-9+'[[UAJ(L)"B"OLZ]F^^'_'3BC)X[*='O+^7 ) T
MD]-GI-^N&PY&7:+\0>9)V_'"5TU!:.J%\ Y^RNO-EF$;X;#]ZPTR]WI..53M
MF5[T70"(M R9MQ+V@4=5,]_)NST.L\G?3#*-I0CLHQ25+#NKF+](S3Q:2YD2
MA#=%#5T ZJU'!*>"Q8P*G6Z6ZD8DSR%=0QTN&8_,.$9YW]6>5XJ65-^1>FG_
MXN:;.Y./[/:[2:H)C0+K+.;8@FV%W/2I]6Y<F3\>CHIZ>)=YFJQL4+6BJM05
M1UF!'F>@SS\YL&Q5Q_]2&#L(<+TM>O$!3I<R?LV$6EQ)KA7]'&ZP)6=X\8<4
MK9I'W!$?JSY]0GTG]_?<&+@U$L,"\=J>FCFVT@V&Y]S>8KHW[U(D7S*T4487
M?,NO?3/L"D6G6)PG3;=A>#*/#YFU&Z63 <V5$0$#^A)!K0=.3._(:.L;ASO/
M&VM&%,5)7_@7\*G*+I/I576)#-C$LK;KC1BM#N-.=K/:[$1P5I8="17V6'YX
MYW:C&VU=?R2>"D4%"EUAAL0&RBLH+4K>/#J$]C\PL-W(Y&]):2('BH4=\+Z=
MK96;]G[2'+F5P.JZCULU,E+JY=L<5E64LQ>#,>S9C8K<I[#O#YY?"H?]:&AQ
M,VENN3&&XTL]3;8/2ZU"\.NK>XG)V>Y^7:*F&)I\(3C@,L%T(O_C8-Z"H'HJ
MD/%RX"!90RYI1.IXWG[PSOWV*&O:X \?G+AO+'P29!VCM4A^8,(A'-B1:5J\
M!$QSWK5P3+TV]1WUAO;*/]&_W]'5?S-:NBGX5U9U\Y\*6;"Y*,0_E+0H0.7&
MV3.0P#+6K]@XOBD$.Z1DA#VS UC*ROT202B(K5OI9,!F:S_=\*^<UO9Q47Y?
M>;I:CF1NQ[G['*71(RY^X];IFI[<V]&K5=^\TWE_++/OSEX DM,K>X2?;"4\
M^ :OAXL-C]">W"C=G</TOPR7D%I*/5U[LVM^_N-T^>?OREU ;E):91"9@8^+
M=_I-R2,4-S+1LB4P,/D%B6A:'UV6VW0^26X7M]FRDT#+V)A0H9Z0A6F"4C>V
M,HY%?,"=:75L1=,]9U-JL *=,)ZSZ3@LM;-] 8 &N>3:P>=FSLNNKA@%2(0M
M8)2:HD)F#ZN:G]P+&6Z<2Q(.?7SMV=<G-3?M;4V42*VRJ@YEE[!$X45@Z?F3
M&:'.U:FU+M>4)NOHP8;AA,G Q;T*=F[NV^CA=%?\.]QW+AM+KX#PD*)7HJ'P
M]L_#IN3'L<<0!HP/8/KE7(Q<3:-2C]G3J[[*ANV!)S&L9JM&CR' ?FW*K5B<
M:(_=QDUK! /MJBD7.S"KF H<<BCYU)-"PD+"K:*A+/B5ZV(;]\\E=%$Z$C]7
MD'<2W:+8QZJ(H^W*>W0@Y)FS:GI&/=CL-.L$;QG0D-P%H^M$UMUDL.5D?0'L
MF5T M#K8J,D-Y2^S;)TBP9G:J_#9.KF^_<&WG^[D\T]WXH#CEQ]:R[3"%K8_
MVOG5[)J>,U1^]SK(7DGWF7/FTTV\,KIVI.T9XJ:G>7A)\]GH^A+3D";__1-P
MY;'NU,B,1*Y/*U5JVE?)CS?(W<MX'&J)QDZ 1B^CU\&F9>J2K\[,[QC>]#F%
MZ(H1M7^H>#1/35%BH,.8NLJ!K9A[YF0'=,,('L'7L:):6/&:+JI^)Z^I>J:D
M61/Z!B/\%<R)TAC*UOA(3OW-%I%Q=NMA@,7M-&[51^?3V?W,)R]3#'J<J[#1
M#PJ'O$/#NZV0ZI,R\/CGK#:K->5'GNAAB%R/5P !@O2RBA)[>CR8[Z?#&"3J
M^K5&O-:YW@H$&PR+83^<;6 ;J7Y>,*3OO0N-O@#D%Y2?+)9G.0Y=[9-)KR8S
MPP9,!M@9V%-=TFP@F@NA1D+R;440KD/QW/6?*7G]WWJFT>CW1X*%_5>5BJ#V
M8XS;8/K+;?SI08K%3?YR&YK_2$3H31,XQ,/8G^+9RPM.O]K.#E>2EYYW0S+;
M$UGIF>H\GO]6022Q.A2?.6Y-BX!"V_0H&UMU[HS@RWVAA]2]8-Y^X2;<#*XT
MJ"$)02SD?#5S.<??YHX/+!V9B';9O.<\6G+.X3%@Z:G_>%2$ZKICXXKA9%T>
M3V1&CTL+;IX;T0^YEH3"]B"A*A2KD[1I0-<S==V'*M]8HE;E$U9ET?R=G9EW
M]&R-8B8%=LE4>61$9+K<VN6>I>+?:B1$LKMS><SZW[A\VC7%ZVG-?\7WN:!1
M]YP3_G7EFX_\>-0(.,?.J4_%B'+S8>#3YE@2L2&VI@9\F=R)._N?MT)%EX;J
M$EO47:TR[EE%VCVMO)Q>E3=@+\<A$'(4/3>RIRJT7D 4;UP1-J@P_7[7J-%9
MZ$N<N<VN 67A-#G%ZG"4D3)=TM(FX^#JDRNG O"9,0[*,Y)GX30%1FVV26WU
MK2[*J?YYM#_(]31=WQ3F2>YT>?NA]#M=D5U A<5G(A2[DB7;AX;E536U'OI?
MN-1GH. 2[1[I(X79Q$?K$-6XI^$A3K#LL'-:F.=64-QYU] CO24'H;G(+X[9
MAE05D7':#Z:'E<E;>J[KC5TVJ;XCT6607N0L7R9Q+%[SA.!(Z&;UNTNYE/S)
M1T6WMQL"[^Q4()"#K ;Z#Q?\)$B=C[T\_-N/6_B^.'R7U[,#'!3I#[NJBL\,
M![0EPG!J(OF4]KLL3%2D@NL%#6^WNNA32*>Y)076@LT7D Y?]98H5L_)CKRD
M$&S>IH\C:]/=\>V55C!<Y)SIS=3Z^,TJ*9ZY,%++;.-D_)39D/T-I4_LI*=&
ML2N38D=&+AY=9_[V0:$CC+&+#S<TOXH2$I2'*L=38B39$F'\WZ3U_KV,-G!=
M\"6"/=MXY(]B!Q7-G56.^VR'KY= KY^V A/[3YIW,US@DTQ)E&1@#R1UUF8X
MI@=)RO1SQ&=QA$CF!+8MKU5"<XPN=L*6B[3\/!8G8$UC?!SY87Z@9;9$:$A<
M1 @<^DT#8M9N$,0$5=\8L7YWI=0LN?0IQ,"2U34/HJ!^5D/*-!8QS.^G')"Y
MS,+[S#2;=EXT=:V8 &5*K'J9)M?K$N/758B^7TIJ(?7\]:S]9>L@#8JUHOXP
MV^B5Q]K9GT/R9#O*WYM'@"?]]$;:FM"T4#FE1I/ W//4,\Z8<V%4D?8%0,,:
MVUJ]O)Z.N6VN'ZW$B;'UVM$X V@X*?NJE51@EIS-L@OOOGFY?DZ!+?'9X\*X
M5<[N_!UZ(<E;ZC E<ABG -^62LJ9OC?'V0K6\-@CA:K XW,HJ;F%\S)254>,
M-^'=S['NS2X9+\>8B/)E23_,7Z FV\](A[=_.AYRV(**L6%#2,9:IE>2%-=
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MN O/FA7+3KCM?X O "Z:U!GM$Q1WH6_6('QNHDQNU:178PVNJ5Q-6^>4;Z3
M^52PIK2,U%WXC/'&#[%^3^A\XYGJ>>E0_EG_8RUXH5"A4&Z7[IQXGX(GI[DC
M;$03K8E^)H&;P#'0CTX8>;OYN.QD'SGZD5ORS&I8<"@[3>T6EBV,-BIQL.^G
MMY2E);H>YM7I59\,&F'\U]+@.$9@*>==,'<E[_K5_MF3IK=6.]ZKP12D77]W
M7GUA6 S#TZBS6;^AEW?X!,M\M$>Z)*RLR*'0U>7G6PZI?3)I5X(Q@U99"3>'
M8K./TQYG_UQ'@C56T_4P]SZYW02;!'M: KP K*YQU_\H5,2&U+Y@&) >O>LK
M00U+E/\[K$]Q)2)48M^0'4$AO]#6PD(Q+NR+1/>J%V83V-3ZSW>#32S_N4Y@
M-CSNG!W>,3 %G0N'K?NP7P ZAGZV-_R^72/' J;"+QC!?(6=AJKX'VI1[NYG
M(K7\U5.[I,A6-G*L':3?5-K34.P'QEIR[;VQO TBR1-X(G J5/NQOU;QX,T/
MV3:RYT6IT>WUU,SP@Y< D5:'P?$F<\+6#8V1H^<ZC[Y NHF<H!9SKE[DK>'7
M+4>[DR-')@B9T;5.MQ^[\7WVTU&Z=4G<(U3.KY(<NOJ =]I0KC7NNRI,%L)Q
M^S31=,NH?=N]1<PMW)8+<JA,PUQG??]96F:IO/CIC:$9WXY=7$0-8K'V^_$5
MX[JX;S%XUQJ+<HL>/)^9*C&X"V/_JN'+N<C@..1MMVJ9^5G\QN,F-75-RFSD
MJ=11>):'A>()]VSR\PY4RPOK[24#B1>KIH3T/H*7X_*TJ\/CEOK@VS6U]RLM
MO-TD&7947R-L0\I?K3.6?;]6H3OMY,TY[D-QE"&/%K2HJ$TRAGM^=BGM#98^
MX!P+6B],7NCY["^TP,A\]#%]?'1\I(VZXUY6M;=]NP]]HD)5!>+,\-VCHK?[
M.'2P_DZF"7,6)FB"AOOEFY7O[M0F6,;,! O&Z49/3&3RMU=EBN"FF9[>5BU;
M?4)ZHSG!_MCGHTNRPPG"VSK=L;>*(>6U8*+ZZWHJ6_GMVQ./WCV![AC"C:IV
MF().OXV__?K>[*#+_E1QYWW">8ZM;1;KH-I5LK<H&H=,#JE:->?'3D''[7+7
MVJ<]SKMQ;D]5H#@7TY^<4U+S=-5V'<)I-VOQ=D2L>N$6JX3\IO3'$$VFF96!
MP#*6W(/8'R]/ANRX%"Q0ES.WM6A\F2KG)"N+8NPZJ+ZGAZ#FC+(Q?"%X9_6J
MM[^R5-5*._*Y,K_)HX61Q6J.ASD8IV!(+COR:\*SWXFW/^IP_\T2Q#D5+.=A
M^.2:.1;(0FM4FN+Z"#E N72_P.ASM*T\\\KC],7ID!^A/P8+=4I<G.Y&=B[6
MK+0MKV?%!DOV8XRR!-UNYHG*V;Q]=T:S9U^/,U2$63Z2;=0"PW%"?Z#IWKP4
MB6P0LY LS9 LK<*+B;2SP[T %-AW%^A-J P3T8R$#*HPU,&4;X*:WA\6+#"0
MS(=]=;[>7T,4QOQ6-],.@$%>V#KX1WZDQM9PMPI5S*]3>795*0G%O+-:5K:2
MJZ?CR&90($(+'15-6*D97J>H)+G/2D(XA:I1NP"$@XXAMQM\JC?$SR6H5@QB
MRT57X]K'4UU2O3\3*LU9<)J@&0=* ]^R:@Q*S8T/LTN>0"!Y\!RASW ZR#.&
ML#R,.8$\[L5BXL:;#,L;2N)HMX),5A<QIN/R0O_# --E^.IH.?DDBBCE6KN6
M8_O/1*@\^UUL)+\"G9FS= '0G5)"5N6)K(4?_8 7@C3'X>U?SF!W]XQ+AJ_@
MWT)F"A7)CFABG*E:R_@3*/H/^G5_J+14'9L46<HI-5,VS<%8MAX1;"4;X*S9
M %5X7CFL[3.#TM*] !A8>XHG-,OZKB@_$M,<=NTNN_,T$RD8,T9UCPBLJ,1N
M0Q]Y)_O4NVBH1J1AH A=^>7)T<F30C='>![&M>E:</^,]=$8L*>'F/O6A1B:
M4T4XZEE9\2)=[Z>Z+^;:X85 GG%8FJV5?K4O^;*B,#*_5UAP DZ!];\M*K0T
M.0M[HB39SHNT61H-Z?O*AN#W:>?QU.!:N(Z'&-UXKSE_720WQL]$>=3SPR<\
MLD&[] K1$.VR=N['V5+":1A_$="45H6Y.S!8X-+9XZP*@9P] 0E+H&>?81(9
M6Z6&92KZGA?&UFO)/2WS^8+4@#98H#_DN("Y^T 4W6Y8CX([]V0SX7/\F54A
MY"3K Q+#<:VA%@R.22N66R";;DML-;V&*Y$X6 &F\KI*HFB*(DM,]UG15"$_
MNBK34QL+'U)'L1Q%)3G0MF=*R*C X&Q79RV/CM';L G!GB5="@;QWR*5Y*WG
MR"X4XZV_RZ(CT:6'\5=:IB<ODPS6]]*QY#D20E3H?@CKTJW!LJW@U9!-#+5%
MK"T_'\(6G%D;8P4W.</KRJE0MM5YIJ[%]A 2XZX>:XNQW\!<2$!W*38N0<><
M<O:X(..P"]:#(5U:WKOZ6J*<W)>VL'2HI*, ,T2X):I2TPV9N6X)JJ'B@IUA
M$S]?[N=.*3_%4$(>ZS\+QU54_TZX\C"$R^ 7X1K[KX3KG^-T5(!,*?9Y]#$$
MG+4LQM!RMW\57R\D<D71[TN6<'2R55HG:N[\6A%I[IR68/], UET9"YMI,%L
M!1/L/MG^*+Q):&;K^ I3=_B1_ OQ"X ,\X]^:4>O.-^UA WXS/_%VWN -;6U
MZZ)14 0%+$$Z$5&J@$J3$@(B74I 0$-30"E!>F\1D6*D5P'IA)X@0J07J38Z
M!*1*$02D":&3W!G66O]:_][[[+//?>ZYSZ,FCCEGYIRC?._[CC&^[V-=6SVD
MCJ!JD>?D(]U626N:?DFS\@9B9ZL"^]U;1J3\;A0C0TK&$H#6I[I#R:"?5U R
M(<^F;Z1C4YPN>>)&@>/T9%#/W3[(F1U'TO,GP9F1HCP<Y]1#2*QTAT+OR: 7
MEBTOG LSNN* ,QDH9_;[!+:"EL@@81WYS<8(CZ6I*(:8KCR4#&R*>6W^D+I[
M'OZVB\^)*DZ%B!LBG<M@B$Q)AD5 UB*\?$G/^3;R/<30$[(<>JXC2J:5!SQF
MG&109LS! FJ*Y8^+M:[?BD3-9V'&ZI?^N'G&Y@58&A]P)A=PYLM\9PYM_;[G
MHU5CS@N4ZP..2C%<K&N &GD=D[U-%=9L?65VKS_P[BSQZ &.'EJM#]4L-M5/
M!MW@V>VC>FF1_/'[7K_OX89I]P$/UQ^/\!.XFS5PM_.'-F\Y8)^E9\1KG\U+
MC))!P(6->[1L,*"J)X&J-GCA+)L8\<FT](!'_NC*',I+4N[1^_ 6=@;/WN:1
M ;RL)^FY"M!@==*4!E/+>351_4FNQ]S3[(0[6V1HSLAH$KYF0XV(LS[-P_3S
MA-ZQ3$]. 5N:+[\CXRO^CWV9FJ(IRVH>="JS%S35)MWZC2,<7%(*R2 U"54F
M3\"21<7=*^[%E(WJ/&SC%;#!CHI;6$2CW;F7%59H O6_,6[&[PWP870> PI
M@%B27WXS3F8GY#(B(?1X3M2AWD!H9NE-50Z*,Q#/#0I,N/P+)NK.@!?^1@FN
M^/A\S%5>1B<,Q"<VWG_Q+HOH?P,3>S4T&C0 5N D7<2% 1+'NI>_%V3R>G_9
M] F@>X9X ;!XRAF9<I<R;=4[, N,H9O@9YXY.S9FFRCZQ]S2G RA)&RQ%;'D
M*2-%ZRR9,,GS)#K\TB>@&>'*5E;/LZM@U99Z _HB/\.*C%-,>:)JIJ?*)K*Q
MIU,O>K]D@FRY#OGXT!NJY>_T&L'*TZ-^S17IB2[1M8D(L./-2%UV#&\ZF$RF
MMW[FJ@AI*D]_=X6CK*4E/.^^L\%1<0V^^)$I\RDGD^+E,'V#LES*S*I_GWG+
MS#ZO\MGWC0=)H-W\%$+BG$N<BL9"U:(MJARI,$^(FR/BDGAH3.-AY?X+L')5
MK(WKDGHW5O[AUJ^LPQ0H<)9W\5COAC660:'X70F;Q[<@ANP:_L#[\5S9[Z;&
MYQB0#P)^XA"1<^MQT8#YM#)]CA901;#<S_$ZH<>#,:LK4L6XZ2,X#+#.0._I
M:Y>E[,JI."Z/ )]!,VK0P.$\:CR&DX?W"^WX88/HQ.J)>?N+@4>:0'<,$(,2
M$DJNI))^X^1N2S$"&FJ#ZPIE'^,7U[5EA;8"#9_UEH(1!<+FY0OW!V3X$W]F
MHYM^'7G=AC2.2R2([O4C2K>U'FL",J>B2V/&]TC<N-X1$+ 5#"J CZ!E]:R@
MGY8##FTC$Y*1VTMWW7"V7!'" .H62+ZE'-;E*P-T3811L92YU^ C4]WAC47*
M].--&4#DZI^G(J0Q3X+[*?\RG1=,GRM!.>D7EAU^T,9Y^-Q   I K?C$O3H^
M#H.:?(]6!KN9ZC15*]V%3^"<=%L7%KT3MW"U-MYU(Z'BKIH5>[T5/<$"M$'*
M(BU+*OT:K=4VW/MXC)WSJ>ERVDN&F,*OE]\51::<YP-804I')F7+?XN5E$A9
MLWH)W\"E,]YS>#QL9],!^2(>(MW@0!R\+64=]ZI@VLU2-RR]3N^P ;)*-]?X
M'1CVYW#;=WXG>+@U.H;N-T=5MAQ.F0P=T,613NC_4EJB%\O;]X--@)^3S@VL
M4\J#Z@JEB]SL0\KHR]_W.UB^CDXH[/;YX7>CJNP3KEBZ5*2H(LKWS&@87)DI
M(;+V+P7UYP2@YM]X=$_G/PFH@3\%U.@_!%3T<\KV+T5K$_K6)VAMCC=;3-?N
MZNT;.[YV\5\ E[^AD3\84OUN>G+2G%"7;%Q6U'"MG[N'F/0^[""P3.V,B_8T
M=6B4C\'8J(+'IVW<LARGG=_9D8;5]"HY 7>%UO-.IW*;;FNHOU=G]9?."_5O
M._:$+ZM4M:_NPF/'''I]W7'!F5M4XJ\P7I8/*F.$K26W04[L:/7 >6__NG(J
M8LYVX$W.UX=V@X>9;^N]+BH*!H5'VI5SH(IG1DJHKS8[B@QSJMBBNV:\/$87
M$#+W:+V+C8VUMGD?TOOHA#=P*.;;E)D.<[:*W*<+O?+"^Y;K)9'PS\5#O E2
M-^/FWQ"Z0]R,"/B?]N,:3<LA$M^\MIL2 R#OHWX)S<DR# A<DNN?=ZSE;EKJ
M9(P]_C+,85ZBFB9(HOCUV8Z+G6/?T<_W6_82DR\K.3]-##C69M##ZLOREO:&
M@_1<RM?/UZWL#Y&V!]S8#PR(X?87CI.1@[U>OA\(E7O"@\M?_-:"VI@574.T
M^DH_?X5NJ#W8*!?.,!G\6%$[KO$@.-Y*F?VLMF!;1JB[T )]G7.TZOHYC9\B
M3_S(($_@M#Z_);Z;YZOF4WKJ>HA0&<?R;M8/M\;1OX3EV72D@D?AHNEB"ES^
M2;.A]OZVGI)BU<^@&WKCHQ*!-]*]L600G9>*XP63DQ[?;"'7;*HX/GA 1%]_
MV^L/X@H<CNM/V1SJK3N;1 9](X-L414,-WV>5&=<]#*#,8+31PP2I>1 -C54
MKZU!U!LL,$+X#*3.PG?#+.X[8^A6^N7^W/HZ_]#WR(1UJ= K/0=W[+E-2<A'
M8GV15C3RG1N/G\CZ]B>T9 EQ\RV91="\<-.BNAOI[X^NR+D%'E?]4,.%R:U?
M"?;(L8A58I-^X?W)H_O:9YIZ[FBFSY_;ZT\W<8'[\4C-3_B+U[B[4'3OW<B@
M$SH^XCNS MRW.CF:O-]=%-3>6.X4F3Z[8IF!=0\06T/;Z+=OE=:,[^J;1$T8
MTA2 +XIV&<UY?-C.I:(Z'H\J1@CV@%A8_KDY^G^XH3E9[<A?D&'S^O<>F1Z=
MDY$YB/*XP= ]]2()E,$1JM)M$.KIC#G?XI]'VDKN]U;L$?8NCC"GW+V@PHAE
MD<=K-/?HT>L\81S17S+X*(^W^ JIR(<N28]\[5)]!-G#%#+:H6%$3;WTP1]J
ML]'Q<&4-;MI/$L'8S3;'AP1YK%T?>B1]+B965;*.SF2P\==\4\Z^]%)/>(74
M7K/RW=Z4RL,WFRAK*$>KW&W!)\\"'!)<]Z5_LMFGUO3,0NXK&T"@[C5.9) R
M?-ED<:'/<<E4 FT?>(]XO!H)I4U0%G[%6:8FX%.6PX+3YVU^)J;,L969.IQ3
MD".GK(![7))K)/>D9O3-KY*6[2BF?O4*KM'XUOTK#?'^L>8:8P<",+KQSE=+
MO*+?KI*6(59)^WGO=S=SY_LR9)D)=Q]9\[-V(.3;1"82WJE38416:)B$WR5>
MGJFP21%_V,*$4_$N2@P5M)NWFTG=#NR:!HP:E>+=Z$>,XGOVC4[]QB\F0NYF
M+ E(8Y)64S26(CO.Y*YP[/5V@N$NWJ]=U5PUU7ST>=*>\>'LVM+]OLX51]4:
M7B/ME.0^I96TM8@#5QA)CS([M;%DHT]?X$3>G+70&""6?,D@XG.Y\B6,LFCT
M5?@YM83=WMRV0",TU!15??A7M;*PG[C)H/M"!@$_2PI0!+I!\QJA%&M3R38
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M$X5// C8S<5]M'?2I,SJ^<8V1V]B@-^(IEH9? 5K$*S:QUMTKZ(_JZR)%U!
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M0OM*QLU)<J,+"/V=2 "HG"&M9!""1@/VDE3!D+"BOZ.37%AE$:[7B\"&4W>
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M-EP(J@7J,&EO@ >CXP'KRUC2C4Q8UA_>32&#SK[IU51VO) RK2O3UXMP8[=
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M?,C@C^0AG8?RD *2-DJE=S+F2L,X]52H/+'.L+I5(>LE,RSK-P[7IHW:]%V
M\G'% )15<Q>02<VJN:CNYHSVNM/S@,7 [O:1-BJPNX2N@L;R6.@&Z;P6\(O,
M&[GR5_H J@BA@[&MZ4S\85'$+I%!B=C=WF7EP_0H7Z OQZF=!D[AV2CV,6O$
M?/%F4W4Z'=?4Z?=[3B%CB7T#6TJ[VSCZ/E>M=85S23#!(47D%A.G#H[;OC78
MYYS>B1$LNM1*P_9]6TT"$Y*&KV<HNJN@O=F#XCZH&3'2]F'9S'^=JK7,A@SR
M]S'*>J[D:X3VLZ8SPCAJ3E^&Z_>TZKQ\G^O_V?/@VA?S%:,$5;;E[_KO&5>&
M\EF_L0*4;]$GX^!:K?D*'."%@OW[^!^I-.XY7\PUH 7IQ_F)L)T'AAEC&-@%
M81#58V_SQ(9X>[V 93Z#V+<WH(:B+PVCKK/+#E5X 3J1\QR?6>1-H5GCQW"/
M'$>?O<JIGQW!WS='323FOT98AMXCJFK+WSN.5MPXIPU%Q@_:7.4Y5S%?+\S-
M>O+9V*S\)3,MRTS9)B=G<SE8.!YUXUGR6T:L_[%U =1T6IQ\P@9URR'WFF_*
M2N:OP)[PB-6=N^ZHW<5)P/"_7B2#-@9([H$[O=U8M\*7#[,[R:#_<'BP4::I
MHYYENVA.:+&B<WU&V#Q CG"PD-,NTWZ?U3C#IX4*>;*3YS?MR?+XH,6*[BS2
MV44C1,*;"+<?[S<[?8+<)68SJ#<.,T20A-%""M4,_IR3S=",EJ43$GIF0.\8
M<=D?&Q4_N)>%+2!]S(B:$N\?L).2UURG?8,<8G_R:(.+F#JG,_&DFU!1IQRU
MO!2U'?'$>2%E,WM3:#A/-%GJ8,NQ*^HF:O?79!HOS;9-TR^\I]#B3],-H"L]
M.?BYP3>"\IM,XSLX&5Y4^+F_RM^4KESG+958@/M/U*D7$=/BO$]XH&)F+I()
M72.;YB^H&<]=ZO"9+]CD[E';@S<0KTJ3B))5(FJ4T7*<#*+R%YH31<-^W] D
MEN:C AL2-IC;(+LLN7N$"D_)/*=7?8DQ/GI#SGT4]JQU@L\.H3V02\_.Q4P&
MQ82,'DZ9&]LV'EE'-Z-/\O]%(:<^;2+%E=WBX;!>Z00XOG@[&!3%NC-(*C *
M4=T6&B.)DT%%3%,QAY]_Y91]TWDT %=VL*&$"E \N)T!.?#G(R3_]:4\^;Q\
MX8X[&70YH;&O)LNDM*5T%XPE)0P:@1MX4A2.DC2HIS57D4$O(;]%/I&6/9@Z
M#M2 1_+0V;;+J<Z5DC=&[>PF+6EA*!^'BQJ;AAUVE&!$-)2H\3Q5IP97(=2-
M YJ;I31VVU'/88M7]PR9MJXG+VT"JF9L[BC/V6>9[H/G !2Y#7TRNPJ@RV''
M?GL#GH":O0#;SVO06!<]"%V!34CTJKKZJ%C;\2\KNXME4=8!MMCIH/PY?;'#
MIHP*.SID$(_@(7+!=73!7-R/#WC"A #\9O7R)B4*PR==#?[L\NJ(YJ!M]@5E
M&@#67D6(S:%>07YS ;"F.G$@U+!31@9QSQ!QU/ZKS;6 ZM*GO,0WRHSMF>-X
M/RAP<-1\.W2CI&AP;?L@]"EJ M*5G?<!&H43[]ZE'D55"78:]L-F+SB2OA=+
MS(]-)5+B"+K<KFN<$3UXINP3[(UJ=]P%H0L<3*3DO:)6^OHM]RL6-V4XOU"<
M];,OY1#04#N?YV.1?T,6G_*.T9??J([&&7-=ORO ^\C FJN7D@UDB_BSJQU<
MCE+"";V6!VQBC,O\88OY51,RJ&/YJ.K6HPY>)<%6V'8%YTDP!Z#J^N\L9HOA
MP1[9-0]J*0CK?[(Y9%F9?B1)P9BK98V')+\B-*ZC3RREVSD'V$]/II7\0@#$
M]*=O%5'RJ6E]/<K=24G7ECLL^1]!3.T/L2=,I.3BH3]* F!+ ;0=Y'MV3OA#
MGQ0-_8$^PVT1R@YI2B*2_VOY,_]UTO\TO:#^V[ZC]&/!G+8E 0_DXZ<&]"$K
MGS:S1^)C@/$JNLL".5R</N$Q"6Z<?8C:+G[)*=2;5R'+35EI-(0(T=' E:D*
MBGJDJ8K/&<N#;ZV?J-R?+FL,)W0$HV8?OB>#_ SUAU_R+/F*N.W[;?RF*SM@
M.A%UX*5(!IFT:<,&A]*[;&F5P7HJ#P$<.;"EK/>/1 &,WN_HJYUO&G@ZZIP.
MT2*)-P8VB$:LO@\UP%6<Z54&QS*+.JLB[L!\ @DO2#)/+_VX$G3H%U!=6BQW
M#!C%V,;][ ;]T$,_%&*OO GR6W"4#*H1BBP,5L[J9\"J8BXM#M0'N[[Y*N#+
MI@'OZ=FBCA2=MCYXY>(O]*.###+E&Q@:0%V S1K'+9B+-.[MRN?5_+1WZP^+
MARN[%:094ERQBEGWL\;T8'2VJ# ]V+C$FV@;W]4/.KLT7\PJD)_DZ5 ?Y1'$
M%A.)B_E7=<*TF]%0_I)?"@;TKB0%P-+6V!WJ C)H]APPL%,0$9"K7E$DI4K(
M*ELG5O0<ZJ//S.', _R"LHU[R\-.5N!6-C:L.072V9'M"<]HQDOO["@#@QR,
M0FR4;2-[Y8$+6B#[@^&$$)?A/3AI/:\_8Y7MJ=/P#*5108U-DQJ[KX">&:X'
M,-[)[XX8OS8*P1*0Q^,Y.PO?7-[$Y)K%X\?<*,'16?0@M9IJ <L"5))^HL ]
M@*9L;L#WHV:9'4D_2V/K_JV,%2C#R>1#;P]>Y5]0O_^F\X3@X92Z1J.7KKA7
M=WL&\7;=35BUV?QZ_J%NZ9FH%4K$F,^^#-EH(5=*6*WCC-/@'3)H9D&^HONO
M;_@W'V.(.O^RO$)K2R1E(13&_7859IVCCXI"! 7O_OK;\"+?4K3-P:MWJ%H#
MSD[NZM_]P-#_VKBJI]=XX/>%1+SJ(V2)I\2/I*+XKIT;H_[+]!H%X7T[/H@2
MSQ\*T>VSW#W2(R6N1UDZ<TH ZLN+VM;R2Y@VWV4<0P%TV-2:I"@&M!IRMO0\
M<#1@AL*'/:5RGWAD1PX8&<M0LK/I/'J;TX>&"@@']VPRO@"$PLU20D,2%( \
MU6;4+JO1DKEFI2/&FRC/$YL)]")K2_83%/N+9AQSQ%QD4_U*!EV$S<H%X)NB
MZG>,_-<M24H=2R:G]B>#/?6&5XY6]=]1MH2RG+#;\24IO6]<99Q_8% \M;K+
M, )0=EB:LM9S7PA%3= >J8D4+* F>$<!-8'LMCFRPGIEW&;FZZDDA<OU?YEC
M$RD1]@S9CFW;@6'2LDP]0Z@+Q=@7A/$3LZ,0Z9F5/'$DP."S[05-\1V\["4Q
M_3[(6%_=&1J T,)FM5^MX7SF#+07T?PX30Z/(P,2#OE3-TR5QN)0,UM /9DC
M=CI(RE\RMNG]$EP!FTKIY(O9[G#6$;0LW/3:."5*@'S0(R6/[)!ES4SAJ$?_
MM+S!?J?(H*A:]+;^P"&RN_#/5'[9[89_94O,[1G^]SDW@\LQOU?_C*&)],!U
M3S\C@]"%#?CVMPNF;X<7PT*Q+/GG.GF%?"_R\K>)\+==9+L MD@"6[P"O<X!
M5^6 [U.WL6#:6+*;_CQ\[(:*@+,*_UN*M$/?4'YV%XXV@:.O';<(UYL.AS_\
M__'B?:'_X51>^^NC1,_'"#'5ZE!G#9F^LW+5M-!"<W@>,/#O')NF&?,=8MPQ
M>KI^)V::698E8B*A==7RHR$DV%,_/?3>%4A@SEJ.*\J]45!*:MOX=_'\W=$,
MA>ZR'+G-/TLE Y8"[IF83%NM+!B;,<V;OV^:]RJQ?Z_S>3+!W@N>2CK/KLO4
ML%,89WA9SU"^LNQ6_R4^W ?]XTY0>J6'2@MOJ3X,"SHLXIN<QQ#\V8&GPV/,
MA-9SST'XT%LQL4T>I4P[P_<SZ3 -"6X3F+;TJZPG3LBB+=3./#PU?&X(;=JQ
M'[%KY)-2-LC*,!T;Y[E/OPNO/0PY*/+&27'[]F2F[=M*64=$[.J6?.2P=_R<
MUO(Z]LS+G&ZL_X.U?=@:NLDX;V179=(Y_2:\+$-CKW:*I!.,_?#]*<Z'4!9A
M!.""-^=/ZC?S^#,>R\?CAZ2[P"Y>8+WS31$5KTUF GA1'QLODT'OD#\Z:);/
M'S0]TV$B,K>.<1[;N;(,%?K1?'M<,\%^=@N'OEG6JQ7B'R'B7S V.>[X.:+S
MD'!07#S"8WWI@/^ _^^R@KG+/U6NG&L3N/U1+5-RYGE$!D:%Z^[;4\/=&*'@
MWE4RZ,3-:U=/UC_=Z1+Z%$ ;/GS7R775K*)#FJD#OM\A-Y$I0R< %4#*QCB5
M'-J30:W9?D';6C: /( -;ZPL5?2D8Y0SKNZ$HUHIH_!! F;Z$JH2=UK(TKFD
M<R)L>,\H2]MN) T>71$ 3FT<=OP<?^,7=M= .FN#YKNMDYH<O+JQ9B"\.Y*I
M43#]T<8I%J[KR-Z <\?]%%DA$Z4RU$7G\.6;  [)L^_[G[;R&[QI]S5Q4S[!
ML5XK'S:1-T1[E*GX=)CZ,!FDL1LW'8F:NN2ZB%QX3ZTR#RV>@Z%KVVM:!7B@
M10N?OQ)2!Z9(9L\C!4[3YYSZMJ?G !MS_%P;/QA97,PP';<FGAIEY?@YZ:CK
MI2/COD*"17J8S[C8WJ348[13:P+0S#VN.9;-31EGC?=6F(BXY(Q?Q7[$$:'9
M#+I$>9[*I^',3LOFQ@L=,E;4*#<C"6/6>[%E-FZY4%M5#49$TWQ5_)E9"S3H
M:@@#/W4WZT[?S&=0)++%D@PRZO1-:H_;+ZLXKXKQNN_QF.K+HRB[!8P0IV[,
MU3_J+&+RE]0/4P:;P8_FS5%-O4"532;PSI& X;$;[<KM.[N5?Z=IC+MC75^*
MRP6[J]?<M:%R47*_!6_-JV0]F,'P49[IV;&1FJ(? 9R U<2"H,ZF!L[=T])Y
M1"IE@=S"RU,FGJU^P&G.[4)E.-GI&P)3U:KZZ()ZC5<#NT\_[M^M\\S-??+(
M7<32H2'^9!-E9+CQEGBT:S3W[N@YD$&/@+'*!0Q*!AN3S],DL"7T)/\72BV>
MODZZ>%#4K^S*72WKHBJQ"J,NW_)FD#4*DI5*"HYXN6=4=W!^3!CBQ1-)_&(P
MUOR4JU$9;'2CF]*B3)\1#;!W\S1':H19GKN*VKEJB)#R$1!%=^=AS5ZEL0=W
M'[B/!I4UK"\C^A.2\=)VC]-9(@<"3L:H\W@0#@I=**U6*ST8B7O\$!@-].RI
M^]A=>")090;R?;,"H=]M?2[QQKE:KE3^4*_:M9RUG^\KTC<4^'1_$Q),0Q(4
MO^19BBF/!O0YK/DI&;06DR6HT.UL?O>-<Y3&]]3:6W.M@(AP4*:HF_^'N*^,
MBJMKUFP\P4EP#Y#@WKB3X.[00"!XT[@V;L$:A^ ::-S=0W"W1H.[0X! ($$R
MY+W?O?.M67?6_)E9\Z//6EV]S]G[5->N>JK[U%/1%S(T7U>V81PDXI:W56H_
M?XUD6;7P]-(CMW=%H6M4QQ,FY,QU_TAX,I\VL/)Q\2L;^.ICK[_V?^AM=9Q<
M4?J1T'HINOG)!1:P/^W64ED;C42D45=$HZ_0#\C/K[C1K&S\&"S??NOFAMXT
M1["?1Z-O+A7!YT*%#OP<"U^X9?K^C<)MQ84<P!(>KR7!\N1^UYA.Z2?8OM7B
M6<UU.P0_:#E]GR.\D'ION=8F,)JRW0B\YN#4VH\8&A"9B2"B?+?-]N01!)LE
MG+M8SC[.Q2X.ZWL2.JNL!+2L)U/\M;YPH#)<!,;<'G=#<5G@(<LOL*M=% 8/
M4\AE7.:[NNGA"=C$C<Y)_H$=[1L#BU803WZ2B?N2D7/WX@ZTVH[L$;UV[7C"
M8B@Y_S3]XA*U<-X<S9'XN##L:<%^=>]N;@*"/F&2?C[7V'8UHDN99<$ON6[V
M-W&V:YG"S"/=ZU0E]S@"SJOQE3.(['\,WWU5_V!/ZI9< O.?N/&/TLK%?5[L
MEO@3OA#--_SN\8^HC$>_S]#<PD?KTUS8[N>3+J3;EA8V(4;8S7LIH;]Y%^Y[
MA6*.0B>?A7;JHA;XM>#>]=^:FM;_:@0.'_A?\JXIHU\!6^'WT6=^.,Z5-]H+
MD O!@'XEQOF6>1HZ/TC;4^KEC0/\=,G4[P!K&6&^+2#LV68JWHI6)R&3D2 T
M"_P/&=J AEH_:1X'#\R?J1_)^9/6A2P35G1^+HQ;TLB2\%X#AOS_]*1<\_]-
M<QZA@7]KSE/\3^-XW.XL5Q4&M%%</%M->=2@1%8!_8Z,7I7$O57L^NV/A::U
MN:50>KDY!]29KQ5J1G,HYPN]EK'L4BBE1,E@RRU[?X$.KYP%RH\3+&IXMTU;
M"]I)2AT4\]P_.C639(K-E1Z)<L-ZSOA',#I%'HGBPKESZZ)UE=:/_-\L,,!Z
M-%-&IT*4F^>O37".H\Q+6Z%&F_I3.X-C=GAA[RG%V,/$;&BP?06][G@2=-PK
M34"=[<1MOJ_- K:12VPA55#0V/MQ-XM);<9":H34V'C*+7AS:I$X<*^PZ=8]
M#Z3X)HS(0'M7K9"$FH/XD33L>N!ULN#O>:(.\L=2J]\?M7C*?+M=YU-%3'>\
M4>WHWWW]I;=;NABS4<W7#Y7HTS0V$@O=YRG];IQ'/R8B@^Y!]633Q/A9\4@#
MK*QZYW-A31*( FRQ8T6PLKH"K7)==)SWC[VD/O\WL_"/)/6A>-B"XUA2!1I?
MR&_=F%EM*^34F6AP?(57L#1RKL-^SU=NVK^G$"G^H3&!8EUI UE[G?'S)P4[
M-VQLPW'0MLK*!FY$@],A.![:I!7;TL]XS^J(:Q'W-(5M_RR%\7E2O_=EP[2\
MOW-.<GWI;<[1]EN%JY:H<5J*&F'-?1O?WL%>$]QK_C*\8L*9IV^JI*^QA>QG
MQ2>$J ):PIQ%N]W)BKDYHJF#8DO!?=3 K$UM;7 MSJ8WS>86LKFED;)H2J-X
M6%%A-E/Q..D81'X..#62B/(U+#-\*]:8W6H<\GVKN0,O0+P@#][,R+.]!Q3B
M?Y<]$26X5)QTK#H@@D!*Q.'4!!.8%C!8$ZI[6R,"Y<L#BI9LFP8H DEI0'MR
MO9RX*5802S;_9+T^\I1&U]+*;+@*>5+,AJY#XT/S9@1]9\K)4 %J*7#&!O&3
M/[Q7#9??V99'1#/NR1SH'\7TQ+.TR5.C9VT\$-*8*Q/Y]?"9CG=NWT]?>6SX
MG;:>JJ7'I2U*8-\+%F=JP"0V#6Z='I8MZ<^+#JEY?!Z(W^[N';UJ=BRM:*?
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MEK?06(J1WK%,CV7N-B3<\'1">V4%XL-*X/+6T2MVM!+L9^5?8YKEX$X^<-K
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M)H-W[U&@BQ8-^EAQMIMV[!P!FWCM<>;6SK1F@1Q01\,+3!N"86P#F8DMB$,
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ME$[Z/X RX-E>VB W'Q C!'K$XSZL(&K52I-FC=/OL288[E_/.-_*:R5=6W5
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M:>\K(#7^N Z="]/598,L^L$Y&+?19_F)O[@X'CJBZ(.8+2XKPVWEU;M$<OH
M&.!VUF267JZ5ETHYJ(F>NWGVI!3U*WI%D/B#?37FOG?WDP[+2T9N_[L*V=M:
MQM-4L*)VRQ_8JS^D(M8'HD8'6"LEJ],9Z'">8]O!1 (/VK"S:M .=L)D(.;(
M^]C+ZF6]9I,>=%[(EQ/'>&S-"LVDHL@L7*IV6P/HE9;DA4?D@9C+)6[C@\I&
MPR^SY6"/#\?B)21U41H(0\FD>C]/\RFN87KO"YKD'Z:SQU:/.G9>XN92XE-O
MY&QCUJU"*/S<*, S^-1;*(]#&M^AV(VNI,)KW'#>$SU/C:QJF-N1R[3,<!V5
MS%(='[Q2_-OJB HZG.\T2"^&GBMN7AAN77G.-%HR!>J8E7]QL:2$GWA<@A=.
MF:'U;:?F]2.G0H$"JR-3?Z8A$Q.K\-+C(J7$(#A 5;OBY9\-SW2NV/G6WO[0
M9KX@;T/X%S+3/33;Z;=H+8!S-H_7$%4Y"P5][^'SH;]L+6?$>>F<QK)S\*SS
MP7:L>Q0@':L;;_=.KRQUF< 59CS,P./*]<[>D5I(3!D2]?K,'G57"F[?CS.W
M$\&4TOR$.@] , '8U,HMHU,4Y/O=\  .D;B!AY;!T <U&N-8G,C1'K<!9KA?
M6U<BI2A^*$M\[)"$,(8/B40Y#X[CQ 8]WRNAP*=3O:#(.^0&%H\W,]-6HPP'
MIH=!(M*AI< ".1=[[V)"'UCG:;6DA9_/F;9);\*  ] .Y\08JY5;!GF+&W8G
M%FX"4/.@K*QRA:H.U8']#'D*+XR*%:Y/;57VGF3I4A_L'KT8#V7;O#IHS3#+
MN,82A2&[KLD%$]B#8-4LX!,YK&,EU^77^_[A/L*5:WLCY5M"S(!EIU<:48BV
M;*E3J7(Z"J0\ 1+%D./%P&?J]]^[I+J8_\Q82J4-6 DH8ZZJ<*0/UH@/C;GF
M*0[J2U<1C&.V_A8<C^.)^O?ME])X3E$6COO*O'\ /$GB/L*S?Z&U:3SGC)3"
MCD;60X7S8LR"-4OBL!S$]3W<P5IHPI:+/],PACC(ITV\5K5\;%>QG#17?[/=
MBO^FD*;9]KSMUP!5.1E\.7: P#F0EP@8^W?.VREJ+*UMMT38W'QEC4UZA+EC
M BP;Y^U*T$F;-2FDI[5^7X>MYIGZAQO/K7*LY26JM^I[O0*],L0YH;L@FE'*
M5:8%Y#CDGSYLOR<_R<7M3O)CA5M\W2@)S\]AE!=EU:UBC[=6GGV^7G9>I+Q\
M!4T@)5[[D:W$S+U61XQYOO$;.OAG$K]LE;7-'A]&$+NX@-C/#PY,HT<CLZXG
M( J?+?Y4JM)9\P=-IL^4=;Q*#_G^TZ:X2VM+ L8'<_VV\M4D.+_.E3V-;<$B
MLZA*9'IH/2$G F2:+;.*93@FS6+=KJC*MRJ@;M[&*>K]7"V8I<PG.C,H/Z3%
M7 MW-/6W;9NSV\5@3O8T/HU.YR]P:H!-X#OJ3#M49<SQ.^6G?*BWH1 !,E-!
M8Y$:MI1 >Y\7]@.VX=I!TQF#QM]JCU[&N*]##5+A$HO*;YDMP7WZF[ODK<+!
MN6Z(+]G^#+=06D;\[R+8@95ZG=M.NXJH;1:#-,S&Y;:2+++3W!&I>5=H@&GE
MIZ4%6^M)'&_TG?3=AQT<BPI2MOSJ*+V$<H=EG+<J0=$Z7(YTQC8^AA_5TDS%
M5,5Q6Z AW/Z^U&#2[-X6[4^XE0"RC$)O/:KI@4\]Z/%;T %UEOS/XMZW_P ^
M!%T<19)-T.V)2&Q'F\ISH\M5;566)* .T_RT.J*K^'^XMOKP^UI2)@.5)7<R
M\BFJI%C;:/VX1-N8LW;:?D[S-[ N57%(H=J+J%&\^EXAFTO)/C2YNJU1V^=[
MN<VA>^?.7N-#\Q>PZ\'J8_#-$LMUX^^*K#\( B<1B9\1\ZP"^LHV',:.(BV.
MZX<3BO3;(:U7(N3H"/^J\&7_%W]?&!X]-<U-H6%V=*5]W8"/\,E>HRG020B[
MTCW4+!Z\R:X'/C6X%.Z<-LT=W^J1(GB8,Q]I>D8=<&3!?:N\ S2E'VSQP>N5
M^TNFMJO5+%GF-\'G0U-88ZCY? H)E50^XTRAK:N8?I![!B%V#>CN)9;2.4T@
MO!&=BJ8[*ON$6\4T7=O$CRZ*\(Y PE:6GFP[+>=8MB[+R&HL]G1$U':Q_8K^
M'!VC-NY73=S!GA9A(76KJ/KNXD-_XU^Z.:<>L< PA!H9QS'8^V76XD<Z%T9(
M8GQ(&^QAQ/,0="-+]:7)O"X.6.A&[L!(9,FBL"9?NSK!+BQKY*U$(^U*_4Z/
M,UTA1GW/:M!8(XYLJ([!Q(=<[T:^K]EBDZBH-'9,0*J,9;ED.SMC[.,]7+([
MF1Z\9O/>Q^A@Q/S[#?W__IS"W2F/?]^NNRJ-I-+SJ<*8P(Y<J,P3[$VLJV)S
M,6 F+_-T[]@B@12 9 .@I3.3&U_G%L2Q*IRK7H5#RD5O1Y3,[^OB]?V%JVBQ
M$A55X '?[S*75(9Q\[D]A3+Z#RV__1#<Z#ATQQ,.XW0U,L:5[1!):Y;H]0HU
M0X"BN\9LWB7S><=_? .7G(I;?MO;Z<Y%WJ\8T&!FKU7E FY-M"/8O"K&_>9+
MV@[6B[4/JTSGV&4G+;EM_T7QS$5-,A526>%8K5 W%AA(N?1Y%$ W;U9^*X#^
MM0I)_SU+\D'?/82_3BGD1I22N_$? -9%_N?<->K>64<4C83IYS6Y.9HI^(PK
MX\83E41A^V9\&>YJI#3-/X"EPYJUM-Z@VG@+JX'Y9\[OE_)=[LW?$S-)X;3'
MHU^E/:N5X9[\RXX 'H%=V2=V[N8#*Q,ZH)%K3Z?6FJ2-UVM"%/P=>02QSV/9
M(NA(HJO%(GV?M6/9E]=$3[RNEU_:$CH0&BWP6$S,/WK0_\ERQ@MOQ=5)>D+-
MW&M>/!A^:^ACLH#Y!2%/)U*/_K%(<3;NXW\I$+648UKP5HNSB)O=5#?L'X!(
M)_M0=O*3(NHFCT]J^_ICZ[QN=S._=CO#E8VQ""<$"GWGMA'_ **AIMLN=AA3
MZI?\1'NOP%WL2Z8):BPAQ8--\_V4:N6C]CND:<U:?F@_/;-]9R<D)J;K!"!@
M#O;%O^PP_T-0B!:SZA8=2589'_0Z],5QD1>_6?64^B]A?GQ85O6:ED\"1V&Z
M^+ZI<3%IV%SUUWVV%YE;CB4E1%+L9A/T.\'*Z5M)XR^NH+T$U")RA):PZLZ
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M;63;@&SBG>5MBFZHY#>@-SR<2 C=RV]\>MF5\W%>.]+>E%Q^Q9G!ZN/>DHM
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M^>M]DR-\>Q;CUQM/H@ZPT7KAY-%!*#]I"!)5=^TQ$Y6<N5I"W%'WVF^UH[+
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MQ9&-V4^5E_N:0D@'<K-, .4 ZJ<@-1593#!$%LL>V&V!&N!"B=JW5H)45#E
M0E[90Y-!.).I(SLC8^N/(S=HZR);E\#7(-4#98!8F9\%L'[\^_&EJ'#.?D-X
M9\]Q'F);Q;PQ8KXE.,FUW@Y!F6<5%S0RIF?!Q??F17\K[OHUZ-E(IFYO#,*/
MNRZ)\.JSNV$ R;!"66QJ),6FP='7ZNKA)99%EX5F\835M$./=3?=A@Z?^$OG
M>[@5N["NG*S^M)]B7Q 5-D0,'KLE7QIP5#2[V+A?&J6W RH4/2I.+ TF;L+E
M0.3EP7"4(!SP&&/C)*92P'ZY-?I8K.!JZS D6X<]JCOS2>?"8*+.0@+SB*Z[
M,@*K'2H@I4!+?_2^L)&L=Q"BILC5\-9UA /119D'76-EY00GSKZYFQLMY6#?
M\!"B%GD(!^_<S86*[CANO?7&5=7AZ.+&74"940-?E=-5D8N]$B'HU-ZZ3QW=
M8O32(/'4X$H>,EYRS_&LV:+;W\MBEXC.X;!M+,M4_1C^ :+ RA3ZEWELXZ%_
M$C4"G/AG^29!%6^10RJR>#!!%040WS],-:2B)HNIQ*Z:($R;P5GV;>,5>_+I
M^-7#[H:#JT(#N47=:Q"IC>E!8%%%(.$VQJMD02-#_^HJDVF>2D9K(M7#&,*-
M.NI@- 'PY]+ VQ-RPG7OF;"<_;86ZL)XGLNVJLYU]NU+W'\\R8->[=JO*F;N
MR+-]%PV6&HOI^]$O\X+Y:>'0X+C8@H;.HF:MP,/0B,5;C?Q=^HW!5 8GA91^
MU,B$D>Z/S5JT#3"UDA#)H>?LF0H/ VS:NKP"N(>1')*]L1S'Y<(/,<ZJ8.?X
MDL-*O0LY#F@:Z79"B02M[6Z<KN;!DN/U@'4B=>^@6NU;*-7*X@#QUP6ZB4;S
MSZQ@%W&80.LL64AA G=<*-AU4PW::E]*6XH)QJ</%VK6U:DW5.7T@5>H>E,"
M..*##%%Q=^M#(J2GC(^#[ T0LGJLKL)6*!/GI S>6$W%Y"VG_:T4,N5\5B7V
M:6$^+LZ ]5*N#'"=%&D;P]Z\66*@5_U/C,">4"_(Y>39-ZWN[Q_:7F$D0A3<
M,E,A,%4.M+]"#0P8!UARU4<\2,A#D# -JC-4:K5M %+KCX"D97&=4MB\XM6E
M7^U?/4O'-&&EJO[;1VO:IUI$9*7?C=5\6()E1(2?H04[9>X9RX&)\UPXSL*_
M89J.+C>9D8C44,6BI3\6?SIMW)([9?Z:W<*X?<RVTG&,O:66.B;,^N'4PT*Q
M\\?4A"4$T];M.H(,Z,+D33ZZ7Y%E,=]\%I'%YJ>.:C2BOW@-SQ:3;U7]>+\_
MO9--H^M 2YBXS\W<<?+ @%SM.*D#;;;6%=:G],2+R:K+Y9/HNV4CD<-?9IN$
MW-B=?C[-P],V/)C.#_7C.MX5^&3J:$WJJ>Y!W2,;8U050DM7XD7HUI6\*O+@
MW/ E_CN.#S.K=3QS&R'=@]7X%>P(X2!F]#+A/,9;-4\A/ZAU#>R4<AU<9V7W
M'U@9>O/G/4""?'21C:UXC+\Q"B2M/^14JET:^WB_ZBH9\#1.D")3W!/$ZRQK
MB3$?F=OKO<U.55XDR>U RF7:BR:=G].TZ]?27DWTNP+RN!)#4E"LP-[&G(97
M-3L6F\IQDZ)=GT11-I4J7 ZV<D0@8B:P^B5Q/O4BR8E$OD,@/4S-O5:KT8\:
MO\ >Y/)R7"W?YVDYXTSA!ST9#UC]*\&G+,Y@DI+[ZR'R78S^1O#X[\F9V<.T
MY8\9YXZ*RLL058TB P+N06:$6?/VR[4D,])=TLW:>[?-VZI@:)#:D"2I]>.W
M84?R##.D7\H3?31Q\KF=^9;HE(53I#-C-THL"XK:A-^71Y%3Y1(\Y67DX)T2
M.RSVC;I#+GFNGUF Z'E:*(='NW129K>;IR.NQARJY8=X^Y&HI-;-DBIB]59&
MQF=%\7$#S_EW7A$PI/8W>+;P5R$2WI]Q,;-VX*L/# ;V3L]E(3%"(1B8[- -
MG@M.O$Z6YD1F!ET=HML**Q10[<TM^_,^HA*I <CQ$J;0F_CV4K.ILG($RZ/+
MR= S*N/- BD^MP$"98'NIX^HV!I_.Q/*LZ6MR) D#7!G#FY'=</IL90EQ_4\
MBY6<2Y3LFJ@6R587'&>-Z4.I5> 1]0:U#3X9?O1<8RFXLV9<=67VI_G#?<TD
MS]OCTD=YL=_O8JLCCR?O)M$(:+QHYU;IX.Q^J6\@=ESVBUPA.%QR[+:8-G=Y
MY(Z+7E1JM0[$[$OZ]@;Z+QVHW$F1PJ/^G :1K&L0PU!@BWF/PU4N:K^T\M\=
MHMM#AS\<[#T+J&-$A5Y4\)Q3QN2FP025<PYU!17MT?[9GB' WY KKQE@ZDC;
MR,%;P/)I^QX&"K!G ^;+$J*@9(G^V?8S2NJZ*]I;RR<.&X<*(=T<XS+D4_=B
M+H*SULT=B,YSS%,6&<XP99#-2(:CARWI]#U?;?%F;7IFA,*7IWZI2J_GR=PW
M]:IX*D6$4VF13+FM?SAEXU_TJ%A4MU\WKK+?\PIG^)-=1@^R>=I,C9L^&C=+
M4((ETL28@Y8IVHG!K.Z=WH<G$0T]9(%ZR8^BK"#[,ABC@5QX$NHE2]$*OG=F
M5P<?U[%SKNB82+W)YU02*^Q+8-L9'3M]I_5;(]>L>#[&>*EM+GJA)5U8,WQ@
M@=.MTJR!$H$O)M3;O;7RNI5?>(HY:.U! %I9!JF"V2,2C2>-!?'^3J6[+_39
M;08-1+A>50YNYA#:D!H/MU:QX(KKVS_%R#+>EC1[QB=T".-/]RR71K(V-(;=
M%9L),3W<?%F@7NCXPN&*-GI5ZP%ACVB_]70W8U*.^>C:6&4/OLQ3]1=XO14R
MH_JVXS!* S'A=*>FB/E#+B4.A?V?1=DYFN%WQQ9\-'U351CQ?L(J N<WFV39
M+&"LF]"UZ+NK'E2)5&;-5;'VSB(B7/=EEY#=U.='UD&$\VT+C9B[D?T'*G?-
M.G*$!3H)M)^^I".7F)'Z)>]!%A7;]?J*%/KK^>$8\E#,<C/6*831Q@';K3N)
MJRP:P8U'><"N0#? 71+3KO]1\:,6WS2@K_F[9NTRDV1CI]G-?H]YP9$%Z @[
M8[=/H4@HV$=- R.T'EOZ**K8GF1]T8/=0\K=B']Z1A'];">0>LM#(G&T>KPV
M+L)28LPU'5XBD@BN5F+\W4 XIZD@KG&E/\(-\QSA)<\><\GA,:Z9WWWSO=8(
M,4'T;%RU/-I!VYO?1GML.3UJL4:1;DD2Q&\,*P\226_W9,VE<U6QR:-3'=K)
M$9T4(\LMC_ P@U+UQ4_?SU<B]OPBM4[FS@RG)1,MX_#P[4]+3V<LX%H+58A7
MRS?A?=U$0O#9H_]ICKY_>*N\L:[]./%ZF%+LF;]C2]2;D]-H<-\UR"_'@'OB
M8R-<5G7ICD/0VSHON0386NZNK]+L\'+EL/ [7R?I%+>AQJ<J"T4&<EM41E3F
M]X1<.@J%CHD32?HFF#^4J?$2+NK5"F 2\[W<4_.??__V>5VW_)L-;*%DU@?6
MB/"/ OA1S+>PR#-@\LQ?0KDH[# @9O<S!E0>MB.I.0E>1(;FQD,CMIS4IW;K
M+L)R*_2-]V-PKT&]CEQ'5I.?G"GVLLQ2+C RUD?I?1']KH*3T1UK^;:12 Y_
M\+<A&.A/&^#@#EE)$0)=#,%L'>2RL8'QOR/[OP(<)QL;HMY/E8T]](]VF&5=
MT8%R3^.%G>Z\9&NW_!4[6\./@&4/:4&9/3'A@2]]XW4*O]^>\:A=SJ])$WP_
MMOS\RXSEY(-1MH,A[JHD9>""(<5LR>FP2]A]VJ@>LC83(_I,>DU^<;D% DG\
M-.Q5N?$MF=6/5YY?C$XA.]O$WPKB] T^A[1T!'B&<WTJ\*Y.4%*Z;+&Y!DFE
M'.1_+3<4""RW&/@@,X]I<7;J/ ![A4^15?U@]7'B"SMVMK#3+$CPICHW:<CI
M.#BR.-4*MBX\@_U;0G.:-M,I3:X!ZZ5!9:CR6;.-X\-YI9EU!6RZ(NX1R5I>
MH%1AM =*3W(H4+[<W,0A!D!@W2?H]LSE3F);#GBF:X>MA$J!SJO*$\9U]T*%
M\CUE'-#"GXU&B67*$$B@A]36(QK29G6&/]S=Z_<9Y9*V&0]E6?!H# ^]I; R
M*;U%.)J0]T-X>Z\VU896?_4-7WF!"LE#(] O-6L]2<4U"@P80F\B5,6T;63+
M!OE+HU%$_NB[(^)UY$/:<8LRGQ=J4S\EO+!;;,Q]W#;Z!(4,76<;.<<'NQ$$
M'@(NQ7@B[EJ1N14[ X;G0[3>WE4\KHIXA 3.[*&FG50S^O)3PA5UBM)=J;+/
M=+Y_.2X,X>8F[7(TMZ]K=*1*=8Y\[.>5PE:7QD3Y8P37PE"!"S_;8$< AA\4
M@K509]$AJ!@Z,V)3ZRBTN]S?_A344R93RO@2RQH3&R,S\3B9O^,6M\^II@4[
MXTC]-BR,[M;*_#?=NZ;>0OY6V!]LY7I-H_53S6[WA< FFG<O5[*H/#JR2Z?T
MZD=,.S"873:['KO>U@QA.M#K0^^2"$QA!@D0."O,*_D(<A=_68?!7^;,3/2T
M?.;<U#UZ\Z.@<G  J/4-3,V&OHC^@!+PWLTMHZIT%)->U%V/]^\&BE.A.J4<
M'^8KN:,?2B?<4;M*%R&;E3$[!@/6 2+^87ASK*B5RK0@7QIJ:]\/^G>;C;63
MUZ_6@V#L0:A./'JT$AV, -DA,' 1]8BBA+*LT^0OAQ4,LT,SS7$,Z5(OR:NQ
MCU^URIO+46+M/ST17I^'^]!C\4\JY9_Z;3M7+W^9EFW#*G&DIT_\?OR.G,E"
MSC0KK"9L>">2S^7->,&/@11BGD(?ILHR"G+G,$<UW>]Y1M4S?E3.<@*9W(.6
M5JR-39%A5&W%)XV/*$XX):$XQ@VT5@^S?Y>8_M[QXC!:4ZXLGLL&^>$FNG%)
M/NT6QWU?8_WC!YE5?M'T'9.OS(4ESY&5PE'FO/S>,L;%WI_"1=A4>#4IND2P
M!K;Z%,FB+*-U7=:<[,S'# SF_7![8M >DEHHA+742,M0L"QGOX[468G==>$4
M-(^7' OEK7X"80J7#83&E"DUP&/Y?]=$Z>74<+-Y!=QQ!FJ?0ZS"M3LY>[1;
M*M-Y"^4^VC$?-==[L(KMW<+&5S^OLC4[=,UDEK*4&NR93?=H?XY+P8[4G\WP
MO+\[4FZ8C!YB^NO=D_T:XKATV'2M]2<*+_3B$3<)LH%R]W/)JMH:&A6)%S;M
M*[47SYVI7CI%T)"P<V'[K0II*S:]F%M:17A*L[S[/K+]:A_CE8ZK0Q(56^2^
M<-8=(Z:'^/8A5&4$>'*?AG>25K*\"]E*-U/J8$_S\/*Z&@S='C^FQJ<N'6=:
M./JAUT0=I:'SCMN1/#,P8I'E5O:!7K-9X?=5WD1U&U-+8MT-'1HBDAZ>LK=?
M?NF<OE=+/M,_'I7'MX/F=2+7#';5A^5==E487QWU"^S!9"@50;V\8V6G#Y0;
M@AWX7H3-S* 5I_#LGK9YXP=/ZSRKR9&)&!8_2MNZW6^ZY]D9NQYW.[U\CA]:
ML"#[O<S$7X%>R!KF7_>![%6%/-47IKK@O+CR&=NTU'-2W:ZGQS$4O1.4NNF/
MZ0FU#G.O:B0L:.Z1U>Z0Q; E:."2J(=T?=1@W9>G[:>^EU-B3M 4.ZOFS%(Z
M1RC@> ^\3F%05=9?\*ULW> 5,[S?VMPD*)PI.E2*:F S[LWX#A[U (\>CG%+
M.=8UZ$VT]4^/43+]Y&TKN3;A3=W 1LG)6C?QG]B3]Y4:N+_0VI;,GCIK-XYU
M'?L0P$8RY]9@N&\__X2NDG9Y7\G3.WU--+%[SEE80O?@[=;3AB'MI&]OQ9@:
M @D."C&<FPD\,AE&\T:W$&&N!\3=3H0#,X?7(&+*"4_'4/(T]T3SPH2N\$L6
MCBUN3*)>;N\N5G@CH:(<V>O2_B^49.OS8^$)9AO2T!?V_7YX\C%>'+]'JD/*
MR$AL1[X 6$ZOWEUN'$MHG9[$7 Z92Q0$]AQ:_#*H-(J9_OO7'S@ONY1#/N)6
M%%QX.4N>A&<(EH6WKDB!#(JUC1PYM5"]_RD1#<O!][#HPZ=$2VT,R7-(OT:0
M(B9(04UK2E4)#/JLP.<0'J(" R4(=8PE"&6OO,8E4G4QY_32QC"""]]+YMCO
M BG !'7.K&-X4%V>:LM0C>#7S#.*&PF6<,N<".*P6PF2(TU8G A9,N6!G*^G
MG=>@SJ*KI)78:U 15LN];IE]G 2@.J8X#ZVPN'TH[41;/K%WHD',2?S)[QA^
MZE#Z@ ]\,;IEQO+JP/PH+#9 V]^W0G=W/\]8G56)Q=W<F2W#JW:=J5M9>G1T
M?9:YYL,PN42P_B-:='-I]EF[RC<I3.(:QE=C8_BF]VD:#:3H*_.3\5@*[*5K
MOCG!FF$=.Y$9)48?%37*YT]"'W$@Z#3K(G22PXNFSR@FY5-==)V_FELP$INK
MT7ABC =FB]%3ZUPE=5KXVFDGU0\XF?+%5_:_BW=<(HX,FYJ,YZ\GT2"FI>B1
MUWAD->!38;H'VV!YKZ=<WM%>K)C!3Y_4^\V@;T# J7RWI&JB-]NK0@(\'?<S
MS(&"9R?^O&]EZ.P)%K#Y)_@1L^W[Q&J_NQ/V7OZ32>"=&1.9O27]K5TE^.3T
MM&7 +O7!N,#@X0Z,0'R>[Z@IS<;F Q\WMUK5;P/HLM<2)UM*VSZ5\<HS%W>M
MP9UX&5)-VKE:1V-[1TBE72?YY+?QESR$S%T:\*F-8*3)<P6W]SYLQ3[O#4<.
MO[8<QZ5H64$<8)^:BJ:^L'9*F]YU<84BW!@XV4(+$$F7WTJA7DO0CM&:S88C
MDB^,RD.-^K-!W/WN[K31.'>#^MW%H]X,;FB!>]LH,_)PO9[DQ\T8F4M=@\(S
M#38_-N^A/= 1O!SL;IKAFU6S(!07O:+G?F-'_^3=U5!YI(!827Q;2.&CGVV-
MC:W@<@_#F!HW??CS)<88FE#/3US12D@F8DZ9>X[% ]\&TDU$3_>.W4P0'ID$
MD2P)TB\-^#Z8J5&&]UF=&KCF&.8G()H/:BDKY(WZ9[$.AR-KN-?O*[DNB#WE
M(L3I=C3S&C9M2GQGD<P_3&;0\4"-KT&$""-=]VC&V6!8F.E#]W?B]2#32;C7
M0K\&6]_>8<3SH_MXST7[K4X#=.V*OQ=4=KY0)G-7;1WU!,<O>'($^5&O).\K
M'R5(N* O"N>J1X@FUV3P+^SAFK1+*SU+UV^-X).IJG[+:S/_A:K,?MNZJ>4=
M9.!AF9LT9]/O%]G%!:&.4BNJRR)'SZY![0PXWWDC1_OY1 ^S"'$^/!!8%=;2
M_;(;R1483B:)=UDR'P3F3=9;5_U6TKEB.>8<,(WL7?TZD]5>\VG&:8%.A_*.
M&W^\4V;TV/).0/?0!XG*= ,#@JCH*"&,.VQ6_7JI+<C9NJ>%I&2UF2*/*##*
M](>>>:K1)) M.H>>[Y30,XU4/.-%OI0U)<[D%M0<%=9X[K8QM+A;&.S-5< ;
M^9/X!R*SY'=5QT&040V\7()WLH=S>K'%=J7%^$'EDEY-5QY<R+8I87#9"LJO
M:-__J-^A3",&+[#WA?B1I1+9LCG9-2AVVG.C3T#AU<Z]1>FZ>Z>@([BG2K5M
MQG(%PJ5J2K53HK!? [AG3Y;0H2*W[P>RAV2E+#&0FSX9PK^"T>Y(#A?]1B4;
M#S@T8-)I3Q;+P>$U,D065QG\1-<X'4L!1-6;_^1Q<;..K_5KYMYL6,)7,'#'
MU$]5]*I2*9GC%I#P4O[JHBDV"T[Y:J$*"O=D?#;R&U-Q#5O5R5T\"V<Y4PBH
MWMD:CC'RG7+V"J]!$0WE_C$[)5/P4J+XSG6=U>Q3[BM)?FA(#UY27<])J,K<
MF%6!"]<]:FG&T-1=&N$V/6GWD1SAKT7##KA8&81$N]#A;B<8LJ9$X4.$L1X&
MQR]CBRDO2U2MWK"*0_>A!*-&Z'@!=CIE]'.JUN+@1Z#XD\9M:+GZUS,DQ-ZM
M!,_^B4_SHKKPJJH\'W?=GB+BN6>!M1C:ZEA]J$Y)O;MY-ZG\\EZ"YL,W4Y]S
MXTSK6*Q3A+<\) OJ(8H.@JKS5O9Y_53YC*@V&Q-UUO U>3B:+-42TC9NT9S!
M6SA#(XHS[\?,J3_Y<\9XF] N@X0./[GI61\JR0,-Y!=Q_#<DA-SQOGS&WIW]
MK_ULF^VT8'Z9'XN^DM9 -S4&GV5]<>D<TPQQ>U'3(1'3[,:=$9>7C$7XH^NY
M#Z3J50@=II-.<.2+R/71YG>S]\;X<IN5+5D?>W:9[HY.;5 _;5>?>HM=9GF*
M^.H8:FB#K/"QRN3E^^6L"UN!>(FG#S_E)3^?4A_9&7M6G9?Q6G=5X\75>E[=
M+#@3TV)W(.VYJ[?4:'N8IQ0!Z\]W?&452W7!P[<+0*%%ST-SG_$\D-F-_D)W
M^C6T]"=&]ANS0.]T_8CZ^L9!VV37X(Z[^G;!*X0I:M.V!9#:N)"*#0IVW;A7
M*X8G'EB-OWTU*L+TGUBKF-=T;.*M.KJ'_"BI8J<G 'FICK;E128FB&U30!K>
MFV@_M0YM)#6^NC_"7CEQ=_X]LN$GT:W&/!X)V,1>WJSI4%5D](AH=4<&Q:%:
M@R<!B96+VV=W6,>0L&CUU-F(4GV\:Y Q/8VM^/-AFS!:W69A._3I[SR%I9_C
MT1"V4--2^$ORJB*SM.=XQ0F?RZ--C*Y!\[1/6V1:]$I-?I+_E/,[]JKU:?O,
MZ)0=[[NR.]72VXGP+7J7PN\&@4AN>9\C%^*T+,KXG*;AE8MZ?N\4&(72RKY1
M;CS)<BUR5_ZY,;5N^/VQ!W*&/F0NY@Q[W+P QS0E&/M"+=0+31'SU2SSHMWX
MW">,!YXTQ<Z\_AS[X\@&+>UPS_]-_) !JWTV9MX"U#B1+]<5=GOAM5CV8;$)
M5%'_YE^$ 6'-KR_B^Q;+-XZVG:_DD)?</6>_U>&U&\?W+7 .TL+.\>[V89M3
MM]"T>6N)I(1+0@]2N K$+K@'7Y%X.VS-'EHO1-[W9.VW^8!A \Z1UMU4_Q%/
M(WR_@K'WW)Z[)*X;(=<O(ZDC^'P%[IMD>.LS^H83./U=8KP!N=+G<M)N)'.A
MCF]Y\34($C;+9AOG<RB\XC=;<EGAY=J>T^4WH4IA%Q33.6-$I?]E.01F]J8_
M?22M?2'5@%VLPDOH#'*@J=&BP Q3]>+H<B"7IX$^OMQ(>C%2'8B#WF)BP"I!
M42JL/VSE,PS7Y76.BOSN%<+:4/P:5,\L].95TTL#GL+\%\4?7[XO&&415&U5
M'PT=RU<3J<+;S^0*$I,-><U!.;<8IS:1?5R^N+U*GH(G0)3A.(8H,MWHHLQH
M\M-CZZ!=B'9][:K+Q>%:VO\N$#QM^"A6A2$5VUW+F6):,GM[,N1#J28.39BK
M:IM1T*1T4D)'6;\^8[[]C%E%1 7S.PDJ+5T3$HN?/IXV=7'XE0_D(\=Y?FZ2
M*[=Z?9TV4'!8$'[I2G9H=>R/'/TJSG=.YU(.$_:0,EY\W)AD+@B&_+9N*-.\
M3.C4N$N3S-Q6DA+ I/MB=TJ1>68T^0/DO1/66<1&=SK'IQSQ=8J*(^^FIF@7
M,6-A#>T-UQ[20 )(Y.T8]4$0H06=4R,8TJ,#?_J>0*&4 6<,P3-9<YZ^\- 1
M^IK!BY/)KK:9%$X;@LQ'D%GI% ^+OX\R/Y%7>-/Y1%MTH;I:0]]?[DFFSS='
M;%<C5Y]H3NM;*V1N4HXTWTEV@G)J([3OMW6YO!19MFF=+*$2GU[PAV2(K>0&
MS_,BC%27H$&*+'R:*@A1FWCNT0(\Q9[W.MYQB"(G 8O.=S')52J6;0\C=<B^
M:_)K$71SD8'5"H><-$?RALOQLC^3\9PW39OY5]%"^Z?B?3<U*8G/?!82"TL2
MBYO(7QPIC4SXA@3IJ06":'%QH][+]K1P1175'97-XU%J&M H2("M:Q@9X66\
MZ&5DZ5%6#3::UZ"8M=;9"NLJX,;G&C1#MMCH?1&H<'7TDB[K_"VJ8WZQ3FEX
M&9&CY(=YSV__>XY<G*("+QA?'2K :9^-T0L'5UN_)@5;IX"U;^GP+V2H!U (
MH>%((FW3FEA0/UO9*ZZDP4A_:6-VK2OZYM'R@IZLH/X[F (&H/[^TEF(?XVO
M0]S%QWE[(>AN#[A[78N.,^K/_VH#ETC9D<U(F:-;0,G-?,6JX\_];?$:I%.S
M9452>6#X,R(^D "73''^I)".HZ]"TK;%5\$M$_<T.D1M[Q$_U]2T(FZ%&[>B
M$P&-*>M0>QW"]74.CVHDC-&[EJ6+$6,\0QRG:?K08>1CI?7"CV?.K,',#8X8
M^#N,YFKTB??237L%=D9'?-QE#TS-IB\0OFVE=BQQCN]?K/UXPQL3_E"E;<H\
M4(2EP0L[<EQWH1\"(A^Z/S4X-\Y,./@-K;?L0Z5!@VA4A _D*._9-L)C $E
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M0X<LPN:IS:7U<O;4JH4Z18V]D,49197F6GDB*EKE%6^6? ")BL5+-GMC7T$
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M,B+C\UG2;\9" 1-PWJ%#$J+"9JG/!2F%/S49+(.NV'$48$BG@3G(7 K7L-$
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MG)?AJ7E$2*]M6Q8=!J*Q-^T&7LT]-_\\!)(,Y=]ESBUWV&_DBS>)\8$0D6<
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M7<]=)8J"ASVI0J\G,HN%<4(>VH]"2Y &6D:VY8*0*1U28T5F64JLP?QJ1QV
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MFX+VVI4Z@I06Q=7C!Q'7?KGO*JY8L16=BX2(M,?38+E\P V*=HN:5?N22S9
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M,O@"KQR.N6"8#D4HTJF+@ATJ)2\DY;UE'.1[]SUI7DYI5I8,L<<VO74W;K>
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M=^[ '<3(-9M!O',)/#2G[7KWDFS01*Q.==95(ZTPW^X89[->\%? $# NW=;
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MNE3FD9'BP?3: )9 )6ND9@S8\*MJ:,NQV8[-Y5#,-PX[96H7.Q0KWW_('<N
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MD"2X5QU\&@R- M@8_,+0",1&BY)+,5D@Z@";:>!:1]</W-7U79K?ZYJ@Y/Q
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MD]9KS;L><0SH#XB.&AU]_V7=&Z/+X'SO(\E(G]V63L9MP;I=J(34?7!-4PV
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M=J!9%$J!N1+KKED$ 7#D79!^K/$B23AQD?8,+6NG^#$.:><,R+F)G7)Z.10
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M<,RS.8LK*VF7M>*3K:VL'>HX\*E:62T/3],WPJG9+WN,",SE/(!BI#AM8QJ
M@" $/++#.?U04(I70XNX7Z"?":+@)=531UD_6?NH$.C.V<))5/A68&)>[7Q3
M[</;UNG37?Y4#U+F4"E"B(*D-=D U[_!! 6K(."?^L;*?Y0_9,EE_B8^%/]]
MA4<J(.J?^L9_E3^0JJ37R_7^)D'\\[A41P$9 F##Y2)"HE$1'1#E7@7-Z'["
M0<G93&')8U=E_42PGC;Z\N=[.&=)6-(2W*.;;]YN\NH/@)N)BW.96T(/>:QK
M\XT7PPO4M8X*XGI0!=-8+O6N<'7L^GR,8P#I!U2H]^,ML[(M78-]*<C"#[*G
MG;RFVMCZD_>#907*O$%/K.C0N"8*>$]*'/K#A/8YF'[U9L"E\V"3MH-N;LL/
MLNYG1:G#?:)R9[D:*B'1H6:R<#.&)#\#+6>"Q4>4C7J#D.,BQ.K$9CH5@G<0
M!XW+OZ"Z(?;,V?:U:V]*=])VUA %WKU4NZ%2*'W==$_L*7QE&;=0?&Z&6<R#
M. RE.< HQ1@\!4I7<W3@XYKLS8<!DVD)_ P/QW8=BP6-<"]KGY"IQ.Q@[O;;
M< #D(C[K1"$]%U16_L#XENVJ3I"T_0_@8Z>2IRW(RWD3NV=4Q7Z3RT@^1G?R
M='G4DS W.8 "<$VR*  @PZ!N5,7X+L^[[B%@SL-PER3(ZJTP@Y_%\$-@PC"6
M:Y.2I'[F_V+M+:/B?+HOT<8AN+L$=X([:4)PAV"-!H?&70.! ,$=$IS@TGCC
M#2&X>^/N[A(@9/B],W/O.S/_>^^Z:[T?SN>JIZJ><_:NM6L?;IZ86K6??"\S
MU:]C]!]$0&$7$[#6V=9+/I*B:[U ^]I9>WP6EO0+P4V-7^M B@E6EZDYK=)I
MIU\@;D73@'#XMBT%=8#LKKPUI]ZNL-+Z$)CS\=?V335G0T2/=RO'847I2900
M"_G)!PG-/_E5=GZJTR,CR/D^ @@GB2(YQ*GJR)84>A[1."OJQ+E%_8)%7S X
MG/[,;TU';;8KDN1+GG2I&CO^B%5F3\O#E;/D8V5WL=,)=@OK<YUJ3^KN!95.
M6'U1L4RQQ C37=D4YY*:^Y"IP4UC^LT&"O"GHW3#Z(>Y>]-P-4;TO)T?)=D[
MOAFU!S56;"H_!HJK?/MYF%=O0YQ8:$>:X=WS+B.[/VO)QV$"K>J'J,O(&AO5
M*RP%IM]JM'."B9NJAH^D<G97Z4Y$<\1%!Y_89\@%?6X(=TC&4W-F$&;&-VU"
M39.5,6"S[J 'G9F[M#.!BV_GK@US64I3U3'%S5?!W\UW @^ASTU5M+A(*/ %
MD&,+S?<\7! N&1:]BS[6R:CE_&&2Z2$N55IEOIJP'B8O7$+*\8REE6NWE-&Z
M$I?8"#0TQ8^"T\D##Y;D"?"_K0][NS+*4!JKB$4<..K;D5IPG_Q!NPRVT150
M;@,UG#NY$0]!NRUMG,_U:-(&4EOG^V58Y]Q)\Y/M$9.&W^17&[0_>I5GO;J*
M93!J;PG?4H$U7R5*=^M9G#]];6C94O_^/ML6J?KMZV$J7) TU.VQ;QQT]9;B
M/FW_/D22A#*^GN,O@+P\XU-9Z<*J4()SQ[R!-ZIVE@9:*2:E^]O%1M3T>AW*
M;)!F1;\-$<J6I"5U171\S]W$O=OZ[]P#,'>OR7TIPQR4BU^_*<KB4IGD$A<"
M\#/NEG6(E?A"(CM  XW?^!,8\/X.5>!RBF11'N)RL70?VH?A&^CL\S&._@.S
M']PDHL+H7KO;+\1(_3GE$H]R*E@R&\1V62[-,9?A[^#1M8T#W1)ZR"DHDJ#(
M. S9%*T!T8'E-3O@-Z-^\"75-J$+I<PLZV!))<%(WVBR4^D2Q5JQ-UC^N^V-
MPSW"JP1M.7-:S8] 4<">Q-3!@WSDS4%1I^K[?J?15H'Q%["(6$[H 4D\RG":
M]9"2?@(/0?\""%8ZJAWSBM:2UC^N21ZNA0L^+M$2<,<S]2\FCJ]1O=1-601T
M)*H,S__B79FBLB+PWQU, .4-6ZH@USSD?[5FA!K]Z^)F C7LWRYYL/M'I8U7
M[&8TD(3VXI5\_A&<%&J78?0";)9-008M:8<;YDBU@HP48="9MW9-B9;Q+<0]
M/AGPQ:L/W[=;5Z/XMT.-.B,\_9M/;S!MO9F^O2-6W+=%FBV:;>C/DINS-7SK
M+A@(W+)=C^/HRSL_Z>D@3]9]U,9,34E8:M,KN)=Z\,_%[6?J]HUKMPX6M&YM
M;$ YM<(G?))+6ZBLFAB)IYK?\Q+3R[&?,+I/[QLM_E-AB=["CFVSK!BX$>@7
MR,<6&?9CW/0?R'WZ,24]2H>7!XT:Q0+<P3E]S:JYJ".^Y.BVB#3^%X#.M#TY
MWFJ\O2<X<@C2NVT*SVMK23@S^-D7N(\T][QF>8MO3Z!2V_-3Z-*GS"RG6TN]
MP;!!*^R9CF.4J:YY]D99%8&%P_8U<E5@>:#]6!"RG3)QT=K#=).3+5+G,WRZ
M*//X+\ .N+[E9.][QGD\XSN%3#8P6,T).Q\=;8S J>,>7Z0.S<WXT=G:?H&]
MDMTZI U W7LYI%'VBP[E-J2VFGY7NI SKK,\OL61.KKU!/ @X_F?'AJ^"&7E
M<#P)7\MQ;>W \KM??,N+70P"*NKD8ZQ(T^%E)='QC"NODQ];*H:;G/02P%UT
M:=[0G'.EOOV.=?<IF/K/5LA84<%IBQ:YR. 9$,]G"90IWW!Y/+9@F 77"WDR
M\"\SPE3>X<G=+#?%KZ(T[% E5*4]*+3QJ?P+0+*OM17N5IHM6/J$@^J7 ;@Y
MB<(@&_O'08B2S!)/T2>2;;]PML3M-NXB]WO*UF*[VNG8\YI^ECW3L,3W.(?S
M @&$@X>U: <!DEBG0LW.SV<@K\54R$J[6S^KE-D Z'*-5!]TF*:K^5UJDGUK
M3WNJ@0M24G-A'>N(U3]T&;XS"O#CR71@UN_^S':2D5]U=.NG$Q/CA*?2V9T#
MCKQ@+F+.W?1NCG,BC0V&N]V;[_6 )$^+! ?'3H:$/?)PYKH>#@\GAAE/D6QV
MT& >4Y*MB51)@-$)Z_9T]<:,Z?>D+@HZCG%4<3=%W+4L7V\"N<4Q<(?0OOV<
M0"M!07!]HJ]_(0L&,=@^(2;#&26;V>\<"7]=+I>,,IKAB,^1YM_+.8(F!9<J
MZF+I5A&<4A ."(U!BSUURT/EX@1V']NA,_3,Y"0*CPG@8<.33TQSI&JD3'D1
MH:'P3'_BEVK-G#;&4?=^S?V%;ATXEA[DQU8OIJJKMI2+[44)G.$R8KCI?,GU
MR+CZUO[66RC,NQ0V31DFBB9(4E'2""NP._!\S<_\QAU(4^\,L8NW34?4WS)
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MX:\YE;^  ![[&]&JXW7V>@DP0^"JJ* 8PLZN"M_M*,!W/*1!,%XKYWESLH
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MGO.&*$(=*@1Q,#=EO2&KX,AR5P:2-XH1A^>V'9^'K< KBV+;'0PL #E0ZRA
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MW\S)M/.^5>1&4R2!\;5TDM[[/_IUT<LMT3=*Y^&@WDG7SSQ]+%QR_H@>J0B
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M\GYD".:N>)?^2LH>D!/S68/-:B?.EC(WRQ5(Z(0$8WC33TP)Z#Y0-5W%RCL
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M'!Y$;W(EH-'&*H!Z,B>_!J>N(O _U@YPX@VY<(YYQLGWDBD[%\XDFN6-I^9
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M9XXRFBVUQ7WSK?K:5YV-XZ)LSKXYIQ5*6WAJ,&B-?5<3C -(Z+'DCEC?5F[
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MI8:BANJB2E%L-WP#*[K50A^*WIHR0P6XB/F*"AXNNYNKCR59NO H;R7OV:N
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M\ _ *$>FVFKJI._W1P'"]J%GU50)2I 4TDPSU5=*_>LBU=93[SN_O2.FRU,
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M+?S&G6B+ZJ<?#)YK!_E"7Y@A<7$#^@9,%TYS$EP+;G.N-N5KTZLK 6Y/%)-
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M=DD&%"LZ_R"HBIP[\ID+C8*C5I<'(3  ^&.V5:TZ2$EK.M%N2^4Z7D!=ZS9
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M@,A8:\D;87/O<H\J11+>,3$XH#@"[$0._@:-["M?@R7WT%Y/PV/NSGY3 C=
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MG5\=K[11&'/]'R*"4 R(6D0Y=B%0)@9#WG1\[:ZU(IIG2X\.7ZJ'B_#;89&
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MK0!8!HW4ZK'MH?FY A38Z6:6<1>.I4O&PWBK3Z2\*R%7N__&3PV)0J&$6S%
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M3YT93_W>DP>O@4L!,YA@ HD\K*HE%,,_+PM?(/!5QZU)J[G2%X8N7C_=FQR
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MM^N?/@5ZI]6EZ[!VOK WK]VHOBRE K DK$# EFL0'E-]S(P_?A_-*57%Y6<
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M-(;-K+N)L_0<EAM=D08(CA5> ]Y]5SVR%P]]T7[4%S (8T"D@)<#?RLDW,Q
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MBJ[#C7]F*I>_O$ K]>0]0@MNR/6;2$703>8)B1N8+37CC"M^#]W *(@<^2M
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M!+U2?=0F]@LJC!EGXA(Z'SVJ=N ,I!=0N>6 :UKCH.IYW#+$\WYD0Y]MK=$
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M9]D0-:&G7=L*A,!O#1X6(.Z^$BH]R_$C/]O4G*1_TVI(>8LP..ZHZ%85C?3
M-C;_/A&MT@75Z S?2JH/RWUW&IO/=J& )4*P7RD8=_MY\%JPFJ>'[BPUB_B'
MO!DBNSB\L7I:"3B4E$)-'97YK'!BGX*YG+68S/3$AW--OH[+/HB$X<?^&[B/
M\%E:Z/EHQN.A\_?G"Q"W4HS^P&KYNON%H*[H":P@T96DA1>WLE#I_8Q9;C@
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M&H ?.C8P>MO(VEMG\169A>*>T8MUIK%1.US@$/8[*CJ4[FP6I.IP(*S;30Z
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M;I3\,:&?!O);GL\WCS2A:[L:]O.$)*"AS"):"/,S.I87C%57%8@6N:RIN"C
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M"\E/RU<S9MJ44XA6Q#8V0@7B8C>I3\Q[3MCW$6?[E^#:3_>^9L.D9%=5SS>
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M_B.^W8\S.*!_M_O^[X"&R(CTV5/!G \DGXGN_Z5H7:4L?](V6EI< 5V0*[[
M:(DCF%4NVZM&EW^R-"+8?6.?*@(T5)DS7]2=2$G8&4W9M@9)/ ]3:S8H3A[<
M%\D,UD>NQ6DK^_G)9NXZM^J94<\O%SYXPMV^GX [5RE15>O>F'!MZZJ2M\6(
M\9W+Y[XW([ &E_#MI;,R*!51,/U53LH0 4KYL1AWA?&^[H\?O!@)N,XB.G=N
MTJU3_&3"F@'X <#J#/U>K81F:H6+=73P??7D?--KC* ?/XX&!5%=C!L#X'FI
M<Z-+\+Z]>\II=ZAU29 LUV"_;YY2^HA!EEH4HA=[W:#5$4J-B5;"LA)C*2LP
M7"#Y1 BUZFN88W_D2PTVL:)?_*\CW<ERE+^!75&DL3'R>!CG5#I.C1*A51ED
M3Q<ZUHO;5/4T$+V?]U89)N !T$/E[MI]D3<*"B\U46KBI Q.%ZY+^!6(%*ZJ
MR6K4,YZM:6TI[]K4G]@V-$>':L:"+;N<"VVY'6*TO^S+*E?MO?0-_52_U3\O
M^F4OLRU_5AE4) ]VEK(V(F 55C5JU,I*&96^56S_@LR]Z;<_ZA>5-9H4DW&<
M+Y3UMZ!NM0QP>;M\_5&WIAT,Y=EP3<JI<E.M/;DJ\JN0+[.3T&=R.XMLX!N7
M>Z[5M,0\&.G!+X^&R#$JK:K'^;W:_N\2?/[_\ 7F Q\00/0WQ_%? 9@$326C
MD7[8*\%/)C[0FA18)15)1(9E7^>'G%+4)%Q5[6?U5:X/J2=@[*(]W73K=3K(
M)8W2=8^OI_";NIHG!$'\@U8SWDXW5:6(QPEH>U##FNOO>PCH/M/B;T9?O!B[
M9A8[U+U9YWK#ML)<\0?@)+@O"9]B. CC]EOFKOL=RU.!12F[%FVOLN0D:[DD
ME=0?]V(0]G'F*JI.20F([P;F]NL0KTF9[068_'7H4XO==@ICAB/01"W=H1+/
M^+S[PCO&#2QCCP/=13GYE>\L6WUA?N5 EB4[T!;^V;FQ;GGAPOX7G[=QU\_V
M60DXT>0)#[*^#2NY5C3#=L8WM.D]OZD%O3KIG%3V:;7B=\FS2]R>XPNZQF98
M])TI[[>C#I<K3ND3KB3^1?*.LNXN'_N@Q:F-GLYH]UL;3CM-/?@C%IMF;^,K
M*J87*46@'S/-8DZ4Q35OO*W&E(ZWZPT*;'.DY(AIFMZ=T#</'CZ=&HAUU18D
M9([4MG9I-@EUM^6 G/<L3&4':[]_]GE&,)ILA\.[ZO.,C+(R1H,!12UW*C]1
MS-HF8B=1AW;G0%XB6-O:+2EABU+TC9'')@+,EN"-F,NI&:.;T10,V4C2NY_
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M 0+BO@'%X.7,7$PHN4#$3V6UCK_JDF$WCP"\#W4PBL]*3"A9SQ%Q['AV'H2
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M=66=N*788&B JSP<X.[*_<K!,GNJ*+^*QS0<J&3*IM!3LAIRV@>N"95-)4S
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M,3+#2%.=MLF+J]@^A: -1Q[P]*L@I++ LUXR*48=D]!PMJ*& ,-.4BSL(7:
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MJ>?F=L0NOVFR"H5?HK[0:#>_BH<&S.S+DRU-OKYS]NE>,7_T*7BPXUV<YJE
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MIDK FRB=_O,G?]7@?4P6S2>Q>_U#+F35QOV*]5,W!$#K^S[L?C5G=:6)L+:
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M,RR/J<"YK/62<QER;#<[/1*JTPE9\,2?THOL/5>N4 O>$4*-KFT"N<]8![Y
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M"B^G_G<WK Z=J=./ N7)ZR3"3B.SGW*%X[+),)C:&<X"V %7>8.JZ0'O?TD
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M#B.75A)X!9_'J>@#,V'.V!'KMOQBUQHQSZ;I-&W_ XT23YDDVMPM7RS'@-7
MA N9$M#KNS65T%"BJ>HH43;&AN1IU\IRFN<AZ(6FTPN.IN)%CVUKA??4#95:
MO[:2AY8>).-[W(B#]IODK]PZ4C8 B80[> ,K<QZA:@W!=-5LCF2=YI2?$;(Q
M9E1.J[66N'5,,1V^!:]$X:J%;]Q+GCSP%@47)A]]7)(IPQ2X[GYQQ6&>#'1\
M21/'F>Y2)N>+?Z\^#OUMO,SU&-;/'G@L1C9)+O =*C<TE*]5#DEV_$HN#3%\
M>9#L]3NF-?/G>Y*('&'I\A<4& ;[[^8A-U6F(.D.,44TO\2]1PK)Z _541*O
MJ#[B=1!V9J,+_--4\OG#@'>2\WD1VVFM?@=86>_E*!>_6B!<\&QSWJ2IG+1'
M_!08Y)VU(\&2FP_4NX")]?-T>BST58#U.\% BY'6Q,:%$49[@IME$A)ED^>!
MGK^BAQG#)NBLWO)JM;W:;IK'9,=0;H0D(P''N09&OG<Q@+[:L^4T!5;"WOH2
M>_9LE1;BXH9<%ZH8_Y=CTNO8X V(4NLT,_?.2W>G6(['2P-C!VF\S7;<0($R
MHKTP17'B.,L+PQM9;OL[%(G;\2? 2\GH)X#HJ9_K:C-VO)5YM2NSHY"X5.OS
MM%/.\Q_[P#:2_(@=2?+HO_YPT/$3N+AZI[S%@I&]\=VBE?<[-&35H$^JB#OK
M)&ZW(_IB]\?=3-"O <8R2=]]_C?*F(.'+10ZU)R);G,7KJT_";Z]C5(W%48I
M'I**L"L7[^QL7\,-I6/)K"W0#_H<K\OR:6!P?WMYM^IZ]Z?ARF]KW,9+OH+G
M:6,Y4:7)RROQ^PDPG>QC>#YQ6<;R!#@D=O.?Y]9R?U??^_OT=O)S]^B(-1WU
M?5\@5^  X55NI[/6$((AUR#@ND!H3!K>LQ1Z03F-#\%UUJI:[MBH=9YVQV>/
MB5L:E-[G@B5UV1PG628'IRI.3G;&$S$SC6[IOBI-Q+^N"1DUT:=M4;"UJDK5
M$=\'ZD69.+M8W.R:$.WXPR]7*T?Q\\@I36;71 ^FIG-=,$GT_W2A\HA^R;FS
M.*'C@F"7BN@YYT&NLF*5(36=#M/IV:.;+_0A?\^-S+$;,;!!,B,"#>C+1_+)
MTNFJF61A75./:/@L *H^[.-4;.4X)[X-O[\P9SN>9CUVECQVEC=?WFUO$Q5X
M[H;3VVGRYUNW^)TG$;"T1/!P\=MRB>#Z":#3LW/?%^7?8DDV7-;]7 OFMW._
M<5ZF]P2 6HXV9K/:_G6<=RVZ0I%A?'3-;7?-K87>\J?WQE/^G+IGZ7$\?_%9
MOI(D+??Q"7 @UR1Z_%@;0IBUSMTHNOS<I390J9OGZ\CW_GD454[^K9+'5Y%P
MSM8<_OZ7^4K-#59]BX[7D=K5*^W;W"%6)P(3Q2U>JO^A6X[E9)8#J)J> $K6
M#%X:D+^17 #N1,X30(_A+R G1KR<P*8J!7XU^0P6_N/+6#0I2#E>;)0'[0PE
MCW4$3TK%6V6JRC+FRL:"YAD6_8P^*RT6"9CY_O#A-*39OIBG-G^7>11UUY.G
M=V^9:>JB^9334(&:W*UQO2E/ NHXV!0NDKMZYD%=2Y<6]0YT@N)'[Q&B>\G%
MB$@6ZK62M>Z7_1FUBO67:XF6)Q:SFJ+8J>_OPX*8;L7 _(;X8+-'XDT<PVFH
M'-^,3OV]/':4)%=81_WI53,U81>RI\AZ6+MHF'WY&SEAO[&/D/$.B 899$3&
M.%G<BH)D-],4B4D9(?B+3W<V)%)1J3%<.4!7+$Z7TW01*Z,]TG-C[Y$\BK=%
MKB VR,1(6+C7A<.C6SI(1A<Q<0ZE&_] 8<S<7ZNI*H>Y&#]#)$_@50\=W)B%
MF<G"S<B"8BOVQP:5]",\19E3_;JL4AGS\&U@7)32%4]S-C#&T)H 9[2@8G;6
MC)=-)]ERCUJ:ER4J3?Q4,J,L]];]Y;:[WGK=#\P8/OAVB*=4V .-#0WO_,<G
M@)FQN^?G]291%(\RP_?XJ:ZDN:Z$G.QKI2_%2P2,1*M[;H)R?-OES[,#B/)V
M'$A!IP\-@J1X9JO;;>'3-'*VC, L6F,5:;*#G27);::#O?Q@MQ";]592/'.H
M!1)G6!38^ G0O3(=;[X2FQ;"?7.XW1!#P]Y\7U2^\?'&T=$90=-=7EU14!?B
M.M-+$R7+YRZL<!PZSU);9KRFN6V4/I.;O;I=;</"?!%N&NY5@,1IK4&$+?'3
MCM K[*14+F/QNO)D4X.<@4B&&O=(&$B8[J@W4[6T3?T. ["=YYF(/+(O4M!X
M3' 3QP(OY]G2>\[1,>QA>QQQV>IHFDJ3RC+5: K)0:9. ANH[N$ER Q*ER&#
M!1WB"Y?QU@S(3OWJ;0'>U%?!1S3[UC!N"OPG '"^>?\U3_HW_F5V=,L]Z909
M*457MKE#TX9Y[5@95,$9AIP>GOO&6C()0D_;K\%-J'8U&X>"\O,+#]-"1IYE
MK[+"\#GZAH V'ZLQ/W$I&&W_+#$V3MUUUW0#Z=<L-DKGO;] *GJ_OL 4CMQ\
M'QN5^LAXMA!-K&\];W-G^V#T7I2:38<->YX-?6%^<3$AA2+FS:/K!!JU=_I$
M7SY4 !/;1\SQY9?^F_MKO!U>KJ4?#''K6_ELLYF)) '5>(NZR_&OTC$46[U<
M*DOH4C5Q-P7HQVG)/7]*34!<0.[?;:%T&A.0V&@G*9YA_U*AAYZK0WE4ZF3/
M#>%@6R&!N*I$(?%P8<F%]=;VF#YKMV6!&8FU=E(=Z]T;<H,5G9/M12=M7(:+
M7 +0N.)<@>6UZ[QUB ?BV&&(<-XNNJ[*Q!.@9EDW%2M)Q!$T"'LPRED1HY;1
M>%U(GK@^[.Q.(TG7E-CMNZH@02H;P&Q:1!K'Q%:L35QFNS0*/BPWSE#KY&SQ
M^&75M]I28]QF$ZHU]89RP4"V*,/!NJCF)K5DOJL*:DU/T7,YS$PZW:_F6+7O
M+>.[^#GV\!/&BPW"NYD( Q^%23#J.*4D>0:ZBPC934*RF%11CWISY2Y3I@LM
M3D$F(Z<P:8 8?W&H;)Z%-] 7!31O%HMY_<E1LUD#W_=3K_DS!(3_-W\/B$A'
ME'V9&X #,(V"!OAC@?F%Z;<#" ?*Q#GMJ MK&6X#T> Q93T+&#_'@P"XC$6H
M.9HP4%69.%81T<$GHS@N$%=0+ B@\+W]YSRO<?R@RK*YB)4[@GNA"3PW(("!
MOY\[S>&VH]"DE7LGJM42CDP]A @N;TBL 05P >8_%ZZ2&WUNSAM ;.(>+&6P
M1$:-2-3CNAB%KX!S+7"'&VYH?QDU2*7M7JDQ%B^$R-W!VET>M@ISF:R.E$K(
MR_*"=CL?=O;K>#T,A9 2 ZRH>MJ;.Z)AF2FC0P%0Q(X^/K!R4 !?-O(_1@7^
M(X6$Z7"(H9DA&%>VR*T=V+\&5M@*!+$C#SG/3I^KDL0X";ADIY'[KXZ&FD@D
MEE_RBXR+^'U87-7,!J#,Y[WX>KGY&]C#L=<++]O!!R#VE80CLY)%^L>U'/;5
M[9;X]="'8*/!G;#+@C<:+7GKIKQ<5C&W'$D;E<6QP68YW7'(;SR+;;8#:9$L
MSQC\^OT*'X471&71,[.]YNNW]$;HTO>60*IZ>Q)!GFH0QP(A.F/ 5)+-<?-\
MG4A"T*?6_4K1+2D&D9$>?X:$0U)5,Q*EJ4 +WWFDC7F0C7TJ(10]&JQ')> X
M>;F"4(V)^E%OU;P^3D[E)5.65^>)%]\)5(9&*@A6^S;,XEN^X^&HUY*@I9?R
M.'[/%4M6<[_-A,\])WN@O\!V:$A%Y%S,XNO".N"XA]^9\&VCT/A/]9$TWWAZ
MT;=2K>BTF1YSMS-T3P"4Y<(XB?'.ZWQ#="MQR/C#WCGB2/W/JB/5<_!P23G2
MQ,T,&5NPJ]1]O=1Y:9(!Q61.#'<];< U^*=@!HYP'ETRE8-5&G">D*:V*<XK
M72V'$-!FL,Y0P,#I+A7XP1V])ZI;^MMQ"( 8PGS5XY32JW&63I%HR<'/SZ3^
MN<I^I/;Q4(+9R[43R3((:X('.>X)L)0WZ#<D$93@/\>==;O:GOBF>GQ4B^"L
MX%;%WRVFF\UT&)^"00!=@)7Z&V87^!SB>,U78D1#9@(^ PO]6@]'#/=S+;RF
M/X>(-JH+I8HV2L7373.6(;8+3-PG>$YG+99DRF<MYOV(OT_0>N5G^Z>FK?]S
MS>3'0[H_U^;6>I5I6_$W5^TA^7$O[X?_$8@9<?3='_FZO^67_I+_1<!R^\S(
M&X8^;JF=F3YND3^?.;?3:24#^'M0Z$#Q2%WQK>*1\N:/WX,:+_X_F,Q_-2I1
MN+E+<: 69!1/X0318BKUZ0(G1(JTGLI)2P*E9,7_#:_?QA\TJZC@X@7P4D25
MK-M'*6;&-9^'AH&B[6@?\W>W,1%8"C)ZR?CCY\D1Q]!NOR;?0-83G,;YQF_J
M6:QAL)VHQ",_FAO?7+W\ZDXX H6]V:EHU ?1ZBH8C.DF:(#$@;#\9EJ6+DL
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MY9?VL<M$D4[0&P,1G:'J9->![_7YX=<U![J]M-2)C5K3=6$4[#Q=I5CCC&1
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M!MT_N\?1Z-1R\RXN(Z4IS PLK/;'NH=0J>9:1GR1LJKM=@QL%1FW*R[G:'*
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M&13.4:R!262,&W=ZQ/*?"6(B7Z=*_Y(# 5&P5/LV)\,=8/?D [2;/*3,^>Y
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MB-!RSC^BF/[-EG)<C/\O4$L#!!0    ( .LQ0UH8[+;8?[X% '%X00 ,
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M:D-1NQ*K,YV:/ID<;VP;9"G%CB]V@$WD)=)+F?!6:U@T95R2;+5&T/1.7/2
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M$!=14&$ITYX#IYCA^AT))Q5^%UG U;N#MKQ7[^ZC'+;UU>F39C]B&F&OA1W
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MZ"\ZX2>:_3T]&H<M<,<^JM"199)*(\/:.&P)-3M14[ZU7[?X .$_TI/]3 S
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M;#07F@33(!OC"35$ N30DEX.@@#0D9[Q? #0!9=#DB'Z9OI/7VWGWD/N,RG
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M8H35:*-E*!A715N D:"6C$5:@)&@(F@Q%F DH+RY: NP4=A;&0NP4;P*Q96
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M*]82L^/)_%?.?FQ=9J.F7\;I%WZ7T=:B\6GNVJ8_=U%43#5!0+!V[!! U2V
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M^M3OX[QR * &C<K4%Z+U$H>*>Z&BE@H%&E[0J*5&AJ5&8@ EGY]2MD8"M[2
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M[@V']V5"*U>EW+0;L"FM4N-G(C;=UE?@V+XS.#IP=H9'2SI=WRO0<7YU<G^
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MA@-7Z7]=:XI"H.F]M4M+;?V0(E)W!S]^T>_M#)HRJU;Q-,QY[?8Y_UI^<B<
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M#Z";WK$^^OWLXZ5HJW<XW<C^>'QQ]:=]=7$,UW?R'536_D''>VO<Y3X&/L[
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MGN$!.TV;23<^#_N\-U3A$-/)U#:WDAR&[=W4-_(EPMP#"V/^,XEGIRJ;ZT4
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MJ3)BXQJ&!$Z%#;F.2^G/ZB!D<QJFCC=P#)%&J(*FA5_+:!GU)B_V.0RBYLJ
M7K;D]>41A& S(*RR6#N(A!X@?AJ+&(P6X+OG7-A]ZZ?95#KH D8U^]/X+CA
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M"2N.P<&!<W!P:$C,<G2"4W2'1V;:D,$OC*P&)QAQL;O.SF#(V9>S"99%W^I
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ML*&2:,B54!7H@DQJE#OBV4SB6='(,6T73/IYL"(*P+OA/,U2VXNE>YPA#+"
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M5ZUE4TWYU F1S10BJ]IP1?EF[/DAC8]E@/AM<D32EL)+1>.)BS@Y:J(LDK+
MRZ]8/6#B&.",,P=E@IOA4%Y')M+/FU[#SA:O(KL!-^7ZAHJ"<"I]NBI\%6:Z
MLGD9*4R2J5X0Y@IEP83IZMEG)+O&.+0K:SV.U1S(&S^R(]_W<(ION1N!CJ(A
MUZLD;2@E#C7@_9\N!O_,(!-.%-2Z=5;D:9[SAC8. P*+X*U_18P]=N=B8BZ
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MI*"P,8!EV7_BB2/U7@A1(KU@)7^1?U6))'?<VG%KQZW?V8.C'B]!UT^S!"O
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MFR!MXQ?S2'403G%V"K),&!A#64M"%QXJ#R2<HSEK'IQJ3>%TQZ+/T\^8IUA
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MZ?N1'\9W9MB2@I6[0_AK&.)VM7,TX5X R@-X9AE8:VZCE/UI#" .55&(ZMW
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MA2L2KRMWMF%>R'[:I47LURBT2[; >8J-G:7X.4FK,0QT(70,_WBEH4+> L_
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MEL= (G4?R_0<G;J/8,LQ-=97D3+K1$B3M12E?V*(8Y^,>_(OP;4LT],S3*K
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M-C&"66EMB]]:C*^,[\[^> K&+]@//V)_<)QC*G3MHS@C]\+-THX7^].!F.[
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M(63 *<T(;OT"]4E3:4=B)M];4-O^P\$'J):1FNT%GQV0D(-]'E ,E8)C;[#
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MP)>G!V-\5(OG\9F<YJ/@E2_,VE\OK21  Q[#')T%,K204"/1>A(]2QS9A='
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MHY; /<,)EI[[$1A_Z*=1ZX^\$Y7S\*H7EY?I^<#P!XN>VXS8[MM)L) WD-[
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M U86XLF6(#@Z"MI_)W_+<C<0?LT5<A"/*D%T?*Q+P!;QXLN040B'THT8LA5
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M7RL98H5&ZK8'D5>B<H[V!U3.#:)RG@ZHG,VR7;>WU031/ 0MF@??@ 63 ?D
M07W26>TU6"XS!JCZZ")'Z(:$5^D9+C3@5&_0O0E:SATEB9U/JC:WC^,-%PWQ
MMK_G.ZT8E1.O7@L9&O12 R^0@]<?9Q%*I5^WE'S+*4';% :K6VHJ0L75M'VB
M^F&XR *&Q-OV51[Q%\V%$*QAC+6L7"TVL:LKQ!EBVUW$W\@50I2)O61'B!"A
M/E-HGCF+H),[@=L0JPJ"'I2Q9C+P(7PEVR$X\V]7HYHV?CU)L39+E]P&OI%
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MPBT@32A#*93 '8=)S_DA-?JT92XX,+/2MPD#VQ2N2&K#2:1_2CVV5*=Z::L
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MF6@UIAEP@:A]4&N2&-K/F#OM._8YJF"BS_;VO8G2*N%P#_>I3H@9!.9L5E%
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MQ@E+.<99$X4CM<S.<^D7+SVS':N'HH;ZAG:))7Q/&F<]5<R-ZI3#S= I"'3
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MKZ+\=IYFF:%?1/(*2I>/QV7#X$'65@XE?<J-BXEF#,>@T,)(R21"Q+$GF(X
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MM1CRL&2[<JU!T)SH9?1T)NT5.YM#8IW.Z71.IW.6Z)P4]2'CR5I2=K4/"C\
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M-6S+V)B!Z"U9 NPCRV6CGP5V"#UC4ND!1:/FGZ",FP;.ODOJU<"?YQWP9X/
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M]N<58[%(2UV@W,&2[43CO!^>I2;35J@I0V\,-".+@-2SE  U-UA0PTJ]([$
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M0V+MNNM_EDEJ$JKB$#[Z/YS*C9AF&V!3NO0?MU"437LLUP9+5C]JK6'4&LN
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M-+.>H$_S6*6=7'9RN;]R>7:^OD20[XEDS]04X?MF98&2,.'JELN-@1 (VT:
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MBRQ=,R$T3+\FWE/W2XL:-*/TZ0FY;P>S_%)8BBUC38\^6'<CL7A(N3_#(A\
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M:G,;^)PPO^/H?3*"T O/ICEC!8R4T6]>L>V11!F;&35;*D[%/^IC*(0C>M\
M[_8\[!6(_<P2G#+AKYHIOG M502IO=<JS9.R--PTI"%(>5A>GJ4W08ZL7B45
M5 4H>")FM2+-,DVT_-IKMK&:>"BPF4)H*[R;P>,7$;-I0ZV!Z]5VK<!-8TJ%
M4[IV8\=29"_*WWTE3WIK$M$E-505AW1,DD2806)2TN1#-.]04'AP;Q*&;?/]
M4;3YM-P2#(Q)ON1F4+[FANM2.'8:UORL^ 4)A^Y6;.,'IC$(;+@V4Z_0+B-N
MP 2U?J%:128_^3K8J[[K05#3GC"?&0MOH4P_K65SJ6^,H-WBSO"://HE^16(
M?%1X]*YC)VD%.QY?05/B44=YO5)Z ;9^&<-R=_5L\826A4I:Q.9LL[7.AYCV
MS@9I=($NA73*4&<QGY0Q1@HU+*I$S@=](HT&*D7K1K2P($MJ*5O(. (OH$6A
M&@9M2V%=F!Z/50'[C^QYD3&/STI\<RVTVB'8LL:DTAHC[/&$N2<).- UAQ("
MF9O55E8\(6^C/$URCD)\Q:?A )@OA: O,ZO"?00@$C7SD:<7A7MR2FJ!_)PI
MG!NW7#K\[R0:PV%AR&UP"36-^ ;'-$QPD_MM")DB[5"*XAXX/'DL[E:%: TS
MN65AE;GHDC>\,%6U6X/'U,:C(700K:ZXATA .T ;3<.+YWI494Q(T\GU%D\(
M)6,^"=XRT6I0;"WPV16JZ2K+J0">;LSD_Y" Y27:<KC!E@?40T1J)(@\-Q&B
M=Y-[S0H>UUZ!?0C'M&XV9@!+ S)>H#U,K1;ZV-,V_(N)[M7,.M=VV,+1'Y7+
MF)EPO&EOR.6W8(T>KP)"@1@*<RR2X\F&DI3.LK$ M8<&(CP>1ZWG6 <Y8*$L
M;1-6A<:H\SP+_*BO;6K K9"2 GJAHI$LJW"WUI:L(8]JR4)VTKG%$UI!J9?E
MEVR"STJKX85],[5,L1PTJ=ODL"@M,=1#$SI RSA5<'!QF!3#:JK90T"7.;2]
MH?68!X4Q[^J@$(XHG4@8RJLXJ',N)%_I!$1\\?$-6PJ$$ _#\\V=Y>X6)@_E
M,(M/?"S6<^LED&@:JQ[-12K<"Z4*S"0Z#,8^Y0"1"UI!NCA:(\%*OO2\W#Y3
MDD%7<&C4]K2UCXPEW@,=8H),I9* FUTM$$U 3:#LD[:0#6'N=H8I2Q$ )RHX
MSF4,"D^PT; $7-*.2E!BQ3J?33C_R9Z?227<D':TU8@1(_):GD"!Q7'!-:W&
M;RSK"KF:4-6/-_F7"1XG3AVW?Z2W"R&I5F7)73XD$B@KK97_:C:S%GJHQ3GK
M_5S,RB*:)7$JK\46!F/.H17.PB1EN\ 3+1RW^^YL7(W*>]JA\C:(RCMYF*B\
M_12<'0]Q?I[,@]<Y^MS^H=12C?__=5'='3B9?R*6$22NR_W&'OPM.)9@#1Q+
MN'$<RV\5O!WTI%Z&V3#M(DO2Y=^,>0EOA'D);A?S$EZ%>>&.$DBAYP&#D5KH
M%PP9D\"8 7UAXO62V^A5RY?-A[J$-X.Z9*;%G^!=@MO NX3?@G<).KS+#FOO
M:S*:'Q;3/*\YO1.^LNF=[C[;@8/;W,=@,5W7AKQP9.ZZ1%W/I":_*4FWG'1\
ME@IBQ'-XB]P$/>J.K?73E^3^Z)/D&4V6I2C;<X6B#KS&HRYE&/JM!Q!!18A#
MXJIUUMZU!ZY]9*>TN>Z KV(,<:8*B1IPU,?VLI2P@U'/IE%!/WQ7T0QIO5T[
M69.ZHR^B9RE"P9GI"GL]?_UE:Q6TMPRRTT4RSNFVT'7.(I"<*/F<"![S]8JE
MGMM\$SFAL?'Y8Z0AO 8HG:[?X@G9-MQ!.T?H4@AQ,D"7<"=YB/B8WJS*[TCC
MLH@(IYLXDT.:&88X.J0L9H58F<NT1\"G*LXEV*1S=/M&$P^;>FLT]HFN./!U
M8A G$='Y15DSANH7NNZ@L29DCBF!!4(*:_IG05=P9X<4J4-ZZRQ'[QUCCNHJ
MM>V*6H/ -\-!D4<(E=8XT+Y!_;C/N?ZXW$&=&QNAE8/M7S( RD\2?J*$HAB]
M<;G#;F[@!M+6(;>)6K%C36L(VK(IFJ/-)NAOCD_+\Y$>L=^KAZ D'Q-$8XX^
MFV51HEQ-=_;DW[::"K#2YF3L@AB5; W0>OHK+&K>,82-R3<H@'SCD*ZW_8OO
M8C1-'2OUX^L2":U7GP=SH$U##GJ2SH<)G5R3?'(O'WIX+$^S]U@%.M E5BO#
MV2 W"HX%!\,Y^FPX]ET2&[\RU/MSQ%J_= IQBR?T'OU7ZJYC2$G:? <;2 :C
ML-Q#BK0FF=1M*R,O5AM6*\^-\>R"0J6"^[5-P5K@4;:MT/IE=""8C,ITT$8X
MWI)@KH P<9_(=I^PQM_IRQ9["RS;#>"R5D*Z4[YB0J:$<E8N%E'B=XOQ\(WZ
M,LF4MK@8XC'%5!\<_;_#HR?]?\W&/X2T@__Y@TL&F!#\TR>'LZ\HIMSKS;PZ
M,_.LR\QL,#-S^C S,]NIB[Y#'O= $P!G=79^(#TK8F>GJ@PMJ@4(RTU3:^"C
M130-)1C!/6%T94B5#/.T!-U-Q5;;-&Y=WHPJH*%&0C (&],V,Y2GD-#-"B7F
M+P<  /4#U' %VZ#?T_#-/SXV,-C)-!I;*(-CQR8#ET,39(@D)(I!SH -^H$L
M>SA!?_S^@9T#57 P1!H?^]@&UXJU;HS'D"BN/8*WD$]1RH8Q"E\BB$FEOLT.
M3'C>]/H-M]^\^]CJL\U&N@!-[7;BU3T[4\0OK4^4Y@;026;09<9E1_BV>!!L
M?QT>O3PP_V6<W83^?ED N ]<+ (XPWQF8-5Q,J9SD ;^:JOV4Q@@5XPBI%^2
MG(VNP@3S4Q6Q4ZRR>)8G+L9OXBL6LBL@78!E#3-%SU9N%8H\(1M]$IYULD*C
M(3S=?QL8AW!IN)71U:#ADWFR(&%ZSRNBD=D#WV1:9UN6,;0&UA<EIN+,?"[P
M!*@S"K=X0F?G@1^PJ?>>CJIX-'YG.1OG+%&;4/K"Q,"L4<+YN@O@DL:FTDGR
M10F0IAPXC+F!@?9[93*W"ULWI=?7&F)CX&,.,:=K.)@)H5C=C+)0#)$/X1BX
MZH7FE@W$63]\G[F.V SK=M&NP!$K+PON,%Y5J[0.*7"[!HNQEH!$O0(A6D/3
MVS[1?PQZ#</4B.U&:)ED<((^5TW/C_0 VN[G+3GD]A4(-*Q2[$4N9.YD#\5J
M1O^H:Q6YU-"YG(Q!'9GR6"WW%0[3A'2;"325=&:@;$V0V"?5"20F-ISW3"EN
MZ=4S<C]PTB'9L/,$MWE")/2P,L;2M;9UP.FPT1_\:\!V[Y)8".R6.KTQ8"!Y
MCO#;$CIDPZ?<P^FJ$96F6MA<-W)TS$W*@.\:T.F&)O!M([EGYXT@LZ0@5"0P
M@^7:3*XX6U+G9<@#K]4ZGN,*I9"G/X @U.7'W%!S,?I=VW8L5ZZ@2@#J,T33
MA5C*P$AU@J&@D[: Y/-97I52Y<_WN<K(Y!CZ'%4J&QMCT1BGI> 6R*#+10SG
M!CK+.QC%$P/WL$'O7KUA4^X3H]0,$7W2.2IVIIAHA:0PYHQDFC)$?\+:PN(=
M-,8*AZE<64J"=%M,!S*TRE""J;,<U>.NX[W48(MBP8<=M;87DQW@C0$BPI>T
M?5.[.?0N-N+*2'_IL?$DY?CAZ>'?&DB) <V(OY7EV8%9CM*@08Z>'-*;YV8[
M%V$1G^U),LFQGU#]#B(2#JW3Y>3:V?&PBKKNREYGOA'JI$-8)8V6-(<0==]V
MUP$<5Q?NF)A'&&P&SQBHYL!O%<1;OGCPZ:%60F#=8U]'-.]%2+$I791LICGM
M=%)0FW3@U89-<[J6#*X(=8[(NW!'=3M(;SF,3'?:?XLGQ-7H-8$&?=+/?D3#
M*%93)N)NEJ5[X5ZGN243EB92QIRY1NC+XN3@<QH7Y'3Y)<#I/!CX,"0+&VAB
M"6S')J#^^4R'+D .YRGBQE$%#"L30 _SP;]$+6M[:['5R7BL*-6YZ:MGK<D
M10$8(/\-E]5,@42#BWM Y(')W1#)WTI7DN_)=NWQX?%Q78 PJY@-"4($_0\%
M,J[(,I;&8$ZK"E^ZN0VU35!RDJ(NI#*&W[+A\70N%5U? J0SQ9$+I0G!E:4)
M7H77ZB)SOW <U0<)W\%>I;09II[1]T8@2XDY*\)?P]OA; ?M\(5T"&OQ=]A%
M9#S:3>LK;MR%-) NI+:DA8MIETS;%,V)5(2&!&@ZE2 *#JHVNER;TA5O%8>X
MV6!&N8?9MQF5S(=!3/! <!JF3L@5\+AJ%2Z/SQ:]G4X%;_&$R !G88C)#CM@
MH"^S3T<SQV6J:S4UJE*676F)YVPA$ 09VFHT!B2K#G7)8C.0YT@25Q4F@5EE
MWB_L85Q2TF:.=$53",E\BD4'B\4ZMZ;_Z<$30[N:*OU2[!=!WGJA)!/CG,T<
M(8[Q-VS 2.S%#&$W2P@56(.,Q"@W7*[,G@0<AE!K2,Q-G%:R/B8H[F3K/R^^
MC-+\DE1,FC(#'->_0CBP>@X)9LO'ZNAK0W8$71!X?H#!,&-[9!O8%> 'RC+9
MT300"1[Z@S3*S)3<#U!8V[I(."R[1P=[[3S;\R[/ML$\VY,NS[87%\W2-P\
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MAD^ SCHJ9)<.ZHG^:LSD3XC#+KAFGQ5GVS,3V)RM:_[";=,1M&*F2NX&ZS$
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M;7.W-4Q)8A>T[TRI1R^^B!W!I=8Z_JGU&,:CIN[CYN^V=EB-35>CZ46L>12
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M4+N#/0E&P8RF,\[):B>-<L-Y[/:TS%Z3EKF^M,S==I.6N1%7Q',$2#^:#S'
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M4?ND@@FZP;8I2_:@,["T&BQ153?F'UZ4XZ[!$SW\D]GASL"U5NZH6PSTE#?
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M-Q4:Y9>/8N1%,STO=,J3HZW@B914WC*#K;\4R:FXH"?2T#5!#&VX9ON\%X2
MT(SEKW'\[W OPQMS@_M/1AO&WDI.6@4<:J>VIPKOF$TE*X>MH!]'8;Z60(N+
MO $;30XA%0,0!G&$'E<7MBG$ND@,3B@8$LT_5B(=^25L<*ZIAD@$JDVE=DTY
M!98:![_,6BG;K,BNTW61#-[E)RC:-(Q::"HPR,3G# 9@"N7'T0%K1C)+JU!F
MC<.US@OB1%$%ZJCK TH,0:4)) HUA<T*$$Z-U_;^_9%*Y%<^1[[&B[Q/JPA9
M0QH:SQCF'HS!_(T5YJ256M0Y,.1E *%[E4G>.4WR(L<RH^"S+*/%B/>9W[*
MODOP/[1&\AW"-8,^T'&>#!G_524MJ"P%@XDC=[#2QX!9W^C<'U!R@F2$V94"
M!XRG<Q.A1E10D_71V:?U.65.+:!!28O(L J)TIY:8BMZ\?D%0GM\EC=PLMN4
M!@;*#]BW.S*JS-.65L4D#8BYR9WB374L)S>[>TB*4>8!BRX[%6 A2&R6\+VW
MM6/=UK=)7;RU3=KO2L']F +I60N?=1O.0!H1NG RYT*RC[BSN^5MHT(-(J"I
M+:[Y@M2A.7QHRO0\_C)BR/_#$6)FP+6?H)@ -EXH0$S=(OU%)5?*&&L1L8 ,
MP8(MZ/[V+PS+D4BT522:T:/02U,M(SCMVU%Y&DIM&5,2&2:)!Y0XDQ!=T2N$
M2(MFV1;J4F@ 3T5O6VE51'WH+$GS84I.QDSPJBA^47X97TU%']0@,6"0;D?#
M+ V5WX8D'(HLG^OO3N^V&U>8CB^3'=R!'=P!,$A'GS'$36H58G'@5: VV<?/
MX5>3/*3E.W U450S5^6:HW@6L,C&:%>9Y<:T"ICXG':M!;8:RF$/X7I)ZT7$
MIP"S#G"WJ8^!P<==?KA<-V$DM@FN,38M'TBQDWK3BP,@8&7S=[7]*D@ZGRE]
M$^>*TXY3:9^;P@V6$R\<TRV$FZ7WR5$U@"&^I--P0;?],K=1ER-$U W"/)$6
M)<T5E9>_YE%D#F8SA%L0VVA0&A[<IO@[C#GFB4+ZU4S")^&HGWCO\1.^!1]#
MZ[-1NWCM6"8,%)Y)]FYHA"_3)P,!;SQV?:A-5 TH,)'2W,:DFB$5Q&-'KX=V
MAQ6R&[SU$<0X5:2;:&QKJLN0E!IG@"%['5?I8?(+H;J8L&6,W@]X]=<-DGK+
MQ'@1D+$#,-4 S;T778K/K(SC_%27SGQJN@^]X]_5LLW,L;OV21[L[AVL99;K
M14,D24M3.=<B:RQ.C6!5-YCH+7(M^B>"Z\ ')3W]U5[8@S6AZ]"QW(6M=Q[B
M!!O&OGVZ/RI;#YY'O\CCY+,7T>P./\_S?[LBGV':36"2<UBS2:EHM1PPTE!\
M\+SQMNSQK<YYXE&DU$6CD:#^1#J:@BG42<\PU#!@7\K+I4+CR0FZGD3\XU)M
M,.).] 9_J)9TZSP]X3:2^)G0]/L@]6ARQ]-A(J6F:$RXK%#T,HSAM=,VLU<C
MEVLPJ^=#PZJ?'DY/0P+64BXW=-O0K3U7[@)-9,NXEBNIMI&]#0W7DX;/6S2U
MBU&<98BB-$SB^//3R-\%^D4O=$/##0U_;:Z8%HUSLQLOW$L4V_&C[Z=KFLLM
MND7K41R<CQ)7?Y)$^S6OX2CV)<;'CK.)SO2U3HU0\Q&@(QC-G_$Z-RXCX)-T
M&/C5Q"A'<(X$WER<8]$^5IWCC,[Q_J7HY;&K[;(#ZK^J.T/HCB6(&H>(+84L
M,6UZK>A[*88MI[,PGLMRDN:2 3"K*!H%,TQRJPHSU_IC43&W^$?'ZD-M5-*$
M.JTFF,@-S\*/*J*KD80)Z#" $_,2,<ZCD4*9.L0P\UPG2%0. F7PM0>O8'Q#
MQ:AOY# -J 6$,\FR6?KKBQ<W-S>M.))3Z4<R:XWBZ0L-[KR3R)".)'U!$7:L
M_>3FO'DJ51$"/RG.]9.4;Z6J<$L?Y)RO;!(K3)14"VV4]2J?)(MI[3<>U@Y0
MK-M=MC"/MF6*U$<9$73P(UJF[GSUT4M][V_.DVB246LB"S%=&SM=$[8;GIYL
MTK_JO2!L+;&DD((KG5.NHY?A?(>Q4ZEVB%I^H[BBHQ;FJ+E-5>67&HLV5:TF
MK$ME@IV$X#=^/,.*\^%\196V+02S)5\X4@.5I"%_34,(2O&6X+>X)CY:)=FP
MD-0I*ZGF7BCDJKB?7-T@8ME(ZM?P]"NH"Y/.%.!/!2?(P@LM&JV4ZD$9EJ#T
MVD)'.4;F=Y9\FE,,5S"GCQ5H4X*_)]6(^CRH)11P9/@QTD)8-ZBN+: ^ZG(F
M:7]55KO#%5)>9/D1.!M1_:!NW@O,8\0$?FP%3RA$^,?[JG]JL'/\0%7YH_I0
M^ ,<UN%.3[%T-3V5JLRF4G)A7BD!#G-A"CTM!.Y-L"59,8[]\5+MC;NJP&S9
MUB.>2_F,=49\JLQBM2D>;?_(;'\Q-TIVSW2W':NZP#H'R@J55[D65E214^A%
MO!;G_ ?0AVX':]AOP!K6"-8P^ '!&FKDWAG&H7^/A?"&PN,+9$R_6R21M:Z*
M1@I\./'TO]N=_D]Z:<?_=7STY^7)/X^=PX^OQ>N3\^.CR]-S<73ZX>SXX\7A
MY<GIQW5NPJVGJ3FC++2>N9JT9MI$1ZQSD4^G'BD]4] /4KITQ"7R>>.KJ\_M
MB ILD>K+MU0J6?=1KO,L1N"#D7V,"N*!^KZJAFJ(6N)314ZE3@"4R F6\8!Y
MACH1(Y$M%HH@$"1J2M5R@DTJR[N7$G#W!=Y-7:CF$5<5!!;TBW&WKZD[M/(;
M@D9D2;O6:P(5_*FD.:F23>4_U;WM2@&;<@"L,BNUYV8EG>+.^89IW1(:A.W'
MW_[G3]VJ1O=DF_@7,.**G5JR+4OFL]:=NOWKM3F4I2?P, +H 92IX>\77@@7
M<.6V%<]I!5L_;U>F_]CTTY#JHQSTJSC*JY7>#:4VE%J_@R:O)6W 7?_S;KS$
M;XB[(>[Z'S2V0%9ILPUU-]2]8=1]&(;W(NTXHSX#EN.C(?.&S&M_T)?HKVLH
M];LH=3&;?;F[[*48 O5<)8CSCPZX./E5)%?#K6Z[[W9[^VYW,-A>=*DIKUQO
M[Y>E(;DZ=N$^\_+["<\C+Y7S!Z' =2X+02]D<K^%+8<2_"W-9[]O=8!R\1^W
MT*XZ_.XO#R/PRE_I+*>P!Y'IZI.#RB<)F/ [OHE!@-N_^ 2+;$[OCM_L]/MN
MN]UN#O"Y'J!"1FX.\+D>8&>_#6I(PX'/]@ ;#FP.L#G ISS 7K=?!Q'Z,$;I
MFH_B(2GJL<AHS>9+]PZ?>8CE-$=1_M!^WQWT!\UAU.(P;K\4F]-X9"G5;]]B
MIC>GT?#&CWL:NPUKU.<P>D]XB7^/_OUI$F1R,1+T3*(_!9K:K?\1U%KM8SZF
M'?C]\EPB__;03W=UZ*=AXCN'=!IY^LA'T>FY@TYCH=;C-!K%KSF-YC2:TVA.
MHSF-YW*+/VRJW#,QD S4_ZW_<1^ VAM(WYP4]\;@T90LHUYC&366T?,[BNZ@
M\?O5YC0&C1.V/H?1*'_-:32GT9Q&_4^CN_=TEWB3KO4<":9)UZK+473:N[=D
M73:GT=QKS6DTIU&'T^CTNFZOL4YK<AK=/5";.LUAU.,P=@?NWO[3G,:/FZ_U
M6@Z3.\0CSF408>^+C8Q(A$&$1RT.&>(>X5M>B+,DIF93AY$7SM.,XQ/])C[1
MQ">>WU%TVVY[K]^<1BU.HU'(F]-H3J,YC>8TFM-X+K?X&NVCADJ:J,2/<12=
MW5Z3B5*;T^@>-(=1F\-H-(LZG<;@-N"]YC :UOAQ3Z/;WWWRK"#5\G)S6IJE
M5@NS:HNS>R^PU.9T97^S:DNSNX^_I#OJ8K#GWM-MM[IK;L^WU=GF6=W"@7>?
MY@/3QX>D17,CZ&?N4^U3 V,XL"C-P\R+,MAINSNZ&"?Q5/SA13FVBD0S!_X*
MAN;51'SPYKH)8)?;8\-[$8ZWH@S?O#D)4II'(C/5RED$$3::'DUPM'Y+'$[!
MEE4-GE-J0\UM+."562)3:OXLOXQDFE;Z'G[!?TMZ#QZ\#N(\#>?B*H&5X5II
M$%?<3 +XU(U,N''="+O&AR$\ -. K8CDB$;#-LW<LCY/@P@_!KLR#"+Z5NLK
MIOH3T?I:B9L@$YX/71.\!77P+FC;@$D(.,*1)*K%(!EWUUY-J_II0Y,_P''W
MGI,L2_G,N61OE3!;+;T.9TD0BLY@M?Q:*)83()+@'>PY@D1UQ7* 9@%RXS"_
M@E7^,+32?X:THM,I@%IF7N+AC4 $8M]W<)*GHRS&#K?E[K;+=,/GK1H^F\G_
M-OS="&CG>#H+XSDI#8<)W.M7I$!4&UP]I^4]^MD\=,_JD\A9ID6-PCC%QM/Q
M>*52Y99XD7K7D%8&2JDLSMV[ I%/I\Z#@VS.O"!:TK3Z5X>0L5@S< 56@:L;
M@R4^=DUA=;@E+N'+RS\R2^)KT"%(J_2RG9L@#.TGLXF7P>[/Q5#"QB937 O,
M>CBW%^/03&$ _-\XST#IS%.8A7JJF'KUN:LX]N&^\5+<'?C]-,]R+P2E=O%3
M(-2R0*:/V9'[H4EIXW@#^[DOHS(B+E!DE1*K2(XM($_\W./Z6B!:T&5",022
M%2FU#W:%A 4$PR ,LCE:;XD<220DF+!Z>N2E$S&3"8PU15,'#/8H3QW@PWR&
M;_S<X2HL^!%XQ1N!^G/-DX)'-'/9[U_%7I@R!ZWZN.]3]V_X>@I7+BPDQ^[S
M-D>0RVWO9>K(OW-\>Q;B]J7Y\%\@.' L;X:[@*ME\GX5@_5&/>C!:H0[.DE;
MXB1B]KDVC C&I<V<\--*GC0\=H2\Z&R!ZN?+,0@E,@2S%?)@F]AP8=SB[/#(
MWB+7GA/7BKN/ZXUA3"<-OH@IT,TDQ<46C_*&P]NH>Z;T@Q_#SD9Q!OM^'7^&
M;0<:A=_C/B4RE$@E>(2A%TS30A!;NHZ'LYTJ^0)*S5R@)9V./=S?N5-V!N@3
M6W(2L$B!?^X"L]J\0LSDRU&<D'S_E<D@A+WXZ?=SGJ%B;GJ[\W);6^?JKR!4
MP<*'508)KG%$[JPH%B'L.Y(3?BKX N2SM=O>=GQO#E/!*7_C9,1KZ?GXFX59
MT=G0;OCP:5S\Q*(!O.A*A_5ML[BTAGL-GZG,PIG@_0"W#]PT\(T@0Y^%.J-Q
M'(;Q#=ZO*7!#0GPZ\S3AI.KOZ:]P4MLBX"NX^CFD:EXGTN#6[K:B0W7P%7)T
MAL Z0PD$))$JT>Y&9TPHD2,ZW5O?%7HE6F" 709F7/D5%G OB=*WABMG[9A9
M+WS4.H_J!PLN*W\.9 I_1E.$X3&F1"''8]1L2,+Z-EDZ2KI42:E8+&S56 ;
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MKV0D$RJ1U7"D7/_@<0=V-&GU)&G2A.JCI%-L2;9(5X^@!&)TJP+>R* V)50
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M#=B$'4O@/2_PRVKNO69A%?PU3-HPZ28S*0?5.^[>_@#CZFN] 4OLNB+1MW@
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MZ%"&@;R6C!N*8*"ZG4WD3:L0WQHU5(KKF  T$2\S*(+BL_A&(YK";&<*'IU
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MB?P<BBF% 0A4GV1+08\G3!,(@40$AN+.>M!%Z@*I1L2%Q'03L":9SURD'2+
M:_A[E)&; +/+S8^<'H%1%R(O![7#3!G.4V^.I![**ZJO,32LKK8\*5TWAC7L
MYSR@XBN:O<50E (&-+UCJ[U5)=91^<=)+!*,.BPA;QPGRG6^1B67C2_;XA)M
M&*'&"V)&.*54P/M(8RH@BV*\M>5TQID]B1V8Y<'PERR'075*1TDPRXH_TA=
M)4.U#(8"N4I# 07"6Z 1?4;J1 :Q?5&6ATKK*M:\>-)&M;!4"H^&@0L"F(JI
MO<(7"Y>- QQ5>-S@F;A(@[/>19E0L!#[Y<IFXXTDAJ88J@ZACO,L?]JRC88U
M[L0:EN,*!*OX,U*A<-V0W686XR(!.0C/YOK96]P$WK47A$3-:*<P512^%12V
M(*IM:>\  P W>*%K$R=?3$8Y%L%T%J>%GA+J%":4^:"RT%P^>JGO_4TS!\+&
M !Z^ZQFOAKJ$<AP')P?VCI<$,D-_MZ/M 73P1C37+/&BE N78%.]$=R2:<"S
M0=X#U@[CN92J<C03LQ">YWVC%"NIG$FK-O'_L??N76TCS;OH__H4VNQWSB'K
M&,8WP$YFLI8#)O&$& +D-O^P9*N-%6S)(\F ^?2GJ_JBEBS9LI%OX+U^[QX"
MMM27ZNJZ//44(AEL.C#BWM-_ANXJ=KC#IZZ-L>*^<4=/G^/"Y0C(PV'/!YUD
M D'%T(4L&6"TJ:-%-0_>K2T,XTOD<X?.'U81BK;9<0=E]#C"3Q" 6].!P[9@
M]CU'/^?>PJWH!F6Z+^F0LS.AAJ0S:X6Z/M,3& A-P4 H)SW 4EB>?@O8> '9
M(ZQLKY@OB:O@A+J^#W#./U*IQP)4):)Z9CSHNY .*M+%5.> DS0A(($??,NA
M.G10.^]//AZ?\17'KQ;>O4$[]9:](*>IHZ"BVK5:EH\9%$2)4&L2[30Y,#7$
MVW&=/O6O;HU;K&6G!X,>08X':0=KD6/6'08NF+SGF%E(9\"G8T$"$;"+IJ;H
M+CY@?9?E>BQ1"V+P4G4X-L X,P 8) ,K_@&_P_/+5U09K\RD\1IV?-,;KJOH
M$RW'9-^B-HHV(H8+Z221NX-GF:"_?%;M#Z]OD;;11XT0C%_5O3FZ$5B"OXO3
M%3D_@O$9$)(W^+2X-=-91$-3M"0LL$AZI1X"%K/B#<#K^!!'30VK%@%E9]LO
MWMZ>C',YV.)<,L2Y%#<7Y_(<;IF7>7 V++-Q(>RY%$F:A<\BZ^S8^J?XKF41
M#M0%^H%WXV,$GSFSR:E2-"5\^D1TG>&_$%]%I@.+Q;=,XF-I&,G!1UCH-NZ!
MS(" ZY E=80]0/T B_OU]"\=ZY%=Z4'V(1P R"G>/X.>A[('XU/(Z4&:PPP'
MK'/C@8Z<,$+$/R6K0Q#6R*FQ0V5LN7"P [^9DX478W$VR*S[EC_$#!E&']A*
M\)R)L@(R/,$^P.,ED)FF4Z=FBP]AS0'L N:TN+,(%B;SR]0<?[Q[A6$@L&L(
M=7_:+ A/VE3E>\+&H@:/R2#F5GLL^Y8+-D%99<R H:W'26IXL#X$HX+8:P_7
M '_+5I_S%L5$='+@$AN6*SZO[H0(5752O!1\1VHZ(VH>LP<8&\94F-[N&O8M
M1'@TQ7U4OKV&AMDKR_KS(B9OD^>P^;M 7>P+=$:U'VJQR075S^"075";G*$"
M@^W:;/!;>A3?9AF9+%S"0QL:NN,%&1;"&R3PMY&$J>5",7 ,;);=EB %5'6:
MEKR3E<I#'BL,GFB2(*%@>9J(AEH,/<%IZ^2MIZ000#O3EP;U3$I.@;^,@649
M^%1B4P,X*T(Q6&1%$W"&9P!;Z2*N*5AU*_+Q (:A@GJN"XJ$"S1QXHZ!U',8
M):8"!'DO:FZA^60H+ O22OI?H;!_D%<)[*X5]@5-9'RM?I^8%A6VWD@\!,48
MQL7C]^+96*8+UJ"PQB%,QBDLB:PEDR.!V-A^>/#X4O(XL"!OX6L';Z%>;;^_
M']#CZ<?H'M 7Y. -3>>>%?4?(3:S@N83,=R>)6J: ^,8_J0892(QH*Z+A\O-
M[&%/,8@G%XO*9\#Q55,F$$6CST4"+!/$!P^L%4GY,S-0FJ8<.:)Y5&. F>\2
MQ[TU;.N))UXP<TE%RW#9(^@11\L8[<6A&TE6AI>V190Z2Z9/4%A 5=#E[(VV
M>F)SYH5ZHBZ.I$6E911[0TH1&#NN*+W>D/I<MADX-:(./X2ZLYDO8C%V0Y1?
M.*;L,L(H-R_19^P;2$VH/LRX)7#G26R'/#-<]/@-!RXO/4/@J$\8C:A:82F[
M@"3 4_EJ 5$"3I$%>=41^J0JDLL?._R("02X(@*X, K?HEXFW0*KHUS@;W+@
MQO+A /FNR^8,NJUEV-1O[1( MQBC"(0 W3NMPYWHP.F6^],B<(;E]NSK-06)
M:LB5@&VT'1 QR!Q"B!]J?%@Z)5 L%G6_>\(\">,,#(UC.QD>$^! *B)5PCF%
MZ\W<5_BF7##\_(.T9(1$^/*!3._?4J4&4V*N._T8?D\\):?A/WE>8E?B55%(
ME#\%7*ITG7N@3KTW\J4A 0L^22T@NA]WMO- K:E;>ED\\,*>,*DPN-*07/%0
MQY?WJY@-JNY7_D!IP$$P= EG,,24%%\HV @PMNA.O)$@W>E% .J-JBZ3EK!,
M:^C4;Y5QM.V-R-AJ*AC:H2[HK> ^,4G/ I:S,)HG3,@9(;A2J;&"\X^T"? 6
M@9#BK^'\DA[Q_1YA1TM\13Z(9Q>-)&="(= (:@=K5"BC1-T39#U@?=!4YPK\
M,T &<FU@W1-.R]3&"\A771?$<_- FDLP&"P^%@*E!(ERSP!66PR:03(Z6!)/
M,V7VLD6H8S<V%74I]JE%*5=-XH$#LY<%316N@Z3=CD2OM? *17G/@LWE&Y3*
M[HS?8@BFMPA1[;N<@+G3JQ##BZ3/1LDF!\"48..5HE&LLY35!QQ]STFUVO*&
M5NS(X+H*N]4AE"O<#YS!13KB@CK^P0FIQX%+VH1!2"'CR&!VB.43.VZ)TD^5
M1#[L8P>#"BT8 O!BJA;"=YQ\$NQ[Z/N@_<4)O(>$,#=&T'EY<%P?30B<._T$
MFSJ*BV(.L$)35F<!;KY-10J,#WZ(45?P][VD6V!=TU?/4/]M$E9V+4*MSXCJ
MX"C-ML&%0'ZX@Y4FPD]]^X(6)FZG9\(ZI)]T"/H0(B08IR,(02'2OR(&-+'S
M7E,P$C./-K]?A!7_\WT&#\ETVZJ'1]5@W\(]>=(/<,%1;VJ\S]*N]J'K\, 5
MJ'UZY4!D-#Q);"BTE8T7(!O4QIA%-@PE,)K?SQ<P+LH5]%9$7J:(@!$]DY"
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MN;(B"*PQIG2A.1!W!7HP(RA6O,R'85G,P(5ZZE[?\=C4&*M[%)C$&R\RTV$
MA=H!602.?OQE,J'.0D2VT\>@IDOZAF5CACD.T)7/YPL,&J50?TYX"R>H)+Q9
MKI*EAQ&#<N<FAN?3M[ >VRQN3,URGD=A<5^;VE1MQF^? $*0\ ,1#0[? SF6
MBI\.0J"OL^Q[.B*--V!EG0O4NG%Y^;"6KT'3R, O4J>$R!AF1L%'$]<JR)6&
MX %:.,[.N/O1/@O:&J"9%?+*YE^AG$*-+S*V(J>EMO7D4Y8=0>6Q\P-RDPB9
M2=+4 =DG99"#[>!7D IV&91O>V>O]86P(BAM@D!IW']*0+06<_G#PURE7)[
MW9>H_^(0K;$R[1(M"WBK/@'>6C=X@"-N  K65<L:ZQI'Q9<&ZZHMA8IOBW7=
M,.VQ+*QKPCF- [[&HB>6#GS55LZ,!\I!6S7\E'>963G\%,>E;>&G6_CI5GVO
M&?P4=9JMQ_O62P6BZB$@JK8:(.J$ J4M$/6%'\<E U'CC*IQ4"IG'%YA'4V@
M-8PM&/:5'Y$U L,&QT>4C7O[^NJ L=+C</75 F.U],#8%XH!K.2W&, ,,8!'
MKQ,#N+UZUNOJ61Z4/#;M)V'E6@RL7'\NK#S.%DR&F&OI(.;/91M\+L1\>UBV
M(%D!DHT5\&<#9HVQ($:<69B(G-47AYP='\861/N"9K51(-J8LS<&J!T[/9%\
M:%ILK6$G''>)LET:,Z$V&66[92;<[/.W0I1M''+B.;U1E68CX^#;F)=M17--
MX*IG,@V)^+LS2V#O0"@;=*WZMM6A.RL"J.<=^B_08/#W$XLJ+]]QO4U>@74I
M<'N6()X#6!"B+;A7>(\U[+;C#C@*%;?KPPC[_HAF[%9D=_%6,^\A*ROR6> D
MVM#^3'AZIMAQ_+0CA(&'$P&_ /!)GLH?0++)]X, W\G'X[.<B@^B7_8-3-"A
M3\9S[2",Z(3B_8A1(#0'$)\9&;-H4^^Q(#WV,N3@R?BQ[M.%T3VGS_ 0/&&/
M2^(Q<!'H+<>+69[@55Q3MES'X)!69JI 3!2^$/VNICP?,HP&VC<,J7M"Z*8
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M8' B:4.E:F3385#Y%2) CUV7F+<$Y, &"CI(X:D5U#)<!MGD6S<B!4ESF25
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MP'H&[K_2NA8[AHN"%0Y;'LM7*F9 'YI+FJ1']P0#;("S.(7^&S_V*O7CAL8
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MZQMWR,(%NE4<US"97H@#,-S8260!U*ER122[UT UHZ:0=US*R>M?<N$N.>!
M@DVMT)N%9ALYTI.LA1BZ5X4$+TR0%UU\238X8=LP\HI[IQH8X;D%\5$@+V T
M'C[0&& H((#=8XUG*%(:O]I3TDFAZXB)SK[^@S/?LIYA"JUA^':5"D0T,9T4
M4D&UIWKF?3%PF]_@LA$CO'(4]T+!3WD5Y(\,GU&34($0HZ"K%<0F0,!W@[5N
MC<8R&<J=>51,O+>SC-2EK=U>1]688NS30PS5;8@APQ##X2L),2R1""")OB%3
MZH0(04-1QCC.ZA]K9UKH73WBTP'L<4E^J^_E]PL!YS,\@SZB4):/^%*[OJY?
M7LESGRTAPQ(61VSE(@<>;]B52ON5@VSYM"%N<D]?:EK^*"X[FYC"DA;)P$!*
M)>0Y!?MIB VA^=)<$)>:8^!^640_.[O(X=!^.>Y=3A,_9<,6N:+UR_X22W))
M%GTZY&DO+8:.I?[SHGYY??67-P1US/[_[=E/GRE91,04&+G ;L%RB,PW/4A;
M8VR \^-Q#F^,)6B@;E@$AR6D3PCUEL!X+A5R>C%?+.$GZ0]%X98(OY$JHTLU
MI' E7J'VOZ*6M<^T%_0$&/:OJ-O2_?\^N,X#'?W%<0Y:<B%3,WQ/B7D,ABWJ
M6HF:7Z1[L=Q^#F%</BX6\UTM5U)"#@:$\8PS"(N^*[ %^&<^=DZ /.@9-H-7
M#0S7N'6-05<S6ARO0?\.PP [">M8 CI"TQFVL&=8F[@L 3ND7@;C[.7\:G2L
M0\)8@6\=EL/$3[_9IYX)-%%3-SQN?S0ULAA:<I=PUT0R6AL2&X8H<LO$58*W
M0W3=]3U1ZLK7$#.VL"7T'\O/-.YG3?R\3)U<7HQ.#MMH5?F2'Y_JEW7MU_DW
M_;C6!$#=B?[E_+*NIS+\&LW3\TMJY2'=UM;(6P-%'TX(@!EGN#Z#6H;"LE(-
M0#?!CM4C2O_AJ_HQQ,/#-J!$+(#JP4X\04X@U(-!8%\U2\ T8E\K E7DL6NU
M+-^+S<7)C^\#C3(0D&.$2'U?-.0WY!2F0U=3(;T/A'$SZR-G./E5XR/#(%>[
M2TQDHF2+97B:(==VTKA_T?=Y76Q/Q)D[)7UG:!Y\694[+YS8 ?9VUI^)W7(X
M&[@Z-,3616'T$#U#_8[M 9CVAMZLACT"K!SI>4B[QMET<55P)4T+W0!DUY2#
MPZ?Q7H$RZFHSCT$2=2K+C9>!/:)2[UJ>:7%X$/92A6FS[_'6!;*@)+14##D9
M4 BG7:F<QD.)IM,><I+0A'6+^S8F)-IT&@Q3"!T29613=*ZD2^D1(7&0U!.O
M\M1F+2(K)<* $FP8$U#D0Q9H)N0T72%.9]U!!PNZCI>7,P8-PKL?Y2 Y!NU3
M0=2 =YIQ+G-;TH,D@_,X"AG5DI]Y3 M*W7U.)8C^P!O/,W[":-\>C1N^]Y:!
M7VS S6I3Y<U/'/V^;"/Q0%J>Y2-;8=?W!V___//AX6&?RNC^K7./RJ%/#R2[
M%=0/PZ>HMND3DSYXO^WT\8PCB['19H4,8-;B2H@I@VZDNKY/EVOOL[H\,7__
MFHLNF/QK9>\S,T(!_LI6#N=-SZXF/LLT.;M7>&,+-8TM^M\62KL&MCPI'.R:
M;V*S+NKRZQVH::>?HG]W;W$=8)9R6:A?X0#CO,?;KM ] 60C9+%8&LKH^(*W
MG>XN%2/61)@ =M=U;,XI']S9N? 4?">GWN+)NA.^IZ&&;5/9!C)*W).@8TXN
M-'"NKR?I4W@US^*B:F?78VZ!-5ZK<@C2M\-CI,_+?M^DQ$<UOTU\9)CX.-J8
MQ,>S\QY+8)-.Y2(?+,9%IKYO_:=V?:ZZ@ED^'[SK6O.X43O30XYSUCS5&^LS
M+P/ VWI_[(#"I/><=JR$R!:WZ3+T=A4)C6H\-,H<A2Z8#? ;F][/>I\^JBM"
MI5=DX/-8:1YCI>7-7/DDJ5D\B_,[/?'*63>"YVKQC^7R8$R[[F>>0>6/16L@
MN-)B228RVL9WV)7OEEK!M@DBX[AO=?>VM5O,EW/%4B57/#AXLQXT)W\9.E4<
MG;]W_N\)BQU_LT4J1)>*3E<5G?[!Z&%P_ZH+;:?^^M-X/TDZTJ\C/ZM[8'>]
MU?<*2XC>GNX5ERT&/[IT<==Q[P^4O<?1)6R_<@M1)_5\0%C,,D-!6/2>E[9'
M?WS[#^?:_F.,86# ]IKTP:UW1WK]OR%D^L 60?0F!U#R<)!^@LW<_,V1E_)6
M1W AJ<PG)(;7U4][SL,&Z8B#K8X8W_ZCG?=-Q^=LZ3P)%M@+";(0Y[]LCAP<
M3N0B6YC;M,"8B-I!N)9RZ[2HZZFKKF<Z5$Z&78=7N6@ORN-D/MMSG$YAM OO
M3\'S;JCWB<'^C79 V5ILXB7CW3$(^26#PE$]TU!0=Y<!ZNZ")1]K 6+LU'+[
M<*WHFW&O%(Y6L/UK:5?BGI=VWB\EQK#H;>6C+%2VISJRP^7(#F]^&$'L=75[
MA.]8_.BU!PKX*(OY[>F/",?A9.'8P "!V.O"]O3?*:$!$19X02& 8GR.(!,^
M\A5G3B?C? KOZ+V,E_);>!O'LVW!/_'@'ZH2YH#_%#8&_3.7H,>M6HJV\RMH
M,9_103MOUK_43YKU:^WX_/+B_')!$)T73+RPF**EDU!EU/%Y\Z3>O*J?T%UJ
M7IV?-4YJU_43_4/MK-8\KNM7G^KUZZO-W34Z\]V&K0%OED>-:_I)SBV/["IH
M;V,K*_P7O:*--YL]5YF#V.!Y3.Y./^E:!/%^-!]O2OG:3:%0N!G8);MT\W1;
M&92.1_>%AY%!K\YA'YC^\8-OE0+8O70@CSE"V>ENZ6@H>UJ 6BX3W(UA8W'O
M@5BW71^^TS,3 M/*MZ6]2<<%:_[W3C%8RG+UZ 9@<OEJ*7_S5"F1J^J7T=>/
MWV^C1LC$L'-D1''R$X?,"T\M9AXQ3]]9VL*48&%*!?I_-S>>Z^_M71)975)[
MM+R;&]970O[!_((3I,O8*S]\_E5M/#Z4LU[&L:Q3%JNHN'1R^OG"#1EZ>[>&
M,=C;JWD>/1NU%I3MM?T;Z\/-T^&WSYW^Z-?W\G_=G<DR/;\K'QDR&X68<.Q.
MQIBPS+Z-%QKU<RZ\*LT'XQZX1H.)W<S2V&8>LW*@8$_S!;JKCR?'3N>@?_V]
M:LVQJQ.<]@FBS:; QP/UC'1T;]=P8==J,+&[?*#L,D2::K8)_X'@X[W1@UA$
MS3\V7'=$%02ZMG37BXV;OE$[?K(>?MX\=3N5?\S+*W<PO%W(H>;WX6'^CW$1
MB,(BBV@L8, ,Z_W@!Q+,)+I<_-$ "9ZP2^)"CGG_SOO_)3RS<!CY.-^WOZS'
MM[9CG[JB\Q#U>/_>X3OP-M4&[&"=&7WT)028:MYY!V[&O7QUK\3MG5/Z\#S]
M?^72CLZJT_[>L1[]M_:P;SJ^2=I6W^CMZ/P'[^^=/?I!C^X7'0K]:6A;[-G?
MKDYVWA=RU1*]=\/C?I\T[=A%BA?6%[3ZI;U"<8_>^>QROPG?[9$]*6>P)^6C
M[#8D5BL<JEK!'0U\!V^ 4\-R8Y7 X-?7J\O/'VNM+T?9W0%Q9_N#Y;<=RUZP
M=ITB)S$+,L.A/,Q  (JYPL'A5!E8T=T4<OOV/-+>LQ[WNI9)/:FW.I6OHO78
M<GMT)8YVWN^%HL?/NLGJJKW"H _>)79! 4>Q27QN+D1EU[W\MW9[7OWUH59>
MR 66[M(2(^:-6UA#1YOX*Y7T2<LX@\17,Y#XP]+:BGNV2SC#77*0S^)^/R@^
M<V6G>@\7+AD8EEEGK2+H%7L.% LAGR)Z*(U?M^;@Y*+YX!2SNU"23V+(\XT[
MGGP*0;N+@"FB'?)"4OC6$^V=:3Y_6D&=Y3FI!#G%)J97"0?%3"2W,%5R8S<X
M[1J^^KV;11=EXFL<3C=JYMC1J2;NF"JZIKK(Y[J(*J4G\N3=/!4N'B_J@U[S
MUTEA.>&KZ0YO"973M>,;O2EZ:'(X;Z[P2^J@ZNR7YIQ:Y2 +WRI7RD_W=[-<
MH,W>B5ET1!:N3^GP(/O=B=401S=$1.M/@(?')>:QX_E>T[$#55%H! KB1_>Q
M3TKUJ]I=X$F8EC?H&:.W.ATOR0#-E,J&@9@_&W"H\7,;1K_!EUSJ6_I%7O&9
MS7YJZN;"=8!V=G31,VR?6@L0#1M "HNZ+A&1+Q2;M>J]T3X[:BW93@>;G V3
M]:$38PQYS1NXS=,LN>2M27]1'A8R4,25Z;?D:SF:&>_9#%?J81:.5+6Z-*N[
M/F9U@T)AYC;3*#]/R*?ROZ6Z[:S>R!:S+>X?C <&"HKMG=+F3GCR[&*-7T,>
M\QZ9B@-(R)4\_\$S6) SZ*9,$B2Y4J4RLU#S;<[6Y-[N^)R:+1-G[G#V2VI>
M*9BJ[\Z"+K/T%E!K>EBI3P@K<_?1^>??(^=#V3A<,JI"&28CYXXI/C)%\=':
M@1S6:C!3+6UEK>/!-8;SS_"@?OWM;K@DR-0DG(W2)GD+MIEGZS_$I"@OC!%D
MA:A&H+]QA\0<EPF1'#D[?NJ>?J=.E]EHDLN#YMVW#+/M,Z8I!VS8C ::#5PF
M1^;;CK'K:NY<6XHE36^/'&41V#[,%0ZG)RNR%>_5K^<,M_U1-E9?-45P<(YS
M6U3.K8BL79)[8@])PA']57#JY&?_XOYZA9@"&01TV5@7C8.=+$WQ"S?#0<PB
M>EPN3G<+UA)',,/JS7+LCK( (QU,-[*?B2 X<PQ;J*&$$W?M_W;;3\,/W?X\
MEM*S+D48';W\?'KY,9*&%<I)S$K-<,2R0.H4<]7J<R$E:[YX,YRP2A88G2R6
M=#KZV['QO-"YGY!6%"TGCEFMVCRQ"OYCJU-=08Y+/75_#=XK0X8.&'W+\Z 9
MH VU]E@EMH:.P5H-)E8H:@F*-RH*^6'EO^^CX=U_OU8L":A_^2#U-5SEM1I,
M[):?*%N.3!63[]K?S2-B'UB_W.^_5VC>7C0NZGJ3G?457AHQZY7^QJU4,BG1
M.*AN*#PV[>+-<N-F8<04<H>EZ446<YRT<@ J@9[=]U:O1U*<N.K _%[\>7C^
MN559MG4KAXEG;272<M[\<O)VTG*E/W#5+%+?A5RUL.QP3N;E%]5BIN47^7&T
MU#?;).Z#2V7//25DLH#G1Z6O]<:/4J<W#Y D\XC),!BZWB%$A#M7)_UIUG2&
M4Y!%N*U$E_NY.G*CEG*&2ZB:1?:RE#LH+B2>J;I]5UW']:^)V__@N*[S "TM
MHV?3&/4*7WY?7+:'2\DW3"W&0'L?4Y&%=]#W%SDYH!_BZ,5BB&)V:8;3GDF4
M+U?*+P2=_XIW:Q:%DH6C4$Z1'ED$T@O+3:;G-9\^5K]??+T?/E1:J\5/QZN=
M\U"YEY(,WV YWD*J%P>I/IX(]!!E1L;94\LLW/1]<0J^_J@4OG_Z_>7R@*P>
M 9E<9A0C_ZN)V<^?VR_D,RE:J^0.,\@J)F[/.I<'90X$*.2S\$P*I5RE-'U+
MLH'XG2;G4)J.W0Y7"K'#_O3MWX/Z3_+;NR8KKQ2:G$/9JO;7/?NI<)@SQ[X%
M2S>2*%*%_;[>[9I]<D$.NJL6=AAE[L6XC%L97YR,ER>X+XEJ??CEZ;I^ZM:O
M?BX[4"*\DQX]CGL^/8\OQ#^9;'XD;TQZ&["01055"OOOM1S+3'=L!L.QD E.
M=R'[.#4&JRR(+(?C;J%Q5KNJ/U7_,6Z>2O7BKWSGGGC?YRD)65!I7$RT1"V,
MFZ"%GL.^FU(\G^$=/?/1LWI/,^BK+#(+X+.F()!+1PR<:7G<*]_R611>%GAH
MZBE7YPWK9U\A=^ST^Y:/'7" B-/!YH7$;G.]V BIPTN[7FD]-K]\/LL0$I&N
M'BH8)N.950>J[P(^02^4WBPSSQ_QIY[7-" =@*!0J*@ @CEP!"]X::K/7)HD
MB(4\*K)/7+1V-%_XL# O.]7I"#K8$1S:ME3PN2#<R%X+/N):'ZJS:K[O6JTA
M=L.X=BZ,(+'&6EVH*O._ZD6S\V_YY//#XB(QZ60$C4,_(BEKN#=K-9A80:FJ
M6(X)->583ERZ]XU/1NW@/W^> $5&Y<1QW2QY0?E65SQ7!"Y<CF["50Z1=5,M
MX-P6;YY^?SW]^>G3]]*@LUBN;CD4UK\T!_%6_1Y&I/\OZ#T%4ZB&<J7A*5"-
M=NYB3QX39W-!W"MHS71C40UGF3?MH!7-OP^D?V=_;SY6"CNZ;_DPL& 07F00
M.^^C@SA\UB!8VY>GYMWA]],[YZK[BZ0;Q#3FSA3#2.\]EM)&21K-T["O<(%O
M\A8X8.[[1 :<UMU-'G!^'QX4X^.,_4*UUW)Z5#P.$L6#O:DV]+N.2ZU%,T8V
M_VD,?_Q3OKVTK0FRB3W'J$\A'S0NH^6Y!L%ELV?>NU_*HR_]<VNV0<RPY=%A
MS"";:6%JX:V>1RY3#3)>'M-6%\0/LI"C#X'_S2J.X]NB&[X^WB$+'=*QCD_O
MQH2Y/D6.&IXW#&3(=%19/CER?U;()W?@5*:*D87/&9?CXI3WGP]]SZ=SH9=*
M_" N/UVY)]6OY=O.=%EV@H>-CR3YZIFP$OQ G7QSNO]\Z!O75^;<*U&:>R7X
M(,KNM_,A*9]?5P]G7(F93PQ;B_1'NARNM@"/&4[,@^.:'K$7<::5U9IAF*5E
M#W/"0L:JG?+!NBUD_#"/GC=,VTFC%V?3G/%ZE)U&1N,?S'06G;H>93P%*LMS
MEO&L?NB%3"N0CB*19,>.]8&L\@'[P;C_K'A%!V>-A^'U[?<N*2W$-8[M5(:C
M3.$>Y>.G-HMO]+M8N;CMVQ]_M>0EP5\_W3&JS/]Z<4?5VZ>CWN=?O<>[%*^?
MW'YI^@#2:_[4C2CF]8?F'6VL>CU("X[,VAD:MQ_+\2*1PA,BGW^<GI0JE=;9
M08(HI'"#"K._GDMB]9^?G\^+U>Z3^WN&UZ?=X_F]G]3D^/-<\+..,%[ZTI:@
M)+@^S/')QOD9]\YKDR0B;,,KPOCMR]=_W<>SWO$_I<G2(*WWV=9Y5H/Y,"U=
M3/P:%RNYPM$!_5\<6TR2_3/32L9X(\IR?BHTK(-/E8_WUN35G,$-F32"&=9U
M/CTOU_4H5ZT<Y<K%N'K7T+I.-29SL6O^83;IY;KLX>G+U>?>/[9U5DXIO;-H
M\82MYN\VOWTX__WP97!^55S<7L_J)J4FC\Y$B<[E(AT^3\\72[F#HR*U,^-.
M>"HEFN3YT)WJ+-_+2;OBLW79+&32<W!#6<Q2K=H,0*-,V@PNA+Y,]4MJU+V"
MYQJ]"\,R&_:Q,;!\HQ=-?AV00NGCEZ$YL.=I5_T\[EPY0AVZL>U9MMYF@URI
MN"0LW QW:Q:ER96#7/G@N60'&["",YR[PRQTV!&U7*K/;14\M8'>M4L,;^B.
M4.DP_2/#+LW&C6G=]#UQ O/_?OI8,[\\/OR<)_^<%=.+&+$P5JBM!NVQQOV*
M\N1ILGLYQA0^_7Q:&A+O8ZL8V,+1EWJI[([$MZ8_HJGIE1-<-VK['I7C3B>S
M+.(LVOJLZ\;M2LOZ4?O1/"T,#GI+7;=88RTUYW#\NL4YNF&'-GVX&<K6O &A
MC[DGO45#I79G7MD9[;.C+&BX#HK3&Q>-+\)2<;D3HM]'V?)OJ6G$2^(;EDW,
MNN':0#Y2:[>'_2$6/9XPH%74+#KY^N^__=^GCY5"ANU&GL&UH8PXVFQD VNB
MIARGZ=LUP\&:SQCSZ'#I[\8[@^4**:R'E#51;[9;.+\U."<W=]+&%G+E<MSU
M])R-G5I(.XY/E<V6N2)2T<JGO=O^!^>HV,E7U[K>365'2=$LZ3450TTY->/R
MD%[15>:S(!+.0X$*RKS%GZE6>4SW;;<_[?;/H"0K\Q5S)PE%B2K)Z8&K9PO%
M+&W"8CO'!47#4GGF.]U3J_KXX^++P5*KXQ(;'H[5 Z=M+C?#@7GYO16G2<(,
M^G/;9_,URL(LRG13.W#^B<5P[S7MKX$J,*R(<UK-9]]P;RWZ>/BH_%_XS6U"
ME]6->/K/JBL5L^#!@,$FC?VZ2S2CW7;Z](%0ELBHPW3#A>: ND5?=^MBRL/U
M(</H=XE'J) 80],"[Y[*J E= _$GM"[0Z>]8MF&W+32IZ2^PV'I_,Q<H9G.U
MO_[/WIY^:I&>^5:_,&ZI1K@B_PV)W:;?JA;?Z1A.HP_0]_:XWC*M^[3&&9NE
M_/LA5B[CF:"SZ_7X<?M[A]X(\&\ZKK;X=_@-U!KH&0./#D3\]$Y_L$R_"U/+
M_Q%7($UMF 1KPW<&<0<X(5[$MB'TNIWWIWOJNHD5>Z=?CP9T!#67ZL/V.[U)
MM21;U:8#ZU=4O_2G^!;\)5 ;0F?\]2==YY@5=XEQM]<B5!W21P]PP_@JTVF)
M)98"J8A9L/V#T,/5(<%0<:.SD^FM<N+RV'I_WJQ_J9\TZ]?:\?GEQ?EE[;IQ
MWOSKS];[S9S1JG8#+(.3FWS^8$<N7):[='S>/*DWK^HG=)>:5^=GC9/:=?U$
MO[JF__E2;UY?Z>>G^OE%G6W?U>;N'YWK;L/6_*XS]*@'1#])'ML$E'>779FF
M/B N_Q>]"XTWFSW7;^*FW^!YQ)VY=/>I\.=+^=.;0J'$.1F>?E0_'O\\.OSX
MZ?J.WKG#/IW5"#](;S5A[NA[^K&TC8Y5VTA^!"%;YU1<#+"KO9W9ES/=1;\C
MPA.S<$9,S@>)3<J>*(K. /;I[YUBL/SEZL$-IN:/\H6;FR!)GW\\^='L'!]=
M.*VH[3-OZ$M,#%XR7Z1H>8M2@J4HR44IL47I=3\;3[WFR=%/LH!%*:W[HAPQ
M^2B$):52=@?%#^>?AQ?5UR@I128?A;"D_"@/_W'O?UC-2G==)05C A.\DC71
M58=9K]]UUR5$_T(_W/7T.KU&3/VOEOOG^Q#<9 VE+O.%:%KV4M9!">*OMZ@5
M7X_^6D^5M 'SW.[G?"<_"8YU3^PA\0(RK@\W3]WAOV:C?'WYJ68L!]VP\YZ/
M8PUIK;:#V8C!I)7T4]?I WLK"/L/R^\>8[*)N/7'=F\(YZOF>83^GWEM/$+N
M^J;KN3ZPGSCFL.V?N]0YO;?:I/9H>3<WHJOHU;#EM5UK *XN?P_+6MT\6;^[
ME;NKSZ6G43>[9#?W?TN'?TQOD,3"!.H(=3=\V")/+?XQ,34I?.^85\?D&\6G
MBW_,D46<8\O"B47X)DLR'^WE"T&Z6:08$_<MG&VL9L'#7\A/AVM,7-OX4_%B
M-ZTD-ZTTWZ9E0;I?3,%$OMVTT$DK/.ND98+\*$_O.+_=M-!)*SSKI&4!QCBH
M3J^P2[UI4]&^BS0&?I!6HV_<TF]'3(&'CT^UAW_J53._&(;;\7L_)6IXYST=
MLVZQ02=9!QL$B%^Q59$@ )%#DT7CX^Q@\O%KO]WSM$9)NCW/HAKY:+OG:V+3
MI-OS+"JE"T>S(Q6WF[X0FRC-IA?S6=!25!;2TGXJH'].T^CZIF]\O'@JUOZ]
M>?KOP29-ZWNC0:Q%TKBGA.$R='^"5;-1+8T79KE$I#>3<$>*ZI0LE_,U[-N8
M]1'9MRPB'J7B=+6SW;>Y+ C?23QQ680]#@MQ#'#;G<O4#(CL6Q:1C\-*'.?I
M,_=M:@3DV/'\\PY?IYN^)^[N;T=FNU>\J%3OYFE=ESY($;(T83" %WSIH8?0
MHL]U-6<1-2BF4/%;;R+=?DV[DK/P^(O5Z?'L[7ZE/E]3KN(L_/5*+,GM=L?F
M/&&3KN!")JYV82'[-;53YD?7\;P+U^D ZQ%XT.>-LR>O[M_T?7$?>_>%'[5/
M!\>_'LN+\J5GRA3@D'FIPP9+Y13Z!V5CYKFF"YER/50R"_YM,LO1\S9LRCU=
MR,1UWE[3V1VOR;=T83Z'.>& %5.PN[Z"$_;,39MV4<_G*R?RWTQWFC-@"%-;
MP?%B-ONV_CB RK<P9O;#A\K@UZ=R\>N3N;KVM7*(.N%C7$.DYG8P&S&8J8#:
MC\2FTM:KV6;-[%NV!8<!&&#Y\4"\#+5HZT]GY^[-TV.M,/ ^_+X\^9TAN7D:
M.Y::K&R@6+]LA(:ZX&6?HD\GK]\\=F<QD\Q-KG*XH6SG\RSI%,NPF(5E6,B5
M4GB8+V9)IYIOQ6P(OJJEZ9[1BUG4*>95,8M41#%7/GKNT8^]-TY5IE72ZT'J
MQ3:_&.X=42RJR)71:.:OZX-!M4\6P\:?[O:XHDO%" '[8K@KE9WDY9OKQL@B
MH5!(@4-<RW,XXUI.NRHR"?:G *^_A+6<?D=D$8@_++Z.U9QR.92R"9(_=RVG
M]FJY)!XQW':73ON$W).>,P JF?C;X<[V/Q<J5_\]??N]%H%Q,7:\*LQ@]!L<
M$)J&L9BP6?/<1:4LO)=B=4ZJ[!<8A<UZ_Z;<?Z4L7*5R/K-8[';_9KUS2UGX
M985<(;87Z78/,SJ#$V_Z+-S 0N[@<'G@\_RD&#N'EOO\UN][(D/^5##./O0:
M_Y2:!_.PR,_J':;&FR=8!PR$[B3&YR>$^5]<ZX7)1V),!.8R)3+!R>5*^3E3
MNHOEC]]*0 IC) MGO)"K'LY9;K>5@&7H@"GF3"8AA-SAO "<K0PL0PM,,H?*
M600^RKG*P;(D8&J(1"Y+PVX[?7+F>!Y"!WT)'30:9Z?'YT_?#6HD%5N/I>.O
MIT[[I)5=D&1^*PA&JW?HS@E+R+%?I04T!6D3L\?S&$'E3%&(U!JJS.G6;;N0
M+5@0IMA"Y?D",TG0JUQU7O]^*PB+UPB33:)RIL#)PURU-+W/\5845J03)EI&
MF<(QR[EJ9<ZX[;.[$:K8@J9C.^'UX=9C"*OYI5$]/+%/VT6WL$*LIM\EKH@#
MZ;L6CO9-3K?)]/:"JRV]G>N[&U1:O)W?=GY)RD9E2FD 5S/Q1+A>U3TL5^TU
M&_6GPV_YFZ>K7Q>7;JO2M\[GT3C/0K^*40I5LU)8PX0EF\?#.<@B8UR:GNI8
M%41$[1*TYY'VGO6XU[5,D]#/4'DL6H\MMT>7H;3S?D^V %J/H6<M!I/-VH-,
M$I?%]86QI96$@WDE8:JV.S4L%UL_ULS?0\^'/.5YYX?ANH;M>U%]US[V\B?-
M^^ZQNT+DYG'7L&^);MEZAXY=OX?! \O$ Q_T2H_ Q.6<2Q=FD?+:?%58V3!5
M.)<<3%&&6:0]UK<")*4D'.8S587%&R((?F.W[,*U[@V?-.Q[PG[5L"^&K9[5
M9@VOQQ3DT>>[_N5A^[HZ#WKA609ADEJ\:%S4]28T2%[P#B8$.,Z;7T[BC\.4
MM9U'6QYF&AL_FAX/G1#<6O5!63_K<5D2,EF/'F8:*RW/4ZNT-C*2K5UY$"C3
MCX9E0PSSW)8;>][YY;AW]U:O1T =157GT>?1?Y\*CT[A0W4-C4LY=%2E*SPG
MTQ=V+KTYGY69E%,\G*<J<FT.Q:;8FL^4ARE:,A-K\W ZG<.:VYM'V=J;*N8C
MV+H3@A>==4^O.L]WA]AIN4G\"Y?XC(>Y>6-:-WU#:LN/5Z=']^4?#U_-XKH8
MFJ:<A-ZSC);5HS?T:A2EK,=-N<#S:,RC3&KR4\ 0UU=1'JV?A9EZZ.7-'7KF
M-EM 'NN.!KX#Y+E41NECGHA9L\UOMLO_(<Y3-"4254[Y4>FZ43PNG_^>1SDM
MVI3[8/EM)V"Y6TEX:)Z5GDM+96K7%8KK2\R0]O1LBG&W"$F9;/$=S6?QO5Q9
MJ61K^E6FA!J/'1N59*M'+NB669[GN",,W,7IV/:W+[^,J\9C_ZRT+@9@.YB
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ML2X5N]UCCVL8ENVD!.^:Y]\5?5(P?U4W5.0;.I\ V2W"R%0.R-Z$"=V<H.K
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MJV&F[(. VQ,$%)-9Z?L@X&:#@&(J()4?*@BX!';O&H*  _W.:$R'0]WJ;:'
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M"B81Q(C*%KUO+E_1_N9!"Y#?01$+ZMV7L6I"N@=='WMZI4FZC=P1*)X>P4=
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MDPS@O4AUJ]W#UT?,'\#<-_[Z%-*HDDFOV?6#VVOOS@/Y0!Y(H\P[7XD6H>N
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M-E3O!166\Y #L]-O=F5Z^_M[6UK;0-$P7FEY2CJYGA3$+Q9>?VCA/AO?D^S
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MNQP/T7>ZL4U/!9F0(Y"Z)HP!]!BBQ4^^;%#;[$NZ.J-UW$Q-0\H"MRA9D""
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MOMS8AB,3O)M&WQLCP8VV!:L8XC [NPU$I1&11::Q>[[:=6O.D/$'196>>%S
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MA;1#AN"RPH>#1H"3B=B8Z,$+<,<QJMRH$HPCRX!3-$AE ,0APU<DX(<4NQ$
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MZ::KZ!+:$X?=SWZ%-H;<9LNY_I>3YNN=U5!+=PLB]=MQ_TM.()_^E":_XQD
MP43R785T7.+P\=<.RULX_M.E >B.@EN*5=SYID@F 9 K'68@P!H4C7+GG]
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M%F ?3,Q-DG[T^$Y.!Z]8,.<HD"(_,E(-+A4(<SB34T3/$S!:(C(!PB +5FF
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MX^"1'>H/76^=*<QV3V1=&T(',\*T!;\8>/)X7QO:E,DE&Y\<D79';4LKD$$
M/8&G1)F"1F*J[D9, :A[ V#^UU2:$7"5"U4H'4TQ](IYON1;=O]2T.<P/,;B
M1PO6W]$ZD$$@"\26>!?UD?UR^*[G%1,CZS(Q.4ZC/NO*4 !D?K(F WLN.#UC
M0M)]*0!6?_#G*$!Z[-L5$YQFX.S#FKD^(,O 4 "RYM9UF\*AUXG8IQITM50I
M%RG$3(<"?K[X9@R9_"GP0[#J2XCBL@YFB%9 C^O(.GHPAM6K?].H[KMLCKH
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M>#67K9NYO!!^9\-] DQ&XJ59P DR8*<+/@T!KG9R;H8U&C*WK\#H(Q%;HQ?
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MU-M8G(XA/VGL"VCFH"H.6L6IA5].H8 2,*3,$*5,I%Q_*GAG=P?@@>-Y:$F
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M^]__:3!T_1M>[6=>&(A]4?\[[_S=:]VVFYV7.?_E_)>YR\CI)[H=<5SU8,Q
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MQ@)'$(R)F3=FWH#,ZV7B$$TGH]A,9LL9=\?#O!:+)[IAE\BY9G$O1#1[(4*
M,9)HC.DOIK^0O=ZTQ>NM<(H$M93:!,K]D%-6=PLT&N6'"_$SW;R/1H_* 7*!
M)GZH,8!J%&'HGYC!H\ \,8/']!?3W\'1>!1.QD$BHN><*O0PQ)S$4[P@3C3
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M@#^73.73R536K@/KY+S*D%JT8M7VY51;AHAJ6P_YS<M3P(_83(E^%XY4M?E
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M!9%O):%_)8O/>2FW+U'H/J=^'0.K#DX1RONM"PX+OG>L.FQD]U]Q>*K4&Y;
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MUO<J/G&*PDE:12=FG?$&M5XNK[4U1N'WK?TP3-2'#M1!66RY^V8518&8B\0
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MU>_";]'T+PJ/JX<_4V=G!L?RPM1O '?M?%D<5L-L!"]=% W!_;]OT!)&_X:
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M\-I$,TFQ@;^";_PQ"_PQ.O[8FRNV6"HI]R,V!/QY]"JSODM%?>$/4OT&_LQ
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M_Q$Y1.5 .GNX__8;FHL*4*$,4/%Q>Y#..$&BE+6X#<4M C<JY%H>0 JDM"%
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MB/'IPE\!FCM\H=UM9F^ 5KALL+D\:^-X4MZMKJYHM"?T_=^/UVA9(A=$8$!
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M!D26'G#SPY14J$(VLNZY^"N$*ZCQ%86#2Y;H,G-@"+L3CU' +-JIRBE/H#!
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M74SSEEY*W!*:+0T8THUMZ22F,.8KAX7L'J)NU<5R(RD*O"%6Q0M>?Y%\,6X
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M8'.J\5NX7IJ:M<L5+6PAS,G,2E H+@,HCBNJC4B,2!&9^6*:M_12XM8Z;6G
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MDP@]S S'EGX+2Y:9"V(?F8MO$=I>A-!+4#KO*Z_AA;O(2,*TQ^<4%/18$Y
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MU=XQ8)ZTF0I)@ZZ?;;)L@EIW'>#YFV-,L/>N&H'%J[HT5"3!<4/77=.%LVG
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M4-STEK7G*3C)D-KS52J<OUIUP?C.$++=YOIB.--4I52J;UVK9WS[G7T6GU\
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MF?."H.#NK$<!?R@Z83+SJO+#/N1KN5>P[_A=GY*]H35XC'8(H["O&8Y]@27
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M$#KR; ?U=U5U^;D[CKTJO,YD'3:* Q QYUV%5\VJ*C;!JU/X%N@DKG96G>K
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MN$PDNHN<SPCLEE3;W/K10^>TK3/:#"<5".BK8H835Z^S)ZZN K>/"^_ 2UA
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M3%."UG4!$:<=0]_GX\O*6%J.YT>%V_Y+8UM%S/I-C1FXB*&,/^27CY[N,-Q
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MXAA]#*Q#)IA/-O41+Q'N92R@*DQL;I%  F+>ML@(Q#A]T,@1HNTN^24A-*_
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MG\L"Y.Q#.<MUI0$[L[8W?OC1J.JW^Z57<X#Q0-KUSNS3Y_J3\6GXZYLVW/K
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MBYC:FMA)?#4MFI8V'W4OBDX4()C*<-4Z(D+2PGV*J>K,TW5!D;3% N\/F"1
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M4MD.#<WP*A,^!UB>: L,'ELF\X-N,M*;%>[3.#@Z..7.#-JQ"+O:T#Y%>/T
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M[#Y(#1TNK.B"C)X>].^FJQ2].^,"&WOJ,<9[6)4?$;6\$UD8?2 ,_2;#,5+
M.@G>B54=H[=6RL-D&3,(EFL T9!9AM /+ HE%T#?%03.K?0[A6, "Y0MP%P/
M1T%C*JNCJG?DD"\-!V2#-L T('W2\2]]QPA565\8PX\WY[^M_48ZV4W$4$D$
M%U(G$R>R!%TME:?,"&NW+%$6+';K0Z.YEUAZ]E>DZ"PKW:A)=!.I6E."RI6X
M'UU27.;O/)>W2P@".1Q)B]51G6NNKOU6/X[LKC92SS3GGBA501]?=SKNVB.7
MP__S=/ERZ1]\K?3Q=]X10)&S'=]2FM.KF?Q_S0^7M+^M<F(]$+E!6RE9G"(8
M]#D'7;@\N3P231%82PAK0+M[O,KUO[',U#@;ZY':6!<<$+\9!_H+'!I*5T!-
MCN?RA_J"$V'6&VJN$2"WAMIR7U^V!87@U=@CUJ!FPJT)]&4[KK+-FC\@VZNB
M( I>1%$$.;6Q-]$,6!P14EB!"#DT90!+$0 #V<1Z@DY> ,Q!?C*!_B%CCG:?
M"@MR:'2]H+V)@.B@@\BJ4K%>;M(::_I7D!$[G4#A>E ^$RW?X]O(UR8V<:Z"
M+X= >_'3Y>AK:S;JUX?B4KV,;,HBM2UU3Q*JN(OUW7(S^"LHW5NT^M6LS#Q2
MQDI[R;GY(L_G,H)RG<H5A3!#26J;2U0K&(+#0\!0 :T76)<:EQ8-8C,W!/1$
MS<S0E3FTB!#_(7< '+8;;3)!$8J#9Y&UXXO>.%96,*N@H3SO3\'J^Q4*?T/4
M3T)2;%]&''D5$)W_@U SJ@0I,W$HP'*KO%<3B@\\XWKJ@STBA*8^&K!KL%_D
M-0!_R'41^C:>R>X9EKI=*NXH-^SK0VU*MGH\-HB&B[KJ!))(=8ZT+.$>'(J.
M06$Q XGVJ6!?P3T9-: V6A:4+_NGUM'=CX.;P*X+EK)("DB+3E"<7X+3J[FD
M]"WF='97<5T(.4&P%0?(QV9^H/XB1[(B#LNP?9>SP<%BI+D_BB-1)KI'BL:P
M7KS;%] 2W[(Z)YIF*6%I)^%>'G#<B[A[*$+3[!%)W@>&W80:"(2,B:*&KH8G
M0NRTE);^*F!WI4U[9I9:E0H%WA_3 J60BAA<F^3GHF/\*S4AB G%Z?O5FD'0
M\W%N]ID!J4OO@-2Y E*7W@&I_P2]OZ;9OW*)DZ9UF")S1Y%R6M1C@_87?97K
M_7-G]@)]%K/&0@II'B9B5PIW$A_%=.3<+5=X(8^.U4\^N2NLP-$$6.'=J2*^
MH:.AE?VHF:Q/B&.,--HJ'7L,B;&QA:'!FR]BH0Y/\27_YGC1VW%6X3I2CL*9
M7'-1.BB?SM<RO.C>WE7OO.&AF1YZB232)2($YI[/$]F1I-#-<N7"(<,R<Z)"
M&AKDXE*Q'>PA_$1;.U&(_='([@%5*A,*KN-*16*T)=8<W2WH.[CFJM9<:<^V
M?][U)Q\M>U)+ISVLCMW8&M85J2Z?@'46=P8MGPZDV3_4 Z?-$Y<,9(>VH4CH
M73,IG-S73]MG[MGG<\E7;8^)O6H[4W1T+CI_>;IK.*T\$&.SG-8DO&IZ*Y'7
M(IH(^3YZ8LW$",89/&1Z4_!U/K?CP.(#_#P\GS1.Q@]EHRE.$.9#YPYA1  _
MV<K4S#6A7<#B$Y-/"%XW)J,/=6T*6"F&%3G19A06(GG[MCZ<:4YOR%J35^=2
MQ^@9_L.[!YH[BB8:+,3!J!SE@Y2>ZP$:WR<7(_.B/SX8;@CJ^FJ<6GL>D%:Y
MT2@T&LUEH=E#G:6QLA)TSM0N$*_\\KZ\NZN4/W:U+T;UWW=YU_)0&;-<!P#0
M#9>W[H?,$9[*XQACS<2>@G$I@N(PTZI$6,WKV@V-6;UU_OURV"Q:S=7I!8V+
M+,O)WTJHY:&O518?N6+2QE:.3ALKZ@LJF4 I,+U(>_FN-D*Y[0X-;-:%@!01
ME+#*:_6YO_:<*ZA$5(ZD^LI7Z]=Z8PE42SJT0BE4].X).;EX0H$$#,.S,4P+
MW>90-VZZZ((:A8MNH4\V]UA-- >>I3I&Y'?4845^W#6$:X$U%%;[YI.A2]E/
MH1R/*$ ^PAVIW1B!K.!@KDEV5'-4XX'L_)[:CA<ID+["94]<OE4SN)1"];CN
M2]U"Y5[QR_#LX_69'4 H1>J=4^^>V%FOX;+)P]RL+'9),07""&>38[9X^!:*
MDATE'B6:2IQ\";VERR9J_BV/:YB&5UB;,TPO'6A#[4TOR7YZ3+6=@(UZ:+K
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M+4XO/ A!HR4_UIE]GW4G=_7!L/1)>S4WV7^['VKSZ83D6GXJ#MOVC;O_J=:
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MG^Y"@.U4(V>3<!O,OP93ZXG,<ZG$!ECER;N(VQ019RE1=L="?<EF74)Z$5/
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M%%A247FYI[:]!*>2&(8'%Z@GDVDG*>:D0GV/U+$I:@\6.4O^8.W!N]\Q8P2
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M?Q7;]:-Z*3:&04D&,SRZ+1Y4J\A+/Y.R.G-< A3/;SAI#$G,5$VW7ODG&,"
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M'IX[G\E'FW:K<S(S2\5BH53.S<S<)!_M2BEX=HGU8LJ\=O;GY.%O9>NC74C
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MXYM_SG&^]4GUYFA8OU(X91/.-]Q(<][SS:,S5'$O"D+ =[X%&WM,&<OJI,!
M'SC+CS[F:V;@;YO6QV##!- 7\(9MZ$6Z^4/:'09PS3K(4F#/9/06MH0QWBFX
M^T 6H-D,/+?''I$V"PP&39Z-8<%41B9%!L3*$$#.Z2K@)Q*(95"K8#T#74*3
MP&H58KD##*^LZ9@X,-:QTWT3PSEB2'H'8_$UJ+0)ICD:D*U9$AK;6F1<OE"#
ME1#4X!$B *Q!-7%74F1/G2E"1U%Q3\IS0A+2I78%?2HA-0$]<*%KAOU/="<5
M$WZ/+^2-+/8UY64DFXEHA%XS<"7O?YS6M,.GAS_MZU^=7EXJ3Z[@NP%8OM+C
M="R]G+TJUR=G)_4T6#X /X=]))#3H =0?%('_VG#\?D:2\'G\YW,HO!-U<SF
M7D;X)LIAV1@.F\DN6!L^WD8 8&5T;KU[H*^,&?Z;@?-5+4:"JUPIYO-NUY!Q
M.V<9^AE 8\(0?)D#^)+HC)@%HROPDVH2VHFK5GN+ PG\M-NH^6A\H9R[NM*I
M-AQ9T&AUU$:?$+LIH$T'GXY0K(./P'X=H>TZI;MUA3;+UK0[Y<.7I^;=^$1T
M"P9M)RBK*EW<P1J;FC.X)'R.IC0TEYGQ>]9RG/D+9G^OFZR$,50D#W$$3:U\
MB2-3OZ!Q[>;79=L2_@HN\$#,!4VST++L06*O7MLJFV&-N$^-=T5^';<Z7X<N
M." PU&JQEMH_[&ZH]]$\C&(#Z,'?HNBT>/N'_]N]^S/NO5MZ\/<M\M%#5@=-
M%#WP>XVHO+2Y^>0_[-)R5,(O.PP:TNP$NI4L.0<V>$4.%[XB.<A3>RL.Z$YX
MY:GZ-B@JY2.15Y0,Y)]1H%;+J0)U33G*29TIU\;"DLZG_W1\NR\>_KFH/^5X
M/M4%SV>YVG3"908GGZ/AK9A6CAYEI\%>,JE 7_.4(,("9 *CV^3QVAF_BJ/N
MM=0NYZ8.5]/5X;7>WF6HMJW9SE:R'E*""/F<;R:-5BN_\I,3C3NW:NDTD.I2
MC8\=9)AOA'8:T441YN)74VI%VS4+/7[2%"EX(60*EZHQ#1$C=-7RNSI@OXK:
MK^KM^EVU6QS5-^* 4]MD1APP/\\!URLQ![QRH36[VCG65<$"5_YD]6)J_2HG
M3D2Z<[; IF2^5;XIGW,5J^'FG=$.9Z8SR8(W&H=(&ZRFS,*KMN&JYS*$UT;8
MX=$GGDF G=\75?E ZSQ-&[-2Q7KL\>BUIKAF:ED+QJ),\4IQ+[9K>I1K9B-<
M=3.1A%_DJ<=U4>#^G/<.WCU%Q#MG:EGKIJ(HHEZ-3ZO(S/B"'IEL672-Q^G?
MSL6):$Y5_4%93A:='?]YCTET^<_] [64O-28"WU,0KVT62?N%CX4#"NI\6;!
MWVP3]PEU6WKCEJJJ:F<KTY:EN.^WVPX<'D)W&[0^66($"X^(>XT.#6@%2K\T
M@6_@DDG(& KV//5D^_BSD!2,89'0+37(HS.#*Z/-Q5^9F$43#8TK5JE?@4/R
M?]JKE'^>/?'U)R6$HTGW)+7J--,,8M().6115)V_:GXV5Y\O)N% TY=+A6*E
M%IM"]MI71.A=.826MYIE,L%]SA,J,J;P(J(8\-1W6.B(1N-FY;QZ^O V#L.T
M93RB%4T^4@)&'^U\X85T-!5RM/0VV\U(56 )@A8H48A,_5U!L4WFLL 0)50F
M=T?:Z_3FUTTWKOK&O\3U$\;,T&71Y)(UG=1/+AGJPS&][*U.N*^A\3).AY3?
M1'4DR3_^_9_=7?8( EK?V#8ZD.]HI)>1C,0A&J%4_TZRX=#?[.XN-6(E99PU
M-X=FH]G?5[$*,E/.7'K:&U>$9)FPIA/OG;'T8514,4;!M<_)\[J='T>[WHVS
MM^P["\;,-[9I"!U%_,Y>H,M%MO5"A_TKU[V_^J_],_C*59]MW?G?_Z*-CMAR
M0Q:>=SLR(G\T]A ?&=UFM"Y[CQV2]1"B2PQ#W^#>*<%<R70\-/+>LW_GGCS9
M48SV$Z!D[V<D2Q/?W*4O[]\.6E0G+S4^97T15R3/A5PAR8#8/JC01+7%DL3,
M97V1]L@<A^ILPRH9](H(-GC$*[+;6H@;"XK&R+2"!#TJ*0;2%G3#M"TK<Z1:
MT'2([0MCF>W(LL8*0!Q(H3$<JB&5',1V"GZ*U1^H<(#!%-/"=A2:+_I4UV3\
M&@M-DQ1V,/;# EAZR/@#B]!;:(-X+6O*QACI*,B^E U0/=";.A-B9.IH9KAH
MW%X&F9-;9D$DGM/SW@Q/%Z^. 2UD#+ZIKB>M.;W4+5"ID6^Q0SU4[& GS%]V
MHPM1W7N-KS72!@.?W")]S&S2M2;6./CPA9?XVL>I<'IZV1SQU^51?_Y\_5EN
MWQ)X2*#\H?4X_7-]][M_6+D5+Y_2RA^ @-T-8ST<F;7W;/,K((K+J(!(2U1/
M>#PI*S[OSNZV937;BY=8WI#W HE/ ='IC"M<X12I54O:1&[,06Q$_86MW'W\
M2I,#\ "[E62;7W02N6<7X,(FB!W9VLFO$1NEF(>3CH3T3C4D D>XS/<2:6#&
M35_0J'/+V1&WC<90*VFE.:O H[23J^M;I[R@VWYX:C;EBT,7[,WA@-14*K"7
M7MBW?;N9P2I 5>J; JJ23R>+7/R\V4DHX ;%\@+XAE/(BZF+>GMSIZVFWIQR
M]^VCPX,(P%*?#&,#S&S%1-98#L;+DKOWV45\Y7]"C;&75].U:F[H[PJ\3$[8
M_5,9GQR]6/N'2@(G/ [T2;;WKAQ3W+:<.,B,VS8CZ$;B1OG-]D9>G?\JY4*E
MPJ4BZ6Y$76/.L)TS'F8Z3U\:0V]-#M0#K?IS+ FS,O1W>6]2MWJ)%VOQT&-Y
MKYX.39V9[C>D\P$)_6Z041!"S%L*79)E>[L?$$D8TZ=VX9O^NZU/W\[*HQ.^
MDR ,R:PVL9/"C!NZQ'N<4]L%KE8K\+5MVX6<#GR-0O176SFY?FB^_9D\S2I$
M%[]OFW'=UBE7Y\MAGEFN;I;9.)/+;9,ZU*Z&-T2XW.:#U$RY^D;]UKBV[J\J
M%^4(J8H>_/^6XVM;TZ4/;&NF0H7L5[E:7+!EHU^T5C:KBTL^[L9<V@HLR=V8
M^^WZ=6V>'_8&YV<OW36Y&]=]SV:4JSE<P?GRJ?T)LN7ZIDG3>>S5D \VI[Z9
MS76X69=R/W^_C0;WK4'Y;ZDR@X-U@^Y9!J=J/%+U++=JP0:<]M6JUPO54GH_
MXJ76%Z]:%LWK*\V?VJ53L_9K=%X9SQS\>C=78#X[+I\[,E]ULE?RU/;X](##
M1D3ZWH<G=#6Q[; G-*8/[,(W^%EZ5BL_[\Y+"A\OKSZV"S2?J[I@NTW[OO+5
M2J'!1?5>>/<NT-4H>?.Z0'._6?IMJ\8=2+HVZ6Q=H"L7G=Q\]<U>T5G9JVZ<
M"W3V!$3:TS'-'[IQ;6&Y]3A%#SW9-[FSA,'?2\OL:!>7?^,#CG[7Z"'^[VHZ
MC5:Y3>HTFEO7V1434@;WX.'RA,[A@34\>!J4NN7&S.[!U=):>4E=3[.AY;30
M9;P_:OPL'_."(*^F2FDM%8*?KB3RIB\SEFX)JK>3E!\BYG__7YWG:M]-=FC(
M8T4?F=["00?M0<* *S.4#F+TFQ#H12W'9I-^[<KA*%Q"A[SIZ?U@>FU=EE\%
MUT5SY-N9B,5G4B"7L)!L^F! T\N<?)+0#HW;B_*2^-JA,9'M[D)&S7*/-YBH
M,>W]/CI]DL\O1AZLX?=UO*&,A\#Q9C:L$X\W*O*9T.UNC[W4V#DAL58/>?6)
MV/O2.])5^6)\D?:!W)4-(_9:W"M6_U3#O0U&@AK2),TL[>?R?]GCM&$TKGJ-
M*?_S9V,.5>?]X#^ [)^]2ZVB!3HY0H//GFXH@!A'OA-$D0QKPR" XT4@D /H
M/WB_X5+J0QE?6,UD;-B!(>:!6-< )#3TDR_XA4CM0'S _+IX:\CW<SXY*:-Y
M+3AIN6[I?_-Q^K/>?WK>KXA]LY:E\Z&WR:SW\K*T/>R[+_KWK?T[N^;::ONH
MRHW]QT@->%P2?OVZY(^&E<_3\,_=E.9CE-YHF:W39E5J\J_9_<SKZ ZX(27\
MVV:;&P<-L+EW;X.O$R$'ASGX6F%E[M8._O&^\[-3#>E&\K6M!YW!&*"IAOR6
MB-+%?E.3#J#3MSZ$A^F8MO?RSU2]+4WX1D]W.?4R.H(&Z_%H1U Z16R?2>XD
MEU!K^9^8,>>K%%R@*7UBK"WMP )VTX)5LMA0+Y?20]_K*8_=F"-+K!"9\<A*
M.1Q9M92>VCI/ :;+I"JK8E+'LH;L-Q7M7U,:*)IB6F#-C>4 FSJ73PX&;W\4
M\:P_!YO*V+4F1O;0*1)L==\DUY[IL:QLA:6PMTQ'';@ME1QN"U<HEM,3\C:\
M"F/S#SZ>2<YS\ N6M]*#Y_DHO/P\TTE<EMF:EV5.GRY/A=KOVYO!=6TI.E@Z
MGZ.Y 3<XB)?FO5M[HL%BT?*5,;X 12^8K4@INCQ'0=FF)XYLYGFF!,GX1B[G
M6:\NZ3QG2\[@'Z?5UZMCI?E6>VG,$[%8,X3LOQUG\4'X[>"R\PU=P;>>AH[8
M#WTO&+B<X4 Q156'_E@Q4:ABT>W&F?;+QZE5N2\?W;^=U"N==WE 7'$OX.CG
MN<?I].'L4&MQ?^IEM#D42=W>!N<@5P49OW2,XR4&44NE!*1KV-:^KB+^:I*\
MN@O=DNUMOC2N@)?&QDJ+T3#6LXWY.!U5?KZH<E/Z\_*!D[^\\="^8 ;"G*]T
M=UC=S3AE8\.6B\<IW\NNK2]E;ODM+P*QS<KC])A_J3V7#SM66<D2V[2OE#=-
M^1UCF;^#H&;9&\J\-4N'\MFO4J7[><(I[E9PG@#F6>NR*9Q85?UO[K&Y;0 S
M"P9YJ(QD&[-\QY=L@V_0TDJE(A9#)"9\_8U5+/0.,<JT/5.$#FXIS+94P325
MKB)+'CLA!T2!^*+X] =7V#Y]GLE$^BN]N EX3R^[=#^I[NY1-Z!Y8S_Y:1+7
ML:U9Y[C<T[(/RVY_[9H4HXZI2(I@3*X%Q[#P#]<VE+%@R6UT-T@BIG^LZ:D^
MO#T_.7WAGDOYA8>2L;&CB)1.DW7F&:+0'*.CB6'7^4*D:600U^$2>_O)63VF
MGSQ],/E, [;M@G$@I[ZT7LD$R;41<- 93S1C]5>I&E_]M5BLN/J>&,EI^S#(
M/*SK9K51.II<+RD%)HJ/9 P]PW1C><B'"3JNENV$*"# :G)"E6A4"K5R;J 2
M[S_LG)5--9;5,L-E6/OK95C3IVGC52W=" .MOBQMA2]&JOK1VG8D&2%FBFLZ
MWS/-K9_K^'E+F<N'MU3K7*'(I2.P;9F+G[F49T!;6#NJR-RF,@G&;.WDG.SD
MUC*E!3FK?'3;,[DGB!,(0P<%SEE?>3LQM>(I+RS7/([PV^!)L3"K59%A9FZ0
M@(>Q)J)=@L3B_1(KA>!LN19#2@%QEI=57D96.5?*#S/1O;S<>[F\+5*<KG14
MN6WH \4T=<,74'<:*[8/JQ*GC/N>X.&JK=6='Y[ILNY\69CPQEWSVO::QUSS
MC$07N/4Y&<A<H<[SA5(CW4:>X]X?OI=[WQYUD!H7O.25@^K/DS)_*;SU5BNP
MX_Q0>)9;3U06FS#;U8LZ=_\]J^35AH(K5(K%0K&X%&3%]TD$&45'A5N^,ZJ\
M1DXU;79[#\>EVX,_I?(*E(FM4VH#&%" R2Q8CKAE,JL\Z)F4O,!!Y]3[ 6EL
MU5JA6EQ=714_(X.<5JZ:W>>;WL7^D[01[O6L9:88(O1FR]YBV%N GO/J?\D7
MN*TW?46,*W"$M7?$DK*5494?IZ4_W -_V?Y=>RVML<QAR<GYN'9%?A/5D23_
M^/=_=G?9(T56I6]L6^C)W]%(+R-9$V&$4N,[ 3M&?[.[NY3.)66<E4 #&U#%
M.?4S9;JG)ZMS1<A6#Z?NQP=VT %%44Z,TX+D:/I>M_/C:->[<?:6?6<!@?H;
MVS2$#@B/"W3YR+9>Z+!_Y8;W5_^U?P9?N01K4^N__T4;';'EABP\[W9D=/G0
MV$-\9%["(WOLU%^0KS#MN<0P] WNG1+,E4S'0R/OLF8KH:AP68N)(*D\ET/\
M^DP@&I/#XL+E07DBG.:Z"XISJ,I:J@K7A.)ZJC%($',%*#4S9(*/FP2<'2GG
M2>>$R^ZU+(X,Q5)DLR6HJBSM3X)U?Z") WHR1TI'^/V#>VLB7C=?/"#Y=EV3
M8IHC6<)U<*9LC!51GDL)R3ZY2!V%B]11LE9Y^WN:N"U@RP6NR,<"(7NCH]Z2
M0)$@#Q,<::=H\ N@J//%[U$Q5?P5]_VKO9F6SDJ*(8N6;IC>G07L8X%]M?L3
M"+0_@8V4S Z13H,QK$.PVXTTXCBD8[1A".=+9].Y $GT7TH'#UU-M"[E<-^$
MZ'G-119IT\I.#-6LZ3OQ#6Z*>UR4AP13PQY[JA%4>[LB=)6G0FN\6I/&^*0F
MML<GRN:=2J094<WJPDKJ%1OIM\*G4O!=4GJ[@J>0FE$X.^/DD[N3V![>FU<D
M+B;D?R\U^9K<<J=U<7FJC+A7^;C6V52V&_!I):TG<.Y9LP]B6',9$G2KL:S9
MX;I>3HHAIH$]V#N&0<&"U%#9"&JX>=4#U/ PJ3^TIT>]T[O:.Z2&X'H"U)#5
MF1!-#7RC'..\#E #)0#>WJ0]]@8QZBB)S K0@0"[:'=%-Q</H\B)HC["P.0P
MG*+A#PQ)0(8<\ZI8?;9YW6)K7'W/_H,U8"#H:P!B860Z[56H1@!]5W9Q^PF*
MVS20K;XN4:4 OV4@"Z;;7L7?JB("[&F/0<)(& Y5C+^>[35?A X %Z!S0?\+
MUC(+Q*0@?56 53J-G+ZR!-H=T-YAD^CBL-(":T.72<==+79!OJ#W,P-=DM4"
M*TB@+),',3X\^ASJK?"F: HRA5D1'2@Z.Z0$(ZU:-.U]D@=#59_(,E6IR/"F
ML[].>QJR2Z1V2^\\D=X4Z&Z@-S*2C(8=*!IY7S?<\2,*,XNVFNAAYRZ>+**$
MT8"< _K2GICY7X^Z-E*[BJH2&'RXZ,[TH,<%[ >Z.9*"E\!^4;KXG-!^(Y/_
M*Z:O5_BU(5L"Q=G'@Q!*]4\;[33^#J^P#UTP3 LVU]/I A,/GKY-.^07Z#V,
MV=='JH3>U%71U,E&HPD.,$R_KPV0Y_3)NLG;R!M>\2@=]' 'F40"/>"AH8\1
M)>&SUIQ]<K:)?>W+>'6,<[: MP';;N*+!F^PN;2[7[ +:+'H*HU4>!%</K<O
M092&Y4TEP2W(+G1-%,R^#>*6W%3,P;^DP1JT9%V#;0C@8%*N8;/J4;MV__/W
M2?=Z[*IA^.7V5-.8<\1,9X1K],VHSA5KI4JQ&&"Z6:VC8A#X*I[31K;\X5/.
M(+Y;S\(G<7OXJE5:I6?1X)9[$O'XB1E.HI:YLB"Q94^\I4I;]CBF26)_+L;N
MSQ7H\/.)W"V?K@G<J09229/)%<!:#.;QJFZ"X$AHWP0=7R+Z/B$1%JE6A155
MVNT)+IB*QF;<MD^*AJ0'[0B%9N =S^=B 7J5WY#NH/7HT+[>3T2NVXUIDKI&
MP?OMIZA(9@)6_!"M,F)ABU^.]^.#7>7E6+)'W9-"RP02H<W/ZF+_=+RO:2+C
MP!0-I4,T2IP&7RWXU&C*MA(2YTT/CZ..0"I'2T1WSY)TSX!!Y34W36J#^LU,
MUC$SZUS%'MU%K9-!GR=J.+6(\%K(+$>F;0EXC0EL42&%0D+L#8W+U/D**RDF
M,N1-[Z;XW^685))K%81[B(I85N!1;"L"F94]#:U01&M6)\"[95DBG!=Q9_(/
M9"?(2.^0"@P.>4"TTW\DB'OCZ*3GY:]>XWT UA#:LQ'B[4A]88>Z81G"A.PJ
MZ*?H2/%F8K/)D%7;="&3=@]KZ!P6H\$6SFZ$5*.!0L/Z;[PE<B!W++>;<L;J
M$S.8,6KN#ZZ5WR?2W9VC#5][HQ1I6G$()74VXR2M<"$PWX"2G#G9,4%);F10
MDB-MF'+6(XPW8?(YPJ>[9OVEV?IS-9!6<(9ALV:Q,\Q<<Y9PAO6]>/O3/L..
M#%Q.L/&C7:](%OY-&ADS"=VF_'V,_792@7WM*V(?G#)^3FY&G9+=3#&F1R+C
MZY&X-<$^\(*788)EH_=\[:_LYI;MC?!9:]@&$[2@W14E5KVUW7[FZEEWRWGK
M%;R4(W*6XY!0?J1_U1ZG[8N[R])4>38?2@Y7;07FF^8JRCR%&&G)(4Y;=?ZJ
M!3CG?!&2-E+^DB.DG\ER_7@I88"'Q'Q20_43YX)%"0J,-D8X>ZHYBSB%'I<-
MX>NM#2SY%#]W@)4BTJ">Q%V;(C)-31*864X<I?OVJJO[C>GI043(&T<1<>C1
M)XW2N'3F)>4?<*DMEHZ&,<FBT _#*0_#D8'$L1D0K78&F@^7SDX]VV.\ICV-
M<9N.C/;])LH;@>.D(T6B)K4&X4M"@-1/L5LN[K'7(Z09.X_1("$-*G9D41B9
M,N.SY"6=148W.Y!E&G4T% @/"WABU#=B&;)@8;\"=A5@+T:!E07T*EO;'J"K
M"3%*I\DY^ !8U0: ^DQ"\-,IUM#4@=(S=GTYU()T2D0I@&,*:0)=I$UKHB*H
MOG!WO-^MP"(!=.#\WL1J\(DLH07WT'=()GG2/HB#RNDM0<@04:#G_0XQLB/$
M'%WW%%7\[1NQQS;Q?-!;P-;T><1L<]/T$[^?UB&'5(&;[7KJ8.:^6X<M M=Z
M%K#S#%L:7;^7KHO8(DD1"$SW5H-WH U ^XD8DO^%Q(/&N"M&MK(YP@D;\+ A
M[WHS.2#/ I;3$53\!K,/S  LY3WV'@X$?VL"9_'_LN!=E&=_<8(%8@9V0@J#
MWNE.KN"QO;!) S3@V2PXNYZ&Z$NR;7>Z_TZ>AV.^LW[KW><\I5D>Z,1HT(FQ
MCT]T<D]BEWU*7:O^7Y#IFN2\B7L29B"/9=>KX>E54@B<.=D5!JW/Y[:@!XJS
M7^Q\G#%AMFB*F&43UZW[0S*?K;?B TN1)G9-A7QBQ.V0E  2W<JM"438PY=F
M?^(^TA8FV%<*.4L7NG:)PQ1$AW0M;=-3OT@2&.V\RZ :F@%S(0IB^/BP-C(/
M;@?[9C^LAGH2_U-5SQ4L/0O$0!J(;GV^3/F,>JI?DT2<&O+</+OXF72Q-9BP
MRW9(8&2<S^J2^'2Z==Y.:Y^3 E)M(QP4.2?H#Q7)\0G79A06D?!?(_WZ^$KK
MUZJ&&NFU<(SS6=P6RTC7IX[F[*!6]?F*=3+!S!#A,"1096[1G"=-/L!:G)JY
M6'\')D<<FD\-)1SD48B5.R4=O5W],II7];N*$*:D=95QS4XU\Y7Z^$J\N+U*
M M$@#H+#5,3""L#=8;_2P"E[P]@#I2*R9R8F(W0MF<:@TCG6'GL(]IA_>#!=
MO2.#6TK79#(?&,U+D>]?PB^$)E$N;M$D\D230%=BBR:QQ@[ 'UJS\[;"'0C@
MLI1DF?CZO+7N068+_&_9TG5VHSY2NKY,&N=_]+JV7RQME'3UF>KITG6^Q !_
M67N12Q2N 9&'_=."A?B<8%JV+*7>3]@O*.]"ZJ@E:Q"[(2H7 _0S(&FF/66,
MOG)E;X3 UOT"N\ J7>IC!$\T,@I4>+4IJ!ZE+I1*@KW/)I0QT@Q3)K$\S(/R
MBX^L+1MXAY9"?)?<K];@W/A]T7!5N[9388"UAU1W4LQ\<Z*K^8*5/JVMGI!W
MXJZ3_0(.:[LX%%>&X.-#(@5J427$I,Q19Q?^"3DT)J3;Z49/T)0I<:S#!Z(P
MQ(A]]",GI*$JS_)7/"@P,K[(6H8 C(L!FL46 D1X$!'OTB^ F*F#'!MH2*+B
M5,(9J)4D1!'^2/.@T&L,B?6^@HA<QFOPFK!8_+AS;5C/M:$YC+1INTWQ@>GL
ML;?!Z)'@'82.W)EX36V<8YTR, B! MQZF*F%9(=G2T+C%US^&344L \GX0P2
MQI1M:N-'7C#H$D$:B*MT\(3?PK4$H4$BPU.1[B9P29%0'U@)\)&@(GU7D="R
M6<H]MD3X@7VS,T6LJN\H8A6I7YSP;\5A5QX\=^2/$;-*55@:BT6M,C@G@]SG
MD\>N/EXR+>EIS$0U@-Z&L3ZR,%Q'&&M69/0YH@O.,\%NW;:4:/W5QJV.=ORW
M][3D4%4&F' <5;#3::-G'.#XBX6CXMN)4P.5]H./2JQEY@TTE=84:$HEA9N?
MTB4OR>>WTXA<ZW7'FF:BBI6%F_S124HM8>'A9%B3Z%3L<\P7\!NX]58^$J/)
M^@ X!J8]>!FP&\XY&=M"BAW^*Z0K]F1--I#A@Q,\(;':0M^97?09]K*!.=;3
M,.X%N&$$E;Q(LQ35]O.QX9C9%^+9AS^'4!!NX8I+.K LFU]M;PS->H3W=F3J
M4:9O@,)S438PZ)7K3F!,4=8$0]'-@,>"-756U<$O8Y*!X3CZ,@!1D>>NAU!0
M:; D?1W9D6Z)9O0D]U@,]?.*]K(0O9-.Y)GM"V@4J'TG?B:<QHY=4R0G$N;B
MHJAAMXUNQMFP!70L]NX)F,?X+UO!]2S1]%U<;6<_@AU53D)H_.G[-LCQ]& D
M)#1GS;MG!?9<MM"KD_>.\>Q=S(9Y*@QIQJWGR /G22A P#FQCC/)/7W/HKV_
MI@MAJ)?-A#@O=B=1N@AYQSZ13O/IE#AOQ"I<OQ)/G,LH9F%H,4O:NQ<L;XD=
M&1>\,,LL>'D_=/$I+\(Z"UY<1)99"EXR&EPSU+_$VO.!R\"&*F(HQ$N>!2I,
M;(%*_"6.+UEAYRQ987(M60D6H,Q<LL+,5;*22=&8H8B%V1:Q?$Y&.5-(H#FC
MOV9&=WZJ@7YF-7GN92JU>6DAC_Y"32IG,L07 _5.<\\D< 'BF =S.<8U_S$2
MT&;(O.2VF9>Y9EYRV\S+#>CC%6SFY_MG)OB&'58V16$(E&*,Y #_:NP$6.<1
M4JGP-3I03%!5D1IGWJ!7[*O$+>YI)NCKQI3XN\?IQ!IU1I/![^YY;S5-!W,^
M'H[;8_S2LLY7'Z?BY+YV=/2[\?.O@NX9:*-X#]AS5P$VG?-<50AQM1G"N1)D
MK<C%$N09M120[4.W5[K4KJ L"#3HI@;A>,/^YSYXR&Z -\40;^,@BG@7?<?C
M]*U\=]NI#IZ5%W&-W35787YWD7#37['Q(A ,4=FD[1/"QA<85!8QIU5WCUU?
M,K48);"OO#E1&K:9Z(83OR?U)IM@7^.D6X)J.A0,9$1^P<:?/C+1F\ROW]9Q
MX585NO9SHWW^<:J]-=K=9N]>/'#[2DN*.50%]!9T2>6=']=B7Y9&$/OHLDWW
M3#QT;_,N?!0N2W-VTKNA,VE'V3<]FQZU8W?BCEKI=S:ZH;;;-SNF'3'>;7_+
M[,R=D=$T87?^;X??<=N#-XZBT*(<CK,_<?X\461#,,3^Y S9[6K 9'*>.M6&
M2./'CW#4;HH<UB."C@RBO$WBQO2**X?;V4;9_=7S\]G]Y*!G*$%--U:7CMC%
ML)JZ\P.O@N4R=4$.#1G74#K_$VPN[03YE9Q@;W_\(!P?B3\M83DGR&_Z"1XL
M[01+*SE!J5<\?[AH/8]ON>6<8&G33[#LGN!4'CZ(1:NB[C]W\MZ-&]T2U#SV
M K=E3[#K5RF.N'+>VQ3R)^:V93Z1OF89_HF$W2>2"I^(?6XR;\QPT9$E@&;:
M,_21)H$UH!O?6*/7^<(7RP6^5"_PE<I7#S/P&#'?[&E&;E&$XY1X5:-/P_N<
M 6O*\F#4@-O)O(/)>(C3T3Y\*:T>,HMP>N+<5:VDE1[[KHYG9R'$M<:@<9Y0
M'XSIK\%!N:WPU_6=V6_*?5^QY)W0=MH7EG@K..S H%9UJ?I/5*RA'4@2#NXG
M_37_3S1#\C_%1;[B/S%C<GS@<7JP/F?*KBF+N\K;;E^1)!D]@XZ,5]XZAEJN
M%4L[/W8=GT7T*R(G%$TYF[S2\KM?:6)(-_G690KH)IEOH6>2S#&[7BOJU@;<
MV9F;P92<9C"E4$.?B/CP]H CZN<RG$=UL\XC4M@4UR)L&A->N'Y^.&EZG$29
M7*H+RI[P!D76(-T'A,]L&D.(5!?AM/5X3INOGI/KK!L;->L/R.NYXDIXRP<Z
MK!GV-G/WZ"7NK>/2<UEU:\FL.@*I63ZZO/UY*TR-Z=,<1D&\^3P;C\8(QT&#
M8$E67%86QR4H^VLR0#-//4%[7]?4WQV+3H;\KG%YZ.)<><4,>OWG%;N]T &H
M7&H4 ]N<AXJ]\#9'*M:-Y7-KW)S*9M5"]>>#*9IF_;"[7/]-<"]BW,68:>/^
MOAF\N(EV89I'.2L=SS+.K"PU04V/=%IGG?-'W*L$X^#3[-5[E'<>=N/GPGP>
MQ@A7J)9JJ8QX2R#Y"=CX\\S# %K:>49*V^H<TG8JC'X_G&G<0V7:7X%UPV>4
MGOQ>!6>]0@#4F[]:\*>KINTD'696\L8_8R5]U%'E3'[8&4>945CP"696Y(KG
MYP8?9,,2C+O/M6'O1<0&>&\NAF.A6HW"V]F20^[D$#B]7.S1Y9V>+3MI)=V'
MJ0O:U@;$IF6Y6:T5R&KEWV]MP/1<K5V8I6G[_/E3I4NZ)\@M[0174QM0EZ?7
M]=I44]I+JN[8T"Q0]P0/EW:"JZD-*!=_7QJ=_>?:(/=L^(U.;G5/L.B>X/1(
M[)>>C+/S3J^_V?FO&Y+FOOS:@%P8P+8VX*-DD6^T5/A$['.3>>.V-F [F4V<
M3*2?N[+<J')+U_ -0-9TV] 'BFGJQL079E9$J=EY_MF]T^;)",JI3""&"WEF
M#^BA=/K106@G)7D&CI:1B\V6QYQUM 53]OF$"+5GP@O%US[=GB9$LK=[NF3_
M*[_DB'<:*_0[?DMYA,#Y:H$OEV9)^-^2UC)):SY*R"-XOA)*B%0P:FNI!ZG<
MGXT.A5;ED%.VD?C-#"R7MI'X&3=L&XE_IZ(_0XU(*8\P?48NOR66'(5YEK/-
M(XB_S+,-1_&#P*T>[,EF[7%:/BA?OXV%F_;-TQQ1\'4#HBK.XI4?RX0#+=7G
MA ,EV)QR-/3GT>S0G_[Q'J?=]MWYP^6I>'KT/,?Q>6G)0>R<'VIR?3"?=F\#
MVG+!1HIP&S_AD@.LF&.<2?Q/]UN[@[F8X"5RH$$9/S2HW?5F(@N&":W(92D,
M<X_? !QG$X!!<[V! ?3/UN/4.'R2B[V3B]_3Y^@";IMC>3% W=Y9<#KNUI,C
M6S\4J&\'A9&E9\D :@#(.OVE00(-\--@4E!:!''6, 8-]Z"%J"JB3N@0_"TH
M7'(/?N^7'E--O11+[U[4^5^_CCN32>X)!$%L=WI?PK?%09G!Y,3F_/]FF(:+
M,S#,EAF_OKR'_>(,1V\7%S0U*7C^AS]+1U95^'UGY XNZ6'__RL,AM__[1C_
M1:L*@CELZ@;O9]_@]##-\:_>X/[OSX.;GXTU7C///-=]U=Q]6O=,+D@X*I\;
M'^7#*S5PKQR^R!6Y1S=;*4(-]=C"T%?K5M,[IFR,0;H24QJII#HB1%4A[:O\
M&JJMQ$[P6(_*M5U7PW?/^V;K]NEA^+P4;QZ5O.7J/SL_]DEKK$)('0OEMRP3
MA*B\6""I7'PW>%J+KI1[]RM-=% LY6I%^C6X18(493X'%T>U4*ZG5_@M!$]5
M:BV)E<5L][&@:&>Z:9[B%L*R=*H="H:&'C-MWK8_5D;*[_;3_;.ZS/R'G1]-
M]!&FC"6GIF2^N1N(&I)UZI7-F_I2N,C,5+T3Y33C':?90H'0<AYNU$J!*Z?7
M0LW!6,JK92QMW&X3'0"T^Y21KH+_:S,54WD:_/HYJO[=GP=[-1^8I;B<*M?I
MECWBN<F%]5EYQA;1(_M>;1$]5LO0H[G),IEY)1>(CW*ARE57A0E1JI"6L0Z+
M+ZW8#'Z]LDYO&^WK7BF'5-EX0Y??$"VKPF^>EI5UZAL(YK<A9N9B7*.\NDCZ
M' QB?\T,0KUI5%NM7^/G=B\ZB+8 "O*/?;FG:*#DV]WC-^6N53?OKF6=>FWS
MIOXAV$1]H]B$GTEP2V(2<WN@^N4^?\A7[P_/A149BRMT1FVP6R242S1#2EDU
ME_( [GW"P6[JL<5&J0-GEP\:7J6XJ!]K>WSSBYAJ'@&/<H&K59:AB)96*V.2
MG9%W[8IN-$<GM49CN16>X8U*=#8NB?B_;*KG9B%Y,Y_A9:*-09^%F!<_!]%_
M_4A,*Y=CRRIO<D$ K&R5A;P.;D9)DPL$8*U0X=)CZW.(FN**1<W($/MHQ\UK
MM%#SU#1'X(HPKV7+4DD-CBUV] OAE[C/H=&D38N!H;6I@FDJ74666$MG!6H-
M"2IZ7I%V%6U7%(9*-E"2C0U@9'2"5+>!L>Q[M0V,K5J_2N4WR^3]M?G,_!BU
MJUPK-$KI]D9&0OJ:F@RQ<D?XH<W[*X=5Q>QQU\TW.7^3(U#W&!M'2X7.>L^%
MDZOS!,]NK-3RL,W3^ZUMRV@W@!HRVD"U4CXXVAFLH,]%%AD5EUK>V 618N=@
MS6+G[JVG/O2'/T]$*??X:PI]'&I21&CVG1+5AO*:#))G-1V:/Q>+V5!JR"IY
M:EO)LU;),X-[(;OD^3<;5$;C<=JSU,Z?T9W\7)\':V$#6V.\0[@!Q:[/9MJ(
MN#"/"& '>)$=PK @[W+)<1@G<RSF/2%^"+V>(?< Q\,#MZ%W?0@?6:B ?15,
M]C]^I(I&L>[1)@]D/)PR]J*O (@=5D(YKEA[3*_ #L(;.%,+UKF/*L.Z=-Y5
MAZ^]'=92+-BL9LQ:AW2=0V>==K/K-'$:N:8X<<CMHB7ZE:.8Z?M%8CVK5ZL8
MCD+QA6HQ*GJ(*1R?XB)G%FBC,4^'\VEW-*FV!W4)DM!2SLG7ASS7HYFG]W$]
MJ]LD="Q\J5!J1*7*T5,Q8;$7^IBXQVH>=!O;9\;8/K,":\CF4!9AG>IDCT57
MFFWI S3.A 7MCD*ZP&U>\'X+5FA*C'=*+@S/R,0 0N@%6#?9O1;[NHH8DSZ$
M9>ZBVP80,>Q EV25?47*)YF> STDF.9H@)\UORT3;ZI>7@1O*J0Q^Q7F.#BJ
MZIQP5%E?]S@]KOVTIA=7]<FXMUH-R@4H:CY.KYM'Y_VSZ:C>?XJV[7=^>*&)
M7, AMND>/R9#^!2OT;X?[[*5V3*QC3:UX5GM,2\I<3FY&[;OA/I=[J!%[P2=
MIL'/MY?1(%#5.[/,FY7J3TW\K/MY^#B7UAE!F[W7>JD_^OTZ.:M^ULW<GV\S
M8XCS5)DT;\:UO_W2)N_G)O7URIWPFE@%]:IV&TB"2UJU1\O-C4XVIIE9[GN6
M)7#_$6@CKW4NCQPR=P&; <YOMI>N='8V@N3&3O #;M]F\;+<^]IMMKJU7>MV
MK6M0<8,-:AH>!Y;]LJ8F7<$@YN7(,BT!YU9X LS87X7;U2C2XZ@-O6O<EC7!
MYVXF0SG0&CGXR'5?,&3$P4390;6]Y,_W&YKQU%]*[KK;"V_GQ[6EHX,!)V:(
M>RX3#7&NWDNSG,]\KG&GOT?:&05<KUD3/TXOCCS><R"=G1_%O7IZ<'_#P"PW
MX_@B#>XY3S!KGL;V!!<\05_8,+<+F!7R(>KX*GM\>EK\]OABH[[YG&!C@1.L
M[=72<< 60HXM[J]?3SA\DPU1,?VJ0I<3N@='UY+V<Q[XCB#*C_T*OT(P6^5F
MB&;7+RBRLYF(/?;3:2,K?$,4G7+%O97#-FS@<<S$-M)/)&OB0N2)<'N5SWDB
M<\KA]./(6FNQO2#YR-7T$\F*WK"L"Y+:>GY- A7OV)VN"A9._K9%ZI,V+)F5
M$[DQ+"_%_ YOUN$;Y#S)$CMV)C,?+>>$FK!& 1QY)@%Z7L3:KB,.,P<Y__.Q
MSF,F!I/E2!8QGRN(Q7S*(YE3!&<YCT7LX7+EDUZ1^65PEB-9Q,"M[,V#F?3/
M9ON]KQ3S^<B0Y5-P]<NF=87VVY;!UG1P<O?[H&15:SF8M?<X)@"](-$80D]&
M)&4^[W;1NUG#$S9\MX0[IZR-/P ?Z=:+B]B\I;WZIV0F\\O;S,>RB.%;VDLO
M-/V(QS*GS,U\)HM8O^6M'K2LJ[*("5S>2W<NSR9\C]8O?&V3\T 9*Y*,WNT1
MOI-KKMR>'#=?S7D@.Q<R@"4Z'7:BR*JT;,K.5D1<+[Y;C/EZ<0,QYK-./:%T
M>].GG@#4-H>KK+PY[.)&-@8VF^!^[E<[_)%Q<9^#CIZ!-R 6/V"_*!H[D07#
M7"\@[%I#5,&C\,LZ;A%MO3R76K@!0*_K#E*EG,DBJGIY+@OJ@YS)W&&JE -9
M1$^?SS_V$0\DWTNRB)*^^)F\)]$K_-:N.S?"R]\#86E08^'=RJ]2V=Y*_$YV
MX*Z856#) =7IW=Z594GX10)@6PF_'.:U2 1L*^&7<$D62PG=2OAE7)+%8F"Y
M2/A_LV&W%1^G/P7CM38M5^^?N?>'W98O!-CZ%^-!3F=<Z'068S"Z\#[XGQ]B
MQ1WG^#IK64P0"=$!?L,?+A7#349O0BQ"ECP83Z8-\B2Z=, .73K0(NB %0R9
ME06QCQ@+^(X4#0W9$4STOXAOPF .6IQ4@,$Z% 64UI#)$F/'B^G+]9$EZ@,R
M&1'-0E T=JB;)IZ-*<J:8"BZ26"KT(,=_$8?1E746UC?6W33\Q[%A%]I#-+M
M1:2R6W@!XC-T#<$+,^2ACC9#Z[%#W)D&6EV]]A6Q']HKS=D1W94(!7@>#R2B
M;2FXFR.0"+D@P;%CMSQY/P/A<M8](-]N*H.AJG@>QK%ULAF^CS"V7E]6H6Y0
M@ZE8K([FB<<8V^A(=$$FVU/&LD81OT2+'0H6.DN-$="YBPJ>A(.Y)5*D," #
M^#<:F^RJ)(]E51^"G-K;&#A$YX8M[3+ERT3>S[J;)A. ^Z#@<HC:$<EI,M&<
M'+IIJ3K&>*-W=!\0WV33!.0Y=(4).4JR*1I*1\97#-@+B\835#61(3&OLN%<
M0]+L!XTY0,.1LDLTE""*NB$!:K>7CN$')KX%ACY63 P>II!;H",]4(%>00+B
M7:0'R6>BZ9PP:=_/@D$B1F =NE(N$JFTYO%;>52G [EC.3!]!X@I(\I'RC7&
MP!QJ%:TZ)WJIC8;MI%#?GST?GU?.IF=J(@QFFCF38>I9S<JX+CMU/G-#UHH#
MT5T-09-&6O $X ^=NPI+BX0G;2QV4'. T?D.BAMVQZ_7OY^+=T_K.JA(6/7(
M@\K<Q2/QH**2.0('E8Y8RL8@EJY#55\#R\78I?(;;KG[X]__V=UECR!?XQO;
M1AK7=S32RTA&(@V-4.:_$R!,]#>[NTL](9(RS@H4$5A_%2LV,Z%:I@-3<D5
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M*-[)I#2*66S$P);E9B*F+#0@/RMYF(S\7GQ31=MF_**/+)!Q(9(ZRI&D%B*
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M]+,@ZZ/Z)^G@4J#U:@560SN,GTCU$F;;A$CG8=G1U\JT<!6M_#%FX31CU;_
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MMG8Q>O+#M00W9#8(G(3]6#J)S8?BB2BK;>OJQ;U:I12OJD,:-J8EDJ5"RK/
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M38!S=-$KT5F!DH-4:KHG?LW?YF'8C#1P)#.[@N]EY8PD[]JD0[JG8D@[.P,
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M94>!"PY?,@*]DB1S'"Z(19. 7D:X.BKT,WH%29Z1;[BA8%BT'W*!?8(Z$!9
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M.*SG!Y<HIQQ_>,#FD\A3?/N![/WYUGN($=]WFH/30?.XWV\=MU49USAIAAJ
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MV1Z<IMC/XJ8)):^,>4^[>WR2,)_&LDV5[J"+]*?3[(&L#'KMIQZVA&YE'[M
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MI#JCS$[(%#&7MLBW9'/AEBK5:6/RN0R*;LR++&_R("==P\AJ@+XK4\,0B8L
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M=0/$0I&LE=D#+TLM2XU 54<M2Y;7S=S]NSBJ[=P3"-K'F[_XVP[3JI=@42^
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MBP#V2_1!E%=0B=_L)84E4J0E?9N0HHPT@!4Z!OW7"W*_QPLX_>%W&6',=A<
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M..LS -G+XQWQ55^ PECTUQ3Z,>5R0';VZ(=Q (-S2I9BMS2.4C_V5)#"(-U
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M6NH%C"S!@IE32;1,0?9NK&H3  'TM#3+5DU&T7AK"0_"[!O<?ZU'^UIG-<P
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MOBP4-]5X\.9OW_V\O[_[Z?#X8,%^W/OTO=HJ-::6_NLF+!#YS?\ 4$L#!!0
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ME+4NG_T>3=ZP-\(9.ZG0?Q8M2SXJ3B+L[WP^8@]D,6GK+:D$3I#_UWO\]#9
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M,2_#S0,FZ2TBJQ-,"'YFS\8$47[MQDY@)&$?O.$TYC'(+R.Z'#(! I?0$8D
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MQE7&N)PMOU&MJ9D+.Q3&;J;VV5C;$ECG"ZAQRW('*@'#&CJ)QX9QFR?*)MV
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MG30U87'&N3>7H5*R]"U.'I$?+D,4B.H:"IJ/;"I*]8I5F![)&!P)!"L-.AU
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MG[/F?FJ@X0=>4PT FO6W5454PJ:*_)=2-O%MDY#(@MNB(8!L%J>0JLVB2Q^
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MDO=INDS")ERE-3@%<6Y?C#^5KCB1O8%NM+/F<3.L=BCNSH)WR@E):^#0G[;
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MWZC@]#<D0T%;%/GA1Z$3&]#M?B!2%@SVI)I-*+!E%T:QV=(MJ/C<@WCT=2\
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M&/6]1) (!0)G+('FMSAA*9!1H.3.X;5V&2Y8'A"IOIX&P&#?G!O*U*NU5UN
MG2Z@<!(*)9E . SFV"QR'ZLZ@-JMG41+*@^(5%^G1)^3KG+(E(3:28@ZRP=!
MIOOQU.^8? _C^U/O,4R]B T= )UV0V>!@$0!=:XY<4=9SJ 28RV=&3"!NQA(
M1 *QL,;/H&)/PS1. J<H%8B=,?>#4KR&9:$:&F*F)' 8\Q<(4I"*SJ8@D<MP
M2<4"X3/F6+A%JT=,/+)6#2T%"%R&32@2")DQET*#W>IEWW3%PO&F:4K"NRQE
M=N@MIB<\X9[6N2MC,*M@)$155380;W/%/GH$@%L8\JUAHO8-_WYGS(NQFU=
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M:RSS!R!$/1AX'W"!?MQ%5RP0>$RP#-Y\C';,2="Y*W=!ELH$'DDLP[D8K7J
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MW("MNP9@+_@]3!^N4#I;5N6;6* Z[6V%@FD<W%*Q$A;R)RXL,"H/-H\94\H
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MYC+T*,/33*&GIHRATTCOA5_%L#1[C)323%X?91!DV/$58=-UUG#@V9P(:""
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MJ_"8%M<=(B\8E\ 5C(3L@_ 8<Z'D/.;37K# ;=JX D*38U#OQCPC];&ANL]
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MV! %PL]<FM4FXWE:IM]P1$_(K#9L5PBYY(M/CJ((2P,!^4DOD E):R#2G[8
MTA\6URR) '!"H'^O_=GFX\ NIPH.\I$4"X[]BF%#*6BY^L)\UD:RTS6JTTK+
M6UWE8]K4$JU_I2I;9? N3-OL-!E \^)E&ABL6, >:->.NCQ\]5ZDFJTW&3W:
M1*[9%GO@2F'LP7>9X&J3ENSBZ2IL[M"P9:)"O3@R% ;4S:>I+@H$HN97'A*&
MF-$+A&0I4-H.2B<Q%,[AAEZ"7",J:<C.*$6I%)9S:NJG]-R9K@47.N_%EZ=5
MG^5M3M[KI.K6]*5.[UQ<K;&@,<G9%]-71=LA(94A@810?GNR]R>LN9;2-YC
MQRN:\+#^WJM@67K9U6AFP8L570!AD9S6N7+[2[V5+ Y8A-R5MY+>T0SS-3,7
M<'QD.R:,W$.[-MW7N3^*K/14&!YIEEXI-HS=;Q2AY/KFF\R[+20S='$XZ/J
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M'GN,8H@3JVG0:CF[\V)8D30U7>Y#G 8DSA0K5H6<J_6)%F:]3)$*>>>,"9G
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M<_R"DVS'!G\;"EII.EX'V)HR6!68U,!PT1ZK9,7 -3D?.[KP&'E+<=\$6UW
M;%_$Z8FN!%SO)+?S.QC62$ ))[?T;XC)+'LD5.:OI<L*RCPZ'+.GJO=)-<+.
M=DB-@)N]4:6D=QI8P1L2HLHTW"@@SA P3D)V='!W_WG,5M50Q^.6E1R^9NNJ
MK^"=86-0&K>RRA.<WU"]_+=+G][46[EYG0B!G3^=96F^3PI].+6MICM/-<J4
MUFU9J7EGV'BL@D.KE5&CS>="'?VEV7:#7T<-@'IY9\RR@=WP22<,@T46"(6T
M<?@5 1\0SY(@S]>;*EYS3>Y8M2;-%%HC[W1KU 2[MT6J$O9.+%N$PI8IDV=[
MIG6<;480UUEV&GX=!X]Q0NG,GQ]O8IL+1!9*SER2M0&-7S)J>.?0*)A#(C5Z
MJ%6<_\Z1*CU/55[P+-L^5K5OS'2R4'*7QL?6@#:UCTD#!IUL82H+1G84G='I
M]NKVPN(^HT3*W55&)<3V%J,@ H,22ES"EA"Z0K?HPMEG+R=88T8DDX;C72+K
ML4@O#H,F5A@5FT8>AJ#;_6,2AQ9>0RKGSF]H8+:>0R($@Q0:9(+WX*+NOC^)
M7X*"K>1"'KUB<Q]>K^'P6KP-],[M>)TX$)[88!0OCW$EU&@!O#//2IW$41R0
M PMR66_XCJ6AKI%"WG51&BWL86$:J;!W;MDB%([BJ10/3"I#)1==6>.G(#RP
M/UHLJ)6R[M;1!KCM\EDAZ)T3-NB$Q3(71VMT@WY Y\[&*.7%!#-5K%7]7QTQ
M$,E2#P:OQH$=<Z7$.^?R(T@GZ/IGG<(<BQI:;XIW<K2C:FJY8EZWGL4ZQ?>8
MO,2AYE:<7MY+:1(5;&D-DJ$P#"99(!RRAW[*#Z@2=%SM9A1)1'E?]6OL23(4
MAD<2!4()23[.3I(9DL/TUYW:<""5L-L$,3K _10Q,DGO_+&"9U[I@V'091"3
M'X-DCT\/S1__$F/"0F</URQL5K/:MU5VR;!Q!G499Z<)AH&CX IY@ZD&XBJH
MT>'103>K'Z%<=FNLNDIW^R+G)GW0>CBMAA<2JJ%+F2>*PZ.;$J.:8R>H5#I!
M7 U] .G_?L!!OB?</U\27M\Y/-@Y/[6F)\]G,D7A]E1J\$AHQ#HD8T<<-?+@
M/%T'97['LE815:;2<:I>:&AAC)2'&CUX1#2#U;G%1@.00RRSH0;)59H79,\,
MTSE!E;13QNDA]T@F%X7#*RT^@4JU-&K%P?FTSGSAX^C9VT<HL[>/XV9O'Z'Z
M*R5&^]G;1T#.2F+6I]$D^P2%9)_&D>S3&R#9IXDD^^0H@,8Z;L9WN(Q=E S$
MPQT=--5.F<O06T-E>4'$:="MKB+\X'<@7UL*2A5K.V^%=L5'_EM&OKS$2<+R
M0J71XZ&,VJQSN5K43AS9@#."3#*LH<\H;1CDF@)Y2+VF#50U4M]T:Y+[NBK$
M.&*BTUEF\G'RX: ML*86=SG%,8'NSF]4LMYY9PE0M]_$Y><LS#8[G7C&3CKV
M*HZB[=5\TDMEA(YF0QVP=%, -=+N!'%-Q%7A^K.+KYB$<3Z!@U)-GS34F*)C
MHD0-+!G56"WX6"M#IR2']V.6! 6_9SJ*E I=G[34FJ,CIE01+#5U:"W(67*R
MU8=+S[LX_W))YZE7:8'I2RWN D4*_BD-^"2JV3 =6]7:8"EKA&S!6]8&.]?$
MJ&X%L6;@TI=EX6,YD,[CESC":32:OKH&_ [_)L/TLP"5-ECZ&B%;S0G*-E#=
MR!MA[P,FVTFL[2I"8*MHB U+6RWP[!2@CF$E4_9W<6656J0&&*4.X/J*TBB+
M&RR"KG?V300\ZAX+*_'DZECD/"B"OZ8L+Y.&<A(A9\12 FSH(TC ((D*UI *
M3 Y5@HM7S&8[1,]9$F%RG06IYI.K)-W5P-9";8M=2\5@,$"+35I*J11&7'II
M+OR0GV49RZT=GI'@5<T$N9PS'NA@-BR0"<'@@ :9,"]A.:F8+/HA1$QZ<0:0
MLX2E[]=\^X&$NZ\NA=9^[][/0+ZT#)/PC0DJI999\>0X_-U3]O)MA.-RL4/_
MT*YQZ%]X/H'D(BWB0A;Q+I5P\=$UT-A'E_SL_:.K,<F2,B2H%%LX"?WE7_9%
MH2B=*)5PETA,"JU-'-;[V?O'56,2$H-=HE)J:6_]USA]>LVRZ"S8Q460W :D
M2#')KZ_/U%_;K./L^]O";QAA4H#!$4N40];4:JC20[4BHIH+[X;EI.CLA-&_
MM2,$_<L_[D.<!B3.;@E^B;-]GASN\"XC!8ZD/+-3<4&S,> 9RVSDO9-L!$@Q
MPK(61[6\7V;=43QYG*7KS2VUAMQB^K_1'0ZKG(I5 <?HG_N\4$;I'=&.*PX>
M969-S$F-@&#K,<C%"AIE6RS%&6\-E<WQ^U2]!D]0V^32(_%(REKJ.!N)QU#1
M2L$[[<:@%"G65W/(H[-LNXT-O!%E'&[IR^%U]NW[ C!XH$ E[L#78DM_YE7.
M"@$%J@F40L;99U;!:S[S4 #&9U:@&G[F58YJN<6[,W4;V1:3=:K949,(N>O0
M*H!MCQY*P/C6*EA"GZ[D$!5T];4?7C/SU^X(.?_: D#A:S<2L+[V$);R:U-!
M5U];=RX_%''^I97GZ_W?87UEPSEY+>6L.U,I"_?=$W/?I4608J=N96!]<!&8
MNF,S45=?_I*::O[P72GGWUV$*'SV5@365Q=P*3\ZDW3VS>,7B\[>E7+_S06(
MXC=O1(!]\R$N]3=G50<=??/[^*OYDW>$G']Q :#PP1L)6-]["$OYN:F@LZ^-
M7[#F.%0JYOZ+BR#%;][* /OJ C#U=V>B'DKVJ;^_1MAGB3X%%Y22,!AA@F=5
MB@_,38!;DNTP*0ZL&&ZQ2B.6.V#']@M/#X8[^5::;G,Q6YO23\QL5/-.O/%8
MA>B<+'UZ=TTG(!%ZH/_.0[)7>8[!Y%>CO6.W+S!I3)*Z,Z.TT]K'>LB]RL=R
M43#$TN.3G"IP:=2(+SW<7>Y)&A=[@KND5P]X6G%G0YX%Z&;0T\AZ)XDE0"$9
M6JW!KWHXHTJ3L,GJGI%.VGUB+/,M(K4H#)H8\>DS9RUR*6AD\' 5Z1I%],7D
M.'\(Z%@Y,%4MYBJ,6 >RCB66R7AGB0&8$'A:QA,WLNCO7-HS)Z[IC/ZJP%M9
M9+E:U!,W!+ *?C1R$#DR!&?F"=- 7,4U6<ZSD*<N9E-RB67]GUV10@:J)D+W
M-Q ?7P)(N%!8B? \9(X_\(H^..*9^I/@20)_\+NK3RR%57_CWH\@/K(,D1#8
M4LL@)N3K,Y_C/"3QCNW<Z.SHB3G_Z!*0PK?OR,"B@ A,S82.K"?'?H>?XKP@
M?"OOGD5=L7_4N#&%O&O7KX4]' NDPB!(8X-0.5ITE5"CY8E'JS3=!TEY;4%C
M:%_,-6MD((=DZ<J XH@$F)(:I6QUB\03(_[//B %)O7=%XUE@J1K7BB@#JDQ
M$ /%#CDV)4$:<;\<>2!!FL?,@1E)(HHZ7VXHP I+CX$<*)XHP*F7)(V\7Z;<
M/^,D89OU06IV*#)AUVQ1 Q[R190$Q1@E/"5GN :J5.#0YN*%S<[I-,G2V(Z\
M3_((L'7\:83!4FB(T))%7 TQ/4],*N\QTFDV,7%(D'3-'@74(6\&8J 8(\>F
MY$HICKB\?Y)<I)$511HY/P09P)33HQ("2(X^,A,UJ+1/8ES&>1@D)99+^F^R
MTQ:-K&N"*.$.22((@B**"IV2+*5"S1FNXI4P?\,!L:-+1](/602H<JHT8@")
M,L1FH@F3]T*2LSTA/=3J$4<MZHHF)K U3U1R((AB "<&4'/Q'E$\C4#E:?)E
MG.";O21R2"[B]GA?!-<_UF]_!\$%!2C%,3Z30Z6@ER]?GQ*DQ4VP50?_#,7<
M,D .LL^"O@P@)DB!*=C0RB(F[(419]0S$5;&.L)?_XH/2KL$.;><4,#LDV(@
M!(@5<F0*6E3"B$LC*NZ%&+<DW@;D<!^'AJ%"%'1+#170/C>&4H#(H8"F8$<E
MC>ZOSGR.) _!UZN($K7)O&1@B5+>+5D,L/N<40@#HHX>H8)!5 GUM7P2Z2H-
M,[++.N$.9]F>.L##61:I9R@&+;>DLC*A3RVM"B""V>!4T*RG>E+&I*",H*H!
MQ%KP&>U<_><Z3O$'I?U262_QSC*XTH#GKB @)JG1Z4.>3^H_(*;#<D,!(<W'
M$:9^]$^:C[:D^0B:-!^GD.;A-0-"FD\C3/WDGS2?;$GS"31I/DTB#4M?Y),V
M9_2/:_*0O<J"LY627B@C0I42IA6#1Q<!FXDL3('-9YB*3YKPB=6:W)+L)4Y#
M]919)>Z%, K04M8,9.%11P[0Q)]F0ESK>?4UY:3<V$EJ,3]>I@]2[F)*&7@D
MZ0,S.I=2VB<E;K.\")+_+]YI%^)R82_TD *6DJ0G"8\J,G@FPI0ZB"KY6%A7
M=&4'&M*K9(/?G9TVRV U1\S='T&00(9(3%%2[IZ40JX_,^,HP8'"(_1_=O:1
M):":;]SY#<8G%@$)7YCW:RKCHR-?9RQ&ZCE+U0$"HHBS$G,*<$V-N<'O(+ZX
M I28QXK'FC$Y3[OQ7PN<YG+WW?G-V<@^A-,,Y/4/(+[N$(TP3->_._Z:/Y&X
MH$]F93+V:77*(XL;5,BY^LI:F/47EPJ!^/HZ9$,F5+*H+^R8%O=9$H=Q$:=/
M/]#%)XD#F54R(5>$4 .LV2!*@*""$I90*;H11+6D8Q+<$LQ(B.F'X)< <1IA
MLMYLI*.]3M@5*<R :W*H)4&0Q A/4@3P7=C10*4*XCI^:7.5YWM,1I%'HN*)
M0DKP"B()\A#II )I)%6IZ)-;]SC<T_'Q\.'CXT-<2-/2B2+.QB0%N&9$&OP.
M@AL*4$,N\-]8?<8/'W_S^%M4:SG^_#?9 PDB.B3>'[:/6:+(/B65<D4"#<2:
M!Q(1$%10XQJRX29#E2@J97UDI^J!E9@S^-T5 :2PZD_?^Q'$1Y<A$CI_[UM[
M<OD77\-G"@HK+B3(Q5R[?AG(H?OORH"@@ :8L"BI1%$MZ^-"0CMD/9DG 4_>
M)@%/ADG $\1)P)/M).#)VR2@?FR9(H3ZI?5C$C\%BN2$6FG7I-! 'O)#(@J*
M*FI\2I_1J*!6QW5&2Y[B["K=9&3+GW])_R"Q4B'G+*>E#F:3U%(F!((C.F1"
M6LLRZ5Q'&#%IU[S81W&!HQ+,99P&:1@'29,>4;8C;E9QQA9+\ UQ#/(P.&0'
M4J!3J5;G,FP4VU27KK?2RP",GW"2_#7-7M-['.19BJ-R+T5V4J27=QLQ8X#=
M#YI1"(.@DPU"1>@,4WKWA6FA6JW:"?/"I!^S9)\6 >%WR8DZ ;\@YY8Y"IA]
MQ@R$ #%%CDS!D$88E=)^+FB7V2.:219S>-(4,'IQQ]>UM: 'M[:ELH XHP6H
MNL-=Y?QHY\:EEJ<KE@4F05C$+_@\*((*F])>E;CK2Y4ZT,/;E#)90!32 E3>
MGVQT6*J8H.:4MY0QY(Q.M9XR393X0,I]XA@!HI@[IA$!1 \9+DT&&8)J62]<
MN-\&25)7_U3:-)!RRP4IQ#X7>B* N"##I> "%T6UK!<N7&PQ>:+#V_<D>RV>
MJ_RL2ML4TFZYH87<YXA4%!!7=/@4G*E54*E3I]3U0YZO;4+Q,LNBVE*)J&/:
M*,$.."/(02*,"IS E@2';+_E)BO00X8^YQ@5SQCQ<-:(U=IM,\&7[?BJ-!*&
M[$)$.2M/HX#(**03=EYU1 E8J#TB2((@DA&>N@Y)HX%J%<>L65,.D^XZCH-@
MM?24MQW,*JX89 N^YI%)'@2;+$$..<75^HMKKLCK(OK,9M1-;J^>XO6$',^,
M)0 '$^..! B.*&&IIL7=6@%^<N?M'Y,XO$RR0+W+TI-QG#%/A#=(EM<* &*
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M$;9F2Z85=LHF"N$QR[&.3R:@;VQ_)GUBH[+5/HU,U.U^C1IL?]]&E ,SBFG
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M9HQ#;M4:-;V\$^HRB F/O%I%_]SG/"'S>O-30$B0%JIAT*#CDE16\+NTTBJ
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M8SB"50@[3R2J!"PD$Q4DO<],K>!)BV[4RVXP&SU\5U.Y):K:IS<H.2_+:#1
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M]BW5&X$,C_UCQ(>L$WR[P/@XY6F^>^6,KVST"#G^4:![Y7SVZ7OEKCG3;B+
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M2ZL FFHF_]7AV@\X8"I;$(F.NE6*'JAOS5E"@"PU.3.SFMMTX'9&]%.#ZW7
ML,T2J)@KO+PLS?505Q&2@U,99W^X,*H%"*2T/& 8H0Z>JO;3/#5KO5.570B,
MBW+K**7+9A[$BU,6P6L=/3:R#:>!B%/,ZT4HCFD #&6GH)9E!:C:X(&RO5:
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M_6EY5G&"SG&(F8=%GSZ<(.K$/D%RG*LHXE<<S!:WDKY*R V@JHK&56(0'>D
MF["Q5OT,:F@M5\:6).D)>^*)!+""*AU):-$G6I1#WG0D (R[=SA(XG_A:)5&
MGU-2_>7[($Y97---EF;EH5KZ9/@ZUNTX'K<M^_IX^,//VJKQB*\3E&)O<43'
MC.6_]S"67Z2VW4O$J1S)[^E;JH;R]WPH_[W_SS'-VX'L,3* PK>(BS"+4Q19
MNCS7HZ6TUZL<WTCG(3;C:80=9>08[RZX1H L'0-<Q=Z>7P=P)YAE.[U*\X+L
M^?52S<&!5-(E#350NTR3B($ADQJ;+@R?'5J]>\!DBY@^:AO(P9P<] V[-IP:
M**7]T4F K*;4-;B3 CT^8<W0)Q&L\P$&[BQ+7S!A]PW+/]$%4PN7W>G2O 8+
M7=<DLS9G2#FC(B@"VJ*5TC%LE*L_L@L4<<M1.K;Z#P<Y2X(\7V^JC/-52:R+
MKYB$<8YO21SBYL>F8)8R!&E:6TZG?<>8VYO[36D(#+>/03_D>B6'<*6.=DS?
M.['[X\<YSD,2[S3;?AIY?R.X!+9Z#.\(@R&:":'4<4:MF'<:57X_IC-27GWC
M-CCH I%4TH[C+W60!Z&7,E$P]-'C$P(NKVXO4,IKI.Q*0>_TN259B'&47](O
MQ&MH* R5R#F^H""'.;B6T!<"0Q,5LB%!RBHF4+C!$QQ?Y?D>1^=[5B>H+$_!
MRZ[D[<R3YX6M>\$]JRG$KZ4K7L6QC;I-;3W'"^CGO#ZF13!\GL4,8?>%5VR.
M>:LHXLVB\G0!Y;SA[H(EV]1K%M8VRIO&O?>:_HRB\P+:]\(GL*I%R@A]?_,^
M"[/4\T"-,AB&CT5L6F!#7'-<!B%>;=G=(JN7T!7WQSP1M)IHK2Q07@D Q3N)
M<1K&NR!! 1=C?@_6!%*Z4N_481NSP.^I>=]UD1AAW&#IZ("AG"50U;9)!JBF
MWC5^"I)+K)Q<=GYW21\!5I<GS8]@"#%$)*Q"V.]H@P%,IJ3<K2/HVQGE69 D
M.#H]#+<$Q_2(,:UZ]TWC7X'1==DW"8;(\]BA<'PY8M'=+"LYP70FM]W265S.
MEBC^.T4[&V73"?/65"GE:8NO"U&QM<=$X)!*BDN(_N\L/G=M 60V-_.8>TSZ
MGEF2'WA7+;JHED@,-O-:Z2HM,'T5_$RUR7G:7J"WFNT;V_"WJK(T3[W4,C0
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MP@U5TFQ(N\,O.-UCGH&]J4'>5B[W/EFC'C3'/^\IV@L*M'C0W,>7BSI=(VC
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M?D;ET0M3&'/SUE<HA*)JY#T.]X2//*/C((PMPG/T,]FCKZ/93>V5-\J>./&
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M?1O"-FBF=93O4/)K!<O+L=DEU&;.^_0$&/#6K$%!$VTWM2?XIN+(O2MIGL*
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MDK&^%A3^+SI53M+CZ2GQ0 V&5-_WO/C!?.U+<:@-9Z>*LE007*HQ\J<$C0A
M(D_PR8:!!NETX/'ZHZ(9G&V7ID&BA<+5]386M>?RM $.:O4/404;RU66/!91
M0E^CXL?HYML!!Y=RW!D>JDIB$H9*6EPLV_!KYL(\LW'\:Y&_5R\0G!9E^S'M
MN2#A4I\'QTK6%XE*!"Z1R+X*/""GT"J.X98.*E05><8^QN+:]2ZO_DFK59)O
M*YH8=-;MA&ET%LLZ=(B8C6E.(8++5 ^00+G^:$B1/BW"B!%&C4AR6&:CK[1(
M:;EZ?,\?"NGH\4)LQDL2&S@NM3KQJEZ/ !)9\9.L!H]PQ*![3BG-?49]%&4
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M34UAMC,T.)[YW'$]M6NM"K3<V9F)P=9;&4+@LA 3>XJ/P@_*/O=\^+FTSOF
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M147#K"0+MTX::_!)0P"+_N[TY;AT<)@U=&<INZ55">23S]<X-=,Y*S,6H+6
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M7R<_DH2P($_9WR8_!7$A?I->T9BPR7FZ6L<D)_P/U8?_.OGC'S[^\7'R]=>
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MN"N4?/^4LERD#1,#--2QT5/Y\X0+7-!&SQ!^99N#4776 PE BO9^0 -1NC9
M"H8<U;?I"PW@J;:\^=L IO->>^ ".<? 8GRMK2+P!!J=FIDP<9P[8G9^%B1?
M]/DB#MM@OXLR:,=!N@@9=^@&;].<4NOT82ODUX;Z/:P=9B?ASRNA7P4AC1L7
M(J5?O?'H  :*N1>O9HH-:E !^7 X.0^2(*)!<KDB;$F2<+//?1B*B/5S\AA
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M[DA(N!*)K/8$ (Z6"ON]D!5  /Y''>G+S9IU0"-1N"G)"%\QRG<X!R+2!%!
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MQ. 200>ORYN-60$'QYDC9  #X@T<MDU&%<B#HJ"$0CP"MXI6-H/"[W&5C.J
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MMY9"<<%/%S2LI!C]N\C*-Z8ZI'IVA78;!X3O* DY"BKI 9"@&PR,X>_=(&#
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M<IWLHO]WSVQN:/!(XW*TJ@T21HN=*.!D^Z6-*#T,H9>,?T[71/<T1D^"GEL
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M4F _R^X)F$D$Z!A)UI$'_CGK'6Y/Y,?Z..#FMF<-/8U[9W1B;-9;6I/(#[0
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M5I K'<SA^F/CS>'0(U48^HB@1)8"'$K9]*N_T/_0UWS);_X'4$L! A0#%
M  @ ZS%#6@:\6:NS"   H5,   L              ( !     &5X,3 M,C0N
M:'1M4$L! A0#%     @ ZS%#6HCZ80C.60  BC8"  L              ( !
MW @  &5X,3 M,C4N:'1M4$L! A0#%     @ ZS%#6LU#MMJ*#   3*0   D
M             ( !TV(  &5X,3 W+FAT;5!+ 0(4 Q0    ( .LQ0UK/A! S
MZ@,  !P5   *              "  81O  !E>#(S+3$N:'1M4$L! A0#%
M  @ ZS%#6C;&HI'X"   ]D4   D              ( !EG,  &5X-"TV+FAT
M;5!+ 0(4 Q0    ( .LQ0UH(RC/\Q X  -@/   /              "  ;5\
M  !F;W)M<RTQ7S P,2YJ<&=02P$"% ,4    " #K,4-:C9,%6?E& 0 ]7 $
M#P              @ &FBP  9F]R;7,M,5\P,3(N:G!G4$L! A0#%     @
MZS%#6OL$&E%A]@  ) T!  \              ( !S-(! &9O<FUS+3%?,#$S
M+FIP9U!+ 0(4 Q0    ( .LQ0UH6N)9)<B\! )%  0 /              "
M 5K) @!F;W)M<RTQ7S Q-"YJ<&=02P$"% ,4    " #K,4-:8MM[P+^S  !O
MU@  #P              @ 'Y^ , 9F]R;7,M,5\P,34N:G!G4$L! A0#%
M  @ ZS%#6J6EW4<V0P$ X&<!  \              ( !Y:P$ &9O<FUS+3%?
M,#$V+FIP9U!+ 0(4 Q0    ( .LQ0UH)<5?E=+(! #S* 0 /
M  "  4CP!0!F;W)M<RTQ7S Q-RYJ<&=02P$"% ,4    " #K,4-:^G)TCT@C
M 0 =.0$ #P              @ 'IH@< 9F]R;7,M,5\P,3@N:G!G4$L! A0#
M%     @ ZS%#6ACLMMA_O@4 <7A!  P              ( !7L8( &9O<FUS
M+3%A+FAT;5!+ 0(4 Q0    ( .LQ0UH";EWL9!D  &%* 0 1
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M#P!O;FUD+3(P,C0P.3,P7W!R92YX;6Q02P4&     !, $P"%!   +UT0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>forms-1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ONMD="http://onemednet.com/20240930"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="onmd-20240930.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_TemporaryEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2023-12-21</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:TwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:TwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BitcoinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CryptoAssetAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ConvertibleNotesWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertibleNotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2023-06-282023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-28</startDate>
            <endDate>2023-06-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-03-282024-03-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2024-03-28</instant>
        </period>
    </context>
    <context id="From2024-03-282024-03-28_custom_HelenaTerminationAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:HelenaTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-17</instant>
        </period>
    </context>
    <context id="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="From2024-06-182024-06-18_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-18</startDate>
            <endDate>2024-06-18</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-17_custom_BeneficialOwnershipMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">ONMD:BeneficialOwnershipMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-17</instant>
        </period>
    </context>
    <context id="AsOf2024-10-01_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="AsOf2019-11-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyTwoNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-11-11_custom_TwentyTwentyTwoNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-11</instant>
        </period>
    </context>
    <context id="From2022-11-102022-11-11_custom_TwentyTwentyTwoNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-11</endDate>
        </period>
    </context>
    <context id="From2022-11-102022-11-11_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-11</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-11-062023-11-07_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-06</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-07_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="From2023-11-062023-11-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-11-06</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_BOCBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ONMD:BOCBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-31_custom_BOCBankMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">ONMD:BOCBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2020-12-012020-12-31_custom_CEBALoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CEBALoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_CEBALoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-07</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-28_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-28</instant>
        </period>
    </context>
    <context id="From2023-11-072023-11-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-11-07</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="From2024-08-012024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-07-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-01-01_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StockRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_ConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-06-172024-06-17_srt_MaximumMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="From2024-06-172024-06-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-10-152024-10-15_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-15</startDate>
            <endDate>2024-10-15</endDate>
        </period>
    </context>
    <context id="From2024-06-172024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-17</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-232024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-23</instant>
        </period>
    </context>
    <context id="AsOf2024-07-25_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-25</instant>
        </period>
    </context>
    <context id="AsOf2024-07-23_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-23</instant>
        </period>
    </context>
    <context id="From2024-07-252024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-25</startDate>
            <endDate>2024-07-25</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:JulyTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-25</instant>
        </period>
    </context>
    <context id="From2024-09-242024-09-24_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SeptemberTwoThousandTwentyFourFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-24</startDate>
            <endDate>2024-09-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-24_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24_us-gaap_WarrantMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:SeptemberTwoThousandTwentyFourFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_OptionsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_OptionsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:OptionsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:UnvestedRestrictedStockUnitsAndAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:UnvestedRestrictedStockUnitsAndAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember81071859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember81071859">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember81071875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember81071875">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_SellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_SellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_CostOfSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_SellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_SellingAndMarketingExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:EmployeesDirectorsAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:NewEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:EmployeesDirectorsAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:NewEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:EmployeesDirectorsAndConsultantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ONMD:NewEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember81072609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember81072609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:LiabilityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:LegacyONMDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:LegacyONMDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:EquityClassifiedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-07-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-11-062023-11-07_custom_ConvertiblePromissoryNotesWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-06</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_BusinessCombinationWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="From2024-07-012024-09-30_custom_BusinessCombinationWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentyOneServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:TwentyTwentyOneServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TwentyTwentyTwoServiceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ONMD:TwentyTwentyTwoServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_WarrantMember81073500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_WarrantMember81073500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNotesWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ONMD:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BitcoinMember81074171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BitcoinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember81074390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BusinessCombinationWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember81074640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_PIPEWarrantsMember81074640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:BusinessCombinationWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_PIPENotesMember81075421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_PIPEWarrantsMember81075437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember81075453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_ConvertiblePromissoryNotesAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:ConvertiblePromissoryNotesAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2024-07-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="AsOf2024-09-30_custom_DataKnightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DataKnightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPEWarrantsMember81075625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember81075656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ONMD:ConvertiblePromissoryNotesAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_ShareholderLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ShareholderLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2024-10-08_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:YorkvilleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-08</instant>
        </period>
    </context>
    <context id="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MsCoonseMcCrawMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:MsCoonseMcCrawMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MrClarkeMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">ONMD:MrClarkeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_EFHuttonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ONMD:EFHuttonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ONMD:KingwoodCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember81076734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:KingwoodCapitalPartnersLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-03-282024-03-28_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-28</startDate>
            <endDate>2024-03-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-14_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-14</instant>
        </period>
    </context>
    <context id="From2024-07-232024-07-23_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-23</startDate>
            <endDate>2024-07-23</endDate>
        </period>
    </context>
    <context id="From2024-07-252024-07-25_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-25</startDate>
            <endDate>2024-07-25</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-23_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-23</instant>
        </period>
    </context>
    <context id="AsOf2024-07-25_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-25</instant>
        </period>
    </context>
    <context id="From2024-09-242024-09-24_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-24</startDate>
            <endDate>2024-09-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-24_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24_srt_ScenarioForecastMember_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-24</instant>
        </period>
    </context>
    <context id="From2024-06-172024-06-17_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-17_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-17</instant>
        </period>
    </context>
    <context id="AsOf2024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-17</instant>
        </period>
    </context>
    <context id="From2024-06-172024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-17</startDate>
            <endDate>2024-06-17</endDate>
        </period>
    </context>
    <context id="From2024-03-222024-03-22_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-22</startDate>
            <endDate>2024-03-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-22_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="From2024-08-302024-08-30_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-30</startDate>
            <endDate>2024-08-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-01_srt_ScenarioForecastMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:SubscriptionRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ONMD:WebImagingRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:ReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestatedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestatedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestatedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestatedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TemporaryEquityMember_custom_RestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:RestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AsRestatedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AsRestatedMember_custom_CommitmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:CommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">ONMD:AsRestatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">ONMD:TemporaryEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomerSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ONMD:CustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-11-072023-11-07_custom_BusinessCombinationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:BusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-07</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <context id="From2023-11-072023-11-07_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-07</startDate>
            <endDate>2023-11-07</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_SeriesATwoPreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesATwoPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_SeriesAOnePreferredStockMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ONMD:SeriesAOnePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">ONMD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-28</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DataKnightsAcquisitionCorpMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ONMD:DataKnightsAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_FurnitureAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ONMD:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_FurnitureAndEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ONMD:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CEBALoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ONMD:CEBALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_PIPENotesAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PIPENotesAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PIPENotesAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PrivateWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PIPENotesAndWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PrivatePlacementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <context id="AsOf2023-11-07_custom_PIPENotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001849380</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ONMD:PIPENotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-07</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>ONMD:Integer</measure>
    </unit>
    <unit id="CAD">
        <measure>iso4217:CAD</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-09-30" id="Fact000003">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-09-30" id="Fact000004">0001849380</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-09-30" id="xdx2ixbrl0013">S-1/A</dei:DocumentType>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      id="xdx2ixbrl0047"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:YorkvilleNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      id="xdx2ixbrl0119"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-09-30"
      id="xdx2ixbrl0130"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      id="xdx2ixbrl0131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TreasuryStockCommonValue
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      id="xdx2ixbrl0172"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0253"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0255"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0258"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0260"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0263"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0265"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:GainLossOnFairValueOfYorkvilleNote
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0268"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:GainLossOnFairValueOfYorkvilleNote
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0270"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0275"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0278"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0280"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-07-012024-09-30"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0365"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0423"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0426"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="From2024-04-012024-06-30"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0437"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0444"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0465"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0476"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee
      contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0498"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0518"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0530"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl0531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0532"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0537"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0538"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl0539"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0540"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0542"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl0547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0548"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0556"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0569"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0570"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0573"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0579"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0587"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0588"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0595"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0597"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0618"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0629"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0631"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0632"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-07-012023-09-30"
      id="xdx2ixbrl0635"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0639"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0641"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0642"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0644"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0648"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0650"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0651"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0659"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0660"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl0665"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl0666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember"
      id="xdx2ixbrl0667"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0668"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0669"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0676"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0690"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0720"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0726"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ChangeInFairValueOfYorkvilleNote
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0729"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetRealizedLossNonoperating
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0735"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0738"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:NoncashInterest
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0741"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0743"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentForAcquisitionCryptoAsset
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0771"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromDisposalCryptoAsset
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0774"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0783"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0792"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0795"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0798"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0801"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RepaymentForCommonStockRepurchase
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0804"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RepaymentOfDeferredUnderwriterFees
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0807"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0810"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0812"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0815"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:BusinessCombinationCosts
      contextRef="From2024-01-01to2024-09-30"
      id="xdx2ixbrl0821"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0849"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses
      contextRef="From2023-01-012023-09-30"
      id="xdx2ixbrl0852"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0900"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1120"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1123"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30_us-gaap_CostOfSalesMember"
      id="xdx2ixbrl1137"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30_us-gaap_SellingAndMarketingExpenseMember"
      id="xdx2ixbrl1143"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30_us-gaap_CostOfSalesMember"
      id="xdx2ixbrl1152"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30_us-gaap_SellingAndMarketingExpenseMember"
      id="xdx2ixbrl1158"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl1201"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember"
      id="xdx2ixbrl1237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember"
      id="xdx2ixbrl1238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1242"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1243"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl1246"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl1247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      id="xdx2ixbrl1251"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      id="xdx2ixbrl1252"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      id="xdx2ixbrl1256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      id="xdx2ixbrl1257"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember"
      id="xdx2ixbrl1261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember"
      id="xdx2ixbrl1262"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember"
      id="xdx2ixbrl1266"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember"
      id="xdx2ixbrl1267"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_StandbyEquityPurchaseAgreementMember"
      id="xdx2ixbrl1268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_custom_StandbyEquityPurchaseAgreementMember"
      id="xdx2ixbrl1269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1271"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1272"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl1276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl1277"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      id="xdx2ixbrl1281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      id="xdx2ixbrl1282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      id="xdx2ixbrl1286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      id="xdx2ixbrl1287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl1292"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl1330"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl1331"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl1333"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl1334"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_YorkvilleNoteMember"
      id="xdx2ixbrl1341"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2024-01-012024-09-30_custom_PIPENotesMember"
      id="xdx2ixbrl1343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      id="xdx2ixbrl1352"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      id="xdx2ixbrl1358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1394"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1479"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1482"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1485"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1494"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1502"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1527"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1546"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1552"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl1572"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1642"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1648"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1651"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1693"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1704"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1705"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1706"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1707"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1708"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1709"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1710"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1718"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1719"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1720"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1721"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1722"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1723"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1724"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1728"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1729"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1730"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1731"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1733"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1738"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1739"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1740"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1741"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1743"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1746"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1747"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1748"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1751"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1754"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1755"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1756"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1757"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1759"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1762"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1763"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1764"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1765"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1766"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1773"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1787"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1798"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1799"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1800"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1801"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1802"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1803"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1804"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1809"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1812"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1813"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1818"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1819"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1820"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1821"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1826"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1827"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1828"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1829"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1830"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1831"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1832"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1836"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1837"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1838"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1839"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1840"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1841"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1842"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1846"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1847"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1848"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1851"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1861"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1862"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1870"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1871"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1872"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1873"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1875"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1880"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1881"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1882"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1883"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1885"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1888"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1889"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1890"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1891"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1892"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1896"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1897"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1898"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1904"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1906"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1910"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1911"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember"
      id="xdx2ixbrl1912"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl1918"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl1920"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1943"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantExpense
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1945"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1949"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:NoncashInterest
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1955"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1988"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1991"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl1997"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl1999"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2021"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonSharesRelatedToConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2024"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonSharesIssuedToDataKnightsShareholders
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2027"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2060"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2061"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2065"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2066"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2067"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2071"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2079"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2080"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2084"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2085"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2088"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2089"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2090"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2091"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2094"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2095"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2100"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2119"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2121"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ExciseTaxCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2124"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ExciseTaxCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2126"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2129"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2130"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2133"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2134"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2135"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2136"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:LoanExtensionsCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2139"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:LoanExtensionsCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LoansPayable
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2144"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LoansPayable
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2146"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CanadaEmergencyBusinessLoanAct
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2149"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CanadaEmergencyBusinessLoanAct
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2151"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2156"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2159"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2160"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2165"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2168"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2169"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2173"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2174"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2176"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2183"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2184"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2186"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2188"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2189"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2190"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2199"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2200"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2203"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2204"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2205"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2206"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2208"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2209"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2210"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2211"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2214"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2218"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2225"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2228"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2229"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2231"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl2238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl2239"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl2240"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl2241"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl2259"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl2260"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl2261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl2262"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2280"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2281"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2290"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2291"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2292"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2293"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2339"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2348"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2370"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2376"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2380"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2394"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2403"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2404"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2430"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2444"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2445"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2465"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:AccruedInterestRelatedParty
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2469"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:AccruedInterestRelatedParty
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2470"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2474"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2475"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2479"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2480"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2484"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2485"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2489"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2504"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2505"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl2512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember"
      id="xdx2ixbrl2514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl2533"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember"
      id="xdx2ixbrl2535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2554"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2556"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2566"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2587"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2592"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2597"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2602"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember"
      id="xdx2ixbrl2620"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember"
      id="xdx2ixbrl2621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember"
      id="xdx2ixbrl2625"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember"
      id="xdx2ixbrl2626"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2631"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2635"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2641"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2651"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2655"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2657"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2660"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2661"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2666"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncomeTaxProvision
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2684"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncomeTaxProvision
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2685"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncomeTaxProvision
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2686"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncomeTaxProvision
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2687"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2691"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2692"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2696"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2701"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2706"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2709"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2711"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2716"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2720"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:UnrealizedGainLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2724"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:UnrealizedGainLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2725"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:UnrealizedGainLoss
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2726"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:UnrealizedGainLoss
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2727"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2739"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2740"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2746"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2762"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2764"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2778"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2780"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SubscriptionRevenueMember"
      id="xdx2ixbrl2800"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_SubscriptionRevenueMember"
      id="xdx2ixbrl2801"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_WebImagingRevenueMember"
      id="xdx2ixbrl2805"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember_custom_WebImagingRevenueMember"
      id="xdx2ixbrl2806"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2815"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2816"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2821"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2831"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2835"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2837"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2840"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2841"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2846"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncomeTaxProvision
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2866"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncomeTaxProvision
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2867"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2871"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2872"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockWarrantExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2874"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockWarrantExpense
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2876"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2881"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2882"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2884"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2886"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2890"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:UnrealizedGainLoss
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2896"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:UnrealizedGainLoss
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2897"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2909"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2910"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2928"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2930"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2940"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      id="xdx2ixbrl2942"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2969"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:BusinessCombinationCost
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2974"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CashHeldInTrustAccount
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2978"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2980"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockWarrantExpenses
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2984"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2988"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl2989"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantExpense
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2990"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ChangeInFairValueOfWarrantLiabilities
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2992"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ChangeInFairValueOfPipeNotes
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl2996"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3000"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:NoncashInterest
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3004"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3013"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3025"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3028"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3029"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3030"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncreaseDecreaseInExerciseTaxLiability
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3034"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncreaseDecreaseInExtensionLoan
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3038"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncreaseDecreaseFranchiseTaxPayable
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3042"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3046"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncreaseDecreaseInWorkingCapitalLoan
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3061"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3065"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3072"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3073"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3074"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromCommonStockSubjectToRedemption
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3086"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromDeferredUnderwritingFee
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3090"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromWarrantLiability
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3094"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3098"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProccedsFromRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3102"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3108"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3110"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3112"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:BusinessCombinationCosts
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3116"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3133"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonSharesIssuedToPreferredShareholders
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3140"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonSharesRelatedToConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3144"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonSharesIssuedToDataKnightsShareholders
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3148"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3175"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CashHeldInTrustAccount
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3184"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockWarrantExpenses
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3186"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:WarrantExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3190"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3220"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncreaseDecreaseInExtensionLoan
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3224"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncreaseDecreaseFranchiseTaxPayable
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3228"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3232"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:IncreaseDecreaseInWorkingCapitalLoan
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3236"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3247"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3251"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3260"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromCommonStockSubjectToRedemption
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3264"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProceedsFromWarrantLiability
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3268"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3272"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:ProccedsFromRetainedEarningsAdjustment
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3282"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:BusinessCombinationCosts
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3286"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3322"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3326"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3328"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3345"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3347"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3348"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3350"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3370"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3375"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3376"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3378"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3379"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3381"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3386"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3387"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3389"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3395"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3397"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3415"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3426"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3437"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3440"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3441"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3443"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3448"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3457"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3460"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3472"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3473"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3484"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3486"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3488"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3514"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3518"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3522"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3537"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3540"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3541"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3543"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3548"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3549"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3551"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3556"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3557"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3559"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3564"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3565"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3582"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3583"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3591"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3593"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3596"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3597"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3599"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3604"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3606"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3607"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3610"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3611"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3613"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3616"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3617"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3618"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3622"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3623"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3624"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3629"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3634"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3638"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3642"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3644"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3646"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3647"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3664"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3665"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3667"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3668"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3684"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3685"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3687"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3690"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3691"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3692"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3693"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3694"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3698"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3699"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3700"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3701"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3702"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3718"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3733"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3734"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3735"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3736"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3738"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3739"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3740"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3741"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3742"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3744"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3745"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3747"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3752"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3753"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3754"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3755"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3756"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3758"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3759"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3761"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3764"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3765"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3766"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3767"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      id="xdx2ixbrl3768"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3770"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3771"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3772"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_RestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3777"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      id="xdx2ixbrl3782"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      id="xdx2ixbrl3784"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember"
      id="xdx2ixbrl3786"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember"
      id="xdx2ixbrl3788"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_TemporaryEquityMember_custom_RestatedMember"
      id="xdx2ixbrl3790"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3808"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3812"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3814"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3818"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3819"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3826"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3827"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3829"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3834"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3835"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3837"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3842"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3843"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3844"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3845"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3846"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3848"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3849"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3850"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3851"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3852"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3854"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3855"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3857"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3860"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      id="xdx2ixbrl3861"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3862"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3874"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3878"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_ScenarioPreviouslyReportedMember"
      id="xdx2ixbrl3880"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3890"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      id="xdx2ixbrl3894"
      unitRef="Shares"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3902"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3903"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3914"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3915"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3917"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3922"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3923"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3925"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3930"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3931"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3933"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3936"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3937"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3939"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3942"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3943"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3945"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3948"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl3949"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3950"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3972"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_AsRestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3973"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl3990"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl3991"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3992"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3993"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember"
      id="xdx2ixbrl3994"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl4002"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl4003"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl4004"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl4005"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember"
      id="xdx2ixbrl4006"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl4010"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl4011"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl4013"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl4018"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      id="xdx2ixbrl4019"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl4021"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl4027"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl4030"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl4031"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl4033"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl4036"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl4037"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl4038"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl4042"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_AsRestatedMember_custom_CommitmentMember"
      id="xdx2ixbrl4043"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember"
      id="xdx2ixbrl4156"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockMember"
      id="xdx2ixbrl4159"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember81071859"
      id="xdx2ixbrl4165"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember81071875"
      id="xdx2ixbrl4168"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember"
      id="xdx2ixbrl4171"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl4297"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl4300"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4308"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl4309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl4312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl4315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4317"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredOtherTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl4318"
      unitRef="USD"
      xsi:nil="true"/>
    <ONMD:DeferredTaxAssetsCapitalizedResearchCosts
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl4361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl4388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MinimumMember"
      id="xdx2ixbrl4502">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl4512"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4540"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4542"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4544"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4546"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4548"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4550"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2023-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      id="xdx2ixbrl4558"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2023-12-31_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl4564"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl4566"
      unitRef="Pure"
      xsi:nil="true"/>
    <ONMD:EquitySecuritiesFvNiMeasurementTerm
      contextRef="From2023-01-012023-12-31_us-gaap_MeasurementInputExpectedTermMember"
      id="xdx2ixbrl4568"
      xsi:nil="true"/>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2023-12-31_us-gaap_MeasurementInputPriceVolatilityMember"
      id="xdx2ixbrl4574"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl4588"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2021-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl4590"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl4612"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl4614"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember"
      id="xdx2ixbrl4636"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember"
      id="xdx2ixbrl4639"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_LiabilityClassifiedWarrantsMember"
      id="xdx2ixbrl4642"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember"
      id="xdx2ixbrl4644"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember"
      id="xdx2ixbrl4647"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember"
      id="xdx2ixbrl4651"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4703"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4704"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4708"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      id="xdx2ixbrl4713"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      id="xdx2ixbrl4714"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      id="xdx2ixbrl4718"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      id="xdx2ixbrl4719"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl4723"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember"
      id="xdx2ixbrl4724"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember"
      id="xdx2ixbrl4728"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember"
      id="xdx2ixbrl4729"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4733"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4734"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4740"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_custom_PIPENotesAndWarrantsMember"
      id="xdx2ixbrl4741"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-12-31_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4744"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-12-31_custom_PIPENotesAndWarrantsMember"
      id="xdx2ixbrl4745"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2022-01-012022-12-31_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4748"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2022-01-012022-12-31_custom_PIPENotesAndWarrantsMember"
      id="xdx2ixbrl4749"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4752"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_PIPENotesAndWarrantsMember"
      id="xdx2ixbrl4753"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4756"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_PIPENotesAndWarrantsMember"
      id="xdx2ixbrl4757"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
      contextRef="From2023-01-012023-12-31_custom_PrivateWarrantsMember"
      id="xdx2ixbrl4768"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
      contextRef="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember"
      id="xdx2ixbrl4769"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_ConvertiblePromissoryNotesMember"
      id="xdx2ixbrl4774"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_ConvertiblePromissoryNotesMember"
      id="xdx2ixbrl4778"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl4806"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl4807"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl4808"
      unitRef="Pure"
      xsi:nil="true"/>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedDividendRateMember"
      id="xdx2ixbrl4809"
      unitRef="Pure"
      xsi:nil="true"/>
    <dei:AmendmentDescription contextRef="From2024-01-01to2024-09-30" id="Fact000012">Amendment
No. 3</dei:AmendmentDescription>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-09-30" id="Fact000014">ONEMEDNET CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-09-30" id="Fact000015">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-01to2024-09-30" id="Fact000016">86-2049355</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-09-30" id="Fact000017">6385 Old Shady Oak Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-09-30" id="Fact000018">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-09-30" id="Fact000019">Eden Prairie</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-09-30" id="Fact000020">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-09-30" id="Fact000021">55344</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-09-30" id="Fact000022">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-09-30" id="Fact000023">918-7189</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000024">Eitan Hoenig</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000025">41 Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000026">Suite 3310</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000027">New York</dei:EntityAddressAddressLine3>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000028">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000029">10036</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000030">(332)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2024-01-012024-09-30_dei_BusinessContactMember"
      id="Fact000031">238-2820</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-09-30" id="Fact000032">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-09-30" id="Fact000033">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-09-30" id="Fact000034">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2024-01-01to2024-09-30" id="Fact000035">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000043"
      unitRef="USD">1934000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000044"
      unitRef="USD">47000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000046"
      unitRef="USD">2156000</us-gaap:CryptoAssetFairValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000049"
      unitRef="USD">63000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000050"
      unitRef="USD">152000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000052"
      unitRef="USD">151000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000053"
      unitRef="USD">166000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000055"
      unitRef="USD">4304000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000056"
      unitRef="USD">365000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000061"
      unitRef="USD">84000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000062"
      unitRef="USD">99000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000064"
      unitRef="USD">4388000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000065"
      unitRef="USD">464000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000073"
      unitRef="USD">6161000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000074"
      unitRef="USD">4965000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000076"
      unitRef="USD">428000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000077"
      unitRef="USD">254000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000079"
      unitRef="USD">2992000</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000080"
      unitRef="USD">2992000</us-gaap:LoansPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000088"
      unitRef="USD">1593000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000089"
      unitRef="USD">1637000</us-gaap:NotesPayableCurrent>
    <ONMD:YorkvilleNotesPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000091"
      unitRef="USD">1911000</ONMD:YorkvilleNotesPayableCurrent>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000094"
      unitRef="USD">3237000</ONMD:DeferredUnderwriterFeePayableCurrent>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000095"
      unitRef="USD">3525000</ONMD:DeferredUnderwriterFeePayableCurrent>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000097"
      unitRef="USD">2306000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000098"
      unitRef="USD">465000</us-gaap:ShortTermBorrowings>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000103"
      unitRef="USD">18628000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000104"
      unitRef="USD">13838000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000112"
      unitRef="USD">28000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000113"
      unitRef="USD">68000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000115"
      unitRef="USD">18656000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000116"
      unitRef="USD">13906000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000133"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000135"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000137"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000139"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000141"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000143"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000145"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000147"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000152"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000154"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000158"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000160"
      unitRef="Shares">28175172</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000162"
      unitRef="Shares">27987427</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000164"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000166"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000149"
      unitRef="USD">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000150"
      unitRef="USD">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000168"
      unitRef="USD">85455000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000169"
      unitRef="USD">77996000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000174"
      unitRef="Shares">187745</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000176"
      unitRef="Shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000171"
      unitRef="USD">529000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000178"
      unitRef="USD">-99196000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000179"
      unitRef="USD">-91440000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000181"
      unitRef="USD">-14268000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000182"
      unitRef="USD">-13442000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000184"
      unitRef="USD">4388000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact000185"
      unitRef="USD">464000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-07-012024-09-30_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact000192"
      unitRef="USD">102000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012023-09-30_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact000193"
      unitRef="USD">256000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-09-30_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact000194"
      unitRef="USD">443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-09-30_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact000195"
      unitRef="USD">595000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-07-012024-09-30_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact000197"
      unitRef="USD">40000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012023-09-30_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact000198"
      unitRef="USD">70000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-09-30_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact000199"
      unitRef="USD">174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-09-30_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact000200"
      unitRef="USD">86000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000202"
      unitRef="USD">142000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000203"
      unitRef="USD">326000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000204"
      unitRef="USD">617000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000205"
      unitRef="USD">681000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000207"
      unitRef="USD">226000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000208"
      unitRef="USD">293000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000209"
      unitRef="USD">872000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000210"
      unitRef="USD">812000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000212"
      unitRef="USD">-84000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000213"
      unitRef="USD">33000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000214"
      unitRef="USD">-255000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000215"
      unitRef="USD">-131000</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000222"
      unitRef="USD">1865000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000223"
      unitRef="USD">1312000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000224"
      unitRef="USD">4934000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000225"
      unitRef="USD">2475000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000227"
      unitRef="USD">140000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000228"
      unitRef="USD">243000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000229"
      unitRef="USD">623000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000230"
      unitRef="USD">813000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000232"
      unitRef="USD">298000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000233"
      unitRef="USD">405000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000234"
      unitRef="USD">1127000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000235"
      unitRef="USD">1566000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000237"
      unitRef="USD">2303000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000238"
      unitRef="USD">1960000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000239"
      unitRef="USD">6684000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000240"
      unitRef="USD">4854000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000242"
      unitRef="USD">-2387000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000243"
      unitRef="USD">-1927000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000244"
      unitRef="USD">-6939000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000245"
      unitRef="USD">-4985000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000252"
      unitRef="USD">36000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000254"
      unitRef="USD">120000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000257"
      unitRef="USD">6000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000259"
      unitRef="USD">5000</us-gaap:FairValueAdjustmentOfWarrants>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000262"
      unitRef="USD">-77000</ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000264"
      unitRef="USD">-44000</ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity>
    <ONMD:GainLossOnFairValueOfYorkvilleNote
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000267"
      unitRef="USD">-262000</ONMD:GainLossOnFairValueOfYorkvilleNote>
    <ONMD:GainLossOnFairValueOfYorkvilleNote
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000269"
      unitRef="USD">561000</ONMD:GainLossOnFairValueOfYorkvilleNote>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000272"
      unitRef="USD">160000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000277"
      unitRef="USD">-124000</us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000279"
      unitRef="USD">-124000</us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000283"
      unitRef="USD">-7621000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000285"
      unitRef="USD">-17872000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000288"
      unitRef="USD">4285000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000289"
      unitRef="USD">33000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000290"
      unitRef="USD">8385000</us-gaap:StockOptionPlanExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000292"
      unitRef="USD">-4000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000293"
      unitRef="USD">-7000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000294"
      unitRef="USD">-17000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000295"
      unitRef="USD">-42000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000297"
      unitRef="USD">329000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000298"
      unitRef="USD">-11913000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000299"
      unitRef="USD">-816000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000300"
      unitRef="USD">-26299000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000312"
      unitRef="USD">-2058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000313"
      unitRef="USD">-13840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000314"
      unitRef="USD">-7755000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000315"
      unitRef="USD">-31284000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000322"
      unitRef="USDPShares">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000324"
      unitRef="USDPShares">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000326"
      unitRef="USDPShares">-3.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000328"
      unitRef="USDPShares">-3.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000330"
      unitRef="USDPShares">-0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000332"
      unitRef="USDPShares">-0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000334"
      unitRef="USDPShares">-7.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000336"
      unitRef="USDPShares">-7.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000338"
      unitRef="Shares">27878399</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-07-012024-09-30"
      decimals="INF"
      id="Fact000340"
      unitRef="Shares">27878399</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000342"
      unitRef="Shares">4280777</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-07-012023-09-30"
      decimals="INF"
      id="Fact000344"
      unitRef="Shares">4280777</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000346"
      unitRef="Shares">25051293</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact000348"
      unitRef="Shares">25051293</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000350"
      unitRef="Shares">4139730</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact000352"
      unitRef="Shares">4139730</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000363"
      unitRef="Shares">23572232</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000357"
      unitRef="USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000359"
      unitRef="USD">77996000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000360"
      unitRef="USD">-91440000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000361"
      unitRef="USD">-13442000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000376"
      unitRef="Shares">277778</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000372"
      unitRef="USD">242000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31"
      decimals="-3"
      id="Fact000374"
      unitRef="USD">242000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000383"
      unitRef="USD">137000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31"
      decimals="-3"
      id="Fact000385"
      unitRef="USD">137000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000396"
      unitRef="Shares">-187745</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-01-012024-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000391"
      unitRef="USD">529000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2024-01-012024-03-31"
      decimals="-3"
      id="Fact000394"
      unitRef="USD">529000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000404"
      unitRef="USD">-2109000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="-3"
      id="Fact000405"
      unitRef="USD">-2109000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000416"
      unitRef="Shares">23850010</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000410"
      unitRef="USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000418"
      unitRef="Shares">-187745</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000411"
      unitRef="USD">-529000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000412"
      unitRef="USD">78375000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000413"
      unitRef="USD">-93549000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="-3"
      id="Fact000414"
      unitRef="USD">-15701000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000429"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000436"
      unitRef="USD">103000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30"
      decimals="-3"
      id="Fact000438"
      unitRef="USD">103000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000446"
      unitRef="USD">-3589000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="-3"
      id="Fact000447"
      unitRef="USD">-3589000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000458"
      unitRef="Shares">24050010</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000452"
      unitRef="USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000460"
      unitRef="Shares">-187745</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000453"
      unitRef="USD">-529000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000454"
      unitRef="USD">78478000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000455"
      unitRef="USD">-97138000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="-3"
      id="Fact000456"
      unitRef="USD">-19187000</us-gaap:StockholdersEquity>
    <ONMD:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000471"
      unitRef="Shares">3598850</ONMD:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000467"
      unitRef="USD">6270000</ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000469"
      unitRef="USD">6270000</ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts>
    <ONMD:StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee
      contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000482"
      unitRef="Shares">526312</ONMD:StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000478"
      unitRef="USD">500000</ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000480"
      unitRef="USD">500000</ONMD:StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000489"
      unitRef="USD">207000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000491"
      unitRef="USD">207000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000499"
      unitRef="USD">-2058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000500"
      unitRef="USD">-2058000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000511"
      unitRef="Shares">28175172</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact000505"
      unitRef="USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact000513"
      unitRef="Shares">-187745</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      id="Fact000506"
      unitRef="USD">-529000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000507"
      unitRef="USD">85455000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000508"
      unitRef="USD">-99196000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000509"
      unitRef="USD">-14268000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact000523"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000515"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact000525"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact000516"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact000517"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000527"
      unitRef="Shares">4033170</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000519"
      unitRef="USD">13657000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000520"
      unitRef="USD">-57660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000521"
      unitRef="USD">-26359000</us-gaap:StockholdersEquity>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000533"
      unitRef="USD">1935000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      id="Fact000535"
      unitRef="USD">1935000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000541"
      unitRef="USD">368000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      id="Fact000543"
      unitRef="USD">368000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000550"
      unitRef="USD">-7843000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      id="Fact000551"
      unitRef="USD">-7843000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact000561"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000553"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact000563"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact000554"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact000555"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000565"
      unitRef="Shares">4033170</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000557"
      unitRef="USD">15960000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000558"
      unitRef="USD">-65503000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="-3"
      id="Fact000559"
      unitRef="USD">-31899000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000575"
      unitRef="Shares">177275</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000581"
      unitRef="USD">2165000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-04-012023-06-30"
      decimals="-3"
      id="Fact000583"
      unitRef="USD">2165000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000589"
      unitRef="USD">280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30"
      decimals="-3"
      id="Fact000591"
      unitRef="USD">280000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000598"
      unitRef="USD">-9601000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      decimals="-3"
      id="Fact000599"
      unitRef="USD">-9601000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact000609"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000601"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact000611"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact000602"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact000603"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000613"
      unitRef="Shares">4210445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000605"
      unitRef="USD">18405000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000606"
      unitRef="USD">-75104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000607"
      unitRef="USD">-39055000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact000623"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000615"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact000625"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact000616"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact000617"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000627"
      unitRef="Shares">4210445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000619"
      unitRef="USD">18405000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000620"
      unitRef="USD">-75104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="-3"
      id="Fact000621"
      unitRef="USD">-39055000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-07-012023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000637"
      unitRef="Shares">88638</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000643"
      unitRef="USD">4285000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000645"
      unitRef="USD">4285000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <ONMD:StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000655"
      unitRef="Shares">5673000</ONMD:StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000647"
      unitRef="USD">16000</ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact000649"
      unitRef="USD">16000</ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000653"
      unitRef="USD">16000</ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000661"
      unitRef="USD">798000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000663"
      unitRef="USD">798000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000670"
      unitRef="USD">-13840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact000671"
      unitRef="USD">-13840000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact000681"
      unitRef="Shares">3421596</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000673"
      unitRef="USD">9650000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact000683"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact000674"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact000675"
      unitRef="USD">17660000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000685"
      unitRef="Shares">4299083</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000677"
      unitRef="USD">23488000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000678"
      unitRef="USD">-88944000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30"
      decimals="-3"
      id="Fact000679"
      unitRef="USD">-47796000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact000695"
      unitRef="Shares">3421596</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact000687"
      unitRef="USD">9650000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact000697"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact000688"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact000689"
      unitRef="USD">17660000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000699"
      unitRef="Shares">4299083</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact000691"
      unitRef="USD">23488000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact000692"
      unitRef="USD">-88944000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-09-30"
      decimals="-3"
      id="Fact000693"
      unitRef="USD">-47796000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000704"
      unitRef="USD">-7755000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000705"
      unitRef="USD">-31284000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000710"
      unitRef="USD">31000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000711"
      unitRef="USD">19000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000713"
      unitRef="USD">447000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000714"
      unitRef="USD">1446000</us-gaap:ShareBasedCompensation>
    <ONMD:StockWarrantExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000716"
      unitRef="USD">33000</ONMD:StockWarrantExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000717"
      unitRef="USD">8385000</ONMD:StockWarrantExpense>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000719"
      unitRef="USD">5000</us-gaap:FairValueAdjustmentOfWarrants>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000725"
      unitRef="USD">-44000</ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity>
    <ONMD:ChangeInFairValueOfYorkvilleNote
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000728"
      unitRef="USD">-561000</ONMD:ChangeInFairValueOfYorkvilleNote>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000731"
      unitRef="USD">-124000</us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating>
    <us-gaap:CryptoAssetRealizedLossNonoperating
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000734"
      unitRef="USD">51000</us-gaap:CryptoAssetRealizedLossNonoperating>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000737"
      unitRef="USD">15000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <ONMD:NoncashInterest
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000740"
      unitRef="USD">96000</ONMD:NoncashInterest>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000744"
      unitRef="USD">17872000</ONMD:ChangeInFairValueOfConvertiblePromissoryNotes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000749"
      unitRef="USD">-89000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000750"
      unitRef="USD">86000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000752"
      unitRef="USD">-15000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000753"
      unitRef="USD">-14000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000755"
      unitRef="USD">1232000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000756"
      unitRef="USD">340000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000758"
      unitRef="USD">174000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000759"
      unitRef="USD">228000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000761"
      unitRef="USD">-4956000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000762"
      unitRef="USD">-3066000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000767"
      unitRef="USD">16000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000768"
      unitRef="USD">28000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentForAcquisitionCryptoAsset
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000770"
      unitRef="USD">2800000</us-gaap:PaymentForAcquisitionCryptoAsset>
    <us-gaap:ProceedsFromDisposalCryptoAsset
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000773"
      unitRef="USD">469000</us-gaap:ProceedsFromDisposalCryptoAsset>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000776"
      unitRef="USD">-2347000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000777"
      unitRef="USD">-28000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000782"
      unitRef="USD">6270000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000785"
      unitRef="USD">2000000</ONMD:ProceedsFromIssuanceOfShareholderLoans>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000786"
      unitRef="USD">704000</ONMD:ProceedsFromIssuanceOfShareholderLoans>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000791"
      unitRef="USD">1350000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000794"
      unitRef="USD">500000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000797"
      unitRef="USD">200000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000800"
      unitRef="USD">500000</us-gaap:RepaymentsOfLinesOfCredit>
    <ONMD:RepaymentForCommonStockRepurchase
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000803"
      unitRef="USD">100000</ONMD:RepaymentForCommonStockRepurchase>
    <ONMD:RepaymentOfDeferredUnderwriterFees
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000806"
      unitRef="USD">100000</ONMD:RepaymentOfDeferredUnderwriterFees>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000809"
      unitRef="USD">30000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000813"
      unitRef="USD">3875000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000816"
      unitRef="USD">16000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <ONMD:BusinessCombinationCosts
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000822"
      unitRef="USD">1160000</ONMD:BusinessCombinationCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000824"
      unitRef="USD">9190000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000825"
      unitRef="USD">3435000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000827"
      unitRef="USD">1887000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact000828"
      unitRef="USD">341000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact000830"
      unitRef="USD">47000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact000831"
      unitRef="USD">271000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000833"
      unitRef="USD">1934000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-09-30"
      decimals="-3"
      id="Fact000834"
      unitRef="USD">612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <ONMD:IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000848"
      unitRef="USD">242000</ONMD:IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable>
    <ONMD:ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000851"
      unitRef="USD">-429000</ONMD:ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000854">&lt;p id="xdx_807_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_znib4Gc2T9Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
&lt;span id="xdx_827_zqInMuCwveq5"&gt;Description of Business&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Organization
and description of business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;OneMedNet
Corporation (the &#x201c;Company&#x201d;) is a healthcare software company with solutions focused on digital medical image management,
exchange, and sharing. The Company was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions
that simplify digital medical image management, exchange, and sharing. The Company has one wholly owned subsidiary, OneMedNet Technologies
(Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional
currency is the Canadian dollar. The Company&#x2019;s headquarters location is Eden Prairie, Minnesota.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 7, 2023, Data Knights Merger Sub, Inc. (&#x201c;Merger Sub&#x201d;)&lt;span style="background-color: white"&gt;,&lt;/span&gt; a Delaware corporation
and a wholly owned subsidiary of Data Knights Acquisition Corp. (&#x201c;Data Knights&#x201d;), a Delaware corporation, merged with and
into OneMedNet Solutions Corporation (formerly named OneMedNet Corporation) (&#x201c;Legacy ONMD&#x201d;), with Legacy ONMD surviving as
a wholly owned subsidiary of Data Knights (the &#x201c;Business Combination&#x201d;). Following the consummation of the Business Combination,
Data Knights was renamed to &#x201c;OneMedNet Corporation.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Basis
of presentation and consolidation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and the rules and regulations of the Securities and Exchange Commission
(&#x201c;SEC&#x201d;) for interim reporting. As permitted under those rules and regulations, certain notes or other financial information
normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The interim unaudited
condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and,
in the opinion of management, reflect all adjustments, which include only normal, recurring adjustments that are necessary to present
fairly the Company&#x2019;s results for the interim periods presented. The results from operations for the three and nine months ended
September 30, 2024, are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or for any future
annual or interim period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the annual consolidated
financial statements and the related notes for the year ended December 31, 2023 in the Company&#x2019;s Annual Report on Form 10-K, as
amended, filed with the SEC on November 5, 2024 (the &#x201c;Form 10-K/A&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
interim unaudited condensed consolidated financial statements include the consolidated accounts of the Company&#x2019;s wholly owned subsidiary,
OneMedNet Technologies (Canada) Inc. All significant intercompany transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidity
and going concern&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has incurred recurring net losses since its inception, including $&lt;span id="xdx_908_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240701__20240930_z6MPxtVWWQwl" title="Net loss"&gt;2.1&lt;/span&gt;
million and $&lt;span id="xdx_901_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20240930_zrBdsC7RWwe6" title="Net loss"&gt;7.8&lt;/span&gt;
million for the three and nine months ended September 30, 2024, respectively. In addition, the Company had an accumulated deficit of
$&lt;span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20240930_zV2Iyaf3OJH5" title="Accumulated defecit"&gt;99.2&lt;/span&gt;
million as of September 30, 2024. The Company&#x2019;s cash and Bitcoin  balance of $&lt;span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20240930_zLEFKpQiCbTb" title="Cash"&gt;1.9&lt;/span&gt;
million and $&lt;span id="xdx_90E_ecustom--CryptoCash_iI_pn5n6_c20240930_zdbeBGvW3d3j" title="Crypto assets"&gt;2.2&lt;/span&gt; million, respectively, is not adequate to fund its operations through at least twelve months from the date these
condensed consolidated financial statements were available for issuance. Therefore, these conditions raise substantial doubt about
the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital
through an equity or debt offering and ultimately hopes to attain profitable operations to fulfill its operating and capital requirements
for at least 12 months from the date of the issuance of the condensed consolidated financial statements. However, the Company may not
be able to secure such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity securities
to raise additional funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences
and privileges senior to those of the Company&#x2019;s existing stockholders. The condensed consolidated financial statements do not include
any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company
be unable to continue as a going concern. The Company&#x2019;s continuation as a going concern is dependent upon its ability to continue
receiving working capital cash payments and generating cash flow from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risks
and uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to risks common to companies in the markets it serves, including, but not limited to, global economic and financial
market conditions, fluctuations in customer demand, acceptance of new products, development by its competitors of new technological innovations,
dependence on key personnel, and protection of proprietary technology.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company has invested in Bitcoin, which is a crypto asset. Crypto assets are loosely regulated and there is no central marketplace
for currency exchange. Supply is determined by a computer code, not by a central bank, and prices have been extremely volatile. Certain
crypto asset exchanges have been closed due to fraud, failure or security breaches. Any of the Company&#x2019;s crypto assets that reside
on an exchange that shuts down may be lost. Several factors may affect the price of crypto assets, including, but not limited to: supply
and demand, investors&#x2019; expectations with respect to the rate of inflation, interest rates, currency exchange rates or future regulatory
measures (if any) that restrict the trading of crypto assets, and the use of crypto assets as a form of payment. There is no assurance
that crypto assets will maintain their long-term value in terms of purchasing power in the future, or that acceptance of crypto asset
payments by mainstream retail merchants and commercial businesses will continue to grow.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
crypto assets have grown in popularity and market size, various countries and jurisdictions have begun to develop regulations governing
the crypto asset industry. To the extent future regulatory actions or policies limit the ability to exchange crypto assets or utilize
them for payments, the demand for crypto assets could be reduced. Furthermore, regulatory actions may limit the ability of end-users
to convert crypto assets into fiat currency (e.g., U.S. dollars) or use crypto assets to pay for goods and services. Such regulatory
actions or policies could result in a reduction of demand, and in turn, a decline in the underlying crypto asset unit prices.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
effect of any future regulatory change on crypto assets in general is impossible to predict, but such change could be substantial and
adverse to the Company and the value of the Company&#x2019;s investments in crypto assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Crypto
assets are not insured or protected under the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) or the Securities Investor Protection
Company (&#x201c;SIPC&#x201d;). Accordingly, with respect to its Bitcoin investment, the Company does not enjoy the protections of other
assets covered by the FDIC or SIPC.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Segment
information&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates in one operating segment and, accordingly, no segment disclosures have been presented herein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-07-012024-09-30"
      decimals="-5"
      id="Fact000856"
      unitRef="USD">-2100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-09-30"
      decimals="-5"
      id="Fact000858"
      unitRef="USD">-7800000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-09-30"
      decimals="-5"
      id="Fact000860"
      unitRef="USD">-99200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-09-30"
      decimals="-5"
      id="Fact000862"
      unitRef="USD">1900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <ONMD:CryptoCash
      contextRef="AsOf2024-09-30"
      decimals="-5"
      id="Fact000864"
      unitRef="USD">2200000</ONMD:CryptoCash>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000866">&lt;p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zH1VqNaltdWe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
&lt;span id="xdx_828_zrIhmBlVwG25"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Except
as described below, the accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained
in the Form 10-K/A, and the accounting policies followed by the Company for interim financial reporting are consistent with the accounting
policies therein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zykcr4STYTP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_ztClUiPVzDv5"&gt;Treasury
stock&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records the repurchase of its common stock, par value $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zV5aGhhoxuBl" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share (&#x201c;Common Stock&#x201d;) at cost on the trade date
of the transaction. These shares are considered treasury stock, which is a reduction to stockholders&#x2019; equity (deficit). Treasury
stock is included in authorized and issued shares but excluded from outstanding shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--DerivativesPolicyTextBlock_zZ2V9HQlBKzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zWX2Asy1zIL7"&gt;Derivative
financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 480, &lt;i&gt;Distinguishing
Liabilities from Equity &lt;/i&gt;and ASC 815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt;. The result of this accounting treatment is that the fair value
of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability.
The change in fair value is recorded in the condensed consolidated statement of operations as a component of other expense (income),
net. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that
fair value is reclassified to equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
reassessed at the end of each reporting period. Derivative instrument liabilities will be classified in the condensed consolidated
balance sheets as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12
months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_esrt--PlatformOperatorCryptoAssetPolicyTextBlock_zibQBfSiylnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zd4ljSuuHwQ9"&gt;Crypto
assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-08, &lt;i&gt;Intangibles
- Goodwill and Other - Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets &lt;/i&gt;(&#x201c;ASU
2023-08&#x201d;), which provides an update to existing crypto asset guidance and requires an entity to measure certain crypto assets
at fair value. In addition, this guidance requires disclosures related to crypto assets once it is adopted. As of January 1, 2024,
the Company has adopted ASU 2023-08.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reflects crypto assets held at fair value on the condensed consolidated balance sheets and condensed consolidated statements
of cash flows, the activity from remeasurement of crypto assets at fair value on the condensed consolidated statements of
operations, and the required expanded disclosures in Note 3, &lt;i&gt;Crypto Assets Held&lt;/i&gt;. The adoption of ASU 2023-08 resulted in no
cumulative-effect adjustment to the opening balance of retained earnings as of January 1, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Crypto
assets are generally valued using prices as reported on reputable and liquid exchanges and may involve using an average of bid and ask
quotes using closing prices provided by such exchanges as of the date and time of determination. The time used is 4:00 pm EST.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zgtB9aGPE3O9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zJw7ipdRavCd"&gt;Net
loss per share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required
for participating securities. Certain warrants participate in distributions of the Company. The pre-funded warrants associated with the
July and September 2024 private placements (see Note 7) are considered outstanding shares in the basic earnings per share calculation
given their nominal exercise price. The net loss attributable to common stockholders is not allocated to the warrant holders as the warrant
holders do not have a contractual obligation to share in losses. Basic net loss per share is calculated by dividing the net loss by the
weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss
by the weighted-average number of shares of Common Stock and common stock equivalents outstanding for the period. Common stock equivalents
are only included when their effect is dilutive. The Company&#x2019;s potentially dilutive securities, including outstanding warrants
to purchase Common Stock and outstanding stock options under the Company&#x2019;s equity incentive plan, have been excluded from the computation
of diluted net loss per share as their inclusion would be anti-dilutive. For all periods presented, there is no difference in the number
of shares used to calculate basic and diluted shares outstanding to the Company&#x2019;s net loss position.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--EmergingGrowthCompanyPolicyTextBlock_zcRl5YIt2WRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_z0NQmbkWgKc4"&gt;Emerging
growth company status&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company&#x201d;, as defined in the Jumpstart Our Business Startups Act of 2012 (&#x201c;JOBS Act&#x201d;).
Under the JOBS Act, emerging growth companies can take advantage of an extended transition period for complying with new or revised accounting
standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company has elected to
use this extended transition period for complying with certain new or revised accounting standards that have different effective dates
for public and private companies until the earlier of the date that it (1) is no longer an emerging growth company or (2) affirmatively
and irrevocably opts out of the extended transition period provided in the JOBS Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUkuk6y4J0ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zBbPJIwc5OK3"&gt;Accounting
pronouncements not yet adopted&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU No.
2023-09, &lt;i&gt;Improvements to Income Tax Disclosures (Topic 740)&lt;/i&gt; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 requires disaggregated information
about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. ASU 2023-09
is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual
financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of
adopting ASU 2023-09 on the presentation of its condensed consolidated financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU No. 2023-07, &lt;i&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment
Disclosures&lt;/i&gt;, which is intended to provide enhancements to segment disclosures, even for entities with only one reportable
segment. In particular, the standard will require disclosures of information related to significant segment expenses regularly
provided to the chief operating decision maker and included within each reported measure of segment profit and loss. The standard
will also require disclosure of all other segment items by reportable segment and a description of its composition. Finally, the
standard will require disclosure of the title and position of the chief operating decision maker and an explanation of how the chief
operating decision maker uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to
allocate resources. The standard is effective for annual periods beginning after December 15, 2023, and interim periods within
annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the
standard on the presentation of its condensed consolidated financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_zNGSKxUsp7Mc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000868">&lt;p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zykcr4STYTP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_ztClUiPVzDv5"&gt;Treasury
stock&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records the repurchase of its common stock, par value $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zV5aGhhoxuBl" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share (&#x201c;Common Stock&#x201d;) at cost on the trade date
of the transaction. These shares are considered treasury stock, which is a reduction to stockholders&#x2019; equity (deficit). Treasury
stock is included in authorized and issued shares but excluded from outstanding shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000870"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000872">&lt;p id="xdx_846_eus-gaap--DerivativesPolicyTextBlock_zZ2V9HQlBKzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zWX2Asy1zIL7"&gt;Derivative
financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 480, &lt;i&gt;Distinguishing
Liabilities from Equity &lt;/i&gt;and ASC 815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt;. The result of this accounting treatment is that the fair value
of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability.
The change in fair value is recorded in the condensed consolidated statement of operations as a component of other expense (income),
net. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that
fair value is reclassified to equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
reassessed at the end of each reporting period. Derivative instrument liabilities will be classified in the condensed consolidated
balance sheets as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12
months of the balance sheet date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <srt:PlatformOperatorCryptoAssetPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000874">&lt;p id="xdx_845_esrt--PlatformOperatorCryptoAssetPolicyTextBlock_zibQBfSiylnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zd4ljSuuHwQ9"&gt;Crypto
assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-08, &lt;i&gt;Intangibles
- Goodwill and Other - Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets &lt;/i&gt;(&#x201c;ASU
2023-08&#x201d;), which provides an update to existing crypto asset guidance and requires an entity to measure certain crypto assets
at fair value. In addition, this guidance requires disclosures related to crypto assets once it is adopted. As of January 1, 2024,
the Company has adopted ASU 2023-08.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reflects crypto assets held at fair value on the condensed consolidated balance sheets and condensed consolidated statements
of cash flows, the activity from remeasurement of crypto assets at fair value on the condensed consolidated statements of
operations, and the required expanded disclosures in Note 3, &lt;i&gt;Crypto Assets Held&lt;/i&gt;. The adoption of ASU 2023-08 resulted in no
cumulative-effect adjustment to the opening balance of retained earnings as of January 1, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Crypto
assets are generally valued using prices as reported on reputable and liquid exchanges and may involve using an average of bid and ask
quotes using closing prices provided by such exchanges as of the date and time of determination. The time used is 4:00 pm EST.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</srt:PlatformOperatorCryptoAssetPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000876">&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zgtB9aGPE3O9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zJw7ipdRavCd"&gt;Net
loss per share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required
for participating securities. Certain warrants participate in distributions of the Company. The pre-funded warrants associated with the
July and September 2024 private placements (see Note 7) are considered outstanding shares in the basic earnings per share calculation
given their nominal exercise price. The net loss attributable to common stockholders is not allocated to the warrant holders as the warrant
holders do not have a contractual obligation to share in losses. Basic net loss per share is calculated by dividing the net loss by the
weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss
by the weighted-average number of shares of Common Stock and common stock equivalents outstanding for the period. Common stock equivalents
are only included when their effect is dilutive. The Company&#x2019;s potentially dilutive securities, including outstanding warrants
to purchase Common Stock and outstanding stock options under the Company&#x2019;s equity incentive plan, have been excluded from the computation
of diluted net loss per share as their inclusion would be anti-dilutive. For all periods presented, there is no difference in the number
of shares used to calculate basic and diluted shares outstanding to the Company&#x2019;s net loss position.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <ONMD:EmergingGrowthCompanyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000878">&lt;p id="xdx_844_ecustom--EmergingGrowthCompanyPolicyTextBlock_zcRl5YIt2WRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_z0NQmbkWgKc4"&gt;Emerging
growth company status&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company&#x201d;, as defined in the Jumpstart Our Business Startups Act of 2012 (&#x201c;JOBS Act&#x201d;).
Under the JOBS Act, emerging growth companies can take advantage of an extended transition period for complying with new or revised accounting
standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company has elected to
use this extended transition period for complying with certain new or revised accounting standards that have different effective dates
for public and private companies until the earlier of the date that it (1) is no longer an emerging growth company or (2) affirmatively
and irrevocably opts out of the extended transition period provided in the JOBS Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ONMD:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000880">&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUkuk6y4J0ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zBbPJIwc5OK3"&gt;Accounting
pronouncements not yet adopted&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU No.
2023-09, &lt;i&gt;Improvements to Income Tax Disclosures (Topic 740)&lt;/i&gt; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 requires disaggregated information
about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. ASU 2023-09
is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual
financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of
adopting ASU 2023-09 on the presentation of its condensed consolidated financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU No. 2023-07, &lt;i&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment
Disclosures&lt;/i&gt;, which is intended to provide enhancements to segment disclosures, even for entities with only one reportable
segment. In particular, the standard will require disclosures of information related to significant segment expenses regularly
provided to the chief operating decision maker and included within each reported measure of segment profit and loss. The standard
will also require disclosure of all other segment items by reportable segment and a description of its composition. Finally, the
standard will require disclosure of the title and position of the chief operating decision maker and an explanation of how the chief
operating decision maker uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to
allocate resources. The standard is effective for annual periods beginning after December 15, 2023, and interim periods within
annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the
standard on the presentation of its condensed consolidated financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CryptoAssetTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000882">&lt;p id="xdx_805_eus-gaap--CryptoAssetTextBlock_zKLCg55gnXuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.
&lt;span id="xdx_827_zoO8pgRsi5F8"&gt;Crypto Assets Held&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--CryptoAssetHoldingTableTextBlock_zTB0AIener44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s crypto assets are comprised solely of Bitcoin. In accordance with ASC Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;, the Company measures the fair value of its Bitcoin based on the quoted
end-of-day price on the measurement date for a single Bitcoin on an active trading platform, River.com. Management has determined that
River.com, an active exchange market, represents a principal market for Bitcoin and the end-of-day quoted price is both readily available
and representative of fair value (Level 1 inputs). The following table sets forth the units held,
cost basis, and fair value of Bitcoin held, as shown on the condensed consolidated balance sheet as of September 30, 2024 (in
thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8B4_zY3UlrZWZ5ne" style="display: none"&gt;Schedule of
Crypto Assets Held&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Units&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost Basis&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Crypto assets held:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; padding-bottom: 1pt"&gt;Bitcoin&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zLOn4p19mJN7" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Units"&gt;34&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zp3DECi0H9Qi" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Cost Basis"&gt;2,280&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zroUcn7ulLG3" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Fair Value"&gt;2,156&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930_zxCzDZA5h31d" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Units"&gt;34&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930_znPTUFykpP3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Cost Basis"&gt;2,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930_zkrQPxzIqVEi" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Fair Value"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_z4zmSbHVicB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--CryptoAssetActivityTableTextBlock_z1bD7UqESyQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents a reconciliation of the fair values of the Company&#x2019;s Bitcoin for the nine months ended September 30, 2024
(in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BA_zCLq1qYiSvyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Crypto Assets Reconciliation of Fair Values&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240101__20240930_ztdl1EyPS13j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Bitcoin&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CryptoAssetFairValue_iS_pn3n3_zQZHqSEdjwW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CryptoAssetAddition_pn3n3_zMGUwIBFwPFg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;Additions&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CryptoAssetDisposition_iN_pn3n3_di_zMvzW35TKVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Dispositions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(520&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CryptoAssetRealizedAndUnrealizedGainLossNonoperating_pn3n3_zm0rtpou1iD4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized loss, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(124&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CryptoAssetFairValue_iE_pn3n3_zoOCyIpKptze" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zV7be24ybcl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions
are the result of the Company acquiring Bitcoin with liquid assets from private placements, while dispositions are the
result of sales of Bitcoin. During the three and nine months ended September 30, 2024, the Company had Bitcoin dispositions of $&lt;span id="xdx_90E_eus-gaap--CryptoAssetDisposition_pn5n6_c20240701__20240930_z8aIxi1EOSC6" title="Bitcoin dispositions"&gt;&lt;span id="xdx_90B_eus-gaap--CryptoAssetDisposition_pn5n6_c20240101__20240930_zcLh8GIt5kVi" title="Bitcoin dispositions"&gt;0.5&lt;/span&gt;&lt;/span&gt; million,
inclusive of realized losses of $&lt;span id="xdx_909_eus-gaap--CryptoAssetRealizedAndUnrealizedLossNonoperating_pn3n3_c20240701__20240930_zgdIrfF1UOv1" title="Bitcoin realized losses"&gt;&lt;span id="xdx_903_eus-gaap--CryptoAssetRealizedAndUnrealizedLossNonoperating_pn3n3_c20240101__20240930_zBKqUhCaUN02" title="Bitcoin realized losses"&gt;51&lt;/span&gt;&lt;/span&gt; thousand. The Company uses a first-in, first-out methodology to assign costs to Bitcoin for purposes
of the Bitcoin held and realized gains and losses disclosure above. Bitcoin is included in current assets in the condensed consolidated
balance sheet due to the Company&#x2019;s ability to sell them in a highly liquid marketplace and its intent to liquidate its Bitcoin
to support operations when needed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CryptoAssetTextBlock>
    <us-gaap:CryptoAssetHoldingTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000884">&lt;p id="xdx_897_eus-gaap--CryptoAssetHoldingTableTextBlock_zTB0AIener44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s crypto assets are comprised solely of Bitcoin. In accordance with ASC Topic 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt;, the Company measures the fair value of its Bitcoin based on the quoted
end-of-day price on the measurement date for a single Bitcoin on an active trading platform, River.com. Management has determined that
River.com, an active exchange market, represents a principal market for Bitcoin and the end-of-day quoted price is both readily available
and representative of fair value (Level 1 inputs). The following table sets forth the units held,
cost basis, and fair value of Bitcoin held, as shown on the condensed consolidated balance sheet as of September 30, 2024 (in
thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8B4_zY3UlrZWZ5ne" style="display: none"&gt;Schedule of
Crypto Assets Held&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Units&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cost Basis&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Crypto assets held:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; padding-bottom: 1pt"&gt;Bitcoin&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zLOn4p19mJN7" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Units"&gt;34&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zp3DECi0H9Qi" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Cost Basis"&gt;2,280&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zroUcn7ulLG3" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Fair Value"&gt;2,156&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930_zxCzDZA5h31d" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Units"&gt;34&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930_znPTUFykpP3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Cost Basis"&gt;2,280&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930_zkrQPxzIqVEi" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Fair Value"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:CryptoAssetHoldingTableTextBlock>
    <us-gaap:CryptoAssetNumberOfUnits
      contextRef="AsOf2024-09-30_custom_BitcoinMember"
      decimals="-3"
      id="Fact000886"
      unitRef="Integer">34000</us-gaap:CryptoAssetNumberOfUnits>
    <us-gaap:CryptoAssetCost
      contextRef="AsOf2024-09-30_custom_BitcoinMember"
      decimals="-3"
      id="Fact000888"
      unitRef="USD">2280000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2024-09-30_custom_BitcoinMember"
      decimals="-3"
      id="Fact000890"
      unitRef="USD">2156000</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetNumberOfUnits
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000892"
      unitRef="Integer">34000</us-gaap:CryptoAssetNumberOfUnits>
    <us-gaap:CryptoAssetCost
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000894"
      unitRef="USD">2280000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000896"
      unitRef="USD">2156000</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetActivityTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000898">&lt;p id="xdx_893_eus-gaap--CryptoAssetActivityTableTextBlock_z1bD7UqESyQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents a reconciliation of the fair values of the Company&#x2019;s Bitcoin for the nine months ended September 30, 2024
(in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BA_zCLq1qYiSvyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Crypto Assets Reconciliation of Fair Values&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240101__20240930_ztdl1EyPS13j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Bitcoin&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CryptoAssetFairValue_iS_pn3n3_zQZHqSEdjwW2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0900"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CryptoAssetAddition_pn3n3_zMGUwIBFwPFg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;Additions&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,800&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CryptoAssetDisposition_iN_pn3n3_di_zMvzW35TKVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Dispositions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(520&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--CryptoAssetRealizedAndUnrealizedGainLossNonoperating_pn3n3_zm0rtpou1iD4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized loss, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(124&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CryptoAssetFairValue_iE_pn3n3_zoOCyIpKptze" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:CryptoAssetActivityTableTextBlock>
    <us-gaap:CryptoAssetAddition
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000902"
      unitRef="USD">2800000</us-gaap:CryptoAssetAddition>
    <us-gaap:CryptoAssetDisposition
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000904"
      unitRef="USD">520000</us-gaap:CryptoAssetDisposition>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000906"
      unitRef="USD">-124000</us-gaap:CryptoAssetRealizedAndUnrealizedGainLossNonoperating>
    <us-gaap:CryptoAssetFairValue
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact000908"
      unitRef="USD">2156000</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetDisposition
      contextRef="From2024-07-012024-09-30"
      decimals="-5"
      id="Fact000910"
      unitRef="USD">500000</us-gaap:CryptoAssetDisposition>
    <us-gaap:CryptoAssetDisposition
      contextRef="From2024-01-01to2024-09-30"
      decimals="-5"
      id="Fact000912"
      unitRef="USD">500000</us-gaap:CryptoAssetDisposition>
    <us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact000914"
      unitRef="USD">51000</us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating>
    <us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000916"
      unitRef="USD">51000</us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating>
    <us-gaap:LongTermDebtTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000918">&lt;p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zgE3dIWpWlTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&lt;span id="xdx_823_zK5JMJPEWQKa"&gt;Convertible Debt&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
2019 to 2023, the Company issued various convertible promissory notes to related and unrelated party investors, which were convertible
into equity securities of Legacy ONMD upon a next equity financing transaction (the &#x201c;Convertible Promissory Notes&#x201d;). The
Convertible Promissory Notes bore interest at a rate of either &lt;span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zqFlkQW35Io2" title="Debt conversion converted instrument rate"&gt;4&lt;/span&gt;% or &lt;span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zI4ZzeUpZyhi" title="Debt conversion converted instrument rate"&gt;6&lt;/span&gt;% annually from the date of issuance until the outstanding principal
was paid or converted. In connection with the issuance of Convertible Promissory Notes in 2022 and 2023, the Company also issued warrants
at an exercise price of $&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240930__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesWarrantsMember_zj1mzTFDZnO9" title="Warrants exercise price"&gt;1.00&lt;/span&gt; per share (the &#x201c;Convertible Promissory Notes Warrants&#x201d;). See additional information on the
accounting for the warrants in Note 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Promissory Notes were issued for general working capital purposes. The Company elected the fair value option (&#x201c;FVO&#x201d;)
of accounting under ASC 825, &lt;i&gt;Financial Instruments&lt;/i&gt;, for its Convertible Promissory Notes. Under the FVO election, the financial
instrument is initially measured at its issue-date estimated fair value and subsequently remeasured at estimated fair value on a recurring
basis at each reporting period date. The estimated fair value adjustment is presented as a single line item within other expense (income),
net in the accompanying condensed consolidated statements of operations under the caption change in fair value of convertible promissory
notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, all Convertible Promissory Notes were converted pursuant to their provision in connection with the Business Combination
between Data Knights and Legacy ONMD and were no longer outstanding as of December 31, 2023. See the Form 10-K/A for all other details
relating to the Convertible Promissory Notes issued prior to December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;PIPE
Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 28, 2023, &lt;span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20230628__20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zn2SjncbvHzc" title="Debt description"&gt;Data
Knights and certain investors (the &#x201c;Purchasers&#x201d;) entered into a Securities Purchase Agreement pursuant to which Data
Knights issued and sold to the Purchasers a new series of senior secured convertible notes (the
&#x201c;PIPE Notes&#x201d;), which are convertible into shares of Common Stock at the Purchasers&#x2019; election at a conversion price equal
to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) Trading
Days immediately preceding the conversion date.&lt;/span&gt; The PIPE Notes matured on the first anniversary of the issuance date, or
November 7, 2024. The majority of the PIPE Notes holders have elected to convert their PIPE Notes into shares of Common Stock, which
will occur upon the Company&#x2019;s filing of a Registration Statement on Form S-1.&lt;/span&gt; &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company elected the FVO of accounting for its PIPE Notes. The estimated fair value adjustment is presented as a single line item
within other expense (income), net in the accompanying condensed consolidated statements of operations under the caption change in
fair value of PIPE Notes. As of September 30, 2024 and December 31, 2023, the fair value of the PIPE Notes was $&lt;span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20240930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zF04u7lLsVK5" title="PIPE Notes"&gt;1.6&lt;/span&gt;
million and $&lt;span id="xdx_90A_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7xn7Wmwz6Oh" title="PIPE Notes"&gt;1.6&lt;/span&gt; million, respectively, which is included in current liabilities on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Shareholder
Loans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
January to June 2024, the Company received gross proceeds of $&lt;span id="xdx_908_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1KAO1HJLP76" title="Loans payable"&gt;1.6&lt;/span&gt; million in connection with shareholder loans with a related party investor
which are convertible into &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240101__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlfrraQ7AUe9" title="Stock issued during period shares conversion of convertible securities"&gt;2,123,312&lt;/span&gt; shares of Common Stock at a conversion price of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH7crsHhNtOi" title="Debt conversion price"&gt;0.7535&lt;/span&gt; per share. These loans do not bear interest
and mature one year from issuance. The balance of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZwwcM2VIfsh" title="Principal amount of notes payable"&gt;1.6&lt;/span&gt; million is included in loan &#x2013; related party on the condensed consolidated
balance sheet as of September 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Helena
Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 28, 2024, the Company entered into a definitive securities purchase agreement (the &#x201c;Helena SPA&#x201d;) with Helena Global
Investment Opportunities 1 Ltd. (&#x201c;Helena&#x201d;), an affiliate of Helena Partners Inc., a Cayman Islands-based advisor and investor
providing for up to $&lt;span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240328__20240328_ztXQ0WdfGwha" title="Proceeds from issuance of convertible notes"&gt;4.5&lt;/span&gt; million in funding through a private placement for the issuance of senior secured convertible notes and warrants
across multiple tranches. The Helena SPA was subsequently terminated in June 2024 prior to the closing of any tranches (the &#x201c;Helena
Termination Agreement&#x201d;). As such, except as described below, the Helena SPA had no impact on the Company&#x2019;s condensed consolidated
financial statements as of and for the &lt;span style="background-color: white"&gt;nine months &lt;/span&gt;ended September 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Helena Termination Agreement, the Company agreed to issue to Helena a warrant to purchase &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240328_zCFfsfDipzhl" title="Warrant outstanding"&gt;50,000&lt;/span&gt; shares of Common Stock at an
exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240328_ziHpzXLON6Dg" title="Warrant exercise price"&gt;1.20&lt;/span&gt; per share (the &#x201c;Helena Termination Warrants&#x201d;) and agreed to reimburse Helena for certain reasonable
and documented out-of-pocket legal fees and expenses incurred in connection with entry into the Helena SPA and Helena Termination Agreement
and related documents. The Company incurred legal fees and expenses of $&lt;span id="xdx_901_eus-gaap--LegalFees_pn3n3_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--HelenaTerminationAgreementMember_zzR87PxCnC26" title="Legal fees"&gt;42&lt;/span&gt; thousand in connection with the Helena Termination Agreement.
As of September 30, 2024, the Helena Termination Warrants were not yet issued or outstanding. However, in accordance with the loss contingency
guidance of ASC Topic 450, &lt;i&gt;Contingencies&lt;/i&gt;, the Company determined that it was probable that a liability had been incurred (its
obligation to issue warrants) and the amount of the loss could be reasonably estimated (the fair value of &lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930_zZrhrCT2XWac" title="Number of warrants"&gt;50,000&lt;/span&gt; warrants at an exercise
price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240930_zc0rvQmwEsK" title="Exercise price of warrant"&gt;1.20&lt;/span&gt; per share). Therefore, the Company recorded stock warrant expense of $&lt;span id="xdx_90B_ecustom--StockWarrantExpense_pn3n3_c20240101__20240930_zRGCkZplq2Kd" title="Stock warrant expense"&gt;33&lt;/span&gt; thousand in its condensed consolidated statement
of operations, with an offsetting liability to accounts payable and accrued expenses on its condensed consolidated balance sheet. The
Company will reclassify the contingent liability to equity or warrant liabilities under applicable guidance when the Helena Termination
Warrants are issued, which occurred in December 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
Note&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 17, 2024, the Company entered into a Standby Equity Purchase Agreement (&#x201c;SEPA&#x201d;) with YA II PN, LTD, a Cayman Islands
exempt limited partnership managed by Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;) (see Note 7). Upon entry into the SEPA,
the Company issued Yorkville a $&lt;span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_pn5n6_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zulY9UuqiMc8" title="Convertible promissory note"&gt;1.5&lt;/span&gt; million convertible promissory note for $&lt;span id="xdx_906_eus-gaap--Cash_iI_pn4n6_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zdRaAM9caZl7" title="Cash"&gt;1.35&lt;/span&gt; million in cash (after a &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zvPgkJeJYYmk" title="Original issue discount"&gt;10&lt;/span&gt;% original issue discount)
(the &#x201c;Yorkville Note&#x201d;). The Yorkville Note does not bear interest and matures on &lt;span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_pid_dd_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zzxsn56vjOY9" title="Maturity date"&gt;June 17, 2025&lt;/span&gt;. &lt;span id="xdx_909_eus-gaap--DebtInstrumentDescription_pid_dd_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zT4Bij1QnXaj" title="Debt description"&gt;The Yorkville Note is convertible
by Yorkville into shares of Common Stock at an aggregate purchase price based on a price per share equal to the lower of (a) $1.3408
per share (subject to downward reset upon the filing of the resale registration statement described below) or (b) 90% of the lowest daily
volume-weighted average price (&#x201c;VWAP&#x201d;) of the Common Stock on Nasdaq during the seven trading days immediately prior to each
conversion (the &#x201c;Variable Price&#x201d;), but which Variable Price may not be lower than the Floor Price then in effect.&lt;/span&gt; The &#x201c;Floor
Price&#x201d; is $&lt;span id="xdx_90F_ecustom--FloorPricePerShare_iI_c20240617__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zb6WTBadgGxb" title="Floor price per share"&gt;0.28&lt;/span&gt; per share, subject to the Company&#x2019;s option to reduce the Floor Price to any amounts set forth in a written
notice to Yorkville. Upon the occurrence and during the continuation of an event of default (as defined in the Yorkville Note), the Yorkville
Note will become immediately due and payable. The issuance of the Common Stock upon conversion of the note and otherwise under the SEPA
is capped at &lt;span id="xdx_902_ecustom--PrecentageOfOutstandingCommonStock_dp_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zpCKLojZ4v" title="Precentage of outstanding common stock"&gt;19.9&lt;/span&gt;% of the outstanding Common Stock as of June 18, 2024. Further, the note and SEPA include a beneficial ownership blocker
for Yorkville such that Yorkville may not be deemed the beneficial owner of more than &lt;span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_c20240617__srt--OwnershipAxis__custom--BeneficialOwnershipMember__srt--RangeAxis__srt--MinimumMember_zwaRDlaPWXqi" title="Beneficial ownership percentage"&gt;4.99&lt;/span&gt;% of the Company&#x2019;s Common Stock. As a
result of the Company&#x2019;s failure to file its Form 10-Q for the fiscal quarter ended June 30, 2024 by August 14, 2024 (i.e., a deemed
Event of Default under the Yorkville Note), the Company began accruing interest at the default rate of &lt;span id="xdx_904_ecustom--DebtInstrumentInterestRateDefaultPercentage_iI_pid_dp_c20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh45U7CPLqtl" title="Debt default interest rate"&gt;18.0&lt;/span&gt;% as of August 14, 2024. A
further event of default occurred as a result of the Company&#x2019;s failure to file a registration statement with the SEC for the resale
by Yorkville of the shares of Common Stock issuable under the SEPA by August 30, 2024 (see Note 7). As such, the full unpaid principal
amount of the Yorkville Note may become immediately due and payable at Yorkville&#x2019;s election. The Company subsequently engaged in
discussions with Yorkville regarding these events of default, which discussions are ongoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company elected the FVO of accounting for the Yorkville Note. The estimated fair value adjustment is presented as a single line item
within other expense (income), net in the accompanying condensed consolidated statements of operations under the caption change in fair
value of Yorkville Note. As of September 30, 2024, the fair value of the Yorkville Note was $&lt;span id="xdx_90C_ecustom--YorkvilleNotesPayableCurrent_iI_pn5n6_c20240930_zTt1BiL2G7s9" title="Fair value of Yorkville Note"&gt;1.9&lt;/span&gt; million, which is included in current
liabilities on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="From2024-01-012024-09-30_srt_MinimumMember"
      decimals="INF"
      id="Fact000920"
      unitRef="Pure">0.04</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="From2024-01-012024-09-30_srt_MaximumMember"
      decimals="INF"
      id="Fact000922"
      unitRef="Pure">0.06</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30_custom_ConvertibleNotesWarrantsMember"
      decimals="INF"
      id="Fact000924"
      unitRef="USDPShares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2023-06-282023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember"
      id="Fact000926">Data
Knights and certain investors (the &#x201c;Purchasers&#x201d;) entered into a Securities Purchase Agreement pursuant to which Data
Knights issued and sold to the Purchasers a new series of senior secured convertible notes (the
&#x201c;PIPE Notes&#x201d;), which are convertible into shares of Common Stock at the Purchasers&#x2019; election at a conversion price equal
to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) Trading
Days immediately preceding the conversion date.</us-gaap:DebtInstrumentDescription>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2024-09-30_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact000928"
      unitRef="USD">1600000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact000930"
      unitRef="USD">1600000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ProceedsFromLoans
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="-5"
      id="Fact000932"
      unitRef="USD">1600000</us-gaap:ProceedsFromLoans>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact000934"
      unitRef="Shares">2123312</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact000936"
      unitRef="USDPShares">0.7535</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember"
      decimals="-5"
      id="Fact000938"
      unitRef="USD">1600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-03-282024-03-28"
      decimals="-5"
      id="Fact000940"
      unitRef="USD">4500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-03-28"
      decimals="INF"
      id="Fact000942"
      unitRef="Shares">50000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-03-28"
      decimals="INF"
      id="Fact000944"
      unitRef="USDPShares">1.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:LegalFees
      contextRef="From2024-03-282024-03-28_custom_HelenaTerminationAgreementMember"
      decimals="-3"
      id="Fact000946"
      unitRef="USD">42000</us-gaap:LegalFees>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000948"
      unitRef="Shares">50000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact000950"
      unitRef="USDPShares">1.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ONMD:StockWarrantExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact000952"
      unitRef="USD">33000</ONMD:StockWarrantExpense>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember"
      decimals="-5"
      id="Fact000954"
      unitRef="USD">1500000</us-gaap:ConvertibleDebt>
    <us-gaap:Cash
      contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember"
      decimals="-4"
      id="Fact000956"
      unitRef="USD">1350000</us-gaap:Cash>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember"
      decimals="INF"
      id="Fact000958"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember"
      id="Fact000960">2025-06-17</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember"
      id="Fact000962">The Yorkville Note is convertible
by Yorkville into shares of Common Stock at an aggregate purchase price based on a price per share equal to the lower of (a) $1.3408
per share (subject to downward reset upon the filing of the resale registration statement described below) or (b) 90% of the lowest daily
volume-weighted average price (&#x201c;VWAP&#x201d;) of the Common Stock on Nasdaq during the seven trading days immediately prior to each
conversion (the &#x201c;Variable Price&#x201d;), but which Variable Price may not be lower than the Floor Price then in effect.</us-gaap:DebtInstrumentDescription>
    <ONMD:FloorPricePerShare
      contextRef="AsOf2024-06-17_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleNoteMember"
      decimals="INF"
      id="Fact000964"
      unitRef="USDPShares">0.28</ONMD:FloorPricePerShare>
    <ONMD:PrecentageOfOutstandingCommonStock
      contextRef="From2024-06-182024-06-18_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact000966"
      unitRef="Pure">0.199</ONMD:PrecentageOfOutstandingCommonStock>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="AsOf2024-06-17_custom_BeneficialOwnershipMember_srt_MinimumMember"
      decimals="INF"
      id="Fact000968"
      unitRef="Pure">0.0499</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <ONMD:DebtInstrumentInterestRateDefaultPercentage
      contextRef="AsOf2024-10-01_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact000970"
      unitRef="Pure">0.180</ONMD:DebtInstrumentInterestRateDefaultPercentage>
    <ONMD:YorkvilleNotesPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-5"
      id="Fact000972"
      unitRef="USD">1900000</ONMD:YorkvilleNotesPayableCurrent>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000974">&lt;p id="xdx_80C_eus-gaap--ShortTermDebtTextBlock_z4jlZwJEgNVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&lt;span id="xdx_821_z9XD6EJMgSTb"&gt;Line of Credit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2024, the Company obtained a line of credit of $&lt;span id="xdx_904_eus-gaap--LineOfCredit_iI_pn5n6_c20240331__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_z2ljrRYshtkj"&gt;1.0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million with BOC Bank to support short-term working
capital needs. The line of credit bears an interest rate of &lt;span id="xdx_900_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20240301__20240331__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_zkT76zUVUPZ"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and matures in 120 days. In July 2024, the maturity date was extended an additional 120 days to November 2, 2024. The line of credit
was terminated at maturity in November 2024. As of September 30, 2024, there was &lt;span id="xdx_90B_eus-gaap--LineOfCredit_iI_pn6n6_do_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_zMfBfm3SyjYl"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;balance outstanding on the line of credit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:LineOfCredit
      contextRef="AsOf2024-03-31_custom_BOCBankMember"
      decimals="-5"
      id="Fact000975"
      unitRef="USD">1000000.0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2024-03-012024-03-31_custom_BOCBankMember"
      decimals="INF"
      id="Fact000976"
      unitRef="Pure">0.050</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000979">&lt;p id="xdx_80D_eus-gaap--DebtDisclosureTextBlock_z1hJ0b91gQV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.
&lt;span id="xdx_82E_zjLpuYW4gLRd"&gt;Canadian Emergency Business Account (&#x201c;CEBA&#x201d;)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
December 2020, the Company applied for and received a $&lt;span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zW2YBo3xqU05" title="Proceeds from loans"&gt;60&lt;/span&gt; thousand CAD ($&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zsSziDGlhTH1" title="Proceeds from loans"&gt;40&lt;/span&gt; thousand USD) equivalent CEBA loan. The loan was provided
by the government of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and
better position them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through
December 31, 2023. If the loan was paid back by January 18, 2024, $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentDecreaseForgiveness_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zCvOcNhwQZp8" title="Forgiven of loan"&gt;15&lt;/span&gt; thousand of the loan would have been forgiven. If the loan was
not paid back by January 18, 2024, the full $&lt;span id="xdx_900_eus-gaap--DebtConversionOriginalDebtAmount1_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zDdu5sArUMTe" title="Conversion of loan"&gt;40&lt;/span&gt; thousand loan would have been converted to a loan repayable over &lt;span id="xdx_905_eus-gaap--DebtInstrumentTerm_dc_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJ1ETCo2z78l" title="Loan payment term"&gt;three years&lt;/span&gt; with a &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJW1VlW8jUH4" title="Interest rate"&gt;5&lt;/span&gt;%
interest rate. The loan was paid back prior to January 18, 2024, and the Company recognized a gain on extinguishment of $&lt;span id="xdx_905_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zhhHczOlBPTj" title="Gain loss on extinguishment of debt"&gt;15&lt;/span&gt; thousand,
which is presented in other expense (income), net in the condensed consolidated statement of operations for the nine months
ended September 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfUnsecuredDebt
      contextRef="From2020-12-012020-12-31_custom_CEBALoanMember"
      decimals="-3"
      id="Fact000981"
      unitRef="CAD">60000</us-gaap:ProceedsFromIssuanceOfUnsecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfUnsecuredDebt
      contextRef="From2020-12-012020-12-31_custom_CEBALoanMember"
      decimals="-3"
      id="Fact000983"
      unitRef="USD">40000</us-gaap:ProceedsFromIssuanceOfUnsecuredDebt>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="From2020-12-012020-12-31_custom_CEBALoanMember"
      decimals="-3"
      id="Fact000985"
      unitRef="USD">15000</us-gaap:DebtInstrumentDecreaseForgiveness>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2020-12-012020-12-31_custom_CEBALoanMember"
      decimals="-3"
      id="Fact000987"
      unitRef="USD">40000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2020-12-012020-12-31_custom_CEBALoanMember"
      id="Fact000989">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-31_custom_CEBALoanMember"
      decimals="INF"
      id="Fact000991"
      unitRef="Pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-012024-09-30_custom_CEBALoanMember"
      decimals="-3"
      id="Fact000993"
      unitRef="USD">15000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact000995">&lt;p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zbu0Xd6kkx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&lt;span id="xdx_824_z8w5WKUjnEca"&gt;Stockholders&#x2019; Deficit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Common
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Business Combination, Data Knights entered into an agreement with their underwriters (&#x201c;EF Hutton&#x201d;) whereby
EF Hutton agreed to waive the related merger underwriting fees that were payable at closing ($&lt;span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z6urNFkClzm" title="Business combination, underwriter fees payable"&gt;4.0&lt;/span&gt; million) in exchange for allocated
payments as follows: (i) $&lt;span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zvUH5CDkDTia" title="Business combination, closing cash balance"&gt;0.5&lt;/span&gt; million in cash at closing; (ii) a $&lt;span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2LBqOIJPwt9" title="Promissory note"&gt;0.5&lt;/span&gt; million promissory note that matured on &lt;span id="xdx_90D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_dd_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zwqfRnR2ompe" title="Debt maturity date"&gt;March 1, 2024&lt;/span&gt;; and (iii)
a transfer of &lt;span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesTransferred_pid_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_ziDLyoHhrEb4" title="Number of shares transferred"&gt;277,778&lt;/span&gt; shares of Common Stock, which were valued at the closing stock price of $&lt;span id="xdx_900_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20230628__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zX32Y339OjGi" title="Closing stock price"&gt;10.89&lt;/span&gt; per share on June 28, 2023. If,
five trading days prior to the six-month anniversary, the aggregate VWAP value of the &lt;span id="xdx_901_ecustom--VolumeWeightedAveragePrice_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zTCVDJ7AbY69" title="Volume weighted average price"&gt;277,778&lt;/span&gt; shares of Common Stock was lower than the
original share value of $&lt;span id="xdx_90A_ecustom--VolumeWeightedAveragePriceValue_pn5n6_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_ziS1IXEzQMT8" title="Volume weighted average price, value"&gt;3.0&lt;/span&gt; million, &lt;span id="xdx_902_eus-gaap--BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_c20231107__20231107_zFiw5oWDxzq8" title="Description of contingent consideration"&gt;the Company was obligated to compensate EF Hutton at a new share price equal to the difference
in amount on such date. Due to the decrease in share value on the six-month anniversary, the Company was required to either pay to EF
Hutton an additional $2.8 million or issue to EF Hutton an additional 3,175,000 shares of Common Stock.&lt;/span&gt; In January 2024, the Company
issued the original &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240131_z5qYSXwZjKpb" title="Number of shares issued"&gt;277,778&lt;/span&gt; shares of Common Stock as consideration for $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20240101__20240131_z2KmEz1Wayy6" title="Number of shares issued, value"&gt;0.2&lt;/span&gt; million owed by the Company. As of September 30, 2024, &lt;span id="xdx_909_eus-gaap--BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_c20240101__20240930_zpEl2i5CdVH1" title="Description of contingent consideration"&gt;the
Company was obligated to pay to EF Hutton the true-up of either $2.8 million or 3,175,000 shares of Common Stock valued at $0.88 per
share, plus the $0.5 million promissory note. Upon the occurrence of an event of default, the promissory note bears interest at a rate
of 12.5% until such event of default is cured.&lt;/span&gt; The promissory note remained unpaid upon maturity on &lt;span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930_zeyArWQOPkud" title="Debt instrument maturity date"&gt;March 1, 2024&lt;/span&gt;, and the Company recorded
interest expense of $&lt;span id="xdx_900_eus-gaap--InterestExpense_pn3n3_c20240701__20240930_zcn8rAIeESu9" title="Interest expense"&gt;14&lt;/span&gt; thousand and $&lt;span id="xdx_905_eus-gaap--InterestExpense_pn3n3_c20240101__20240930_zOKu6Tg4Igm5" title="Interest expense"&gt;55&lt;/span&gt; thousand during the three and nine months ended September 30, 2024, respectively, because of
the event of default. In August 2024, the Company made a promissory note payment of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn5n6_c20240801__20240831_z4eFN6762kA2" title="Promissory note payment"&gt;0.1&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
February 2024, the Company entered into a stock repurchase agreement with a former holder of Convertible Promissory Notes pursuant to
which the Company repurchased &lt;span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_z5nR21WZrNw7" title="Number of shares repurchased"&gt;187,745&lt;/span&gt; shares of Common Stock in exchange for cash of $&lt;span id="xdx_90F_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_z4lZwsyqSJsi" title="Number of shares repurchased, value exchange for cash"&gt;0.5&lt;/span&gt; million that is payable in installments. The
Company made payments of $&lt;span id="xdx_906_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20240701__20240731__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zxuisEtQbsH9" title="Number of shares repurchased, value exchange for cash"&gt;&lt;span id="xdx_906_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20241001__20241031__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zWOI9TrnsEx" title="Number of shares repurchased, value exchange for cash"&gt;0.1&lt;/span&gt;&lt;/span&gt; million in July and October 2024 and the remaining $&lt;span id="xdx_904_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20250101__20250101__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zNwEvUsCi5U6" title="Number of shares repurchased, value exchange for cash"&gt;0.3&lt;/span&gt; million is expected to be repaid in early 2025.
The $&lt;span id="xdx_905_ecustom--PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_pn5n6_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zcjM0GEMUd2k" title="Principal and accrued interest outstanding"&gt;0.5&lt;/span&gt; million represents the principal and accrued interest outstanding on the holder&#x2019;s Convertible Promissory Note immediately
prior to the Business Combination. The $&lt;span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pn5n6_c20240930__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zT2xs2JQhRe6" title="Accounts payable and accrued expenses"&gt;0.4&lt;/span&gt; million outstanding at September 30, 2024 is classified in accounts payable and accrued expenses
on the condensed consolidated balance sheet. The &lt;span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodShares_pid_di_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zgGJ0fXdvaJ" title="Number of shares repurchased"&gt;187,745&lt;/span&gt; repurchased shares were reclassified to treasury stock as of September 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Standby
Equity Purchase Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 17, 2024, the Company and Yorkville entered into the SEPA. Under the SEPA, the Company has the right to sell to Yorkville up to
$&lt;span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20240617__20240617__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zy3RW0tarPAk"&gt;25.0&lt;/span&gt; million of its Common Stock, subject to certain limitations and conditions set forth in the SEPA, from time to time, over a 24-month
period. Sales of the Common Stock to Yorkville under the SEPA, and the timing of any such sales, are at the Company&#x2019;s option, and
the Company is under no obligation to sell any shares of Common Stock to Yorkville under the SEPA except in connection with notices that
may be submitted by Yorkville, in certain circumstances as described below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the satisfaction of the conditions precedent in the SEPA, which include having a resale shelf for shares of Common Stock issued to Yorkville
declared effective, the Company has the right to direct Yorkville to purchase a specified number of shares of Common Stock by delivering
written notice (each an &#x201c;Advance&#x201d;). &lt;span id="xdx_902_ecustom--StockholdersDeficitDescription_c20240617__20240617_zvU7MkX7Ut32" title="Stockholders deficit description"&gt;An Advance may not exceed the greater of (i) 100% of the average of the daily trading
volume of the Common Stock on Nasdaq, during the five consecutive trading days immediately preceding the date of the Advance, and (ii)
five hundred thousand (500,000) shares of Common Stock.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
will generally purchase shares pursuant to an Advance at a price per share equal to 97% of the VWAP, on Nasdaq during the three consecutive
trading days commencing on the date of the delivery of the Advance (unless the Company specifies a minimum acceptable price or there
is no VWAP on the subject trading day).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
SEPA will automatically terminate on the earliest to occur of (i) the first day of the month next following the 24-month anniversary
of the date of the SEPA or (ii) the date on which Yorkville shall have made payment for shares of Common Stock equal to $&lt;span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20240617__20240617__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zIH8y2gxPS1d" title="Sale of stock, value"&gt;25.0&lt;/span&gt; million.
The Company has the right to terminate the SEPA at no cost or penalty upon five trading days&#x2019; prior written notice to Yorkville,
provided that there are no outstanding advances for which shares of Common Stock need to be issued and the Yorkville Note has been paid
in full. The Company and Yorkville may also agree to terminate the SEPA by mutual written consent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
consideration for Yorkville&#x2019;s commitment to purchase the shares of Common Stock pursuant to the SEPA, the Company paid Yorkville
a $&lt;span id="xdx_907_ecustom--CashStructuringFee_pn3n3_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_znZy7cQ2SMKk" title="Cash structuring fee"&gt;25&lt;/span&gt; thousand cash structuring fee. In addition, the Company must pay a commitment fee in shares equal to $&lt;span id="xdx_900_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20240617__20240617_z4UVITkTX5O6" title="Commitment fees"&gt;0.5&lt;/span&gt; million. In September
2024, the Company paid an equivalent of the commitment fee by issuing to Yorkville &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240901__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zf1dBTjppzlc" title="Number of shares, issued"&gt;526,312&lt;/span&gt; shares of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the entry into the SEPA, on June 17, 2024, the Company entered into a registration rights agreement with Yorkville, pursuant
to which the Company agreed to file with the SEC no later than August 30, 2024, a registration statement for the resale by Yorkville
of the shares of Common Stock issued under the SEPA (including the commitment fee shares). The Company agreed to use commercially reasonable
efforts to have such registration statement declared effective within 30 days of such filing and to maintain the effectiveness of such
registration statement during the 24-month commitment period. The Company will not have the ability to request any Advances under the
SEPA (nor may Yorkville convert the Yorkville Note into Common Stock) until such resale registration statement is declared effective
by the SEC. The Company has not yet filed a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock
issued under the SEPA, which is deemed an event of default under the SEPA and as a result, a payment of $&lt;span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_pn5n6_c20241015__20241015__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zojNJMkB7h58" title="Payments of common stock issuance"&gt;0.6&lt;/span&gt; million became due on October
15, 2024. The $&lt;span id="xdx_909_eus-gaap--ConversionOfStockAmountConverted1_pn5n6_c20240617__20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zQ9Hi1T67mEi" title="Conversion of stock amount"&gt;0.6&lt;/span&gt; million due includes the outstanding principal of $&lt;span id="xdx_90C_eus-gaap--ConversionOfStockAmountIssued1_pn5n6_c20240617__20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_z3M4E1zg82Q8" title="Conversion of stock amount issued"&gt;0.5&lt;/span&gt; million, accrued and unpaid interest, and a payment premium
of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zsyvkv30hVMc" title="Interest rate percentage"&gt;10%&lt;/span&gt;. As described in Note 4, the Company subsequently engaged in discussions with Yorkville regarding the events of default, which
discussions are ongoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
SEPA was accounted for as a liability under ASC 815 as it includes an embedded put option and an embedded forward option. The put option
is recognized at inception and the forward option is recognized upon issuance of notice for the sale of the Company&#x2019;s Common Stock.
The fair value of the derivative liability related to the embedded put option was estimated at $&lt;span id="xdx_902_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet_iI_pn5n6_c20240930_zHDJEwQljAKf" title="Fair value of embedded derivative"&gt;0.2&lt;/span&gt; million at the inception of the agreement.
As of September 30, 2024, the embedded put option was determined to have no value because of alternative financing options now available
to the Company making future draws on the SEPA improbable. Further, as described in Note 4, the Company is currently in default on the
SEPA due to its failure to file a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock issuable
under the SEPA by August 30, 2024. As such, no shares can currently be issued under the SEPA. The embedded forward option was also deemed
to have &lt;span id="xdx_908_eus-gaap--ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_pn6n6_do_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zIzYL1tscM74" title="Emdedded derivative liabilities"&gt;no&lt;/span&gt; value as there were no notices for the sale of the Company&#x2019;s Common Stock as of September 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Private
Placements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;July
2024 Financings&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 23, 2024, the Company entered into a securities purchase agreement with a certain institutional investor, pursuant to which the
&lt;span style="background-color: white"&gt;Company agreed to issue and sell &lt;span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240723__20240723__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_ziycdSX0h8t6"&gt;1,297,059
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;shares of its
Common Stock at a price of $&lt;span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240723__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zYyR5fsvYxAb"&gt;1.0278
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;per share and pre-funded
warrants exercisable for &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240725__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zrx2aZ0PW1Eg"&gt;1,323,530
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;shares of its Common
Stock at an exercise price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240723__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zVNzJxMls8yl"&gt;1.0278
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;per share (the &#x201c;July
2024 Pre-Funded Warrants&#x201d;). The investor was required to prepay the exercise price for the pre-funded warrants, other than $&lt;span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20240723__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zcHEiulFOAuf"&gt;0.0001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;per share. The warrants
and pre-funded warrants will be exercisable at any time after the date of issuance and will not expire. &lt;/span&gt;Holders of pre-funded
warrants are entitled to receive dividends, if declared, on an as-if-converted-to-common-stock basis, and in the same form as dividends
actually paid on shares of the Common Stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 25, 2024, the Company entered into a securities purchase agreement with a certain institutional investor, pursuant to which the
&lt;span style="background-color: white"&gt;Company agreed to issue and sell &lt;span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240725__20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_ztn0egyHIIee" title="Shares issued"&gt;2,301,791&lt;/span&gt; shares of its Common Stock at a price of $&lt;span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zM3p4ROkUGz8" title="Share price"&gt;0.85&lt;/span&gt; per share.
&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company received net proceeds of approximately $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240725__20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zvUjTQ7mgbki" title="Proceeds from issuance of private placement"&gt;4.5&lt;/span&gt; million from the July 2024 private placements, after deducting offering expenses
of $&lt;span id="xdx_90C_eus-gaap--DeferredOfferingCosts_iI_pn5n6_c20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zbThqG9oN5jl" title="Offering expenses"&gt;0.1&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;September
2024 Financing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 24, 2024, &lt;span style="background-color: white"&gt;the Company entered into a securities purchase agreement with a certain
institutional investor, pursuant to which the Company agreed to issue and sell to the investor &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240924__20240924__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember_zqaXbNHvWJYf" title="Number of shares issue and sold"&gt;1,918,591&lt;/span&gt;
shares of its Common Stock at a price of $&lt;span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240924__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z1h5FIrPdXg7" title="Common stock price per share"&gt;0.65&lt;/span&gt;
per share, warrants exercisable for &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240924__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z4GbEX3nT4g5" title="Number of warrants exercisable"&gt;133,095&lt;/span&gt;
shares of its Common Stock at an exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zFqKpOrDFCu" title="Exercise price per share"&gt;0.325&lt;/span&gt;
per share (the &#x201c;September 2024 Warrants&#x201d;) and pre-funded warrants exercisable for &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zId4hUKgOcrj" title="Warrants exercisable for common stock"&gt;743,314&lt;/span&gt;
shares of its Common Stock at an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zNXG4Yp6C95i" title="Warrant exercise price"&gt;0.65&lt;/span&gt;
per share (the &#x201c;September 2024 Pre-Funded Warrants&#x201d;). The investor was required to prepay the exercise price for the
pre-funded warrants, other than $&lt;span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zEF4yi1GhB6a" title="Share issued price"&gt;0.0001&lt;/span&gt;
per share. The warrants and pre-funded warrants will be exercisable at any time after the date of issuance and will not
expire.&lt;/span&gt; Holders of pre-funded warrants are entitled to receive dividends, if declared, on an as-if-converted-to-common-stock
basis, and in the same form as dividends actually paid on shares of the Common Stock. The Company received net proceeds of
approximately $&lt;span id="xdx_900_eus-gaap--DeferredOfferingCosts_iI_pn5n6_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zHbqIeVuXAze" title="Offering expenses"&gt;1.7&lt;/span&gt;
million, after deducting an immaterial amount of offering expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2024, the Company had not yet issued the &lt;span id="xdx_90F_eus-gaap--CommonStockSharesSubscriptions_iI_c20240930__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhFakj1H2JH7" title="Common stock shares not yet issued"&gt;1,918,591&lt;/span&gt;
shares of Common Stock in order to keep the investor&#x2019;s ownership percentage below a defined threshold. The net proceeds of
$1.7 million was recorded akin to an equity forward sale contract and was included in additional paid-in-capital in
stockholders&#x2019; deficit in the condensed consolidated balance sheets as it met the criteria for equity accounting under ASC
815.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of September 30, 2024 and December 31, 2023, &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20240930_zB4kRjVHpEWl" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240930_zA8vYPBvdAR8" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20231231_zx1qR4kbKCEk" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zkO4bCSJRIc8" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Preferred Stock were issued or outstanding. All shares of Legacy ONMD Series
A-2 Preferred Stock and Series A-1 Preferred Stock were converted into Common Stock in connection with the Business Combination. See
the Form 10-K/A for all other details relating to the Series A-2 Preferred Stock and Series A-1 Preferred Stock issued prior to December
31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact000997"
      unitRef="USD">4000000.0</ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact000999"
      unitRef="USD">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact001001"
      unitRef="USD">500000</ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable
      contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember"
      id="Fact001003">2024-03-01</ONMD:BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable>
    <ONMD:StockIssuedDuringPeriodSharesTransferred
      contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="INF"
      id="Fact001005"
      unitRef="Shares">277778</ONMD:StockIssuedDuringPeriodSharesTransferred>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2023-06-28_custom_DataKnightsAcquisitionCorpMember"
      decimals="INF"
      id="Fact001007"
      unitRef="USDPShares">10.89</us-gaap:BusinessAcquisitionSharePrice>
    <ONMD:VolumeWeightedAveragePrice
      contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="INF"
      id="Fact001009"
      unitRef="Shares">277778</ONMD:VolumeWeightedAveragePrice>
    <ONMD:VolumeWeightedAveragePriceValue
      contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact001011"
      unitRef="USD">3000000.0</ONMD:VolumeWeightedAveragePriceValue>
    <us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod contextRef="From2023-11-072023-11-07" id="Fact001013">the Company was obligated to compensate EF Hutton at a new share price equal to the difference
in amount on such date. Due to the decrease in share value on the six-month anniversary, the Company was required to either pay to EF
Hutton an additional $2.8 million or issue to EF Hutton an additional 3,175,000 shares of Common Stock.</us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-01-31"
      decimals="INF"
      id="Fact001015"
      unitRef="Shares">277778</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-01-31"
      decimals="-5"
      id="Fact001017"
      unitRef="USD">200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod contextRef="From2024-01-01to2024-09-30" id="Fact001019">the
Company was obligated to pay to EF Hutton the true-up of either $2.8 million or 3,175,000 shares of Common Stock valued at $0.88 per
share, plus the $0.5 million promissory note. Upon the occurrence of an event of default, the promissory note bears interest at a rate
of 12.5% until such event of default is cured.</us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2024-01-01to2024-09-30" id="Fact001021">2024-03-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:InterestExpense
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact001023"
      unitRef="USD">14000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact001025"
      unitRef="USD">55000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="From2024-08-012024-08-31"
      decimals="-5"
      id="Fact001027"
      unitRef="USD">100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember"
      decimals="INF"
      id="Fact001029"
      unitRef="Shares">187745</us-gaap:StockRepurchasedDuringPeriodShares>
    <ONMD:StockRepurchasedDuringPeriodValueExchangeForCash
      contextRef="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember"
      decimals="-5"
      id="Fact001031"
      unitRef="USD">500000</ONMD:StockRepurchasedDuringPeriodValueExchangeForCash>
    <ONMD:StockRepurchasedDuringPeriodValueExchangeForCash
      contextRef="From2024-07-012024-07-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember"
      decimals="-5"
      id="Fact001033"
      unitRef="USD">100000</ONMD:StockRepurchasedDuringPeriodValueExchangeForCash>
    <ONMD:StockRepurchasedDuringPeriodValueExchangeForCash
      contextRef="From2024-10-012024-10-31_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember"
      decimals="-5"
      id="Fact001035"
      unitRef="USD">100000</ONMD:StockRepurchasedDuringPeriodValueExchangeForCash>
    <ONMD:StockRepurchasedDuringPeriodValueExchangeForCash
      contextRef="From2025-01-012025-01-01_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember_srt_ScenarioForecastMember"
      decimals="-5"
      id="Fact001037"
      unitRef="USD">300000</ONMD:StockRepurchasedDuringPeriodValueExchangeForCash>
    <ONMD:PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote
      contextRef="From2024-02-012024-02-29_us-gaap_ConvertibleNotesPayableMember_custom_StockRepurchaseAgreementMember"
      decimals="-5"
      id="Fact001039"
      unitRef="USD">500000</ONMD:PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-09-30_us-gaap_ConvertibleNotesPayableMember"
      decimals="-5"
      id="Fact001041"
      unitRef="USD">400000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-01-012024-09-30_us-gaap_TreasuryStockCommonMember"
      decimals="INF"
      id="Fact001043"
      unitRef="Shares">-187745</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-06-172024-06-17_srt_MaximumMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact001044"
      unitRef="USD">25000000.0</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <ONMD:StockholdersDeficitDescription contextRef="From2024-06-172024-06-17" id="Fact001046">An Advance may not exceed the greater of (i) 100% of the average of the daily trading
volume of the Common Stock on Nasdaq, during the five consecutive trading days immediately preceding the date of the Advance, and (ii)
five hundred thousand (500,000) shares of Common Stock.</ONMD:StockholdersDeficitDescription>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-06-172024-06-17_srt_MaximumMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact001048"
      unitRef="USD">25000000.0</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <ONMD:CashStructuringFee
      contextRef="From2024-06-172024-06-17_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-3"
      id="Fact001050"
      unitRef="USD">25000</ONMD:CashStructuringFee>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-06-172024-06-17"
      decimals="-5"
      id="Fact001052"
      unitRef="USD">500000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-012024-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001054"
      unitRef="Shares">526312</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2024-10-152024-10-15_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact001056"
      unitRef="USD">600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2024-06-172024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact001058"
      unitRef="USD">600000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="From2024-06-172024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact001060"
      unitRef="USD">500000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-06-17_custom_YorkvilleNoteMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact001062"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet
      contextRef="AsOf2024-09-30"
      decimals="-5"
      id="Fact001064"
      unitRef="USD">200000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet>
    <us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
      contextRef="From2024-01-012024-09-30_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-6"
      id="Fact001066"
      unitRef="USD">0</us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-07-232024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember"
      decimals="INF"
      id="Fact001067"
      unitRef="Shares">1297059</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-07-23_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember"
      decimals="INF"
      id="Fact001068"
      unitRef="USDPShares">1.0278</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-07-25_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001069"
      unitRef="Shares">1323530</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-07-23_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001070"
      unitRef="USDPShares">1.0278</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-07-23_custom_JulyTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact001071"
      unitRef="USDPShares">0.0001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-07-252024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember"
      decimals="INF"
      id="Fact001073"
      unitRef="Shares">2301791</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember"
      decimals="INF"
      id="Fact001075"
      unitRef="USDPShares">0.85</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-07-252024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember"
      decimals="-5"
      id="Fact001077"
      unitRef="USD">4500000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2024-07-25_custom_SecuritiesPurchaseAgreementMember_custom_JulyTwoThousandTwentyFourFinancingMember"
      decimals="-5"
      id="Fact001079"
      unitRef="USD">100000</us-gaap:DeferredOfferingCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-09-242024-09-24_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_custom_SeptemberTwoThousandTwentyFourFinancingMember"
      decimals="INF"
      id="Fact001081"
      unitRef="Shares">1918591</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-09-24_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001083"
      unitRef="USDPShares">0.65</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-24_us-gaap_WarrantMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001085"
      unitRef="Shares">133095</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-24_us-gaap_WarrantMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001087"
      unitRef="USDPShares">0.325</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001089"
      unitRef="Shares">743314</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001091"
      unitRef="USDPShares">0.65</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="INF"
      id="Fact001093"
      unitRef="USDPShares">0.0001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DeferredOfferingCosts
      contextRef="AsOf2024-09-24_custom_PrefundedWarrantsMember_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember"
      decimals="-5"
      id="Fact001095"
      unitRef="USD">1700000</us-gaap:DeferredOfferingCosts>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="AsOf2024-09-30_custom_SeptemberTwoThousandTwentyFourFinancingMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001097"
      unitRef="USD">1918591</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001099"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001101"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001103"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001105"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001107">&lt;p id="xdx_802_eus-gaap--EarningsPerShareTextBlock_zo4sKw1lCajl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.
&lt;span id="xdx_82D_znfi6OmWrAm4"&gt;Net Loss per Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the nine months ended September 30, 2024 and 2023, the weighted-average number of shares of Common Stock outstanding used to calculate
both basic and diluted net loss per share is the same. In computing diluted net loss per share for the nine months ended September 30,
2024 and 2023, the Company excluded the following potentially dilutive securities, as the effect would be anti-dilutive and reduce the
net loss per share calculated for each period:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zqtHkWkniuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zY8WtyweXEh" style="display: none"&gt;Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240101__20240930_z6rh7ChKA2Wg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20230930_zKvl5Q7cKBM9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zaJ6qRuqQiMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Options to purchase Common Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;147,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;913,856&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockUnitsAndAwardsMember_z5KFPMnET3Gk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unvested restricted stock units and awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,371,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,275&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9UCKP9FSwd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants for Common Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,314,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zbjJYN3YAy93" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series A-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zvZe6nAtBTo5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,415,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_ztASWlHwy9G3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible promissory notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,118,735&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,643,325&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_zjyHAg7uOSp" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,951,799&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;15,102,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zIvCM8d23g3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001109">&lt;p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zqtHkWkniuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BE_zY8WtyweXEh" style="display: none"&gt;Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240101__20240930_z6rh7ChKA2Wg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20230930_zKvl5Q7cKBM9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Nine Months Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zaJ6qRuqQiMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Options to purchase Common Stock&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;147,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;913,856&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockUnitsAndAwardsMember_z5KFPMnET3Gk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unvested restricted stock units and awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,371,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,275&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9UCKP9FSwd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants for Common Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,314,114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zbjJYN3YAy93" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series A-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1120"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zvZe6nAtBTo5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,415,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_ztASWlHwy9G3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible promissory notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,118,735&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,643,325&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_zjyHAg7uOSp" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,951,799&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;15,102,501&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_custom_OptionsToPurchaseCommonStockMember"
      decimals="INF"
      id="Fact001111"
      unitRef="Shares">147000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_custom_OptionsToPurchaseCommonStockMember"
      decimals="INF"
      id="Fact001112"
      unitRef="Shares">913856</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember"
      decimals="INF"
      id="Fact001114"
      unitRef="Shares">1371950</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_custom_UnvestedRestrictedStockUnitsAndAwardsMember"
      decimals="INF"
      id="Fact001115"
      unitRef="Shares">177275</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001117"
      unitRef="Shares">12314114</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001118"
      unitRef="Shares">3112165</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001121"
      unitRef="Shares">2839957</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001124"
      unitRef="Shares">3415923</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact001126"
      unitRef="Shares">1118735</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30_custom_ConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact001127"
      unitRef="Shares">4643325</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-01to2024-09-30"
      decimals="INF"
      id="Fact001129"
      unitRef="Shares">14951799</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-09-30"
      decimals="INF"
      id="Fact001130"
      unitRef="Shares">15102501</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001132">&lt;p id="xdx_808_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zmmJnBI3xJC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.
&lt;span id="xdx_822_zD5XNNHaN0Qf"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zmQ9ejPefDJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded stock-based compensation expense in the following categories on the accompanying condensed consolidated statements of
operations for the periods presented (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B0_zi0VxjIuHy3i" style="display: none"&gt;Schedule
of Stock-based Compensation Expense&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240701__20240930_zKe5IeXI8tO2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20230930_zPik3Muw8Nki" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_z5CcHjp4W8cg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1137"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlNN63lq1rKd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z0UM3n2cDlXl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1143"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zD4NQnRNXEl1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_zrPprdz5h9x1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;207&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;798&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240101__20240930_zCXyAW0gQ6m9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20230930_zUxBQ3iUyj55" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Nine Months Ended September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zTvqXJwV9Q39" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zbpaTM3KueYe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zuV9qFZzQJR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zA0HIOZurbKf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_zaOnxrxwLm6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,446&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zERfolW97EGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Equity
incentive plan &#x2013; summary&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2023, the Company adopted the OneMedNet Corporation 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;) and reserved an amount of
shares of &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20230101__20231231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zbcMaXdNixLa" title="Share-based payment award, description"&gt;Common Stock equal to 10% of the number of shares of Common Stock of the Company following the Business Combination for issuance
thereunder.&lt;/span&gt; The 2022 Plan became effective immediately upon the closing of the Business Combination and replaced the Legacy ONMD equity
incentive plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Equity
incentive plan &#x2013; stock options&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $&lt;span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zUK9zKMM1Pfb" title="Allocated share based compensation expense"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zIwcSslyOIAe" title="Allocated share based compensation expense"&gt;0.1&lt;/span&gt; million, respectively,
on its outstanding stock options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the nine months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $&lt;span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zlO3F3xU2w4h" title="Allocated share based compensation expense"&gt;34&lt;/span&gt; thousand and $&lt;span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zsjV1UxaDgl7" title="Allocated share based compensation expense"&gt;0.3&lt;/span&gt; million,
respectively, on its outstanding stock options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Equity
incentive plan &#x2013; restricted stock units (&#x201c;RSU&#x201d;)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $&lt;span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zhQRdT52C3og" title="Stock-based compensation expense"&gt;0.2&lt;/span&gt; million and $&lt;span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zS2prSD6oS3f" title="Stock-based compensation expense"&gt;0.7&lt;/span&gt; million,
respectively, on its outstanding restricted stock units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the nine months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $&lt;span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_z6OLIQ8Pc1ja" title="Stock-based compensation expense"&gt;1.1&lt;/span&gt; million and $&lt;span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zEffsyIvwjea" title="Stock-based compensation expense"&gt;0.4&lt;/span&gt; million,
respectively, on its outstanding restricted stock units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001134">&lt;p id="xdx_894_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zmQ9ejPefDJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded stock-based compensation expense in the following categories on the accompanying condensed consolidated statements of
operations for the periods presented (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B0_zi0VxjIuHy3i" style="display: none"&gt;Schedule
of Stock-based Compensation Expense&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240701__20240930_zKe5IeXI8tO2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230701__20230930_zPik3Muw8Nki" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_z5CcHjp4W8cg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1137"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlNN63lq1rKd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;195&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z0UM3n2cDlXl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1143"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zD4NQnRNXEl1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_zrPprdz5h9x1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;207&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;798&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240101__20240930_zCXyAW0gQ6m9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20230930_zUxBQ3iUyj55" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Nine Months Ended September 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zTvqXJwV9Q39" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Cost of revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1152"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zbpaTM3KueYe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,014&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zuV9qFZzQJR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zA0HIOZurbKf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_zaOnxrxwLm6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;447&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,446&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30_us-gaap_CostOfSalesMember"
      decimals="-3"
      id="Fact001136"
      unitRef="USD">5000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001139"
      unitRef="USD">195000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001140"
      unitRef="USD">782000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30_us-gaap_SellingAndMarketingExpenseMember"
      decimals="-3"
      id="Fact001142"
      unitRef="USD">2000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact001145"
      unitRef="USD">5000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact001146"
      unitRef="USD">16000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact001148"
      unitRef="USD">207000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact001149"
      unitRef="USD">798000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_CostOfSalesMember"
      decimals="-3"
      id="Fact001151"
      unitRef="USD">13000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001154"
      unitRef="USD">416000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact001155"
      unitRef="USD">1014000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_SellingAndMarketingExpenseMember"
      decimals="-3"
      id="Fact001157"
      unitRef="USD">4000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact001160"
      unitRef="USD">14000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact001161"
      unitRef="USD">432000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact001163"
      unitRef="USD">447000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact001164"
      unitRef="USD">1446000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="From2023-01-012023-12-31_custom_EquityIncentivePlanMember"
      id="Fact001166">Common Stock equal to 10% of the number of shares of Common Stock of the Company following the Business Combination for issuance
thereunder.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember"
      decimals="-3"
      id="Fact001168"
      unitRef="USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember"
      decimals="-5"
      id="Fact001170"
      unitRef="USD">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember"
      decimals="-3"
      id="Fact001172"
      unitRef="USD">34000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30_us-gaap_EmployeeStockOptionMember_custom_EquityIncentivePlanMember"
      decimals="-5"
      id="Fact001174"
      unitRef="USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-07-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember"
      decimals="-5"
      id="Fact001176"
      unitRef="USD">200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-07-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember"
      decimals="-5"
      id="Fact001178"
      unitRef="USD">700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember"
      decimals="-5"
      id="Fact001180"
      unitRef="USD">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-09-30_us-gaap_RestrictedStockUnitsRSUMember_custom_EquityIncentivePlanMember"
      decimals="-5"
      id="Fact001182"
      unitRef="USD">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ONMD:StockWarrantsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001184">&lt;p id="xdx_80F_ecustom--StockWarrantsDisclosureTextBlock_ztOIwOA4uPL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.
&lt;span id="xdx_823_zFq1DEMSVs97"&gt;Stock Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCMbuaAL3aN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the following warrants outstanding for the periods presented:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BF_zucWbKPNhz7h" style="display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240930_zWJZDgwOrKM5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230930_zeJvgEiBBr9g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Liability Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zl9OioKXlJk2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;585,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;585,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zfjJaZLYqMRb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;95,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;95,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_z4O1VnLEy1kk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;681,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;681,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Equity Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zNapLquh5uid" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zldFgxmFL3gl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Private Placement Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,199,939&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zpBzg3MT2qkk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13,699,939&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_zZvdffyDsfn9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Grand Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,380,958&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_z81XCOvU8O52" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Warrants outstanding &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,380,958&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zKtXBqQzJVdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Private
Placement Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in Note 7, the Company issued the July 2024 Pre-Funded Warrants, the September 2024 Pre-Funded Warrants and the September 2024
Warrants in connection with the July and September 2024 private placements (together, the &#x201c;Private Placement Warrants&#x201d;).
The Private Placement Warrants are classified as equity in accordance with ASC Subtopic 815-40, &lt;i&gt;Derivatives and Hedging - Contracts
in Entity&#x2019;s Own Equity &lt;/i&gt;(&#x201c;ASC 815-40&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
Promissory Notes Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in Note 4, the Company issued Convertible Promissory Notes Warrants in 2022 and 2023. The Convertible Promissory Notes
Warrants are classified as equity in accordance with ASC 815-40. The Company determined that the fair value of the combined
instrument (inclusive of the Convertible Promissory Notes) significantly exceeded the proceeds received; therefore, the Company
concluded that the Convertible Promissory Notes Warrants are most accurately portrayed as an issuance cost related to the
Convertible Promissory Notes. This resulted in an expense of $&lt;span id="xdx_907_ecustom--StockWarrantExpense_pn5n6_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zolgecQDBM7h"&gt;4.3 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million
and $&lt;span id="xdx_904_ecustom--StockWarrantExpense_pn5n6_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zmYnBdlopzO8"&gt;8.4 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million
being allocated to the Convertible Promissory Notes Warrants during the three and nine months ended September 30, 2023,
respectively, which is classified as stock warrant expense in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the closing of the Business Combination on November 7, 2023, all Convertible Promissory Notes Warrants were cashless
exercised into shares of Legacy ONMD common stock and exchanged based on the appropriate conversion ratio for the Common Stock less an
exercise price of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionRatio1_c20231106__20231107__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_z6oys9OoGAe2" title="Conversion ratio"&gt;1.00&lt;/span&gt;. See the Form 10-K/A for all other details relating to the Convertible Promissory Notes Warrants issued prior
to December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;PIPE
Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
conjunction with the issuance of the PIPE Notes described in Note 4, Data Knights also issued and sold to each of the Purchasers &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zN9Dj3BSne9g" title="Warrants to purchase common stock"&gt;95,745&lt;/span&gt;
warrants to purchase Common Stock at an exercise price of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zU4rqCJm5dYg" title="Exercise price of warrants"&gt;10.00&lt;/span&gt; per share (the &#x201c;PIPE Warrants&#x201d;). The PIPE Warrants are classified
as liabilities because they did not meet the criteria for equity treatment under ASC 815-40. During the three and nine months ended September
30, 2024, the Company recognized a change in fair value of PIPE Warrants of $&lt;span id="xdx_90B_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_z8wxBZL1Kkbj" title="Fair value adjustment of warrants"&gt;0&lt;/span&gt; and a gain of $&lt;span id="xdx_909_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zLG20waQ0Uq" title="Change in fair value of warrants"&gt;12&lt;/span&gt; thousand, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Combination Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zIngphbYmskb" title="Warrants to purchase common stock"&gt;585,275&lt;/span&gt; private warrants to purchase
Common Stock at an exercise price of $&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zWNONsMV3EY8" title="Exercise price of warrants"&gt;11.50&lt;/span&gt; per share (the &#x201c;Business Combination Warrants&#x201d;). The Business Combination Warrants
are classified as liabilities because they did not meet the criteria for equity treatment under ASC 815-40. During the three and nine
months ended September 30, 2024, the Company recognized a change in fair value of Business Combination Warrants of $&lt;span id="xdx_908_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zBOohwu0h8V8" title="Change in fair value of warrants"&gt;6&lt;/span&gt; thousand and $&lt;span id="xdx_900_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zakQydafQdN7" title="Change in fair value of warrants"&gt;17&lt;/span&gt;
thousand, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ONMD:StockWarrantsDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001186">&lt;p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCMbuaAL3aN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the following warrants outstanding for the periods presented:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_8BF_zucWbKPNhz7h" style="display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240930_zWJZDgwOrKM5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230930_zeJvgEiBBr9g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September 30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Liability Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zl9OioKXlJk2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;585,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;585,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zfjJaZLYqMRb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;95,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;95,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_z4O1VnLEy1kk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;681,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;681,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Equity Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zNapLquh5uid" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zldFgxmFL3gl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Private Placement Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,199,939&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zpBzg3MT2qkk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13,699,939&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_zZvdffyDsfn9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Grand Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,380,958&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_z81XCOvU8O52" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Warrants outstanding &lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;14,380,958&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember"
      decimals="INF"
      id="Fact001188"
      unitRef="Shares">585275</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_BusinessCombinationWarrantsMember"
      decimals="INF"
      id="Fact001189"
      unitRef="Shares">585275</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember"
      decimals="INF"
      id="Fact001191"
      unitRef="Shares">95744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember"
      decimals="INF"
      id="Fact001192"
      unitRef="Shares">95744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember"
      decimals="INF"
      id="Fact001194"
      unitRef="Shares">681019</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_LiabilityClassifiedWarrantsMember"
      decimals="INF"
      id="Fact001195"
      unitRef="Shares">681019</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact001197"
      unitRef="Shares">11500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact001198"
      unitRef="Shares">11500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember"
      decimals="INF"
      id="Fact001200"
      unitRef="Shares">2199939</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_EquityClassifiedWarrantsMember"
      decimals="INF"
      id="Fact001203"
      unitRef="Shares">13699939</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30_custom_EquityClassifiedWarrantsMember"
      decimals="INF"
      id="Fact001204"
      unitRef="Shares">11500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001206"
      unitRef="Shares">14380958</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="Fact001207"
      unitRef="Shares">12181019</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001209"
      unitRef="Shares">14380958</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-09-30"
      decimals="INF"
      id="Fact001210"
      unitRef="Shares">12181019</us-gaap:ClassOfWarrantOrRightOutstanding>
    <ONMD:StockWarrantExpense
      contextRef="From2023-07-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember"
      decimals="-5"
      id="Fact001211"
      unitRef="USD">4300000</ONMD:StockWarrantExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-09-30_custom_ConvertiblePromissoryNotesWarrantsMember"
      decimals="-5"
      id="Fact001212"
      unitRef="USD">8400000</ONMD:StockWarrantExpense>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="From2023-11-062023-11-07_custom_ConvertiblePromissoryNotesWarrantsMember"
      decimals="INF"
      id="Fact001214"
      unitRef="Pure">1.00</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-06-30_custom_PIPEWarrantsMember"
      decimals="INF"
      id="Fact001216"
      unitRef="Shares">95745</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_PIPEWarrantsMember"
      decimals="INF"
      id="Fact001218"
      unitRef="USDPShares">10.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ONMD:ChangeInFairValueOfWarrants
      contextRef="From2024-07-012024-09-30_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact001220"
      unitRef="USD">0</ONMD:ChangeInFairValueOfWarrants>
    <ONMD:ChangeInFairValueOfWarrants
      contextRef="From2024-01-012024-09-30_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact001222"
      unitRef="USD">12000</ONMD:ChangeInFairValueOfWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-11-07_custom_BusinessCombinationWarrantsMember"
      decimals="INF"
      id="Fact001224"
      unitRef="Shares">585275</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-11-07_custom_BusinessCombinationWarrantsMember"
      decimals="INF"
      id="Fact001226"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ONMD:ChangeInFairValueOfWarrants
      contextRef="From2024-07-012024-09-30_custom_BusinessCombinationWarrantsMember"
      decimals="-3"
      id="Fact001228"
      unitRef="USD">6000</ONMD:ChangeInFairValueOfWarrants>
    <ONMD:ChangeInFairValueOfWarrants
      contextRef="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember"
      decimals="-3"
      id="Fact001230"
      unitRef="USD">17000</ONMD:ChangeInFairValueOfWarrants>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001232">&lt;p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zvVW2LA9B6ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.
&lt;span id="xdx_820_zQIUTrXaomp3"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zRomgSLwyzAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BA_z6OnWbN41Jea" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zs7pR7XVeyMj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk3pYUiIki1g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zXOdtOYYgdYc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240930_zdkwazVils0b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_hus-gaap--FinancialInstrumentAxis__custom--BitcoinMember_zdVOpdadhZDk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 10pt"&gt;Bitcoin&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--AssetsFairValueDisclosure_iI_zoiZUdhtjPae" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total assets, at fair value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1242"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zvinzheDArVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1246"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6mlQXo9f3pk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1251"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1252"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zWZUo7FwPkMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1257"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--YorkvilleNoteMember_zpy6dS3QhFX7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Yorkville Note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1262"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--StandbyEquityPurchaseAgreementMember_z1Xn1KGKY8Cc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;SEPA derivative liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1267"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1268"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1269"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zPmbDddjA7Aa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1272"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zN3iPl8icnZc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxhyQBVx04zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zh3kUdO6GkT9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20231231_zE8iY7eZmuX" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zGWT8OSMZHFe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1277"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_ziPfBuKEeew8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z3bFjG8RlQfl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE Notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1286"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1287"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zKKLbNt0V9Rg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1292"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zuJLVb9AbE4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Business
Combination Warrants and PIPE Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-TLSO_zps6BRM4jDQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the changes in the Business Combination Warrants and PIPE Warrants measured at fair value during the nine months
ended September 30, 2024 (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B2_zusMWR8dIK1d" style="display: none"&gt;Schedule
of Warrants and Notes Measured at Fair Value&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B9_us-gaap--FinancialInstrumentAxis_custom--BusinessCombinationWarrantsMember_zg0zZVWpBMNg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PIPEWarrantsMember_zRZ4VYo3g01h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PIPE Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zhOUxxDJFxxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;14&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_z9qk9ZWF20Cj" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_z6iSqRCmiCo3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(12&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z2MZKufSZT7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;26&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_z1XGBbNMWzcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company remeasured the fair value of the Business Combination Warrants and PIPE Warrants at September 30, 2024 using the Black-Scholes
option-pricing model with the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z0EbGI9XuKg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B9_zbo4lpUx1OU6" style="display: none"&gt;Schedule
of Fair Value Assumptions and Valuation&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6yoFZjdrjI3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember_zdnqqfp3XZQ8" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;PIPE&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Business Combination&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z8ofOzO0ac9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Stock price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;0.61&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;0.61&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zesH5Uq4iOC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zaCri8ck8v0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zr6WHQ05YrM9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zXlftvXvisyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1330"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1331"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zSVXH8G4Gmsl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants measurement input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1333"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1334"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zUh0Fyou3Ww5" title="Expected term (in years)"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zU8xg8Aetap4" title="Expected term (in years)"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zyYLtmo7pxr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;PIPE
Notes and Yorkville Note&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_C09_gL3FVLMORBUIR-TLSO_zJFslKp8psI3"&gt;The
following table presents the changes in the PIPE Notes and Yorkville Note measured at fair value during the nine months ended September
30, 2024 (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div id="xdx_C0F_gL3FVLMORBUIR-TLSO_zrNp9ZRq9Rk8"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_309_134_zREtuuhIhXSl" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--FinancialInstrumentAxis_custom--PIPENotesMember_ze2r3E2jMVR2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PIPE Notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--YorkvilleNoteMember_zYzz8DZAcSY5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Yorkville Note&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlOJacrmtqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1341"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zMhjgFKRCOX2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1343"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zGJO8EE1uXi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;561&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zeIf64bpYuG4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,593&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,911&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_C06_gL3FVLMORBUIR-TLSO_zSEPh11Sejia"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated fair values of the PIPE Notes and Yorkville Note are determined based on the aggregated, probability-weighted average of the
outcomes of certain possible scenarios. The combined value of the probability-weighted average of those outcomes is then discounted back
to each reporting period in which the convertible notes are outstanding, in each case, based on a risk-adjusted discount rate estimated
based on the implied discount rate. The discount rate was held constant over the valuation periods given the fact pattern associated
with the Company and the stage of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;SEPA
Derivative Liability&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_C06_gL3FVLMORBUIR-TLSO_zz4orYY35kX2"&gt;The
following table presents the changes in the SEPA derivative liability measured at fair value during the nine months ended September 30,
2024 (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;div id="xdx_C00_gL3FVLMORBUIR-TLSO_zOsMKlhlCRO"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_300_134_zvn2i2KWbCdj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--YorkvilleStandbyEquityPurchaseAgreementMember_zeuekKn7dFk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Yorkville SEPA&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zBVYNCg9VPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1352"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zTX2QegBErif" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;Additions&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;160&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zNqLPzGMpOE4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(160&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zhdfOaCxSyfa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_C02_gL3FVLMORBUIR-TLSO_z93qpH9mH618"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated fair value of the SEPA derivative liability was determined using a scenario-based valuation model based on the aggregated amount
of draws expected to be made over the 24-month commitment period. The derivative value of such draws was then discounted back to each
reporting period in which the put option was outstanding, in each case, based on a risk-adjusted discount rate based on the implied discount
rate. As of September 30, 2024, the derivative liability was determined to have no value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001234">&lt;p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zRomgSLwyzAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BA_z6OnWbN41Jea" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zs7pR7XVeyMj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk3pYUiIki1g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zXOdtOYYgdYc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240930_zdkwazVils0b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt"&gt;Assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_hus-gaap--FinancialInstrumentAxis__custom--BitcoinMember_zdVOpdadhZDk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 10pt"&gt;Bitcoin&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--AssetsFairValueDisclosure_iI_zoiZUdhtjPae" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt"&gt;Total assets, at fair value&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1242"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"&gt;2,156&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zvinzheDArVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1246"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1247"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6mlQXo9f3pk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1251"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1252"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zWZUo7FwPkMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1256"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1257"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,593&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--YorkvilleNoteMember_zpy6dS3QhFX7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Yorkville Note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1262"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,911&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--StandbyEquityPurchaseAgreementMember_z1Xn1KGKY8Cc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;SEPA derivative liability&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1266"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1267"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1268"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1269"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zPmbDddjA7Aa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1272"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,532&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zN3iPl8icnZc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxhyQBVx04zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zh3kUdO6GkT9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20231231_zE8iY7eZmuX" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zGWT8OSMZHFe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1277"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_ziPfBuKEeew8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z3bFjG8RlQfl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE Notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1286"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1287"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zKKLbNt0V9Rg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1292"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_BitcoinMember"
      decimals="-3"
      id="Fact001236"
      unitRef="USD">2156000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_custom_BitcoinMember81074171"
      decimals="-3"
      id="Fact001239"
      unitRef="USD">2156000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact001241"
      unitRef="USD">2156000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact001244"
      unitRef="USD">2156000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact001248"
      unitRef="USD">26000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact001249"
      unitRef="USD">26000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact001253"
      unitRef="USD">2000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact001254"
      unitRef="USD">2000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      decimals="-3"
      id="Fact001258"
      unitRef="USD">1593000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_custom_PIPENotesMember"
      decimals="-3"
      id="Fact001259"
      unitRef="USD">1593000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_YorkvilleNoteMember"
      decimals="-3"
      id="Fact001263"
      unitRef="USD">1911000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_custom_YorkvilleNoteMember"
      decimals="-3"
      id="Fact001264"
      unitRef="USD">1911000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact001273"
      unitRef="USD">3532000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact001274"
      unitRef="USD">3532000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact001278"
      unitRef="USD">9000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact001279"
      unitRef="USD">9000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact001283"
      unitRef="USD">14000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390"
      decimals="-3"
      id="Fact001284"
      unitRef="USD">14000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      decimals="-3"
      id="Fact001288"
      unitRef="USD">1637000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_PIPENotesMember"
      decimals="-3"
      id="Fact001289"
      unitRef="USD">1637000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact001293"
      unitRef="USD">1660000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001294"
      unitRef="USD">1660000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001302">&lt;p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-TLSO_zps6BRM4jDQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the changes in the Business Combination Warrants and PIPE Warrants measured at fair value during the nine months
ended September 30, 2024 (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B2_zusMWR8dIK1d" style="display: none"&gt;Schedule
of Warrants and Notes Measured at Fair Value&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B9_us-gaap--FinancialInstrumentAxis_custom--BusinessCombinationWarrantsMember_zg0zZVWpBMNg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Business Combination Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PIPEWarrantsMember_zRZ4VYo3g01h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PIPE Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zhOUxxDJFxxb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;14&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_z9qk9ZWF20Cj" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Additions&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_z6iSqRCmiCo3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(12&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z2MZKufSZT7h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;26&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

The
following table presents the changes in the PIPE Notes and Yorkville Note measured at fair value during the nine months ended September
30, 2024 (in thousands):&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_309_134_zREtuuhIhXSl" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--FinancialInstrumentAxis_custom--PIPENotesMember_ze2r3E2jMVR2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PIPE Notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--YorkvilleNoteMember_zYzz8DZAcSY5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Yorkville Note&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlOJacrmtqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1341"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zMhjgFKRCOX2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1343"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zGJO8EE1uXi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;561&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zeIf64bpYuG4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,593&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,911&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&#160;The
following table presents the changes in the SEPA derivative liability measured at fair value during the nine months ended September 30,
2024 (in thousands):&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_300_134_zvn2i2KWbCdj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--YorkvilleStandbyEquityPurchaseAgreementMember_zeuekKn7dFk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Yorkville SEPA&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zBVYNCg9VPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1352"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zTX2QegBErif" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 80%"&gt;Additions&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;160&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zNqLPzGMpOE4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(160&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zhdfOaCxSyfa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&#160;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_BusinessCombinationWarrantsMember"
      decimals="-3"
      id="Fact001304"
      unitRef="USD">9000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390"
      decimals="-3"
      id="Fact001305"
      unitRef="USD">14000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2024-01-012024-09-30_custom_BusinessCombinationWarrantsMember81074640"
      decimals="-3"
      id="Fact001310"
      unitRef="USD">17000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2024-01-012024-09-30_custom_PIPEWarrantsMember81074640"
      decimals="-3"
      id="Fact001311"
      unitRef="USD">-12000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember"
      decimals="-3"
      id="Fact001313"
      unitRef="USD">26000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact001314"
      unitRef="USD">2000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001316">&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z0EbGI9XuKg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span id="xdx_8B9_zbo4lpUx1OU6" style="display: none"&gt;Schedule
of Fair Value Assumptions and Valuation&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6yoFZjdrjI3" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember_zdnqqfp3XZQ8" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of September 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;PIPE&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Business Combination&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z8ofOzO0ac9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Stock price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;0.61&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;0.61&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zesH5Uq4iOC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zaCri8ck8v0j" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;72.1&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zr6WHQ05YrM9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zXlftvXvisyj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1330"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1331"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zSVXH8G4Gmsl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants measurement input&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1333"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1334"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zUh0Fyou3Ww5" title="Expected term (in years)"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zU8xg8Aetap4" title="Expected term (in years)"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact001318"
      unitRef="Pure">0.61</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact001319"
      unitRef="Pure">0.61</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember"
      decimals="INF"
      id="Fact001321"
      unitRef="Pure">10.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExercisePriceMember"
      decimals="INF"
      id="Fact001322"
      unitRef="Pure">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001324"
      unitRef="Pure">72.1</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001325"
      unitRef="Pure">72.1</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001327"
      unitRef="Pure">3.6</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001328"
      unitRef="Pure">3.6</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001336">P4Y1M6D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-09-30_custom_BusinessCombinationWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001338">P4Y2M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_PIPENotesMember"
      decimals="-3"
      id="Fact001340"
      unitRef="USD">1637000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2024-01-012024-09-30_custom_YorkvilleNoteMember"
      decimals="-3"
      id="Fact001344"
      unitRef="USD">1350000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2024-01-012024-09-30_custom_PIPENotesMember"
      decimals="-3"
      id="Fact001346"
      unitRef="USD">-44000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2024-01-012024-09-30_custom_YorkvilleNoteMember"
      decimals="-3"
      id="Fact001347"
      unitRef="USD">561000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2024-09-30_custom_PIPENotesMember"
      decimals="-3"
      id="Fact001349"
      unitRef="USD">1593000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2024-09-30_custom_YorkvilleNoteMember"
      decimals="-3"
      id="Fact001350"
      unitRef="USD">1911000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2024-01-012024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="-3"
      id="Fact001354"
      unitRef="USD">160000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2024-01-012024-09-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="-3"
      id="Fact001356"
      unitRef="USD">-160000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001360">&lt;p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z72lCXGJ7Bkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12.
&lt;span id="xdx_823_zcaO490Ct6w6"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;PIPE
Notes and Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Data
Knights issued and sold PIPE Notes in connection with the Business Combination, which are convertible into shares of Common Stock. Total
proceeds raised from the PIPE Notes were $&lt;span id="xdx_90A_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zxvBfqWuzhld" title="Related party proceeds"&gt;1.5&lt;/span&gt; million, of which $&lt;span id="xdx_907_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zKD4shLrCAAh" title="Related party proceeds"&gt;1.0&lt;/span&gt; million was with related party investors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the issuance of the PIPE Notes, the Company also issued a total of &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zVhs2mYBQuKb" title="Warrants issued"&gt;95,744&lt;/span&gt; shares of PIPE Warrants, of which &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zEhojPn2C22l" title="Warrants issued"&gt;63,829&lt;/span&gt; shares
were issued to the same related party investors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
Promissory Notes and Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in Note 4, the Company issued various Convertible Promissory Notes to related party investors. Total gross proceeds raised
from Convertible Promissory Notes with related parties were $&lt;span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z92zLciIy6D7" title="Gross proceeds from convertible promissory notes"&gt;12.3&lt;/span&gt; million (out of $&lt;span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zzWdKRh7BLf9" title="Gross proceeds from convertible promissory notes"&gt;14.2&lt;/span&gt; million total). In connection with the issuance
of the Convertible Promissory Notes, the Company also issued Convertible Promissory Notes Warrants to purchase &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteWarrantsMember_z6VrAV2L82g9" title="Number of shares issued"&gt;2,976,000&lt;/span&gt; shares of Legacy
ONMD common stock to the same related parties (out of &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConvertiblePromissoryNotesAndWarrantsMember_zdoCtpSCKObe" title="Warrants to purchase common stock"&gt;3,726,000&lt;/span&gt; total). The closing of the Business Combination triggered the conversion
of all Convertible Promissory Notes and Convertible Promissory Notes Warrants into shares of Common Stock. See the Form 10-K/A for all
other details relating to the Convertible Promissory Notes and Convertible Promissory Notes Warrants issued prior to December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Shareholder
Loans&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition to the convertible shareholder loans described in Note 4, the Company also received gross proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20240930_zYokDN1xcVMe" title="Gross proceeds from loans"&gt;0.4&lt;/span&gt; million in connection
with non-convertible shareholder loans with related party investors during the nine months ended September 30, 2024. In June 2024 and
July 2024, the Company repaid $&lt;span id="xdx_905_eus-gaap--OtherLongTermDebt_iI_pn5n6_c20240731_zzqhohe1eolk" title="Non convertible shareholder loan"&gt;&lt;span id="xdx_900_eus-gaap--OtherLongTermDebt_iI_pn5n6_c20240630_zSJP3IguPoQ7" title="Non convertible shareholder loan"&gt;0.1&lt;/span&gt;&lt;/span&gt; million of the outstanding non-convertible shareholder loan balance. These loans bear an interest
rate of &lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930_zTCd9R4V9eu8" title="Loan interest rate"&gt;8.0&lt;/span&gt;% with a maturity date &lt;span id="xdx_900_eus-gaap--DebtInstrumentTerm_dc_c20240101__20240930_zTLaZv1Whwh8" title="Loan term"&gt;one year&lt;/span&gt; from issuance. The following table summarizes shareholder loans outstanding for the periods
presented (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zesL6qwSYE91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B5_z0ak4ixSjEGh" style="display: none"&gt;Schedule
of Shareholder Loans Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240930_zNCE49yHztcl" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231_zvDVQSrNcA7i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
                                            30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_maCNPzu2j_zdGkeCM8yN3i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Shareholder loans &#x2013; nonconvertible&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;654&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;454&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_maCNPzu2j_zkQ0zSIF2Cyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shareholder loans &#x2013; convertible&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1394"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InterestPayableCurrent_iI_pn3n3_maCNPzu2j_z6xU62AlZM37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LongTermDebt_iTI_pn3n3_mtCNPzu2j_zmPrw76GaPF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total loan &#x2013; related party&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,306&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;465&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zTKrshboB99h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Loan
Extensions&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assumed Data Knights&#x2019; liabilities, which included existing loan extensions to related parties. The loan extensions were
to be either repaid in cash or, at the option of the lender, exchanged for a fixed amount of Common Stock at a price of $&lt;span id="xdx_900_eus-gaap--SharePrice_iI_c20240930_zLI7R5vnH7g4"&gt;10.00&lt;/span&gt; per share
upon the closing of a business combination or a similar event. At the closing of the Business Combination, all lenders provided notice
to have their loans converted into shares upon the filing of a registration statement on Form S-1 with the SEC. As of September 30, 2024
and December 31, 2023, a registration statement has not yet been declared effective by the SEC, and a balance of $&lt;span id="xdx_905_eus-gaap--LoansPayableCurrent_iI_pn5n6_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsMember_zl1jqYoxGAx6" title="Loans remains outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--LoansPayableCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsMember_zafvvM4LTVj5" title="Loans remains outstanding"&gt;3.0&lt;/span&gt;&lt;/span&gt; million remains
outstanding on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-01-012024-09-30_custom_PIPENotesMember81075421"
      decimals="-5"
      id="Fact001362"
      unitRef="USD">1500000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_PIPENotesMember"
      decimals="-5"
      id="Fact001364"
      unitRef="USD">1000000.0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_custom_PIPEWarrantsMember81075437"
      decimals="INF"
      id="Fact001366"
      unitRef="Shares">95744</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember"
      decimals="INF"
      id="Fact001368"
      unitRef="Shares">63829</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-012024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember"
      decimals="-5"
      id="Fact001370"
      unitRef="USD">12300000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-012024-09-30_custom_ConvertiblePromissoryNoteMember81075453"
      decimals="-5"
      id="Fact001372"
      unitRef="USD">14200000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember"
      decimals="INF"
      id="Fact001374"
      unitRef="Shares">2976000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-30_custom_ConvertiblePromissoryNotesAndWarrantsMember"
      decimals="INF"
      id="Fact001376"
      unitRef="Shares">3726000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromLoans
      contextRef="From2024-01-01to2024-09-30"
      decimals="-5"
      id="Fact001378"
      unitRef="USD">400000</us-gaap:ProceedsFromLoans>
    <us-gaap:OtherLongTermDebt
      contextRef="AsOf2024-07-31"
      decimals="-5"
      id="Fact001380"
      unitRef="USD">100000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="AsOf2024-06-30"
      decimals="-5"
      id="Fact001382"
      unitRef="USD">100000</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001384"
      unitRef="Pure">0.080</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="From2024-01-01to2024-09-30" id="Fact001386">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001388">&lt;p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zesL6qwSYE91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B5_z0ak4ixSjEGh" style="display: none"&gt;Schedule
of Shareholder Loans Outstanding&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240930_zNCE49yHztcl" style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231_zvDVQSrNcA7i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;September
                                            30,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_maCNPzu2j_zdGkeCM8yN3i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Shareholder loans &#x2013; nonconvertible&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;654&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;454&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_maCNPzu2j_zkQ0zSIF2Cyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shareholder loans &#x2013; convertible&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1394"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InterestPayableCurrent_iI_pn3n3_maCNPzu2j_z6xU62AlZM37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LongTermDebt_iTI_pn3n3_mtCNPzu2j_zmPrw76GaPF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total loan &#x2013; related party&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,306&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;465&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact001390"
      unitRef="USD">654000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001391"
      unitRef="USD">454000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact001393"
      unitRef="USD">1600000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact001396"
      unitRef="USD">52000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001397"
      unitRef="USD">11000</us-gaap:InterestPayableCurrent>
    <us-gaap:LongTermDebt
      contextRef="AsOf2024-09-30"
      decimals="-3"
      id="Fact001399"
      unitRef="USD">2306000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001400"
      unitRef="USD">465000</us-gaap:LongTermDebt>
    <us-gaap:SharePrice
      contextRef="AsOf2024-09-30"
      decimals="INF"
      id="Fact001401"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2024-09-30_custom_DataKnightsMember"
      decimals="-5"
      id="Fact001403"
      unitRef="USD">3000000.0</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2023-12-31_custom_DataKnightsMember"
      decimals="-5"
      id="Fact001405"
      unitRef="USD">3000000.0</us-gaap:LoansPayableCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001407">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zhU0Ncx89oif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13.
&lt;span id="xdx_823_z7gQBnBFOdKk"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Lease
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a month-to-month lease for a suite at a cost of $&lt;span id="xdx_902_eus-gaap--LeaseCost_pp0p0_c20240101__20240930_zCSTbaDzmzE" title="Lease cost"&gt;530&lt;/span&gt; per month. The Company incurred $&lt;span id="xdx_906_eus-gaap--PaymentsForRent_pn3n3_c20240701__20240930_zXMEQALoya99" title="Rent expenses"&gt;&lt;span id="xdx_906_eus-gaap--PaymentsForRent_pn3n3_c20230701__20230930_znug2H9sqLH2" title="Rent expenses"&gt;2&lt;/span&gt;&lt;/span&gt; thousand of rent expense, including
common tenant costs and cancellation costs, during the three months ended September 30, 2024 and 2023, respectively, and $&lt;span id="xdx_907_eus-gaap--PaymentsForRent_pn3n3_c20240101__20240930_zZKWpc76Lks3" title="Rent expense"&gt;&lt;span id="xdx_90C_eus-gaap--PaymentsForRent_pn3n3_c20230101__20230930_zmnRJuF7JT71" title="Rent expense"&gt;6&lt;/span&gt;&lt;/span&gt; thousand
for the nine months ended September 30, 2024 and 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Liabilities for loss contingencies
arising from claims, assessments, litigation, fines, penalties, and other sources are recognized, if and when it is probable that a liability
has been incurred and the amount can be reasonably estimated. The Company was not subject to any material legal proceedings during the
nine months ended September 30, 2024 and 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseCost
      contextRef="From2024-01-01to2024-09-30"
      decimals="0"
      id="Fact001409"
      unitRef="USD">530</us-gaap:LeaseCost>
    <us-gaap:PaymentsForRent
      contextRef="From2024-07-012024-09-30"
      decimals="-3"
      id="Fact001411"
      unitRef="USD">2000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2023-07-012023-09-30"
      decimals="-3"
      id="Fact001413"
      unitRef="USD">2000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2024-01-01to2024-09-30"
      decimals="-3"
      id="Fact001415"
      unitRef="USD">6000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2023-01-012023-09-30"
      decimals="-3"
      id="Fact001417"
      unitRef="USD">6000</us-gaap:PaymentsForRent>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-01-01to2024-09-30" id="Fact001419">&lt;p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zgUvaltT6Vi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
&lt;span id="xdx_82F_zfVEdnL5mIQl"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has evaluated subsequent events occurring through December 17, 2024, the date the condensed consolidated financial statements
were issued, for events requiring recording or disclosure in the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Yorkville
Letter&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 8, 2024, Yorkville sent the Company a letter notifying the Company that it had breached a registration rights agreement with
Yorkville by failing to file a Registration Statement on Form S-1 on the timeline set forth in the registration rights agreement (the
&#x201c;Yorkville Letter&#x201d;). The Yorkville Letter asserted that this breach was an event of default and an amortization event under
the prepaid advance in connection with the SEPA. The Yorkville Letter also asserted that the Company&#x2019;s failure to timely file its
Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 was an event of default under the Yorkville Promissory Note.
The Company subsequently engaged in discussions with Yorkville regarding the Yorkville Letter, which discussions are ongoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Yorkville Promissory Note, upon the occurrence of an amortization event, the Company is required to pay all principal and accrued
interest on the Yorkville Promissory Note, plus a &lt;span id="xdx_909_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_c20241008__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zegkBJys0W3l" title="Payment premium percentage on principal amount"&gt;10&lt;/span&gt;% payment premium on the principal amount, in equal installments over 3 calendar
months or until the amortization event is cured, whichever is earlier. In addition, upon the occurrence of an event of default, the interest
rate on the Yorkville Promissory Note increases to &lt;span id="xdx_909_ecustom--DebtInstrumentInterestRateDefaultPercentage_iI_pid_dp_c20241008__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zFdKUfq7UWFh" title="Debt default interest rate"&gt;18&lt;/span&gt;% retroactive to the date of the event of default.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Board
Turnover&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
previously announced on a Current Report on Form 8-K filed with the SEC on October 8, 2024, on October 1, 2024, Paul J. Casey and
Erkan Akyuz resigned from the Board of Directors of the Company (the &#x201c;Board&#x201d;), effective immediately. Also on October 1, 2024, the Board appointed Jair Clarke and Sherry
Coonse McCraw to the Board to fill the vacancies created by Mr. Casey and Mr. Akyuz, respectively. In connection with Ms. Coonse
McCraw and Mr. Clarke&#x2019;s service on the Board, the Board approved an RSU grant providing for the grant of &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241001__20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MsCoonseMcCrawMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkmul9Br5Qwc" title="Number of restricted stock units granted"&gt;&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241001__20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MrClarkeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPrE32kpU4z3" title="Number of restricted stock units granted"&gt;45,000&lt;/span&gt;&lt;/span&gt;
RSUs to each director for one full year of service (prorated for 2024). The RSUs will vest at the end of December 2024.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="AsOf2024-10-08_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember"
      decimals="INF"
      id="Fact001421"
      unitRef="Pure">0.10</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <ONMD:DebtInstrumentInterestRateDefaultPercentage
      contextRef="AsOf2024-10-08_us-gaap_SubsequentEventMember_custom_YorkvilleNoteMember"
      decimals="INF"
      id="Fact001423"
      unitRef="Pure">0.18</ONMD:DebtInstrumentInterestRateDefaultPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MsCoonseMcCrawMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact001425"
      unitRef="Shares">45000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-10-012024-10-01_us-gaap_SubsequentEventMember_custom_MrClarkeMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact001427"
      unitRef="Shares">45000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001435"
      unitRef="USD">47000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001436"
      unitRef="USD">271000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001441"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001443"
      unitRef="USD">125233000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001438"
      unitRef="USD">152000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001439"
      unitRef="USD">19000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001445"
      unitRef="USD">166000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001446"
      unitRef="USD">101000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001448"
      unitRef="USD">365000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001449"
      unitRef="USD">391000</us-gaap:AssetsCurrent>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001452"
      unitRef="USD">815000</ONMD:DeferredCostsNonCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001454"
      unitRef="USD">99000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001455"
      unitRef="USD">83000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001457"
      unitRef="USD">464000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001458"
      unitRef="USD">1289000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001466"
      unitRef="USD">4682000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001467"
      unitRef="USD">1177000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001469"
      unitRef="USD">254000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001470"
      unitRef="USD">184000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001472"
      unitRef="USD">2992000</us-gaap:LoansPayableCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001476"
      unitRef="USD">24743000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001478"
      unitRef="USD">1637000</us-gaap:NotesPayableCurrent>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001481"
      unitRef="USD">3525000</ONMD:DeferredUnderwriterFeePayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001484"
      unitRef="USD">283000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001487"
      unitRef="USD">13373000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001488"
      unitRef="USD">26104000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001491"
      unitRef="USD">1500000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001493"
      unitRef="USD">465000</us-gaap:LongTermLoansPayable>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001496"
      unitRef="USD">68000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001497"
      unitRef="USD">44000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001499"
      unitRef="USD">13906000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001500"
      unitRef="USD">27648000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001511"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001513"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001515"
      unitRef="Shares">4200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001517"
      unitRef="Shares">4200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001519"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001521"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001523"
      unitRef="Shares">3415923</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001525"
      unitRef="Shares">3415923</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact001509"
      unitRef="USD">9634000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001530"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001532"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001534"
      unitRef="Shares">4400000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001536"
      unitRef="Shares">4400000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001538"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001540"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001542"
      unitRef="Shares">2839957</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001544"
      unitRef="Shares">2839957</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact001528"
      unitRef="USD">8010000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001547"
      unitRef="USD">17644000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001555"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001557"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001559"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001561"
      unitRef="Shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001563"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001565"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001567"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001569"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001574"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001576"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001578"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001580"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001582"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001584"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001586"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact001588"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001571"
      unitRef="USD">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001590"
      unitRef="USD">77996000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001591"
      unitRef="USD">13657000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001593"
      unitRef="USD">-91440000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001594"
      unitRef="USD">-57660000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001596"
      unitRef="USD">-13442000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001597"
      unitRef="USD">-26359000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001599"
      unitRef="USD">464000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001600"
      unitRef="USD">1289000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact001605"
      unitRef="USD">878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact001606"
      unitRef="USD">678000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact001608"
      unitRef="USD">143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact001609"
      unitRef="USD">475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001611"
      unitRef="USD">1021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001612"
      unitRef="USD">1153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001614"
      unitRef="USD">1150000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001615"
      unitRef="USD">1513000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001617"
      unitRef="USD">-129000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001618"
      unitRef="USD">-360000</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001623"
      unitRef="USD">3544000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001624"
      unitRef="USD">4806000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001626"
      unitRef="USD">1115000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001627"
      unitRef="USD">958000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001629"
      unitRef="USD">2065000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001630"
      unitRef="USD">1591000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001632"
      unitRef="USD">6724000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001633"
      unitRef="USD">7355000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001635"
      unitRef="USD">-6853000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001636"
      unitRef="USD">-7715000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001641"
      unitRef="USD">11000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001644"
      unitRef="USD">9207000</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001645"
      unitRef="USD">8073000</us-gaap:StockOptionPlanExpense>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001647"
      unitRef="USD">-129000</us-gaap:FairValueAdjustmentOfWarrants>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001650"
      unitRef="USD">269000</ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001653"
      unitRef="USD">-17517000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001654"
      unitRef="USD">-14616000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001656"
      unitRef="USD">-34000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001657"
      unitRef="USD">-30000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001659"
      unitRef="USD">-26909000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001660"
      unitRef="USD">-22719000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001662"
      unitRef="USD">-33762000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001663"
      unitRef="USD">-30434000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001665"
      unitRef="USD">18000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001666"
      unitRef="USD">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001668"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001669"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001674"
      unitRef="USDPShares">-4.77</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001676"
      unitRef="USDPShares">-4.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001678"
      unitRef="USDPShares">-7.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001680"
      unitRef="USDPShares">-7.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001682"
      unitRef="Shares">7084068</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact001684"
      unitRef="Shares">7084068</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001686"
      unitRef="Shares">3973897</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact001688"
      unitRef="Shares">3973897</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001698"
      unitRef="Shares">3853797</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact001690"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001700"
      unitRef="Shares">3204000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact001691"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact001692"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001702"
      unitRef="Shares">4342666</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001694"
      unitRef="USD">2513000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact001695"
      unitRef="USD">-27209000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact001696"
      unitRef="USD">-7052000</us-gaap:StockholdersEquity>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001712"
      unitRef="Shares">-437874</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001714"
      unitRef="Shares">-364043</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001716"
      unitRef="Shares">-493420</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001726"
      unitRef="Shares">177276</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001736"
      unitRef="Shares">6648</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001732"
      unitRef="USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001734"
      unitRef="USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001742"
      unitRef="USD">8073000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001744"
      unitRef="USD">8073000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001750"
      unitRef="USD">1198000</ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001752"
      unitRef="USD">1198000</ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001758"
      unitRef="USD">1865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001760"
      unitRef="USD">1865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact001767"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001768"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001778"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact001770"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001780"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact001771"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact001772"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001782"
      unitRef="Shares">4033170</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001774"
      unitRef="USD">13657000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact001775"
      unitRef="USD">-57660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001776"
      unitRef="USD">-26359000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001792"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact001784"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001794"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact001785"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact001786"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001796"
      unitRef="Shares">4033170</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001788"
      unitRef="USD">13657000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact001789"
      unitRef="USD">-57660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact001790"
      unitRef="USD">-26359000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001806"
      unitRef="Shares">265914</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001816"
      unitRef="Shares">5673</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact001808"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact001810"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001814"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001822"
      unitRef="USD">9207000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001824"
      unitRef="USD">9207000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001834"
      unitRef="Shares">543056</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <ONMD:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001844"
      unitRef="Shares">3420945</ONMD:StockIssuedDuringPeriodSharesWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001854"
      unitRef="Shares">5475362</ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001849"
      unitRef="USD">1000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001850"
      unitRef="USD">47935000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001852"
      unitRef="USD">47936000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact001864"
      unitRef="Shares">-3421596</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact001856"
      unitRef="USD">-9650000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact001866"
      unitRef="Shares">-2839957</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact001857"
      unitRef="USD">-8010000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember"
      decimals="-3"
      id="Fact001858"
      unitRef="USD">-17660000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001868"
      unitRef="Shares">6261553</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001859"
      unitRef="USD">1000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001860"
      unitRef="USD">17659000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001878"
      unitRef="Shares">3572232</ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001874"
      unitRef="USD">-11937000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001876"
      unitRef="USD">-11937000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001884"
      unitRef="USD">1475000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001886"
      unitRef="USD">1475000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact001893"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001894"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001908"
      unitRef="Shares">23572232</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001899"
      unitRef="USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001900"
      unitRef="USD">77996000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact001901"
      unitRef="USD">-91440000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001902"
      unitRef="USD">-13442000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001922"
      unitRef="Shares">23572232</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact001913"
      unitRef="USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact001914"
      unitRef="USD">77996000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact001915"
      unitRef="USD">-91440000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact001916"
      unitRef="USD">-13442000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001927"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001928"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001933"
      unitRef="USD">28000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001934"
      unitRef="USD">25000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001936"
      unitRef="USD">1475000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001937"
      unitRef="USD">1865000</us-gaap:ShareBasedCompensation>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001939"
      unitRef="USD">9207000</ONMD:StockWarrantExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001940"
      unitRef="USD">8073000</ONMD:StockWarrantExpense>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001942"
      unitRef="USD">-129000</us-gaap:FairValueAdjustmentOfWarrants>
    <ONMD:WarrantExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001946"
      unitRef="USD">-1198000</ONMD:WarrantExpense>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001948"
      unitRef="USD">269000</ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001951"
      unitRef="USD">17517000</ONMD:ChangeInFairValueOfConvertiblePromissoryNotes>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001952"
      unitRef="USD">14616000</ONMD:ChangeInFairValueOfConvertiblePromissoryNotes>
    <ONMD:NoncashInterest
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001954"
      unitRef="USD">11000</ONMD:NoncashInterest>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001960"
      unitRef="USD">133000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001961"
      unitRef="USD">-73000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001963"
      unitRef="USD">43000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001964"
      unitRef="USD">59000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001966"
      unitRef="USD">717000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001967"
      unitRef="USD">415000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001969"
      unitRef="USD">70000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001970"
      unitRef="USD">-458000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001972"
      unitRef="USD">-4791000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001973"
      unitRef="USD">-4703000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001978"
      unitRef="USD">44000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001979"
      unitRef="USD">58000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001981"
      unitRef="USD">-44000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001982"
      unitRef="USD">-58000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001987"
      unitRef="USD">454000</ONMD:ProceedsFromIssuanceOfShareholderLoans>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001990"
      unitRef="USD">1500000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001993"
      unitRef="USD">4175000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact001994"
      unitRef="USD">5140000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact001996"
      unitRef="USD">16000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002000"
      unitRef="USD">8000</us-gaap:ProceedsFromStockOptionsExercised>
    <ONMD:BusinessCombinationCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002002"
      unitRef="USD">1534000</ONMD:BusinessCombinationCosts>
    <ONMD:BusinessCombinationCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002003"
      unitRef="USD">815000</ONMD:BusinessCombinationCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002005"
      unitRef="USD">4611000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002006"
      unitRef="USD">4333000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002008"
      unitRef="USD">-224000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002009"
      unitRef="USD">-428000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002011"
      unitRef="USD">271000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact002012"
      unitRef="USD">699000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002014"
      unitRef="USD">47000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002015"
      unitRef="USD">271000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:StockIssued1
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002020"
      unitRef="USD">17659000</us-gaap:StockIssued1>
    <ONMD:CommonSharesRelatedToConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002023"
      unitRef="USD">47935000</ONMD:CommonSharesRelatedToConvertiblePromissoryNotes>
    <ONMD:CommonSharesIssuedToDataKnightsShareholders
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002026"
      unitRef="USD">-11937000</ONMD:CommonSharesIssuedToDataKnightsShareholders>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact002029">&lt;p id="xdx_809_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zmJ0QR35bxR9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
&lt;span&gt;Organization and Operations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span id="xdx_826_zjtp8qAyKhgl" style="display: none"&gt;Description of Business&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;OneMedNet
Corporation (the &#x201c;Company&#x201d;) is a healthcare software company with solutions focused on digital medical image management,
exchange, and sharing. The Company was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions
that simplify digital medical image management, exchange, and sharing. The Company has one wholly-owned subsidiary, OneMedNet Technologies
(Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional
currency is the Canadian dollar. The Company&#x2019;s headquarters location is Eden Prairie, Minnesota.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
November 7, 2023, we consummated a merger (the &#x201c;Merger&#x201d;) &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;following
the approval at the special meeting of the shareholders of Data Knights Acquisition Corp. (&#x201c;Data Knights&#x201d;), a Delaware corporation,
held on October 17, 2023 (the &#x201c;Special Meeting&#x201d;), of the agreement and plan of merger, dated as of April 25, 2022 (the &#x201c;Merger
Agreement&#x201d;), by and among Data Knights, Data Knights Merger Sub, Inc., a Delaware corporation (&#x201c;Merger Sub&#x201d;) and a
wholly-owned subsidiary of Data Knights, OneMedNet Solutions Corporation (formerly named OneMedNet Corporation) (&#x201c;Legacy ONMD&#x201d;),
Data Knights, LLC, a Delaware limited liability company (&#x201c;Sponsor&#x201d;), and Paul Casey, in his capacity as representative of
the stockholders of Legacy ONMD. Pursuant to the Merger Agreement, Merger Sub merged with and into Legacy ONMD, with Legacy ONMD surviving
the Merger as a wholly-owned subsidiary of Data Knights (such transactions contemplated by the Merger Agreement, the &#x201c;Business
Combination&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risks
and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is subject to risks common to companies in the markets it serves, including, but not limited to, global economic and financial
market conditions, fluctuations in customer demand, acceptance of new products, development by its competitors of new technological innovations,
dependence on key personnel, and protection of proprietary technology.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Going
Concern and Management&#x2019;s Plan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets
and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects
on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of this
uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has incurred recurring net losses since its inception, including $&lt;span id="xdx_90B_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231231_zsU0xSLZvHcl" title="Net loss"&gt;33.8&lt;/span&gt; million and $&lt;span id="xdx_909_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20220101__20221231_z3LJ3ACCrSm3" title="Net loss"&gt;30.5 &lt;/span&gt;million for the years ended December
31, 2023 and 2022, respectively. In addition, the Company had an accumulated deficit of $&lt;span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20231231_zMzKn9enX4Ei" title="Accumulated defecit"&gt;91.4&lt;/span&gt; million as of December 31, 2023. The Company&#x2019;s
cash balance of $&lt;span id="xdx_900_eus-gaap--Cash_iI_pn3n3_c20231221_z8kT95TFPK4i" title="Cash balance"&gt;47&lt;/span&gt; thousand is not adequate to fund its operations through at least twelve months from the date these consolidated financial
statements were available for issuance. Therefore, these conditions raise substantial doubt about the Company&#x2019;s ability to continue
as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital
through an equity or debt offering and ultimately attain profitable operations to fulfill its operating and capital requirements for
at least 12 months from the date of the issuance of the consolidated financial statements. However, the Company may not be able to secure
such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity securities to raise additional
funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences and privileges senior
to those of the Company&#x2019;s existing stockholders. The consolidated financial statements do not include any adjustments relating
to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as
a going concern. The Company&#x2019;s continuation as a going concern is dependent upon its ability to continue receiving working capital
cash payments and generating cash flow from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Nasdaq
Notices&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 7, 2024, the Company received written notice (the &#x201c;MVLS Nasdaq Notice&#x201d;) from the Nasdaq Stock Market (&#x201c;Nasdaq&#x201d;)
indicating that for the preceding 30 consecutive business days, the market value of the Company&#x2019;s listed securities (&#x201c;MVLS&#x201d;)
did not maintain a minimum market value of $50,000,000 (the &#x201c;Minimum MVLS Requirement&#x201d;) as required by Nasdaq Listing Rule
5450(b)(2)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company had a compliance period of 180 calendar days, or until
August 5, 2024, to regain compliance with the Minimum MVLS Requirement. Compliance could have been achieved if the Company&#x2019;s MVLS
closed at $50,000,000 or more for a minimum of ten consecutive business days at any time during the 180-day compliance period, in which
case Nasdaq would notify the Company of its compliance, and the matter would be closed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company did not regain compliance with the Minimum MVLS Requirement by August 5, 2024, Nasdaq would have provided written notification
to the Company that its Common Stock was subject to delisting. At that time, the Company could have appealed the relevant delisting determination
to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. The Company sought to apply for a transfer
to The Nasdaq Capital Market, and on August 15, 2024, the Company received approval from Nasdaq to list the Common Stock and Public Warrants
on The Nasdaq Capital Market. The Common Stock and Public Warrants were transferred from The Nasdaq Global Market to The Nasdaq Capital
Market at the opening of business on August 19, 2024, and continue to trade under the symbols &#x201c;ONMD&#x201d; and &#x201c;ONMDW,&#x201d;
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 26, 2024, the Company received written notice (the &#x201c;Bid Price Nasdaq Notice&#x201d;) from Nasdaq notifying the Company that,
for the 30 consecutive business days prior to the date of the Bid Price Nasdaq Notice, the Common Stock did not meet the minimum bid
price of $1.00 per share requirement (the &#x201c;Minimum Bid Price Requirement&#x201d;) as required by Nasdaq Listing Rule 5450(a)(1).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a compliance period of 180 calendar days, or until September 23,
2024, to regain compliance with the Minimum Bid Price Requirement. Compliance could have been achieved if the closing bid price of the
Company&#x2019;s Common Stock was at least $1 for a minimum of ten consecutive business days. On June 10, 2024, the Nasdaq staff determined
that for the prior 11 consecutive business days, from May 23, 2024, to June 7, 2024, the closing bid price of the Company&#x2019;s Common
Stock had been at $1.00 per share or greater. Accordingly, the Company regained compliance with Listing Rule 5450(a)(1), and this matter
was closed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 20, 2024, the Company received a delinquency notification letter from Nasdaq (the &#x201c;Q1 2024 Form 10-Q Nasdaq Notice&#x201d;),
which indicated that, as a result of the Company&#x2019;s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended
March 31, 2024 (the &#x201c;Q1 2024 Form 10-Q&#x201d;) by the applicable due date, the Company was not in compliance with Nasdaq Listing
Rule 5250(c)(1) (the &#x201c;Periodic Report Rule&#x201d;), which requires Nasdaq-listed companies to timely file all required periodic
financial reports with the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;). The Q1 2024 Form 10-Q Nasdaq Notice stated that
the Company had 60 calendar days to submit to Nasdaq a plan to regain compliance with the Periodic Report Rule. If Nasdaq accepted the
Company&#x2019;s plan to regain compliance, then Nasdaq could have granted the Company up to 180 calendar days from the prescribed due
date of the Form 10-Q to regain compliance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 9, 2024, the Company received a delinquency notification letter from Nasdaq (the &#x201c;Q2 2024 Form 10-Q Nasdaq Notice&#x201d;),
which indicated that, as a result of the Company&#x2019;s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended
June 30, 2024 (together with the Q1 2024 Form 10-Q, the &#x201c;Delinquent Filings&#x201d;) by the applicable due date, the Company was
not in compliance with the Periodic Report Rule, which requires Nasdaq-listed companies to timely file all required periodic financial
reports with the SEC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 10, 2024, the Company received a notification letter from Nasdaq the &#x201c;Nasdaq Compliance Plan Notice&#x201d;), which responded
to the Company&#x2019;s plan to regain compliance regarding its delinquent Q1 2024 Form 10-Q, granting the Company an exception until
October 31, 2024 to file the Delinquent Filings with the SEC and regain compliance with the Periodic Report Rule. In the event the Company
does not regain compliance with the Periodic Report Rule by October 31, 2024, Nasdaq will provide written notification that the Company&#x2019;s
securities will be delisted. At that time, the Company may appeal Nasdaq&#x2019;s determination to a hearings panel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 8, 2024, the Company received a delinquency notification letter from Nasdaq (the &#x201c;Second MVLS Nasdaq Notice&#x201d;) indicating
that for the preceding 30 consecutive business days, the Company&#x2019;s MVLS was below the minimum of $35 million required for continued
listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2). The staff at Nasdaq also noted in the Second MVLS Nasdaq
Notice that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum
stockholders&#x2019; equity of $2.5 million, and Nasdaq Listing Rule 5550(b)(3), which requires listed companies to maintain a minimum
of $500,000 of net income from continuing operations. In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar
days, or until April 7, 2025, to regain compliance with the Minimum MVLS Requirement. Compliance may be achieved if the Company&#x2019;s
MVLS closes at $35 million or more for a minimum of ten consecutive business days at any time during the 180-day compliance period, in
which case Nasdaq will notify the Company of its compliance and the matter will be closed, If the Company does not regain compliance
by the end of the 180-day compliance period, Nasdaq staff will provide written notice to the Company that its securities are subject
to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 16, 2024, the Company received a delinquency notification letter from Nasdaq (the &#x201c;Second Bid Price Nasdaq Notice,&#x201d;
and together with the MVLS Nasdaq Notice, the Bid Price Nasdaq Notice, the Q1 2024 Form 10-Q Nasdaq Notice, the Q2 2024 Form 10 Q Nasdaq
Notice, the Nasdaq Compliance Plan Notice, and the Second MVLS Nasdaq Notice, the &#x201c;Nasdaq Notices&#x201d;) notifying the Company
that, for the 30 consecutive business days prior to the date of the Second Bid Price Nasdaq Notice, the Common Stock did not meet the
Minimum Bid Price Requirement as required by Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the
Company has 180 calendar days, or until April 14, 2025, to regain compliance. The Second Bid Price Nasdaq Notice notes that to regain
compliance, the Common Stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days at any time
during the 180-day compliance period. In the event the Company does not regain compliance by the end of the 180-day compliance period,
the Company may be eligible for additional time to regain compliance. To qualify for additional time, the Company must (i) meet the continued
listing requirement for the market value of its publicly held shares and all other initial listing standards for the Nasdaq Capital Market,
with the exception of the bid price requirement and (ii) provide written notice of its intention to cure the deficiency during the second
compliance period by effecting a reverse stock split, if necessary. If the Company meets these requirements, the Company may be granted
an additional 180 calendar days to regain compliance. However, if it appears to Nasdaq that the Company will be unable to cure the deficiency,
or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide written notice to the Company that its
securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Nasdaq Notices received have no immediate effect on the Company&#x2019;s continued listing on the Nasdaq Capital Market or the trading
of the Company&#x2019;s Common Stock, subject to the Company&#x2019;s compliance with the other continued listing requirements. The Company
is presently evaluating potential actions to regain compliance with all applicable requirements for continued listing on the Nasdaq Capital
Market. There can be no assurance that the Company will be successful in maintaining the listing of its Common Stock on the Nasdaq Capital
Market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-5"
      id="Fact002031"
      unitRef="USD">-33800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-5"
      id="Fact002033"
      unitRef="USD">-30500000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="Fact002035"
      unitRef="USD">-91400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:Cash
      contextRef="AsOf2023-12-21"
      decimals="-3"
      id="Fact002037"
      unitRef="USD">47000</us-gaap:Cash>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-012023-12-31" id="Fact002039">&lt;p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zfl75WnLdHg5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
&lt;span id="xdx_829_zf1Bh0qhZm65"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zV1XxAmYpNw2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_z66TBxyppqMl"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#x201c;GAAP&#x201d;). The accompanying consolidated financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include the accounts of OneMedNet Corporation, formerly Data Knights, and its wholly-owned
subsidiary, OneMedNet Technologies Canada Ltd. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--RestatementToFinancialStatementsPolicyTextBlock_zlfs5i9HvsA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zF84H1NjBDH9"&gt;Restatement
to Previously Issued Consolidated Financial Statements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s consolidated financial statements for the years ended December 31, 2023 and 2022, as previously filed with the SEC on
April 9, 2024, have been restated. The previously filed consolidated financial statements did not reflect the proper accounting for the
business combination transaction, convertible notes, warrants, preferred stock, stock-based compensation expense, and accounts payable
and accrued expenses. The Company has also restated related amounts within the accompanying footnotes to the consolidated financial statements
to conform to the restated amounts in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following consolidated financial statements provide a reconciliation from the originally &#x201c;as reported&#x201d; financial information
to the now &#x201c;as restated&#x201d; consolidated financial information as of and for the years ended December 31, 2023 and 2022 (in
thousands, except share and per share data).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zQobtUlY9Fg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zmqNIyggURV3"&gt;Schedule
of Restatement of Financial Statements&lt;/span&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--StatementOfFinancialPositionAbstract_pn3n3_zHB7otDeIImb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheet (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zruyu53jUhca" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zcfTKFbd2jqd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zCrqV71XHMwj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zseXWl5ARgmk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (&lt;span id="xdx_F56_zoHeAO3yRzkb"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z3fZH6OQ10X3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zXmzyt8ADHpc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACznbB_zwfJYNAqd4h2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AssetsHeldInTrustCurrent_i02I_zQhwodfyf5vd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Investments held in trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2064"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2066"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2067"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACznbB_zhZl1KSXxike" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts receivable, net of allowance for credit losses of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zPo9iq8qLwpk" title="Accounts receivable, allowance"&gt;0&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zMIhH9k6HRqe" title="Accounts receivable, allowance"&gt;125,233&lt;/span&gt; at December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2070"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2071"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACznbB_zUCqDZwvR8h1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2080"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACznbB_maAzRE3_zWVgddrEhU8f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left"&gt;Total current assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;365&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2084"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2085"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;365&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredCostsNonCurrent_i01I_pn3n3_maAzRE3_zadfKDc4WIPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred transaction costs&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2089"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2091"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzRE3_zG9krXgkbKe1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2095"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Assets_i01TI_pn3n3_mtAzRE3_zRG9OArPib89" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zq1I6hLyExog" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Liabilities, temporary equity and stockholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbZJCma4btqj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zssMDVKCKb27" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;498&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zNPcfhGy81Dl" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z5EoFfgXn103" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan amount due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2121"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ExciseTaxCurrent_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_zoHwN3FbTAHf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Excise tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredRevenueCurrent_i02I_pn3n3_maLCzjPj_zgTzWhgM5q78" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2129"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2130"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zqzqEDRPdHVe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2133"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2134"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2135"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2136"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LoanExtensionsCurrent_i02I_pn3n3_maLCzjPj_zxQs4dQZsJhi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan extensions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2139"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LoansPayable_i02I_pn3n3_maLCzjPj_z4rAes4v5eLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2146"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--CanadaEmergencyBusinessLoanAct_i02I_pn3n3_maLCzjPj_zh8sEs0vfagg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2149"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2151"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccruedIncomeTaxesCurrent_i02I_pn3n3_maLCzjPj_zMZx9uIWYCb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(120&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_pn3n3_maLCzjPj_zBTLDRUX27Ba" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_pn3n3_maLCzjPj_zjmSYJKQeNEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;PIPE notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2165"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z70r7UPIkBw8" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zxhw1hbC8X8d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_z7XLQgC9gMPe" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2173"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2174"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2176"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzjPj_maLzhoA_zUAVIkx4mgr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Total current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;585&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,373&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleDebtNoncurrent_i01I_pn3n3_maLzhoA_zXYxZv4wnbE2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2183"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_z0sV3xK1qwE8" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2188"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2189"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2191"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_z3W70HCcYUcf" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_pn3n3_maLzhoA_zWCkZbDgLii7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loan, related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2200"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_z3TrqGM1swRk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2204"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2205"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2206"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WorkingCapitalLoan_i01I_maLzhoA_znG3RD0bmoD8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2208"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2209"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2210"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2211"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--WarrantLiabilityNonCurrent_i01I_pn3n3_maLzhoA_zvrWCZOR9MLe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2214"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(25&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2216"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLzhoA_zzAZ5vz1nGW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other long-term liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zdVxtDBJ0vy4" style="padding-bottom: 1pt; text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Liabilities_i01TI_pn3n3_mtLzhoA_maLASEzB9f_zWurd1Dcwf66" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13,323&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;583&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2225"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13,906&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_maLASEzB9f_zriAse0CJx5e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Commitments and contingencies (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2229"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2230"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--TemporaryEquityAbstract_i01B_zCjF4hRjdSM9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Temporary equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxCEJ7wpVb28" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Series A-2, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zcQDvHCATRy3" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmw2jLMPLdv3" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zk2kv65ICmXe" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8QQZwnKdLZf" title="Temporary equity, shares authorized"&gt;4,200,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zbwzb6ONsLgi" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBohDzYt6cuc" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zPYyjWP6t8nl" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zDpri74qdrj4" title="Temporary equity, shares outstanding"&gt;3,415,923&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2239"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2240"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2241"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zvgShIKHTHql" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Preferred Shares A-1, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUdnjUXJ4Nc1" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUBfnzNHxmQ7" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zD2AuNLE5jti" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYuIuwhSTul" title="Temporary equity, shares authorized"&gt;4,400,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zFfkQRyVN4Y8" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgXlLITRaRd" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z75ktmKy0962" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z5lkoDhcdVvc" title="Temporary equity, shares outstanding"&gt;2,839,957 &lt;/span&gt;&lt;/span&gt;shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2259"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2262"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEzB9f_zFJ3TKul93Da" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total temporary equity &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2280"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zWgvLMcwUEad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Stockholders&#x2019; (deficit) equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_pn3n3_maSEzYAb_zDP929DLJBcj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zTouxWv5xMNj" title="Preferred stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zoAhJQ97gzT" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zY9mbTXbyWjg" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zaAG4dvCdMGb" title="Preferred stock, shares authorized"&gt;0&lt;/span&gt; shares authorized at December 31, 2023 and 2022, respectively; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zeXWFKcteVZa" title="Preferred stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zFLSOBzdiIYi" title="Preferred stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2RDRUICTuA3" title="Preferred stock, shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zF0OtUHrvAid" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares issued and outstanding at December 31, 2023 and 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2290"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2293"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzYAb_zKclxpQQ1fc5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Common Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zO8f1W2CvHd1" title="Common stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z0fgb54GPpF7" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z87XB46c1rqk" title="Common stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zlJ0WFifrcwj" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt;&lt;/span&gt; shares authorized and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z37TR95QhdKj" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zhQfhe7EP9Z4" title="Common stock, shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zD5XPgF0KCAh" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zOrvrjW3oymd" title="Common stock, shares outstanding"&gt;4,033,170&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2313"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pn3n3_maSEzYAb_zr99liLi1UOj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,775&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77,996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zsHwSQ1sDr3" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pn3n3_maSEzYAb_zaNz42WzTBF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(55,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(36,357&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2339"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(91,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zKvHtgqXejJk" style="padding-bottom: 1pt; text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzYAb_maLASEzB9f_zPwz0JsddSC7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total stockholders&#x2019; deficit &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(13,442&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzB9f_zgvnToSh7PEc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, temporary equity, and stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2348"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2349"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0A_zxpPh2kj3NLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zv3t0HiTxmkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F01_zHmIIEvFd8Ne" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zQ2Kprb6wXq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_z45MNyUdVjC3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_z1BUgtO53Nk2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F01_zI0DPexFF7Xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1D_z8uJZPF6GN1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of liability-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0C_zzIQLbw8bWJj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zWvic4rLmBCb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F09_zfMaYzeUq0yi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_z9pixMR8yD4a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ivgJzJjlvk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBNy3rflnLOh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zDVc23ZbTal1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F5B_z2orGC7gqCVd"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20221231_zyrQoTWDbpmg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zoHhxMUlwOn3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zylrCrVigph8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zklWvSmRU3hg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;302&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;271&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zWiYZ0g0Crw7" style="width: 6%; text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AssetsHeldInTrustCurrent_i02I_z5i7O4J0zNh9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Investments held in trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2376"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zlMEbFIQFeXl" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_z91VCg6KuhUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts receivable, net of allowance of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zXowDYdGPzGi" title="Accounts receivable, allowance"&gt;0&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zIJD7O8FvRM6" title="Accounts receivable, allowance"&gt;125,233&lt;/span&gt; at December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2380"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zQeyB686mQ62" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;101&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2388"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;101&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtACznbB_maAzRE3_zeC41by6Wz69" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left"&gt;Total current assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;29,451&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(29,060&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2394"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;391&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredCostsNonCurrent_i02I_maAzRE3_zjz3cdl7FRTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred transaction costs&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;900&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(85&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;815&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zugrWwR5FxFg" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAzRE3_zbYTPH2Futm7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2404"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Assets_iTI_mtAzRE3_zuFdBSWVj8ce" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(29,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2409"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3idIMSAttVf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Liabilities, temporary equity and stockholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfMGnFVZHtZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzjPj_zlbUKNPQwEya" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,637&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z1PDq4D8k1bg" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherLiabilities_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z387LtueELU9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan amount due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2430"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zSY0KCHBsjBj" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_maLCzjPj_z9JdmARHcJg6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2433"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2434"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zIdFD76ACDwf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,253&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,743&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zHBwRYiaiQg5" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzjPj_zd0KrYwUO0fh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2444"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2445"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zPc4odgOaoCa" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_zvh30x1dLpB5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2449"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2450"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zT5OAzrQZl5f" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzALC_maLzDXj_zJod9ww4Wxj7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Total current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,785&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,104&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzhoA_zIHuzIhaWiC5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_zfKNTjGJYna2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2463"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(44&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2465"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_zGr6iAAo4DVb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(691&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2470"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zWbk5Oymcxfk" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--WarrantLiabilityNonCurrent_i01I_maLzhoA_zGpl8dgESeb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;363&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(363&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2474"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2475"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zoFnY3Hr2jo6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_zmTEozCqcKo5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,025&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2480"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zy1llbxdPwRd" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--WorkingCapitalLoan_i01I_maLzhoA_zCJ6wwyiyxX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(207&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2485"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zy8mdZVEYor6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LongTermLoansPayable_i01I_maLzhoA_zLbIae4ITDb1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Extension loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2489"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2490"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zj7IDgjpWd1b" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzhoA_zTmH1HjVwx28" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other long-term liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2492"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2493"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtLzhoA_maLASEzB9f_zJPu33kIRNI8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;21,161&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;6,488&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2499"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;27,648&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzB9f_z4bET9jAmas6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Commitments and contingencies (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2505"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--TemporaryEquityAbstract_i01B_zChswc4s12K1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Temporary equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zCNQhtB5sb38" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Series A-2, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMglAdrlMTt5" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8CjB97Kyrk8" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zuhtwF938LQ" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zvZjuO1dS995" title="Temporary equity, shares authorized"&gt;4,200,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span title="Preferred stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zYta6rHV0Uib" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zacGgWoOstM" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_ziGtk3V4nsb6" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zOLOUQaIz6v7" title="Temporary equity, shares outstanding"&gt;3,415,923&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_z50ydQvD68Td" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgG0PJuk8Sdf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Preferred Shares A-1, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUXcga9S2JVd" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYCHWXEzs9ai" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zcQRvID0AXgg" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zQOdJGerQ3jb" title="Temporary equity, shares authorized"&gt;4,400,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zg3c3qDYeBj" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Aai5K2fUv4" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrtw0CUjcqna" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMctTmHlLhfa" title="Temporary equity, shares outstanding"&gt;2,839,957&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2533"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_z0vVaUYkTlw9" style="text-align: center; padding-bottom: 1pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_zQNtilKUcrb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
temporary equity &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2554"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zlBYW8gmYu2d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Stockholders&#x2019; (deficit) equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CommonStockValue_i02I_maSEzYAb_zc9TdGIsqNa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Common Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z5EF10mnZfIg" title="Common stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZset6MUT9Se" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zQcjfsQlc3r3" title="Common stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zDDZaWxqSTr5" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt;&lt;/span&gt; shares authorized and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zzH2BT9iwqQ4" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z24UGTu0EBAg" title="Common stock, shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zr2XpGWsvCs3" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zFaCWuPdJL7b" title="Common stock, shares outstanding"&gt;4,033,170&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2566"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzYAb_z6yOhGiOFPc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2587"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zejDbpADROE9" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzYAb_ze7UyEDUJZR1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2592"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzYAb_maLASEzB9f_zq9LusNyoTo7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzB9f_zQ7TyynSymYi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, temporary equity, and stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(29,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zQQ25kVU5LG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1D_zcom1f3JbKv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F08_zxRpE7ddi9se" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_zqdJW85EC7P9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zaUqYTsXpy75" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F17_z12r7OJ9cdv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F0D_zkzbOYh5KVrc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1E_z0YDHGimDoYl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zhrofTMKWeul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1C_zGaauYyovNfl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F07_zg7mY89UOBh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_zu9Mge4cdMl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting for historical preferred stock as temporary equity.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F09_zjbye4RasFl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F17_zTscRma7hil8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zwkFbooRqn5b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Operations (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaXGkJXpTCe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z028oDaLxcnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z40LEykJTRCe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F50_zZzgLezQkhG9"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zi0ZRYIKnBM3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zfQPdTtBiee3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zHeJfx3Vozbg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subscription revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2620"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2621"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zPcMCXCGZPc9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Web imaging revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2626"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHDo_z9waVkSQPWO7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left"&gt;Total revenue&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,021&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2630"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2631"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,021&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHDo_z6GMLbvVfSac" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2635"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHDo_znNyLw8scYyi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross margin&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2641"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zCYcQRN6Sc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zq3x0GU7zIea" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,730&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2651"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zE9FiJGZnz6l" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zDBuLJ2WlWs8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2655"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(226&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2657"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zryX8YnXH7Yc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2661"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zaz5jo1m1yvc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;433&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,065&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z9ClZTf3FKq8" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zJHTG9nQ0lGe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;8,247&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1,297&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(226&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,724&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zbQSvWT10ge1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss from operations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(8,376&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,523&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(6,853&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8jXu5rEIzza" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other expense (income), net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zIkUcqgVzEBc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Income tax provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2684"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2686"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2687"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AssetImpairmentCharges_i01_msNIEzJuG_zSWikkgtMta9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zMsz0tSF3PPe" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zy58V1qNXhb3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;749&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(738&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zUF6AddaOctl" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zj7QMQhvOLi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zPun54PZDMy8" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zpKYnI4UO24l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(47&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(82&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zXwujTSGCHxc" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEzbEL_zb5UH1P07sL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2711"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zQGlpsX4Pmdi" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zJEambHaPBre" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2716"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zzPTykfoVGAl" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zPo3ZpZ7XnEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2720"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zL4eFL1DWeh6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized gain or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2725"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2726"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2727"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_ziS6Q11zdOnd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,097&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,909&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zPKUMtZQ1iU6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;18&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(33,762&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zgynma3E0s1d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzord_zgVpHaAbAfT9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zgtaMKf18hbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per common share outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zfMorvUR0clk" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zpRU0cyDmo7b" title="Diluted net loss per common share outstanding"&gt;(0.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zmNg5vQC4Bo8" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zFkAcqHuTXUi" title="Diluted net loss per common share outstanding"&gt;(3.78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zJ0ZQpMQvn22" title="us-gaap:EarningsPerShareBasic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zVerDL4ZXGak" title="Diluted net loss per common share outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2762"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2764"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fOA_____zaBkgZhbjVei" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fOA_____zmwUHhQcSOc5" title="Diluted net loss per common share outstanding"&gt;(4.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average number of common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____z36ArBhqPUy6" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zErTzsc1irw3" title="Diluted weighted average number of common shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zoMuYwYXrcGa" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zyyYt7a033s" title="Diluted weighted average number of common shares outstanding"&gt;(16,488,164&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zsBYKMj5kk97" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zDQ3reWdjQE7" title="Basic weighted average number of common shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2778"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2780"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zt2ybXAaUhe8" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zDgEREjS19nb" title="Diluted weighted average number of common shares outstanding"&gt;7,084,068&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_z39dTMQ7aKS1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F13_zBDhOn7yGByb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0B_zkIyW9V6GaL5" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1F_z6pc3v68oqb6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F08_zbAjVkGiaN6h" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1A_zmaqyPMOauU5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zUiPPdP75J9g" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_z4AQVNJgwwje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zfMpc6kW3D1j" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_z30zalgt25Q7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_znmNTrFvBWK8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zqbSoM383NGc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F08_zTL2gO4Z7NK1" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z7OzvY6Ptmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zgGQG6V9gICj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_z2vSr1u7Bt34" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EPS
    impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAqyObC2l9kb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTj9bNOVZAOd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z7veP8m81sFd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F55_zM3RLW9AQV3j"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220101__20221231_z7s5h9N5psD8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zhSG1L632XDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zmHR78PheYDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subscription revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2801"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zfuzVjy0bBO5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Web imaging revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2806"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHNd_z3M7b4W4iwk4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left"&gt;Total revenue&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHNd_zp2gco9roem6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2815"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2816"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHNd_zq3yDkZbOD2e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross margin&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zMh80MASqE16" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zkvLEULoFTgd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,756&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,950&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zzjd3qehnLZi" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zBXkCMPrzTD7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(399&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zKEs7uT3IEsi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zoahsy8GI69d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;953&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;638&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2846"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,591&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_z2kghhNL2bcg" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zScGRpGXcBLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;11,066&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(3,312&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(399&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;7,355&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zwUEJLMn9Lq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss from operations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(11,426&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;399&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(7,715&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8Q9WxvWWZJc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other expense (income), net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zgoKVFgTyK7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Income tax provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2867"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F41_z6C8HsKy7cj1" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zXSimJByCVFj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(403&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2871"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2872"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zv3crlecuyh8" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zBEXfcaZ2Tnh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2874"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2876"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F41_zrwCVEVSOSW7" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zJsTq68EZYH2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2882"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z7PyhTCf4XM2" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zUXxZiut0JIl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2886"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zazMZoxkpDv6" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zplVkutO87u5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Other&lt;/p&gt;
                                                     &lt;p style="margin-top: 0; margin-bottom: 0"&gt;expense&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zKLZPn97d85g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized gain or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zxXsAtefuDHc" style="text-align: center; padding-bottom: 1pt"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_zck2r7mIQ1ua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;27,932&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,719&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zQQsZ98kFFhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;416&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(30,434&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zlXyhHrqYtG6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2910"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzord_zxSEeHKVrTTh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;399&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zLpq4rZCb2K3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per common share outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted net loss per common share outstanding"&gt;N/M&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zLdkHTcYaNcb" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zWqk08J9R21j" title="Diluted net loss per common share outstanding"&gt;(7.66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zALngv2ajKAa" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zmVC2juKldy3" title="Diluted net loss per common share outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2928"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fNg_____zr4Fpw3Z764f" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fNg_____z5J1Eds5vKJb" title="Diluted net loss per common share outstanding"&gt;(7.66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average number of common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted weighted average number of common shares outstanding"&gt;N/M&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zGauFJJaMMa2" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____z2m8eKFmBKdi" title="Diluted weighted average number of common shares outstanding"&gt;3,973,897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zupxhmAMKlB" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zAANc7O5PDva" title="Diluted weighted average number of common shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2940"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2942"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_fNg_____zI6r7ZgLzbhg" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_fNg_____zO0Kt17dPiZ3" title="Diluted weighted average number of common shares outstanding"&gt;3,973,897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F02_zMW0yTCrPjCc" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zOXZ2WhRJaBb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zElkDXBk5h94" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F19_zodThWHzZ69i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0D_zTdonRR7Nadi" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F13_znclEY6Lw4te" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_z8AAMabERG51" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_z8S0HYfft0v8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0C_zwrpnNPz4BW2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_ztJ1mOOHa1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F05_z08xFT13J7Uf" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F12_zpWOpJCTLxQ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EPS
    impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Cash Flows for the Year Ended December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_zRnKaIw7jdjk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYZd2yEkwFr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zr7cwzqut9Ii" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zBcdhZk85qA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGvm_z64DQItPSa96" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 47%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zw3VLV9eU38g" style="width: 6%; text-align: center"&gt;1&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzSqX_z1Siz3WmGyPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationCost_i02_maNCPBUzSqX_zKu7p8ybV0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Business combination cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(900&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zhSRmmNKghZj" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zIioh3o057C2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Cash held in trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2978"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zvkI2gMnv3K4" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzSqX_ztlKU4wKp3L" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2980"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F40_zuT4zzgsB7S7" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_z1LfWwh2ycDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2984"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zWhhCrOvLBH1" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--WarrantExpense_i02_msNCPBUz449_zroQluWiV8M5" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Board of director warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2989"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfWarrantLiabilities_i02N_di_zly6v0jfmvIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zLzzviNlbyti" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ChangeInFairValueOfPipeNotes_i02_maNCPBUz449_ztCqzYltXv2j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2996"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zBYtlwHGJs4a" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_z6Wa9gfFadpl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3000"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zUuACnxP3RHe" style="text-align: center"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--NoncashInterest_i02_maNCPBUz449_zRk5FKwAcIlj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-cash interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zX8QjC4r71w1" style="text-align: center"&gt;10&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zmyVVkwjHxCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Change in operating assets and liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_zkjFOQ06zN9g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3013"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zsMiljgIih9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(65&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(43&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_z8iICOZIL45l" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_zxkdC3Z1VQSe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,372&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(655&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zgbHqM25Rwih" style="text-align: center"&gt;2, 3, 9&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zS794PTHhJgg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_zKQni9fVV3Pf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Amount due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3028"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3029"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncreaseDecreaseInExerciseTaxLiability_i03_maNCPBUzSqX_zZPZkw6z6kg7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Excise tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zTpyxRxtxAA2" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncreaseDecreaseInExtensionLoan_i03_pp3d_maNCPBUzSqX_zSXrTBuq4qfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Extension loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zUlA1KyjgDe1" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zDM2jYf7zMT6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(70&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zqJtwPbubevg" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zhTXU4CWz6xj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(95&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zYqLLsaf7Lh1" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zirFCYKadrqb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zH1aXYrl5jG7" style="text-align: center; padding-bottom: 1pt"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zE1wO1c9Wxi5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(13,012&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,791&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zKOBqaEyKXva" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from investing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zYXgFU3g6oD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Purchases of property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zqHSZoyjrJ1l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkxDU18xN9nb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01_maNCPBUzy34_zJEOsi6pVYlc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payments of Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3072"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3073"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3074"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzGlA_zOdW1gnmqlp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of shareholder loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;454&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zaFdLfoupmci" style="text-align: center"&gt;10&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzGlA_zg5nyHeTYEI" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of PIPE notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_z7M2VCjCnc7k" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_z07juzthWC5b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock subject to redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3086"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_z3atOgujEQs4" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ProceedsFromDeferredUnderwritingFee_i01_maNCPBUzy34_z9DVkGtZLhz8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriting fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(500&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zGwrp2TfzbYk" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_zZ0dyaR3S7wd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(338&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zf9QU9Misnz9" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_zAYoX8b1m1Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zYzwxZ33MZH7" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zWwMIO92Lofd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3102"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zx7FQKfwoy5h" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzy34_zR6lDSHfT83b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds (repayment) from issuance of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,681&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zxaWnkX1BqN2" style="text-align: center"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zsP3rV8DUkjg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3109"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3110"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProceedsFromIssuanceOfSeriesA2PreferredStock_i01N_di_msNCPBUzy34_zDu7i4VAkpD1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3112"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zISOUvH1P1t6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z8WjtJFHZn59" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Business Combination costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F40_zyrejfqwdML3" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zfXYzRVj6q5a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,611&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_z8gBwTb88MTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left"&gt;Net decrease in cash and cash equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(255&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(224&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zW01Oi5i7WK7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash and cash equivalents at beginning of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zXFeWXa49hi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3133"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoOYkLkcKEY8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Supplemental disclosures of non-cash investing and financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CommonSharesIssuedToPreferredShareholders_i01_zL5AXy97jdhe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares issued to preferred shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zsN1AMyCjzzd" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zoPsrtyw1oY" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares related to convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zZAuoRZhbqq6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zK8SHJvpIxr8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares issued to Data Knights shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zurSmY3KUYv1" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F01_zhL240hE6k3b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z9dm4Vp0An6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zGGQ55l6kmh1" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zUeE55Ju80t3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0A_z4MZv7ZYiCC8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zI2WxXsdey6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zG13g7DRpeth" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1C_zYTXI3E04L3i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_zHRA8LZW1Ws9" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F11_zg5hJyL5Obpi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F01_zyqW1Xm1i1Kh" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_zrt2utkjYT66" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F0F_zIYCaCTFZ5G9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1B_zgD8LP6mENc7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0F_z7fNBeaoaagc" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1E_zTJJUc68HjP" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F05_zrYUaf70UVgf" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_z2QRlzGBbmY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zjJ3QhCQi3U6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F12_zWah1vcZocA8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper presentation of non-cash interest expense in financing activities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation of the
Original and Restated Statement of Cash Flows for the Year Ended December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd1GVUj81Op9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBhCw3tfNvi7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_ztK2LT4qQfpe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_pn3n3_zFzKoT6TF5kc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUz449_zhjXV3tvln2c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 47%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zjxT1FD9l7P" style="width: 6%; text-align: center"&gt;1&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_pn3n3_z0076fqc8VT5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DepreciationDepletionAndAmortization_i02_pn3n3_maNCPBUz449_zm9JPLeVIQE8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maNCPBUz449_z6Q7ZgrwjTL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zIJNrmfhBsRc" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zS5SB85M13E2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Cash held in trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,292&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z1NfzNBC5JKe" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_zC68WqLkgJX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_z6tBAOitcY1h" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantExpense_i02N_di_msNCPBUz449_zEuTdXmz78d8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Board of director warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zkBk4aNHnwei" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_zCUJBEmM2g0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zpczmZJibJ92" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zAzE1OfS3Mo7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Change in operating assets and liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_ztG0vsbqUXte" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zluTWoieg0s6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(876&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(59&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zNedHdvlJBW" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_z0I3mGes2Dxf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,929&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,514&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z37tNNq9Qes9" style="text-align: center"&gt;2, 7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zeDSeDuJMSm6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(458&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3215"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(458&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_z2GxU8Wb6ygk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Amount due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3220"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zSE3xgLclZB5" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--IncreaseDecreaseInExtensionLoan_i03_maNCPBUzSqX_zgskN7980aF2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Extension loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3224"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zmZ2D62zyLMe" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zyV7jFslgyRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(94&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3228"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zQybhbNoVMKf" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zL2rQVS8QfE" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zdRnntdJgKm" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zzuEL6o9ruce" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3236"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zNJP4fjQSaP9" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zJJhW4QBOtek" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;87,241&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(91,944&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,703&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zilVvTyW6epe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from investing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zNGRgLG7f9O3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Purchases of property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3247"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zjhR5EClnx7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3251"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zyvRblK7SBoe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01I_maNCPBUzy34_z2KX3jMiyK3i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payments of Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/M&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_zrfUrQmF8m43" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock subject to redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,550&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3264"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zA55vPOU2Hib" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_z9RjVyh6e9h6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3268"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z1Q1QdwsjcB" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_z6L0fxtNkTd5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3272"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zVJ0w3BVrU96" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zYdeays3yNz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zvYGPpCF8ALi" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzGlA_zxuSCkdEwgk1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,543&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(403&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zQ8Xe760x2r2" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zYGmsnBOP9B5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/M&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z3TyDWcTRTM6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Business Combination Costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3286"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zKeSKcvznUJk" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zwmIc6mhnd5e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(88,033&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;92,366&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zp4EyvM8G2Tg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net decrease in cash and cash equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(850&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;422&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(428&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDY2bKGDYzo7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash and cash equivalents at beginning of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,152&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(453&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;699&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zKczG8qKbiOc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zYSJMmCsa0ka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zLKRQx9dshs8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_z87rmpJn3ZB8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_zDRZS1dv1eOl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zxbQFNbtYzE9" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_z42bK2J0pX1f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_zAgkZCBqrDZc" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1A_zFDMqwcniOib" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_zCFiNFZCBLKj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F13_zrElvg95e3hb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zMeCuTCN8Un6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F17_z00H9AjztdPb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Improper
    presentation of Business Combination costs as well as errors identified related to capitalization of such costs. Refer to balance
    sheet restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#x2019; Deficit as of December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zbzwUQkL3AE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zd8vvcZGRvQ" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zK5CmsM1ZRH1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zqwRhzUrgNN" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zWLv2SAVVLB" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_zJ1EbxPqWHa2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-2&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-1&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Temporary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Additional&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Paid-in&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Stockholders&#x2019;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;As Previously Reported&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zkuypag4rQ83" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSbLFbtZqFHd" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlv5Cf5sOUO3" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3322"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1NbSqGrvhck" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8AgftvLtU5f" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3326"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUidXthwSV4a" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3328"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXBFGFyRKYs2" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;9,388,958&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXjcEC2yKbDd" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zww2RJZCA4ii" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTybYcahs77" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fMg_____z83jL5Bb2Imd" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3350"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3345"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3347"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3348"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM6gBXLBUoac" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKviQDmZq1Bf" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of stock options, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrI4xcsaTqM3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdXG50votS8i" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3364"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3365"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3367"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3368"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoFXc0EowaZ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3372"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3373"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3376"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqMk9V97gCEa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcyI1ubllCfe" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;612,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3378"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3381"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3isqa2ILvij" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0wDNGMku6F5" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;3,859,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3386"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB1ofR7bGO37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible loans upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCuKJG4XINv" style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;6,177,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3395"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3397"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjRLnI869rq7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWPCyxfSZ185" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4v1VSB6GRm4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOvsvOeYyLy8" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(3,853,797&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBDYBabeNKUb" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(3,204,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zp8TtqKLkxy6" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;7,057,797&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3415"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3417"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4R3JHuzW4d4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZtIFRsSvo14" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares"&gt;(2,257,326&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3426"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3427"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zImjAQyx1dl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3434"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3435"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3437"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgVEMYmeVYy3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHK8uetxWRNh" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;(1,266,560&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3440"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3441"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3443"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf5V5sZPtbyj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3448"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3451"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwO9nIUVQfV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3454"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3457"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqIeAYcOEJbg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3460"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3461"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5nNrvH7L1L9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcqEVw4aErc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3472"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3473"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z4K0kNmW97ad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (as previously reported)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjvqdYJmE8N2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0iPc6CFVON" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3486"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zy620ElYt97c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3488"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zz3W42bVrfFi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3490"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdbBjALrE3Gc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3492"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd0cvaM8AvNe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;23,572,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;42,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(55,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zLnYlZvsp0f9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zDAvoewh2ue2" style="border-bottom: Black 1pt solid; text-align: center"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zpxqTeO4I9oj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(437,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z3b6qXBzzlG9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zNnUY7L7xiFg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(364,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zHGmzmExCnHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zvzFm0ziawq9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z8CWxY9bZ134" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(5,355,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zygwwWmssSs5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zHj5CkaxLx3i" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z7bwirrTghH1" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;265,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3515"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3516"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3517"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3518"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhw8GZcbOHQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zCtEitmMNUb6" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zq0XsuIEjQvb" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;5,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zQsW2gSboNpd" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z1nHfpTejBah" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3523"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3524"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zsl433z8PvWb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F48_zTC0qdQyxOY2" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3534"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3537"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zRyPxcD6Gycd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zhV9klln87bd" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zAVkHqJQ1fb2" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;(69,614&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3541"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(613&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3543"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(613&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjBvsJuZkRNl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_zcH3UUXvIdIc" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zpIkisGK5jO4" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;(438,519&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3548"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3551"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zplLOy1ht2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_ziLCg9j2iOU2" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zRbYZNCGx08i" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(701,867&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3559"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zaAxdbDBbKxl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4A_z0OGPFi514ba" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zMlytimJOcF6" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;432,201&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zFcFkIPEa4kh" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(9,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____z9frGH3YO8Og" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zT27h15QDmob" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(8,010&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zbrxmPwclQl8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(17,660&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zITjZmoEl281" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(796,244&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3564"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3565"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGSxBeU5qafe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F43_zDEM3QbSe4Z8" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zD5Fu6pKoZ99" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares"&gt;2,257,326&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3582"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3583"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuatop1tYVa3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_zH7SDweyyBr1" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3590"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3591"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3593"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zu7klaV3kl0e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F41_zXvkqXSkdojg" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zQZ4FUPjak9f" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;4,838,792&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3596"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,683&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3599"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,683&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZcv5xa7e8kd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F45_zbh8HYc2n1da" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3604"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3606"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3607"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zqFv5qjxO3F8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4B_zPksoWAMCJv6" style="text-align: center"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3610"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3611"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(418&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3613"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(418&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z1PrgZqUBDwg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4B_zEpLKUsQUK54" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3616"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3617"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3618"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgO3DzksH894" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_zebKylsMKZnd" style="border-bottom: Black 1pt solid; text-align: center"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3623"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3624"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zEzrIG974kB6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (restatement adjustments)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3xQtxPEgetg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3634"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z0LbHAIAdUp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zWsGyytsoFY1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3638"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3dqYsKfeCd7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_ziLn7iNhwNub" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGiZyyb9ObIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3629"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;35,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(36,357&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;As Restated&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zCERd0BC8Edb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zi65lAIuLzI5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,415,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z6uXJ7vZHdjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zcrTCJ23Lc8h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;2,839,957&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zSIzwmTqxAae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zQlhYEki4WHj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zEa3Euv8yG7b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;4,033,170&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3646"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3647"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zRh9MNfOQbN6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zKhabU7B1IXj" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;265,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3664"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3665"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3667"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3668"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zhvp3TSV5JVc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zkKNCOHCGNYi" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;5,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zBl8PdJEW3Fg" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_ztPun9js0gHl" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zAmG6EO8ecvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3684"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3687"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zV9qXvnTf4X3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zof3JCdzGJy6" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;543,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3693"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3694"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zcMHotUSQHRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zeypJR6uOcGa" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;3,420,945&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3700"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3702"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zfItEKG9a5D5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z8Q793oFY6nc" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;5,475,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,936&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zg0xUHJQhupl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_ztPA7LA28WGd" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(3,421,596&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zM2ygMU7QyFk" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(9,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zFWUKYVBc9i5" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z91jAoZWsSK4" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(8,010&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zVxd72lcoUS8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(17,660&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z842Un0CdEeg" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;6,261,553&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3718"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z8QjpVGyUPod" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3732"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3733"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3734"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3735"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zVfX9LzWmXC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3738"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3741"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z4FQbGPN3q37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zGyfI7Nay6Tf" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;3,572,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3747"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zn28LbtLErUe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3755"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3756"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zPS9BXk3A5Q6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3759"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3761"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zoyWjR9ZfmX4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3765"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3766"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3768"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zpMrABjxHPM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3770"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3771"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zfRwOC5WxoLl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (as restated)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zA8QIoRKWpBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zrinSGD4zYy" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zTYsCn8TomIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zVYGhC0pQrw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zRQ4EtchBpk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zboRJOiguk2e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;23,572,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;77,996&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(91,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(13,442&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F06_zUiD7Qvo1dF5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zbiLSN0c8sW" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    impact of corrections of errors to the prior year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F03_zuwvJHWa9Qsc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zoyXhvCVdcj2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting and presentation of the recapitalization.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F00_zXFfXM0FUxdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_z8741aGRMBg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F03_zR4FwFBByqVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zyRwSInVDUs2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zlaXOkrERoi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_zG6TTXuWq7t7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F02_zXs8hJHKY1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F19_zUXZ0owxwFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#x2019; Deficit as of December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zW5uco0SMtSh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zrIdmjFOdate" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_ztCUO5HaRbVk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zhuYeBR4mRoh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_zkCvhsJ1MJPl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-2&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-1&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Temporary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Additional&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Paid-in&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Stockholders&#x2019;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrNm0ijsZPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAcgwhinqMD4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1T2qWsARIe4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3808"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuS7rvgTthDk" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAPwynqPG39e" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmIeWOsviLx8" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3814"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGS035o8Ql7d" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;7,802,941&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;19,607&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;(33,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;14,438&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuKXvvBVg7qa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcpL8pWl3lf2" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;1,378,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(534&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIWlWMbHJUOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9ML9jv2UZS3" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3826"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBYL9zVXKgk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNn9md3kQVj9" style="text-align: right" title="Exercise of stock options, shares"&gt;7,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3834"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvh2OxydzaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3842"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3843"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3844"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3845"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3846"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaiX9poMuPoh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3849"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3850"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3851"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3852"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5thZ2Xh2Hsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3854"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3857"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0tYj64RAV6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3861"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3862"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zobHW8vZbi64" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (as previously reported)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyvTNxCFGuE5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8vxe5cfXKMl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3874"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuu4od7drGh4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoiV8vo2EkS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3878"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNG5tnOqwZd3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3880"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfDbaFYqc7d1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;9,388,958&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Restatement Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zhDxKNCYKEJj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4F_zNoljWR8FXOg" style="border-bottom: Black 1pt solid; text-align: center"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zOiSKm9Y18M5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z4SX7bmLswU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zp50a3vBuuyc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3894"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zbwued2BiB6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zLCW3sTmfox5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z5j9fZFJU6s1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(3,460,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(17,094&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,711&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(21,490&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zmjfh2oZy4n5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_z4BL9SKw3H43" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zBqgxqtz2p6c" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(437,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zsXNpsNJNxp5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zkFrQeWMPwqe" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(1,871,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3902"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3903"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zUwl79ZHOcIi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F48_zLyF1icLyyY7" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zvEl2Uhodt9a" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;(22,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3914"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhK8jGiUmqO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4D_z3pfjJmavaVd" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zlNdzOClaP1i" style="text-align: right" title="Exercise of stock options, shares"&gt;(852&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3922"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3923"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3925"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_za9Aev5bcs01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4C_zGaE6XDWo0We" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3930"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3931"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z8hLbwNTPbb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F49_zCojnMZDTpW6" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3936"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3937"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3939"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zEVLrZSKq5Bl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4C_zae9qLTfo1K5" style="text-align: center"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3942"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3943"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3945"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zclWPo1aIwbe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_zBbAJaZMwUgg" style="border-bottom: Black 1pt solid; text-align: center"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3948"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3950"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zyYjTX0xhooj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (restatement adjustments)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgWvh1mNxHC1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(437,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zefDHoLOM7El" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuXimcaSYwmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(364,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVF3mcJLaYTc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVW6xo9eel76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zO8CGAdbB5Se" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(5,355,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrXFWLTIonP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_znrSJXtswFu1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zDWmfRBTLSv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9eknUZYUPk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zLWYelQ5MJg9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_zAD8l9lcw6Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zEbjcWBfmguh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;4,342,666&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3972"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3973"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(27,209&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(7,052&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zGTdqTNBZigd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zMytJlaMvyi5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(437,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zjkVEXnj5cM" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zS3jYyKzBF04" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(493,420&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3991"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3993"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3994"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zcFGLAmG0cU9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_z0wnuWNESsub" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;177,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4002"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4003"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4005"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4006"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zHMgzJLqZJb6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zajonvshXIY2" style="text-align: right" title="Exercise of stock options, shares"&gt;6,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4010"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4011"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4013"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTnAIjQZ5aT8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4018"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4019"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4021"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_z8tAwixWGQHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4027"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zaJ6OskwPPY7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4031"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zmUgeFgH4gy" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4036"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z6eucAVAQpA4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (as restated)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zW5wCE0trGKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,415,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zIKJ6AxaTxh8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_z3lPg63tnHJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;2,839,957&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zcL2aOMXs0D5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_ztospgNmuhO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9vePJiASM6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;4,033,170&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0F_zGF24QwsV3Ke" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F1A_zGlRskPx0Ma4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    impact of corrections of errors to the prior year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zGSobA1i1T6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F11_zodBNv0iJGqk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting and presentation of the recapitalization.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F0D_zsNEl2u7LGlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F11_zbg3ir20cxef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zrPYGRKo8Joa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F10_zerEnUYVHRTd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of error related to identificatoin and recognition of board of director warrante expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zDtv9dtOoYMi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F19_zFz7iviKaa8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F05_zMr7Ef6oH2v7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F1E_zuS5qUnBBoP6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zpvQ5rh7nhV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zYjKwepWsD0e"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the accounts of the Company, including its subsidiaries. All intercompany accounts and transactions
have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--UseOfEstimates_zr2hwzXh7qd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z3i8w8qiCyLh"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in these notes to the consolidated
financial statements. Actual results and outcomes may differ materially from management&#x2019;s estimates, judgments, and assumptions.
Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to
revenue such as determining the nature and timing of the satisfaction of performance obligations, allowances for accounts receivable,
useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and stock-based compensation.
Estimates are periodically reviewed in light of changes in circumstances, facts, and experience.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--OperatingSegmentsPolicyTextBlock_zgianBikxImj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zRjKMzLPlLFc"&gt;Operating
Segments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial
information is regularly evaluated by the chief operating decision maker (&#x201c;CODM&#x201d;), which is the Company&#x2019;s Chief Executive
Officer, in deciding how to allocate resources and assess performance. The Company&#x2019;s CODM evaluates the Company&#x2019;s financial
information and resources and assesses the performance of these resources on a consolidated basis. The Company is not organized by market
and is managed and operated as one business. A single management team that reports to the chief executive officer comprehensively manages
the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and
does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial
segment information can be found in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgvoIrAOYflg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zrYd84kCcMGb"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents
consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC insured
limits. The Company believes that, as of December 31, 2023 and 2022, its risk relating to deposits exceeding federally insured limits
was not significant. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s
financial condition, results of operations, and cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zdRDjIpsIbS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zvZhFGQmgyM1"&gt;Accounts
Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable is unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable is considered past due if not
paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections
have been exhausted. The Company determines the need for an allowance for credit losses based upon factors surrounding the credit risk
of specific customers, historical trends and other information. As of December 31, 2023 and 2022, the Company established allowances
for credit losses of $&lt;span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zStClmmHs8Z4" title="Accounts receivable"&gt;0&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_z8w2bWI5XRIf" title="Accounts receivable"&gt;0.1&lt;/span&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not
require collateral from its customers and generally requires payment from 0 to 90 days from the invoice date. For the year ended December
31, 2023, there was 1 customer that accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zrvQn5txl485" title="Percentage of revenue"&gt;10&lt;/span&gt;% or more of total revenue, and there were 2 customers that accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z3ByJ3wUEWOf" title="Percentage of revenue"&gt;10&lt;/span&gt;% or
more of total revenue for the year ended December 31, 2022. The following table represents these customers&#x2019; aggregate percent of
total revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_ztBzoaioJk74" style="display: none"&gt;Schedule
of Aggregate Percentage Revenue and Accounts Receivable&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, three customers accounted for more than &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance, and four customers
accounted for over &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#x2019; aggregate percent of total accounts receivable:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 4&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 5&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 6&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 7&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of total accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate Percent of Revenue and Accounts Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zqJD9t4ymDAb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zbneL7aFcAJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zpfxMSc0ozV2"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The straight-line method is used for computing depreciation
and amortization. Assets are depreciated and amortized over their estimated useful lives ranging from three to five years. Cost of maintenance
and repairs are charged to expense when incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZXcFP3hWAY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zVpXbo6CoYFj"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances
indicate that the carrying amount of an asset may not be fully recoverable. An impairment loss would be recognized when the estimated
future undiscounted net cash flows from the use of the asset are less than the carrying amount of that asset. There were &lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20230101__20231231_zAMAdUgdylq7" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zxpllUrCgDsc" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; such losses
during the years ended December 31, 2023 or December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--FairValueOptionOfAccountingPolicyTextBlock_zPgodBycYS55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zOFCpgo5lkt9"&gt;Fair
value option of accounting&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
financial instruments contain various embedded derivatives which may require bifurcation and separate accounting of those derivatives
apart from the entire host instrument, if eligible, ASC 825, &lt;i&gt;Financial Instruments&lt;/i&gt;, allows issuers to elect the fair value option
(&#x201c;FVO&#x201d;) of accounting for those instruments. The FVO may be elected on an instrument-by-instrument basis and is irrevocable
unless a new election date occurs. The FVO allows the issuer to account for the entire financial instrument at fair value with subsequent
remeasurements of that fair value recorded through the statements of operations at each reporting date. A financial instrument is generally
eligible for the FVO if, amongst other factors, no part of the convertible, or contingently convertible, instrument is classified in
stockholders&#x2019; equity and the instrument does not contain a beneficial conversion feature at issuance. In addition, because a contingent
beneficial conversion feature, if any, is not separately recognized within stockholders&#x2019; equity at the issuance date, a convertible
debt instrument with a contingent beneficial conversion feature is therefore eligible for the FVO if all other criteria are met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on the eligibility assessment discussed above, the Company concluded that its convertible notes payable is eligible for the FVO and accordingly
elected the FVO for those debt instruments. This election was made because of operational efficiencies in valuing and reporting for these
debt instruments in their entirety at each reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
promissory notes and the PIPE Notes contain embedded derivatives, which require bifurcation and separate accounting under GAAP, for which
the Company elected the FVO. In addition, certain term PIPE Notes were issued with separately exercisable and freestanding warrants to
purchase common stock, were issued with substantial discounts at issuance and contained certain embedded derivatives to be bifurcated
and accounted for separately for those term notes, unless the FVO is eligible and elected. Accordingly, the Company qualified for and
elected the FVO for the entire PIPE Notes instruments. The convertible debt and accrued interest at their stated interest rates were
initially recorded at fair value as liabilities on the consolidated balance sheets and were subsequently re-measured at fair value at
the end of each reporting period presented within the consolidated financial statements. The changes in the fair value of the convertible
promissory notes and PIPE Notes are recorded in changes in fair value of convertible debt and change in fair value of PIPE Notes, included
as a component of other (income) expenses, net, in the consolidated statements of operations. The change in fair value related to the
accrued interest components is also included within the respective single line of change in fair value of convertible debt and change
in fair value of PIPE Notes on the consolidated statements of operations. See additional information on valuation methodologies and significant
assumptions used in Note 6 and Note 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_ecustom--WarrantPolicyTextBlock_zFCbjB1MuvZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zlRvn7HvG6e5"&gt;Warrants&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s
specific terms and applicable authoritative guidance in ASC 480, &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;, and ASC 815, &lt;i&gt;Derivatives
and Hedging&lt;/i&gt;. Warrants that meet the definition of a derivative financial instrument and the equity scope exception in ASC 815-10-15-74(a)
are classified as equity and are not subject to remeasurement provided that the Company continues to meet the criteria for equity classification.
Warrants that are classified as liabilities are accounted for at fair value and remeasured at each reporting date until exercise, expiration,
or modification that results in equity classification. Any change in the fair value of the warrants is recognized as change in fair value
of warrant liabilities included as a component of other (income) expenses, net in the consolidated statements of operations. The classification
of warrants, including whether warrants should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The fair value of liability-classified warrants is determined using the Black-Scholes options pricing model (&#x201c;Black-Scholes model&#x201d;)
which includes Level 3 inputs, as shown in Note 11 to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z7mrkflN4v37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zgP8byl9dztb"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes
the inputs to valuation methodologies used to measure fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Level
1&lt;/b&gt; - Valuations based on quoted prices for identical assets and liabilities in active markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Level
2&lt;/b&gt; - Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets
and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other
inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Level
3&lt;/b&gt; - Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made
by other market participants. These valuations require significant judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
quoted market prices are available in active markets, the fair value of assets and liabilities is estimated within Level 1 of the valuation
hierarchy. If quoted prices are not available, then fair values are estimated by using pricing models, quoted prices of assets and liabilities
with similar characteristics, or discounted cash flows, within Level 2 of the valuation hierarchy. In cases where Level 1 or Level 2
inputs are not available, the fair values are estimated by using inputs within Level 3 of the hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies&#x37e; however,
considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative
of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using
different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based
on carrying values and future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, convertible notes
payable, liability classified financial instruments and certain privately issued warrants. The carrying amounts of cash and cash equivalents
and accounts payable financial instruments approximate their fair value due to their short-term nature. The carrying amount of accounts
receivable is net of an allowance that reflects management&#x2019;s best estimate of expected credit losses. See Note 11 for fair value
measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--StockholdersEquityPolicyTextBlock_zJjjHU9EiIXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Classification
of Series A-1, and Series A-2 preferred stock&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_864_zuHE7wZUI1Lf" style="display: none"&gt;Treasury
stock&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company originally classified its Series A-1 and Series A-2 preferred stock (collectively &#x201c;Preferred Stock&#x201d;) outside of permanent
equity because the Preferred Stock contained certain redemption features that result in those shares being redeemable upon the occurrence
of certain events that are not solely within the Company&#x2019;s control, including liquidation, sale or transfer of control. Accordingly,
the Preferred Stock was recorded outside of permanent equity and was subject to the classification guidance provided under ASC 480-10-S99.
Because dividends were not contractually required to be accrued on the Preferred Stock as there was no stated or required dividend rate
per annum, the Company was not required to accrete dividends into the carrying amount of the Preferred Stock in anticipation of a future
contingent event or redemption value. Accordingly, the Company did not adjust the carrying values of the Preferred Stock to the respective
liquidation preferences of such shares because of the uncertainty of whether or when such events would occur. As of December 31, 2023,
all shares of Preferred Stock were converted into Common Stock pursuant to their provisions in connection with the Business Combination,
which closed on November 7, 2023 (see Note 3).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zixMabdmKOj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zghowmw5w7cc"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with ASC Topic 606, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, which aligns revenue recognition
with the transference of promised goods or services to customers in an amount that reflects the consideration to which the Company expects
to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
core principle is achieved to the application of a five-step model: (1) identify the contract with a customer, (2) identify the performance
obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to performance obligations in the
contract, and (5) recognize revenue as performance obligations are satisfied. Payment terms between customers related to product and
services sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable
or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to
a customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit
of account under Topic 606. A contract&#x2019;s transaction price is allocated to each distinct performance obligation in proportion to
the standalone selling price for each and recognized as revenue when, or as, the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Individual
promised goods and services in a contract are considered a performance obligation and accounted for separately if the good or service
is distinct. A good or service is considered distinct if the customer can benefit from the good or service on its own or with other resources
that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction price for the products is the invoiced amount. Advanced billings from contracts are deferred and recognized as revenue when
earned. Revenue is recognized only to the extent that it is probable that a significant reversal of revenue will not occur and when collection
is considered probable. The Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority
and imposed on and concurrent with a specific revenue-producing transaction. Deferred revenue consists of payments received in advance
of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives
payments from customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes
unconditional. Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subscription
Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
revenues are generated from the Company&#x2019;s data exchange (BEAM) product, which is a medical imaging exchange platform between hospital/healthcare
systems, imaging centers, physicians and patients. Subscriptions to the BEAM platform offering are recognized over time as the customer
consumes the benefits of the services as the Company stands ready to provide access to the programs throughout the subscription period.
Subscription customers are invoiced either quarterly or annually in advance with the customer contracts automatically renewing unless
the customer issues a cancellation notice. The timing of revenue recognition is based on a time-based measure of progress as the Company
provides access to the programs evenly over the course of the subscription period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Web
Imaging Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Web
imaging revenues are generated from the Company&#x2019;s data broker (iRWD) product, which provides regulatory grade imaging and clinical
data in the pharmaceutical, device manufacturing, clinical research organizations, and artificial intelligence markets. Web imaging customers
are invoiced in installments as the related data is delivered. Revenue from the sale of web imaging products is recognized over time
using an output measure of progress, which is based on the number of data units delivered relative to the total data units committed
by the customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zbR50DAB7kV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zKJcBN4npTdf"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes income taxes under the asset and liability method. Deferred income taxes are recognized for differences between the
financial reporting and tax bases of assets and liabilities, at enacted statutory tax rates in effect for the years in which the differences
are expected to reverse. The Company establishes a valuation allowance if it believes it is more likely than not that the deferred tax
assets will not be recovered based on an evaluation of all available evidence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely
than not that a position will be sustained, none of the benefit attributable to the position is recognized. The tax benefit to be recognized
for any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than
50% likely to be realized upon resolution of the contingency. The Company accounts for interest and penalties related to uncertain tax
positions as part of its provision for income taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_ecustom--PatentsAndTrademarksPolicyTextBlock_zzT15pKsuKh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_z477QSUwNVti"&gt;Patents
and Trademarks&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
associated with the submission of a patent application are expensed as incurred given the uncertainty of the patents resulting in probable
future economic benefits to the Company and are included in research and development expenses on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4Hi9QUf8Quf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zOHYXgR61V4k"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its research and development (&#x201c;R&amp;amp;D&#x201d;) costs in accordance with ASC 730, &lt;i&gt;Research and Development
&lt;/i&gt;(&#x201c;ASC 730&#x201d;). ASC 730 requires that R&amp;amp;D costs are generally recognized as an expense as incurred. However, some costs
associated with R&amp;amp;D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.
For the years ended December 31, 2023 and December 31, 2022 research and development expenditures were charged to operating expense as
incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_znU3DnHp0JGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zgmkIrGoakvg"&gt;Stock-based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes compensation expense related to employee option grants and restricted stock grants, if any, in accordance with ASC
718, &lt;i&gt;Compensation - Stock Compensation&lt;/i&gt; (&#x201c;ASC 718&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures all stock options and other stock-based awards granted based on the fair value of the award on the date of the grant
and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the
respective award. The Company has elected to recognize forfeitures as they occur. The reversal of compensation cost previously recognized
for an award that is forfeited because of a failure to satisfy a service condition is recognized in the period of the forfeiture. Generally,
and unless otherwise specified, the Company grants stock options with service-based only vesting conditions and records the expense for
these awards using the straight-line method over the requisite service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award
recipient&#x2019;s payroll costs are classified or in which the award recipients&#x2019; service payments are classified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the Business Combination, the Company was required to periodically estimate the fair value of its Common Stock with the assistance
of an independent third-party valuation firm when issuing stock options and computing estimated stock-based compensation expense. The
assumptions underlying these valuations represented the Company&#x2019;s best estimates, which involved inherent uncertainties and the
application of significant levels of judgment. In order to determine the fair value of its Common Stock, the Company considered, among
other items, previous transactions involving the sale of Company securities, the business, financial condition and results of operations,
economic and industry trends, the market performance of comparable publicly traded companies, and the lack of marketability of the Company&#x2019;s
Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. These estimates and assumptions include
a number of objective and subjective factors, including external market conditions, guideline public company information, the prices
at which the Company sold convertible preferred stock and common stock to third parties in arms&#x2019; length transactions, the rights
and preferences of securities senior to the Company&#x2019;s common stock at the time, and the likelihood of achieving a liquidity event
such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in materially
different fair values of stock options at each valuation date, as applicable. Following the Business Combination (see Note 3), the Company
used the public price of its Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each stock option grant is estimated using the Black-Scholes option-pricing model. The Company estimates its expected stock
volatility based on the historical volatility of a publicly traded set of peer companies within the biotechnology industry with characteristics
similar to the Company. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d;
method, which reflects the weighted-average of time-to-vesting. The risk-free interest rate is determined by reference to the U.S. Treasury
yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected
dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends
in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zpI0qE49LlHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Net
loss per common share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86B_zl2x1xmQ1a1e" style="display: none"&gt;Net
loss per share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnings
per share attributable to common stockholders is calculated using the two-class method, which is an earnings allocation formula that
determines earnings per share for the holders of the Company&#x2019;s Common Stock and participating securities. Although the Company&#x2019;s
historical Preferred Stock contained participating rights in any dividend declared and paid by the Company and were therefore participating
securities, the Preferred Stock had no stated dividends and OneMedNet has never paid any cash dividends and does not plan to pay any
dividends in the foreseeable future. Net loss attributable to common stockholders and participating securities is allocated to each share
on an if-converted basis as if all of the earnings for the period had been distributed. However, the participating securities do not
include a contractual obligation to share in the losses of the Company and are not included in the calculation of net loss per share
in the periods that have a net loss. In addition, common stock equivalent shares (whether or not participating) are excluded from the
computation of diluted earnings per share in periods in which they have an anti-dilutive effect on net loss per common share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
net loss per share is computed using the more dilutive of (a) the two-class method or (b) the if-converted method and treasury stock
method, as applicable. Contingently convertible notes payable and PIPE Notes were not included for purposes of calculating the number
of diluted shares outstanding as the number of dilutive shares is based on a conversion contingency associated with the completion of
a future financing event that had not occurred, and the contingency was not resolved, in the reporting periods presented herein. In periods
in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders
is the same as basic net loss per share attributable to common stockholders since dilutive common shares are not assumed to have been
issued if their effect is anti-dilutive. Diluted net loss per share is equivalent to basic net loss per share for the periods presented
herein because common stock equivalent shares from the Preferred Stock, convertible notes, stock option awards and outstanding warrants
to purchase common stock were antidilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the Company reporting net loss attributable to common stockholders for all periods presented herein, the following common
stock equivalents were excluded from the computation of diluted net loss per common share for the years ended December 31, 2023 and 2022
because including them would have been antidilutive (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none"&gt;Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022
    &lt;span id="xdx_F53_zMknzVxwFW2d"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022 (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Employee stock options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;913,856&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants for common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,367,607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series A-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4165"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,415,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible promissory notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4171"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,786,610&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total common stock equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,501,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Retroactively restated
for the reverse recapitalization in Note 3.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AD_zdniDLLHaxk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zAtmvX74dVB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zHJ6xeHhZUah"&gt;General
and Administrative&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
and administrative expenses include all costs that are not directly related to satisfaction of customer contracts. General and administrative
expenses include items for the Company&#x2019;s selling and administrative functions, such as sales, finance, legal, human resources,
and information technology support. These functions include costs for items such as salaries and benefits and other personnel-related
costs, maintenance and supplies, professional fees for external legal, accounting, and other consulting services, and depreciation expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zYqQNQ3xCV7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_86C_zEsoVgjxUZrh" style="display: none"&gt;Emerging
growth company status&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an emerging growth company, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#x201c;JOBS Act&#x201d;). Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to
comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934,
as amended (the &#x201c;Exchange Act&#x201d;)) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has not elected to opt out of such extended transition
period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK1ZhnNCN3aa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zW7YQkl7K4D5"&gt;Accounting
Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU No. 2023-09, &lt;i&gt;Improvements to Income Tax Disclosures (Topic 740)&lt;/i&gt; (&#x201c;ASU 2023-09&#x201d;).
ASU 2023-09 requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional
information on income taxes paid. ASU 2023-09 is effective on a prospective basis for annual periods beginning after December 15, 2024.
Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. The Company
is currently evaluating the impact of adopting ASU 2023-09.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): &lt;i&gt;Improvements to Reportable Segment Disclosures&lt;/i&gt;, which
is intended to provide enhancements to segment disclosures, even for entities with only one reportable segment. In particular, the standard
will require disclosures of significant segment expenses regularly provided to the chief operating decision maker and included within
each reported measure of segment profit and loss. The standard will also require disclosure of all other segment items by reportable
segment and a description of its composition. Finally, the standard will require disclosure of the title and position of the chief operating
decision maker and an explanation of how the chief operating decision maker uses the reported measure(s) of segment profit or loss in
assessing segment performance and deciding how to allocate resources. The standard is effective for annual periods beginning after December
15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently
evaluating the impact of the standard on the presentation of its consolidated financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_zZpd1abxoVL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zkTd0xEMhp11"&gt;Recently
adopted accounting pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU No. 2016-13, &lt;i&gt;Financial Instruments - Credit Losses&lt;/i&gt;, &#x201c;Topic 326&#x201d;, an amendment on measurement
of credit losses on financial assets held by at each reporting date. The guidance requires the use of a new current expected credit loss
(&#x201c;CECL&#x201d;) model in estimating allowances for doubtful accounts with respect to accounts receivable. The CECL model requires
that the Company estimate its lifetime expected credit loss with respect to these receivables and record allowances that, when deducted
from the balance of the receivables, represent the estimated net amounts expected to be collected. Effective January 1, 2023, the Company
adopted ASU No. 2016-13 and the adoption of this standard did not have a material impact on the Company&#x2019;s consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU No. 2022-03, &lt;i&gt;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions &lt;/i&gt;(&#x201c;ASU
2022-03&#x201d;), which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit
of account of the equity security and, therefore, is not considered in measuring fair value. ASU 2022-03 is effective for public business
entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. The Company adopted
ASU No. 2022-03 and the adoption of this standard did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p id="xdx_854_z0kpDrFoQhHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact002041">&lt;p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zV1XxAmYpNw2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_z66TBxyppqMl"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#x201c;GAAP&#x201d;). The accompanying consolidated financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements include the accounts of OneMedNet Corporation, formerly Data Knights, and its wholly-owned
subsidiary, OneMedNet Technologies Canada Ltd. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <ONMD:RestatementToFinancialStatementsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact002043">&lt;p id="xdx_84E_ecustom--RestatementToFinancialStatementsPolicyTextBlock_zlfs5i9HvsA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zF84H1NjBDH9"&gt;Restatement
to Previously Issued Consolidated Financial Statements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s consolidated financial statements for the years ended December 31, 2023 and 2022, as previously filed with the SEC on
April 9, 2024, have been restated. The previously filed consolidated financial statements did not reflect the proper accounting for the
business combination transaction, convertible notes, warrants, preferred stock, stock-based compensation expense, and accounts payable
and accrued expenses. The Company has also restated related amounts within the accompanying footnotes to the consolidated financial statements
to conform to the restated amounts in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following consolidated financial statements provide a reconciliation from the originally &#x201c;as reported&#x201d; financial information
to the now &#x201c;as restated&#x201d; consolidated financial information as of and for the years ended December 31, 2023 and 2022 (in
thousands, except share and per share data).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zQobtUlY9Fg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zmqNIyggURV3"&gt;Schedule
of Restatement of Financial Statements&lt;/span&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--StatementOfFinancialPositionAbstract_pn3n3_zHB7otDeIImb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheet (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zruyu53jUhca" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zcfTKFbd2jqd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zCrqV71XHMwj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zseXWl5ARgmk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (&lt;span id="xdx_F56_zoHeAO3yRzkb"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z3fZH6OQ10X3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zXmzyt8ADHpc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACznbB_zwfJYNAqd4h2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AssetsHeldInTrustCurrent_i02I_zQhwodfyf5vd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Investments held in trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2064"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2066"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2067"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACznbB_zhZl1KSXxike" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts receivable, net of allowance for credit losses of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zPo9iq8qLwpk" title="Accounts receivable, allowance"&gt;0&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zMIhH9k6HRqe" title="Accounts receivable, allowance"&gt;125,233&lt;/span&gt; at December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2070"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2071"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACznbB_zUCqDZwvR8h1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2080"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACznbB_maAzRE3_zWVgddrEhU8f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left"&gt;Total current assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;365&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2084"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2085"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;365&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredCostsNonCurrent_i01I_pn3n3_maAzRE3_zadfKDc4WIPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred transaction costs&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2089"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2091"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzRE3_zG9krXgkbKe1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2095"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Assets_i01TI_pn3n3_mtAzRE3_zRG9OArPib89" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zq1I6hLyExog" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Liabilities, temporary equity and stockholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbZJCma4btqj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zssMDVKCKb27" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;498&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zNPcfhGy81Dl" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z5EoFfgXn103" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan amount due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2121"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ExciseTaxCurrent_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_zoHwN3FbTAHf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Excise tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredRevenueCurrent_i02I_pn3n3_maLCzjPj_zgTzWhgM5q78" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2129"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2130"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zqzqEDRPdHVe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2133"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2134"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2135"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2136"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LoanExtensionsCurrent_i02I_pn3n3_maLCzjPj_zxQs4dQZsJhi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan extensions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2139"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LoansPayable_i02I_pn3n3_maLCzjPj_z4rAes4v5eLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2146"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--CanadaEmergencyBusinessLoanAct_i02I_pn3n3_maLCzjPj_zh8sEs0vfagg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2149"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2151"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccruedIncomeTaxesCurrent_i02I_pn3n3_maLCzjPj_zMZx9uIWYCb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(120&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_pn3n3_maLCzjPj_zBTLDRUX27Ba" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_pn3n3_maLCzjPj_zjmSYJKQeNEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;PIPE notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2165"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z70r7UPIkBw8" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zxhw1hbC8X8d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_z7XLQgC9gMPe" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2173"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2174"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2176"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzjPj_maLzhoA_zUAVIkx4mgr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Total current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;585&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,373&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleDebtNoncurrent_i01I_pn3n3_maLzhoA_zXYxZv4wnbE2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2183"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_z0sV3xK1qwE8" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2188"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2189"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2191"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_z3W70HCcYUcf" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_pn3n3_maLzhoA_zWCkZbDgLii7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loan, related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2200"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_z3TrqGM1swRk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2204"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2205"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2206"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WorkingCapitalLoan_i01I_maLzhoA_znG3RD0bmoD8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2208"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2209"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2210"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2211"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--WarrantLiabilityNonCurrent_i01I_pn3n3_maLzhoA_zvrWCZOR9MLe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2214"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(25&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2216"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLzhoA_zzAZ5vz1nGW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other long-term liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zdVxtDBJ0vy4" style="padding-bottom: 1pt; text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Liabilities_i01TI_pn3n3_mtLzhoA_maLASEzB9f_zWurd1Dcwf66" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13,323&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;583&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2225"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13,906&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_maLASEzB9f_zriAse0CJx5e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Commitments and contingencies (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2229"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2230"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--TemporaryEquityAbstract_i01B_zCjF4hRjdSM9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Temporary equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxCEJ7wpVb28" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Series A-2, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zcQDvHCATRy3" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmw2jLMPLdv3" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zk2kv65ICmXe" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8QQZwnKdLZf" title="Temporary equity, shares authorized"&gt;4,200,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zbwzb6ONsLgi" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBohDzYt6cuc" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zPYyjWP6t8nl" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zDpri74qdrj4" title="Temporary equity, shares outstanding"&gt;3,415,923&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2239"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2240"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2241"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zvgShIKHTHql" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Preferred Shares A-1, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUdnjUXJ4Nc1" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUBfnzNHxmQ7" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zD2AuNLE5jti" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYuIuwhSTul" title="Temporary equity, shares authorized"&gt;4,400,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zFfkQRyVN4Y8" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgXlLITRaRd" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z75ktmKy0962" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z5lkoDhcdVvc" title="Temporary equity, shares outstanding"&gt;2,839,957 &lt;/span&gt;&lt;/span&gt;shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2259"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2262"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEzB9f_zFJ3TKul93Da" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total temporary equity &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2280"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zWgvLMcwUEad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Stockholders&#x2019; (deficit) equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_pn3n3_maSEzYAb_zDP929DLJBcj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zTouxWv5xMNj" title="Preferred stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zoAhJQ97gzT" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zY9mbTXbyWjg" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zaAG4dvCdMGb" title="Preferred stock, shares authorized"&gt;0&lt;/span&gt; shares authorized at December 31, 2023 and 2022, respectively; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zeXWFKcteVZa" title="Preferred stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zFLSOBzdiIYi" title="Preferred stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2RDRUICTuA3" title="Preferred stock, shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zF0OtUHrvAid" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares issued and outstanding at December 31, 2023 and 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2290"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2293"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzYAb_zKclxpQQ1fc5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Common Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zO8f1W2CvHd1" title="Common stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z0fgb54GPpF7" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z87XB46c1rqk" title="Common stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zlJ0WFifrcwj" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt;&lt;/span&gt; shares authorized and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z37TR95QhdKj" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zhQfhe7EP9Z4" title="Common stock, shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zD5XPgF0KCAh" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zOrvrjW3oymd" title="Common stock, shares outstanding"&gt;4,033,170&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2313"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pn3n3_maSEzYAb_zr99liLi1UOj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,775&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77,996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zsHwSQ1sDr3" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pn3n3_maSEzYAb_zaNz42WzTBF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(55,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(36,357&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2339"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(91,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zKvHtgqXejJk" style="padding-bottom: 1pt; text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzYAb_maLASEzB9f_zPwz0JsddSC7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total stockholders&#x2019; deficit &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(13,442&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzB9f_zgvnToSh7PEc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, temporary equity, and stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2348"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2349"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0A_zxpPh2kj3NLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zv3t0HiTxmkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F01_zHmIIEvFd8Ne" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zQ2Kprb6wXq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_z45MNyUdVjC3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_z1BUgtO53Nk2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F01_zI0DPexFF7Xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1D_z8uJZPF6GN1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of liability-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0C_zzIQLbw8bWJj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zWvic4rLmBCb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F09_zfMaYzeUq0yi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_z9pixMR8yD4a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ivgJzJjlvk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBNy3rflnLOh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zDVc23ZbTal1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F5B_z2orGC7gqCVd"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20221231_zyrQoTWDbpmg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zoHhxMUlwOn3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zylrCrVigph8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zklWvSmRU3hg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;302&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;271&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zWiYZ0g0Crw7" style="width: 6%; text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AssetsHeldInTrustCurrent_i02I_z5i7O4J0zNh9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Investments held in trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2376"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zlMEbFIQFeXl" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_z91VCg6KuhUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts receivable, net of allowance of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zXowDYdGPzGi" title="Accounts receivable, allowance"&gt;0&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zIJD7O8FvRM6" title="Accounts receivable, allowance"&gt;125,233&lt;/span&gt; at December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2380"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zQeyB686mQ62" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;101&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2388"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;101&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtACznbB_maAzRE3_zeC41by6Wz69" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left"&gt;Total current assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;29,451&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(29,060&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2394"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;391&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredCostsNonCurrent_i02I_maAzRE3_zjz3cdl7FRTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred transaction costs&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;900&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(85&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;815&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zugrWwR5FxFg" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAzRE3_zbYTPH2Futm7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2404"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Assets_iTI_mtAzRE3_zuFdBSWVj8ce" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(29,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2409"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3idIMSAttVf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Liabilities, temporary equity and stockholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfMGnFVZHtZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzjPj_zlbUKNPQwEya" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,637&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z1PDq4D8k1bg" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherLiabilities_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z387LtueELU9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan amount due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2430"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zSY0KCHBsjBj" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_maLCzjPj_z9JdmARHcJg6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2433"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2434"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zIdFD76ACDwf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,253&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,743&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zHBwRYiaiQg5" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzjPj_zd0KrYwUO0fh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2444"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2445"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zPc4odgOaoCa" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_zvh30x1dLpB5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2449"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2450"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zT5OAzrQZl5f" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzALC_maLzDXj_zJod9ww4Wxj7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Total current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,785&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,104&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzhoA_zIHuzIhaWiC5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_zfKNTjGJYna2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2463"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(44&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2465"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_zGr6iAAo4DVb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(691&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2470"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zWbk5Oymcxfk" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--WarrantLiabilityNonCurrent_i01I_maLzhoA_zGpl8dgESeb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;363&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(363&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2474"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2475"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zoFnY3Hr2jo6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_zmTEozCqcKo5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,025&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2480"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zy1llbxdPwRd" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--WorkingCapitalLoan_i01I_maLzhoA_zCJ6wwyiyxX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(207&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2485"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zy8mdZVEYor6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LongTermLoansPayable_i01I_maLzhoA_zLbIae4ITDb1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Extension loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2489"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2490"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zj7IDgjpWd1b" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzhoA_zTmH1HjVwx28" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other long-term liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2492"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2493"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtLzhoA_maLASEzB9f_zJPu33kIRNI8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;21,161&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;6,488&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2499"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;27,648&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzB9f_z4bET9jAmas6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Commitments and contingencies (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2505"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--TemporaryEquityAbstract_i01B_zChswc4s12K1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Temporary equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zCNQhtB5sb38" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Series A-2, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMglAdrlMTt5" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8CjB97Kyrk8" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zuhtwF938LQ" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zvZjuO1dS995" title="Temporary equity, shares authorized"&gt;4,200,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span title="Preferred stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zYta6rHV0Uib" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zacGgWoOstM" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_ziGtk3V4nsb6" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zOLOUQaIz6v7" title="Temporary equity, shares outstanding"&gt;3,415,923&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_z50ydQvD68Td" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgG0PJuk8Sdf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Preferred Shares A-1, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUXcga9S2JVd" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYCHWXEzs9ai" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zcQRvID0AXgg" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zQOdJGerQ3jb" title="Temporary equity, shares authorized"&gt;4,400,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zg3c3qDYeBj" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Aai5K2fUv4" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrtw0CUjcqna" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMctTmHlLhfa" title="Temporary equity, shares outstanding"&gt;2,839,957&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2533"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_z0vVaUYkTlw9" style="text-align: center; padding-bottom: 1pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_zQNtilKUcrb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
temporary equity &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2554"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zlBYW8gmYu2d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Stockholders&#x2019; (deficit) equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CommonStockValue_i02I_maSEzYAb_zc9TdGIsqNa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Common Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z5EF10mnZfIg" title="Common stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZset6MUT9Se" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zQcjfsQlc3r3" title="Common stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zDDZaWxqSTr5" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt;&lt;/span&gt; shares authorized and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zzH2BT9iwqQ4" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z24UGTu0EBAg" title="Common stock, shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zr2XpGWsvCs3" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zFaCWuPdJL7b" title="Common stock, shares outstanding"&gt;4,033,170&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2566"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzYAb_z6yOhGiOFPc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2587"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zejDbpADROE9" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzYAb_ze7UyEDUJZR1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2592"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzYAb_maLASEzB9f_zq9LusNyoTo7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzB9f_zQ7TyynSymYi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, temporary equity, and stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(29,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zQQ25kVU5LG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1D_zcom1f3JbKv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F08_zxRpE7ddi9se" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_zqdJW85EC7P9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zaUqYTsXpy75" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F17_z12r7OJ9cdv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F0D_zkzbOYh5KVrc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1E_z0YDHGimDoYl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zhrofTMKWeul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1C_zGaauYyovNfl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F07_zg7mY89UOBh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_zu9Mge4cdMl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting for historical preferred stock as temporary equity.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F09_zjbye4RasFl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F17_zTscRma7hil8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zwkFbooRqn5b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Operations (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaXGkJXpTCe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z028oDaLxcnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z40LEykJTRCe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F50_zZzgLezQkhG9"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zi0ZRYIKnBM3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zfQPdTtBiee3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zHeJfx3Vozbg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subscription revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2620"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2621"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zPcMCXCGZPc9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Web imaging revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2626"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHDo_z9waVkSQPWO7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left"&gt;Total revenue&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,021&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2630"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2631"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,021&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHDo_z6GMLbvVfSac" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2635"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHDo_znNyLw8scYyi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross margin&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2641"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zCYcQRN6Sc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zq3x0GU7zIea" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,730&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2651"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zE9FiJGZnz6l" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zDBuLJ2WlWs8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2655"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(226&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2657"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zryX8YnXH7Yc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2661"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zaz5jo1m1yvc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;433&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,065&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z9ClZTf3FKq8" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zJHTG9nQ0lGe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;8,247&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1,297&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(226&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,724&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zbQSvWT10ge1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss from operations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(8,376&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,523&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(6,853&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8jXu5rEIzza" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other expense (income), net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zIkUcqgVzEBc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Income tax provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2684"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2686"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2687"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AssetImpairmentCharges_i01_msNIEzJuG_zSWikkgtMta9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zMsz0tSF3PPe" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zy58V1qNXhb3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;749&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(738&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zUF6AddaOctl" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zj7QMQhvOLi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zPun54PZDMy8" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zpKYnI4UO24l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(47&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(82&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zXwujTSGCHxc" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEzbEL_zb5UH1P07sL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2711"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zQGlpsX4Pmdi" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zJEambHaPBre" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2716"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zzPTykfoVGAl" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zPo3ZpZ7XnEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2720"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zL4eFL1DWeh6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized gain or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2725"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2726"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2727"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_ziS6Q11zdOnd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,097&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,909&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zPKUMtZQ1iU6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;18&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(33,762&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zgynma3E0s1d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzord_zgVpHaAbAfT9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zgtaMKf18hbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per common share outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zfMorvUR0clk" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zpRU0cyDmo7b" title="Diluted net loss per common share outstanding"&gt;(0.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zmNg5vQC4Bo8" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zFkAcqHuTXUi" title="Diluted net loss per common share outstanding"&gt;(3.78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zJ0ZQpMQvn22" title="us-gaap:EarningsPerShareBasic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zVerDL4ZXGak" title="Diluted net loss per common share outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2762"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2764"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fOA_____zaBkgZhbjVei" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fOA_____zmwUHhQcSOc5" title="Diluted net loss per common share outstanding"&gt;(4.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average number of common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____z36ArBhqPUy6" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zErTzsc1irw3" title="Diluted weighted average number of common shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zoMuYwYXrcGa" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zyyYt7a033s" title="Diluted weighted average number of common shares outstanding"&gt;(16,488,164&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zsBYKMj5kk97" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zDQ3reWdjQE7" title="Basic weighted average number of common shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2778"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2780"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zt2ybXAaUhe8" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zDgEREjS19nb" title="Diluted weighted average number of common shares outstanding"&gt;7,084,068&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_z39dTMQ7aKS1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F13_zBDhOn7yGByb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0B_zkIyW9V6GaL5" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1F_z6pc3v68oqb6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F08_zbAjVkGiaN6h" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1A_zmaqyPMOauU5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zUiPPdP75J9g" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_z4AQVNJgwwje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zfMpc6kW3D1j" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_z30zalgt25Q7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_znmNTrFvBWK8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zqbSoM383NGc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F08_zTL2gO4Z7NK1" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z7OzvY6Ptmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zgGQG6V9gICj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_z2vSr1u7Bt34" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EPS
    impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAqyObC2l9kb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTj9bNOVZAOd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z7veP8m81sFd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F55_zM3RLW9AQV3j"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220101__20221231_z7s5h9N5psD8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zhSG1L632XDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zmHR78PheYDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subscription revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2801"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zfuzVjy0bBO5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Web imaging revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2806"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHNd_z3M7b4W4iwk4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left"&gt;Total revenue&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHNd_zp2gco9roem6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2815"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2816"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHNd_zq3yDkZbOD2e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross margin&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zMh80MASqE16" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zkvLEULoFTgd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,756&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,950&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zzjd3qehnLZi" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zBXkCMPrzTD7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(399&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zKEs7uT3IEsi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zoahsy8GI69d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;953&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;638&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2846"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,591&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_z2kghhNL2bcg" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zScGRpGXcBLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;11,066&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(3,312&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(399&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;7,355&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zwUEJLMn9Lq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss from operations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(11,426&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;399&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(7,715&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8Q9WxvWWZJc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other expense (income), net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zgoKVFgTyK7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Income tax provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2867"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F41_z6C8HsKy7cj1" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zXSimJByCVFj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(403&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2871"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2872"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zv3crlecuyh8" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zBEXfcaZ2Tnh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2874"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2876"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F41_zrwCVEVSOSW7" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zJsTq68EZYH2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2882"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z7PyhTCf4XM2" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zUXxZiut0JIl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2886"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zazMZoxkpDv6" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zplVkutO87u5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Other&lt;/p&gt;
                                                     &lt;p style="margin-top: 0; margin-bottom: 0"&gt;expense&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zKLZPn97d85g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized gain or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zxXsAtefuDHc" style="text-align: center; padding-bottom: 1pt"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_zck2r7mIQ1ua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;27,932&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,719&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zQQsZ98kFFhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;416&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(30,434&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zlXyhHrqYtG6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2910"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzord_zxSEeHKVrTTh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;399&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zLpq4rZCb2K3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per common share outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted net loss per common share outstanding"&gt;N/M&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zLdkHTcYaNcb" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zWqk08J9R21j" title="Diluted net loss per common share outstanding"&gt;(7.66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zALngv2ajKAa" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zmVC2juKldy3" title="Diluted net loss per common share outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2928"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fNg_____zr4Fpw3Z764f" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fNg_____z5J1Eds5vKJb" title="Diluted net loss per common share outstanding"&gt;(7.66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average number of common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted weighted average number of common shares outstanding"&gt;N/M&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zGauFJJaMMa2" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____z2m8eKFmBKdi" title="Diluted weighted average number of common shares outstanding"&gt;3,973,897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zupxhmAMKlB" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zAANc7O5PDva" title="Diluted weighted average number of common shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2940"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2942"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_fNg_____zI6r7ZgLzbhg" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_fNg_____zO0Kt17dPiZ3" title="Diluted weighted average number of common shares outstanding"&gt;3,973,897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F02_zMW0yTCrPjCc" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zOXZ2WhRJaBb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zElkDXBk5h94" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F19_zodThWHzZ69i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0D_zTdonRR7Nadi" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F13_znclEY6Lw4te" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_z8AAMabERG51" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_z8S0HYfft0v8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0C_zwrpnNPz4BW2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_ztJ1mOOHa1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F05_z08xFT13J7Uf" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F12_zpWOpJCTLxQ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EPS
    impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Cash Flows for the Year Ended December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_zRnKaIw7jdjk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYZd2yEkwFr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zr7cwzqut9Ii" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zBcdhZk85qA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGvm_z64DQItPSa96" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 47%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zw3VLV9eU38g" style="width: 6%; text-align: center"&gt;1&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzSqX_z1Siz3WmGyPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationCost_i02_maNCPBUzSqX_zKu7p8ybV0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Business combination cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(900&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zhSRmmNKghZj" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zIioh3o057C2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Cash held in trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2978"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zvkI2gMnv3K4" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzSqX_ztlKU4wKp3L" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2980"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F40_zuT4zzgsB7S7" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_z1LfWwh2ycDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2984"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zWhhCrOvLBH1" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--WarrantExpense_i02_msNCPBUz449_zroQluWiV8M5" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Board of director warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2989"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfWarrantLiabilities_i02N_di_zly6v0jfmvIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zLzzviNlbyti" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ChangeInFairValueOfPipeNotes_i02_maNCPBUz449_ztCqzYltXv2j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2996"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zBYtlwHGJs4a" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_z6Wa9gfFadpl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3000"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zUuACnxP3RHe" style="text-align: center"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--NoncashInterest_i02_maNCPBUz449_zRk5FKwAcIlj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-cash interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zX8QjC4r71w1" style="text-align: center"&gt;10&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zmyVVkwjHxCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Change in operating assets and liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_zkjFOQ06zN9g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3013"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zsMiljgIih9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(65&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(43&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_z8iICOZIL45l" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_zxkdC3Z1VQSe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,372&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(655&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zgbHqM25Rwih" style="text-align: center"&gt;2, 3, 9&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zS794PTHhJgg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_zKQni9fVV3Pf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Amount due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3028"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3029"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncreaseDecreaseInExerciseTaxLiability_i03_maNCPBUzSqX_zZPZkw6z6kg7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Excise tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zTpyxRxtxAA2" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncreaseDecreaseInExtensionLoan_i03_pp3d_maNCPBUzSqX_zSXrTBuq4qfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Extension loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zUlA1KyjgDe1" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zDM2jYf7zMT6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(70&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zqJtwPbubevg" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zhTXU4CWz6xj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(95&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zYqLLsaf7Lh1" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zirFCYKadrqb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zH1aXYrl5jG7" style="text-align: center; padding-bottom: 1pt"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zE1wO1c9Wxi5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(13,012&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,791&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zKOBqaEyKXva" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from investing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zYXgFU3g6oD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Purchases of property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zqHSZoyjrJ1l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkxDU18xN9nb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01_maNCPBUzy34_zJEOsi6pVYlc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payments of Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3072"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3073"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3074"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzGlA_zOdW1gnmqlp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of shareholder loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;454&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zaFdLfoupmci" style="text-align: center"&gt;10&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzGlA_zg5nyHeTYEI" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of PIPE notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_z7M2VCjCnc7k" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_z07juzthWC5b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock subject to redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3086"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_z3atOgujEQs4" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ProceedsFromDeferredUnderwritingFee_i01_maNCPBUzy34_z9DVkGtZLhz8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriting fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(500&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zGwrp2TfzbYk" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_zZ0dyaR3S7wd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(338&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zf9QU9Misnz9" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_zAYoX8b1m1Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zYzwxZ33MZH7" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zWwMIO92Lofd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3102"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zx7FQKfwoy5h" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzy34_zR6lDSHfT83b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds (repayment) from issuance of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,681&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zxaWnkX1BqN2" style="text-align: center"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zsP3rV8DUkjg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3109"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3110"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProceedsFromIssuanceOfSeriesA2PreferredStock_i01N_di_msNCPBUzy34_zDu7i4VAkpD1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3112"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zISOUvH1P1t6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z8WjtJFHZn59" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Business Combination costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F40_zyrejfqwdML3" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zfXYzRVj6q5a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,611&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_z8gBwTb88MTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left"&gt;Net decrease in cash and cash equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(255&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(224&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zW01Oi5i7WK7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash and cash equivalents at beginning of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zXFeWXa49hi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3133"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoOYkLkcKEY8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Supplemental disclosures of non-cash investing and financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CommonSharesIssuedToPreferredShareholders_i01_zL5AXy97jdhe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares issued to preferred shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zsN1AMyCjzzd" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zoPsrtyw1oY" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares related to convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zZAuoRZhbqq6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zK8SHJvpIxr8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares issued to Data Knights shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zurSmY3KUYv1" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F01_zhL240hE6k3b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z9dm4Vp0An6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zGGQ55l6kmh1" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zUeE55Ju80t3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0A_z4MZv7ZYiCC8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zI2WxXsdey6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zG13g7DRpeth" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1C_zYTXI3E04L3i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_zHRA8LZW1Ws9" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F11_zg5hJyL5Obpi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F01_zyqW1Xm1i1Kh" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_zrt2utkjYT66" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F0F_zIYCaCTFZ5G9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1B_zgD8LP6mENc7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0F_z7fNBeaoaagc" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1E_zTJJUc68HjP" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F05_zrYUaf70UVgf" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_z2QRlzGBbmY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zjJ3QhCQi3U6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F12_zWah1vcZocA8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper presentation of non-cash interest expense in financing activities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation of the
Original and Restated Statement of Cash Flows for the Year Ended December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd1GVUj81Op9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBhCw3tfNvi7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_ztK2LT4qQfpe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_pn3n3_zFzKoT6TF5kc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUz449_zhjXV3tvln2c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 47%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zjxT1FD9l7P" style="width: 6%; text-align: center"&gt;1&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_pn3n3_z0076fqc8VT5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DepreciationDepletionAndAmortization_i02_pn3n3_maNCPBUz449_zm9JPLeVIQE8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maNCPBUz449_z6Q7ZgrwjTL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zIJNrmfhBsRc" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zS5SB85M13E2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Cash held in trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,292&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z1NfzNBC5JKe" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_zC68WqLkgJX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_z6tBAOitcY1h" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantExpense_i02N_di_msNCPBUz449_zEuTdXmz78d8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Board of director warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zkBk4aNHnwei" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_zCUJBEmM2g0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zpczmZJibJ92" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zAzE1OfS3Mo7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Change in operating assets and liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_ztG0vsbqUXte" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zluTWoieg0s6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(876&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(59&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zNedHdvlJBW" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_z0I3mGes2Dxf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,929&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,514&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z37tNNq9Qes9" style="text-align: center"&gt;2, 7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zeDSeDuJMSm6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(458&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3215"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(458&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_z2GxU8Wb6ygk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Amount due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3220"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zSE3xgLclZB5" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--IncreaseDecreaseInExtensionLoan_i03_maNCPBUzSqX_zgskN7980aF2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Extension loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3224"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zmZ2D62zyLMe" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zyV7jFslgyRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(94&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3228"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zQybhbNoVMKf" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zL2rQVS8QfE" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zdRnntdJgKm" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zzuEL6o9ruce" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3236"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zNJP4fjQSaP9" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zJJhW4QBOtek" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;87,241&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(91,944&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,703&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zilVvTyW6epe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from investing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zNGRgLG7f9O3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Purchases of property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3247"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zjhR5EClnx7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3251"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zyvRblK7SBoe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01I_maNCPBUzy34_z2KX3jMiyK3i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payments of Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/M&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_zrfUrQmF8m43" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock subject to redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,550&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3264"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zA55vPOU2Hib" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_z9RjVyh6e9h6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3268"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z1Q1QdwsjcB" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_z6L0fxtNkTd5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3272"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zVJ0w3BVrU96" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zYdeays3yNz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zvYGPpCF8ALi" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzGlA_zxuSCkdEwgk1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,543&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(403&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zQ8Xe760x2r2" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zYGmsnBOP9B5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/M&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z3TyDWcTRTM6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Business Combination Costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3286"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zKeSKcvznUJk" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zwmIc6mhnd5e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(88,033&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;92,366&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zp4EyvM8G2Tg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net decrease in cash and cash equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(850&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;422&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(428&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDY2bKGDYzo7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash and cash equivalents at beginning of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,152&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(453&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;699&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zKczG8qKbiOc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zYSJMmCsa0ka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zLKRQx9dshs8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_z87rmpJn3ZB8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_zDRZS1dv1eOl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zxbQFNbtYzE9" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_z42bK2J0pX1f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_zAgkZCBqrDZc" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1A_zFDMqwcniOib" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_zCFiNFZCBLKj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F13_zrElvg95e3hb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zMeCuTCN8Un6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F17_z00H9AjztdPb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Improper
    presentation of Business Combination costs as well as errors identified related to capitalization of such costs. Refer to balance
    sheet restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#x2019; Deficit as of December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zbzwUQkL3AE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zd8vvcZGRvQ" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zK5CmsM1ZRH1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zqwRhzUrgNN" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zWLv2SAVVLB" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_zJ1EbxPqWHa2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-2&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-1&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Temporary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Additional&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Paid-in&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Stockholders&#x2019;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;As Previously Reported&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zkuypag4rQ83" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSbLFbtZqFHd" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlv5Cf5sOUO3" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3322"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1NbSqGrvhck" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8AgftvLtU5f" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3326"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUidXthwSV4a" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3328"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXBFGFyRKYs2" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;9,388,958&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXjcEC2yKbDd" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zww2RJZCA4ii" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTybYcahs77" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fMg_____z83jL5Bb2Imd" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3350"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3345"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3347"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3348"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM6gBXLBUoac" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKviQDmZq1Bf" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of stock options, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrI4xcsaTqM3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdXG50votS8i" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3364"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3365"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3367"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3368"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoFXc0EowaZ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3372"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3373"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3376"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqMk9V97gCEa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcyI1ubllCfe" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;612,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3378"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3381"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3isqa2ILvij" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0wDNGMku6F5" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;3,859,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3386"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB1ofR7bGO37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible loans upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCuKJG4XINv" style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;6,177,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3395"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3397"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjRLnI869rq7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWPCyxfSZ185" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4v1VSB6GRm4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOvsvOeYyLy8" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(3,853,797&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBDYBabeNKUb" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(3,204,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zp8TtqKLkxy6" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;7,057,797&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3415"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3417"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4R3JHuzW4d4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZtIFRsSvo14" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares"&gt;(2,257,326&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3426"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3427"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zImjAQyx1dl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3434"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3435"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3437"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgVEMYmeVYy3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHK8uetxWRNh" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;(1,266,560&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3440"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3441"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3443"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf5V5sZPtbyj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3448"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3451"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwO9nIUVQfV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3454"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3457"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqIeAYcOEJbg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3460"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3461"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5nNrvH7L1L9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcqEVw4aErc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3472"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3473"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z4K0kNmW97ad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (as previously reported)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjvqdYJmE8N2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0iPc6CFVON" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3486"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zy620ElYt97c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3488"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zz3W42bVrfFi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3490"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdbBjALrE3Gc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3492"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd0cvaM8AvNe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;23,572,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;42,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(55,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zLnYlZvsp0f9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zDAvoewh2ue2" style="border-bottom: Black 1pt solid; text-align: center"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zpxqTeO4I9oj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(437,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z3b6qXBzzlG9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zNnUY7L7xiFg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(364,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zHGmzmExCnHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zvzFm0ziawq9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z8CWxY9bZ134" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(5,355,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zygwwWmssSs5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zHj5CkaxLx3i" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z7bwirrTghH1" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;265,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3515"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3516"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3517"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3518"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhw8GZcbOHQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zCtEitmMNUb6" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zq0XsuIEjQvb" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;5,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zQsW2gSboNpd" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z1nHfpTejBah" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3523"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3524"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zsl433z8PvWb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F48_zTC0qdQyxOY2" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3534"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3537"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zRyPxcD6Gycd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zhV9klln87bd" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zAVkHqJQ1fb2" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;(69,614&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3541"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(613&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3543"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(613&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjBvsJuZkRNl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_zcH3UUXvIdIc" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zpIkisGK5jO4" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;(438,519&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3548"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3551"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zplLOy1ht2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_ziLCg9j2iOU2" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zRbYZNCGx08i" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(701,867&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3559"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zaAxdbDBbKxl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4A_z0OGPFi514ba" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zMlytimJOcF6" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;432,201&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zFcFkIPEa4kh" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(9,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____z9frGH3YO8Og" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zT27h15QDmob" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(8,010&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zbrxmPwclQl8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(17,660&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zITjZmoEl281" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(796,244&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3564"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3565"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGSxBeU5qafe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F43_zDEM3QbSe4Z8" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zD5Fu6pKoZ99" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares"&gt;2,257,326&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3582"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3583"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuatop1tYVa3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_zH7SDweyyBr1" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3590"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3591"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3593"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zu7klaV3kl0e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F41_zXvkqXSkdojg" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zQZ4FUPjak9f" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;4,838,792&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3596"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,683&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3599"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,683&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZcv5xa7e8kd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F45_zbh8HYc2n1da" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3604"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3606"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3607"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zqFv5qjxO3F8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4B_zPksoWAMCJv6" style="text-align: center"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3610"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3611"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(418&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3613"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(418&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z1PrgZqUBDwg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4B_zEpLKUsQUK54" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3616"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3617"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3618"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgO3DzksH894" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_zebKylsMKZnd" style="border-bottom: Black 1pt solid; text-align: center"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3623"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3624"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zEzrIG974kB6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (restatement adjustments)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3xQtxPEgetg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3634"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z0LbHAIAdUp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zWsGyytsoFY1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3638"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3dqYsKfeCd7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_ziLn7iNhwNub" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGiZyyb9ObIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3629"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;35,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(36,357&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;As Restated&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zCERd0BC8Edb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zi65lAIuLzI5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,415,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z6uXJ7vZHdjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zcrTCJ23Lc8h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;2,839,957&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zSIzwmTqxAae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zQlhYEki4WHj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zEa3Euv8yG7b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;4,033,170&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3646"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3647"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zRh9MNfOQbN6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zKhabU7B1IXj" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;265,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3664"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3665"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3667"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3668"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zhvp3TSV5JVc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zkKNCOHCGNYi" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;5,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zBl8PdJEW3Fg" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_ztPun9js0gHl" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zAmG6EO8ecvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3684"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3687"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zV9qXvnTf4X3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zof3JCdzGJy6" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;543,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3693"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3694"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zcMHotUSQHRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zeypJR6uOcGa" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;3,420,945&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3700"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3702"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zfItEKG9a5D5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z8Q793oFY6nc" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;5,475,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,936&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zg0xUHJQhupl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_ztPA7LA28WGd" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(3,421,596&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zM2ygMU7QyFk" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(9,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zFWUKYVBc9i5" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z91jAoZWsSK4" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(8,010&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zVxd72lcoUS8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(17,660&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z842Un0CdEeg" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;6,261,553&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3718"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z8QjpVGyUPod" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3732"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3733"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3734"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3735"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zVfX9LzWmXC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3738"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3741"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z4FQbGPN3q37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zGyfI7Nay6Tf" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;3,572,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3747"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zn28LbtLErUe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3755"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3756"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zPS9BXk3A5Q6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3759"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3761"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zoyWjR9ZfmX4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3765"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3766"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3768"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zpMrABjxHPM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3770"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3771"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zfRwOC5WxoLl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (as restated)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zA8QIoRKWpBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zrinSGD4zYy" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zTYsCn8TomIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zVYGhC0pQrw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zRQ4EtchBpk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zboRJOiguk2e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;23,572,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;77,996&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(91,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(13,442&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F06_zUiD7Qvo1dF5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zbiLSN0c8sW" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    impact of corrections of errors to the prior year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F03_zuwvJHWa9Qsc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zoyXhvCVdcj2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting and presentation of the recapitalization.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F00_zXFfXM0FUxdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_z8741aGRMBg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F03_zR4FwFBByqVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zyRwSInVDUs2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zlaXOkrERoi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_zG6TTXuWq7t7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F02_zXs8hJHKY1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F19_zUXZ0owxwFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#x2019; Deficit as of December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zW5uco0SMtSh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zrIdmjFOdate" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_ztCUO5HaRbVk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zhuYeBR4mRoh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_zkCvhsJ1MJPl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-2&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-1&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Temporary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Additional&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Paid-in&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Stockholders&#x2019;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrNm0ijsZPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAcgwhinqMD4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1T2qWsARIe4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3808"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuS7rvgTthDk" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAPwynqPG39e" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmIeWOsviLx8" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3814"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGS035o8Ql7d" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;7,802,941&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;19,607&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;(33,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;14,438&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuKXvvBVg7qa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcpL8pWl3lf2" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;1,378,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(534&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIWlWMbHJUOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9ML9jv2UZS3" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3826"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBYL9zVXKgk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNn9md3kQVj9" style="text-align: right" title="Exercise of stock options, shares"&gt;7,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3834"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvh2OxydzaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3842"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3843"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3844"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3845"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3846"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaiX9poMuPoh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3849"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3850"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3851"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3852"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5thZ2Xh2Hsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3854"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3857"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0tYj64RAV6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3861"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3862"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zobHW8vZbi64" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (as previously reported)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyvTNxCFGuE5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8vxe5cfXKMl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3874"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuu4od7drGh4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoiV8vo2EkS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3878"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNG5tnOqwZd3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3880"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfDbaFYqc7d1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;9,388,958&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Restatement Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zhDxKNCYKEJj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4F_zNoljWR8FXOg" style="border-bottom: Black 1pt solid; text-align: center"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zOiSKm9Y18M5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z4SX7bmLswU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zp50a3vBuuyc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3894"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zbwued2BiB6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zLCW3sTmfox5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z5j9fZFJU6s1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(3,460,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(17,094&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,711&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(21,490&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zmjfh2oZy4n5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_z4BL9SKw3H43" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zBqgxqtz2p6c" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(437,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zsXNpsNJNxp5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zkFrQeWMPwqe" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(1,871,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3902"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3903"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zUwl79ZHOcIi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F48_zLyF1icLyyY7" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zvEl2Uhodt9a" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;(22,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3914"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhK8jGiUmqO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4D_z3pfjJmavaVd" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zlNdzOClaP1i" style="text-align: right" title="Exercise of stock options, shares"&gt;(852&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3922"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3923"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3925"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_za9Aev5bcs01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4C_zGaE6XDWo0We" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3930"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3931"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z8hLbwNTPbb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F49_zCojnMZDTpW6" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3936"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3937"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3939"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zEVLrZSKq5Bl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4C_zae9qLTfo1K5" style="text-align: center"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3942"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3943"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3945"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zclWPo1aIwbe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_zBbAJaZMwUgg" style="border-bottom: Black 1pt solid; text-align: center"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3948"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3950"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zyYjTX0xhooj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (restatement adjustments)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgWvh1mNxHC1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(437,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zefDHoLOM7El" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuXimcaSYwmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(364,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVF3mcJLaYTc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVW6xo9eel76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zO8CGAdbB5Se" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(5,355,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrXFWLTIonP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_znrSJXtswFu1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zDWmfRBTLSv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9eknUZYUPk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zLWYelQ5MJg9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_zAD8l9lcw6Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zEbjcWBfmguh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;4,342,666&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3972"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3973"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(27,209&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(7,052&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zGTdqTNBZigd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zMytJlaMvyi5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(437,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zjkVEXnj5cM" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zS3jYyKzBF04" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(493,420&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3991"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3993"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3994"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zcFGLAmG0cU9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_z0wnuWNESsub" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;177,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4002"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4003"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4005"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4006"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zHMgzJLqZJb6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zajonvshXIY2" style="text-align: right" title="Exercise of stock options, shares"&gt;6,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4010"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4011"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4013"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTnAIjQZ5aT8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4018"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4019"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4021"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_z8tAwixWGQHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4027"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zaJ6OskwPPY7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4031"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zmUgeFgH4gy" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4036"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z6eucAVAQpA4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (as restated)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zW5wCE0trGKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,415,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zIKJ6AxaTxh8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_z3lPg63tnHJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;2,839,957&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zcL2aOMXs0D5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_ztospgNmuhO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9vePJiASM6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;4,033,170&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0F_zGF24QwsV3Ke" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F1A_zGlRskPx0Ma4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    impact of corrections of errors to the prior year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zGSobA1i1T6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F11_zodBNv0iJGqk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting and presentation of the recapitalization.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F0D_zsNEl2u7LGlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F11_zbg3ir20cxef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zrPYGRKo8Joa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F10_zerEnUYVHRTd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of error related to identificatoin and recognition of board of director warrante expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zDtv9dtOoYMi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F19_zFz7iviKaa8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F05_zMr7Ef6oH2v7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F1E_zuS5qUnBBoP6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zpvQ5rh7nhV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zYjKwepWsD0e"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the accounts of the Company, including its subsidiaries. All intercompany accounts and transactions
have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--UseOfEstimates_zr2hwzXh7qd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z3i8w8qiCyLh"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in these notes to the consolidated
financial statements. Actual results and outcomes may differ materially from management&#x2019;s estimates, judgments, and assumptions.
Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to
revenue such as determining the nature and timing of the satisfaction of performance obligations, allowances for accounts receivable,
useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and stock-based compensation.
Estimates are periodically reviewed in light of changes in circumstances, facts, and experience.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--OperatingSegmentsPolicyTextBlock_zgianBikxImj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zRjKMzLPlLFc"&gt;Operating
Segments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial
information is regularly evaluated by the chief operating decision maker (&#x201c;CODM&#x201d;), which is the Company&#x2019;s Chief Executive
Officer, in deciding how to allocate resources and assess performance. The Company&#x2019;s CODM evaluates the Company&#x2019;s financial
information and resources and assesses the performance of these resources on a consolidated basis. The Company is not organized by market
and is managed and operated as one business. A single management team that reports to the chief executive officer comprehensively manages
the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and
does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial
segment information can be found in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgvoIrAOYflg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zrYd84kCcMGb"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents
consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC insured
limits. The Company believes that, as of December 31, 2023 and 2022, its risk relating to deposits exceeding federally insured limits
was not significant. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s
financial condition, results of operations, and cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zdRDjIpsIbS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zvZhFGQmgyM1"&gt;Accounts
Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable is unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable is considered past due if not
paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections
have been exhausted. The Company determines the need for an allowance for credit losses based upon factors surrounding the credit risk
of specific customers, historical trends and other information. As of December 31, 2023 and 2022, the Company established allowances
for credit losses of $&lt;span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zStClmmHs8Z4" title="Accounts receivable"&gt;0&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_z8w2bWI5XRIf" title="Accounts receivable"&gt;0.1&lt;/span&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not
require collateral from its customers and generally requires payment from 0 to 90 days from the invoice date. For the year ended December
31, 2023, there was 1 customer that accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zrvQn5txl485" title="Percentage of revenue"&gt;10&lt;/span&gt;% or more of total revenue, and there were 2 customers that accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z3ByJ3wUEWOf" title="Percentage of revenue"&gt;10&lt;/span&gt;% or
more of total revenue for the year ended December 31, 2022. The following table represents these customers&#x2019; aggregate percent of
total revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_ztBzoaioJk74" style="display: none"&gt;Schedule
of Aggregate Percentage Revenue and Accounts Receivable&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, three customers accounted for more than &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance, and four customers
accounted for over &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#x2019; aggregate percent of total accounts receivable:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 4&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 5&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 6&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 7&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of total accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate Percent of Revenue and Accounts Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zqJD9t4ymDAb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</ONMD:RestatementToFinancialStatementsPolicyTextBlock>
    <us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock contextRef="From2023-01-012023-12-31" id="Fact002045">&lt;p id="xdx_893_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zQobtUlY9Fg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zmqNIyggURV3"&gt;Schedule
of Restatement of Financial Statements&lt;/span&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--StatementOfFinancialPositionAbstract_pn3n3_zHB7otDeIImb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheet (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zruyu53jUhca" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zcfTKFbd2jqd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zCrqV71XHMwj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zseXWl5ARgmk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (&lt;span id="xdx_F56_zoHeAO3yRzkb"&gt;1&lt;/span&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z3fZH6OQ10X3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zXmzyt8ADHpc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACznbB_zwfJYNAqd4h2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;47&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AssetsHeldInTrustCurrent_i02I_zQhwodfyf5vd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Investments held in trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2064"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2066"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2067"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACznbB_zhZl1KSXxike" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts receivable, net of allowance for credit losses of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zPo9iq8qLwpk" title="Accounts receivable, allowance"&gt;0&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zMIhH9k6HRqe" title="Accounts receivable, allowance"&gt;125,233&lt;/span&gt; at December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2070"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2071"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACznbB_zUCqDZwvR8h1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2079"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2080"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;166&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACznbB_maAzRE3_zWVgddrEhU8f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left"&gt;Total current assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;365&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2084"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2085"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;365&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredCostsNonCurrent_i01I_pn3n3_maAzRE3_zadfKDc4WIPc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred transaction costs&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2089"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2091"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzRE3_zG9krXgkbKe1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2095"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Assets_i01TI_pn3n3_mtAzRE3_zRG9OArPib89" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2099"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2100"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zq1I6hLyExog" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Liabilities, temporary equity and stockholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbZJCma4btqj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zssMDVKCKb27" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;498&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,682&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zNPcfhGy81Dl" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z5EoFfgXn103" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan amount due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2121"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ExciseTaxCurrent_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_zoHwN3FbTAHf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Excise tax&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--DeferredRevenueCurrent_i02I_pn3n3_maLCzjPj_zgTzWhgM5q78" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2129"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2130"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;254&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zqzqEDRPdHVe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2133"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2134"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2135"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2136"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LoanExtensionsCurrent_i02I_pn3n3_maLCzjPj_zxQs4dQZsJhi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan extensions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2139"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LoansPayable_i02I_pn3n3_maLCzjPj_z4rAes4v5eLf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(39&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2146"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--CanadaEmergencyBusinessLoanAct_i02I_pn3n3_maLCzjPj_zh8sEs0vfagg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2149"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2151"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccruedIncomeTaxesCurrent_i02I_pn3n3_maLCzjPj_zMZx9uIWYCb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2154"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(120&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_pn3n3_maLCzjPj_zBTLDRUX27Ba" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_pn3n3_maLCzjPj_zjmSYJKQeNEf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;PIPE notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2165"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z70r7UPIkBw8" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zxhw1hbC8X8d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_z7XLQgC9gMPe" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2173"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2174"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2176"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzjPj_maLzhoA_zUAVIkx4mgr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Total current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;585&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(45&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,373&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleDebtNoncurrent_i01I_pn3n3_maLzhoA_zXYxZv4wnbE2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2183"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_z0sV3xK1qwE8" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2188"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2189"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2191"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_z3W70HCcYUcf" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_pn3n3_maLzhoA_zWCkZbDgLii7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loan, related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2200"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_z3TrqGM1swRk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2204"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2205"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2206"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--WorkingCapitalLoan_i01I_maLzhoA_znG3RD0bmoD8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2208"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2209"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2210"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2211"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--WarrantLiabilityNonCurrent_i01I_pn3n3_maLzhoA_zvrWCZOR9MLe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2214"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(25&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2216"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLzhoA_zzAZ5vz1nGW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other long-term liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zdVxtDBJ0vy4" style="padding-bottom: 1pt; text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--Liabilities_i01TI_pn3n3_mtLzhoA_maLASEzB9f_zWurd1Dcwf66" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13,323&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;583&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2225"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;13,906&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_maLASEzB9f_zriAse0CJx5e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Commitments and contingencies (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2229"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2230"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2231"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--TemporaryEquityAbstract_i01B_zCjF4hRjdSM9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Temporary equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxCEJ7wpVb28" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Series A-2, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zcQDvHCATRy3" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmw2jLMPLdv3" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zk2kv65ICmXe" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8QQZwnKdLZf" title="Temporary equity, shares authorized"&gt;4,200,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zbwzb6ONsLgi" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBohDzYt6cuc" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zPYyjWP6t8nl" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zDpri74qdrj4" title="Temporary equity, shares outstanding"&gt;3,415,923&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2239"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2240"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2241"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zvgShIKHTHql" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Preferred Shares A-1, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUdnjUXJ4Nc1" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUBfnzNHxmQ7" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zD2AuNLE5jti" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYuIuwhSTul" title="Temporary equity, shares authorized"&gt;4,400,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zFfkQRyVN4Y8" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgXlLITRaRd" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z75ktmKy0962" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z5lkoDhcdVvc" title="Temporary equity, shares outstanding"&gt;2,839,957 &lt;/span&gt;&lt;/span&gt;shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2259"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2262"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEzB9f_zFJ3TKul93Da" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total temporary equity &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2280"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2281"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zWgvLMcwUEad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Stockholders&#x2019; (deficit) equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_pn3n3_maSEzYAb_zDP929DLJBcj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zTouxWv5xMNj" title="Preferred stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zoAhJQ97gzT" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zY9mbTXbyWjg" title="Preferred stock, shares authorized"&gt;1,000,000&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zaAG4dvCdMGb" title="Preferred stock, shares authorized"&gt;0&lt;/span&gt; shares authorized at December 31, 2023 and 2022, respectively; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zeXWFKcteVZa" title="Preferred stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zFLSOBzdiIYi" title="Preferred stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2RDRUICTuA3" title="Preferred stock, shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zF0OtUHrvAid" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares issued and outstanding at December 31, 2023 and 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2290"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2293"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzYAb_zKclxpQQ1fc5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Common Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zO8f1W2CvHd1" title="Common stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z0fgb54GPpF7" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z87XB46c1rqk" title="Common stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zlJ0WFifrcwj" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt;&lt;/span&gt; shares authorized and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z37TR95QhdKj" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zhQfhe7EP9Z4" title="Common stock, shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zD5XPgF0KCAh" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zOrvrjW3oymd" title="Common stock, shares outstanding"&gt;4,033,170&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2313"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pn3n3_maSEzYAb_zr99liLi1UOj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35,775&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2334"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77,996&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zsHwSQ1sDr3" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pn3n3_maSEzYAb_zaNz42WzTBF6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(55,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(36,357&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2339"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(91,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zKvHtgqXejJk" style="padding-bottom: 1pt; text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzYAb_maLASEzB9f_zPwz0JsddSC7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total stockholders&#x2019; deficit &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(13,442&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzB9f_zgvnToSh7PEc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, temporary equity, and stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2348"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2349"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;464&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F0A_zxpPh2kj3NLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zv3t0HiTxmkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F01_zHmIIEvFd8Ne" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_zQ2Kprb6wXq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_z45MNyUdVjC3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_z1BUgtO53Nk2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F01_zI0DPexFF7Xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1D_z8uJZPF6GN1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of liability-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0C_zzIQLbw8bWJj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F11_zWvic4rLmBCb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F09_zfMaYzeUq0yi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_z9pixMR8yD4a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ivgJzJjlvk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBNy3rflnLOh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zDVc23ZbTal1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F5B_z2orGC7gqCVd"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20221231_zyrQoTWDbpmg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zoHhxMUlwOn3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zylrCrVigph8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zklWvSmRU3hg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;302&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;271&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zWiYZ0g0Crw7" style="width: 6%; text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AssetsHeldInTrustCurrent_i02I_z5i7O4J0zNh9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Investments held in trust&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2376"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zlMEbFIQFeXl" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_z91VCg6KuhUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts receivable, net of allowance of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zXowDYdGPzGi" title="Accounts receivable, allowance"&gt;0&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zIJD7O8FvRM6" title="Accounts receivable, allowance"&gt;125,233&lt;/span&gt; at December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2380"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zQeyB686mQ62" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;101&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2388"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;101&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtACznbB_maAzRE3_zeC41by6Wz69" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left"&gt;Total current assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;29,451&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(29,060&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2394"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;391&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeferredCostsNonCurrent_i02I_maAzRE3_zjz3cdl7FRTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred transaction costs&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;900&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(85&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;815&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zugrWwR5FxFg" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAzRE3_zbYTPH2Futm7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2404"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--Assets_iTI_mtAzRE3_zuFdBSWVj8ce" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total assets&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(29,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2409"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3idIMSAttVf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Liabilities, temporary equity and stockholders&#x2019; deficit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfMGnFVZHtZj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzjPj_zlbUKNPQwEya" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,814&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,637&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2424"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z1PDq4D8k1bg" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherLiabilities_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z387LtueELU9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Loan amount due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2430"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zSY0KCHBsjBj" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_maLCzjPj_z9JdmARHcJg6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2433"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2434"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;184&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zIdFD76ACDwf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,490&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,253&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,743&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zHBwRYiaiQg5" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzjPj_zd0KrYwUO0fh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2444"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2445"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zPc4odgOaoCa" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_zvh30x1dLpB5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2449"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2450"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zT5OAzrQZl5f" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzALC_maLzDXj_zJod9ww4Wxj7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Total current liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,785&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,319&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2454"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,104&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzhoA_zIHuzIhaWiC5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2458"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_zfKNTjGJYna2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2463"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(44&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2465"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_zGr6iAAo4DVb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;691&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(691&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2470"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zWbk5Oymcxfk" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--WarrantLiabilityNonCurrent_i01I_maLzhoA_zGpl8dgESeb6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;363&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(363&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2474"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2475"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zoFnY3Hr2jo6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_zmTEozCqcKo5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,025&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2480"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zy1llbxdPwRd" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--WorkingCapitalLoan_i01I_maLzhoA_zCJ6wwyiyxX8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(207&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2485"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zy8mdZVEYor6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LongTermLoansPayable_i01I_maLzhoA_zLbIae4ITDb1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Extension loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2489"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2490"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zj7IDgjpWd1b" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzhoA_zTmH1HjVwx28" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Other long-term liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2492"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2493"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtLzhoA_maLASEzB9f_zJPu33kIRNI8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left"&gt;Total liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;21,161&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;6,488&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2499"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;27,648&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzB9f_z4bET9jAmas6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Commitments and contingencies (Note 13)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2504"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2505"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--TemporaryEquityAbstract_i01B_zChswc4s12K1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Temporary equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zCNQhtB5sb38" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Preferred Series A-2, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMglAdrlMTt5" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8CjB97Kyrk8" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zuhtwF938LQ" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zvZjuO1dS995" title="Temporary equity, shares authorized"&gt;4,200,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span title="Preferred stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zYta6rHV0Uib" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zacGgWoOstM" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_ziGtk3V4nsb6" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zOLOUQaIz6v7" title="Temporary equity, shares outstanding"&gt;3,415,923&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_z50ydQvD68Td" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgG0PJuk8Sdf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; padding-bottom: 1pt"&gt;Preferred Shares A-1, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUXcga9S2JVd" title="Temporary equity, par value per share"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYCHWXEzs9ai" title="Temporary equity, par value per share"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zcQRvID0AXgg" title="Temporary equity, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zQOdJGerQ3jb" title="Temporary equity, shares authorized"&gt;4,400,000&lt;/span&gt;&lt;/span&gt; shares authorized, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zg3c3qDYeBj" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Aai5K2fUv4" title="Temporary equity, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrtw0CUjcqna" title="Temporary equity, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMctTmHlLhfa" title="Temporary equity, shares outstanding"&gt;2,839,957&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2533"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_z0vVaUYkTlw9" style="text-align: center; padding-bottom: 1pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_zQNtilKUcrb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Total
temporary equity &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2554"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,644&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zlBYW8gmYu2d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Stockholders&#x2019; (deficit) equity:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CommonStockValue_i02I_maSEzYAb_zc9TdGIsqNa6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Common Stock, par value $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z5EF10mnZfIg" title="Common stock, par value"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZset6MUT9Se" title="Common stock, par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt;, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zQcjfsQlc3r3" title="Common stock, shares authorized"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zDDZaWxqSTr5" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt;&lt;/span&gt; shares authorized and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zzH2BT9iwqQ4" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z24UGTu0EBAg" title="Common stock, shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt; and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zr2XpGWsvCs3" title="Common stock, shares issued"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zFaCWuPdJL7b" title="Common stock, shares outstanding"&gt;4,033,170&lt;/span&gt;&lt;/span&gt; shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2566"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzYAb_z6yOhGiOFPc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Additional paid-in-capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2587"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zejDbpADROE9" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzYAb_ze7UyEDUJZR1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Accumulated deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2592"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzYAb_maLASEzB9f_zq9LusNyoTo7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzB9f_zQ7TyynSymYi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, temporary equity, and stockholders&#x2019; deficit&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(29,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2602"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,289&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zQQ25kVU5LG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1D_zcom1f3JbKv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F08_zxRpE7ddi9se" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_zqdJW85EC7P9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zaUqYTsXpy75" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F17_z12r7OJ9cdv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F0D_zkzbOYh5KVrc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1E_z0YDHGimDoYl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zhrofTMKWeul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1C_zGaauYyovNfl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F07_zg7mY89UOBh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_zu9Mge4cdMl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting for historical preferred stock as temporary equity.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F09_zjbye4RasFl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F17_zTscRma7hil8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zwkFbooRqn5b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Operations (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaXGkJXpTCe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z028oDaLxcnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z40LEykJTRCe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F50_zZzgLezQkhG9"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zi0ZRYIKnBM3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zfQPdTtBiee3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zHeJfx3Vozbg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subscription revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2620"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2621"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;878&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zPcMCXCGZPc9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Web imaging revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2626"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHDo_z9waVkSQPWO7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left"&gt;Total revenue&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,021&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2630"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2631"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,021&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHDo_z6GMLbvVfSac" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2635"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHDo_znNyLw8scYyi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross margin&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2641"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zCYcQRN6Sc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zq3x0GU7zIea" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,730&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2651"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,544&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zE9FiJGZnz6l" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zDBuLJ2WlWs8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;226&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2655"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(226&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2657"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zryX8YnXH7Yc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2661"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,115&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zaz5jo1m1yvc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;433&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,065&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_z9ClZTf3FKq8" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zJHTG9nQ0lGe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;8,247&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1,297&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(226&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,724&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zbQSvWT10ge1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss from operations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(8,376&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,523&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(6,853&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8jXu5rEIzza" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other expense (income), net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zIkUcqgVzEBc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Income tax provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2684"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2686"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2687"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AssetImpairmentCharges_i01_msNIEzJuG_zSWikkgtMta9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Impairment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,504&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zMsz0tSF3PPe" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zy58V1qNXhb3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;749&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(738&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2696"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zUF6AddaOctl" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zj7QMQhvOLi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zPun54PZDMy8" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zpKYnI4UO24l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(47&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(82&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zXwujTSGCHxc" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEzbEL_zb5UH1P07sL2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2711"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zQGlpsX4Pmdi" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zJEambHaPBre" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2716"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zzPTykfoVGAl" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zPo3ZpZ7XnEe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other expense&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;52&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2720"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zL4eFL1DWeh6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized gain or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2725"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2726"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2727"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_ziS6Q11zdOnd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,097&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;26,909&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zPKUMtZQ1iU6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;18&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(33,762&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zgynma3E0s1d" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzord_zgVpHaAbAfT9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zgtaMKf18hbg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per common share outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zfMorvUR0clk" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zpRU0cyDmo7b" title="Diluted net loss per common share outstanding"&gt;(0.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zmNg5vQC4Bo8" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zFkAcqHuTXUi" title="Diluted net loss per common share outstanding"&gt;(3.78&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zJ0ZQpMQvn22" title="us-gaap:EarningsPerShareBasic"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zVerDL4ZXGak" title="Diluted net loss per common share outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2762"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2764"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fOA_____zaBkgZhbjVei" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fOA_____zmwUHhQcSOc5" title="Diluted net loss per common share outstanding"&gt;(4.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average number of common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____z36ArBhqPUy6" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zErTzsc1irw3" title="Diluted weighted average number of common shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zoMuYwYXrcGa" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zyyYt7a033s" title="Diluted weighted average number of common shares outstanding"&gt;(16,488,164&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zsBYKMj5kk97" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zDQ3reWdjQE7" title="Basic weighted average number of common shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2778"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2780"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zt2ybXAaUhe8" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zDgEREjS19nb" title="Diluted weighted average number of common shares outstanding"&gt;7,084,068&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F05_z39dTMQ7aKS1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F13_zBDhOn7yGByb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0B_zkIyW9V6GaL5" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1F_z6pc3v68oqb6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F08_zbAjVkGiaN6h" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1A_zmaqyPMOauU5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zUiPPdP75J9g" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_z4AQVNJgwwje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zfMpc6kW3D1j" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1C_z30zalgt25Q7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_znmNTrFvBWK8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zqbSoM383NGc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F08_zTL2gO4Z7NK1" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z7OzvY6Ptmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zgGQG6V9gICj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_z2vSr1u7Bt34" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EPS
    impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAqyObC2l9kb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTj9bNOVZAOd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z7veP8m81sFd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification
    Adjustments &lt;sup id="xdx_F55_zM3RLW9AQV3j"&gt;1&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20220101__20221231_z7s5h9N5psD8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reclassification Adjustments (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zhSG1L632XDa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zmHR78PheYDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 40%; text-align: left"&gt;Subscription revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2800"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2801"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;678&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 6%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zfuzVjy0bBO5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Web imaging revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2805"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2806"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHNd_z3M7b4W4iwk4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left"&gt;Total revenue&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2811"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHNd_zp2gco9roem6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2815"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2816"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHNd_zq3yDkZbOD2e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Gross margin&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,153&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(360&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zMh80MASqE16" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Operating expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zkvLEULoFTgd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;General and administrative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,756&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,950&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zzjd3qehnLZi" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zBXkCMPrzTD7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Operations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;399&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(399&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zKEs7uT3IEsi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales and marketing&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2840"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;958&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zoahsy8GI69d" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Research and development&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;953&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;638&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2846"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,591&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_z2kghhNL2bcg" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zScGRpGXcBLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Total operating expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;11,066&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(3,312&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(399&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;7,355&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zwUEJLMn9Lq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss from operations&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(11,426&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,711&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;399&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(7,715&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8Q9WxvWWZJc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Other expense (income), net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zgoKVFgTyK7k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Income tax provision&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2867"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F41_z6C8HsKy7cj1" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zXSimJByCVFj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(403&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2871"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2872"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zv3crlecuyh8" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zBEXfcaZ2Tnh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2874"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2876"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F41_zrwCVEVSOSW7" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zJsTq68EZYH2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2881"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2882"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z7PyhTCf4XM2" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zUXxZiut0JIl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2886"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zazMZoxkpDv6" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zplVkutO87u5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Other&lt;/p&gt;
                                                     &lt;p style="margin-top: 0; margin-bottom: 0"&gt;expense&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(17&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zKLZPn97d85g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Unrealized gain or loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zxXsAtefuDHc" style="text-align: center; padding-bottom: 1pt"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_zck2r7mIQ1ua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"&gt;Total other expense, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,196&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;27,932&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,719&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zQQsZ98kFFhi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;416&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(30,434&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zlXyhHrqYtG6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Income tax expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2910"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzord_zxSEeHKVrTTh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net loss&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;399&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zLpq4rZCb2K3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Earnings per share:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted net loss per common share outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted net loss per common share outstanding"&gt;N/M&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zLdkHTcYaNcb" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zWqk08J9R21j" title="Diluted net loss per common share outstanding"&gt;(7.66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zALngv2ajKAa" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zmVC2juKldy3" title="Diluted net loss per common share outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2928"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fNg_____zr4Fpw3Z764f" title="Basic net loss per common share outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fNg_____z5J1Eds5vKJb" title="Diluted net loss per common share outstanding"&gt;(7.66&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic and diluted weighted average number of common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted weighted average number of common shares outstanding"&gt;N/M&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zGauFJJaMMa2" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____z2m8eKFmBKdi" title="Diluted weighted average number of common shares outstanding"&gt;3,973,897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zupxhmAMKlB" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zAANc7O5PDva" title="Diluted weighted average number of common shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2940"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2942"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_fNg_____zI6r7ZgLzbhg" title="Basic weighted average number of common shares outstanding"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_fNg_____zO0Kt17dPiZ3" title="Diluted weighted average number of common shares outstanding"&gt;3,973,897&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 2.5pt"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F02_zMW0yTCrPjCc" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zOXZ2WhRJaBb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zElkDXBk5h94" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F19_zodThWHzZ69i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0D_zTdonRR7Nadi" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F13_znclEY6Lw4te" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_z8AAMabERG51" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_z8S0HYfft0v8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0C_zwrpnNPz4BW2" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_ztJ1mOOHa1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F05_z08xFT13J7Uf" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F12_zpWOpJCTLxQ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;EPS
    impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Cash Flows for the Year Ended December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_zRnKaIw7jdjk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYZd2yEkwFr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zr7cwzqut9Ii" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zBcdhZk85qA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2023&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGvm_z64DQItPSa96" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 47%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zw3VLV9eU38g" style="width: 6%; text-align: center"&gt;1&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzSqX_z1Siz3WmGyPa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--BusinessCombinationCost_i02_maNCPBUzSqX_zKu7p8ybV0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Business combination cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(900&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zhSRmmNKghZj" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zIioh3o057C2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Cash held in trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(29,029&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2978"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zvkI2gMnv3K4" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzSqX_ztlKU4wKp3L" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2980"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F40_zuT4zzgsB7S7" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_z1LfWwh2ycDa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2984"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zWhhCrOvLBH1" style="text-align: center"&gt;5&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--WarrantExpense_i02_msNCPBUz449_zroQluWiV8M5" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Board of director warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2989"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfWarrantLiabilities_i02N_di_zly6v0jfmvIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(129&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zLzzviNlbyti" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ChangeInFairValueOfPipeNotes_i02_maNCPBUz449_ztCqzYltXv2j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of PIPE Notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2996"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zBYtlwHGJs4a" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_z6Wa9gfFadpl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3000"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zUuACnxP3RHe" style="text-align: center"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--NoncashInterest_i02_maNCPBUz449_zRk5FKwAcIlj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Non-cash interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F42_zX8QjC4r71w1" style="text-align: center"&gt;10&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zmyVVkwjHxCk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Change in operating assets and liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_zkjFOQ06zN9g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3013"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(133&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zsMiljgIih9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(65&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(43&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_z8iICOZIL45l" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_zxkdC3Z1VQSe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,372&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(655&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zgbHqM25Rwih" style="text-align: center"&gt;2, 3, 9&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zS794PTHhJgg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_zKQni9fVV3Pf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Amount due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3028"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3029"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--IncreaseDecreaseInExerciseTaxLiability_i03_maNCPBUzSqX_zZPZkw6z6kg7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Excise tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;113&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(113&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4E_zTpyxRxtxAA2" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncreaseDecreaseInExtensionLoan_i03_pp3d_maNCPBUzSqX_zSXrTBuq4qfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Extension loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;446&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(446&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zUlA1KyjgDe1" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zDM2jYf7zMT6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(70&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zqJtwPbubevg" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zhTXU4CWz6xj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(95&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;95&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zYqLLsaf7Lh1" style="text-align: center"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zirFCYKadrqb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;168&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3050"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zH1aXYrl5jG7" style="text-align: center; padding-bottom: 1pt"&gt;2, 3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zE1wO1c9Wxi5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;8,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(13,012&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,791&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zKOBqaEyKXva" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from investing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zYXgFU3g6oD2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Purchases of property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3061"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zqHSZoyjrJ1l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3065"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkxDU18xN9nb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01_maNCPBUzy34_zJEOsi6pVYlc" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payments of Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3072"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3073"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3074"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzGlA_zOdW1gnmqlp1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of shareholder loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;454&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zaFdLfoupmci" style="text-align: center"&gt;10&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzGlA_zg5nyHeTYEI" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of PIPE notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(50&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_z7M2VCjCnc7k" style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_z07juzthWC5b" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock subject to redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3086"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_z3atOgujEQs4" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--ProceedsFromDeferredUnderwritingFee_i01_maNCPBUzy34_z9DVkGtZLhz8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriting fee&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(500&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zGwrp2TfzbYk" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_zZ0dyaR3S7wd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(338&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;338&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zf9QU9Misnz9" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_zAYoX8b1m1Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(18,189&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3098"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F49_zYzwxZ33MZH7" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zWwMIO92Lofd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3102"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zx7FQKfwoy5h" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzy34_zR6lDSHfT83b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds (repayment) from issuance of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,681&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,856&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zxaWnkX1BqN2" style="text-align: center"&gt;8&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zsP3rV8DUkjg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3109"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3110"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ProceedsFromIssuanceOfSeriesA2PreferredStock_i01N_di_msNCPBUzy34_zDu7i4VAkpD1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3112"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zISOUvH1P1t6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z8WjtJFHZn59" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Business Combination costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,534&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F40_zyrejfqwdML3" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zfXYzRVj6q5a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(8,432&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,611&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_z8gBwTb88MTj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left"&gt;Net decrease in cash and cash equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(255&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(224&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zW01Oi5i7WK7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash and cash equivalents at beginning of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zXFeWXa49hi3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3133"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;47&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoOYkLkcKEY8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Supplemental disclosures of non-cash investing and financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CommonSharesIssuedToPreferredShareholders_i01_zL5AXy97jdhe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares issued to preferred shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zsN1AMyCjzzd" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zoPsrtyw1oY" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares related to convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4F_zZAuoRZhbqq6" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zK8SHJvpIxr8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Common shares issued to Data Knights shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zurSmY3KUYv1" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F01_zhL240hE6k3b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_z9dm4Vp0An6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zGGQ55l6kmh1" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zUeE55Ju80t3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0A_z4MZv7ZYiCC8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F18_zI2WxXsdey6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F06_zG13g7DRpeth" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1C_zYTXI3E04L3i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_zHRA8LZW1Ws9" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F11_zg5hJyL5Obpi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F01_zyqW1Xm1i1Kh" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_zrt2utkjYT66" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F0F_zIYCaCTFZ5G9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1B_zgD8LP6mENc7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0F_z7fNBeaoaagc" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1E_zTJJUc68HjP" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F05_zrYUaf70UVgf" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_z2QRlzGBbmY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F00_zjJ3QhCQi3U6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F12_zWah1vcZocA8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper presentation of non-cash interest expense in financing activities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation of the
Original and Restated Statement of Cash Flows for the Year Ended December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd1GVUj81Op9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBhCw3tfNvi7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_ztK2LT4qQfpe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31, 2022&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As &lt;br/&gt; Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_pn3n3_zFzKoT6TF5kc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUz449_zhjXV3tvln2c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 47%; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_zjxT1FD9l7P" style="width: 6%; text-align: center"&gt;1&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_pn3n3_z0076fqc8VT5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Adjustments to reconcile net loss to net cash used in operating activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DepreciationDepletionAndAmortization_i02_pn3n3_maNCPBUz449_zm9JPLeVIQE8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maNCPBUz449_z6Q7ZgrwjTL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zIJNrmfhBsRc" style="text-align: center"&gt;3&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zS5SB85M13E2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Cash held in trust account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,292&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3184"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z1NfzNBC5JKe" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_zC68WqLkgJX6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_z6tBAOitcY1h" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantExpense_i02N_di_msNCPBUz449_zEuTdXmz78d8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Board of director warrant expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4A_zkBk4aNHnwei" style="text-align: center"&gt;4&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_zCUJBEmM2g0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3194"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zpczmZJibJ92" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zAzE1OfS3Mo7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left"&gt;Change in operating assets and liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_ztG0vsbqUXte" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3203"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;73&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zluTWoieg0s6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(876&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;817&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(59&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4B_zNedHdvlJBW" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_z0I3mGes2Dxf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,929&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,514&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;415&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z37tNNq9Qes9" style="text-align: center"&gt;2, 7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zeDSeDuJMSm6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Deferred revenues&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(458&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3215"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(458&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_z2GxU8Wb6ygk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Amount due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3220"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zSE3xgLclZB5" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--IncreaseDecreaseInExtensionLoan_i03_maNCPBUzSqX_zgskN7980aF2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Extension loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,546&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3224"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4C_zmZ2D62zyLMe" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zyV7jFslgyRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Franchise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(94&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;94&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3228"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F44_zQybhbNoVMKf" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zL2rQVS8QfE" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Income tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;215&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zdRnntdJgKm" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zzuEL6o9ruce" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 30pt; text-align: left"&gt;Working capital loan&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3236"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zNJP4fjQSaP9" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zJJhW4QBOtek" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in operating activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;87,241&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(91,944&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,703&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zilVvTyW6epe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from investing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zNGRgLG7f9O3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Purchases of property and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3247"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zjhR5EClnx7a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash used in investing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3251"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(58&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zyvRblK7SBoe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Cash flows from financing activities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01I_maNCPBUzy34_z2KX3jMiyK3i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payments of Canada Emergency Business Loan Act&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/M&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_zrfUrQmF8m43" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock subject to redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(88,550&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,550&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3264"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F45_zA55vPOU2Hib" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_z9RjVyh6e9h6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3268"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F4D_z1Q1QdwsjcB" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_z6L0fxtNkTd5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additional paid-in capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3272"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F46_zVJ0w3BVrU96" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zYdeays3yNz7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3276"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F47_zvYGPpCF8ALi" style="text-align: center"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzGlA_zxuSCkdEwgk1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from issuance of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,543&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(403&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F48_zQ8Xe760x2r2" style="text-align: center"&gt;6&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zYGmsnBOP9B5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Proceeds from exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;N/M&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z3TyDWcTRTM6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Business Combination Costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3286"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_F43_zKeSKcvznUJk" style="text-align: center; padding-bottom: 1pt"&gt;2&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zwmIc6mhnd5e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net cash provided by financing activities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(88,033&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;92,366&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zp4EyvM8G2Tg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt"&gt;Net decrease in cash and cash equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(850&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;422&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(428&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDY2bKGDYzo7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Cash and cash equivalents at beginning of year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,152&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(453&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;699&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zKczG8qKbiOc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Cash and cash equivalents at end of year&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;302&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F00_zYSJMmCsa0ka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zLKRQx9dshs8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_z87rmpJn3ZB8" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F15_zDRZS1dv1eOl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zxbQFNbtYzE9" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F10_z42bK2J0pX1f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F04_zAgkZCBqrDZc" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F1A_zFDMqwcniOib" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F0E_zCFiNFZCBLKj" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F13_zrElvg95e3hb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_F07_zMeCuTCN8Un6" style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F17_z00H9AjztdPb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Improper
    presentation of Business Combination costs as well as errors identified related to capitalization of such costs. Refer to balance
    sheet restatement reconciliation for more information.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#x2019; Deficit as of December 31, 2023&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zbzwUQkL3AE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zd8vvcZGRvQ" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zK5CmsM1ZRH1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zqwRhzUrgNN" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zWLv2SAVVLB" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_zJ1EbxPqWHa2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-2&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-1&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Temporary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Additional&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Paid-in&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Stockholders&#x2019;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;As Previously Reported&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zkuypag4rQ83" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSbLFbtZqFHd" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlv5Cf5sOUO3" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3322"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1NbSqGrvhck" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8AgftvLtU5f" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3326"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUidXthwSV4a" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3328"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXBFGFyRKYs2" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;9,388,958&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXjcEC2yKbDd" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zww2RJZCA4ii" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTybYcahs77" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fMg_____z83jL5Bb2Imd" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3350"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3344"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3345"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3347"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3348"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM6gBXLBUoac" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKviQDmZq1Bf" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of stock options, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrI4xcsaTqM3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdXG50votS8i" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3370"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3364"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3365"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3367"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3368"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoFXc0EowaZ4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3372"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3373"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3376"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqMk9V97gCEa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcyI1ubllCfe" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;612,670&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3378"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3381"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3isqa2ILvij" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0wDNGMku6F5" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;3,859,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3386"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB1ofR7bGO37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible loans upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCuKJG4XINv" style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;6,177,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3395"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,177&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3397"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjRLnI869rq7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWPCyxfSZ185" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination, shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4v1VSB6GRm4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOvsvOeYyLy8" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(3,853,797&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBDYBabeNKUb" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(3,204,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zp8TtqKLkxy6" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;7,057,797&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3415"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3417"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4R3JHuzW4d4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZtIFRsSvo14" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares"&gt;(2,257,326&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3426"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3427"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3429"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zImjAQyx1dl4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3434"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3435"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3437"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgVEMYmeVYy3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHK8uetxWRNh" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;(1,266,560&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3440"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3441"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3443"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf5V5sZPtbyj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3448"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3451"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwO9nIUVQfV2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3454"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3457"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,893&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqIeAYcOEJbg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3460"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3461"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5nNrvH7L1L9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcqEVw4aErc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3472"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3473"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(23,206&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z4K0kNmW97ad" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (as previously reported)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjvqdYJmE8N2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0iPc6CFVON" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3486"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zy620ElYt97c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3488"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zz3W42bVrfFi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3490"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdbBjALrE3Gc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3492"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd0cvaM8AvNe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;23,572,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;42,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(55,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Restatement Adjustments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zLnYlZvsp0f9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zDAvoewh2ue2" style="border-bottom: Black 1pt solid; text-align: center"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zpxqTeO4I9oj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(437,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z3b6qXBzzlG9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zNnUY7L7xiFg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(364,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zHGmzmExCnHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zvzFm0ziawq9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z8CWxY9bZ134" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(5,355,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zygwwWmssSs5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zHj5CkaxLx3i" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z7bwirrTghH1" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;265,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3515"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3516"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3517"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3518"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhw8GZcbOHQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zCtEitmMNUb6" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zq0XsuIEjQvb" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;5,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zQsW2gSboNpd" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z1nHfpTejBah" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3523"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3524"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zsl433z8PvWb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F48_zTC0qdQyxOY2" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3534"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3537"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zRyPxcD6Gycd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F40_zhV9klln87bd" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zAVkHqJQ1fb2" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;(69,614&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3541"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(613&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3543"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(613&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjBvsJuZkRNl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_zcH3UUXvIdIc" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zpIkisGK5jO4" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;(438,519&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3548"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3551"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,859&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zplLOy1ht2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_ziLCg9j2iOU2" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zRbYZNCGx08i" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;(701,867&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3559"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zaAxdbDBbKxl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4A_z0OGPFi514ba" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zMlytimJOcF6" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;432,201&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zFcFkIPEa4kh" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(9,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____z9frGH3YO8Og" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zT27h15QDmob" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(8,010&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zbrxmPwclQl8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(17,660&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zITjZmoEl281" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(796,244&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3564"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3565"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,602&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(7,058&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGSxBeU5qafe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F43_zDEM3QbSe4Z8" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zD5Fu6pKoZ99" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares"&gt;2,257,326&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3582"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3583"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuatop1tYVa3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_zH7SDweyyBr1" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3590"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3591"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3593"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(101&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zu7klaV3kl0e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F41_zXvkqXSkdojg" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zQZ4FUPjak9f" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;4,838,792&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3596"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,683&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3599"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,683&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZcv5xa7e8kd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F45_zbh8HYc2n1da" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3604"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3606"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3607"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zqFv5qjxO3F8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4B_zPksoWAMCJv6" style="text-align: center"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3610"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3611"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(418&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3613"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(418&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z1PrgZqUBDwg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4B_zEpLKUsQUK54" style="text-align: center"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3616"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3617"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3618"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,633&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgO3DzksH894" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4E_zebKylsMKZnd" style="border-bottom: Black 1pt solid; text-align: center"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3623"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3624"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(10,574&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zEzrIG974kB6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (restatement adjustments)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3xQtxPEgetg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3634"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z0LbHAIAdUp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zWsGyytsoFY1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3638"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3dqYsKfeCd7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_ziLn7iNhwNub" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGiZyyb9ObIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3629"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;35,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(36,357&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(583&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;As Restated&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zCERd0BC8Edb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zi65lAIuLzI5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,415,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z6uXJ7vZHdjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zcrTCJ23Lc8h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;2,839,957&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zSIzwmTqxAae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zQlhYEki4WHj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zEa3Euv8yG7b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;4,033,170&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3646"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3647"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zRh9MNfOQbN6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zKhabU7B1IXj" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;265,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3664"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3665"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3666"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3667"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3668"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zhvp3TSV5JVc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Series A-2 Preferred Stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zkKNCOHCGNYi" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"&gt;5,673&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zBl8PdJEW3Fg" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_ztPun9js0gHl" style="text-align: right" title="Issuance of Series A-2 Preferred Stock"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zAmG6EO8ecvg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3684"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3685"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3687"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,207&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zV9qXvnTf4X3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN stock options upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zof3JCdzGJy6" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares"&gt;543,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3691"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3692"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3693"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3694"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zcMHotUSQHRe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Exercise of OMN warrants upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zeypJR6uOcGa" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares"&gt;3,420,945&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3699"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3700"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3701"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3702"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zfItEKG9a5D5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Conversion of OMN convertible promissory notes upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z8Q793oFY6nc" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares"&gt;5,475,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,935&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;47,936&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zg0xUHJQhupl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Conversion of preferred stock to common stock upon Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_ztPA7LA28WGd" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(3,421,596&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zM2ygMU7QyFk" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(9,650&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zFWUKYVBc9i5" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;(2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z91jAoZWsSK4" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(8,010&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zVxd72lcoUS8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination"&gt;(17,660&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z842Un0CdEeg" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares"&gt;6,261,553&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3718"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z8QjpVGyUPod" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Private OneMedNet to ONMD Public Shares&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3732"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3733"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3734"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3735"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zVfX9LzWmXC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3738"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3739"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3741"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3742"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z4FQbGPN3q37" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zGyfI7Nay6Tf" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares"&gt;3,572,232&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3747"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zn28LbtLErUe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Common stock redemption&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3754"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3755"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3756"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zPS9BXk3A5Q6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3758"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3759"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3761"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zoyWjR9ZfmX4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retained earnings adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3764"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3765"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3766"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3767"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3768"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zpMrABjxHPM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3770"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3771"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3772"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,780&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zfRwOC5WxoLl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2023 (as restated)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zA8QIoRKWpBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3782"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zrinSGD4zYy" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zTYsCn8TomIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zVYGhC0pQrw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zRQ4EtchBpk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zboRJOiguk2e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;23,572,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3777"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;77,996&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(91,440&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(13,442&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span id="xdx_F06_zUiD7Qvo1dF5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zbiLSN0c8sW" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    impact of corrections of errors to the prior year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F03_zuwvJHWa9Qsc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F15_zoyXhvCVdcj2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting and presentation of the recapitalization.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F00_zXFfXM0FUxdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1A_z8741aGRMBg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F03_zR4FwFBByqVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F10_zyRwSInVDUs2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F04_zlaXOkrERoi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1B_zG6TTXuWq7t7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F02_zXs8hJHKY1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F19_zUXZ0owxwFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#x2019; Deficit as of December 31, 2022&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zW5uco0SMtSh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zrIdmjFOdate" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_ztCUO5HaRbVk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zhuYeBR4mRoh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_zkCvhsJ1MJPl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-2&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;Series A-1&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Temporary&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Additional&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Equity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Common Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Paid-in&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Accumulated&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center"&gt;Stockholders&#x2019;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Ref.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Commitments&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Deficit&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;As Previously Reported&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrNm0ijsZPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 16%; font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAcgwhinqMD4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1T2qWsARIe4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3808"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuS7rvgTthDk" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAPwynqPG39e" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmIeWOsviLx8" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3814"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGS035o8Ql7d" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;7,802,941&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;19,607&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;(33,920&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right"&gt;14,438&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuKXvvBVg7qa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcpL8pWl3lf2" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;1,378,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3819"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(534&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIWlWMbHJUOc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9ML9jv2UZS3" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;200,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3826"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3829"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;200&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBYL9zVXKgk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNn9md3kQVj9" style="text-align: right" title="Exercise of stock options, shares"&gt;7,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3834"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvh2OxydzaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3842"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3843"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3844"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3845"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3846"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaiX9poMuPoh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3848"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3849"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3850"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3851"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3852"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5thZ2Xh2Hsj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3854"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3857"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,392&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0tYj64RAV6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3860"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3861"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3862"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,230&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zobHW8vZbi64" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (as previously reported)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyvTNxCFGuE5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8vxe5cfXKMl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3874"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuu4od7drGh4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoiV8vo2EkS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3878"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNG5tnOqwZd3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3880"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfDbaFYqc7d1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;9,388,958&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;24,032&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(43,510&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,273&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Restatement Adjustments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zhDxKNCYKEJj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4F_zNoljWR8FXOg" style="border-bottom: Black 1pt solid; text-align: center"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zOiSKm9Y18M5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3890"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z4SX7bmLswU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zp50a3vBuuyc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3894"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zbwued2BiB6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zLCW3sTmfox5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z5j9fZFJU6s1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;(3,460,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(17,094&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;6,711&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(21,490&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zmjfh2oZy4n5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_z4BL9SKw3H43" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zBqgxqtz2p6c" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(437,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zsXNpsNJNxp5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zkFrQeWMPwqe" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(1,871,937&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3902"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3903"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,360&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zUwl79ZHOcIi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F48_zLyF1icLyyY7" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zvEl2Uhodt9a" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;(22,724&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3914"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(200&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhK8jGiUmqO8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4D_z3pfjJmavaVd" style="text-align: center"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zlNdzOClaP1i" style="text-align: right" title="Exercise of stock options, shares"&gt;(852&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3922"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3923"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3925"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_za9Aev5bcs01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4C_zGaE6XDWo0We" style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3930"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3931"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z8hLbwNTPbb9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F49_zCojnMZDTpW6" style="text-align: center"&gt;4&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3936"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3937"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3939"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zEVLrZSKq5Bl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F4C_zae9qLTfo1K5" style="text-align: center"&gt;5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3942"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3943"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3945"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;473&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zclWPo1aIwbe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_F47_zBbAJaZMwUgg" style="border-bottom: Black 1pt solid; text-align: center"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3948"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3950"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(24,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zyYjTX0xhooj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (restatement adjustments)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgWvh1mNxHC1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(437,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zefDHoLOM7El" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuXimcaSYwmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(364,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVF3mcJLaYTc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVW6xo9eel76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zO8CGAdbB5Se" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;(5,355,788&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,750&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(10,375&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(14,150&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(35,632&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;As Restated&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrXFWLTIonP6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2021&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_znrSJXtswFu1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,853,797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zDWmfRBTLSv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9eknUZYUPk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;3,204,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zLWYelQ5MJg9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_zAD8l9lcw6Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zEbjcWBfmguh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"&gt;4,342,666&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3972"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3973"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;2,513&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(27,209&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(7,052&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zGTdqTNBZigd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retroactive application of recapitalization due to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zMytJlaMvyi5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(437,874&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zjkVEXnj5cM" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(364,043&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zS3jYyKzBF04" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares"&gt;(493,420&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3990"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3991"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3992"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3993"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3994"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zcFGLAmG0cU9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of common shares in exchange for services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_z0wnuWNESsub" style="text-align: right" title="Issuance of common shares in exchange for services, shares"&gt;177,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4002"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4003"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4005"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4006"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zHMgzJLqZJb6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise of stock options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zajonvshXIY2" style="text-align: right" title="Exercise of stock options, shares"&gt;6,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4010"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4011"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4013"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTnAIjQZ5aT8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants in conjunction with convertible promissory notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4018"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4019"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4021"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,073&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_z8tAwixWGQHh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of OMN warrants to board of directors&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4027"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,198&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zaJ6OskwPPY7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4030"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4031"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zmUgeFgH4gy" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net loss&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4036"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4037"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(30,451&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z6eucAVAQpA4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balances as of December 31, 2022 (as restated)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zW5wCE0trGKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;3,415,923&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zIKJ6AxaTxh8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;9,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_z3lPg63tnHJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;2,839,957&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zcL2aOMXs0D5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;8,010&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_ztospgNmuhO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"&gt;17,644&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9vePJiASM6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"&gt;4,033,170&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4042"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4043"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;13,657&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(57,660&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(26,359&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 0.25in; text-align: left"&gt;&lt;span id="xdx_F0F_zGF24QwsV3Ke" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F1A_zGlRskPx0Ma4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cumulative
    impact of corrections of errors to the prior year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zGSobA1i1T6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F11_zodBNv0iJGqk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to the accounting and presentation of the recapitalization.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F0D_zsNEl2u7LGlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F11_zbg3ir20cxef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to identification, classification and valuation of equity-classified warrants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zrPYGRKo8Joa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F10_zerEnUYVHRTd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of error related to identificatoin and recognition of board of director warrante expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F03_zDtv9dtOoYMi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"&gt;&lt;span id="xdx_F19_zFz7iviKaa8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Impact
    of errors related to improper valuation of stock compensation expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"&gt;&lt;span id="xdx_F05_zMr7Ef6oH2v7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"&gt;&lt;span id="xdx_F1E_zuS5qUnBBoP6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    year impact of corrections of errors to the consolidated statements of operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002059"
      unitRef="USD">47000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002062"
      unitRef="USD">47000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002074"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002076"
      unitRef="USD">125233000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002069"
      unitRef="USD">152000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002072"
      unitRef="USD">152000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002078"
      unitRef="USD">166000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002081"
      unitRef="USD">166000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002083"
      unitRef="USD">365000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002086"
      unitRef="USD">365000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002093"
      unitRef="USD">99000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002096"
      unitRef="USD">99000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002098"
      unitRef="USD">464000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002101"
      unitRef="USD">464000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002113"
      unitRef="USD">4184000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002114"
      unitRef="USD">498000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002116"
      unitRef="USD">4682000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember"
      decimals="-3"
      id="Fact002118"
      unitRef="USD">11000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember"
      decimals="-3"
      id="Fact002120"
      unitRef="USD">-11000</us-gaap:OtherLiabilities>
    <ONMD:ExciseTaxCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember"
      decimals="-3"
      id="Fact002123"
      unitRef="USD">113000</ONMD:ExciseTaxCurrent>
    <ONMD:ExciseTaxCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember_us-gaap_RelatedPartyMember"
      decimals="-3"
      id="Fact002125"
      unitRef="USD">-113000</ONMD:ExciseTaxCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002128"
      unitRef="USD">254000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002131"
      unitRef="USD">254000</us-gaap:DeferredRevenueCurrent>
    <ONMD:LoanExtensionsCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002138"
      unitRef="USD">2992000</ONMD:LoanExtensionsCurrent>
    <ONMD:LoanExtensionsCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002141"
      unitRef="USD">2992000</ONMD:LoanExtensionsCurrent>
    <us-gaap:LoansPayable
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002143"
      unitRef="USD">39000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002145"
      unitRef="USD">-39000</us-gaap:LoansPayable>
    <ONMD:CanadaEmergencyBusinessLoanAct
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002148"
      unitRef="USD">45000</ONMD:CanadaEmergencyBusinessLoanAct>
    <ONMD:CanadaEmergencyBusinessLoanAct
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002150"
      unitRef="USD">-45000</ONMD:CanadaEmergencyBusinessLoanAct>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002153"
      unitRef="USD">120000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002155"
      unitRef="USD">-120000</us-gaap:AccruedIncomeTaxesCurrent>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002158"
      unitRef="USD">3525000</ONMD:DeferredUnderwriterFeePayableCurrent>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002161"
      unitRef="USD">3525000</ONMD:DeferredUnderwriterFeePayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002163"
      unitRef="USD">1550000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002164"
      unitRef="USD">87000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002166"
      unitRef="USD">1637000</us-gaap:NotesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002170"
      unitRef="USD">283000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002171"
      unitRef="USD">283000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002178"
      unitRef="USD">12833000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002179"
      unitRef="USD">585000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002180"
      unitRef="USD">-45000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002181"
      unitRef="USD">13373000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002198"
      unitRef="USD">465000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002201"
      unitRef="USD">465000</us-gaap:LongTermLoansPayable>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002213"
      unitRef="USD">25000</ONMD:WarrantLiabilityNonCurrent>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002215"
      unitRef="USD">-25000</ONMD:WarrantLiabilityNonCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002219"
      unitRef="USD">-2000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002220"
      unitRef="USD">70000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002221"
      unitRef="USD">68000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002223"
      unitRef="USD">13323000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002224"
      unitRef="USD">583000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002226"
      unitRef="USD">13906000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002243"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002245"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002247"
      unitRef="Shares">4200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002249"
      unitRef="Shares">4200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002251"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002253"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002255"
      unitRef="Shares">3415923</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002257"
      unitRef="Shares">3415923</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002264"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002266"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002268"
      unitRef="Shares">4400000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002270"
      unitRef="Shares">4400000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002272"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002274"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002276"
      unitRef="Shares">2839957</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002278"
      unitRef="Shares">2839957</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002295"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002297"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002299"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002301"
      unitRef="Shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002303"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002305"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002307"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002309"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002316"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002318"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002320"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002322"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002324"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002326"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002328"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002330"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002311"
      unitRef="USD">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002312"
      unitRef="USD">-1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002314"
      unitRef="USD">2000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002332"
      unitRef="USD">42221000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002333"
      unitRef="USD">35775000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002335"
      unitRef="USD">77996000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002337"
      unitRef="USD">-55083000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002338"
      unitRef="USD">-36357000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002340"
      unitRef="USD">-91440000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002342"
      unitRef="USD">-12859000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002343"
      unitRef="USD">-583000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002345"
      unitRef="USD">-13442000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002347"
      unitRef="USD">464000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002350"
      unitRef="USD">464000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002368"
      unitRef="USD">302000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002369"
      unitRef="USD">-31000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002371"
      unitRef="USD">271000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002373"
      unitRef="USD">29029000</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:AssetsHeldInTrustCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002374"
      unitRef="USD">-29029000</us-gaap:AssetsHeldInTrustCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact002383"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002385"
      unitRef="USD">125233000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002378"
      unitRef="USD">19000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002381"
      unitRef="USD">19000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002387"
      unitRef="USD">101000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002390"
      unitRef="USD">101000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002392"
      unitRef="USD">29451000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002393"
      unitRef="USD">-29060000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002395"
      unitRef="USD">391000</us-gaap:AssetsCurrent>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002397"
      unitRef="USD">900000</ONMD:DeferredCostsNonCurrent>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002398"
      unitRef="USD">-85000</ONMD:DeferredCostsNonCurrent>
    <ONMD:DeferredCostsNonCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002400"
      unitRef="USD">815000</ONMD:DeferredCostsNonCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002402"
      unitRef="USD">83000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002405"
      unitRef="USD">83000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002407"
      unitRef="USD">30434000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002408"
      unitRef="USD">-29145000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002410"
      unitRef="USD">1289000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002422"
      unitRef="USD">2814000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002423"
      unitRef="USD">-1637000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002425"
      unitRef="USD">1177000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RelatedPartyMember"
      decimals="-3"
      id="Fact002427"
      unitRef="USD">12000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RelatedPartyMember"
      decimals="-3"
      id="Fact002428"
      unitRef="USD">-12000</us-gaap:OtherLiabilities>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002432"
      unitRef="USD">184000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002435"
      unitRef="USD">184000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002437"
      unitRef="USD">8490000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002438"
      unitRef="USD">16253000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002440"
      unitRef="USD">24743000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002442"
      unitRef="USD">215000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002443"
      unitRef="USD">-215000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002447"
      unitRef="USD">70000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002448"
      unitRef="USD">-70000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002452"
      unitRef="USD">11785000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002453"
      unitRef="USD">14319000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002455"
      unitRef="USD">26104000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002457"
      unitRef="USD">1500000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002460"
      unitRef="USD">1500000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002462"
      unitRef="USD">44000</us-gaap:UnsecuredDebtCurrent>
    <us-gaap:UnsecuredDebtCurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002464"
      unitRef="USD">-44000</us-gaap:UnsecuredDebtCurrent>
    <ONMD:AccruedInterestRelatedParty
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002467"
      unitRef="USD">691000</ONMD:AccruedInterestRelatedParty>
    <ONMD:AccruedInterestRelatedParty
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002468"
      unitRef="USD">-691000</ONMD:AccruedInterestRelatedParty>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002472"
      unitRef="USD">363000</ONMD:WarrantLiabilityNonCurrent>
    <ONMD:WarrantLiabilityNonCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002473"
      unitRef="USD">-363000</ONMD:WarrantLiabilityNonCurrent>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002477"
      unitRef="USD">4025000</ONMD:DeferredUnderwriterFeePayableNonCurrent>
    <ONMD:DeferredUnderwriterFeePayableNonCurrent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002478"
      unitRef="USD">-4025000</ONMD:DeferredUnderwriterFeePayableNonCurrent>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002482"
      unitRef="USD">207000</ONMD:WorkingCapitalLoan>
    <ONMD:WorkingCapitalLoan
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002483"
      unitRef="USD">-207000</ONMD:WorkingCapitalLoan>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002487"
      unitRef="USD">2546000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002488"
      unitRef="USD">-2546000</us-gaap:LongTermLoansPayable>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002494"
      unitRef="USD">44000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002495"
      unitRef="USD">44000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002497"
      unitRef="USD">21161000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002498"
      unitRef="USD">6488000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002500"
      unitRef="USD">27648000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002502"
      unitRef="USD">28750000</us-gaap:CommitmentsAndContingencies>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002503"
      unitRef="USD">-28750000</us-gaap:CommitmentsAndContingencies>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002517"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002519"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002521"
      unitRef="Shares">4200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002523"
      unitRef="Shares">4200000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002525"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002527"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002529"
      unitRef="Shares">3415923</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact002531"
      unitRef="Shares">3415923</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact002513"
      unitRef="USD">9634000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="-3"
      id="Fact002515"
      unitRef="USD">9634000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002538"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002540"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002542"
      unitRef="Shares">4400000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002544"
      unitRef="Shares">4400000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002546"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002548"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002550"
      unitRef="Shares">2839957</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact002552"
      unitRef="Shares">2839957</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact002534"
      unitRef="USD">8010000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="-3"
      id="Fact002536"
      unitRef="USD">8010000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002555"
      unitRef="USD">17644000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002557"
      unitRef="USD">17644000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002569"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002571"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002573"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002575"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002577"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002579"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002581"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002583"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002564"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002565"
      unitRef="USD">-1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002585"
      unitRef="USD">24032000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002586"
      unitRef="USD">-10375000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002588"
      unitRef="USD">13657000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002590"
      unitRef="USD">-43510000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002591"
      unitRef="USD">-14150000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002593"
      unitRef="USD">-57660000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002595"
      unitRef="USD">9273000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002596"
      unitRef="USD">-35632000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002598"
      unitRef="USD">-26359000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002600"
      unitRef="USD">30434000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002601"
      unitRef="USD">-29145000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact002603"
      unitRef="USD">1289000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact002619"
      unitRef="USD">878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact002622"
      unitRef="USD">878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact002624"
      unitRef="USD">143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact002627"
      unitRef="USD">143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002629"
      unitRef="USD">1021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002632"
      unitRef="USD">1021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002634"
      unitRef="USD">1150000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002637"
      unitRef="USD">1150000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002639"
      unitRef="USD">-129000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002642"
      unitRef="USD">-129000</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002649"
      unitRef="USD">5274000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002650"
      unitRef="USD">-1730000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002652"
      unitRef="USD">3544000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002654"
      unitRef="USD">226000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002656"
      unitRef="USD">-226000</us-gaap:OtherGeneralExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002659"
      unitRef="USD">1115000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002662"
      unitRef="USD">1115000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002664"
      unitRef="USD">1632000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002665"
      unitRef="USD">433000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002667"
      unitRef="USD">2065000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002669"
      unitRef="USD">8247000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002670"
      unitRef="USD">-1297000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002671"
      unitRef="USD">-226000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002672"
      unitRef="USD">6724000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002674"
      unitRef="USD">-8376000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002675"
      unitRef="USD">1523000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002677"
      unitRef="USD">-6853000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002689"
      unitRef="USD">10504000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002690"
      unitRef="USD">-10504000</us-gaap:AssetImpairmentCharges>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002694"
      unitRef="USD">749000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002695"
      unitRef="USD">-738000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002697"
      unitRef="USD">11000</us-gaap:InterestExpenseNonoperating>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002699"
      unitRef="USD">3572000</ONMD:StockWarrantExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002700"
      unitRef="USD">5635000</ONMD:StockWarrantExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002702"
      unitRef="USD">9207000</ONMD:StockWarrantExpense>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002704"
      unitRef="USD">-47000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002705"
      unitRef="USD">-82000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002707"
      unitRef="USD">-129000</us-gaap:FairValueAdjustmentOfWarrants>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002710"
      unitRef="USD">269000</ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity>
    <ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002712"
      unitRef="USD">269000</ONMD:FairValueAdjustmentOfPrivateInvestmentInPublicEquity>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002715"
      unitRef="USD">-17517000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002717"
      unitRef="USD">-17517000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002719"
      unitRef="USD">-52000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002721"
      unitRef="USD">18000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002722"
      unitRef="USD">-34000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002729"
      unitRef="USD">-14830000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002730"
      unitRef="USD">-12097000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002731"
      unitRef="USD">18000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002732"
      unitRef="USD">-26909000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002734"
      unitRef="USD">-23206000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002735"
      unitRef="USD">-10574000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002736"
      unitRef="USD">18000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002737"
      unitRef="USD">-33762000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002741"
      unitRef="USD">18000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002742"
      unitRef="USD">18000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002744"
      unitRef="USD">-23206000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002745"
      unitRef="USD">-10574000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002747"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact002754"
      unitRef="USDPShares">-0.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact002756"
      unitRef="USDPShares">-0.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002758"
      unitRef="USDPShares">-3.78</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002760"
      unitRef="USDPShares">-3.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002766"
      unitRef="USDPShares">-4.77</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002768"
      unitRef="USDPShares">-4.77</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact002770"
      unitRef="Shares">23572232</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact002772"
      unitRef="Shares">23572232</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002774"
      unitRef="Shares">-16488164</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002776"
      unitRef="Shares">-16488164</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002782"
      unitRef="Shares">7084068</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002784"
      unitRef="Shares">7084068</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact002799"
      unitRef="USD">678000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_SubscriptionRevenueMember"
      decimals="-3"
      id="Fact002802"
      unitRef="USD">678000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact002804"
      unitRef="USD">475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_WebImagingRevenueMember"
      decimals="-3"
      id="Fact002807"
      unitRef="USD">475000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002809"
      unitRef="USD">1153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002810"
      unitRef="USD">1153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002812"
      unitRef="USD">1153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002814"
      unitRef="USD">1513000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002817"
      unitRef="USD">1513000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002819"
      unitRef="USD">-360000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002820"
      unitRef="USD">1153000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002822"
      unitRef="USD">-360000</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002829"
      unitRef="USD">8756000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002830"
      unitRef="USD">-3950000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002832"
      unitRef="USD">4806000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002834"
      unitRef="USD">399000</us-gaap:OtherGeneralExpense>
    <us-gaap:OtherGeneralExpense
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002836"
      unitRef="USD">-399000</us-gaap:OtherGeneralExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002839"
      unitRef="USD">958000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002842"
      unitRef="USD">958000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002844"
      unitRef="USD">953000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002845"
      unitRef="USD">638000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002847"
      unitRef="USD">1591000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002849"
      unitRef="USD">11066000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002850"
      unitRef="USD">-3312000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002851"
      unitRef="USD">-399000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002852"
      unitRef="USD">7355000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002854"
      unitRef="USD">-11426000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002855"
      unitRef="USD">3711000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002856"
      unitRef="USD">399000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002857"
      unitRef="USD">-7715000</us-gaap:OperatingIncomeLoss>
    <ONMD:IncomeTaxProvision
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002864"
      unitRef="USD">215000</ONMD:IncomeTaxProvision>
    <ONMD:IncomeTaxProvision
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002865"
      unitRef="USD">-215000</ONMD:IncomeTaxProvision>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002869"
      unitRef="USD">403000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002870"
      unitRef="USD">-403000</us-gaap:InterestExpenseNonoperating>
    <ONMD:StockWarrantExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002875"
      unitRef="USD">8073000</ONMD:StockWarrantExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002877"
      unitRef="USD">8073000</ONMD:StockWarrantExpense>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002879"
      unitRef="USD">-4489000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002880"
      unitRef="USD">4489000</us-gaap:FairValueAdjustmentOfWarrants>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002885"
      unitRef="USD">-14616000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002887"
      unitRef="USD">-14616000</ONMD:FairValueAdjustmentOfConvertiblePromissoryNotes>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002889"
      unitRef="USD">-47000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002891"
      unitRef="USD">17000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002892"
      unitRef="USD">-30000</us-gaap:OtherNonoperatingIncomeExpense>
    <ONMD:UnrealizedGainLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002894"
      unitRef="USD">1372000</ONMD:UnrealizedGainLoss>
    <ONMD:UnrealizedGainLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002895"
      unitRef="USD">-1372000</ONMD:UnrealizedGainLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002899"
      unitRef="USD">5196000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002900"
      unitRef="USD">-27932000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002901"
      unitRef="USD">17000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002902"
      unitRef="USD">-22719000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002904"
      unitRef="USD">-6230000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002905"
      unitRef="USD">-24221000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002906"
      unitRef="USD">416000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002907"
      unitRef="USD">-30434000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002911"
      unitRef="USD">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002912"
      unitRef="USD">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002914"
      unitRef="USD">-6230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002915"
      unitRef="USD">-24221000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_ReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002916"
      unitRef="USD">399000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact002917"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002924"
      unitRef="USDPShares">-7.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002926"
      unitRef="USDPShares">-7.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002932"
      unitRef="USDPShares">-7.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002934"
      unitRef="USDPShares">-7.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002936"
      unitRef="Shares">3973897</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact002938"
      unitRef="Shares">3973897</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002944"
      unitRef="Shares">3973897</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002946"
      unitRef="Shares">3973897</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002960"
      unitRef="USD">-23206000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002961"
      unitRef="USD">-10574000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002962"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002968"
      unitRef="USD">28000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002970"
      unitRef="USD">28000</us-gaap:DepreciationDepletionAndAmortization>
    <ONMD:BusinessCombinationCost
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002972"
      unitRef="USD">900000</ONMD:BusinessCombinationCost>
    <ONMD:BusinessCombinationCost
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002973"
      unitRef="USD">-900000</ONMD:BusinessCombinationCost>
    <ONMD:CashHeldInTrustAccount
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact002976"
      unitRef="USD">29029000</ONMD:CashHeldInTrustAccount>
    <ONMD:CashHeldInTrustAccount
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002977"
      unitRef="USD">-29029000</ONMD:CashHeldInTrustAccount>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002981"
      unitRef="USD">1475000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002982"
      unitRef="USD">1475000</us-gaap:ShareBasedCompensation>
    <ONMD:StockWarrantExpenses
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002985"
      unitRef="USD">9207000</ONMD:StockWarrantExpenses>
    <ONMD:StockWarrantExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002986"
      unitRef="USD">9207000</ONMD:StockWarrantExpenses>
    <ONMD:ChangeInFairValueOfWarrantLiabilities
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002993"
      unitRef="USD">129000</ONMD:ChangeInFairValueOfWarrantLiabilities>
    <ONMD:ChangeInFairValueOfWarrantLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002994"
      unitRef="USD">129000</ONMD:ChangeInFairValueOfWarrantLiabilities>
    <ONMD:ChangeInFairValueOfPipeNotes
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact002997"
      unitRef="USD">269000</ONMD:ChangeInFairValueOfPipeNotes>
    <ONMD:ChangeInFairValueOfPipeNotes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact002998"
      unitRef="USD">269000</ONMD:ChangeInFairValueOfPipeNotes>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003001"
      unitRef="USD">17517000</ONMD:ChangeInFairValueOfConvertiblePromissoryNotes>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003002"
      unitRef="USD">17517000</ONMD:ChangeInFairValueOfConvertiblePromissoryNotes>
    <ONMD:NoncashInterest
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003005"
      unitRef="USD">11000</ONMD:NoncashInterest>
    <ONMD:NoncashInterest
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003006"
      unitRef="USD">11000</ONMD:NoncashInterest>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003012"
      unitRef="USD">133000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003014"
      unitRef="USD">133000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003016"
      unitRef="USD">65000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003017"
      unitRef="USD">-22000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003018"
      unitRef="USD">43000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003020"
      unitRef="USD">1372000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003021"
      unitRef="USD">-655000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003022"
      unitRef="USD">717000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003024"
      unitRef="USD">70000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003026"
      unitRef="USD">70000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <ONMD:IncreaseDecreaseInExerciseTaxLiability
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003032"
      unitRef="USD">113000</ONMD:IncreaseDecreaseInExerciseTaxLiability>
    <ONMD:IncreaseDecreaseInExerciseTaxLiability
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003033"
      unitRef="USD">-113000</ONMD:IncreaseDecreaseInExerciseTaxLiability>
    <ONMD:IncreaseDecreaseInExtensionLoan
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="3"
      id="Fact003036"
      unitRef="USD">446</ONMD:IncreaseDecreaseInExtensionLoan>
    <ONMD:IncreaseDecreaseInExtensionLoan
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="3"
      id="Fact003037"
      unitRef="USD">-446</ONMD:IncreaseDecreaseInExtensionLoan>
    <ONMD:IncreaseDecreaseFranchiseTaxPayable
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003040"
      unitRef="USD">-70000</ONMD:IncreaseDecreaseFranchiseTaxPayable>
    <ONMD:IncreaseDecreaseFranchiseTaxPayable
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003041"
      unitRef="USD">70000</ONMD:IncreaseDecreaseFranchiseTaxPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003044"
      unitRef="USD">-95000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003045"
      unitRef="USD">95000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <ONMD:IncreaseDecreaseInWorkingCapitalLoan
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003048"
      unitRef="USD">-168000</ONMD:IncreaseDecreaseInWorkingCapitalLoan>
    <ONMD:IncreaseDecreaseInWorkingCapitalLoan
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003049"
      unitRef="USD">168000</ONMD:IncreaseDecreaseInWorkingCapitalLoan>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003052"
      unitRef="USD">8221000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003053"
      unitRef="USD">-13012000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003054"
      unitRef="USD">-4791000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003060"
      unitRef="USD">44000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003062"
      unitRef="USD">44000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003064"
      unitRef="USD">-44000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003066"
      unitRef="USD">-44000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003076"
      unitRef="USD">465000</ONMD:ProceedsFromIssuanceOfShareholderLoans>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003077"
      unitRef="USD">-11000</ONMD:ProceedsFromIssuanceOfShareholderLoans>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003078"
      unitRef="USD">454000</ONMD:ProceedsFromIssuanceOfShareholderLoans>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003080"
      unitRef="USD">1550000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003081"
      unitRef="USD">-50000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003082"
      unitRef="USD">1500000</us-gaap:ProceedsFromNotesPayable>
    <ONMD:ProceedsFromCommonStockSubjectToRedemption
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003084"
      unitRef="USD">-28750000</ONMD:ProceedsFromCommonStockSubjectToRedemption>
    <ONMD:ProceedsFromCommonStockSubjectToRedemption
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003085"
      unitRef="USD">28750000</ONMD:ProceedsFromCommonStockSubjectToRedemption>
    <ONMD:ProceedsFromDeferredUnderwritingFee
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003088"
      unitRef="USD">-500000</ONMD:ProceedsFromDeferredUnderwritingFee>
    <ONMD:ProceedsFromDeferredUnderwritingFee
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003089"
      unitRef="USD">500000</ONMD:ProceedsFromDeferredUnderwritingFee>
    <ONMD:ProceedsFromWarrantLiability
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003092"
      unitRef="USD">338000</ONMD:ProceedsFromWarrantLiability>
    <ONMD:ProceedsFromWarrantLiability
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003093"
      unitRef="USD">-338000</ONMD:ProceedsFromWarrantLiability>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003096"
      unitRef="USD">18189000</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003097"
      unitRef="USD">-18189000</us-gaap:ProceedsFromContributedCapital>
    <ONMD:ProccedsFromRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003100"
      unitRef="USD">11633000</ONMD:ProccedsFromRetainedEarningsAdjustment>
    <ONMD:ProccedsFromRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003101"
      unitRef="USD">-11633000</ONMD:ProccedsFromRetainedEarningsAdjustment>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003104"
      unitRef="USD">-10681000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003105"
      unitRef="USD">14856000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003106"
      unitRef="USD">4175000</us-gaap:ProceedsFromConvertibleDebt>
    <ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003113"
      unitRef="USD">-16000</ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock>
    <ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003114"
      unitRef="USD">-16000</ONMD:ProceedsFromIssuanceOfSeriesA2PreferredStock>
    <ONMD:BusinessCombinationCosts
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003117"
      unitRef="USD">1534000</ONMD:BusinessCombinationCosts>
    <ONMD:BusinessCombinationCosts
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003118"
      unitRef="USD">1534000</ONMD:BusinessCombinationCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003120"
      unitRef="USD">-8432000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003121"
      unitRef="USD">13043000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003122"
      unitRef="USD">4611000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003124"
      unitRef="USD">-255000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003125"
      unitRef="USD">31000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003126"
      unitRef="USD">-224000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003128"
      unitRef="USD">302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003129"
      unitRef="USD">-31000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003130"
      unitRef="USD">271000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003132"
      unitRef="USD">47000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact003134"
      unitRef="USD">47000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <ONMD:CommonSharesIssuedToPreferredShareholders
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003141"
      unitRef="USD">17659000</ONMD:CommonSharesIssuedToPreferredShareholders>
    <ONMD:CommonSharesIssuedToPreferredShareholders
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003142"
      unitRef="USD">17659000</ONMD:CommonSharesIssuedToPreferredShareholders>
    <ONMD:CommonSharesRelatedToConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003145"
      unitRef="USD">47935000</ONMD:CommonSharesRelatedToConvertiblePromissoryNotes>
    <ONMD:CommonSharesRelatedToConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003146"
      unitRef="USD">47935000</ONMD:CommonSharesRelatedToConvertiblePromissoryNotes>
    <ONMD:CommonSharesIssuedToDataKnightsShareholders
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003149"
      unitRef="USD">-11937000</ONMD:CommonSharesIssuedToDataKnightsShareholders>
    <ONMD:CommonSharesIssuedToDataKnightsShareholders
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact003150"
      unitRef="USD">-11937000</ONMD:CommonSharesIssuedToDataKnightsShareholders>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003166"
      unitRef="USD">-6230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003167"
      unitRef="USD">-24221000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003168"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003174"
      unitRef="USD">25000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003176"
      unitRef="USD">25000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003178"
      unitRef="USD">1600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003179"
      unitRef="USD">265000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003180"
      unitRef="USD">1865000</us-gaap:ShareBasedCompensation>
    <ONMD:CashHeldInTrustAccount
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003182"
      unitRef="USD">88292000</ONMD:CashHeldInTrustAccount>
    <ONMD:CashHeldInTrustAccount
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003183"
      unitRef="USD">-88292000</ONMD:CashHeldInTrustAccount>
    <ONMD:StockWarrantExpenses
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003187"
      unitRef="USD">8073000</ONMD:StockWarrantExpenses>
    <ONMD:StockWarrantExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003188"
      unitRef="USD">8073000</ONMD:StockWarrantExpenses>
    <ONMD:WarrantExpense
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003191"
      unitRef="USD">-1198000</ONMD:WarrantExpense>
    <ONMD:WarrantExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003192"
      unitRef="USD">-1198000</ONMD:WarrantExpense>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003195"
      unitRef="USD">14616000</ONMD:ChangeInFairValueOfConvertiblePromissoryNotes>
    <ONMD:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003196"
      unitRef="USD">14616000</ONMD:ChangeInFairValueOfConvertiblePromissoryNotes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003202"
      unitRef="USD">-73000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003204"
      unitRef="USD">-73000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003206"
      unitRef="USD">876000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003207"
      unitRef="USD">-817000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003208"
      unitRef="USD">59000</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003210"
      unitRef="USD">1929000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003211"
      unitRef="USD">-1514000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003212"
      unitRef="USD">415000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003214"
      unitRef="USD">-458000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003216"
      unitRef="USD">-458000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003218"
      unitRef="USD">12000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003219"
      unitRef="USD">-12000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <ONMD:IncreaseDecreaseInExtensionLoan
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003222"
      unitRef="USD">2546000</ONMD:IncreaseDecreaseInExtensionLoan>
    <ONMD:IncreaseDecreaseInExtensionLoan
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003223"
      unitRef="USD">-2546000</ONMD:IncreaseDecreaseInExtensionLoan>
    <ONMD:IncreaseDecreaseFranchiseTaxPayable
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003226"
      unitRef="USD">-94000</ONMD:IncreaseDecreaseFranchiseTaxPayable>
    <ONMD:IncreaseDecreaseFranchiseTaxPayable
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003227"
      unitRef="USD">94000</ONMD:IncreaseDecreaseFranchiseTaxPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003230"
      unitRef="USD">215000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003231"
      unitRef="USD">-215000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <ONMD:IncreaseDecreaseInWorkingCapitalLoan
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003234"
      unitRef="USD">207000</ONMD:IncreaseDecreaseInWorkingCapitalLoan>
    <ONMD:IncreaseDecreaseInWorkingCapitalLoan
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003235"
      unitRef="USD">-207000</ONMD:IncreaseDecreaseInWorkingCapitalLoan>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003238"
      unitRef="USD">87241000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003239"
      unitRef="USD">-91944000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003240"
      unitRef="USD">-4703000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003246"
      unitRef="USD">58000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003248"
      unitRef="USD">58000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003250"
      unitRef="USD">-58000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003252"
      unitRef="USD">-58000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003258"
      unitRef="USD">-3000</ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct>
    <ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003259"
      unitRef="USD">3000</ONMD:ProceedsFromCanadaEmergencyBusinessLoanAct>
    <ONMD:ProceedsFromCommonStockSubjectToRedemption
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003262"
      unitRef="USD">-88550000</ONMD:ProceedsFromCommonStockSubjectToRedemption>
    <ONMD:ProceedsFromCommonStockSubjectToRedemption
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003263"
      unitRef="USD">88550000</ONMD:ProceedsFromCommonStockSubjectToRedemption>
    <ONMD:ProceedsFromWarrantLiability
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003266"
      unitRef="USD">4489000</ONMD:ProceedsFromWarrantLiability>
    <ONMD:ProceedsFromWarrantLiability
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003267"
      unitRef="USD">-4489000</ONMD:ProceedsFromWarrantLiability>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003270"
      unitRef="USD">2826000</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003271"
      unitRef="USD">-2826000</us-gaap:ProceedsFromContributedCapital>
    <ONMD:ProccedsFromRetainedEarningsAdjustment
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003274"
      unitRef="USD">-3360000</ONMD:ProccedsFromRetainedEarningsAdjustment>
    <ONMD:ProccedsFromRetainedEarningsAdjustment
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003275"
      unitRef="USD">3360000</ONMD:ProccedsFromRetainedEarningsAdjustment>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003278"
      unitRef="USD">5543000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003279"
      unitRef="USD">-403000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003280"
      unitRef="USD">5140000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003283"
      unitRef="USD">8000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003284"
      unitRef="USD">8000</us-gaap:ProceedsFromStockOptionsExercised>
    <ONMD:BusinessCombinationCosts
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003287"
      unitRef="USD">815000</ONMD:BusinessCombinationCosts>
    <ONMD:BusinessCombinationCosts
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003288"
      unitRef="USD">815000</ONMD:BusinessCombinationCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003290"
      unitRef="USD">-88033000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003291"
      unitRef="USD">92366000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003292"
      unitRef="USD">4333000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003294"
      unitRef="USD">-850000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003295"
      unitRef="USD">422000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact003296"
      unitRef="USD">-428000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003298"
      unitRef="USD">1152000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003299"
      unitRef="USD">-453000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact003300"
      unitRef="USD">699000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003302"
      unitRef="USD">302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003303"
      unitRef="USD">-31000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact003304"
      unitRef="USD">271000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003320"
      unitRef="Shares">3853797</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003324"
      unitRef="Shares">3204000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003330"
      unitRef="Shares">9388958</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003314"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003315"
      unitRef="USD">28750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003316"
      unitRef="USD">24032000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003317"
      unitRef="USD">-43510000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003318"
      unitRef="USD">9273000</us-gaap:StockholdersEquity>
    <ONMD:StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003384"
      unitRef="Shares">612670</ONMD:StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003380"
      unitRef="USD">613000</ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003382"
      unitRef="USD">613000</ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003392"
      unitRef="Shares">3859464</ONMD:StockIssuedDuringPeriodSharesWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003388"
      unitRef="USD">3859000</ONMD:StockIssuedDuringPeriodValueWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003390"
      unitRef="USD">3859000</ONMD:StockIssuedDuringPeriodValueWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003400"
      unitRef="Shares">6177229</ONMD:StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003394"
      unitRef="USD">1000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003396"
      unitRef="USD">6177000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003398"
      unitRef="USD">6178000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003420"
      unitRef="Shares">-3853797</ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003422"
      unitRef="Shares">-3204000</ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003424"
      unitRef="Shares">7057797</ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003414"
      unitRef="USD">1000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003416"
      unitRef="USD">7057000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003418"
      unitRef="USD">7058000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003432"
      unitRef="Shares">-2257326</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003428"
      unitRef="USD">-2257000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003430"
      unitRef="USD">-2257000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003436"
      unitRef="USD">101000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003438"
      unitRef="USD">101000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003446"
      unitRef="Shares">-1266560</ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003442"
      unitRef="USD">746000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003444"
      unitRef="USD">746000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003449"
      unitRef="USD">-28750000</ONMD:CommonStockSubjectToPossibleRedemptionValue>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003452"
      unitRef="USD">-28750000</ONMD:CommonStockSubjectToPossibleRedemptionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003456"
      unitRef="USD">1893000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003458"
      unitRef="USD">1893000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003463"
      unitRef="USD">11633000</ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003464"
      unitRef="USD">11633000</ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003475"
      unitRef="USD">-23206000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003476"
      unitRef="USD">-23206000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003494"
      unitRef="Shares">23572232</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003478"
      unitRef="USD">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003480"
      unitRef="USD">42221000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003481"
      unitRef="USD">-55083000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003482"
      unitRef="USD">-12859000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003502"
      unitRef="Shares">-437874</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003504"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003506"
      unitRef="Shares">-364043</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003508"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003510"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003512"
      unitRef="Shares">-5355788</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003496"
      unitRef="USD">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003497"
      unitRef="USD">-28750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003498"
      unitRef="USD">-10375000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003499"
      unitRef="USD">-14150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003500"
      unitRef="USD">-35632000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003520"
      unitRef="Shares">265914</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003528"
      unitRef="Shares">5673</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003530"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003532"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003526"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003536"
      unitRef="USD">9207000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003538"
      unitRef="USD">9207000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <ONMD:StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003546"
      unitRef="Shares">-69614</ONMD:StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003542"
      unitRef="USD">-613000</ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003544"
      unitRef="USD">-613000</ONMD:StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003554"
      unitRef="Shares">-438519</ONMD:StockIssuedDuringPeriodSharesWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003550"
      unitRef="USD">-3859000</ONMD:StockIssuedDuringPeriodValueWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003552"
      unitRef="USD">-3859000</ONMD:StockIssuedDuringPeriodValueWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003562"
      unitRef="Shares">-701867</ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003558"
      unitRef="USD">41758000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003560"
      unitRef="USD">41758000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003570"
      unitRef="Shares">432201</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003572"
      unitRef="USD">-9650000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003574"
      unitRef="Shares">364043</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003576"
      unitRef="USD">-8010000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003578"
      unitRef="USD">-17660000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003580"
      unitRef="Shares">-796244</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003566"
      unitRef="USD">10602000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003568"
      unitRef="USD">-7058000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003588"
      unitRef="Shares">2257326</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003584"
      unitRef="USD">2257000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003586"
      unitRef="USD">2257000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003592"
      unitRef="USD">-101000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003594"
      unitRef="USD">-101000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003602"
      unitRef="Shares">4838792</ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003598"
      unitRef="USD">-12683000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003600"
      unitRef="USD">-12683000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003605"
      unitRef="USD">28750000</ONMD:CommonStockSubjectToPossibleRedemptionValue>
    <ONMD:CommonStockSubjectToPossibleRedemptionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003608"
      unitRef="USD">28750000</ONMD:CommonStockSubjectToPossibleRedemptionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003612"
      unitRef="USD">-418000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003614"
      unitRef="USD">-418000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003619"
      unitRef="USD">-11633000</ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment>
    <ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003620"
      unitRef="USD">-11633000</ONMD:StockIssuedDuringPeriodValueRetainedEarningsAdjustment>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003625"
      unitRef="USD">-10574000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003626"
      unitRef="USD">-10574000</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003628"
      unitRef="USD">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003630"
      unitRef="USD">35775000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003631"
      unitRef="USD">-36357000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003632"
      unitRef="USD">-583000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      decimals="INF"
      id="Fact003652"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003654"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember"
      decimals="INF"
      id="Fact003656"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003658"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003660"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003662"
      unitRef="Shares">4033170</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003648"
      unitRef="USD">13657000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003649"
      unitRef="USD">-57660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003650"
      unitRef="USD">-26359000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003670"
      unitRef="Shares">265914</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      decimals="INF"
      id="Fact003678"
      unitRef="Shares">5673</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003680"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003682"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003676"
      unitRef="USD">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003686"
      unitRef="USD">9207000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003688"
      unitRef="USD">9207000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003696"
      unitRef="Shares">543056</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <ONMD:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003704"
      unitRef="Shares">3420945</ONMD:StockIssuedDuringPeriodSharesWarrantsExercised>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003712"
      unitRef="Shares">5475362</ONMD:StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003706"
      unitRef="USD">1000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003708"
      unitRef="USD">47935000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003710"
      unitRef="USD">47936000</ONMD:StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      decimals="INF"
      id="Fact003720"
      unitRef="Shares">-3421596</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003722"
      unitRef="USD">-9650000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember"
      decimals="INF"
      id="Fact003724"
      unitRef="Shares">-2839957</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003726"
      unitRef="USD">-8010000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_TemporaryEquityMember_custom_RestatedMember"
      decimals="-3"
      id="Fact003728"
      unitRef="USD">-17660000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003730"
      unitRef="Shares">6261553</ONMD:StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003714"
      unitRef="USD">1000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003716"
      unitRef="USD">17659000</ONMD:StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination>
    <ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003750"
      unitRef="Shares">3572232</ONMD:StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003746"
      unitRef="USD">-11937000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003748"
      unitRef="USD">-11937000</ONMD:StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003760"
      unitRef="USD">1475000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003762"
      unitRef="USD">1475000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003773"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003774"
      unitRef="USD">-33780000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003792"
      unitRef="Shares">23572232</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003776"
      unitRef="USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003778"
      unitRef="USD">77996000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_RestatedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003779"
      unitRef="USD">-91440000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_RestatedMember"
      decimals="-3"
      id="Fact003780"
      unitRef="USD">-13442000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003806"
      unitRef="Shares">3853797</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003810"
      unitRef="Shares">3204000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003816"
      unitRef="Shares">7802941</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003800"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003801"
      unitRef="USD">28750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003802"
      unitRef="USD">19607000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003803"
      unitRef="USD">-33920000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003804"
      unitRef="USD">14438000</us-gaap:StockholdersEquity>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003824"
      unitRef="Shares">1378517</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003820"
      unitRef="USD">2826000</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003821"
      unitRef="USD">-3360000</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003822"
      unitRef="USD">-534000</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003832"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003828"
      unitRef="USD">200000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003830"
      unitRef="USD">200000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003840"
      unitRef="Shares">7500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003836"
      unitRef="USD">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003838"
      unitRef="USD">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003856"
      unitRef="USD">1392000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003858"
      unitRef="USD">1392000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003863"
      unitRef="USD">-6230000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003864"
      unitRef="USD">-6230000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003872"
      unitRef="Shares">3853797</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact003876"
      unitRef="Shares">3204000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003882"
      unitRef="Shares">9388958</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003866"
      unitRef="USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003867"
      unitRef="USD">28750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003868"
      unitRef="USD">24032000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003869"
      unitRef="USD">-43510000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_ScenarioPreviouslyReportedMember"
      decimals="-3"
      id="Fact003870"
      unitRef="USD">9273000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003892"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003896"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003898"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003900"
      unitRef="Shares">-3460275</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003884"
      unitRef="USD">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003885"
      unitRef="USD">-28750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003886"
      unitRef="USD">-17094000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003887"
      unitRef="USD">6711000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003888"
      unitRef="USD">-21490000</us-gaap:StockholdersEquity>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003908"
      unitRef="Shares">-437874</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003910"
      unitRef="Shares">-364043</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003912"
      unitRef="Shares">-1871937</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003904"
      unitRef="USD">-2826000</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003905"
      unitRef="USD">3360000</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003906"
      unitRef="USD">534000</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003920"
      unitRef="Shares">-22724</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003916"
      unitRef="USD">-200000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003918"
      unitRef="USD">-200000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003928"
      unitRef="Shares">-852</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003924"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003926"
      unitRef="USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003932"
      unitRef="USD">8073000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003934"
      unitRef="USD">8073000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003938"
      unitRef="USD">1198000</ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003940"
      unitRef="USD">1198000</ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003944"
      unitRef="USD">473000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003946"
      unitRef="USD">473000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003951"
      unitRef="USD">-24221000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003952"
      unitRef="USD">-24221000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003960"
      unitRef="Shares">-437874</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003962"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="INF"
      id="Fact003964"
      unitRef="Shares">-364043</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003966"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003968"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003970"
      unitRef="Shares">-5355788</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_CommonStockMember"
      decimals="-3"
      id="Fact003954"
      unitRef="USD">-1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_custom_CommitmentMember"
      decimals="-3"
      id="Fact003955"
      unitRef="USD">-28750000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003956"
      unitRef="USD">-10375000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003957"
      unitRef="USD">-14150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact003958"
      unitRef="USD">-35632000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember"
      decimals="INF"
      id="Fact003978"
      unitRef="Shares">3853797</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember"
      decimals="-3"
      id="Fact003980"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember"
      decimals="INF"
      id="Fact003982"
      unitRef="Shares">3204000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember"
      decimals="-3"
      id="Fact003984"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember"
      decimals="-3"
      id="Fact003986"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003988"
      unitRef="Shares">4342666</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact003974"
      unitRef="USD">2513000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact003975"
      unitRef="USD">-27209000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_custom_AsRestatedMember"
      decimals="-3"
      id="Fact003976"
      unitRef="USD">-7052000</us-gaap:StockholdersEquity>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember"
      decimals="INF"
      id="Fact003996"
      unitRef="Shares">-437874</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember"
      decimals="INF"
      id="Fact003998"
      unitRef="Shares">-364043</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004000"
      unitRef="Shares">-493420</ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004008"
      unitRef="Shares">177276</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004016"
      unitRef="Shares">6648</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact004012"
      unitRef="USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004014"
      unitRef="USD">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact004020"
      unitRef="USD">8073000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
      contextRef="From2022-01-012022-12-31_srt_RevisionOfPriorPeriodReclassificationAdjustmentMember"
      decimals="-3"
      id="Fact004022"
      unitRef="USD">8073000</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact004026"
      unitRef="USD">1198000</ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors>
    <ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004028"
      unitRef="USD">1198000</ONMD:StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact004032"
      unitRef="USD">1865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004034"
      unitRef="USD">1865000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact004039"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004040"
      unitRef="USD">-30451000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember"
      decimals="INF"
      id="Fact004048"
      unitRef="Shares">3415923</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004050"
      unitRef="USD">9634000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember"
      decimals="INF"
      id="Fact004052"
      unitRef="Shares">2839957</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_SeriesAOnePreferredStockMember_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004054"
      unitRef="USD">8010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_TemporaryEquityMember_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004056"
      unitRef="USD">17644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004058"
      unitRef="Shares">4033170</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact004044"
      unitRef="USD">13657000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_AsRestatedMember_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="Fact004045"
      unitRef="USD">-57660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_custom_AsRestatedMember"
      decimals="-3"
      id="Fact004046"
      unitRef="USD">-26359000</us-gaap:StockholdersEquity>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004066">&lt;p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zpvQ5rh7nhV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zYjKwepWsD0e"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the accounts of the Company, including its subsidiaries. All intercompany accounts and transactions
have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-01-012023-12-31" id="Fact004068">&lt;p id="xdx_842_eus-gaap--UseOfEstimates_zr2hwzXh7qd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z3i8w8qiCyLh"&gt;Use
of Estimates&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in these notes to the consolidated
financial statements. Actual results and outcomes may differ materially from management&#x2019;s estimates, judgments, and assumptions.
Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to
revenue such as determining the nature and timing of the satisfaction of performance obligations, allowances for accounts receivable,
useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and stock-based compensation.
Estimates are periodically reviewed in light of changes in circumstances, facts, and experience.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <ONMD:OperatingSegmentsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004070">&lt;p id="xdx_844_ecustom--OperatingSegmentsPolicyTextBlock_zgianBikxImj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zRjKMzLPlLFc"&gt;Operating
Segments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial
information is regularly evaluated by the chief operating decision maker (&#x201c;CODM&#x201d;), which is the Company&#x2019;s Chief Executive
Officer, in deciding how to allocate resources and assess performance. The Company&#x2019;s CODM evaluates the Company&#x2019;s financial
information and resources and assesses the performance of these resources on a consolidated basis. The Company is not organized by market
and is managed and operated as one business. A single management team that reports to the chief executive officer comprehensively manages
the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and
does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial
segment information can be found in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ONMD:OperatingSegmentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004072">&lt;p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgvoIrAOYflg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zrYd84kCcMGb"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents
consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC insured
limits. The Company believes that, as of December 31, 2023 and 2022, its risk relating to deposits exceeding federally insured limits
was not significant. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s
financial condition, results of operations, and cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2023-01-012023-12-31" id="Fact004074">&lt;p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zdRDjIpsIbS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zvZhFGQmgyM1"&gt;Accounts
Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable is unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable is considered past due if not
paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections
have been exhausted. The Company determines the need for an allowance for credit losses based upon factors surrounding the credit risk
of specific customers, historical trends and other information. As of December 31, 2023 and 2022, the Company established allowances
for credit losses of $&lt;span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zStClmmHs8Z4" title="Accounts receivable"&gt;0&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_z8w2bWI5XRIf" title="Accounts receivable"&gt;0.1&lt;/span&gt; million, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not
require collateral from its customers and generally requires payment from 0 to 90 days from the invoice date. For the year ended December
31, 2023, there was 1 customer that accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zrvQn5txl485" title="Percentage of revenue"&gt;10&lt;/span&gt;% or more of total revenue, and there were 2 customers that accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z3ByJ3wUEWOf" title="Percentage of revenue"&gt;10&lt;/span&gt;% or
more of total revenue for the year ended December 31, 2022. The following table represents these customers&#x2019; aggregate percent of
total revenue:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_ztBzoaioJk74" style="display: none"&gt;Schedule
of Aggregate Percentage Revenue and Accounts Receivable&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, three customers accounted for more than &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance, and four customers
accounted for over &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#x2019; aggregate percent of total accounts receivable:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 4&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 5&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 6&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 7&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of total accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate Percent of Revenue and Accounts Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004076"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2022-12-31"
      decimals="-5"
      id="Fact004078"
      unitRef="USD">100000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember"
      decimals="INF"
      id="Fact004080"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember"
      decimals="INF"
      id="Fact004082"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="From2023-01-012023-12-31" id="Fact004084">&lt;p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_ztBzoaioJk74" style="display: none"&gt;Schedule
of Aggregate Percentage Revenue and Accounts Receivable&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;51&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;29&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, three customers accounted for more than &lt;span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance, and four customers
accounted for over &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue"&gt;10&lt;/span&gt;% of the Company&#x2019;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#x2019; aggregate percent of total accounts receivable:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Customer 1&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 2&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 3&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;27&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 4&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Customer 5&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Customer 6&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Customer 7&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;13&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate percent of total accounts receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Aggregate Percent of Revenue and Accounts Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;96&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact004086"
      unitRef="Pure">0.51</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact004087"
      unitRef="Pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      id="Fact004089"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      id="Fact004090"
      unitRef="Pure">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember"
      decimals="INF"
      id="Fact004092"
      unitRef="Pure">0.51</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember"
      decimals="INF"
      id="Fact004093"
      unitRef="Pure">0.51</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember"
      decimals="INF"
      id="Fact004095"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember"
      decimals="INF"
      id="Fact004097"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact004099"
      unitRef="Pure">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember"
      decimals="INF"
      id="Fact004100"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      id="Fact004102"
      unitRef="Pure">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember"
      decimals="INF"
      id="Fact004103"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember"
      decimals="INF"
      id="Fact004105"
      unitRef="Pure">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember"
      decimals="INF"
      id="Fact004106"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember"
      decimals="INF"
      id="Fact004108"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFourMember"
      decimals="INF"
      id="Fact004109"
      unitRef="Pure">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember"
      decimals="INF"
      id="Fact004111"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerFiveMember"
      decimals="INF"
      id="Fact004112"
      unitRef="Pure">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember"
      decimals="INF"
      id="Fact004114"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSixMember"
      decimals="INF"
      id="Fact004115"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember"
      decimals="INF"
      id="Fact004117"
      unitRef="Pure">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerSevenMember"
      decimals="INF"
      id="Fact004118"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember"
      decimals="INF"
      id="Fact004120"
      unitRef="Pure">0.96</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember"
      decimals="INF"
      id="Fact004121"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember"
      decimals="INF"
      id="Fact004123"
      unitRef="Pure">0.96</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomersMember"
      decimals="INF"
      id="Fact004124"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004126">&lt;p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zbneL7aFcAJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zpfxMSc0ozV2"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The straight-line method is used for computing depreciation
and amortization. Assets are depreciated and amortized over their estimated useful lives ranging from three to five years. Cost of maintenance
and repairs are charged to expense when incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004128">&lt;p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZXcFP3hWAY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86A_zVpXbo6CoYFj"&gt;Impairment
of Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances
indicate that the carrying amount of an asset may not be fully recoverable. An impairment loss would be recognized when the estimated
future undiscounted net cash flows from the use of the asset are less than the carrying amount of that asset. There were &lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20230101__20231231_zAMAdUgdylq7" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zxpllUrCgDsc" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; such losses
during the years ended December 31, 2023 or December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004130"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004132"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <ONMD:FairValueOptionOfAccountingPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004134">&lt;p id="xdx_845_ecustom--FairValueOptionOfAccountingPolicyTextBlock_zPgodBycYS55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zOFCpgo5lkt9"&gt;Fair
value option of accounting&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
financial instruments contain various embedded derivatives which may require bifurcation and separate accounting of those derivatives
apart from the entire host instrument, if eligible, ASC 825, &lt;i&gt;Financial Instruments&lt;/i&gt;, allows issuers to elect the fair value option
(&#x201c;FVO&#x201d;) of accounting for those instruments. The FVO may be elected on an instrument-by-instrument basis and is irrevocable
unless a new election date occurs. The FVO allows the issuer to account for the entire financial instrument at fair value with subsequent
remeasurements of that fair value recorded through the statements of operations at each reporting date. A financial instrument is generally
eligible for the FVO if, amongst other factors, no part of the convertible, or contingently convertible, instrument is classified in
stockholders&#x2019; equity and the instrument does not contain a beneficial conversion feature at issuance. In addition, because a contingent
beneficial conversion feature, if any, is not separately recognized within stockholders&#x2019; equity at the issuance date, a convertible
debt instrument with a contingent beneficial conversion feature is therefore eligible for the FVO if all other criteria are met.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Based
on the eligibility assessment discussed above, the Company concluded that its convertible notes payable is eligible for the FVO and accordingly
elected the FVO for those debt instruments. This election was made because of operational efficiencies in valuing and reporting for these
debt instruments in their entirety at each reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Convertible
promissory notes and the PIPE Notes contain embedded derivatives, which require bifurcation and separate accounting under GAAP, for which
the Company elected the FVO. In addition, certain term PIPE Notes were issued with separately exercisable and freestanding warrants to
purchase common stock, were issued with substantial discounts at issuance and contained certain embedded derivatives to be bifurcated
and accounted for separately for those term notes, unless the FVO is eligible and elected. Accordingly, the Company qualified for and
elected the FVO for the entire PIPE Notes instruments. The convertible debt and accrued interest at their stated interest rates were
initially recorded at fair value as liabilities on the consolidated balance sheets and were subsequently re-measured at fair value at
the end of each reporting period presented within the consolidated financial statements. The changes in the fair value of the convertible
promissory notes and PIPE Notes are recorded in changes in fair value of convertible debt and change in fair value of PIPE Notes, included
as a component of other (income) expenses, net, in the consolidated statements of operations. The change in fair value related to the
accrued interest components is also included within the respective single line of change in fair value of convertible debt and change
in fair value of PIPE Notes on the consolidated statements of operations. See additional information on valuation methodologies and significant
assumptions used in Note 6 and Note 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ONMD:FairValueOptionOfAccountingPolicyTextBlock>
    <ONMD:WarrantPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004136">&lt;p id="xdx_849_ecustom--WarrantPolicyTextBlock_zFCbjB1MuvZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zlRvn7HvG6e5"&gt;Warrants&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s
specific terms and applicable authoritative guidance in ASC 480, &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;, and ASC 815, &lt;i&gt;Derivatives
and Hedging&lt;/i&gt;. Warrants that meet the definition of a derivative financial instrument and the equity scope exception in ASC 815-10-15-74(a)
are classified as equity and are not subject to remeasurement provided that the Company continues to meet the criteria for equity classification.
Warrants that are classified as liabilities are accounted for at fair value and remeasured at each reporting date until exercise, expiration,
or modification that results in equity classification. Any change in the fair value of the warrants is recognized as change in fair value
of warrant liabilities included as a component of other (income) expenses, net in the consolidated statements of operations. The classification
of warrants, including whether warrants should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The fair value of liability-classified warrants is determined using the Black-Scholes options pricing model (&#x201c;Black-Scholes model&#x201d;)
which includes Level 3 inputs, as shown in Note 11 to the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ONMD:WarrantPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-012023-12-31" id="Fact004138">&lt;p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z7mrkflN4v37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zgP8byl9dztb"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes
the inputs to valuation methodologies used to measure fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Level
1&lt;/b&gt; - Valuations based on quoted prices for identical assets and liabilities in active markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Level
2&lt;/b&gt; - Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets
and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other
inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Level
3&lt;/b&gt; - Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made
by other market participants. These valuations require significant judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
quoted market prices are available in active markets, the fair value of assets and liabilities is estimated within Level 1 of the valuation
hierarchy. If quoted prices are not available, then fair values are estimated by using pricing models, quoted prices of assets and liabilities
with similar characteristics, or discounted cash flows, within Level 2 of the valuation hierarchy. In cases where Level 1 or Level 2
inputs are not available, the fair values are estimated by using inputs within Level 3 of the hierarchy.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies&#x37e; however,
considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative
of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using
different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based
on carrying values and future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, convertible notes
payable, liability classified financial instruments and certain privately issued warrants. The carrying amounts of cash and cash equivalents
and accounts payable financial instruments approximate their fair value due to their short-term nature. The carrying amount of accounts
receivable is net of an allowance that reflects management&#x2019;s best estimate of expected credit losses. See Note 11 for fair value
measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004140">&lt;p id="xdx_84C_eus-gaap--StockholdersEquityPolicyTextBlock_zJjjHU9EiIXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Classification
of Series A-1, and Series A-2 preferred stock&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_864_zuHE7wZUI1Lf" style="display: none"&gt;Treasury
stock&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company originally classified its Series A-1 and Series A-2 preferred stock (collectively &#x201c;Preferred Stock&#x201d;) outside of permanent
equity because the Preferred Stock contained certain redemption features that result in those shares being redeemable upon the occurrence
of certain events that are not solely within the Company&#x2019;s control, including liquidation, sale or transfer of control. Accordingly,
the Preferred Stock was recorded outside of permanent equity and was subject to the classification guidance provided under ASC 480-10-S99.
Because dividends were not contractually required to be accrued on the Preferred Stock as there was no stated or required dividend rate
per annum, the Company was not required to accrete dividends into the carrying amount of the Preferred Stock in anticipation of a future
contingent event or redemption value. Accordingly, the Company did not adjust the carrying values of the Preferred Stock to the respective
liquidation preferences of such shares because of the uncertainty of whether or when such events would occur. As of December 31, 2023,
all shares of Preferred Stock were converted into Common Stock pursuant to their provisions in connection with the Business Combination,
which closed on November 7, 2023 (see Note 3).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004142">&lt;p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zixMabdmKOj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zghowmw5w7cc"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with ASC Topic 606, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;, which aligns revenue recognition
with the transference of promised goods or services to customers in an amount that reflects the consideration to which the Company expects
to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
core principle is achieved to the application of a five-step model: (1) identify the contract with a customer, (2) identify the performance
obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to performance obligations in the
contract, and (5) recognize revenue as performance obligations are satisfied. Payment terms between customers related to product and
services sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable
or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to
a customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit
of account under Topic 606. A contract&#x2019;s transaction price is allocated to each distinct performance obligation in proportion to
the standalone selling price for each and recognized as revenue when, or as, the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Individual
promised goods and services in a contract are considered a performance obligation and accounted for separately if the good or service
is distinct. A good or service is considered distinct if the customer can benefit from the good or service on its own or with other resources
that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
transaction price for the products is the invoiced amount. Advanced billings from contracts are deferred and recognized as revenue when
earned. Revenue is recognized only to the extent that it is probable that a significant reversal of revenue will not occur and when collection
is considered probable. The Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority
and imposed on and concurrent with a specific revenue-producing transaction. Deferred revenue consists of payments received in advance
of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives
payments from customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes
unconditional. Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Subscription
Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subscription
revenues are generated from the Company&#x2019;s data exchange (BEAM) product, which is a medical imaging exchange platform between hospital/healthcare
systems, imaging centers, physicians and patients. Subscriptions to the BEAM platform offering are recognized over time as the customer
consumes the benefits of the services as the Company stands ready to provide access to the programs throughout the subscription period.
Subscription customers are invoiced either quarterly or annually in advance with the customer contracts automatically renewing unless
the customer issues a cancellation notice. The timing of revenue recognition is based on a time-based measure of progress as the Company
provides access to the programs evenly over the course of the subscription period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Web
Imaging Revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Web
imaging revenues are generated from the Company&#x2019;s data broker (iRWD) product, which provides regulatory grade imaging and clinical
data in the pharmaceutical, device manufacturing, clinical research organizations, and artificial intelligence markets. Web imaging customers
are invoiced in installments as the related data is delivered. Revenue from the sale of web imaging products is recognized over time
using an output measure of progress, which is based on the number of data units delivered relative to the total data units committed
by the customer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004144">&lt;p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zbR50DAB7kV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_864_zKJcBN4npTdf"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes income taxes under the asset and liability method. Deferred income taxes are recognized for differences between the
financial reporting and tax bases of assets and liabilities, at enacted statutory tax rates in effect for the years in which the differences
are expected to reverse. The Company establishes a valuation allowance if it believes it is more likely than not that the deferred tax
assets will not be recovered based on an evaluation of all available evidence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely
than not that a position will be sustained, none of the benefit attributable to the position is recognized. The tax benefit to be recognized
for any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than
50% likely to be realized upon resolution of the contingency. The Company accounts for interest and penalties related to uncertain tax
positions as part of its provision for income taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <ONMD:PatentsAndTrademarksPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004146">&lt;p id="xdx_848_ecustom--PatentsAndTrademarksPolicyTextBlock_zzT15pKsuKh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_z477QSUwNVti"&gt;Patents
and Trademarks&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
associated with the submission of a patent application are expensed as incurred given the uncertainty of the patents resulting in probable
future economic benefits to the Company and are included in research and development expenses on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ONMD:PatentsAndTrademarksPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2023-01-012023-12-31" id="Fact004148">&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4Hi9QUf8Quf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zOHYXgR61V4k"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for its research and development (&#x201c;R&amp;amp;D&#x201d;) costs in accordance with ASC 730, &lt;i&gt;Research and Development
&lt;/i&gt;(&#x201c;ASC 730&#x201d;). ASC 730 requires that R&amp;amp;D costs are generally recognized as an expense as incurred. However, some costs
associated with R&amp;amp;D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.
For the years ended December 31, 2023 and December 31, 2022 research and development expenditures were charged to operating expense as
incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004150">&lt;p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_znU3DnHp0JGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zgmkIrGoakvg"&gt;Stock-based
Compensation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes compensation expense related to employee option grants and restricted stock grants, if any, in accordance with ASC
718, &lt;i&gt;Compensation - Stock Compensation&lt;/i&gt; (&#x201c;ASC 718&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures all stock options and other stock-based awards granted based on the fair value of the award on the date of the grant
and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the
respective award. The Company has elected to recognize forfeitures as they occur. The reversal of compensation cost previously recognized
for an award that is forfeited because of a failure to satisfy a service condition is recognized in the period of the forfeiture. Generally,
and unless otherwise specified, the Company grants stock options with service-based only vesting conditions and records the expense for
these awards using the straight-line method over the requisite service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award
recipient&#x2019;s payroll costs are classified or in which the award recipients&#x2019; service payments are classified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the Business Combination, the Company was required to periodically estimate the fair value of its Common Stock with the assistance
of an independent third-party valuation firm when issuing stock options and computing estimated stock-based compensation expense. The
assumptions underlying these valuations represented the Company&#x2019;s best estimates, which involved inherent uncertainties and the
application of significant levels of judgment. In order to determine the fair value of its Common Stock, the Company considered, among
other items, previous transactions involving the sale of Company securities, the business, financial condition and results of operations,
economic and industry trends, the market performance of comparable publicly traded companies, and the lack of marketability of the Company&#x2019;s
Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. These estimates and assumptions include
a number of objective and subjective factors, including external market conditions, guideline public company information, the prices
at which the Company sold convertible preferred stock and common stock to third parties in arms&#x2019; length transactions, the rights
and preferences of securities senior to the Company&#x2019;s common stock at the time, and the likelihood of achieving a liquidity event
such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in materially
different fair values of stock options at each valuation date, as applicable. Following the Business Combination (see Note 3), the Company
used the public price of its Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each stock option grant is estimated using the Black-Scholes option-pricing model. The Company estimates its expected stock
volatility based on the historical volatility of a publicly traded set of peer companies within the biotechnology industry with characteristics
similar to the Company. The expected term of the Company&#x2019;s stock options has been determined utilizing the &#x201c;simplified&#x201d;
method, which reflects the weighted-average of time-to-vesting. The risk-free interest rate is determined by reference to the U.S. Treasury
yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected
dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends
in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004152">&lt;p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zpI0qE49LlHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Net
loss per common share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span id="xdx_86B_zl2x1xmQ1a1e" style="display: none"&gt;Net
loss per share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Earnings
per share attributable to common stockholders is calculated using the two-class method, which is an earnings allocation formula that
determines earnings per share for the holders of the Company&#x2019;s Common Stock and participating securities. Although the Company&#x2019;s
historical Preferred Stock contained participating rights in any dividend declared and paid by the Company and were therefore participating
securities, the Preferred Stock had no stated dividends and OneMedNet has never paid any cash dividends and does not plan to pay any
dividends in the foreseeable future. Net loss attributable to common stockholders and participating securities is allocated to each share
on an if-converted basis as if all of the earnings for the period had been distributed. However, the participating securities do not
include a contractual obligation to share in the losses of the Company and are not included in the calculation of net loss per share
in the periods that have a net loss. In addition, common stock equivalent shares (whether or not participating) are excluded from the
computation of diluted earnings per share in periods in which they have an anti-dilutive effect on net loss per common share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
net loss per share is computed using the more dilutive of (a) the two-class method or (b) the if-converted method and treasury stock
method, as applicable. Contingently convertible notes payable and PIPE Notes were not included for purposes of calculating the number
of diluted shares outstanding as the number of dilutive shares is based on a conversion contingency associated with the completion of
a future financing event that had not occurred, and the contingency was not resolved, in the reporting periods presented herein. In periods
in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders
is the same as basic net loss per share attributable to common stockholders since dilutive common shares are not assumed to have been
issued if their effect is anti-dilutive. Diluted net loss per share is equivalent to basic net loss per share for the periods presented
herein because common stock equivalent shares from the Preferred Stock, convertible notes, stock option awards and outstanding warrants
to purchase common stock were antidilutive.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the Company reporting net loss attributable to common stockholders for all periods presented herein, the following common
stock equivalents were excluded from the computation of diluted net loss per common share for the years ended December 31, 2023 and 2022
because including them would have been antidilutive (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none"&gt;Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022
    &lt;span id="xdx_F53_zMknzVxwFW2d"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022 (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Employee stock options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;913,856&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants for common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,367,607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series A-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4165"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,415,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible promissory notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4171"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,786,610&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total common stock equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,501,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Retroactively restated
for the reverse recapitalization in Note 3.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AD_zdniDLLHaxk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-01-012023-12-31" id="Fact004154">&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none"&gt;Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022
    &lt;span id="xdx_F53_zMknzVxwFW2d"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022 (1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Employee stock options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;913,856&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Restricted stock awards&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4159"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;177,276&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrants for common stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,367,607&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Series A-1 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4165"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,839,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Series A-2 preferred stock&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4168"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,415,923&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Convertible promissory notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4171"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,786,610&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Total common stock equivalents&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,501,229&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Retroactively restated
for the reverse recapitalization in Note 3.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact004157"
      unitRef="Shares">913856000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockMember"
      decimals="-3"
      id="Fact004160"
      unitRef="Shares">177276000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact004162"
      unitRef="Shares">12181019000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember"
      decimals="-3"
      id="Fact004163"
      unitRef="Shares">2367607000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember81071859"
      decimals="-3"
      id="Fact004166"
      unitRef="Shares">2839957000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember81071875"
      decimals="-3"
      id="Fact004169"
      unitRef="Shares">3415923000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNoteMember"
      decimals="-3"
      id="Fact004172"
      unitRef="Shares">3786610000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004174"
      unitRef="Shares">12181019000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004175"
      unitRef="Shares">13501229000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004178">&lt;p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zAtmvX74dVB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_zHJ6xeHhZUah"&gt;General
and Administrative&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;General
and administrative expenses include all costs that are not directly related to satisfaction of customer contracts. General and administrative
expenses include items for the Company&#x2019;s selling and administrative functions, such as sales, finance, legal, human resources,
and information technology support. These functions include costs for items such as salaries and benefits and other personnel-related
costs, maintenance and supplies, professional fees for external legal, accounting, and other consulting services, and depreciation expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <ONMD:EmergingGrowthCompanyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004180">&lt;p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zYqQNQ3xCV7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span&gt;Emerging
Growth Company&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_86C_zEsoVgjxUZrh" style="display: none"&gt;Emerging
growth company status&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an emerging growth company, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#x201c;JOBS Act&#x201d;). Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to
comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934,
as amended (the &#x201c;Exchange Act&#x201d;)) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has not elected to opt out of such extended transition
period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ONMD:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004182">&lt;p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK1ZhnNCN3aa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zW7YQkl7K4D5"&gt;Accounting
Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU No. 2023-09, &lt;i&gt;Improvements to Income Tax Disclosures (Topic 740)&lt;/i&gt; (&#x201c;ASU 2023-09&#x201d;).
ASU 2023-09 requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional
information on income taxes paid. ASU 2023-09 is effective on a prospective basis for annual periods beginning after December 15, 2024.
Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. The Company
is currently evaluating the impact of adopting ASU 2023-09.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): &lt;i&gt;Improvements to Reportable Segment Disclosures&lt;/i&gt;, which
is intended to provide enhancements to segment disclosures, even for entities with only one reportable segment. In particular, the standard
will require disclosures of significant segment expenses regularly provided to the chief operating decision maker and included within
each reported measure of segment profit and loss. The standard will also require disclosure of all other segment items by reportable
segment and a description of its composition. Finally, the standard will require disclosure of the title and position of the chief operating
decision maker and an explanation of how the chief operating decision maker uses the reported measure(s) of segment profit or loss in
assessing segment performance and deciding how to allocate resources. The standard is effective for annual periods beginning after December
15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently
evaluating the impact of the standard on the presentation of its consolidated financial statements and footnotes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <ONMD:RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact004184">&lt;p id="xdx_842_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_zZpd1abxoVL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zkTd0xEMhp11"&gt;Recently
adopted accounting pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2016, the FASB issued ASU No. 2016-13, &lt;i&gt;Financial Instruments - Credit Losses&lt;/i&gt;, &#x201c;Topic 326&#x201d;, an amendment on measurement
of credit losses on financial assets held by at each reporting date. The guidance requires the use of a new current expected credit loss
(&#x201c;CECL&#x201d;) model in estimating allowances for doubtful accounts with respect to accounts receivable. The CECL model requires
that the Company estimate its lifetime expected credit loss with respect to these receivables and record allowances that, when deducted
from the balance of the receivables, represent the estimated net amounts expected to be collected. Effective January 1, 2023, the Company
adopted ASU No. 2016-13 and the adoption of this standard did not have a material impact on the Company&#x2019;s consolidated financial
statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2022, the FASB issued ASU No. 2022-03, &lt;i&gt;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions &lt;/i&gt;(&#x201c;ASU
2022-03&#x201d;), which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit
of account of the equity security and, therefore, is not considered in measuring fair value. ASU 2022-03 is effective for public business
entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. The Company adopted
ASU No. 2022-03 and the adoption of this standard did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;
</ONMD:RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004186">&lt;p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z3R99EqtFyhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.
&lt;span id="xdx_827_zlyxvGrPX9Ph"&gt;Business Combination&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 7, 2023, the Company closed the previously announced Business Combination pursuant to the Merger Agreement, dated April 25,
2022, by and among Data Knights, Merger Sub, and Legacy ONMD, as described in Note 1.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Merger Agreement: (i) Merger Sub merged with and into Legacy ONMD, with Legacy ONMD surviving the Merger, as a wholly-owned subsidiary
of Data Knights, and (ii) Data Knights, which had been formed as a Delaware corporation solely for the purpose of facilitating the Business
Combination, changed its name to OneMedNet Corporation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Data
Knights was treated as the acquired company for financial reporting purposes. This determination is primarily based on the fact that
subsequent to the Business Combination, Legacy ONMD&#x2019;s stockholders have the majority of the voting power of the combined entity,
Legacy ONMD comprised all of the ongoing operations of the combined entity, Legacy ONMD comprised a majority of the governing body of
the combined entity, and Legacy ONMD&#x2019;s senior management comprised all of the senior management of the combined entity. Accordingly,
for accounting purposes, the Business Combination was treated as the equivalent of Legacy ONMD issuing shares for the net assets of Data
Knights, accompanied by a recapitalization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
this is considered a recapitalization for accounting purposes, the net assets of Data Knights were not remeasured at fair value but were
stated at historical cost and there was no goodwill or intangibles recognized. Operations prior to the Business Combination are those
of Legacy ONMD.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate consideration to the stockholders of Legacy ONMD at the closing of the Business Combination was approximately $&lt;span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zZrIMnXzNyMk" title="Business combination transfered"&gt;20.0&lt;/span&gt; million,
which consisted of the Company&#x2019;s shares of common stock, par value $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231107_zl8Bo6GlONw5" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share (&#x201c;Common Stock&#x201d;), valued at $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231107_zf0hmCOPqbMd" title="Share issued price per share"&gt;10.00&lt;/span&gt;
per share, resulting in the issuance of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231107__20231107_ztzPtfHo23Gj" title="Issuance of shares"&gt;20,000,000&lt;/span&gt; shares of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the closing, each of Legacy ONMD&#x2019;s outstanding convertible notes, with a fair value of $&lt;span id="xdx_904_eus-gaap--FairValueOfAssetsAcquired_pn5n6_c20231107__20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOBrwTAadHA2" title="Fair value of common stock"&gt;47.9&lt;/span&gt; million, converted into &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231107__20231107_zg9E7qZgwyWk" title="Conversion of convertible securities"&gt;5,475,362&lt;/span&gt;
shares of the Company&#x2019;s Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Also,
upon the closing, &lt;span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zdX6qskCQdia" title="Temporary equity shares outstanding"&gt;3,853,797&lt;/span&gt; shares of Series A-2 Preferred Stock and &lt;span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrsFeo5Bwm47" title="Temporary equity shares outstanding"&gt;3,204,000&lt;/span&gt; shares of Series A-1 Preferred Stock converted into &lt;span id="xdx_90A_eus-gaap--SharesOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9fFhcQvSdZi" title="Shares outstanding"&gt;6,261,553&lt;/span&gt;
shares of Common Stock. Legacy ONMD&#x2019;s &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231107_zLRlOIAINj81" title="Stock options outstanding"&gt;612,670&lt;/span&gt; outstanding stock options and &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107_zYHJp0Z4Ty7f" title="Warrant outstanding"&gt;3,859,464&lt;/span&gt; outstanding warrants converted into &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znblmrgQpkRi" title="Warrant outstanding"&gt;543,057&lt;/span&gt;
and &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFWXoqZmsHb" title="Warrant outstanding"&gt;3,420,945&lt;/span&gt; shares, respectively, of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the above, the share figures in the consolidated statement of temporary equity and stockholders&#x2019; deficit for the year
ended December 31, 2022 have been adjusted for the application of the recapitalization ratio of &lt;span id="xdx_90D_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_c20221231_zS7cyIYfXSO7" title="Temporaray equity liquidation preference per share"&gt;0.88637847&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zRy8eAdFV65e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company received net cash consideration of approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107_zbbqF5bZQ9o3" title="Business combination net cash"&gt;0.1&lt;/span&gt; million and net liabilities of Data Knights of approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn5n6_c20231107_zTn2aNDCmvh9" title="Business combination net liabilities"&gt;11.0&lt;/span&gt; million.
The net liabilities of Data Knights were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zHJ1yIjtART1" style="display: none"&gt;Schedule
of Business Combination Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7elQfgFA4Kk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3_maBCRIAzlc7_zgyL2s3cJb8a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_iNI_pn3n3_di_msBCRIAzlc7_zWeMZxmWTzX7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,501&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_iNI_pn3n3_di_msBCRIAzlc7_zcTLjIZHttxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loan extensions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_iNI_pn3n3_di_msBCRIAzlc7_zrbKiKasH2c1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_iNI_pn3n3_di_msBCRIAzlc7_zFHOfonhcp2g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pn3n3_mtBCRIAzlc7_zMtAJwotwOA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(11,016&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_z1Epc1DulgYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company incurred transaction costs of $&lt;span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn5n6_c20231107_z4ovNNGng9f6" title="Business combination transaction cost"&gt;0.9&lt;/span&gt; million in connection with the Business Combination. Following consummation of the Business
Combination, the Company owned all of the issued and outstanding equity interests in Legacy ONMD and its subsidiary, and the Legacy ONMD
securityholders held approximately &lt;span id="xdx_909_ecustom--BusinessAcquisitionCostPercentage_iI_dp_uPure_c20231107_zfOehGTNqnB7" title="Business combination percentage"&gt;78.2&lt;/span&gt;% of the Company. Following consummation of the Business Combination, the Company&#x2019;s Common
Stock and the Company&#x2019;s Public Warrants began trading on the Nasdaq Global Market under the symbols &#x201c;ONMD&#x201d; and &#x201c;ONMDW&#x201d;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Private
Investment in Public Equity (&#x201c;PIPE&#x201d;) Financing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
June 28, 2023, the Company and Data Knights entered into a Securities Purchase Agreement (the &#x201c;SPA&#x201d;) with certain investors
(collectively referred to as the &#x201c;Purchasers&#x201d;) for PIPE financing in the aggregate original principal amount of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20230628__20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z0HPlQ9zlf6h" title="Principal amount"&gt;1.5&lt;/span&gt; million.
Pursuant to the Securities Purchase Agreement, Data Knights issued and sold to each of the Purchasers, a new series of senior secured
convertible notes (the &#x201c;PIPE Notes&#x201d;), which are convertible into shares of Common Stock at the Purchasers election at a conversion
price equal to the lower of (i) $10.00 per share, pr (ii) 92.5% of the lowest volume weighted average trading price for the ten (10)
Trading Days immediately preceding the Conversion Date. The Purchasers&#x2019; $&lt;span id="xdx_902_eus-gaap--Investments_iI_pn5n6_c20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2PfLnEjXCT6" title="Investment"&gt;1.5&lt;/span&gt; million investment in the PIPE Notes closed and funded
contemporaneous to the Closing of the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Effective
immediately prior to the Closing, Data Knights issued the PIPE Notes to the Purchasers under the private offering exemptions under Securities
Act of 1933, as amended (the &#x201c;Securities Act&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Deferred
Underwriter Fees&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Business Combination, Data Knights entered into an agreement with their underwriters (&#x201c;EF Hutton&#x201d;) whereby
EF Hutton agreed to waive the related merger underwriting fees that were payable at closing ($&lt;span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2ObVj4jthDi" title="Business combination underwriter fees"&gt;4.0&lt;/span&gt; million) in exchange for allocated
payments as follows: (i) $&lt;span id="xdx_90D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zooYjfpGnop5" title="Business combination cash"&gt;0.5&lt;/span&gt; million in cash at closing; (ii) a $&lt;span id="xdx_900_eus-gaap--NotesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zIk6LAMsMJN" title="Promissory note"&gt;0.5&lt;/span&gt; million promissory note that matures on &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zJhNp7Imv2e8" title="Debt maturity date"&gt;March 1, 2024&lt;/span&gt;; and (iii)
a transfer of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zeWpOliOfmCh" title="Issuance of shares"&gt;277,778&lt;/span&gt; shares of Common Stock. The Company paid the $&lt;span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zPjj32GbaKe4" title="Business combination cash"&gt;0.5&lt;/span&gt; million of cash due at closing and the remaining $&lt;span id="xdx_901_ecustom--DeferredUnderwriterFeePayableCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zz69NWPh80n8" title="Business combination cash"&gt;3.5&lt;/span&gt; million
is recorded as deferred underwriter fee payable on its consolidated balance sheet as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Loan
Extensions&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Business Combination, the Company assumed Data Knights&#x2019; liabilities, which included existing loan extensions
to related parties. The loan extensions were to be exchanged for a fixed amount of Common Stock upon the closing of a business combination
or a similar event. As of December 31, 2023, a balance of $&lt;span id="xdx_908_ecustom--LoanExtensionsCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2c0KhMGSMo9" title="Loan extensions"&gt;3.0&lt;/span&gt; million remained outstanding and is recorded as loan extensions on the
Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-11-072023-11-07_custom_BusinessCombinationMember"
      decimals="-5"
      id="Fact004188"
      unitRef="USD">20000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004190"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004192"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-11-072023-11-07"
      decimals="INF"
      id="Fact004194"
      unitRef="Shares">20000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="From2023-11-072023-11-07_us-gaap_CommonStockMember"
      decimals="-5"
      id="Fact004196"
      unitRef="USD">47900000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-11-072023-11-07"
      decimals="INF"
      id="Fact004198"
      unitRef="Shares">5475362</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-11-07_custom_SeriesATwoPreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact004200"
      unitRef="Shares">3853797</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2023-11-07_custom_SeriesAOnePreferredStockMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact004202"
      unitRef="Shares">3204000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-11-07_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004204"
      unitRef="Shares">6261553</us-gaap:SharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004206"
      unitRef="Shares">612670</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004208"
      unitRef="Shares">3859464</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-11-07_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004210"
      unitRef="Shares">543057</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-11-07_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004212"
      unitRef="Shares">3420945</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004214"
      unitRef="USDPShares">0.88637847</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="From2023-01-012023-12-31_custom_DataKnightsAcquisitionCorpMember"
      id="Fact004216">&lt;p id="xdx_898_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zRy8eAdFV65e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company received net cash consideration of approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107_zbbqF5bZQ9o3" title="Business combination net cash"&gt;0.1&lt;/span&gt; million and net liabilities of Data Knights of approximately $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn5n6_c20231107_zTn2aNDCmvh9" title="Business combination net liabilities"&gt;11.0&lt;/span&gt; million.
The net liabilities of Data Knights were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zHJ1yIjtART1" style="display: none"&gt;Schedule
of Business Combination Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7elQfgFA4Kk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3_maBCRIAzlc7_zgyL2s3cJb8a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 20%; text-align: right"&gt;22&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_iNI_pn3n3_di_msBCRIAzlc7_zWeMZxmWTzX7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable &amp;amp; accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,501&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_iNI_pn3n3_di_msBCRIAzlc7_zcTLjIZHttxe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loan extensions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,992&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_iNI_pn3n3_di_msBCRIAzlc7_zrbKiKasH2c1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred underwriter fee payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,525&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_iNI_pn3n3_di_msBCRIAzlc7_zFHOfonhcp2g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pn3n3_mtBCRIAzlc7_zMtAJwotwOA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(11,016&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2023-11-07"
      decimals="-5"
      id="Fact004218"
      unitRef="USD">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2023-11-07"
      decimals="-5"
      id="Fact004220"
      unitRef="USD">11000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-3"
      id="Fact004222"
      unitRef="USD">22000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-3"
      id="Fact004224"
      unitRef="USD">4501000</ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-3"
      id="Fact004226"
      unitRef="USD">2992000</ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-3"
      id="Fact004228"
      unitRef="USD">3525000</ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-3"
      id="Fact004230"
      unitRef="USD">20000</ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-3"
      id="Fact004232"
      unitRef="USD">-11016000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2023-11-07"
      decimals="-5"
      id="Fact004234"
      unitRef="USD">900000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <ONMD:BusinessAcquisitionCostPercentage
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004236"
      unitRef="Pure">0.782</ONMD:BusinessAcquisitionCostPercentage>
    <us-gaap:DebtInstrumentIssuedPrincipal
      contextRef="From2023-06-282023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004238"
      unitRef="USD">1500000</us-gaap:DebtInstrumentIssuedPrincipal>
    <us-gaap:Investments
      contextRef="AsOf2023-06-28_custom_SecuritiesPurchaseAgreementMember_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004240"
      unitRef="USD">1500000</us-gaap:Investments>
    <ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees
      contextRef="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004242"
      unitRef="USD">4000000.0</ONMD:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004244"
      unitRef="USD">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004246"
      unitRef="USD">500000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember"
      id="Fact004248">2024-03-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-11-072023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="INF"
      id="Fact004250"
      unitRef="Shares">277778</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004252"
      unitRef="USD">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <ONMD:DeferredUnderwriterFeePayableCurrent
      contextRef="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004254"
      unitRef="USD">3500000</ONMD:DeferredUnderwriterFeePayableCurrent>
    <ONMD:LoanExtensionsCurrent
      contextRef="AsOf2023-12-31_custom_DataKnightsAcquisitionCorpMember"
      decimals="-5"
      id="Fact004256"
      unitRef="USD">3000000.0</ONMD:LoanExtensionsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004258">&lt;p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zI3WrqxnE3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&lt;span id="xdx_820_zryoLV1ClL83"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are summarized as of December 31 (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zctF042YaQBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zsdgk10zk6S2" style="display: none"&gt;Schedule
of Property and Equipment &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20231231_zScowbnVX4r8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20221231_zSU3yWvcNnRg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zmMLhg6gxMr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Computers&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;303&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndEquipmentMember_zKjXoUbbvTVf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Furniture and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzSdJ_zBDrk6m2BQQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;307&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzSdJ_z65ajHtdtx35" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less: accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(208&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(180&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzSdJ_z8519SR6uWia" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A8_zwUdgbVD3zwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
and amortization expense was $&lt;span id="xdx_90E_eus-gaap--DepreciationAndAmortization_pn4n6_c20230101__20231231_za7kmkupZMad" title="Depreciation and amortization expense"&gt;0.03&lt;/span&gt; million and $&lt;span id="xdx_903_eus-gaap--DepreciationAndAmortization_pn4n6_c20220101__20221231_zKa7PPYBZwXk" title="Depreciation and amortization expense"&gt;0.02&lt;/span&gt; million for the years ended December 31, 2023 and 2022, respectively, which is recorded
within general and administrative expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-01-012023-12-31" id="Fact004260">&lt;p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zctF042YaQBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zsdgk10zk6S2" style="display: none"&gt;Schedule
of Property and Equipment &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20231231_zScowbnVX4r8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20221231_zSU3yWvcNnRg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zmMLhg6gxMr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Computers&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;303&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndEquipmentMember_zKjXoUbbvTVf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Furniture and equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzSdJ_zBDrk6m2BQQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;307&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;263&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzSdJ_z65ajHtdtx35" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less: accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(208&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(180&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzSdJ_z8519SR6uWia" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;99&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_ComputerEquipmentMember"
      decimals="-3"
      id="Fact004262"
      unitRef="USD">303000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_ComputerEquipmentMember"
      decimals="-3"
      id="Fact004263"
      unitRef="USD">259000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_custom_FurnitureAndEquipmentMember"
      decimals="-3"
      id="Fact004265"
      unitRef="USD">4000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_custom_FurnitureAndEquipmentMember"
      decimals="-3"
      id="Fact004266"
      unitRef="USD">4000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004268"
      unitRef="USD">307000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004269"
      unitRef="USD">263000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004271"
      unitRef="USD">208000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004272"
      unitRef="USD">180000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004274"
      unitRef="USD">99000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004275"
      unitRef="USD">83000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-01-012023-12-31"
      decimals="-4"
      id="Fact004277"
      unitRef="USD">30000.00</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-01-012022-12-31"
      decimals="-4"
      id="Fact004279"
      unitRef="USD">20000.00</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004281">&lt;p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zWzbpj6gh1Ha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&lt;span id="xdx_828_zx0hAoTsBH57"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zz2CDF9Xeoi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has operations in the United States and Canada. The components of income (loss) before the provision for income taxes are as
follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zQTOOeov4NVh" style="display: none"&gt;Schedule
of Components of Income (Loss) Before Provision for Income Tax&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_zFL9j071bVj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20221231_zsYuUmfCvrs9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pn3n3_maILFCOzkfc_z8EUKV3XXp13" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(33,827&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(30,456&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pn3n3_maILFCOzkfc_zvC4tlK0ELh9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;65&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pn3n3_mtILFCOzkfc_z10nWaDT2DZd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total loss before income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(33,762&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zWxVPdswhZGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYDZ9Jadipe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the income tax provision for the years ended December 31, 2023 and 2022 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zO05iQweijl6" style="display: none"&gt;Schedule
of Income Tax Provision&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230101__20231231_zqBXVBFcUOLk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231_zgYoS1eO7HAc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCITEBz04w_zGN0u9zFCaza" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4296"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4297"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCITEBz04w_zh67G1FT8SPh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Current state&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4299"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4300"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentForeignTaxExpenseBenefit_pn3n3_maCITEBz04w_ziHBSRkZEypi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 1pt"&gt;Current foreign&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;18&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;17&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pn3n3_mtCITEBz04w_maITEBzoUt_zV2WZZOV3jHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Total current tax provision (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_z5t8b0vJCsI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4308"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4309"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zz1dXMgyjO5h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred state&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4311"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4312"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zfo1x4Qtobcf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Deferred foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4314"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4315"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredOtherTaxExpenseBenefit_iT_pn3n3_mtDOTEBz8fT_maITEBzoUt_zipeTfX0cS11" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Total deferred tax provision (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4317"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4318"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtITEBzoUt_zFVUU1sujEae" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zlok7NUULzo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuhQpduCjgzk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zKcFvDGMybEj" style="display: none"&gt;Schedule
of Reconciliation of Income Tax Benefit&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zgp3TP5wiPX9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231_z6ojoo4FoUtb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maA91O_zNocUp5KIQej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Tax provision at statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maA91O_zTekL1evozOc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;State taxes, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.2&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_pid_dp_uPure_maA91O_z9DpQZJhwmlf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_pid_dp_uPure_maA91O_zK7kcATDWhu" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Permanent differences - other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_pid_dp_uPure_maA91O_zJXgkx4VyDic" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10.5&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_pid_dp_uPure_maA91O_zAwT4x19t7M4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maA91O_zbxozSWzftM7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_pid_dp_uPure_maA91O_zGZOfZDfpHi9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1.2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtA91O_z2AjT5u3dcB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective income tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-0.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-0.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zIDiT5N71Ckg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSK7CbxAzVsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are as follows
(in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zErVYRkVefe4" style="display: none"&gt;Schedule
of Components of Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_zuw1iEzGQ6T" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20221231_zus8BdIoMwTl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zJCjM3nGYhn8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzqvH_zaLcZourTz2h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;7,393&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalizedResearchCosts_iI_pn3n3_maDTAGzqvH_zIDBvLOxQ3r" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Capitalized research costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsFixedAssets_iI_pn3n3_maDTAGzqvH_zuVmYqAMaLt6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Fixed assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzqvH_zwenP6nEqmKh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzqvH_maDTANzhf6_zTdbmAIfpww6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Total gross deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,759&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,601&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzhf6_zwXYLUTJSVRa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less: valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(7,753&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,597&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzhf6_maDTALNzTQu_zL2kMVGTT5uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zMvwfAqU62Hj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iI_pn3n3_zDmqy1gEjvyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pn3n3_di_msDTALNzTQu_zZmIn0dnsln1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzTQu_zWflyjbJOhU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4388"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AE_ztSceRVsz8k7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has generated both federal and state net operating losses (NOL) of approximately $&lt;span id="xdx_90D_eus-gaap--FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pn5n6_c20230101__20231231_zVehpsR5P5ah" title="Federal and state net operating losses"&gt;31.3&lt;/span&gt; million and $&lt;span id="xdx_909_eus-gaap--FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pn5n6_c20220101__20221231_zHX0bWmkbQuk" title="Federal and state net operating losses"&gt;15.9&lt;/span&gt; million, respectively.
The federal NOLs include $&lt;span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231_zOZ9Jq2eHiI3" title="Operating loss carry forward"&gt;12.2&lt;/span&gt; million which expire at various dates beginning in 2030 and $&lt;span id="xdx_90B_ecustom--OperatingLossCarryForwardIndefinitely_iI_pn5n6_c20231231_zG37F84hkPse" title="Operating loss carry forward indefinitely"&gt;19.1&lt;/span&gt; million which carry forward indefinitely.
The state NOLs expire at various dates beginning in 2030.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ownership
changes, as defined in the Internal Revenue Code Section 382, could limit the amount of NOLs that can be utilized annually to offset
future taxable income. Generally, an ownership change occurs when the ownership percentage of 5% or greater stockholders increases by
more than &lt;span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe_dp_uPure_c20230101__20231231_z4v0DuH9cosg" title="Effective federal income tax percentage"&gt;50&lt;/span&gt;% over a three-year period. The Company&#x2019;s ability to utilize its federal and state tax attributes may be limited by
ownership changes that have occurred in the past or may occur in the future. The Company has not yet conducted a formal study of whether,
or to what extent, past changes in control of the Company impacts its ability to utilize NOL carryforwards because such NOL carryforwards
cannot be utilized until the Company achieves profitability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
has evaluated the positive and negative evidence bearing upon the realizability of the Company&#x2019;s net deferred tax assets, which
are comprised primarily of net operating loss carryforwards and research costs capitalized for tax purposes. Management has considered
the Company&#x2019;s history of cumulative operating losses and estimated future tax losses and has determined that it is more likely
than not that the Company will not recognize the benefits of the net deferred tax assets. As a result, the Company has recorded a full
valuation allowance at December 31, 2023 and 2022. The valuation allowance increased by $&lt;span id="xdx_900_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn5n6_c20230101__20231231_zR3Kx372k8Y2" title="Deferred tax assets valuation allowance"&gt;1.2&lt;/span&gt; million in 2023 due to the increase in deferred
tax assets, primarily due to net operating loss carryforwards and capitalized research costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, the Company had no uncertain tax positions. The Company recognizes both interest and penalties associated
with unrecognized tax benefits as a component of income tax expense. The Company has not recorded any interest or penalties for unrecognized
tax benefits since its inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company files federal, various state, and Canada tax returns. In the U.S., all tax years since inception remain open to examination by
major tax jurisdictions to which the Company is subject, as carryforward attributes generated in years past may still be adjusted upon
examination by the respective tax authorities if they have or will be used in a future period. In Canada, the Company is generally no
longer subject to income tax examinations for the years before 2020. The Company is currently not under examination by any tax authority.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004283">&lt;p id="xdx_893_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zz2CDF9Xeoi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has operations in the United States and Canada. The components of income (loss) before the provision for income taxes are as
follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zQTOOeov4NVh" style="display: none"&gt;Schedule
of Components of Income (Loss) Before Provision for Income Tax&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_zFL9j071bVj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20220101__20221231_zsYuUmfCvrs9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pn3n3_maILFCOzkfc_z8EUKV3XXp13" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;United States&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(33,827&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(30,456&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pn3n3_maILFCOzkfc_zvC4tlK0ELh9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;65&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pn3n3_mtILFCOzkfc_z10nWaDT2DZd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total loss before income taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(33,762&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(30,434&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004285"
      unitRef="USD">-33827000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004286"
      unitRef="USD">-30456000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004288"
      unitRef="USD">65000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004289"
      unitRef="USD">22000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004291"
      unitRef="USD">-33762000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004292"
      unitRef="USD">-30434000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004294">&lt;p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYDZ9Jadipe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of the income tax provision for the years ended December 31, 2023 and 2022 were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zO05iQweijl6" style="display: none"&gt;Schedule
of Income Tax Provision&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20230101__20231231_zqBXVBFcUOLk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231_zgYoS1eO7HAc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCITEBz04w_zGN0u9zFCaza" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Current federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4296"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4297"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCITEBz04w_zh67G1FT8SPh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Current state&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4299"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4300"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--CurrentForeignTaxExpenseBenefit_pn3n3_maCITEBz04w_ziHBSRkZEypi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 1pt"&gt;Current foreign&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;18&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;17&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pn3n3_mtCITEBz04w_maITEBzoUt_zV2WZZOV3jHc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Total current tax provision (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_z5t8b0vJCsI6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4308"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4309"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zz1dXMgyjO5h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred state&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4311"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4312"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zfo1x4Qtobcf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Deferred foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4314"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4315"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredOtherTaxExpenseBenefit_iT_pn3n3_mtDOTEBz8fT_maITEBzoUt_zipeTfX0cS11" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Total deferred tax provision (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4317"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4318"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtITEBzoUt_zFVUU1sujEae" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total income tax provision (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;18&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;17&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004302"
      unitRef="USD">18000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004303"
      unitRef="USD">17000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004305"
      unitRef="USD">18000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004306"
      unitRef="USD">17000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004320"
      unitRef="USD">18000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004321"
      unitRef="USD">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004323">&lt;p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuhQpduCjgzk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zKcFvDGMybEj" style="display: none"&gt;Schedule
of Reconciliation of Income Tax Benefit&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zgp3TP5wiPX9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231_z6ojoo4FoUtb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maA91O_zNocUp5KIQej" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Tax provision at statutory rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maA91O_zTekL1evozOc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;State taxes, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.2&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_pid_dp_uPure_maA91O_z9DpQZJhwmlf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Stock-based compensation expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_pid_dp_uPure_maA91O_zK7kcATDWhu" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Permanent differences - other&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.2&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_pid_dp_uPure_maA91O_zJXgkx4VyDic" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10.5&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_pid_dp_uPure_maA91O_zAwT4x19t7M4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in fair value of warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maA91O_zbxozSWzftM7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Change in valuation allowance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.0&lt;/td&gt;&lt;td style="text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_pid_dp_uPure_maA91O_zGZOfZDfpHi9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1.2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtA91O_z2AjT5u3dcB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Effective income tax rate&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-0.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-0.1&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004325"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004326"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004328"
      unitRef="Pure">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004329"
      unitRef="Pure">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004331"
      unitRef="Pure">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004332"
      unitRef="Pure">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004334"
      unitRef="Pure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004335"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004337"
      unitRef="Pure">-0.110</ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes>
    <ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004338"
      unitRef="Pure">-0.105</ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes>
    <ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004340"
      unitRef="Pure">-0.057</ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants>
    <ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004341"
      unitRef="Pure">-0.058</ONMD:EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004343"
      unitRef="Pure">-0.034</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004344"
      unitRef="Pure">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004346"
      unitRef="Pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004347"
      unitRef="Pure">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsOther>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004349"
      unitRef="Pure">-0.001</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004350"
      unitRef="Pure">-0.001</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004352">&lt;p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSK7CbxAzVsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are as follows
(in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B0_zErVYRkVefe4" style="display: none"&gt;Schedule
of Components of Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_zuw1iEzGQ6T" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20221231_zus8BdIoMwTl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zJCjM3nGYhn8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzqvH_zaLcZourTz2h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Net operating loss carryforwards&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;7,393&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalizedResearchCosts_iI_pn3n3_maDTAGzqvH_zIDBvLOxQ3r" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Capitalized research costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;337&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxAssetsFixedAssets_iI_pn3n3_maDTAGzqvH_zuVmYqAMaLt6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Fixed assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzqvH_zwenP6nEqmKh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzqvH_maDTANzhf6_zTdbmAIfpww6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Total gross deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,759&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,601&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzhf6_zwXYLUTJSVRa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Less: valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(7,753&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6,597&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzhf6_maDTALNzTQu_zL2kMVGTT5uj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Net deferred tax assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zMvwfAqU62Hj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iI_pn3n3_zDmqy1gEjvyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pn3n3_di_msDTALNzTQu_zZmIn0dnsln1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(6&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(4&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzTQu_zWflyjbJOhU8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4388"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004357"
      unitRef="USD">7393000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004358"
      unitRef="USD">6551000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <ONMD:DeferredTaxAssetsCapitalizedResearchCosts
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004360"
      unitRef="USD">337000</ONMD:DeferredTaxAssetsCapitalizedResearchCosts>
    <ONMD:DeferredTaxAssetsFixedAssets
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004363"
      unitRef="USD">25000</ONMD:DeferredTaxAssetsFixedAssets>
    <ONMD:DeferredTaxAssetsFixedAssets
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004364"
      unitRef="USD">34000</ONMD:DeferredTaxAssetsFixedAssets>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004366"
      unitRef="USD">4000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004367"
      unitRef="USD">16000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004369"
      unitRef="USD">7759000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004370"
      unitRef="USD">6601000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004372"
      unitRef="USD">7753000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004373"
      unitRef="USD">6597000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004375"
      unitRef="USD">6000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004376"
      unitRef="USD">4000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004381"
      unitRef="USD">-6000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004382"
      unitRef="USD">-4000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004384"
      unitRef="USD">6000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004385"
      unitRef="USD">4000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="-5"
      id="Fact004390"
      unitRef="USD">31300000</us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="-5"
      id="Fact004392"
      unitRef="USD">15900000</us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="Fact004394"
      unitRef="USD">12200000</us-gaap:OperatingLossCarryforwards>
    <ONMD:OperatingLossCarryForwardIndefinitely
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="Fact004396"
      unitRef="USD">19100000</ONMD:OperatingLossCarryForwardIndefinitely>
    <ONMD:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004398"
      unitRef="Pure">0.50</ONMD:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="From2023-01-012023-12-31"
      decimals="-5"
      id="Fact004400"
      unitRef="USD">1200000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:LongTermDebtTextBlock contextRef="From2023-01-012023-12-31" id="Fact004402">&lt;p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zC9TDOK2uHLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.
&lt;span id="xdx_82E_zDVmmJ93akyj"&gt;Convertible Debt&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Convertible
Promissory Notes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2019
Notes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
November 2019, the Company entered into a convertible promissory note (the &#x201c;2019 Note&#x201d;) agreement with a related party investor.
The total amount of the 2019 Note is $&lt;span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20191130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesMember_z7BHlTR6w47a" title="Convertible promissory note"&gt;1.5&lt;/span&gt; million. The 2019 Note is unsecured and bears interest at a rate of four percent annually from
the date of issuance until the outstanding principal is paid or converted. The 2019 Note matures on January 1, 2025. The 2019 Note shall
automatically convert into the next offering of preferred stock upon closing of such next equity financing. The number of shares of preferred
stock to be issued upon conversion shall be equal to the number obtained by dividing the outstanding principal and unpaid accrued interest
owed on the date of conversion, by the conversion price. The conversion price is 100 percent of the lowest price per share paid for the
next equity preferred stock by other investors in the next equity financing. In the event that prior to the conversion or repayment of
amounts owed, the Company completes a financing transaction in which the Company sells equity securities but such transaction does not
qualify as next equity financing (i.e., an &#x201c;alternative financing&#x201d;), then the principal and unpaid accrued interest may (upon
written election of the purchaser holding the 2019 Note) convert into the securities issued by the Company in the alternative financing.
The number of alternative financing equity securities to be issued upon such conversion shall be equal to the number obtained by dividing
the outstanding principal and unpaid accrued interest owed by an amount equal to 100 percent multiplied by the lowest price per share
at which the alternative financing equity securities are sold and issued for cash in the alternative financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;2022
Notes and 2023 Notes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2022, the Company entered into convertible promissory notes with related party investors totaling $&lt;span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zaEIMSCzD1wk"&gt;4.7
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million and unrelated party investors totaling
$&lt;span id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z84gLen9mjC5"&gt;0.4
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million (each investor, a &#x201c;Purchaser&#x201d;)
(the &#x201c;2022 Notes&#x201d;). During 2023, the Company entered into various convertible promissory notes with related party investors
totaling $&lt;span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zScIJdljMyq1"&gt;2.3
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million and unrelated party investors totaling
$&lt;span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zPiEqF6dGaxa"&gt;1.9
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million (the &#x201c;2023 Notes&#x201d;, and together
with the 2019 Notes and 2022 Notes, the &#x201c;Convertible Promissory Notes&#x201d;). The 2022 Notes and 2023 Notes issued are unsecured
and bear an interest rate of six percent annually from the date of issuance until the outstanding principal is paid or converted. On
November 11, 2022, the 2022 Notes were amended and restated in order to (i) provide for the sale and issuance to Purchasers of additional
convertible promissory notes and warrants to purchase shares of the Company&#x2019;s capital stock, (ii) provide for the sale and issuance
of warrants to purchase shares of the Company&#x2019;s common stock at an exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221111__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zMg9smYsOPXi"&gt;1.00
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share to Purchasers who purchased 2022 Notes
between January 1, 2022 and November 11, 2022; and (iii) &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20221110__20221111__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zM9SsSGgiV91"&gt;extend
the maturity date of all outstanding 2022 Notes from December 31, 2022 to March 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
principal and unpaid accrued interest on each of the 2022 Notes and 2023 Notes will convert: (i) automatically, upon the Company&#x2019;s
issuance of equity securities (the &#x201c;Next Equity Financing&#x201d;) in a single transaction, or series of related transactions, with
aggregate gross proceeds to the Company of at least $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20221110__20221111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zb9buOx6XVB7" title="Proceeds from equity financing"&gt;5,000,000&lt;/span&gt;, into shares of the Company&#x2019;s capital stock issued to investors
in the Next Equity Financing, at a conversion price equal to the lesser of (A) &lt;span id="xdx_902_ecustom--EquityFinancingDescription_c20221110__20221111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zFfxmD1ydLoc" title="Equity financing, description"&gt;a 20% discount to the lowest price per share of shares
sold in the Next Equity Financing, or (B) $2.50 per share; (ii) at the noteholder&#x2019;s option, in the event of a defined Corporate
Transaction (as defined in the next paragraph) while the 2022 Notes and 2023 Notes remain outstanding, into shares of the Company&#x2019;s
Series A-2 Preferred Stock at a conversion price equal to $2.50 per share; and (iii) at the noteholder&#x2019;s option, on or after the
maturity date while the 2022 Notes and 2023 Notes remains outstanding, into shares of the Company&#x2019;s Series A-2 Preferred Stock
at a conversion price equal to $2.50 per share&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
a Corporate Transaction occurs before the repayment or conversion of the 2022 Notes and 2023 Notes, the Company will pay at the closing
of the Corporate Transaction to each noteholder that elects not to convert its 2022 Notes and 2023 Notes in connection with such Corporate
Transaction an amount equal to the outstanding principal amount of such noteholder&#x2019;s Note plus a 20% premium. &#x201c;Corporate
Transaction&#x201d; means (a) a sale by the Company of all or substantially all of its assets, (b) a merger of the Company with or into
another entity (if after such merger the holders of a majority of the Company&#x2019;s voting securities immediately prior to the transaction
do not hold a majority of the voting securities of the successor entity) or (c) the transfer of more than 50% of the Company&#x2019;s
voting securities to a person or group.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the issuance of the 2022 Notes and 2023 Notes, the Company also issued &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zm5Ff5qL1Vgf" title="Warrant issued"&gt;2,056,000&lt;/span&gt; and &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zFmpnIUAy6Ta" title="Warrant issued"&gt;1,670,000&lt;/span&gt; warrants (the &#x201c;Convertible Notes Warrants&#x201d;) in 2022 and 2023, respectively, with an exercise
price of $&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zP4hBCP8Ullf" title="Warrant exercise price"&gt;&lt;span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zBfU8sqpchoa" title="Warrant exercise price"&gt;1.00&lt;/span&gt;&lt;/span&gt; per share. The expiration date of the Convertible Notes Warrant is the earliest to occur the expiration of the
five-year period following the date of issuance, the closing of a firm commitment underwritten public offering of the
Company&#x2019;s Common Stock; or the closing of an Corporation Transaction. The Convertible Notes Warrants when exercised entitles
the holder to one share of the Company&#x2019;s Common Stock. The Convertible Notes Warrants include anti-dilutive measure to address
stock dividends, stock splits, and additional shares of Common Stock due to reorganization of the Company. In the case of
reclassification or reorganization, each holder shall be entitled to receive, in lieu of stock or other securities and property
receivable, the stock or other securities or property to which such holder would have been entitled if the holder had exercised the
Convertible Notes Warrants immediately prior. The Convertible Notes Warrants will terminate at the earliest of (1) the expiration of
five-year period following the date of issuance, (2) the closing of a firm commitment underwritten public offering of the
Company&#x2019;s Common Stock; (3) the closing of a sale of the Company. The holders of the Convertible Notes Warrants are not
permitted to sell, pledge, distribute, offer for sale, transfer, or otherwise dispose of the Convertible Notes Warrants in the
absence of (i) an effective registration statement under the Securities Act, or (ii) an opinion of counsel, satisfactory to the
Company and to be provided at the sole cost of the holder, that such registration and qualification are not required. Furthermore,
neither the Convertible Notes Warrants nor any rights may be assigned, conveyed, or transferred, in whole or in part, without the
Company&#x2019;s prior written consent. See additional information on the accounting for the warrants in Note 10.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Promissory Notes were issued for general working capital purposes. The Company elected the FVO of accounting for its Convertible
Promissory Notes. Under the FVO election, the financial instrument is initially measured at its issue-date estimated fair value and subsequently
remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value adjustment is presented
as a single line item within other (income) expenses, net in the accompanying consolidated statements of operations under the caption
change in fair value of convertible debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022 the fair value of the 2019 Notes and 2022 Notes was $&lt;span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zBi7Qikvai4j"&gt;26.2&lt;/span&gt; million which was included in both short-term and long-term
liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the Convertible Promissory Notes were converted pursuant to their provision in connection with the Business Combination
between Data Knights and the Company and were no longer outstanding as of December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PIPE
Notes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
June 2023, the Company entered into the PIPE SPA in which the Company was required to sell senior secured convertible notes and warrants
to directors of the Company. The PIPE SPA stipulates a collateral security agreement between the Company and the directors for punctual
payment and performance by the Company on its obligations to the Directors. The intellectual property of the Company serves as the collateral
for the PIPE Notes. The PIPE Notes and related warrants were issued through a PIPE financing transaction, which is a form of debt and
equity offering under an exemption in the securities laws for qualifying private placements by issuers of publicly traded securities.
On November 7, 2023, the Company received a total of $&lt;span id="xdx_900_eus-gaap--ProceedsFromNotesPayable_pn5n6_c20231106__20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_z8k0D0yOkjKc" title="Proceeds from PIPE notes payable"&gt;1.5&lt;/span&gt; million from the directors in exchange for PIPE Notes in the aggregate principal
amount of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zlkShAiGVR8h" title="Principal amount of notes payable"&gt;1.6&lt;/span&gt; million (plus accrued interest of $&lt;span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn5n6_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zvbTkj1vYl62" title="Accrued interest"&gt;0.1&lt;/span&gt; million) and &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zyED3tIWHpzj" title="Warrants to acquire common stock"&gt;95,745&lt;/span&gt; warrants to acquire Common Stock. &lt;span id="xdx_90F_eus-gaap--DebtConversionDescription_c20231106__20231107_zLTTrexhiRe2"&gt;The PIPE Notes are convertible
into shares of Common Stock at the PIPE Investor&#x2019;s election at a conversion price equal to the lower of (i) $10.00 per share, and
(ii) 92.5% of the lowest VWAP for the ten (10) trading days immediately preceding the conversion date, subject to the floor price of
$1.14 (representing 20% of the closing price of the Common Stock on the last trading day before the closing of the Business Combination),
or the alternative conversion ratio of the greater of the floor price and the lesser of 80% of the VWAP of the common stock as of the
trading day and 80% of the price computed as the quotient of the sum of the VWAP of the Common Stock for each of the three trading days
with the lowest VWAP of the Common Stock during the fifteen consecutive trading day period ending and including the trading day immediately
preceding the delivery or deemed delivery of the applicable conversion notice, divided by three&lt;/span&gt;. All such determinations are to be appropriately
adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases
or increases the Common Stock. The PIPE Notes mature on the first anniversary of the issuance date, or November 7, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company elected the FVO of accounting for its PIPE Notes. Under the FVO election, the financial instrument is initially measured at its
issue-date estimated fair value and subsequently remeasured at estimated fair value on a recurring basis at each reporting period date.
The estimated fair value adjustment is presented as a single line item within other (income) expenses, net in the accompanying consolidated
statements of operations under the caption change in fair value of pipe notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 the fair value of the PIPE Notes was $&lt;span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231_zgoCh02dX8d6" title="PIPE notes payable"&gt;1.6&lt;/span&gt; million which was included in current liabilities on the consolidated
balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2019-11-30_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNotesMember"
      decimals="-5"
      id="Fact004404"
      unitRef="USD">1500000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesMember"
      decimals="-5"
      id="Fact004405"
      unitRef="USD">4700000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyTwoNotesMember"
      decimals="-5"
      id="Fact004406"
      unitRef="USD">400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_TwentyTwentyThreeNotesMember"
      decimals="-5"
      id="Fact004407"
      unitRef="USD">2300000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember_custom_TwentyTwentyThreeNotesMember"
      decimals="-5"
      id="Fact004408"
      unitRef="USD">1900000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-11-11_custom_TwentyTwentyTwoNotesMember"
      decimals="INF"
      id="Fact004409"
      unitRef="USDPShares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="From2022-11-102022-11-11_custom_TwentyTwentyTwoNotesMember"
      id="Fact004410">extend
the maturity date of all outstanding 2022 Notes from December 31, 2022 to March 31, 2023.</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="From2022-11-102022-11-11_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember"
      decimals="0"
      id="Fact004412"
      unitRef="USD">5000000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <ONMD:EquityFinancingDescription
      contextRef="From2022-11-102022-11-11_us-gaap_RelatedPartyMember_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember"
      id="Fact004414">a 20% discount to the lowest price per share of shares
sold in the Next Equity Financing, or (B) $2.50 per share; (ii) at the noteholder&#x2019;s option, in the event of a defined Corporate
Transaction (as defined in the next paragraph) while the 2022 Notes and 2023 Notes remain outstanding, into shares of the Company&#x2019;s
Series A-2 Preferred Stock at a conversion price equal to $2.50 per share; and (iii) at the noteholder&#x2019;s option, on or after the
maturity date while the 2022 Notes and 2023 Notes remains outstanding, into shares of the Company&#x2019;s Series A-2 Preferred Stock
at a conversion price equal to $2.50 per share</ONMD:EquityFinancingDescription>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember"
      decimals="INF"
      id="Fact004416"
      unitRef="Shares">2056000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember"
      decimals="INF"
      id="Fact004418"
      unitRef="Shares">1670000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember"
      decimals="INF"
      id="Fact004420"
      unitRef="USDPShares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember"
      decimals="INF"
      id="Fact004422"
      unitRef="USDPShares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember"
      decimals="-5"
      id="Fact004423"
      unitRef="USD">26200000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-11-062023-11-07_srt_DirectorMember"
      decimals="-5"
      id="Fact004425"
      unitRef="USD">1500000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-11-07_srt_DirectorMember"
      decimals="-5"
      id="Fact004427"
      unitRef="USD">1600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2023-11-07_srt_DirectorMember"
      decimals="-5"
      id="Fact004429"
      unitRef="USD">100000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-11-07_srt_DirectorMember"
      decimals="INF"
      id="Fact004431"
      unitRef="Shares">95745</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtConversionDescription contextRef="From2023-11-062023-11-07" id="Fact004432">The PIPE Notes are convertible
into shares of Common Stock at the PIPE Investor&#x2019;s election at a conversion price equal to the lower of (i) $10.00 per share, and
(ii) 92.5% of the lowest VWAP for the ten (10) trading days immediately preceding the conversion date, subject to the floor price of
$1.14 (representing 20% of the closing price of the Common Stock on the last trading day before the closing of the Business Combination),
or the alternative conversion ratio of the greater of the floor price and the lesser of 80% of the VWAP of the common stock as of the
trading day and 80% of the price computed as the quotient of the sum of the VWAP of the Common Stock for each of the three trading days
with the lowest VWAP of the Common Stock during the fifteen consecutive trading day period ending and including the trading day immediately
preceding the delivery or deemed delivery of the applicable conversion notice, divided by three</us-gaap:DebtConversionDescription>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="Fact004434"
      unitRef="USD">1600000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004436">&lt;p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zbByYFCJ25A1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&lt;span id="xdx_82A_zufdttgdxKAf"&gt;Canadian Emergency Business Loan Act (&#x201c;CEBA&#x201d;)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
December 2020, the Company applied for and received a $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_z51TPmXNcXJk" title="Proceeds from loans"&gt;0.06&lt;/span&gt; CAD ($&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zxvovi9W7qR6" title="Proceeds from loans"&gt;0.04&lt;/span&gt; USD) equivalent CEBA loan. The loan was provided by the Government
of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and better position
them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through December 31,
2023. If the loan was paid back by January 18, 2024, $&lt;span id="xdx_900_eus-gaap--DebtInstrumentDecreaseForgiveness_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zcINTLeES6l7" title="Forgiven of loan"&gt;0.01&lt;/span&gt; million of the loan would have been forgiven. If the loan was not paid back
by January 18, 2024, the full $&lt;span id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zilxXcAVSdJd" title="Loan repayable"&gt;0.04&lt;/span&gt; million loan would have been converted to loan repayable over &lt;span id="xdx_902_eus-gaap--DebtInstrumentTerm_dc_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zSLYP65LwAj" title="Loan payment term"&gt;three years&lt;/span&gt; with a &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zFaaRuPr70p6" title="Interest rate"&gt;5&lt;/span&gt;% interest rate.
The loan was paid back prior to January 18, 2024. At December 31, 2023 the loan was classified as Canada Emergency Business Loan Act
under other long-term liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for the loan as debt in accordance with FASB ASC 470, &lt;i&gt;Debt&lt;/i&gt;, and accrued interest in accordance with the interest
method under FASB ASC 835-30.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfUnsecuredDebt
      contextRef="From2020-12-012020-12-31_custom_CEBALoanMember"
      decimals="-4"
      id="Fact004438"
      unitRef="CAD">60000.00</us-gaap:ProceedsFromIssuanceOfUnsecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfUnsecuredDebt
      contextRef="From2020-12-012020-12-31_custom_CEBALoanMember"
      decimals="-4"
      id="Fact004440"
      unitRef="USD">40000.00</us-gaap:ProceedsFromIssuanceOfUnsecuredDebt>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="From2020-01-012020-12-31_custom_CEBALoanMember"
      decimals="-4"
      id="Fact004442"
      unitRef="USD">10000.00</us-gaap:DebtInstrumentDecreaseForgiveness>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="From2020-01-012020-12-31_custom_CEBALoanMember"
      decimals="-4"
      id="Fact004444"
      unitRef="USD">40000.00</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2020-01-012020-12-31_custom_CEBALoanMember"
      id="Fact004446">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-12-31_custom_CEBALoanMember"
      decimals="INF"
      id="Fact004448"
      unitRef="Pure">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004450">&lt;p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zi7ZxxHRJrQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.
&lt;span id="xdx_82A_zVYHd5BfLrad"&gt;Stockholders&#x2019; Deficit&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2022, &lt;span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziD1ppxE4qj9" title="Common stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKN7exbp24Mg" title="Common stock, shares outstanding"&gt;4,033,170&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_znKxiQssX0m8" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGvP0XY6gBJ8" title="Preferred stock, shares outstanding"&gt;6,255,880&lt;/span&gt;&lt;/span&gt; shares of Common Stock and Preferred Stock were issued and outstanding, respectively (after
giving effect to the exchange ratio in Note 3). Subsequent to the Business Combination, the Company was authorized to issue up to &lt;span id="xdx_905_eus-gaap--CapitalUnitsAuthorized_iI_pid_c20231107_zU4mp57hBj43" title="Capital stock authorized"&gt;101,000,000&lt;/span&gt;
shares of capital stock, par value $&lt;span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231107_zKKAc21qZoca" title="Capital stock par value"&gt;0.0001&lt;/span&gt; per share, consisting of (a) &lt;span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231107_z4HVtrbs4vie" title="Common stock, shares authorized"&gt;100,000,000&lt;/span&gt; shares of Common Stock and (b) &lt;span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231107_zMDtvyv8Amy2" title="Preferred stock, shares authorized"&gt;1,000,000 &lt;/span&gt;shares of
preferred stock (the &#x201c;Preferred Stock&#x201d;). As of December 31, 2023, &lt;span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zixxKZSE5Ar1" title="Common stock, shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_znhu3H33Aaqe" title="Common stock, shares outstanding"&gt;23,572,232&lt;/span&gt;&lt;/span&gt; shares of Common Stock were issued and outstanding.
The Company had &lt;span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zK95ULydJLX2" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt; Preferred Stock outstanding at December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series
A-2 Preferred Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s previously issued and outstanding Series A-2 preferred stock included a $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBKJPxLe8OA6" title="Share price"&gt;0.15&lt;/span&gt; per share annual noncumulative dividend
when and if declared by the Board of Directors. &lt;span id="xdx_906_eus-gaap--DividendsPreferredStock_do_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zdsKi8CzXLs5" title="Dividends"&gt;&lt;span id="xdx_90A_eus-gaap--DividendsPreferredStock_do_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zflOYliUMIxk" title="Dividends"&gt;No&lt;/span&gt;&lt;/span&gt; dividends were declared in the years ended December 31, 2023 or December 31, 2022.
The Series A-2 preferred stock also included a liquidation preference of 1.25 times the original issue price plus any declared but unpaid
dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and had a preference upon
liquidation over Series A-1 preferred stock and Common Stock. Each share of Series A-2 preferred stock could have been converted into
equal shares of Common Stock at the option of the holder at any time. In addition, the Series A-2 preferred stock shares were automatically
convertible into common shares upon the sale of shares of common stock to the public at the then applicable conversion price in a firm
commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, resulting in at least
$&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn5n6_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zlRRO4uYC9e1" title="Proceeds"&gt;20&lt;/span&gt; million in proceeds, net of underwriting discounts and commissions. Each share of Series A-2 preferred stock had voting rights equal
to the number of shares of Common Stock then issuable upon conversion of such share of Series A-2 preferred stock. The Company was obligated
to redeem shares of Series A-2 Preferred Stock upon liquidation, dissolution, or winding-up of the Company, or a merger, consolidation,
lease or transfer of the Company (a &#x201c;Deemed Liquidation Event&#x201d;), unless a majority of the holders of Series A-2 Preferred
Stock and a majority of the holders of Series A-1 Preferred Stock consent otherwise. As of December 31, 2022, the liquidation preference
of the Series A-2 Preferred Stock was $&lt;span id="xdx_909_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn5n6_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMyVwPLyQKs4" title="Liquidation preference amount"&gt;10.7&lt;/span&gt; million (after giving effect to the Business Combination exchange ratio described Note 3).
In connection with the Business Combination, the shares of &lt;span id="xdx_902_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8MXT69UcHY1" title="Convertible preferred stock terms of conversion"&gt;Series A-2 preferred stock were converted into Common Stock using an exchange
ratio of 1:1.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Series
A-1 Preferred Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s previously issued and outstanding Series A-1 preferred stock included a $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9DcjHvxUBuj" title="Share price"&gt;0.15&lt;/span&gt; per share annual noncumulative dividend
when and if declared by the Board of Directors. &lt;span id="xdx_90B_eus-gaap--DividendsPreferredStock_do_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zTGP1H9Th8S3" title="Dividends"&gt;&lt;span id="xdx_90F_eus-gaap--DividendsPreferredStock_do_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zCjKSq33MIH3" title="Dividends"&gt;No&lt;/span&gt;&lt;/span&gt; dividends were declared in the years ended December 31, 2023 or December 31 2022.
The Series A-1 preferred stock also included a liquidation preference of 1.25 times the original issue price plus any declared but unpaid
dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and had a preference upon
liquidation over Common Stock. Each share of Series A-1 preferred stock could have been converted into equal shares of Common Stock at
the option of the holder at any time. In addition, the Series A-1 preferred stock shares were automatically convertible into common shares
upon the sale of shares of common stock to the public at the then applicable conversion price in a firm commitment underwritten public
offering pursuant to an effective registration statement under the Securities Act, resulting in at least $&lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn5n6_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrhmugFeTule" title="Proceeds"&gt;20&lt;/span&gt; million in proceeds, net
of underwriting discounts and commissions. Each share of Series A-1 preferred stock had voting rights equal to the number of shares of
Common Stock then issuable upon conversion of such share of Series A-1 preferred stock. The Company was obligated to redeem shares of
Series A-1 Preferred Stock upon a Deemed Liquidation Event, unless a majority of the holders of Series A-1 Preferred Stock consent otherwise.
As of December 31, 2022, the Series A-1 preferred stock has a liquidation preference of $&lt;span id="xdx_90B_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn5n6_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zaPzycsYQTBi" title="Liquidation preference amount"&gt;8.9&lt;/span&gt; million (after giving effect to the Business
Combination exchange ratio described in Note 3). In connection with the Business Combination, the shares of &lt;span id="xdx_908_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zuwR6ZzPZde3" title="Convertible preferred stock terms of conversion"&gt;Series A-1 preferred stock
were converted into Common Stock using an exchange ratio of 1:1.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004452"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact004454"
      unitRef="Shares">4033170</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact004456"
      unitRef="Shares">6255880</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact004458"
      unitRef="Shares">6255880</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CapitalUnitsAuthorized
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004460"
      unitRef="Shares">101000000</us-gaap:CapitalUnitsAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004462"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004464"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004466"
      unitRef="Shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004468"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004470"
      unitRef="Shares">23572232</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004472"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="INF"
      id="Fact004474"
      unitRef="USDPShares">0.15</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="0"
      id="Fact004476"
      unitRef="USD">0</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2022-01-012022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="0"
      id="Fact004478"
      unitRef="USD">0</us-gaap:DividendsPreferredStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="-5"
      id="Fact004480"
      unitRef="USD">20000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="AsOf2022-12-31_custom_SeriesATwoPreferredStockMember"
      decimals="-5"
      id="Fact004482"
      unitRef="USD">10700000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="From2023-01-012023-12-31_custom_SeriesATwoPreferredStockMember"
      id="Fact004484">Series A-2 preferred stock were converted into Common Stock using an exchange
ratio of 1:1.</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="INF"
      id="Fact004486"
      unitRef="USDPShares">0.15</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="0"
      id="Fact004488"
      unitRef="USD">0</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2022-01-012022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="0"
      id="Fact004490"
      unitRef="USD">0</us-gaap:DividendsPreferredStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="-5"
      id="Fact004492"
      unitRef="USD">20000000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:PreferredStockLiquidationPreferenceValue
      contextRef="AsOf2022-12-31_custom_SeriesAOnePreferredStockMember"
      decimals="-5"
      id="Fact004494"
      unitRef="USD">8900000</us-gaap:PreferredStockLiquidationPreferenceValue>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="From2023-01-012023-12-31_custom_SeriesAOnePreferredStockMember"
      id="Fact004496">Series A-1 preferred stock
were converted into Common Stock using an exchange ratio of 1:1.</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2023-01-012023-12-31" id="Fact004498">&lt;p id="xdx_805_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zn1CW1MJFz76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.
&lt;span&gt;Stock Based Compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_822_zs7tydbu9lU2" style="display: none"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2020, the Company adopted an equity incentive plan (the &#x201c;2020 Plan&#x201d;), which provided for the granting of incentive and nonqualified
stock options to employees, directors, and consultants of Legacy ONMD. As of December 31, 2020, the Company had reserved &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember_zDOj9LDparpd" title="Number of shares issued"&gt;3,000,000&lt;/span&gt; shares
of common stock under the 2020 Plan. Under the 2020 Plan, option awards were generally granted with an exercise price equal to the fair
market value of the Company&#x2019;s stock at the date of grant; those option awards generally vested with a range of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zlZpHg7eG1f4" title="Vesting period::XDX::P1Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4502"&gt;one&lt;/span&gt;&lt;/span&gt; to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zy90sXbISqYk" title="Vesting period"&gt;four years&lt;/span&gt;
of continuous service and had ten-year contractual terms. Certain option awards provided for accelerated vesting if there was a change
in control, as defined in the 2020 Plan. The 2020 Plan also permitted the granting of restricted stock and other stock-based awards.
Unexercised options were cancelled upon termination of employment and became available for reissuance under the 2020 Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;At
the Special Meeting &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;held on October 17, 2023&lt;span style="background-color: white"&gt;,
Data Knights shareholders considered and approved the OneMedNet Corporation 2022 Equity Incentive Plan (the &#x201c;2022 Plan&#x201d;)
and reserved an amount of shares of Common Stock equal to 10% of the number of shares of Common Stock of OneMedNet following the Business
Combination for issuance thereunder. The 2022 Plan was approved by the Legacy ONMD Board of Directors on October 17, 2023. The 2022 Plan
became effective immediately upon the Closing of the Business Combination and replaced the 2020 Plan.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z2t4WLtze2Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to options outstanding is summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zI0hPK0P8F83" style="display: none"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-bottom: 1pt"&gt;Outstanding as of December 31, 2021&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_z0U5wRYmtbh1" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Options outstanding, beginning balance"&gt;728,603&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zypioOXRPhOh" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20221231_z2shuwnGqzv7" style="padding-bottom: 1pt; width: 12%; text-align: right" title="Aggregate Intrinsic value, begining balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zkHMNrDUKqhe" style="text-align: right" title="Options, Granted - under the Plan"&gt;511,440&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zk4YloymnWac" style="text-align: right" title="Weighted average exercise price, granted"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zSOuwTZiIgnh" style="text-align: right" title="Options, Exercised - under the Plan"&gt;(6,648&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_zMm45h2raGe8" style="text-align: right" title="Weighted average exercise price, exercised"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231_z4SWf21Q8baj" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled"&gt;(319,539&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zCs3JyTynD6g" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zG6cgN86wjbc" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, beginning balance"&gt;913,856&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_ziK5f5y9plyi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, beginning balance"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20220101__20221231_zacYP68Ics54" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, ending balance"&gt;3,199&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zPkyqh888cac" style="text-align: right" title="Options, Exercised - under the Plan"&gt;(613,510&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zQAZULygsM78" style="text-align: right" title="Weighted average exercise price, exercised"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231_z2d2eoaUXYkb" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled"&gt;(300,346&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zqse2nLXHYZ5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding as of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zU6jFtbBUQul" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zWf8X159Qfye" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4542"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zdxFOEhSQHri" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic value, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4544"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Vested and exercisable as of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20230101__20231231_zN0GsflAab1" style="border-bottom: Black 1pt solid; text-align: right" title="Options vested and exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4546"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zGLHNwZ28Ntc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, vested and exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4548"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20230101__20231231_zbWHYtXkhaD8" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4550"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zYbHAJ80DLd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the years ended December 31, 2023 and 2022, the Company recorded stock-based compensation expense of $&lt;span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zmHPvBDFJHJ8" title="Stock-based compensation expense"&gt;0.4&lt;/span&gt; million and $&lt;span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8y6TFp8Ri1i" title="Stock-based compensation expense"&gt;0.3&lt;/span&gt; million, respectively,
on its outstanding stock options. The Company has determined its share-based payments to be a Level 3 fair value measurement. For the
year ended December 31, 2023 and 2022, the Company has used the Black-Scholes option pricing model and estimated no expected dividends
and the following weighted average assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z7nEjYXPSKbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zvdqLwiSHLH8" style="display: none"&gt;Schedule
of Fair Value of  Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zb4EqjAVvHcj" title="Expected life in years"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4558"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zv7TKOPtaZah" title="Risk-free interest rate"&gt;0.73&lt;/span&gt;% - &lt;span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zI0UX2ZfVXvg" title="Risk-free interest rate"&gt;2.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;% &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlxm0i4Fc2ii" title="Risk-free interest rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4564"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zhjGUBcEXN8j" title="Risk-free interest rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4566"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--EquitySecuritiesFvNiMeasurementTerm_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zwbvwcufSdP4" title="Expected life in years"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4568"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zn4w2yHn1Mt7" title="Expected life in years"&gt;1.36&lt;/span&gt; - &lt;span id="xdx_904_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zh6oP8V6f0u8" title="Expected life in years"&gt;1.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z2C4T4M15t91" title="Equity securities, measurement input"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4574"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zMW0leDnbjz9" title="Equity securities, measurement input"&gt;50.0&lt;/span&gt;% - &lt;span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zlG8ca1XMgD" title="Equity securities, measurement input"&gt;86.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;% &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zZbNHcszloYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 7, 2023, as part of the Business Combination, the 2020 Plan was cancelled and all vested shares were exercised and converted
at the appropriate conversion ratio to Common Stock of the Company. The Company issued shares of Common Stock of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231106__20231107_zg54JLj28jij" title="Options vested"&gt;543,057&lt;/span&gt; which represents
&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231107_zuvA5M6IYxvc" title="Options vested"&gt;613,510&lt;/span&gt; vested options less an exercise price of $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_pid_c20231107_z5yVFnwzTKTf" title="Options vested exercise price"&gt;1.00&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Restricted
Stock Awards&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
employees, directors and consultants have been awarded restricted stock. The restricted stock vesting consists of milestone and time-based
vesting as well as compensation for services performed by the Board of Directors. The following table summarizes restricted stock award
activity for the years ended December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zaIIOAu2S4uh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zXSVQhE5UcOj" style="display: none"&gt;Schedule of Restricted Stock Award Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average Grant&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Awards&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Date Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Nonvested as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zvfPYjAAeNEl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Outstanding, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4588"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAoAz1WPFED5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4590"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfX5vHFqtBEi" style="width: 14%; text-align: right" title="Number of Awards, Granted"&gt;354,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCyDlDn6Jvda" style="width: 14%; text-align: right" title="Weighted Average Grant Date Fair Value,Granted"&gt;4.80&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pn3n3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQPozxL4uH2b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Vested"&gt;(177,276&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKPiHSYAxXyj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested"&gt;4.80&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Nonvested as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr8UrStWR5N4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of RSU's, Outstanding, Beginning"&gt;177,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKSsMEgmMLqf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning"&gt;1.48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxumWCm4Z35" style="text-align: right" title="Number of Awards, Granted"&gt;88,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQdIs7KuM5v5" style="text-align: right" title="Weighted Average Grant Date Fair Value,Granted"&gt;7.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkdkl5JVM3i2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards,Vested"&gt;(265,914&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoUC71Ddonyb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested"&gt;5.60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Nonvested as of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmZOtsbnNOZb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Awards Outstanding, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4612"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zEDtpDjm3f49" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4614"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zmWF9J4G2aae" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total fair value of the Company&#x2019;s previous stock awards vested during the years ended December 31, 2023 and 2022 was $&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20230101__20231231_zIWmzStO4wa5" title="Fair value of stock awards vested"&gt;1.1&lt;/span&gt; million
and $&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20220101__20221231_zgQFIjeMNuP4" title="Fair value of stock awards vested"&gt;1.5&lt;/span&gt; million, respectively. On November 7, 2023, as part of the Business Combination, all vested shares were exercised and converted
at the appropriate conversion ratio to Common Stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z9r9Rg9z2JJ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations
for the periods presented (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"&gt;&lt;span id="xdx_8BA_zJ8hjkB5chs7" style="display: none"&gt;Schedule
of Stock-based Compensation Expense&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230101__20231231_zIv3aKKO2Fp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20221231_ztsCIA6dA2wd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zXzlU3y29go5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;434&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zMeHDmxXicLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;General and administrative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,041&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,227&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zjOIa7QUTmS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_z6wRGiAx7q99" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember"
      decimals="INF"
      id="Fact004500"
      unitRef="Shares">3000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2020-01-012020-12-31_custom_EmployeesDirectorsAndConsultantsMember_custom_NewEquityIncentivePlanMember_srt_MaximumMember"
      id="Fact004504">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004506">&lt;p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z2t4WLtze2Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
with respect to options outstanding is summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zI0hPK0P8F83" style="display: none"&gt;Schedule of Options Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; padding-bottom: 1pt"&gt;Outstanding as of December 31, 2021&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_z0U5wRYmtbh1" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Options outstanding, beginning balance"&gt;728,603&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zypioOXRPhOh" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Weighted average exercise price, beginning balance"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20221231_z2shuwnGqzv7" style="padding-bottom: 1pt; width: 12%; text-align: right" title="Aggregate Intrinsic value, begining balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zkHMNrDUKqhe" style="text-align: right" title="Options, Granted - under the Plan"&gt;511,440&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zk4YloymnWac" style="text-align: right" title="Weighted average exercise price, granted"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zSOuwTZiIgnh" style="text-align: right" title="Options, Exercised - under the Plan"&gt;(6,648&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_zMm45h2raGe8" style="text-align: right" title="Weighted average exercise price, exercised"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231_z4SWf21Q8baj" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled"&gt;(319,539&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zCs3JyTynD6g" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zG6cgN86wjbc" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, beginning balance"&gt;913,856&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_ziK5f5y9plyi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, beginning balance"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20220101__20221231_zacYP68Ics54" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, ending balance"&gt;3,199&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zPkyqh888cac" style="text-align: right" title="Options, Exercised - under the Plan"&gt;(613,510&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zQAZULygsM78" style="text-align: right" title="Weighted average exercise price, exercised"&gt;1.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231_z2d2eoaUXYkb" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled"&gt;(300,346&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zqse2nLXHYZ5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled"&gt;1.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding as of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zU6jFtbBUQul" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4540"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zWf8X159Qfye" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4542"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zdxFOEhSQHri" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic value, ending balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4544"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Vested and exercisable as of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20230101__20231231_zN0GsflAab1" style="border-bottom: Black 1pt solid; text-align: right" title="Options vested and exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4546"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zGLHNwZ28Ntc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, vested and exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4548"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20230101__20231231_zbWHYtXkhaD8" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4550"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact004508"
      unitRef="Shares">728603000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact004510"
      unitRef="USDPShares">1000.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004514"
      unitRef="Shares">511440000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004516"
      unitRef="USDPShares">1000.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004518"
      unitRef="Shares">6648000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004520"
      unitRef="USDPShares">1000.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004522"
      unitRef="Shares">319539000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004524"
      unitRef="USDPShares">1000.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004526"
      unitRef="Shares">913856000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004528"
      unitRef="USDPShares">1000.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004530"
      unitRef="USD">3199000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004532"
      unitRef="Shares">613510000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004534"
      unitRef="USDPShares">1000.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004536"
      unitRef="Shares">300346000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004538"
      unitRef="USDPShares">1000.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember81072609"
      decimals="-5"
      id="Fact004552"
      unitRef="USD">400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember81072609"
      decimals="-5"
      id="Fact004554"
      unitRef="USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004556">&lt;p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z7nEjYXPSKbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B3_zvdqLwiSHLH8" style="display: none"&gt;Schedule
of Fair Value of  Stock Options&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zb4EqjAVvHcj" title="Expected life in years"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4558"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zv7TKOPtaZah" title="Risk-free interest rate"&gt;0.73&lt;/span&gt;% - &lt;span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zI0UX2ZfVXvg" title="Risk-free interest rate"&gt;2.96&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;% &lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlxm0i4Fc2ii" title="Risk-free interest rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4564"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zhjGUBcEXN8j" title="Risk-free interest rate"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4566"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected term in years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--EquitySecuritiesFvNiMeasurementTerm_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zwbvwcufSdP4" title="Expected life in years"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4568"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zn4w2yHn1Mt7" title="Expected life in years"&gt;1.36&lt;/span&gt; - &lt;span id="xdx_904_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zh6oP8V6f0u8" title="Expected life in years"&gt;1.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z2C4T4M15t91" title="Equity securities, measurement input"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4574"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zMW0leDnbjz9" title="Equity securities, measurement input"&gt;50.0&lt;/span&gt;% - &lt;span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zlG8ca1XMgD" title="Equity securities, measurement input"&gt;86.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;% &lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004560"
      unitRef="Pure">0.73</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember"
      decimals="INF"
      id="Fact004562"
      unitRef="Pure">2.96</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <ONMD:EquitySecuritiesFvNiMeasurementTerm
      contextRef="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember"
      id="Fact004570">P1Y4M9D</ONMD:EquitySecuritiesFvNiMeasurementTerm>
    <ONMD:EquitySecuritiesFvNiMeasurementTerm
      contextRef="From2022-01-012022-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember"
      id="Fact004572">P1Y10M6D</ONMD:EquitySecuritiesFvNiMeasurementTerm>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004576"
      unitRef="Pure">50.0</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:EquitySecuritiesFvNiMeasurementInput
      contextRef="AsOf2022-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember"
      decimals="INF"
      id="Fact004578"
      unitRef="Pure">86.3</us-gaap:EquitySecuritiesFvNiMeasurementInput>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-11-062023-11-07"
      decimals="INF"
      id="Fact004580"
      unitRef="Shares">543057</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004582"
      unitRef="Shares">613510</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-11-07"
      decimals="INF"
      id="Fact004584"
      unitRef="USDPShares">1.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004586">&lt;p id="xdx_898_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zaIIOAu2S4uh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BC_zXSVQhE5UcOj" style="display: none"&gt;Schedule of Restricted Stock Award Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Weighted&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Average Grant&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Awards&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Date Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Nonvested as of December 31, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zvfPYjAAeNEl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Outstanding, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4588"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAoAz1WPFED5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4590"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfX5vHFqtBEi" style="width: 14%; text-align: right" title="Number of Awards, Granted"&gt;354,551&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCyDlDn6Jvda" style="width: 14%; text-align: right" title="Weighted Average Grant Date Fair Value,Granted"&gt;4.80&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pn3n3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQPozxL4uH2b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Vested"&gt;(177,276&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKPiHSYAxXyj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested"&gt;4.80&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Nonvested as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr8UrStWR5N4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of RSU's, Outstanding, Beginning"&gt;177,275&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKSsMEgmMLqf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning"&gt;1.48&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxumWCm4Z35" style="text-align: right" title="Number of Awards, Granted"&gt;88,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQdIs7KuM5v5" style="text-align: right" title="Weighted Average Grant Date Fair Value,Granted"&gt;7.21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt"&gt;Vested&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkdkl5JVM3i2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards,Vested"&gt;(265,914&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoUC71Ddonyb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested"&gt;5.60&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Nonvested as of December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmZOtsbnNOZb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Awards Outstanding, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4612"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zEDtpDjm3f49" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Ending"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4614"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact004592"
      unitRef="Shares">354551000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact004594"
      unitRef="USDPShares">4.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact004596"
      unitRef="Shares">177276000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact004598"
      unitRef="USDPShares">4.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact004600"
      unitRef="Shares">177275000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact004602"
      unitRef="USDPShares">1.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact004604"
      unitRef="Shares">88639000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact004606"
      unitRef="USDPShares">7.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact004608"
      unitRef="Shares">265914000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact004610"
      unitRef="USDPShares">5.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2023-01-012023-12-31"
      decimals="-5"
      id="Fact004616"
      unitRef="USD">1100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="From2022-01-012022-12-31"
      decimals="-5"
      id="Fact004618"
      unitRef="USD">1500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock contextRef="From2023-01-012023-12-31" id="Fact004620">&lt;p id="xdx_899_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z9r9Rg9z2JJ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations
for the periods presented (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"&gt;&lt;span id="xdx_8BA_zJ8hjkB5chs7" style="display: none"&gt;Schedule
of Stock-based Compensation Expense&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230101__20231231_zIv3aKKO2Fp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20220101__20221231_ztsCIA6dA2wd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the year ended December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zXzlU3y29go5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Research and development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;434&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;638&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zMeHDmxXicLh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;General and administrative&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,041&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,227&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zjOIa7QUTmS7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total stock-based compensation expense&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,475&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact004622"
      unitRef="USD">434000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact004623"
      unitRef="USD">638000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact004625"
      unitRef="USD">1041000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact004626"
      unitRef="USD">1227000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004628"
      unitRef="USD">1475000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31"
      decimals="-3"
      id="Fact004629"
      unitRef="USD">1865000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ONMD:StockWarrantsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004631">&lt;p id="xdx_800_ecustom--StockWarrantsDisclosureTextBlock_zt5W4FWxH85b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.&lt;span id="xdx_821_zzYLEnC1X84k"&gt;
Stock Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zu5JqleAdXq" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the following warrants outstanding for the periods presented:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zG2q7k4Ebt4i" style="display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zIUs3EeLK35f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231_zLCOAaHt6oZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Liability Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zIopUMHIq1k3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: left"&gt;Private Placement Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;585,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PIPEWarrantsMember_ztSA693FySo5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;95,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4639"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_zjz9wl3Tamn8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;681,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Equity Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--LegacyONMDWarrantsMember_zLhixHsn0I2a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Legacy ONMD Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;545,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConvertiblePromissoryNoteWarrantsMember_zvPE6d1ivh4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Convertible Promissory Note Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4647"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,822,394&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_z5D6JH42Oaxg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Public Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4651"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zAfgYG3UDX34" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,367,607&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_z5RAfkTgNBjd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Grant Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,367,607&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_z3X1Y2OPQ7w3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Legacy
ONMD Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2021, there were &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211231_z2BDWtycSAq9" title="Warrants issued for service"&gt;174,102&lt;/span&gt; Legacy ONMD outstanding common stock warrants (&#x201c;Legacy ONMD Warrants&#x201d;) issued to directors for service
at a weighted average exercise price of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211231_zhq3DYfnctOe" title="Weighted average exercise price"&gt;0.10&lt;/span&gt;. In 2022 for the exercise price of $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231_zCy9vH7cPvHi" title="Weighted average exercise price"&gt;1.00&lt;/span&gt;, Legacy ONMD issued &lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--TwentyTwentyOneServiceMember_zK4ziu1weG7b" title="Warrants issued for service"&gt;145,746&lt;/span&gt; warrants to directors
for 2021 service and &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--TwentyTwentyTwoServiceMember_zYy8YPzFgIV7" title="Warrants issued for service"&gt;294,000&lt;/span&gt; warrants for 2022 service. The Legacy ONMD Warrants are equity-classified and accounted for in accordance
with ASC 718. ASC 718 requires the use of the &#x201c;fair-value-based method&#x201d; for measuring the value of stock-based compensation.
In applying &#x201c;fair-value-based method&#x201d; (absent identical or similar instruments) companies are required to use an option-pricing
model, adjusted to accommodate the unique characteristics of the employee stock options. ASC 718&#x2019;s measurement objective is to
determine the fair value of stock-based compensation at the grant date assuming that employees/directors fulfill the award&#x2019;s vesting
conditions (if applicable) and will retain the award. The fair value of an award is the cost to the Company for granting the award and
should reflect the estimated value of the instruments that the company would be obligated to provide to an employee/director when the
employee has satisfied the service conditions. This resulted in an expense of $&lt;span id="xdx_90E_eus-gaap--OtherNoncashExpense_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuP7WJQHfSvi" title="Other expense"&gt;0&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--OtherNoncashExpense_pn5n6_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUEwn5C3kcr1" title="Other expense"&gt;1.2&lt;/span&gt; million for the years ended December 31, 2023
and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the closing of the Business Combination on November 7, 2023, all Legacy ONMD Warrants issued for services were cashless
exercised into shares of Legacy ONMD common stock and exchanged for Common Stock based on the appropriate conversion ratio less the applicable
exercise price per Legacy ONMD Warrant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Convertible
Promissory Notes Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
described in Note 6, the Company issued Convertible Promissory Notes Warrants in 2022 and 2023. The Convertible Promissory Note Warrants
are classified as equity in accordance with ASC 815. The Company has elected to measure the Notes using the fair value option under ASC
825 discussed in Note 6. The Company determined that the fair value of the combined instrument significantly exceeds the proceeds received,
therefore, the Company concluded that the warrants are most accurately portrayed as an issuance cost related to the convertible promissory
notes. This resulted in an expense of $&lt;span id="xdx_906_ecustom--StockWarrantExpense_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zsBmSiQHdVV" title="Stock warrant expense"&gt;9.2&lt;/span&gt; million and $&lt;span id="xdx_904_ecustom--StockWarrantExpense_pn5n6_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zjVA8qACXRmd" title="Stock warrant expense"&gt;8.0&lt;/span&gt; million being allocated to the Convertible Promissory Notes Warrants during
the year ended December 31, 2023 and 2022, respectively, which is classified as stock warrant expense in the consolidated statements
of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the closing of the Business Combination on November 7, 2023, all Convertible Promissory Notes Warrants were cashless
exercised into shares of Legacy ONMD common stock and exchanged based on the appropriate conversion ratio for the Common Stock less an
exercise price of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionRatio1_c20231106__20231107_zPNVO3ziksY3" title="Conversion ratio"&gt;1.00&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;PIPE
Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the PIPE Notes described in Note 6, the Company also issued &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfxwolB9zID7" title="Warrants to acquire common stock"&gt;95,745&lt;/span&gt; warrants to purchase Common Stock (&#x201c;PIPE Warrants&#x201d;).
The Company accounts for the PIPE Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because
the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting treatment of derivative financial instruments in accordance with ASC 815, &lt;i&gt;Derivatives and Hedging, &lt;/i&gt;requires that the
Company record a derivative liability upon issuance of the warrants. Accordingly, the Company classifies each warrant as a liability
at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This
liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted
to fair value, with the change in fair value recognized in the Company&#x2019;s statement of operations. The Company will reassess the
classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be
reclassified as of the date of the event that causes the reclassification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, all &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PIPEWarrantsMember_zGE7usDUmBsh" title="Warrants outstanding"&gt;95,745&lt;/span&gt; PIPE Warrants remain outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Public
Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuoSGRnh76rl" title="Warrants to purchase common stock"&gt;11,500,000&lt;/span&gt; public warrants (the &#x201c;Public
Warrants&#x201d;) to purchase Common Stock with an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zFxRKrAR8V5a" title="Warrants exercise price"&gt;11.50&lt;/span&gt; per share. The Public Warrants became exercisable 30 days
after the Closing of the Business Combination. Each Public Warrant is exercisable for one share of Common Stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may redeem the outstanding Public Warrants for $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zqy9MXo8nB03" title="Warrants exercise price"&gt;0.01&lt;/span&gt; per Public Warrant upon at least 30 days&#x2019; prior written notice of
redemption given after the Public Warrants become exercisable, if the reported last sale price of the Common Stock equals or exceeds
$&lt;span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zO1KCmMrQN9a" title="Price per share"&gt;18.00&lt;/span&gt; per share (as adjusted for stock dividends, sub-divisions, reorganizations, recapitalizations and the like) for any 20 trading
days within a 30-trading day period commencing after the Public Warrants become exercisable and ending on the third trading day before
the Company sends the notice of redemption to the holders of the Public Warrants. Upon issuance of a redemption notice by the Company,
the holders of the Public Warrants may, at any time after the redemption notice, exercise the Public Warrants on a cashless basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants are classified as equity, with the fair value of the Public Warrants as of the date of the Business Combination closed
to additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, all &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zH2x0pfemkbe" title="Warrants outstanding"&gt;11,500,000&lt;/span&gt; Public Warrants remain outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Private
Placement Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zCZnvCbnGZgj" title="Warrants to purchase common stock"&gt;585,275&lt;/span&gt; private warrants to purchase
Common Stock with an exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zTJdO2deMUz7" title="Warrants exercise price"&gt;11.50&lt;/span&gt; per share (the &#x201c;Private Placement Warrants&#x201d;). The Private Placement Warrants
(and shares of Common Stock issued or issuable upon exercise of the Private Placement Warrants) in general were not transferable, assignable
or salable until 30 days after the Closing (excluding permitted transferees) and they will not be redeemable under certain redemption
scenarios by the Company so long as they are held by the Sponsor or their respective permitted transferees. Otherwise, the Private Placement
Warrants have terms and provisions that are identical to those of the Public Warrants, including as to exercise price, exercisability
and exercise period. If the Private Placement Warrants are held by holders other than the Sponsor, Metric or their respective permitted
transferees, the Private Placement Warrants will be redeemable by the Company under all redemption scenarios and exercisable by the holders
on the same basis as the Public Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for the Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that
because the Private Placement Warrants do not meet the criteria for equity treatment thereunder, each Private Placement Warrant must
be recorded as a liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accounting treatment of derivative financial instruments in accordance with ASC 815, &lt;i&gt;Derivatives and Hedging, &lt;/i&gt;required that the
Company record a derivative liability upon the closing of the Business Combination. Accordingly, the Company classifies each Private
Placement Warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each
such re-measurement, the Private Placement Warrant liability will be adjusted to fair value, with the change in fair value recognized
in the Company&#x2019;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification
changes as a result of events during the period, the Private Placement Warrants will be reclassified as of the date of the event that
causes the reclassification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, all &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zLtA21qzdP2d" title="Warrants outstanding"&gt;585,275&lt;/span&gt; Private Placement Warrants remained outstanding.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</ONMD:StockWarrantsDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-01-012023-12-31" id="Fact004633">&lt;p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zu5JqleAdXq" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has the following warrants outstanding for the periods presented:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B5_zG2q7k4Ebt4i" style="display: none"&gt;Schedule
of Warrants Outstanding&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
&lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zIUs3EeLK35f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231_zLCOAaHt6oZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Liability Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zIopUMHIq1k3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 64%; text-align: left"&gt;Private Placement Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;585,275&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4636"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PIPEWarrantsMember_ztSA693FySo5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;95,744&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4639"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_zjz9wl3Tamn8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;681,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Equity Classified Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--LegacyONMDWarrantsMember_zLhixHsn0I2a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Legacy ONMD Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4644"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;545,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConvertiblePromissoryNoteWarrantsMember_zvPE6d1ivh4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Convertible Promissory Note Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4647"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,822,394&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_z5D6JH42Oaxg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Public Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4651"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zAfgYG3UDX34" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,367,607&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_z5RAfkTgNBjd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1pt"&gt;Grant Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,181,019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,367,607&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PrivatePlacementWarrantsMember"
      decimals="-3"
      id="Fact004635"
      unitRef="Shares">585275000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact004638"
      unitRef="Shares">95744000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_LiabilityClassifiedWarrantsMember"
      decimals="-3"
      id="Fact004641"
      unitRef="Shares">681019000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_LegacyONMDWarrantsMember"
      decimals="-3"
      id="Fact004645"
      unitRef="Shares">545213000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember_custom_ConvertiblePromissoryNoteWarrantsMember"
      decimals="-3"
      id="Fact004648"
      unitRef="Shares">1822394000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember_custom_PublicWarrantsMember"
      decimals="-3"
      id="Fact004650"
      unitRef="Shares">11500000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_EquityClassifiedWarrantsMember"
      decimals="-3"
      id="Fact004653"
      unitRef="Shares">11500000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31_custom_EquityClassifiedWarrantsMember"
      decimals="-3"
      id="Fact004654"
      unitRef="Shares">2367607000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004656"
      unitRef="Shares">12181019000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2022-12-31"
      decimals="-3"
      id="Fact004657"
      unitRef="Shares">2367607000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact004659"
      unitRef="Shares">174102</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact004661"
      unitRef="USDPShares">0.10</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004663"
      unitRef="USDPShares">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-12-31_custom_TwentyTwentyOneServiceMember"
      decimals="INF"
      id="Fact004665"
      unitRef="Shares">145746</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2022-12-31_custom_TwentyTwentyTwoServiceMember"
      decimals="INF"
      id="Fact004667"
      unitRef="Shares">294000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:OtherNoncashExpense
      contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember81073500"
      decimals="0"
      id="Fact004669"
      unitRef="USD">0</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="From2022-01-012022-12-31_us-gaap_WarrantMember81073500"
      decimals="-5"
      id="Fact004671"
      unitRef="USD">1200000</us-gaap:OtherNoncashExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesWarrantsMember"
      decimals="-5"
      id="Fact004673"
      unitRef="USD">9200000</ONMD:StockWarrantExpense>
    <ONMD:StockWarrantExpense
      contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesWarrantsMember"
      decimals="-5"
      id="Fact004675"
      unitRef="USD">8000000.0</ONMD:StockWarrantExpense>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="From2023-11-062023-11-07"
      decimals="INF"
      id="Fact004677"
      unitRef="Pure">1.00</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-12-31_us-gaap_WarrantMember81073500"
      decimals="INF"
      id="Fact004679"
      unitRef="Shares">95745</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember"
      decimals="INF"
      id="Fact004681"
      unitRef="Shares">95745</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-11-07_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004683"
      unitRef="Shares">11500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-11-07_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004685"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004687"
      unitRef="USDPShares">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004689"
      unitRef="USDPShares">18.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004691"
      unitRef="Shares">11500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-11-07_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact004693"
      unitRef="Shares">585275</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-11-07_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact004695"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact004697"
      unitRef="Shares">585275</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2023-01-012023-12-31" id="Fact004699">&lt;p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_zytubuymQfMg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.
&lt;span id="xdx_826_zcyW7FFQ9JZi"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zx4VUb6mkiqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_znx9PfAgWcDd" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWRkkLWyDgri" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgBvYaGFcJta" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdg0MYNCkvU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zepYc0t5lBkb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zjzKmD4Pi2S8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;Private warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4703"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z9y2aSkYHAta" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zeFOUJUazrzj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4713"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4714"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_za6JYscss8Ef" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4718"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4719"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zauQYLn1Y5zh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4723"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzMl7Ns3zPMk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8ezS87zniPi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z40QOrbBk7mb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20221231_zFch3jrLMbgh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--ConvertiblePromissoryNotesMember_zicdAbkJfVnj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left; padding-bottom: 1pt"&gt;Convertible promissory notes&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4729"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z5WLuEaC5E1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4733"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4734"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z4D4SxvaTPTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zfPVMYOIcIFk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the changes in the Private Warrants, PIPE Notes and PIPE Warrants, and the convertible promissory notes measured
at fair value for the years ended December 31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zrEje0gHNQzk" style="display: none"&gt;&#160;Schedule
of Warrants and Promissory Notes Measured at Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Level 3 Rollforward:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PrivateWarrantsMember_zWco2KKGbyyb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Private&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--PIPENotesAndWarrantsMember_zEJ3Ft6aQVr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PIPE Notes &amp;amp;&lt;br/&gt;
 Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--ConvertiblePromissoryNotesMember_zGKgmWZJDTJ9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Convertible&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Promissory&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Notes&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_z2fMhsCUjYpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4741"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;6,487&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zBviuiQPjWkl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zsijmKJu6ZB8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4748"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4749"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zwRtIU9PSg3j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlT96CCKvkPg" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Beginning balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4756"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4757"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_431_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zh4h2E26WEMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zVP5orAuH799" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_zoNaKcB1iatd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Reclassified to additional paid-in-capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4768"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(47,935&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z5E6isg1SAxe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4774"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zVxglYhpJHcd" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4778"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zgtlbXuVek8k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Private
Placement Warrants and PIPE Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate fair value of the Private Placement Warrants and PIPE Warrants was $&lt;span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20231107__us-gaap--FinancialInstrumentAxis__custom--PrivatePlacementWarrantsMember_zu5p8dMflpwg" title="Aggregate fair value of private placement warrants"&gt;152,602&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zzfuy6Pm8d58" title="Aggregate fair value of PIPE warrants"&gt;23,393&lt;/span&gt; as of November 7, 2023 and December
31, 2023, respectively. The Company remeasured the fair value of the Private Placement Warrants and PIPE Warrants at November 7, 2023
and December 31, 2023 using the Black-Scholes option-pricing model with the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zG7JtzNR8yvg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span id="xdx_8BA_zSAFMhLzu8hj" style="display: none"&gt;Schedule
of Fair Value Assumptions and Valuation&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zOyVpPVa8Vb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6Vs42s56Jnc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231107__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zgw83huQwyL6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231107__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6IiyATv7Zh3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of November 7,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;PIPE&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Private&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;PIPE&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Private&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zEO2MB9nrjh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Stock price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0.81&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0.81&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;7.76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zf1afDFSdnJa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zjnp3s5He9p4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ztzmHVQD3t67" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.9&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zyS14PyGAws9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4806"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4807"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4808"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z1JB6b2FrNW7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zaQnSbTaqZDa" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants
     measurement input&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_zJarw7z46Wk1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Promissory Notes and PIPE Notes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated fair values of the convertible promissory notes and PIPE Notes are each determined based on the aggregated, probability-weighted
average of the outcomes of certain possible scenarios. The combined value of the probability-weighted average of those outcomes is then
discounted back to each reporting period in which the convertible notes are outstanding, in each case, based on a risk-adjusted discount
rate estimated based on the implied discount rate. The discount rate was held constant over the valuation periods given the fact pattern
associated with the company and the stage of development.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, in connection with the Closing of the Business Combination described in Note 3, all convertible promissory notes
were converted to Common Stock in accordance with the conversion provisions in the original agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the PIPE Notes was $&lt;span id="xdx_907_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pn5n6_c20231107__us-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zjWLkGM5LzLl" title="Aggregate fair value"&gt;1.8&lt;/span&gt; million and $&lt;span id="xdx_909_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pn5n6_c20231231__us-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z1pfvwSQk0Vj" title="Aggregate fair value"&gt;1.6&lt;/span&gt; million as of November 7, 2023 and December 31, 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004701">&lt;p id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zx4VUb6mkiqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_znx9PfAgWcDd" style="display: none"&gt;Schedule
of Assets and Liabilities Measured at Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWRkkLWyDgri" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgBvYaGFcJta" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdg0MYNCkvU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zepYc0t5lBkb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zjzKmD4Pi2S8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left"&gt;Private warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4703"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;9&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z9y2aSkYHAta" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Business Combination Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4708"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4709"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zeFOUJUazrzj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;PIPE warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4713"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4714"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_za6JYscss8Ef" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;PIPE notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4718"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4719"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,637&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zauQYLn1Y5zh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4723"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,660&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzMl7Ns3zPMk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8ezS87zniPi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z40QOrbBk7mb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20221231_zFch3jrLMbgh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--ConvertiblePromissoryNotesMember_zicdAbkJfVnj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 36%; text-align: left; padding-bottom: 1pt"&gt;Convertible promissory notes&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4729"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z5WLuEaC5E1i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"&gt;Total liabilities, at fair value&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4733"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4734"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004705"
      unitRef="USD">9000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004706"
      unitRef="USD">9000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004710"
      unitRef="USD">9000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004711"
      unitRef="USD">9000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPEWarrantsMember"
      decimals="-3"
      id="Fact004715"
      unitRef="USD">14000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390"
      decimals="-3"
      id="Fact004716"
      unitRef="USD">14000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PIPENotesMember"
      decimals="-3"
      id="Fact004720"
      unitRef="USD">1637000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_PIPENotesMember"
      decimals="-3"
      id="Fact004721"
      unitRef="USD">1637000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact004725"
      unitRef="USD">1660000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2023-12-31"
      decimals="-3"
      id="Fact004726"
      unitRef="USD">1660000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004730"
      unitRef="USD">26243000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004731"
      unitRef="USD">26243000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004735"
      unitRef="USD">26243000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2022-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004736"
      unitRef="USD">26243000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="From2023-01-012023-12-31" id="Fact004738">&lt;p id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zfPVMYOIcIFk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the changes in the Private Warrants, PIPE Notes and PIPE Warrants, and the convertible promissory notes measured
at fair value for the years ended December 31, 2023 and 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zrEje0gHNQzk" style="display: none"&gt;&#160;Schedule
of Warrants and Promissory Notes Measured at Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Level 3 Rollforward:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PrivateWarrantsMember_zWco2KKGbyyb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Private&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Warrants&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--PIPENotesAndWarrantsMember_zEJ3Ft6aQVr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PIPE Notes &amp;amp;&lt;br/&gt;
 Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--ConvertiblePromissoryNotesMember_zGKgmWZJDTJ9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Convertible&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Promissory&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Notes&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_z2fMhsCUjYpk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%"&gt;Balance, December 31, 2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4740"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4741"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;6,487&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zBviuiQPjWkl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4745"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,140&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zsijmKJu6ZB8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Changes in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4748"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4749"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,616&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zwRtIU9PSg3j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance, December 31, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4752"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4753"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlT96CCKvkPg" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Beginning balance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4756"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4757"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,243&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_431_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zh4h2E26WEMa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,175&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zVP5orAuH799" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Changes in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;151&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,517&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_zoNaKcB1iatd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Reclassified to additional paid-in-capital&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4768"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(47,935&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z5E6isg1SAxe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4774"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zVxglYhpJHcd" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Ending balance&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,651&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4778"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2021-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004742"
      unitRef="USD">6487000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004746"
      unitRef="USD">5140000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2022-01-012022-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004750"
      unitRef="USD">14616000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004754"
      unitRef="USD">26243000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2022-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004758"
      unitRef="USD">26243000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004760"
      unitRef="USD">21000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember"
      decimals="-3"
      id="Fact004761"
      unitRef="USD">1500000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004762"
      unitRef="USD">4175000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2023-01-012023-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004764"
      unitRef="USD">-12000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2023-01-012023-12-31_custom_PIPENotesAndWarrantsMember"
      decimals="-3"
      id="Fact004765"
      unitRef="USD">151000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004766"
      unitRef="USD">17517000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
      contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesMember"
      decimals="-3"
      id="Fact004770"
      unitRef="USD">-47935000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004772"
      unitRef="USD">9000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_PIPENotesAndWarrantsMember"
      decimals="-3"
      id="Fact004773"
      unitRef="USD">1651000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember"
      decimals="-3"
      id="Fact004776"
      unitRef="USD">9000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="AsOf2023-12-31_custom_PIPENotesAndWarrantsMember"
      decimals="-3"
      id="Fact004777"
      unitRef="USD">1651000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2023-11-07_custom_PrivatePlacementWarrantsMember"
      decimals="0"
      id="Fact004780"
      unitRef="USD">152602</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81074390"
      decimals="0"
      id="Fact004782"
      unitRef="USD">23393</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="From2023-01-012023-12-31" id="Fact004784">&lt;p id="xdx_896_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zG7JtzNR8yvg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span id="xdx_8BA_zSAFMhLzu8hj" style="display: none"&gt;Schedule
of Fair Value Assumptions and Valuation&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zOyVpPVa8Vb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6Vs42s56Jnc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231107__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zgw83huQwyL6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20231107__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6IiyATv7Zh3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of November 7,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;PIPE&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Private&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;PIPE&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Private&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zEO2MB9nrjh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%"&gt;Stock price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0.81&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0.81&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;5.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;7.76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zf1afDFSdnJa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;10.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;11.50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zjnp3s5He9p4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;80.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;45.0&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.2&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ztzmHVQD3t67" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.8&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.9&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.5&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.6&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zyS14PyGAws9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4806"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4807"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4808"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z1JB6b2FrNW7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zaQnSbTaqZDa" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrants
     measurement input&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.9&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.8&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact004786"
      unitRef="Pure">0.81</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact004787"
      unitRef="Pure">0.81</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact004788"
      unitRef="Pure">5.25</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputSharePriceMember"
      decimals="INF"
      id="Fact004789"
      unitRef="Pure">7.76</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember"
      decimals="INF"
      id="Fact004791"
      unitRef="Pure">10.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember"
      decimals="INF"
      id="Fact004792"
      unitRef="Pure">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExercisePriceMember"
      decimals="INF"
      id="Fact004793"
      unitRef="Pure">10.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExercisePriceMember"
      decimals="INF"
      id="Fact004794"
      unitRef="Pure">11.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact004796"
      unitRef="Pure">80.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact004797"
      unitRef="Pure">51.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact004798"
      unitRef="Pure">45.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact004799"
      unitRef="Pure">5.2</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact004801"
      unitRef="Pure">3.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact004802"
      unitRef="Pure">3.9</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact004803"
      unitRef="Pure">4.5</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact004804"
      unitRef="Pure">4.6</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004811"
      unitRef="Pure">4.9</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004812"
      unitRef="Pure">4.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004813"
      unitRef="Pure">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004814"
      unitRef="Pure">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004816"
      unitRef="Pure">4.9</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-12-31_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004817"
      unitRef="Pure">4.8</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PIPEWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004818"
      unitRef="Pure">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2023-11-07_custom_PrivateWarrantsMember_us-gaap_MeasurementInputExpectedTermMember"
      decimals="INF"
      id="Fact004819"
      unitRef="Pure">5.0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-11-07_custom_PIPENotesMember"
      decimals="-5"
      id="Fact004821"
      unitRef="USD">1800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-12-31_custom_PIPENotesMember"
      decimals="-5"
      id="Fact004823"
      unitRef="USD">1600000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004825">&lt;p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zsXhXjToTkUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12.
&lt;span id="xdx_824_z8bVfPCGmR92"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;PIPE
Notes and Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
disclosed in Note 3 and Note 6, &lt;span style="background-color: white"&gt;Data Knights issued and sold PIPE Notes in connection with the
Business Combination, which are convertible into shares of the Company&#x2019;s Common Stock. Total proceeds raised from the PIPE Notes
were $&lt;span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zqyuQVvSZ6xh" title="Related party proceeds"&gt;1.5&lt;/span&gt; million, of which $&lt;span id="xdx_901_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_znyIsT87tOd8" title="Related party proceeds"&gt;1.0&lt;/span&gt; million were with related party investors. Refer to Note 3 and Note 6 for additional details on the
terms of the PIPE Notes.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the issuance of the PIPE Notes, the Company also issued a total of &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zd4nIU6zM2xj" title="Warrants issued"&gt;95,744&lt;/span&gt; shares of PIPE Warrants, of which &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zsSFb7AMlCYd" title="Warrants issued"&gt;63,829&lt;/span&gt; shares
were issued to the same related party investors. Refer to Note 10 for additional details on the terms of the PIPE Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Promissory Notes and Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
2019 to 2023, the Company issued various Convertible Promissory Notes to related party investors. Total gross proceeds raised from Convertible
Promissory Notes with related parties was $&lt;span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zMYiNMEsFLok" title="Gross proceeds from convertible promissory notes"&gt;12.3&lt;/span&gt; million (out of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z9GTc5SDlPb2" title="Gross proceeds from convertible promissory notes"&gt;14.2&lt;/span&gt; million total). In connection with the issuance of the Convertible
Promissory Notes, the Company also issued &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteWarrantsMember_z3m9Ls9o7ft3" title="Number of shares issued"&gt;2,976,000&lt;/span&gt; shares of Convertible Promissory Note Warrants to the same related parties (out of
&lt;span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConvertiblePromissoryNotesAndWarrantsMember_zNrDfrawjOL1" title="Number of warrants issued"&gt;3,726,000&lt;/span&gt; total). Refer to Note 6 and Note 10 for additional details on the terms of the Convertible Promissory Notes and Convertible
Promissory Note Warrants, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Closing of the Business Combination triggered the conversion of all Convertible Promissory Notes into shares of Common Stock of the Company,
as disclosed in Note 3.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Shareholder
Loans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
April 2023 to December 2023, the Company entered into shareholder loans with two related party investors (the &#x201c;Shareholder Loans&#x201d;)
for aggregate gross proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromLoans_pn3n3_c20230401__20231231_zB5USk2fmhKl" title="Loans payable"&gt;954&lt;/span&gt; thousand. The Shareholder Loans bear an interest rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20231231_zGLH05NCNbUe" title="Interest rate"&gt;8.0&lt;/span&gt;% and mature &lt;span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dc_c20230401__20231231_zlG3K0VQUHhk" title="Debt term"&gt;one year&lt;/span&gt; after the commencement
date of each agreement. There are no financial or non-financial covenants associated with the Shareholder Loans. The Shareholder Loans
are not convertible into equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 7, 2023, in connection with the Business Combination, one of the Shareholder Loans for $&lt;span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn5n6_c20231107__us-gaap--DebtInstrumentAxis__custom--ShareholderLoansMember_z8nK6Rw9ZgE9" title="Shareholder loan"&gt;0.5&lt;/span&gt; million was converted into a PIPE
Note equal to the amount of principal and interest outstanding at the time of Closing. The Company accounted for the exchange as an extinguishment
whereby the Shareholder Loan was written off and a separate PIPE Note was recorded at fair value, as disclosed in Note 6. The extinguishment
had no impact on the Company&#x2019;s consolidated statement of operations for the year ended December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, a total of $&lt;span id="xdx_903_ecustom--ProceedsFromIssuanceOfShareholderLoans_pn3n3_c20230101__20231231_zlPH2RzABGx7" title="Shareholder loans outstanding"&gt;454&lt;/span&gt; thousand of Shareholder Loans remains outstanding which is classified as loan &#x2013; related party
on the consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Loan
Extensions&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
disclosed in Note 3, in connection with the Business Combination, the Company assumed Data Knights&#x2019; liabilities, which included
existing loan extensions to related parties. The loan extensions were to be exchanged for a fixed amount of the Company&#x2019;s Common
Stock upon the closing of a business combination or a similar event. As of December 31, 2023, a balance of $&lt;span id="xdx_903_ecustom--LoanExtension_iI_pn5n6_c20231231_zYYxp7LkBjZ5" title="Loan extensions"&gt;3.0&lt;/span&gt; million remains outstanding
and is recorded as loan extensions on the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-01-012023-12-31_custom_PIPENotesMember"
      decimals="-5"
      id="Fact004827"
      unitRef="USD">1500000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_PIPENotesMember"
      decimals="-5"
      id="Fact004829"
      unitRef="USD">1000000.0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_custom_PIPEWarrantsMember81075625"
      decimals="INF"
      id="Fact004831"
      unitRef="Shares">95744</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember_custom_PIPEWarrantsMember"
      decimals="INF"
      id="Fact004833"
      unitRef="Shares">63829</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteMember"
      decimals="-5"
      id="Fact004835"
      unitRef="USD">12300000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNoteMember81075656"
      decimals="-5"
      id="Fact004837"
      unitRef="USD">14200000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember_custom_ConvertiblePromissoryNoteWarrantsMember"
      decimals="INF"
      id="Fact004839"
      unitRef="Shares">2976000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-01-012023-12-31_custom_ConvertiblePromissoryNotesAndWarrantsMember"
      decimals="INF"
      id="Fact004841"
      unitRef="Shares">3726000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ProceedsFromLoans
      contextRef="From2023-04-012023-12-31"
      decimals="-3"
      id="Fact004843"
      unitRef="USD">954000</us-gaap:ProceedsFromLoans>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004845"
      unitRef="Pure">0.080</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="From2023-04-012023-12-31" id="Fact004847">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="AsOf2023-11-07_custom_ShareholderLoansMember"
      decimals="-5"
      id="Fact004849"
      unitRef="USD">500000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <ONMD:ProceedsFromIssuanceOfShareholderLoans
      contextRef="From2023-01-012023-12-31"
      decimals="-3"
      id="Fact004851"
      unitRef="USD">454000</ONMD:ProceedsFromIssuanceOfShareholderLoans>
    <ONMD:LoanExtension
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="Fact004853"
      unitRef="USD">3000000.0</ONMD:LoanExtension>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004855">&lt;p id="xdx_807_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXYkCDbsfPyg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13.
&lt;span id="xdx_826_zkxTMBMkPgV"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Lease
Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has a month-to-month lease for a suite at a cost of $&lt;span id="xdx_90D_eus-gaap--LeaseCost_c20230101__20231231_zpIm00S5UX23" title="Lease cost"&gt;530&lt;/span&gt; per month. The Company incurred $&lt;span id="xdx_90B_eus-gaap--PaymentsForRent_c20230101__20231231_zB0D3imQifNd" title="Rent expenses"&gt;7,695&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--PaymentsForRent_c20220101__20221231_zct23zrZB2va" title="Rent expenses"&gt;7,694&lt;/span&gt; of rent expense, including
common tenant costs and cancellation costs, during the years ended December 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Liabilities for loss
contingencies arising from claims, assessments, litigation, fines, penalties, and other sources are recognized, if and when it is
probable that a liability has been incurred and the amount can be reasonably estimated. The Company was not subject to any material
legal proceedings during the years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseCost
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004857"
      unitRef="USD">530</us-gaap:LeaseCost>
    <us-gaap:PaymentsForRent
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004859"
      unitRef="USD">7695</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004861"
      unitRef="USD">7694</us-gaap:PaymentsForRent>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-01-012023-12-31" id="Fact004863">&lt;p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zPBy6qAhhAna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
&lt;span id="xdx_824_zTqWkPMINjKc"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has evaluated subsequent events occurring through November 4, 2024, the date the consolidated financial statements were issued,
for events requiring recording or disclosure in the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Settlement
of Deferred Underwriting Fees&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2024, through the date of this report, the Company issued &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__dei--LegalEntityAxis__custom--EFHuttonMember_zBftqySKYD17" title="Stock issued during period, shares, new issues"&gt;256,944&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__dei--LegalEntityAxis__custom--KingwoodCapitalPartnersLLCMember_zAfDykodpXHe" title="Stock issued during period, shares, new issues"&gt;20,834&lt;/span&gt; shares of Common Stock to EF Hutton LLC and Kingwood Capital
Partners, LLC, respectively, as consideration for $&lt;span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--BusinessAcquisitionAxis__custom--KingwoodCapitalPartnersLLCMember_zo7ZtAxpXrZ4" title="Business combination, consideration underwriting commission"&gt;3.0&lt;/span&gt; million owed by the Company for underwriting commission due at the Closing of
the Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Share
Repurchase&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2024, through the date of this report, the Company bought back &lt;span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodShares_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbxxIiqKyiQ2" title="Bought back shares of Common Stock"&gt;187,745&lt;/span&gt; shares of Common Stock from a convertible note holder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;i&gt;Shareholder Loans&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;During
2024, through the date of this report, the Company received gross proceeds of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIVB1s45zjO7" title="Gross proceeds from related party loans"&gt;2.0&lt;/span&gt; million in connection with shareholder loans with
related party investors. Of the $&lt;span id="xdx_90D_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zs9XWGdV7ft2" title="Gross proceeds from related party loans"&gt;2.0&lt;/span&gt; million, $&lt;span id="xdx_908_eus-gaap--ConvertibleDebt_iI_pn5n6_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKkdBCFLQ73i" title="Loans converted into common stock"&gt;1.6&lt;/span&gt; million is convertible into shares of Common Stock at a conversion price of
$&lt;span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdrlsXYPnNuj" title="Debt conversion price"&gt;0.7535&lt;/span&gt; per share. The remaining $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGNe1qVqMNDf" title="Non convertible loans"&gt;0.4&lt;/span&gt; million is not convertible into equity and bears an interest rate of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKwzmjr2xkbf" title="Business combination, consideration underwriting commission"&gt;8.0&lt;/span&gt;% with a maturity date
one year from issuance. The Company subsequently repaid $&lt;span id="xdx_908_eus-gaap--DebtInstrumentRepaidPrincipal_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zYDuQglPKcik" title="Non convertible loans repaid"&gt;0.2&lt;/span&gt; million of the non-convertible shareholder loans through the date of
this report.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Private
Placements&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
previously announced on a Current Report on Form 8-K filed with the SEC on April 2, 2024, on March 28, 2024, the Company &lt;span style="background-color: white"&gt;entered
into a definitive securities purchase agreement (the &#x201c;Helena SPA&#x201d;) with Helena Global Investment Opportunities 1 Ltd. (&#x201c;Helena&#x201d;),
an affiliate of Helena Partners Inc., a Cayman-Islands based advisor and investor providing for up to $&lt;span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxokvY670cSd" title="Proceeds form convertible notes"&gt;4.5&lt;/span&gt;&lt;/span&gt; million &lt;span style="background-color: white"&gt;in
funding through a private placement for the issuance of senior secured convertible notes (the &#x201c;Helena Notes&#x201d;). On June 14,
2024, the Company and Helena entered into a termination agreement (the &#x201c;Helena Termination Agreement&#x201d;) to terminate the Helena
SPA and related documents. Pursuant to the Helena Termination Agreement, the Company issued to Helena a warrant to purchase &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240614__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zCr5M7stk2Ne" title="Warrants outstanding"&gt;50,000&lt;/span&gt; shares
of Common Stock at an exercise price of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240614__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvUkTrj6JmB" title="Warrant exercise price"&gt;1.20&lt;/span&gt; per share and agreed to reimburse Helena for certain reasonable and documented out-of-pocket
legal fees and expenses incurred in connection with entry into the Helena SPA and Helena Termination Agreement and related documents.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
July 23, 2024 and July 25, 2024, the Company entered into securities purchase agreements (the &#x201c;Securities Purchase Agreements&#x201d;)
with certain institutional investors in connection with the private placement of its Common Stock and pre-funded warrants with aggregate
gross proceeds of approximately $&lt;span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240723__20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zX7izELbJGS7" title="Proceeds form private placement"&gt;&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240725__20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zp6qxt2VR9Eb" title="Proceeds form private placement"&gt;4.6&lt;/span&gt;&lt;/span&gt; million, before deducting fees and expenses payable by the Company. The Company intends to use the
net proceeds for working capital and general corporate purposes. Pending use of the funds, the Company used a portion of the net proceeds
to purchase Bitcoin ($BTC). There is no guarantee on the holding period for the purchased Bitcoin.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Pursuant
to the Securities Purchase Agreements, the Company agreed to issue and sell to the investors &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240723__20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z8wqyx1MpH5g" title="Shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240725__20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zAdDFfpgPsnk" title="Shares issued"&gt;1,297,059&lt;/span&gt;&lt;/span&gt; shares of its Common Stock at
a price of $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zAVN7FBPZ893" title="Share price"&gt;&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zsYZ31Cls7d4" title="Share price"&gt;1.0278&lt;/span&gt;&lt;/span&gt; per share, pre-funded warrants exercisable for &lt;span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvawEyY9i0li" title="Warrants outstanding"&gt;&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z1wKcfgBP8wg" title="Warrants outstanding"&gt;1,323,530&lt;/span&gt;&lt;/span&gt; shares of its Common Stock at an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zNZCzUTb3Mzg" title="Warrant exercise price"&gt;&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zQKuNYG6xlMl" title="Warrant exercise price"&gt;1.0278&lt;/span&gt;&lt;/span&gt;
per share, and &lt;span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zN3OKGGh6yz3" title="Shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zijLi9OYJpd6" title="Shares issued"&gt;2,301,791&lt;/span&gt;&lt;/span&gt; shares of its Common Stock at a price of $&lt;span id="xdx_90E_eus-gaap--SharePrice_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zgzy8ikCO8Zd" title="Share price"&gt;&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zWYLOicPMrF1" title="Share price"&gt;0.85&lt;/span&gt;&lt;/span&gt; per share. The investors were required to prepay the exercise
price for the pre-funded warrants, other than $&lt;span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zf3RXXknyvib" title="Share price"&gt;&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYMgyXWVTMna" title="Share price"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share. The pre-funded warrants will be exercisable at any time after the date
of issuance and will not expire. The price per share of all Common Stock and pre-funded warrants sold in the private placement meets
the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued to institutional accredited investors in
a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
September 24, 2024, the Company entered into securities purchase agreements (the &#x201c;Follow-on SPA&#x201d;) with an institutional investor
in connection with the private placement of its Common Stock, warrants and pre-funded warrants with aggregate gross proceeds of approximately
$&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240924__20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zSTxumnw4BQi" title="Proceeds from issuance of private placement"&gt;1.7&lt;/span&gt; million, before deducting fees and expenses payable by the Company. The Company intends to use the net proceeds from the Private
Placement for working capital and general corporate purposes. Pending use of the funds, the Company plans to use a portion of the net
proceeds to purchase Bitcoin ($BTC).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Pursuant
to the Follow-on SPA, the Company agreed to issue and sell to the investor &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240924__20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGc3RjPunQWk" title="Shares issued"&gt;1,918,591&lt;/span&gt; shares of its Common Stock at a price of $&lt;span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z1gcZAEZr328" title="Sale of share price"&gt;0.65&lt;/span&gt; per
share, warrants exercisable for &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdNWhpB7bqAd" title="Warrants exercisable"&gt;133,095&lt;/span&gt; shares of its Common Stock at an exercise price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zU08lBCI29Gk" title="Share price"&gt;0.325&lt;/span&gt; per share and pre-funded warrants exercisable
for &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zsCkIckSPkAd" title="Warrants exercisable"&gt;743,314&lt;/span&gt; shares of its Common Stock at an exercise price of &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGLNeMTAVWU9" title="Warrant exercise price"&gt;$0.65&lt;/span&gt; per share. The investor was required to prepay the exercise price
for the pre-funded warrants, other than $&lt;span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zUeqEEafWzPj" title="Share issued price"&gt;0.0001&lt;/span&gt; per share. The warrants and pre-funded warrants will be exercisable at any time after
the date of issuance and will not expire. The price per share of all Common Stock and pre-funded warrants sold in the private placement
meets the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued to institutional accredited investors
in a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities Act.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Standby
Equity Purchase Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 17, 2024, the Company entered into a standby equity purchase agreement (the &#x201c;SEPA&#x201d;) with YA II PN, LTD, a Cayman Islands
exempt limited partnership managed by Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;). Pursuant to the SEPA, subject to certain
conditions, the Company has the option to sell to Yorkville an aggregate amount of up to up to $&lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_za5ulDzBSSyb" title="Proceeds from issuance of common stock"&gt;25.0&lt;/span&gt; million of the Company&#x2019;s shares
of Common Stock at the Company&#x2019;s request from time to time following both the repayment of the Promissory Note described below
and the effectiveness of a resale registration statement covering the shares of Common Stock issued under the SEPA. The SEPA terminates
on its 24-month anniversary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--EquityPurchaseAgreementDescription_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYAq5pWfzSrh" title="Equity purchase agreement description"&gt;Each
advance may not exceed the greater of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zHQhy3JzpGG" title="Shares issued"&gt;500,000&lt;/span&gt; shares and 100% of the average daily volume traded of the Common Stock during the five
trading days immediately prior to requested advance. The shares would be purchased at a price equal to 97% of the Market Price as defined
in the SEPA. The Company may establish a minimum acceptable price in each advance below which the Company will not be obligated to make
any sales to Yorkville&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
purchase under an advance would be subject to certain limitations, including that Yorkville will not purchase or acquire any shares that
would result in it and its affiliates beneficially owning more than &lt;span id="xdx_906_ecustom--ShareOutstandingVotingPercentage_dp_uPure_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zBBpmClKZkqd" title="Shares outstanding voting percentage"&gt;4.99&lt;/span&gt;% of the then outstanding voting power or number of shares of
Common Stock or any shares that when aggregated with shares issued under all other earlier advances, would exceed &lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zSIkTYfZ2dKl" title="Shares outstanding"&gt;4,767,616&lt;/span&gt; shares of
Common Stock (representing &lt;span id="xdx_90A_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_dp_uPure_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zZxGWmk9dCx6" title="Sale of stock percentage"&gt;19.99&lt;/span&gt;% of the aggregate number of then outstanding shares of Common Stock) (the &#x201c;Exchange Cap&#x201d;)
unless shareholders approved issuances in excess of the Exchange Cap.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the execution of the SEPA, the Company paid a $&lt;span id="xdx_90B_eus-gaap--LoanProcessingFee_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqS8XQiua3Q6" title="Structuring fees"&gt;25,000&lt;/span&gt; structuring fee to Yorkville. The Company agreed to pay a commitment
fee of $&lt;span id="xdx_905_eus-gaap--PaymentForManagementFee_pn5n6_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zn0k3FaPCwv1" title="Commitment fees"&gt;0.5&lt;/span&gt; million to Yorkville, which will be paid in shares in two tranches.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
Yorkville agreed to advance to the Company, in exchange for a convertible promissory note (the &#x201c;Yorkville Promissory Note&#x201d;),
a principal amount of $&lt;span id="xdx_907_eus-gaap--LoansPayable_iI_pn5n6_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z0SPG43PmNoc" title="Principal amount"&gt;1.5&lt;/span&gt; million, which was funded on June 18, 2024. &lt;span id="xdx_904_eus-gaap--DebtInstrumentDescription_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z2KdxXcCgXl8" title="Debt instrument description"&gt;The Yorkville Promissory Note is due on June 18, 2025, and interest shall accrue at an annual rate equal to 0%, subject to an increase to 18% upon an event of default as described in the Yorkville Promissory Note. &lt;/span&gt;The Yorkville Promissory Note will be convertible by Yorkville into shares of Common Stock at an aggregate purchase price based
on a price per share equal to the lower of &lt;span id="xdx_90A_eus-gaap--DerivativeDescriptionOfTerms_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zsT4HGZdcNOe" title="Description of promissory note"&gt;(a) $1.3408 per share (subject to downward reset upon the filing of the resale registration
statement described below) or (b) 90% of the lowest daily VWAP of the Common Stock on Nasdaq during the seven trading days immediately
prior to each conversion (the &#x201c;Variable Price&#x201d;), but which Variable Price may not be lower than the Floor Price then in effect&lt;/span&gt;.
The &#x201c;Floor Price&#x201d; is $&lt;span id="xdx_90E_eus-gaap--DerivativeFloorPrice_iI_pid_uUSDPShares_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zRdng1nVbrFk" title="Floor price"&gt;0.28&lt;/span&gt; per share, subject to the Company&#x2019;s option to reduce the Floor Price to any amounts set
forth in a written notice to Yorkville. While the Promissory Note is outstanding, Yorkville may initiate an investor advance under the
SEPA at the Promissory Note conversion price, the proceeds of which would be used to repay the Yorkville Promissory Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Yorkville Promissory Note may be accelerated by Yorkville upon specified events of default, and may become amortizable for cash if (i)
the daily VWAP is less than the Floor Price for five trading days during a period of seven consecutive trading days, (ii) the Company
has issued in excess of 95% of the shares of Common Stock available under the Exchange Cap or (iii) the Company is in material breach
of its obligations under a Registration Rights Agreement it entered into with Yorkville in connection with the SEPA or Yorkville becomes
limited in its ability to freely resell shares subject to an advance as further described in the Yorkville Promissory Note, subject to
de-amortization after certain cures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Yorkville
Letter&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;On
October 8, 2024, Yorkville sent the Company a letter notifying the Company that it had breached a registration rights agreement with
Yorkville by failing to file a Registration Statement on Form S-1 on the timeline set forth in the registration rights agreement (the
&#x201c;Yorkville Letter&#x201d;). The Yorkville Letter asserted that this breach was an event of default and an amortization event under
the prepaid advance in connection with SEPA. The Yorkville Letter also asserted that the Company&#x2019;s failure to timely file its Quarterly
Report on Form 10-Q for the fiscal quarter ended June 30, 2024 was an event of default under the Yorkville Promissory Note. The Company
subsequently engaged in discussions with Yorkville regarding the Yorkville Letter, which discussions are ongoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Pursuant
to the Yorkville Promissory Note, upon the occurrence of an amortization event, the Company is required to pay all principal and accrued
interest on the Yorkville Promissory Note, plus a 10% payment premium on the principal amount, in equal installments over 3 calendar
months or until the amortization event is cured, whichever is earlier. In addition, upon the occurrence of an event of default, the interest
rate on the Yorkville Promissory Note increases to 18% retroactive to the date of the event of default.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Executive
Turnover&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
previously announced on a Current Report on Form 8-K filed with the SEC on April 2, 2024, on March 22, 2024, Paul J. Casey notified the
Company of his intention to retire as Chief Executive Officer of the Company effective March 29, 2024. Mr. Casey continued to serve as
a member of the Board of Directors until October 1, 2024. In connection with Mr. Casey&#x2019;s retirement from the Company, Mr. Casey
and the Company entered into a Resignation Agreement and Release, dated March 22, 2024, pursuant to which Mr. Casey was paid $&lt;span id="xdx_904_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240322__20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zGcIbdExzlSg" title="Monthly shares"&gt;12,000&lt;/span&gt;
as a severance payment, and the Board of Directors approved a stock option grant providing for the grant of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240322__20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUBl9VGx7qbe" title="Shares exerciseable"&gt;147,000&lt;/span&gt; five-year options
exercisable at $&lt;span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrAvHy9n9e61" title="Share price"&gt;1.00&lt;/span&gt; per share to Mr. Casey. On March 27, 2024, Scott Holbrook, a member of the Board of Directors and a member of the
Company&#x2019;s Audit Committee, notified the Company of his intention to retire from the Company&#x2019;s Board of Directors effective
March 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
March 29, 2024, the Board of Directors (i) appointed Aaron Green to serve as Chief Executive Officer of the Company to fill the vacancy
created by the retirement of Paul Casey; (ii) appointed Mr. Green, to serve as a member of the Board of Directors to fill the vacancy
created by the retirement of Scott Holbrook; and (iii) appointed Dr. Thomas Kosasa, a member of the Board of Directors, to serve on the
Company&#x2019;s Audit Committee, also to fill the vacancy created by the retirement of Scott Holbrook.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
previously announced on Form 8-K, on August 26, 2024, Lisa Embree, Chief Financial Officer (&#x201c;CFO&#x201d;), Executive Vice President,
Treasurer and Secretary, notified the Company of her intention to resign from her position effective August 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
August 30, 2024, the Board appointed Mr. Robert Golden to serve as the Chief Financial Officer on an interim basis to fill the vacancy
created by the resignation of Lisa Embree. Effective on his appointment as interim CFO, Mr. Golden stepped down as a member and the chair
of the Audit Committee of the Board. In connection with his appointment as interim CFO, the Company entered into a consulting agreement
with Mr. Golden, pursuant to which Mr. Golden will receive a $&lt;span id="xdx_908_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240830__20240830__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqix75530DOa" title="Monthly shares"&gt;12,000&lt;/span&gt; monthly salary and a grant of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20240830__20240830__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvOQfNAEF0Fb" title="Restricted stock units"&gt;100,000&lt;/span&gt; restricted stock units, which
will vest on the first anniversary of the consulting agreement, subject to the terms and conditions set forth in the consulting agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
previously announced on a Current Report on Form 8-K filed with the SEC on October 8, 2024, on October 1, 2024, Paul J. Casey and Erkan
Akyuz resigned from the Board, effective immediately. Also on October 1, 2024, the Board of Directors appointed Jair Clarke and Sherry
Coonse McCraw to the Board to fill the vacancies created by Mr. Casey and Mr. Akyuz, respectively. In connection with Ms. Coonse McCraw
and Mr. Clarke&#x2019;s service on the Advisory Board of the Company, the Board of Directors approved a restricted stock unit (&#x201c;RSU&#x201d;)
grant providing for the grant of &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20241001__srt--StatementScenarioAxis__srt--ScenarioForecastMember_ztmeWu91wV0c" title="Restricted stock units issued"&gt;45,000&lt;/span&gt; RSUs to each director for one full year of service (pro-rated for 2024). The RSUs will vest at
the end of December 2024.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_EFHuttonMember"
      decimals="INF"
      id="Fact004865"
      unitRef="Shares">256944</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember"
      decimals="INF"
      id="Fact004867"
      unitRef="Shares">20834</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_custom_KingwoodCapitalPartnersLLCMember81076734"
      decimals="-5"
      id="Fact004869"
      unitRef="USD">3000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004871"
      unitRef="Shares">187745</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromLoans
      contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember"
      decimals="-5"
      id="Fact004873"
      unitRef="USD">2000000.0</us-gaap:ProceedsFromLoans>
    <us-gaap:ProceedsFromLoans
      contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember"
      decimals="-5"
      id="Fact004875"
      unitRef="USD">2000000.0</us-gaap:ProceedsFromLoans>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember"
      decimals="-5"
      id="Fact004877"
      unitRef="USD">1600000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact004879"
      unitRef="USDPShares">0.7535</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember"
      decimals="-5"
      id="Fact004881"
      unitRef="USD">400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact004883"
      unitRef="Pure">0.080</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="From2024-01-012024-12-31_srt_ScenarioForecastMember_us-gaap_RelatedPartyMember"
      decimals="-5"
      id="Fact004885"
      unitRef="USD">200000</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-03-282024-03-28_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact004887"
      unitRef="USD">4500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-14_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004889"
      unitRef="Shares">50000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-14_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004891"
      unitRef="USDPShares">1.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-07-232024-07-23_srt_ScenarioForecastMember"
      decimals="-5"
      id="Fact004893"
      unitRef="USD">4600000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-07-252024-07-25_srt_ScenarioForecastMember"
      decimals="-5"
      id="Fact004895"
      unitRef="USD">4600000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-232024-07-23_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004897"
      unitRef="Shares">1297059</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-07-252024-07-25_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004899"
      unitRef="Shares">1297059</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-07-23_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004901"
      unitRef="USDPShares">1.0278</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-07-25_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004903"
      unitRef="USDPShares">1.0278</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-07-23_srt_ScenarioForecastMember"
      decimals="0"
      id="Fact004905"
      unitRef="USD">1323530</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-07-25_srt_ScenarioForecastMember"
      decimals="0"
      id="Fact004907"
      unitRef="USD">1323530</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-07-23_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004909"
      unitRef="USDPShares">1.0278</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-07-25_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004911"
      unitRef="USDPShares">1.0278</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-07-23_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004913"
      unitRef="Shares">2301791</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-07-25_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004915"
      unitRef="Shares">2301791</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharePrice
      contextRef="AsOf2024-07-23_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004917"
      unitRef="USDPShares">0.85</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-07-25_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004919"
      unitRef="USDPShares">0.85</us-gaap:SharePrice>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-07-23_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004921"
      unitRef="USDPShares">0.0001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-07-25_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004923"
      unitRef="USDPShares">0.0001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2024-09-242024-09-24_srt_ScenarioForecastMember"
      decimals="-5"
      id="Fact004925"
      unitRef="USD">1700000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-242024-09-24_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004927"
      unitRef="Shares">1918591</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-09-24_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004929"
      unitRef="USDPShares">0.65</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004931"
      unitRef="Shares">133095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact004933"
      unitRef="USDPShares">0.325</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact004935"
      unitRef="Shares">743314</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact004937"
      unitRef="USDPShares">0.65</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-09-24_srt_ScenarioForecastMember_custom_PrefundedWarrantsMember"
      decimals="INF"
      id="Fact004939"
      unitRef="USDPShares">0.0001</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember"
      decimals="-5"
      id="Fact004941"
      unitRef="USD">25000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <ONMD:EquityPurchaseAgreementDescription
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember"
      id="Fact004943">Each
advance may not exceed the greater of 500,000 shares and 100% of the average daily volume traded of the Common Stock during the five
trading days immediately prior to requested advance. The shares would be purchased at a price equal to 97% of the Market Price as defined
in the SEPA. The Company may establish a minimum acceptable price in each advance below which the Company will not be obligated to make
any sales to Yorkville</ONMD:EquityPurchaseAgreementDescription>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004945"
      unitRef="Shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ONMD:ShareOutstandingVotingPercentage
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004947"
      unitRef="Pure">0.0499</ONMD:ShareOutstandingVotingPercentage>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-17_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004949"
      unitRef="Shares">4767616</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004951"
      unitRef="Pure">0.1999</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:LoanProcessingFee
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember"
      decimals="0"
      id="Fact004953"
      unitRef="USD">25000</us-gaap:LoanProcessingFee>
    <us-gaap:PaymentForManagementFee
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember"
      decimals="-5"
      id="Fact004955"
      unitRef="USD">500000</us-gaap:PaymentForManagementFee>
    <us-gaap:LoansPayable
      contextRef="AsOf2024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember"
      decimals="-5"
      id="Fact004957"
      unitRef="USD">1500000</us-gaap:LoansPayable>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember"
      id="Fact004959">The Yorkville Promissory Note is due on June 18, 2025, and interest shall accrue at an annual rate equal to 0%, subject to an increase to 18% upon an event of default as described in the Yorkville Promissory Note.</us-gaap:DebtInstrumentDescription>
    <us-gaap:DerivativeDescriptionOfTerms
      contextRef="From2024-06-172024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember"
      id="Fact004961">(a) $1.3408 per share (subject to downward reset upon the filing of the resale registration
statement described below) or (b) 90% of the lowest daily VWAP of the Common Stock on Nasdaq during the seven trading days immediately
prior to each conversion (the &#x201c;Variable Price&#x201d;), but which Variable Price may not be lower than the Floor Price then in effect</us-gaap:DerivativeDescriptionOfTerms>
    <us-gaap:DerivativeFloorPrice
      contextRef="AsOf2024-06-17_srt_ScenarioForecastMember_custom_ConvertiblePromissoryNoteMember"
      decimals="INF"
      id="Fact004963"
      unitRef="USDPShares">0.28</us-gaap:DerivativeFloorPrice>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-03-222024-03-22_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact004965"
      unitRef="USD">12000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-222024-03-22_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact004967"
      unitRef="Shares">147000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharePrice
      contextRef="AsOf2024-03-22_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact004969"
      unitRef="USDPShares">1.00</us-gaap:SharePrice>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-08-302024-08-30_srt_ScenarioForecastMember"
      decimals="0"
      id="Fact004971"
      unitRef="USD">12000</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2024-08-302024-08-30_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004973"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2024-10-01_srt_ScenarioForecastMember"
      decimals="INF"
      id="Fact004975"
      unitRef="Shares">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001674"
          xlink:label="Fact001674"
          xlink:type="locator"/>
        <link:footnote id="Footnote002351" xlink:label="Footnote002351" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001674"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001676"
          xlink:label="Fact001676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001676"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001678"
          xlink:label="Fact001678"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001678"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001680"
          xlink:label="Fact001680"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001680"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2061"
          xlink:label="xdx2ixbrl2061"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2061"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2066"
          xlink:label="xdx2ixbrl2066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2066"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2071"
          xlink:label="xdx2ixbrl2071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2071"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2080"
          xlink:label="xdx2ixbrl2080"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2080"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2085"
          xlink:label="xdx2ixbrl2085"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2085"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2090"
          xlink:label="xdx2ixbrl2090"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2090"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2095"
          xlink:label="xdx2ixbrl2095"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2095"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2100"
          xlink:label="xdx2ixbrl2100"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2100"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2115"
          xlink:label="xdx2ixbrl2115"
          xlink:type="locator"/>
        <link:footnote id="Footnote002352" xlink:label="Footnote002352" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2115"
          xlink:to="Footnote002352"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2115"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002120"
          xlink:label="Fact002120"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002120"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002125"
          xlink:label="Fact002125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002125"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2130"
          xlink:label="xdx2ixbrl2130"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2130"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2135"
          xlink:label="xdx2ixbrl2135"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2135"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2140"
          xlink:label="xdx2ixbrl2140"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2140"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002145"
          xlink:label="Fact002145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002145"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002150"
          xlink:label="Fact002150"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002150"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002155"
          xlink:label="Fact002155"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002155"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2160"
          xlink:label="xdx2ixbrl2160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2160"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2165"
          xlink:label="xdx2ixbrl2165"
          xlink:type="locator"/>
        <link:footnote id="Footnote002353" xlink:label="Footnote002353" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2165"
          xlink:to="Footnote002353"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2165"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002170"
          xlink:label="Fact002170"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002170"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2175"
          xlink:label="xdx2ixbrl2175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2175"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002180"
          xlink:label="Fact002180"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002180"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2190"
          xlink:label="xdx2ixbrl2190"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2190"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2200"
          xlink:label="xdx2ixbrl2200"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2200"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2205"
          xlink:label="xdx2ixbrl2205"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2205"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2210"
          xlink:label="xdx2ixbrl2210"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2210"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002215"
          xlink:label="Fact002215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002215"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002220"
          xlink:label="Fact002220"
          xlink:type="locator"/>
        <link:footnote id="Footnote002354" xlink:label="Footnote002354" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the valuation of liability-classified warrants.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002220"
          xlink:to="Footnote002354"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002220"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2225"
          xlink:label="xdx2ixbrl2225"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2225"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2230"
          xlink:label="xdx2ixbrl2230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2230"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2240"
          xlink:label="xdx2ixbrl2240"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2240"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2261"
          xlink:label="xdx2ixbrl2261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2261"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2282"
          xlink:label="xdx2ixbrl2282"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2282"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2292"
          xlink:label="xdx2ixbrl2292"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2292"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2313"
          xlink:label="xdx2ixbrl2313"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2313"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2334"
          xlink:label="xdx2ixbrl2334"
          xlink:type="locator"/>
        <link:footnote id="Footnote002355" xlink:label="Footnote002355" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2334"
          xlink:to="Footnote002355"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2334"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2339"
          xlink:label="xdx2ixbrl2339"
          xlink:type="locator"/>
        <link:footnote id="Footnote002356" xlink:label="Footnote002356" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2339"
          xlink:to="Footnote002356"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2339"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2344"
          xlink:label="xdx2ixbrl2344"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2344"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2349"
          xlink:label="xdx2ixbrl2349"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2349"
          xlink:to="Footnote002351"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002113"
          xlink:label="Fact002113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002113"
          xlink:to="Footnote002352"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002114"
          xlink:label="Fact002114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002114"
          xlink:to="Footnote002352"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002116"
          xlink:label="Fact002116"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002116"
          xlink:to="Footnote002352"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002163"
          xlink:label="Fact002163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002163"
          xlink:to="Footnote002353"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002164"
          xlink:label="Fact002164"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002164"
          xlink:to="Footnote002353"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002166"
          xlink:label="Fact002166"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002166"
          xlink:to="Footnote002353"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2218"
          xlink:label="xdx2ixbrl2218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2218"
          xlink:to="Footnote002354"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002219"
          xlink:label="Fact002219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002219"
          xlink:to="Footnote002354"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002221"
          xlink:label="Fact002221"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002221"
          xlink:to="Footnote002354"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002332"
          xlink:label="Fact002332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002332"
          xlink:to="Footnote002355"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002333"
          xlink:label="Fact002333"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002333"
          xlink:to="Footnote002355"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002335"
          xlink:label="Fact002335"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002335"
          xlink:to="Footnote002355"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002337"
          xlink:label="Fact002337"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002337"
          xlink:to="Footnote002356"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002338"
          xlink:label="Fact002338"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002338"
          xlink:to="Footnote002356"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002340"
          xlink:label="Fact002340"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002340"
          xlink:to="Footnote002356"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2370"
          xlink:label="xdx2ixbrl2370"
          xlink:type="locator"/>
        <link:footnote id="Footnote002604" xlink:label="Footnote002604" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.</xhtml:span></link:footnote>
        <link:footnote id="Footnote002605" xlink:label="Footnote002605" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2370"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2370"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2375"
          xlink:label="xdx2ixbrl2375"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2375"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2375"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2380"
          xlink:label="xdx2ixbrl2380"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2380"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2389"
          xlink:label="xdx2ixbrl2389"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2389"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2394"
          xlink:label="xdx2ixbrl2394"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2394"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2399"
          xlink:label="xdx2ixbrl2399"
          xlink:type="locator"/>
        <link:footnote id="Footnote002606" xlink:label="Footnote002606" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2399"
          xlink:to="Footnote002606"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2399"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2404"
          xlink:label="xdx2ixbrl2404"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2404"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2409"
          xlink:label="xdx2ixbrl2409"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2409"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2424"
          xlink:label="xdx2ixbrl2424"
          xlink:type="locator"/>
        <link:footnote id="Footnote002607" xlink:label="Footnote002607" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2424"
          xlink:to="Footnote002607"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2424"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2429"
          xlink:label="xdx2ixbrl2429"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2429"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2429"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2434"
          xlink:label="xdx2ixbrl2434"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2434"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2439"
          xlink:label="xdx2ixbrl2439"
          xlink:type="locator"/>
        <link:footnote id="Footnote002608" xlink:label="Footnote002608" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2439"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2439"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2444"
          xlink:label="xdx2ixbrl2444"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2444"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2444"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2449"
          xlink:label="xdx2ixbrl2449"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2449"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2449"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2454"
          xlink:label="xdx2ixbrl2454"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2454"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002464"
          xlink:label="Fact002464"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002464"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2469"
          xlink:label="xdx2ixbrl2469"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2469"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2469"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2474"
          xlink:label="xdx2ixbrl2474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2474"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2474"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2479"
          xlink:label="xdx2ixbrl2479"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2479"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2479"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2484"
          xlink:label="xdx2ixbrl2484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2484"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2484"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2489"
          xlink:label="xdx2ixbrl2489"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2489"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2489"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002494"
          xlink:label="Fact002494"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002494"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2499"
          xlink:label="xdx2ixbrl2499"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2499"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2504"
          xlink:label="xdx2ixbrl2504"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2504"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2514"
          xlink:label="xdx2ixbrl2514"
          xlink:type="locator"/>
        <link:footnote id="Footnote002609" xlink:label="Footnote002609" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for historical preferred stock as temporary equity.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2514"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2514"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2535"
          xlink:label="xdx2ixbrl2535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2535"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2535"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2556"
          xlink:label="xdx2ixbrl2556"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2556"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2566"
          xlink:label="xdx2ixbrl2566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2566"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2587"
          xlink:label="xdx2ixbrl2587"
          xlink:type="locator"/>
        <link:footnote id="Footnote002610" xlink:label="Footnote002610" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2587"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2587"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2592"
          xlink:label="xdx2ixbrl2592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2592"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2597"
          xlink:label="xdx2ixbrl2597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2597"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2602"
          xlink:label="xdx2ixbrl2602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2602"
          xlink:to="Footnote002604"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002368"
          xlink:label="Fact002368"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002368"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002369"
          xlink:label="Fact002369"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002369"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002371"
          xlink:label="Fact002371"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002371"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002373"
          xlink:label="Fact002373"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002373"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002374"
          xlink:label="Fact002374"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002374"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2376"
          xlink:label="xdx2ixbrl2376"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2376"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002427"
          xlink:label="Fact002427"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002427"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002428"
          xlink:label="Fact002428"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002428"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2430"
          xlink:label="xdx2ixbrl2430"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2430"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002442"
          xlink:label="Fact002442"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002442"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002443"
          xlink:label="Fact002443"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002443"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2445"
          xlink:label="xdx2ixbrl2445"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2445"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002447"
          xlink:label="Fact002447"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002447"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002448"
          xlink:label="Fact002448"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002448"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2450"
          xlink:label="xdx2ixbrl2450"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2450"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002472"
          xlink:label="Fact002472"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002472"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002473"
          xlink:label="Fact002473"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002473"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2475"
          xlink:label="xdx2ixbrl2475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2475"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002477"
          xlink:label="Fact002477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002477"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002478"
          xlink:label="Fact002478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002478"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2480"
          xlink:label="xdx2ixbrl2480"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2480"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002482"
          xlink:label="Fact002482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002482"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002483"
          xlink:label="Fact002483"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002483"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2485"
          xlink:label="xdx2ixbrl2485"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2485"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002487"
          xlink:label="Fact002487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002487"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002488"
          xlink:label="Fact002488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002488"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2490"
          xlink:label="xdx2ixbrl2490"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2490"
          xlink:to="Footnote002605"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002397"
          xlink:label="Fact002397"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002397"
          xlink:to="Footnote002606"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002398"
          xlink:label="Fact002398"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002398"
          xlink:to="Footnote002606"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002400"
          xlink:label="Fact002400"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002400"
          xlink:to="Footnote002606"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002422"
          xlink:label="Fact002422"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002422"
          xlink:to="Footnote002607"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002423"
          xlink:label="Fact002423"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002423"
          xlink:to="Footnote002607"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002425"
          xlink:label="Fact002425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002425"
          xlink:to="Footnote002607"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002437"
          xlink:label="Fact002437"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002437"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002438"
          xlink:label="Fact002438"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002438"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002440"
          xlink:label="Fact002440"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002440"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002467"
          xlink:label="Fact002467"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002467"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002468"
          xlink:label="Fact002468"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002468"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2470"
          xlink:label="xdx2ixbrl2470"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2470"
          xlink:to="Footnote002608"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2512"
          xlink:label="xdx2ixbrl2512"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2512"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002513"
          xlink:label="Fact002513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002513"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002515"
          xlink:label="Fact002515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002515"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2533"
          xlink:label="xdx2ixbrl2533"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2533"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002534"
          xlink:label="Fact002534"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002534"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002536"
          xlink:label="Fact002536"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002536"
          xlink:to="Footnote002609"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002585"
          xlink:label="Fact002585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002585"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002586"
          xlink:label="Fact002586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002586"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002588"
          xlink:label="Fact002588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002588"
          xlink:to="Footnote002610"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2621"
          xlink:label="xdx2ixbrl2621"
          xlink:type="locator"/>
        <link:footnote id="Footnote002785" xlink:label="Footnote002785" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2621"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2626"
          xlink:label="xdx2ixbrl2626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2626"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2631"
          xlink:label="xdx2ixbrl2631"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2631"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2636"
          xlink:label="xdx2ixbrl2636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2636"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2641"
          xlink:label="xdx2ixbrl2641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2641"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2651"
          xlink:label="xdx2ixbrl2651"
          xlink:type="locator"/>
        <link:footnote id="Footnote002786" xlink:label="Footnote002786" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2651"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2651"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002656"
          xlink:label="Fact002656"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002656"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2661"
          xlink:label="xdx2ixbrl2661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2661"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2666"
          xlink:label="xdx2ixbrl2666"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2666"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2666"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002671"
          xlink:label="Fact002671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002671"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2686"
          xlink:label="xdx2ixbrl2686"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2686"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2691"
          xlink:label="xdx2ixbrl2691"
          xlink:type="locator"/>
        <link:footnote id="Footnote002787" xlink:label="Footnote002787" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2691"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2691"
          xlink:to="Footnote002787"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2696"
          xlink:label="xdx2ixbrl2696"
          xlink:type="locator"/>
        <link:footnote id="Footnote002788" xlink:label="Footnote002788" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2696"
          xlink:to="Footnote002788"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2696"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2701"
          xlink:label="xdx2ixbrl2701"
          xlink:type="locator"/>
        <link:footnote id="Footnote002789" xlink:label="Footnote002789" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2701"
          xlink:to="Footnote002789"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2701"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2706"
          xlink:label="xdx2ixbrl2706"
          xlink:type="locator"/>
        <link:footnote id="Footnote002790" xlink:label="Footnote002790" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2706"
          xlink:to="Footnote002790"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2706"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2711"
          xlink:label="xdx2ixbrl2711"
          xlink:type="locator"/>
        <link:footnote id="Footnote002791" xlink:label="Footnote002791" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2711"
          xlink:to="Footnote002791"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2711"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2716"
          xlink:label="xdx2ixbrl2716"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2716"
          xlink:to="Footnote002788"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2716"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002721"
          xlink:label="Fact002721"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002721"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2726"
          xlink:label="xdx2ixbrl2726"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2726"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002731"
          xlink:label="Fact002731"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002731"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002736"
          xlink:label="Fact002736"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002736"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002741"
          xlink:label="Fact002741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002741"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2746"
          xlink:label="xdx2ixbrl2746"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2746"
          xlink:to="Footnote002785"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002649"
          xlink:label="Fact002649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002649"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002650"
          xlink:label="Fact002650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002650"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002652"
          xlink:label="Fact002652"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002652"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002664"
          xlink:label="Fact002664"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002664"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002665"
          xlink:label="Fact002665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002665"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002667"
          xlink:label="Fact002667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002667"
          xlink:to="Footnote002786"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002689"
          xlink:label="Fact002689"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002689"
          xlink:to="Footnote002787"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002690"
          xlink:label="Fact002690"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002690"
          xlink:to="Footnote002787"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2692"
          xlink:label="xdx2ixbrl2692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2692"
          xlink:to="Footnote002787"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002694"
          xlink:label="Fact002694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002694"
          xlink:to="Footnote002788"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002695"
          xlink:label="Fact002695"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002695"
          xlink:to="Footnote002788"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002697"
          xlink:label="Fact002697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002697"
          xlink:to="Footnote002788"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002715"
          xlink:label="Fact002715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002715"
          xlink:to="Footnote002788"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002717"
          xlink:label="Fact002717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002717"
          xlink:to="Footnote002788"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002699"
          xlink:label="Fact002699"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002699"
          xlink:to="Footnote002789"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002700"
          xlink:label="Fact002700"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002700"
          xlink:to="Footnote002789"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002702"
          xlink:label="Fact002702"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002702"
          xlink:to="Footnote002789"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002704"
          xlink:label="Fact002704"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002704"
          xlink:to="Footnote002790"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002705"
          xlink:label="Fact002705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002705"
          xlink:to="Footnote002790"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002707"
          xlink:label="Fact002707"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002707"
          xlink:to="Footnote002790"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2709"
          xlink:label="xdx2ixbrl2709"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2709"
          xlink:to="Footnote002791"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002710"
          xlink:label="Fact002710"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002710"
          xlink:to="Footnote002791"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002712"
          xlink:label="Fact002712"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002712"
          xlink:to="Footnote002791"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002754"
          xlink:label="Fact002754"
          xlink:type="locator"/>
        <link:footnote id="Footnote002792" xlink:label="Footnote002792" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002754"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002756"
          xlink:label="Fact002756"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002756"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002758"
          xlink:label="Fact002758"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002758"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002760"
          xlink:label="Fact002760"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002760"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2762"
          xlink:label="xdx2ixbrl2762"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2762"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2764"
          xlink:label="xdx2ixbrl2764"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2764"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002766"
          xlink:label="Fact002766"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002766"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002768"
          xlink:label="Fact002768"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002768"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002770"
          xlink:label="Fact002770"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002770"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002772"
          xlink:label="Fact002772"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002772"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002774"
          xlink:label="Fact002774"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002774"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002776"
          xlink:label="Fact002776"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002776"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2778"
          xlink:label="xdx2ixbrl2778"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2778"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2780"
          xlink:label="xdx2ixbrl2780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2780"
          xlink:to="Footnote002792"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2801"
          xlink:label="xdx2ixbrl2801"
          xlink:type="locator"/>
        <link:footnote id="Footnote002947" xlink:label="Footnote002947" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2801"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2806"
          xlink:label="xdx2ixbrl2806"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2806"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2811"
          xlink:label="xdx2ixbrl2811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2811"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2816"
          xlink:label="xdx2ixbrl2816"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2816"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2821"
          xlink:label="xdx2ixbrl2821"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2821"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2831"
          xlink:label="xdx2ixbrl2831"
          xlink:type="locator"/>
        <link:footnote id="Footnote002948" xlink:label="Footnote002948" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2831"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2831"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002836"
          xlink:label="Fact002836"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002836"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2841"
          xlink:label="xdx2ixbrl2841"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2841"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2846"
          xlink:label="xdx2ixbrl2846"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2846"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2846"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002851"
          xlink:label="Fact002851"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002851"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002856"
          xlink:label="Fact002856"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002856"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2866"
          xlink:label="xdx2ixbrl2866"
          xlink:type="locator"/>
        <link:footnote id="Footnote002949" xlink:label="Footnote002949" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2866"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2866"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2871"
          xlink:label="xdx2ixbrl2871"
          xlink:type="locator"/>
        <link:footnote id="Footnote002950" xlink:label="Footnote002950" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2871"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2871"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2876"
          xlink:label="xdx2ixbrl2876"
          xlink:type="locator"/>
        <link:footnote id="Footnote002951" xlink:label="Footnote002951" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2876"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2876"
          xlink:to="Footnote002951"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2881"
          xlink:label="xdx2ixbrl2881"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2881"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2881"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2886"
          xlink:label="xdx2ixbrl2886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2886"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2886"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002891"
          xlink:label="Fact002891"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002891"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2896"
          xlink:label="xdx2ixbrl2896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2896"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2896"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002901"
          xlink:label="Fact002901"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002901"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002906"
          xlink:label="Fact002906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002906"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002911"
          xlink:label="Fact002911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002911"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002916"
          xlink:label="Fact002916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002916"
          xlink:to="Footnote002947"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002829"
          xlink:label="Fact002829"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002829"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002830"
          xlink:label="Fact002830"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002830"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002832"
          xlink:label="Fact002832"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002832"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002844"
          xlink:label="Fact002844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002844"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002845"
          xlink:label="Fact002845"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002845"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002847"
          xlink:label="Fact002847"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002847"
          xlink:to="Footnote002948"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002864"
          xlink:label="Fact002864"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002864"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002865"
          xlink:label="Fact002865"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002865"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2867"
          xlink:label="xdx2ixbrl2867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2867"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002879"
          xlink:label="Fact002879"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002879"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002880"
          xlink:label="Fact002880"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002880"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2882"
          xlink:label="xdx2ixbrl2882"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2882"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002894"
          xlink:label="Fact002894"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002894"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002895"
          xlink:label="Fact002895"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002895"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2897"
          xlink:label="xdx2ixbrl2897"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2897"
          xlink:to="Footnote002949"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002869"
          xlink:label="Fact002869"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002869"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002870"
          xlink:label="Fact002870"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002870"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2872"
          xlink:label="xdx2ixbrl2872"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2872"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2884"
          xlink:label="xdx2ixbrl2884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2884"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002885"
          xlink:label="Fact002885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002885"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002887"
          xlink:label="Fact002887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002887"
          xlink:to="Footnote002950"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2874"
          xlink:label="xdx2ixbrl2874"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2874"
          xlink:to="Footnote002951"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002875"
          xlink:label="Fact002875"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002875"
          xlink:to="Footnote002951"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002877"
          xlink:label="Fact002877"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002877"
          xlink:to="Footnote002951"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002924"
          xlink:label="Fact002924"
          xlink:type="locator"/>
        <link:footnote id="Footnote002952" xlink:label="Footnote002952" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002924"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002926"
          xlink:label="Fact002926"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002926"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2928"
          xlink:label="xdx2ixbrl2928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2928"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2930"
          xlink:label="xdx2ixbrl2930"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2930"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002932"
          xlink:label="Fact002932"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002932"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002934"
          xlink:label="Fact002934"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002934"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002936"
          xlink:label="Fact002936"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002936"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002938"
          xlink:label="Fact002938"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002938"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2940"
          xlink:label="xdx2ixbrl2940"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2940"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2942"
          xlink:label="xdx2ixbrl2942"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2942"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002944"
          xlink:label="Fact002944"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002944"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002946"
          xlink:label="Fact002946"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002946"
          xlink:to="Footnote002952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002960"
          xlink:label="Fact002960"
          xlink:type="locator"/>
        <link:footnote id="Footnote003151" xlink:label="Footnote003151" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002960"
          xlink:to="Footnote003151"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002961"
          xlink:label="Fact002961"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002961"
          xlink:to="Footnote003151"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002962"
          xlink:label="Fact002962"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002962"
          xlink:to="Footnote003151"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002972"
          xlink:label="Fact002972"
          xlink:type="locator"/>
        <link:footnote id="Footnote003152" xlink:label="Footnote003152" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002972"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002973"
          xlink:label="Fact002973"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002973"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2974"
          xlink:label="xdx2ixbrl2974"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2974"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003016"
          xlink:label="Fact003016"
          xlink:type="locator"/>
        <link:footnote id="Footnote003153" xlink:label="Footnote003153" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003016"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003016"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003017"
          xlink:label="Fact003017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003017"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003017"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003018"
          xlink:label="Fact003018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003018"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003018"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003020"
          xlink:label="Fact003020"
          xlink:type="locator"/>
        <link:footnote id="Footnote003159" xlink:label="Footnote003159" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003020"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003020"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003020"
          xlink:to="Footnote003159"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003021"
          xlink:label="Fact003021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003021"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003021"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003021"
          xlink:to="Footnote003159"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003022"
          xlink:label="Fact003022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003022"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003022"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003022"
          xlink:to="Footnote003159"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003032"
          xlink:label="Fact003032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003032"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003032"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003033"
          xlink:label="Fact003033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003033"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003033"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3034"
          xlink:label="xdx2ixbrl3034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3034"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3034"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003036"
          xlink:label="Fact003036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003036"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003036"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003037"
          xlink:label="Fact003037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003037"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003037"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3038"
          xlink:label="xdx2ixbrl3038"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3038"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3038"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003040"
          xlink:label="Fact003040"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003040"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003040"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003041"
          xlink:label="Fact003041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003041"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003041"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3042"
          xlink:label="xdx2ixbrl3042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3042"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3042"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003044"
          xlink:label="Fact003044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003044"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003044"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003045"
          xlink:label="Fact003045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003045"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003045"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3046"
          xlink:label="xdx2ixbrl3046"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3046"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3046"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003048"
          xlink:label="Fact003048"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003048"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003048"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003049"
          xlink:label="Fact003049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003049"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003049"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3050"
          xlink:label="xdx2ixbrl3050"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3050"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3050"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003084"
          xlink:label="Fact003084"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003084"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003085"
          xlink:label="Fact003085"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003085"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3086"
          xlink:label="xdx2ixbrl3086"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3086"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003088"
          xlink:label="Fact003088"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003088"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003089"
          xlink:label="Fact003089"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003089"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3090"
          xlink:label="xdx2ixbrl3090"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3090"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003092"
          xlink:label="Fact003092"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003092"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003093"
          xlink:label="Fact003093"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003093"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3094"
          xlink:label="xdx2ixbrl3094"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3094"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003096"
          xlink:label="Fact003096"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003096"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003097"
          xlink:label="Fact003097"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003097"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3098"
          xlink:label="xdx2ixbrl3098"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3098"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003100"
          xlink:label="Fact003100"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003100"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003101"
          xlink:label="Fact003101"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003101"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3102"
          xlink:label="xdx2ixbrl3102"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3102"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3112"
          xlink:label="xdx2ixbrl3112"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3112"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003113"
          xlink:label="Fact003113"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003113"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003114"
          xlink:label="Fact003114"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003114"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3116"
          xlink:label="xdx2ixbrl3116"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3116"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003117"
          xlink:label="Fact003117"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003117"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003118"
          xlink:label="Fact003118"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003118"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3140"
          xlink:label="xdx2ixbrl3140"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3140"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003141"
          xlink:label="Fact003141"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003141"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003142"
          xlink:label="Fact003142"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003142"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3144"
          xlink:label="xdx2ixbrl3144"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3144"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003145"
          xlink:label="Fact003145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003145"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003146"
          xlink:label="Fact003146"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003146"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3148"
          xlink:label="xdx2ixbrl3148"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3148"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003149"
          xlink:label="Fact003149"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003149"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003150"
          xlink:label="Fact003150"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003150"
          xlink:to="Footnote003152"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002976"
          xlink:label="Fact002976"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002976"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002977"
          xlink:label="Fact002977"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002977"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2978"
          xlink:label="xdx2ixbrl2978"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2978"
          xlink:to="Footnote003153"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2980"
          xlink:label="xdx2ixbrl2980"
          xlink:type="locator"/>
        <link:footnote id="Footnote003154" xlink:label="Footnote003154" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2980"
          xlink:to="Footnote003154"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002981"
          xlink:label="Fact002981"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002981"
          xlink:to="Footnote003154"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002982"
          xlink:label="Fact002982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002982"
          xlink:to="Footnote003154"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2984"
          xlink:label="xdx2ixbrl2984"
          xlink:type="locator"/>
        <link:footnote id="Footnote003155" xlink:label="Footnote003155" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2984"
          xlink:to="Footnote003155"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002985"
          xlink:label="Fact002985"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002985"
          xlink:to="Footnote003155"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002986"
          xlink:label="Fact002986"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002986"
          xlink:to="Footnote003155"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2992"
          xlink:label="xdx2ixbrl2992"
          xlink:type="locator"/>
        <link:footnote id="Footnote003156" xlink:label="Footnote003156" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2992"
          xlink:to="Footnote003156"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002993"
          xlink:label="Fact002993"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002993"
          xlink:to="Footnote003156"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002994"
          xlink:label="Fact002994"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002994"
          xlink:to="Footnote003156"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2996"
          xlink:label="xdx2ixbrl2996"
          xlink:type="locator"/>
        <link:footnote id="Footnote003157" xlink:label="Footnote003157" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2996"
          xlink:to="Footnote003157"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002997"
          xlink:label="Fact002997"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002997"
          xlink:to="Footnote003157"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002998"
          xlink:label="Fact002998"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002998"
          xlink:to="Footnote003157"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003080"
          xlink:label="Fact003080"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003080"
          xlink:to="Footnote003157"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003081"
          xlink:label="Fact003081"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003081"
          xlink:to="Footnote003157"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003082"
          xlink:label="Fact003082"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003082"
          xlink:to="Footnote003157"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3000"
          xlink:label="xdx2ixbrl3000"
          xlink:type="locator"/>
        <link:footnote id="Footnote003158" xlink:label="Footnote003158" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3000"
          xlink:to="Footnote003158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003001"
          xlink:label="Fact003001"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003001"
          xlink:to="Footnote003158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003002"
          xlink:label="Fact003002"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003002"
          xlink:to="Footnote003158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003104"
          xlink:label="Fact003104"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003104"
          xlink:to="Footnote003158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003105"
          xlink:label="Fact003105"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003105"
          xlink:to="Footnote003158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003106"
          xlink:label="Fact003106"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003106"
          xlink:to="Footnote003158"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3004"
          xlink:label="xdx2ixbrl3004"
          xlink:type="locator"/>
        <link:footnote id="Footnote003160" xlink:label="Footnote003160" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3004"
          xlink:to="Footnote003160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003005"
          xlink:label="Fact003005"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003005"
          xlink:to="Footnote003160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003006"
          xlink:label="Fact003006"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003006"
          xlink:to="Footnote003160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003076"
          xlink:label="Fact003076"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003076"
          xlink:to="Footnote003160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003077"
          xlink:label="Fact003077"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003077"
          xlink:to="Footnote003160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003078"
          xlink:label="Fact003078"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003078"
          xlink:to="Footnote003160"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003166"
          xlink:label="Fact003166"
          xlink:type="locator"/>
        <link:footnote id="Footnote003305" xlink:label="Footnote003305" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003166"
          xlink:to="Footnote003305"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003167"
          xlink:label="Fact003167"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003167"
          xlink:to="Footnote003305"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003168"
          xlink:label="Fact003168"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003168"
          xlink:to="Footnote003305"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003182"
          xlink:label="Fact003182"
          xlink:type="locator"/>
        <link:footnote id="Footnote003306" xlink:label="Footnote003306" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003182"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003183"
          xlink:label="Fact003183"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003183"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3184"
          xlink:label="xdx2ixbrl3184"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3184"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003206"
          xlink:label="Fact003206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003206"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003207"
          xlink:label="Fact003207"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003207"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003208"
          xlink:label="Fact003208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003208"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003210"
          xlink:label="Fact003210"
          xlink:type="locator"/>
        <link:footnote id="Footnote003310" xlink:label="Footnote003310" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003210"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003210"
          xlink:to="Footnote003310"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003211"
          xlink:label="Fact003211"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003211"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003211"
          xlink:to="Footnote003310"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003212"
          xlink:label="Fact003212"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003212"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003212"
          xlink:to="Footnote003310"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003218"
          xlink:label="Fact003218"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003218"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003219"
          xlink:label="Fact003219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003219"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3220"
          xlink:label="xdx2ixbrl3220"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3220"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003222"
          xlink:label="Fact003222"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003222"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003223"
          xlink:label="Fact003223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003223"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3224"
          xlink:label="xdx2ixbrl3224"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3224"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003226"
          xlink:label="Fact003226"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003226"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003227"
          xlink:label="Fact003227"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003227"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3228"
          xlink:label="xdx2ixbrl3228"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3228"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003230"
          xlink:label="Fact003230"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003230"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003231"
          xlink:label="Fact003231"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003231"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3232"
          xlink:label="xdx2ixbrl3232"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3232"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003234"
          xlink:label="Fact003234"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003234"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003235"
          xlink:label="Fact003235"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003235"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3236"
          xlink:label="xdx2ixbrl3236"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3236"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003262"
          xlink:label="Fact003262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003262"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003263"
          xlink:label="Fact003263"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003263"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3264"
          xlink:label="xdx2ixbrl3264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3264"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003266"
          xlink:label="Fact003266"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003266"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003267"
          xlink:label="Fact003267"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003267"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3268"
          xlink:label="xdx2ixbrl3268"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3268"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003270"
          xlink:label="Fact003270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003270"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003271"
          xlink:label="Fact003271"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003271"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3272"
          xlink:label="xdx2ixbrl3272"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3272"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003274"
          xlink:label="Fact003274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003274"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003275"
          xlink:label="Fact003275"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003275"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3276"
          xlink:label="xdx2ixbrl3276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3276"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3286"
          xlink:label="xdx2ixbrl3286"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3286"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003287"
          xlink:label="Fact003287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003287"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003288"
          xlink:label="Fact003288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003288"
          xlink:to="Footnote003306"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003178"
          xlink:label="Fact003178"
          xlink:type="locator"/>
        <link:footnote id="Footnote003307" xlink:label="Footnote003307" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003178"
          xlink:to="Footnote003307"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003179"
          xlink:label="Fact003179"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003179"
          xlink:to="Footnote003307"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003180"
          xlink:label="Fact003180"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003180"
          xlink:to="Footnote003307"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3186"
          xlink:label="xdx2ixbrl3186"
          xlink:type="locator"/>
        <link:footnote id="Footnote003308" xlink:label="Footnote003308" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3186"
          xlink:to="Footnote003308"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003187"
          xlink:label="Fact003187"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003187"
          xlink:to="Footnote003308"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003188"
          xlink:label="Fact003188"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003188"
          xlink:to="Footnote003308"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3190"
          xlink:label="xdx2ixbrl3190"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3190"
          xlink:to="Footnote003308"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003191"
          xlink:label="Fact003191"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003191"
          xlink:to="Footnote003308"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003192"
          xlink:label="Fact003192"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003192"
          xlink:to="Footnote003308"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3194"
          xlink:label="xdx2ixbrl3194"
          xlink:type="locator"/>
        <link:footnote id="Footnote003309" xlink:label="Footnote003309" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3194"
          xlink:to="Footnote003309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003195"
          xlink:label="Fact003195"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003195"
          xlink:to="Footnote003309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003196"
          xlink:label="Fact003196"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003196"
          xlink:to="Footnote003309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003278"
          xlink:label="Fact003278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003278"
          xlink:to="Footnote003309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003279"
          xlink:label="Fact003279"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003279"
          xlink:to="Footnote003309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003280"
          xlink:label="Fact003280"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003280"
          xlink:to="Footnote003309"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003496"
          xlink:label="Fact003496"
          xlink:type="locator"/>
        <link:footnote id="Footnote003793" xlink:label="Footnote003793" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Cumulative
    impact of corrections of errors to the prior year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003496"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003497"
          xlink:label="Fact003497"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003497"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003498"
          xlink:label="Fact003498"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003498"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003499"
          xlink:label="Fact003499"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003499"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003500"
          xlink:label="Fact003500"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003500"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003502"
          xlink:label="Fact003502"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003502"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003504"
          xlink:label="Fact003504"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003504"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003506"
          xlink:label="Fact003506"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003506"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003508"
          xlink:label="Fact003508"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003508"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003510"
          xlink:label="Fact003510"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003510"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003512"
          xlink:label="Fact003512"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003512"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3596"
          xlink:label="xdx2ixbrl3596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3596"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3597"
          xlink:label="xdx2ixbrl3597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3597"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003598"
          xlink:label="Fact003598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003598"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3599"
          xlink:label="xdx2ixbrl3599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3599"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003600"
          xlink:label="Fact003600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003600"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003602"
          xlink:label="Fact003602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003602"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3604"
          xlink:label="xdx2ixbrl3604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3604"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003605"
          xlink:label="Fact003605"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003605"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3606"
          xlink:label="xdx2ixbrl3606"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3606"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3607"
          xlink:label="xdx2ixbrl3607"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3607"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003608"
          xlink:label="Fact003608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003608"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3616"
          xlink:label="xdx2ixbrl3616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3616"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3617"
          xlink:label="xdx2ixbrl3617"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3617"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3618"
          xlink:label="xdx2ixbrl3618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3618"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003619"
          xlink:label="Fact003619"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003619"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003620"
          xlink:label="Fact003620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003620"
          xlink:to="Footnote003793"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3350"
          xlink:label="xdx2ixbrl3350"
          xlink:type="locator"/>
        <link:footnote id="Footnote003794" xlink:label="Footnote003794" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the accounting and presentation of the recapitalization.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3350"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3514"
          xlink:label="xdx2ixbrl3514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3514"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3515"
          xlink:label="xdx2ixbrl3515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3515"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3516"
          xlink:label="xdx2ixbrl3516"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3516"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3517"
          xlink:label="xdx2ixbrl3517"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3517"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3518"
          xlink:label="xdx2ixbrl3518"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3518"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003520"
          xlink:label="Fact003520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003520"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3522"
          xlink:label="xdx2ixbrl3522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3522"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3523"
          xlink:label="xdx2ixbrl3523"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3523"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3524"
          xlink:label="xdx2ixbrl3524"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3524"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3525"
          xlink:label="xdx2ixbrl3525"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3525"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003526"
          xlink:label="Fact003526"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003526"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003528"
          xlink:label="Fact003528"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003528"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003530"
          xlink:label="Fact003530"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003530"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003532"
          xlink:label="Fact003532"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003532"
          xlink:to="Footnote003794"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3534"
          xlink:label="xdx2ixbrl3534"
          xlink:type="locator"/>
        <link:footnote id="Footnote003795" xlink:label="Footnote003795" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3534"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3535"
          xlink:label="xdx2ixbrl3535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3535"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003536"
          xlink:label="Fact003536"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003536"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3537"
          xlink:label="xdx2ixbrl3537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3537"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003538"
          xlink:label="Fact003538"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003538"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3590"
          xlink:label="xdx2ixbrl3590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3590"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3591"
          xlink:label="xdx2ixbrl3591"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3591"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003592"
          xlink:label="Fact003592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003592"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3593"
          xlink:label="xdx2ixbrl3593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3593"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003594"
          xlink:label="Fact003594"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003594"
          xlink:to="Footnote003795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3540"
          xlink:label="xdx2ixbrl3540"
          xlink:type="locator"/>
        <link:footnote id="Footnote003796" xlink:label="Footnote003796" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3540"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3541"
          xlink:label="xdx2ixbrl3541"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3541"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003542"
          xlink:label="Fact003542"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003542"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3543"
          xlink:label="xdx2ixbrl3543"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3543"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003544"
          xlink:label="Fact003544"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003544"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003546"
          xlink:label="Fact003546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003546"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3548"
          xlink:label="xdx2ixbrl3548"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3548"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3549"
          xlink:label="xdx2ixbrl3549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3549"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003550"
          xlink:label="Fact003550"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003550"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3551"
          xlink:label="xdx2ixbrl3551"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3551"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003552"
          xlink:label="Fact003552"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003552"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003554"
          xlink:label="Fact003554"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003554"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3556"
          xlink:label="xdx2ixbrl3556"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3556"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3557"
          xlink:label="xdx2ixbrl3557"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3557"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003558"
          xlink:label="Fact003558"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003558"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3559"
          xlink:label="xdx2ixbrl3559"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3559"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003560"
          xlink:label="Fact003560"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003560"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003562"
          xlink:label="Fact003562"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003562"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3564"
          xlink:label="xdx2ixbrl3564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3564"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3565"
          xlink:label="xdx2ixbrl3565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3565"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003566"
          xlink:label="Fact003566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003566"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3567"
          xlink:label="xdx2ixbrl3567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3567"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003568"
          xlink:label="Fact003568"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003568"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003570"
          xlink:label="Fact003570"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003570"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003572"
          xlink:label="Fact003572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003572"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003574"
          xlink:label="Fact003574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003574"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003576"
          xlink:label="Fact003576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003576"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003578"
          xlink:label="Fact003578"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003578"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003580"
          xlink:label="Fact003580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003580"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3582"
          xlink:label="xdx2ixbrl3582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3582"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3583"
          xlink:label="xdx2ixbrl3583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3583"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003584"
          xlink:label="Fact003584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003584"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3585"
          xlink:label="xdx2ixbrl3585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3585"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003586"
          xlink:label="Fact003586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003586"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003588"
          xlink:label="Fact003588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003588"
          xlink:to="Footnote003796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3610"
          xlink:label="xdx2ixbrl3610"
          xlink:type="locator"/>
        <link:footnote id="Footnote003797" xlink:label="Footnote003797" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to improper valuation of stock compensation expense.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3610"
          xlink:to="Footnote003797"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3611"
          xlink:label="xdx2ixbrl3611"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3611"
          xlink:to="Footnote003797"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003612"
          xlink:label="Fact003612"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003612"
          xlink:to="Footnote003797"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3613"
          xlink:label="xdx2ixbrl3613"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3613"
          xlink:to="Footnote003797"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003614"
          xlink:label="Fact003614"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003614"
          xlink:to="Footnote003797"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3622"
          xlink:label="xdx2ixbrl3622"
          xlink:type="locator"/>
        <link:footnote id="Footnote003798" xlink:label="Footnote003798" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Current
    year impact of corrections of errors to the consolidated statements of operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3622"
          xlink:to="Footnote003798"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3623"
          xlink:label="xdx2ixbrl3623"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3623"
          xlink:to="Footnote003798"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3624"
          xlink:label="xdx2ixbrl3624"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3624"
          xlink:to="Footnote003798"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003625"
          xlink:label="Fact003625"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003625"
          xlink:to="Footnote003798"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003626"
          xlink:label="Fact003626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003626"
          xlink:to="Footnote003798"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003884"
          xlink:label="Fact003884"
          xlink:type="locator"/>
        <link:footnote id="Footnote004059" xlink:label="Footnote004059" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Cumulative
    impact of corrections of errors to the prior year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003884"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003885"
          xlink:label="Fact003885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003885"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003886"
          xlink:label="Fact003886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003886"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003887"
          xlink:label="Fact003887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003887"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003888"
          xlink:label="Fact003888"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003888"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3890"
          xlink:label="xdx2ixbrl3890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3890"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003892"
          xlink:label="Fact003892"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003892"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3894"
          xlink:label="xdx2ixbrl3894"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3894"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003896"
          xlink:label="Fact003896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003896"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003898"
          xlink:label="Fact003898"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003898"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003900"
          xlink:label="Fact003900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003900"
          xlink:to="Footnote004059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3902"
          xlink:label="xdx2ixbrl3902"
          xlink:type="locator"/>
        <link:footnote id="Footnote004060" xlink:label="Footnote004060" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to the accounting and presentation of the recapitalization.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3902"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3903"
          xlink:label="xdx2ixbrl3903"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3903"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003904"
          xlink:label="Fact003904"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003904"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003905"
          xlink:label="Fact003905"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003905"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003906"
          xlink:label="Fact003906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003906"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003908"
          xlink:label="Fact003908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003908"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003910"
          xlink:label="Fact003910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003910"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003912"
          xlink:label="Fact003912"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003912"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3914"
          xlink:label="xdx2ixbrl3914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3914"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3915"
          xlink:label="xdx2ixbrl3915"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3915"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003916"
          xlink:label="Fact003916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003916"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3917"
          xlink:label="xdx2ixbrl3917"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3917"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003918"
          xlink:label="Fact003918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003918"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003920"
          xlink:label="Fact003920"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003920"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3922"
          xlink:label="xdx2ixbrl3922"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3922"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3923"
          xlink:label="xdx2ixbrl3923"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3923"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003924"
          xlink:label="Fact003924"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003924"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3925"
          xlink:label="xdx2ixbrl3925"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3925"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003926"
          xlink:label="Fact003926"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003926"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003928"
          xlink:label="Fact003928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003928"
          xlink:to="Footnote004060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3930"
          xlink:label="xdx2ixbrl3930"
          xlink:type="locator"/>
        <link:footnote id="Footnote004061" xlink:label="Footnote004061" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3930"
          xlink:to="Footnote004061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3931"
          xlink:label="xdx2ixbrl3931"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3931"
          xlink:to="Footnote004061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003932"
          xlink:label="Fact003932"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003932"
          xlink:to="Footnote004061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3933"
          xlink:label="xdx2ixbrl3933"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3933"
          xlink:to="Footnote004061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003934"
          xlink:label="Fact003934"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003934"
          xlink:to="Footnote004061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3936"
          xlink:label="xdx2ixbrl3936"
          xlink:type="locator"/>
        <link:footnote id="Footnote004062" xlink:label="Footnote004062" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of error related to identificatoin and recognition of board of director warrante expense.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3936"
          xlink:to="Footnote004062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3937"
          xlink:label="xdx2ixbrl3937"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3937"
          xlink:to="Footnote004062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003938"
          xlink:label="Fact003938"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003938"
          xlink:to="Footnote004062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3939"
          xlink:label="xdx2ixbrl3939"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3939"
          xlink:to="Footnote004062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003940"
          xlink:label="Fact003940"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003940"
          xlink:to="Footnote004062"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3942"
          xlink:label="xdx2ixbrl3942"
          xlink:type="locator"/>
        <link:footnote id="Footnote004063" xlink:label="Footnote004063" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Impact
    of errors related to improper valuation of stock compensation expense.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3942"
          xlink:to="Footnote004063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3943"
          xlink:label="xdx2ixbrl3943"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3943"
          xlink:to="Footnote004063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003944"
          xlink:label="Fact003944"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003944"
          xlink:to="Footnote004063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3945"
          xlink:label="xdx2ixbrl3945"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3945"
          xlink:to="Footnote004063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003946"
          xlink:label="Fact003946"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003946"
          xlink:to="Footnote004063"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3948"
          xlink:label="xdx2ixbrl3948"
          xlink:type="locator"/>
        <link:footnote id="Footnote004064" xlink:label="Footnote004064" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Current
    year impact of corrections of errors to the consolidated statements of operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3948"
          xlink:to="Footnote004064"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3949"
          xlink:label="xdx2ixbrl3949"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3949"
          xlink:to="Footnote004064"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3950"
          xlink:label="xdx2ixbrl3950"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3950"
          xlink:to="Footnote004064"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003951"
          xlink:label="Fact003951"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003951"
          xlink:to="Footnote004064"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003952"
          xlink:label="Fact003952"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003952"
          xlink:to="Footnote004064"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004157"
          xlink:label="Fact004157"
          xlink:type="locator"/>
        <link:footnote id="Footnote004176" xlink:label="Footnote004176" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Retroactively restated
for the reverse recapitalization in Note 3.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004157"
          xlink:to="Footnote004176"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004160"
          xlink:label="Fact004160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004160"
          xlink:to="Footnote004176"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004163"
          xlink:label="Fact004163"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004163"
          xlink:to="Footnote004176"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004166"
          xlink:label="Fact004166"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004166"
          xlink:to="Footnote004176"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004169"
          xlink:label="Fact004169"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004169"
          xlink:to="Footnote004176"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004172"
          xlink:label="Fact004172"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004172"
          xlink:to="Footnote004176"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004175"
          xlink:label="Fact004175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004175"
          xlink:to="Footnote004176"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590131024288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">Amendment
No. 3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ONEMEDNET
CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001849380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-2049355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6385
Old Shady Oak Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Eden Prairie<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">918-7189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">41
Madison Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 3310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(332)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">238-2820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Eitan
Hoenig<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590129777504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,934<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Bitcoin</a></td>
<td class="nump">2,156<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,304<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredCostsNonCurrent', window );">Deferred transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">4,388<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="nump">6,161<span></span>
</td>
<td class="nump">4,682<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="nump">428<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loan extensions</a></td>
<td class="nump">2,992<span></span>
</td>
<td class="nump">2,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loan Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">PIPE Notes</a></td>
<td class="nump">1,593<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_YorkvilleNotesPayableCurrent', window );">Yorkville Note</a></td>
<td class="nump">1,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="nump">3,237<span></span>
</td>
<td class="nump">3,525<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Loan &#8211; related party</a></td>
<td class="nump">2,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">18,628<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Loan, related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">18,656<span></span>
</td>
<td class="nump">13,906<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (deficit) equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">85,455<span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 187,745 and 0 shares at September 30, 2024 and December 31, 2023, respectively</a></td>
<td class="num">(529)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(99,196)<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(14,268)<span></span>
</td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity, and stockholders&#8217; deficit</a></td>
<td class="nump">$ 4,388<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Bitcoin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loan extensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">PIPE Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_YorkvilleNotesPayableCurrent', window );">Yorkville Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,525<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Loan &#8211; related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,906<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (deficit) equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 187,745 and 0 shares at September 30, 2024 and December 31, 2023, respectively</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity, and stockholders&#8217; deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of liability-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredCostsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredCostsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredUnderwriterFeePayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriter fee payable current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredUnderwriterFeePayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_YorkvilleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yorkville notes payable current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_YorkvilleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=ONMD_RestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=ONMD_RestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590130751680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">28,175,172<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">27,987,427<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares</a></td>
<td class="nump">187,745<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590122506352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Web imaging revenue</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
<td class="nump">$ 681<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">617<span></span>
</td>
<td class="nump">681<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">226<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">872<span></span>
</td>
<td class="nump">812<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="num">(84)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="num">(255)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(360)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">1,865<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">4,934<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">3,544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,806<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">140<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="nump">623<span></span>
</td>
<td class="nump">813<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,591<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">2,303<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
<td class="nump">6,684<span></span>
</td>
<td class="nump">4,854<span></span>
</td>
<td class="nump">6,724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(2,387)<span></span>
</td>
<td class="num">(1,927)<span></span>
</td>
<td class="num">(6,939)<span></span>
</td>
<td class="num">(4,985)<span></span>
</td>
<td class="num">(6,853)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,715)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense (income), net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">36<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="nump">6<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity', window );">Change in fair value of PIPE Notes</a></td>
<td class="num">(77)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_GainLossOnFairValueOfYorkvilleNote', window );">Change in fair value of Yorkville Note</a></td>
<td class="num">(262)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">561<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of derivative liability</a></td>
<td class="num">(160)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating', window );">Change in fair value of Bitcoin</a></td>
<td class="nump">124<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,621<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,872<span></span>
</td>
<td class="nump">17,517<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">14,616<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock warrant expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">8,385<span></span>
</td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(329)<span></span>
</td>
<td class="nump">11,913<span></span>
</td>
<td class="nump">816<span></span>
</td>
<td class="nump">26,299<span></span>
</td>
<td class="nump">26,909<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,719<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,762)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30,434)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (2,058)<span></span>
</td>
<td class="num">$ (13,840)<span></span>
</td>
<td class="num">$ (7,755)<span></span>
</td>
<td class="num">$ (31,284)<span></span>
</td>
<td class="num">$ (33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="num">$ (30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share outstanding</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (7.56)<span></span>
</td>
<td class="num">$ (4.77)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10],[11]</sup></td>
<td class="num">$ (7.66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11],[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share outstanding</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (7.56)<span></span>
</td>
<td class="num">$ (4.77)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10],[11]</sup></td>
<td class="num">$ (7.66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11],[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average number of common shares outstanding</a></td>
<td class="nump">27,878,399<span></span>
</td>
<td class="nump">4,280,777<span></span>
</td>
<td class="nump">25,051,293<span></span>
</td>
<td class="nump">4,139,730<span></span>
</td>
<td class="nump">7,084,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,973,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average number of common shares outstanding</a></td>
<td class="nump">27,878,399<span></span>
</td>
<td class="nump">4,280,777<span></span>
</td>
<td class="nump">25,051,293<span></span>
</td>
<td class="nump">4,139,730<span></span>
</td>
<td class="nump">7,084,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,973,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ONMD_SubscriptionRevenueMember', window );">Subscription Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Web imaging revenue</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="nump">$ 595<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">256<span></span>
</td>
<td class="nump">443<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="nump">878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ONMD_WebImagingRevenueMember', window );">Web Imaging Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Web imaging revenue</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of convertible promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of private investment in public equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_GainLossOnFairValueOfYorkvilleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain loss on fair value of Yorkville note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_GainLossOnFairValueOfYorkvilleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ONMD_SubscriptionRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ONMD_SubscriptionRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ONMD_WebImagingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ONMD_WebImagingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590127622576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Temporary Equity [Member] </div>
<div>Series A-2 Preferred Stock [Member]</div>
</th>
<th class="th">
<div>Temporary Equity [Member] </div>
<div>Series A-1 Preferred Stock [Member]</div>
</th>
<th class="th"><div>Temporary Equity [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th" colspan="2"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">$ 17,644<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,513<span></span>
</td>
<td class="num">$ (27,209)<span></span>
</td>
<td class="num">$ (7,052)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td>
<td class="nump">3,853,797<span></span>
</td>
<td class="nump">3,204,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,342,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(30,451)<span></span>
</td>
<td class="num">(30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,073<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to the Business Combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to the Business Combination, shares</a></td>
<td class="num">(437,874)<span></span>
</td>
<td class="num">(364,043)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(493,420)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of OMN stock options upon Business Combination, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,648,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,198<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="num">(26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,843)<span></span>
</td>
<td class="num">(7,843)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,935<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,960<span></span>
</td>
<td class="num">(65,503)<span></span>
</td>
<td class="num">(31,899)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="num">(26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,284)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="nump">$ 9,650<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,660<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,488<span></span>
</td>
<td class="num">(88,944)<span></span>
</td>
<td class="num">(47,796)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">3,421,596<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,299,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="num">(26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="nump">5,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,475<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(33,780)<span></span>
</td>
<td class="num">(33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,207<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">265,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of OMN stock options upon Business Combination, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">613,510,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,420,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,935<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">47,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,475,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="num">$ (9,650)<span></span>
</td>
<td class="num">$ (8,010)<span></span>
</td>
<td class="num">(17,660)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,659<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="num">(3,421,596)<span></span>
</td>
<td class="num">(2,839,957)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,261,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,937)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(11,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,960<span></span>
</td>
<td class="num">(65,503)<span></span>
</td>
<td class="num">(31,899)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(9,601)<span></span>
</td>
<td class="num">(9,601)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,165<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,165<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,405<span></span>
</td>
<td class="num">(75,104)<span></span>
</td>
<td class="num">(39,055)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2023</a></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,210,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(13,840)<span></span>
</td>
<td class="num">(13,840)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock', window );">Issuance of Legacy ONMD Series A-2 Preferred Stock</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock', window );">Issuance of Legacy ONMD Series A-2 Preferred Stock, shares</a></td>
<td class="nump">5,673,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2023</a></td>
<td class="nump">$ 9,650<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">17,660<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,488<span></span>
</td>
<td class="num">(88,944)<span></span>
</td>
<td class="num">(47,796)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2023</a></td>
<td class="nump">3,421,596<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,299,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(529)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(529)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,109)<span></span>
</td>
<td class="num">(2,109)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (529)<span></span>
</td>
<td class="nump">78,375<span></span>
</td>
<td class="num">(93,549)<span></span>
</td>
<td class="num">(15,701)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,850,010<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,755)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (529)<span></span>
</td>
<td class="nump">85,455<span></span>
</td>
<td class="num">(99,196)<span></span>
</td>
<td class="num">(14,268)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (529)<span></span>
</td>
<td class="nump">78,375<span></span>
</td>
<td class="num">(93,549)<span></span>
</td>
<td class="num">(15,701)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,850,010<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,589)<span></span>
</td>
<td class="num">(3,589)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Vesting of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted stock units, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (529)<span></span>
</td>
<td class="nump">78,478<span></span>
</td>
<td class="num">(97,138)<span></span>
</td>
<td class="num">(19,187)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,050,010<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,058)<span></span>
</td>
<td class="num">(2,058)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts', window );">Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,270<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,270<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts', window );">Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,598,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee', window );">Issuance of common stock to settle Yorkville commitment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee', window );">Issuance of common stock to settle Yorkville commitment fee, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Sep. 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (529)<span></span>
</td>
<td class="nump">$ 85,455<span></span>
</td>
<td class="num">$ (99,196)<span></span>
</td>
<td class="num">$ (14,268)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retroactive application of recapitalization due to business combination shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares conversion of preferred stock to common stock upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock options upon business combination with net of liabilities assumed and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value conversion of convertible promissory notes upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of common stock to settle commitment fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of warrants to board of directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value stock options upon business combination with net of liabilities assumed and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590127781936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,755)<span></span>
</td>
<td class="num">$ (31,284)<span></span>
</td>
<td class="num">$ (33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">1,446<span></span>
</td>
<td class="nump">1,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">1,865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">8,385<span></span>
</td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantExpense', window );">Board of director warrant expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity', window );">Change in fair value of PIPE Notes</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfYorkvilleNote', window );">Change in fair value of Yorkville Note</a></td>
<td class="nump">561<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating', window );">Change in fair value of Bitcoin</a></td>
<td class="nump">124<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetRealizedLossNonoperating', window );">Realized loss on sale of Bitcoin</a></td>
<td class="nump">51<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on forgiveness of CEBA loan</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_NoncashInterest', window );">Non-cash interest</a></td>
<td class="nump">96<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,872<span></span>
</td>
<td class="nump">17,517<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">14,616<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">89<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">73<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14],[15]</sup></td>
<td class="num">(59)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="nump">1,232<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14],[15],[17]</sup></td>
<td class="nump">415<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16],[18]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenues</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(458)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(4,956)<span></span>
</td>
<td class="num">(3,066)<span></span>
</td>
<td class="num">(4,791)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,703)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(58)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForAcquisitionCryptoAsset', window );">Purchases of Bitcoin</a></td>
<td class="num">(2,800)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDisposalCryptoAsset', window );">Sales of Bitcoin</a></td>
<td class="nump">469<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,347)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(58)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from private placements, net of issuance costs</a></td>
<td class="nump">6,270<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfShareholderLoans', window );">Proceeds from issuance of shareholder loans</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">704<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of pipe notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from issuance of Yorkville Note, net of issuance costs</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from line of credit borrowings</a></td>
<td class="nump">500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of shareholder loan</a></td>
<td class="num">(200)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of line of credit borrowings</a></td>
<td class="num">(500)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RepaymentForCommonStockRepurchase', window );">Repayment for common stock repurchase</a></td>
<td class="num">(100)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RepaymentOfDeferredUnderwriterFees', window );">Repayment of deferred underwriter fees</a></td>
<td class="num">(100)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfBankDebt', window );">Repayment of CEBA loan</a></td>
<td class="num">(30)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,875<span></span>
</td>
<td class="nump">4,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">5,140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuance of Series A-2 preferred stock</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationCosts', window );">Business Combination costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,160)<span></span>
</td>
<td class="num">(1,534)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="num">(815)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[16]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">9,190<span></span>
</td>
<td class="nump">3,435<span></span>
</td>
<td class="nump">4,611<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,333<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="nump">1,887<span></span>
</td>
<td class="nump">341<span></span>
</td>
<td class="num">(224)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(428)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning year</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">1,934<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common shares issued to preferred shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,659<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesRelatedToConvertiblePromissoryNotes', window );">Common shares related to convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesIssuedToDataKnightsShareholders', window );">Common shares issued to Data Knights shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable', window );">Issuance of common stock to settle deferred underwriter fee payable</a></td>
<td class="nump">242<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses', window );">Consideration for repurchase of common stock included in accounts payable and accrued expenses</a></td>
<td class="num">$ (429)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top">Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[16]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[17]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[18]</td>
<td style="vertical-align: top;" valign="top">Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[19]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ChangeInFairValueOfConvertiblePromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ChangeInFairValueOfConvertiblePromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ChangeInFairValueOfYorkvilleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ChangeInFairValueOfYorkvilleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CommonSharesIssuedToDataKnightsShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued to data knights shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CommonSharesIssuedToDataKnightsShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CommonSharesRelatedToConvertiblePromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares related to convertible promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CommonSharesRelatedToConvertiblePromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consideration for repurchase of common stock included in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of private investment in public equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock to settle deferred underwriter fee payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_NoncashInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_NoncashInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromIssuanceOfShareholderLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromIssuanceOfShareholderLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RepaymentForCommonStockRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment for common stock repurchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RepaymentForCommonStockRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RepaymentOfDeferredUnderwriterFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of deferred underwriter fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RepaymentOfDeferredUnderwriterFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockWarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockWarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_WarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_WarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetRealizedLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetRealizedLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForAcquisitionCryptoAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForAcquisitionCryptoAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDisposalCryptoAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from disposal of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDisposalCryptoAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle a bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132256464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of Business</a></td>
<td class="text"><p id="xdx_807_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_znib4Gc2T9Mb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span id="xdx_827_zqInMuCwveq5">Description of Business</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organization
and description of business</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
Corporation (the &#8220;Company&#8221;) is a healthcare software company with solutions focused on digital medical image management,
exchange, and sharing. The Company was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions
that simplify digital medical image management, exchange, and sharing. The Company has one wholly owned subsidiary, OneMedNet Technologies
(Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional
currency is the Canadian dollar. The Company&#8217;s headquarters location is Eden Prairie, Minnesota.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, Data Knights Merger Sub, Inc. (&#8220;Merger Sub&#8221;)<span style="background-color: white">,</span> a Delaware corporation
and a wholly owned subsidiary of Data Knights Acquisition Corp. (&#8220;Data Knights&#8221;), a Delaware corporation, merged with and
into OneMedNet Solutions Corporation (formerly named OneMedNet Corporation) (&#8220;Legacy ONMD&#8221;), with Legacy ONMD surviving as
a wholly owned subsidiary of Data Knights (the &#8220;Business Combination&#8221;). Following the consummation of the Business Combination,
Data Knights was renamed to &#8220;OneMedNet Corporation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Basis
of presentation and consolidation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and the rules and regulations of the Securities and Exchange Commission
(&#8220;SEC&#8221;) for interim reporting. As permitted under those rules and regulations, certain notes or other financial information
normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The interim unaudited
condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and,
in the opinion of management, reflect all adjustments, which include only normal, recurring adjustments that are necessary to present
fairly the Company&#8217;s results for the interim periods presented. The results from operations for the three and nine months ended
September 30, 2024, are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or for any future
annual or interim period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the annual consolidated
financial statements and the related notes for the year ended December 31, 2023 in the Company&#8217;s Annual Report on Form 10-K, as
amended, filed with the SEC on November 5, 2024 (the &#8220;Form 10-K/A&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
interim unaudited condensed consolidated financial statements include the consolidated accounts of the Company&#8217;s wholly owned subsidiary,
OneMedNet Technologies (Canada) Inc. All significant intercompany transactions have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
and going concern</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred recurring net losses since its inception, including $<span id="xdx_908_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240701__20240930_z6MPxtVWWQwl" title="Net loss">2.1</span>
million and $<span id="xdx_901_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20240101__20240930_zrBdsC7RWwe6" title="Net loss">7.8</span>
million for the three and nine months ended September 30, 2024, respectively. In addition, the Company had an accumulated deficit of
$<span id="xdx_90C_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20240930_zV2Iyaf3OJH5" title="Accumulated defecit">99.2</span>
million as of September 30, 2024. The Company&#8217;s cash and Bitcoin  balance of $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pn5n6_c20240930_zLEFKpQiCbTb" title="Cash">1.9</span>
million and $<span id="xdx_90E_ecustom--CryptoCash_iI_pn5n6_c20240930_zdbeBGvW3d3j" title="Crypto assets">2.2</span> million, respectively, is not adequate to fund its operations through at least twelve months from the date these
condensed consolidated financial statements were available for issuance. Therefore, these conditions raise substantial doubt about
the Company&#8217;s ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital
through an equity or debt offering and ultimately hopes to attain profitable operations to fulfill its operating and capital requirements
for at least 12 months from the date of the issuance of the condensed consolidated financial statements. However, the Company may not
be able to secure such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity securities
to raise additional funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences
and privileges senior to those of the Company&#8217;s existing stockholders. The condensed consolidated financial statements do not include
any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company
be unable to continue as a going concern. The Company&#8217;s continuation as a going concern is dependent upon its ability to continue
receiving working capital cash payments and generating cash flow from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to risks common to companies in the markets it serves, including, but not limited to, global economic and financial
market conditions, fluctuations in customer demand, acceptance of new products, development by its competitors of new technological innovations,
dependence on key personnel, and protection of proprietary technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Company has invested in Bitcoin, which is a crypto asset. Crypto assets are loosely regulated and there is no central marketplace
for currency exchange. Supply is determined by a computer code, not by a central bank, and prices have been extremely volatile. Certain
crypto asset exchanges have been closed due to fraud, failure or security breaches. Any of the Company&#8217;s crypto assets that reside
on an exchange that shuts down may be lost. Several factors may affect the price of crypto assets, including, but not limited to: supply
and demand, investors&#8217; expectations with respect to the rate of inflation, interest rates, currency exchange rates or future regulatory
measures (if any) that restrict the trading of crypto assets, and the use of crypto assets as a form of payment. There is no assurance
that crypto assets will maintain their long-term value in terms of purchasing power in the future, or that acceptance of crypto asset
payments by mainstream retail merchants and commercial businesses will continue to grow.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
crypto assets have grown in popularity and market size, various countries and jurisdictions have begun to develop regulations governing
the crypto asset industry. To the extent future regulatory actions or policies limit the ability to exchange crypto assets or utilize
them for payments, the demand for crypto assets could be reduced. Furthermore, regulatory actions may limit the ability of end-users
to convert crypto assets into fiat currency (e.g., U.S. dollars) or use crypto assets to pay for goods and services. Such regulatory
actions or policies could result in a reduction of demand, and in turn, a decline in the underlying crypto asset unit prices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect of any future regulatory change on crypto assets in general is impossible to predict, but such change could be substantial and
adverse to the Company and the value of the Company&#8217;s investments in crypto assets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crypto
assets are not insured or protected under the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) or the Securities Investor Protection
Company (&#8220;SIPC&#8221;). Accordingly, with respect to its Bitcoin investment, the Company does not enjoy the protections of other
assets covered by the FDIC or SIPC.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Segment
information</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates in one operating segment and, accordingly, no segment disclosures have been presented herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zmJ0QR35bxR9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
<span>Organization and Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_826_zjtp8qAyKhgl" style="display: none">Description of Business</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OneMedNet
Corporation (the &#8220;Company&#8221;) is a healthcare software company with solutions focused on digital medical image management,
exchange, and sharing. The Company was founded in Delaware on November 20, 2015. The Company has been solely focused on creating solutions
that simplify digital medical image management, exchange, and sharing. The Company has one wholly-owned subsidiary, OneMedNet Technologies
(Canada) Inc., incorporated on October 16, 2015 under the provisions of the Business Corporations Act of British Columbia whose functional
currency is the Canadian dollar. The Company&#8217;s headquarters location is Eden Prairie, Minnesota.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
November 7, 2023, we consummated a merger (the &#8220;Merger&#8221;) </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">following
the approval at the special meeting of the shareholders of Data Knights Acquisition Corp. (&#8220;Data Knights&#8221;), a Delaware corporation,
held on October 17, 2023 (the &#8220;Special Meeting&#8221;), of the agreement and plan of merger, dated as of April 25, 2022 (the &#8220;Merger
Agreement&#8221;), by and among Data Knights, Data Knights Merger Sub, Inc., a Delaware corporation (&#8220;Merger Sub&#8221;) and a
wholly-owned subsidiary of Data Knights, OneMedNet Solutions Corporation (formerly named OneMedNet Corporation) (&#8220;Legacy ONMD&#8221;),
Data Knights, LLC, a Delaware limited liability company (&#8220;Sponsor&#8221;), and Paul Casey, in his capacity as representative of
the stockholders of Legacy ONMD. Pursuant to the Merger Agreement, Merger Sub merged with and into Legacy ONMD, with Legacy ONMD surviving
the Merger as a wholly-owned subsidiary of Data Knights (such transactions contemplated by the Merger Agreement, the &#8220;Business
Combination&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to risks common to companies in the markets it serves, including, but not limited to, global economic and financial
market conditions, fluctuations in customer demand, acceptance of new products, development by its competitors of new technological innovations,
dependence on key personnel, and protection of proprietary technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going
Concern and Management&#8217;s Plan</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets
and settlement of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects
on the recoverability and classification of assets or amounts and classification of liabilities that may result from the outcome of this
uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred recurring net losses since its inception, including $<span id="xdx_90B_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231231_zsU0xSLZvHcl" title="Net loss">33.8</span> million and $<span id="xdx_909_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20220101__20221231_z3LJ3ACCrSm3" title="Net loss">30.5 </span>million for the years ended December
31, 2023 and 2022, respectively. In addition, the Company had an accumulated deficit of $<span id="xdx_900_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20231231_zMzKn9enX4Ei" title="Accumulated defecit">91.4</span> million as of December 31, 2023. The Company&#8217;s
cash balance of $<span id="xdx_900_eus-gaap--Cash_iI_pn3n3_c20231221_z8kT95TFPK4i" title="Cash balance">47</span> thousand is not adequate to fund its operations through at least twelve months from the date these consolidated financial
statements were available for issuance. Therefore, these conditions raise substantial doubt about the Company&#8217;s ability to continue
as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
continue in existence and expand its operations, the Company will be required to, and management plans to, raise additional working capital
through an equity or debt offering and ultimately attain profitable operations to fulfill its operating and capital requirements for
at least 12 months from the date of the issuance of the consolidated financial statements. However, the Company may not be able to secure
such financing in a timely manner or on favorable terms, if at all. Furthermore, if the Company issues equity securities to raise additional
funds, its existing stockholders may experience dilution, and the new equity securities may have rights, preferences and privileges senior
to those of the Company&#8217;s existing stockholders. The consolidated financial statements do not include any adjustments relating
to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as
a going concern. The Company&#8217;s continuation as a going concern is dependent upon its ability to continue receiving working capital
cash payments and generating cash flow from operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nasdaq
Notices</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2024, the Company received written notice (the &#8220;MVLS Nasdaq Notice&#8221;) from the Nasdaq Stock Market (&#8220;Nasdaq&#8221;)
indicating that for the preceding 30 consecutive business days, the market value of the Company&#8217;s listed securities (&#8220;MVLS&#8221;)
did not maintain a minimum market value of $50,000,000 (the &#8220;Minimum MVLS Requirement&#8221;) as required by Nasdaq Listing Rule
5450(b)(2)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company had a compliance period of 180 calendar days, or until
August 5, 2024, to regain compliance with the Minimum MVLS Requirement. Compliance could have been achieved if the Company&#8217;s MVLS
closed at $50,000,000 or more for a minimum of ten consecutive business days at any time during the 180-day compliance period, in which
case Nasdaq would notify the Company of its compliance, and the matter would be closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company did not regain compliance with the Minimum MVLS Requirement by August 5, 2024, Nasdaq would have provided written notification
to the Company that its Common Stock was subject to delisting. At that time, the Company could have appealed the relevant delisting determination
to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. The Company sought to apply for a transfer
to The Nasdaq Capital Market, and on August 15, 2024, the Company received approval from Nasdaq to list the Common Stock and Public Warrants
on The Nasdaq Capital Market. The Common Stock and Public Warrants were transferred from The Nasdaq Global Market to The Nasdaq Capital
Market at the opening of business on August 19, 2024, and continue to trade under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW,&#8221;
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2024, the Company received written notice (the &#8220;Bid Price Nasdaq Notice&#8221;) from Nasdaq notifying the Company that,
for the 30 consecutive business days prior to the date of the Bid Price Nasdaq Notice, the Common Stock did not meet the minimum bid
price of $1.00 per share requirement (the &#8220;Minimum Bid Price Requirement&#8221;) as required by Nasdaq Listing Rule 5450(a)(1).
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company had a compliance period of 180 calendar days, or until September 23,
2024, to regain compliance with the Minimum Bid Price Requirement. Compliance could have been achieved if the closing bid price of the
Company&#8217;s Common Stock was at least $1 for a minimum of ten consecutive business days. On June 10, 2024, the Nasdaq staff determined
that for the prior 11 consecutive business days, from May 23, 2024, to June 7, 2024, the closing bid price of the Company&#8217;s Common
Stock had been at $1.00 per share or greater. Accordingly, the Company regained compliance with Listing Rule 5450(a)(1), and this matter
was closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 20, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Q1 2024 Form 10-Q Nasdaq Notice&#8221;),
which indicated that, as a result of the Company&#8217;s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended
March 31, 2024 (the &#8220;Q1 2024 Form 10-Q&#8221;) by the applicable due date, the Company was not in compliance with Nasdaq Listing
Rule 5250(c)(1) (the &#8220;Periodic Report Rule&#8221;), which requires Nasdaq-listed companies to timely file all required periodic
financial reports with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;). The Q1 2024 Form 10-Q Nasdaq Notice stated that
the Company had 60 calendar days to submit to Nasdaq a plan to regain compliance with the Periodic Report Rule. If Nasdaq accepted the
Company&#8217;s plan to regain compliance, then Nasdaq could have granted the Company up to 180 calendar days from the prescribed due
date of the Form 10-Q to regain compliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 9, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Q2 2024 Form 10-Q Nasdaq Notice&#8221;),
which indicated that, as a result of the Company&#8217;s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended
June 30, 2024 (together with the Q1 2024 Form 10-Q, the &#8220;Delinquent Filings&#8221;) by the applicable due date, the Company was
not in compliance with the Periodic Report Rule, which requires Nasdaq-listed companies to timely file all required periodic financial
reports with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 10, 2024, the Company received a notification letter from Nasdaq the &#8220;Nasdaq Compliance Plan Notice&#8221;), which responded
to the Company&#8217;s plan to regain compliance regarding its delinquent Q1 2024 Form 10-Q, granting the Company an exception until
October 31, 2024 to file the Delinquent Filings with the SEC and regain compliance with the Periodic Report Rule. In the event the Company
does not regain compliance with the Periodic Report Rule by October 31, 2024, Nasdaq will provide written notification that the Company&#8217;s
securities will be delisted. At that time, the Company may appeal Nasdaq&#8217;s determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Second MVLS Nasdaq Notice&#8221;) indicating
that for the preceding 30 consecutive business days, the Company&#8217;s MVLS was below the minimum of $35 million required for continued
listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(2). The staff at Nasdaq also noted in the Second MVLS Nasdaq
Notice that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum
stockholders&#8217; equity of $2.5 million, and Nasdaq Listing Rule 5550(b)(3), which requires listed companies to maintain a minimum
of $500,000 of net income from continuing operations. In accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar
days, or until April 7, 2025, to regain compliance with the Minimum MVLS Requirement. Compliance may be achieved if the Company&#8217;s
MVLS closes at $35 million or more for a minimum of ten consecutive business days at any time during the 180-day compliance period, in
which case Nasdaq will notify the Company of its compliance and the matter will be closed, If the Company does not regain compliance
by the end of the 180-day compliance period, Nasdaq staff will provide written notice to the Company that its securities are subject
to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 16, 2024, the Company received a delinquency notification letter from Nasdaq (the &#8220;Second Bid Price Nasdaq Notice,&#8221;
and together with the MVLS Nasdaq Notice, the Bid Price Nasdaq Notice, the Q1 2024 Form 10-Q Nasdaq Notice, the Q2 2024 Form 10 Q Nasdaq
Notice, the Nasdaq Compliance Plan Notice, and the Second MVLS Nasdaq Notice, the &#8220;Nasdaq Notices&#8221;) notifying the Company
that, for the 30 consecutive business days prior to the date of the Second Bid Price Nasdaq Notice, the Common Stock did not meet the
Minimum Bid Price Requirement as required by Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the
Company has 180 calendar days, or until April 14, 2025, to regain compliance. The Second Bid Price Nasdaq Notice notes that to regain
compliance, the Common Stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days at any time
during the 180-day compliance period. In the event the Company does not regain compliance by the end of the 180-day compliance period,
the Company may be eligible for additional time to regain compliance. To qualify for additional time, the Company must (i) meet the continued
listing requirement for the market value of its publicly held shares and all other initial listing standards for the Nasdaq Capital Market,
with the exception of the bid price requirement and (ii) provide written notice of its intention to cure the deficiency during the second
compliance period by effecting a reverse stock split, if necessary. If the Company meets these requirements, the Company may be granted
an additional 180 calendar days to regain compliance. However, if it appears to Nasdaq that the Company will be unable to cure the deficiency,
or if the Company is not otherwise eligible for the additional cure period, Nasdaq will provide written notice to the Company that its
securities are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nasdaq Notices received have no immediate effect on the Company&#8217;s continued listing on the Nasdaq Capital Market or the trading
of the Company&#8217;s Common Stock, subject to the Company&#8217;s compliance with the other continued listing requirements. The Company
is presently evaluating potential actions to regain compliance with all applicable requirements for continued listing on the Nasdaq Capital
Market. There can be no assurance that the Company will be successful in maintaining the listing of its Common Stock on the Nasdaq Capital
Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132171072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zH1VqNaltdWe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_828_zrIhmBlVwG25">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described below, the accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained
in the Form 10-K/A, and the accounting policies followed by the Company for interim financial reporting are consistent with the accounting
policies therein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zykcr4STYTP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_ztClUiPVzDv5">Treasury
stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records the repurchase of its common stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zV5aGhhoxuBl" title="Common stock, par value">0.0001</span> per share (&#8220;Common Stock&#8221;) at cost on the trade date
of the transaction. These shares are considered treasury stock, which is a reduction to stockholders&#8217; equity (deficit). Treasury
stock is included in authorized and issued shares but excluded from outstanding shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--DerivativesPolicyTextBlock_zZ2V9HQlBKzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zWX2Asy1zIL7">Derivative
financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 480, <i>Distinguishing
Liabilities from Equity </i>and ASC 815, <i>Derivatives and Hedging</i>. The result of this accounting treatment is that the fair value
of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability.
The change in fair value is recorded in the condensed consolidated statement of operations as a component of other expense (income),
net. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that
fair value is reclassified to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
reassessed at the end of each reporting period. Derivative instrument liabilities will be classified in the condensed consolidated
balance sheets as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12
months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_esrt--PlatformOperatorCryptoAssetPolicyTextBlock_zibQBfSiylnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zd4ljSuuHwQ9">Crypto
assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-08, <i>Intangibles
- Goodwill and Other - Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets </i>(&#8220;ASU
2023-08&#8221;), which provides an update to existing crypto asset guidance and requires an entity to measure certain crypto assets
at fair value. In addition, this guidance requires disclosures related to crypto assets once it is adopted. As of January 1, 2024,
the Company has adopted ASU 2023-08.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reflects crypto assets held at fair value on the condensed consolidated balance sheets and condensed consolidated statements
of cash flows, the activity from remeasurement of crypto assets at fair value on the condensed consolidated statements of
operations, and the required expanded disclosures in Note 3, <i>Crypto Assets Held</i>. The adoption of ASU 2023-08 resulted in no
cumulative-effect adjustment to the opening balance of retained earnings as of January 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crypto
assets are generally valued using prices as reported on reputable and liquid exchanges and may involve using an average of bid and ask
quotes using closing prices provided by such exchanges as of the date and time of determination. The time used is 4:00 pm EST.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zgtB9aGPE3O9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zJw7ipdRavCd">Net
loss per share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required
for participating securities. Certain warrants participate in distributions of the Company. The pre-funded warrants associated with the
July and September 2024 private placements (see Note 7) are considered outstanding shares in the basic earnings per share calculation
given their nominal exercise price. The net loss attributable to common stockholders is not allocated to the warrant holders as the warrant
holders do not have a contractual obligation to share in losses. Basic net loss per share is calculated by dividing the net loss by the
weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss
by the weighted-average number of shares of Common Stock and common stock equivalents outstanding for the period. Common stock equivalents
are only included when their effect is dilutive. The Company&#8217;s potentially dilutive securities, including outstanding warrants
to purchase Common Stock and outstanding stock options under the Company&#8217;s equity incentive plan, have been excluded from the computation
of diluted net loss per share as their inclusion would be anti-dilutive. For all periods presented, there is no difference in the number
of shares used to calculate basic and diluted shares outstanding to the Company&#8217;s net loss position.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_ecustom--EmergingGrowthCompanyPolicyTextBlock_zcRl5YIt2WRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_z0NQmbkWgKc4">Emerging
growth company status</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company&#8221;, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;).
Under the JOBS Act, emerging growth companies can take advantage of an extended transition period for complying with new or revised accounting
standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company has elected to
use this extended transition period for complying with certain new or revised accounting standards that have different effective dates
for public and private companies until the earlier of the date that it (1) is no longer an emerging growth company or (2) affirmatively
and irrevocably opts out of the extended transition period provided in the JOBS Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUkuk6y4J0ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zBbPJIwc5OK3">Accounting
pronouncements not yet adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No.
2023-09, <i>Improvements to Income Tax Disclosures (Topic 740)</i> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires disaggregated information
about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. ASU 2023-09
is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual
financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of
adopting ASU 2023-09 on the presentation of its condensed consolidated financial statements and footnotes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment
Disclosures</i>, which is intended to provide enhancements to segment disclosures, even for entities with only one reportable
segment. In particular, the standard will require disclosures of information related to significant segment expenses regularly
provided to the chief operating decision maker and included within each reported measure of segment profit and loss. The standard
will also require disclosure of all other segment items by reportable segment and a description of its composition. Finally, the
standard will require disclosure of the title and position of the chief operating decision maker and an explanation of how the chief
operating decision maker uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to
allocate resources. The standard is effective for annual periods beginning after December 15, 2023, and interim periods within
annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the
standard on the presentation of its condensed consolidated financial statements and footnotes.</span></p>

<p id="xdx_852_zNGSKxUsp7Mc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zfl75WnLdHg5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.
<span id="xdx_829_zf1Bh0qhZm65">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zV1XxAmYpNw2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z66TBxyppqMl">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#8220;GAAP&#8221;). The accompanying consolidated financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of OneMedNet Corporation, formerly Data Knights, and its wholly-owned
subsidiary, OneMedNet Technologies Canada Ltd. All intercompany transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--RestatementToFinancialStatementsPolicyTextBlock_zlfs5i9HvsA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zF84H1NjBDH9">Restatement
to Previously Issued Consolidated Financial Statements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s consolidated financial statements for the years ended December 31, 2023 and 2022, as previously filed with the SEC on
April 9, 2024, have been restated. The previously filed consolidated financial statements did not reflect the proper accounting for the
business combination transaction, convertible notes, warrants, preferred stock, stock-based compensation expense, and accounts payable
and accrued expenses. The Company has also restated related amounts within the accompanying footnotes to the consolidated financial statements
to conform to the restated amounts in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following consolidated financial statements provide a reconciliation from the originally &#8220;as reported&#8221; financial information
to the now &#8220;as restated&#8221; consolidated financial information as of and for the years ended December 31, 2023 and 2022 (in
thousands, except share and per share data).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p id="xdx_893_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zQobtUlY9Fg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zmqNIyggURV3">Schedule
of Restatement of Financial Statements</span><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--StatementOfFinancialPositionAbstract_pn3n3_zHB7otDeIImb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheet (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zruyu53jUhca" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zcfTKFbd2jqd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zCrqV71XHMwj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zseXWl5ARgmk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (<span id="xdx_F56_zoHeAO3yRzkb">1</span>)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z3fZH6OQ10X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zXmzyt8ADHpc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACznbB_zwfJYNAqd4h2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%; text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsHeldInTrustCurrent_i02I_zQhwodfyf5vd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2064">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2065">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2066">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2067">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACznbB_zhZl1KSXxike" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance for credit losses of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zPo9iq8qLwpk" title="Accounts receivable, allowance">0</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zMIhH9k6HRqe" title="Accounts receivable, allowance">125,233</span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2070">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACznbB_zUCqDZwvR8h1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">166</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2079">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2080">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">166</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACznbB_maAzRE3_zWVgddrEhU8f" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">365</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2084">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2085">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">365</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeferredCostsNonCurrent_i01I_pn3n3_maAzRE3_zadfKDc4WIPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2088">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2089">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2090">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2091">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzRE3_zG9krXgkbKe1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2095">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Assets_i01TI_pn3n3_mtAzRE3_zRG9OArPib89" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2099">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zq1I6hLyExog" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbZJCma4btqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zssMDVKCKb27" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">498</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2115">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zNPcfhGy81Dl" style="text-align: center">2</td></tr>
  <tr id="xdx_408_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z5EoFfgXn103" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2121">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ExciseTaxCurrent_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_zoHwN3FbTAHf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Excise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2126">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredRevenueCurrent_i02I_pn3n3_maLCzjPj_zgTzWhgM5q78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2129">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2130">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zqzqEDRPdHVe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2133">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2134">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2135">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LoanExtensionsCurrent_i02I_pn3n3_maLCzjPj_zxQs4dQZsJhi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,992</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2139">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,992</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LoansPayable_i02I_pn3n3_maLCzjPj_z4rAes4v5eLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--CanadaEmergencyBusinessLoanAct_i02I_pn3n3_maLCzjPj_zh8sEs0vfagg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2149">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2151">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccruedIncomeTaxesCurrent_i02I_pn3n3_maLCzjPj_zMZx9uIWYCb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2154">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2156">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_pn3n3_maLCzjPj_zBTLDRUX27Ba" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_pn3n3_maLCzjPj_zjmSYJKQeNEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,637</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z70r7UPIkBw8" style="text-align: center">3</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zxhw1hbC8X8d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Other current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2168">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_z7XLQgC9gMPe" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2173">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2174">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzjPj_maLzhoA_zUAVIkx4mgr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">585</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,373</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ConvertibleDebtNoncurrent_i01I_pn3n3_maLzhoA_zXYxZv4wnbE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2183">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_z0sV3xK1qwE8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2188">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2189">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2191">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_z3W70HCcYUcf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_pn3n3_maLzhoA_zWCkZbDgLii7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loan, related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2199">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2200">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_z3TrqGM1swRk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2206">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WorkingCapitalLoan_i01I_maLzhoA_znG3RD0bmoD8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2210">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--WarrantLiabilityNonCurrent_i01I_pn3n3_maLzhoA_zvrWCZOR9MLe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2214">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2216">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLzhoA_zzAZ5vz1nGW5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2218">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4E_zdVxtDBJ0vy4" style="padding-bottom: 1pt; text-align: center">4</td></tr>
  <tr id="xdx_401_eus-gaap--Liabilities_i01TI_pn3n3_mtLzhoA_maLASEzB9f_zWurd1Dcwf66" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13,323</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">583</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2225">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13,906</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_maLASEzB9f_zriAse0CJx5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2228">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2229">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2230">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2231">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--TemporaryEquityAbstract_i01B_zCjF4hRjdSM9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxCEJ7wpVb28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zcQDvHCATRy3" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmw2jLMPLdv3" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zk2kv65ICmXe" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8QQZwnKdLZf" title="Temporary equity, shares authorized">4,200,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zbwzb6ONsLgi" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBohDzYt6cuc" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zPYyjWP6t8nl" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zDpri74qdrj4" title="Temporary equity, shares outstanding">3,415,923</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2238">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2240">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2241">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zvgShIKHTHql" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUdnjUXJ4Nc1" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUBfnzNHxmQ7" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zD2AuNLE5jti" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYuIuwhSTul" title="Temporary equity, shares authorized">4,400,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zFfkQRyVN4Y8" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgXlLITRaRd" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z75ktmKy0962" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z5lkoDhcdVvc" title="Temporary equity, shares outstanding">2,839,957 </span></span>shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2260">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2261">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2262">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEzB9f_zFJ3TKul93Da" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2280">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2283">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zWgvLMcwUEad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_pn3n3_maSEzYAb_zDP929DLJBcj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zTouxWv5xMNj" title="Preferred stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zoAhJQ97gzT" title="Preferred stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zY9mbTXbyWjg" title="Preferred stock, shares authorized">1,000,000</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zaAG4dvCdMGb" title="Preferred stock, shares authorized">0</span> shares authorized at December 31, 2023 and 2022, respectively; <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zeXWFKcteVZa" title="Preferred stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zFLSOBzdiIYi" title="Preferred stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2RDRUICTuA3" title="Preferred stock, shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zF0OtUHrvAid" title="Preferred stock, shares outstanding">no</span></span></span></span> shares issued and outstanding at December 31, 2023 and 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2290">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzYAb_zKclxpQQ1fc5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zO8f1W2CvHd1" title="Common stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z0fgb54GPpF7" title="Common stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z87XB46c1rqk" title="Common stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zlJ0WFifrcwj" title="Common stock, shares authorized">100,000,000</span></span> shares authorized and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z37TR95QhdKj" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zhQfhe7EP9Z4" title="Common stock, shares outstanding">23,572,232</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zD5XPgF0KCAh" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zOrvrjW3oymd" title="Common stock, shares outstanding">4,033,170</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2313">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pn3n3_maSEzYAb_zr99liLi1UOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,221</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2334">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zsHwSQ1sDr3" style="text-align: center">5</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pn3n3_maSEzYAb_zaNz42WzTBF6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(55,083</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(36,357</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(91,440</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F49_zKvHtgqXejJk" style="padding-bottom: 1pt; text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzYAb_maLASEzB9f_zPwz0JsddSC7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total stockholders&#8217; deficit </b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(12,859</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(583</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(13,442</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzB9f_zgvnToSh7PEc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0A_zxpPh2kj3NLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zv3t0HiTxmkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zHmIIEvFd8Ne" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zQ2Kprb6wXq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_z45MNyUdVjC3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z1BUgtO53Nk2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zI0DPexFF7Xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_z8uJZPF6GN1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of liability-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zzIQLbw8bWJj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zWvic4rLmBCb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zfMaYzeUq0yi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_z9pixMR8yD4a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ivgJzJjlvk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBNy3rflnLOh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zDVc23ZbTal1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F5B_z2orGC7gqCVd">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zyrQoTWDbpmg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zoHhxMUlwOn3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zylrCrVigph8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zklWvSmRU3hg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">302</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(31</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2370">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">271</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F44_zWiYZ0g0Crw7" style="width: 6%; text-align: center">2</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsHeldInTrustCurrent_i02I_z5i7O4J0zNh9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,029</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2376">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zlMEbFIQFeXl" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_z91VCg6KuhUk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zXowDYdGPzGi" title="Accounts receivable, allowance">0</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zIJD7O8FvRM6" title="Accounts receivable, allowance">125,233</span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2380">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zQeyB686mQ62" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2388">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2389">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtACznbB_maAzRE3_zeC41by6Wz69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">29,451</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(29,060</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2394">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">391</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredCostsNonCurrent_i02I_maAzRE3_zjz3cdl7FRTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">900</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(85</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">815</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zugrWwR5FxFg" style="text-align: center">3</td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAzRE3_zbYTPH2Futm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">83</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2404">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">83</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_iTI_mtAzRE3_zuFdBSWVj8ce" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">30,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(29,145</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2409">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3idIMSAttVf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfMGnFVZHtZj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzjPj_zlbUKNPQwEya" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,814</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,637</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,177</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z1PDq4D8k1bg" style="text-align: center">4</td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilities_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z387LtueELU9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2430">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zSY0KCHBsjBj" style="text-align: center">2</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_maLCzjPj_z9JdmARHcJg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2433">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zIdFD76ACDwf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,743</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zHBwRYiaiQg5" style="text-align: center">5</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzjPj_zd0KrYwUO0fh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2444">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2445">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zPc4odgOaoCa" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_zvh30x1dLpB5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(70</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4F_zT5OAzrQZl5f" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzALC_maLzDXj_zJod9ww4Wxj7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,785</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,104</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzhoA_zIHuzIhaWiC5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2458">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_zfKNTjGJYna2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2463">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(44</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_zGr6iAAo4DVb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(691</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2469">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zWbk5Oymcxfk" style="text-align: center">5</td></tr>
  <tr id="xdx_409_ecustom--WarrantLiabilityNonCurrent_i01I_maLzhoA_zGpl8dgESeb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">363</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(363</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2474">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zoFnY3Hr2jo6" style="text-align: center">2</td></tr>
  <tr id="xdx_40C_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_zmTEozCqcKo5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,025</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2480">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy1llbxdPwRd" style="text-align: center">2</td></tr>
  <tr id="xdx_408_ecustom--WorkingCapitalLoan_i01I_maLzhoA_zCJ6wwyiyxX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2484">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy8mdZVEYor6" style="text-align: center">2</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermLoansPayable_i01I_maLzhoA_zLbIae4ITDb1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Extension loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,546</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2489">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2490">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zj7IDgjpWd1b" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzhoA_zTmH1HjVwx28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2492">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtLzhoA_maLASEzB9f_zJPu33kIRNI8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">21,161</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">6,488</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">27,648</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzB9f_z4bET9jAmas6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--TemporaryEquityAbstract_i01B_zChswc4s12K1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zCNQhtB5sb38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMglAdrlMTt5" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8CjB97Kyrk8" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zuhtwF938LQ" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zvZjuO1dS995" title="Temporary equity, shares authorized">4,200,000</span></span> shares authorized, and <span title="Preferred stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zYta6rHV0Uib" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zacGgWoOstM" title="Temporary equity, shares outstanding">0</span></span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_ziGtk3V4nsb6" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zOLOUQaIz6v7" title="Temporary equity, shares outstanding">3,415,923</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2512">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_z50ydQvD68Td" style="text-align: center">6</td></tr>
  <tr id="xdx_401_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgG0PJuk8Sdf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUXcga9S2JVd" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYCHWXEzs9ai" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zcQRvID0AXgg" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zQOdJGerQ3jb" title="Temporary equity, shares authorized">4,400,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zg3c3qDYeBj" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Aai5K2fUv4" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrtw0CUjcqna" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMctTmHlLhfa" title="Temporary equity, shares outstanding">2,839,957</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2533">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,010</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2535">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,010</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4B_z0vVaUYkTlw9" style="text-align: center; padding-bottom: 1pt">6</td></tr>
<tr id="xdx_40C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_zQNtilKUcrb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2554">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,644</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,644</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zlBYW8gmYu2d" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockValue_i02I_maSEzYAb_zc9TdGIsqNa6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z5EF10mnZfIg" title="Common stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZset6MUT9Se" title="Common stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zQcjfsQlc3r3" title="Common stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zDDZaWxqSTr5" title="Common stock, shares authorized">100,000,000</span></span> shares authorized and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zzH2BT9iwqQ4" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z24UGTu0EBAg" title="Common stock, shares outstanding">23,572,232</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zr2XpGWsvCs3" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zFaCWuPdJL7b" title="Common stock, shares outstanding">4,033,170</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2566">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzYAb_z6yOhGiOFPc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,375</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2587">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zejDbpADROE9" style="text-align: center">7</td></tr>
  <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzYAb_ze7UyEDUJZR1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(43,510</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,150</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(57,660</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzYAb_maLASEzB9f_zq9LusNyoTo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,273</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzB9f_zQ7TyynSymYi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">30,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(29,145</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zQQ25kVU5LG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td id="xdx_F1D_zcom1f3JbKv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F08_zxRpE7ddi9se" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F10_zqdJW85EC7P9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zaUqYTsXpy75" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F17_z12r7OJ9cdv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0D_zkzbOYh5KVrc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1E_z0YDHGimDoYl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zhrofTMKWeul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F1C_zGaauYyovNfl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F07_zg7mY89UOBh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F15_zu9Mge4cdMl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for historical preferred stock as temporary equity.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zjbye4RasFl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F17_zTscRma7hil8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zwkFbooRqn5b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Operations (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaXGkJXpTCe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z028oDaLxcnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z40LEykJTRCe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F50_zZzgLezQkhG9">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zi0ZRYIKnBM3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zfQPdTtBiee3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zHeJfx3Vozbg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2620">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2621">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zPcMCXCGZPc9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2625">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2626">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHDo_z9waVkSQPWO7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,021</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2631">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,021</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHDo_z6GMLbvVfSac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2635">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHDo_znNyLw8scYyi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2640">-</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2641">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zCYcQRN6Sc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zq3x0GU7zIea" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,730</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2651">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,544</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zE9FiJGZnz6l" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zDBuLJ2WlWs8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(226</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zryX8YnXH7Yc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2661">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zaz5jo1m1yvc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,632</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">433</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2666">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,065</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F45_z9ClZTf3FKq8" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zJHTG9nQ0lGe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">8,247</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1,297</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(226</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">6,724</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zbQSvWT10ge1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(8,376</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,523</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(6,853</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8jXu5rEIzza" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zIkUcqgVzEBc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2686">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetImpairmentCharges_i01_msNIEzJuG_zSWikkgtMta9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zMsz0tSF3PPe" style="text-align: center">3</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zy58V1qNXhb3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">749</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(738</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2696">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUF6AddaOctl" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zj7QMQhvOLi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zPun54PZDMy8" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zpKYnI4UO24l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(47</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(82</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F49_zXwujTSGCHxc" style="text-align: center">6</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEzbEL_zb5UH1P07sL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2711">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zQGlpsX4Pmdi" style="text-align: center">7</td></tr>
  <tr id="xdx_401_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zJEambHaPBre" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2716">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zzPTykfoVGAl" style="text-align: center">4</td></tr>
  <tr id="xdx_404_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zPo3ZpZ7XnEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2720">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">34</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zL4eFL1DWeh6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2725">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_ziS6Q11zdOnd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,830</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,097</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,909</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zPKUMtZQ1iU6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(23,206</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(10,574</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">18</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(33,762</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zgynma3E0s1d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2739">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2740">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzord_zgVpHaAbAfT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(23,206</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(10,574</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2746">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(33,780</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zgtaMKf18hbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zfMorvUR0clk" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zpRU0cyDmo7b" title="Diluted net loss per common share outstanding">(0.98</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zmNg5vQC4Bo8" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zFkAcqHuTXUi" title="Diluted net loss per common share outstanding">(3.78</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zJ0ZQpMQvn22" title="us-gaap:EarningsPerShareBasic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zVerDL4ZXGak" title="Diluted net loss per common share outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2762"><span style="-sec-ix-hidden: xdx2ixbrl2764">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fOA_____zaBkgZhbjVei" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fOA_____zmwUHhQcSOc5" title="Diluted net loss per common share outstanding">(4.77</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____z36ArBhqPUy6" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zErTzsc1irw3" title="Diluted weighted average number of common shares outstanding">23,572,232</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zoMuYwYXrcGa" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zyyYt7a033s" title="Diluted weighted average number of common shares outstanding">(16,488,164</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zsBYKMj5kk97" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zDQ3reWdjQE7" title="Basic weighted average number of common shares outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2778"><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zt2ybXAaUhe8" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zDgEREjS19nb" title="Diluted weighted average number of common shares outstanding">7,084,068</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z39dTMQ7aKS1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zBDhOn7yGByb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0B_zkIyW9V6GaL5" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z6pc3v68oqb6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zbAjVkGiaN6h" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F1A_zmaqyPMOauU5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zUiPPdP75J9g" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z4AQVNJgwwje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zfMpc6kW3D1j" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z30zalgt25Q7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_znmNTrFvBWK8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zqbSoM383NGc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zTL2gO4Z7NK1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z7OzvY6Ptmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zgGQG6V9gICj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F10_z2vSr1u7Bt34" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAqyObC2l9kb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTj9bNOVZAOd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z7veP8m81sFd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F55_zM3RLW9AQV3j">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220101__20221231_z7s5h9N5psD8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zhSG1L632XDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zmHR78PheYDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2800">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zfuzVjy0bBO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2805">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2806">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHNd_z3M7b4W4iwk4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2811">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHNd_zp2gco9roem6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,513</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2816">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,513</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHNd_zq3yDkZbOD2e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,153</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zMh80MASqE16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zkvLEULoFTgd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,756</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,950</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zzjd3qehnLZi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zBXkCMPrzTD7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(399</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zKEs7uT3IEsi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zoahsy8GI69d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">953</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">638</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2846">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,591</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F42_z2kghhNL2bcg" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zScGRpGXcBLh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">11,066</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(3,312</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(399</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">7,355</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zwUEJLMn9Lq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(11,426</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,711</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">399</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(7,715</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8Q9WxvWWZJc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zgoKVFgTyK7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2866">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2867">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_z6C8HsKy7cj1" style="text-align: center">3</td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zXSimJByCVFj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2871">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zv3crlecuyh8" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zBEXfcaZ2Tnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_zrwCVEVSOSW7" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zJsTq68EZYH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2882">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z7PyhTCf4XM2" style="text-align: center">3</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zUXxZiut0JIl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2884">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zazMZoxkpDv6" style="text-align: center">4</td></tr>
  <tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zplVkutO87u5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><p style="margin-top: 0; margin-bottom: 0">Other</p>
                                                     <p style="margin-top: 0; margin-bottom: 0">expense</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2890">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zKLZPn97d85g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,372</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,372</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F46_zxXsAtefuDHc" style="text-align: center; padding-bottom: 1pt">3</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_zck2r7mIQ1ua" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,196</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,932</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(17</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22,719</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zQQsZ98kFFhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(6,230</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(24,221</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">416</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(30,434</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zlXyhHrqYtG6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2910">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzord_zxSEeHKVrTTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(6,230</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(24,221</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">399</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(30,451</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zLpq4rZCb2K3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic net loss per common share outstanding"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted net loss per common share outstanding">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zLdkHTcYaNcb" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zWqk08J9R21j" title="Diluted net loss per common share outstanding">(7.66</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zALngv2ajKAa" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zmVC2juKldy3" title="Diluted net loss per common share outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2928"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fNg_____zr4Fpw3Z764f" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fNg_____z5J1Eds5vKJb" title="Diluted net loss per common share outstanding">(7.66</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted weighted average number of common shares outstanding">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zGauFJJaMMa2" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____z2m8eKFmBKdi" title="Diluted weighted average number of common shares outstanding">3,973,897</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zupxhmAMKlB" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zAANc7O5PDva" title="Diluted weighted average number of common shares outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2940"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_fNg_____zI6r7ZgLzbhg" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_fNg_____zO0Kt17dPiZ3" title="Diluted weighted average number of common shares outstanding">3,973,897</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F02_zMW0yTCrPjCc" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zOXZ2WhRJaBb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zElkDXBk5h94" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zodThWHzZ69i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0D_zTdonRR7Nadi" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F13_znclEY6Lw4te" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_z8AAMabERG51" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_z8S0HYfft0v8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zwrpnNPz4BW2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_ztJ1mOOHa1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_z08xFT13J7Uf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F12_zpWOpJCTLxQ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Cash Flows for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_zRnKaIw7jdjk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYZd2yEkwFr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zr7cwzqut9Ii" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zBcdhZk85qA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGvm_z64DQItPSa96" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(23,206</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(10,574</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(33,780</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F43_zw3VLV9eU38g" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzSqX_z1Siz3WmGyPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2969">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationCost_i02_maNCPBUzSqX_zKu7p8ybV0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Business combination cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(900</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zhSRmmNKghZj" style="text-align: center">2</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zIioh3o057C2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,029</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zvkI2gMnv3K4" style="text-align: center">3</td></tr>
  <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzSqX_ztlKU4wKp3L" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2980">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F40_zuT4zzgsB7S7" style="text-align: center">4</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_z1LfWwh2ycDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2984">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zWhhCrOvLBH1" style="text-align: center">5</td></tr>
  <tr id="xdx_402_ecustom--WarrantExpense_i02_msNCPBUz449_zroQluWiV8M5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2989">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ChangeInFairValueOfWarrantLiabilities_i02N_di_zly6v0jfmvIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4C_zLzzviNlbyti" style="text-align: center">6</td></tr>
  <tr id="xdx_405_ecustom--ChangeInFairValueOfPipeNotes_i02_maNCPBUz449_ztCqzYltXv2j" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2996">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zBYtlwHGJs4a" style="text-align: center">7</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_z6Wa9gfFadpl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zUuACnxP3RHe" style="text-align: center">8</td></tr>
  <tr id="xdx_40C_ecustom--NoncashInterest_i02_maNCPBUz449_zRk5FKwAcIlj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-cash interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zX8QjC4r71w1" style="text-align: center">10</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zmyVVkwjHxCk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_zkjFOQ06zN9g" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zsMiljgIih9h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4E_z8iICOZIL45l" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_zxkdC3Z1VQSe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(655</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zgbHqM25Rwih" style="text-align: center">2, 3, 9</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zS794PTHhJgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3025">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_zKQni9fVV3Pf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3028">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3029">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInExerciseTaxLiability_i03_maNCPBUzSqX_zZPZkw6z6kg7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Excise tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zTpyxRxtxAA2" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInExtensionLoan_i03_pp3d_maNCPBUzSqX_zSXrTBuq4qfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(446</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUlA1KyjgDe1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zDM2jYf7zMT6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zqJtwPbubevg" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zhTXU4CWz6xj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(95</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3046">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zYqLLsaf7Lh1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_406_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zirFCYKadrqb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(168</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">168</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3050">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4D_zH1aXYrl5jG7" style="text-align: center; padding-bottom: 1pt">2, 3</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zE1wO1c9Wxi5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,221</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(13,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,791</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zKOBqaEyKXva" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zYXgFU3g6oD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3061">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zqHSZoyjrJ1l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3065">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkxDU18xN9nb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01_maNCPBUzy34_zJEOsi6pVYlc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3072">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3073">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3074">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzGlA_zOdW1gnmqlp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of shareholder loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zaFdLfoupmci" style="text-align: center">10</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzGlA_zg5nyHeTYEI" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_z7M2VCjCnc7k" style="text-align: center">7</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_z07juzthWC5b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3086">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_z3atOgujEQs4" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--ProceedsFromDeferredUnderwritingFee_i01_maNCPBUzy34_z9DVkGtZLhz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriting fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(500</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3090">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zGwrp2TfzbYk" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_zZ0dyaR3S7wd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(338</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zf9QU9Misnz9" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_zAYoX8b1m1Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zYzwxZ33MZH7" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zWwMIO92Lofd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3102">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zx7FQKfwoy5h" style="text-align: center">2</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzy34_zR6lDSHfT83b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds (repayment) from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,681</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zxaWnkX1BqN2" style="text-align: center">8</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zsP3rV8DUkjg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3108">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3109">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3110">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ProceedsFromIssuanceOfSeriesA2PreferredStock_i01N_di_msNCPBUzy34_zDu7i4VAkpD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3112">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zISOUvH1P1t6" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z8WjtJFHZn59" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3116">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,534</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,534</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F40_zyrejfqwdML3" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zfXYzRVj6q5a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,432</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,043</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,611</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_z8gBwTb88MTj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(255</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(224</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zW01Oi5i7WK7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">302</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(31</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">271</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zXFeWXa49hi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3133">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoOYkLkcKEY8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_ecustom--CommonSharesIssuedToPreferredShareholders_i01_zL5AXy97jdhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to preferred shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zsN1AMyCjzzd" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zoPsrtyw1oY" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Common shares related to convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zZAuoRZhbqq6" style="text-align: center">2</td></tr>
  <tr id="xdx_40D_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zK8SHJvpIxr8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to Data Knights shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3148">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F45_zurSmY3KUYv1" style="text-align: center">2</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F01_zhL240hE6k3b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z9dm4Vp0An6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zGGQ55l6kmh1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zUeE55Ju80t3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0A_z4MZv7ZYiCC8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zI2WxXsdey6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zG13g7DRpeth" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1C_zYTXI3E04L3i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zHRA8LZW1Ws9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F11_zg5hJyL5Obpi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F01_zyqW1Xm1i1Kh" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F10_zrt2utkjYT66" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0F_zIYCaCTFZ5G9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F1B_zgD8LP6mENc7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0F_z7fNBeaoaagc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F1E_zTJJUc68HjP" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_zrYUaf70UVgf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td id="xdx_F15_z2QRlzGBbmY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zjJ3QhCQi3U6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td id="xdx_F12_zWah1vcZocA8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b><i>Reconciliation of the
Original and Restated Statement of Cash Flows for the Year Ended December 31, 2022</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd1GVUj81Op9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBhCw3tfNvi7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_ztK2LT4qQfpe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_pn3n3_zFzKoT6TF5kc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUz449_zhjXV3tvln2c" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(6,230</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(24,221</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(30,451</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F4D_zjxT1FD9l7P" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_pn3n3_z0076fqc8VT5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DepreciationDepletionAndAmortization_i02_pn3n3_maNCPBUz449_zm9JPLeVIQE8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maNCPBUz449_z6Q7ZgrwjTL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zIJNrmfhBsRc" style="text-align: center">3</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zS5SB85M13E2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,292</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1NfzNBC5JKe" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_zC68WqLkgJX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_z6tBAOitcY1h" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--WarrantExpense_i02N_di_msNCPBUz449_zEuTdXmz78d8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zkBk4aNHnwei" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_zCUJBEmM2g0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3194">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zpczmZJibJ92" style="text-align: center">6</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zAzE1OfS3Mo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_ztG0vsbqUXte" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zluTWoieg0s6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(876</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4B_zNedHdvlJBW" style="text-align: center">2</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_z0I3mGes2Dxf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z37tNNq9Qes9" style="text-align: center">2, 7</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zeDSeDuJMSm6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(458</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3215">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(458</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_z2GxU8Wb6ygk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3220">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zSE3xgLclZB5" style="text-align: center">2</td></tr>
  <tr id="xdx_409_ecustom--IncreaseDecreaseInExtensionLoan_i03_maNCPBUzSqX_zgskN7980aF2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,546</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zmZ2D62zyLMe" style="text-align: center">2</td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zyV7jFslgyRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(94</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">94</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3228">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zQybhbNoVMKf" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zL2rQVS8QfE" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zdRnntdJgKm" style="text-align: center">2</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zzuEL6o9ruce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">207</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(207</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3236">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F47_zNJP4fjQSaP9" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zJJhW4QBOtek" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,241</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(91,944</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,703</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zilVvTyW6epe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zNGRgLG7f9O3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3247">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zjhR5EClnx7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3251">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zyvRblK7SBoe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01I_maNCPBUzy34_z2KX3jMiyK3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3260">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_zrfUrQmF8m43" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,550</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3264">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zA55vPOU2Hib" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_z9RjVyh6e9h6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3268">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1Q1QdwsjcB" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_z6L0fxtNkTd5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3272">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zVJ0w3BVrU96" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zYdeays3yNz7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,360</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3276">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zvYGPpCF8ALi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzGlA_zxuSCkdEwgk1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,543</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,140</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zQ8Xe760x2r2" style="text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zYGmsnBOP9B5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z3TyDWcTRTM6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination Costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3286">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(815</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(815</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F43_zKeSKcvznUJk" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zwmIc6mhnd5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(88,033</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">92,366</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zp4EyvM8G2Tg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(850</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(428</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDY2bKGDYzo7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,152</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(453</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">699</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zKczG8qKbiOc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">302</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">271</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zYSJMmCsa0ka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zLKRQx9dshs8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_z87rmpJn3ZB8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F15_zDRZS1dv1eOl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zxbQFNbtYzE9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F10_z42bK2J0pX1f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_zAgkZCBqrDZc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1A_zFDMqwcniOib" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zCFiNFZCBLKj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F13_zrElvg95e3hb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zMeCuTCN8Un6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z00H9AjztdPb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improper
    presentation of Business Combination costs as well as errors identified related to capitalization of such costs. Refer to balance
    sheet restatement reconciliation for more information.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zbzwUQkL3AE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zd8vvcZGRvQ" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zK5CmsM1ZRH1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zqwRhzUrgNN" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zWLv2SAVVLB" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zJ1EbxPqWHa2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zkuypag4rQ83" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSbLFbtZqFHd" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlv5Cf5sOUO3" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3322">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1NbSqGrvhck" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8AgftvLtU5f" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3326">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUidXthwSV4a" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3328">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXBFGFyRKYs2" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">9,388,958</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">1</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">28,750</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">24,032</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(43,510</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">9,273</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXjcEC2yKbDd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zww2RJZCA4ii" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTybYcahs77" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fMg_____z83jL5Bb2Imd" style="text-align: right" title="Issuance of common shares in exchange for services, shares"><span style="-sec-ix-hidden: xdx2ixbrl3350">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3344">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3345">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3347">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3348">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM6gBXLBUoac" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKviQDmZq1Bf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrI4xcsaTqM3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdXG50votS8i" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"><span style="-sec-ix-hidden: xdx2ixbrl3370">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3364">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3365">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3368">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoFXc0EowaZ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3372">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3373">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3376">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqMk9V97gCEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcyI1ubllCfe" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">612,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3378">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3381">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">613</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3isqa2ILvij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0wDNGMku6F5" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">3,859,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3386">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3387">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,859</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,859</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB1ofR7bGO37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible loans upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCuKJG4XINv" style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">6,177,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3395">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,177</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3397">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,178</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjRLnI869rq7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWPCyxfSZ185" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4v1VSB6GRm4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOvsvOeYyLy8" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(3,853,797</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBDYBabeNKUb" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(3,204,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zp8TtqKLkxy6" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">7,057,797</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3415">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,057</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3417">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,058</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4R3JHuzW4d4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZtIFRsSvo14" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares">(2,257,326</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3427">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,257</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,257</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zImjAQyx1dl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3435">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgVEMYmeVYy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHK8uetxWRNh" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">(1,266,560</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3440">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3441">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3443">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf5V5sZPtbyj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3448">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwO9nIUVQfV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3455">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,893</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3457">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,893</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqIeAYcOEJbg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3461">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5nNrvH7L1L9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Issuance of OMN warrants to board of directors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcqEVw4aErc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3472">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3473">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,206</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,206</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z4K0kNmW97ad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjvqdYJmE8N2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3484">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0iPc6CFVON" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3486">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zy620ElYt97c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3488">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zz3W42bVrfFi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3490">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdbBjALrE3Gc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3492">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd0cvaM8AvNe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">23,572,232</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3479">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">42,221</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(55,083</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(12,859</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Restatement Adjustments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zLnYlZvsp0f9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F40_zDAvoewh2ue2" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zpxqTeO4I9oj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(437,874</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z3b6qXBzzlG9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zNnUY7L7xiFg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(364,043</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zHGmzmExCnHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zvzFm0ziawq9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z8CWxY9bZ134" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(5,355,788</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(10,375</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(14,150</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zygwwWmssSs5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zHj5CkaxLx3i" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z7bwirrTghH1" style="text-align: right" title="Issuance of common shares in exchange for services, shares">265,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3515">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3516">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3517">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3518">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhw8GZcbOHQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zCtEitmMNUb6" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zq0XsuIEjQvb" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares">5,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zQsW2gSboNpd" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z1nHfpTejBah" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3522">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3523">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3524">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3525">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zsl433z8PvWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zTC0qdQyxOY2" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3534">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zRyPxcD6Gycd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zhV9klln87bd" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zAVkHqJQ1fb2" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">(69,614</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3541">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(613</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3543">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(613</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjBvsJuZkRNl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_zcH3UUXvIdIc" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zpIkisGK5jO4" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">(438,519</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3548">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3549">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,859</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3551">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,859</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zplLOy1ht2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_ziLCg9j2iOU2" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zRbYZNCGx08i" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(701,867</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3557">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3559">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,758</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zaAxdbDBbKxl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4A_z0OGPFi514ba" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zMlytimJOcF6" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">432,201</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zFcFkIPEa4kh" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(9,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____z9frGH3YO8Og" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">364,043</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zT27h15QDmob" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(8,010</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zbrxmPwclQl8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(17,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zITjZmoEl281" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(796,244</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3564">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3565">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,058</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGSxBeU5qafe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F43_zDEM3QbSe4Z8" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zD5Fu6pKoZ99" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares">2,257,326</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3583">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3585">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,257</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuatop1tYVa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_zH7SDweyyBr1" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3590">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3591">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3593">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zu7klaV3kl0e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F41_zXvkqXSkdojg" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zQZ4FUPjak9f" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">4,838,792</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3596">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,683</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3599">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,683</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZcv5xa7e8kd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F45_zbh8HYc2n1da" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3604">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3606">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3607">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zqFv5qjxO3F8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zPksoWAMCJv6" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3610">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3611">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(418</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3613">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(418</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z1PrgZqUBDwg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zEpLKUsQUK54" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3616">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3617">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3618">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgO3DzksH894" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4E_zebKylsMKZnd" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3622">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3623">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3624">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,574</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,574</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zEzrIG974kB6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (restatement adjustments)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3xQtxPEgetg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3634">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z0LbHAIAdUp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3636">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zWsGyytsoFY1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3638">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3dqYsKfeCd7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3640">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_ziLn7iNhwNub" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3642">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGiZyyb9ObIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3644">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3629">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">35,775</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(36,357</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(583</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">As Restated</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zCERd0BC8Edb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zi65lAIuLzI5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,415,923</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z6uXJ7vZHdjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zcrTCJ23Lc8h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">2,839,957</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zSIzwmTqxAae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zQlhYEki4WHj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zEa3Euv8yG7b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">4,033,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3646">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3647">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">13,657</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(57,660</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zRh9MNfOQbN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zKhabU7B1IXj" style="text-align: right" title="Issuance of common shares in exchange for services, shares">265,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3664">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3665">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3666">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3667">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3668">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zhvp3TSV5JVc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zkKNCOHCGNYi" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares">5,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zBl8PdJEW3Fg" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_ztPun9js0gHl" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zAmG6EO8ecvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zV9qXvnTf4X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zof3JCdzGJy6" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">543,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3690">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3693">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3694">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zcMHotUSQHRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zeypJR6uOcGa" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">3,420,945</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3698">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3700">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3702">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zfItEKG9a5D5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z8Q793oFY6nc" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">5,475,362</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,936</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zg0xUHJQhupl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_ztPA7LA28WGd" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(3,421,596</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zM2ygMU7QyFk" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(9,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zFWUKYVBc9i5" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(2,839,957</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z91jAoZWsSK4" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(8,010</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zVxd72lcoUS8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(17,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z842Un0CdEeg" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">6,261,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3718">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z8QjpVGyUPod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3732">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3733">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3734">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3735">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3736">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zVfX9LzWmXC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3738">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3739">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3740">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3741">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3742">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z4FQbGPN3q37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zGyfI7Nay6Tf" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">3,572,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3744">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3747">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zn28LbtLErUe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3755">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3756">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zPS9BXk3A5Q6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3759">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3761">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zoyWjR9ZfmX4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3765">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3766">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3768">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zpMrABjxHPM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3770">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3771">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3772">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,780</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,780</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zfRwOC5WxoLl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zA8QIoRKWpBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3782">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zrinSGD4zYy" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3784">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zTYsCn8TomIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3786">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zVYGhC0pQrw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3788">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zRQ4EtchBpk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3790">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zboRJOiguk2e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">23,572,232</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3777">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">77,996</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(91,440</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(13,442</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F06_zUiD7Qvo1dF5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zbiLSN0c8sW" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    impact of corrections of errors to the prior year.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zuwvJHWa9Qsc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zoyXhvCVdcj2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting and presentation of the recapitalization.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F00_zXFfXM0FUxdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_z8741aGRMBg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zR4FwFBByqVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zyRwSInVDUs2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zlaXOkrERoi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zG6TTXuWq7t7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F02_zXs8hJHKY1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zUXZ0owxwFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zW5uco0SMtSh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zrIdmjFOdate" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_ztCUO5HaRbVk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zhuYeBR4mRoh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zkCvhsJ1MJPl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrNm0ijsZPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAcgwhinqMD4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1T2qWsARIe4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3808">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuS7rvgTthDk" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAPwynqPG39e" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3812">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmIeWOsviLx8" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3814">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGS035o8Ql7d" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">7,802,941</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">1</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">28,750</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">19,607</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(33,920</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">14,438</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuKXvvBVg7qa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcpL8pWl3lf2" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">1,378,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3818">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3819">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,360</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(534</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIWlWMbHJUOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9ML9jv2UZS3" style="text-align: right" title="Issuance of common shares in exchange for services, shares">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3826">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3827">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3829">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBYL9zVXKgk" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNn9md3kQVj9" style="text-align: right" title="Exercise of stock options, shares">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3834">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvh2OxydzaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3842">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3843">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3844">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3845">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3846">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaiX9poMuPoh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3849">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3850">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3851">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3852">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5thZ2Xh2Hsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3854">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3857">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,392</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0tYj64RAV6g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3860">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3861">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3862">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,230</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,230</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zobHW8vZbi64" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyvTNxCFGuE5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,853,797</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8vxe5cfXKMl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3874">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuu4od7drGh4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,204,000</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoiV8vo2EkS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3878">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNG5tnOqwZd3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3880">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfDbaFYqc7d1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">9,388,958</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">24,032</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(43,510</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,273</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Restatement Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zhDxKNCYKEJj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4F_zNoljWR8FXOg" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zOiSKm9Y18M5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3890">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z4SX7bmLswU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zp50a3vBuuyc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3894">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zbwued2BiB6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zLCW3sTmfox5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z5j9fZFJU6s1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(3,460,275</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(17,094</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">6,711</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(21,490</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zmjfh2oZy4n5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_z4BL9SKw3H43" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zBqgxqtz2p6c" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(437,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zsXNpsNJNxp5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(364,043</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zkFrQeWMPwqe" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(1,871,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3902">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3903">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">534</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zUwl79ZHOcIi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zLyF1icLyyY7" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zvEl2Uhodt9a" style="text-align: right" title="Issuance of common shares in exchange for services, shares">(22,724</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3914">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3915">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(200</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(200</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhK8jGiUmqO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4D_z3pfjJmavaVd" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zlNdzOClaP1i" style="text-align: right" title="Exercise of stock options, shares">(852</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3922">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3923">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3925">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_za9Aev5bcs01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zGaE6XDWo0We" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3930">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3931">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3933">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z8hLbwNTPbb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F49_zCojnMZDTpW6" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3936">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3937">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3939">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zEVLrZSKq5Bl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zae9qLTfo1K5" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3942">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3943">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">473</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3945">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">473</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zclWPo1aIwbe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F47_zBbAJaZMwUgg" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3948">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3949">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3950">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,221</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,221</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43F_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zyYjTX0xhooj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (restatement adjustments)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgWvh1mNxHC1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(437,874</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zefDHoLOM7El" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuXimcaSYwmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(364,043</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVF3mcJLaYTc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVW6xo9eel76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zO8CGAdbB5Se" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(5,355,788</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(10,375</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(14,150</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">As Restated</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrXFWLTIonP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_znrSJXtswFu1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zDWmfRBTLSv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9eknUZYUPk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zLWYelQ5MJg9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_zAD8l9lcw6Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zEbjcWBfmguh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">4,342,666</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3973">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2,513</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(27,209</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(7,052</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zGTdqTNBZigd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zMytJlaMvyi5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(437,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zjkVEXnj5cM" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(364,043</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zS3jYyKzBF04" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(493,420</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3991">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3993">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3994">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zcFGLAmG0cU9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_z0wnuWNESsub" style="text-align: right" title="Issuance of common shares in exchange for services, shares">177,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4002">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4003">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4005">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4006">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zHMgzJLqZJb6" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zajonvshXIY2" style="text-align: right" title="Exercise of stock options, shares">6,648</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4010">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4011">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTnAIjQZ5aT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4018">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4019">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4021">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_z8tAwixWGQHh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4027">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zaJ6OskwPPY7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4031">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4033">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zmUgeFgH4gy" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4036">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4037">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4038">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,451</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,451</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z6eucAVAQpA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zW5wCE0trGKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,415,923</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zIKJ6AxaTxh8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_z3lPg63tnHJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">2,839,957</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zcL2aOMXs0D5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_ztospgNmuhO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9vePJiASM6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">4,033,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4042">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4043">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">13,657</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(57,660</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 0.25in; text-align: left"><span id="xdx_F0F_zGF24QwsV3Ke" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1A_zGlRskPx0Ma4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    impact of corrections of errors to the prior year.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zGSobA1i1T6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F11_zodBNv0iJGqk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting and presentation of the recapitalization.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F0D_zsNEl2u7LGlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F11_zbg3ir20cxef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zrPYGRKo8Joa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F10_zerEnUYVHRTd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of error related to identificatoin and recognition of board of director warrante expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zDtv9dtOoYMi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F19_zFz7iviKaa8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F05_zMr7Ef6oH2v7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1E_zuS5qUnBBoP6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zpvQ5rh7nhV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zYjKwepWsD0e">Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company, including its subsidiaries. All intercompany accounts and transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_842_eus-gaap--UseOfEstimates_zr2hwzXh7qd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z3i8w8qiCyLh">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in these notes to the consolidated
financial statements. Actual results and outcomes may differ materially from management&#8217;s estimates, judgments, and assumptions.
Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to
revenue such as determining the nature and timing of the satisfaction of performance obligations, allowances for accounts receivable,
useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and stock-based compensation.
Estimates are periodically reviewed in light of changes in circumstances, facts, and experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_ecustom--OperatingSegmentsPolicyTextBlock_zgianBikxImj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zRjKMzLPlLFc">Operating
Segments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial
information is regularly evaluated by the chief operating decision maker (&#8220;CODM&#8221;), which is the Company&#8217;s Chief Executive
Officer, in deciding how to allocate resources and assess performance. The Company&#8217;s CODM evaluates the Company&#8217;s financial
information and resources and assesses the performance of these resources on a consolidated basis. The Company is not organized by market
and is managed and operated as one business. A single management team that reports to the chief executive officer comprehensively manages
the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and
does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial
segment information can be found in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgvoIrAOYflg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrYd84kCcMGb">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents
consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC insured
limits. The Company believes that, as of December 31, 2023 and 2022, its risk relating to deposits exceeding federally insured limits
was not significant. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s
financial condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zdRDjIpsIbS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zvZhFGQmgyM1">Accounts
Receivable and Allowance for Credit Losses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable is unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable is considered past due if not
paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections
have been exhausted. The Company determines the need for an allowance for credit losses based upon factors surrounding the credit risk
of specific customers, historical trends and other information. As of December 31, 2023 and 2022, the Company established allowances
for credit losses of $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zStClmmHs8Z4" title="Accounts receivable">0</span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_z8w2bWI5XRIf" title="Accounts receivable">0.1</span> million, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not
require collateral from its customers and generally requires payment from 0 to 90 days from the invoice date. For the year ended December
31, 2023, there was 1 customer that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zrvQn5txl485" title="Percentage of revenue">10</span>% or more of total revenue, and there were 2 customers that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z3ByJ3wUEWOf" title="Percentage of revenue">10</span>% or
more of total revenue for the year ended December 31, 2022. The following table represents these customers&#8217; aggregate percent of
total revenue:</span></p>

<p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_ztBzoaioJk74" style="display: none">Schedule
of Aggregate Percentage Revenue and Accounts Receivable</span> </span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">51</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">29</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Customer 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Aggregate percent of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, three customers accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance, and four customers
accounted for over <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#8217; aggregate percent of total accounts receivable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">36</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White">
    <td>Customer 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White">
    <td>Customer 4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White">
    <td>Customer 6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Customer 7</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate percent of total accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate Percent of Revenue and Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A4_zqJD9t4ymDAb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zbneL7aFcAJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zpfxMSc0ozV2">Property
and Equipment</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The straight-line method is used for computing depreciation
and amortization. Assets are depreciated and amortized over their estimated useful lives ranging from three to five years. Cost of maintenance
and repairs are charged to expense when incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZXcFP3hWAY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zVpXbo6CoYFj">Impairment
of Long-Lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances
indicate that the carrying amount of an asset may not be fully recoverable. An impairment loss would be recognized when the estimated
future undiscounted net cash flows from the use of the asset are less than the carrying amount of that asset. There were <span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20230101__20231231_zAMAdUgdylq7" title="Impairment of long-lived assets"><span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zxpllUrCgDsc" title="Impairment of long-lived assets">no</span></span> such losses
during the years ended December 31, 2023 or December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_845_ecustom--FairValueOptionOfAccountingPolicyTextBlock_zPgodBycYS55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zOFCpgo5lkt9">Fair
value option of accounting</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
financial instruments contain various embedded derivatives which may require bifurcation and separate accounting of those derivatives
apart from the entire host instrument, if eligible, ASC 825, <i>Financial Instruments</i>, allows issuers to elect the fair value option
(&#8220;FVO&#8221;) of accounting for those instruments. The FVO may be elected on an instrument-by-instrument basis and is irrevocable
unless a new election date occurs. The FVO allows the issuer to account for the entire financial instrument at fair value with subsequent
remeasurements of that fair value recorded through the statements of operations at each reporting date. A financial instrument is generally
eligible for the FVO if, amongst other factors, no part of the convertible, or contingently convertible, instrument is classified in
stockholders&#8217; equity and the instrument does not contain a beneficial conversion feature at issuance. In addition, because a contingent
beneficial conversion feature, if any, is not separately recognized within stockholders&#8217; equity at the issuance date, a convertible
debt instrument with a contingent beneficial conversion feature is therefore eligible for the FVO if all other criteria are met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the eligibility assessment discussed above, the Company concluded that its convertible notes payable is eligible for the FVO and accordingly
elected the FVO for those debt instruments. This election was made because of operational efficiencies in valuing and reporting for these
debt instruments in their entirety at each reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
promissory notes and the PIPE Notes contain embedded derivatives, which require bifurcation and separate accounting under GAAP, for which
the Company elected the FVO. In addition, certain term PIPE Notes were issued with separately exercisable and freestanding warrants to
purchase common stock, were issued with substantial discounts at issuance and contained certain embedded derivatives to be bifurcated
and accounted for separately for those term notes, unless the FVO is eligible and elected. Accordingly, the Company qualified for and
elected the FVO for the entire PIPE Notes instruments. The convertible debt and accrued interest at their stated interest rates were
initially recorded at fair value as liabilities on the consolidated balance sheets and were subsequently re-measured at fair value at
the end of each reporting period presented within the consolidated financial statements. The changes in the fair value of the convertible
promissory notes and PIPE Notes are recorded in changes in fair value of convertible debt and change in fair value of PIPE Notes, included
as a component of other (income) expenses, net, in the consolidated statements of operations. The change in fair value related to the
accrued interest components is also included within the respective single line of change in fair value of convertible debt and change
in fair value of PIPE Notes on the consolidated statements of operations. See additional information on valuation methodologies and significant
assumptions used in Note 6 and Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_849_ecustom--WarrantPolicyTextBlock_zFCbjB1MuvZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zlRvn7HvG6e5">Warrants</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in ASC 480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, <i>Derivatives
and Hedging</i>. Warrants that meet the definition of a derivative financial instrument and the equity scope exception in ASC 815-10-15-74(a)
are classified as equity and are not subject to remeasurement provided that the Company continues to meet the criteria for equity classification.
Warrants that are classified as liabilities are accounted for at fair value and remeasured at each reporting date until exercise, expiration,
or modification that results in equity classification. Any change in the fair value of the warrants is recognized as change in fair value
of warrant liabilities included as a component of other (income) expenses, net in the consolidated statements of operations. The classification
of warrants, including whether warrants should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The fair value of liability-classified warrants is determined using the Black-Scholes options pricing model (&#8220;Black-Scholes model&#8221;)
which includes Level 3 inputs, as shown in Note 11 to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z7mrkflN4v37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zgP8byl9dztb">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes
the inputs to valuation methodologies used to measure fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
1</b> - Valuations based on quoted prices for identical assets and liabilities in active markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
2</b> - Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets
and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other
inputs that are observable or can be corroborated by observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
3</b> - Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made
by other market participants. These valuations require significant judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
quoted market prices are available in active markets, the fair value of assets and liabilities is estimated within Level 1 of the valuation
hierarchy. If quoted prices are not available, then fair values are estimated by using pricing models, quoted prices of assets and liabilities
with similar characteristics, or discounted cash flows, within Level 2 of the valuation hierarchy. In cases where Level 1 or Level 2
inputs are not available, the fair values are estimated by using inputs within Level 3 of the hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies&#894; however,
considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative
of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using
different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based
on carrying values and future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, convertible notes
payable, liability classified financial instruments and certain privately issued warrants. The carrying amounts of cash and cash equivalents
and accounts payable financial instruments approximate their fair value due to their short-term nature. The carrying amount of accounts
receivable is net of an allowance that reflects management&#8217;s best estimate of expected credit losses. See Note 11 for fair value
measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84C_eus-gaap--StockholdersEquityPolicyTextBlock_zJjjHU9EiIXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Classification
of Series A-1, and Series A-2 preferred stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_zuHE7wZUI1Lf" style="display: none">Treasury
stock</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company originally classified its Series A-1 and Series A-2 preferred stock (collectively &#8220;Preferred Stock&#8221;) outside of permanent
equity because the Preferred Stock contained certain redemption features that result in those shares being redeemable upon the occurrence
of certain events that are not solely within the Company&#8217;s control, including liquidation, sale or transfer of control. Accordingly,
the Preferred Stock was recorded outside of permanent equity and was subject to the classification guidance provided under ASC 480-10-S99.
Because dividends were not contractually required to be accrued on the Preferred Stock as there was no stated or required dividend rate
per annum, the Company was not required to accrete dividends into the carrying amount of the Preferred Stock in anticipation of a future
contingent event or redemption value. Accordingly, the Company did not adjust the carrying values of the Preferred Stock to the respective
liquidation preferences of such shares because of the uncertainty of whether or when such events would occur. As of December 31, 2023,
all shares of Preferred Stock were converted into Common Stock pursuant to their provisions in connection with the Business Combination,
which closed on November 7, 2023 (see Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zixMabdmKOj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zghowmw5w7cc">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic 606, <i>Revenue from Contracts with Customers</i>, which aligns revenue recognition
with the transference of promised goods or services to customers in an amount that reflects the consideration to which the Company expects
to be entitled in exchange for those goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
core principle is achieved to the application of a five-step model: (1) identify the contract with a customer, (2) identify the performance
obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to performance obligations in the
contract, and (5) recognize revenue as performance obligations are satisfied. Payment terms between customers related to product and
services sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable
or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to
a customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit
of account under Topic 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation in proportion to
the standalone selling price for each and recognized as revenue when, or as, the performance obligation is satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
promised goods and services in a contract are considered a performance obligation and accounted for separately if the good or service
is distinct. A good or service is considered distinct if the customer can benefit from the good or service on its own or with other resources
that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price for the products is the invoiced amount. Advanced billings from contracts are deferred and recognized as revenue when
earned. Revenue is recognized only to the extent that it is probable that a significant reversal of revenue will not occur and when collection
is considered probable. The Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority
and imposed on and concurrent with a specific revenue-producing transaction. Deferred revenue consists of payments received in advance
of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives
payments from customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes
unconditional. Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subscription
Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenues are generated from the Company&#8217;s data exchange (BEAM) product, which is a medical imaging exchange platform between hospital/healthcare
systems, imaging centers, physicians and patients. Subscriptions to the BEAM platform offering are recognized over time as the customer
consumes the benefits of the services as the Company stands ready to provide access to the programs throughout the subscription period.
Subscription customers are invoiced either quarterly or annually in advance with the customer contracts automatically renewing unless
the customer issues a cancellation notice. The timing of revenue recognition is based on a time-based measure of progress as the Company
provides access to the programs evenly over the course of the subscription period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Web
Imaging Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Web
imaging revenues are generated from the Company&#8217;s data broker (iRWD) product, which provides regulatory grade imaging and clinical
data in the pharmaceutical, device manufacturing, clinical research organizations, and artificial intelligence markets. Web imaging customers
are invoiced in installments as the related data is delivered. Revenue from the sale of web imaging products is recognized over time
using an output measure of progress, which is based on the number of data units delivered relative to the total data units committed
by the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zbR50DAB7kV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zKJcBN4npTdf">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes income taxes under the asset and liability method. Deferred income taxes are recognized for differences between the
financial reporting and tax bases of assets and liabilities, at enacted statutory tax rates in effect for the years in which the differences
are expected to reverse. The Company establishes a valuation allowance if it believes it is more likely than not that the deferred tax
assets will not be recovered based on an evaluation of all available evidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely
than not that a position will be sustained, none of the benefit attributable to the position is recognized. The tax benefit to be recognized
for any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than
50% likely to be realized upon resolution of the contingency. The Company accounts for interest and penalties related to uncertain tax
positions as part of its provision for income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_848_ecustom--PatentsAndTrademarksPolicyTextBlock_zzT15pKsuKh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z477QSUwNVti">Patents
and Trademarks</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
associated with the submission of a patent application are expensed as incurred given the uncertainty of the patents resulting in probable
future economic benefits to the Company and are included in research and development expenses on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4Hi9QUf8Quf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zOHYXgR61V4k">Research
and Development</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its research and development (&#8220;R&amp;D&#8221;) costs in accordance with ASC 730, <i>Research and Development
</i>(&#8220;ASC 730&#8221;). ASC 730 requires that R&amp;D costs are generally recognized as an expense as incurred. However, some costs
associated with R&amp;D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.
For the years ended December 31, 2023 and December 31, 2022 research and development expenditures were charged to operating expense as
incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_znU3DnHp0JGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zgmkIrGoakvg">Stock-based
Compensation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense related to employee option grants and restricted stock grants, if any, in accordance with ASC
718, <i>Compensation - Stock Compensation</i> (&#8220;ASC 718&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures all stock options and other stock-based awards granted based on the fair value of the award on the date of the grant
and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the
respective award. The Company has elected to recognize forfeitures as they occur. The reversal of compensation cost previously recognized
for an award that is forfeited because of a failure to satisfy a service condition is recognized in the period of the forfeiture. Generally,
and unless otherwise specified, the Company grants stock options with service-based only vesting conditions and records the expense for
these awards using the straight-line method over the requisite service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award
recipient&#8217;s payroll costs are classified or in which the award recipients&#8217; service payments are classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Business Combination, the Company was required to periodically estimate the fair value of its Common Stock with the assistance
of an independent third-party valuation firm when issuing stock options and computing estimated stock-based compensation expense. The
assumptions underlying these valuations represented the Company&#8217;s best estimates, which involved inherent uncertainties and the
application of significant levels of judgment. In order to determine the fair value of its Common Stock, the Company considered, among
other items, previous transactions involving the sale of Company securities, the business, financial condition and results of operations,
economic and industry trends, the market performance of comparable publicly traded companies, and the lack of marketability of the Company&#8217;s
Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. These estimates and assumptions include
a number of objective and subjective factors, including external market conditions, guideline public company information, the prices
at which the Company sold convertible preferred stock and common stock to third parties in arms&#8217; length transactions, the rights
and preferences of securities senior to the Company&#8217;s common stock at the time, and the likelihood of achieving a liquidity event
such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in materially
different fair values of stock options at each valuation date, as applicable. Following the Business Combination (see Note 3), the Company
used the public price of its Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each stock option grant is estimated using the Black-Scholes option-pricing model. The Company estimates its expected stock
volatility based on the historical volatility of a publicly traded set of peer companies within the biotechnology industry with characteristics
similar to the Company. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221;
method, which reflects the weighted-average of time-to-vesting. The risk-free interest rate is determined by reference to the U.S. Treasury
yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected
dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends
in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zpI0qE49LlHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Net
loss per common share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86B_zl2x1xmQ1a1e" style="display: none">Net
loss per share</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
per share attributable to common stockholders is calculated using the two-class method, which is an earnings allocation formula that
determines earnings per share for the holders of the Company&#8217;s Common Stock and participating securities. Although the Company&#8217;s
historical Preferred Stock contained participating rights in any dividend declared and paid by the Company and were therefore participating
securities, the Preferred Stock had no stated dividends and OneMedNet has never paid any cash dividends and does not plan to pay any
dividends in the foreseeable future. Net loss attributable to common stockholders and participating securities is allocated to each share
on an if-converted basis as if all of the earnings for the period had been distributed. However, the participating securities do not
include a contractual obligation to share in the losses of the Company and are not included in the calculation of net loss per share
in the periods that have a net loss. In addition, common stock equivalent shares (whether or not participating) are excluded from the
computation of diluted earnings per share in periods in which they have an anti-dilutive effect on net loss per common share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
net loss per share is computed using the more dilutive of (a) the two-class method or (b) the if-converted method and treasury stock
method, as applicable. Contingently convertible notes payable and PIPE Notes were not included for purposes of calculating the number
of diluted shares outstanding as the number of dilutive shares is based on a conversion contingency associated with the completion of
a future financing event that had not occurred, and the contingency was not resolved, in the reporting periods presented herein. In periods
in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders
is the same as basic net loss per share attributable to common stockholders since dilutive common shares are not assumed to have been
issued if their effect is anti-dilutive. Diluted net loss per share is equivalent to basic net loss per share for the periods presented
herein because common stock equivalent shares from the Preferred Stock, convertible notes, stock option awards and outstanding warrants
to purchase common stock were antidilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Company reporting net loss attributable to common stockholders for all periods presented herein, the following common
stock equivalents were excluded from the computation of diluted net loss per common share for the years ended December 31, 2023 and 2022
because including them would have been antidilutive (in thousands):</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none">Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022
    <span id="xdx_F53_zMknzVxwFW2d">(1)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022 (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Employee stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4156">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">913,856</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,276</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,367,607</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,839,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4168">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,415,923</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4171">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,786,610</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total common stock equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,501,229</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retroactively restated
for the reverse recapitalization in Note 3.</span></td>
</tr></table>

<p id="xdx_8AD_zdniDLLHaxk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zAtmvX74dVB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zHJ6xeHhZUah">General
and Administrative</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses include all costs that are not directly related to satisfaction of customer contracts. General and administrative
expenses include items for the Company&#8217;s selling and administrative functions, such as sales, finance, legal, human resources,
and information technology support. These functions include costs for items such as salaries and benefits and other personnel-related
costs, maintenance and supplies, professional fees for external legal, accounting, and other consulting services, and depreciation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zYqQNQ3xCV7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86C_zEsoVgjxUZrh" style="display: none">Emerging
growth company status</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an emerging growth company, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#8220;JOBS Act&#8221;). Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to
comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has not elected to opt out of such extended transition
period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK1ZhnNCN3aa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zW7YQkl7K4D5">Accounting
Pronouncements Not Yet Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No. 2023-09, <i>Improvements to Income Tax Disclosures (Topic 740)</i> (&#8220;ASU 2023-09&#8221;).
ASU 2023-09 requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional
information on income taxes paid. ASU 2023-09 is effective on a prospective basis for annual periods beginning after December 15, 2024.
Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. The Company
is currently evaluating the impact of adopting ASU 2023-09.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): <i>Improvements to Reportable Segment Disclosures</i>, which
is intended to provide enhancements to segment disclosures, even for entities with only one reportable segment. In particular, the standard
will require disclosures of significant segment expenses regularly provided to the chief operating decision maker and included within
each reported measure of segment profit and loss. The standard will also require disclosure of all other segment items by reportable
segment and a description of its composition. Finally, the standard will require disclosure of the title and position of the chief operating
decision maker and an explanation of how the chief operating decision maker uses the reported measure(s) of segment profit or loss in
assessing segment performance and deciding how to allocate resources. The standard is effective for annual periods beginning after December
15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently
evaluating the impact of the standard on the presentation of its consolidated financial statements and footnotes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_842_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_zZpd1abxoVL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zkTd0xEMhp11">Recently
adopted accounting pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU No. 2016-13, <i>Financial Instruments - Credit Losses</i>, &#8220;Topic 326&#8221;, an amendment on measurement
of credit losses on financial assets held by at each reporting date. The guidance requires the use of a new current expected credit loss
(&#8220;CECL&#8221;) model in estimating allowances for doubtful accounts with respect to accounts receivable. The CECL model requires
that the Company estimate its lifetime expected credit loss with respect to these receivables and record allowances that, when deducted
from the balance of the receivables, represent the estimated net amounts expected to be collected. Effective January 1, 2023, the Company
adopted ASU No. 2016-13 and the adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU No. 2022-03, <i>Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </i>(&#8220;ASU
2022-03&#8221;), which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit
of account of the equity security and, therefore, is not considered in measuring fair value. ASU 2022-03 is effective for public business
entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. The Company adopted
ASU No. 2022-03 and the adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial statements.</span></p>
<p id="xdx_854_z0kpDrFoQhHh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132205744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Crypto Assets Held<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetTextBlock', window );">Crypto Assets Held</a></td>
<td class="text"><p id="xdx_805_eus-gaap--CryptoAssetTextBlock_zKLCg55gnXuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
<span id="xdx_827_zoO8pgRsi5F8">Crypto Assets Held</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_897_eus-gaap--CryptoAssetHoldingTableTextBlock_zTB0AIener44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s crypto assets are comprised solely of Bitcoin. In accordance with ASC Topic 820, <i>Fair Value Measurement</i>, the Company measures the fair value of its Bitcoin based on the quoted
end-of-day price on the measurement date for a single Bitcoin on an active trading platform, River.com. Management has determined that
River.com, an active exchange market, represents a principal market for Bitcoin and the end-of-day quoted price is both readily available
and representative of fair value (Level 1 inputs). The following table sets forth the units held,
cost basis, and fair value of Bitcoin held, as shown on the condensed consolidated balance sheet as of September 30, 2024 (in
thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B4_zY3UlrZWZ5ne" style="display: none">Schedule of
Crypto Assets Held</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Units</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost Basis</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Crypto assets held:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; padding-bottom: 1pt">Bitcoin</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zLOn4p19mJN7" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Units">34</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zp3DECi0H9Qi" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Cost Basis">2,280</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zroUcn7ulLG3" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Fair Value">2,156</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930_zxCzDZA5h31d" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Units">34</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930_znPTUFykpP3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Cost Basis">2,280</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930_zkrQPxzIqVEi" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Fair Value">2,156</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_z4zmSbHVicB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--CryptoAssetActivityTableTextBlock_z1bD7UqESyQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents a reconciliation of the fair values of the Company&#8217;s Bitcoin for the nine months ended September 30, 2024
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify; text-indent: 0.5in"><span id="xdx_8BA_zCLq1qYiSvyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Crypto Assets Reconciliation of Fair Values</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20240930_ztdl1EyPS13j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bitcoin</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CryptoAssetFairValue_iS_pn3n3_zQZHqSEdjwW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0900">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CryptoAssetAddition_pn3n3_zMGUwIBFwPFg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Additions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">2,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CryptoAssetDisposition_iN_pn3n3_di_zMvzW35TKVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Dispositions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(520</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--CryptoAssetRealizedAndUnrealizedGainLossNonoperating_pn3n3_zm0rtpou1iD4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized loss, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(124</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--CryptoAssetFairValue_iE_pn3n3_zoOCyIpKptze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,156</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zV7be24ybcl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions
are the result of the Company acquiring Bitcoin with liquid assets from private placements, while dispositions are the
result of sales of Bitcoin. During the three and nine months ended September 30, 2024, the Company had Bitcoin dispositions of $<span id="xdx_90E_eus-gaap--CryptoAssetDisposition_pn5n6_c20240701__20240930_z8aIxi1EOSC6" title="Bitcoin dispositions"><span id="xdx_90B_eus-gaap--CryptoAssetDisposition_pn5n6_c20240101__20240930_zcLh8GIt5kVi" title="Bitcoin dispositions">0.5</span></span> million,
inclusive of realized losses of $<span id="xdx_909_eus-gaap--CryptoAssetRealizedAndUnrealizedLossNonoperating_pn3n3_c20240701__20240930_zgdIrfF1UOv1" title="Bitcoin realized losses"><span id="xdx_903_eus-gaap--CryptoAssetRealizedAndUnrealizedLossNonoperating_pn3n3_c20240101__20240930_zBKqUhCaUN02" title="Bitcoin realized losses">51</span></span> thousand. The Company uses a first-in, first-out methodology to assign costs to Bitcoin for purposes
of the Bitcoin held and realized gains and losses disclosure above. Bitcoin is included in current assets in the condensed consolidated
balance sheet due to the Company&#8217;s ability to sell them in a highly liquid marketplace and its intent to liquidate its Bitcoin
to support operations when needed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132144512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Convertible Debt</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zgE3dIWpWlTh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_823_zK5JMJPEWQKa">Convertible Debt</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
Promissory Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
2019 to 2023, the Company issued various convertible promissory notes to related and unrelated party investors, which were convertible
into equity securities of Legacy ONMD upon a next equity financing transaction (the &#8220;Convertible Promissory Notes&#8221;). The
Convertible Promissory Notes bore interest at a rate of either <span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240101__20240930__srt--RangeAxis__srt--MinimumMember_zqFlkQW35Io2" title="Debt conversion converted instrument rate">4</span>% or <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240101__20240930__srt--RangeAxis__srt--MaximumMember_zI4ZzeUpZyhi" title="Debt conversion converted instrument rate">6</span>% annually from the date of issuance until the outstanding principal
was paid or converted. In connection with the issuance of Convertible Promissory Notes in 2022 and 2023, the Company also issued warrants
at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240930__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesWarrantsMember_zj1mzTFDZnO9" title="Warrants exercise price">1.00</span> per share (the &#8220;Convertible Promissory Notes Warrants&#8221;). See additional information on the
accounting for the warrants in Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Promissory Notes were issued for general working capital purposes. The Company elected the fair value option (&#8220;FVO&#8221;)
of accounting under ASC 825, <i>Financial Instruments</i>, for its Convertible Promissory Notes. Under the FVO election, the financial
instrument is initially measured at its issue-date estimated fair value and subsequently remeasured at estimated fair value on a recurring
basis at each reporting period date. The estimated fair value adjustment is presented as a single line item within other expense (income),
net in the accompanying condensed consolidated statements of operations under the caption change in fair value of convertible promissory
notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, all Convertible Promissory Notes were converted pursuant to their provision in connection with the Business Combination
between Data Knights and Legacy ONMD and were no longer outstanding as of December 31, 2023. See the Form 10-K/A for all other details
relating to the Convertible Promissory Notes issued prior to December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 28, 2023, <span id="xdx_900_eus-gaap--DebtInstrumentDescription_c20230628__20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zn2SjncbvHzc" title="Debt description">Data
Knights and certain investors (the &#8220;Purchasers&#8221;) entered into a Securities Purchase Agreement pursuant to which Data
Knights issued and sold to the Purchasers a new series of senior secured convertible notes (the
&#8220;PIPE Notes&#8221;), which are convertible into shares of Common Stock at the Purchasers&#8217; election at a conversion price equal
to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) Trading
Days immediately preceding the conversion date.</span> The PIPE Notes matured on the first anniversary of the issuance date, or
November 7, 2024. The majority of the PIPE Notes holders have elected to convert their PIPE Notes into shares of Common Stock, which
will occur upon the Company&#8217;s filing of a Registration Statement on Form S-1.</span> </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected the FVO of accounting for its PIPE Notes. The estimated fair value adjustment is presented as a single line item
within other expense (income), net in the accompanying condensed consolidated statements of operations under the caption change in
fair value of PIPE Notes. As of September 30, 2024 and December 31, 2023, the fair value of the PIPE Notes was $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20240930__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zF04u7lLsVK5" title="PIPE Notes">1.6</span>
million and $<span id="xdx_90A_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7xn7Wmwz6Oh" title="PIPE Notes">1.6</span> million, respectively, which is included in current liabilities on the condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholder
Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
January to June 2024, the Company received gross proceeds of $<span id="xdx_908_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1KAO1HJLP76" title="Loans payable">1.6</span> million in connection with shareholder loans with a related party investor
which are convertible into <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240101__20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zlfrraQ7AUe9" title="Stock issued during period shares conversion of convertible securities">2,123,312</span> shares of Common Stock at a conversion price of $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zH7crsHhNtOi" title="Debt conversion price">0.7535</span> per share. These loans do not bear interest
and mature one year from issuance. The balance of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZwwcM2VIfsh" title="Principal amount of notes payable">1.6</span> million is included in loan &#8211; related party on the condensed consolidated
balance sheet as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Helena
Notes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 28, 2024, the Company entered into a definitive securities purchase agreement (the &#8220;Helena SPA&#8221;) with Helena Global
Investment Opportunities 1 Ltd. (&#8220;Helena&#8221;), an affiliate of Helena Partners Inc., a Cayman Islands-based advisor and investor
providing for up to $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240328__20240328_ztXQ0WdfGwha" title="Proceeds from issuance of convertible notes">4.5</span> million in funding through a private placement for the issuance of senior secured convertible notes and warrants
across multiple tranches. The Helena SPA was subsequently terminated in June 2024 prior to the closing of any tranches (the &#8220;Helena
Termination Agreement&#8221;). As such, except as described below, the Helena SPA had no impact on the Company&#8217;s condensed consolidated
financial statements as of and for the <span style="background-color: white">nine months </span>ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Helena Termination Agreement, the Company agreed to issue to Helena a warrant to purchase <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240328_zCFfsfDipzhl" title="Warrant outstanding">50,000</span> shares of Common Stock at an
exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240328_ziHpzXLON6Dg" title="Warrant exercise price">1.20</span> per share (the &#8220;Helena Termination Warrants&#8221;) and agreed to reimburse Helena for certain reasonable
and documented out-of-pocket legal fees and expenses incurred in connection with entry into the Helena SPA and Helena Termination Agreement
and related documents. The Company incurred legal fees and expenses of $<span id="xdx_901_eus-gaap--LegalFees_pn3n3_c20240328__20240328__us-gaap--TypeOfArrangementAxis__custom--HelenaTerminationAgreementMember_zzR87PxCnC26" title="Legal fees">42</span> thousand in connection with the Helena Termination Agreement.
As of September 30, 2024, the Helena Termination Warrants were not yet issued or outstanding. However, in accordance with the loss contingency
guidance of ASC Topic 450, <i>Contingencies</i>, the Company determined that it was probable that a liability had been incurred (its
obligation to issue warrants) and the amount of the loss could be reasonably estimated (the fair value of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930_zZrhrCT2XWac" title="Number of warrants">50,000</span> warrants at an exercise
price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240930_zc0rvQmwEsK" title="Exercise price of warrant">1.20</span> per share). Therefore, the Company recorded stock warrant expense of $<span id="xdx_90B_ecustom--StockWarrantExpense_pn3n3_c20240101__20240930_zRGCkZplq2Kd" title="Stock warrant expense">33</span> thousand in its condensed consolidated statement
of operations, with an offsetting liability to accounts payable and accrued expenses on its condensed consolidated balance sheet. The
Company will reclassify the contingent liability to equity or warrant liabilities under applicable guidance when the Helena Termination
Warrants are issued, which occurred in December 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Yorkville
Note</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company entered into a Standby Equity Purchase Agreement (&#8220;SEPA&#8221;) with YA II PN, LTD, a Cayman Islands
exempt limited partnership managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;) (see Note 7). Upon entry into the SEPA,
the Company issued Yorkville a $<span id="xdx_90E_eus-gaap--ConvertibleDebt_iI_pn5n6_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zulY9UuqiMc8" title="Convertible promissory note">1.5</span> million convertible promissory note for $<span id="xdx_906_eus-gaap--Cash_iI_pn4n6_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zdRaAM9caZl7" title="Cash">1.35</span> million in cash (after a <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zvPgkJeJYYmk" title="Original issue discount">10</span>% original issue discount)
(the &#8220;Yorkville Note&#8221;). The Yorkville Note does not bear interest and matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_pid_dd_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zzxsn56vjOY9" title="Maturity date">June 17, 2025</span>. <span id="xdx_909_eus-gaap--DebtInstrumentDescription_pid_dd_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zT4Bij1QnXaj" title="Debt description">The Yorkville Note is convertible
by Yorkville into shares of Common Stock at an aggregate purchase price based on a price per share equal to the lower of (a) $1.3408
per share (subject to downward reset upon the filing of the resale registration statement described below) or (b) 90% of the lowest daily
volume-weighted average price (&#8220;VWAP&#8221;) of the Common Stock on Nasdaq during the seven trading days immediately prior to each
conversion (the &#8220;Variable Price&#8221;), but which Variable Price may not be lower than the Floor Price then in effect.</span> The &#8220;Floor
Price&#8221; is $<span id="xdx_90F_ecustom--FloorPricePerShare_iI_c20240617__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zb6WTBadgGxb" title="Floor price per share">0.28</span> per share, subject to the Company&#8217;s option to reduce the Floor Price to any amounts set forth in a written
notice to Yorkville. Upon the occurrence and during the continuation of an event of default (as defined in the Yorkville Note), the Yorkville
Note will become immediately due and payable. The issuance of the Common Stock upon conversion of the note and otherwise under the SEPA
is capped at <span id="xdx_902_ecustom--PrecentageOfOutstandingCommonStock_dp_c20240618__20240618__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zpCKLojZ4v" title="Precentage of outstanding common stock">19.9</span>% of the outstanding Common Stock as of June 18, 2024. Further, the note and SEPA include a beneficial ownership blocker
for Yorkville such that Yorkville may not be deemed the beneficial owner of more than <span id="xdx_902_eus-gaap--MinorityInterestOwnershipPercentageByNoncontrollingOwners_iI_pid_dp_c20240617__srt--OwnershipAxis__custom--BeneficialOwnershipMember__srt--RangeAxis__srt--MinimumMember_zwaRDlaPWXqi" title="Beneficial ownership percentage">4.99</span>% of the Company&#8217;s Common Stock. As a
result of the Company&#8217;s failure to file its Form 10-Q for the fiscal quarter ended June 30, 2024 by August 14, 2024 (i.e., a deemed
Event of Default under the Yorkville Note), the Company began accruing interest at the default rate of <span id="xdx_904_ecustom--DebtInstrumentInterestRateDefaultPercentage_iI_pid_dp_c20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh45U7CPLqtl" title="Debt default interest rate">18.0</span>% as of August 14, 2024. A
further event of default occurred as a result of the Company&#8217;s failure to file a registration statement with the SEC for the resale
by Yorkville of the shares of Common Stock issuable under the SEPA by August 30, 2024 (see Note 7). As such, the full unpaid principal
amount of the Yorkville Note may become immediately due and payable at Yorkville&#8217;s election. The Company subsequently engaged in
discussions with Yorkville regarding these events of default, which discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected the FVO of accounting for the Yorkville Note. The estimated fair value adjustment is presented as a single line item
within other expense (income), net in the accompanying condensed consolidated statements of operations under the caption change in fair
value of Yorkville Note. As of September 30, 2024, the fair value of the Yorkville Note was $<span id="xdx_90C_ecustom--YorkvilleNotesPayableCurrent_iI_pn5n6_c20240930_zTt1BiL2G7s9" title="Fair value of Yorkville Note">1.9</span> million, which is included in current
liabilities on the condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--LongTermDebtTextBlock_zC9TDOK2uHLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
<span id="xdx_82E_zDVmmJ93akyj">Convertible Debt</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
Promissory Notes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2019
Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
November 2019, the Company entered into a convertible promissory note (the &#8220;2019 Note&#8221;) agreement with a related party investor.
The total amount of the 2019 Note is $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20191130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesMember_z7BHlTR6w47a" title="Convertible promissory note">1.5</span> million. The 2019 Note is unsecured and bears interest at a rate of four percent annually from
the date of issuance until the outstanding principal is paid or converted. The 2019 Note matures on January 1, 2025. The 2019 Note shall
automatically convert into the next offering of preferred stock upon closing of such next equity financing. The number of shares of preferred
stock to be issued upon conversion shall be equal to the number obtained by dividing the outstanding principal and unpaid accrued interest
owed on the date of conversion, by the conversion price. The conversion price is 100 percent of the lowest price per share paid for the
next equity preferred stock by other investors in the next equity financing. In the event that prior to the conversion or repayment of
amounts owed, the Company completes a financing transaction in which the Company sells equity securities but such transaction does not
qualify as next equity financing (i.e., an &#8220;alternative financing&#8221;), then the principal and unpaid accrued interest may (upon
written election of the purchaser holding the 2019 Note) convert into the securities issued by the Company in the alternative financing.
The number of alternative financing equity securities to be issued upon such conversion shall be equal to the number obtained by dividing
the outstanding principal and unpaid accrued interest owed by an amount equal to 100 percent multiplied by the lowest price per share
at which the alternative financing equity securities are sold and issued for cash in the alternative financing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>2022
Notes and 2023 Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2022, the Company entered into convertible promissory notes with related party investors totaling $<span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zaEIMSCzD1wk">4.7
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and unrelated party investors totaling
$<span id="xdx_90E_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_z84gLen9mjC5">0.4
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (each investor, a &#8220;Purchaser&#8221;)
(the &#8220;2022 Notes&#8221;). During 2023, the Company entered into various convertible promissory notes with related party investors
totaling $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zScIJdljMyq1">2.3
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and unrelated party investors totaling
$<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyThreeNotesMember_zPiEqF6dGaxa">1.9
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (the &#8220;2023 Notes&#8221;, and together
with the 2019 Notes and 2022 Notes, the &#8220;Convertible Promissory Notes&#8221;). The 2022 Notes and 2023 Notes issued are unsecured
and bear an interest rate of six percent annually from the date of issuance until the outstanding principal is paid or converted. On
November 11, 2022, the 2022 Notes were amended and restated in order to (i) provide for the sale and issuance to Purchasers of additional
convertible promissory notes and warrants to purchase shares of the Company&#8217;s capital stock, (ii) provide for the sale and issuance
of warrants to purchase shares of the Company&#8217;s common stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221111__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zMg9smYsOPXi">1.00
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share to Purchasers who purchased 2022 Notes
between January 1, 2022 and November 11, 2022; and (iii) <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDateDescription_c20221110__20221111__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesMember_zM9SsSGgiV91">extend
the maturity date of all outstanding 2022 Notes from December 31, 2022 to March 31, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal and unpaid accrued interest on each of the 2022 Notes and 2023 Notes will convert: (i) automatically, upon the Company&#8217;s
issuance of equity securities (the &#8220;Next Equity Financing&#8221;) in a single transaction, or series of related transactions, with
aggregate gross proceeds to the Company of at least $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20221110__20221111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zb9buOx6XVB7" title="Proceeds from equity financing">5,000,000</span>, into shares of the Company&#8217;s capital stock issued to investors
in the Next Equity Financing, at a conversion price equal to the lesser of (A) <span id="xdx_902_ecustom--EquityFinancingDescription_c20221110__20221111__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zFfxmD1ydLoc" title="Equity financing, description">a 20% discount to the lowest price per share of shares
sold in the Next Equity Financing, or (B) $2.50 per share; (ii) at the noteholder&#8217;s option, in the event of a defined Corporate
Transaction (as defined in the next paragraph) while the 2022 Notes and 2023 Notes remain outstanding, into shares of the Company&#8217;s
Series A-2 Preferred Stock at a conversion price equal to $2.50 per share; and (iii) at the noteholder&#8217;s option, on or after the
maturity date while the 2022 Notes and 2023 Notes remains outstanding, into shares of the Company&#8217;s Series A-2 Preferred Stock
at a conversion price equal to $2.50 per share</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a Corporate Transaction occurs before the repayment or conversion of the 2022 Notes and 2023 Notes, the Company will pay at the closing
of the Corporate Transaction to each noteholder that elects not to convert its 2022 Notes and 2023 Notes in connection with such Corporate
Transaction an amount equal to the outstanding principal amount of such noteholder&#8217;s Note plus a 20% premium. &#8220;Corporate
Transaction&#8221; means (a) a sale by the Company of all or substantially all of its assets, (b) a merger of the Company with or into
another entity (if after such merger the holders of a majority of the Company&#8217;s voting securities immediately prior to the transaction
do not hold a majority of the voting securities of the successor entity) or (c) the transfer of more than 50% of the Company&#8217;s
voting securities to a person or group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the issuance of the 2022 Notes and 2023 Notes, the Company also issued <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zm5Ff5qL1Vgf" title="Warrant issued">2,056,000</span> and <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zFmpnIUAy6Ta" title="Warrant issued">1,670,000</span> warrants (the &#8220;Convertible Notes Warrants&#8221;) in 2022 and 2023, respectively, with an exercise
price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zP4hBCP8Ullf" title="Warrant exercise price"><span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zBfU8sqpchoa" title="Warrant exercise price">1.00</span></span> per share. The expiration date of the Convertible Notes Warrant is the earliest to occur the expiration of the
five-year period following the date of issuance, the closing of a firm commitment underwritten public offering of the
Company&#8217;s Common Stock; or the closing of an Corporation Transaction. The Convertible Notes Warrants when exercised entitles
the holder to one share of the Company&#8217;s Common Stock. The Convertible Notes Warrants include anti-dilutive measure to address
stock dividends, stock splits, and additional shares of Common Stock due to reorganization of the Company. In the case of
reclassification or reorganization, each holder shall be entitled to receive, in lieu of stock or other securities and property
receivable, the stock or other securities or property to which such holder would have been entitled if the holder had exercised the
Convertible Notes Warrants immediately prior. The Convertible Notes Warrants will terminate at the earliest of (1) the expiration of
five-year period following the date of issuance, (2) the closing of a firm commitment underwritten public offering of the
Company&#8217;s Common Stock; (3) the closing of a sale of the Company. The holders of the Convertible Notes Warrants are not
permitted to sell, pledge, distribute, offer for sale, transfer, or otherwise dispose of the Convertible Notes Warrants in the
absence of (i) an effective registration statement under the Securities Act, or (ii) an opinion of counsel, satisfactory to the
Company and to be provided at the sole cost of the holder, that such registration and qualification are not required. Furthermore,
neither the Convertible Notes Warrants nor any rights may be assigned, conveyed, or transferred, in whole or in part, without the
Company&#8217;s prior written consent. See additional information on the accounting for the warrants in Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Convertible Promissory Notes were issued for general working capital purposes. The Company elected the FVO of accounting for its Convertible
Promissory Notes. Under the FVO election, the financial instrument is initially measured at its issue-date estimated fair value and subsequently
remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value adjustment is presented
as a single line item within other (income) expenses, net in the accompanying consolidated statements of operations under the caption
change in fair value of convertible debt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022 the fair value of the 2019 Notes and 2022 Notes was $<span id="xdx_906_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20221231__us-gaap--DebtInstrumentAxis__custom--TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember_zBi7Qikvai4j">26.2</span> million which was included in both short-term and long-term
liabilities on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the Convertible Promissory Notes were converted pursuant to their provision in connection with the Business Combination
between Data Knights and the Company and were no longer outstanding as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PIPE
Notes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2023, the Company entered into the PIPE SPA in which the Company was required to sell senior secured convertible notes and warrants
to directors of the Company. The PIPE SPA stipulates a collateral security agreement between the Company and the directors for punctual
payment and performance by the Company on its obligations to the Directors. The intellectual property of the Company serves as the collateral
for the PIPE Notes. The PIPE Notes and related warrants were issued through a PIPE financing transaction, which is a form of debt and
equity offering under an exemption in the securities laws for qualifying private placements by issuers of publicly traded securities.
On November 7, 2023, the Company received a total of $<span id="xdx_900_eus-gaap--ProceedsFromNotesPayable_pn5n6_c20231106__20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_z8k0D0yOkjKc" title="Proceeds from PIPE notes payable">1.5</span> million from the directors in exchange for PIPE Notes in the aggregate principal
amount of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zlkShAiGVR8h" title="Principal amount of notes payable">1.6</span> million (plus accrued interest of $<span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn5n6_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zvbTkj1vYl62" title="Accrued interest">0.1</span> million) and <span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__srt--TitleOfIndividualAxis__srt--DirectorMember_zyED3tIWHpzj" title="Warrants to acquire common stock">95,745</span> warrants to acquire Common Stock. <span id="xdx_90F_eus-gaap--DebtConversionDescription_c20231106__20231107_zLTTrexhiRe2">The PIPE Notes are convertible
into shares of Common Stock at the PIPE Investor&#8217;s election at a conversion price equal to the lower of (i) $10.00 per share, and
(ii) 92.5% of the lowest VWAP for the ten (10) trading days immediately preceding the conversion date, subject to the floor price of
$1.14 (representing 20% of the closing price of the Common Stock on the last trading day before the closing of the Business Combination),
or the alternative conversion ratio of the greater of the floor price and the lesser of 80% of the VWAP of the common stock as of the
trading day and 80% of the price computed as the quotient of the sum of the VWAP of the Common Stock for each of the three trading days
with the lowest VWAP of the Common Stock during the fifteen consecutive trading day period ending and including the trading day immediately
preceding the delivery or deemed delivery of the applicable conversion notice, divided by three</span>. All such determinations are to be appropriately
adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases
or increases the Common Stock. The PIPE Notes mature on the first anniversary of the issuance date, or November 7, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected the FVO of accounting for its PIPE Notes. Under the FVO election, the financial instrument is initially measured at its
issue-date estimated fair value and subsequently remeasured at estimated fair value on a recurring basis at each reporting period date.
The estimated fair value adjustment is presented as a single line item within other (income) expenses, net in the accompanying consolidated
statements of operations under the caption change in fair value of pipe notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 the fair value of the PIPE Notes was $<span id="xdx_905_eus-gaap--ConvertibleNotesPayable_iI_pn5n6_c20231231_zgoCh02dX8d6" title="PIPE notes payable">1.6</span> million which was included in current liabilities on the consolidated
balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132692576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Line of Credit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">Line of Credit</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--ShortTermDebtTextBlock_z4jlZwJEgNVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
<span id="xdx_821_z9XD6EJMgSTb">Line of Credit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2024, the Company obtained a line of credit of $<span id="xdx_904_eus-gaap--LineOfCredit_iI_pn5n6_c20240331__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_z2ljrRYshtkj">1.0
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million with BOC Bank to support short-term working
capital needs. The line of credit bears an interest rate of <span id="xdx_900_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_uPure_c20240301__20240331__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_zkT76zUVUPZ">5.0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and matures in 120 days. In July 2024, the maturity date was extended an additional 120 days to November 2, 2024. The line of credit
was terminated at maturity in November 2024. As of September 30, 2024, there was <span id="xdx_90B_eus-gaap--LineOfCredit_iI_pn6n6_do_c20240930__us-gaap--ShortTermDebtTypeAxis__custom--BOCBankMember_zMfBfm3SyjYl">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">balance outstanding on the line of credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132147120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Canadian Emergency Business Account (&#8220;CEBA&#8221;)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Canadian Emergency Business Account (&#8220;CEBA&#8221;)</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--DebtDisclosureTextBlock_z1hJ0b91gQV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
<span id="xdx_82E_zjLpuYW4gLRd">Canadian Emergency Business Account (&#8220;CEBA&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, the Company applied for and received a $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zW2YBo3xqU05" title="Proceeds from loans">60</span> thousand CAD ($<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zsSziDGlhTH1" title="Proceeds from loans">40</span> thousand USD) equivalent CEBA loan. The loan was provided
by the government of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and
better position them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through
December 31, 2023. If the loan was paid back by January 18, 2024, $<span id="xdx_90F_eus-gaap--DebtInstrumentDecreaseForgiveness_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zCvOcNhwQZp8" title="Forgiven of loan">15</span> thousand of the loan would have been forgiven. If the loan was
not paid back by January 18, 2024, the full $<span id="xdx_900_eus-gaap--DebtConversionOriginalDebtAmount1_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zDdu5sArUMTe" title="Conversion of loan">40</span> thousand loan would have been converted to a loan repayable over <span id="xdx_905_eus-gaap--DebtInstrumentTerm_dc_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJ1ETCo2z78l" title="Loan payment term">three years</span> with a <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJW1VlW8jUH4" title="Interest rate">5</span>%
interest rate. The loan was paid back prior to January 18, 2024, and the Company recognized a gain on extinguishment of $<span id="xdx_905_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zhhHczOlBPTj" title="Gain loss on extinguishment of debt">15</span> thousand,
which is presented in other expense (income), net in the condensed consolidated statement of operations for the nine months
ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zbByYFCJ25A1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_82A_zufdttgdxKAf">Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, the Company applied for and received a $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_z51TPmXNcXJk" title="Proceeds from loans">0.06</span> CAD ($<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zxvovi9W7qR6" title="Proceeds from loans">0.04</span> USD) equivalent CEBA loan. The loan was provided by the Government
of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and better position
them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through December 31,
2023. If the loan was paid back by January 18, 2024, $<span id="xdx_900_eus-gaap--DebtInstrumentDecreaseForgiveness_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zcINTLeES6l7" title="Forgiven of loan">0.01</span> million of the loan would have been forgiven. If the loan was not paid back
by January 18, 2024, the full $<span id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zilxXcAVSdJd" title="Loan repayable">0.04</span> million loan would have been converted to loan repayable over <span id="xdx_902_eus-gaap--DebtInstrumentTerm_dc_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zSLYP65LwAj" title="Loan payment term">three years</span> with a <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zFaaRuPr70p6" title="Interest rate">5</span>% interest rate.
The loan was paid back prior to January 18, 2024. At December 31, 2023 the loan was classified as Canada Emergency Business Loan Act
under other long-term liabilities on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the loan as debt in accordance with FASB ASC 470, <i>Debt</i>, and accrued interest in accordance with the interest
method under FASB ASC 835-30.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132201840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Deficit<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Deficit</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zbu0Xd6kkx3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_824_z8w5WKUjnEca">Stockholders&#8217; Deficit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, Data Knights entered into an agreement with their underwriters (&#8220;EF Hutton&#8221;) whereby
EF Hutton agreed to waive the related merger underwriting fees that were payable at closing ($<span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z6urNFkClzm" title="Business combination, underwriter fees payable">4.0</span> million) in exchange for allocated
payments as follows: (i) $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zvUH5CDkDTia" title="Business combination, closing cash balance">0.5</span> million in cash at closing; (ii) a $<span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2LBqOIJPwt9" title="Promissory note">0.5</span> million promissory note that matured on <span id="xdx_90D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable_dd_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zwqfRnR2ompe" title="Debt maturity date">March 1, 2024</span>; and (iii)
a transfer of <span id="xdx_90E_ecustom--StockIssuedDuringPeriodSharesTransferred_pid_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_ziDLyoHhrEb4" title="Number of shares transferred">277,778</span> shares of Common Stock, which were valued at the closing stock price of $<span id="xdx_900_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20230628__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zX32Y339OjGi" title="Closing stock price">10.89</span> per share on June 28, 2023. If,
five trading days prior to the six-month anniversary, the aggregate VWAP value of the <span id="xdx_901_ecustom--VolumeWeightedAveragePrice_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zTCVDJ7AbY69" title="Volume weighted average price">277,778</span> shares of Common Stock was lower than the
original share value of $<span id="xdx_90A_ecustom--VolumeWeightedAveragePriceValue_pn5n6_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_ziS1IXEzQMT8" title="Volume weighted average price, value">3.0</span> million, <span id="xdx_902_eus-gaap--BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_c20231107__20231107_zFiw5oWDxzq8" title="Description of contingent consideration">the Company was obligated to compensate EF Hutton at a new share price equal to the difference
in amount on such date. Due to the decrease in share value on the six-month anniversary, the Company was required to either pay to EF
Hutton an additional $2.8 million or issue to EF Hutton an additional 3,175,000 shares of Common Stock.</span> In January 2024, the Company
issued the original <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240131_z5qYSXwZjKpb" title="Number of shares issued">277,778</span> shares of Common Stock as consideration for $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20240101__20240131_z2KmEz1Wayy6" title="Number of shares issued, value">0.2</span> million owed by the Company. As of September 30, 2024, <span id="xdx_909_eus-gaap--BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_c20240101__20240930_zpEl2i5CdVH1" title="Description of contingent consideration">the
Company was obligated to pay to EF Hutton the true-up of either $2.8 million or 3,175,000 shares of Common Stock valued at $0.88 per
share, plus the $0.5 million promissory note. Upon the occurrence of an event of default, the promissory note bears interest at a rate
of 12.5% until such event of default is cured.</span> The promissory note remained unpaid upon maturity on <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930_zeyArWQOPkud" title="Debt instrument maturity date">March 1, 2024</span>, and the Company recorded
interest expense of $<span id="xdx_900_eus-gaap--InterestExpense_pn3n3_c20240701__20240930_zcn8rAIeESu9" title="Interest expense">14</span> thousand and $<span id="xdx_905_eus-gaap--InterestExpense_pn3n3_c20240101__20240930_zOKu6Tg4Igm5" title="Interest expense">55</span> thousand during the three and nine months ended September 30, 2024, respectively, because of
the event of default. In August 2024, the Company made a promissory note payment of $<span id="xdx_907_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn5n6_c20240801__20240831_z4eFN6762kA2" title="Promissory note payment">0.1</span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2024, the Company entered into a stock repurchase agreement with a former holder of Convertible Promissory Notes pursuant to
which the Company repurchased <span id="xdx_90C_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_z5nR21WZrNw7" title="Number of shares repurchased">187,745</span> shares of Common Stock in exchange for cash of $<span id="xdx_90F_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_z4lZwsyqSJsi" title="Number of shares repurchased, value exchange for cash">0.5</span> million that is payable in installments. The
Company made payments of $<span id="xdx_906_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20240701__20240731__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zxuisEtQbsH9" title="Number of shares repurchased, value exchange for cash"><span id="xdx_906_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20241001__20241031__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zWOI9TrnsEx" title="Number of shares repurchased, value exchange for cash">0.1</span></span> million in July and October 2024 and the remaining $<span id="xdx_904_ecustom--StockRepurchasedDuringPeriodValueExchangeForCash_pn5n6_c20250101__20250101__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zNwEvUsCi5U6" title="Number of shares repurchased, value exchange for cash">0.3</span> million is expected to be repaid in early 2025.
The $<span id="xdx_905_ecustom--PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote_pn5n6_c20240201__20240229__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember__us-gaap--TypeOfArrangementAxis__custom--StockRepurchaseAgreementMember_zcjM0GEMUd2k" title="Principal and accrued interest outstanding">0.5</span> million represents the principal and accrued interest outstanding on the holder&#8217;s Convertible Promissory Note immediately
prior to the Business Combination. The $<span id="xdx_90F_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_iI_pn5n6_c20240930__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleNotesPayableMember_zT2xs2JQhRe6" title="Accounts payable and accrued expenses">0.4</span> million outstanding at September 30, 2024 is classified in accounts payable and accrued expenses
on the condensed consolidated balance sheet. The <span id="xdx_906_eus-gaap--StockRepurchasedDuringPeriodShares_pid_di_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zgGJ0fXdvaJ" title="Number of shares repurchased">187,745</span> repurchased shares were reclassified to treasury stock as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Standby
Equity Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company and Yorkville entered into the SEPA. Under the SEPA, the Company has the right to sell to Yorkville up to
$<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20240617__20240617__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zy3RW0tarPAk">25.0</span> million of its Common Stock, subject to certain limitations and conditions set forth in the SEPA, from time to time, over a 24-month
period. Sales of the Common Stock to Yorkville under the SEPA, and the timing of any such sales, are at the Company&#8217;s option, and
the Company is under no obligation to sell any shares of Common Stock to Yorkville under the SEPA except in connection with notices that
may be submitted by Yorkville, in certain circumstances as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the satisfaction of the conditions precedent in the SEPA, which include having a resale shelf for shares of Common Stock issued to Yorkville
declared effective, the Company has the right to direct Yorkville to purchase a specified number of shares of Common Stock by delivering
written notice (each an &#8220;Advance&#8221;). <span id="xdx_902_ecustom--StockholdersDeficitDescription_c20240617__20240617_zvU7MkX7Ut32" title="Stockholders deficit description">An Advance may not exceed the greater of (i) 100% of the average of the daily trading
volume of the Common Stock on Nasdaq, during the five consecutive trading days immediately preceding the date of the Advance, and (ii)
five hundred thousand (500,000) shares of Common Stock.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville
will generally purchase shares pursuant to an Advance at a price per share equal to 97% of the VWAP, on Nasdaq during the three consecutive
trading days commencing on the date of the delivery of the Advance (unless the Company specifies a minimum acceptable price or there
is no VWAP on the subject trading day).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEPA will automatically terminate on the earliest to occur of (i) the first day of the month next following the 24-month anniversary
of the date of the SEPA or (ii) the date on which Yorkville shall have made payment for shares of Common Stock equal to $<span id="xdx_900_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pn5n6_c20240617__20240617__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zIH8y2gxPS1d" title="Sale of stock, value">25.0</span> million.
The Company has the right to terminate the SEPA at no cost or penalty upon five trading days&#8217; prior written notice to Yorkville,
provided that there are no outstanding advances for which shares of Common Stock need to be issued and the Yorkville Note has been paid
in full. The Company and Yorkville may also agree to terminate the SEPA by mutual written consent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for Yorkville&#8217;s commitment to purchase the shares of Common Stock pursuant to the SEPA, the Company paid Yorkville
a $<span id="xdx_907_ecustom--CashStructuringFee_pn3n3_c20240617__20240617__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_znZy7cQ2SMKk" title="Cash structuring fee">25</span> thousand cash structuring fee. In addition, the Company must pay a commitment fee in shares equal to $<span id="xdx_900_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_pn5n6_c20240617__20240617_z4UVITkTX5O6" title="Commitment fees">0.5</span> million. In September
2024, the Company paid an equivalent of the commitment fee by issuing to Yorkville <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240901__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zf1dBTjppzlc" title="Number of shares, issued">526,312</span> shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the entry into the SEPA, on June 17, 2024, the Company entered into a registration rights agreement with Yorkville, pursuant
to which the Company agreed to file with the SEC no later than August 30, 2024, a registration statement for the resale by Yorkville
of the shares of Common Stock issued under the SEPA (including the commitment fee shares). The Company agreed to use commercially reasonable
efforts to have such registration statement declared effective within 30 days of such filing and to maintain the effectiveness of such
registration statement during the 24-month commitment period. The Company will not have the ability to request any Advances under the
SEPA (nor may Yorkville convert the Yorkville Note into Common Stock) until such resale registration statement is declared effective
by the SEC. The Company has not yet filed a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock
issued under the SEPA, which is deemed an event of default under the SEPA and as a result, a payment of $<span id="xdx_902_eus-gaap--PaymentsOfStockIssuanceCosts_pn5n6_c20241015__20241015__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zojNJMkB7h58" title="Payments of common stock issuance">0.6</span> million became due on October
15, 2024. The $<span id="xdx_909_eus-gaap--ConversionOfStockAmountConverted1_pn5n6_c20240617__20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zQ9Hi1T67mEi" title="Conversion of stock amount">0.6</span> million due includes the outstanding principal of $<span id="xdx_90C_eus-gaap--ConversionOfStockAmountIssued1_pn5n6_c20240617__20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_z3M4E1zg82Q8" title="Conversion of stock amount issued">0.5</span> million, accrued and unpaid interest, and a payment premium
of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240617__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YorkvilleNoteMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zsyvkv30hVMc" title="Interest rate percentage">10%</span>. As described in Note 4, the Company subsequently engaged in discussions with Yorkville regarding the events of default, which
discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEPA was accounted for as a liability under ASC 815 as it includes an embedded put option and an embedded forward option. The put option
is recognized at inception and the forward option is recognized upon issuance of notice for the sale of the Company&#8217;s Common Stock.
The fair value of the derivative liability related to the embedded put option was estimated at $<span id="xdx_902_eus-gaap--EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet_iI_pn5n6_c20240930_zHDJEwQljAKf" title="Fair value of embedded derivative">0.2</span> million at the inception of the agreement.
As of September 30, 2024, the embedded put option was determined to have no value because of alternative financing options now available
to the Company making future draws on the SEPA improbable. Further, as described in Note 4, the Company is currently in default on the
SEPA due to its failure to file a registration statement with the SEC for the resale by Yorkville of the shares of Common Stock issuable
under the SEPA by August 30, 2024. As such, no shares can currently be issued under the SEPA. The embedded forward option was also deemed
to have <span id="xdx_908_eus-gaap--ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_pn6n6_do_c20240101__20240930__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zIzYL1tscM74" title="Emdedded derivative liabilities">no</span> value as there were no notices for the sale of the Company&#8217;s Common Stock as of September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>July
2024 Financings</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 23, 2024, the Company entered into a securities purchase agreement with a certain institutional investor, pursuant to which the
<span style="background-color: white">Company agreed to issue and sell <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240723__20240723__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_ziycdSX0h8t6">1,297,059
</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of its
Common Stock at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240723__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zYyR5fsvYxAb">1.0278
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">per share and pre-funded
warrants exercisable for <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240725__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zrx2aZ0PW1Eg">1,323,530
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of its Common
Stock at an exercise price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240723__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zVNzJxMls8yl">1.0278
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">per share (the &#8220;July
2024 Pre-Funded Warrants&#8221;). The investor was required to prepay the exercise price for the pre-funded warrants, other than $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20240723__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zcHEiulFOAuf">0.0001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">per share. The warrants
and pre-funded warrants will be exercisable at any time after the date of issuance and will not expire. </span>Holders of pre-funded
warrants are entitled to receive dividends, if declared, on an as-if-converted-to-common-stock basis, and in the same form as dividends
actually paid on shares of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 25, 2024, the Company entered into a securities purchase agreement with a certain institutional investor, pursuant to which the
<span style="background-color: white">Company agreed to issue and sell <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240725__20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_ztn0egyHIIee" title="Shares issued">2,301,791</span> shares of its Common Stock at a price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zM3p4ROkUGz8" title="Share price">0.85</span> per share.
</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received net proceeds of approximately $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240725__20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zvUjTQ7mgbki" title="Proceeds from issuance of private placement">4.5</span> million from the July 2024 private placements, after deducting offering expenses
of $<span id="xdx_90C_eus-gaap--DeferredOfferingCosts_iI_pn5n6_c20240725__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--AwardTypeAxis__custom--JulyTwoThousandTwentyFourFinancingMember_zbThqG9oN5jl" title="Offering expenses">0.1</span> million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>September
2024 Financing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 24, 2024, <span style="background-color: white">the Company entered into a securities purchase agreement with a certain
institutional investor, pursuant to which the Company agreed to issue and sell to the investor <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240924__20240924__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember_zqaXbNHvWJYf" title="Number of shares issue and sold">1,918,591</span>
shares of its Common Stock at a price of $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240924__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z1h5FIrPdXg7" title="Common stock price per share">0.65</span>
per share, warrants exercisable for <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240924__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z4GbEX3nT4g5" title="Number of warrants exercisable">133,095</span>
shares of its Common Stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zFqKpOrDFCu" title="Exercise price per share">0.325</span>
per share (the &#8220;September 2024 Warrants&#8221;) and pre-funded warrants exercisable for <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zId4hUKgOcrj" title="Warrants exercisable for common stock">743,314</span>
shares of its Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zNXG4Yp6C95i" title="Warrant exercise price">0.65</span>
per share (the &#8220;September 2024 Pre-Funded Warrants&#8221;). The investor was required to prepay the exercise price for the
pre-funded warrants, other than $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zEF4yi1GhB6a" title="Share issued price">0.0001</span>
per share. The warrants and pre-funded warrants will be exercisable at any time after the date of issuance and will not
expire.</span> Holders of pre-funded warrants are entitled to receive dividends, if declared, on an as-if-converted-to-common-stock
basis, and in the same form as dividends actually paid on shares of the Common Stock. The Company received net proceeds of
approximately $<span id="xdx_900_eus-gaap--DeferredOfferingCosts_iI_pn5n6_c20240924__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zHbqIeVuXAze" title="Offering expenses">1.7</span>
million, after deducting an immaterial amount of offering expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024, the Company had not yet issued the <span id="xdx_90F_eus-gaap--CommonStockSharesSubscriptions_iI_c20240930__us-gaap--AwardTypeAxis__custom--SeptemberTwoThousandTwentyFourFinancingMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhFakj1H2JH7" title="Common stock shares not yet issued">1,918,591</span>
shares of Common Stock in order to keep the investor&#8217;s ownership percentage below a defined threshold. The net proceeds of
$1.7 million was recorded akin to an equity forward sale contract and was included in additional paid-in-capital in
stockholders&#8217; deficit in the condensed consolidated balance sheets as it met the criteria for equity accounting under ASC
815.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred
Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2024 and December 31, 2023, <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20240930_zB4kRjVHpEWl" title="Preferred stock, shares issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240930_zA8vYPBvdAR8" title="Preferred stock, shares outstanding"><span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20231231_zx1qR4kbKCEk" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zkO4bCSJRIc8" title="Preferred stock, shares outstanding">no</span></span></span></span> shares of Preferred Stock were issued or outstanding. All shares of Legacy ONMD Series
A-2 Preferred Stock and Series A-1 Preferred Stock were converted into Common Stock in connection with the Business Combination. See
the Form 10-K/A for all other details relating to the Series A-2 Preferred Stock and Series A-1 Preferred Stock issued prior to December
31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80F_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zi7ZxxHRJrQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
<span id="xdx_82A_zVYHd5BfLrad">Stockholders&#8217; Deficit</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2022, <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziD1ppxE4qj9" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKN7exbp24Mg" title="Common stock, shares outstanding">4,033,170</span></span> and <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_znKxiQssX0m8" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGvP0XY6gBJ8" title="Preferred stock, shares outstanding">6,255,880</span></span> shares of Common Stock and Preferred Stock were issued and outstanding, respectively (after
giving effect to the exchange ratio in Note 3). Subsequent to the Business Combination, the Company was authorized to issue up to <span id="xdx_905_eus-gaap--CapitalUnitsAuthorized_iI_pid_c20231107_zU4mp57hBj43" title="Capital stock authorized">101,000,000</span>
shares of capital stock, par value $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231107_zKKAc21qZoca" title="Capital stock par value">0.0001</span> per share, consisting of (a) <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231107_z4HVtrbs4vie" title="Common stock, shares authorized">100,000,000</span> shares of Common Stock and (b) <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231107_zMDtvyv8Amy2" title="Preferred stock, shares authorized">1,000,000 </span>shares of
preferred stock (the &#8220;Preferred Stock&#8221;). As of December 31, 2023, <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zixxKZSE5Ar1" title="Common stock, shares issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_znhu3H33Aaqe" title="Common stock, shares outstanding">23,572,232</span></span> shares of Common Stock were issued and outstanding.
The Company had <span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zK95ULydJLX2" title="Preferred stock, shares outstanding">no</span> Preferred Stock outstanding at December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
A-2 Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s previously issued and outstanding Series A-2 preferred stock included a $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBKJPxLe8OA6" title="Share price">0.15</span> per share annual noncumulative dividend
when and if declared by the Board of Directors. <span id="xdx_906_eus-gaap--DividendsPreferredStock_do_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zdsKi8CzXLs5" title="Dividends"><span id="xdx_90A_eus-gaap--DividendsPreferredStock_do_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zflOYliUMIxk" title="Dividends">No</span></span> dividends were declared in the years ended December 31, 2023 or December 31, 2022.
The Series A-2 preferred stock also included a liquidation preference of 1.25 times the original issue price plus any declared but unpaid
dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and had a preference upon
liquidation over Series A-1 preferred stock and Common Stock. Each share of Series A-2 preferred stock could have been converted into
equal shares of Common Stock at the option of the holder at any time. In addition, the Series A-2 preferred stock shares were automatically
convertible into common shares upon the sale of shares of common stock to the public at the then applicable conversion price in a firm
commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, resulting in at least
$<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn5n6_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zlRRO4uYC9e1" title="Proceeds">20</span> million in proceeds, net of underwriting discounts and commissions. Each share of Series A-2 preferred stock had voting rights equal
to the number of shares of Common Stock then issuable upon conversion of such share of Series A-2 preferred stock. The Company was obligated
to redeem shares of Series A-2 Preferred Stock upon liquidation, dissolution, or winding-up of the Company, or a merger, consolidation,
lease or transfer of the Company (a &#8220;Deemed Liquidation Event&#8221;), unless a majority of the holders of Series A-2 Preferred
Stock and a majority of the holders of Series A-1 Preferred Stock consent otherwise. As of December 31, 2022, the liquidation preference
of the Series A-2 Preferred Stock was $<span id="xdx_909_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn5n6_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMyVwPLyQKs4" title="Liquidation preference amount">10.7</span> million (after giving effect to the Business Combination exchange ratio described Note 3).
In connection with the Business Combination, the shares of <span id="xdx_902_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8MXT69UcHY1" title="Convertible preferred stock terms of conversion">Series A-2 preferred stock were converted into Common Stock using an exchange
ratio of 1:1.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
A-1 Preferred Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s previously issued and outstanding Series A-1 preferred stock included a $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9DcjHvxUBuj" title="Share price">0.15</span> per share annual noncumulative dividend
when and if declared by the Board of Directors. <span id="xdx_90B_eus-gaap--DividendsPreferredStock_do_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zTGP1H9Th8S3" title="Dividends"><span id="xdx_90F_eus-gaap--DividendsPreferredStock_do_c20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zCjKSq33MIH3" title="Dividends">No</span></span> dividends were declared in the years ended December 31, 2023 or December 31 2022.
The Series A-1 preferred stock also included a liquidation preference of 1.25 times the original issue price plus any declared but unpaid
dividends upon the liquidation, dissolution, merger or sale of substantially all the assets of the Company and had a preference upon
liquidation over Common Stock. Each share of Series A-1 preferred stock could have been converted into equal shares of Common Stock at
the option of the holder at any time. In addition, the Series A-1 preferred stock shares were automatically convertible into common shares
upon the sale of shares of common stock to the public at the then applicable conversion price in a firm commitment underwritten public
offering pursuant to an effective registration statement under the Securities Act, resulting in at least $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_pn5n6_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrhmugFeTule" title="Proceeds">20</span> million in proceeds, net
of underwriting discounts and commissions. Each share of Series A-1 preferred stock had voting rights equal to the number of shares of
Common Stock then issuable upon conversion of such share of Series A-1 preferred stock. The Company was obligated to redeem shares of
Series A-1 Preferred Stock upon a Deemed Liquidation Event, unless a majority of the holders of Series A-1 Preferred Stock consent otherwise.
As of December 31, 2022, the Series A-1 preferred stock has a liquidation preference of $<span id="xdx_90B_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_pn5n6_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zaPzycsYQTBi" title="Liquidation preference amount">8.9</span> million (after giving effect to the Business
Combination exchange ratio described in Note 3). In connection with the Business Combination, the shares of <span id="xdx_908_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20230101__20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zuwR6ZzPZde3" title="Convertible preferred stock terms of conversion">Series A-1 preferred stock
were converted into Common Stock using an exchange ratio of 1:1.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590025200544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss per Share</a></td>
<td class="text"><p id="xdx_802_eus-gaap--EarningsPerShareTextBlock_zo4sKw1lCajl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
<span id="xdx_82D_znfi6OmWrAm4">Net Loss per Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the weighted-average number of shares of Common Stock outstanding used to calculate
both basic and diluted net loss per share is the same. In computing diluted net loss per share for the nine months ended September 30,
2024 and 2023, the Company excluded the following potentially dilutive securities, as the effect would be anti-dilutive and reduce the
net loss per share calculated for each period:</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zqtHkWkniuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zY8WtyweXEh" style="display: none">Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20240930_z6rh7ChKA2Wg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20230930_zKvl5Q7cKBM9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zaJ6qRuqQiMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Options to purchase Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">147,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">913,856</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockUnitsAndAwardsMember_z5KFPMnET3Gk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unvested restricted stock units and awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,371,950</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,275</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9UCKP9FSwd5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,314,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,112,165</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zbjJYN3YAy93" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,839,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zvZe6nAtBTo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,415,923</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_ztASWlHwy9G3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,118,735</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,643,325</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_zjyHAg7uOSp" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,951,799</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,102,501</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_zIvCM8d23g3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132174752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_808_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zmmJnBI3xJC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span id="xdx_822_zD5XNNHaN0Qf">Stock-Based Compensation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zmQ9ejPefDJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded stock-based compensation expense in the following categories on the accompanying condensed consolidated statements of
operations for the periods presented (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_zi0VxjIuHy3i" style="display: none">Schedule
of Stock-based Compensation Expense</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240701__20240930_zKe5IeXI8tO2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20230930_zPik3Muw8Nki" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_z5CcHjp4W8cg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1137">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlNN63lq1rKd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">782</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z0UM3n2cDlXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zD4NQnRNXEl1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_zrPprdz5h9x1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">207</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20240101__20240930_zCXyAW0gQ6m9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20230930_zUxBQ3iUyj55" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nine Months Ended September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zTvqXJwV9Q39" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zbpaTM3KueYe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,014</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zuV9qFZzQJR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zA0HIOZurbKf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_zaOnxrxwLm6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,446</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zERfolW97EGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
incentive plan &#8211; summary</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2023, the Company adopted the OneMedNet Corporation 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;) and reserved an amount of
shares of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20230101__20231231__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zbcMaXdNixLa" title="Share-based payment award, description">Common Stock equal to 10% of the number of shares of Common Stock of the Company following the Business Combination for issuance
thereunder.</span> The 2022 Plan became effective immediately upon the closing of the Business Combination and replaced the Legacy ONMD equity
incentive plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
incentive plan &#8211; stock options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zUK9zKMM1Pfb" title="Allocated share based compensation expense">0</span> and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zIwcSslyOIAe" title="Allocated share based compensation expense">0.1</span> million, respectively,
on its outstanding stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zlO3F3xU2w4h" title="Allocated share based compensation expense">34</span> thousand and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zsjV1UxaDgl7" title="Allocated share based compensation expense">0.3</span> million,
respectively, on its outstanding stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity
incentive plan &#8211; restricted stock units (&#8220;RSU&#8221;)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240701__20240930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zhQRdT52C3og" title="Stock-based compensation expense">0.2</span> million and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230701__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zS2prSD6oS3f" title="Stock-based compensation expense">0.7</span> million,
respectively, on its outstanding restricted stock units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2024 and 2023, the Company recorded stock-based compensation expense of $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20240101__20240930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_z6OLIQ8Pc1ja" title="Stock-based compensation expense">1.1</span> million and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20230930__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember_zEffsyIvwjea" title="Stock-based compensation expense">0.4</span> million,
respectively, on its outstanding restricted stock units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zn1CW1MJFz76" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
<span>Stock Based Compensation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_822_zs7tydbu9lU2" style="display: none">Stock-Based Compensation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2020, the Company adopted an equity incentive plan (the &#8220;2020 Plan&#8221;), which provided for the granting of incentive and nonqualified
stock options to employees, directors, and consultants of Legacy ONMD. As of December 31, 2020, the Company had reserved <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember_zDOj9LDparpd" title="Number of shares issued">3,000,000</span> shares
of common stock under the 2020 Plan. Under the 2020 Plan, option awards were generally granted with an exercise price equal to the fair
market value of the Company&#8217;s stock at the date of grant; those option awards generally vested with a range of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember__srt--RangeAxis__srt--MinimumMember_zlZpHg7eG1f4" title="Vesting period::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl4502">one</span></span> to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20200101__20201231__srt--TitleOfIndividualAxis__custom--EmployeesDirectorsAndConsultantsMember__us-gaap--PlanNameAxis__custom--NewEquityIncentivePlanMember__srt--RangeAxis__srt--MaximumMember_zy90sXbISqYk" title="Vesting period">four years</span>
of continuous service and had ten-year contractual terms. Certain option awards provided for accelerated vesting if there was a change
in control, as defined in the 2020 Plan. The 2020 Plan also permitted the granting of restricted stock and other stock-based awards.
Unexercised options were cancelled upon termination of employment and became available for reissuance under the 2020 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">At
the Special Meeting </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">held on October 17, 2023<span style="background-color: white">,
Data Knights shareholders considered and approved the OneMedNet Corporation 2022 Equity Incentive Plan (the &#8220;2022 Plan&#8221;)
and reserved an amount of shares of Common Stock equal to 10% of the number of shares of Common Stock of OneMedNet following the Business
Combination for issuance thereunder. The 2022 Plan was approved by the Legacy ONMD Board of Directors on October 17, 2023. The 2022 Plan
became effective immediately upon the Closing of the Business Combination and replaced the 2020 Plan.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z2t4WLtze2Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to options outstanding is summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zI0hPK0P8F83" style="display: none">Schedule of Options Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 1pt">Outstanding as of December 31, 2021</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_z0U5wRYmtbh1" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Options outstanding, beginning balance">728,603</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zypioOXRPhOh" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Weighted average exercise price, beginning balance">1.00</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20221231_z2shuwnGqzv7" style="padding-bottom: 1pt; width: 12%; text-align: right" title="Aggregate Intrinsic value, begining balance"><span style="-sec-ix-hidden: xdx2ixbrl4512">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zkHMNrDUKqhe" style="text-align: right" title="Options, Granted - under the Plan">511,440</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zk4YloymnWac" style="text-align: right" title="Weighted average exercise price, granted">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zSOuwTZiIgnh" style="text-align: right" title="Options, Exercised - under the Plan">(6,648</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_zMm45h2raGe8" style="text-align: right" title="Weighted average exercise price, exercised">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231_z4SWf21Q8baj" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled">(319,539</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zCs3JyTynD6g" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled">1.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Outstanding as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zG6cgN86wjbc" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, beginning balance">913,856</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_ziK5f5y9plyi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, beginning balance">1.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20220101__20221231_zacYP68Ics54" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, ending balance">3,199</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zPkyqh888cac" style="text-align: right" title="Options, Exercised - under the Plan">(613,510</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zQAZULygsM78" style="text-align: right" title="Weighted average exercise price, exercised">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231_z2d2eoaUXYkb" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled">(300,346</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zqse2nLXHYZ5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled">1.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding as of December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zU6jFtbBUQul" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl4540">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zWf8X159Qfye" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl4542">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zdxFOEhSQHri" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic value, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl4544">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Vested and exercisable as of December 31, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20230101__20231231_zN0GsflAab1" style="border-bottom: Black 1pt solid; text-align: right" title="Options vested and exercisable"><span style="-sec-ix-hidden: xdx2ixbrl4546">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zGLHNwZ28Ntc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, vested and exercisable"><span style="-sec-ix-hidden: xdx2ixbrl4548">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20230101__20231231_zbWHYtXkhaD8" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, exercisable"><span style="-sec-ix-hidden: xdx2ixbrl4550">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_zYbHAJ80DLd6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2023 and 2022, the Company recorded stock-based compensation expense of $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zmHPvBDFJHJ8" title="Stock-based compensation expense">0.4</span> million and $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pn5n6_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8y6TFp8Ri1i" title="Stock-based compensation expense">0.3</span> million, respectively,
on its outstanding stock options. The Company has determined its share-based payments to be a Level 3 fair value measurement. For the
year ended December 31, 2023 and 2022, the Company has used the Black-Scholes option pricing model and estimated no expected dividends
and the following weighted average assumptions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z7nEjYXPSKbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zvdqLwiSHLH8" style="display: none">Schedule
of Fair Value of  Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zb4EqjAVvHcj" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4558">-</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zv7TKOPtaZah" title="Risk-free interest rate">0.73</span>% - <span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zI0UX2ZfVXvg" title="Risk-free interest rate">2.96</span></span></td><td style="width: 1%; text-align: left">% </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlxm0i4Fc2ii" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4564">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zhjGUBcEXN8j" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4566">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--EquitySecuritiesFvNiMeasurementTerm_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zwbvwcufSdP4" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4568">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zn4w2yHn1Mt7" title="Expected life in years">1.36</span> - <span id="xdx_904_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zh6oP8V6f0u8" title="Expected life in years">1.85</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z2C4T4M15t91" title="Equity securities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl4574">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zMW0leDnbjz9" title="Equity securities, measurement input">50.0</span>% - <span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zlG8ca1XMgD" title="Equity securities, measurement input">86.3</span></span></td><td style="text-align: left">% </td></tr>
  </table>

<p id="xdx_8A9_zZbNHcszloYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, as part of the Business Combination, the 2020 Plan was cancelled and all vested shares were exercised and converted
at the appropriate conversion ratio to Common Stock of the Company. The Company issued shares of Common Stock of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231106__20231107_zg54JLj28jij" title="Options vested">543,057</span> which represents
<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_pid_c20231107_zuvA5M6IYxvc" title="Options vested">613,510</span> vested options less an exercise price of $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_pid_c20231107_z5yVFnwzTKTf" title="Options vested exercise price">1.00</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted
Stock Awards</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
employees, directors and consultants have been awarded restricted stock. The restricted stock vesting consists of milestone and time-based
vesting as well as compensation for services performed by the Board of Directors. The following table summarizes restricted stock award
activity for the years ended December 31, 2023 and 2022:</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zaIIOAu2S4uh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zXSVQhE5UcOj" style="display: none">Schedule of Restricted Stock Award Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Grant</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Nonvested as of December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zvfPYjAAeNEl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl4588">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAoAz1WPFED5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl4590">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfX5vHFqtBEi" style="width: 14%; text-align: right" title="Number of Awards, Granted">354,551</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCyDlDn6Jvda" style="width: 14%; text-align: right" title="Weighted Average Grant Date Fair Value,Granted">4.80</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pn3n3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQPozxL4uH2b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Vested">(177,276</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKPiHSYAxXyj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested">4.80</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Nonvested as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr8UrStWR5N4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of RSU's, Outstanding, Beginning">177,275</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKSsMEgmMLqf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning">1.48</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxumWCm4Z35" style="text-align: right" title="Number of Awards, Granted">88,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQdIs7KuM5v5" style="text-align: right" title="Weighted Average Grant Date Fair Value,Granted">7.21</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkdkl5JVM3i2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards,Vested">(265,914</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoUC71Ddonyb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested">5.60</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Nonvested as of December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmZOtsbnNOZb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Awards Outstanding, Ending"><span style="-sec-ix-hidden: xdx2ixbrl4612">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zEDtpDjm3f49" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Ending"><span style="-sec-ix-hidden: xdx2ixbrl4614">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_zmWF9J4G2aae" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total fair value of the Company&#8217;s previous stock awards vested during the years ended December 31, 2023 and 2022 was $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20230101__20231231_zIWmzStO4wa5" title="Fair value of stock awards vested">1.1</span> million
and $<span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn5n6_c20220101__20221231_zgQFIjeMNuP4" title="Fair value of stock awards vested">1.5</span> million, respectively. On November 7, 2023, as part of the Business Combination, all vested shares were exercised and converted
at the appropriate conversion ratio to Common Stock of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z9r9Rg9z2JJ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations
for the periods presented (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span id="xdx_8BA_zJ8hjkB5chs7" style="display: none">Schedule
of Stock-based Compensation Expense</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230101__20231231_zIv3aKKO2Fp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20221231_ztsCIA6dA2wd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zXzlU3y29go5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">434</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">638</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zMeHDmxXicLh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,041</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,227</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zjOIa7QUTmS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,475</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_z6wRGiAx7q99" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132199472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DisclosureStockWarrantsAbstract', window );"><strong>Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantsDisclosureTextBlock', window );">Stock Warrants</a></td>
<td class="text"><p id="xdx_80F_ecustom--StockWarrantsDisclosureTextBlock_ztOIwOA4uPL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
<span id="xdx_823_zFq1DEMSVs97">Stock Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCMbuaAL3aN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following warrants outstanding for the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BF_zucWbKPNhz7h" style="display: none">Schedule
of Warrants Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240930_zWJZDgwOrKM5" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230930_zeJvgEiBBr9g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Liability Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zl9OioKXlJk2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">585,275</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">585,275</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zfjJaZLYqMRb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">95,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">95,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_z4O1VnLEy1kk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">681,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">681,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Equity Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zNapLquh5uid" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zldFgxmFL3gl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Private Placement Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,199,939</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zpBzg3MT2qkk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,699,939</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_zZvdffyDsfn9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt">Grand Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,380,958</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,181,019</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_z81XCOvU8O52" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt">Warrants outstanding </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,380,958</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,181,019</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zKtXBqQzJVdj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 7, the Company issued the July 2024 Pre-Funded Warrants, the September 2024 Pre-Funded Warrants and the September 2024
Warrants in connection with the July and September 2024 private placements (together, the &#8220;Private Placement Warrants&#8221;).
The Private Placement Warrants are classified as equity in accordance with ASC Subtopic 815-40, <i>Derivatives and Hedging - Contracts
in Entity&#8217;s Own Equity </i>(&#8220;ASC 815-40&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
Promissory Notes Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 4, the Company issued Convertible Promissory Notes Warrants in 2022 and 2023. The Convertible Promissory Notes
Warrants are classified as equity in accordance with ASC 815-40. The Company determined that the fair value of the combined
instrument (inclusive of the Convertible Promissory Notes) significantly exceeded the proceeds received; therefore, the Company
concluded that the Convertible Promissory Notes Warrants are most accurately portrayed as an issuance cost related to the
Convertible Promissory Notes. This resulted in an expense of $<span id="xdx_907_ecustom--StockWarrantExpense_pn5n6_c20230701__20230930__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zolgecQDBM7h">4.3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million
and $<span id="xdx_904_ecustom--StockWarrantExpense_pn5n6_c20230101__20230930__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zmYnBdlopzO8">8.4 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million
being allocated to the Convertible Promissory Notes Warrants during the three and nine months ended September 30, 2023,
respectively, which is classified as stock warrant expense in the condensed consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, all Convertible Promissory Notes Warrants were cashless
exercised into shares of Legacy ONMD common stock and exchanged based on the appropriate conversion ratio for the Common Stock less an
exercise price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionRatio1_c20231106__20231107__us-gaap--StatementEquityComponentsAxis__custom--ConvertiblePromissoryNotesWarrantsMember_z6oys9OoGAe2" title="Conversion ratio">1.00</span>. See the Form 10-K/A for all other details relating to the Convertible Promissory Notes Warrants issued prior
to December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
conjunction with the issuance of the PIPE Notes described in Note 4, Data Knights also issued and sold to each of the Purchasers <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240630__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zN9Dj3BSne9g" title="Warrants to purchase common stock">95,745</span>
warrants to purchase Common Stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zU4rqCJm5dYg" title="Exercise price of warrants">10.00</span> per share (the &#8220;PIPE Warrants&#8221;). The PIPE Warrants are classified
as liabilities because they did not meet the criteria for equity treatment under ASC 815-40. During the three and nine months ended September
30, 2024, the Company recognized a change in fair value of PIPE Warrants of $<span id="xdx_90B_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_z8wxBZL1Kkbj" title="Fair value adjustment of warrants">0</span> and a gain of $<span id="xdx_909_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zLG20waQ0Uq" title="Change in fair value of warrants">12</span> thousand, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zIngphbYmskb" title="Warrants to purchase common stock">585,275</span> private warrants to purchase
Common Stock at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zWNONsMV3EY8" title="Exercise price of warrants">11.50</span> per share (the &#8220;Business Combination Warrants&#8221;). The Business Combination Warrants
are classified as liabilities because they did not meet the criteria for equity treatment under ASC 815-40. During the three and nine
months ended September 30, 2024, the Company recognized a change in fair value of Business Combination Warrants of $<span id="xdx_908_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zBOohwu0h8V8" title="Change in fair value of warrants">6</span> thousand and $<span id="xdx_900_ecustom--ChangeInFairValueOfWarrants_pn3n3_c20240101__20240930__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zakQydafQdN7" title="Change in fair value of warrants">17</span>
thousand, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_ecustom--StockWarrantsDisclosureTextBlock_zt5W4FWxH85b" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.<span id="xdx_821_zzYLEnC1X84k">
Stock Warrants</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zu5JqleAdXq" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following warrants outstanding for the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zG2q7k4Ebt4i" style="display: none">Schedule
of Warrants Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zIUs3EeLK35f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_zLCOAaHt6oZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Liability Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zIopUMHIq1k3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Private Placement Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">585,275</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4636">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PIPEWarrantsMember_ztSA693FySo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">95,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4639">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_zjz9wl3Tamn8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">681,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4642">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Equity Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--LegacyONMDWarrantsMember_zLhixHsn0I2a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Legacy ONMD Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4644">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">545,213</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConvertiblePromissoryNoteWarrantsMember_zvPE6d1ivh4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Convertible Promissory Note Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4647">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,822,394</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_z5D6JH42Oaxg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Public Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4651">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zAfgYG3UDX34" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,367,607</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_z5RAfkTgNBjd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1pt">Grant Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,181,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,367,607</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A4_z3X1Y2OPQ7w3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legacy
ONMD Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2021, there were <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20211231_z2BDWtycSAq9" title="Warrants issued for service">174,102</span> Legacy ONMD outstanding common stock warrants (&#8220;Legacy ONMD Warrants&#8221;) issued to directors for service
at a weighted average exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211231_zhq3DYfnctOe" title="Weighted average exercise price">0.10</span>. In 2022 for the exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231_zCy9vH7cPvHi" title="Weighted average exercise price">1.00</span>, Legacy ONMD issued <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--TwentyTwentyOneServiceMember_zK4ziu1weG7b" title="Warrants issued for service">145,746</span> warrants to directors
for 2021 service and <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20221231__us-gaap--AwardTypeAxis__custom--TwentyTwentyTwoServiceMember_zYy8YPzFgIV7" title="Warrants issued for service">294,000</span> warrants for 2022 service. The Legacy ONMD Warrants are equity-classified and accounted for in accordance
with ASC 718. ASC 718 requires the use of the &#8220;fair-value-based method&#8221; for measuring the value of stock-based compensation.
In applying &#8220;fair-value-based method&#8221; (absent identical or similar instruments) companies are required to use an option-pricing
model, adjusted to accommodate the unique characteristics of the employee stock options. ASC 718&#8217;s measurement objective is to
determine the fair value of stock-based compensation at the grant date assuming that employees/directors fulfill the award&#8217;s vesting
conditions (if applicable) and will retain the award. The fair value of an award is the cost to the Company for granting the award and
should reflect the estimated value of the instruments that the company would be obligated to provide to an employee/director when the
employee has satisfied the service conditions. This resulted in an expense of $<span id="xdx_90E_eus-gaap--OtherNoncashExpense_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zuP7WJQHfSvi" title="Other expense">0</span> and $<span id="xdx_902_eus-gaap--OtherNoncashExpense_pn5n6_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zUEwn5C3kcr1" title="Other expense">1.2</span> million for the years ended December 31, 2023
and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, all Legacy ONMD Warrants issued for services were cashless
exercised into shares of Legacy ONMD common stock and exchanged for Common Stock based on the appropriate conversion ratio less the applicable
exercise price per Legacy ONMD Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Convertible
Promissory Notes Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 6, the Company issued Convertible Promissory Notes Warrants in 2022 and 2023. The Convertible Promissory Note Warrants
are classified as equity in accordance with ASC 815. The Company has elected to measure the Notes using the fair value option under ASC
825 discussed in Note 6. The Company determined that the fair value of the combined instrument significantly exceeds the proceeds received,
therefore, the Company concluded that the warrants are most accurately portrayed as an issuance cost related to the convertible promissory
notes. This resulted in an expense of $<span id="xdx_906_ecustom--StockWarrantExpense_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zsBmSiQHdVV" title="Stock warrant expense">9.2</span> million and $<span id="xdx_904_ecustom--StockWarrantExpense_pn5n6_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNotesWarrantsMember_zjVA8qACXRmd" title="Stock warrant expense">8.0</span> million being allocated to the Convertible Promissory Notes Warrants during
the year ended December 31, 2023 and 2022, respectively, which is classified as stock warrant expense in the consolidated statements
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, all Convertible Promissory Notes Warrants were cashless
exercised into shares of Legacy ONMD common stock and exchanged based on the appropriate conversion ratio for the Common Stock less an
exercise price of $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionRatio1_c20231106__20231107_zPNVO3ziksY3" title="Conversion ratio">1.00</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PIPE
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the PIPE Notes described in Note 6, the Company also issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfxwolB9zID7" title="Warrants to acquire common stock">95,745</span> warrants to purchase Common Stock (&#8220;PIPE Warrants&#8221;).
The Company accounts for the PIPE Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that because
the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting treatment of derivative financial instruments in accordance with ASC 815, <i>Derivatives and Hedging, </i>requires that the
Company record a derivative liability upon issuance of the warrants. Accordingly, the Company classifies each warrant as a liability
at its fair value and the warrants were allocated a portion of the proceeds from the issuance of the Units equal to its fair value. This
liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted
to fair value, with the change in fair value recognized in the Company&#8217;s statement of operations. The Company will reassess the
classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be
reclassified as of the date of the event that causes the reclassification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, all <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PIPEWarrantsMember_zGE7usDUmBsh" title="Warrants outstanding">95,745</span> PIPE Warrants remain outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Public
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zuoSGRnh76rl" title="Warrants to purchase common stock">11,500,000</span> public warrants (the &#8220;Public
Warrants&#8221;) to purchase Common Stock with an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zFxRKrAR8V5a" title="Warrants exercise price">11.50</span> per share. The Public Warrants became exercisable 30 days
after the Closing of the Business Combination. Each Public Warrant is exercisable for one share of Common Stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may redeem the outstanding Public Warrants for $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zqy9MXo8nB03" title="Warrants exercise price">0.01</span> per Public Warrant upon at least 30 days&#8217; prior written notice of
redemption given after the Public Warrants become exercisable, if the reported last sale price of the Common Stock equals or exceeds
$<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zO1KCmMrQN9a" title="Price per share">18.00</span> per share (as adjusted for stock dividends, sub-divisions, reorganizations, recapitalizations and the like) for any 20 trading
days within a 30-trading day period commencing after the Public Warrants become exercisable and ending on the third trading day before
the Company sends the notice of redemption to the holders of the Public Warrants. Upon issuance of a redemption notice by the Company,
the holders of the Public Warrants may, at any time after the redemption notice, exercise the Public Warrants on a cashless basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Public Warrants are classified as equity, with the fair value of the Public Warrants as of the date of the Business Combination closed
to additional paid-in capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, all <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zH2x0pfemkbe" title="Warrants outstanding">11,500,000</span> Public Warrants remain outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Private
Placement Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the closing of the Business Combination on November 7, 2023, the Company assumed <span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zCZnvCbnGZgj" title="Warrants to purchase common stock">585,275</span> private warrants to purchase
Common Stock with an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231107__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zTJdO2deMUz7" title="Warrants exercise price">11.50</span> per share (the &#8220;Private Placement Warrants&#8221;). The Private Placement Warrants
(and shares of Common Stock issued or issuable upon exercise of the Private Placement Warrants) in general were not transferable, assignable
or salable until 30 days after the Closing (excluding permitted transferees) and they will not be redeemable under certain redemption
scenarios by the Company so long as they are held by the Sponsor or their respective permitted transferees. Otherwise, the Private Placement
Warrants have terms and provisions that are identical to those of the Public Warrants, including as to exercise price, exercisability
and exercise period. If the Private Placement Warrants are held by holders other than the Sponsor, Metric or their respective permitted
transferees, the Private Placement Warrants will be redeemable by the Company under all redemption scenarios and exercisable by the holders
on the same basis as the Public Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for the Private Placement Warrants in accordance with the guidance contained in ASC 815-40. Such guidance provides that
because the Private Placement Warrants do not meet the criteria for equity treatment thereunder, each Private Placement Warrant must
be recorded as a liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accounting treatment of derivative financial instruments in accordance with ASC 815, <i>Derivatives and Hedging, </i>required that the
Company record a derivative liability upon the closing of the Business Combination. Accordingly, the Company classifies each Private
Placement Warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each
such re-measurement, the Private Placement Warrant liability will be adjusted to fair value, with the change in fair value recognized
in the Company&#8217;s statement of operations. The Company will reassess the classification at each balance sheet date. If the classification
changes as a result of events during the period, the Private Placement Warrants will be reclassified as of the date of the event that
causes the reclassification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, all <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--PrivatePlacementMember_zLtA21qzdP2d" title="Warrants outstanding">585,275</span> Private Placement Warrants remained outstanding.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DisclosureStockWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DisclosureStockWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockWarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock warrants disclosure text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockWarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590126963456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--FairValueDisclosuresTextBlock_zvVW2LA9B6ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_820_zQIUTrXaomp3">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zRomgSLwyzAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_z6OnWbN41Jea" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zs7pR7XVeyMj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk3pYUiIki1g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zXOdtOYYgdYc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240930_zdkwazVils0b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_hus-gaap--FinancialInstrumentAxis__custom--BitcoinMember_zdVOpdadhZDk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 10pt">Bitcoin</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--AssetsFairValueDisclosure_iI_zoiZUdhtjPae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets, at fair value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1242">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zvinzheDArVi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">26</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">26</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6mlQXo9f3pk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">PIPE Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zWZUo7FwPkMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1257">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,593</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--YorkvilleNoteMember_zpy6dS3QhFX7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Yorkville Note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,911</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--StandbyEquityPurchaseAgreementMember_z1Xn1KGKY8Cc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">SEPA derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1267">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1269">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zPmbDddjA7Aa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zN3iPl8icnZc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxhyQBVx04zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zh3kUdO6GkT9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20231231_zE8iY7eZmuX" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zGWT8OSMZHFe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1277">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_ziPfBuKEeew8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z3bFjG8RlQfl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zKKLbNt0V9Rg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1291">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1292">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zuJLVb9AbE4i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination Warrants and PIPE Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-TLSO_zps6BRM4jDQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the Business Combination Warrants and PIPE Warrants measured at fair value during the nine months
ended September 30, 2024 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B2_zusMWR8dIK1d" style="display: none">Schedule
of Warrants and Notes Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--FinancialInstrumentAxis_custom--BusinessCombinationWarrantsMember_zg0zZVWpBMNg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Business Combination Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PIPEWarrantsMember_zRZ4VYo3g01h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zhOUxxDJFxxb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Balance, December 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_z9qk9ZWF20Cj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Additions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_z6iSqRCmiCo3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(12</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z2MZKufSZT7h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_z1XGBbNMWzcc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company remeasured the fair value of the Business Combination Warrants and PIPE Warrants at September 30, 2024 using the Black-Scholes
option-pricing model with the following assumptions:</span></p>

<p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z0EbGI9XuKg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_zbo4lpUx1OU6" style="display: none">Schedule
of Fair Value Assumptions and Valuation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6yoFZjdrjI3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember_zdnqqfp3XZQ8" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Business Combination</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z8ofOzO0ac9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.61</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.61</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zesH5Uq4iOC1" style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zaCri8ck8v0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.1</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zr6WHQ05YrM9" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.6</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zXlftvXvisyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1331">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zSVXH8G4Gmsl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants measurement input</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1334">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zUh0Fyou3Ww5" title="Expected term (in years)">4.1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zU8xg8Aetap4" title="Expected term (in years)">4.2</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zyYLtmo7pxr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Notes and Yorkville Note</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C09_gL3FVLMORBUIR-TLSO_zJFslKp8psI3">The
following table presents the changes in the PIPE Notes and Yorkville Note measured at fair value during the nine months ended September
30, 2024 (in thousands):</span></span></p>

<div id="xdx_C0F_gL3FVLMORBUIR-TLSO_zrNp9ZRq9Rk8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_134_zREtuuhIhXSl" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--FinancialInstrumentAxis_custom--PIPENotesMember_ze2r3E2jMVR2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Notes</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--YorkvilleNoteMember_zYzz8DZAcSY5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Yorkville Note</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlOJacrmtqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Balance, December 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,637</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1341">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zMhjgFKRCOX2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1343">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,350</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zGJO8EE1uXi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">561</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zeIf64bpYuG4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,593</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,911</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C06_gL3FVLMORBUIR-TLSO_zSEPh11Sejia">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair values of the PIPE Notes and Yorkville Note are determined based on the aggregated, probability-weighted average of the
outcomes of certain possible scenarios. The combined value of the probability-weighted average of those outcomes is then discounted back
to each reporting period in which the convertible notes are outstanding, in each case, based on a risk-adjusted discount rate estimated
based on the implied discount rate. The discount rate was held constant over the valuation periods given the fact pattern associated
with the Company and the stage of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>SEPA
Derivative Liability</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C06_gL3FVLMORBUIR-TLSO_zz4orYY35kX2">The
following table presents the changes in the SEPA derivative liability measured at fair value during the nine months ended September 30,
2024 (in thousands):</span></span></p>

<div id="xdx_C00_gL3FVLMORBUIR-TLSO_zOsMKlhlCRO"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_134_zvn2i2KWbCdj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--YorkvilleStandbyEquityPurchaseAgreementMember_zeuekKn7dFk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Yorkville SEPA</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_438_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zBVYNCg9VPa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1352">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zTX2QegBErif" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Additions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">160</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zNqLPzGMpOE4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(160</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zhdfOaCxSyfa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C02_gL3FVLMORBUIR-TLSO_z93qpH9mH618">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair value of the SEPA derivative liability was determined using a scenario-based valuation model based on the aggregated amount
of draws expected to be made over the 24-month commitment period. The derivative value of such draws was then discounted back to each
reporting period in which the put option was outstanding, in each case, based on a risk-adjusted discount rate based on the implied discount
rate. As of September 30, 2024, the derivative liability was determined to have no value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_zytubuymQfMg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.
<span id="xdx_826_zcyW7FFQ9JZi">Fair Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zx4VUb6mkiqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_znx9PfAgWcDd" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWRkkLWyDgri" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgBvYaGFcJta" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdg0MYNCkvU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zepYc0t5lBkb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zjzKmD4Pi2S8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Private warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4703">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4704">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z9y2aSkYHAta" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Business Combination Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4708">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zeFOUJUazrzj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4713">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4714">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_za6JYscss8Ef" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4718">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4719">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zauQYLn1Y5zh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4723">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4724">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzMl7Ns3zPMk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8ezS87zniPi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z40QOrbBk7mb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zFch3jrLMbgh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--ConvertiblePromissoryNotesMember_zicdAbkJfVnj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4728">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4729">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">26,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">26,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z5WLuEaC5E1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4733">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4734">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26,243</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26,243</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_z4D4SxvaTPTj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zfPVMYOIcIFk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the Private Warrants, PIPE Notes and PIPE Warrants, and the convertible promissory notes measured
at fair value for the years ended December 31, 2023 and 2022 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zrEje0gHNQzk" style="display: none">&#160;Schedule
of Warrants and Promissory Notes Measured at Fair Value</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">Level 3 Rollforward:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PrivateWarrantsMember_zWco2KKGbyyb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Private</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--PIPENotesAndWarrantsMember_zEJ3Ft6aQVr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Notes &amp;<br/>
 Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--ConvertiblePromissoryNotesMember_zGKgmWZJDTJ9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Convertible</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Promissory</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Notes</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_z2fMhsCUjYpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">Balance, December 31, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4740">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4741">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,487</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zBviuiQPjWkl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4744">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,140</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zsijmKJu6ZB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4748">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4749">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,616</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zwRtIU9PSg3j" style="vertical-align: bottom; background-color: White">
    <td>Balance, December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,243</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlT96CCKvkPg" style="display: none; vertical-align: bottom; background-color: White">
    <td>Beginning balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4756">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4757">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,243</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_431_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zh4h2E26WEMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,175</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zVP5orAuH799" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">151</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_zoNaKcB1iatd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Reclassified to additional paid-in-capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4768">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4769">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(47,935</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z5E6isg1SAxe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,651</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4774">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zVxglYhpJHcd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,651</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4778">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A9_zgtlbXuVek8k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placement Warrants and PIPE Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate fair value of the Private Placement Warrants and PIPE Warrants was $<span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20231107__us-gaap--FinancialInstrumentAxis__custom--PrivatePlacementWarrantsMember_zu5p8dMflpwg" title="Aggregate fair value of private placement warrants">152,602</span> and $<span id="xdx_908_eus-gaap--DerivativeLiabilities_iI_c20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zzfuy6Pm8d58" title="Aggregate fair value of PIPE warrants">23,393</span> as of November 7, 2023 and December
31, 2023, respectively. The Company remeasured the fair value of the Private Placement Warrants and PIPE Warrants at November 7, 2023
and December 31, 2023 using the Black-Scholes option-pricing model with the following assumptions:</span></p>

<p id="xdx_896_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zG7JtzNR8yvg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_8BA_zSAFMhLzu8hj" style="display: none">Schedule
of Fair Value Assumptions and Valuation</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zOyVpPVa8Vb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6Vs42s56Jnc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20231107__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zgw83huQwyL6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231107__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6IiyATv7Zh3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of November 7,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Private</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Private</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zEO2MB9nrjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.81</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.81</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5.25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7.76</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zf1afDFSdnJa" style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zjnp3s5He9p4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.2</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ztzmHVQD3t67" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.6</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zyS14PyGAws9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4806">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4807">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4808">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4809">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z1JB6b2FrNW7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zaQnSbTaqZDa" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
     measurement input</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A0_zJarw7z46Wk1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Promissory Notes and PIPE Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated fair values of the convertible promissory notes and PIPE Notes are each determined based on the aggregated, probability-weighted
average of the outcomes of certain possible scenarios. The combined value of the probability-weighted average of those outcomes is then
discounted back to each reporting period in which the convertible notes are outstanding, in each case, based on a risk-adjusted discount
rate estimated based on the implied discount rate. The discount rate was held constant over the valuation periods given the fact pattern
associated with the company and the stage of development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, in connection with the Closing of the Business Combination described in Note 3, all convertible promissory notes
were converted to Common Stock in accordance with the conversion provisions in the original agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the PIPE Notes was $<span id="xdx_907_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pn5n6_c20231107__us-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zjWLkGM5LzLl" title="Aggregate fair value">1.8</span> million and $<span id="xdx_909_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_pn5n6_c20231231__us-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z1pfvwSQk0Vj" title="Aggregate fair value">1.6</span> million as of November 7, 2023 and December 31, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132191360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z72lCXGJ7Bkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_823_zcaO490Ct6w6">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PIPE
Notes and Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Data
Knights issued and sold PIPE Notes in connection with the Business Combination, which are convertible into shares of Common Stock. Total
proceeds raised from the PIPE Notes were $<span id="xdx_90A_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zxvBfqWuzhld" title="Related party proceeds">1.5</span> million, of which $<span id="xdx_907_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zKD4shLrCAAh" title="Related party proceeds">1.0</span> million was with related party investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the issuance of the PIPE Notes, the Company also issued a total of <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zVhs2mYBQuKb" title="Warrants issued">95,744</span> shares of PIPE Warrants, of which <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zEhojPn2C22l" title="Warrants issued">63,829</span> shares
were issued to the same related party investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Convertible
Promissory Notes and Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 4, the Company issued various Convertible Promissory Notes to related party investors. Total gross proceeds raised
from Convertible Promissory Notes with related parties were $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240101__20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z92zLciIy6D7" title="Gross proceeds from convertible promissory notes">12.3</span> million (out of $<span id="xdx_906_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zzWdKRh7BLf9" title="Gross proceeds from convertible promissory notes">14.2</span> million total). In connection with the issuance
of the Convertible Promissory Notes, the Company also issued Convertible Promissory Notes Warrants to purchase <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteWarrantsMember_z6VrAV2L82g9" title="Number of shares issued">2,976,000</span> shares of Legacy
ONMD common stock to the same related parties (out of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConvertiblePromissoryNotesAndWarrantsMember_zdoCtpSCKObe" title="Warrants to purchase common stock">3,726,000</span> total). The closing of the Business Combination triggered the conversion
of all Convertible Promissory Notes and Convertible Promissory Notes Warrants into shares of Common Stock. See the Form 10-K/A for all
other details relating to the Convertible Promissory Notes and Convertible Promissory Notes Warrants issued prior to December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholder
Loans</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the convertible shareholder loans described in Note 4, the Company also received gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20240930_zYokDN1xcVMe" title="Gross proceeds from loans">0.4</span> million in connection
with non-convertible shareholder loans with related party investors during the nine months ended September 30, 2024. In June 2024 and
July 2024, the Company repaid $<span id="xdx_905_eus-gaap--OtherLongTermDebt_iI_pn5n6_c20240731_zzqhohe1eolk" title="Non convertible shareholder loan"><span id="xdx_900_eus-gaap--OtherLongTermDebt_iI_pn5n6_c20240630_zSJP3IguPoQ7" title="Non convertible shareholder loan">0.1</span></span> million of the outstanding non-convertible shareholder loan balance. These loans bear an interest
rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240930_zTCd9R4V9eu8" title="Loan interest rate">8.0</span>% with a maturity date <span id="xdx_900_eus-gaap--DebtInstrumentTerm_dc_c20240101__20240930_zTLaZv1Whwh8" title="Loan term">one year</span> from issuance. The following table summarizes shareholder loans outstanding for the periods
presented (in thousands):</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zesL6qwSYE91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_z0ak4ixSjEGh" style="display: none">Schedule
of Shareholder Loans Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240930_zNCE49yHztcl" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231_zvDVQSrNcA7i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_maCNPzu2j_zdGkeCM8yN3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Shareholder loans &#8211; nonconvertible</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">654</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">454</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_maCNPzu2j_zkQ0zSIF2Cyc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shareholder loans &#8211; convertible</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestPayableCurrent_iI_pn3n3_maCNPzu2j_z6xU62AlZM37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LongTermDebt_iTI_pn3n3_mtCNPzu2j_zmPrw76GaPF6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total loan &#8211; related party</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,306</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">465</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_zTKrshboB99h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loan
Extensions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assumed Data Knights&#8217; liabilities, which included existing loan extensions to related parties. The loan extensions were
to be either repaid in cash or, at the option of the lender, exchanged for a fixed amount of Common Stock at a price of $<span id="xdx_900_eus-gaap--SharePrice_iI_c20240930_zLI7R5vnH7g4">10.00</span> per share
upon the closing of a business combination or a similar event. At the closing of the Business Combination, all lenders provided notice
to have their loans converted into shares upon the filing of a registration statement on Form S-1 with the SEC. As of September 30, 2024
and December 31, 2023, a registration statement has not yet been declared effective by the SEC, and a balance of $<span id="xdx_905_eus-gaap--LoansPayableCurrent_iI_pn5n6_c20240930__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsMember_zl1jqYoxGAx6" title="Loans remains outstanding"><span id="xdx_90D_eus-gaap--LoansPayableCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsMember_zafvvM4LTVj5" title="Loans remains outstanding">3.0</span></span> million remains
outstanding on the Company&#8217;s condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zsXhXjToTkUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.
<span id="xdx_824_z8bVfPCGmR92">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PIPE
Notes and Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in Note 3 and Note 6, <span style="background-color: white">Data Knights issued and sold PIPE Notes in connection with the
Business Combination, which are convertible into shares of the Company&#8217;s Common Stock. Total proceeds raised from the PIPE Notes
were $<span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_zqyuQVvSZ6xh" title="Related party proceeds">1.5</span> million, of which $<span id="xdx_901_eus-gaap--ProceedsFromRelatedPartyDebt_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--PIPENotesMember_znyIsT87tOd8" title="Related party proceeds">1.0</span> million were with related party investors. Refer to Note 3 and Note 6 for additional details on the
terms of the PIPE Notes.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the issuance of the PIPE Notes, the Company also issued a total of <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zd4nIU6zM2xj" title="Warrants issued">95,744</span> shares of PIPE Warrants, of which <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zsSFb7AMlCYd" title="Warrants issued">63,829</span> shares
were issued to the same related party investors. Refer to Note 10 for additional details on the terms of the PIPE Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
Promissory Notes and Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
2019 to 2023, the Company issued various Convertible Promissory Notes to related party investors. Total gross proceeds raised from Convertible
Promissory Notes with related parties was $<span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zMYiNMEsFLok" title="Gross proceeds from convertible promissory notes">12.3</span> million (out of $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z9GTc5SDlPb2" title="Gross proceeds from convertible promissory notes">14.2</span> million total). In connection with the issuance of the Convertible
Promissory Notes, the Company also issued <span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteWarrantsMember_z3m9Ls9o7ft3" title="Number of shares issued">2,976,000</span> shares of Convertible Promissory Note Warrants to the same related parties (out of
<span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConvertiblePromissoryNotesAndWarrantsMember_zNrDfrawjOL1" title="Number of warrants issued">3,726,000</span> total). Refer to Note 6 and Note 10 for additional details on the terms of the Convertible Promissory Notes and Convertible
Promissory Note Warrants, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Closing of the Business Combination triggered the conversion of all Convertible Promissory Notes into shares of Common Stock of the Company,
as disclosed in Note 3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
Loans</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
April 2023 to December 2023, the Company entered into shareholder loans with two related party investors (the &#8220;Shareholder Loans&#8221;)
for aggregate gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromLoans_pn3n3_c20230401__20231231_zB5USk2fmhKl" title="Loans payable">954</span> thousand. The Shareholder Loans bear an interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20231231_zGLH05NCNbUe" title="Interest rate">8.0</span>% and mature <span id="xdx_90D_eus-gaap--DebtInstrumentTerm_dc_c20230401__20231231_zlG3K0VQUHhk" title="Debt term">one year</span> after the commencement
date of each agreement. There are no financial or non-financial covenants associated with the Shareholder Loans. The Shareholder Loans
are not convertible into equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, in connection with the Business Combination, one of the Shareholder Loans for $<span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn5n6_c20231107__us-gaap--DebtInstrumentAxis__custom--ShareholderLoansMember_z8nK6Rw9ZgE9" title="Shareholder loan">0.5</span> million was converted into a PIPE
Note equal to the amount of principal and interest outstanding at the time of Closing. The Company accounted for the exchange as an extinguishment
whereby the Shareholder Loan was written off and a separate PIPE Note was recorded at fair value, as disclosed in Note 6. The extinguishment
had no impact on the Company&#8217;s consolidated statement of operations for the year ended December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, a total of $<span id="xdx_903_ecustom--ProceedsFromIssuanceOfShareholderLoans_pn3n3_c20230101__20231231_zlPH2RzABGx7" title="Shareholder loans outstanding">454</span> thousand of Shareholder Loans remains outstanding which is classified as loan &#8211; related party
on the consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Extensions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
disclosed in Note 3, in connection with the Business Combination, the Company assumed Data Knights&#8217; liabilities, which included
existing loan extensions to related parties. The loan extensions were to be exchanged for a fixed amount of the Company&#8217;s Common
Stock upon the closing of a business combination or a similar event. As of December 31, 2023, a balance of $<span id="xdx_903_ecustom--LoanExtension_iI_pn5n6_c20231231_zYYxp7LkBjZ5" title="Loan extensions">3.0</span> million remains outstanding
and is recorded as loan extensions on the Company&#8217;s consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132195776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zhU0Ncx89oif" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_823_z7gQBnBFOdKk">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a month-to-month lease for a suite at a cost of $<span id="xdx_902_eus-gaap--LeaseCost_pp0p0_c20240101__20240930_zCSTbaDzmzE" title="Lease cost">530</span> per month. The Company incurred $<span id="xdx_906_eus-gaap--PaymentsForRent_pn3n3_c20240701__20240930_zXMEQALoya99" title="Rent expenses"><span id="xdx_906_eus-gaap--PaymentsForRent_pn3n3_c20230701__20230930_znug2H9sqLH2" title="Rent expenses">2</span></span> thousand of rent expense, including
common tenant costs and cancellation costs, during the three months ended September 30, 2024 and 2023, respectively, and $<span id="xdx_907_eus-gaap--PaymentsForRent_pn3n3_c20240101__20240930_zZKWpc76Lks3" title="Rent expense"><span id="xdx_90C_eus-gaap--PaymentsForRent_pn3n3_c20230101__20230930_zmnRJuF7JT71" title="Rent expense">6</span></span> thousand
for the nine months ended September 30, 2024 and 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Liabilities for loss contingencies
arising from claims, assessments, litigation, fines, penalties, and other sources are recognized, if and when it is probable that a liability
has been incurred and the amount can be reasonably estimated. The Company was not subject to any material legal proceedings during the
nine months ended September 30, 2024 and 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_807_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXYkCDbsfPyg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.
<span id="xdx_826_zkxTMBMkPgV">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lease
Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a month-to-month lease for a suite at a cost of $<span id="xdx_90D_eus-gaap--LeaseCost_c20230101__20231231_zpIm00S5UX23" title="Lease cost">530</span> per month. The Company incurred $<span id="xdx_90B_eus-gaap--PaymentsForRent_c20230101__20231231_zB0D3imQifNd" title="Rent expenses">7,695</span> and $<span id="xdx_90D_eus-gaap--PaymentsForRent_c20220101__20221231_zct23zrZB2va" title="Rent expenses">7,694</span> of rent expense, including
common tenant costs and cancellation costs, during the years ended December 31, 2023 and 2022, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. Liabilities for loss
contingencies arising from claims, assessments, litigation, fines, penalties, and other sources are recognized, if and when it is
probable that a liability has been incurred and the amount can be reasonably estimated. The Company was not subject to any material
legal proceedings during the years ended December 31, 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132143984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zgUvaltT6Vi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_82F_zfVEdnL5mIQl">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events occurring through December 17, 2024, the date the condensed consolidated financial statements
were issued, for events requiring recording or disclosure in the Company&#8217;s condensed consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Letter</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, Yorkville sent the Company a letter notifying the Company that it had breached a registration rights agreement with
Yorkville by failing to file a Registration Statement on Form S-1 on the timeline set forth in the registration rights agreement (the
&#8220;Yorkville Letter&#8221;). The Yorkville Letter asserted that this breach was an event of default and an amortization event under
the prepaid advance in connection with the SEPA. The Yorkville Letter also asserted that the Company&#8217;s failure to timely file its
Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024 was an event of default under the Yorkville Promissory Note.
The Company subsequently engaged in discussions with Yorkville regarding the Yorkville Letter, which discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Yorkville Promissory Note, upon the occurrence of an amortization event, the Company is required to pay all principal and accrued
interest on the Yorkville Promissory Note, plus a <span id="xdx_909_eus-gaap--LongTermDebtPercentageBearingFixedInterestRate_iI_pid_dp_c20241008__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zegkBJys0W3l" title="Payment premium percentage on principal amount">10</span>% payment premium on the principal amount, in equal installments over 3 calendar
months or until the amortization event is cured, whichever is earlier. In addition, upon the occurrence of an event of default, the interest
rate on the Yorkville Promissory Note increases to <span id="xdx_909_ecustom--DebtInstrumentInterestRateDefaultPercentage_iI_pid_dp_c20241008__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleNoteMember_zFdKUfq7UWFh" title="Debt default interest rate">18</span>% retroactive to the date of the event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Board
Turnover</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on October 8, 2024, on October 1, 2024, Paul J. Casey and
Erkan Akyuz resigned from the Board of Directors of the Company (the &#8220;Board&#8221;), effective immediately. Also on October 1, 2024, the Board appointed Jair Clarke and Sherry
Coonse McCraw to the Board to fill the vacancies created by Mr. Casey and Mr. Akyuz, respectively. In connection with Ms. Coonse
McCraw and Mr. Clarke&#8217;s service on the Board, the Board approved an RSU grant providing for the grant of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241001__20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MsCoonseMcCrawMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkmul9Br5Qwc" title="Number of restricted stock units granted"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241001__20241001__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MrClarkeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPrE32kpU4z3" title="Number of restricted stock units granted">45,000</span></span>
RSUs to each director for one full year of service (prorated for 2024). The RSUs will vest at the end of December 2024.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_zPBy6qAhhAna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.
<span id="xdx_824_zTqWkPMINjKc">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has evaluated subsequent events occurring through November 4, 2024, the date the consolidated financial statements were issued,
for events requiring recording or disclosure in the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Settlement
of Deferred Underwriting Fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024, through the date of this report, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__dei--LegalEntityAxis__custom--EFHuttonMember_zBftqySKYD17" title="Stock issued during period, shares, new issues">256,944</span> and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__dei--LegalEntityAxis__custom--KingwoodCapitalPartnersLLCMember_zAfDykodpXHe" title="Stock issued during period, shares, new issues">20,834</span> shares of Common Stock to EF Hutton LLC and Kingwood Capital
Partners, LLC, respectively, as consideration for $<span id="xdx_90D_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--BusinessAcquisitionAxis__custom--KingwoodCapitalPartnersLLCMember_zo7ZtAxpXrZ4" title="Business combination, consideration underwriting commission">3.0</span> million owed by the Company for underwriting commission due at the Closing of
the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share
Repurchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2024, through the date of this report, the Company bought back <span id="xdx_907_eus-gaap--StockRepurchasedDuringPeriodShares_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zbxxIiqKyiQ2" title="Bought back shares of Common Stock">187,745</span> shares of Common Stock from a convertible note holder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i>Shareholder Loans</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in">During
2024, through the date of this report, the Company received gross proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zIVB1s45zjO7" title="Gross proceeds from related party loans">2.0</span> million in connection with shareholder loans with
related party investors. Of the $<span id="xdx_90D_eus-gaap--ProceedsFromLoans_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zs9XWGdV7ft2" title="Gross proceeds from related party loans">2.0</span> million, $<span id="xdx_908_eus-gaap--ConvertibleDebt_iI_pn5n6_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKkdBCFLQ73i" title="Loans converted into common stock">1.6</span> million is convertible into shares of Common Stock at a conversion price of
$<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zdrlsXYPnNuj" title="Debt conversion price">0.7535</span> per share. The remaining $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zGNe1qVqMNDf" title="Non convertible loans">0.4</span> million is not convertible into equity and bears an interest rate of <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zKwzmjr2xkbf" title="Business combination, consideration underwriting commission">8.0</span>% with a maturity date
one year from issuance. The Company subsequently repaid $<span id="xdx_908_eus-gaap--DebtInstrumentRepaidPrincipal_pn5n6_c20240101__20241231__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zYDuQglPKcik" title="Non convertible loans repaid">0.2</span> million of the non-convertible shareholder loans through the date of
this report.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Placements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on April 2, 2024, on March 28, 2024, the Company <span style="background-color: white">entered
into a definitive securities purchase agreement (the &#8220;Helena SPA&#8221;) with Helena Global Investment Opportunities 1 Ltd. (&#8220;Helena&#8221;),
an affiliate of Helena Partners Inc., a Cayman-Islands based advisor and investor providing for up to $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_pn5n6_c20240328__20240328__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxokvY670cSd" title="Proceeds form convertible notes">4.5</span></span> million <span style="background-color: white">in
funding through a private placement for the issuance of senior secured convertible notes (the &#8220;Helena Notes&#8221;). On June 14,
2024, the Company and Helena entered into a termination agreement (the &#8220;Helena Termination Agreement&#8221;) to terminate the Helena
SPA and related documents. Pursuant to the Helena Termination Agreement, the Company issued to Helena a warrant to purchase <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240614__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zCr5M7stk2Ne" title="Warrants outstanding">50,000</span> shares
of Common Stock at an exercise price of $<span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_uUSDPShares_c20240614__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvUkTrj6JmB" title="Warrant exercise price">1.20</span> per share and agreed to reimburse Helena for certain reasonable and documented out-of-pocket
legal fees and expenses incurred in connection with entry into the Helena SPA and Helena Termination Agreement and related documents.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
July 23, 2024 and July 25, 2024, the Company entered into securities purchase agreements (the &#8220;Securities Purchase Agreements&#8221;)
with certain institutional investors in connection with the private placement of its Common Stock and pre-funded warrants with aggregate
gross proceeds of approximately $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240723__20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zX7izELbJGS7" title="Proceeds form private placement"><span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240725__20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zp6qxt2VR9Eb" title="Proceeds form private placement">4.6</span></span> million, before deducting fees and expenses payable by the Company. The Company intends to use the
net proceeds for working capital and general corporate purposes. Pending use of the funds, the Company used a portion of the net proceeds
to purchase Bitcoin ($BTC). There is no guarantee on the holding period for the purchased Bitcoin.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Securities Purchase Agreements, the Company agreed to issue and sell to the investors <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240723__20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z8wqyx1MpH5g" title="Shares issued"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240725__20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zAdDFfpgPsnk" title="Shares issued">1,297,059</span></span> shares of its Common Stock at
a price of $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zAVN7FBPZ893" title="Share price"><span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zsYZ31Cls7d4" title="Share price">1.0278</span></span> per share, pre-funded warrants exercisable for <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvawEyY9i0li" title="Warrants outstanding"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z1wKcfgBP8wg" title="Warrants outstanding">1,323,530</span></span> shares of its Common Stock at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zNZCzUTb3Mzg" title="Warrant exercise price"><span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zQKuNYG6xlMl" title="Warrant exercise price">1.0278</span></span>
per share, and <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zN3OKGGh6yz3" title="Shares issued"><span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zijLi9OYJpd6" title="Shares issued">2,301,791</span></span> shares of its Common Stock at a price of $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zgzy8ikCO8Zd" title="Share price"><span id="xdx_90C_eus-gaap--SharePrice_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zWYLOicPMrF1" title="Share price">0.85</span></span> per share. The investors were required to prepay the exercise
price for the pre-funded warrants, other than $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20240723__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zf3RXXknyvib" title="Share price"><span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20240725__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYMgyXWVTMna" title="Share price">0.0001</span></span> per share. The pre-funded warrants will be exercisable at any time after the date
of issuance and will not expire. The price per share of all Common Stock and pre-funded warrants sold in the private placement meets
the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued to institutional accredited investors in
a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
September 24, 2024, the Company entered into securities purchase agreements (the &#8220;Follow-on SPA&#8221;) with an institutional investor
in connection with the private placement of its Common Stock, warrants and pre-funded warrants with aggregate gross proceeds of approximately
$<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn5n6_c20240924__20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zSTxumnw4BQi" title="Proceeds from issuance of private placement">1.7</span> million, before deducting fees and expenses payable by the Company. The Company intends to use the net proceeds from the Private
Placement for working capital and general corporate purposes. Pending use of the funds, the Company plans to use a portion of the net
proceeds to purchase Bitcoin ($BTC).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Follow-on SPA, the Company agreed to issue and sell to the investor <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240924__20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGc3RjPunQWk" title="Shares issued">1,918,591</span> shares of its Common Stock at a price of $<span id="xdx_90B_eus-gaap--SaleOfStockPricePerShare_iI_pid_uUSDPShares_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember_z1gcZAEZr328" title="Sale of share price">0.65</span> per
share, warrants exercisable for <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zdNWhpB7bqAd" title="Warrants exercisable">133,095</span> shares of its Common Stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zU08lBCI29Gk" title="Share price">0.325</span> per share and pre-funded warrants exercisable
for <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zsCkIckSPkAd" title="Warrants exercisable">743,314</span> shares of its Common Stock at an exercise price of <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zGLNeMTAVWU9" title="Warrant exercise price">$0.65</span> per share. The investor was required to prepay the exercise price
for the pre-funded warrants, other than $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20240924__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--StatementEquityComponentsAxis__custom--PrefundedWarrantsMember_zUeqEEafWzPj" title="Share issued price">0.0001</span> per share. The warrants and pre-funded warrants will be exercisable at any time after
the date of issuance and will not expire. The price per share of all Common Stock and pre-funded warrants sold in the private placement
meets the minimum price requirement under Nasdaq Listing Rule 5635(d). The securities were issued to institutional accredited investors
in a private placement pursuant to Section 4(a)(2) and Regulation D promulgated under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Standby
Equity Purchase Agreement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company entered into a standby equity purchase agreement (the &#8220;SEPA&#8221;) with YA II PN, LTD, a Cayman Islands
exempt limited partnership managed by Yorkville Advisors Global, LP (&#8220;Yorkville&#8221;). Pursuant to the SEPA, subject to certain
conditions, the Company has the option to sell to Yorkville an aggregate amount of up to up to $<span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn5n6_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_za5ulDzBSSyb" title="Proceeds from issuance of common stock">25.0</span> million of the Company&#8217;s shares
of Common Stock at the Company&#8217;s request from time to time following both the repayment of the Promissory Note described below
and the effectiveness of a resale registration statement covering the shares of Common Stock issued under the SEPA. The SEPA terminates
on its 24-month anniversary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--EquityPurchaseAgreementDescription_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zYAq5pWfzSrh" title="Equity purchase agreement description">Each
advance may not exceed the greater of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zHQhy3JzpGG" title="Shares issued">500,000</span> shares and 100% of the average daily volume traded of the Common Stock during the five
trading days immediately prior to requested advance. The shares would be purchased at a price equal to 97% of the Market Price as defined
in the SEPA. The Company may establish a minimum acceptable price in each advance below which the Company will not be obligated to make
any sales to Yorkville</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
purchase under an advance would be subject to certain limitations, including that Yorkville will not purchase or acquire any shares that
would result in it and its affiliates beneficially owning more than <span id="xdx_906_ecustom--ShareOutstandingVotingPercentage_dp_uPure_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zBBpmClKZkqd" title="Shares outstanding voting percentage">4.99</span>% of the then outstanding voting power or number of shares of
Common Stock or any shares that when aggregated with shares issued under all other earlier advances, would exceed <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zSIkTYfZ2dKl" title="Shares outstanding">4,767,616</span> shares of
Common Stock (representing <span id="xdx_90A_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_dp_uPure_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zZxGWmk9dCx6" title="Sale of stock percentage">19.99</span>% of the aggregate number of then outstanding shares of Common Stock) (the &#8220;Exchange Cap&#8221;)
unless shareholders approved issuances in excess of the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the execution of the SEPA, the Company paid a $<span id="xdx_90B_eus-gaap--LoanProcessingFee_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqS8XQiua3Q6" title="Structuring fees">25,000</span> structuring fee to Yorkville. The Company agreed to pay a commitment
fee of $<span id="xdx_905_eus-gaap--PaymentForManagementFee_pn5n6_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zn0k3FaPCwv1" title="Commitment fees">0.5</span> million to Yorkville, which will be paid in shares in two tranches.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
Yorkville agreed to advance to the Company, in exchange for a convertible promissory note (the &#8220;Yorkville Promissory Note&#8221;),
a principal amount of $<span id="xdx_907_eus-gaap--LoansPayable_iI_pn5n6_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z0SPG43PmNoc" title="Principal amount">1.5</span> million, which was funded on June 18, 2024. <span id="xdx_904_eus-gaap--DebtInstrumentDescription_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_z2KdxXcCgXl8" title="Debt instrument description">The Yorkville Promissory Note is due on June 18, 2025, and interest shall accrue at an annual rate equal to 0%, subject to an increase to 18% upon an event of default as described in the Yorkville Promissory Note. </span>The Yorkville Promissory Note will be convertible by Yorkville into shares of Common Stock at an aggregate purchase price based
on a price per share equal to the lower of <span id="xdx_90A_eus-gaap--DerivativeDescriptionOfTerms_c20240617__20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zsT4HGZdcNOe" title="Description of promissory note">(a) $1.3408 per share (subject to downward reset upon the filing of the resale registration
statement described below) or (b) 90% of the lowest daily VWAP of the Common Stock on Nasdaq during the seven trading days immediately
prior to each conversion (the &#8220;Variable Price&#8221;), but which Variable Price may not be lower than the Floor Price then in effect</span>.
The &#8220;Floor Price&#8221; is $<span id="xdx_90E_eus-gaap--DerivativeFloorPrice_iI_pid_uUSDPShares_c20240617__srt--StatementScenarioAxis__srt--ScenarioForecastMember__us-gaap--DebtInstrumentAxis__custom--ConvertiblePromissoryNoteMember_zRdng1nVbrFk" title="Floor price">0.28</span> per share, subject to the Company&#8217;s option to reduce the Floor Price to any amounts set
forth in a written notice to Yorkville. While the Promissory Note is outstanding, Yorkville may initiate an investor advance under the
SEPA at the Promissory Note conversion price, the proceeds of which would be used to repay the Yorkville Promissory Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Yorkville Promissory Note may be accelerated by Yorkville upon specified events of default, and may become amortizable for cash if (i)
the daily VWAP is less than the Floor Price for five trading days during a period of seven consecutive trading days, (ii) the Company
has issued in excess of 95% of the shares of Common Stock available under the Exchange Cap or (iii) the Company is in material breach
of its obligations under a Registration Rights Agreement it entered into with Yorkville in connection with the SEPA or Yorkville becomes
limited in its ability to freely resell shares subject to an advance as further described in the Yorkville Promissory Note, subject to
de-amortization after certain cures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Yorkville
Letter</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
October 8, 2024, Yorkville sent the Company a letter notifying the Company that it had breached a registration rights agreement with
Yorkville by failing to file a Registration Statement on Form S-1 on the timeline set forth in the registration rights agreement (the
&#8220;Yorkville Letter&#8221;). The Yorkville Letter asserted that this breach was an event of default and an amortization event under
the prepaid advance in connection with SEPA. The Yorkville Letter also asserted that the Company&#8217;s failure to timely file its Quarterly
Report on Form 10-Q for the fiscal quarter ended June 30, 2024 was an event of default under the Yorkville Promissory Note. The Company
subsequently engaged in discussions with Yorkville regarding the Yorkville Letter, which discussions are ongoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Pursuant
to the Yorkville Promissory Note, upon the occurrence of an amortization event, the Company is required to pay all principal and accrued
interest on the Yorkville Promissory Note, plus a 10% payment premium on the principal amount, in equal installments over 3 calendar
months or until the amortization event is cured, whichever is earlier. In addition, upon the occurrence of an event of default, the interest
rate on the Yorkville Promissory Note increases to 18% retroactive to the date of the event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Executive
Turnover</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on April 2, 2024, on March 22, 2024, Paul J. Casey notified the
Company of his intention to retire as Chief Executive Officer of the Company effective March 29, 2024. Mr. Casey continued to serve as
a member of the Board of Directors until October 1, 2024. In connection with Mr. Casey&#8217;s retirement from the Company, Mr. Casey
and the Company entered into a Resignation Agreement and Release, dated March 22, 2024, pursuant to which Mr. Casey was paid $<span id="xdx_904_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240322__20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zGcIbdExzlSg" title="Monthly shares">12,000</span>
as a severance payment, and the Board of Directors approved a stock option grant providing for the grant of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240322__20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUBl9VGx7qbe" title="Shares exerciseable">147,000</span> five-year options
exercisable at $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20240322__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrAvHy9n9e61" title="Share price">1.00</span> per share to Mr. Casey. On March 27, 2024, Scott Holbrook, a member of the Board of Directors and a member of the
Company&#8217;s Audit Committee, notified the Company of his intention to retire from the Company&#8217;s Board of Directors effective
March 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
March 29, 2024, the Board of Directors (i) appointed Aaron Green to serve as Chief Executive Officer of the Company to fill the vacancy
created by the retirement of Paul Casey; (ii) appointed Mr. Green, to serve as a member of the Board of Directors to fill the vacancy
created by the retirement of Scott Holbrook; and (iii) appointed Dr. Thomas Kosasa, a member of the Board of Directors, to serve on the
Company&#8217;s Audit Committee, also to fill the vacancy created by the retirement of Scott Holbrook.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on Form 8-K, on August 26, 2024, Lisa Embree, Chief Financial Officer (&#8220;CFO&#8221;), Executive Vice President,
Treasurer and Secretary, notified the Company of her intention to resign from her position effective August 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
August 30, 2024, the Board appointed Mr. Robert Golden to serve as the Chief Financial Officer on an interim basis to fill the vacancy
created by the resignation of Lisa Embree. Effective on his appointment as interim CFO, Mr. Golden stepped down as a member and the chair
of the Audit Committee of the Board. In connection with his appointment as interim CFO, the Company entered into a consulting agreement
with Mr. Golden, pursuant to which Mr. Golden will receive a $<span id="xdx_908_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20240830__20240830__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zqix75530DOa" title="Monthly shares">12,000</span> monthly salary and a grant of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20240830__20240830__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zvOQfNAEF0Fb" title="Restricted stock units">100,000</span> restricted stock units, which
will vest on the first anniversary of the consulting agreement, subject to the terms and conditions set forth in the consulting agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced on a Current Report on Form 8-K filed with the SEC on October 8, 2024, on October 1, 2024, Paul J. Casey and Erkan
Akyuz resigned from the Board, effective immediately. Also on October 1, 2024, the Board of Directors appointed Jair Clarke and Sherry
Coonse McCraw to the Board to fill the vacancies created by Mr. Casey and Mr. Akyuz, respectively. In connection with Ms. Coonse McCraw
and Mr. Clarke&#8217;s service on the Advisory Board of the Company, the Board of Directors approved a restricted stock unit (&#8220;RSU&#8221;)
grant providing for the grant of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20241001__srt--StatementScenarioAxis__srt--ScenarioForecastMember_ztmeWu91wV0c" title="Restricted stock units issued">45,000</span> RSUs to each director for one full year of service (pro-rated for 2024). The RSUs will vest at
the end of December 2024.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132210944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--BusinessCombinationDisclosureTextBlock_z3R99EqtFyhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
<span id="xdx_827_zlyxvGrPX9Ph">Business Combination</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2023, the Company closed the previously announced Business Combination pursuant to the Merger Agreement, dated April 25,
2022, by and among Data Knights, Merger Sub, and Legacy ONMD, as described in Note 1.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement: (i) Merger Sub merged with and into Legacy ONMD, with Legacy ONMD surviving the Merger, as a wholly-owned subsidiary
of Data Knights, and (ii) Data Knights, which had been formed as a Delaware corporation solely for the purpose of facilitating the Business
Combination, changed its name to OneMedNet Corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Data
Knights was treated as the acquired company for financial reporting purposes. This determination is primarily based on the fact that
subsequent to the Business Combination, Legacy ONMD&#8217;s stockholders have the majority of the voting power of the combined entity,
Legacy ONMD comprised all of the ongoing operations of the combined entity, Legacy ONMD comprised a majority of the governing body of
the combined entity, and Legacy ONMD&#8217;s senior management comprised all of the senior management of the combined entity. Accordingly,
for accounting purposes, the Business Combination was treated as the equivalent of Legacy ONMD issuing shares for the net assets of Data
Knights, accompanied by a recapitalization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
this is considered a recapitalization for accounting purposes, the net assets of Data Knights were not remeasured at fair value but were
stated at historical cost and there was no goodwill or intangibles recognized. Operations prior to the Business Combination are those
of Legacy ONMD.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate consideration to the stockholders of Legacy ONMD at the closing of the Business Combination was approximately $<span id="xdx_902_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--BusinessCombinationMember_zZrIMnXzNyMk" title="Business combination transfered">20.0</span> million,
which consisted of the Company&#8217;s shares of common stock, par value $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231107_zl8Bo6GlONw5" title="Common stock, par value">0.0001</span> per share (&#8220;Common Stock&#8221;), valued at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231107_zf0hmCOPqbMd" title="Share issued price per share">10.00</span>
per share, resulting in the issuance of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231107__20231107_ztzPtfHo23Gj" title="Issuance of shares">20,000,000</span> shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing, each of Legacy ONMD&#8217;s outstanding convertible notes, with a fair value of $<span id="xdx_904_eus-gaap--FairValueOfAssetsAcquired_pn5n6_c20231107__20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOBrwTAadHA2" title="Fair value of common stock">47.9</span> million, converted into <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231107__20231107_zg9E7qZgwyWk" title="Conversion of convertible securities">5,475,362</span>
shares of the Company&#8217;s Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
upon the closing, <span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zdX6qskCQdia" title="Temporary equity shares outstanding">3,853,797</span> shares of Series A-2 Preferred Stock and <span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_c20231107__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrsFeo5Bwm47" title="Temporary equity shares outstanding">3,204,000</span> shares of Series A-1 Preferred Stock converted into <span id="xdx_90A_eus-gaap--SharesOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9fFhcQvSdZi" title="Shares outstanding">6,261,553</span>
shares of Common Stock. Legacy ONMD&#8217;s <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231107_zLRlOIAINj81" title="Stock options outstanding">612,670</span> outstanding stock options and <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107_zYHJp0Z4Ty7f" title="Warrant outstanding">3,859,464</span> outstanding warrants converted into <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_znblmrgQpkRi" title="Warrant outstanding">543,057</span>
and <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFWXoqZmsHb" title="Warrant outstanding">3,420,945</span> shares, respectively, of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the above, the share figures in the consolidated statement of temporary equity and stockholders&#8217; deficit for the year
ended December 31, 2022 have been adjusted for the application of the recapitalization ratio of <span id="xdx_90D_eus-gaap--TemporaryEquityLiquidationPreferencePerShare_iI_c20221231_zS7cyIYfXSO7" title="Temporaray equity liquidation preference per share">0.88637847</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_898_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zRy8eAdFV65e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received net cash consideration of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107_zbbqF5bZQ9o3" title="Business combination net cash">0.1</span> million and net liabilities of Data Knights of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn5n6_c20231107_zTn2aNDCmvh9" title="Business combination net liabilities">11.0</span> million.
The net liabilities of Data Knights were as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zHJ1yIjtART1" style="display: none">Schedule
of Business Combination Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7elQfgFA4Kk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3_maBCRIAzlc7_zgyL2s3cJb8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid expenses and other current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">22</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_iNI_pn3n3_di_msBCRIAzlc7_zWeMZxmWTzX7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,501</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_iNI_pn3n3_di_msBCRIAzlc7_zcTLjIZHttxe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,992</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_iNI_pn3n3_di_msBCRIAzlc7_zrbKiKasH2c1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,525</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_iNI_pn3n3_di_msBCRIAzlc7_zFHOfonhcp2g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(20</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pn3n3_mtBCRIAzlc7_zMtAJwotwOA2" style="vertical-align: bottom; background-color: White">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Liabilities</span></td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(11,016</td><td style="text-align: left">)</td></tr>
  </table>

<p id="xdx_8AA_z1Epc1DulgYg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company incurred transaction costs of $<span id="xdx_901_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_pn5n6_c20231107_z4ovNNGng9f6" title="Business combination transaction cost">0.9</span> million in connection with the Business Combination. Following consummation of the Business
Combination, the Company owned all of the issued and outstanding equity interests in Legacy ONMD and its subsidiary, and the Legacy ONMD
securityholders held approximately <span id="xdx_909_ecustom--BusinessAcquisitionCostPercentage_iI_dp_uPure_c20231107_zfOehGTNqnB7" title="Business combination percentage">78.2</span>% of the Company. Following consummation of the Business Combination, the Company&#8217;s Common
Stock and the Company&#8217;s Public Warrants began trading on the Nasdaq Global Market under the symbols &#8220;ONMD&#8221; and &#8220;ONMDW&#8221;,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Investment in Public Equity (&#8220;PIPE&#8221;) Financing</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
June 28, 2023, the Company and Data Knights entered into a Securities Purchase Agreement (the &#8220;SPA&#8221;) with certain investors
(collectively referred to as the &#8220;Purchasers&#8221;) for PIPE financing in the aggregate original principal amount of $<span id="xdx_909_eus-gaap--DebtInstrumentIssuedPrincipal_pn5n6_c20230628__20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z0HPlQ9zlf6h" title="Principal amount">1.5</span> million.
Pursuant to the Securities Purchase Agreement, Data Knights issued and sold to each of the Purchasers, a new series of senior secured
convertible notes (the &#8220;PIPE Notes&#8221;), which are convertible into shares of Common Stock at the Purchasers election at a conversion
price equal to the lower of (i) $10.00 per share, pr (ii) 92.5% of the lowest volume weighted average trading price for the ten (10)
Trading Days immediately preceding the Conversion Date. The Purchasers&#8217; $<span id="xdx_902_eus-gaap--Investments_iI_pn5n6_c20230628__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2PfLnEjXCT6" title="Investment">1.5</span> million investment in the PIPE Notes closed and funded
contemporaneous to the Closing of the Business Combination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Effective
immediately prior to the Closing, Data Knights issued the PIPE Notes to the Purchasers under the private offering exemptions under Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Deferred
Underwriter Fees</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, Data Knights entered into an agreement with their underwriters (&#8220;EF Hutton&#8221;) whereby
EF Hutton agreed to waive the related merger underwriting fees that were payable at closing ($<span id="xdx_902_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2ObVj4jthDi" title="Business combination underwriter fees">4.0</span> million) in exchange for allocated
payments as follows: (i) $<span id="xdx_90D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zooYjfpGnop5" title="Business combination cash">0.5</span> million in cash at closing; (ii) a $<span id="xdx_900_eus-gaap--NotesPayable_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zIk6LAMsMJN" title="Promissory note">0.5</span> million promissory note that matures on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zJhNp7Imv2e8" title="Debt maturity date">March 1, 2024</span>; and (iii)
a transfer of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20231107__20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zeWpOliOfmCh" title="Issuance of shares">277,778</span> shares of Common Stock. The Company paid the $<span id="xdx_907_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zPjj32GbaKe4" title="Business combination cash">0.5</span> million of cash due at closing and the remaining $<span id="xdx_901_ecustom--DeferredUnderwriterFeePayableCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zz69NWPh80n8" title="Business combination cash">3.5</span> million
is recorded as deferred underwriter fee payable on its consolidated balance sheet as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Loan
Extensions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Business Combination, the Company assumed Data Knights&#8217; liabilities, which included existing loan extensions
to related parties. The loan extensions were to be exchanged for a fixed amount of Common Stock upon the closing of a business combination
or a similar event. As of December 31, 2023, a balance of $<span id="xdx_908_ecustom--LoanExtensionsCurrent_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z2c0KhMGSMo9" title="Loan extensions">3.0</span> million remained outstanding and is recorded as loan extensions on the
Company&#8217;s consolidated balance sheet.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132152304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zI3WrqxnE3R4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.
<span id="xdx_820_zryoLV1ClL83">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are summarized as of December 31 (in thousands):</span></p>

<p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zctF042YaQBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zsdgk10zk6S2" style="display: none">Schedule
of Property and Equipment </span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20231231_zScowbnVX4r8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zSU3yWvcNnRg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zmMLhg6gxMr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Computers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">303</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">259</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndEquipmentMember_zKjXoUbbvTVf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Furniture and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzSdJ_zBDrk6m2BQQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">307</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">263</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzSdJ_z65ajHtdtx35" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(208</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(180</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzSdJ_z8519SR6uWia" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">99</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p id="xdx_8A8_zwUdgbVD3zwk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense was $<span id="xdx_90E_eus-gaap--DepreciationAndAmortization_pn4n6_c20230101__20231231_za7kmkupZMad" title="Depreciation and amortization expense">0.03</span> million and $<span id="xdx_903_eus-gaap--DepreciationAndAmortization_pn4n6_c20220101__20221231_zKa7PPYBZwXk" title="Depreciation and amortization expense">0.02</span> million for the years ended December 31, 2023 and 2022, respectively, which is recorded
within general and administrative expenses in the consolidated statements of operations.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132194752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zWzbpj6gh1Ha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
<span id="xdx_828_zx0hAoTsBH57">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_893_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zz2CDF9Xeoi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has operations in the United States and Canada. The components of income (loss) before the provision for income taxes are as
follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zQTOOeov4NVh" style="display: none">Schedule
of Components of Income (Loss) Before Provision for Income Tax</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_zFL9j071bVj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zsYuUmfCvrs9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pn3n3_maILFCOzkfc_z8EUKV3XXp13" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">United States</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(33,827</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(30,456</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pn3n3_maILFCOzkfc_zvC4tlK0ELh9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">65</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pn3n3_mtILFCOzkfc_z10nWaDT2DZd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total loss before income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(33,762</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(30,434</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A8_zWxVPdswhZGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYDZ9Jadipe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the income tax provision for the years ended December 31, 2023 and 2022 were as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zO05iQweijl6" style="display: none">Schedule
of Income Tax Provision</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230101__20231231_zqBXVBFcUOLk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_zgYoS1eO7HAc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCITEBz04w_zGN0u9zFCaza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4297">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCITEBz04w_zh67G1FT8SPh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current state</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4299">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4300">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentForeignTaxExpenseBenefit_pn3n3_maCITEBz04w_ziHBSRkZEypi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1pt">Current foreign</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">18</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">17</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pn3n3_mtCITEBz04w_maITEBzoUt_zV2WZZOV3jHc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total current tax provision (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_z5t8b0vJCsI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4308">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4309">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zz1dXMgyjO5h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred state</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4312">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zfo1x4Qtobcf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Deferred foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4314">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4315">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredOtherTaxExpenseBenefit_iT_pn3n3_mtDOTEBz8fT_maITEBzoUt_zipeTfX0cS11" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total deferred tax provision (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4317">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4318">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtITEBzoUt_zFVUU1sujEae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total income tax provision (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_zlok7NUULzo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuhQpduCjgzk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zKcFvDGMybEj" style="display: none">Schedule
of Reconciliation of Income Tax Benefit</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zgp3TP5wiPX9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_z6ojoo4FoUtb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maA91O_zNocUp5KIQej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Tax provision at statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maA91O_zTekL1evozOc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">State taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.2</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_pid_dp_uPure_maA91O_z9DpQZJhwmlf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.9</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.4</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_pid_dp_uPure_maA91O_zK7kcATDWhu" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Permanent differences - other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.2</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_pid_dp_uPure_maA91O_zJXgkx4VyDic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11.0</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.5</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_405_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_pid_dp_uPure_maA91O_zAwT4x19t7M4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.7</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.8</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maA91O_zbxozSWzftM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.4</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.0</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_pid_dp_uPure_maA91O_zGZOfZDfpHi9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.2</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtA91O_z2AjT5u3dcB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective income tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-0.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-0.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<p id="xdx_8A7_zIDiT5N71Ckg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSK7CbxAzVsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are as follows
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zErVYRkVefe4" style="display: none">Schedule
of Components of Deferred Tax Assets and Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_zuw1iEzGQ6T" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20221231_zus8BdIoMwTl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zJCjM3nGYhn8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzqvH_zaLcZourTz2h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,393</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,551</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalizedResearchCosts_iI_pn3n3_maDTAGzqvH_zIDBvLOxQ3r" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Capitalized research costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">337</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4361">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsFixedAssets_iI_pn3n3_maDTAGzqvH_zuVmYqAMaLt6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzqvH_zwenP6nEqmKh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzqvH_maDTANzhf6_zTdbmAIfpww6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total gross deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,759</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,601</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzhf6_zwXYLUTJSVRa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,753</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,597</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzhf6_maDTALNzTQu_zL2kMVGTT5uj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zMvwfAqU62Hj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iI_pn3n3_zDmqy1gEjvyc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(4</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pn3n3_di_msDTALNzTQu_zZmIn0dnsln1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(4</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzTQu_zWflyjbJOhU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4387">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4388">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p id="xdx_8AE_ztSceRVsz8k7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has generated both federal and state net operating losses (NOL) of approximately $<span id="xdx_90D_eus-gaap--FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pn5n6_c20230101__20231231_zVehpsR5P5ah" title="Federal and state net operating losses">31.3</span> million and $<span id="xdx_909_eus-gaap--FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pn5n6_c20220101__20221231_zHX0bWmkbQuk" title="Federal and state net operating losses">15.9</span> million, respectively.
The federal NOLs include $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20231231_zOZ9Jq2eHiI3" title="Operating loss carry forward">12.2</span> million which expire at various dates beginning in 2030 and $<span id="xdx_90B_ecustom--OperatingLossCarryForwardIndefinitely_iI_pn5n6_c20231231_zG37F84hkPse" title="Operating loss carry forward indefinitely">19.1</span> million which carry forward indefinitely.
The state NOLs expire at various dates beginning in 2030.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership
changes, as defined in the Internal Revenue Code Section 382, could limit the amount of NOLs that can be utilized annually to offset
future taxable income. Generally, an ownership change occurs when the ownership percentage of 5% or greater stockholders increases by
more than <span id="xdx_904_ecustom--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe_dp_uPure_c20230101__20231231_z4v0DuH9cosg" title="Effective federal income tax percentage">50</span>% over a three-year period. The Company&#8217;s ability to utilize its federal and state tax attributes may be limited by
ownership changes that have occurred in the past or may occur in the future. The Company has not yet conducted a formal study of whether,
or to what extent, past changes in control of the Company impacts its ability to utilize NOL carryforwards because such NOL carryforwards
cannot be utilized until the Company achieves profitability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
has evaluated the positive and negative evidence bearing upon the realizability of the Company&#8217;s net deferred tax assets, which
are comprised primarily of net operating loss carryforwards and research costs capitalized for tax purposes. Management has considered
the Company&#8217;s history of cumulative operating losses and estimated future tax losses and has determined that it is more likely
than not that the Company will not recognize the benefits of the net deferred tax assets. As a result, the Company has recorded a full
valuation allowance at December 31, 2023 and 2022. The valuation allowance increased by $<span id="xdx_900_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pn5n6_c20230101__20231231_zR3Kx372k8Y2" title="Deferred tax assets valuation allowance">1.2</span> million in 2023 due to the increase in deferred
tax assets, primarily due to net operating loss carryforwards and capitalized research costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023 and 2022, the Company had no uncertain tax positions. The Company recognizes both interest and penalties associated
with unrecognized tax benefits as a component of income tax expense. The Company has not recorded any interest or penalties for unrecognized
tax benefits since its inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company files federal, various state, and Canada tax returns. In the U.S., all tax years since inception remain open to examination by
major tax jurisdictions to which the Company is subject, as carryforward attributes generated in years past may still be adjusted upon
examination by the respective tax authorities if they have or will be used in a future period. In Canada, the Company is generally no
longer subject to income tax examinations for the years before 2020. The Company is currently not under examination by any tax authority.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132146064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--DebtDisclosureTextBlock_z1hJ0b91gQV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.
<span id="xdx_82E_zjLpuYW4gLRd">Canadian Emergency Business Account (&#8220;CEBA&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, the Company applied for and received a $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zW2YBo3xqU05" title="Proceeds from loans">60</span> thousand CAD ($<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn3n3_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zsSziDGlhTH1" title="Proceeds from loans">40</span> thousand USD) equivalent CEBA loan. The loan was provided
by the government of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and
better position them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through
December 31, 2023. If the loan was paid back by January 18, 2024, $<span id="xdx_90F_eus-gaap--DebtInstrumentDecreaseForgiveness_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zCvOcNhwQZp8" title="Forgiven of loan">15</span> thousand of the loan would have been forgiven. If the loan was
not paid back by January 18, 2024, the full $<span id="xdx_900_eus-gaap--DebtConversionOriginalDebtAmount1_pn3n3_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zDdu5sArUMTe" title="Conversion of loan">40</span> thousand loan would have been converted to a loan repayable over <span id="xdx_905_eus-gaap--DebtInstrumentTerm_dc_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJ1ETCo2z78l" title="Loan payment term">three years</span> with a <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zJW1VlW8jUH4" title="Interest rate">5</span>%
interest rate. The loan was paid back prior to January 18, 2024, and the Company recognized a gain on extinguishment of $<span id="xdx_905_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pn3n3_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zhhHczOlBPTj" title="Gain loss on extinguishment of debt">15</span> thousand,
which is presented in other expense (income), net in the condensed consolidated statement of operations for the nine months
ended September 30, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zbByYFCJ25A1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
<span id="xdx_82A_zufdttgdxKAf">Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;)</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
December 2020, the Company applied for and received a $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uCAD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_z51TPmXNcXJk" title="Proceeds from loans">0.06</span> CAD ($<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfUnsecuredDebt_pn4n6_uUSD_c20201201__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zxvovi9W7qR6" title="Proceeds from loans">0.04</span> USD) equivalent CEBA loan. The loan was provided by the Government
of Canada to provide capital to organizations to see them through the challenges related to the COVID-19 pandemic and better position
them to return to providing services and creating employment. The loan is unsecured. The loan was interest free through December 31,
2023. If the loan was paid back by January 18, 2024, $<span id="xdx_900_eus-gaap--DebtInstrumentDecreaseForgiveness_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zcINTLeES6l7" title="Forgiven of loan">0.01</span> million of the loan would have been forgiven. If the loan was not paid back
by January 18, 2024, the full $<span id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_pn4n6_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zilxXcAVSdJd" title="Loan repayable">0.04</span> million loan would have been converted to loan repayable over <span id="xdx_902_eus-gaap--DebtInstrumentTerm_dc_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zSLYP65LwAj" title="Loan payment term">three years</span> with a <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20201231__us-gaap--DebtInstrumentAxis__custom--CEBALoanMember_zFaaRuPr70p6" title="Interest rate">5</span>% interest rate.
The loan was paid back prior to January 18, 2024. At December 31, 2023 the loan was classified as Canada Emergency Business Loan Act
under other long-term liabilities on the consolidated balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounted for the loan as debt in accordance with FASB ASC 470, <i>Debt</i>, and accrued interest in accordance with the interest
method under FASB ASC 835-30.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590131293392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Treasury stock</a></td>
<td class="text"><p id="xdx_842_eus-gaap--StockholdersEquityPolicyTextBlock_zykcr4STYTP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_ztClUiPVzDv5">Treasury
stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records the repurchase of its common stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240930_zV5aGhhoxuBl" title="Common stock, par value">0.0001</span> per share (&#8220;Common Stock&#8221;) at cost on the trade date
of the transaction. These shares are considered treasury stock, which is a reduction to stockholders&#8217; equity (deficit). Treasury
stock is included in authorized and issued shares but excluded from outstanding shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--StockholdersEquityPolicyTextBlock_zJjjHU9EiIXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Classification
of Series A-1, and Series A-2 preferred stock</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_zuHE7wZUI1Lf" style="display: none">Treasury
stock</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company originally classified its Series A-1 and Series A-2 preferred stock (collectively &#8220;Preferred Stock&#8221;) outside of permanent
equity because the Preferred Stock contained certain redemption features that result in those shares being redeemable upon the occurrence
of certain events that are not solely within the Company&#8217;s control, including liquidation, sale or transfer of control. Accordingly,
the Preferred Stock was recorded outside of permanent equity and was subject to the classification guidance provided under ASC 480-10-S99.
Because dividends were not contractually required to be accrued on the Preferred Stock as there was no stated or required dividend rate
per annum, the Company was not required to accrete dividends into the carrying amount of the Preferred Stock in anticipation of a future
contingent event or redemption value. Accordingly, the Company did not adjust the carrying values of the Preferred Stock to the respective
liquidation preferences of such shares because of the uncertainty of whether or when such events would occur. As of December 31, 2023,
all shares of Preferred Stock were converted into Common Stock pursuant to their provisions in connection with the Business Combination,
which closed on November 7, 2023 (see Note 3).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative financial instruments</a></td>
<td class="text"><p id="xdx_846_eus-gaap--DerivativesPolicyTextBlock_zZ2V9HQlBKzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zWX2Asy1zIL7">Derivative
financial instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its convertible debt, warrants or other contracts to determine if those contracts or embedded components of those contracts
qualify as derivatives to be separately accounted for in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 480, <i>Distinguishing
Liabilities from Equity </i>and ASC 815, <i>Derivatives and Hedging</i>. The result of this accounting treatment is that the fair value
of the embedded derivative, if required to be bifurcated, is marked-to-market at each balance sheet date and recorded as a liability.
The change in fair value is recorded in the condensed consolidated statement of operations as a component of other expense (income),
net. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that
fair value is reclassified to equity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is
reassessed at the end of each reporting period. Derivative instrument liabilities will be classified in the condensed consolidated
balance sheets as current or non-current based on whether net-cash settlement of the derivative instrument is expected within 12
months of the balance sheet date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_PlatformOperatorCryptoAssetPolicyTextBlock', window );">Crypto assets</a></td>
<td class="text"><p id="xdx_845_esrt--PlatformOperatorCryptoAssetPolicyTextBlock_zibQBfSiylnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zd4ljSuuHwQ9">Crypto
assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-08, <i>Intangibles
- Goodwill and Other - Crypto Assets (Subtopic 350-60): Accounting for and Disclosure of Crypto Assets </i>(&#8220;ASU
2023-08&#8221;), which provides an update to existing crypto asset guidance and requires an entity to measure certain crypto assets
at fair value. In addition, this guidance requires disclosures related to crypto assets once it is adopted. As of January 1, 2024,
the Company has adopted ASU 2023-08.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reflects crypto assets held at fair value on the condensed consolidated balance sheets and condensed consolidated statements
of cash flows, the activity from remeasurement of crypto assets at fair value on the condensed consolidated statements of
operations, and the required expanded disclosures in Note 3, <i>Crypto Assets Held</i>. The adoption of ASU 2023-08 resulted in no
cumulative-effect adjustment to the opening balance of retained earnings as of January 1, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crypto
assets are generally valued using prices as reported on reputable and liquid exchanges and may involve using an average of bid and ask
quotes using closing prices provided by such exchanges as of the date and time of determination. The time used is 4:00 pm EST.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net loss per share</a></td>
<td class="text"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_zgtB9aGPE3O9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zJw7ipdRavCd">Net
loss per share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates basic and diluted net loss per share attributable to common stockholders in conformity with the two-class method required
for participating securities. Certain warrants participate in distributions of the Company. The pre-funded warrants associated with the
July and September 2024 private placements (see Note 7) are considered outstanding shares in the basic earnings per share calculation
given their nominal exercise price. The net loss attributable to common stockholders is not allocated to the warrant holders as the warrant
holders do not have a contractual obligation to share in losses. Basic net loss per share is calculated by dividing the net loss by the
weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss
by the weighted-average number of shares of Common Stock and common stock equivalents outstanding for the period. Common stock equivalents
are only included when their effect is dilutive. The Company&#8217;s potentially dilutive securities, including outstanding warrants
to purchase Common Stock and outstanding stock options under the Company&#8217;s equity incentive plan, have been excluded from the computation
of diluted net loss per share as their inclusion would be anti-dilutive. For all periods presented, there is no difference in the number
of shares used to calculate basic and diluted shares outstanding to the Company&#8217;s net loss position.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zpI0qE49LlHa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Net
loss per common share</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86B_zl2x1xmQ1a1e" style="display: none">Net
loss per share</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earnings
per share attributable to common stockholders is calculated using the two-class method, which is an earnings allocation formula that
determines earnings per share for the holders of the Company&#8217;s Common Stock and participating securities. Although the Company&#8217;s
historical Preferred Stock contained participating rights in any dividend declared and paid by the Company and were therefore participating
securities, the Preferred Stock had no stated dividends and OneMedNet has never paid any cash dividends and does not plan to pay any
dividends in the foreseeable future. Net loss attributable to common stockholders and participating securities is allocated to each share
on an if-converted basis as if all of the earnings for the period had been distributed. However, the participating securities do not
include a contractual obligation to share in the losses of the Company and are not included in the calculation of net loss per share
in the periods that have a net loss. In addition, common stock equivalent shares (whether or not participating) are excluded from the
computation of diluted earnings per share in periods in which they have an anti-dilutive effect on net loss per common share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted
net loss per share is computed using the more dilutive of (a) the two-class method or (b) the if-converted method and treasury stock
method, as applicable. Contingently convertible notes payable and PIPE Notes were not included for purposes of calculating the number
of diluted shares outstanding as the number of dilutive shares is based on a conversion contingency associated with the completion of
a future financing event that had not occurred, and the contingency was not resolved, in the reporting periods presented herein. In periods
in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders
is the same as basic net loss per share attributable to common stockholders since dilutive common shares are not assumed to have been
issued if their effect is anti-dilutive. Diluted net loss per share is equivalent to basic net loss per share for the periods presented
herein because common stock equivalent shares from the Preferred Stock, convertible notes, stock option awards and outstanding warrants
to purchase common stock were antidilutive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the Company reporting net loss attributable to common stockholders for all periods presented herein, the following common
stock equivalents were excluded from the computation of diluted net loss per common share for the years ended December 31, 2023 and 2022
because including them would have been antidilutive (in thousands):</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none">Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022
    <span id="xdx_F53_zMknzVxwFW2d">(1)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022 (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Employee stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4156">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">913,856</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,276</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,367,607</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,839,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4168">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,415,923</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4171">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,786,610</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total common stock equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,501,229</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retroactively restated
for the reverse recapitalization in Note 3.</span></td>
</tr></table>

<p id="xdx_8AD_zdniDLLHaxk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging growth company status</a></td>
<td class="text"><p id="xdx_844_ecustom--EmergingGrowthCompanyPolicyTextBlock_zcRl5YIt2WRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_z0NQmbkWgKc4">Emerging
growth company status</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an &#8220;emerging growth company&#8221;, as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;).
Under the JOBS Act, emerging growth companies can take advantage of an extended transition period for complying with new or revised accounting
standards, delaying the adoption of these accounting standards until they would apply to private companies. The Company has elected to
use this extended transition period for complying with certain new or revised accounting standards that have different effective dates
for public and private companies until the earlier of the date that it (1) is no longer an emerging growth company or (2) affirmatively
and irrevocably opts out of the extended transition period provided in the JOBS Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_846_ecustom--EmergingGrowthCompanyPolicyTextBlock_zYqQNQ3xCV7f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span>Emerging
Growth Company</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86C_zEsoVgjxUZrh" style="display: none">Emerging
growth company status</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an emerging growth company, as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the &#8220;JOBS Act&#8221;). Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to
comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act
registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such an election to opt out is irrevocable. The Company has not elected to opt out of such extended transition
period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUkuk6y4J0ce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zBbPJIwc5OK3">Accounting
pronouncements not yet adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No.
2023-09, <i>Improvements to Income Tax Disclosures (Topic 740)</i> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 requires disaggregated information
about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. ASU 2023-09
is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual
financial statements that have not yet been issued or made available for issuance. The Company is currently evaluating the impact of
adopting ASU 2023-09 on the presentation of its condensed consolidated financial statements and footnotes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU No. 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment
Disclosures</i>, which is intended to provide enhancements to segment disclosures, even for entities with only one reportable
segment. In particular, the standard will require disclosures of information related to significant segment expenses regularly
provided to the chief operating decision maker and included within each reported measure of segment profit and loss. The standard
will also require disclosure of all other segment items by reportable segment and a description of its composition. Finally, the
standard will require disclosure of the title and position of the chief operating decision maker and an explanation of how the chief
operating decision maker uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to
allocate resources. The standard is effective for annual periods beginning after December 15, 2023, and interim periods within
annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of the
standard on the presentation of its condensed consolidated financial statements and footnotes.</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zK1ZhnNCN3aa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zW7YQkl7K4D5">Accounting
Pronouncements Not Yet Adopted</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU No. 2023-09, <i>Improvements to Income Tax Disclosures (Topic 740)</i> (&#8220;ASU 2023-09&#8221;).
ASU 2023-09 requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional
information on income taxes paid. ASU 2023-09 is effective on a prospective basis for annual periods beginning after December 15, 2024.
Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. The Company
is currently evaluating the impact of adopting ASU 2023-09.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): <i>Improvements to Reportable Segment Disclosures</i>, which
is intended to provide enhancements to segment disclosures, even for entities with only one reportable segment. In particular, the standard
will require disclosures of significant segment expenses regularly provided to the chief operating decision maker and included within
each reported measure of segment profit and loss. The standard will also require disclosure of all other segment items by reportable
segment and a description of its composition. Finally, the standard will require disclosure of the title and position of the chief operating
decision maker and an explanation of how the chief operating decision maker uses the reported measure(s) of segment profit or loss in
assessing segment performance and deciding how to allocate resources. The standard is effective for annual periods beginning after December
15, 2023, and interim periods within annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently
evaluating the impact of the standard on the presentation of its consolidated financial statements and footnotes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_840_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zV1XxAmYpNw2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z66TBxyppqMl">Basis
of Presentation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#8220;GAAP&#8221;). The accompanying consolidated financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements include the accounts of OneMedNet Corporation, formerly Data Knights, and its wholly-owned
subsidiary, OneMedNet Technologies Canada Ltd. All intercompany transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RestatementToFinancialStatementsPolicyTextBlock', window );">Restatement to Previously Issued Consolidated Financial Statements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84E_ecustom--RestatementToFinancialStatementsPolicyTextBlock_zlfs5i9HvsA" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zF84H1NjBDH9">Restatement
to Previously Issued Consolidated Financial Statements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 12.95pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s consolidated financial statements for the years ended December 31, 2023 and 2022, as previously filed with the SEC on
April 9, 2024, have been restated. The previously filed consolidated financial statements did not reflect the proper accounting for the
business combination transaction, convertible notes, warrants, preferred stock, stock-based compensation expense, and accounts payable
and accrued expenses. The Company has also restated related amounts within the accompanying footnotes to the consolidated financial statements
to conform to the restated amounts in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following consolidated financial statements provide a reconciliation from the originally &#8220;as reported&#8221; financial information
to the now &#8220;as restated&#8221; consolidated financial information as of and for the years ended December 31, 2023 and 2022 (in
thousands, except share and per share data).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p id="xdx_893_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zQobtUlY9Fg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zmqNIyggURV3">Schedule
of Restatement of Financial Statements</span><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--StatementOfFinancialPositionAbstract_pn3n3_zHB7otDeIImb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheet (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zruyu53jUhca" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zcfTKFbd2jqd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zCrqV71XHMwj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zseXWl5ARgmk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (<span id="xdx_F56_zoHeAO3yRzkb">1</span>)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z3fZH6OQ10X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zXmzyt8ADHpc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACznbB_zwfJYNAqd4h2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%; text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsHeldInTrustCurrent_i02I_zQhwodfyf5vd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2064">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2065">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2066">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2067">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACznbB_zhZl1KSXxike" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance for credit losses of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zPo9iq8qLwpk" title="Accounts receivable, allowance">0</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zMIhH9k6HRqe" title="Accounts receivable, allowance">125,233</span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2070">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACznbB_zUCqDZwvR8h1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">166</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2079">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2080">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">166</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACznbB_maAzRE3_zWVgddrEhU8f" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">365</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2084">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2085">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">365</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeferredCostsNonCurrent_i01I_pn3n3_maAzRE3_zadfKDc4WIPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2088">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2089">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2090">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2091">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzRE3_zG9krXgkbKe1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2095">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Assets_i01TI_pn3n3_mtAzRE3_zRG9OArPib89" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2099">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zq1I6hLyExog" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbZJCma4btqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zssMDVKCKb27" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">498</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2115">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zNPcfhGy81Dl" style="text-align: center">2</td></tr>
  <tr id="xdx_408_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z5EoFfgXn103" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2121">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ExciseTaxCurrent_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_zoHwN3FbTAHf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Excise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2126">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredRevenueCurrent_i02I_pn3n3_maLCzjPj_zgTzWhgM5q78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2129">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2130">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zqzqEDRPdHVe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2133">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2134">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2135">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LoanExtensionsCurrent_i02I_pn3n3_maLCzjPj_zxQs4dQZsJhi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,992</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2139">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,992</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LoansPayable_i02I_pn3n3_maLCzjPj_z4rAes4v5eLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--CanadaEmergencyBusinessLoanAct_i02I_pn3n3_maLCzjPj_zh8sEs0vfagg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2149">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2151">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccruedIncomeTaxesCurrent_i02I_pn3n3_maLCzjPj_zMZx9uIWYCb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2154">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2156">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_pn3n3_maLCzjPj_zBTLDRUX27Ba" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_pn3n3_maLCzjPj_zjmSYJKQeNEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,637</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z70r7UPIkBw8" style="text-align: center">3</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zxhw1hbC8X8d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Other current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2168">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_z7XLQgC9gMPe" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2173">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2174">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzjPj_maLzhoA_zUAVIkx4mgr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">585</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,373</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ConvertibleDebtNoncurrent_i01I_pn3n3_maLzhoA_zXYxZv4wnbE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2183">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_z0sV3xK1qwE8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2188">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2189">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2191">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_z3W70HCcYUcf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_pn3n3_maLzhoA_zWCkZbDgLii7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loan, related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2199">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2200">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_z3TrqGM1swRk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2206">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WorkingCapitalLoan_i01I_maLzhoA_znG3RD0bmoD8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2210">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--WarrantLiabilityNonCurrent_i01I_pn3n3_maLzhoA_zvrWCZOR9MLe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2214">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2216">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLzhoA_zzAZ5vz1nGW5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2218">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4E_zdVxtDBJ0vy4" style="padding-bottom: 1pt; text-align: center">4</td></tr>
  <tr id="xdx_401_eus-gaap--Liabilities_i01TI_pn3n3_mtLzhoA_maLASEzB9f_zWurd1Dcwf66" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13,323</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">583</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2225">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13,906</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_maLASEzB9f_zriAse0CJx5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2228">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2229">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2230">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2231">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--TemporaryEquityAbstract_i01B_zCjF4hRjdSM9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxCEJ7wpVb28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zcQDvHCATRy3" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmw2jLMPLdv3" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zk2kv65ICmXe" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8QQZwnKdLZf" title="Temporary equity, shares authorized">4,200,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zbwzb6ONsLgi" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBohDzYt6cuc" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zPYyjWP6t8nl" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zDpri74qdrj4" title="Temporary equity, shares outstanding">3,415,923</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2238">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2240">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2241">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zvgShIKHTHql" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUdnjUXJ4Nc1" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUBfnzNHxmQ7" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zD2AuNLE5jti" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYuIuwhSTul" title="Temporary equity, shares authorized">4,400,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zFfkQRyVN4Y8" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgXlLITRaRd" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z75ktmKy0962" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z5lkoDhcdVvc" title="Temporary equity, shares outstanding">2,839,957 </span></span>shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2260">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2261">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2262">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEzB9f_zFJ3TKul93Da" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2280">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2283">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zWgvLMcwUEad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_pn3n3_maSEzYAb_zDP929DLJBcj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zTouxWv5xMNj" title="Preferred stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zoAhJQ97gzT" title="Preferred stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zY9mbTXbyWjg" title="Preferred stock, shares authorized">1,000,000</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zaAG4dvCdMGb" title="Preferred stock, shares authorized">0</span> shares authorized at December 31, 2023 and 2022, respectively; <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zeXWFKcteVZa" title="Preferred stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zFLSOBzdiIYi" title="Preferred stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2RDRUICTuA3" title="Preferred stock, shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zF0OtUHrvAid" title="Preferred stock, shares outstanding">no</span></span></span></span> shares issued and outstanding at December 31, 2023 and 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2290">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzYAb_zKclxpQQ1fc5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zO8f1W2CvHd1" title="Common stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z0fgb54GPpF7" title="Common stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z87XB46c1rqk" title="Common stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zlJ0WFifrcwj" title="Common stock, shares authorized">100,000,000</span></span> shares authorized and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z37TR95QhdKj" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zhQfhe7EP9Z4" title="Common stock, shares outstanding">23,572,232</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zD5XPgF0KCAh" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zOrvrjW3oymd" title="Common stock, shares outstanding">4,033,170</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2313">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pn3n3_maSEzYAb_zr99liLi1UOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,221</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2334">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zsHwSQ1sDr3" style="text-align: center">5</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pn3n3_maSEzYAb_zaNz42WzTBF6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(55,083</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(36,357</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(91,440</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F49_zKvHtgqXejJk" style="padding-bottom: 1pt; text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzYAb_maLASEzB9f_zPwz0JsddSC7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total stockholders&#8217; deficit </b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(12,859</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(583</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(13,442</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzB9f_zgvnToSh7PEc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0A_zxpPh2kj3NLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zv3t0HiTxmkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zHmIIEvFd8Ne" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zQ2Kprb6wXq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_z45MNyUdVjC3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z1BUgtO53Nk2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zI0DPexFF7Xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_z8uJZPF6GN1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of liability-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zzIQLbw8bWJj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zWvic4rLmBCb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zfMaYzeUq0yi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_z9pixMR8yD4a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ivgJzJjlvk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBNy3rflnLOh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zDVc23ZbTal1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F5B_z2orGC7gqCVd">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zyrQoTWDbpmg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zoHhxMUlwOn3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zylrCrVigph8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zklWvSmRU3hg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">302</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(31</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2370">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">271</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F44_zWiYZ0g0Crw7" style="width: 6%; text-align: center">2</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsHeldInTrustCurrent_i02I_z5i7O4J0zNh9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,029</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2376">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zlMEbFIQFeXl" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_z91VCg6KuhUk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zXowDYdGPzGi" title="Accounts receivable, allowance">0</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zIJD7O8FvRM6" title="Accounts receivable, allowance">125,233</span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2380">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zQeyB686mQ62" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2388">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2389">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtACznbB_maAzRE3_zeC41by6Wz69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">29,451</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(29,060</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2394">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">391</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredCostsNonCurrent_i02I_maAzRE3_zjz3cdl7FRTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">900</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(85</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">815</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zugrWwR5FxFg" style="text-align: center">3</td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAzRE3_zbYTPH2Futm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">83</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2404">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">83</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_iTI_mtAzRE3_zuFdBSWVj8ce" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">30,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(29,145</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2409">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3idIMSAttVf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfMGnFVZHtZj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzjPj_zlbUKNPQwEya" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,814</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,637</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,177</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z1PDq4D8k1bg" style="text-align: center">4</td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilities_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z387LtueELU9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2430">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zSY0KCHBsjBj" style="text-align: center">2</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_maLCzjPj_z9JdmARHcJg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2433">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zIdFD76ACDwf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,743</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zHBwRYiaiQg5" style="text-align: center">5</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzjPj_zd0KrYwUO0fh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2444">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2445">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zPc4odgOaoCa" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_zvh30x1dLpB5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(70</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4F_zT5OAzrQZl5f" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzALC_maLzDXj_zJod9ww4Wxj7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,785</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,104</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzhoA_zIHuzIhaWiC5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2458">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_zfKNTjGJYna2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2463">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(44</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_zGr6iAAo4DVb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(691</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2469">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zWbk5Oymcxfk" style="text-align: center">5</td></tr>
  <tr id="xdx_409_ecustom--WarrantLiabilityNonCurrent_i01I_maLzhoA_zGpl8dgESeb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">363</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(363</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2474">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zoFnY3Hr2jo6" style="text-align: center">2</td></tr>
  <tr id="xdx_40C_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_zmTEozCqcKo5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,025</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2480">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy1llbxdPwRd" style="text-align: center">2</td></tr>
  <tr id="xdx_408_ecustom--WorkingCapitalLoan_i01I_maLzhoA_zCJ6wwyiyxX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2484">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy8mdZVEYor6" style="text-align: center">2</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermLoansPayable_i01I_maLzhoA_zLbIae4ITDb1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Extension loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,546</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2489">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2490">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zj7IDgjpWd1b" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzhoA_zTmH1HjVwx28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2492">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtLzhoA_maLASEzB9f_zJPu33kIRNI8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">21,161</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">6,488</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">27,648</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzB9f_z4bET9jAmas6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--TemporaryEquityAbstract_i01B_zChswc4s12K1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zCNQhtB5sb38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMglAdrlMTt5" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8CjB97Kyrk8" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zuhtwF938LQ" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zvZjuO1dS995" title="Temporary equity, shares authorized">4,200,000</span></span> shares authorized, and <span title="Preferred stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zYta6rHV0Uib" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zacGgWoOstM" title="Temporary equity, shares outstanding">0</span></span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_ziGtk3V4nsb6" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zOLOUQaIz6v7" title="Temporary equity, shares outstanding">3,415,923</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2512">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_z50ydQvD68Td" style="text-align: center">6</td></tr>
  <tr id="xdx_401_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgG0PJuk8Sdf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUXcga9S2JVd" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYCHWXEzs9ai" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zcQRvID0AXgg" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zQOdJGerQ3jb" title="Temporary equity, shares authorized">4,400,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zg3c3qDYeBj" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Aai5K2fUv4" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrtw0CUjcqna" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMctTmHlLhfa" title="Temporary equity, shares outstanding">2,839,957</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2533">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,010</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2535">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,010</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4B_z0vVaUYkTlw9" style="text-align: center; padding-bottom: 1pt">6</td></tr>
<tr id="xdx_40C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_zQNtilKUcrb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2554">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,644</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,644</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zlBYW8gmYu2d" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockValue_i02I_maSEzYAb_zc9TdGIsqNa6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z5EF10mnZfIg" title="Common stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZset6MUT9Se" title="Common stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zQcjfsQlc3r3" title="Common stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zDDZaWxqSTr5" title="Common stock, shares authorized">100,000,000</span></span> shares authorized and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zzH2BT9iwqQ4" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z24UGTu0EBAg" title="Common stock, shares outstanding">23,572,232</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zr2XpGWsvCs3" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zFaCWuPdJL7b" title="Common stock, shares outstanding">4,033,170</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2566">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzYAb_z6yOhGiOFPc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,375</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2587">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zejDbpADROE9" style="text-align: center">7</td></tr>
  <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzYAb_ze7UyEDUJZR1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(43,510</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,150</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(57,660</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzYAb_maLASEzB9f_zq9LusNyoTo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,273</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzB9f_zQ7TyynSymYi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">30,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(29,145</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zQQ25kVU5LG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td id="xdx_F1D_zcom1f3JbKv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F08_zxRpE7ddi9se" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F10_zqdJW85EC7P9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zaUqYTsXpy75" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F17_z12r7OJ9cdv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0D_zkzbOYh5KVrc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1E_z0YDHGimDoYl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zhrofTMKWeul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F1C_zGaauYyovNfl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F07_zg7mY89UOBh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F15_zu9Mge4cdMl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for historical preferred stock as temporary equity.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zjbye4RasFl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F17_zTscRma7hil8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zwkFbooRqn5b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Operations (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaXGkJXpTCe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z028oDaLxcnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z40LEykJTRCe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F50_zZzgLezQkhG9">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zi0ZRYIKnBM3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zfQPdTtBiee3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zHeJfx3Vozbg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2620">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2621">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zPcMCXCGZPc9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2625">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2626">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHDo_z9waVkSQPWO7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,021</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2631">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,021</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHDo_z6GMLbvVfSac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2635">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHDo_znNyLw8scYyi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2640">-</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2641">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zCYcQRN6Sc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zq3x0GU7zIea" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,730</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2651">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,544</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zE9FiJGZnz6l" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zDBuLJ2WlWs8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(226</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zryX8YnXH7Yc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2661">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zaz5jo1m1yvc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,632</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">433</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2666">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,065</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F45_z9ClZTf3FKq8" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zJHTG9nQ0lGe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">8,247</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1,297</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(226</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">6,724</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zbQSvWT10ge1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(8,376</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,523</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(6,853</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8jXu5rEIzza" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zIkUcqgVzEBc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2686">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetImpairmentCharges_i01_msNIEzJuG_zSWikkgtMta9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zMsz0tSF3PPe" style="text-align: center">3</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zy58V1qNXhb3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">749</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(738</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2696">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUF6AddaOctl" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zj7QMQhvOLi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zPun54PZDMy8" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zpKYnI4UO24l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(47</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(82</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F49_zXwujTSGCHxc" style="text-align: center">6</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEzbEL_zb5UH1P07sL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2711">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zQGlpsX4Pmdi" style="text-align: center">7</td></tr>
  <tr id="xdx_401_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zJEambHaPBre" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2716">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zzPTykfoVGAl" style="text-align: center">4</td></tr>
  <tr id="xdx_404_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zPo3ZpZ7XnEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2720">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">34</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zL4eFL1DWeh6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2725">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_ziS6Q11zdOnd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,830</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,097</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,909</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zPKUMtZQ1iU6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(23,206</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(10,574</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">18</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(33,762</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zgynma3E0s1d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2739">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2740">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzord_zgVpHaAbAfT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(23,206</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(10,574</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2746">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(33,780</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zgtaMKf18hbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zfMorvUR0clk" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zpRU0cyDmo7b" title="Diluted net loss per common share outstanding">(0.98</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zmNg5vQC4Bo8" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zFkAcqHuTXUi" title="Diluted net loss per common share outstanding">(3.78</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zJ0ZQpMQvn22" title="us-gaap:EarningsPerShareBasic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zVerDL4ZXGak" title="Diluted net loss per common share outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2762"><span style="-sec-ix-hidden: xdx2ixbrl2764">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fOA_____zaBkgZhbjVei" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fOA_____zmwUHhQcSOc5" title="Diluted net loss per common share outstanding">(4.77</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____z36ArBhqPUy6" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zErTzsc1irw3" title="Diluted weighted average number of common shares outstanding">23,572,232</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zoMuYwYXrcGa" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zyyYt7a033s" title="Diluted weighted average number of common shares outstanding">(16,488,164</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zsBYKMj5kk97" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zDQ3reWdjQE7" title="Basic weighted average number of common shares outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2778"><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zt2ybXAaUhe8" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zDgEREjS19nb" title="Diluted weighted average number of common shares outstanding">7,084,068</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z39dTMQ7aKS1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zBDhOn7yGByb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0B_zkIyW9V6GaL5" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z6pc3v68oqb6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zbAjVkGiaN6h" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F1A_zmaqyPMOauU5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zUiPPdP75J9g" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z4AQVNJgwwje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zfMpc6kW3D1j" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z30zalgt25Q7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_znmNTrFvBWK8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zqbSoM383NGc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zTL2gO4Z7NK1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z7OzvY6Ptmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zgGQG6V9gICj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F10_z2vSr1u7Bt34" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAqyObC2l9kb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTj9bNOVZAOd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z7veP8m81sFd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F55_zM3RLW9AQV3j">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220101__20221231_z7s5h9N5psD8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zhSG1L632XDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zmHR78PheYDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2800">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zfuzVjy0bBO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2805">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2806">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHNd_z3M7b4W4iwk4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2811">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHNd_zp2gco9roem6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,513</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2816">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,513</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHNd_zq3yDkZbOD2e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,153</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zMh80MASqE16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zkvLEULoFTgd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,756</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,950</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zzjd3qehnLZi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zBXkCMPrzTD7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(399</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zKEs7uT3IEsi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zoahsy8GI69d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">953</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">638</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2846">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,591</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F42_z2kghhNL2bcg" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zScGRpGXcBLh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">11,066</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(3,312</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(399</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">7,355</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zwUEJLMn9Lq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(11,426</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,711</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">399</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(7,715</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8Q9WxvWWZJc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zgoKVFgTyK7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2866">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2867">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_z6C8HsKy7cj1" style="text-align: center">3</td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zXSimJByCVFj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2871">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zv3crlecuyh8" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zBEXfcaZ2Tnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_zrwCVEVSOSW7" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zJsTq68EZYH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2882">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z7PyhTCf4XM2" style="text-align: center">3</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zUXxZiut0JIl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2884">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zazMZoxkpDv6" style="text-align: center">4</td></tr>
  <tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zplVkutO87u5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><p style="margin-top: 0; margin-bottom: 0">Other</p>
                                                     <p style="margin-top: 0; margin-bottom: 0">expense</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2890">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zKLZPn97d85g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,372</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,372</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F46_zxXsAtefuDHc" style="text-align: center; padding-bottom: 1pt">3</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_zck2r7mIQ1ua" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,196</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,932</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(17</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22,719</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zQQsZ98kFFhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(6,230</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(24,221</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">416</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(30,434</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zlXyhHrqYtG6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2910">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzord_zxSEeHKVrTTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(6,230</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(24,221</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">399</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(30,451</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zLpq4rZCb2K3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic net loss per common share outstanding"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted net loss per common share outstanding">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zLdkHTcYaNcb" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zWqk08J9R21j" title="Diluted net loss per common share outstanding">(7.66</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zALngv2ajKAa" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zmVC2juKldy3" title="Diluted net loss per common share outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2928"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fNg_____zr4Fpw3Z764f" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fNg_____z5J1Eds5vKJb" title="Diluted net loss per common share outstanding">(7.66</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted weighted average number of common shares outstanding">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zGauFJJaMMa2" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____z2m8eKFmBKdi" title="Diluted weighted average number of common shares outstanding">3,973,897</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zupxhmAMKlB" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zAANc7O5PDva" title="Diluted weighted average number of common shares outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2940"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_fNg_____zI6r7ZgLzbhg" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_fNg_____zO0Kt17dPiZ3" title="Diluted weighted average number of common shares outstanding">3,973,897</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F02_zMW0yTCrPjCc" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zOXZ2WhRJaBb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zElkDXBk5h94" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zodThWHzZ69i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0D_zTdonRR7Nadi" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F13_znclEY6Lw4te" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_z8AAMabERG51" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_z8S0HYfft0v8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zwrpnNPz4BW2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_ztJ1mOOHa1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_z08xFT13J7Uf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F12_zpWOpJCTLxQ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Cash Flows for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_zRnKaIw7jdjk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYZd2yEkwFr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zr7cwzqut9Ii" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zBcdhZk85qA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGvm_z64DQItPSa96" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(23,206</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(10,574</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(33,780</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F43_zw3VLV9eU38g" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzSqX_z1Siz3WmGyPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2969">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationCost_i02_maNCPBUzSqX_zKu7p8ybV0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Business combination cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(900</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zhSRmmNKghZj" style="text-align: center">2</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zIioh3o057C2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,029</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zvkI2gMnv3K4" style="text-align: center">3</td></tr>
  <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzSqX_ztlKU4wKp3L" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2980">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F40_zuT4zzgsB7S7" style="text-align: center">4</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_z1LfWwh2ycDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2984">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zWhhCrOvLBH1" style="text-align: center">5</td></tr>
  <tr id="xdx_402_ecustom--WarrantExpense_i02_msNCPBUz449_zroQluWiV8M5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2989">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ChangeInFairValueOfWarrantLiabilities_i02N_di_zly6v0jfmvIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4C_zLzzviNlbyti" style="text-align: center">6</td></tr>
  <tr id="xdx_405_ecustom--ChangeInFairValueOfPipeNotes_i02_maNCPBUz449_ztCqzYltXv2j" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2996">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zBYtlwHGJs4a" style="text-align: center">7</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_z6Wa9gfFadpl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zUuACnxP3RHe" style="text-align: center">8</td></tr>
  <tr id="xdx_40C_ecustom--NoncashInterest_i02_maNCPBUz449_zRk5FKwAcIlj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-cash interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zX8QjC4r71w1" style="text-align: center">10</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zmyVVkwjHxCk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_zkjFOQ06zN9g" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zsMiljgIih9h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4E_z8iICOZIL45l" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_zxkdC3Z1VQSe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(655</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zgbHqM25Rwih" style="text-align: center">2, 3, 9</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zS794PTHhJgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3025">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_zKQni9fVV3Pf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3028">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3029">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInExerciseTaxLiability_i03_maNCPBUzSqX_zZPZkw6z6kg7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Excise tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zTpyxRxtxAA2" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInExtensionLoan_i03_pp3d_maNCPBUzSqX_zSXrTBuq4qfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(446</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUlA1KyjgDe1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zDM2jYf7zMT6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zqJtwPbubevg" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zhTXU4CWz6xj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(95</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3046">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zYqLLsaf7Lh1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_406_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zirFCYKadrqb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(168</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">168</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3050">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4D_zH1aXYrl5jG7" style="text-align: center; padding-bottom: 1pt">2, 3</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zE1wO1c9Wxi5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,221</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(13,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,791</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zKOBqaEyKXva" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zYXgFU3g6oD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3061">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zqHSZoyjrJ1l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3065">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkxDU18xN9nb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01_maNCPBUzy34_zJEOsi6pVYlc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3072">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3073">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3074">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzGlA_zOdW1gnmqlp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of shareholder loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zaFdLfoupmci" style="text-align: center">10</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzGlA_zg5nyHeTYEI" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_z7M2VCjCnc7k" style="text-align: center">7</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_z07juzthWC5b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3086">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_z3atOgujEQs4" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--ProceedsFromDeferredUnderwritingFee_i01_maNCPBUzy34_z9DVkGtZLhz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriting fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(500</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3090">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zGwrp2TfzbYk" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_zZ0dyaR3S7wd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(338</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zf9QU9Misnz9" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_zAYoX8b1m1Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zYzwxZ33MZH7" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zWwMIO92Lofd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3102">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zx7FQKfwoy5h" style="text-align: center">2</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzy34_zR6lDSHfT83b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds (repayment) from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,681</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zxaWnkX1BqN2" style="text-align: center">8</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zsP3rV8DUkjg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3108">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3109">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3110">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ProceedsFromIssuanceOfSeriesA2PreferredStock_i01N_di_msNCPBUzy34_zDu7i4VAkpD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3112">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zISOUvH1P1t6" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z8WjtJFHZn59" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3116">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,534</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,534</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F40_zyrejfqwdML3" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zfXYzRVj6q5a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,432</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,043</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,611</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_z8gBwTb88MTj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(255</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(224</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zW01Oi5i7WK7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">302</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(31</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">271</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zXFeWXa49hi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3133">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoOYkLkcKEY8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_ecustom--CommonSharesIssuedToPreferredShareholders_i01_zL5AXy97jdhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to preferred shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zsN1AMyCjzzd" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zoPsrtyw1oY" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Common shares related to convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zZAuoRZhbqq6" style="text-align: center">2</td></tr>
  <tr id="xdx_40D_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zK8SHJvpIxr8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to Data Knights shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3148">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F45_zurSmY3KUYv1" style="text-align: center">2</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F01_zhL240hE6k3b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z9dm4Vp0An6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zGGQ55l6kmh1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zUeE55Ju80t3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0A_z4MZv7ZYiCC8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zI2WxXsdey6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zG13g7DRpeth" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1C_zYTXI3E04L3i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zHRA8LZW1Ws9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F11_zg5hJyL5Obpi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F01_zyqW1Xm1i1Kh" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F10_zrt2utkjYT66" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0F_zIYCaCTFZ5G9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F1B_zgD8LP6mENc7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0F_z7fNBeaoaagc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F1E_zTJJUc68HjP" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_zrYUaf70UVgf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td id="xdx_F15_z2QRlzGBbmY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zjJ3QhCQi3U6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td id="xdx_F12_zWah1vcZocA8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b><i>Reconciliation of the
Original and Restated Statement of Cash Flows for the Year Ended December 31, 2022</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd1GVUj81Op9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBhCw3tfNvi7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_ztK2LT4qQfpe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_pn3n3_zFzKoT6TF5kc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUz449_zhjXV3tvln2c" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(6,230</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(24,221</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(30,451</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F4D_zjxT1FD9l7P" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_pn3n3_z0076fqc8VT5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DepreciationDepletionAndAmortization_i02_pn3n3_maNCPBUz449_zm9JPLeVIQE8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maNCPBUz449_z6Q7ZgrwjTL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zIJNrmfhBsRc" style="text-align: center">3</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zS5SB85M13E2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,292</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1NfzNBC5JKe" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_zC68WqLkgJX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_z6tBAOitcY1h" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--WarrantExpense_i02N_di_msNCPBUz449_zEuTdXmz78d8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zkBk4aNHnwei" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_zCUJBEmM2g0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3194">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zpczmZJibJ92" style="text-align: center">6</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zAzE1OfS3Mo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_ztG0vsbqUXte" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zluTWoieg0s6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(876</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4B_zNedHdvlJBW" style="text-align: center">2</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_z0I3mGes2Dxf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z37tNNq9Qes9" style="text-align: center">2, 7</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zeDSeDuJMSm6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(458</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3215">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(458</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_z2GxU8Wb6ygk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3220">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zSE3xgLclZB5" style="text-align: center">2</td></tr>
  <tr id="xdx_409_ecustom--IncreaseDecreaseInExtensionLoan_i03_maNCPBUzSqX_zgskN7980aF2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,546</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zmZ2D62zyLMe" style="text-align: center">2</td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zyV7jFslgyRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(94</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">94</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3228">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zQybhbNoVMKf" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zL2rQVS8QfE" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zdRnntdJgKm" style="text-align: center">2</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zzuEL6o9ruce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">207</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(207</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3236">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F47_zNJP4fjQSaP9" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zJJhW4QBOtek" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,241</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(91,944</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,703</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zilVvTyW6epe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zNGRgLG7f9O3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3247">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zjhR5EClnx7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3251">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zyvRblK7SBoe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01I_maNCPBUzy34_z2KX3jMiyK3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3260">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_zrfUrQmF8m43" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,550</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3264">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zA55vPOU2Hib" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_z9RjVyh6e9h6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3268">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1Q1QdwsjcB" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_z6L0fxtNkTd5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3272">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zVJ0w3BVrU96" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zYdeays3yNz7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,360</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3276">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zvYGPpCF8ALi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzGlA_zxuSCkdEwgk1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,543</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,140</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zQ8Xe760x2r2" style="text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zYGmsnBOP9B5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z3TyDWcTRTM6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination Costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3286">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(815</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(815</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F43_zKeSKcvznUJk" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zwmIc6mhnd5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(88,033</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">92,366</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zp4EyvM8G2Tg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(850</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(428</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDY2bKGDYzo7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,152</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(453</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">699</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zKczG8qKbiOc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">302</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">271</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zYSJMmCsa0ka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zLKRQx9dshs8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_z87rmpJn3ZB8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F15_zDRZS1dv1eOl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zxbQFNbtYzE9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F10_z42bK2J0pX1f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_zAgkZCBqrDZc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1A_zFDMqwcniOib" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zCFiNFZCBLKj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F13_zrElvg95e3hb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zMeCuTCN8Un6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z00H9AjztdPb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improper
    presentation of Business Combination costs as well as errors identified related to capitalization of such costs. Refer to balance
    sheet restatement reconciliation for more information.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zbzwUQkL3AE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zd8vvcZGRvQ" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zK5CmsM1ZRH1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zqwRhzUrgNN" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zWLv2SAVVLB" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zJ1EbxPqWHa2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zkuypag4rQ83" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSbLFbtZqFHd" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlv5Cf5sOUO3" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3322">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1NbSqGrvhck" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8AgftvLtU5f" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3326">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUidXthwSV4a" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3328">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXBFGFyRKYs2" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">9,388,958</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">1</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">28,750</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">24,032</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(43,510</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">9,273</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXjcEC2yKbDd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zww2RJZCA4ii" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTybYcahs77" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fMg_____z83jL5Bb2Imd" style="text-align: right" title="Issuance of common shares in exchange for services, shares"><span style="-sec-ix-hidden: xdx2ixbrl3350">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3344">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3345">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3347">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3348">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM6gBXLBUoac" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKviQDmZq1Bf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrI4xcsaTqM3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdXG50votS8i" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"><span style="-sec-ix-hidden: xdx2ixbrl3370">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3364">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3365">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3368">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoFXc0EowaZ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3372">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3373">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3376">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqMk9V97gCEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcyI1ubllCfe" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">612,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3378">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3381">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">613</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3isqa2ILvij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0wDNGMku6F5" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">3,859,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3386">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3387">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,859</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,859</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB1ofR7bGO37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible loans upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCuKJG4XINv" style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">6,177,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3395">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,177</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3397">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,178</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjRLnI869rq7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWPCyxfSZ185" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4v1VSB6GRm4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOvsvOeYyLy8" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(3,853,797</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBDYBabeNKUb" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(3,204,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zp8TtqKLkxy6" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">7,057,797</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3415">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,057</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3417">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,058</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4R3JHuzW4d4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZtIFRsSvo14" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares">(2,257,326</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3427">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,257</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,257</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zImjAQyx1dl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3435">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgVEMYmeVYy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHK8uetxWRNh" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">(1,266,560</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3440">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3441">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3443">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf5V5sZPtbyj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3448">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwO9nIUVQfV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3455">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,893</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3457">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,893</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqIeAYcOEJbg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3461">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5nNrvH7L1L9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Issuance of OMN warrants to board of directors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcqEVw4aErc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3472">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3473">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,206</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,206</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z4K0kNmW97ad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjvqdYJmE8N2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3484">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0iPc6CFVON" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3486">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zy620ElYt97c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3488">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zz3W42bVrfFi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3490">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdbBjALrE3Gc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3492">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd0cvaM8AvNe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">23,572,232</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3479">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">42,221</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(55,083</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(12,859</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Restatement Adjustments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zLnYlZvsp0f9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F40_zDAvoewh2ue2" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zpxqTeO4I9oj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(437,874</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z3b6qXBzzlG9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zNnUY7L7xiFg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(364,043</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zHGmzmExCnHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zvzFm0ziawq9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z8CWxY9bZ134" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(5,355,788</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(10,375</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(14,150</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zygwwWmssSs5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zHj5CkaxLx3i" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z7bwirrTghH1" style="text-align: right" title="Issuance of common shares in exchange for services, shares">265,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3515">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3516">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3517">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3518">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhw8GZcbOHQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zCtEitmMNUb6" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zq0XsuIEjQvb" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares">5,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zQsW2gSboNpd" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z1nHfpTejBah" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3522">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3523">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3524">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3525">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zsl433z8PvWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zTC0qdQyxOY2" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3534">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zRyPxcD6Gycd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zhV9klln87bd" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zAVkHqJQ1fb2" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">(69,614</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3541">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(613</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3543">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(613</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjBvsJuZkRNl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_zcH3UUXvIdIc" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zpIkisGK5jO4" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">(438,519</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3548">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3549">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,859</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3551">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,859</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zplLOy1ht2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_ziLCg9j2iOU2" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zRbYZNCGx08i" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(701,867</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3557">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3559">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,758</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zaAxdbDBbKxl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4A_z0OGPFi514ba" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zMlytimJOcF6" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">432,201</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zFcFkIPEa4kh" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(9,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____z9frGH3YO8Og" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">364,043</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zT27h15QDmob" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(8,010</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zbrxmPwclQl8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(17,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zITjZmoEl281" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(796,244</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3564">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3565">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,058</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGSxBeU5qafe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F43_zDEM3QbSe4Z8" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zD5Fu6pKoZ99" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares">2,257,326</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3583">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3585">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,257</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuatop1tYVa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_zH7SDweyyBr1" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3590">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3591">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3593">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zu7klaV3kl0e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F41_zXvkqXSkdojg" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zQZ4FUPjak9f" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">4,838,792</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3596">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,683</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3599">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,683</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZcv5xa7e8kd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F45_zbh8HYc2n1da" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3604">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3606">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3607">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zqFv5qjxO3F8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zPksoWAMCJv6" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3610">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3611">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(418</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3613">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(418</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z1PrgZqUBDwg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zEpLKUsQUK54" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3616">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3617">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3618">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgO3DzksH894" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4E_zebKylsMKZnd" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3622">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3623">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3624">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,574</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,574</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zEzrIG974kB6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (restatement adjustments)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3xQtxPEgetg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3634">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z0LbHAIAdUp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3636">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zWsGyytsoFY1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3638">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3dqYsKfeCd7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3640">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_ziLn7iNhwNub" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3642">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGiZyyb9ObIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3644">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3629">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">35,775</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(36,357</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(583</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">As Restated</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zCERd0BC8Edb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zi65lAIuLzI5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,415,923</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z6uXJ7vZHdjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zcrTCJ23Lc8h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">2,839,957</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zSIzwmTqxAae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zQlhYEki4WHj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zEa3Euv8yG7b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">4,033,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3646">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3647">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">13,657</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(57,660</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zRh9MNfOQbN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zKhabU7B1IXj" style="text-align: right" title="Issuance of common shares in exchange for services, shares">265,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3664">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3665">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3666">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3667">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3668">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zhvp3TSV5JVc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zkKNCOHCGNYi" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares">5,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zBl8PdJEW3Fg" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_ztPun9js0gHl" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zAmG6EO8ecvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zV9qXvnTf4X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zof3JCdzGJy6" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">543,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3690">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3693">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3694">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zcMHotUSQHRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zeypJR6uOcGa" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">3,420,945</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3698">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3700">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3702">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zfItEKG9a5D5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z8Q793oFY6nc" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">5,475,362</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,936</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zg0xUHJQhupl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_ztPA7LA28WGd" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(3,421,596</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zM2ygMU7QyFk" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(9,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zFWUKYVBc9i5" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(2,839,957</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z91jAoZWsSK4" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(8,010</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zVxd72lcoUS8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(17,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z842Un0CdEeg" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">6,261,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3718">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z8QjpVGyUPod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3732">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3733">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3734">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3735">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3736">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zVfX9LzWmXC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3738">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3739">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3740">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3741">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3742">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z4FQbGPN3q37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zGyfI7Nay6Tf" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">3,572,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3744">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3747">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zn28LbtLErUe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3755">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3756">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zPS9BXk3A5Q6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3759">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3761">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zoyWjR9ZfmX4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3765">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3766">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3768">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zpMrABjxHPM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3770">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3771">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3772">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,780</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,780</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zfRwOC5WxoLl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zA8QIoRKWpBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3782">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zrinSGD4zYy" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3784">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zTYsCn8TomIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3786">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zVYGhC0pQrw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3788">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zRQ4EtchBpk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3790">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zboRJOiguk2e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">23,572,232</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3777">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">77,996</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(91,440</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(13,442</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F06_zUiD7Qvo1dF5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zbiLSN0c8sW" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    impact of corrections of errors to the prior year.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zuwvJHWa9Qsc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zoyXhvCVdcj2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting and presentation of the recapitalization.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F00_zXFfXM0FUxdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_z8741aGRMBg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zR4FwFBByqVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zyRwSInVDUs2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zlaXOkrERoi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zG6TTXuWq7t7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F02_zXs8hJHKY1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zUXZ0owxwFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zW5uco0SMtSh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zrIdmjFOdate" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_ztCUO5HaRbVk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zhuYeBR4mRoh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zkCvhsJ1MJPl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrNm0ijsZPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAcgwhinqMD4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1T2qWsARIe4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3808">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuS7rvgTthDk" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAPwynqPG39e" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3812">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmIeWOsviLx8" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3814">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGS035o8Ql7d" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">7,802,941</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">1</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">28,750</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">19,607</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(33,920</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">14,438</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuKXvvBVg7qa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcpL8pWl3lf2" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">1,378,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3818">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3819">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,360</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(534</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIWlWMbHJUOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9ML9jv2UZS3" style="text-align: right" title="Issuance of common shares in exchange for services, shares">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3826">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3827">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3829">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBYL9zVXKgk" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNn9md3kQVj9" style="text-align: right" title="Exercise of stock options, shares">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3834">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvh2OxydzaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3842">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3843">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3844">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3845">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3846">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaiX9poMuPoh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3849">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3850">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3851">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3852">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5thZ2Xh2Hsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3854">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3857">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,392</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0tYj64RAV6g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3860">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3861">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3862">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,230</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,230</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zobHW8vZbi64" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyvTNxCFGuE5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,853,797</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8vxe5cfXKMl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3874">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuu4od7drGh4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,204,000</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoiV8vo2EkS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3878">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNG5tnOqwZd3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3880">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfDbaFYqc7d1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">9,388,958</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">24,032</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(43,510</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,273</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Restatement Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zhDxKNCYKEJj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4F_zNoljWR8FXOg" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zOiSKm9Y18M5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3890">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z4SX7bmLswU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zp50a3vBuuyc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3894">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zbwued2BiB6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zLCW3sTmfox5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z5j9fZFJU6s1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(3,460,275</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(17,094</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">6,711</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(21,490</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zmjfh2oZy4n5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_z4BL9SKw3H43" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zBqgxqtz2p6c" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(437,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zsXNpsNJNxp5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(364,043</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zkFrQeWMPwqe" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(1,871,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3902">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3903">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">534</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zUwl79ZHOcIi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zLyF1icLyyY7" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zvEl2Uhodt9a" style="text-align: right" title="Issuance of common shares in exchange for services, shares">(22,724</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3914">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3915">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(200</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(200</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhK8jGiUmqO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4D_z3pfjJmavaVd" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zlNdzOClaP1i" style="text-align: right" title="Exercise of stock options, shares">(852</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3922">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3923">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3925">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_za9Aev5bcs01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zGaE6XDWo0We" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3930">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3931">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3933">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z8hLbwNTPbb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F49_zCojnMZDTpW6" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3936">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3937">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3939">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zEVLrZSKq5Bl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zae9qLTfo1K5" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3942">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3943">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">473</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3945">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">473</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zclWPo1aIwbe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F47_zBbAJaZMwUgg" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3948">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3949">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3950">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,221</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,221</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43F_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zyYjTX0xhooj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (restatement adjustments)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgWvh1mNxHC1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(437,874</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zefDHoLOM7El" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuXimcaSYwmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(364,043</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVF3mcJLaYTc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVW6xo9eel76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zO8CGAdbB5Se" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(5,355,788</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(10,375</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(14,150</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">As Restated</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrXFWLTIonP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_znrSJXtswFu1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zDWmfRBTLSv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9eknUZYUPk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zLWYelQ5MJg9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_zAD8l9lcw6Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zEbjcWBfmguh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">4,342,666</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3973">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2,513</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(27,209</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(7,052</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zGTdqTNBZigd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zMytJlaMvyi5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(437,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zjkVEXnj5cM" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(364,043</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zS3jYyKzBF04" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(493,420</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3991">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3993">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3994">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zcFGLAmG0cU9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_z0wnuWNESsub" style="text-align: right" title="Issuance of common shares in exchange for services, shares">177,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4002">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4003">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4005">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4006">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zHMgzJLqZJb6" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zajonvshXIY2" style="text-align: right" title="Exercise of stock options, shares">6,648</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4010">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4011">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTnAIjQZ5aT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4018">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4019">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4021">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_z8tAwixWGQHh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4027">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zaJ6OskwPPY7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4031">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4033">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zmUgeFgH4gy" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4036">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4037">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4038">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,451</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,451</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z6eucAVAQpA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zW5wCE0trGKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,415,923</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zIKJ6AxaTxh8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_z3lPg63tnHJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">2,839,957</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zcL2aOMXs0D5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_ztospgNmuhO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9vePJiASM6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">4,033,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4042">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4043">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">13,657</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(57,660</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 0.25in; text-align: left"><span id="xdx_F0F_zGF24QwsV3Ke" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1A_zGlRskPx0Ma4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    impact of corrections of errors to the prior year.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zGSobA1i1T6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F11_zodBNv0iJGqk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting and presentation of the recapitalization.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F0D_zsNEl2u7LGlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F11_zbg3ir20cxef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zrPYGRKo8Joa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F10_zerEnUYVHRTd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of error related to identificatoin and recognition of board of director warrante expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zDtv9dtOoYMi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F19_zFz7iviKaa8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F05_zMr7Ef6oH2v7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1E_zuS5qUnBBoP6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zpvQ5rh7nhV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zYjKwepWsD0e">Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company, including its subsidiaries. All intercompany accounts and transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_842_eus-gaap--UseOfEstimates_zr2hwzXh7qd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z3i8w8qiCyLh">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in these notes to the consolidated
financial statements. Actual results and outcomes may differ materially from management&#8217;s estimates, judgments, and assumptions.
Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to
revenue such as determining the nature and timing of the satisfaction of performance obligations, allowances for accounts receivable,
useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and stock-based compensation.
Estimates are periodically reviewed in light of changes in circumstances, facts, and experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_ecustom--OperatingSegmentsPolicyTextBlock_zgianBikxImj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zRjKMzLPlLFc">Operating
Segments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial
information is regularly evaluated by the chief operating decision maker (&#8220;CODM&#8221;), which is the Company&#8217;s Chief Executive
Officer, in deciding how to allocate resources and assess performance. The Company&#8217;s CODM evaluates the Company&#8217;s financial
information and resources and assesses the performance of these resources on a consolidated basis. The Company is not organized by market
and is managed and operated as one business. A single management team that reports to the chief executive officer comprehensively manages
the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and
does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial
segment information can be found in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgvoIrAOYflg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrYd84kCcMGb">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents
consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC insured
limits. The Company believes that, as of December 31, 2023 and 2022, its risk relating to deposits exceeding federally insured limits
was not significant. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s
financial condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zdRDjIpsIbS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zvZhFGQmgyM1">Accounts
Receivable and Allowance for Credit Losses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable is unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable is considered past due if not
paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections
have been exhausted. The Company determines the need for an allowance for credit losses based upon factors surrounding the credit risk
of specific customers, historical trends and other information. As of December 31, 2023 and 2022, the Company established allowances
for credit losses of $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zStClmmHs8Z4" title="Accounts receivable">0</span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_z8w2bWI5XRIf" title="Accounts receivable">0.1</span> million, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not
require collateral from its customers and generally requires payment from 0 to 90 days from the invoice date. For the year ended December
31, 2023, there was 1 customer that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zrvQn5txl485" title="Percentage of revenue">10</span>% or more of total revenue, and there were 2 customers that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z3ByJ3wUEWOf" title="Percentage of revenue">10</span>% or
more of total revenue for the year ended December 31, 2022. The following table represents these customers&#8217; aggregate percent of
total revenue:</span></p>

<p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_ztBzoaioJk74" style="display: none">Schedule
of Aggregate Percentage Revenue and Accounts Receivable</span> </span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">51</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">29</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Customer 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Aggregate percent of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, three customers accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance, and four customers
accounted for over <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#8217; aggregate percent of total accounts receivable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">36</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White">
    <td>Customer 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White">
    <td>Customer 4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White">
    <td>Customer 6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Customer 7</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate percent of total accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate Percent of Revenue and Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
</table>

<p id="xdx_8A4_zqJD9t4ymDAb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zpvQ5rh7nhV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zYjKwepWsD0e">Principles
of Consolidation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company, including its subsidiaries. All intercompany accounts and transactions
have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_842_eus-gaap--UseOfEstimates_zr2hwzXh7qd3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z3i8w8qiCyLh">Use
of Estimates</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses, and the amounts disclosed in these notes to the consolidated
financial statements. Actual results and outcomes may differ materially from management&#8217;s estimates, judgments, and assumptions.
Significant estimates, judgments, and assumptions used in these financial statements include, but are not limited to, those related to
revenue such as determining the nature and timing of the satisfaction of performance obligations, allowances for accounts receivable,
useful lives and realizability of long-lived assets, accounting for income taxes and related valuation allowances, and stock-based compensation.
Estimates are periodically reviewed in light of changes in circumstances, facts, and experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_OperatingSegmentsPolicyTextBlock', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_844_ecustom--OperatingSegmentsPolicyTextBlock_zgianBikxImj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zRjKMzLPlLFc">Operating
Segments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial
information is regularly evaluated by the chief operating decision maker (&#8220;CODM&#8221;), which is the Company&#8217;s Chief Executive
Officer, in deciding how to allocate resources and assess performance. The Company&#8217;s CODM evaluates the Company&#8217;s financial
information and resources and assesses the performance of these resources on a consolidated basis. The Company is not organized by market
and is managed and operated as one business. A single management team that reports to the chief executive officer comprehensively manages
the entire business. Accordingly, the Company does not accumulate discrete financial information with respect to separate divisions and
does not have separate operating or reportable segments. Since the Company operates in one operating segment, all required financial
segment information can be found in the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zgvoIrAOYflg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zrYd84kCcMGb">Cash
and Cash Equivalents</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents consist of highly liquid, short-term investments with a maturity of three months or less when purchased. Cash equivalents
consist of money market funds and are carried at cost, which approximates fair value. The balances, at times, may exceed FDIC insured
limits. The Company believes that, as of December 31, 2023 and 2022, its risk relating to deposits exceeding federally insured limits
was not significant. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s
financial condition, results of operations, and cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zdRDjIpsIbS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zvZhFGQmgyM1">Accounts
Receivable and Allowance for Credit Losses</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable is unsecured, recorded at net realizable value, and do not bear interest. Accounts receivable is considered past due if not
paid within the terms established between the Company and the customer. Amounts are only written off after all attempts at collections
have been exhausted. The Company determines the need for an allowance for credit losses based upon factors surrounding the credit risk
of specific customers, historical trends and other information. As of December 31, 2023 and 2022, the Company established allowances
for credit losses of $<span id="xdx_903_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20231231_zStClmmHs8Z4" title="Accounts receivable">0</span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pn5n6_c20221231_z8w2bWI5XRIf" title="Accounts receivable">0.1</span> million, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes its credit policies are prudent and reflect normal industry terms and business risk. The Company generally does not
require collateral from its customers and generally requires payment from 0 to 90 days from the invoice date. For the year ended December
31, 2023, there was 1 customer that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zrvQn5txl485" title="Percentage of revenue">10</span>% or more of total revenue, and there were 2 customers that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_z3ByJ3wUEWOf" title="Percentage of revenue">10</span>% or
more of total revenue for the year ended December 31, 2022. The following table represents these customers&#8217; aggregate percent of
total revenue:</span></p>

<p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_ztBzoaioJk74" style="display: none">Schedule
of Aggregate Percentage Revenue and Accounts Receivable</span> </span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">51</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">29</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Customer 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Aggregate percent of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, three customers accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance, and four customers
accounted for over <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#8217; aggregate percent of total accounts receivable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">36</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White">
    <td>Customer 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White">
    <td>Customer 4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White">
    <td>Customer 6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Customer 7</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate percent of total accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate Percent of Revenue and Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zbneL7aFcAJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zpfxMSc0ozV2">Property
and Equipment</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are recorded at cost, less accumulated depreciation and amortization. The straight-line method is used for computing depreciation
and amortization. Assets are depreciated and amortized over their estimated useful lives ranging from three to five years. Cost of maintenance
and repairs are charged to expense when incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zZXcFP3hWAY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zVpXbo6CoYFj">Impairment
of Long-Lived Assets</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances
indicate that the carrying amount of an asset may not be fully recoverable. An impairment loss would be recognized when the estimated
future undiscounted net cash flows from the use of the asset are less than the carrying amount of that asset. There were <span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20230101__20231231_zAMAdUgdylq7" title="Impairment of long-lived assets"><span id="xdx_908_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20220101__20221231_zxpllUrCgDsc" title="Impairment of long-lived assets">no</span></span> such losses
during the years ended December 31, 2023 or December 31, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueOptionOfAccountingPolicyTextBlock', window );">Fair value option of accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_845_ecustom--FairValueOptionOfAccountingPolicyTextBlock_zPgodBycYS55" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zOFCpgo5lkt9">Fair
value option of accounting</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
financial instruments contain various embedded derivatives which may require bifurcation and separate accounting of those derivatives
apart from the entire host instrument, if eligible, ASC 825, <i>Financial Instruments</i>, allows issuers to elect the fair value option
(&#8220;FVO&#8221;) of accounting for those instruments. The FVO may be elected on an instrument-by-instrument basis and is irrevocable
unless a new election date occurs. The FVO allows the issuer to account for the entire financial instrument at fair value with subsequent
remeasurements of that fair value recorded through the statements of operations at each reporting date. A financial instrument is generally
eligible for the FVO if, amongst other factors, no part of the convertible, or contingently convertible, instrument is classified in
stockholders&#8217; equity and the instrument does not contain a beneficial conversion feature at issuance. In addition, because a contingent
beneficial conversion feature, if any, is not separately recognized within stockholders&#8217; equity at the issuance date, a convertible
debt instrument with a contingent beneficial conversion feature is therefore eligible for the FVO if all other criteria are met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the eligibility assessment discussed above, the Company concluded that its convertible notes payable is eligible for the FVO and accordingly
elected the FVO for those debt instruments. This election was made because of operational efficiencies in valuing and reporting for these
debt instruments in their entirety at each reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
promissory notes and the PIPE Notes contain embedded derivatives, which require bifurcation and separate accounting under GAAP, for which
the Company elected the FVO. In addition, certain term PIPE Notes were issued with separately exercisable and freestanding warrants to
purchase common stock, were issued with substantial discounts at issuance and contained certain embedded derivatives to be bifurcated
and accounted for separately for those term notes, unless the FVO is eligible and elected. Accordingly, the Company qualified for and
elected the FVO for the entire PIPE Notes instruments. The convertible debt and accrued interest at their stated interest rates were
initially recorded at fair value as liabilities on the consolidated balance sheets and were subsequently re-measured at fair value at
the end of each reporting period presented within the consolidated financial statements. The changes in the fair value of the convertible
promissory notes and PIPE Notes are recorded in changes in fair value of convertible debt and change in fair value of PIPE Notes, included
as a component of other (income) expenses, net, in the consolidated statements of operations. The change in fair value related to the
accrued interest components is also included within the respective single line of change in fair value of convertible debt and change
in fair value of PIPE Notes on the consolidated statements of operations. See additional information on valuation methodologies and significant
assumptions used in Note 6 and Note 10.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantPolicyTextBlock', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_ecustom--WarrantPolicyTextBlock_zFCbjB1MuvZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zlRvn7HvG6e5">Warrants</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s
specific terms and applicable authoritative guidance in ASC 480, <i>Distinguishing Liabilities from Equity</i>, and ASC 815, <i>Derivatives
and Hedging</i>. Warrants that meet the definition of a derivative financial instrument and the equity scope exception in ASC 815-10-15-74(a)
are classified as equity and are not subject to remeasurement provided that the Company continues to meet the criteria for equity classification.
Warrants that are classified as liabilities are accounted for at fair value and remeasured at each reporting date until exercise, expiration,
or modification that results in equity classification. Any change in the fair value of the warrants is recognized as change in fair value
of warrant liabilities included as a component of other (income) expenses, net in the consolidated statements of operations. The classification
of warrants, including whether warrants should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
The fair value of liability-classified warrants is determined using the Black-Scholes options pricing model (&#8220;Black-Scholes model&#8221;)
which includes Level 3 inputs, as shown in Note 11 to the consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z7mrkflN4v37" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zgP8byl9dztb">Fair
Value of Financial Instruments</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes
the inputs to valuation methodologies used to measure fair value:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
1</b> - Valuations based on quoted prices for identical assets and liabilities in active markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
2</b> - Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets
and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other
inputs that are observable or can be corroborated by observable market data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level
3</b> - Valuations based on unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made
by other market participants. These valuations require significant judgment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 12.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
quoted market prices are available in active markets, the fair value of assets and liabilities is estimated within Level 1 of the valuation
hierarchy. If quoted prices are not available, then fair values are estimated by using pricing models, quoted prices of assets and liabilities
with similar characteristics, or discounted cash flows, within Level 2 of the valuation hierarchy. In cases where Level 1 or Level 2
inputs are not available, the fair values are estimated by using inputs within Level 3 of the hierarchy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has determined the estimated fair value of its financial instruments based on appropriate valuation methodologies&#894; however,
considerable judgment is required to develop these estimates. Accordingly, these estimated fair values are not necessarily indicative
of the amounts the Company could realize in a current market exchange. The estimated fair values can be materially affected by using
different assumptions or methodologies. The methods and assumptions used in estimating the fair values of financial instruments are based
on carrying values and future cash flows.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial instruments consist of cash and cash equivalents, accounts receivable, accounts payable, convertible notes
payable, liability classified financial instruments and certain privately issued warrants. The carrying amounts of cash and cash equivalents
and accounts payable financial instruments approximate their fair value due to their short-term nature. The carrying amount of accounts
receivable is net of an allowance that reflects management&#8217;s best estimate of expected credit losses. See Note 11 for fair value
measurements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_zixMabdmKOj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zghowmw5w7cc">Revenue
Recognition</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic 606, <i>Revenue from Contracts with Customers</i>, which aligns revenue recognition
with the transference of promised goods or services to customers in an amount that reflects the consideration to which the Company expects
to be entitled in exchange for those goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
core principle is achieved to the application of a five-step model: (1) identify the contract with a customer, (2) identify the performance
obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to performance obligations in the
contract, and (5) recognize revenue as performance obligations are satisfied. Payment terms between customers related to product and
services sales vary by the type of customer, country of sale, and the products or services offered and could result in an unbilled receivable
or deferred revenue balance depending on whether the performance obligation has been satisfied (or partially satisfied).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
from all customers is recognized when a performance obligation is satisfied by transferring control of a distinct good or service to
a customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit
of account under Topic 606. A contract&#8217;s transaction price is allocated to each distinct performance obligation in proportion to
the standalone selling price for each and recognized as revenue when, or as, the performance obligation is satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
promised goods and services in a contract are considered a performance obligation and accounted for separately if the good or service
is distinct. A good or service is considered distinct if the customer can benefit from the good or service on its own or with other resources
that are readily available to the customer and the good or service is separately identifiable from other promises in the arrangement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price for the products is the invoiced amount. Advanced billings from contracts are deferred and recognized as revenue when
earned. Revenue is recognized only to the extent that it is probable that a significant reversal of revenue will not occur and when collection
is considered probable. The Company excludes from revenue taxes collected from a customer that are assessed by a governmental authority
and imposed on and concurrent with a specific revenue-producing transaction. Deferred revenue consists of payments received in advance
of performance under the contract. Such amounts are generally recognized as revenue over the contractual period. The Company receives
payments from customers based upon contractual billing schedules. Accounts receivable is recorded when the right to consideration becomes
unconditional. Payment terms on invoiced amounts typically range from zero to 90 days, with typical terms of 30 days.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subscription
Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
revenues are generated from the Company&#8217;s data exchange (BEAM) product, which is a medical imaging exchange platform between hospital/healthcare
systems, imaging centers, physicians and patients. Subscriptions to the BEAM platform offering are recognized over time as the customer
consumes the benefits of the services as the Company stands ready to provide access to the programs throughout the subscription period.
Subscription customers are invoiced either quarterly or annually in advance with the customer contracts automatically renewing unless
the customer issues a cancellation notice. The timing of revenue recognition is based on a time-based measure of progress as the Company
provides access to the programs evenly over the course of the subscription period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Web
Imaging Revenue</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Web
imaging revenues are generated from the Company&#8217;s data broker (iRWD) product, which provides regulatory grade imaging and clinical
data in the pharmaceutical, device manufacturing, clinical research organizations, and artificial intelligence markets. Web imaging customers
are invoiced in installments as the related data is delivered. Revenue from the sale of web imaging products is recognized over time
using an output measure of progress, which is based on the number of data units delivered relative to the total data units committed
by the customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zbR50DAB7kV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zKJcBN4npTdf">Income
Taxes</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes income taxes under the asset and liability method. Deferred income taxes are recognized for differences between the
financial reporting and tax bases of assets and liabilities, at enacted statutory tax rates in effect for the years in which the differences
are expected to reverse. The Company establishes a valuation allowance if it believes it is more likely than not that the deferred tax
assets will not be recovered based on an evaluation of all available evidence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines whether it is more likely than not that a tax position will be sustained upon examination. If it is not more likely
than not that a position will be sustained, none of the benefit attributable to the position is recognized. The tax benefit to be recognized
for any tax position that meets the more-likely-than-not recognition threshold is calculated as the largest amount that is more than
50% likely to be realized upon resolution of the contingency. The Company accounts for interest and penalties related to uncertain tax
positions as part of its provision for income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_PatentsAndTrademarksPolicyTextBlock', window );">Patents and Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_ecustom--PatentsAndTrademarksPolicyTextBlock_zzT15pKsuKh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_z477QSUwNVti">Patents
and Trademarks</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
associated with the submission of a patent application are expensed as incurred given the uncertainty of the patents resulting in probable
future economic benefits to the Company and are included in research and development expenses on the consolidated statements of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z4Hi9QUf8Quf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zOHYXgR61V4k">Research
and Development</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its research and development (&#8220;R&amp;D&#8221;) costs in accordance with ASC 730, <i>Research and Development
</i>(&#8220;ASC 730&#8221;). ASC 730 requires that R&amp;D costs are generally recognized as an expense as incurred. However, some costs
associated with R&amp;D activities that have an alternative future use (e.g., materials, equipment, facilities) may be capitalizable.
For the years ended December 31, 2023 and December 31, 2022 research and development expenditures were charged to operating expense as
incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 30pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--CompensationRelatedCostsPolicyTextBlock_znU3DnHp0JGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zgmkIrGoakvg">Stock-based
Compensation</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense related to employee option grants and restricted stock grants, if any, in accordance with ASC
718, <i>Compensation - Stock Compensation</i> (&#8220;ASC 718&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures all stock options and other stock-based awards granted based on the fair value of the award on the date of the grant
and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the
respective award. The Company has elected to recognize forfeitures as they occur. The reversal of compensation cost previously recognized
for an award that is forfeited because of a failure to satisfy a service condition is recognized in the period of the forfeiture. Generally,
and unless otherwise specified, the Company grants stock options with service-based only vesting conditions and records the expense for
these awards using the straight-line method over the requisite service period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies stock-based compensation expense in its consolidated statements of operations in the same manner in which the award
recipient&#8217;s payroll costs are classified or in which the award recipients&#8217; service payments are classified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Business Combination, the Company was required to periodically estimate the fair value of its Common Stock with the assistance
of an independent third-party valuation firm when issuing stock options and computing estimated stock-based compensation expense. The
assumptions underlying these valuations represented the Company&#8217;s best estimates, which involved inherent uncertainties and the
application of significant levels of judgment. In order to determine the fair value of its Common Stock, the Company considered, among
other items, previous transactions involving the sale of Company securities, the business, financial condition and results of operations,
economic and industry trends, the market performance of comparable publicly traded companies, and the lack of marketability of the Company&#8217;s
Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. These estimates and assumptions include
a number of objective and subjective factors, including external market conditions, guideline public company information, the prices
at which the Company sold convertible preferred stock and common stock to third parties in arms&#8217; length transactions, the rights
and preferences of securities senior to the Company&#8217;s common stock at the time, and the likelihood of achieving a liquidity event
such as an initial public offering or sale. Significant changes to the assumptions used in the valuations could result in materially
different fair values of stock options at each valuation date, as applicable. Following the Business Combination (see Note 3), the Company
used the public price of its Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each stock option grant is estimated using the Black-Scholes option-pricing model. The Company estimates its expected stock
volatility based on the historical volatility of a publicly traded set of peer companies within the biotechnology industry with characteristics
similar to the Company. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221;
method, which reflects the weighted-average of time-to-vesting. The risk-free interest rate is determined by reference to the U.S. Treasury
yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected
dividend yield is zero, based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends
in the foreseeable future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zAtmvX74dVB1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zHJ6xeHhZUah">General
and Administrative</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses include all costs that are not directly related to satisfaction of customer contracts. General and administrative
expenses include items for the Company&#8217;s selling and administrative functions, such as sales, finance, legal, human resources,
and information technology support. These functions include costs for items such as salaries and benefits and other personnel-related
costs, maintenance and supplies, professional fees for external legal, accounting, and other consulting services, and depreciation expense.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently adopted accounting pronouncements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_842_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_zZpd1abxoVL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zkTd0xEMhp11">Recently
adopted accounting pronouncements</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2016, the FASB issued ASU No. 2016-13, <i>Financial Instruments - Credit Losses</i>, &#8220;Topic 326&#8221;, an amendment on measurement
of credit losses on financial assets held by at each reporting date. The guidance requires the use of a new current expected credit loss
(&#8220;CECL&#8221;) model in estimating allowances for doubtful accounts with respect to accounts receivable. The CECL model requires
that the Company estimate its lifetime expected credit loss with respect to these receivables and record allowances that, when deducted
from the balance of the receivables, represent the estimated net amounts expected to be collected. Effective January 1, 2023, the Company
adopted ASU No. 2016-13 and the adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial
statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2022, the FASB issued ASU No. 2022-03, <i>Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions </i>(&#8220;ASU
2022-03&#8221;), which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit
of account of the equity security and, therefore, is not considered in measuring fair value. ASU 2022-03 is effective for public business
entities for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2023. The Company adopted
ASU No. 2022-03 and the adoption of this standard did not have a material impact on the Company&#8217;s consolidated financial statements.</span></p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_FairValueOptionOfAccountingPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value option of accounting [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_FairValueOptionOfAccountingPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_OperatingSegmentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Segments [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_OperatingSegmentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_PatentsAndTrademarksPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patents And Trademarks [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_PatentsAndTrademarksPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recently Adopted Accounting Pronouncements Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RestatementToFinancialStatementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restatement to financial statements [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RestatementToFinancialStatementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_WarrantPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_WarrantPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_PlatformOperatorCryptoAssetPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for safeguarding liability and corresponding asset for crypto-asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section FF<br> -Paragraph Question 2<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.FF.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476188/405-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_PlatformOperatorCryptoAssetPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132252512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Crypto Assets Held (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetHoldingTableTextBlock', window );">Schedule of Crypto Assets Held</a></td>
<td class="text"><p id="xdx_897_eus-gaap--CryptoAssetHoldingTableTextBlock_zTB0AIener44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s crypto assets are comprised solely of Bitcoin. In accordance with ASC Topic 820, <i>Fair Value Measurement</i>, the Company measures the fair value of its Bitcoin based on the quoted
end-of-day price on the measurement date for a single Bitcoin on an active trading platform, River.com. Management has determined that
River.com, an active exchange market, represents a principal market for Bitcoin and the end-of-day quoted price is both readily available
and representative of fair value (Level 1 inputs). The following table sets forth the units held,
cost basis, and fair value of Bitcoin held, as shown on the condensed consolidated balance sheet as of September 30, 2024 (in
thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8B4_zY3UlrZWZ5ne" style="display: none">Schedule of
Crypto Assets Held</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Units</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cost Basis</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Crypto assets held:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; padding-bottom: 1pt">Bitcoin</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zLOn4p19mJN7" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Units">34</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zp3DECi0H9Qi" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Cost Basis">2,280</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930__srt--CryptoAssetAxis__custom--BitcoinMember_zroUcn7ulLG3" style="border-bottom: Black 1pt solid; width: 16%; text-align: right" title="Crypto assets, Fair Value">2,156</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--CryptoAssetNumberOfUnits_iI_uInteger_c20240930_zxCzDZA5h31d" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Units">34</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--CryptoAssetCost_iI_pn3n3_c20240930_znPTUFykpP3e" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Cost Basis">2,280</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--CryptoAssetFairValue_iI_pn3n3_c20240930_zkrQPxzIqVEi" style="border-bottom: Black 2.5pt double; text-align: right" title="Crypto assets, Fair Value">2,156</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetActivityTableTextBlock', window );">Schedule of Crypto Assets Reconciliation of Fair Values</a></td>
<td class="text"><p id="xdx_893_eus-gaap--CryptoAssetActivityTableTextBlock_z1bD7UqESyQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents a reconciliation of the fair values of the Company&#8217;s Bitcoin for the nine months ended September 30, 2024
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify; text-indent: 0.5in"><span id="xdx_8BA_zCLq1qYiSvyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Crypto Assets Reconciliation of Fair Values</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20240930_ztdl1EyPS13j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bitcoin</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CryptoAssetFairValue_iS_pn3n3_zQZHqSEdjwW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0900">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CryptoAssetAddition_pn3n3_zMGUwIBFwPFg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Additions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">2,800</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CryptoAssetDisposition_iN_pn3n3_di_zMvzW35TKVd4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Dispositions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(520</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--CryptoAssetRealizedAndUnrealizedGainLossNonoperating_pn3n3_zm0rtpou1iD4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized loss, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(124</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--CryptoAssetFairValue_iE_pn3n3_zoOCyIpKptze" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,156</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about activity for crypto asset. Excludes information about crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetHoldingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about crypto asset. Includes, but is not limited to, name, cost basis, fair value, and number of units held. Excludes information about crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetHoldingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132233952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zqtHkWkniuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zY8WtyweXEh" style="display: none">Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20240930_z6rh7ChKA2Wg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20230930_zKvl5Q7cKBM9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zaJ6qRuqQiMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Options to purchase Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">147,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">913,856</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockUnitsAndAwardsMember_z5KFPMnET3Gk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unvested restricted stock units and awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,371,950</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,275</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9UCKP9FSwd5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,314,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,112,165</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zbjJYN3YAy93" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,839,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zvZe6nAtBTo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,415,923</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_ztASWlHwy9G3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,118,735</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,643,325</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_zjyHAg7uOSp" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,951,799</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,102,501</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none">Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022
    <span id="xdx_F53_zMknzVxwFW2d">(1)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022 (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Employee stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4156">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">913,856</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,276</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,367,607</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,839,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4168">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,415,923</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4171">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,786,610</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total common stock equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,501,229</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retroactively restated
for the reverse recapitalization in Note 3.</span></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590124276656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock', window );">Schedule of Stock-based Compensation Expense</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_zmQ9ejPefDJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded stock-based compensation expense in the following categories on the accompanying condensed consolidated statements of
operations for the periods presented (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B0_zi0VxjIuHy3i" style="display: none">Schedule
of Stock-based Compensation Expense</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240701__20240930_zKe5IeXI8tO2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230701__20230930_zPik3Muw8Nki" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_z5CcHjp4W8cg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1137">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zlNN63lq1rKd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">195</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">782</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_z0UM3n2cDlXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1143">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zD4NQnRNXEl1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_zrPprdz5h9x1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">207</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">798</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20240101__20240930_zCXyAW0gQ6m9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20230930_zUxBQ3iUyj55" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Nine Months Ended September 30,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--CostOfSalesMember_zTvqXJwV9Q39" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Cost of revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1152">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zbpaTM3KueYe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,014</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--SellingAndMarketingExpenseMember_zuV9qFZzQJR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1158">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zA0HIOZurbKf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">432</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AllocatedShareBasedCompensationExpense_zaOnxrxwLm6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">447</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,446</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock_z9r9Rg9z2JJ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations
for the periods presented (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span id="xdx_8BA_zJ8hjkB5chs7" style="display: none">Schedule
of Stock-based Compensation Expense</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230101__20231231_zIv3aKKO2Fp5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20220101__20221231_ztsCIA6dA2wd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--ResearchAndDevelopmentExpenseMember_zXzlU3y29go5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Research and development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">434</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">638</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_hus-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zMeHDmxXicLh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">General and administrative</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,041</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,227</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_pn3n3_zjOIa7QUTmS7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total stock-based compensation expense</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,475</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,865</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z2t4WLtze2Fj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
with respect to options outstanding is summarized as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zI0hPK0P8F83" style="display: none">Schedule of Options Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Aggregate</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Intrinsic</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; padding-bottom: 1pt">Outstanding as of December 31, 2021</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_z0U5wRYmtbh1" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Options outstanding, beginning balance">728,603</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zypioOXRPhOh" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Weighted average exercise price, beginning balance">1.00</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20221231_z2shuwnGqzv7" style="padding-bottom: 1pt; width: 12%; text-align: right" title="Aggregate Intrinsic value, begining balance"><span style="-sec-ix-hidden: xdx2ixbrl4512">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zkHMNrDUKqhe" style="text-align: right" title="Options, Granted - under the Plan">511,440</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zk4YloymnWac" style="text-align: right" title="Weighted average exercise price, granted">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zSOuwTZiIgnh" style="text-align: right" title="Options, Exercised - under the Plan">(6,648</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_zMm45h2raGe8" style="text-align: right" title="Weighted average exercise price, exercised">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231_z4SWf21Q8baj" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled">(319,539</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_zCs3JyTynD6g" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled">1.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Outstanding as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zG6cgN86wjbc" style="border-bottom: Black 1pt solid; text-align: right" title="Options outstanding, beginning balance">913,856</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_ziK5f5y9plyi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, beginning balance">1.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20220101__20221231_zacYP68Ics54" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, ending balance">3,199</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zPkyqh888cac" style="text-align: right" title="Options, Exercised - under the Plan">(613,510</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_zQAZULygsM78" style="text-align: right" title="Weighted average exercise price, exercised">1.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231_z2d2eoaUXYkb" style="border-bottom: Black 1pt solid; text-align: right" title="Options, cancelled">(300,346</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_zqse2nLXHYZ5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, cancelled">1.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding as of December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zU6jFtbBUQul" style="border-bottom: Black 2.5pt double; text-align: right" title="Options outstanding, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl4540">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zWf8X159Qfye" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl4542">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zdxFOEhSQHri" style="padding-bottom: 2.5pt; text-align: right" title="Aggregate Intrinsic value, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl4544">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Vested and exercisable as of December 31, 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_c20230101__20231231_zN0GsflAab1" style="border-bottom: Black 1pt solid; text-align: right" title="Options vested and exercisable"><span style="-sec-ix-hidden: xdx2ixbrl4546">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_c20230101__20231231_zGLHNwZ28Ntc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, vested and exercisable"><span style="-sec-ix-hidden: xdx2ixbrl4548">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20230101__20231231_zbWHYtXkhaD8" style="padding-bottom: 1pt; text-align: right" title="Aggregate Intrinsic value, exercisable"><span style="-sec-ix-hidden: xdx2ixbrl4550">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value of Stock Options</a></td>
<td class="text"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z0EbGI9XuKg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_zbo4lpUx1OU6" style="display: none">Schedule
of Fair Value Assumptions and Valuation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6yoFZjdrjI3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember_zdnqqfp3XZQ8" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Business Combination</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z8ofOzO0ac9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.61</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.61</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zesH5Uq4iOC1" style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zaCri8ck8v0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.1</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zr6WHQ05YrM9" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.6</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zXlftvXvisyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1331">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zSVXH8G4Gmsl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants measurement input</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1334">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zUh0Fyou3Ww5" title="Expected term (in years)">4.1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zU8xg8Aetap4" title="Expected term (in years)">4.2</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z7nEjYXPSKbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zvdqLwiSHLH8" style="display: none">Schedule
of Fair Value of  Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zb4EqjAVvHcj" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4558">-</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zv7TKOPtaZah" title="Risk-free interest rate">0.73</span>% - <span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zI0UX2ZfVXvg" title="Risk-free interest rate">2.96</span></span></td><td style="width: 1%; text-align: left">% </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlxm0i4Fc2ii" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4564">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zhjGUBcEXN8j" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4566">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--EquitySecuritiesFvNiMeasurementTerm_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zwbvwcufSdP4" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4568">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zn4w2yHn1Mt7" title="Expected life in years">1.36</span> - <span id="xdx_904_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zh6oP8V6f0u8" title="Expected life in years">1.85</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z2C4T4M15t91" title="Equity securities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl4574">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zMW0leDnbjz9" title="Equity securities, measurement input">50.0</span>% - <span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zlG8ca1XMgD" title="Equity securities, measurement input">86.3</span></span></td><td style="text-align: left">% </td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Award Activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_zaIIOAu2S4uh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_zXSVQhE5UcOj" style="display: none">Schedule of Restricted Stock Award Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Average Grant</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Date Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Nonvested as of December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zvfPYjAAeNEl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl4588">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAoAz1WPFED5" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl4590">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%">Granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pn3n3_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfX5vHFqtBEi" style="width: 14%; text-align: right" title="Number of Awards, Granted">354,551</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCyDlDn6Jvda" style="width: 14%; text-align: right" title="Weighted Average Grant Date Fair Value,Granted">4.80</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_pn3n3_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQPozxL4uH2b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards, Vested">(177,276</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKPiHSYAxXyj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested">4.80</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Nonvested as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zr8UrStWR5N4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of RSU's, Outstanding, Beginning">177,275</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKSsMEgmMLqf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning">1.48</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQxumWCm4Z35" style="text-align: right" title="Number of Awards, Granted">88,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQdIs7KuM5v5" style="text-align: right" title="Weighted Average Grant Date Fair Value,Granted">7.21</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkdkl5JVM3i2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Awards,Vested">(265,914</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zoUC71Ddonyb" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value,Vested">5.60</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Nonvested as of December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pn3n3_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zmZOtsbnNOZb" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Awards Outstanding, Ending"><span style="-sec-ix-hidden: xdx2ixbrl4612">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zEDtpDjm3f49" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Ending"><span style="-sec-ix-hidden: xdx2ixbrl4614">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483043/710-10-30-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482943/710-10-55-8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132138768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DisclosureStockWarrantsAbstract', window );"><strong>Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants Outstanding</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zCMbuaAL3aN6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following warrants outstanding for the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_8BF_zucWbKPNhz7h" style="display: none">Schedule
of Warrants Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20240930_zWJZDgwOrKM5" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230930_zeJvgEiBBr9g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Liability Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--BusinessCombinationWarrantsMember_zl9OioKXlJk2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">585,275</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">585,275</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PIPEWarrantsMember_zfjJaZLYqMRb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">95,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">95,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_z4O1VnLEy1kk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">681,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">681,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Equity Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PublicWarrantsMember_zNapLquh5uid" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Public Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--StatementEquityComponentsAxis__custom--PrivatePlacementWarrantsMember_zldFgxmFL3gl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Private Placement Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,199,939</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zpBzg3MT2qkk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,699,939</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_zZvdffyDsfn9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt">Grand Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,380,958</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,181,019</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pip0_z81XCOvU8O52" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt">Warrants outstanding </td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,380,958</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">12,181,019</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zu5JqleAdXq" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has the following warrants outstanding for the periods presented:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zG2q7k4Ebt4i" style="display: none">Schedule
of Warrants Outstanding</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zIUs3EeLK35f" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20221231_zLCOAaHt6oZ6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Liability Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementWarrantsMember_zIopUMHIq1k3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 64%; text-align: left">Private Placement Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">585,275</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4636">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PIPEWarrantsMember_ztSA693FySo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">95,744</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4639">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--LiabilityClassifiedWarrantsMember_zjz9wl3Tamn8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">681,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4642">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Equity Classified Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--LegacyONMDWarrantsMember_zLhixHsn0I2a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Legacy ONMD Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4644">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">545,213</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--ConvertiblePromissoryNoteWarrantsMember_zvPE6d1ivh4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Convertible Promissory Note Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4647">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,822,394</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicWarrantsMember_z5D6JH42Oaxg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Public Warrants</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4651">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_hus-gaap--ClassOfWarrantOrRightAxis__custom--EquityClassifiedWarrantsMember_zAfgYG3UDX34" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; padding-bottom: 1pt">Subtotal</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,500,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,367,607</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_z5RAfkTgNBjd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; font-style: italic; text-align: left; padding-bottom: 1pt">Grant Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,181,019</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,367,607</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DisclosureStockWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DisclosureStockWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590120229504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zRomgSLwyzAk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_z6OnWbN41Jea" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zs7pR7XVeyMj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zk3pYUiIki1g" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20240930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zXOdtOYYgdYc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240930_zdkwazVils0b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">Assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--AssetsFairValueDisclosure_iI_hus-gaap--FinancialInstrumentAxis__custom--BitcoinMember_zdVOpdadhZDk" style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; padding-bottom: 1pt; padding-left: 10pt">Bitcoin</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1238">-</span></td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 1pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--AssetsFairValueDisclosure_iI_zoiZUdhtjPae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Total assets, at fair value</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1242">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1243">-</span></td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right">2,156</td><td style="padding-bottom: 2.5pt; font-size: 10pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zvinzheDArVi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1247">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">26</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">26</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6mlQXo9f3pk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">PIPE Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1251">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_zWZUo7FwPkMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1256">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1257">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,593</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,593</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--YorkvilleNoteMember_zpy6dS3QhFX7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Yorkville Note</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1261">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,911</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--StandbyEquityPurchaseAgreementMember_z1Xn1KGKY8Cc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">SEPA derivative liability</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1266">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1267">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1268">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1269">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zPmbDddjA7Aa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1272">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,532</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zN3iPl8icnZc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxhyQBVx04zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zh3kUdO6GkT9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20231231_zE8iY7eZmuX" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zGWT8OSMZHFe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Business Combination Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1277">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_ziPfBuKEeew8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE Warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_z3bFjG8RlQfl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE Notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zKKLbNt0V9Rg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1291">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1292">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zx4VUb6mkiqc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis, inclusive of
related party (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_znx9PfAgWcDd" style="display: none">Schedule
of Assets and Liabilities Measured at Fair Value</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zWRkkLWyDgri" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zgBvYaGFcJta" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zdg0MYNCkvU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20231231_zepYc0t5lBkb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_zjzKmD4Pi2S8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left">Private warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4703">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4704">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z9y2aSkYHAta" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Business Combination Warrants</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4708">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zeFOUJUazrzj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4713">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4714">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PIPENotesMember_za6JYscss8Ef" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">PIPE notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4718">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4719">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,637</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_zauQYLn1Y5zh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4723">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4724">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,660</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zzMl7Ns3zPMk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z8ezS87zniPi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z40QOrbBk7mb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zFch3jrLMbgh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--ConvertiblePromissoryNotesMember_zicdAbkJfVnj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 36%; text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4728">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4729">-</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">26,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 12%; text-align: right">26,243</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_hus-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z5WLuEaC5E1i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total liabilities, at fair value</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4733">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4734">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26,243</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26,243</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value Assumptions and Valuation</a></td>
<td class="text"><p id="xdx_893_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_gL3FVLMORBUIR-TLSO_zps6BRM4jDQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the Business Combination Warrants and PIPE Warrants measured at fair value during the nine months
ended September 30, 2024 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B2_zusMWR8dIK1d" style="display: none">Schedule
of Warrants and Notes Measured at Fair Value</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--FinancialInstrumentAxis_custom--BusinessCombinationWarrantsMember_zg0zZVWpBMNg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Business Combination Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PIPEWarrantsMember_zRZ4VYo3g01h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zhOUxxDJFxxb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Balance, December 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">9</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">14</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_z9qk9ZWF20Cj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Additions</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_z6iSqRCmiCo3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(12</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z2MZKufSZT7h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">26</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

The
following table presents the changes in the PIPE Notes and Yorkville Note measured at fair value during the nine months ended September
30, 2024 (in thousands):<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_309_134_zREtuuhIhXSl" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--FinancialInstrumentAxis_custom--PIPENotesMember_ze2r3E2jMVR2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Notes</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--YorkvilleNoteMember_zYzz8DZAcSY5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Yorkville Note</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlOJacrmtqR6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Balance, December 31, 2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,637</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1341">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zMhjgFKRCOX2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1343">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,350</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zGJO8EE1uXi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">561</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zeIf64bpYuG4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,593</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,911</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

&#160;The
following table presents the changes in the SEPA derivative liability measured at fair value during the nine months ended September 30,
2024 (in thousands):<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_134_zvn2i2KWbCdj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--YorkvilleStandbyEquityPurchaseAgreementMember_zeuekKn7dFk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Yorkville SEPA</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_438_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zBVYNCg9VPa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Balance, December 31, 2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1352">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zTX2QegBErif" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 80%">Additions</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">160</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zNqLPzGMpOE4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(160</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20240101__20240930_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zhdfOaCxSyfa" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, September 30, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1358">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

&#160;<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zG7JtzNR8yvg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span id="xdx_8BA_zSAFMhLzu8hj" style="display: none">Schedule
of Fair Value Assumptions and Valuation</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20231231__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zOyVpPVa8Vb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6Vs42s56Jnc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20231107__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_zgw83huQwyL6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231107__us-gaap--FinancialInstrumentAxis__custom--PrivateWarrantsMember_z6IiyATv7Zh3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of November 7,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Private</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Private</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zEO2MB9nrjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.81</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">0.81</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5.25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">7.76</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zf1afDFSdnJa" style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zjnp3s5He9p4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45.0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.2</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_ztzmHVQD3t67" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.8</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.5</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.6</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zyS14PyGAws9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4806">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4807">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4808">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4809">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z1JB6b2FrNW7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zaQnSbTaqZDa" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
     measurement input</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.0</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value Assumptions and Valuation</a></td>
<td class="text"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z0EbGI9XuKg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B9_zbo4lpUx1OU6" style="display: none">Schedule
of Fair Value Assumptions and Valuation</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49F_20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember_z6yoFZjdrjI3" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49B_20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember_zdnqqfp3XZQ8" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of September 30, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">PIPE</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Business Combination</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_z8ofOzO0ac9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Stock price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.61</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">0.61</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember_zesH5Uq4iOC1" style="vertical-align: bottom; background-color: White">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zaCri8ck8v0j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.1</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72.1</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zr6WHQ05YrM9" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.6</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zXlftvXvisyj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1331">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_hus-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zSVXH8G4Gmsl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants measurement input</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1333">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1334">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected term (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--PIPEWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zUh0Fyou3Ww5" title="Expected term (in years)">4.1</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240930__us-gaap--FinancialInstrumentAxis__custom--BusinessCombinationWarrantsMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zU8xg8Aetap4" title="Expected term (in years)">4.2</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_899_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_z7nEjYXPSKbg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zvdqLwiSHLH8" style="display: none">Schedule
of Fair Value of  Stock Options</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zb4EqjAVvHcj" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4558">-</span></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zv7TKOPtaZah" title="Risk-free interest rate">0.73</span>% - <span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zI0UX2ZfVXvg" title="Risk-free interest rate">2.96</span></span></td><td style="width: 1%; text-align: left">% </td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zlxm0i4Fc2ii" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4564">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_904_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zhjGUBcEXN8j" title="Risk-free interest rate"><span style="-sec-ix-hidden: xdx2ixbrl4566">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected term in years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_ecustom--EquitySecuritiesFvNiMeasurementTerm_c20230101__20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zwbvwcufSdP4" title="Expected life in years"><span style="-sec-ix-hidden: xdx2ixbrl4568">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zn4w2yHn1Mt7" title="Expected life in years">1.36</span> - <span id="xdx_904_ecustom--EquitySecuritiesFvNiMeasurementTerm_dtY_c20220101__20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MaximumMember_zh6oP8V6f0u8" title="Expected life in years">1.85</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20231231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z2C4T4M15t91" title="Equity securities, measurement input"><span style="-sec-ix-hidden: xdx2ixbrl4574">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zMW0leDnbjz9" title="Equity securities, measurement input">50.0</span>% - <span id="xdx_908_eus-gaap--EquitySecuritiesFvNiMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zlG8ca1XMgD" title="Equity securities, measurement input">86.3</span></span></td><td style="text-align: left">% </td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Schedule of Warrants and Promissory Notes Measured at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zfPVMYOIcIFk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the changes in the Private Warrants, PIPE Notes and PIPE Warrants, and the convertible promissory notes measured
at fair value for the years ended December 31, 2023 and 2022 (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zrEje0gHNQzk" style="display: none">&#160;Schedule
of Warrants and Promissory Notes Measured at Fair Value</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold">Level 3 Rollforward:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--FinancialInstrumentAxis_custom--PrivateWarrantsMember_zWco2KKGbyyb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Private</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Warrants</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B0_us-gaap--FinancialInstrumentAxis_custom--PIPENotesAndWarrantsMember_zEJ3Ft6aQVr1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PIPE Notes &amp;<br/>
 Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BB_us-gaap--FinancialInstrumentAxis_custom--ConvertiblePromissoryNotesMember_zGKgmWZJDTJ9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Convertible</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Promissory</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Notes</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_z2fMhsCUjYpk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%">Balance, December 31, 2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4740">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4741">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,487</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43C_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zBviuiQPjWkl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4744">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,140</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20220101__20221231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zsijmKJu6ZB8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Changes in fair value</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4748">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4749">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,616</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_435_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zwRtIU9PSg3j" style="vertical-align: bottom; background-color: White">
    <td>Balance, December 31, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,243</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pn3n3_zlT96CCKvkPg" style="display: none; vertical-align: bottom; background-color: White">
    <td>Beginning balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4756">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4757">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,243</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_431_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_pn3n3_zh4h2E26WEMa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,175</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_433_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pn3n3_zVP5orAuH799" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Changes in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">151</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_pn3n3_zoNaKcB1iatd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Reclassified to additional paid-in-capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4768">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4769">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(47,935</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_z5E6isg1SAxe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balance, December 31, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,651</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4774">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43D_c20230101__20231231_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pn3n3_zVxglYhpJHcd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Ending balance</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,651</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4778">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132182096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Shareholder Loans Outstanding</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfDebtTableTextBlock_zesL6qwSYE91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B5_z0ak4ixSjEGh" style="display: none">Schedule
of Shareholder Loans Outstanding</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240930_zNCE49yHztcl" style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20231231_zvDVQSrNcA7i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September
                                            30,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_maCNPzu2j_zdGkeCM8yN3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Shareholder loans &#8211; nonconvertible</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">654</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">454</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ConvertibleNotesPayableCurrent_iI_pn3n3_maCNPzu2j_zkQ0zSIF2Cyc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shareholder loans &#8211; convertible</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1394">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestPayableCurrent_iI_pn3n3_maCNPzu2j_z6xU62AlZM37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LongTermDebt_iTI_pn3n3_mtCNPzu2j_zmPrw76GaPF6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total loan &#8211; related party</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,306</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">465</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590127363968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock', window );">Schedule of Aggregate Percentage Revenue and Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock_zQobtUlY9Fg9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zmqNIyggURV3">Schedule
of Restatement of Financial Statements</span><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--StatementOfFinancialPositionAbstract_pn3n3_zHB7otDeIImb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Restatement of Balance Sheet (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zruyu53jUhca" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zcfTKFbd2jqd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zCrqV71XHMwj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20231231_zseXWl5ARgmk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (<span id="xdx_F56_zoHeAO3yRzkb">1</span>)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_z3fZH6OQ10X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zXmzyt8ADHpc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_pn3n3_maACznbB_zwfJYNAqd4h2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2060">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%; text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsHeldInTrustCurrent_i02I_zQhwodfyf5vd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2064">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2065">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2066">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2067">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_pn3n3_maACznbB_zhZl1KSXxike" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance for credit losses of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zPo9iq8qLwpk" title="Accounts receivable, allowance">0</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zMIhH9k6HRqe" title="Accounts receivable, allowance">125,233</span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2070">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2071">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">152</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_pn3n3_maACznbB_zUCqDZwvR8h1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">166</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2079">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2080">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">166</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i02TI_pn3n3_mtACznbB_maAzRE3_zWVgddrEhU8f" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">365</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2084">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2085">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">365</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--DeferredCostsNonCurrent_i01I_pn3n3_maAzRE3_zadfKDc4WIPc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2088">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2089">-</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2090">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2091">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pn3n3_maAzRE3_zG9krXgkbKe1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2094">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2095">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Assets_i01TI_pn3n3_mtAzRE3_zRG9OArPib89" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2099">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zq1I6hLyExog" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zbZJCma4btqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zssMDVKCKb27" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">498</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2115">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,682</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zNPcfhGy81Dl" style="text-align: center">2</td></tr>
  <tr id="xdx_408_eus-gaap--OtherLiabilities_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z5EoFfgXn103" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2121">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ExciseTaxCurrent_i02I_pn3n3_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_zoHwN3FbTAHf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Excise tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2126">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--DeferredRevenueCurrent_i02I_pn3n3_maLCzjPj_zgTzWhgM5q78" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2129">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2130">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">254</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zqzqEDRPdHVe" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2133">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2134">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2135">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LoanExtensionsCurrent_i02I_pn3n3_maLCzjPj_zxQs4dQZsJhi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,992</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2139">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,992</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--LoansPayable_i02I_pn3n3_maLCzjPj_z4rAes4v5eLf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Loan payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(39</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2146">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--CanadaEmergencyBusinessLoanAct_i02I_pn3n3_maLCzjPj_zh8sEs0vfagg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2149">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2151">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccruedIncomeTaxesCurrent_i02I_pn3n3_maLCzjPj_zMZx9uIWYCb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">120</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2154">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(120</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2156">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DeferredUnderwriterFeePayableCurrent_i02I_pn3n3_maLCzjPj_zBTLDRUX27Ba" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_pn3n3_maLCzjPj_zjmSYJKQeNEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">87</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,637</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z70r7UPIkBw8" style="text-align: center">3</td></tr>
  <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_i02I_pn3n3_maLCzjPj_zxhw1hbC8X8d" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Other current liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2168">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_z7XLQgC9gMPe" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2173">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2174">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2175">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesCurrent_i02TI_pn3n3_mtLCzjPj_maLzhoA_zUAVIkx4mgr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">585</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(45</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,373</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--ConvertibleDebtNoncurrent_i01I_pn3n3_maLzhoA_zXYxZv4wnbE2" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2183">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_z0sV3xK1qwE8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2188">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2189">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2191">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_z3W70HCcYUcf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LongTermLoansPayable_i01I_pn3n3_maLzhoA_zWCkZbDgLii7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loan, related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2199">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2200">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_z3TrqGM1swRk" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2204">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2205">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2206">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--WorkingCapitalLoan_i01I_maLzhoA_znG3RD0bmoD8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2208">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2209">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2210">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2211">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--WarrantLiabilityNonCurrent_i01I_pn3n3_maLzhoA_zvrWCZOR9MLe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2214">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(25</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2216">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OtherLiabilitiesNoncurrent_i01I_pn3n3_maLzhoA_zzAZ5vz1nGW5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2218">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">68</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4E_zdVxtDBJ0vy4" style="padding-bottom: 1pt; text-align: center">4</td></tr>
  <tr id="xdx_401_eus-gaap--Liabilities_i01TI_pn3n3_mtLzhoA_maLASEzB9f_zWurd1Dcwf66" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13,323</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">583</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2225">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">13,906</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pn3n3_maLASEzB9f_zriAse0CJx5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2228">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2229">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2230">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2231">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--TemporaryEquityAbstract_i01B_zCjF4hRjdSM9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zxCEJ7wpVb28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zcQDvHCATRy3" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zmw2jLMPLdv3" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zk2kv65ICmXe" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8QQZwnKdLZf" title="Temporary equity, shares authorized">4,200,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zbwzb6ONsLgi" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zBohDzYt6cuc" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zPYyjWP6t8nl" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zDpri74qdrj4" title="Temporary equity, shares outstanding">3,415,923</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2238">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2239">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2240">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2241">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zvgShIKHTHql" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUdnjUXJ4Nc1" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUBfnzNHxmQ7" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zD2AuNLE5jti" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYuIuwhSTul" title="Temporary equity, shares authorized">4,400,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zFfkQRyVN4Y8" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgXlLITRaRd" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z75ktmKy0962" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z5lkoDhcdVvc" title="Temporary equity, shares outstanding">2,839,957 </span></span>shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2259">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2260">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2261">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2262">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_pn3n3_maLASEzB9f_zFJ3TKul93Da" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2280">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2281">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2283">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zWgvLMcwUEad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_pn3n3_maSEzYAb_zDP929DLJBcj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_zTouxWv5xMNj" title="Preferred stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zoAhJQ97gzT" title="Preferred stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zY9mbTXbyWjg" title="Preferred stock, shares authorized">1,000,000</span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_zaAG4dvCdMGb" title="Preferred stock, shares authorized">0</span> shares authorized at December 31, 2023 and 2022, respectively; <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_zeXWFKcteVZa" title="Preferred stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zFLSOBzdiIYi" title="Preferred stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_z2RDRUICTuA3" title="Preferred stock, shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zF0OtUHrvAid" title="Preferred stock, shares outstanding">no</span></span></span></span> shares issued and outstanding at December 31, 2023 and 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2290">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2291">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2293">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CommonStockValue_i02I_pn3n3_maSEzYAb_zKclxpQQ1fc5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zO8f1W2CvHd1" title="Common stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z0fgb54GPpF7" title="Common stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_z87XB46c1rqk" title="Common stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zlJ0WFifrcwj" title="Common stock, shares authorized">100,000,000</span></span> shares authorized and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_z37TR95QhdKj" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_zhQfhe7EP9Z4" title="Common stock, shares outstanding">23,572,232</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zD5XPgF0KCAh" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zOrvrjW3oymd" title="Common stock, shares outstanding">4,033,170</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2313">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_i02I_pn3n3_maSEzYAb_zr99liLi1UOj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,221</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,775</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2334">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,996</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zsHwSQ1sDr3" style="text-align: center">5</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pn3n3_maSEzYAb_zaNz42WzTBF6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(55,083</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(36,357</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2339">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(91,440</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F49_zKvHtgqXejJk" style="padding-bottom: 1pt; text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtSEzYAb_maLASEzB9f_zPwz0JsddSC7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total stockholders&#8217; deficit </b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(12,859</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(583</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2344">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(13,442</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtLASEzB9f_zgvnToSh7PEc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2348">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2349">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">464</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F0A_zxpPh2kj3NLd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zv3t0HiTxmkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zHmIIEvFd8Ne" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zQ2Kprb6wXq5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_z45MNyUdVjC3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z1BUgtO53Nk2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F01_zI0DPexFF7Xd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_z8uJZPF6GN1c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of liability-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zzIQLbw8bWJj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F11_zWvic4rLmBCb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zfMaYzeUq0yi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_z9pixMR8yD4a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Balance Sheet as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z6ivgJzJjlvk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBNy3rflnLOh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_zDVc23ZbTal1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F5B_z2orGC7gqCVd">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zyrQoTWDbpmg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsAbstract_iB_zoHhxMUlwOn3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Assets</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrentAbstract_i01B_zylrCrVigph8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_zklWvSmRU3hg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">302</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(31</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2370">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">271</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F44_zWiYZ0g0Crw7" style="width: 6%; text-align: center">2</td></tr>
  <tr id="xdx_409_eus-gaap--AssetsHeldInTrustCurrent_i02I_z5i7O4J0zNh9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Investments held in trust</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,029</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2376">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zlMEbFIQFeXl" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--AccountsReceivableNetCurrent_i02I_z91VCg6KuhUk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts receivable, net of allowance of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zXowDYdGPzGi" title="Accounts receivable, allowance">0</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zIJD7O8FvRM6" title="Accounts receivable, allowance">125,233</span> at December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2380">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_zQeyB686mQ62" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2388">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2389">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">101</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtACznbB_maAzRE3_zeC41by6Wz69" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left">Total current assets</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">29,451</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(29,060</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2394">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">391</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--DeferredCostsNonCurrent_i02I_maAzRE3_zjz3cdl7FRTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred transaction costs</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">900</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(85</td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">815</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zugrWwR5FxFg" style="text-align: center">3</td></tr>
  <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_iI_maAzRE3_zbYTPH2Futm7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Property and equipment, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">83</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2403">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2404">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">83</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Assets_iTI_mtAzRE3_zuFdBSWVj8ce" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">30,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(29,145</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2409">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_z3idIMSAttVf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities, temporary equity and stockholders&#8217; deficit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfMGnFVZHtZj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_i02I_maLCzjPj_zlbUKNPQwEya" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,814</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,637</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2424">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,177</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_z1PDq4D8k1bg" style="text-align: center">4</td></tr>
  <tr id="xdx_409_eus-gaap--OtherLiabilities_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzjPj_z387LtueELU9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Loan amount due to related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2430">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zSY0KCHBsjBj" style="text-align: center">2</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredRevenueCurrent_i02I_maLCzjPj_z9JdmARHcJg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2433">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtCurrent_i02I_maLCzjPj_zIdFD76ACDwf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,253</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,743</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zHBwRYiaiQg5" style="text-align: center">5</td></tr>
  <tr id="xdx_400_eus-gaap--AccruedIncomeTaxesCurrent_i02I_maLCzjPj_zd0KrYwUO0fh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2444">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2445">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zPc4odgOaoCa" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_eus-gaap--AccrualForTaxesOtherThanIncomeTaxesCurrent_i02I_maLCzjPj_zvh30x1dLpB5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Franchise tax payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">70</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(70</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4F_zT5OAzrQZl5f" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesCurrent_i01TI_mtLCzALC_maLzDXj_zJod9ww4Wxj7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,785</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,319</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,104</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ConvertibleDebtNoncurrent_i01I_maLzhoA_zIHuzIhaWiC5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2458">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--UnsecuredDebtCurrent_i01I_maLzhoA_zfKNTjGJYna2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2463">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(44</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2465">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_404_ecustom--AccruedInterestRelatedParty_i01I_maLzhoA_zGr6iAAo4DVb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(691</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2469">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2470">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zWbk5Oymcxfk" style="text-align: center">5</td></tr>
  <tr id="xdx_409_ecustom--WarrantLiabilityNonCurrent_i01I_maLzhoA_zGpl8dgESeb6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">363</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(363</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2474">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zoFnY3Hr2jo6" style="text-align: center">2</td></tr>
  <tr id="xdx_40C_ecustom--DeferredUnderwriterFeePayableNonCurrent_i01I_maLzhoA_zmTEozCqcKo5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,025</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,025</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2480">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy1llbxdPwRd" style="text-align: center">2</td></tr>
  <tr id="xdx_408_ecustom--WorkingCapitalLoan_i01I_maLzhoA_zCJ6wwyiyxX8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Working capital loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2484">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zy8mdZVEYor6" style="text-align: center">2</td></tr>
  <tr id="xdx_407_eus-gaap--LongTermLoansPayable_i01I_maLzhoA_zLbIae4ITDb1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Extension loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,546</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2489">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2490">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zj7IDgjpWd1b" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--OtherLiabilitiesNoncurrent_i01I_maLzhoA_zTmH1HjVwx28" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Other long-term liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2492">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">44</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--Liabilities_i01TI_mtLzhoA_maLASEzB9f_zJPu33kIRNI8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left">Total liabilities</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">21,161</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">6,488</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2499">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">27,648</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzB9f_z4bET9jAmas6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Commitments and contingencies (Note 13)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2504">-</span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2505">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--TemporaryEquityAbstract_i01B_zChswc4s12K1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Temporary equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zCNQhtB5sb38" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Preferred Series A-2, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zMglAdrlMTt5" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_z8CjB97Kyrk8" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zuhtwF938LQ" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zvZjuO1dS995" title="Temporary equity, shares authorized">4,200,000</span></span> shares authorized, and <span title="Preferred stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zYta6rHV0Uib" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zacGgWoOstM" title="Temporary equity, shares outstanding">0</span></span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_ziGtk3V4nsb6" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember_zOLOUQaIz6v7" title="Temporary equity, shares outstanding">3,415,923</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2512">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_z50ydQvD68Td" style="text-align: center">6</td></tr>
  <tr id="xdx_401_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_hus-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zgG0PJuk8Sdf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; padding-bottom: 1pt">Preferred Shares A-1, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zUXcga9S2JVd" title="Temporary equity, par value per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eus-gaap--TemporaryEquityParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zYCHWXEzs9ai" title="Temporary equity, par value per share">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zcQRvID0AXgg" title="Temporary equity, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--TemporaryEquitySharesAuthorized_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zQOdJGerQ3jb" title="Temporary equity, shares authorized">4,400,000</span></span> shares authorized, and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zg3c3qDYeBj" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_z9Aai5K2fUv4" title="Temporary equity, shares outstanding">0</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zrtw0CUjcqna" title="Temporary equity, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20221231__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember_zMctTmHlLhfa" title="Temporary equity, shares outstanding">2,839,957</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2533">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,010</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2535">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,010</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4B_z0vVaUYkTlw9" style="text-align: center; padding-bottom: 1pt">6</td></tr>
<tr id="xdx_40C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i02I_zQNtilKUcrb1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
temporary equity </b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2554">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,644</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,644</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_zlBYW8gmYu2d" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholders&#8217; (deficit) equity:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CommonStockValue_i02I_maSEzYAb_zc9TdGIsqNa6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Common Stock, par value $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_z5EF10mnZfIg" title="Common stock, par value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_zZset6MUT9Se" title="Common stock, par value">0.0001</span></span>, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231_zQcjfsQlc3r3" title="Common stock, shares authorized"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zDDZaWxqSTr5" title="Common stock, shares authorized">100,000,000</span></span> shares authorized and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231_zzH2BT9iwqQ4" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231_z24UGTu0EBAg" title="Common stock, shares outstanding">23,572,232</span></span> and <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zr2XpGWsvCs3" title="Common stock, shares issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zFaCWuPdJL7b" title="Common stock, shares outstanding">4,033,170</span></span> shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2566">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AdditionalPaidInCapital_i02I_maSEzYAb_z6yOhGiOFPc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,375</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2587">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,657</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zejDbpADROE9" style="text-align: center">7</td></tr>
  <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maSEzYAb_ze7UyEDUJZR1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(43,510</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,150</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2592">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(57,660</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEzYAb_maLASEzB9f_zq9LusNyoTo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,273</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2597">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzB9f_zQ7TyynSymYi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities, temporary equity, and stockholders&#8217; deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">30,434</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(29,145</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2602">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,289</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zQQ25kVU5LG8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td id="xdx_F1D_zcom1f3JbKv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F08_zxRpE7ddi9se" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F10_zqdJW85EC7P9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zaUqYTsXpy75" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F17_z12r7OJ9cdv1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0D_zkzbOYh5KVrc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1E_z0YDHGimDoYl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zhrofTMKWeul" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F1C_zGaauYyovNfl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F07_zg7mY89UOBh9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F15_zu9Mge4cdMl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for historical preferred stock as temporary equity.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zjbye4RasFl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F17_zTscRma7hil8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--IncomeStatementAbstract_pn3n3_zwkFbooRqn5b" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Operations (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaXGkJXpTCe4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z028oDaLxcnl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z40LEykJTRCe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F50_zZzgLezQkhG9">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zi0ZRYIKnBM3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zfQPdTtBiee3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zHeJfx3Vozbg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2620">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2621">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">878</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zPcMCXCGZPc9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2625">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2626">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHDo_z9waVkSQPWO7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,021</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2630">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2631">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,021</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHDo_z6GMLbvVfSac" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2635">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2636">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,150</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHDo_znNyLw8scYyi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2640">-</span></td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2641">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(129</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zCYcQRN6Sc3a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zq3x0GU7zIea" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,730</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2651">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,544</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zE9FiJGZnz6l" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zDBuLJ2WlWs8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">226</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2655">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(226</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zryX8YnXH7Yc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2660">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2661">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,115</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zaz5jo1m1yvc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,632</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">433</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2666">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,065</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F45_z9ClZTf3FKq8" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zJHTG9nQ0lGe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">8,247</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1,297</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(226</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">6,724</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zbQSvWT10ge1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(8,376</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,523</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(6,853</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8jXu5rEIzza" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zIkUcqgVzEBc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2686">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetImpairmentCharges_i01_msNIEzJuG_zSWikkgtMta9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Impairment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,504</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,504</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zMsz0tSF3PPe" style="text-align: center">3</td></tr>
  <tr id="xdx_40B_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zy58V1qNXhb3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">749</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(738</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2696">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUF6AddaOctl" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zj7QMQhvOLi2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,635</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4B_zPun54PZDMy8" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zpKYnI4UO24l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(47</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(82</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2706">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F49_zXwujTSGCHxc" style="text-align: center">6</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfPrivateInvestmentInPublicEquity_i01_msNIEzbEL_zb5UH1P07sL2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2709">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2711">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zQGlpsX4Pmdi" style="text-align: center">7</td></tr>
  <tr id="xdx_401_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zJEambHaPBre" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2716">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zzPTykfoVGAl" style="text-align: center">4</td></tr>
  <tr id="xdx_404_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zPo3ZpZ7XnEe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expense</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2720">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">34</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zL4eFL1DWeh6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2724">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2725">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_ziS6Q11zdOnd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,830</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">12,097</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(18</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26,909</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zPKUMtZQ1iU6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(23,206</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(10,574</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">18</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(33,762</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zgynma3E0s1d" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2739">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2740">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLoss_iT_pn3n3_mtNILzord_zgVpHaAbAfT9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(23,206</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(10,574</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2746">-</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(33,780</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zgtaMKf18hbg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zfMorvUR0clk" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zpRU0cyDmo7b" title="Diluted net loss per common share outstanding">(0.98</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zmNg5vQC4Bo8" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zFkAcqHuTXUi" title="Diluted net loss per common share outstanding">(3.78</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zJ0ZQpMQvn22" title="us-gaap:EarningsPerShareBasic"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90E_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zVerDL4ZXGak" title="Diluted net loss per common share outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2762"><span style="-sec-ix-hidden: xdx2ixbrl2764">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_906_eus-gaap--EarningsPerShareBasic_i01_pid_c20230101__20231231_fOA_____zaBkgZhbjVei" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareDiluted_i01_pid_c20230101__20231231_fOA_____zmwUHhQcSOc5" title="Diluted net loss per common share outstanding">(4.77</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____z36ArBhqPUy6" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fOA_____zErTzsc1irw3" title="Diluted weighted average number of common shares outstanding">23,572,232</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zoMuYwYXrcGa" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fOA_____zyyYt7a033s" title="Diluted weighted average number of common shares outstanding">(16,488,164</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zsBYKMj5kk97" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fOA_____zDQ3reWdjQE7" title="Basic weighted average number of common shares outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2778"><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20230101__20231231_zt2ybXAaUhe8" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20230101__20231231_zDgEREjS19nb" title="Diluted weighted average number of common shares outstanding">7,084,068</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">8</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F05_z39dTMQ7aKS1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F13_zBDhOn7yGByb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0B_zkIyW9V6GaL5" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z6pc3v68oqb6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zbAjVkGiaN6h" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F1A_zmaqyPMOauU5" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zUiPPdP75J9g" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z4AQVNJgwwje" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zfMpc6kW3D1j" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_z30zalgt25Q7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_znmNTrFvBWK8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zqbSoM383NGc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F08_zTL2gO4Z7NK1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z7OzvY6Ptmi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zgGQG6V9gICj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F10_z2vSr1u7Bt34" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Operations for the Year Ended December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAqyObC2l9kb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTj9bNOVZAOd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_z7veP8m81sFd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification
    Adjustments <sup id="xdx_F55_zM3RLW9AQV3j">1</sup></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20220101__20221231_z7s5h9N5psD8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="17" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reclassification Adjustments (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40E_eus-gaap--RevenuesAbstract_iB_maGPzI7h_zhSG1L632XDa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--SubscriptionRevenueMember_zmHR78PheYDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 40%; text-align: left">Subscription revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2800">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2801">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">678</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 6%">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_hsrt--ProductOrServiceAxis__custom--WebImagingRevenueMember_zfuzVjy0bBO5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Web imaging revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2805">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2806">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_i01T_maGPzHNd_z3M7b4W4iwk4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left">Total revenue</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2811">-</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,153</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CostOfRevenue_msGPzI7h_msGPzHNd_zp2gco9roem6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Cost of revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,513</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2815">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2816">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,513</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GrossProfit_iT_maOILzsEt_mtGPzHNd_zq3yDkZbOD2e" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,153</td><td style="padding-bottom: 1pt; text-align: left"></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2821">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(360</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpensesAbstract_iB_zMh80MASqE16" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzLOr_zkvLEULoFTgd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,756</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,950</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2831">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zzjd3qehnLZi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--OtherGeneralExpense_i01_maOEzLOr_zBXkCMPrzTD7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">399</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(399</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--SellingAndMarketingExpense_i01_maOEzLOr_zKEs7uT3IEsi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2840">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2841">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">958</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ResearchAndDevelopmentExpense_i01_maOEzLOr_zoahsy8GI69d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">953</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">638</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2846">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,591</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F42_z2kghhNL2bcg" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--OperatingExpenses_i01T_mtOEzLOr_msOILzsEt_zScGRpGXcBLh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">11,066</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(3,312</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(399</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">7,355</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingIncomeLoss_iT_mtOILzsEt_maNILzord_zwUEJLMn9Lq5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(11,426</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,711</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">399</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(7,715</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z8Q9WxvWWZJc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other expense (income), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxProvision_i01_msNIEzJuG_zgoKVFgTyK7k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Income tax provision</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2866">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2867">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_z6C8HsKy7cj1" style="text-align: center">3</td></tr>
  <tr id="xdx_402_eus-gaap--InterestExpenseNonoperating_i01_msNIEzJuG_zXSimJByCVFj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">403</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2871">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zv3crlecuyh8" style="text-align: center">4</td></tr>
  <tr id="xdx_403_ecustom--StockWarrantExpense_i01_msNIEzbEL_zBEXfcaZ2Tnh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2874">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F41_zrwCVEVSOSW7" style="text-align: center">5</td></tr>
  <tr id="xdx_409_eus-gaap--FairValueAdjustmentOfWarrants_i01_msNIEzJuG_zJsTq68EZYH2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2881">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2882">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z7PyhTCf4XM2" style="text-align: center">3</td></tr>
  <tr id="xdx_403_ecustom--FairValueAdjustmentOfConvertiblePromissoryNotes_i01N_di_msNIEzbEL_zUXxZiut0JIl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2884">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zazMZoxkpDv6" style="text-align: center">4</td></tr>
  <tr id="xdx_406_eus-gaap--OtherNonoperatingIncomeExpense_i01N_di_maNIEzJuG_zplVkutO87u5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><p style="margin-top: 0; margin-bottom: 0">Other</p>
                                                     <p style="margin-top: 0; margin-bottom: 0">expense</p></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2890">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(17</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_ecustom--UnrealizedGainLoss_iN_di_maNIEzJuG_zKLZPn97d85g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Unrealized gain or loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,372</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,372</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F46_zxXsAtefuDHc" style="text-align: center; padding-bottom: 1pt">3</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01NT_di_mtNIEzJuG_maNILzord_zck2r7mIQ1ua" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left; padding-bottom: 1pt">Total other expense, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,196</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">27,932</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(17</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22,719</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_maNILzObA_mtILFCOzyLM_zQQsZ98kFFhi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(6,230</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(24,221</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">416</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(30,434</td><td style="font-weight: bold; text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_msNILzObA_zlXyhHrqYtG6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Income tax expense</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2909">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2910">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzord_zxSEeHKVrTTh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(6,230</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(24,221</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">399</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(30,451</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareAbstract_iB_zLpq4rZCb2K3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Earnings per share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic net loss per common share outstanding"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted net loss per common share outstanding">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zLdkHTcYaNcb" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zWqk08J9R21j" title="Diluted net loss per common share outstanding">(7.66</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90A_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zALngv2ajKAa" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_900_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zmVC2juKldy3" title="Diluted net loss per common share outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2928"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareBasic_i01_pid_c20220101__20221231_fNg_____zr4Fpw3Z764f" title="Basic net loss per common share outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--EarningsPerShareDiluted_i01_pid_c20220101__20221231_fNg_____z5J1Eds5vKJb" title="Diluted net loss per common share outstanding">(7.66</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_" title="Diluted weighted average number of common shares outstanding">N/M</span></span> </span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____zGauFJJaMMa2" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNg_____z2m8eKFmBKdi" title="Diluted weighted average number of common shares outstanding">3,973,897</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zupxhmAMKlB" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231__srt--RestatementAxis__custom--ReclassificationAdjustmentMember_fNg_____zAANc7O5PDva" title="Diluted weighted average number of common shares outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2940"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pid_c20220101__20221231_fNg_____zI6r7ZgLzbhg" title="Basic weighted average number of common shares outstanding"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIHRoZSBPcmlnaW5hbCBhbmQgUmVzdGF0ZWQgU3RhdGVtZW50IG9mIE9wZXJhdGlvbnMgKERldGFpbHMpAA__" id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pid_c20220101__20221231_fNg_____zO0Kt17dPiZ3" title="Diluted weighted average number of common shares outstanding">3,973,897</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 2.5pt">6</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F02_zMW0yTCrPjCc" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_zOXZ2WhRJaBb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zElkDXBk5h94" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zodThWHzZ69i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0D_zTdonRR7Nadi" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F13_znclEY6Lw4te" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_z8AAMabERG51" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F12_z8S0HYfft0v8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0C_zwrpnNPz4BW2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_ztJ1mOOHa1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_z08xFT13J7Uf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F12_zpWOpJCTLxQ9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Cash Flows for the Year Ended December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--StatementOfCashFlowsAbstract_pn3n3_zRnKaIw7jdjk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zYZd2yEkwFr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zr7cwzqut9Ii" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zBcdhZk85qA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2023</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUzGvm_z64DQItPSa96" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(23,206</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(10,574</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(33,780</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F43_zw3VLV9eU38g" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzSqX_z1Siz3WmGyPa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2969">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_ecustom--BusinessCombinationCost_i02_maNCPBUzSqX_zKu7p8ybV0Nf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Business combination cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">900</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(900</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2974">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zhSRmmNKghZj" style="text-align: center">2</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zIioh3o057C2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">29,029</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(29,029</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zvkI2gMnv3K4" style="text-align: center">3</td></tr>
  <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_i02_maNCPBUzSqX_ztlKU4wKp3L" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2980">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F40_zuT4zzgsB7S7" style="text-align: center">4</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_z1LfWwh2ycDa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2984">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zWhhCrOvLBH1" style="text-align: center">5</td></tr>
  <tr id="xdx_402_ecustom--WarrantExpense_i02_msNCPBUz449_zroQluWiV8M5" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2989">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ChangeInFairValueOfWarrantLiabilities_i02N_di_zly6v0jfmvIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrant liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(129</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4C_zLzzviNlbyti" style="text-align: center">6</td></tr>
  <tr id="xdx_405_ecustom--ChangeInFairValueOfPipeNotes_i02_maNCPBUz449_ztCqzYltXv2j" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of PIPE Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2996">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">269</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zBYtlwHGJs4a" style="text-align: center">7</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_z6Wa9gfFadpl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3000">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zUuACnxP3RHe" style="text-align: center">8</td></tr>
  <tr id="xdx_40C_ecustom--NoncashInterest_i02_maNCPBUz449_zRk5FKwAcIlj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Non-cash interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F42_zX8QjC4r71w1" style="text-align: center">10</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zmyVVkwjHxCk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_zkjFOQ06zN9g" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(133</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zsMiljgIih9h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(65</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(43</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4E_z8iICOZIL45l" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_zxkdC3Z1VQSe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,372</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(655</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zgbHqM25Rwih" style="text-align: center">2, 3, 9</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zS794PTHhJgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3025">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_zKQni9fVV3Pf" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3028">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3029">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInExerciseTaxLiability_i03_maNCPBUzSqX_zZPZkw6z6kg7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Excise tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">113</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(113</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3034">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4E_zTpyxRxtxAA2" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInExtensionLoan_i03_pp3d_maNCPBUzSqX_zSXrTBuq4qfl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">446</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(446</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3038">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zUlA1KyjgDe1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zDM2jYf7zMT6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(70</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3042">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zqJtwPbubevg" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zhTXU4CWz6xj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(95</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3046">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zYqLLsaf7Lh1" style="text-align: center">2, 3</td></tr>
  <tr id="xdx_406_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zirFCYKadrqb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(168</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">168</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3050">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F4D_zH1aXYrl5jG7" style="text-align: center; padding-bottom: 1pt">2, 3</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zE1wO1c9Wxi5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,221</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(13,012</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,791</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zKOBqaEyKXva" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zYXgFU3g6oD2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3061">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zqHSZoyjrJ1l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3065">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(44</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zkxDU18xN9nb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01_maNCPBUzy34_zJEOsi6pVYlc" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3072">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3073">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3074">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_403_ecustom--ProceedsFromIssuanceOfShareholderLoans_i01_maNCPBUzGlA_zOdW1gnmqlp1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of shareholder loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">465</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">454</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zaFdLfoupmci" style="text-align: center">10</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzGlA_zg5nyHeTYEI" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of PIPE notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(50</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_z7M2VCjCnc7k" style="text-align: center">7</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_z07juzthWC5b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3086">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_z3atOgujEQs4" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--ProceedsFromDeferredUnderwritingFee_i01_maNCPBUzy34_z9DVkGtZLhz8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred underwriting fee</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(500</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3090">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zGwrp2TfzbYk" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_zZ0dyaR3S7wd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(338</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">338</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3094">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zf9QU9Misnz9" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_zAYoX8b1m1Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(18,189</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3098">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F49_zYzwxZ33MZH7" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zWwMIO92Lofd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3102">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zx7FQKfwoy5h" style="text-align: center">2</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzy34_zR6lDSHfT83b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds (repayment) from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,681</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,175</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zxaWnkX1BqN2" style="text-align: center">8</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zsP3rV8DUkjg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3108">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3109">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3110">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ProceedsFromIssuanceOfSeriesA2PreferredStock_i01N_di_msNCPBUzy34_zDu7i4VAkpD1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3112">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zISOUvH1P1t6" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z8WjtJFHZn59" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3116">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,534</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,534</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F40_zyrejfqwdML3" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zfXYzRVj6q5a" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(8,432</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13,043</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,611</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_z8gBwTb88MTj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(255</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(224</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zW01Oi5i7WK7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">302</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(31</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">271</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zXFeWXa49hi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3133">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">47</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zoOYkLkcKEY8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of non-cash investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_ecustom--CommonSharesIssuedToPreferredShareholders_i01_zL5AXy97jdhe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to preferred shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3140">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_zsN1AMyCjzzd" style="text-align: center">2</td></tr>
  <tr id="xdx_405_ecustom--CommonSharesRelatedToConvertiblePromissoryNotes_i01_zoPsrtyw1oY" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Common shares related to convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3144">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4F_zZAuoRZhbqq6" style="text-align: center">2</td></tr>
  <tr id="xdx_40D_ecustom--CommonSharesIssuedToDataKnightsShareholders_i01_zK8SHJvpIxr8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Common shares issued to Data Knights shareholders</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3148">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F45_zurSmY3KUYv1" style="text-align: center">2</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F01_zhL240hE6k3b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_z9dm4Vp0An6b" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zGGQ55l6kmh1" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zUeE55Ju80t3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0A_z4MZv7ZYiCC8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F18_zI2WxXsdey6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F06_zG13g7DRpeth" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1C_zYTXI3E04L3i" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zHRA8LZW1Ws9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td id="xdx_F11_zg5hJyL5Obpi" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F01_zyqW1Xm1i1Kh" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F10_zrt2utkjYT66" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0F_zIYCaCTFZ5G9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td id="xdx_F1B_zgD8LP6mENc7" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0F_z7fNBeaoaagc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td id="xdx_F1E_zTJJUc68HjP" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F05_zrYUaf70UVgf" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
    <td id="xdx_F15_z2QRlzGBbmY" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F00_zjJ3QhCQi3U6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
    <td id="xdx_F12_zWah1vcZocA8" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><b><i>Reconciliation of the
Original and Restated Statement of Cash Flows for the Year Ended December 31, 2022</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd1GVUj81Op9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zBhCw3tfNvi7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_ztK2LT4qQfpe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31, 2022</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As Previously Reported</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Restatement Adjustments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As <br/> Restated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_pn3n3_zFzKoT6TF5kc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_i01_pn3n3_maNCPBUz449_zhjXV3tvln2c" style="vertical-align: bottom; background-color: White">
    <td style="width: 47%; text-align: left">Net loss</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(6,230</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(24,221</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">(30,451</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td id="xdx_F4D_zjxT1FD9l7P" style="width: 6%; text-align: center">1</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_pn3n3_z0076fqc8VT5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--DepreciationDepletionAndAmortization_i02_pn3n3_maNCPBUz449_zm9JPLeVIQE8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ShareBasedCompensation_i02_maNCPBUz449_z6Q7ZgrwjTL4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zIJNrmfhBsRc" style="text-align: center">3</td></tr>
  <tr id="xdx_400_ecustom--CashHeldInTrustAccount_i02_maNCPBUzSqX_zS5SB85M13E2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash held in trust account</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,292</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,292</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3184">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1NfzNBC5JKe" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--StockWarrantExpenses_i02_maNCPBUz449_zC68WqLkgJX6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_z6tBAOitcY1h" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--WarrantExpense_i02N_di_msNCPBUz449_zEuTdXmz78d8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Board of director warrant expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3190">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4A_zkBk4aNHnwei" style="text-align: center">4</td></tr>
  <tr id="xdx_407_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_i02_maNCPBUz449_zCUJBEmM2g0g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3194">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,616</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F43_zpczmZJibJ92" style="text-align: center">6</td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zAzE1OfS3Mo7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Change in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUz449_ztG0vsbqUXte" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3203">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInPrepaidExpensesOther_i03N_di_msNCPBUz449_zluTWoieg0s6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(876</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">817</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(59</td><td style="text-align: left">)</td><td>&#160;</td>
    <td id="xdx_F4B_zNedHdvlJBW" style="text-align: center">2</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i03_maNCPBUz449_z0I3mGes2Dxf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,929</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">415</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z37tNNq9Qes9" style="text-align: center">2, 7</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i03_maNCPBUz449_zeDSeDuJMSm6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Deferred revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(458</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3215">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(458</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUzSqX_z2GxU8Wb6ygk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Amount due to related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3220">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zSE3xgLclZB5" style="text-align: center">2</td></tr>
  <tr id="xdx_409_ecustom--IncreaseDecreaseInExtensionLoan_i03_maNCPBUzSqX_zgskN7980aF2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Extension loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,546</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,546</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3224">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4C_zmZ2D62zyLMe" style="text-align: center">2</td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseFranchiseTaxPayable_i03_maNCPBUzSqX_zyV7jFslgyRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Franchise tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(94</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">94</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3228">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F44_zQybhbNoVMKf" style="text-align: center">2</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i03_maNCPBUzSqX_zL2rQVS8QfE" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 30pt; text-align: left">Income tax payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">215</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3232">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zdRnntdJgKm" style="text-align: center">2</td></tr>
  <tr id="xdx_403_ecustom--IncreaseDecreaseInWorkingCapitalLoan_i03_maNCPBUzSqX_zzuEL6o9ruce" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 30pt; text-align: left">Working capital loan</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">207</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(207</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3236">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F47_zNJP4fjQSaP9" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_maCCERCzG9C_mtNCPBUz449_zJJhW4QBOtek" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">87,241</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(91,944</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4,703</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zilVvTyW6epe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz4Jr_zNGRgLG7f9O3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Purchases of property and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3247">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz4Jr_maCCERCzG9C_zjhR5EClnx7a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3251">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(58</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zyvRblK7SBoe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_406_ecustom--ProceedsFromCanadaEmergencyBusinessLoanAct_i01I_maNCPBUzy34_z2KX3jMiyK3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payments of Canada Emergency Business Loan Act</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3260">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40A_ecustom--ProceedsFromCommonStockSubjectToRedemption_i01_maNCPBUzy34_zrfUrQmF8m43" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock subject to redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(88,550</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">88,550</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3264">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F45_zA55vPOU2Hib" style="text-align: center">2</td></tr>
  <tr id="xdx_40E_ecustom--ProceedsFromWarrantLiability_i01N_di_msNCPBUzy34_z9RjVyh6e9h6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,489</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3268">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F4D_z1Q1QdwsjcB" style="text-align: center">2</td></tr>
  <tr id="xdx_40A_eus-gaap--ProceedsFromContributedCapital_i01_maNCPBUzy34_z6L0fxtNkTd5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3272">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F46_zVJ0w3BVrU96" style="text-align: center">2</td></tr>
  <tr id="xdx_402_ecustom--ProccedsFromRetainedEarningsAdjustment_i01_maNCPBUzy34_zYdeays3yNz7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,360</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3276">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F47_zvYGPpCF8ALi" style="text-align: center">2</td></tr>
  <tr id="xdx_403_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzGlA_zxuSCkdEwgk1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,543</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(403</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,140</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td id="xdx_F48_zQ8Xe760x2r2" style="text-align: center">6</td></tr>
  <tr id="xdx_40E_eus-gaap--ProceedsFromStockOptionsExercised_i01_maNCPBUzGlA_zYGmsnBOP9B5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3282">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">N/M</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationCosts_i01N_di_msNCPBUzGlA_z3TyDWcTRTM6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Business Combination Costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3286">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(815</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(815</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_F43_zKeSKcvznUJk" style="text-align: center; padding-bottom: 1pt">2</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzGlA_maCCERCzG9C_zwmIc6mhnd5e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(88,033</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">92,366</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzG9C_zp4EyvM8G2Tg" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net decrease in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(850</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(428</td><td style="text-align: left">)</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zDY2bKGDYzo7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,152</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(453</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">699</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zKczG8qKbiOc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">302</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(31</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">271</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zYSJMmCsa0ka" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zLKRQx9dshs8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_z87rmpJn3ZB8" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td id="xdx_F15_zDRZS1dv1eOl" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zxbQFNbtYzE9" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td id="xdx_F10_z42bK2J0pX1f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F04_zAgkZCBqrDZc" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td id="xdx_F1A_zFDMqwcniOib" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F0E_zCFiNFZCBLKj" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td id="xdx_F13_zrElvg95e3hb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td id="xdx_F07_zMeCuTCN8Un6" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_z00H9AjztdPb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improper
    presentation of Business Combination costs as well as errors identified related to capitalization of such costs. Refer to balance
    sheet restatement reconciliation for more information.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--StatementOfStockholdersEquityAbstract_pn3n3_zbzwUQkL3AE" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zd8vvcZGRvQ" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zK5CmsM1ZRH1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zqwRhzUrgNN" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zWLv2SAVVLB" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zJ1EbxPqWHa2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_439_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zkuypag4rQ83" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zSbLFbtZqFHd" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zlv5Cf5sOUO3" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3322">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1NbSqGrvhck" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8AgftvLtU5f" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3326">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zUidXthwSV4a" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3328">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXBFGFyRKYs2" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">9,388,958</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">1</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">28,750</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">24,032</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(43,510</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">9,273</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zXjcEC2yKbDd" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zww2RJZCA4ii" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zTybYcahs77" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_fMg_____z83jL5Bb2Imd" style="text-align: right" title="Issuance of common shares in exchange for services, shares"><span style="-sec-ix-hidden: xdx2ixbrl3350">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3344">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3345">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3347">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3348">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zM6gBXLBUoac" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKviQDmZq1Bf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of stock options, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zrI4xcsaTqM3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdXG50votS8i" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares"><span style="-sec-ix-hidden: xdx2ixbrl3370">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3364">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3365">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3368">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoFXc0EowaZ4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3372">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3373">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3375">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3376">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqMk9V97gCEa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcyI1ubllCfe" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">612,670</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3378">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3379">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3381">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">613</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3isqa2ILvij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0wDNGMku6F5" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">3,859,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3386">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3387">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,859</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,859</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zB1ofR7bGO37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible loans upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zCuKJG4XINv" style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">6,177,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3395">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,177</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3397">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,178</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjRLnI869rq7" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zWPCyxfSZ185" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination, shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right" title="Conversion of OMN convertible loans upon Business Combination, shares">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4v1VSB6GRm4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zOvsvOeYyLy8" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(3,853,797</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBDYBabeNKUb" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(3,204,000</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zp8TtqKLkxy6" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">7,057,797</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3415">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,057</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3417">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,058</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z4R3JHuzW4d4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZtIFRsSvo14" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares">(2,257,326</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3426">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3427">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,257</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3429">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,257</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zImjAQyx1dl4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3434">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3435">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zgVEMYmeVYy3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zHK8uetxWRNh" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">(1,266,560</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3440">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3441">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3443">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">746</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zf5V5sZPtbyj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3448">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(28,750</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zwO9nIUVQfV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3454">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3455">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,893</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3457">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,893</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zqIeAYcOEJbg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3460">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3461">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,633</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5nNrvH7L1L9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Issuance of OMN warrants to board of directors</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zZcqEVw4aErc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3472">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3473">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,206</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(23,206</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z4K0kNmW97ad" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zjvqdYJmE8N2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3484">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0iPc6CFVON" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3486">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zy620ElYt97c" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3488">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zz3W42bVrfFi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3490">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zdbBjALrE3Gc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3492">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zd0cvaM8AvNe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">23,572,232</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">3</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3479">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">42,221</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(55,083</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(12,859</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Restatement Adjustments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zLnYlZvsp0f9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F40_zDAvoewh2ue2" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zpxqTeO4I9oj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(437,874</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z3b6qXBzzlG9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zNnUY7L7xiFg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(364,043</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zHGmzmExCnHh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zvzFm0ziawq9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z8CWxY9bZ134" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(5,355,788</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(10,375</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(14,150</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zygwwWmssSs5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zHj5CkaxLx3i" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z7bwirrTghH1" style="text-align: right" title="Issuance of common shares in exchange for services, shares">265,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3514">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3515">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3516">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3517">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3518">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhw8GZcbOHQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zCtEitmMNUb6" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zq0XsuIEjQvb" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares">5,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zQsW2gSboNpd" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____z1nHfpTejBah" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3522">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3523">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3524">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3525">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zsl433z8PvWb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zTC0qdQyxOY2" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3534">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zRyPxcD6Gycd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F40_zhV9klln87bd" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zAVkHqJQ1fb2" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">(69,614</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3540">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3541">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(613</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3543">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(613</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zjBvsJuZkRNl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_zcH3UUXvIdIc" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zpIkisGK5jO4" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">(438,519</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3548">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3549">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,859</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3551">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,859</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zplLOy1ht2pe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_ziLCg9j2iOU2" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zRbYZNCGx08i" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">(701,867</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3556">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3557">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3559">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,758</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zaAxdbDBbKxl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4A_z0OGPFi514ba" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zMlytimJOcF6" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">432,201</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zFcFkIPEa4kh" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(9,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____z9frGH3YO8Og" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">364,043</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zT27h15QDmob" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(8,010</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zbrxmPwclQl8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(17,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zITjZmoEl281" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(796,244</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3564">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3565">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,602</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3567">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(7,058</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGSxBeU5qafe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F43_zDEM3QbSe4Z8" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fNA_____zD5Fu6pKoZ99" style="text-align: right" title="Private OneMedNet to ONMD Public Shares, shares">2,257,326</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3582">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3583">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,257</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3585">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,257</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuatop1tYVa3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4E_zH7SDweyyBr1" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3590">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3591">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3593">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(101</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zu7klaV3kl0e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F41_zXvkqXSkdojg" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zQZ4FUPjak9f" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">4,838,792</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3596">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3597">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,683</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3599">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,683</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zZcv5xa7e8kd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F45_zbh8HYc2n1da" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3604">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3606">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3607">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,750</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zqFv5qjxO3F8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zPksoWAMCJv6" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3610">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3611">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(418</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3613">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(418</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z1PrgZqUBDwg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4B_zEpLKUsQUK54" style="text-align: center">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3616">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3617">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3618">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,633</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgO3DzksH894" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4E_zebKylsMKZnd" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3622">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3623">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3624">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,574</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(10,574</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43B_c20230101__20231231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zEzrIG974kB6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (restatement adjustments)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3xQtxPEgetg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3634">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z0LbHAIAdUp" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3636">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zWsGyytsoFY1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3638">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z3dqYsKfeCd7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3640">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_ziLn7iNhwNub" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3642">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zGiZyyb9ObIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3644">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3629">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">35,775</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(36,357</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(583</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">As Restated</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_434_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zCERd0BC8Edb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zi65lAIuLzI5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,415,923</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z6uXJ7vZHdjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zcrTCJ23Lc8h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">2,839,957</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zSIzwmTqxAae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zQlhYEki4WHj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zEa3Euv8yG7b" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">4,033,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3646">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3647">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">13,657</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(57,660</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zRh9MNfOQbN6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zKhabU7B1IXj" style="text-align: right" title="Issuance of common shares in exchange for services, shares">265,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3664">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3665">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3666">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3667">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3668">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zhvp3TSV5JVc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Series A-2 Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zkKNCOHCGNYi" style="text-align: right" title="Issuance of Series A-2 Preferred Stock, shares">5,673</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zBl8PdJEW3Fg" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_ztPun9js0gHl" style="text-align: right" title="Issuance of Series A-2 Preferred Stock">16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zAmG6EO8ecvg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3684">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3685">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3687">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,207</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zV9qXvnTf4X3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Exercise of OMN stock options upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zof3JCdzGJy6" style="text-align: right" title="Exercise of OMN stock options upon Business Combination, shares">543,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3690">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3691">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3692">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3693">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3694">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--StockIssuedDuringPeriodValueWarrantsExercised_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zcMHotUSQHRe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Exercise of OMN warrants upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesWarrantsExercised_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zeypJR6uOcGa" style="text-align: right" title="Exercise of OMN warrants upon Business Combination, shares">3,420,945</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3698">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3699">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3700">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3701">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3702">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zfItEKG9a5D5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of OMN convertible promissory notes upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z8Q793oFY6nc" style="text-align: right" title="Conversion of OMN convertible promissory notes upon Business Combination, shares">5,475,362</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,935</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">47,936</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zg0xUHJQhupl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of preferred stock to common stock upon Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_ztPA7LA28WGd" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(3,421,596</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zM2ygMU7QyFk" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(9,650</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zFWUKYVBc9i5" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">(2,839,957</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_z91jAoZWsSK4" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(8,010</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zVxd72lcoUS8" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination">(17,660</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_z842Un0CdEeg" style="text-align: right" title="Conversion of preferred stock to common stock upon Business Combination, shares">6,261,553</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,659</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3718">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueOther_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z8QjpVGyUPod" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Private OneMedNet to ONMD Public Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3732">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3733">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3734">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3735">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3736">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalWarrantIssued_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zVfX9LzWmXC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of PIPE warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3738">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3739">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3740">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3741">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3742">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_z4FQbGPN3q37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zGyfI7Nay6Tf" style="text-align: right" title="Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares">3,572,232</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3744">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3745">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3747">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11,937</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--CommonStockSubjectToPossibleRedemptionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zn28LbtLErUe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Common stock redemption</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3752">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3753">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3754">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3755">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3756">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zPS9BXk3A5Q6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3758">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3759">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3761">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,475</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueRetainedEarningsAdjustment_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zoyWjR9ZfmX4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retained earnings adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3764">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3765">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3766">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3767">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3768">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--RestatedMember_zpMrABjxHPM9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3770">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3771">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3772">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,780</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,780</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20230101__20231231__srt--RestatementAxis__custom--RestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zfRwOC5WxoLl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2023 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zA8QIoRKWpBf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3782">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zrinSGD4zYy" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3784">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zTYsCn8TomIb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3786">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--RestatedMember_zVYGhC0pQrw8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3788">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--RestatedMember_zRQ4EtchBpk7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3790">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230101__20231231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--RestatedMember_zboRJOiguk2e" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">23,572,232</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3777">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">77,996</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(91,440</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(13,442</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F06_zUiD7Qvo1dF5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zbiLSN0c8sW" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    impact of corrections of errors to the prior year.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zuwvJHWa9Qsc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zoyXhvCVdcj2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting and presentation of the recapitalization.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F00_zXFfXM0FUxdd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_z8741aGRMBg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F03_zR4FwFBByqVj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zyRwSInVDUs2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F04_zlaXOkrERoi4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zG6TTXuWq7t7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F02_zXs8hJHKY1f2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F19_zUXZ0owxwFbb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reconciliation
of the Original and Restated Statement of Changes in Temporary Equity and Stockholders&#8217; Deficit as of December 31, 2022</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zW5uco0SMtSh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_custom--CommitmentMember_zrIdmjFOdate" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_ztCUO5HaRbVk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zhuYeBR4mRoh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BA_zkCvhsJ1MJPl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-2</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">Series A-1</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Temporary</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="6">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Total</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Equity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Paid-in</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Accumulated</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Stockholders&#8217;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Ref.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Commitments</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Capital</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Deficit</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">As Previously Reported</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrNm0ijsZPx4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 16%; font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: center">&#160;</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAcgwhinqMD4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z1T2qWsARIe4" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3808">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuS7rvgTthDk" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zAPwynqPG39e" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3812">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zmIeWOsviLx8" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl3814">-</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zGS035o8Ql7d" style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right" title="Beginning balance, shares">7,802,941</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">1</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">28,750</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">19,607</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">(33,920</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 3%; font-weight: bold; text-align: right">14,438</td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuKXvvBVg7qa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zcpL8pWl3lf2" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">1,378,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3818">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3819">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,360</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(534</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIWlWMbHJUOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z9ML9jv2UZS3" style="text-align: right" title="Issuance of common shares in exchange for services, shares">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3826">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3827">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3829">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBYL9zVXKgk" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNn9md3kQVj9" style="text-align: right" title="Exercise of stock options, shares">7,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3834">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3837">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zvh2OxydzaY9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3842">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3843">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3844">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3845">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3846">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zaiX9poMuPoh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3848">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3849">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3850">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3851">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3852">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z5thZ2Xh2Hsj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3854">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3857">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,392</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z0tYj64RAV6g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3860">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3861">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3862">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,230</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,230</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43A_c20220101__20221231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_eus-gaap--StockholdersEquity_iE_pn3n3_zobHW8vZbi64" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as previously reported)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zyvTNxCFGuE5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,853,797</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z8vxe5cfXKMl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3874">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zuu4od7drGh4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,204,000</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_986_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zoiV8vo2EkS5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3878">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zNG5tnOqwZd3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl3880">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zfDbaFYqc7d1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">9,388,958</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">24,032</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(43,510</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">9,273</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Restatement Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iS_pn3n3_zhDxKNCYKEJj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F4F_zNoljWR8FXOg" style="border-bottom: Black 1pt solid; text-align: center">1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zOiSKm9Y18M5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3890">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z4SX7bmLswU1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zp50a3vBuuyc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl3894">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zbwued2BiB6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____zLCW3sTmfox5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMQ_____z5j9fZFJU6s1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">(3,460,275</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(17,094</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">6,711</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(21,490</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40E_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zmjfh2oZy4n5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F47_z4BL9SKw3H43" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zBqgxqtz2p6c" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(437,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zsXNpsNJNxp5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(364,043</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zkFrQeWMPwqe" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(1,871,937</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3902">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3903">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">534</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zUwl79ZHOcIi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F48_zLyF1icLyyY7" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zvEl2Uhodt9a" style="text-align: right" title="Issuance of common shares in exchange for services, shares">(22,724</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3914">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3915">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(200</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(200</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zhK8jGiUmqO8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4D_z3pfjJmavaVd" style="text-align: center">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_fMg_____zlNdzOClaP1i" style="text-align: right" title="Exercise of stock options, shares">(852</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3922">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3923">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3925">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_za9Aev5bcs01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zGaE6XDWo0We" style="text-align: center">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3930">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3931">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3933">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_z8hLbwNTPbb9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F49_zCojnMZDTpW6" style="text-align: center">4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3936">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3937">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3939">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zEVLrZSKq5Bl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_F4C_zae9qLTfo1K5" style="text-align: center">5</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3942">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3943">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">473</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3945">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">473</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zclWPo1aIwbe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_F47_zBbAJaZMwUgg" style="border-bottom: Black 1pt solid; text-align: center">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3948">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3949">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3950">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,221</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,221</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43F_c20220101__20221231__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_eus-gaap--StockholdersEquity_iE_pn3n3_zyYjTX0xhooj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (restatement adjustments)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zgWvh1mNxHC1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(437,874</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zefDHoLOM7El" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zuXimcaSYwmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(364,043</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVF3mcJLaYTc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zVW6xo9eel76" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zO8CGAdbB5Se" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">(5,355,788</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(1</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(28,750</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(10,375</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(14,150</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(35,632</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">As Restated</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr id="xdx_431_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iS_pn3n3_zrXFWLTIonP6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2021</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_znrSJXtswFu1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,853,797</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zDWmfRBTLSv8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9eknUZYUPk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">3,204,000</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zLWYelQ5MJg9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--StockholdersEquity_iS_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_zAD8l9lcw6Zd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zEbjcWBfmguh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Beginning balance, shares">4,342,666</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3973">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2,513</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(27,209</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(7,052</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_407_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombination_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zGTdqTNBZigd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retroactive application of recapitalization due to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zMytJlaMvyi5" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(437,874</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zjkVEXnj5cM" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(364,043</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zS3jYyKzBF04" style="text-align: right" title="Retroactive application of recapitalization due to Business Combination, shares">(493,420</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3990">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3991">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3992">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3993">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl3994">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zcFGLAmG0cU9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares in exchange for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_z0wnuWNESsub" style="text-align: right" title="Issuance of common shares in exchange for services, shares">177,276</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4002">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4003">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4004">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4005">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4006">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zHMgzJLqZJb6" style="vertical-align: bottom; background-color: White">
    <td>Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zajonvshXIY2" style="text-align: right" title="Exercise of stock options, shares">6,648</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4010">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4011">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4013">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_pn3n3_hsrt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zTnAIjQZ5aT8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of OMN warrants in conjunction with convertible promissory notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4018">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4019">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4021">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,073</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_z8tAwixWGQHh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of OMN warrants to board of directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4027">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zaJ6OskwPPY7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4030">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4031">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4033">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,865</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLoss_pn3n3_hsrt--RestatementAxis__custom--AsRestatedMember_zmUgeFgH4gy" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4036">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4037">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4038">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,451</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(30,451</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20220101__20221231__srt--RestatementAxis__custom--AsRestatedMember_eus-gaap--StockholdersEquity_iE_pn3n3_z6eucAVAQpA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balances as of December 31, 2022 (as restated)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zW5wCE0trGKd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">3,415,923</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98C_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesATwoPreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zIKJ6AxaTxh8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">9,634</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_z3lPg63tnHJ3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">2,839,957</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_98A_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__us-gaap--StatementClassOfStockAxis__custom--SeriesAOnePreferredStockMember__srt--RestatementAxis__custom--AsRestatedMember_zcL2aOMXs0D5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">8,010</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--StockholdersEquity_iE_pn3n3_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TemporaryEquityMember__srt--RestatementAxis__custom--AsRestatedMember_ztospgNmuhO5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance">17,644</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RestatementAxis__custom--AsRestatedMember_zH9vePJiASM6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Ending balance, shares">4,033,170</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4042">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4043">-</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">13,657</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(57,660</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(26,359</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 0.25in; text-align: left"><span id="xdx_F0F_zGF24QwsV3Ke" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1A_zGlRskPx0Ma4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cumulative
    impact of corrections of errors to the prior year.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zGSobA1i1T6j" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F11_zodBNv0iJGqk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting and presentation of the recapitalization.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F0D_zsNEl2u7LGlj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F11_zbg3ir20cxef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zrPYGRKo8Joa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F10_zerEnUYVHRTd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of error related to identificatoin and recognition of board of director warrante expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F03_zDtv9dtOoYMi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span id="xdx_F19_zFz7iviKaa8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: left"><span id="xdx_F05_zMr7Ef6oH2v7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span id="xdx_F1E_zuS5qUnBBoP6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    year impact of corrections of errors to the consolidated statements of operations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Schedule of Aggregate Percentage Revenue and Accounts Receivable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Aggregate Percentage Revenue and Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_890_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zgGvtOyEhOV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BC_ztBzoaioJk74" style="display: none">Schedule
of Aggregate Percentage Revenue and Accounts Receivable</span> </span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_ztAMsg3u6Fq" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20220101__20221231_z5i9CaU9Qsb5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_ztkjHnOoUclj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">51</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">29</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_403_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zRyc7wWAsNc2" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Customer 2</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_406_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zlOm3itLOZng" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Aggregate percent of revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, three customers accounted for more than <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember_z4vLYrfR9Vo4" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance, and four customers
accounted for over <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zKKVT2TK64oi" title="Percentage of revenue">10</span>% of the Company&#8217;s accounts receivable balance at December 31, 2022. The following table represents these
customers&#8217; aggregate percent of total accounts receivable:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230101__20231231_zhWEHprsBNIh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231_ztKbhcWnbuUb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zd69tNom6u7b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Customer 1</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">36</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_40B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zhJ53AgNeC0e" style="vertical-align: bottom; background-color: White">
    <td>Customer 2</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zXm0qN1wzCKf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 3</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_408_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zwvTjo7tYXV4" style="vertical-align: bottom; background-color: White">
    <td>Customer 4</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zm9usFqQhgHl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Customer 5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_407_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSixMember_zjv30vQ4FSf" style="vertical-align: bottom; background-color: White">
    <td>Customer 6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_409_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerSevenMember_zNlcLsmjUi94" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Customer 7</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: left">%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">13</td><td style="padding-bottom: 1pt; text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zepabVYQt8Ah" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate percent of total accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_401_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_hus-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zwSheWq0zHde" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Aggregate Percent of Revenue and Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zqtHkWkniuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BE_zY8WtyweXEh" style="display: none">Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20240930_z6rh7ChKA2Wg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230101__20230930_zKvl5Q7cKBM9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nine Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>September 30,</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--OptionsToPurchaseCommonStockMember_zaJ6qRuqQiMl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Options to purchase Common Stock</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">147,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">913,856</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedStockUnitsAndAwardsMember_z5KFPMnET3Gk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unvested restricted stock units and awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,371,950</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,275</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9UCKP9FSwd5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for Common Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,314,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,112,165</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zbjJYN3YAy93" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1120">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,839,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zvZe6nAtBTo5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1123">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,415,923</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_ztASWlHwy9G3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,118,735</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,643,325</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pip0_zjyHAg7uOSp" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">14,951,799</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,102,501</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_z3zqwc3RXG6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zBK0YFbpA5Ph" style="display: none">Schedule
of Antidilutive Securities Excluded from Computation of Diluted Net Loss</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_496_20230101__20231231_zHubyMdknZW8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20220101__20221231_z7JgAdIy58vf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022
    <span id="xdx_F53_zMknzVxwFW2d">(1)</span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022 (1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zU2VjfHSk2Mi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Employee stock options</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4156">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">913,856</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_z4kTBU4jg4A9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Restricted stock awards</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4159">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">177,276</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zLAmJaVsTCZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrants for common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,367,607</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesAOnePreferredStockMember_zw2Ade2FVFvj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Series A-1 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4165">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,839,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--SeriesATwoPreferredStockMember_zsL23DNbYjvd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Series A-2 preferred stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4168">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,415,923</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertiblePromissoryNoteMember_zIz5fcMrzk61" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Convertible promissory notes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4171">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,786,610</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zmnh9FeCfyYk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Total common stock equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,181,019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,501,229</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F00_zObFy7NMKtm7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_zLJqjuwlb2Gj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retroactively restated
for the reverse recapitalization in Note 3.</span></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590025128304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember', window );">Data Knights Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Combination Liabilities</a></td>
<td class="text"><p id="xdx_898_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_zRy8eAdFV65e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received net cash consideration of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pn5n6_c20231107_zbbqF5bZQ9o3" title="Business combination net cash">0.1</span> million and net liabilities of Data Knights of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIEJ1c2luZXNzIENvbWJpbmF0aW9uIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_904_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pn5n6_c20231107_zTn2aNDCmvh9" title="Business combination net liabilities">11.0</span> million.
The net liabilities of Data Knights were as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zHJ1yIjtART1" style="display: none">Schedule
of Business Combination Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20231107__us-gaap--BusinessAcquisitionAxis__custom--DataKnightsAcquisitionCorpMember_z7elQfgFA4Kk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pn3n3_maBCRIAzlc7_zgyL2s3cJb8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Prepaid expenses and other current assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">22</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses_iNI_pn3n3_di_msBCRIAzlc7_zWeMZxmWTzX7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts payable &amp; accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,501</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_409_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension_iNI_pn3n3_di_msBCRIAzlc7_zcTLjIZHttxe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loan extensions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,992</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable_iNI_pn3n3_di_msBCRIAzlc7_zrbKiKasH2c1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred underwriter fee payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,525</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability_iNI_pn3n3_di_msBCRIAzlc7_zFHOfonhcp2g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warrant liability</td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(20</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pn3n3_mtBCRIAzlc7_zMtAJwotwOA2" style="vertical-align: bottom; background-color: White">
    <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Liabilities</span></td><td>&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(11,016</td><td style="text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132245648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zctF042YaQBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zsdgk10zk6S2" style="display: none">Schedule
of Property and Equipment </span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 95%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20231231_zScowbnVX4r8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20221231_zSU3yWvcNnRg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zmMLhg6gxMr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Computers</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">303</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">259</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--FurnitureAndEquipmentMember_zKjXoUbbvTVf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Furniture and equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzSdJ_zBDrk6m2BQQ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">307</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">263</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzSdJ_z65ajHtdtx35" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(208</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(180</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzSdJ_z8519SR6uWia" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">99</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">83</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132045440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Components of Income (Loss) Before Provision for Income Tax</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zz2CDF9Xeoi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has operations in the United States and Canada. The components of income (loss) before the provision for income taxes are as
follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B3_zQTOOeov4NVh" style="display: none">Schedule
of Components of Income (Loss) Before Provision for Income Tax</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230101__20231231_zFL9j071bVj9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20220101__20221231_zsYuUmfCvrs9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the year ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pn3n3_maILFCOzkfc_z8EUKV3XXp13" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">United States</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(33,827</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(30,456</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_pn3n3_maILFCOzkfc_zvC4tlK0ELh9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">65</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">22</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_pn3n3_mtILFCOzkfc_z10nWaDT2DZd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total loss before income taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(33,762</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(30,434</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Income Tax Provision</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zYDZ9Jadipe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the income tax provision for the years ended December 31, 2023 and 2022 were as follows (in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B0_zO05iQweijl6" style="display: none">Schedule
of Income Tax Provision</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20230101__20231231_zqBXVBFcUOLk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_zgYoS1eO7HAc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CurrentFederalTaxExpenseBenefit_pn3n3_maCITEBz04w_zGN0u9zFCaza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current federal</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4297">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pn3n3_maCITEBz04w_zh67G1FT8SPh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Current state</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4299">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4300">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CurrentForeignTaxExpenseBenefit_pn3n3_maCITEBz04w_ziHBSRkZEypi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left; padding-bottom: 1pt">Current foreign</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">18</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">17</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pn3n3_mtCITEBz04w_maITEBzoUt_zV2WZZOV3jHc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total current tax provision (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">18</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">17</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_z5t8b0vJCsI6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4308">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4309">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zz1dXMgyjO5h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred state</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4311">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4312">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pn3n3_maDOTEBz8fT_zfo1x4Qtobcf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Deferred foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4314">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4315">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredOtherTaxExpenseBenefit_iT_pn3n3_mtDOTEBz8fT_maITEBzoUt_zipeTfX0cS11" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Total deferred tax provision (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4317">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4318">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeTaxExpenseBenefit_iT_pn3n3_mtITEBzoUt_zFVUU1sujEae" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Total income tax provision (benefit)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">18</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">17</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Income Tax Benefit</a></td>
<td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zuhQpduCjgzk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zKcFvDGMybEj" style="display: none">Schedule
of Reconciliation of Income Tax Benefit</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230101__20231231_zgp3TP5wiPX9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231_z6ojoo4FoUtb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_maA91O_zNocUp5KIQej" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Tax provision at statutory rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_maA91O_zTekL1evozOc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">State taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.2</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.2</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_pid_dp_uPure_maA91O_z9DpQZJhwmlf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.9</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.4</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_pid_dp_uPure_maA91O_zK7kcATDWhu" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Permanent differences - other</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.2</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">%</td></tr>
  <tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes_pid_dp_uPure_maA91O_zJXgkx4VyDic" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11.0</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10.5</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_405_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants_pid_dp_uPure_maA91O_zAwT4x19t7M4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Change in fair value of warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.7</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.8</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_maA91O_zbxozSWzftM7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Change in valuation allowance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3.4</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.0</td><td style="text-align: left">)%</td></tr>
  <tr id="xdx_40E_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxSettlementsOther_pid_dp_uPure_maA91O_zGZOfZDfpHi9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="padding-bottom: 1pt; text-align: left">)%</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.2</td><td style="padding-bottom: 1pt; text-align: left">)%</td></tr>
  <tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_pid_dp_uPure_mtA91O_z2AjT5u3dcB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Effective income tax rate</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-0.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-0.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zSK7CbxAzVsh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are as follows
(in thousands):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zErVYRkVefe4" style="display: none">Schedule
of Components of Deferred Tax Assets and Liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 85%; margin-right: auto">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20231231_zuw1iEzGQ6T" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20221231_zus8BdIoMwTl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNetAbstract_iB_zJCjM3nGYhn8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pn3n3_maDTAGzqvH_zaLcZourTz2h" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carryforwards</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,393</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,551</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DeferredTaxAssetsCapitalizedResearchCosts_iI_pn3n3_maDTAGzqvH_zIDBvLOxQ3r" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Capitalized research costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">337</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4361">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--DeferredTaxAssetsFixedAssets_iI_pn3n3_maDTAGzqvH_zuVmYqAMaLt6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Fixed assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_pn3n3_maDTAGzqvH_zwenP6nEqmKh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">16</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsGross_iTI_pn3n3_mtDTAGzqvH_maDTANzhf6_zTdbmAIfpww6" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total gross deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,759</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,601</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pn3n3_di_msDTANzhf6_zwXYLUTJSVRa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,753</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(6,597</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsNet_iTI_pn3n3_mtDTANzhf6_maDTALNzTQu_zL2kMVGTT5uj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net deferred tax assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesNetAbstract_iB_zMvwfAqU62Hj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iI_pn3n3_zDmqy1gEjvyc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; padding-bottom: 1pt">Other</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(4</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pn3n3_di_msDTALNzTQu_zZmIn0dnsln1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(6</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(4</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pn3n3_mtDTALNzTQu_zWflyjbJOhU8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4387">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl4388">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590122044768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 21, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 2,058<span></span>
</td>
<td class="nump">$ 3,589<span></span>
</td>
<td class="nump">$ 2,109<span></span>
</td>
<td class="nump">$ 13,840<span></span>
</td>
<td class="nump">$ 9,601<span></span>
</td>
<td class="nump">$ 7,843<span></span>
</td>
<td class="nump">$ 7,755<span></span>
</td>
<td class="nump">$ 31,284<span></span>
</td>
<td class="nump">$ 33,780<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 30,451<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated defecit</a></td>
<td class="nump">99,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,440<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">57,660<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">1,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CryptoCash', window );">Crypto assets</a></td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CryptoCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Crypto cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CryptoCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590122565312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenue</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_TwoCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_TwoCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590122602864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Crypto Assets Held (Details)<br> Integer in Thousands, $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetHoldingLineItems', window );"><strong>Crypto Asset, Holding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetNumberOfUnits', window );">Crypto assets, Units | Integer</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetCost', window );">Crypto assets, Cost Basis</a></td>
<td class="nump">$ 2,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Crypto assets, Fair Value</a></td>
<td class="nump">$ 2,156<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CryptoAssetAxis=ONMD_BitcoinMember', window );">Bitcoin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetHoldingLineItems', window );"><strong>Crypto Asset, Holding [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetNumberOfUnits', window );">Crypto assets, Units | Integer</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetCost', window );">Crypto assets, Cost Basis</a></td>
<td class="nump">$ 2,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Crypto assets, Fair Value</a></td>
<td class="nump">$ 2,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetHoldingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetHoldingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetNumberOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of restricted and unrestricted crypto asset units held. Excludes crypto asset units held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetNumberOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CryptoAssetAxis=ONMD_BitcoinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CryptoAssetAxis=ONMD_BitcoinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590128068496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Crypto Assets Reconciliation of Fair Values (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Balance, December 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetAddition', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetDisposition', window );">Dispositions</a></td>
<td class="num">$ (500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating', window );">Unrealized loss, net</a></td>
<td class="num">(124)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetFairValue', window );">Balance, September 30, 2024</a></td>
<td class="nump">$ 2,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetAddition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in crypto asset from addition. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetAddition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetDisposition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in crypto asset from disposition. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetDisposition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of crypto asset. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132083232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Crypto Assets Held (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetDisposition', window );">Bitcoin dispositions</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating', window );">Bitcoin realized losses</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetDisposition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in crypto asset from disposition. Excludes crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetDisposition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized loss from remeasurement of crypto asset, classified as nonoperating. Excludes change for crypto asset held for platform user.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476167/350-60-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476168/350-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590119130352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Debt (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 18, 2024</div></th>
<th class="th"><div>Jun. 17, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Jun. 28, 2023</div></th>
<th class="th"><div>Nov. 11, 2022</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 08, 2024</div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Dec. 21, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 954,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period shares conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,475,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,875,000<span></span>
</td>
<td class="nump">$ 4,175,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 5,140,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">3,859,464<span></span>
</td>
<td class="nump">3,859,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,380,958<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="nump">12,181,019<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,367,607,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,385,000<span></span>
</td>
<td class="nump">$ 9,207,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 8,073,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_YorkvilleNotesPayableCurrent', window );">Fair value of Yorkville Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,911,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionDescription', window );">Debt Conversion, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The PIPE Notes are convertible
into shares of Common Stock at the PIPE Investor&#8217;s election at a conversion price equal to the lower of (i) $10.00 per share, and
(ii) 92.5% of the lowest VWAP for the ten (10) trading days immediately preceding the conversion date, subject to the floor price of
$1.14 (representing 20% of the closing price of the Common Stock on the last trading day before the closing of the Business Combination),
or the alternative conversion ratio of the greater of the floor price and the lesser of 80% of the VWAP of the common stock as of the
trading day and 80% of the price computed as the quotient of the sum of the VWAP of the Common Stock for each of the three trading days
with the lowest VWAP of the Common Stock during the fifteen consecutive trading day period ending and including the trading day immediately
preceding the delivery or deemed delivery of the applicable conversion notice, divided by three<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,745<span></span>
</td>
<td class="nump">95,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DebtInstrumentInterestRateDefaultPercentage', window );">Debt default interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period shares conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,123,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember', window );">Data Knights Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Data Knights Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Data
Knights and certain investors (the &#8220;Purchasers&#8221;) entered into a Securities Purchase Agreement pursuant to which Data
Knights issued and sold to the Purchasers a new series of senior secured convertible notes (the
&#8220;PIPE Notes&#8221;), which are convertible into shares of Common Stock at the Purchasers&#8217; election at a conversion price equal
to the lower of (i) $10.00 per share, or (ii) 92.5% of the lowest volume weighted average trading price for the ten (10) Trading
Days immediately preceding the conversion date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_HelenaTerminationAgreementMember', window );">Helena Termination Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_PrecentageOfOutstandingCommonStock', window );">Precentage of outstanding common stock</a></td>
<td class="nump">19.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertibleNotesWarrantsMember', window );">Convertible Notes Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_YorkvilleNoteMember', window );">Yorkville Note [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DebtInstrumentInterestRateDefaultPercentage', window );">Debt default interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_YorkvilleNoteMember', window );">Yorkville Note [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Yorkville Note is convertible
by Yorkville into shares of Common Stock at an aggregate purchase price based on a price per share equal to the lower of (a) $1.3408
per share (subject to downward reset upon the filing of the resale registration statement described below) or (b) 90% of the lowest daily
volume-weighted average price (&#8220;VWAP&#8221;) of the Common Stock on Nasdaq during the seven trading days immediately prior to each
conversion (the &#8220;Variable Price&#8221;), but which Variable Price may not be lower than the Floor Price then in effect.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun. 17,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FloorPricePerShare', window );">Floor price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember', window );">Convertible Promissory Notes [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesMember', window );">Twenty Twenty Two Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt Instrument, Maturity Date, Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">extend
the maturity date of all outstanding 2022 Notes from December 31, 2022 to March 31, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesMember', window );">Twenty Twenty Two Notes [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,700,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesMember', window );">Twenty Twenty Two Notes [Member] | Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyThreeNotesMember', window );">Twenty Twenty Three Notes [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyThreeNotesMember', window );">Twenty Twenty Three Notes [Member] | Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember', window );">Twenty Twenty Two Notes And Twenty Twenty Three Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">PIPE notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 26,200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,670,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,056,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember', window );">Twenty Twenty Two Notes And Twenty Twenty Three Notes [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from equity financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EquityFinancingDescription', window );">Equity financing, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">a 20% discount to the lowest price per share of shares
sold in the Next Equity Financing, or (B) $2.50 per share; (ii) at the noteholder&#8217;s option, in the event of a defined Corporate
Transaction (as defined in the next paragraph) while the 2022 Notes and 2023 Notes remain outstanding, into shares of the Company&#8217;s
Series A-2 Preferred Stock at a conversion price equal to $2.50 per share; and (iii) at the noteholder&#8217;s option, on or after the
maturity date while the 2022 Notes and 2023 Notes remains outstanding, into shares of the Company&#8217;s Series A-2 Preferred Stock
at a conversion price equal to $2.50 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Debt conversion converted instrument rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Beneficial Ownership [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Beneficial ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Debt conversion converted instrument rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="21"></td></tr>
<tr><td colspan="21"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DebtInstrumentInterestRateDefaultPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument interest rate default percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DebtInstrumentInterestRateDefaultPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_EquityFinancingDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity financing description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_EquityFinancingDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_FloorPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Floor price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_FloorPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_PrecentageOfOutstandingCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Precentage of outstanding common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_PrecentageOfOutstandingCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockWarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockWarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_YorkvilleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yorkville notes payable current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_YorkvilleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of conversion of original debt instrument in noncash or part noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ONMD_HelenaTerminationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ONMD_HelenaTerminationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertibleNotesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_ConvertibleNotesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_YorkvilleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_YorkvilleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=ONMD_BeneficialOwnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=ONMD_BeneficialOwnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590131996224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Line of Credit (Details Narrative) - B O C Bank [Member]<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-Term Line of Credit</a></td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Line of Credit Facility, Interest Rate During Period</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=ONMD_BOCBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=ONMD_BOCBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590119760080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Canadian Emergency Business Account (&#8220;CEBA&#8221;) (Details Narrative)<br> $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_CEBALoanMember', window );">CEBA Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfUnsecuredDebt', window );">Proceeds from loans</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Forgiven of loan</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Conversion of loan</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan payment term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_CEBALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_CEBALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590110738352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Deficit (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="6">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2025</div></th>
<th class="th"><div>Oct. 15, 2024</div></th>
<th class="th"><div>Sep. 24, 2024</div></th>
<th class="th"><div>Jul. 25, 2024</div></th>
<th class="th"><div>Jul. 23, 2024</div></th>
<th class="th"><div>Jun. 17, 2024</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 14, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Jun. 28, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business combination, closing cash balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod', window );">Description of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company was obligated to compensate EF Hutton at a new share price equal to the difference
in amount on such date. Due to the decrease in share value on the six-month anniversary, the Company was required to either pay to EF
Hutton an additional $2.8 million or issue to EF Hutton an additional 3,175,000 shares of Common Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the
Company was obligated to pay to EF Hutton the true-up of either $2.8 million or 3,175,000 shares of Common Stock valued at $0.88 per
share, plus the $0.5 million promissory note. Upon the occurrence of an event of default, the promissory note bears interest at a rate
of 12.5% until such event of default is cured.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Promissory note payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockholdersDeficitDescription', window );">Stockholders deficit description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">An Advance may not exceed the greater of (i) 100% of the average of the daily trading
volume of the Common Stock on Nasdaq, during the five consecutive trading days immediately preceding the date of the Advance, and (ii)
five hundred thousand (500,000) shares of Common Stock.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Commitment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet', window );">Fair value of embedded derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable for common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,270,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,987,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,987,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,987,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalUnitsAuthorized', window );">Capital stock authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,000,000<span></span>
</td>
<td class="nump">101,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Capital stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation preference amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible preferred stock terms of conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Series A-2 preferred stock were converted into Common Stock using an exchange
ratio of 1:1.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockLiquidationPreferenceValue', window );">Liquidation preference amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockTermsOfConversion', window );">Convertible preferred stock terms of conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Series A-1 preferred stock
were converted into Common Stock using an exchange ratio of 1:1.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember', window );">Treasury Stock, Common [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(187,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,255,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,255,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,918,591<span></span>
</td>
<td class="nump">1,297,059<span></span>
</td>
<td class="nump">1,297,059<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="nump">$ 1.0278<span></span>
</td>
<td class="nump">$ 1.0278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0278<span></span>
</td>
<td class="nump">1.0278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,301,791<span></span>
</td>
<td class="nump">2,301,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,767,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CashStructuringFee', window );">Cash structuring fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1', window );">Emdedded derivative liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of stock amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion of stock amount issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | Subsequent Event [Member] | Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of common stock issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Sale of stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | July Two Thousand Twenty Four Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issue and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,301,791<span></span>
</td>
<td class="nump">1,297,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="nump">$ 1.0278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | September Two Thousand Twenty Four Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common stock shares not yet issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,918,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,918,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,918,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Investor [Member] | September Two Thousand Twenty Four Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issue and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,918,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Prefunded Warrants [Member] | July Two Thousand Twenty Four Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable for common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,323,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Prefunded Warrants [Member] | Investor [Member] | September Two Thousand Twenty Four Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable for common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Warrant [Member] | Investor [Member] | September Two Thousand Twenty Four Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants exercisable for common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | Stock Repurchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockRepurchasedDuringPeriodValueExchangeForCash', window );">Number of shares repurchased, value exchange for cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote', window );">Principal and accrued interest outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member] | Stock Repurchase Agreement [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockRepurchasedDuringPeriodValueExchangeForCash', window );">Number of shares repurchased, value exchange for cash</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember', window );">Data Knights Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable', window );">Business combination, underwriter fees payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business combination, closing cash balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable', window );">Promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesTransferred', window );">Number of shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Closing stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_VolumeWeightedAveragePrice', window );">Volume weighted average price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_VolumeWeightedAveragePriceValue', window );">Volume weighted average price, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets maturity date assumed notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CashStructuringFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash structuring fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CashStructuringFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal and accrued interest outstanding on convertible promissory note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockRepurchasedDuringPeriodValueExchangeForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock repurchased during period value exchange for cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockRepurchasedDuringPeriodValueExchangeForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockholdersDeficitDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders deficit description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockholdersDeficitDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_VolumeWeightedAveragePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Volume weighted average price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_VolumeWeightedAveragePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_VolumeWeightedAveragePriceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Volume weighted average price value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_VolumeWeightedAveragePriceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The method of determining the fair value of the equity interests of the acquirer, including the number of instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalUnitsAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalUnitsAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 25<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480238/815-25-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscriptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481142/505-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscriptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockTermsOfConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of conversion terms for preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockTermsOfConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480341/340-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as assets, net of those classified as liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480463/815-10-45-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockLiquidationPreferenceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the difference between preference in liquidation and the par or stated values of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockLiquidationPreferenceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockCommonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ONMD_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ONMD_YorkvilleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ONMD_YorkvilleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ONMD_JulyTwoThousandTwentyFourFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ONMD_JulyTwoThousandTwentyFourFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ONMD_SeptemberTwoThousandTwentyFourFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ONMD_SeptemberTwoThousandTwentyFourFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ONMD_StockRepurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ONMD_StockRepurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590110616032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="nump">14,951,799<span></span>
</td>
<td class="nump">15,102,501<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td colspan="2" class="nump">13,501,229,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_OptionsToPurchaseCommonStockMember', window );">Options To Purchase Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="nump">147,000<span></span>
</td>
<td class="nump">913,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_UnvestedRestrictedStockUnitsAndAwardsMember', window );">Unvested Restricted Stock Units And Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="nump">1,371,950<span></span>
</td>
<td class="nump">177,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="nump">12,314,114<span></span>
</td>
<td class="nump">3,112,165<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td colspan="2" class="nump">2,367,607,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="nump">2,839,957,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="nump">3,415,923,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="nump">1,118,735<span></span>
</td>
<td class="nump">4,643,325<span></span>
</td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="nump">3,786,610,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="nump">913,856,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total common stock equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="nump">177,276,000<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Retroactively restated
for the reverse recapitalization in Note 3.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_OptionsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_OptionsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_UnvestedRestrictedStockUnitsAndAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_UnvestedRestrictedStockUnitsAndAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ONMD_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590127793536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 798<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 1,446<span></span>
</td>
<td class="nump">$ 1,475<span></span>
</td>
<td class="nump">$ 1,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">5<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">1,014<span></span>
</td>
<td class="nump">1,041<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and Marketing Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 432<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590110583312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 798<span></span>
</td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">$ 1,446<span></span>
</td>
<td class="nump">$ 1,475<span></span>
</td>
<td class="nump">$ 1,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Options vested</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested</a></td>
<td class="nump">613,510<span></span>
</td>
<td class="nump">613,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested exercise price</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of stock awards vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ONMD_EquityIncentivePlanMember', window );">Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Share-based payment award, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Common Stock equal to 10% of the number of shares of Common Stock of the Company following the Business Combination for issuance
thereunder.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ONMD_EquityIncentivePlanMember', window );">Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ONMD_EquityIncentivePlanMember', window );">Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ONMD_NewEquityIncentivePlanMember', window );">New Equity Incentive Plan [Member] | Employees Directors and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ONMD_NewEquityIncentivePlanMember', window );">New Equity Incentive Plan [Member] | Employees Directors and Consultants [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ONMD_NewEquityIncentivePlanMember', window );">New Equity Incentive Plan [Member] | Employees Directors and Consultants [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ONMD_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ONMD_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ONMD_NewEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ONMD_NewEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ONMD_EmployeesDirectorsAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ONMD_EmployeesDirectorsAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590130093120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Warrants Outstanding (Details) - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">14,380,958<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="nump">3,859,464<span></span>
</td>
<td class="nump">12,181,019<span></span>
</td>
<td class="nump">2,367,607,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">95,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_LiabilityClassifiedWarrantsMember', window );">Liability Classified Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">681,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681,019,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">681,019<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_LiabilityClassifiedWarrantsMember', window );">Liability Classified Warrants [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_LiabilityClassifiedWarrantsMember', window );">Liability Classified Warrants [Member] | P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_LiabilityClassifiedWarrantsMember', window );">Liability Classified Warrants [Member] | Business Combination Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_LiabilityClassifiedWarrantsMember', window );">Liability Classified Warrants [Member] | P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">95,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember', window );">Equity Classified Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">13,699,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">2,367,607,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember', window );">Equity Classified Warrants [Member] | Legacy O N M D Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">545,213,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember', window );">Equity Classified Warrants [Member] | Convertible Promissory Note Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,822,394,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember', window );">Equity Classified Warrants [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember', window );">Equity Classified Warrants [Member] | Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember', window );">Equity Classified Warrants [Member] | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Grant Total</a></td>
<td class="nump">2,199,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_LiabilityClassifiedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ONMD_LiabilityClassifiedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ONMD_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ONMD_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_BusinessCombinationWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_BusinessCombinationWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ONMD_EquityClassifiedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ONMD_LegacyONMDWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ONMD_LegacyONMDWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ONMD_ConvertiblePromissoryNoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ONMD_ConvertiblePromissoryNoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ONMD_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ONMD_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590129849840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 07, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="nump">$ 8,385,000<span></span>
</td>
<td class="nump">$ 9,207,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 8,073,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">3,859,464<span></span>
</td>
<td class="nump">14,380,958<span></span>
</td>
<td class="nump">12,181,019<span></span>
</td>
<td class="nump">14,380,958<span></span>
</td>
<td class="nump">12,181,019<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,367,607,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,745<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_PublicWarrantsMember', window );">Public Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price | $ / shares</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price | $ / shares</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585,275<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNotesWarrantsMember', window );">Convertible Promissory Notes Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,000,000.0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ONMD_TwentyTwentyOneServiceMember', window );">2021 Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">145,746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ONMD_TwentyTwentyTwoServiceMember', window );">2022 Service [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">294,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_ConvertiblePromissoryNotesWarrantsMember', window );">Convertible Promissory Notes Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">95,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfWarrants', window );">Change in fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="nump">585,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price | $ / shares</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfWarrants', window );">Change in fair value of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Other expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,745<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="nump">543,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ChangeInFairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ChangeInFairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockWarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockWarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ONMD_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ONMD_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNotesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNotesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ONMD_TwentyTwentyOneServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ONMD_TwentyTwentyOneServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ONMD_TwentyTwentyTwoServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ONMD_TwentyTwentyTwoServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_ConvertiblePromissoryNotesWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_ConvertiblePromissoryNotesWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_BusinessCombinationWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_BusinessCombinationWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590151468304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="nump">$ 2,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">3,532<span></span>
</td>
<td class="nump">$ 1,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BitcoinMember', window );">Bitcoin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="nump">2,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 26,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember', window );">P I P E Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">1,593<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleNoteMember', window );">Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">1,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_StandbyEquityPurchaseAgreementMember', window );">Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember', window );">Convertible Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="nump">2,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Bitcoin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="nump">2,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | P I P E Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Convertible Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Bitcoin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | P I P E Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Convertible Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">3,532<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Bitcoin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">26,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | P I P E Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">1,593<span></span>
</td>
<td class="nump">$ 1,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="nump">1,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Convertible Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_BitcoinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_BitcoinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_StandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_StandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590117135680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warrants and Notes Measured at Fair Value (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember', window );">P I P E Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="nump">1,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Additions</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="num">(44)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="nump">1,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleNoteMember', window );">Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Additions</a></td>
<td class="nump">1,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="nump">561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="nump">1,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleStandbyEquityPurchaseAgreementMember', window );">Yorkville Standby Equity Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Additions</a></td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="num">(160)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleStandbyEquityPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_YorkvilleStandbyEquityPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590128188768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fair Value Assumptions and Valuation (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member] | Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">0.61<span></span>
</td>
<td class="nump">0.81<span></span>
</td>
<td class="nump">5.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">10.00<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">72.1<span></span>
</td>
<td class="nump">80.0<span></span>
</td>
<td class="nump">45.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected term (in years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member] | Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">0.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">72.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember', window );">Business Combination Warrants [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Expected term (in years)</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member] | Measurement Input, Share Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.81<span></span>
</td>
<td class="nump">7.76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member] | Measurement Input, Exercise Price [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member] | Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member] | Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_BusinessCombinationWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590126065344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Shareholder Loans Outstanding (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Shareholder loans &#8211; nonconvertible</a></td>
<td class="nump">$ 654<span></span>
</td>
<td class="nump">$ 454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Shareholder loans &#8211; convertible</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total loan &#8211; related party</a></td>
<td class="nump">$ 2,306<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590123256256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Related party proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,380,958<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="nump">12,181,019<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,367,607,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,859,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Gross proceeds from convertible promissory notes</a></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,875<span></span>
</td>
<td class="nump">$ 4,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 5,140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Non convertible shareholder loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans remains outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,992<span></span>
</td>
<td class="nump">$ 2,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Shareholder loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfShareholderLoans', window );">Shareholder loans outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 704<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_LoanExtension', window );">Loan extensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsMember', window );">Data Knights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans remains outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,744<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,829<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ONMD_ConvertiblePromissoryNotesAndWarrantsMember', window );">Convertible Promissory Notes And Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,726,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,726,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_PIPENotesMember', window );">P I P E Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Related party proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_PIPENotesMember', window );">P I P E Notes [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Related party proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Gross proceeds from convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Gross proceeds from convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteWarrantsMember', window );">Convertible Promissory Note Warrants [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to acquire common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,976,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Number of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,976,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ShareholderLoansMember', window );">Shareholder Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Shareholder loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_LoanExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loan extension.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_LoanExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromIssuanceOfShareholderLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromIssuanceOfShareholderLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ONMD_ConvertiblePromissoryNotesAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ONMD_ConvertiblePromissoryNotesAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_PIPENotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_PIPENotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_ShareholderLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_ShareholderLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590130873504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Rent expenses</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">$ 7,695<span></span>
</td>
<td class="nump">$ 7,694<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590122731280">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedule of Restatement of Balance Sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Investments held in trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredCostsNonCurrent', window );">Deferred transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">815<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,682<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,743<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_LoanExtensionsCurrent', window );">Loan extensions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loan payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CanadaEmergencyBusinessLoanAct', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,525<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">PIPE notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Franchise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_AccruedInterestRelatedParty', window );">Accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Extension loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableNonCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantLiabilityNonCurrent', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,906<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (deficit) equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(99,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,268)<span></span>
</td>
<td class="num">$ (19,187)<span></span>
</td>
<td class="num">$ (15,701)<span></span>
</td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (47,796)<span></span>
</td>
<td class="num">$ (39,055)<span></span>
</td>
<td class="num">$ (31,899)<span></span>
</td>
<td class="num">(26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7,052)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity, and stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Loan amount due to related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ExciseTaxCurrent', window );">Excise tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Investments held in trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,451<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredCostsNonCurrent', window );">Deferred transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,434<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,814<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_LoanExtensionsCurrent', window );">Loan extensions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loan payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CanadaEmergencyBusinessLoanAct', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,525<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">PIPE notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Franchise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,833<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,785<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_AccruedInterestRelatedParty', window );">Accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">691<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Extension loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,546<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableNonCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,025<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantLiabilityNonCurrent', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,161<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (deficit) equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,083)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,510)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,859)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity, and stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,434<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Loan amount due to related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ExciseTaxCurrent', window );">Excise tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Investments held in trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,029)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,060)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredCostsNonCurrent', window );">Deferred transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,637)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,253<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_LoanExtensionsCurrent', window );">Loan extensions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loan payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CanadaEmergencyBusinessLoanAct', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">PIPE notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Franchise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">585<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,319<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_AccruedInterestRelatedParty', window );">Accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(691)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Extension loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,546)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableNonCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,025)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantLiabilityNonCurrent', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(363)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">583<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,488<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (deficit) equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,775<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,375)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,357)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(583)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,632)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="num">$ (21,490)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity, and stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Loan amount due to related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ExciseTaxCurrent', window );">Excise tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember', window );">Reclassification Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustCurrent', window );">Investments held in trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredCostsNonCurrent', window );">Deferred transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_LoanExtensionsCurrent', window );">Loan extensions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loan payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CanadaEmergencyBusinessLoanAct', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">PIPE notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6],[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Franchise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebtCurrent', window );">Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_AccruedInterestRelatedParty', window );">Accrued interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Extension loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableNonCurrent', window );">Deferred underwriter fee payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantLiabilityNonCurrent', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7],[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; (deficit) equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8],[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10],[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, temporary equity, and stockholders&#8217; deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember', window );">Reclassification Adjustment [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember', window );">Reclassification Adjustment [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total temporary equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember', window );">Reclassification Adjustment [Member] | Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Loan amount due to related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ExciseTaxCurrent', window );">Excise tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (113)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information prior to the closing of the Business Combination.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of: (i) improper capitalization of interim review expenses; and (ii) exclusion of certain transaction-related costs for the Business
    Combination.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to: (i) improper cutoff of miscellaneous vendor payables; and (ii) under-accruals related to the year-end bonus
    and taxes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of (i) under-accruals related to the year-end bonus and taxes; and (ii) improper inclusion of Data Knights accounts payable and accrued
    expenses.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of liability-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination and
    associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to: (i) valuation of stock compensation expense; (2) identification, classification and valuation of equity-classified
    warrants; and (3) improper inclusion of Data Knights APIC balances.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">Cumulative
    and current year impacts of corrections of errors to the consolidated statements of operations, primarily related to historical adjustments
    within fair value of convertible debt, warrants and stock-based compensation expense.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the accounting for historical preferred stock as temporary equity.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top">Cumulative
    impact of corrections of errors to the prior year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top">Cumulative
    impact of corrections of errors to the prior year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    reclassification adjustment made to the consolidated balance sheet that are separate from the restatement but were included herein
    for completeness purposes.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_AccruedInterestRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued interest related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_AccruedInterestRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CanadaEmergencyBusinessLoanAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Canada emergency business loan act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CanadaEmergencyBusinessLoanAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredCostsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredCostsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredUnderwriterFeePayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriter fee payable current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredUnderwriterFeePayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredUnderwriterFeePayableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriter fee payable noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredUnderwriterFeePayableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ExciseTaxCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excise tax current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ExciseTaxCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_LoanExtensionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loan extensions current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_LoanExtensionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_WarrantLiabilityNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant liability non current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_WarrantLiabilityNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590024701184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Restatement of Balance Sheet (Details) (Parenthetical) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">28,175,172<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">27,987,427<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Temporary equity, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590118394800">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of the Original and Restated Statement of Operations (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
<td class="nump">$ 681<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">872<span></span>
</td>
<td class="nump">812<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(84)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(360)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,934<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">3,544<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,806<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">623<span></span>
</td>
<td class="nump">813<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,591<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,684<span></span>
</td>
<td class="nump">4,854<span></span>
</td>
<td class="nump">6,724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,387)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,939)<span></span>
</td>
<td class="num">(4,985)<span></span>
</td>
<td class="num">(6,853)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,715)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense (income), net</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncomeTaxProvision', window );">Income tax provision</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">8,385<span></span>
</td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity', window );">Change in fair value of PIPE Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,872<span></span>
</td>
<td class="nump">17,517<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">14,616<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_UnrealizedGainLoss', window );">Unrealized gain or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(329)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">816<span></span>
</td>
<td class="nump">26,299<span></span>
</td>
<td class="nump">26,909<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,719<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,762)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30,434)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (2,058)<span></span>
</td>
<td class="num">$ (3,589)<span></span>
</td>
<td class="num">$ (2,109)<span></span>
</td>
<td class="num">$ (13,840)<span></span>
</td>
<td class="num">$ (9,601)<span></span>
</td>
<td class="num">$ (7,843)<span></span>
</td>
<td class="num">$ (7,755)<span></span>
</td>
<td class="num">$ (31,284)<span></span>
</td>
<td class="num">$ (33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="num">$ (30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (7.56)<span></span>
</td>
<td class="num">$ (4.77)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13],[14]</sup></td>
<td class="num">$ (7.66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14],[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (7.56)<span></span>
</td>
<td class="num">$ (4.77)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13],[14]</sup></td>
<td class="num">$ (7.66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14],[15]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,878,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,280,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,051,293<span></span>
</td>
<td class="nump">4,139,730<span></span>
</td>
<td class="nump">7,084,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,973,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,878,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,280,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,051,293<span></span>
</td>
<td class="nump">4,139,730<span></span>
</td>
<td class="nump">7,084,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,973,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ONMD_SubscriptionRevenueMember', window );">Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="nump">$ 595<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ONMD_WebImagingRevenueMember', window );">Web Imaging Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(360)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">399<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,632<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">953<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,066<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,376)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,426)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense (income), net</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncomeTaxProvision', window );">Income tax provision</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">215<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,504<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">749<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">403<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,572<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="num">(4,489)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity', window );">Change in fair value of PIPE Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_UnrealizedGainLoss', window );">Unrealized gain or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,372)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,196)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,206)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,230)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (23,206)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="num">$ (6,230)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 878<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 678<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Web Imaging Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,153<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,730)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3,950)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,297)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,312)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,523<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,711<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense (income), net</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncomeTaxProvision', window );">Income tax provision</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(215)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,504)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(738)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="num">(403)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,635<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="nump">4,489<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity', window );">Change in fair value of PIPE Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,517<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">14,616<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_UnrealizedGainLoss', window );">Unrealized gain or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,372<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,097<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,932<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,574)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(24,221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10,574)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11],[16]</sup></td>
<td class="num">$ (24,221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12],[17]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3.78)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="num">$ (7.66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3.78)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="num">$ (7.66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,488,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="nump">3,973,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,488,164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="nump">3,973,897<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Web Imaging Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember', window );">Reclassification Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralExpense', window );">Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(226)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="num">(399)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[19]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(226)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="num">(399)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[19]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">399<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense (income), net</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncomeTaxProvision', window );">Income tax provision</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[19]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[18]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6],[19]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpense', window );">Stock warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7],[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8],[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9],[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[19]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity', window );">Change in fair value of PIPE Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10],[18]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6],[19]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_UnrealizedGainLoss', window );">Unrealized gain or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[19]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="nump">416<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="nump">$ 399<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per common share outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[15]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average number of common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[15]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember', window );">Reclassification Adjustment [Member] | Subscription Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember', window );">Reclassification Adjustment [Member] | Web Imaging Revenue [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[18]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[19]</sup></td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to (i) improper valuation of stock compensation expense; (ii) improper capitalization of deferred transaction costs;
    and (iii) under-accrued bonus and taxes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of Data Knights income tax provision, liability classified warrants and unrealized gain/loss prior to the
    closing of the Business Combination.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper recognition of impairment expense upon the closing of the Business Combination with Data Knights.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations
    (including interest expense).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO with changes in fair value reflected in the consolidated statements of operations (including
    interest expense).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top">Represents
    certain reclassification adjustments made to the consolidated balance sheet that are separate from the restatement but were included
    herein for completeness purposes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EPS
    impact of corrections of errors to the consolidated statements of operations.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[16]</td>
<td style="vertical-align: top;" valign="top">Current
    year impact of corrections of errors to the consolidated statements of operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[17]</td>
<td style="vertical-align: top;" valign="top">Current
    year impact of corrections of errors to the consolidated statements of operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[18]</td>
<td style="vertical-align: top;" valign="top">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[19]</td>
<td style="vertical-align: top;" valign="top">Represents
    certain reclassification adjustments made to the consolidated income statement that are separate from the restatement but were included
    herein for completeness purposes.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of convertible promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value adjustment of private investment in public equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_IncomeTaxProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_IncomeTaxProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockWarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockWarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_UnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_UnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general expenses not normally included in Other Operating Costs and Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ONMD_SubscriptionRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ONMD_SubscriptionRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ONMD_WebImagingRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ONMD_WebImagingRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=ONMD_ReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590107344800">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of the Original and Restated Statement of Cash Flows (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,058,000)<span></span>
</td>
<td class="num">$ (3,589,000)<span></span>
</td>
<td class="num">$ (2,109,000)<span></span>
</td>
<td class="num">$ (13,840,000)<span></span>
</td>
<td class="num">$ (9,601,000)<span></span>
</td>
<td class="num">$ (7,843,000)<span></span>
</td>
<td class="num">$ (7,755,000)<span></span>
</td>
<td class="num">$ (31,284,000)<span></span>
</td>
<td class="num">$ (33,780,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (30,451,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationCost', window );">Business combination cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CashHeldInTrustAccount', window );">Cash held in trust account</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447,000<span></span>
</td>
<td class="nump">1,446,000<span></span>
</td>
<td class="nump">1,475,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">1,865,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpenses', window );">Stock warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,207,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">8,073,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantExpense', window );">Board of director warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,198,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfWarrantLiabilities', window );">Change in fair value of warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(129,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfPipeNotes', window );">Change in fair value of PIPE Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,872,000<span></span>
</td>
<td class="nump">17,517,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">14,616,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_NoncashInterest', window );">Non-cash interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
<td class="num">(86,000)<span></span>
</td>
<td class="num">(133,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">73,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="num">(43,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="num">(59,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,232,000<span></span>
</td>
<td class="nump">340,000<span></span>
</td>
<td class="nump">717,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[15]</sup></td>
<td class="nump">415,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,000<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(458,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Amount due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInExerciseTaxLiability', window );">Excise tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInExtensionLoan', window );">Extension loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseFranchiseTaxPayable', window );">Franchise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInWorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,956,000)<span></span>
</td>
<td class="num">(3,066,000)<span></span>
</td>
<td class="num">(4,791,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,703,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
<td class="num">(44,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(58,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,347,000)<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
<td class="num">(44,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(58,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct', window );">Payments of Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfShareholderLoans', window );">Proceeds from issuance of shareholder loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">704,000<span></span>
</td>
<td class="nump">454,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of PIPE notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromCommonStockSubjectToRedemption', window );">Common stock subject to redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromDeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromWarrantLiability', window );">Warrant liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProccedsFromRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,875,000<span></span>
</td>
<td class="nump">4,175,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">5,140,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock', window );">Proceeds from issuance of Series A-2 preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationCosts', window );">Business Combination Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,160,000)<span></span>
</td>
<td class="num">(1,534,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(815,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,190,000<span></span>
</td>
<td class="nump">3,435,000<span></span>
</td>
<td class="nump">4,611,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,333,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,887,000<span></span>
</td>
<td class="nump">341,000<span></span>
</td>
<td class="num">(224,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(428,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">271,000<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="nump">271,000<span></span>
</td>
<td class="nump">271,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">699,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,934,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 612,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,934,000<span></span>
</td>
<td class="nump">612,000<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">271,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesIssuedToPreferredShareholders', window );">Common shares issued to preferred shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,659,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesRelatedToConvertiblePromissoryNotes', window );">Common shares related to convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,935,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesIssuedToDataKnightsShareholders', window );">Common shares issued to Data Knights shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,937,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantExpense', window );">Board of director warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,206,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(6,230,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationCost', window );">Business combination cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CashHeldInTrustAccount', window );">Cash held in trust account</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,029,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">88,292,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpenses', window );">Stock warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantExpense', window );">Board of director warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfWarrantLiabilities', window );">Change in fair value of warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfPipeNotes', window );">Change in fair value of PIPE Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_NoncashInterest', window );">Non-cash interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(133,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">73,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="num">(876,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,372,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[15]</sup></td>
<td class="nump">1,929,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[16]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(458,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Amount due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInExerciseTaxLiability', window );">Excise tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInExtensionLoan', window );">Extension loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">2,546,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseFranchiseTaxPayable', window );">Franchise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="num">(94,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">215,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInWorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">207,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,221,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">87,241,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(58,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(58,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct', window );">Payments of Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfShareholderLoans', window );">Proceeds from issuance of shareholder loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of PIPE notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,550,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromCommonStockSubjectToRedemption', window );">Common stock subject to redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,750,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(88,550,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromDeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromWarrantLiability', window );">Warrant liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(338,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(4,489,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,189,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">2,826,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProccedsFromRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,633,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(3,360,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,681,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">5,543,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock', window );">Proceeds from issuance of Series A-2 preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationCosts', window );">Business Combination Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,432,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(88,033,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(255,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(850,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
<td class="nump">302,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,152,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">302,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesIssuedToPreferredShareholders', window );">Common shares issued to preferred shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesRelatedToConvertiblePromissoryNotes', window );">Common shares related to convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesIssuedToDataKnightsShareholders', window );">Common shares issued to Data Knights shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantExpense', window );">Board of director warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,574,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[17]</sup></td>
<td class="num">(24,221,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[18]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationCost', window );">Business combination cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(900,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CashHeldInTrustAccount', window );">Cash held in trust account</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,029,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(88,292,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,475,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">265,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockWarrantExpenses', window );">Stock warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,207,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="nump">8,073,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantExpense', window );">Board of director warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,198,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfWarrantLiabilities', window );">Change in fair value of warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(129,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfPipeNotes', window );">Change in fair value of PIPE Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ChangeInFairValueOfConvertiblePromissoryNotes', window );">Change in fair value of convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,517,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="nump">14,616,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_NoncashInterest', window );">Non-cash interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">817,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(655,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4],[15]</sup></td>
<td class="num">(1,514,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5],[16]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Amount due to related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInExerciseTaxLiability', window );">Excise tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(113,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInExtensionLoan', window );">Extension loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="num">(2,546,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseFranchiseTaxPayable', window );">Franchise tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="nump">94,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="num">(215,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_IncreaseDecreaseInWorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3],[4]</sup></td>
<td class="num">(207,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,012,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(91,944,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct', window );">Payments of Canada Emergency Business Loan Act</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfShareholderLoans', window );">Proceeds from issuance of shareholder loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[14]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of PIPE notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[11]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromCommonStockSubjectToRedemption', window );">Common stock subject to redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">88,550,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromDeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromWarrantLiability', window );">Warrant liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">4,489,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,189,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(2,826,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProccedsFromRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,633,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">3,360,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,856,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="num">(403,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock', window );">Proceeds from issuance of Series A-2 preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationCosts', window );">Business Combination Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,534,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(815,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,043,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">92,366,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">422,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at beginning year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (31,000)<span></span>
</td>
<td class="num">(31,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(453,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(31,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesIssuedToPreferredShareholders', window );">Common shares issued to preferred shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,659,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesRelatedToConvertiblePromissoryNotes', window );">Common shares related to convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,935,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonSharesIssuedToDataKnightsShareholders', window );">Common shares issued to Data Knights shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,937,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_WarrantExpense', window );">Board of director warrant expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,198,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[9]</sup></td>
</tr>
<tr><td colspan="14"></td></tr>
<tr><td colspan="14"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Includes
    impact of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper inclusion of Data Knights financial information as of December 31, 2022 prior to the closing of the Business Combination.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to improper valuation of stock compensation expense.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the identification, classification and valuation of equity-classified warrants.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to valuation of liability classified warrant values and the corresponding changes in fair value reflected in the
    consolidated statements of operations.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the PIPE notes containing certain embedded features that were not previously considered, which
    are now accounted for under the FVO.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of improper presentation of non-cash interest expense in financing activities.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[15]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    current year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance
    sheet restatement reconciliation for more information.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[16]</td>
<td style="vertical-align: top;" valign="top">Current
    year and prior year impact of errors related to improper cutoff of accounts payable and accrued expenses. Refer to balance sheet
    restatement reconciliation for more information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[17]</td>
<td style="vertical-align: top;" valign="top">Current
    year impact of corrections of errors to the consolidated statements of operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[18]</td>
<td style="vertical-align: top;" valign="top">Current
    year impact of corrections of errors to the consolidated statements of operations.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CashHeldInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash held in trust account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CashHeldInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ChangeInFairValueOfConvertiblePromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ChangeInFairValueOfConvertiblePromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ChangeInFairValueOfPipeNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of pipe notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ChangeInFairValueOfPipeNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ChangeInFairValueOfWarrantLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ChangeInFairValueOfWarrantLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CommonSharesIssuedToDataKnightsShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued to data knights shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CommonSharesIssuedToDataKnightsShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CommonSharesIssuedToPreferredShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued to preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CommonSharesIssuedToPreferredShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CommonSharesRelatedToConvertiblePromissoryNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares related to convertible promissory notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CommonSharesRelatedToConvertiblePromissoryNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_IncreaseDecreaseFranchiseTaxPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease franchise tax payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_IncreaseDecreaseFranchiseTaxPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_IncreaseDecreaseInExerciseTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in exercise tax liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_IncreaseDecreaseInExerciseTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_IncreaseDecreaseInExtensionLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in extension loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_IncreaseDecreaseInExtensionLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_IncreaseDecreaseInWorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in working capital loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_IncreaseDecreaseInWorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_NoncashInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_NoncashInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProccedsFromRetainedEarningsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Procceds from retained earnings adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProccedsFromRetainedEarningsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from canada emergency business loan act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromCommonStockSubjectToRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from common stock subject to redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromCommonStockSubjectToRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromDeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from deferred under writing fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromDeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of series A2 preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromIssuanceOfShareholderLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromIssuanceOfShareholderLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ProceedsFromWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ProceedsFromWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockWarrantExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock warrant expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockWarrantExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_WarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_WarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received by a corporation from a shareholder during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590004620416">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="7">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th" colspan="2"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th" colspan="2"><div>Sep. 30, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,442)<span></span>
</td>
<td class="num">$ (19,187)<span></span>
</td>
<td class="num">$ (15,701)<span></span>
</td>
<td class="num">$ (13,442)<span></span>
</td>
<td class="num">$ (39,055)<span></span>
</td>
<td class="num">$ (31,899)<span></span>
</td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (13,442)<span></span>
</td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7,052)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">613,510,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,648,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="nump">2,165<span></span>
</td>
<td class="nump">1,935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">47,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,058)<span></span>
</td>
<td class="num">(3,589)<span></span>
</td>
<td class="num">(2,109)<span></span>
</td>
<td class="num">(13,840)<span></span>
</td>
<td class="num">(9,601)<span></span>
</td>
<td class="num">(7,843)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,755)<span></span>
</td>
<td class="num">(31,284)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,268)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,268)<span></span>
</td>
<td class="num">(19,187)<span></span>
</td>
<td class="num">(15,701)<span></span>
</td>
<td class="num">(47,796)<span></span>
</td>
<td class="num">(39,055)<span></span>
</td>
<td class="num">(31,899)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14,268)<span></span>
</td>
<td class="num">(47,796)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">24,050,010<span></span>
</td>
<td class="nump">23,850,010<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">4,210,445<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,342,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(493,420)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,638<span></span>
</td>
<td class="nump">177,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">265,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">177,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">543,056<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,420,945<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,261,553<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,475,362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,261,553<span></span>
</td>
<td class="nump">6,261,553<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="nump">24,050,010<span></span>
</td>
<td class="nump">23,850,010<span></span>
</td>
<td class="nump">4,299,083<span></span>
</td>
<td class="nump">4,210,445<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,175,172<span></span>
</td>
<td class="nump">4,299,083<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,996<span></span>
</td>
<td class="nump">$ 78,478<span></span>
</td>
<td class="nump">$ 78,375<span></span>
</td>
<td class="nump">$ 77,996<span></span>
</td>
<td class="nump">$ 18,405<span></span>
</td>
<td class="nump">$ 15,960<span></span>
</td>
<td class="nump">$ 13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 77,996<span></span>
</td>
<td class="nump">$ 13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
<td class="nump">2,165<span></span>
</td>
<td class="nump">1,935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,659<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">47,935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,455<span></span>
</td>
<td class="nump">78,478<span></span>
</td>
<td class="nump">78,375<span></span>
</td>
<td class="nump">23,488<span></span>
</td>
<td class="nump">18,405<span></span>
</td>
<td class="nump">15,960<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">85,455<span></span>
</td>
<td class="nump">23,488<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">77,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="num">(97,138)<span></span>
</td>
<td class="num">(93,549)<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="num">(75,104)<span></span>
</td>
<td class="num">(65,503)<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(91,440)<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,209)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,058)<span></span>
</td>
<td class="num">(3,589)<span></span>
</td>
<td class="num">(2,109)<span></span>
</td>
<td class="num">(13,840)<span></span>
</td>
<td class="num">(9,601)<span></span>
</td>
<td class="num">(7,843)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,196)<span></span>
</td>
<td class="num">(97,138)<span></span>
</td>
<td class="num">(93,549)<span></span>
</td>
<td class="num">(88,944)<span></span>
</td>
<td class="num">(75,104)<span></span>
</td>
<td class="num">(65,503)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(99,196)<span></span>
</td>
<td class="num">(88,944)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(91,440)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_TemporaryEquityMember', window );">Temporary Equity [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,660<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,660<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_TemporaryEquityMember', window );">Temporary Equity [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,853,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(437,874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (9,650)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,421,596)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,650<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,421,596<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,421,596<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=ONMD_TemporaryEquityMember', window );">Temporary Equity [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,204,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(364,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (8,010)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,839,957)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,859)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,859)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,859)<span></span>
</td>
<td class="nump">$ 9,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 14,438<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(534)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,859<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination', window );">Conversion of OMN convertible loans upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,058<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,257)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,392<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(23,206)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(6,230)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,859)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,388,958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">9,388,958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,388,958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,802,941<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,378,517<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">612,670<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,859,464<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination', window );">Conversion of OMN convertible loans upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination', window );">Conversion of OMN convertible loans upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,177,229<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,057,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Private OneMedNet to ONMD Public Shares, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,257,326)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,266,560)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,388,958<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Commitment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination', window );">Conversion of OMN convertible loans upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">42,221<span></span>
</td>
<td class="nump">24,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,607<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,826<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,859<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination', window );">Conversion of OMN convertible loans upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,057<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,257)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">746<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,893<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,392<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">42,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,083)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,083)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,510)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(55,083)<span></span>
</td>
<td class="num">(43,510)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(43,510)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,920)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,360)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination', window );">Conversion of OMN convertible loans upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(23,206)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,230)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(55,083)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(43,510)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Temporary Equity [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,853,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,853,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,853,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,853,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,853,797)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,853,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,204,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,204,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,204,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,204,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,204,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,204,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (583)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (583)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (35,632)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (583)<span></span>
</td>
<td class="num">$ (35,632)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (35,632)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (21,490)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">534<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(200)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(613)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,859)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,058)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">41,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(101)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,683)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(418)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,633)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,574)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[13]</sup></td>
<td class="num">(24,221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[14]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(583)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(35,632)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,355,788)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(5,355,788)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(5,355,788)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(3,460,275)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,871,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">265,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(22,724)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(852)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(69,614)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(438,519)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(796,244)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(701,867)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Private OneMedNet to ONMD Public Shares, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,257,326<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,838,792<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,355,788)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Commitment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,375)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">35,775<span></span>
</td>
<td class="num">(10,375)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(10,375)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(17,094)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,826)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(200)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">8,073<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(613)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,859)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,602<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">41,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,257<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(101)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,683)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(418)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">35,775<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,375)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,357)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,357)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(36,357)<span></span>
</td>
<td class="num">(14,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(14,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">6,711<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[8]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination', window );">Exercise of OMN stock options upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[11]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,633)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[12]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,574)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[13]</sup></td>
<td class="num">(24,221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[14]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(36,357)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Temporary Equity [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(437,874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(437,874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(437,874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(437,874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (9,650)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">432,201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(437,874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember', window );">Revision of Prior Period, Reclassification, Adjustment [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(364,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(364,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(364,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(364,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (8,010)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">364,043<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(364,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (13,442)<span></span>
</td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">47,936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13,442)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">265,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">543,056<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,420,945<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,261,553<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,475,362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member] | Commitment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member] | Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">77,996<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,659<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination', window );">Conversion of OMN convertible promissory notes upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">47,935<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,937)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">77,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member] | Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(91,440)<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of OMN warrants in conjunction with convertible promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Exercise of OMN warrants upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Private OneMedNet to ONMD Public Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of PIPE warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts', window );">Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_CommonStockSubjectToPossibleRedemptionValue', window );">Common stock redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment', window );">Retained earnings adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,780)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(91,440)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member] | Temporary Equity [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series A-2 Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,673<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (9,650)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,421,596)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_RestatedMember', window );">Restated [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (8,010)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination', window );">Conversion of preferred stock to common stock upon Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,839,957)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7,052)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(26,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member] | Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,342,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(493,420)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common shares in exchange for services, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">177,276<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,648<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member] | Commitment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member] | Additional Paid-in Capital [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,513<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,865<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,198<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member] | Retained Earnings [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,209)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination', window );">Retroactive application of recapitalization due to Business Combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common shares in exchange for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors', window );">Issuance of OMN warrants to board of directors</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(30,451)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(57,660)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member] | Temporary Equity [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member] | Temporary Equity [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,853,797<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(437,874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,634<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,415,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=ONMD_AsRestatedMember', window );">As Restated [Member] | Temporary Equity [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,204,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares', window );">Retroactive application of recapitalization due to Business Combination, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(364,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,839,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="19"></td></tr>
<tr><td colspan="19"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Accumulated
    effects of adjustments due to the restatement of the consolidated statement of operations for the year ended December 31, 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the accounting and presentation of the recapitalization.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Cumulative
    impact of corrections of errors to the prior year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Cumulative
    impact of corrections of errors to the prior year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to the accounting and presentation of the recapitalization.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to identification, classification and valuation of equity-classified warrants.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">Includes
    impact of errors related to the accounting for the Business Combination. Management did not properly assess the Business Combination
    and associated recapitalization of the shares. Additionally, an impairment charge was erroneously included in the initial filed financial
    statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to improper valuation of stock compensation expense.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[11]</td>
<td style="vertical-align: top;" valign="top">Impact
    of errors related to improper valuation of stock compensation expense.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[12]</td>
<td style="vertical-align: top;" valign="top">Impact
    of error related to identificatoin and recognition of board of director warrante expense.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[13]</td>
<td style="vertical-align: top;" valign="top">Current
    year impact of corrections of errors to the consolidated statements of operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[14]</td>
<td style="vertical-align: top;" valign="top">Current
    year impact of corrections of errors to the consolidated statements of operations.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_CommonStockSubjectToPossibleRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock subject to possible redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_CommonStockSubjectToPossibleRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retroactive application of recapitalization due to business combination shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares conversion of convertible loans upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares conversion of preferred stock to common stock upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock options exercised upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock options upon business combination with net of liabilities assumed and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value conversion of convertible loans upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value conversion of convertible promissory notes upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of warrants to board of directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value retained earnings adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value stock options exercised upon business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value stock options upon business combination with net of liabilities assumed and transaction costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_TemporaryEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_TemporaryEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_CommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_CommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodReclassificationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=ONMD_RestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=ONMD_RestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=ONMD_AsRestatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=ONMD_AsRestatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590130951056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details) - Customer Concentration Risk [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">96.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Six [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | Customer Seven [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Aggregate Percent of Revenue and Accounts Receivable</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomerFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomerFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomerFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomerFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomerSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomerSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ONMD_CustomerSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ONMD_CustomerSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590118476784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 24, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 25, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 23, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 17, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 28, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 22, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 07, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 07, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Oct. 08, 2024</div></th>
<th class="th">
<div>Jun. 14, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Gross proceeds from related party loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 954,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Business combination, consideration underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds form convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,175,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 5,140,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,859,464<span></span>
</td>
<td class="nump">3,859,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,380,958<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="nump">12,181,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,367,607,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,270,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,987,427<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,033,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares exerciseable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">613,510,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,648,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Gross proceeds from related party loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Non convertible loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,918,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,297,059<span></span>
</td>
<td class="nump">1,297,059<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Bought back shares of Common Stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0278<span></span>
</td>
<td class="nump">$ 1.0278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0278<span></span>
</td>
<td class="nump">$ 1.0278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,323,530<span></span>
</td>
<td class="nump">$ 1,323,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,301,791<span></span>
</td>
<td class="nump">2,301,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EquityPurchaseAgreementDescription', window );">Equity purchase agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each
advance may not exceed the greater of 500,000 shares and 100% of the average daily volume traded of the Common Stock during the five
trading days immediately prior to requested advance. The shares would be purchased at a price equal to 97% of the Market Price as defined
in the SEPA. The Company may establish a minimum acceptable price in each advance below which the Company will not be obligated to make
any sales to Yorkville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_ShareOutstandingVotingPercentage', window );">Shares outstanding voting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,767,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of stock percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoanProcessingFee', window );">Structuring fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForManagementFee', window );">Commitment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Monthly shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock units | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Restricted stock units issued | shares</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Warrants exercisable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,095<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Prefunded Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Warrants exercisable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Gross proceeds from related party loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Loans converted into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Non convertible loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Business combination, consideration underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepaidPrincipal', window );">Non convertible loans repaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Kingwood Capital Partners LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, consideration underwriting commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | EF Hutton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member] | Kingwood Capital Partners LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds form convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds form convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Yorkville Promissory Note is due on June 18, 2025, and interest shall accrue at an annual rate equal to 0%, subject to an increase to 18% upon an event of default as described in the Yorkville Promissory Note.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeDescriptionOfTerms', window );">Description of promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(a) $1.3408 per share (subject to downward reset upon the filing of the resale registration
statement described below) or (b) 90% of the lowest daily VWAP of the Common Stock on Nasdaq during the seven trading days immediately
prior to each conversion (the &#8220;Variable Price&#8221;), but which Variable Price may not be lower than the Floor Price then in effect<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFloorPrice', window );">Floor price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DebtInstrumentInterestRateDefaultPercentage', window );">Debt default interest rate</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds form convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Monthly shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares exerciseable | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Ms Coonse Mc Craw [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock units granted | shares</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Mr Clarke [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted stock units granted | shares</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Yorkville Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Payment premium percentage on principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DebtInstrumentInterestRateDefaultPercentage', window );">Debt default interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="24"></td></tr>
<tr><td colspan="24"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impact
    of errors related to the valuation of the convertible promissory notes containing certain embedded features that were not previously
    considered, which are now accounted for under the FVO (including accrued interest).</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DebtInstrumentInterestRateDefaultPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument interest rate default percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DebtInstrumentInterestRateDefaultPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_EquityPurchaseAgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity purchase agreement description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_EquityPurchaseAgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_ShareOutstandingVotingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share outstanding voting percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_ShareOutstandingVotingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepaidPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt repaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepaidPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeDescriptionOfTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the relevant terms of the derivative. Includes the type of instrument, risk being hedged, notional amount, counterparty, inception date, maturity date, relevant interest rates, strike price, cap price, and floor price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeDescriptionOfTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFloorPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Floor rate on a price risk derivative such as a floor or a collar. A payment or receipt is triggered if the market rate falls below the floor rate on the contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFloorPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:perUnitItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanProcessingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses paid for obtaining loans which includes expenses such as application and origination fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanProcessingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForManagementFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForManagementFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=ONMD_PrefundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=ONMD_PrefundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_KingwoodCapitalPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_KingwoodCapitalPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ONMD_EFHuttonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ONMD_EFHuttonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ONMD_KingwoodCapitalPartnersLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ONMD_KingwoodCapitalPartnersLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ONMD_MsCoonseMcCrawMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ONMD_MsCoonseMcCrawMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=ONMD_MrClarkeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=ONMD_MrClarkeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_YorkvilleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_YorkvilleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590121757824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Business Combination Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Nov. 07, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net Liabilities</a></td>
<td class="nump">$ 11,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember', window );">Data Knights Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses', window );">Accounts payable &amp; accrued expenses</a></td>
<td class="num">(4,501)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension', window );">Loan extensions</a></td>
<td class="num">(2,992)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable', window );">Deferred underwriter fee payable</a></td>
<td class="num">(3,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability', window );">Warrant liability</a></td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net Liabilities</a></td>
<td class="num">$ (11,016)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed deferred underwriter fee payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Loan Extension.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed warrant liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590128171120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Nov. 07, 2023</div></th>
<th class="th"><div>Jun. 28, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 28, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
<td class="nump">5,475,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding</a></td>
<td class="nump">612,670<span></span>
</td>
<td class="nump">612,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">913,856,000<span></span>
</td>
<td class="nump">728,603,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="nump">3,859,464<span></span>
</td>
<td class="nump">3,859,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,380,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,380,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">12,181,019,000<span></span>
</td>
<td class="nump">12,181,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,367,607,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporaray equity liquidation preference per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.88637847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business combination cash</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business combination net liabilities</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business combination transaction cost</a></td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessAcquisitionCostPercentage', window );">Business combination percentage</a></td>
<td class="nump">78.20%<span></span>
</td>
<td class="nump">78.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Business combination cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_LoanExtensionsCurrent', window );">Loan extensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember', window );">Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,415,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember', window );">Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,839,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of common stock</a></td>
<td class="nump">$ 47,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">6,261,553<span></span>
</td>
<td class="nump">6,261,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,850,010<span></span>
</td>
<td class="nump">28,175,172<span></span>
</td>
<td class="nump">24,050,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,572,232<span></span>
</td>
<td class="nump">4,299,083<span></span>
</td>
<td class="nump">4,210,445<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="nump">4,033,170<span></span>
</td>
<td class="nump">4,342,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="nump">3,420,945<span></span>
</td>
<td class="nump">3,420,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member] | Series A-2 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity shares outstanding</a></td>
<td class="nump">3,853,797<span></span>
</td>
<td class="nump">3,853,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member] | Series A-1 Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity shares outstanding</a></td>
<td class="nump">3,204,000<span></span>
</td>
<td class="nump">3,204,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrant outstanding</a></td>
<td class="nump">543,057<span></span>
</td>
<td class="nump">543,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_BusinessCombinationMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination transfered</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember', window );">Data Knights Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series A-2 Preferred Stock. shares</a></td>
<td class="nump">277,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Business combination cash</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Business combination net liabilities</a></td>
<td class="num">(11,016)<span></span>
</td>
<td class="num">(11,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees', window );">Business combination underwriter fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt maturity date</a></td>
<td class="text">Mar.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredUnderwriterFeePayableCurrent', window );">Business combination cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_LoanExtensionsCurrent', window );">Loan extensions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember', window );">Data Knights Acquisition Corp [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIssuedPrincipal', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessAcquisitionCostPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisition cost percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessAcquisitionCostPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed underwriter fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredUnderwriterFeePayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred underwriter fee payable current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredUnderwriterFeePayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_LoanExtensionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loan extensions current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_LoanExtensionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIssuedPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of principal of debt issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIssuedPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 80<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480078/944-80-55-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesATwoPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ONMD_SeriesAOnePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_BusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_BusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ONMD_DataKnightsAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=ONMD_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590147790512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(208)<span></span>
</td>
<td class="num">(180)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ONMD_FurnitureAndEquipmentMember', window );">Furniture And Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ONMD_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ONMD_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132273856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590126135184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Components of Income (Loss) Before Provision for Income Tax (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (33,827)<span></span>
</td>
<td class="num">$ (30,456)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total loss before income taxes</a></td>
<td class="num">$ (33,762)<span></span>
</td>
<td class="num">$ (30,434)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45589996503440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current state</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current foreign</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current tax provision (benefit)</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred federal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">Deferred state</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Deferred foreign</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOtherTaxExpenseBenefit', window );">Total deferred tax provision (benefit)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision (benefit)</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590106957936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Reconciliation of Income Tax Benefit (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax provision at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation expense</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Permanent differences - other</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="num">(11.00%)<span></span>
</td>
<td class="num">(10.50%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants', window );">Change in fair value of warrants</a></td>
<td class="num">(5.70%)<span></span>
</td>
<td class="num">(5.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(3.40%)<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther', window );">Other, net</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Change In Fair Value Of Convertible Notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation change in fair value of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590132754480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 7,393<span></span>
</td>
<td class="nump">$ 6,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredTaxAssetsCapitalizedResearchCosts', window );">Capitalized research costs</a></td>
<td class="nump">337<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_DeferredTaxAssetsFixedAssets', window );">Fixed assets</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">7,759<span></span>
</td>
<td class="nump">6,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(7,753)<span></span>
</td>
<td class="num">(6,597)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredTaxAssetsCapitalizedResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets capitalized research costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredTaxAssetsCapitalizedResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_DeferredTaxAssetsFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets fixed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_DeferredTaxAssetsFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590333704176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">Federal and state net operating losses</a></td>
<td class="nump">$ 31.3<span></span>
</td>
<td class="nump">$ 15.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_OperatingLossCarryForwardIndefinitely', window );">Operating loss carry forward indefinitely</a></td>
<td class="nump">$ 19.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe', window );">Effective federal income tax percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax assets valuation allowance</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation state and local income taxe.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_OperatingLossCarryForwardIndefinitely">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforward indefinitely.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_OperatingLossCarryForwardIndefinitely</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590024825584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Options Outstanding (Details) - USD ($)<br> shares in Thousands, $ / shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning balance</a></td>
<td class="nump">913,856<span></span>
</td>
<td class="nump">728,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, beginning balance</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic value, begining balance</a></td>
<td class="nump">$ 3,199<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options, Granted - under the Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">511,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, Exercised - under the Plan</a></td>
<td class="num">(613,510)<span></span>
</td>
<td class="num">(6,648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options, cancelled</a></td>
<td class="num">(300,346)<span></span>
</td>
<td class="num">(319,539)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, cancelled</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic value, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">913,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options vested and exercisable</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, vested and exercisable</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic value, exercisable</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590024507232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Fair Value of Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Equity securities, measurement input</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Equity securities, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.73<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Equity securities, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Measurement Input, Expected Dividend Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Equity securities, measurement input</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EquitySecuritiesFvNiMeasurementTerm', window );">Expected life in years</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EquitySecuritiesFvNiMeasurementTerm', window );">Expected life in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 9 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Measurement Input, Expected Term [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ONMD_EquitySecuritiesFvNiMeasurementTerm', window );">Expected life in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Equity securities, measurement input</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Equity securities, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Measurement Input, Price Volatility [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiMeasurementInput', window );">Equity securities, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ONMD_EquitySecuritiesFvNiMeasurementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity securities FvNi measurement term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ONMD_EquitySecuritiesFvNiMeasurementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ONMD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590124793216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Restricted Stock Award Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of RSU's, Outstanding, Beginning</a></td>
<td class="nump">177,275<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Beginning</a></td>
<td class="nump">$ 1.48<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Awards, Granted</a></td>
<td class="nump">88,639<span></span>
</td>
<td class="nump">354,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value,Granted</a></td>
<td class="nump">$ 7.21<span></span>
</td>
<td class="nump">$ 4.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Awards,Vested</a></td>
<td class="num">(265,914)<span></span>
</td>
<td class="num">(177,276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value,Vested</a></td>
<td class="nump">$ 5.60<span></span>
</td>
<td class="nump">$ 4.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Awards Outstanding, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">177,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1.48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590130930560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warrants and Promissory Notes Measured at Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember', window );">Private Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Additions</a></td>
<td class="nump">21<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Reclassified to additional paid-in-capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="nump">9<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesAndWarrantsMember', window );">P I P E Notes And Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Additions</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="nump">151<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Reclassified to additional paid-in-capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="nump">1,651<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember', window );">Convertible Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems', window );"><strong>Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, December 31, 2023</a></td>
<td class="nump">26,243<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Additions</a></td>
<td class="nump">4,175<span></span>
</td>
<td class="nump">5,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Changes in fair value</a></td>
<td class="nump">17,517<span></span>
</td>
<td class="nump">14,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Reclassified to additional paid-in-capital</a></td>
<td class="num">(47,935)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, September 30, 2024</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 26,243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_ConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45590024967872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Canadian Emergency Business Loan Act (&#8220;CEBA&#8221;) (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 07, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan payment term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Aggregate fair value of PIPE warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember', window );">P I P E Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Aggregate fair value of PIPE warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember', window );">P I P E Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Aggregate fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ONMD_CEBALoanMember', window );">CEBA Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfUnsecuredDebt', window );">Proceeds from loans</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Forgiven of loan</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Loan repayable</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Loan payment term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ONMD_PIPENotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ONMD_CEBALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ONMD_CEBALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>695</ContextCount>
  <ElementCount>457</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>130</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>999007 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/DescriptionOfBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>999008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>999009 - Disclosure - Crypto Assets Held</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CryptoAssetsHeld</Role>
      <ShortName>Crypto Assets Held</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>999010 - Disclosure - Convertible Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ConvertibleDebt</Role>
      <ShortName>Convertible Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>999011 - Disclosure - Line of Credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/LineOfCredit</Role>
      <ShortName>Line of Credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>999012 - Disclosure - Canadian Emergency Business Account (???CEBA???)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba</Role>
      <ShortName>Canadian Emergency Business Account (???CEBA???)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>999013 - Disclosure - Stockholders??? Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StockholdersDeficit</Role>
      <ShortName>Stockholders??? Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>999014 - Disclosure - Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>999015 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/Stock-basedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>999016 - Disclosure - Stock Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StockWarrants</Role>
      <ShortName>Stock Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>999017 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>999018 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>999019 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>999020 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>999021 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>999022 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>999023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>999024 - Disclosure - Canadian Emergency Business Loan Act (???CEBA???)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba</Role>
      <ShortName>Canadian Emergency Business Loan Act (???CEBA???)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>999025 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://onemednet.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>999026 - Disclosure - Crypto Assets Held (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CryptoAssetsHeldTables</Role>
      <ShortName>Crypto Assets Held (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/CryptoAssetsHeld</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>999027 - Disclosure - Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/NetLossPerShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>999028 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/Stock-basedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/Stock-basedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>999029 - Disclosure - Stock Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StockWarrantsTables</Role>
      <ShortName>Stock Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/StockWarrants</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>999030 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/FairValueMeasurements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>999031 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/RelatedPartyTransactions</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>999032 - Disclosure - Subsequent Events (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/SubsequentEventsTables</Role>
      <ShortName>Subsequent Events (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/SubsequentEvents</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>999033 - Disclosure - Business Combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/BusinessCombinationTables</Role>
      <ShortName>Business Combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/BusinessCombination</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>999034 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/PropertyAndEquipment</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>999035 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://onemednet.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>999036 - Disclosure - Description of Business (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative</Role>
      <ShortName>Description of Business (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/DescriptionOfBusiness</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>999037 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>999038 - Disclosure - Schedule of Crypto Assets Held (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails</Role>
      <ShortName>Schedule of Crypto Assets Held (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>999039 - Disclosure - Schedule of Crypto Assets Reconciliation of Fair Values (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails</Role>
      <ShortName>Schedule of Crypto Assets Reconciliation of Fair Values (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>999040 - Disclosure - Crypto Assets Held (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative</Role>
      <ShortName>Crypto Assets Held (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/CryptoAssetsHeldTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>999041 - Disclosure - Convertible Debt (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ConvertibleDebtDetailsNarrative</Role>
      <ShortName>Convertible Debt (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/ConvertibleDebt</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>999042 - Disclosure - Line of Credit (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/LineOfCreditDetailsNarrative</Role>
      <ShortName>Line of Credit (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/LineOfCredit</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>999043 - Disclosure - Canadian Emergency Business Account (???CEBA???) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative</Role>
      <ShortName>Canadian Emergency Business Account (???CEBA???) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>999044 - Disclosure - Stockholders??? Deficit (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StockholdersDeficitDetailsNarrative</Role>
      <ShortName>Stockholders??? Deficit (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/StockholdersDeficit</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>999045 - Disclosure - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails</Role>
      <ShortName>Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>999046 - Disclosure - Schedule of Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails</Role>
      <ShortName>Schedule of Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>999047 - Disclosure - Stock-Based Compensation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/Stock-basedCompensationDetailsNarrative</Role>
      <ShortName>Stock-Based Compensation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/Stock-basedCompensationTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>999048 - Disclosure - Schedule of Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails</Role>
      <ShortName>Schedule of Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>999049 - Disclosure - Stock Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/StockWarrantsDetailsNarrative</Role>
      <ShortName>Stock Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/StockWarrantsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>999050 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails</Role>
      <ShortName>Schedule of Assets and Liabilities Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>999051 - Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails</Role>
      <ShortName>Schedule of Warrants and Notes Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>999052 - Disclosure - Schedule of Fair Value Assumptions and Valuation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails</Role>
      <ShortName>Schedule of Fair Value Assumptions and Valuation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>999053 - Disclosure - Schedule of Shareholder Loans Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails</Role>
      <ShortName>Schedule of Shareholder Loans Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>999054 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>999055 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>999056 - Disclosure - Schedule of Restatement of Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails</Role>
      <ShortName>Schedule of Restatement of Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>999057 - Disclosure - Schedule of Restatement of Balance Sheet (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical</Role>
      <ShortName>Schedule of Restatement of Balance Sheet (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>999058 - Disclosure - Schedule of the Original and Restated Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails</Role>
      <ShortName>Schedule of the Original and Restated Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>999059 - Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails</Role>
      <ShortName>Schedule of the Original and Restated Statement of Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>999060 - Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails</Role>
      <ShortName>Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>999061 - Disclosure - Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails</Role>
      <ShortName>Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>999062 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/SubsequentEventsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>999063 - Disclosure - Schedule of Business Combination Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails</Role>
      <ShortName>Schedule of Business Combination Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>999064 - Disclosure - Business Combination (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/BusinessCombinationDetailsNarrative</Role>
      <ShortName>Business Combination (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/BusinessCombinationTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>999065 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>999066 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>999067 - Disclosure - Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails</Role>
      <ShortName>Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>999068 - Disclosure - Schedule of Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails</Role>
      <ShortName>Schedule of Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>999069 - Disclosure - Schedule of Reconciliation of Income Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails</Role>
      <ShortName>Schedule of Reconciliation of Income Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>999070 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Schedule of Components of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>999071 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/IncomeTaxesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>999072 - Disclosure - Schedule of Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails</Role>
      <ShortName>Schedule of Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>999073 - Disclosure - Schedule of Fair Value of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails</Role>
      <ShortName>Schedule of Fair Value of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>999074 - Disclosure - Schedule of Restricted Stock Award Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails</Role>
      <ShortName>Schedule of Restricted Stock Award Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>999075 - Disclosure -  Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails</Role>
      <ShortName>Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>999076 - Disclosure - Canadian Emergency Business Loan Act (???CEBA???) (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative</Role>
      <ShortName>Canadian Emergency Business Loan Act (???CEBA???) (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba</ParentRole>
      <Position>76</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" isDefinitelyFs="true" isUsgaap="true" original="forms-1a.htm">forms-1a.htm</File>
    <File>onmd-20240930.xsd</File>
    <File>onmd-20240930_cal.xml</File>
    <File>onmd-20240930_def.xml</File>
    <File>onmd-20240930_lab.xml</File>
    <File>onmd-20240930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>forms-1_001.jpg</File>
    <File>forms-1_012.jpg</File>
    <File>forms-1_013.jpg</File>
    <File>forms-1_014.jpg</File>
    <File>forms-1_015.jpg</File>
    <File>forms-1_016.jpg</File>
    <File>forms-1_017.jpg</File>
    <File>forms-1_018.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="2457">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>187
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forms-1a.htm": {
   "nsprefix": "ONMD",
   "nsuri": "http://onemednet.com/20240930",
   "dts": {
    "inline": {
     "local": [
      "forms-1a.htm"
     ]
    },
    "schema": {
     "local": [
      "onmd-20240930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "onmd-20240930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "onmd-20240930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "onmd-20240930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "onmd-20240930_pre.xml"
     ]
    }
   },
   "keyStandard": 350,
   "keyCustom": 107,
   "axisStandard": 31,
   "axisCustom": 0,
   "memberStandard": 40,
   "memberCustom": 68,
   "hidden": {
    "total": 947,
    "http://fasb.org/us-gaap/2024": 714,
    "http://onemednet.com/20240930": 230,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 695,
   "entityCount": 1,
   "segmentCount": 130,
   "elementCount": 739,
   "unitCount": 6,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 2457,
    "http://xbrl.sec.gov/dei/2024": 26,
    "http://fasb.org/srt/2024": 1
   },
   "report": {
    "R1": {
     "role": "http://onemednet.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://onemednet.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:ShortTermBorrowings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://onemednet.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:TreasuryStockCommonShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://onemednet.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "ONMD:GainLossOnFairValueOfYorkvilleNote",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit",
     "shortName": "Condensed Consolidated Statements of Changes in Temporary Equity and Stockholders' Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2021-12-31_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-07-012023-09-30_custom_TemporaryEquityMember_custom_SeriesATwoPreferredStockMember",
      "name": "ONMD:StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://onemednet.com/role/StatementsOfCashFlows",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "ONMD:ChangeInFairValueOfYorkvilleNote",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://onemednet.com/role/DescriptionOfBusiness",
     "longName": "999007 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://onemednet.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "999008 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://onemednet.com/role/CryptoAssetsHeld",
     "longName": "999009 - Disclosure - Crypto Assets Held",
     "shortName": "Crypto Assets Held",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CryptoAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CryptoAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://onemednet.com/role/ConvertibleDebt",
     "longName": "999010 - Disclosure - Convertible Debt",
     "shortName": "Convertible Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LongTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://onemednet.com/role/LineOfCredit",
     "longName": "999011 - Disclosure - Line of Credit",
     "shortName": "Line of Credit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba",
     "longName": "999012 - Disclosure - Canadian Emergency Business Account (\u201cCEBA\u201d)",
     "shortName": "Canadian Emergency Business Account (\u201cCEBA\u201d)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R13": {
     "role": "http://onemednet.com/role/StockholdersDeficit",
     "longName": "999013 - Disclosure - Stockholders\u2019 Deficit",
     "shortName": "Stockholders\u2019 Deficit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://onemednet.com/role/NetLossPerShare",
     "longName": "999014 - Disclosure - Net Loss per Share",
     "shortName": "Net Loss per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://onemednet.com/role/Stock-basedCompensation",
     "longName": "999015 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://onemednet.com/role/StockWarrants",
     "longName": "999016 - Disclosure - Stock Warrants",
     "shortName": "Stock Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "ONMD:StockWarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "ONMD:StockWarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://onemednet.com/role/FairValueMeasurements",
     "longName": "999017 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://onemednet.com/role/RelatedPartyTransactions",
     "longName": "999018 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://onemednet.com/role/CommitmentsAndContingencies",
     "longName": "999019 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://onemednet.com/role/SubsequentEvents",
     "longName": "999020 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://onemednet.com/role/BusinessCombination",
     "longName": "999021 - Disclosure - Business Combination",
     "shortName": "Business Combination",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://onemednet.com/role/PropertyAndEquipment",
     "longName": "999022 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://onemednet.com/role/IncomeTaxes",
     "longName": "999023 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba",
     "longName": "999024 - Disclosure - Canadian Emergency Business Loan Act (\u201cCEBA\u201d)",
     "shortName": "Canadian Emergency Business Loan Act (\u201cCEBA\u201d)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R25": {
     "role": "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "999025 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:StockholdersEquityPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://onemednet.com/role/CryptoAssetsHeldTables",
     "longName": "999026 - Disclosure - Crypto Assets Held (Tables)",
     "shortName": "Crypto Assets Held (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CryptoAssetHoldingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CryptoAssetHoldingTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://onemednet.com/role/NetLossPerShareTables",
     "longName": "999027 - Disclosure - Net Loss per Share (Tables)",
     "shortName": "Net Loss per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R28": {
     "role": "http://onemednet.com/role/Stock-basedCompensationTables",
     "longName": "999028 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://onemednet.com/role/StockWarrantsTables",
     "longName": "999029 - Disclosure - Stock Warrants (Tables)",
     "shortName": "Stock Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ONMD:StockWarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ONMD:StockWarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://onemednet.com/role/FairValueMeasurementsTables",
     "longName": "999030 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://onemednet.com/role/RelatedPartyTransactionsTables",
     "longName": "999031 - Disclosure - Related Party Transactions (Tables)",
     "shortName": "Related Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://onemednet.com/role/SubsequentEventsTables",
     "longName": "999032 - Disclosure - Subsequent Events (Tables)",
     "shortName": "Subsequent Events (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://onemednet.com/role/BusinessCombinationTables",
     "longName": "999033 - Disclosure - Business Combination (Tables)",
     "shortName": "Business Combination (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_DataKnightsAcquisitionCorpMember",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_DataKnightsAcquisitionCorpMember",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://onemednet.com/role/PropertyAndEquipmentTables",
     "longName": "999034 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://onemednet.com/role/IncomeTaxesTables",
     "longName": "999035 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative",
     "longName": "999036 - Disclosure - Description of Business (Details Narrative)",
     "shortName": "Description of Business (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R37": {
     "role": "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "999037 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails",
     "longName": "999038 - Disclosure - Schedule of Crypto Assets Held (Details)",
     "shortName": "Schedule of Crypto Assets Held (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CryptoAssetNumberOfUnits",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CryptoAssetHoldingTableTextBlock",
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CryptoAssetNumberOfUnits",
      "unitRef": "Integer",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CryptoAssetHoldingTableTextBlock",
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails",
     "longName": "999039 - Disclosure - Schedule of Crypto Assets Reconciliation of Fair Values (Details)",
     "shortName": "Schedule of Crypto Assets Reconciliation of Fair Values (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CryptoAssetAddition",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CryptoAssetActivityTableTextBlock",
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:CryptoAssetAddition",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CryptoAssetActivityTableTextBlock",
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative",
     "longName": "999040 - Disclosure - Crypto Assets Held (Details Narrative)",
     "shortName": "Crypto Assets Held (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:CryptoAssetDisposition",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:CryptoAssetRealizedAndUnrealizedLossNonoperating",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CryptoAssetTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
     "longName": "999041 - Disclosure - Convertible Debt (Details Narrative)",
     "shortName": "Convertible Debt (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-28",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-11-062023-11-07",
      "name": "us-gaap:DebtConversionDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://onemednet.com/role/LineOfCreditDetailsNarrative",
     "longName": "999042 - Disclosure - Line of Credit (Details Narrative)",
     "shortName": "Line of Credit (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2024-03-31_custom_BOCBankMember",
      "name": "us-gaap:LineOfCredit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-31_custom_BOCBankMember",
      "name": "us-gaap:LineOfCredit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ShortTermDebtTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
     "longName": "999043 - Disclosure - Canadian Emergency Business Account (\u201cCEBA\u201d) (Details Narrative)",
     "shortName": "Canadian Emergency Business Account (\u201cCEBA\u201d) (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-012024-09-30_custom_CEBALoanMember",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
     "longName": "999044 - Disclosure - Stockholders\u2019 Deficit (Details Narrative)",
     "shortName": "Stockholders\u2019 Deficit (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "AsOf2023-11-07",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-11-072023-11-07",
      "name": "us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails",
     "longName": "999045 - Disclosure - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)",
     "shortName": "Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails",
     "longName": "999046 - Disclosure - Schedule of Stock-based Compensation Expense (Details)",
     "shortName": "Schedule of Stock-based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-07-012024-09-30_us-gaap_CostOfSalesMember",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
     "longName": "999047 - Disclosure - Stock-Based Compensation (Details Narrative)",
     "shortName": "Stock-Based Compensation (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
     "longName": "999048 - Disclosure - Schedule of Warrants Outstanding (Details)",
     "shortName": "Schedule of Warrants Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ONMD:StockWarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_custom_LiabilityClassifiedWarrantsMember",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ONMD:StockWarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://onemednet.com/role/StockWarrantsDetailsNarrative",
     "longName": "999049 - Disclosure - Stock Warrants (Details Narrative)",
     "shortName": "Stock Warrants (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "ONMD:StockWarrantExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-11-062023-11-07",
      "name": "us-gaap:DebtInstrumentConvertibleConversionRatio1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "ONMD:StockWarrantsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
     "longName": "999050 - Disclosure - Schedule of Assets and Liabilities Measured at Fair Value (Details)",
     "shortName": "Schedule of Assets and Liabilities Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
     "longName": "999051 - Disclosure - Schedule of Warrants and Notes Measured at Fair Value (Details)",
     "shortName": "Schedule of Warrants and Notes Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_custom_BusinessCombinationWarrantsMember",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31_custom_BusinessCombinationWarrantsMember",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
     "longName": "999052 - Disclosure - Schedule of Fair Value Assumptions and Valuation (Details)",
     "shortName": "Schedule of Fair Value Assumptions and Valuation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30_custom_PIPEWarrantsMember_us-gaap_MeasurementInputSharePriceMember",
      "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails",
     "longName": "999053 - Disclosure - Schedule of Shareholder Loans Outstanding (Details)",
     "shortName": "Schedule of Shareholder Loans Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:ConvertibleLongTermNotesPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:ConvertibleLongTermNotesPayable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "999054 - Disclosure - Related Party Transactions (Details Narrative)",
     "shortName": "Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "us-gaap:OtherLongTermDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "us-gaap:OtherLongTermDebt",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "999055 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:LeaseCost",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
     "longName": "999056 - Disclosure - Schedule of Restatement of Balance Sheet (Details)",
     "shortName": "Schedule of Restatement of Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-30",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
     "longName": "999057 - Disclosure - Schedule of Restatement of Balance Sheet (Details) (Parenthetical)",
     "shortName": "Schedule of Restatement of Balance Sheet (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
     "longName": "999058 - Disclosure - Schedule of the Original and Restated Statement of Operations (Details)",
     "shortName": "Schedule of the Original and Restated Statement of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_srt_ScenarioPreviouslyReportedMember",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
     "longName": "999059 - Disclosure - Schedule of the Original and Restated Statement of Cash Flows (Details)",
     "shortName": "Schedule of the Original and Restated Statement of Cash Flows (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "From2024-07-012024-09-30",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "ONMD:StockWarrantExpenses",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
     "longName": "999060 - Disclosure - Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)",
     "shortName": "Schedule of Original and Restated Statement of Changes in Temporary Equity and Stockholders Deficit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-01-012022-12-31_srt_ScenarioPreviouslyReportedMember",
      "name": "ONMD:RetroactiveApplicationOfRecapitalizationDueToBusinessCombination",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
     "longName": "999061 - Disclosure - Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)",
     "shortName": "Schedule of Aggregate Percentage Revenue and Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "us-gaap:TradeAndOtherAccountsReceivablePolicy",
       "ONMD:RestatementToFinancialStatementsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://onemednet.com/role/SubsequentEventsDetailsNarrative",
     "longName": "999062 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2023-11-072023-11-07",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-14_srt_ScenarioForecastMember",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails",
     "longName": "999063 - Disclosure - Schedule of Business Combination Liabilities (Details)",
     "shortName": "Schedule of Business Combination Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2023-11-07",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-11-07_custom_DataKnightsAcquisitionCorpMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
     "longName": "999064 - Disclosure - Business Combination (Details Narrative)",
     "shortName": "Business Combination (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2023-11-07",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:TemporaryEquityLiquidationPreferencePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "999065 - Disclosure - Schedule of Property and Equipment (Details)",
     "shortName": "Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "999066 - Disclosure - Property and Equipment (Details Narrative)",
     "shortName": "Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails",
     "longName": "999067 - Disclosure - Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)",
     "shortName": "Schedule of Components of Income (Loss) Before Provision for Income Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails",
     "longName": "999068 - Disclosure - Schedule of Income Tax Provision (Details)",
     "shortName": "Schedule of Income Tax Provision (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:CurrentForeignTaxExpenseBenefit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails",
     "longName": "999069 - Disclosure - Schedule of Reconciliation of Income Tax Benefit (Details)",
     "shortName": "Schedule of Reconciliation of Income Tax Benefit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "999070 - Disclosure - Schedule of Components of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Schedule of Components of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://onemednet.com/role/IncomeTaxesDetailsNarrative",
     "longName": "999071 - Disclosure - Income Taxes (Details Narrative)",
     "shortName": "Income Taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31",
      "name": "us-gaap:FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails",
     "longName": "999072 - Disclosure - Schedule of Options Outstanding (Details)",
     "shortName": "Schedule of Options Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2021-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails",
     "longName": "999073 - Disclosure - Schedule of Fair Value of Stock Options (Details)",
     "shortName": "Schedule of Fair Value of Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember",
      "name": "us-gaap:EquitySecuritiesFvNiMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember",
      "name": "us-gaap:EquitySecuritiesFvNiMeasurementInput",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails",
     "longName": "999074 - Disclosure - Schedule of Restricted Stock Award Activity (Details)",
     "shortName": "Schedule of Restricted Stock Award Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2022-12-31_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_us-gaap_RestrictedStockUnitsRSUMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails",
     "longName": "999075 - Disclosure -  Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)",
     "shortName": "Schedule of Warrants and Promissory Notes Measured at Fair Value (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_PrivateWarrantsMember",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-012023-12-31_custom_PrivateWarrantsMember",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
     "longName": "999076 - Disclosure - Canadian Emergency Business Loan Act (\u201cCEBA\u201d) (Details Narrative)",
     "shortName": "Canadian Emergency Business Loan Act (\u201cCEBA\u201d) (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-09-30",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-11-07_custom_PrivatePlacementWarrantsMember",
      "name": "us-gaap:DerivativeLiabilities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable &amp; accrued expenses",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r148"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net of allowance for credit losses of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively",
        "verboseLabel": "Accounts receivable, net of allowance of $0 and $125,233 at December 31, 2023 and December 31, 2022, respectively",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r915"
     ]
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Franchise tax payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r782",
      "r978"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax payable",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r146"
     ]
    },
    "ONMD_AccruedInterestRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "AccruedInterestRelatedParty",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued interest",
        "documentation": "Accrued interest related party.",
        "label": "AccruedInterestRelatedParty"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r197",
      "r627"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in-capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r823",
      "r1057"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r672",
      "r901",
      "r902",
      "r903",
      "r906",
      "r988",
      "r1058"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation expense",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r429"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of PIPE warrants",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r45",
      "r131"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total stock-based compensation expense",
        "verboseLabel": "Stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r463"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r276",
      "r312",
      "r315",
      "r316",
      "r1023"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, allowance",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r276",
      "r312"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total common stock equivalents",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "ONMD_AsRestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "AsRestatedMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "As Restated [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r42"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets [Default Label]",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r158",
      "r198",
      "r220",
      "r258",
      "r262",
      "r270",
      "r271",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r508",
      "r510",
      "r546",
      "r615",
      "r715",
      "r789",
      "r790",
      "r823",
      "r844",
      "r948",
      "r949",
      "r1010"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r204",
      "r220",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r508",
      "r510",
      "r546",
      "r823",
      "r948",
      "r949",
      "r1010"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total assets, at fair value",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r526",
      "r810"
     ]
    },
    "us-gaap_AssetsHeldInTrustCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsHeldInTrustCurrent",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments held in trust",
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "ONMD_BOCBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BOCBankMember",
     "presentation": [
      "http://onemednet.com/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "B O C Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BeneficialOwnershipMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BeneficialOwnershipMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Beneficial Ownership [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BitcoinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BitcoinMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bitcoin [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/BusinessCombinationTables",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r503",
      "r804",
      "r805"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/BusinessCombinationTables",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r503",
      "r804",
      "r805"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder loan",
        "verboseLabel": "Business combination transaction cost",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessAcquisitionCostPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessAcquisitionCostPercentage",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination percentage",
        "documentation": "Business acquisition cost percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/BusinessCombinationTables",
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r503"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing stock price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination, consideration underwriting commission",
        "verboseLabel": "Business combination transfered",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3",
      "r15"
     ]
    },
    "ONMD_BusinessCombinationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationCost",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination cost",
        "documentation": "Business combination cost."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of contingent consideration",
        "documentation": "The method of determining the fair value of the equity interests of the acquirer, including the number of instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ONMD_BusinessCombinationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationCosts",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Business Combination costs",
        "negatedTerseLabel": "Business Combination Costs",
        "documentation": "Business combination costs",
        "label": "BusinessCombinationCosts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/BusinessCombination"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r504"
     ]
    },
    "ONMD_BusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationMember",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable &amp; accrued expenses",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed accounts payable and accrued expenses.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination, closing cash balance",
        "verboseLabel": "Business combination cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses and other current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred underwriter fee payable",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed deferred underwriter fee payable.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredUnderwriterFeePayable"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loan extensions",
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Loan Extension.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoanExtension"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Liabilities",
        "label": "Business combination net liabilities",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64"
     ]
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed notes payable."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFees",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination underwriter fees",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed underwriter fees."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnderwriterFeesPayable",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combination, underwriter fees payable"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Warrant liability",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed warrant liability",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable": {
     "xbrltype": "dateItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsMaturityDateAssumedNotesPayable",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt maturity date",
        "documentation": "Business combination recognized identifiable assets maturity date assumed notes payable."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_BusinessCombinationWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "BusinessCombinationWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r858",
      "r859"
     ]
    },
    "ONMD_CEBALoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CEBALoanMember",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CEBA Loan [Member]",
        "documentation": "CEBA Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CanadaEmergencyBusinessLoanAct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CanadaEmergencyBusinessLoanAct",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canada Emergency Business Loan Act",
        "documentation": "Canada emergency business loan act."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalUnitsAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalUnitsAuthorized",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital stock authorized",
        "documentation": "Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash balance",
        "verboseLabel": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r619",
      "r683",
      "r710",
      "r823",
      "r844",
      "r886"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "verboseLabel": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r195",
      "r781"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning year",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r113",
      "r215"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net decrease in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r113"
     ]
    },
    "ONMD_CashHeldInTrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CashHeldInTrustAccount",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash held in trust account",
        "documentation": "Cash held in trust account."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CashStructuringFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CashStructuringFee",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash structuring fee",
        "documentation": "Cash structuring fee."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ChangeInFairValueOfConvertiblePromissoryNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ChangeInFairValueOfConvertiblePromissoryNotes",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of convertible promissory notes"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ChangeInFairValueOfPipeNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ChangeInFairValueOfPipeNotes",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value of PIPE Notes",
        "documentation": "Change in fair value of pipe notes.",
        "label": "ChangeInFairValueOfPipeNotes"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ChangeInFairValueOfWarrantLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ChangeInFairValueOfWarrantLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of warrant liabilities",
        "documentation": "Change in fair value of warrant liabilities.",
        "label": "ChangeInFairValueOfWarrantLiabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ChangeInFairValueOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ChangeInFairValueOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value of warrants",
        "documentation": "Change in fair value of warrants.",
        "label": "ChangeInFairValueOfWarrants"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ChangeInFairValueOfYorkvilleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ChangeInFairValueOfYorkvilleNote",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of Yorkville Note",
        "label": "ChangeInFairValueOfYorkvilleNote"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emdedded derivative liabilities",
        "documentation": "Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r200",
      "r201",
      "r202",
      "r220",
      "r247",
      "r248",
      "r250",
      "r252",
      "r260",
      "r261",
      "r307",
      "r359",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r398",
      "r399",
      "r401",
      "r404",
      "r411",
      "r546",
      "r663",
      "r664",
      "r665",
      "r666",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r702",
      "r724",
      "r746",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r865",
      "r894",
      "r907"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant exercise price",
        "verboseLabel": "Warrants exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to acquire common stock",
        "verboseLabel": "Warrants exercisable for common stock",
        "terseLabel": "Warrants to purchase common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant outstanding",
        "verboseLabel": "Grant Total",
        "terseLabel": "Warrants outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ONMD_CommitmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CommitmentMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment [Member]",
        "documentation": "Commitment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies (Note 13)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r151",
      "r618",
      "r701"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r351",
      "r352",
      "r774",
      "r940",
      "r945"
     ]
    },
    "ONMD_CommonSharesIssuedToDataKnightsShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CommonSharesIssuedToDataKnightsShareholders",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares issued to Data Knights shareholders",
        "documentation": "Common shares issued to data knights shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CommonSharesIssuedToPreferredShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CommonSharesIssuedToPreferredShareholders",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common shares issued to preferred shareholders",
        "documentation": "Common shares issued to preferred shareholders.",
        "label": "CommonSharesIssuedToPreferredShareholders"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CommonSharesRelatedToConvertiblePromissoryNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CommonSharesRelatedToConvertiblePromissoryNotes",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares related to convertible promissory notes",
        "documentation": "Common shares related to convertible promissory notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r834",
      "r835",
      "r836",
      "r838",
      "r839",
      "r840",
      "r841",
      "r901",
      "r902",
      "r906",
      "r988",
      "r1054",
      "r1058"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par value",
        "verboseLabel": "Capital stock par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r702"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "verboseLabel": "Shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "verboseLabel": "Shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r96",
      "r702",
      "r721",
      "r1058",
      "r1059"
     ]
    },
    "us-gaap_CommonStockSharesSubscriptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesSubscriptions",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock shares not yet issued",
        "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r96"
     ]
    },
    "ONMD_CommonStockSubjectToPossibleRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CommonStockSubjectToPossibleRedemptionValue",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock redemption",
        "documentation": "Common stock subject to possible redemption value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001, 100,000,000 shares authorized and 23,572,232 and 4,033,170 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r621",
      "r823"
     ]
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r137"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r72",
      "r73",
      "r274",
      "r773"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r72",
      "r73",
      "r274",
      "r657",
      "r773"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r72",
      "r73",
      "r274",
      "r773",
      "r869"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of revenue",
        "verboseLabel": "Aggregate Percent of Revenue and Accounts Receivable",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r72",
      "r73",
      "r274"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r72",
      "r73",
      "r274",
      "r773"
     ]
    },
    "ONMD_ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ConsiderationForRepurchaseOfCommonStockIncludedInAccountsPayableAndAccruedExpenses",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration for repurchase of common stock included in accounts payable and accrued expenses",
        "documentation": "Consideration for repurchase of common stock included in accounts payable and accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r784"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of stock amount",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of stock amount issued",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible promissory note",
        "verboseLabel": "Loans converted into common stock",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r150",
      "r1021"
     ]
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible promissory notes",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate fair value",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r992",
      "r993",
      "r994",
      "r995",
      "r998"
     ]
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible promissory notes",
        "label": "Convertible Debt, Noncurrent",
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleLongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder loans \u2013 nonconvertible",
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PIPE notes payable",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r150",
      "r1021"
     ]
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder loans \u2013 convertible",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayableMember",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Payable [Member]",
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r145"
     ]
    },
    "ONMD_ConvertibleNotesWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ConvertibleNotesWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockTermsOfConversion": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockTermsOfConversion",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible preferred stock terms of conversion",
        "documentation": "Description of conversion terms for preferred stock."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r50",
      "r51",
      "r95",
      "r128",
      "r130"
     ]
    },
    "ONMD_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ConvertiblePromissoryNoteWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ConvertiblePromissoryNoteWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Note Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ConvertiblePromissoryNotesAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ConvertiblePromissoryNotesAndWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Notes And Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ConvertiblePromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ConvertiblePromissoryNotesMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Notes [Member]",
        "documentation": "Convertible Promissory Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ConvertiblePromissoryNotesWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ConvertiblePromissoryNotesWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Promissory Notes Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r220",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r546",
      "r789",
      "r948"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CryptoAssetActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetActivityTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/CryptoAssetsHeldTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Crypto Assets Reconciliation of Fair Values",
        "documentation": "Tabular disclosure of information about activity for crypto asset. Excludes information about crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "us-gaap_CryptoAssetAddition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetAddition",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions",
        "documentation": "Amount of increase in crypto asset from addition. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "srt_CryptoAssetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CryptoAssetAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset [Axis]",
        "documentation": "Information by crypto-asset."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r343",
      "r928",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939"
     ]
    },
    "us-gaap_CryptoAssetCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetCost",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto assets, Cost Basis",
        "documentation": "Cost of crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r331"
     ]
    },
    "us-gaap_CryptoAssetDisposition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetDisposition",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dispositions",
        "label": "Bitcoin dispositions",
        "documentation": "Amount of decrease in crypto asset from disposition. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "srt_CryptoAssetDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CryptoAssetDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Crypto-asset."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r343",
      "r928",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939"
     ]
    },
    "us-gaap_CryptoAssetFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetFairValue",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails",
      "http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bitcoin",
        "verboseLabel": "Crypto assets, Fair Value",
        "periodStartLabel": "Balance, December 31, 2023",
        "periodEndLabel": "Balance, September 30, 2024",
        "documentation": "Fair value of crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329",
      "r332",
      "r334"
     ]
    },
    "us-gaap_CryptoAssetHoldingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetHoldingLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Holding [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ]
    },
    "us-gaap_CryptoAssetHoldingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetHoldingTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Asset, Holding [Table]",
        "documentation": "Disclosure of information about crypto asset. Includes, but is not limited to, name, cost basis, fair value, and number of units held. Excludes information about crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333"
     ]
    },
    "us-gaap_CryptoAssetHoldingTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetHoldingTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/CryptoAssetsHeldTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Crypto Assets Held",
        "documentation": "Tabular disclosure of information about crypto asset. Includes, but is not limited to, name, cost basis, fair value, and number of units held. Excludes information about crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r930"
     ]
    },
    "us-gaap_CryptoAssetNumberOfUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetNumberOfUnits",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto assets, Units",
        "documentation": "Number of restricted and unrestricted crypto asset units held. Excludes crypto asset units held for platform user."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "us-gaap_CryptoAssetRealizedAndUnrealizedGainLossNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetRealizedAndUnrealizedGainLossNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfCryptoAssetsReconciliationOfFairValuesDetails",
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of Bitcoin",
        "label": "Unrealized loss, net",
        "documentation": "Amount of realized and unrealized gain (loss) from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r929",
      "r931"
     ]
    },
    "us-gaap_CryptoAssetRealizedAndUnrealizedLossNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetRealizedAndUnrealizedLossNonoperating",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/CryptoAssetsHeldDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bitcoin realized losses",
        "documentation": "Amount of realized and unrealized loss from remeasurement of crypto asset, classified as nonoperating. Excludes change for crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r929"
     ]
    },
    "us-gaap_CryptoAssetRealizedLossNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetRealizedLossNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Realized loss on sale of Bitcoin",
        "documentation": "Amount of realized loss from remeasurement of crypto asset, classified as nonoperating. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r936"
     ]
    },
    "us-gaap_CryptoAssetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CryptoAssetTextBlock",
     "presentation": [
      "http://onemednet.com/role/CryptoAssetsHeld"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto Assets Held",
        "documentation": "The entire disclosure for crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r339",
      "r340"
     ]
    },
    "ONMD_CryptoCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CryptoCash",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Crypto assets",
        "documentation": "Crypto cash.",
        "label": "CryptoCash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r897",
      "r987"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current foreign",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r897"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current tax provision (benefit)",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r489",
      "r897"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current state",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r897",
      "r987"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r274"
     ]
    },
    "ONMD_CustomerFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomerFiveMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Five [Member]",
        "documentation": "Customer Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CustomerFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomerFourMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Four [Member]",
        "documentation": "Customer Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer One [Member]",
        "documentation": "Customer One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CustomerSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomerSevenMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CustomerSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomerSixMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CustomerThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomerThreeMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Three [Member]",
        "documentation": "Customer Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CustomerTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomerTwoMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Two [Member]",
        "documentation": "Customer Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_CustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "CustomersMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customers [Member]",
        "documentation": "Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_DataKnightsAcquisitionCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DataKnightsAcquisitionCorpMember",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/BusinessCombinationTables",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Data Knights Acquisition Corp [Member]",
        "documentation": "Data Knights Acquisition Corp [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_DataKnightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DataKnightsMember",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Data Knights [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentRate",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversion converted instrument rate",
        "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of warrants issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_DebtConversionDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionDescription",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Description",
        "documentation": "Description of conversion of original debt instrument in noncash or part noncash transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionOriginalDebtAmount1",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of loan",
        "verboseLabel": "Loan repayable",
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCeba",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCeba"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Canadian Emergency Business Account (\u201cCEBA\u201d)",
        "verboseLabel": "Canadian Emergency Business Loan Act (\u201cCEBA\u201d)",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r217",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r357",
      "r358",
      "r368",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r384",
      "r391",
      "r392",
      "r394",
      "r555"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r81",
      "r82",
      "r145",
      "r150",
      "r226",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r821",
      "r895",
      "r941",
      "r942",
      "r943",
      "r1002",
      "r1003"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt conversion price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r371"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion ratio",
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r86",
      "r129",
      "r130",
      "r371"
     ]
    },
    "us-gaap_DebtInstrumentDecreaseForgiveness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentDecreaseForgiveness",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgiven of loan",
        "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r895"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt description",
        "verboseLabel": "Debt instrument description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r50",
      "r77",
      "r81",
      "r145",
      "r150",
      "r555"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount of notes payable",
        "verboseLabel": "Non convertible loans",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r555",
      "r556",
      "r794",
      "r795",
      "r821"
     ]
    },
    "ONMD_DebtInstrumentInterestRateDefaultPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DebtInstrumentInterestRateDefaultPercentage",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt default interest rate",
        "documentation": "Debt instrument interest rate default percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original issue discount",
        "verboseLabel": "Interest rate percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r396",
      "r555",
      "r556",
      "r821"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "verboseLabel": "Business combination, consideration underwriting commission",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r370"
     ]
    },
    "us-gaap_DebtInstrumentIssuedPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentIssuedPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount",
        "documentation": "Amount of principal of debt issued."
       }
      }
     },
     "auth_ref": [
      "r663"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r393",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r821",
      "r895",
      "r1002",
      "r1003"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date",
        "verboseLabel": "Debt instrument maturity date",
        "terseLabel": "Debt maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r793",
      "r994",
      "r995"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDateDescription",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Maturity Date, Description",
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r226",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r821",
      "r895",
      "r941",
      "r942",
      "r943",
      "r1002",
      "r1003"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note payment",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_DebtInstrumentRepaidPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRepaidPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non convertible loans repaid",
        "documentation": "Amount of principal of debt repaid."
       }
      }
     },
     "auth_ref": [
      "r666"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r50",
      "r51",
      "r76",
      "r128",
      "r130",
      "r226",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r393",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r821",
      "r895",
      "r1002",
      "r1003"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan payment term",
        "verboseLabel": "Debt term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitment fees",
        "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]",
        "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "ONMD_DeferredCostsNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DeferredCostsNonCurrent",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredOtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r986",
      "r987"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredOtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred foreign",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r986"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r147",
      "r482"
     ]
    },
    "us-gaap_DeferredOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering expenses",
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_DeferredOtherTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredOtherTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax provision (benefit)",
        "label": "Deferred Other Tax Expense (Benefit)",
        "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r985"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenues",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_DeferredOtherTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred state",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r986",
      "r987"
     ]
    },
    "ONMD_DeferredTaxAssetsCapitalizedResearchCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DeferredTaxAssetsCapitalizedResearchCosts",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized research costs",
        "documentation": "Deferred tax assets capitalized research costs."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_DeferredTaxAssetsFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DeferredTaxAssetsFixedAssets",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed assets",
        "documentation": "Deferred tax assets fixed assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred taxes",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r984"
     ]
    },
    "ONMD_DeferredUnderwriterFeePayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DeferredUnderwriterFeePayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriter fee payable",
        "verboseLabel": "Business combination cash",
        "documentation": "Deferred underwriter fee payable current."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_DeferredUnderwriterFeePayableNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DeferredUnderwriterFeePayableNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred underwriter fee payable",
        "documentation": "Deferred underwriter fee payable noncurrent.",
        "label": "DeferredUnderwriterFeePayableNonCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization expense",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r43"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r258",
      "r266",
      "r271",
      "r789",
      "r790"
     ]
    },
    "us-gaap_DerivativeDescriptionOfTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeDescriptionOfTerms",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of promissory note",
        "documentation": "Description of the relevant terms of the derivative. Includes the type of instrument, risk being hedged, notional amount, counterparty, inception date, maturity date, relevant interest rates, strike price, cap price, and floor price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeFloorPrice": {
     "xbrltype": "perUnitItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFloorPrice",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Floor price",
        "documentation": "Floor rate on a price risk derivative such as a floor or a collar. A payment or receipt is triggered if the market rate falls below the floor rate on the contract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate fair value of PIPE warrants",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r206",
      "r525",
      "r526",
      "r537",
      "r545",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r716",
      "r718",
      "r719",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r783",
      "r993",
      "r994",
      "r995",
      "r1055"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative financial instruments",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r66",
      "r67",
      "r68",
      "r70",
      "r225",
      "r242"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "documentation": "Person serving on board of directors."
       }
      }
     },
     "auth_ref": [
      "r884",
      "r914",
      "r1056"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r431",
      "r459",
      "r460",
      "r461",
      "r807"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_DisclosureStockWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "DisclosureStockWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends",
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r131"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r856",
      "r858",
      "r859"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "ONMD_EFHuttonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EFHuttonMember",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EF Hutton [Member]",
        "documentation": "EF Hutton [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings per share:",
        "verboseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic net loss per common share outstanding",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r239",
      "r245",
      "r247",
      "r250",
      "r251",
      "r252",
      "r257",
      "r501",
      "r506",
      "r522",
      "r523",
      "r610",
      "r633",
      "r786"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted net loss per common share outstanding",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r239",
      "r247",
      "r250",
      "r251",
      "r252",
      "r257",
      "r501",
      "r506",
      "r522",
      "r523",
      "r610",
      "r633",
      "r786"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net loss per share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r254"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://onemednet.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r253",
      "r255",
      "r256"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r809"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax provision at statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r472",
      "r492",
      "r809"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r475",
      "r809",
      "r898",
      "r980"
     ]
    },
    "ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInFairValueOfConvertibleNotes",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of convertible notes",
        "documentation": "Effective Income Tax Rate Reconciliation Change In Fair Value Of Convertible Notes."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants": {
     "xbrltype": "percentItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Change in fair value of warrants",
        "documentation": "Effective income tax rate reconciliation change in fair value of warrants.",
        "label": "EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent differences - other",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r898",
      "r980",
      "r982"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation expense",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r809",
      "r898",
      "r980",
      "r982"
     ]
    },
    "ONMD_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe": {
     "xbrltype": "percentItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxe",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective federal income tax percentage",
        "documentation": "Effective income tax rate reconciliation state and local income taxe."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State taxes, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r809",
      "r898",
      "r980"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsOther": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsOther",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfReconciliationOfIncomeTaxBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other, net",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other income tax settlements."
       }
      }
     },
     "auth_ref": [
      "r898",
      "r980",
      "r981"
     ]
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of embedded derivative",
        "documentation": "Net fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as assets, net of those classified as liabilities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r993",
      "r994",
      "r995"
     ]
    },
    "ONMD_EmergingGrowthCompanyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Emerging growth company status",
        "documentation": "Emerging Growth Company [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Monthly shares",
        "documentation": "Amount of expense for employee benefit and equity-based compensation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_EmployeesDirectorsAndConsultantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EmployeesDirectorsAndConsultantsMember",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employees Directors and Consultants [Member]",
        "documentation": "Employees Directors and Consultants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_EquityClassifiedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EquityClassifiedWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Classified Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r189",
      "r210",
      "r211",
      "r212",
      "r227",
      "r228",
      "r229",
      "r231",
      "r237",
      "r240",
      "r242",
      "r259",
      "r308",
      "r311",
      "r341",
      "r414",
      "r490",
      "r491",
      "r498",
      "r499",
      "r500",
      "r502",
      "r505",
      "r506",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r521",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r558",
      "r560",
      "r564",
      "r631",
      "r646",
      "r647",
      "r648",
      "r672",
      "r746"
     ]
    },
    "ONMD_EquityFinancingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EquityFinancingDescription",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity financing, description",
        "documentation": "Equity financing description."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EquityIncentivePlanMember",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_EquityPurchaseAgreementDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EquityPurchaseAgreementDescription",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity purchase agreement description",
        "documentation": "Equity purchase agreement description."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesFvNiMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiMeasurementInput",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity securities, measurement input",
        "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529"
     ]
    },
    "ONMD_EquitySecuritiesFvNiMeasurementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "EquitySecuritiesFvNiMeasurementTerm",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life in years",
        "documentation": "Equity securities FvNi measurement term."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ExciseTaxCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ExciseTaxCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Excise tax",
        "documentation": "Excise tax current."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_FairValueAdjustmentOfConvertiblePromissoryNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "FairValueAdjustmentOfConvertiblePromissoryNotes",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of convertible promissory notes",
        "documentation": "Fair value adjustment of convertible promissory notes.",
        "label": "FairValueAdjustmentOfConvertiblePromissoryNotes"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_FairValueAdjustmentOfPrivateInvestmentInPublicEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "FairValueAdjustmentOfPrivateInvestmentInPublicEquity",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of PIPE Notes",
        "documentation": "Fair value adjustment of private investment in public equity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of warrants",
        "verboseLabel": "Change in fair value of warrant liabilities",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r526",
      "r537",
      "r810"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r526",
      "r537",
      "r810"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/FairValueMeasurementsTables",
      "http://onemednet.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Stock Options",
        "verboseLabel": "Schedule of Fair Value Assumptions and Valuation",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r814"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r536",
      "r537",
      "r539",
      "r579",
      "r580",
      "r581",
      "r794",
      "r795",
      "r801",
      "r802",
      "r803",
      "r810",
      "r814"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r526",
      "r527",
      "r529",
      "r810",
      "r994",
      "r1000"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://onemednet.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r532",
      "r534",
      "r535",
      "r536",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r609",
      "r810",
      "r815"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r418",
      "r423",
      "r526",
      "r537",
      "r579",
      "r801",
      "r802",
      "r803",
      "r810"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r418",
      "r423",
      "r526",
      "r527",
      "r537",
      "r580",
      "r794",
      "r795",
      "r801",
      "r802",
      "r803",
      "r810"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r526",
      "r527",
      "r528",
      "r529",
      "r537",
      "r581",
      "r794",
      "r795",
      "r801",
      "r802",
      "r803",
      "r810",
      "r814"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assets and Liabilities Measured at Fair Value",
        "documentation": "Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r526"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://onemednet.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warrants and Promissory Notes Measured at Fair Value",
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r992"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://onemednet.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value Assumptions and Valuation",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r533",
      "r538"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r525",
      "r526",
      "r527",
      "r529",
      "r810",
      "r994",
      "r1000"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additions",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r538"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in fair value",
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r996",
      "r999"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassified to additional paid-in-capital",
        "documentation": "Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r997",
      "r999"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, December 31, 2023",
        "periodEndLabel": "Balance, September 30, 2024",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r530",
      "r538"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r536",
      "r537",
      "r539",
      "r579",
      "r580",
      "r581",
      "r794",
      "r795",
      "r801",
      "r802",
      "r803",
      "r810",
      "r814"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1000"
     ]
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfAssetsAcquired",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of common stock",
        "documentation": "The fair value of assets acquired in noncash investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_FairValueOptionOfAccountingPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "FairValueOptionOfAccountingPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value option of accounting",
        "documentation": "Fair value option of accounting [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal and state net operating losses",
        "documentation": "Amount of current and deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r313",
      "r314",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r393",
      "r409",
      "r518",
      "r544",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r632",
      "r792",
      "r810",
      "r812",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r824",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r919",
      "r920",
      "r921",
      "r922",
      "r990",
      "r993",
      "r994",
      "r995",
      "r998",
      "r1000"
     ]
    },
    "ONMD_FloorPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "FloorPricePerShare",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Floor price per share",
        "documentation": "Floor price per share."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_FurnitureAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "FurnitureAndEquipmentMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture And Equipment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of derivative liability",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ONMD_GainLossOnFairValueOfYorkvilleNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "GainLossOnFairValueOfYorkvilleNote",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of Yorkville Note",
        "documentation": "Gain loss on fair value of Yorkville note."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on forgiveness of CEBA loan",
        "label": "Gain loss on extinguishment of debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r46",
      "r47"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r726"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross margin",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r104",
      "r157",
      "r220",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r546",
      "r788",
      "r789",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r948"
     ]
    },
    "ONMD_HelenaTerminationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "HelenaTerminationAgreementMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Helena Termination Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of long-lived assets",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r121",
      "r811"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r123"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r471"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss before income taxes",
        "totalLabel": "Total loss before income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r153",
      "r157",
      "r611",
      "r629",
      "r788",
      "r789",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfComponentsOfIncomeLossBeforeProvisionForIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r471"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Aggregate Percentage Revenue and Accounts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r349",
      "r350",
      "r531",
      "r533",
      "r538",
      "r643",
      "r645",
      "r731",
      "r777",
      "r813",
      "r1025"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r349",
      "r350",
      "r531",
      "r533",
      "r538",
      "r643",
      "r645",
      "r731",
      "r777",
      "r813",
      "r1025"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r467",
      "r472",
      "r476",
      "r477",
      "r478",
      "r479",
      "r486",
      "r493",
      "r495",
      "r496",
      "r497",
      "r668",
      "r809"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfIncomeTaxProvisionDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax expense",
        "totalLabel": "Total income tax provision (benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r171",
      "r241",
      "r242",
      "r258",
      "r267",
      "r271",
      "r470",
      "r472",
      "r494",
      "r634",
      "r809"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r468",
      "r469",
      "r479",
      "r480",
      "r485",
      "r488",
      "r662"
     ]
    },
    "ONMD_IncomeTaxProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "IncomeTaxProvision",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax provision",
        "documentation": "Income tax provision."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_IncreaseDecreaseFranchiseTaxPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "IncreaseDecreaseFranchiseTaxPayable",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Franchise tax payable",
        "documentation": "Increase decrease franchise tax payable.",
        "label": "IncreaseDecreaseFranchiseTaxPayable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable &amp; accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income tax payable",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenues",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount due to related party",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ONMD_IncreaseDecreaseInExerciseTaxLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "IncreaseDecreaseInExerciseTaxLiability",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Excise tax liability",
        "documentation": "Increase decrease in exercise tax liability."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_IncreaseDecreaseInExtensionLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "IncreaseDecreaseInExtensionLoan",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension loan",
        "documentation": "Increase decrease in extension loan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ONMD_IncreaseDecreaseInWorkingCapitalLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "IncreaseDecreaseInWorkingCapitalLoan",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Working capital loan",
        "documentation": "Increase decrease in working capital loan.",
        "label": "IncreaseDecreaseInWorkingCapitalLoan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest expense",
        "label": "Interest Expense, Operating and Nonoperating",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r262",
      "r265",
      "r268",
      "r271",
      "r554",
      "r789",
      "r790"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r889"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued interest",
        "label": "Interest Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r1019"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Investments",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r613",
      "r614",
      "r831",
      "r833"
     ]
    },
    "us-gaap_InvestorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestorMember",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor [Member]",
        "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value."
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1007"
     ]
    },
    "ONMD_IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "IssuanceOfCommonStockToSettleDeferredUnderwriterFeePayable",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock to settle deferred underwriter fee payable",
        "documentation": "Issuance of common stock to settle deferred underwriter fee payable."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_JulyTwoThousandTwentyFourFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "JulyTwoThousandTwentyFourFinancingMember",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "July Two Thousand Twenty Four Financing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_KingwoodCapitalPartnersLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "KingwoodCapitalPartnersLLCMember",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Kingwood Capital Partners LLC [Member]",
        "documentation": "Kingwood Capital Partners LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r561",
      "r822"
     ]
    },
    "ONMD_LegacyONMDWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "LegacyONMDWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legacy O N M D Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalFees",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal fees",
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r81",
      "r82",
      "r83",
      "r88",
      "r89",
      "r90",
      "r93",
      "r220",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r509",
      "r510",
      "r511",
      "r546",
      "r700",
      "r787",
      "r844",
      "r948",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities, temporary equity, and stockholders\u2019 deficit",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r152",
      "r624",
      "r823",
      "r896",
      "r923",
      "r1001"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, temporary equity and stockholders\u2019 deficit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r194",
      "r220",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r509",
      "r510",
      "r511",
      "r546",
      "r823",
      "r948",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total liabilities, at fair value",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r991"
     ]
    },
    "ONMD_LiabilityClassifiedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "LiabilityClassifiedWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Classified Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r150",
      "r1021"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "presentation": [
      "http://onemednet.com/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Interest Rate During Period",
        "documentation": "The effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r87"
     ]
    },
    "ONMD_LoanExtension": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "LoanExtension",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loan extensions",
        "documentation": "Loan extension.",
        "label": "LoanExtension"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_LoanExtensionsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "LoanExtensionsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loan extensions",
        "documentation": "Loan extensions current.",
        "label": "LoanExtensionsCurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoanProcessingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoanProcessingFee",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Structuring fees",
        "documentation": "Expenses paid for obtaining loans which includes expenses such as application and origination fees."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansPayable",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Payable",
        "verboseLabel": "Loan payable",
        "terseLabel": "Principal amount",
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r150",
      "r1021"
     ]
    },
    "us-gaap_LoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan extensions",
        "verboseLabel": "Loans remains outstanding",
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfShareholderLoansOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total loan \u2013 related party",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r150",
      "r381",
      "r395",
      "r794",
      "r795",
      "r821",
      "r1021"
     ]
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment premium percentage on principal amount",
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_LongTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtTextBlock",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt",
        "documentation": "The entire disclosure for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_LongTermLoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermLoansPayable",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan, related party",
        "verboseLabel": "Extension loans",
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r800",
      "r826",
      "r829",
      "r951",
      "r1024",
      "r1026",
      "r1027",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r187",
      "r188",
      "r353",
      "r354",
      "r355",
      "r356",
      "r425",
      "r464",
      "r529",
      "r607",
      "r642",
      "r644",
      "r656",
      "r692",
      "r693",
      "r755",
      "r756",
      "r757",
      "r758",
      "r766",
      "r775",
      "r776",
      "r791",
      "r798",
      "r806",
      "r814",
      "r815",
      "r819",
      "r820",
      "r827",
      "r950",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "us-gaap_MeasurementInputExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExercisePriceMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Exercise Price [Member]",
        "documentation": "Measurement input using agreed upon price for exchange of underlying asset."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r814"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r527",
      "r528",
      "r529",
      "r814"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r187",
      "r188",
      "r353",
      "r354",
      "r355",
      "r356",
      "r425",
      "r464",
      "r529",
      "r607",
      "r642",
      "r644",
      "r656",
      "r692",
      "r693",
      "r755",
      "r756",
      "r757",
      "r758",
      "r766",
      "r775",
      "r776",
      "r791",
      "r798",
      "r806",
      "r814",
      "r815",
      "r819",
      "r827",
      "r950",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Beneficial ownership percentage",
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_MrClarkeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "MrClarkeMember",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr Clarke [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_MsCoonseMcCrawMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "MsCoonseMcCrawMember",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ms Coonse Mc Craw [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r800",
      "r826",
      "r829",
      "r951",
      "r1024",
      "r1026",
      "r1027",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r116"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      },
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "label": "Net loss",
        "negatedLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r116",
      "r154",
      "r192",
      "r207",
      "r208",
      "r212",
      "r220",
      "r230",
      "r232",
      "r233",
      "r235",
      "r236",
      "r237",
      "r241",
      "r242",
      "r249",
      "r307",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r501",
      "r506",
      "r523",
      "r546",
      "r630",
      "r723",
      "r744",
      "r745",
      "r842",
      "r948"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Pronouncements Not Yet Adopted",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_NewEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "NewEquityIncentivePlanMember",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Equity Incentive Plan [Member]",
        "documentation": "New Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_NoncashInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "NoncashInterest",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total other expense, net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expense (income), net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r900"
     ]
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Promissory note",
        "label": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r150",
      "r1021",
      "r1022"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PIPE Notes",
        "verboseLabel": "PIPE notes",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82"
     ]
    },
    "ONMD_OneCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "OneCustomerMember",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Customer [Member]",
        "documentation": "One Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r788",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912"
     ]
    },
    "ONMD_OperatingLossCarryForwardIndefinitely": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "OperatingLossCarryForwardIndefinitely",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carry forward indefinitely",
        "documentation": "Operating loss carryforward indefinitely."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carry forward",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "ONMD_OperatingSegmentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "OperatingSegmentsPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments",
        "documentation": "Operating Segments [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_OptionsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "OptionsToPurchaseCommonStockMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options To Purchase Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/DescriptionOfBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Business",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r140",
      "r658",
      "r659"
     ]
    },
    "us-gaap_OtherGeneralExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherGeneralExpense",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operations",
        "documentation": "Amount of general expenses not normally included in Other Operating Costs and Expenses."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r789"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan amount due to related parties",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r616",
      "r696",
      "r697",
      "r844",
      "r1022",
      "r1056"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r823"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other long-term liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_OtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non convertible shareholder loan",
        "documentation": "Amount of long-term debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r150",
      "r1021"
     ]
    },
    "us-gaap_OtherNoncashExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashExpense",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expense",
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      },
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other expense",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_PIPENotesAndWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PIPENotesAndWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "P I P E Notes And Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_PIPENotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PIPENotesMember",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "P I P E Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_PIPEWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PIPEWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "P I P E Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_PatentsAndTrademarksPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PatentsAndTrademarksPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Patents and Trademarks",
        "documentation": "Patents And Trademarks [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForAcquisitionCryptoAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForAcquisitionCryptoAsset",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of Bitcoin",
        "label": "Payment for Acquisition, Crypto Asset",
        "documentation": "Amount of cash outflow to acquire crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_PaymentForManagementFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForManagementFee",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitment fees",
        "label": "Payment for Management Fee",
        "documentation": "Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP)."
       }
      }
     },
     "auth_ref": [
      "r892",
      "r1006"
     ]
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent expenses",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of common stock issuance",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977"
     ]
    },
    "srt_PlatformOperatorCryptoAssetPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "PlatformOperatorCryptoAssetPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Crypto assets",
        "documentation": "Disclosure of accounting policy for safeguarding liability and corresponding asset for crypto-asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r343"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ONMD_PrecentageOfOutstandingCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PrecentageOfOutstandingCommonStock",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Precentage of outstanding common stock",
        "documentation": "Precentage of outstanding common stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockLiquidationPreferenceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockLiquidationPreferenceValue",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidation preference amount",
        "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r401",
      "r413"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r834",
      "r835",
      "r838",
      "r839",
      "r840",
      "r841",
      "r1054",
      "r1058"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r398"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r702"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r398"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r702",
      "r721",
      "r1058",
      "r1059"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022",
        "verboseLabel": "Preferred Stock, par value $0.0001, 1,000,000 and 0 shares authorized at December 31, 2023 and 2022, respectively; no shares issued and outstanding at December 31, 2023 and 2022, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r620",
      "r823"
     ]
    },
    "ONMD_PrefundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PrefundedWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prefunded Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ONMD_PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PrincipalAndAccruedInterestOutstandingOnConvertiblePromissoryNote",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal and accrued interest outstanding",
        "documentation": "Principal and accrued interest outstanding on convertible promissory note."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_PrivatePlacementWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PrivatePlacementWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_PrivateWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PrivateWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Warrants [Member]",
        "documentation": "Private Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ProccedsFromRetainedEarningsAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ProccedsFromRetainedEarningsAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings adjustment",
        "documentation": "Procceds from retained earnings adjustment."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ProceedsFromCanadaEmergencyBusinessLoanAct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ProceedsFromCanadaEmergencyBusinessLoanAct",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Canada Emergency Business Loan Act",
        "documentation": "Proceeds from canada emergency business loan act."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ProceedsFromCommonStockSubjectToRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ProceedsFromCommonStockSubjectToRedemption",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock subject to redemption",
        "documentation": "Proceeds from common stock subject to redemption."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromContributedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromContributedCapital",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of convertible notes",
        "verboseLabel": "Gross proceeds from convertible promissory notes",
        "terseLabel": "Proceeds form convertible notes",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ONMD_ProceedsFromDeferredUnderwritingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ProceedsFromDeferredUnderwritingFee",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting fee",
        "documentation": "Proceeds from deferred under writing fee."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDisposalCryptoAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromDisposalCryptoAsset",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales of Bitcoin",
        "documentation": "Amount of cash inflow from disposal of crypto asset. Excludes crypto asset held for platform user."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of common stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of Series A-2 preferred stock",
        "verboseLabel": "Proceeds",
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from private placements, net of issuance costs",
        "verboseLabel": "Proceeds from issuance of private placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ONMD_ProceedsFromIssuanceOfSeriesA2PreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ProceedsFromIssuanceOfSeriesA2PreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Proceeds from issuance of Series A-2 preferred stock",
        "documentation": "Proceeds from issuance of series A2 preferred stock.",
        "label": "ProceedsFromIssuanceOfSeriesA2PreferredStock"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ProceedsFromIssuanceOfShareholderLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ProceedsFromIssuanceOfShareholderLoans",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of shareholder loans",
        "verboseLabel": "Shareholder loans outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfUnsecuredDebt",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from loans",
        "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from equity financing",
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r663"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from line of credit borrowings",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r895"
     ]
    },
    "us-gaap_ProceedsFromLoans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLoans",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans payable",
        "verboseLabel": "Gross proceeds from related party loans",
        "documentation": "Cash received from principal payments made on loans related to operating activities."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of pipe notes",
        "verboseLabel": "Proceeds from PIPE notes payable",
        "terseLabel": "Proceeds from issuance of PIPE notes",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of Yorkville Note, net of issuance costs",
        "verboseLabel": "Related party proceeds",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from exercise of stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r20"
     ]
    },
    "ONMD_ProceedsFromWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ProceedsFromWarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Warrant liability",
        "documentation": "Proceeds from warrant liability.",
        "label": "ProceedsFromWarrantLiability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r272",
      "r608",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r780",
      "r799",
      "r825",
      "r827",
      "r828",
      "r830",
      "r832",
      "r885",
      "r946",
      "r947",
      "r951",
      "r1024",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r272",
      "r608",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r780",
      "r799",
      "r825",
      "r827",
      "r828",
      "r830",
      "r832",
      "r885",
      "r946",
      "r947",
      "r951",
      "r1024",
      "r1026",
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r562"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r166",
      "r169",
      "r170"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total property and equipment",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r196",
      "r628"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r562",
      "r612",
      "r628",
      "r823"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r166",
      "r169",
      "r626"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://onemednet.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r562"
     ]
    },
    "ONMD_PublicWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "PublicWarrantsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r187",
      "r188",
      "r353",
      "r354",
      "r355",
      "r356",
      "r417",
      "r425",
      "r454",
      "r455",
      "r456",
      "r464",
      "r529",
      "r582",
      "r591",
      "r607",
      "r642",
      "r644",
      "r656",
      "r692",
      "r693",
      "r755",
      "r756",
      "r757",
      "r758",
      "r766",
      "r775",
      "r776",
      "r791",
      "r798",
      "r806",
      "r814",
      "r815",
      "r819",
      "r820",
      "r827",
      "r836",
      "r944",
      "r950",
      "r994",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfFairValueOfStockOptionsDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r187",
      "r188",
      "r353",
      "r354",
      "r355",
      "r356",
      "r417",
      "r425",
      "r454",
      "r455",
      "r456",
      "r464",
      "r529",
      "r582",
      "r591",
      "r607",
      "r642",
      "r644",
      "r656",
      "r692",
      "r693",
      "r755",
      "r756",
      "r757",
      "r758",
      "r766",
      "r775",
      "r776",
      "r791",
      "r798",
      "r806",
      "r814",
      "r815",
      "r819",
      "r820",
      "r827",
      "r836",
      "r944",
      "r950",
      "r994",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017"
     ]
    },
    "ONMD_RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "RecentlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently adopted accounting pronouncements",
        "documentation": "Recently Adopted Accounting Pronouncements Policy [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_ReclassificationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ReclassificationAdjustmentMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification Adjustment [Member]",
        "documentation": "Reclassification Adjustment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r424",
      "r568",
      "r569",
      "r617",
      "r625",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r720",
      "r722",
      "r754"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r223",
      "r224",
      "r568",
      "r569",
      "r570",
      "r571",
      "r617",
      "r625",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r720",
      "r722",
      "r754"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r727",
      "r728",
      "r731"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r424",
      "r568",
      "r569",
      "r617",
      "r625",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r720",
      "r722",
      "r754",
      "r1009"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r569",
      "r572",
      "r669",
      "r670",
      "r671",
      "r729",
      "r730",
      "r731",
      "r751",
      "r753"
     ]
    },
    "ONMD_RepaymentForCommonStockRepurchase": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "RepaymentForCommonStockRepurchase",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment for common stock repurchase",
        "documentation": "Repayment for common stock repurchase.",
        "label": "RepaymentForCommonStockRepurchase"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_RepaymentOfDeferredUnderwriterFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "RepaymentOfDeferredUnderwriterFees",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of deferred underwriter fees",
        "documentation": "Repayment of deferred underwriter fees.",
        "label": "RepaymentOfDeferredUnderwriterFees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfBankDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfBankDebt",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of CEBA loan",
        "label": "Repayments of Bank Debt",
        "documentation": "The cash outflow to settle a bank borrowing during the year."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of line of credit borrowings",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r895"
     ]
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of shareholder loan",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r666"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r466",
      "r777",
      "r789",
      "r1018"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "ONMD_RestatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "RestatedMember",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restated [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementAxis",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r190",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r257",
      "r309",
      "r310",
      "r499",
      "r500",
      "r501",
      "r502",
      "r505",
      "r506",
      "r520",
      "r521",
      "r522",
      "r523",
      "r557",
      "r559",
      "r563",
      "r564",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r660",
      "r913"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RestatementDomain",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r190",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r257",
      "r309",
      "r310",
      "r499",
      "r500",
      "r501",
      "r502",
      "r505",
      "r506",
      "r520",
      "r521",
      "r522",
      "r523",
      "r557",
      "r559",
      "r563",
      "r564",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r660",
      "r913"
     ]
    },
    "ONMD_RestatementToFinancialStatementsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "RestatementToFinancialStatementsPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement to Previously Issued Consolidated Financial Statements",
        "documentation": "Restatement to financial statements [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      },
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/DescriptionOfBusinessDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated defecit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r131",
      "r623",
      "r650",
      "r655",
      "r667",
      "r703",
      "r823"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r189",
      "r227",
      "r228",
      "r229",
      "r231",
      "r237",
      "r240",
      "r242",
      "r308",
      "r311",
      "r341",
      "r490",
      "r491",
      "r498",
      "r499",
      "r500",
      "r502",
      "r505",
      "r506",
      "r512",
      "r514",
      "r515",
      "r517",
      "r521",
      "r558",
      "r560",
      "r646",
      "r648",
      "r672",
      "r1058"
     ]
    },
    "ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "RetroactiveApplicationOfRecapitalizationDueToBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retroactive application of recapitalization due to the Business Combination",
        "verboseLabel": "Retroactive application of recapitalization due to Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "RetroactiveApplicationOfRecapitalizationDueToBusinessCombinationShares",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retroactive application of recapitalization due to the Business Combination, shares",
        "verboseLabel": "Retroactive application of recapitalization due to Business Combination, shares",
        "documentation": "Retroactive application of recapitalization due to business combination shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Web imaging revenue",
        "totalLabel": "Total revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r156",
      "r258",
      "r263",
      "r264",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r415",
      "r416",
      "r608"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r868"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r725",
      "r779",
      "r785"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RevisionOfPriorPeriodReclassificationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RevisionOfPriorPeriodReclassificationAdjustmentMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Reclassification, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) to previously issued financial statements for reclassification. Excludes adjustment for reclassification from amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r913"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock, value",
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issue and sold",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock percentage",
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock price per share",
        "verboseLabel": "Price per share",
        "terseLabel": "Sale of share price",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r883",
      "r905"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r227",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r242",
      "r257",
      "r499",
      "r501",
      "r502",
      "r505",
      "r506",
      "r520",
      "r521",
      "r522",
      "r557",
      "r559",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r660",
      "r870",
      "r871",
      "r872",
      "r873",
      "r904",
      "r913",
      "r924",
      "r925",
      "r989",
      "r1004",
      "r1005"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r243",
      "r426",
      "r866",
      "r905"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://onemednet.com/role/NetLossPerShareTables",
      "http://onemednet.com/role/SubsequentEventsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/BusinessCombinationTables",
      "http://onemednet.com/role/ScheduleOfBusinessCombinationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62",
      "r503"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Combination Liabilities",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r62"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income Tax Provision",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r985"
     ]
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Shareholder Loans Outstanding",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock-based Compensation Expense",
        "documentation": "Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r54",
      "r56",
      "r132"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r983"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Income Tax Benefit",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r809",
      "r980"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Aggregate Percentage Revenue and Accounts Receivable",
        "documentation": "Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32"
     ]
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, off-Balance-Sheet Risk [Table]",
        "documentation": "Disclosure of information about fair value of financial asset and liability not recognized in financial statement because of failure to meet criterion for recognition."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r142"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income (Loss) Before Provision for Income Tax",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAggregatePercentageRevenueAndAccountsReceivableDetails",
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operation, Product Information, Concentration of Risk [Table]",
        "documentation": "Disclosure of information about concentration risk of product within nature of operation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r562"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r727",
      "r728",
      "r731"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Options Outstanding",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r134"
     ]
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Restricted Stock Award Activity",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warrants Outstanding",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Aggregate Percentage Revenue and Accounts Receivable",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r72",
      "r143"
     ]
    },
    "ONMD_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfStock-basedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r979"
     ]
    },
    "ONMD_SeptemberTwoThousandTwentyFourFinancingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "SeptemberTwoThousandTwentyFourFinancingMember",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "September Two Thousand Twenty Four Financing [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_SeriesAOnePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "SeriesAOnePreferredStockMember",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A-1 Preferred Stock [Member]",
        "documentation": "Series A One Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_SeriesATwoPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "SeriesATwoPreferredStockMember",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A-2 Preferred Stock [Member]",
        "documentation": "Series A Two Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment award, description",
        "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r57"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Awards, Granted",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Grant Date Fair Value,Granted",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of RSU's, Outstanding, Beginning",
        "periodEndLabel": "Number of Awards Outstanding, Ending",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Grant Date Fair Value, Beginning",
        "periodEndLabel": "Weighted Average Grant Date Fair Value, Ending",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r443",
      "r444"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Awards,Vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Grant Date Fair Value,Vested",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants outstanding",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units issued",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercisable",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted average exercise price, vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options, cancelled",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, cancelled",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options, Granted - under the Plan",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Aggregate Intrinsic value, begining balance",
        "periodEndLabel": "Aggregate Intrinsic value, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options outstanding",
        "periodStartLabel": "Options outstanding, beginning balance",
        "periodEndLabel": "Options outstanding, ending balance",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average exercise price, beginning balance",
        "periodEndLabel": "Weighted average exercise price, ending balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Options vested and exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options vested",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options vested exercise price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestrictedStockAwardActivityDetails",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price, granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r439"
     ]
    },
    "ONMD_ShareOutstandingVotingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ShareOutstandingVotingPercentage",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares outstanding voting percentage",
        "documentation": "Share outstanding voting percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "verboseLabel": "Share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic value, exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of stock awards vested",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "ONMD_ShareholderLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ShareholderLoansMember",
     "presentation": [
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Loans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "verboseLabel": "Share issued price",
        "terseLabel": "Share issued price per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan \u2013 related party",
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r145",
      "r823",
      "r1020"
     ]
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessAccountCebaDetailsNarrative",
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTextBlock",
     "presentation": [
      "http://onemednet.com/role/LineOfCredit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit",
        "documentation": "The entire disclosure for short-term debt."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeAxis",
     "presentation": [
      "http://onemednet.com/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt, Type [Axis]",
        "documentation": "Information by type of short-term debt arrangement."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r941",
      "r942",
      "r943"
     ]
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtTypeDomain",
     "presentation": [
      "http://onemednet.com/role/LineOfCreditDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r941",
      "r942",
      "r943"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r216"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ONMD_StandbyEquityPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StandbyEquityPurchaseAgreementMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standby Equity Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r200",
      "r201",
      "r202",
      "r220",
      "r247",
      "r248",
      "r250",
      "r252",
      "r260",
      "r261",
      "r307",
      "r359",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r398",
      "r399",
      "r401",
      "r404",
      "r411",
      "r546",
      "r663",
      "r664",
      "r665",
      "r666",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r684",
      "r702",
      "r724",
      "r746",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r865",
      "r894",
      "r907"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r96",
      "r99",
      "r100",
      "r189",
      "r210",
      "r211",
      "r212",
      "r227",
      "r228",
      "r229",
      "r231",
      "r237",
      "r240",
      "r242",
      "r259",
      "r308",
      "r311",
      "r341",
      "r414",
      "r490",
      "r491",
      "r498",
      "r499",
      "r500",
      "r502",
      "r505",
      "r506",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r521",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r558",
      "r560",
      "r564",
      "r631",
      "r646",
      "r647",
      "r648",
      "r672",
      "r746"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StatementsOfOperations",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r259",
      "r560",
      "r608",
      "r661",
      "r684",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r702",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r711",
      "r712",
      "r713",
      "r714",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r722",
      "r725",
      "r726",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r746",
      "r837"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "verboseLabel": "Schedule of Aggregate Percentage Revenue and Accounts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Aggregate Percentage Revenue and Accounts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Aggregate Percentage Revenue and Accounts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r243",
      "r426",
      "r866",
      "r867",
      "r905"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StatementsOfOperations",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r259",
      "r275",
      "r560",
      "r608",
      "r661",
      "r684",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r702",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r711",
      "r712",
      "r713",
      "r714",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r722",
      "r725",
      "r726",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r746",
      "r837"
     ]
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of OMN warrants in conjunction with convertible promissory notes",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common shares issued to preferred shareholders",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants to acquire common stock",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r131"
     ]
    },
    "ONMD_StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleLoansUponBusinessCombination",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of OMN convertible loans upon Business Combination, shares",
        "documentation": "Stock issued during period shares conversion of convertible loans upon business combination."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertiblePromissoryNotesUponBusinessCombination",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of OMN convertible promissory notes upon Business Combination, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock issued during period shares conversion of convertible securities",
        "verboseLabel": "Conversion of convertible securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r50",
      "r96",
      "r99",
      "r131",
      "r385"
     ]
    },
    "ONMD_StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesConversionOfPreferredStockToCommonStockUponBusinessCombination",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of preferred stock to common stock upon Business Combination, shares",
        "documentation": "Stock issued during period shares conversion of preferred stock to common stock upon business combination."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommonStockToSettleCommitmentFee",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock to settle Yorkville commitment fee, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfLegacySeriesATwoPreferredStock",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Legacy ONMD Series A-2 Preferred Stock, shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common shares in exchange for services, shares",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series A-2 Preferred Stock. shares",
        "verboseLabel": "Number of shares, issued",
        "terseLabel": "Options vested",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r96",
      "r131",
      "r663",
      "r746",
      "r768"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private OneMedNet to ONMD Public Shares, shares",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock units, shares",
        "verboseLabel": "Number of restricted stock units granted",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r131"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted stock units",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r96",
      "r131"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOptionsOutstandingDetails",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of OMN stock options upon Business Combination, shares",
        "verboseLabel": "Exercise of stock options, shares",
        "terseLabel": "Shares exerciseable",
        "negatedLabel": "Options, Exercised - under the Plan",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r96",
      "r131",
      "r440"
     ]
    },
    "ONMD_StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise of OMN stock options upon Business Combination, shares",
        "documentation": "Stock issued during period shares stock options exercised upon business combination.",
        "label": "StockIssuedDuringPeriodSharesStockOptionsExercisedUponBusinessCombination"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs, shares",
        "documentation": "Stock issued during period shares stock options upon business combination with net of liabilities assumed and transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodSharesTransferred": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesTransferred",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares transferred",
        "documentation": "Stock issued during period shares transferred."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of OMN warrants upon Business Combination, shares"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleLoansUponBusinessCombination",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of OMN convertible loans upon Business Combination",
        "documentation": "Stock issued during period value conversion of convertible loans upon business combination."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertiblePromissoryNotesUponBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of OMN convertible promissory notes upon Business Combination",
        "documentation": "Stock issued during period value conversion of convertible promissory notes upon business combination."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueConversionOfPreferredStockToCommonStockUponBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of preferred stock to common stock upon Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockAndPrefundedWarrantsInConnectionWithPrivatePlacementsNetOfIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock and pre-funded warrants in connection with private placements, net of issuance costs"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommonStockToSettleCommitmentFee",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock to settle Yorkville commitment fee",
        "documentation": "Stock issued during period value issuance of common stock to settle commitment fee."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfLegacySeriesATwoPreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Legacy ONMD Series A-2 Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfWarrantsToBoardOfDirectors",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of OMN warrants to board of directors",
        "documentation": "Stock issued during period value issuance of warrants to board of directors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common shares in exchange for services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Series A-2 Preferred Stock",
        "verboseLabel": "Number of shares issued, value",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r96",
      "r131",
      "r672",
      "r746",
      "r768",
      "r843"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private OneMedNet to ONMD Public Shares",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting of restricted stock units",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r96",
      "r131"
     ]
    },
    "ONMD_StockIssuedDuringPeriodValueRetainedEarningsAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueRetainedEarningsAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Retained earnings adjustment",
        "documentation": "Stock issued during period value retained earnings adjustment.",
        "label": "StockIssuedDuringPeriodValueRetainedEarningsAdjustment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of OMN stock options upon Business Combination",
        "verboseLabel": "Exercise of stock options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r96",
      "r99",
      "r100",
      "r131"
     ]
    },
    "ONMD_StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise of OMN stock options upon Business Combination",
        "documentation": "Stock issued during period value stock options exercised upon business combination.",
        "label": "StockIssuedDuringPeriodValueStockOptionsExercisedUponBusinessCombination"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueStockOptionsUponBusinessCombinationWithNetOfLiabilitiesAssumedAndTransactionCosts",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock upon Business Combination with Data Knights, net of liabilities assumed and transaction costs",
        "documentation": "Stock issued during period value stock options upon business combination with net of liabilities assumed and transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockIssuedDuringPeriodValueWarrantsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of OMN warrants upon Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockOptionPlanExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionPlanExpense",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock warrant expense",
        "documentation": "Amount of noncash expense for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ONMD_StockRepurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockRepurchaseAgreementMember",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase of common stock, shares",
        "verboseLabel": "Number of shares repurchased",
        "terseLabel": "Bought back shares of Common Stock",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r96",
      "r131",
      "r666",
      "r746",
      "r770"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of common stock",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r95",
      "r96",
      "r131",
      "r672",
      "r746",
      "r770",
      "r843"
     ]
    },
    "ONMD_StockRepurchasedDuringPeriodValueExchangeForCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockRepurchasedDuringPeriodValueExchangeForCash",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares repurchased, value exchange for cash",
        "documentation": "Stock repurchased during period value exchange for cash."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockWarrantExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockWarrantExpense",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock warrant expense",
        "label": "StockWarrantExpense"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockWarrantExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockWarrantExpenses",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock warrant expense",
        "documentation": "Stock warrant expenses.",
        "label": "StockWarrantExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockWarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockWarrantsDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/StockWarrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock Warrants",
        "documentation": "Stock warrants disclosure text block.",
        "label": "StockWarrantsDisclosureTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_StockholdersDeficitDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "StockholdersDeficitDescription",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders deficit description",
        "documentation": "Stockholders deficit description."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 deficit",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r99",
      "r100",
      "r119",
      "r704",
      "r721",
      "r747",
      "r748",
      "r823",
      "r844",
      "r896",
      "r923",
      "r1001",
      "r1058"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 (deficit) equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Deficit",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r219",
      "r397",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r414",
      "r519",
      "r749",
      "r752",
      "r772"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury stock",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r750"
     ]
    },
    "ONMD_SubscriptionRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "SubscriptionRevenueMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r574"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r574"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r574"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r574"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r574"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://onemednet.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r573",
      "r575"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental disclosures of non-cash investing and financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityAbstract",
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      },
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total temporary equity",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r361",
      "r362",
      "r363",
      "r366",
      "r367",
      "r462",
      "r622"
     ]
    },
    "us-gaap_TemporaryEquityLiquidationPreferencePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLiquidationPreferencePerShare",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporaray equity liquidation preference per share",
        "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_TemporaryEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "TemporaryEquityMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfChangesInTemporaryEquityAndStockholdersDeficitDetails",
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, par value per share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r48"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical",
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetailsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary equity, shares outstanding",
        "verboseLabel": "Temporary equity shares outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ONMD_ThreeCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "ThreeCustomersMember",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Customers [Member]",
        "documentation": "Three Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r914",
      "r1008"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/Stock-basedCompensationDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable and Allowance for Credit Losses",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r916",
      "r917",
      "r918"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://onemednet.com/role/CanadianEmergencyBusinessLoanActCebaDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndPromissoryNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r393",
      "r409",
      "r518",
      "r544",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r632",
      "r810",
      "r812",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r824",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r919",
      "r920",
      "r921",
      "r922",
      "r990",
      "r993",
      "r994",
      "r995",
      "r998",
      "r1000"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://onemednet.com/role/StatementsOfChangesInTemporaryEquityAndStockholdersDeficit",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://onemednet.com/role/BalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury stock, shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 187,745 and 0 shares at September 30, 2024 and December 31, 2023, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r99"
     ]
    },
    "ONMD_TwentyTwentyOneServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "TwentyTwentyOneServiceMember",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2021 Service [Member]",
        "documentation": "Twenty Twenty One Service [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_TwentyTwentyThreeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "TwentyTwentyThreeNotesMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twenty Twenty Three Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "TwentyTwentyTwoNotesAndTwentyTwentyThreeNotesMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twenty Twenty Two Notes And Twenty Twenty Three Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_TwentyTwentyTwoNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "TwentyTwentyTwoNotesMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twenty Twenty Two Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_TwentyTwentyTwoServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "TwentyTwentyTwoServiceMember",
     "presentation": [
      "http://onemednet.com/role/StockWarrantsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2022 Service [Member]",
        "documentation": "Twenty Twenty Two Service [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_TwoCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "TwoCustomersMember",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Customers [Member]",
        "documentation": "Two Customers [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r507"
     ]
    },
    "ONMD_UnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "UnrealizedGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unrealized gain or loss",
        "documentation": "Unrealized gain loss.",
        "label": "UnrealizedGainLoss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Canada Emergency Business Loan Act",
        "label": "Unsecured Debt, Current",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term, uncollateralized debt obligations due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r145"
     ]
    },
    "ONMD_UnvestedRestrictedStockUnitsAndAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "UnvestedRestrictedStockUnitsAndAwardsMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested Restricted Stock Units And Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r164",
      "r165",
      "r167",
      "r168"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets valuation allowance",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ONMD_VolumeWeightedAveragePrice": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "VolumeWeightedAveragePrice",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volume weighted average price",
        "documentation": "Volume weighted average price."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_VolumeWeightedAveragePriceValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "VolumeWeightedAveragePriceValue",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Volume weighted average price, value",
        "documentation": "Volume weighted average price value."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_WarrantExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "WarrantExpense",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://onemednet.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfCashFlowsDetails",
      "http://onemednet.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Board of director warrant expense",
        "label": "Board of director warrant expense",
        "documentation": "Warrant expense."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_WarrantLiabilityNonCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "WarrantLiabilityNonCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant liabilities",
        "documentation": "Warrant liability non current."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://onemednet.com/role/BusinessCombinationDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfDilutedNetLossDetails",
      "http://onemednet.com/role/StockWarrantsDetailsNarrative",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r834",
      "r835",
      "r838",
      "r839",
      "r840",
      "r841"
     ]
    },
    "ONMD_WarrantPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "WarrantPolicyTextBlock",
     "presentation": [
      "http://onemednet.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants",
        "documentation": "Warrant [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants outstanding",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants measurement input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfFairValueAssumptionsAndValuationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected term (in years)",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r993",
      "r994",
      "r995"
     ]
    },
    "ONMD_WebImagingRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "WebImagingRevenueMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Web Imaging Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted weighted average number of common shares outstanding",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r252"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfOriginalAndRestatedStatementOfOperationsDetails",
      "http://onemednet.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic weighted average number of common shares outstanding",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r252"
     ]
    },
    "ONMD_WorkingCapitalLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "WorkingCapitalLoan",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/ScheduleOfRestatementOfBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital loan",
        "documentation": "Working capital loan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://onemednet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "ONMD_YorkvilleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "YorkvilleNoteMember",
     "presentation": [
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative",
      "http://onemednet.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails",
      "http://onemednet.com/role/StockholdersDeficitDetailsNarrative",
      "http://onemednet.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_YorkvilleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "YorkvilleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://onemednet.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://onemednet.com/role/BalanceSheets",
      "http://onemednet.com/role/ConvertibleDebtDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Note",
        "verboseLabel": "Fair value of Yorkville Note",
        "documentation": "Yorkville notes payable current."
       }
      }
     },
     "auth_ref": []
    },
    "ONMD_YorkvilleStandbyEquityPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://onemednet.com/20240930",
     "localname": "YorkvilleStandbyEquityPurchaseAgreementMember",
     "presentation": [
      "http://onemednet.com/role/ScheduleOfWarrantsAndNotesMeasuredAtFairValueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yorkville Standby Equity Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481766/480-10-25-13"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480463/815-10-45-5"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482943/710-10-55-8"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-15"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483043/710-10-30-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "25",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480238/815-25-50-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "M",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "FF",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-4"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.FF.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476188/405-10-S99-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-14"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-9"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "11",
   "Subsection": "03",
   "Publisher": "SEC"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "6",
   "Subsection": "04",
   "Paragraph": "12",
   "Subparagraph": "(b)(1)",
   "Publisher": "SEC"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-12"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476167/350-60-45-2"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-3"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-4"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476168/350-60-50-6"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
